Citrus Sinensis ID: 008171
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 575 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.462 | 0.682 | 0.450 | 3e-70 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.450 | 0.282 | 0.442 | 9e-65 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.453 | 0.406 | 0.434 | 6e-60 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.497 | 0.348 | 0.406 | 3e-59 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.453 | 0.378 | 0.426 | 8e-59 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.467 | 0.288 | 0.419 | 9e-58 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.466 | 0.208 | 0.411 | 1e-56 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.460 | 0.163 | 0.407 | 5e-55 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.48 | 0.166 | 0.399 | 8e-55 | |
| P18161 | 1155 | Dual specificity protein | no | no | 0.446 | 0.222 | 0.395 | 1e-52 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 266 bits (680), Expect = 3e-70, Method: Compositional matrix adjust.
Identities = 122/271 (45%), Positives = 183/271 (67%), Gaps = 5/271 (1%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK----PERINSDMQKEFAQEVFI 342
W D L G+K ASG++ +YRG Y + VA+K+++ E + ++++F EV +
Sbjct: 79 WTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEVAL 138
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSK 401
+ ++ H N+VQFI AC KPP CI+TE+MS G++ YL+K + + ++L++A+D+S+
Sbjct: 139 LSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISR 198
Query: 402 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 461
GM YLH +IHRDLK+ NLL+++ VKVADFG + ++ Q GTYRWMAPE+I
Sbjct: 199 GMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQCREAKGNMGTYRWMAPEMI 258
Query: 462 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521
+ KPY K DV+SFGIVLWEL T LP++ +TP+QAA V +K RP +P + QP LA L
Sbjct: 259 KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQPALAHL 318
Query: 522 LERCWQQDPALRPDFSEIIEILQQIAKEVGE 552
++RCW ++P+ RPDFS I+ +L++ + V E
Sbjct: 319 IKRCWSENPSKRPDFSNIVAVLEKYDECVKE 349
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 248 bits (633), Expect = 9e-65, Method: Compositional matrix adjust.
Identities = 115/260 (44%), Positives = 175/260 (67%), Gaps = 1/260 (0%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEVFIMRKV 346
EI LK SK+ G++G +Y+G + VAIK +K E +N+ + +EF +E+ I+ ++
Sbjct: 656 EISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSRL 715
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
RH N+V + ACT PP+LC +TE++ GGS+YD LH K + K+AI +++GMNYL
Sbjct: 716 RHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMNYL 775
Query: 407 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 466
H + +IHRD+K+ NLL+DE+ VK+ DFG++++K++S MT G+ WM+PE++ + Y
Sbjct: 776 HLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIGSPIWMSPELLMGEDY 835
Query: 467 DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 526
K DV++FGI+LWEL TG+LPY L +Q A+ V K LRP IP +L+ L++ CW
Sbjct: 836 TEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACW 895
Query: 527 QQDPALRPDFSEIIEILQQI 546
QDP RP F+EI+ +L +I
Sbjct: 896 HQDPLKRPSFTEILNLLNEI 915
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 232 bits (591), Expect = 6e-60, Method: Compositional matrix adjust.
Identities = 116/267 (43%), Positives = 169/267 (63%), Gaps = 6/267 (2%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 341
DG D ID +K G ++ G+YG++Y GT+ VA+K L IN ++ KEF +E+
Sbjct: 365 DGKD---IDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 421
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
+M+ +RH NV+QF+G+C PP +CI TE+M GS+Y LH + L+K+ ID +K
Sbjct: 422 LMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAK 481
Query: 402 GMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 459
G+ YLH + I+HRDLK+ NLL+DEN VKVADFG++ ++ Q MTA GT W +PE
Sbjct: 482 GVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPE 540
Query: 460 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 519
V+ + Y KADV+SFGI+LWE T + PY + P Q V ++G+RP +P+N PK
Sbjct: 541 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKYI 600
Query: 520 ELLERCWQQDPALRPDFSEIIEILQQI 546
+LL C ++P+ RP + +E L+ I
Sbjct: 601 QLLIDCLNENPSHRPTMEQCLERLESI 627
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 230 bits (586), Expect = 3e-59, Method: Compositional matrix adjust.
Identities = 122/300 (40%), Positives = 187/300 (62%), Gaps = 14/300 (4%)
Query: 262 TSEPEDTGMKSHPYHLKIPN--------DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 313
+++ E M + P +PN DG D+ +I L K+ +GS+G ++R +
Sbjct: 512 SNQIEAAPMNAPPISQPVPNRANRELGLDGDDM-DIPWCDLNIKEKIGAGSFGTVHRAEW 570
Query: 314 CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373
DVA+K+L + +++ EF +EV IM+++RH N+V F+GA T+PP+L IVTE++S
Sbjct: 571 HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 630
Query: 374 GSVYDYLHKLKGVFKLPSL--LKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVV 429
GS+Y LHK +L L +A DV+KGMNYLH N I+HRDLK+ NLL+D+ V
Sbjct: 631 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTV 690
Query: 430 KVADFGVARVKAQSGVMT-AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 488
KV DFG++R+KA + + + + GT WMAPEV+ +P + K+DV+SFG++LWEL T + P
Sbjct: 691 KVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 750
Query: 489 YEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548
+ L P Q V K R IP+N P++A ++E CW +P RP F+ I+++L+ + K
Sbjct: 751 WGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 810
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 228 bits (582), Expect = 8e-59, Method: Compositional matrix adjust.
Identities = 114/267 (42%), Positives = 168/267 (62%), Gaps = 6/267 (2%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 341
DG D ID + +K G ++ G++G++Y GT+ VA+K L IN ++ KEF +E+
Sbjct: 382 DGKD---IDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 438
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
+M+ +RH NV+QF+G+C P +CI TE+M GS+Y LH K + ++ ID +K
Sbjct: 439 LMKNLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAK 498
Query: 402 GMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 459
G+ YLH + I+HRDLK+ NLL+DEN VKVADFG++ ++ Q MTA GT W +PE
Sbjct: 499 GIIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPE 557
Query: 460 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 519
V+ + Y KADV+SFGI+LWE T + PY + P Q V ++G+RP PK PK
Sbjct: 558 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYI 617
Query: 520 ELLERCWQQDPALRPDFSEIIEILQQI 546
+LL+ C ++P+ RP + +EIL+ I
Sbjct: 618 QLLKDCLNENPSQRPTMEQCLEILESI 644
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 225 bits (573), Expect = 9e-58, Method: Compositional matrix adjust.
Identities = 115/274 (41%), Positives = 167/274 (60%), Gaps = 5/274 (1%)
Query: 282 DGTDV--WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQE 339
D DV EI L ++ GSYG++Y + +VA+K + + EF E
Sbjct: 655 DDADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSE 714
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
V IMR++RH NVV F+GA T+PP+L IVTEF+ GS+Y LH+ K +K+A+DV
Sbjct: 715 VRIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDV 774
Query: 400 SKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET-GTYRWM 456
+ GMN LH + I+HRDLK NLL+D N VKV DFG++R+K + + + T GT WM
Sbjct: 775 AMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWM 834
Query: 457 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 516
APEV+ ++P + K DV+SFG++LWEL T +LP+ + P+Q V + R IPK P
Sbjct: 835 APEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDP 894
Query: 517 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550
+ ++ CWQ DP LRP F+++ E+L+ + + V
Sbjct: 895 VVGRIILECWQTDPNLRPSFAQLTEVLKPLNRLV 928
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (563), Expect = 1e-56, Method: Compositional matrix adjust.
Identities = 112/272 (41%), Positives = 167/272 (61%), Gaps = 4/272 (1%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
WE+ + G+++ G YG ++RG++ +VA+K+L + +N + + +EV ++ K+
Sbjct: 844 WEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRKEVDLLCKL 903
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
RH N+V F+GACT+P S CIVTE++S GS+ + L L++ D ++GM YL
Sbjct: 904 RHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTYL 963
Query: 407 HQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 464
H N IIHRDLK NLL+D++ VKVADFG+A VK+ + T GT W+APEV+ +
Sbjct: 964 HSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTFAKTM-CGTTGWVAPEVLAEE 1022
Query: 465 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524
Y KADV+S+ IVLWELLT +PY +Q V + +G R +P PK A L+ R
Sbjct: 1023 GYTEKADVYSYAIVLWELLTRLIPYAGKNTMQ-VVRSIDRGERLPMPAWCPPKYAALMNR 1081
Query: 525 CWQQDPALRPDFSEIIEILQQIAKEVGEENEE 556
CW+ DP RP F EI+ I++ + E +E +E
Sbjct: 1082 CWETDPTHRPSFPEILPIMEGMISEFQKEKKE 1113
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 216 bits (549), Expect = 5e-55, Method: Compositional matrix adjust.
Identities = 113/277 (40%), Positives = 173/277 (62%), Gaps = 12/277 (4%)
Query: 281 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEV 340
N + WEID L+ G + +G YG++Y+ + +VA+K++ + ++ DM++ F +EV
Sbjct: 773 NTTNNDWEIDFSELEIGETLGTGGYGEVYKSIWKGTEVAVKLISSKHVSKDMERSFFEEV 832
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV--AID 398
IM +RH NVV F+ A TK P++CIV EFMS GS+YD L + + ++P LK+ A
Sbjct: 833 KIMTSLRHPNVVLFMAASTKSPNMCIVMEFMSLGSLYDLLGN-ELIPEIPYALKIKMAYQ 891
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE---TGTYRW 455
SKGM++LH + I+HRDLK+ NLL+D VKV+DFG+ +VK++ GT W
Sbjct: 892 ASKGMHFLHSSGIVHRDLKSLNLLLDSKWNVKVSDFGLTKVKSELDKKKTNDNIIGTIHW 951
Query: 456 MAPEVI-EHKPYDH-KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN 513
+APE++ + D+ ADV+SFGI+LWELLT + PY+ +TP AV V++ G+RP I
Sbjct: 952 IAPEILNDSTEVDYILADVYSFGIILWELLTREQPYKGMTPAAIAVSVIRDGMRPPISDE 1011
Query: 514 S----QPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
+ + +L+++CW D +RP F EI+ L I
Sbjct: 1012 AVTAHSIEYIDLIKQCWHSDTIIRPTFLEIMTRLSNI 1048
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 215 bits (547), Expect = 8e-55, Method: Compositional matrix adjust.
Identities = 115/288 (39%), Positives = 178/288 (61%), Gaps = 12/288 (4%)
Query: 275 YHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPER-INSDMQ 333
+ L+ +D WEID L+ G ++ +G++G++++GT+ +VA+K++ P++ I D++
Sbjct: 767 FSLRFRKGISDDWEIDFHELELGEQLGTGAFGEVHKGTWRGTEVAVKMISPDKTITKDIE 826
Query: 334 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+ F EV +M +RH NVV F+ A TKPP +CIV EFM+ GS++D L K + + +P L
Sbjct: 827 RNFKDEVRVMTTLRHPNVVLFMAASTKPPKMCIVMEFMALGSLHDLL-KNELIPDIPFAL 885
Query: 394 KVAI--DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-- 449
KV I SKGM++LH + I HRDLK+ NLL+D VKV+DFG+ + K+ + E
Sbjct: 886 KVKIAYQASKGMHFLHSSGITHRDLKSLNLLLDIKWNVKVSDFGLTKFKSDVKSINPEKF 945
Query: 450 TGTYRWMAPEVI-EHKPYDH-KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 507
GT +W APE++ E + D+ +DV+SFGI++WEL+T PY ++P AV V++ R
Sbjct: 946 AGTIQWTAPEILSEDREVDYILSDVYSFGIIMWELITRDQPYFGMSPAAIAVSVIRDNYR 1005
Query: 508 PTIPKNSQ----PKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551
P I + P+ ELL CW DP +RP F EI+ L + + G
Sbjct: 1006 PVISDQLRSEVAPEYIELLTSCWHFDPTIRPTFLEIMTRLSNLMGDSG 1053
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18161|SPLB_DICDI Dual specificity protein kinase splB OS=Dictyostelium discoideum GN=splB PE=2 SV=2 | Back alignment and function description |
|---|
Score = 207 bits (528), Expect = 1e-52, Method: Compositional matrix adjust.
Identities = 106/268 (39%), Positives = 164/268 (61%), Gaps = 11/268 (4%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 348
ID ++F KV G++ +++ G + VAIK LK ++ F +EV ++K H
Sbjct: 848 IDINDIQFIQKVGEGAFSEVWEGWWKGIHVAIKKLKIIGDEEQFKERFIREVQNLKKGNH 907
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-----KGVFKLPSLLKVAIDVSKGM 403
+N+V FIGAC KP CI+TE+M+GGS+Y+ LH K + P +LK+A D++ G+
Sbjct: 908 QNIVMFIGACYKPA--CIITEYMAGGSLYNILHNPNSSTPKVKYSFPLVLKMATDMALGL 965
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEV 460
+LH I+HRDL + N+L+DE +K++DFG++R K++ G MT G RW PE+
Sbjct: 966 LHLHSITIVHRDLTSQNILLDELGNIKISDFGLSREKSREGSMTMTNGGICNPRWRPPEL 1025
Query: 461 IEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 519
++ Y K DV+ F +V+WE+LTG++P+ L QA+ V GLRP IP+ P+L
Sbjct: 1026 TKNLGHYSEKVDVYCFSLVVWEILTGEIPFSDLDGSQASAQVAYAGLRPPIPEYCDPELK 1085
Query: 520 ELLERCWQQDPALRPDFSEIIEILQQIA 547
LL +CW+ DP RP F+ I+ L++I+
Sbjct: 1086 LLLTQCWEADPNDRPPFTYIVNKLKEIS 1113
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 575 | ||||||
| 297744550 | 580 | unnamed protein product [Vitis vinifera] | 0.984 | 0.975 | 0.809 | 0.0 | |
| 449454245 | 573 | PREDICTED: protein-tyrosine kinase 2-bet | 0.977 | 0.980 | 0.796 | 0.0 | |
| 359474826 | 1515 | PREDICTED: uncharacterized mscS family p | 0.977 | 0.370 | 0.766 | 0.0 | |
| 255560441 | 558 | protein kinase, putative [Ricinus commun | 0.96 | 0.989 | 0.789 | 0.0 | |
| 283132359 | 578 | ACT-domain-containing protein kinase [Lo | 0.986 | 0.980 | 0.755 | 0.0 | |
| 356574129 | 581 | PREDICTED: uncharacterized protein LOC10 | 0.987 | 0.977 | 0.751 | 0.0 | |
| 357444821 | 771 | Protein kinase like protein [Medicago tr | 0.939 | 0.700 | 0.751 | 0.0 | |
| 357483963 | 574 | Dual specificity protein kinase pyk2 [Me | 0.975 | 0.977 | 0.703 | 0.0 | |
| 18420244 | 575 | ACT-like protein tyrosine kinase family | 0.977 | 0.977 | 0.731 | 0.0 | |
| 224286063 | 594 | unknown [Picea sitchensis] | 0.947 | 0.917 | 0.729 | 0.0 |
| >gi|297744550|emb|CBI37812.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 963 bits (2490), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 477/589 (80%), Positives = 518/589 (87%), Gaps = 23/589 (3%)
Query: 1 MVMEENNNESCGSRASDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRF 60
MVME +NESC SR D+SS + QSRQ RQKL VYNEVL RLK+S+N+EA +P F
Sbjct: 1 MVME--DNESCSSRVHDSSSPA------QSRQQRQKLEVYNEVLRRLKDSDNEEAFEPGF 52
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDR- 119
D+ELW HF RLPTRYALDVNVERAEDVL HKRLLHLAHDP NRPAIEVRLVQVHP+SD
Sbjct: 53 DEELWAHFVRLPTRYALDVNVERAEDVLTHKRLLHLAHDPTNRPAIEVRLVQVHPISDGI 112
Query: 120 NSAVSSLLDSEVP-----------AQRQSIHPPPAFGSSPNLEALAIEANNSH--NLDGD 166
+ ++ + S P + +QSI PPPAFGSSPNLEALAIEANNSH + DGD
Sbjct: 113 HGNIADSIHSNSPTIGPAHGSPKYSSKQSILPPPAFGSSPNLEALAIEANNSHVQDGDGD 172
Query: 167 NSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV 226
+SVHA+ Q+SRPMHEITFS+DDKPKLLSQLT LL+++ LNIQEAHAFSTVDGYSLDVFVV
Sbjct: 173 DSVHASSQYSRPMHEITFSSDDKPKLLSQLTCLLSELELNIQEAHAFSTVDGYSLDVFVV 232
Query: 227 DGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDV 286
DGWPYEETEQLR ALEKEV K+E+Q WP+H S SPT E E+TG+K + IPNDGTDV
Sbjct: 233 DGWPYEETEQLRTALEKEVFKIEKQSWPNHHSLSPTGEQEETGIKCESDFVTIPNDGTDV 292
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
WEID + LKF +KVASGSYGDLY+GTYCSQ+VAIKVLKPER+NSDMQKEFAQEVFIMRKV
Sbjct: 293 WEIDVRQLKFENKVASGSYGDLYKGTYCSQEVAIKVLKPERLNSDMQKEFAQEVFIMRKV 352
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
RHKNVVQFIGACT+PPSL IVTEFMSGGSVYDYLHK KGVFKLP+LLKV+IDVSKGMNYL
Sbjct: 353 RHKNVVQFIGACTRPPSLYIVTEFMSGGSVYDYLHKQKGVFKLPALLKVSIDVSKGMNYL 412
Query: 407 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 466
HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY
Sbjct: 413 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 472
Query: 467 DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 526
DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT+PKN+ PKLAELLERCW
Sbjct: 473 DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTMPKNTHPKLAELLERCW 532
Query: 527 QQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKSSGGFLSVLRRGHH 575
QQDP LRPDFSEIIEILQQIAKEVG+E E+RRKEKSS GFLSVLRRGHH
Sbjct: 533 QQDPTLRPDFSEIIEILQQIAKEVGDE-EDRRKEKSSSGFLSVLRRGHH 580
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454245|ref|XP_004144866.1| PREDICTED: protein-tyrosine kinase 2-beta-like [Cucumis sativus] gi|449528766|ref|XP_004171374.1| PREDICTED: protein-tyrosine kinase 2-beta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 943 bits (2438), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/586 (79%), Positives = 506/586 (86%), Gaps = 24/586 (4%)
Query: 1 MVMEENNNESCGSRASDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRF 60
MVME +NESCGSRA D S + QSRQ RQK VYNEVL RLK+SNN+EAIQP F
Sbjct: 1 MVME--DNESCGSRAYDLLSPA------QSRQQRQKFEVYNEVLRRLKDSNNEEAIQPGF 52
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRN 120
DDELW HFNRLPTRYALDVNVERAEDVLMHKRLL AHDP NRPAIEVRLVQV VSD +
Sbjct: 53 DDELWVHFNRLPTRYALDVNVERAEDVLMHKRLLQFAHDPANRPAIEVRLVQVQAVSDEH 112
Query: 121 SAVSSLLDSEVPAQ-----------RQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSV 169
SA DS P + RQS+HPPPAFGSSPNLEALA+EANN+ +L+ D SV
Sbjct: 113 SA--DFADS-CPVKDTDHNSSNCLSRQSMHPPPAFGSSPNLEALALEANNTQDLEVDQSV 169
Query: 170 HANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGW 229
HA QF RPMHEITFSTDDKPKLLSQLT+LLA+IGLNIQEAHAFSTVDGYSLDVFVVDGW
Sbjct: 170 HARTQFFRPMHEITFSTDDKPKLLSQLTSLLAEIGLNIQEAHAFSTVDGYSLDVFVVDGW 229
Query: 230 PYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEI 289
PYEETE+L+ ALE EVL +ER+GWP+ +SSSP E + T K ++IP DGTDVWEI
Sbjct: 230 PYEETERLKTALESEVLLVERRGWPNQKSSSPVGELDITA-KCESDRVEIPTDGTDVWEI 288
Query: 290 DPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
+P+HLKF KVASGSYGDLY+GTYCSQ+VAIKVLK ER+N+DMQ EFAQEV+IMRKVRHK
Sbjct: 289 NPRHLKFEHKVASGSYGDLYKGTYCSQEVAIKVLKTERVNTDMQSEFAQEVYIMRKVRHK 348
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK KG F+LPSLLKVAIDVSKGMNYLHQN
Sbjct: 349 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKQKGTFRLPSLLKVAIDVSKGMNYLHQN 408
Query: 410 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 469
NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK
Sbjct: 409 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 468
Query: 470 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 529
ADVFSFGIVLWELLTGKLPYE+LTPLQAAVGVVQKGLRPT+PK++ PKLA+LLE+CWQQD
Sbjct: 469 ADVFSFGIVLWELLTGKLPYEFLTPLQAAVGVVQKGLRPTMPKHTNPKLADLLEKCWQQD 528
Query: 530 PALRPDFSEIIEILQQIAKEVGEENEERRKEKSSGGFLSVLRRGHH 575
P+ RPDF EII+IL QI KEV EE E+RRKEK SGGFLSVLRR HH
Sbjct: 529 PSCRPDFCEIIDILLQITKEVAEEGEDRRKEK-SGGFLSVLRRNHH 573
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474826|ref|XP_002280985.2| PREDICTED: uncharacterized mscS family protein At1g78610-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 932 bits (2409), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 473/617 (76%), Positives = 515/617 (83%), Gaps = 55/617 (8%)
Query: 1 MVMEENNNESCGSRASDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRF 60
MVME +NESC SR D+SS + QSRQ RQKL VYNEVL RLK+S+N+EA +P F
Sbjct: 1 MVME--DNESCSSRVHDSSSPA------QSRQQRQKLEVYNEVLRRLKDSDNEEAFEPGF 52
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQ-------- 112
D+ELW HF RLPTRYALDVNVERAEDVL HKRLLHLAHDP NRPAIEVRLVQ
Sbjct: 53 DEELWAHFVRLPTRYALDVNVERAEDVLTHKRLLHLAHDPTNRPAIEVRLVQFGKFDVSH 112
Query: 113 ---------------------VHPVSDR-NSAVSSLLDSEVP-----------AQRQSIH 139
VHP+SD + ++ + S P + +QSI
Sbjct: 113 KRYVRCGWALRQGKRNIISLTVHPISDGIHGNIADSIHSNSPTIGPAHGSPKYSSKQSIL 172
Query: 140 PPPAFGSSPNLEALAIEANNSH--NLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLT 197
PPPAFGSSPNLEALAIEANNSH + DGD+SVHA+ S+PMHEITFS+DDKPKLLSQLT
Sbjct: 173 PPPAFGSSPNLEALAIEANNSHVQDGDGDDSVHAS---SQPMHEITFSSDDKPKLLSQLT 229
Query: 198 ALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHR 257
LL+++ LNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR ALEKEV K+E+Q WP+H
Sbjct: 230 CLLSELELNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRTALEKEVFKIEKQSWPNHH 289
Query: 258 SSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD 317
S SPT E E+TG+K + IPNDGTDVWEID + LKF +KVASGSYGDLY+GTYCSQ+
Sbjct: 290 SLSPTGEQEETGIKCESDFVTIPNDGTDVWEIDVRQLKFENKVASGSYGDLYKGTYCSQE 349
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
VAIKVLKPER+NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT+PPSL IVTEFMSGGSVY
Sbjct: 350 VAIKVLKPERLNSDMQKEFAQEVFIMRKVRHKNVVQFIGACTRPPSLYIVTEFMSGGSVY 409
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437
DYLHK KGVFKLP+LLKV+IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA
Sbjct: 410 DYLHKQKGVFKLPALLKVSIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 469
Query: 438 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA
Sbjct: 470 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 529
Query: 498 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEER 557
AVGVVQKGLRPT+PKN+ PKLAELLERCWQQDP LRPDFSEIIEILQQIAKEVG+E E+R
Sbjct: 530 AVGVVQKGLRPTMPKNTHPKLAELLERCWQQDPTLRPDFSEIIEILQQIAKEVGDE-EDR 588
Query: 558 RKEKSSGGFLSVLRRGH 574
RKEKSS GFLSVLRRG+
Sbjct: 589 RKEKSSSGFLSVLRRGY 605
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255560441|ref|XP_002521235.1| protein kinase, putative [Ricinus communis] gi|223539503|gb|EEF41091.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 902 bits (2332), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/580 (78%), Positives = 497/580 (85%), Gaps = 28/580 (4%)
Query: 1 MVMEENNNESCGSRASDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRF 60
MV+ NESCGSR D++++S P H R RQKL VYNEVL RLKESNN+EA QP F
Sbjct: 1 MVVMMEENESCGSRVQDSTTSSPSP-SHAGRNQRQKLEVYNEVLRRLKESNNEEANQPGF 59
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRN 120
DDELW+HF+RLPTRYALDVNVERAEDVLMHKRLL LAHDP NRPAIE+RLVQV PVSD N
Sbjct: 60 DDELWSHFHRLPTRYALDVNVERAEDVLMHKRLLQLAHDPDNRPAIEIRLVQVPPVSDGN 119
Query: 121 SAVSSLLDS----EVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLD-GDNSVHANVQF 175
SA S L S + + R+SIHPPPAFGSSPNLEALA+EA N G++ + ++Q
Sbjct: 120 SADSDLSGSPRKGDTQSNRKSIHPPPAFGSSPNLEALALEAINPKMXXLGNSDLLYHLQ- 178
Query: 176 SRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETE 235
PMHEITFSTDDKPKLLSQLT+LLA+IGLNIQEAHAFSTVDGYSLDVFVVDGWPYE
Sbjct: 179 --PMHEITFSTDDKPKLLSQLTSLLAEIGLNIQEAHAFSTVDGYSLDVFVVDGWPYE--- 233
Query: 236 QLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLK 295
+ WP+ S SP+SE + T +K P H+ IPNDGTDVWEIDPK+LK
Sbjct: 234 --------------KHTWPT-LSLSPSSEHKQTKIKCDPDHVTIPNDGTDVWEIDPKNLK 278
Query: 296 FGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
F +KVASGSYGDLY+GTYCSQ+VAIK+LKPERINSD++KEFAQEVFIMRKVRHKNVVQFI
Sbjct: 279 FENKVASGSYGDLYKGTYCSQEVAIKILKPERINSDLEKEFAQEVFIMRKVRHKNVVQFI 338
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
GACTKPPSLCIVTEFMSGGSVYDYLHK KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD
Sbjct: 339 GACTKPPSLCIVTEFMSGGSVYDYLHKQKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 398
Query: 416 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 475
LKAANLLMDENEVVKVADFGVARVKAQ+GVMTAETGTYRWMAPEVIEHKPYDHKAD+FSF
Sbjct: 399 LKAANLLMDENEVVKVADFGVARVKAQTGVMTAETGTYRWMAPEVIEHKPYDHKADIFSF 458
Query: 476 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD 535
IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK++ PKLAELLE+CWQQDPALRPD
Sbjct: 459 AIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKHTHPKLAELLEKCWQQDPALRPD 518
Query: 536 FSEIIEILQQIAKEVGEENEERRKEKSSGGFLSVLRRGHH 575
FSEIIE+LQQI KEVGEE E RKEKSSGGFLSVLRRGHH
Sbjct: 519 FSEIIEMLQQIVKEVGEEG-EGRKEKSSGGFLSVLRRGHH 557
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|283132359|dbj|BAI63585.1| ACT-domain-containing protein kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 900 bits (2327), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 441/584 (75%), Positives = 496/584 (84%), Gaps = 17/584 (2%)
Query: 1 MVMEENNNESCGSRASDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRF 60
MV+ ++N+ S TS+ + P Q+RQHR K+ VYNE+L RL +S N EA+QP F
Sbjct: 3 MVVVDDND------TSGTSNHRATPSPSQTRQHRHKVEVYNEILRRLNDSGNPEALQPGF 56
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRN 120
D+LW HFNRLP RYALDVNVERA DVLMHKRLLHLAHDP NRP+IEVRLVQVHP SD N
Sbjct: 57 HDQLWAHFNRLPARYALDVNVERAADVLMHKRLLHLAHDPANRPSIEVRLVQVHPTSDGN 116
Query: 121 SAVSSLLDS---------EVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHA 171
SA S DS + RQSIHPPPAFGSSPNLEALA+E NNS ++D + SVHA
Sbjct: 117 SADSFHSDSPGTESGQSSSKYSSRQSIHPPPAFGSSPNLEALALEENNSEDID-ERSVHA 175
Query: 172 NVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPY 231
+VQ+SRPMHEITFST+DKPKLLSQLTALLA+IGLNIQEAHAFST DGYSLDVFVVDGWPY
Sbjct: 176 SVQYSRPMHEITFSTEDKPKLLSQLTALLAEIGLNIQEAHAFSTSDGYSLDVFVVDGWPY 235
Query: 232 EETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDP 291
EETE+L+ ALEKE+LK+ERQ + +S S EP+ MK HL IPNDGTDVWEID
Sbjct: 236 EETEKLKVALEKEILKIERQARSNQQSVSSADEPDQARMKHEQDHLTIPNDGTDVWEIDA 295
Query: 292 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351
KHL +G+++ASGSYG+L++GTYCSQ+VAIKVLK E +N++MQ+EF QEV+IMRKVRHKNV
Sbjct: 296 KHLTYGNQIASGSYGELFKGTYCSQEVAIKVLKGEHVNAEMQREFVQEVYIMRKVRHKNV 355
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
VQFIGACTKPP LCI+TEFMSGGSVYDYLHK KG FK PSLLKVAIDVSKGMNYLHQ+NI
Sbjct: 356 VQFIGACTKPPRLCIITEFMSGGSVYDYLHKQKGFFKFPSLLKVAIDVSKGMNYLHQHNI 415
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKAD 471
IHRDLK ANLLMDEN VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKAD
Sbjct: 416 IHRDLKGANLLMDENGVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKAD 475
Query: 472 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 531
VFSFG+VLWELLTGKLPYEYLTPLQAA+GVVQKGLRPTIPKN+ PK ELLER WQQD
Sbjct: 476 VFSFGVVLWELLTGKLPYEYLTPLQAAIGVVQKGLRPTIPKNTHPKFVELLERSWQQDST 535
Query: 532 LRPDFSEIIEILQQIAKEVGEENEERRKEKSSGGFLSVLRRGHH 575
LRPDFSEII+ILQ++AKEVG++ E+RR++K SGGFLS LRRGHH
Sbjct: 536 LRPDFSEIIDILQKLAKEVGDDGEDRRRDK-SGGFLSALRRGHH 578
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574129|ref|XP_003555204.1| PREDICTED: uncharacterized protein LOC100804170 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 877 bits (2266), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 441/587 (75%), Positives = 495/587 (84%), Gaps = 19/587 (3%)
Query: 2 VMEENNNESCGSRAS-DTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRF 60
++ E NN SCGS + +TSS QSR RQKL VYNE+L RLK+S N+EA+QP F
Sbjct: 1 MLTEGNNSSCGSGSGVQHHTTSSSSSPAQSRLQRQKLEVYNEILRRLKDSGNEEAMQPGF 60
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRN 120
D+LW HFNRLPT YALDVNVERA DVLMHKRLLHLAHDP NRP+IEVRLVQVHP S+ N
Sbjct: 61 HDQLWAHFNRLPTWYALDVNVERAADVLMHKRLLHLAHDPANRPSIEVRLVQVHPTSNGN 120
Query: 121 SAVSSLLDSEVPA-----------QRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSV 169
SA +S+ P RQSIHPPPAFGSSPNLEALA+EANNS +++ + S
Sbjct: 121 SA--DTFESDDPGIESGQSSSKYSSRQSIHPPPAFGSSPNLEALALEANNSEDIEEEQSA 178
Query: 170 HANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGW 229
HANVQ+SR MHEIT STDDKPKLLSQLTALL++IGLNIQEAHAFST DG+SLDVFVV+GW
Sbjct: 179 HANVQYSRHMHEITISTDDKPKLLSQLTALLSEIGLNIQEAHAFSTTDGFSLDVFVVEGW 238
Query: 230 PYEETEQLRAALEKEVL-KLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWE 288
P+EETE+L+AALE+ VL K+E + P +S S +P+ MKS +L IP DGTDVWE
Sbjct: 239 PHEETEKLKAALERGVLKKIEVKSSP--QSVSSVDKPDQAKMKSELDYLTIPTDGTDVWE 296
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 348
IDPKHLK+G+++ASGSYG+L++G YCSQ+VAIKVLK + +NS++Q+EFAQEV+IMRKVRH
Sbjct: 297 IDPKHLKYGTQIASGSYGELFKGVYCSQEVAIKVLKADHVNSELQREFAQEVYIMRKVRH 356
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
KNVVQFIGACTKPP LCIVTEFMSGGSVYDYLHK KG FK P+LLKVAIDVSKGMNYLHQ
Sbjct: 357 KNVVQFIGACTKPPGLCIVTEFMSGGSVYDYLHKQKGFFKFPTLLKVAIDVSKGMNYLHQ 416
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 468
+NIIHRDLKAANLLMDEN VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH
Sbjct: 417 HNIIHRDLKAANLLMDENCTVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 476
Query: 469 KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 528
KADVFSFGIVLWELLTGKLPYEYLTPLQAA+GVVQKGLRPTIPKN+ PK ELLER WQQ
Sbjct: 477 KADVFSFGIVLWELLTGKLPYEYLTPLQAAIGVVQKGLRPTIPKNTHPKYVELLERSWQQ 536
Query: 529 DPALRPDFSEIIEILQQIAKEVGEENEERRKEKSSGGFLSVLRRGHH 575
DP LRPDFSEIIEILQQ+AKEVG + EER K+K GG LSVLRRGHH
Sbjct: 537 DPTLRPDFSEIIEILQQLAKEVG-DGEERHKDK-YGGLLSVLRRGHH 581
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357444821|ref|XP_003592688.1| Protein kinase like protein [Medicago truncatula] gi|355481736|gb|AES62939.1| Protein kinase like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 850 bits (2196), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/552 (75%), Positives = 472/552 (85%), Gaps = 12/552 (2%)
Query: 7 NNESCGSRASDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRFDDELWT 66
+NESCGS +S+S P QSRQ RQK+ VYNE+L RLK+S N+EA+QP FDD+LW
Sbjct: 8 DNESCGSGIHHRTSSSIPA---QSRQQRQKVEVYNEILRRLKDSGNEEAMQPGFDDQLWN 64
Query: 67 HFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSA---- 122
HFNRLP+RYALDVNVERAEDVLMHKRLLHLAHDP NRP+IEV LVQ+HP SD NSA
Sbjct: 65 HFNRLPSRYALDVNVERAEDVLMHKRLLHLAHDPANRPSIEVHLVQLHPSSDGNSADSFQ 124
Query: 123 -----VSSLLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSR 177
V S S + +Q I PPPAFGSSPNLEALA+E N+S +L+ + SVHA+VQ+SR
Sbjct: 125 SCAPGVDSGQSSSKYSSKQGILPPPAFGSSPNLEALALEENDSEDLEEEQSVHASVQYSR 184
Query: 178 PMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQL 237
PMHEIT STDDKPKLLSQLTALLA++GLNIQEAHAFST DG+SLDVFVV+GWPYEETE+L
Sbjct: 185 PMHEITVSTDDKPKLLSQLTALLAEVGLNIQEAHAFSTTDGFSLDVFVVEGWPYEETEKL 244
Query: 238 RAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFG 297
+ LEKEVLK+ER S +S S E + + MK+ IPNDGTDVWEIDPKHLK+G
Sbjct: 245 KETLEKEVLKIERGERSSQQSVSSVDECDQSRMKNELDRFTIPNDGTDVWEIDPKHLKYG 304
Query: 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
+++AS SYG+LY+G YCSQ+VAIKVLK E ++S+MQKEFAQEV+IMRKVRHKNVVQF+GA
Sbjct: 305 TQIASASYGELYKGIYCSQEVAIKVLKAEHVSSEMQKEFAQEVYIMRKVRHKNVVQFMGA 364
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 417
CT+PP LCIVTEFMSGGSVYDYLHK KG FK P++LKVAIDVSKGMNYLHQ+NIIHRDLK
Sbjct: 365 CTQPPRLCIVTEFMSGGSVYDYLHKQKGFFKFPTVLKVAIDVSKGMNYLHQHNIIHRDLK 424
Query: 418 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGI 477
AANLLMDEN VVKVADFGVARV+AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFG+
Sbjct: 425 AANLLMDENGVVKVADFGVARVRAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGV 484
Query: 478 VLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFS 537
VLWELLTGKLPYE+LTPLQAA+GVVQKGLRPTIPK++ PK +LLE+ WQQDP LRPDFS
Sbjct: 485 VLWELLTGKLPYEFLTPLQAAIGVVQKGLRPTIPKSTHPKFVQLLEKSWQQDPTLRPDFS 544
Query: 538 EIIEILQQIAKE 549
EIIE LQQ+AKE
Sbjct: 545 EIIESLQQLAKE 556
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357483963|ref|XP_003612268.1| Dual specificity protein kinase pyk2 [Medicago truncatula] gi|355513603|gb|AES95226.1| Dual specificity protein kinase pyk2 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 826 bits (2134), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/581 (70%), Positives = 475/581 (81%), Gaps = 20/581 (3%)
Query: 5 ENNNESCGSRASDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRFDDEL 64
EN+ ESCGSRA S ++P R HRQKL VYNEVL R+++S+ ++A+ P FDD+L
Sbjct: 4 ENDIESCGSRA--VQSHANP------RHHRQKLEVYNEVLRRIQDSDCEDALVPGFDDQL 55
Query: 65 WTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRN---S 121
W HFNRLP RYALDVNVERAEDVL HKRLL LA DP NRPA +VRLVQV+P + N S
Sbjct: 56 WLHFNRLPARYALDVNVERAEDVLAHKRLLELAEDPANRPAFQVRLVQVYPFAGANHNDS 115
Query: 122 AVSSLLDSEVPAQ-------RQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQ 174
+V S + AQ +Q IHPPP FGSS NLEALA+ N ++ DGDN++
Sbjct: 116 SVHSDPSEKDDAQSSLNYSLKQGIHPPPTFGSSSNLEALALHTNKNNIEDGDNTMGVTPN 175
Query: 175 FSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEET 234
F+RPMHEITFST DKPKLLSQLT++L +IGLNIQEAHAFST DG+SLDVFVV+GWP EET
Sbjct: 176 FNRPMHEITFSTIDKPKLLSQLTSILGEIGLNIQEAHAFSTSDGFSLDVFVVEGWPNEET 235
Query: 235 EQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHL 294
E+L+ LEKE+LK++ Q + + +++ T M+S P ++IP DG DVWEIDP L
Sbjct: 236 EELKGVLEKEILKVKDQYLSNQGTLYSSNDQYQTRMESSPDCIQIPFDGADVWEIDPSQL 295
Query: 295 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
K+ +KV SGS+GDL+RG+YCSQDVAIKVLKPERI++DM KEFAQEV+IMRK+RHKNVVQF
Sbjct: 296 KYENKVGSGSFGDLFRGSYCSQDVAIKVLKPERISTDMLKEFAQEVYIMRKIRHKNVVQF 355
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
IGACT+PP+LCIVTEFMS GS+YD+LH+ KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR
Sbjct: 356 IGACTRPPNLCIVTEFMSRGSLYDFLHRQKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 415
Query: 415 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 474
DLK ANLLMDENE+VKVADFGVARV+ QSGVMTAETGTYRWMAPEVIEHKPYD KADVFS
Sbjct: 416 DLKTANLLMDENELVKVADFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDQKADVFS 475
Query: 475 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP 534
FGI LWELLTG+LPY YLTPLQAAVGVVQKGLRPTIPKN+ P+++ELL+RCWQQDP RP
Sbjct: 476 FGIALWELLTGELPYSYLTPLQAAVGVVQKGLRPTIPKNTHPRISELLQRCWQQDPKERP 535
Query: 535 DFSEIIEILQQIAKEVGEENEERRKEKSSGGFLSVLRRGHH 575
FSEIIEILQ IAKEV + +R K+KSS GFLS LRRGHH
Sbjct: 536 AFSEIIEILQHIAKEVND--VDRHKDKSSHGFLSSLRRGHH 574
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18420244|ref|NP_568041.1| ACT-like protein tyrosine kinase family protein [Arabidopsis thaliana] gi|332661531|gb|AEE86931.1| ACT-like protein tyrosine kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 820 bits (2117), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 430/588 (73%), Positives = 484/588 (82%), Gaps = 26/588 (4%)
Query: 1 MVMEENNNESCGSRA-SDTSSTSSPPPQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPR 59
MVME +NESC SR D TS R+ R K+ V++EVL RL++S+ ++A P
Sbjct: 1 MVME--DNESCASRVIFDALPTSQAT---MDRRERIKMEVFDEVLRRLRQSDIEDAHLPG 55
Query: 60 FDDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDR 119
F+D+LW HFNRLP RYALDVNVERAEDVLMHKRLLH A+DP+NRPAIEV LVQV P
Sbjct: 56 FEDDLWNHFNRLPARYALDVNVERAEDVLMHKRLLHSAYDPQNRPAIEVHLVQVQP---- 111
Query: 120 NSAVSSLLDS------EVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANV 173
+ +S+ LDS R+SIHPPPAFGSSPNLEALA+ A+ S + D DNSVH N
Sbjct: 112 -AGISADLDSTSNDAGHSSPTRKSIHPPPAFGSSPNLEALALAASLSQDEDADNSVHNNS 170
Query: 174 QFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEE 233
+SRP+HEITFST+DKPKLL QLTALLA++GLNIQEAHAFST DGYSLDVFVVDGWPYEE
Sbjct: 171 LYSRPLHEITFSTEDKPKLLFQLTALLAELGLNIQEAHAFSTTDGYSLDVFVVDGWPYEE 230
Query: 234 TEQLRAALEKEVLKLE--RQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDP 291
TE+LR +LEKE K+E Q WP +S SP E TG ++H + IPNDGTDVWEI+
Sbjct: 231 TERLRISLEKEAAKIELQSQSWPMQQSFSPEKENGQTGARTH---VPIPNDGTDVWEINL 287
Query: 292 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351
KHLKFG K+ASGSYGDLY+GTYCSQ+VAIKVLKPER++SD++KEFAQEVFIMRKVRHKNV
Sbjct: 288 KHLKFGHKIASGSYGDLYKGTYCSQEVAIKVLKPERLDSDLEKEFAQEVFIMRKVRHKNV 347
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
VQFIGACTKPP LCIVTEFM GGSVYDYLHK KGVFKLP+L KVAID+ KGM+YLHQNNI
Sbjct: 348 VQFIGACTKPPHLCIVTEFMPGGSVYDYLHKQKGVFKLPTLFKVAIDICKGMSYLHQNNI 407
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKAD 471
IHRDLKAANLLMDENEVVKVADFGVARVKAQ+GVMTAETGTYRWMAPEVIEHKPYDHKAD
Sbjct: 408 IHRDLKAANLLMDENEVVKVADFGVARVKAQTGVMTAETGTYRWMAPEVIEHKPYDHKAD 467
Query: 472 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 531
VFS+GIVLWELLTGKLPYEY+TPLQAAVGVVQKGLRPTIPKN+ PKLAELLER W+ D
Sbjct: 468 VFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQKGLRPTIPKNTHPKLAELLERLWEHDST 527
Query: 532 LRPDFSEIIEILQQIAKEVGEENEERRKEKS--SGGFLSVLRRG--HH 575
RPDFSEIIE LQ+IAKEVGEE EE++K + GG + LRR HH
Sbjct: 528 QRPDFSEIIEQLQEIAKEVGEEGEEKKKSSTGLGGGIFAALRRSTTHH 575
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224286063|gb|ACN40743.1| unknown [Picea sitchensis] | Back alignment and taxonomy information |
|---|
Score = 817 bits (2110), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/565 (72%), Positives = 452/565 (80%), Gaps = 20/565 (3%)
Query: 22 SSPP-PQHQSRQHRQKLGVYNEVLGRLKESNNDEAIQPRFDDELWTHFNRLPTRYALDVN 80
SSP P+HQ R+KL YNE+L RLKES ++ P F+DEL +HFNRLP RYALDVN
Sbjct: 31 SSPTHPRHQ----RRKLEAYNEILRRLKESGSEAVNAPGFEDELLSHFNRLPPRYALDVN 86
Query: 81 VERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDSEVPAQRQ---- 136
ER EDVL HKRLL LA DP NRPA +VR+V V P + S L SE P
Sbjct: 87 TERPEDVLTHKRLLQLAEDPANRPAFDVRVVNVLPATGGRSP--DLSPSESPKGEDTYSV 144
Query: 137 --------SIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDD 188
S HPPPAFGSSPNLEALA+EAN D D + + F+RPMHEITFS+DD
Sbjct: 145 SSHAIPWPSAHPPPAFGSSPNLEALALEANKQSYGDDDTERNGDHIFARPMHEITFSSDD 204
Query: 189 KPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKL 248
KPKLLSQLT+LLAD+GLNIQEAHAFST DGYSLDVFVVDGWP EE EQLR ALE E+
Sbjct: 205 KPKLLSQLTSLLADLGLNIQEAHAFSTTDGYSLDVFVVDGWPLEEMEQLRQALESEIANT 264
Query: 249 ERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDL 308
E+ W SS E G S+ ++IPNDGTD WEID K LKF KVASGSYGDL
Sbjct: 265 EKTTWSKPSPSSSPIEQMAVGSGSNVECVRIPNDGTDDWEIDSKFLKFDYKVASGSYGDL 324
Query: 309 YRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368
YRGTYC QDVAIKVLK ER+++D+Q+EFAQEVFIMRKVRHKNVVQFIGACT+PP+LCIVT
Sbjct: 325 YRGTYCGQDVAIKVLKSERLDADLQREFAQEVFIMRKVRHKNVVQFIGACTRPPNLCIVT 384
Query: 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
EFMSGGSVYDYLHK KGVFKLP+LLKVAIDVS+GM+YLHQNNIIHRDLKAANLLMDENEV
Sbjct: 385 EFMSGGSVYDYLHKQKGVFKLPALLKVAIDVSRGMDYLHQNNIIHRDLKAANLLMDENEV 444
Query: 429 VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 488
VKVADFGVARV+AQSGVMTAETGTYRWMAPEVIEHKPYD KADVFSFGIVLWELLTGKLP
Sbjct: 445 VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDQKADVFSFGIVLWELLTGKLP 504
Query: 489 YEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548
Y+YLTPLQAAVGVVQKGLRPTIPKN+ P+LA+LLERCWQQDP LRPDFSE+ EILQQ K
Sbjct: 505 YDYLTPLQAAVGVVQKGLRPTIPKNTHPRLADLLERCWQQDPTLRPDFSEMTEILQQTLK 564
Query: 549 EVGEENE-ERRKEKSSGGFLSVLRR 572
E G+E E ERRK+KSSGGF S RR
Sbjct: 565 EAGDEGENERRKDKSSGGFFSAFRR 589
|
Source: Picea sitchensis Species: Picea sitchensis Genus: Picea Family: Pinaceae Order: Coniferales Class: Coniferopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 575 | ||||||
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.986 | 0.986 | 0.711 | 5.2e-216 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.979 | 0.987 | 0.641 | 3.7e-190 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.930 | 0.979 | 0.650 | 9e-180 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.460 | 0.643 | 0.494 | 1.6e-70 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.464 | 0.649 | 0.476 | 1.8e-69 | |
| DICTYBASE|DDB_G0267514 | 916 | DDB_G0267514 "protein kinase, | 0.453 | 0.284 | 0.445 | 4.1e-64 | |
| TAIR|locus:2180992 | 333 | AT5G01850 [Arabidopsis thalian | 0.443 | 0.765 | 0.468 | 1e-59 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.514 | 0.386 | 0.398 | 4.2e-59 | |
| TAIR|locus:2154573 | 525 | AT5G58950 [Arabidopsis thalian | 0.462 | 0.506 | 0.406 | 7.3e-59 | |
| DICTYBASE|DDB_G0289791 | 642 | drkA "DRK subfamily protein ki | 0.478 | 0.428 | 0.419 | 8.4e-58 |
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2087 (739.7 bits), Expect = 5.2e-216, P = 5.2e-216
Identities = 415/583 (71%), Positives = 465/583 (79%)
Query: 1 MVMEENNNESCGSRASDXXXXXXXXXXXXXXXXXXKLGVYNEVLGRLKESNNDEAIQPRF 60
MVME+N ESC SR K+ V++EVL RL++S+ ++A P F
Sbjct: 1 MVMEDN--ESCASRV--IFDALPTSQATMDRRERIKMEVFDEVLRRLRQSDIEDAHLPGF 56
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHP--VSD 118
+D+LW HFNRLP RYALDVNVERAEDVLMHKRLLH A+DP+NRPAIEV LVQV P +S
Sbjct: 57 EDDLWNHFNRLPARYALDVNVERAEDVLMHKRLLHSAYDPQNRPAIEVHLVQVQPAGISA 116
Query: 119 RNSAVSSLLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRP 178
+ S+ P R+SIHPPPAFGSSPNLEALA+ A+ S + D DNSVH N +SRP
Sbjct: 117 DLDSTSNDAGHSSPT-RKSIHPPPAFGSSPNLEALALAASLSQDEDADNSVHNNSLYSRP 175
Query: 179 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 238
+HEITFST+DKPKLL QLTALLA++GLNIQEAHAFST DGYSLDVFVVDGWPYEETE+LR
Sbjct: 176 LHEITFSTEDKPKLLFQLTALLAELGLNIQEAHAFSTTDGYSLDVFVVDGWPYEETERLR 235
Query: 239 AALEKEVLKLE--RQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKF 296
+LEKE K+E Q WP +S SP E TG ++H + IPNDGTDVWEI+ KHLKF
Sbjct: 236 ISLEKEAAKIELQSQSWPMQQSFSPEKENGQTGARTH---VPIPNDGTDVWEINLKHLKF 292
Query: 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
G K+ASGSYGDLY+GTYCSQ+VAIKVLKPER++SD++KEFAQEVFIMRKVRHKNVVQFIG
Sbjct: 293 GHKIASGSYGDLYKGTYCSQEVAIKVLKPERLDSDLEKEFAQEVFIMRKVRHKNVVQFIG 352
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
ACTKPP LCIVTEFM GGSVYDYLHK KGVFKLP+L KVAID+ KGM+YLHQNNIIHRDL
Sbjct: 353 ACTKPPHLCIVTEFMPGGSVYDYLHKQKGVFKLPTLFKVAIDICKGMSYLHQNNIIHRDL 412
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFG 476
KAANLLMDENEVVKVADFGVARVKAQ+GVMTAETGTYRWMAPEVIEHKPYDHKADVFS+G
Sbjct: 413 KAANLLMDENEVVKVADFGVARVKAQTGVMTAETGTYRWMAPEVIEHKPYDHKADVFSYG 472
Query: 477 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 536
IVLWELLTGKLPYEY+TPLQAAVGVVQKGLRPTIPKN+ PKLAELLER W+ D RPDF
Sbjct: 473 IVLWELLTGKLPYEYMTPLQAAVGVVQKGLRPTIPKNTHPKLAELLERLWEHDSTQRPDF 532
Query: 537 SEIIEILQQIAKXXXXXXXXXXXXXXXXG--FLSVLRRG--HH 575
SEIIE LQ+IAK G + LRR HH
Sbjct: 533 SEIIEQLQEIAKEVGEEGEEKKKSSTGLGGGIFAALRRSTTHH 575
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1843 (653.8 bits), Expect = 3.7e-190, P = 3.7e-190
Identities = 372/580 (64%), Positives = 431/580 (74%)
Query: 1 MVMEENNNESCGSRASDXXXXXXXXXXXXXXXXXXKLGVYNEVLGRLKESNNDEAIQPRF 60
M ++E ESCGSRA KL VY EVL R++ESN +EA P F
Sbjct: 1 MAIKEETEESCGSRA-----VVASITKESPRQHRMKLEVYGEVLQRIQESNYEEANFPGF 55
Query: 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRN 120
DD LW HFNRLP RYALDVNVERAEDVL H+RLL LA DP RP EVR VQV P + N
Sbjct: 56 DDLLWLHFNRLPARYALDVNVERAEDVLTHQRLLKLAEDPATRPVFEVRCVQVSPTLNGN 115
Query: 121 SAVSSLLDSEVPAQRQSIH-----PPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQF 175
S D V QS + PP FGSSPN EAL +A H D D++V+A +
Sbjct: 116 SGDVDPSDPAVNEDAQSSYNSRSLAPPTFGSSPNFEALT-QAYKDHAQDDDSAVNAQLPN 174
Query: 176 SRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETE 235
SRPMHEITFST D+PKLLSQLT++L ++GLNIQEAHAFST DG+SLDVFVVDGW EETE
Sbjct: 175 SRPMHEITFSTIDRPKLLSQLTSMLGELGLNIQEAHAFSTADGFSLDVFVVDGWSQEETE 234
Query: 236 QLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSH-PYHLKIPNDGTDVWEIDPKHL 294
L+ AL+KE+ K + Q P + S T D P ++IP DGTD WEID K L
Sbjct: 235 GLKDALKKEIRKFKDQ--PCSKQKSITFFEHDKSTNELLPACVEIPTDGTDEWEIDMKQL 292
Query: 295 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
K KVA GSYG+L+RGTYCSQ+VAIK+LKPER+N++M +EF+QEV+IMRKVRHKNVVQF
Sbjct: 293 KIEKKVACGSYGELFRGTYCSQEVAIKILKPERVNAEMLREFSQEVYIMRKVRHKNVVQF 352
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
IGACT+ P+LCIVTEFM+ GS+YD+LHK KGVFK+ SLLKVA+DVSKGMNYLHQNNIIHR
Sbjct: 353 IGACTRSPNLCIVTEFMTRGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHR 412
Query: 415 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 474
DLK ANLLMDE+EVVKVADFGVARV+ +SGVMTAETGTYRWMAPEVIEHKPYDH+ADVFS
Sbjct: 413 DLKTANLLMDEHEVVKVADFGVARVQTESGVMTAETGTYRWMAPEVIEHKPYDHRADVFS 472
Query: 475 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP 534
+ IVLWELLTG+LPY YLTPLQAAVGVVQKGLRP IPK + PKL ELLE+CWQQDPALRP
Sbjct: 473 YAIVLWELLTGELPYSYLTPLQAAVGVVQKGLRPKIPKETHPKLTELLEKCWQQDPALRP 532
Query: 535 DFSEIIEILQQIAKXXXXXXXXXXXXXXXXGFLSVLRRGH 574
+F+EIIE+L Q+ + G+ S L++GH
Sbjct: 533 NFAEIIEMLNQLIREVGDDERHKDKHG---GYFSGLKKGH 569
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1745 (619.3 bits), Expect = 9.0e-180, P = 9.0e-180
Identities = 355/546 (65%), Positives = 414/546 (75%)
Query: 5 ENNNESCGSRASDXXXXXXXXXXXXXXXXXXKLGVYNEVLGRLKESNNDEAIQPRFDDEL 64
++ +ESCGSRA KL VY+EVL RL+ESN +EA P F+D+L
Sbjct: 4 KDESESCGSRA-----VVASPSQENPRHYRMKLDVYSEVLQRLQESNYEEATLPDFEDQL 58
Query: 65 WTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHP-VS-DRNSA 122
W HFNRLP RYALDV VERAEDVL H+RLL LA DP RP EVR VQV P +S D + A
Sbjct: 59 WLHFNRLPARYALDVKVERAEDVLTHQRLLKLAADPATRPVFEVRSVQVSPRISADSDPA 118
Query: 123 VSSLLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEI 182
V S + PP FGSSPN EA I + D D+ V+A + +RPMHEI
Sbjct: 119 VEEDAQSSHQPSGPGVLAPPTFGSSPNFEA--ITQGSKIVEDVDSVVNATLS-TRPMHEI 175
Query: 183 TFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALE 242
TFST DKPKLLSQLT+LL ++GLNIQEAHAFSTVDG+SLDVFVVDGW EET+ LR AL
Sbjct: 176 TFSTIDKPKLLSQLTSLLGELGLNIQEAHAFSTVDGFSLDVFVVDGWSQEETDGLRDALS 235
Query: 243 KEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVAS 302
KE+LKL+ Q +S S E + + + P ++IP DGTD WEID LK KVAS
Sbjct: 236 KEILKLKDQPGSKQKSIS-FFEHDKSSNELIPACIEIPTDGTDEWEIDVTQLKIEKKVAS 294
Query: 303 GSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362
GSYGDL+RGTYCSQ+VAIK LKP+R+N++M +EF+QEVFIMRKVRHKNVVQF+GACT+ P
Sbjct: 295 GSYGDLHRGTYCSQEVAIKFLKPDRVNNEMLREFSQEVFIMRKVRHKNVVQFLGACTRSP 354
Query: 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422
+LCIVTEFM+ GS+YD+LHK K FKL +LLKVA+DV+KGM+YLHQNNIIHRDLK ANLL
Sbjct: 355 TLCIVTEFMARGSIYDFLHKQKCAFKLQTLLKVALDVAKGMSYLHQNNIIHRDLKTANLL 414
Query: 423 MDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWEL 482
MDE+ +VKVADFGVARV+ +SGVMTAETGTYRWMAPEVIEHKPY+HKADVFS+ IVLWEL
Sbjct: 415 MDEHGLVKVADFGVARVQIESGVMTAETGTYRWMAPEVIEHKPYNHKADVFSYAIVLWEL 474
Query: 483 LTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI 542
LTG +PY +LTPLQAAVGVVQKGLRP IPK + PK+ LLERCW QDP RP F EIIE+
Sbjct: 475 LTGDIPYAFLTPLQAAVGVVQKGLRPKIPKKTHPKVKGLLERCWHQDPEQRPLFEEIIEM 534
Query: 543 LQQIAK 548
LQQI K
Sbjct: 535 LQQIMK 540
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 714 (256.4 bits), Expect = 1.6e-70, P = 1.6e-70
Identities = 137/277 (49%), Positives = 194/277 (70%)
Query: 278 KIPNDGT---DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK-----PERIN 329
K P +G + W ID + L G A G++G LYRGTY +DVAIK+L+ PE+
Sbjct: 112 KYPTEGLVNYEEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQ 171
Query: 330 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 389
+ ++++F QEV ++ ++H N+V+FIGAC KP CIVTE+ GGSV +L K + +
Sbjct: 172 A-LEQQFQQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNR-AV 229
Query: 390 PSLLKV--AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 447
P L V A+DV++GM Y+H+ N IHRDLK+ NLL+ + +K+ADFGVAR++ Q+ MT
Sbjct: 230 PLKLAVMQALDVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMT 289
Query: 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 507
ETGTYRWMAPE+I+H+PY K DV+SFGIVLWEL+TG LP++ +T +QAA VV +G+R
Sbjct: 290 PETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVR 349
Query: 508 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 544
PT+P + P L E++ RCW DP +RP F+EI+ +L+
Sbjct: 350 PTVPADCLPVLGEIMTRCWDADPEVRPCFAEIVNLLE 386
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 704 (252.9 bits), Expect = 1.8e-69, P = 1.8e-69
Identities = 131/275 (47%), Positives = 192/275 (69%)
Query: 278 KIPNDGT---DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVL-KPERINSD-- 331
+ P +G D W ID + L G A G++G LY+GTY +DVAIK+L +PE
Sbjct: 111 RYPTEGLTNYDEWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQ 170
Query: 332 -MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKL 389
M+++F QEV ++ ++H N+V+FIGAC KP CIVTE+ GGSV +L + + L
Sbjct: 171 FMEQQFQQEVSMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 230
Query: 390 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449
+K A+DV++GM Y+H N IHRDLK+ NLL+ ++ +K+ADFGVAR++ Q+ MT E
Sbjct: 231 KLAVKQALDVARGMAYVHGRNFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 290
Query: 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT 509
TGTYRWMAPE+I+H+ Y+ K DV+SFGIVLWEL+TG LP++ +T +QAA VV +G+RPT
Sbjct: 291 TGTYRWMAPEMIQHRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPT 350
Query: 510 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 544
+P + P L++++ RCW +P +RP F E++++L+
Sbjct: 351 VPNDCLPVLSDIMTRCWDANPEVRPCFVEVVKLLE 385
|
|
| DICTYBASE|DDB_G0267514 DDB_G0267514 "protein kinase, TKL group" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 628 (226.1 bits), Expect = 4.1e-64, Sum P(2) = 4.1e-64
Identities = 118/265 (44%), Positives = 181/265 (68%)
Query: 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEVFI 342
+D+ EI LK SK+ G++G +Y+G + VAIK +K E +N+ + +EF +E+ I
Sbjct: 653 SDI-EISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTI 711
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
+ ++RH N+V + ACT PP+LC +TE++ GGS+YD LH K + K+AI +++G
Sbjct: 712 LSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQG 771
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 462
MNYLH + +IHRD+K+ NLL+DE+ VK+ DFG++++K++S MT G+ WM+PE++
Sbjct: 772 MNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIGSPIWMSPELLM 831
Query: 463 HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP-KLAEL 521
+ Y K DV++FGI+LWEL TG+LPY L +Q A+ V K LRP IP N+ P +L+ L
Sbjct: 832 GEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIP-NAWPYQLSHL 890
Query: 522 LERCWQQDPALRPDFSEIIEILQQI 546
++ CW QDP RP F+EI+ +L +I
Sbjct: 891 IQACWHQDPLKRPSFTEILNLLNEI 915
|
|
| TAIR|locus:2180992 AT5G01850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 612 (220.5 bits), Expect = 1.0e-59, P = 1.0e-59
Identities = 127/271 (46%), Positives = 183/271 (67%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVL----KPERINSDMQKEFAQEVFIMR 344
+DPK L GSK+ G++G +Y+G Y Q VAIKV+ KP++ S ++ F +EV +M
Sbjct: 13 VDPKLLFIGSKIGEGAHGKVYQGRYGRQIVAIKVVNRGSKPDQ-QSSLESRFVREVNMMS 71
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGM 403
+V+H N+V+FIGAC K P + IVTE + G S+ YL ++ + LP L A+D+++ +
Sbjct: 72 RVQHHNLVKFIGAC-KDPLMVIVTELLPGMSLRKYLTSIRPQLLHLPLALSFALDIARAL 130
Query: 404 NYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI- 461
+ LH N IIHRDLK NLL+ EN + VK+ADFG+AR ++ + +MTAETGTYRWMAPE+
Sbjct: 131 HCLHANGIIHRDLKPDNLLLTENHKSVKLADFGLAREESVTEMMTAETGTYRWMAPELYS 190
Query: 462 -------EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 514
E K Y++K DV+SFGIVLWELLT ++P+E ++ LQAA K RP +P+
Sbjct: 191 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPVMPEGI 250
Query: 515 QPKLAELLERCWQQDPALRPDFSEIIEILQQ 545
P LA +++ CW +DP +RP FS+II +L +
Sbjct: 251 SPSLAFIVQSCWVEDPNMRPSFSQIIRLLNE 281
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 578 (208.5 bits), Expect = 4.2e-59, Sum P(2) = 4.2e-59
Identities = 121/304 (39%), Positives = 187/304 (61%)
Query: 249 ERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDL 308
E G + S+S S T S + + +D D +EI + L G ++ GS G +
Sbjct: 444 ENMGSVNVNSASSASSCGSTS-SSVMNKVDMDSDCLD-YEILWEDLTIGEQIGQGSCGTV 501
Query: 309 YRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368
Y G + DVA+KV + + ++ F QEV +M+++RH NV+ F+GA P LCIVT
Sbjct: 502 YHGLWFGSDVAVKVFSKQEYSEEIITSFKQEVSLMKRLRHPNVLLFMGAVASPQRLCIVT 561
Query: 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDEN 426
EF+ GS++ L + K L + +A D+++GMNYLH + IIHRDLK++NLL+D N
Sbjct: 562 EFLPRGSLFRLLQRNKSKLDLRRRIHMASDIARGMNYLHHCSPPIIHRDLKSSNLLVDRN 621
Query: 427 EVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 486
VKVADFG++R+K ++ + T GT +WMAPEV+ ++ D K+DV+SFG+VLWEL+T K
Sbjct: 622 WTVKVADFGLSRIKHETYLTTNGRGTPQWMAPEVLRNEAADEKSDVYSFGVVLWELVTEK 681
Query: 487 LPYEYLTPLQA--AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 544
+P+E L +Q AVG + + L +PK+ P+ L+E CW +P RP F E+++ L+
Sbjct: 682 IPWENLNAMQVIGAVGFMNQRLE--VPKDVDPQWIALMESCWHSEPQCRPSFQELMDKLR 739
Query: 545 QIAK 548
++ +
Sbjct: 740 ELQR 743
|
|
| TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 604 (217.7 bits), Expect = 7.3e-59, P = 7.3e-59
Identities = 111/273 (40%), Positives = 178/273 (65%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLK-PER-----INSDMQKE 335
+ ++ + +D L FG K A G Y LY G Y + VA+K++ P+ + + ++K+
Sbjct: 195 EASEEFRVDMSKLFFGLKFAHGLYSRLYHGKYEDKAVAVKLITVPDDDDNGCLGARLEKQ 254
Query: 336 FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLK 394
F +EV ++ ++ H NV++F+GA PP C++T+++ GS+ +LHK + L L++
Sbjct: 255 FTKEVTLLSRLTHPNVIKFVGAYKDPPVYCVLTQYLPEGSLRSFLHKPENRSLPLKKLIE 314
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 454
AID+++GM Y+H IIHRDLK N+L+DE +K+ADFG+A + ++ + GTYR
Sbjct: 315 FAIDIARGMEYIHSRRIIHRDLKPENVLIDEEFHLKIADFGIACEEEYCDMLADDPGTYR 374
Query: 455 WMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 514
WMAPE+I+ KP+ KADV+SFG+VLWE++ G +PYE + P+QAA VV K +RP IP +
Sbjct: 375 WMAPEMIKRKPHGRKADVYSFGLVLWEMVAGAIPYEDMNPIQAAFAVVHKNIRPAIPGDC 434
Query: 515 QPKLAELLERCWQQDPALRPDFSEIIEILQQIA 547
+ L+E+CW P RP+F +I+++L+Q A
Sbjct: 435 PVAMKALIEQCWSVAPDKRPEFWQIVKVLEQFA 467
|
|
| DICTYBASE|DDB_G0289791 drkA "DRK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 594 (214.2 bits), Expect = 8.4e-58, P = 8.4e-58
Identities = 118/281 (41%), Positives = 175/281 (62%)
Query: 271 KSHPYHLKIPNDGTDVWE---IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPER 327
+S Y+ ND T + + ID +K G ++ G+YG++Y GT+ VA+K L
Sbjct: 348 RSSGYYKPDKNDYTQIKDGKDIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHN 407
Query: 328 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 387
IN ++ KEF +E+ +M+ +RH NV+QF+G+C PP +CI TE+M GS+Y LH
Sbjct: 408 INENILKEFHREINLMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQL 467
Query: 388 KLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445
+ L+K+ ID +KG+ YLH + I+HRDLK+ NLL+DEN VKVADFG++ ++ Q
Sbjct: 468 QWSLLIKMMIDAAKGVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGAT 527
Query: 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG 505
MTA GT W +PEV+ + Y KADV+SFGI+LWE T + PY + P Q V ++G
Sbjct: 528 MTA-CGTPCWTSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREG 586
Query: 506 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
+RP +P+N PK +LL C ++P+ RP + +E L+ I
Sbjct: 587 MRPPVPQNGPPKYIQLLIDCLNENPSHRPTMEQCLERLESI 627
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00036186001 | SubName- Full=Chromosome chr3 scaffold_8, whole genome shotgun sequence; (580 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 575 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-94 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-93 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-92 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-83 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-74 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-74 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-67 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-66 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-66 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-65 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-63 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-62 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-62 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-59 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-59 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-56 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-56 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-55 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-55 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-55 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-55 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-53 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-53 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-53 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-52 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-52 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-51 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-51 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-50 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-50 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-50 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-50 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-49 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-49 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-49 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-49 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-49 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-48 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-48 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-48 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-48 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-46 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-45 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-45 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-45 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-45 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-44 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-44 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-44 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-44 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-43 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-42 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-41 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-41 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-41 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-41 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-41 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-41 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-40 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-40 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-40 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-40 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-40 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-39 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-39 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-39 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-39 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-39 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-38 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-38 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-38 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-38 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-38 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-38 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-38 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-37 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-37 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-37 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-37 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-37 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-37 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-36 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-36 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-36 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-36 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-35 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-35 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-35 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-35 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-35 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-34 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-34 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-34 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-34 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-34 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-33 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-33 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-33 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-33 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-33 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-33 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-33 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-33 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-32 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-32 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-32 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-32 | |
| cd04928 | 68 | cd04928, ACT_TyrKc, Uncharacterized, N-terminal AC | 5e-32 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-32 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-31 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-31 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-31 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-31 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-31 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-31 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-30 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-30 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-30 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-30 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-30 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-29 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-29 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-28 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-28 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-28 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-28 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-28 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-28 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-28 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-28 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-28 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-28 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-28 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-27 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-27 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-27 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-27 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-27 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-27 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-27 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-27 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-27 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-27 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-27 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-27 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-27 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-27 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-27 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-27 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-26 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-26 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-26 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-26 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-26 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-25 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-25 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-25 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-25 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-25 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-24 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-24 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-24 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-24 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-24 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-24 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-23 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-23 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-23 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-23 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-23 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-23 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-23 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-23 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-21 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-21 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-21 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-21 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-21 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-20 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-20 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-20 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-20 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-20 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-20 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-20 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-20 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-20 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-20 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-19 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-19 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-19 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-19 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-19 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-18 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-18 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-18 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-18 | |
| cd04900 | 73 | cd04900, ACT_UUR-like_1, ACT domain family, ACT_UU | 4e-18 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-17 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-17 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-17 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-17 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-17 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-17 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-17 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-17 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-17 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-16 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-16 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-16 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-16 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-16 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-16 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-16 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-16 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-15 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-15 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-14 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-14 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-14 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-12 | |
| cd04873 | 70 | cd04873, ACT_UUR-ACR-like, ACT domains of the bact | 7e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-11 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-11 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-11 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-07 | |
| PRK05092 | 931 | PRK05092, PRK05092, PII uridylyl-transferase; Prov | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| cd02116 | 60 | cd02116, ACT, ACT domains are commonly involved in | 1e-06 | |
| COG2844 | 867 | COG2844, GlnD, UTP:GlnB (protein PII) uridylyltran | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-06 | |
| pfam01842 | 66 | pfam01842, ACT, ACT domain | 5e-06 | |
| cd04899 | 70 | cd04899, ACT_ACR-UUR-like_2, C-terminal ACT domain | 7e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-05 | |
| TIGR01693 | 850 | TIGR01693, UTase_glnD, [Protein-PII] uridylyltrans | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-05 | |
| PRK05007 | 884 | PRK05007, PRK05007, PII uridylyl-transferase; Prov | 2e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-04 | |
| PRK00275 | 895 | PRK00275, glnD, PII uridylyl-transferase; Provisio | 0.001 | |
| PRK03381 | 774 | PRK03381, PRK03381, PII uridylyl-transferase; Prov | 0.002 | |
| PRK03381 | 774 | PRK03381, PRK03381, PII uridylyl-transferase; Prov | 0.003 | |
| COG2844 | 867 | COG2844, GlnD, UTP:GlnB (protein PII) uridylyltran | 0.004 | |
| TIGR01693 | 850 | TIGR01693, UTase_glnD, [Protein-PII] uridylyltrans | 0.004 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 287 bits (738), Expect = 6e-94
Identities = 101/259 (38%), Positives = 151/259 (58%), Gaps = 11/259 (4%)
Query: 294 LKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
L G K+ G++G++Y+G +VA+K LK + + +EF +E IMRK+
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLD 59
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H NVV+ +G CT+ L IV E+M GG + YL K + L LL A+ +++GM YL
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG--TYRWMAPEVIEHKP 465
N IHRDL A N L+ EN VVK++DFG++R G RWMAPE ++
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 466 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524
+ K+DV+SFG++LWE+ T G+ PY ++ + + ++ G R P N P+L +L+ +
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-VLEYLKNGYRLPQPPNCPPELYDLMLQ 238
Query: 525 CWQQDPALRPDFSEIIEIL 543
CW +DP RP FSE++EIL
Sbjct: 239 CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 284 bits (730), Expect = 9e-93
Identities = 99/260 (38%), Positives = 156/260 (60%), Gaps = 12/260 (4%)
Query: 294 LKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
L+ G K+ G++G++Y+GT VA+K LK + + ++EF +E IM+K+
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG-ASEEEREEFLEEASIMKKLS 59
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H N+V+ +G CT+ L IVTE+M GG + D+L K L LL++A+ ++KGM YL
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHK 464
N +HRDL A N L+ EN VVK++DFG++R + G +WMAPE ++
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179
Query: 465 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 523
+ K+DV+SFG++LWE+ T G+ PY ++ + + +++ G R P+N +L EL+
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-VLELLEDGYRLPRPENCPDELYELML 238
Query: 524 RCWQQDPALRPDFSEIIEIL 543
+CW DP RP FSE++E L
Sbjct: 239 QCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 283 bits (727), Expect = 2e-92
Identities = 103/260 (39%), Positives = 155/260 (59%), Gaps = 12/260 (4%)
Query: 294 LKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
L G K+ G++G++Y+GT +VA+K LK + + +EF +E IMRK+
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED-ASEQQIEEFLREARIMRKLD 59
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYL 406
H N+V+ +G CT+ L IV E+M GG + DYL K + L LL A+ +++GM YL
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 407 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG--TYRWMAPEVIEHK 464
N IHRDL A N L+ EN VVK++DFG++R + G RWMAPE ++
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 465 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 523
+ K+DV+SFG++LWE+ T G+ PY ++ + + ++KG R P N P+L +L+
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE-VLEYLKKGYRLPKPPNCPPELYKLML 238
Query: 524 RCWQQDPALRPDFSEIIEIL 543
+CW +DP RP FSE++EIL
Sbjct: 239 QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 259 bits (665), Expect = 4e-83
Identities = 100/260 (38%), Positives = 152/260 (58%), Gaps = 19/260 (7%)
Query: 302 SGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
G++G++Y+G + +VA+K LK E + + +K+F +E +M+K+ H NVV+ +G
Sbjct: 5 EGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVVRLLG 63
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--------LLKVAIDVSKGMNYLHQ 408
CT+ L +V E+M GG + DYL K + VF P LL AI ++KGM YL
Sbjct: 64 VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS 123
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKP 465
+HRDL A N L+ E+ VVK++DFG++R +TG RWMAPE ++
Sbjct: 124 KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGI 183
Query: 466 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524
+ K+DV+SFG++LWE+ T G PY L+ + + ++KG R P+ +L EL+
Sbjct: 184 FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-VLEYLRKGYRLPKPEYCPDELYELMLS 242
Query: 525 CWQQDPALRPDFSEIIEILQ 544
CWQ DP RP FSE++E L+
Sbjct: 243 CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 237 bits (607), Expect = 2e-74
Identities = 93/257 (36%), Positives = 146/257 (56%), Gaps = 10/257 (3%)
Query: 294 LKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351
+ K+ SGS+G +Y+ + + VA+K+LK S + +E+ I+R++ H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V+ I A L +V E+ GG ++DYL + G K+A+ + +G+ YLH N I
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVI-EHKPYDHK 469
IHRDLK N+L+DEN VVK+ADFG+A+ +S +T GT +MAPEV+ Y K
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 470 ADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVVQKGLRPTIPK--NSQPKLAELLER 524
DV+S G++L+ELLTGK P+ L LQ ++ L PK + + +L+++
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239
Query: 525 CWQQDPALRPDFSEIIE 541
C +DP+ RP EI++
Sbjct: 240 CLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 236 bits (604), Expect = 4e-74
Identities = 80/251 (31%), Positives = 128/251 (50%), Gaps = 6/251 (2%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ K+ GS+G +Y + VAIKV+K ++I D ++ +E+ I++K++H N+V
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD-RERILREIKILKKLKHPNIV 60
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ L +V E+ GG ++D L K +G + + YLH I+
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKGIV 119
Query: 413 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADV 472
HRDLK N+L+DE+ VK+ADFG+AR +T GT +MAPEV+ K Y D+
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179
Query: 473 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQDP 530
+S G++L+ELLTGK P+ L + K P P P+ +L+ + +DP
Sbjct: 180 WSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDP 239
Query: 531 ALRPDFSEIIE 541
R E ++
Sbjct: 240 EKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 217 bits (554), Expect = 3e-67
Identities = 77/247 (31%), Positives = 129/247 (52%), Gaps = 39/247 (15%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
G +G +Y + VAIK++K E +S ++ E +E+ I++K+ H N+V+ G
Sbjct: 3 EGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE-ELLREIEILKKLNHPNIVKLYGVFE 61
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
L +V E+ GGS+ D L + +G +L++ + + +G+ YLH N IIHRDLK
Sbjct: 62 DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPE 121
Query: 420 NLLMDENE-VVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKP-YDHKADVFSFG 476
N+L+D + VK+ADFG+++ + + ++ GT +MAPEV+ K Y K+D++S G
Sbjct: 122 NILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLG 181
Query: 477 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 536
++L+EL P+L +L+ + Q+DP RP
Sbjct: 182 VILYEL---------------------------------PELKDLIRKMLQKDPEKRPSA 208
Query: 537 SEIIEIL 543
EI+E L
Sbjct: 209 KEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 2e-66
Identities = 105/264 (39%), Positives = 159/264 (60%), Gaps = 12/264 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
W I+ K LK G+ + G +GD+ G Y Q VA+K LK +S + F E +M +
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTL 57
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNY 405
RH N+VQ +G + L IVTE+M+ GS+ DYL + + V L L A+DV +GM Y
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEH 463
L + N +HRDL A N+L+ E+ V KV+DFG+A+ +A G ++G +W APE +
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-EASQGQ---DSGKLPVKWTAPEALRE 173
Query: 464 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 522
K + K+DV+SFGI+LWE+ + G++PY + PL+ V V+KG R P+ P++ +++
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPHVEKGYRMEAPEGCPPEVYKVM 232
Query: 523 ERCWQQDPALRPDFSEIIEILQQI 546
+ CW+ DPA RP F ++ E L I
Sbjct: 233 KDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 5e-66
Identities = 97/262 (37%), Positives = 151/262 (57%), Gaps = 14/262 (5%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
IDP L F ++ SG +G ++ G + + DVAIK+++ ++ D +F +E +M K+
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLS 57
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H N+VQ G CTK + IVTE+M+ G + +YL + KG LL + DV + M YL
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVMTAETGT---YRWMAPEVIE 462
N IHRDL A N L+ E+ VVKV+DFG+AR + Q T+ GT +W PEV +
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFD 174
Query: 463 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521
+ + K+DV+SFG+++WE+ + GK+PYE + + V V G R PK + ++ +
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-VVESVSAGYRLYRPKLAPTEVYTI 233
Query: 522 LERCWQQDPALRPDFSEIIEIL 543
+ CW + P RP F +++ L
Sbjct: 234 MYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 8e-65
Identities = 88/246 (35%), Positives = 139/246 (56%), Gaps = 7/246 (2%)
Query: 293 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 350
+ K+ G +G++Y+ + ++VAIKV+K E + + +++ E+ I++K +H N
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPN 58
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 410
+V++ G+ K L IV EF SGGS+ D L + V ++ KG+ YLH N
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 411 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 470
IIHRD+KAAN+L+ + VK+ DFG++ + + GT WMAPEVI KPYD+KA
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKA 178
Query: 471 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQ 528
D++S GI EL GK PY L P++A + G P + + + + L++C Q+
Sbjct: 179 DIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP-PGLRNPEKWSDEFKDFLKKCLQK 237
Query: 529 DPALRP 534
+P RP
Sbjct: 238 NPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 1e-63
Identities = 100/264 (37%), Positives = 150/264 (56%), Gaps = 15/264 (5%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WEID ++ K+ +G +G+++ G + + VA+K LKP ++ K+F E IM+K
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP---KDFLAEAQIMKK 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMN 404
+RH ++Q CT + IVTE M GS+ +YL G KLP L+ +A V+ GM
Sbjct: 58 LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVI 461
YL N IHRDL A N+L+ EN + KVADFG+ARV + + A G +W APE
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED-IYEAREGAKFPIKWTAPEAA 176
Query: 462 EHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 520
+ + K+DV+SFGI+L E++T G++PY +T + + V +G R P +L +
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-VLQQVDQGYRMPCPPGCPKELYD 235
Query: 521 LLERCWQQDPALRPDFSEIIEILQ 544
++ CW++DP RP F E LQ
Sbjct: 236 IMLDCWKEDPDDRPTF----ETLQ 255
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 206 bits (527), Expect = 1e-62
Identities = 103/267 (38%), Positives = 156/267 (58%), Gaps = 13/267 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKE-FAQEVFIMR 344
WEI + LK K+ +G +G+++ GT+ + VA+K LKP M E F QE IM+
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKP----GTMSPEAFLQEAQIMK 56
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGM 403
K+RH +VQ C++ + IVTE+MS GS+ D+L +G +LP L+ +A +++GM
Sbjct: 57 KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGM 116
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEV 460
YL N IHRDL A N+L+ EN V K+ADFG+AR+ TA G +W APE
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD-EYTAREGAKFPIKWTAPEA 175
Query: 461 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 519
+ + K+DV+SFGI+L E++T G++PY +T + + V++G R P N +L
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQVERGYRMPRPPNCPEELY 234
Query: 520 ELLERCWQQDPALRPDFSEIIEILQQI 546
+L+ +CW +DP RP F + L+
Sbjct: 235 DLMLQCWDKDPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 204 bits (522), Expect = 5e-62
Identities = 79/246 (32%), Positives = 128/246 (52%), Gaps = 9/246 (3%)
Query: 297 GSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
G + GS+G +Y +A+K ++ + + + +E+ I+ ++H N+V++
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 355 IGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
G+ +L I E++SGGS+ L K G P + K + +G+ YLH N I+
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLAYLHSNGIV 123
Query: 413 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET---GTYRWMAPEVIEHKPYDHK 469
HRD+K AN+L+D + VVK+ADFG A+ GT WMAPEVI + Y
Sbjct: 124 HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRA 183
Query: 470 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVG-VVQKGLRPTIPKNSQPKLAELLERCWQQ 528
AD++S G + E+ TGK P+ L AA+ + G P IP++ + + L +C ++
Sbjct: 184 ADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRR 243
Query: 529 DPALRP 534
DP RP
Sbjct: 244 DPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 4e-59
Identities = 97/268 (36%), Positives = 156/268 (58%), Gaps = 14/268 (5%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMR 344
WE++ + K+ G YG++Y G + VA+K LK + + + EF +E +M+
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMK 57
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKG 402
+++H N+VQ +G CT+ P I+TEFM+ G++ DYL + ++ + LL +A +S
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSA 116
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 459
M YL + N IHRDL A N L+ EN +VKVADFG++R+ TA G +W APE
Sbjct: 117 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPE 175
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518
+ + + K+DV++FG++LWE+ T G PY + L +++KG R P+ PK+
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKGYRMERPEGCPPKV 234
Query: 519 AELLERCWQQDPALRPDFSEIIEILQQI 546
EL+ CWQ +P+ RP F+EI + + +
Sbjct: 235 YELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 9e-59
Identities = 91/249 (36%), Positives = 141/249 (56%), Gaps = 11/249 (4%)
Query: 293 HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 350
+ + G + G++G +Y+G VAIK + E+I + K QE+ +++ ++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS---KGMNYLH 407
+V++IG+ SL I+ E+ GS+ + K P L VA+ V +G+ YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESL-VAVYVYQVLQGLAYLH 116
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPY 466
+ +IHRD+KAAN+L ++ VVK+ADFGVA ++ S + GT WMAPEVIE
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 467 DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 526
+D++S G + ELLTG PY L P+ A +VQ P +P+ P+L + L +C+
Sbjct: 177 STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPPLPEGISPELKDFLMQCF 235
Query: 527 QQDPALRPD 535
Q+DP LRP
Sbjct: 236 QKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 5e-56
Identities = 89/252 (35%), Positives = 141/252 (55%), Gaps = 9/252 (3%)
Query: 299 KVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
K+ G++GD+Y+G +VA+K + +K F QE I+++ H N+V+ IG
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIGV 60
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 417
C + + IV E + GGS+ +L K K + LL++++D + GM YL N IHRDL
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLA 120
Query: 418 AANLLMDENEVVKVADFGVARVKAQSGVMTAETGT----YRWMAPEVIEHKPYDHKADVF 473
A N L+ EN V+K++DFG++R + + G+ T G +W APE + + Y ++DV+
Sbjct: 121 ARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVW 179
Query: 474 SFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 532
S+GI+LWE + G PY ++ Q ++ G R P+ ++ L+ +CW DP
Sbjct: 180 SYGILLWETFSLGDTPYPGMSNQQTR-ERIESGYRMPAPQLCPEEIYRLMLQCWAYDPEN 238
Query: 533 RPDFSEIIEILQ 544
RP FSEI LQ
Sbjct: 239 RPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 8e-56
Identities = 94/267 (35%), Positives = 148/267 (55%), Gaps = 13/267 (4%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQK-EFAQEVFI 342
IDP ++ + G +G++ RG DVAIK LK +SD Q+ +F E I
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG--SSDKQRLDFLTEASI 58
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
M + H N+++ G TK + I+TE+M GS+ +L + G F + L+ + ++ G
Sbjct: 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASG 118
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETG--TYRWMAPE 459
M YL + N +HRDL A N+L++ N V KV+DFG++R S T + G RW APE
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE 178
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518
I ++ + +DV+SFGIV+WE+++ G+ PY ++ Q + V+ G R P + L
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDGYRLPPPMDCPSAL 237
Query: 519 AELLERCWQQDPALRPDFSEIIEILQQ 545
+L+ CWQ+D RP FS+I+ L +
Sbjct: 238 YQLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 187 bits (475), Expect = 2e-55
Identities = 95/260 (36%), Positives = 150/260 (57%), Gaps = 10/260 (3%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
I P L ++ SG +G ++ G + + VAIK ++ ++ +++F +E +M K+
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLS 57
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H +VQ G CT+ +C+V EFM G + DYL +G F +LL + +DV +GM YL
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHK 464
+N+IHRDL A N L+ EN+VVKV+DFG+ R T+ TGT +W +PEV
Sbjct: 118 SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSFS 176
Query: 465 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 523
Y K+DV+SFG+++WE+ + GK PYE + + V + G R P+ + + EL++
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-VVETINAGFRLYKPRLASQSVYELMQ 235
Query: 524 RCWQQDPALRPDFSEIIEIL 543
CW++ P RP FS ++ L
Sbjct: 236 HCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 6e-55
Identities = 88/264 (33%), Positives = 148/264 (56%), Gaps = 7/264 (2%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WE + K+ SG +G+++ G + VAIK+LK + + Q++F +EV +++
Sbjct: 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKR 58
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMN 404
+RHK+++ C+ + I+TE M GS+ +L +G V + SL+ +A V++GM
Sbjct: 59 LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT-YRWMAPEVIEH 463
YL + N IHRDL A N+L+ E+ V KVADFG+AR+ + ++++ Y+W APE H
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH 178
Query: 464 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 522
+ K+DV+SFGI+L+E+ T G++PY + + G R P ++ +++
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQITAGYRMPCPAKCPQEIYKIM 237
Query: 523 ERCWQQDPALRPDFSEIIEILQQI 546
CW +P RP F + E L I
Sbjct: 238 LECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 6e-55
Identities = 97/263 (36%), Positives = 148/263 (56%), Gaps = 10/263 (3%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
W ++ K LK + G +GD+ G Y VA+K +K N + F E +M ++
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 56
Query: 347 RHKNVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMN 404
RH N+VQ +G + L IVTE+M+ GS+ DYL + + V LLK ++DV + M
Sbjct: 57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 464
YL NN +HRDL A N+L+ E+ V KV+DFG+ K S +W APE + K
Sbjct: 117 YLEANNFVHRDLAARNVLVSEDNVAKVSDFGLT--KEASSTQDTGKLPVKWTAPEALREK 174
Query: 465 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 523
+ K+DV+SFGI+LWE+ + G++PY + PL+ V V+KG + P P + ++++
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPVVYDVMK 233
Query: 524 RCWQQDPALRPDFSEIIEILQQI 546
+CW D A RP F ++ E L+ I
Sbjct: 234 QCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 8e-55
Identities = 88/264 (33%), Positives = 143/264 (54%), Gaps = 22/264 (8%)
Query: 290 DP-KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
DP + K K+ G+ G++Y+ T + ++VAIK + R+ ++ E+ IM+
Sbjct: 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINEILIMKDC 72
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
+H N+V + + L +V E+M GGS+ D + + P + V +V +G+ YL
Sbjct: 73 KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 407 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET-------GTYRWMAPE 459
H N+IHRD+K+ N+L+ ++ VK+ADFG A AQ +T E GT WMAPE
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFA---AQ---LTKEKSKRNSVVGTPYWMAPE 186
Query: 460 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPK 517
VI+ K Y K D++S GI+ E+ G+ PY PL+A + KG+ P + P+ P+
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI-PPLKNPEKWSPE 245
Query: 518 LAELLERCWQQDPALRPDFSEIIE 541
+ L +C +DP RP E+++
Sbjct: 246 FKDFLNKCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 1e-53
Identities = 90/259 (34%), Positives = 145/259 (55%), Gaps = 8/259 (3%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
I+P L F ++ SG +G ++ G + +Q VAIK + ++ + +F +E +M K+
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLS 57
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H +VQ G CT+ L IVTEFM G + +YL + +G LL + DV +GM YL
Sbjct: 58 HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEHKP 465
+N+ IHRDL A N L+ VVKV+DFG+ R ++ + +W PEV
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK 177
Query: 466 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524
Y K+DV+SFG+++WE+ T GK+P+E + + V ++ +G R PK + + E++
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-VVEMISRGFRLYRPKLASMTVYEVMYS 236
Query: 525 CWQQDPALRPDFSEIIEIL 543
CW + P RP F+E++ +
Sbjct: 237 CWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 2e-53
Identities = 94/261 (36%), Positives = 148/261 (56%), Gaps = 10/261 (3%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
IDPK L F ++ +G +G + G + Q DVAIK++K ++ D EF +E +M K+
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLS 57
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H+ +VQ G CTK + IVTE+MS G + +YL + F+ LL++ DV +GM YL
Sbjct: 58 HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE 117
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHK 464
IHRDL A N L+D+ VKV+DFG++R T+ G+ RW PEV+ +
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLLYS 176
Query: 465 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 523
+ K+DV++FG+++WE+ + GK+PYE + V Q GLR P + K+ ++
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ-GLRLYRPHLASEKVYAIMY 235
Query: 524 RCWQQDPALRPDFSEIIEILQ 544
CW + RP F +++ ++
Sbjct: 236 SCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 5e-53
Identities = 83/258 (32%), Positives = 143/258 (55%), Gaps = 18/258 (6%)
Query: 299 KVASGSYGDLYRGTYCSQDVAIKVLKPERIN-SDM---QKEFA-QEVFIMRKVRHKNVVQ 353
++ GS+G +Y D + VLK I+ S+M ++E A EV I++K+ H N+++
Sbjct: 7 QIGKGSFGKVYLVR-RKSDGKLYVLK--EIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS---LLKVAIDVSKGMNYLHQNN 410
+ + + LCIV E+ GG + + K K K +L + + + YLH
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123
Query: 411 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDH 468
I+HRD+K N+ + N +VK+ DFG+++V + + + A+T GT +++PE+ ++KPY++
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL-AKTVVGTPYYLSPELCQNKPYNY 182
Query: 469 KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 528
K+D++S G VL+EL T K P+E L+ A+ +++ P IP +L L+ Q+
Sbjct: 183 KSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP-IPSQYSSELRNLVSSLLQK 241
Query: 529 DPALRPDFSEIIEILQQI 546
DP RP I +ILQ
Sbjct: 242 DPEERPS---IAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 2e-52
Identities = 89/271 (32%), Positives = 139/271 (51%), Gaps = 11/271 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVF 341
+EI + + G + G +GD+Y+G Y S + VA+K K S +K F QE +
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAY 59
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
IMR+ H ++V+ IG T+ P IV E G + YL K L SL+ + +S
Sbjct: 60 IMRQFDHPHIVKLIGVITENPVW-IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118
Query: 402 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPE 459
+ YL +HRD+ A N+L+ + VK+ DFG++R A G +WMAPE
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518
I + + +DV+ FG+ +WE+L G P++ + +G ++ G R +P N P L
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGERLPMPPNCPPTL 237
Query: 519 AELLERCWQQDPALRPDFSEIIEILQQIAKE 549
L+ +CW DP+ RP F+E+ L I +E
Sbjct: 238 YSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 2e-52
Identities = 88/266 (33%), Positives = 143/266 (53%), Gaps = 13/266 (4%)
Query: 294 LKFGSKVASGSYGDLYRGTYCSQ------DVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
L+ + SG++G +Y+G + + VAIKVL+ E + KE E ++M V
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASVD 67
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H +VV+ +G C + ++T+ M G + DY+ K LL + ++KGM+YL
Sbjct: 68 HPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHK 464
+ ++HRDL A N+L+ + VK+ DFG+A+ + AE G +WMA E I H+
Sbjct: 127 EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR 186
Query: 465 PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 523
Y HK+DV+S+G+ +WEL+T G PYE + P +++KG R P + +L
Sbjct: 187 IYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERLPQPPICTIDVYMVLV 245
Query: 524 RCWQQDPALRPDFSEIIEILQQIAKE 549
+CW D RP F E+I ++A++
Sbjct: 246 KCWMIDAESRPTFKELINEFSKMARD 271
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 1e-51
Identities = 88/263 (33%), Positives = 151/263 (57%), Gaps = 14/263 (5%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
W ++ + L G + G +G + +G Y Q VA+K +K + + F +E +M K+
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKL 56
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNY 405
HKN+V+ +G L IV E MS G++ ++L + + + + LL+ ++DV++GM Y
Sbjct: 57 HHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIEH 463
L ++HRDL A N+L+ E+ V KV+DFG+ARV G M + +W APE ++H
Sbjct: 116 LESKKLVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKH 171
Query: 464 KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 522
K + K+DV+S+G++LWE+ + G+ PY ++ L+ V+KG R P+ + L+
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-LKEVKECVEKGYRMEPPEGCPADVYVLM 230
Query: 523 ERCWQQDPALRPDFSEIIEILQQ 545
CW+ +P RP F ++ E L++
Sbjct: 231 TSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 3e-51
Identities = 86/283 (30%), Positives = 139/283 (49%), Gaps = 32/283 (11%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQD-----VAIKVLKPERINSDMQKEFAQE 339
WE+ + + ++ GS+G +Y G + VAIK + E + + EF E
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN-ENASMRERIEFLNE 59
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLL 393
+M++ +VV+ +G + +V E M+ G + YL + P+L
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 394 KV---AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--------KAQ 442
K A +++ GM YL +HRDL A N ++ E+ VK+ DFG+ R K
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG 179
Query: 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 501
G++ RWMAPE ++ + K+DV+SFG+VLWE+ T + PY+ L+ + V
Sbjct: 180 KGLLPV-----RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234
Query: 502 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 544
+ G +P+N KL EL+ CWQ +P +RP F EI+ L+
Sbjct: 235 IDGGHLD-LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 1e-50
Identities = 86/260 (33%), Positives = 129/260 (49%), Gaps = 36/260 (13%)
Query: 299 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ GS+G++Y+ +Q VAIKV+ E +++ + QE+ + + R + ++ G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE-DIQQEIQFLSQCRSPYITKYYG 66
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ K L I+ E+ GGS D L G + + +V G+ YLH+ IHRD+
Sbjct: 67 SFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGLEYLHEEGKIHRDI 124
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAET-------GTYRWMAPEVIEHKPYDHK 469
KAAN+L+ E VK+ADFGV SG +T+ GT WMAPEVI+ YD K
Sbjct: 125 KAANILLSEEGDVKLADFGV------SGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEK 178
Query: 470 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA---------E 520
AD++S GI EL G+ P L P++ L IPKN+ P L +
Sbjct: 179 ADIWSLGITAIELAKGEPPLSDLHPMRV--------LF-LIPKNNPPSLEGNKFSKPFKD 229
Query: 521 LLERCWQQDPALRPDFSEII 540
+ C +DP RP E++
Sbjct: 230 FVSLCLNKDPKERPSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 5e-50
Identities = 86/266 (32%), Positives = 134/266 (50%), Gaps = 19/266 (7%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 348
+ + G+ +Y C ++ VAIK + E+ + + E +EV M + H
Sbjct: 1 DDYELIEVIGVGATAVVYAA-ICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAMSQCNH 58
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL-HKLK-GVFKLPSLLKVAIDVSKGMNYL 406
NVV++ + L +V ++SGGS+ D + G + V +V KG+ YL
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 407 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET-----GTYRWMAPEVI 461
H N IHRD+KA N+L+ E+ VK+ADFGV+ A G T + GT WMAPEV+
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 462 E-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK--- 517
E YD KAD++SFGI EL TG PY P++ + +Q P++ + K
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PPSLETGADYKKYS 237
Query: 518 --LAELLERCWQQDPALRPDFSEIIE 541
+++ C Q+DP+ RP E+++
Sbjct: 238 KSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 7e-50
Identities = 98/264 (37%), Positives = 160/264 (60%), Gaps = 12/264 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WEI + L+ K+ +G +G+++ GT+ + VA+K LKP ++ + F +E IM+K
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKK 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMN 404
+RH +VQ ++ P + IVTE+MS GS+ D+L +G KLP+L+ +A V+ GM
Sbjct: 58 LRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVI 461
Y+ + N IHRDL++AN+L+ + V K+ADFG+AR+ + TA G +W APE
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 462 EHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 520
+ + K+DV+SFGI+L EL+T G++PY + + + V++G R P++ L E
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERGYRMPCPQDCPISLHE 234
Query: 521 LLERCWQQDPALRPDFSEIIEILQ 544
L+ +CW++DP RP F + L+
Sbjct: 235 LMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 9e-50
Identities = 84/256 (32%), Positives = 137/256 (53%), Gaps = 13/256 (5%)
Query: 299 KVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
K+ GS+G + RG + + VA+K LK +++ SD+ +F +E IM + H+N+++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL-SDIMDDFLKEAAIMHSLDHENLIR 60
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
G P L +VTE GS+ D L K G F + +L A+ ++ GM YL I
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119
Query: 413 HRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGT-YRWMAPEVIEHKPYDH 468
HRDL A N+L+ ++ VK+ DFG+ R Q+ VM + W APE + + + H
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSH 179
Query: 469 KADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527
+DV+ FG+ LWE+ T G+ P+ L+ Q + ++G R P+ + ++ +CW
Sbjct: 180 ASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWA 239
Query: 528 QDPALRPDFSEIIEIL 543
+PA RP F+ + E L
Sbjct: 240 HNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 2e-49
Identities = 84/251 (33%), Positives = 134/251 (53%), Gaps = 7/251 (2%)
Query: 297 GSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQ---KEFAQEVFIMRKVRHKNV 351
G + SGS+G +Y G A+K + Q K+ QE+ ++ K++H N+
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
VQ++G + +L I E + GGS+ L K G F P + + G+ YLH N
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNT 123
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKA 470
+HRD+K AN+L+D N VVK+ADFG+A+ + + G+ WMAPEVI + Y A
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183
Query: 471 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 530
D++S G + E+ TGK P+ L + A + + P IP + + + + +C Q+DP
Sbjct: 184 DIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDP 243
Query: 531 ALRPDFSEIIE 541
+LRP +E++E
Sbjct: 244 SLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 4e-49
Identities = 102/264 (38%), Positives = 157/264 (59%), Gaps = 12/264 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WEI + L+ K+ G +G+++ GT+ + VAIK LKP + M + F QE IM+K
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKK 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMN 404
+RH +V ++ P + IVTEFM GS+ D+L + G + KLP L+ +A ++ GM
Sbjct: 58 LRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVI 461
Y+ + N IHRDL+AAN+L+ +N V K+ADFG+AR+ + TA G +W APE
Sbjct: 117 YIERMNYIHRDLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 462 EHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 520
+ + K+DV+SFGI+L EL+T G++PY + + + V++G R P+ L E
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-REVLEQVERGYRMPCPQGCPESLHE 234
Query: 521 LLERCWQQDPALRPDFSEIIEILQ 544
L++ CW++DP RP F I L+
Sbjct: 235 LMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 5e-49
Identities = 82/288 (28%), Positives = 137/288 (47%), Gaps = 39/288 (13%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRK 345
+HLKF ++ G +G + Y VA+K L +F +E+ I+R
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHR-SDFEREIEILRT 62
Query: 346 VRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+ H+N+V++ G C KP SL ++ E++ GS+ DYL + + L LL + + KGM
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----VMTAETGTYRWMAPE 459
+YL IHRDL A N+L++ ++VK++DFG+A+V + V W APE
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 460 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 519
+ + +DV+SFG+ L+EL T Y P Q+ + + + +L
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT------YGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236
Query: 520 ELLE--------------------RCWQQDPALRPDFSEIIEILQQIA 547
ELL+ CW+ +P RP F+++I I+ ++
Sbjct: 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 6e-49
Identities = 87/263 (33%), Positives = 153/263 (58%), Gaps = 10/263 (3%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WE+ + LK K+ +G +G+++ G Y VAIK LK ++ + F E +M++
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---AFLAEANLMKQ 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMN 404
++H +V+ T+ P + I+TE+M GS+ D+L +G+ + L+ +A +++GM
Sbjct: 58 LQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 462
++ + N IHRDL+AAN+L+ E K+ADFG+AR+ + E + +W APE I
Sbjct: 117 FIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 176
Query: 463 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521
+ + K+DV+SFGI+L E++T G++PY +T + + +++G R P N +L EL
Sbjct: 177 YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-VIQNLERGYRMPRPDNCPEELYEL 235
Query: 522 LERCWQQDPALRPDFSEIIEILQ 544
+ CW++ P RP F + +L+
Sbjct: 236 MRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 8e-49
Identities = 88/247 (35%), Positives = 142/247 (57%), Gaps = 12/247 (4%)
Query: 300 VASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358
+ G++G++++GT + VA+K K E + +++ +F E I+++ H N+V+ IG C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCK-EDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418
T+ + IV E + GG +L K K K L+K A+D + GM YL N IHRDL A
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAA 121
Query: 419 ANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 473
N L+ EN V+K++DFG++R + + SG+ +W APE + + Y ++DV+
Sbjct: 122 RNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI---KWTAPEALNYGRYSSESDVW 178
Query: 474 SFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 532
S+GI+LWE + G PY +T Q A V+KG R + P+ + ++++RCW P
Sbjct: 179 SYGILLWETFSLGVCPYPGMTN-QQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPEN 237
Query: 533 RPDFSEI 539
RP FSE+
Sbjct: 238 RPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 1e-48
Identities = 81/243 (33%), Positives = 126/243 (51%), Gaps = 14/243 (5%)
Query: 299 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ GSYG +Y+ + Q VAIKV+ E ++ KE + I+++ +V++ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKE----ISILKQCDSPYIVKYYG 65
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ K L IV E+ GSV D + + + KG+ YLH N IHRD+
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDI 125
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFS 474
KA N+L++E K+ADFGV+ + + T GT WMAPEVI+ Y++KAD++S
Sbjct: 126 KAGNILLNEEGQAKLADFGVSG-QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWS 184
Query: 475 FGIVLWELLTGKLPYEYLTPLQAAVGVVQK---GLRPTIPKNSQPKLAELLERCWQQDPA 531
GI E+ GK PY + P++A + K L P+ P+ + +++C +DP
Sbjct: 185 LGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLS--DPEKWSPEFNDFVKKCLVKDPE 242
Query: 532 LRP 534
RP
Sbjct: 243 ERP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 2e-48
Identities = 79/255 (30%), Positives = 131/255 (51%), Gaps = 14/255 (5%)
Query: 302 SGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
G++G + +G Y + VA+K LK E I + +KEF +E +M ++ H +V+ IG
Sbjct: 5 HGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAG-KKEFLREASVMAQLDHPCIVRLIG 63
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
C K L +V E G + YL K + + L ++A V+ GM YL + +HRDL
Sbjct: 64 VC-KGEPLMLVMELAPLGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKHFVHRDL 121
Query: 417 KAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETG---TYRWMAPEVIEHKPYDHKADV 472
A N+L+ K++DFG++R + A S A T +W APE I + + K+DV
Sbjct: 122 AARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDV 181
Query: 473 FSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 531
+S+G+ LWE + G PY + + +++ G R P+ ++ ++ CW+ P
Sbjct: 182 WSYGVTLWEAFSYGAKPYGEMKG-AEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPE 240
Query: 532 LRPDFSEIIEILQQI 546
RP FSE+ ++
Sbjct: 241 DRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 3e-48
Identities = 98/264 (37%), Positives = 157/264 (59%), Gaps = 12/264 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WEI + L+ K+ G +G+++ GT+ + VAIK LKP ++ + F QE +M+K
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKK 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMN 404
+RH+ +VQ ++ P + IVTE+MS GS+ D+L G + +LP L+ +A ++ GM
Sbjct: 58 LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVI 461
Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+ + TA G +W APE
Sbjct: 117 YVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 462 EHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 520
+ + K+DV+SFGI+L EL T G++PY + + + V++G R P L +
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESLHD 234
Query: 521 LLERCWQQDPALRPDFSEIIEILQ 544
L+ +CW+++P RP F + L+
Sbjct: 235 LMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 8e-48
Identities = 88/262 (33%), Positives = 153/262 (58%), Gaps = 9/262 (3%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WEI + +K K+ +G +G+++ G Y S VA+K LKP ++ + F +E +M+
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV---QAFLEEANLMKT 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMN 404
++H +V+ TK + I+TE+M+ GS+ D+L +G LP L+ + +++GM
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 462
Y+ + N IHRDL+AAN+L+ E+ + K+ADFG+ARV + E + +W APE I
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 177
Query: 463 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521
+ K+DV+SFGI+L+E++T GK+PY ++ +Q+G R +N +L ++
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA-LQRGYRMPRMENCPDELYDI 236
Query: 522 LERCWQQDPALRPDFSEIIEIL 543
++ CW++ RP F + +L
Sbjct: 237 MKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 3e-46
Identities = 88/300 (29%), Positives = 154/300 (51%), Gaps = 41/300 (13%)
Query: 279 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------VAIKVLKPERINSD 331
+P D WE+ L G + G++G + + D VA+K+LK + D
Sbjct: 1 LPLD--PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD 58
Query: 332 MQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------- 380
+ + E+ +M+ + +HKN++ +G CT+ L +V E+ + G++ D+L
Sbjct: 59 L-SDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYA 117
Query: 381 -----HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
+ L+ A V++GM +L IHRDL A N+L+ E+ V+K+ADFG
Sbjct: 118 SPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFG 177
Query: 436 VAR--------VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GK 486
+AR K +G + +WMAPE + + Y H++DV+SFG++LWE+ T G
Sbjct: 178 LARDIHHIDYYRKTTNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 232
Query: 487 LPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
PY + P++ ++++G R P+N +L L+ CW + P+ RP F +++E L ++
Sbjct: 233 SPYPGI-PVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 1e-45
Identities = 91/269 (33%), Positives = 142/269 (52%), Gaps = 12/269 (4%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQEVFI 342
EI P H+ + +G +G+++RG VAIK LKP Q +F E I
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQ-DFLSEASI 59
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
M + H N+++ G TK I+TE+M G++ YL G F L+ + ++ G
Sbjct: 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAG 119
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ--SGVMTAETGT--YRWMAP 458
M YL N +HRDL A N+L++ N KV+DFG++RV G T G RW AP
Sbjct: 120 MKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 459 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 517
E I ++ + +DV+SFGIV+WE+++ G+ PY ++ + + G R P +
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDGFRLPAPMDCPSA 238
Query: 518 LAELLERCWQQDPALRPDFSEIIEILQQI 546
+ +L+ +CWQQD A RP F +I+ +L ++
Sbjct: 239 VYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 2e-45
Identities = 84/253 (33%), Positives = 144/253 (56%), Gaps = 10/253 (3%)
Query: 299 KVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
++ G++G+++ G + + VA+K + E + D++ +F QE I+++ H N+V+ IG
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
CT+ + IV E + GG +L K+ L+++ + + GM YL + IHRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT----YRWMAPEVIEHKPYDHKADV 472
A N L+ E V+K++DFG++R + + GV + G +W APE + + Y ++DV
Sbjct: 121 AARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179
Query: 473 FSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 531
+SFGI+LWE + G +PY L+ Q +++G+R P+ + L+ERCW+ DP
Sbjct: 180 WSFGILLWEAFSLGAVPYANLSN-QQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPG 238
Query: 532 LRPDFSEIIEILQ 544
RP FS + + LQ
Sbjct: 239 QRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 3e-45
Identities = 95/268 (35%), Positives = 139/268 (51%), Gaps = 25/268 (9%)
Query: 300 VASGSYGDLYRGTYCSQD--------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351
+ SG++G++Y GT VA+K L+ + + +KEF +E +M H N+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLKEAHLMSNFNHPNI 61
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNY 405
V+ +G C I+ E M GG + YL + + L LL + +DV+KG Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 406 LHQNNIIHRDLKAANLLMDENE-----VVKVADFGVARVKAQSGVMTAETG---TYRWMA 457
L Q + IHRDL A N L+ E VVK+ DFG+AR +S E RWMA
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMA 181
Query: 458 PEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 516
PE + + ++DV+SFG+++WE+LT G+ PY L + + V G R P+N
Sbjct: 182 PESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-VLQHVTAGGRLQKPENCPD 240
Query: 517 KLAELLERCWQQDPALRPDFSEIIEILQ 544
K+ +L+ CW QDP+ RP F I EILQ
Sbjct: 241 KIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 4e-45
Identities = 90/289 (31%), Positives = 154/289 (53%), Gaps = 26/289 (8%)
Query: 274 PYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPE 326
PY LK WE +L FG + +G++G + T VA+K+LKP
Sbjct: 25 PYDLK--------WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP- 75
Query: 327 RINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG 385
+S ++ E+ IM + H+N+V +GACT + ++TE+ G + ++L + +
Sbjct: 76 TAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE 135
Query: 386 VF-KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQS 443
F L LL + V+KGM +L N IHRDL A N+L+ ++VK+ DFG+AR + S
Sbjct: 136 SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS 195
Query: 444 GVMTAETGTYR----WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 498
+ G R WMAPE I + Y ++DV+S+GI+LWE+ + G PY +
Sbjct: 196 NYVV--KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF 253
Query: 499 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA 547
++++G R P+++ ++ ++++ CW DP RP F +I++++ +
Sbjct: 254 YKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 1e-44
Identities = 78/262 (29%), Positives = 132/262 (50%), Gaps = 16/262 (6%)
Query: 291 PKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKE---FAQEVFI 342
P + + G + G++G +Y C +++A+K + + + + +KE E+ +
Sbjct: 1 PTNWRRGKLLGQGAFGRVY---LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQL 57
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
++ ++H+ +VQ+ G +L I E+M GGSV D L K G K + +G
Sbjct: 58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILEG 116
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR----VKAQSGVMTAETGTYRWMAP 458
+ YLH N I+HRD+K AN+L D VK+ DFG ++ + + M + TGT WM+P
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 459 EVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518
EVI + Y KADV+S G + E+LT K P+ + A + + P +P + P
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDA 236
Query: 519 AELLERCWQQDPALRPDFSEII 540
L R + ++ RP E++
Sbjct: 237 RNFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 1e-44
Identities = 84/253 (33%), Positives = 132/253 (52%), Gaps = 15/253 (5%)
Query: 298 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
++ SG+YGD+Y R + VAIKV+K E D + QE+ ++++ RH N+V +
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
G+ + L IV E+ GGS+ D +G + V + KG+ YLH+ IHRD
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRD 126
Query: 416 LKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMAPEVIEHK---PYDHKAD 471
+K AN+L+ E+ VK+ADFGV A++ A + GT WMAPEV + YD K D
Sbjct: 127 IKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCD 186
Query: 472 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ-----PKLAELLERCW 526
+++ GI EL + P L P++A + + P PK P + +++C
Sbjct: 187 IWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP--PKLKDKEKWSPVFHDFIKKCL 244
Query: 527 QQDPALRPDFSEI 539
+DP RP +++
Sbjct: 245 TKDPKKRPTATKL 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 5e-44
Identities = 79/260 (30%), Positives = 134/260 (51%), Gaps = 17/260 (6%)
Query: 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 350
L+ + GS G +Y+ + + A+K + + + +K+ +E+ +R
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPY 60
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN- 409
VV+ GA K + IV E+M GGS+ D L K G P L +A + KG++YLH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119
Query: 410 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDH 468
+IIHRD+K +NLL++ VK+ADFG+++V + GT +M+PE I+ + Y +
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSY 179
Query: 469 KADVFSFGIVLWELLTGKLPYE------YLTPLQAAVGVVQKGLRPTIPKNS-QPKLAEL 521
AD++S G+ L E GK P+ + +QA + G P++P P+ +
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA----ICDGPPPSLPAEEFSPEFRDF 235
Query: 522 LERCWQQDPALRPDFSEIIE 541
+ C Q+DP RP +E+++
Sbjct: 236 ISACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 8e-44
Identities = 69/246 (28%), Positives = 132/246 (53%), Gaps = 15/246 (6%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ GS+G +++ + + A+K + ++N ++E E ++ K+ ++++
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQNNIIHR 414
+ L IV E+ G ++ L +G LP + + I + G+ +LH I+HR
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLHSKKILHR 125
Query: 415 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADV 472
D+K+ NL +D + VK+ D GVA++ + + A T GT +++PE+ E KPY+ K+DV
Sbjct: 126 DIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-ANTIVGTPYYLSPELCEDKPYNEKSDV 184
Query: 473 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---PTIPKNSQPKLAELLERCWQQD 529
++ G+VL+E TGK P++ ++ K +R P + + +LA+L+++C +D
Sbjct: 185 WALGVVLYECCTGKHPFD----ANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKD 240
Query: 530 PALRPD 535
RPD
Sbjct: 241 YRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 2e-43
Identities = 91/263 (34%), Positives = 152/263 (57%), Gaps = 10/263 (3%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 345
WEI + LK K+ +G +G+++ TY VA+K +KP ++ + F E +M+
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKT 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMN 404
++H +V+ TK P + I+TEFM+ GS+ D+L +G LP L+ + +++GM
Sbjct: 58 LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 116
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RWMAPEVIE 462
++ Q N IHRDL+AAN+L+ + V K+ADFG+ARV + E + +W APE I
Sbjct: 117 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 176
Query: 463 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521
+ K+DV+SFGI+L E++T G++PY ++ + + +++G R P+N +L +
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRMPRPENCPEELYNI 235
Query: 522 LERCWQQDPALRPDFSEIIEILQ 544
+ RCW+ P RP F I +L
Sbjct: 236 MMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-42
Identities = 84/270 (31%), Positives = 141/270 (52%), Gaps = 14/270 (5%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIM 343
ID +K + +G +G++ RG VAIK LK +++F E IM
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIM 59
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+ H N++ G TK + I+TEFM G++ +L + G F + L+ + ++ GM
Sbjct: 60 GQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGM 119
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY------RWMA 457
YL + N +HRDL A N+L++ N V KV+DFG++R T + RW A
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 458 PEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 516
PE I ++ + +DV+S+GIV+WE+++ G+ PY ++ Q + +++ R P +
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVINAIEQDYRLPPPMDCPT 238
Query: 517 KLAELLERCWQQDPALRPDFSEIIEILQQI 546
L +L+ CWQ+D RP F +I+ L ++
Sbjct: 239 ALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 1e-41
Identities = 91/284 (32%), Positives = 138/284 (48%), Gaps = 36/284 (12%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------VAIKVLKPERINSDMQKEFAQEV 340
E+ + + G++G++Y G Y +D VA+K L PE + + +F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL-PESCSEQDESDFLMEA 60
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS------LLK 394
IM K H+N+V+ IG + I+ E M+GG + +L + + + PS LL
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSGVMTAETG 451
A DV+KG YL +N+ IHRD+ A N L+ V K+ADFG+AR ++
Sbjct: 121 CARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY------ 174
Query: 452 TYR----------WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVG 500
YR WM PE + K DV+SFG++LWE+ + G +PY T Q +
Sbjct: 175 -YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVME 232
Query: 501 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 544
V G R PK + ++ CWQ P RP+F+ I+E +Q
Sbjct: 233 FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 88/268 (32%), Positives = 141/268 (52%), Gaps = 12/268 (4%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFIM 343
ID +K + +G +G++ G VAIK LK +++F E IM
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIM 59
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+ H N++ G TK + IVTE+M GS+ +L K G F + L+ + ++ GM
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGM 119
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ--SGVMTAETGT--YRWMAPE 459
YL +HRDL A N+L++ N V KV+DFG++RV T G RW APE
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518
I ++ + +DV+S+GIV+WE+++ G+ PY ++ Q + +++G R P + L
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKAIEEGYRLPAPMDCPAAL 238
Query: 519 AELLERCWQQDPALRPDFSEIIEILQQI 546
+L+ CWQ+D RP F +I+ IL ++
Sbjct: 239 HQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 82/259 (31%), Positives = 135/259 (52%), Gaps = 16/259 (6%)
Query: 294 LKFGSKVASGSYGD----LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
L++ ++ +G+ G L+R T + +A+K ++ E IN +QK+ +E+ I+ K
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPT--GKIMAVKTIRLE-INEAIQKQILRELDILHKCNSP 59
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-Q 408
+V F GA + I E+M GGS+ L +++G L K+A+ V KG+ YLH +
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 468
+ IIHRD+K +N+L++ +K+ DFGV+ S T GT +MAPE I+ Y
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPERIQGNDYSV 178
Query: 469 KADVFSFGIVLWELLTGKLPY-----EYLTPLQAAVGVVQKGLRPTIPK-NSQPKLAELL 522
K+D++S G+ L EL TG+ PY + +V P +P P + +
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-EPPPRLPSGKFSPDFQDFV 237
Query: 523 ERCWQQDPALRPDFSEIIE 541
C +DP RP + E++E
Sbjct: 238 NLCLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 3e-41
Identities = 89/301 (29%), Positives = 149/301 (49%), Gaps = 41/301 (13%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 337
WE L G + G +G + R D VA+K+LK + D+ +
Sbjct: 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDL-ADLI 65
Query: 338 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK------------ 384
E+ +M+ + +HKN++ +G CT+ L ++ E+ + G++ ++L +
Sbjct: 66 SEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK 125
Query: 385 ---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--- 438
L+ A V++GM YL IHRDL A N+L+ E+ V+K+ADFG+AR
Sbjct: 126 VPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185
Query: 439 -----VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 492
K +G + +WMAPE + + Y H++DV+SFGI++WE+ T G PY +
Sbjct: 186 DIDYYKKTSNGRLPV-----KWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240
Query: 493 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 552
P++ ++++G R P N +L L+ CW P RP F +++E L ++ V E
Sbjct: 241 -PVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299
Query: 553 E 553
E
Sbjct: 300 E 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 5e-41
Identities = 83/278 (29%), Positives = 142/278 (51%), Gaps = 28/278 (10%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINSDMQKEFAQEV 340
EI ++F ++ G++G +Y+G + VAIK LK E +Q+EF QE
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEA 59
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------HKLKG 385
+M ++H N+V +G CTK C++ E+++ G ++++L +K
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 386 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444
L +AI ++ GM YL ++ +HRDL A N L+ E VK++DFG++R +
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY 179
Query: 445 --VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 501
V + RWM PE I + + ++D++SFG+VLWE+ + G PY Y Q + +
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY-YGFSNQEVIEM 238
Query: 502 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 539
++ P++ ++ L+ CW + PA RP F +I
Sbjct: 239 IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 8e-41
Identities = 84/262 (32%), Positives = 139/262 (53%), Gaps = 20/262 (7%)
Query: 300 VASGSYGDLYRGTY--CSQDVAIKVLK---PERINSDMQKEFAQEVFIMRKVRH---KNV 351
+ G+YG +YRG + + VA+K++ P+ SD+Q+E A ++ ++R N+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVA----LLSQLRQSQPPNI 64
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
++ G+ K P L I+ E+ GGSV + G + + +V + Y+H+ +
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGV 122
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTYRWMAPEVI-EHKPYDHK 469
IHRD+KAAN+L+ VK+ DFGVA + Q S + GT WMAPEVI E K YD K
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTK 182
Query: 470 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS-QPKLAELLERCWQQ 528
AD++S GI ++E+ TG PY + + A+ ++ K P + N L E + C +
Sbjct: 183 ADIWSLGITIYEMATGNPPYSDVDAFR-AMMLIPKSKPPRLEDNGYSKLLREFVAACLDE 241
Query: 529 DPALRPDFSEIIEI--LQQIAK 548
+P R E+++ ++ +K
Sbjct: 242 EPKERLSAEELLKSKWIKAHSK 263
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 88/283 (31%), Positives = 139/283 (49%), Gaps = 41/283 (14%)
Query: 294 LKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVFIMRKVRH 348
LK G + G +G + G D VA+K +K + +EF E M+ H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 349 KNVVQFIGAC------TKPPSLCIVTEFMSGGSVYDYLHKLK---GVFKLP--SLLKVAI 397
NV++ IG C K P ++ FM G ++ +L + KLP +LLK +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT----Y 453
D++ GM YL N IHRDL A N ++ E+ V VADFG+++ K SG +
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK-KIYSGDYYRQGRIAKMPV 179
Query: 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLP---------YEYLTPLQAAVGVVQ 503
+W+A E + + Y K+DV++FG+ +WE+ T G+ P Y+YL +
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL----------R 229
Query: 504 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
G R P++ +L +L+ CW+ DP RP F+++ E+L+ I
Sbjct: 230 HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 5e-40
Identities = 83/271 (30%), Positives = 141/271 (52%), Gaps = 22/271 (8%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKE-FAQ 338
+ D+WEI ++ G++G +Y+ + + A K+++ I S+ + E F
Sbjct: 2 NPNDIWEII-------GELGDGAFGKVYKAQHKETGLFAAAKIIQ---IESEEELEDFMV 51
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
E+ I+ + +H N+V A L I+ EF GG++ + +L+ P + V
Sbjct: 52 EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMA 457
+ + +N+LH + +IHRDLKA N+L+ + VK+ADFGV A+ K+ GT WMA
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMA 171
Query: 458 PEVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI-- 510
PEV+ + PYD+KAD++S GI L EL + P+ L P++ + + K PT+
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK-ILKSEPPTLDQ 230
Query: 511 PKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
P + L+ C +DP RP +E+++
Sbjct: 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 7e-40
Identities = 85/265 (32%), Positives = 135/265 (50%), Gaps = 26/265 (9%)
Query: 300 VASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQK--EFAQEVFIMRKVRHKNVV 352
+ G +G +Y GT D A+K L RI +D+++ +F +E IM+ H NV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLN--RI-TDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 353 QFIGACTKPPSL-CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
+G C +V +M G + +++ + L+ + V+KGM YL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKF 119
Query: 412 IHRDLKAANLLMDENEVVKVADFGVAR---------VKAQSGVMTAETGTYRWMAPEVIE 462
+HRDL A N ++DE+ VKVADFG+AR V +G +WMA E ++
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP----VKWMALESLQ 175
Query: 463 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521
+ + K+DV+SFG++LWEL+T G PY + V ++Q G R P+ L E+
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ-GRRLLQPEYCPDPLYEV 234
Query: 522 LERCWQQDPALRPDFSEIIEILQQI 546
+ CW P +RP FSE++ ++QI
Sbjct: 235 MLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 9e-40
Identities = 74/248 (29%), Positives = 132/248 (53%), Gaps = 7/248 (2%)
Query: 298 SKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
K+ GSYG +Y+ S Q A+K + ++ +++ E+ I+ V H N++ +
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
A LCIV E+ G + + K + + + ++ I + +G+ LH+ I+
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKIL 125
Query: 413 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADV 472
HRDLK+AN+L+ N++VK+ D G+++V + + + GT +MAPEV + +PY +K+D+
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKV-LKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDI 184
Query: 473 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 532
+S G +L+E+ T P+E + +Q VQ+G P IP L + Q P L
Sbjct: 185 WSLGCLLYEMATFAPPFEARS-MQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKL 243
Query: 533 RPDFSEII 540
RP+ +I+
Sbjct: 244 RPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 9e-40
Identities = 83/261 (31%), Positives = 146/261 (55%), Gaps = 20/261 (7%)
Query: 297 GSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSD-------MQKEFAQEVFIMRKVR 347
G+ + SGS+G +Y G S +A+K ++ +++ M A+E+ ++++++
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H+N+VQ++G+ L I E++ GGSV L+ G F+ + + KG+NYLH
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLH 123
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR--------WMAPE 459
IIHRD+K AN+L+D +K++DFG+++ K ++ ++ +T R WMAPE
Sbjct: 124 NRGIIHRDIKGANILVDNKGGIKISDFGISK-KLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 460 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 519
V++ Y KAD++S G ++ E+LTGK P+ T LQA + + P IP N +
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN-ASPEIPSNISSEAI 241
Query: 520 ELLERCWQQDPALRPDFSEII 540
+ LE+ ++ D RP +E++
Sbjct: 242 DFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-39
Identities = 77/259 (29%), Positives = 132/259 (50%), Gaps = 17/259 (6%)
Query: 297 GSKVASGSYGDLYRGTYCSQD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
G+K+ G++G +Y + D +A+K ++ + + KE A E+ ++ ++H N+V
Sbjct: 5 GNKIGGGTFGKVYTAV--NLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
++ G + I E+ SGG++ + L + + + + +G+ YLH + I+
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSHGIV 121
Query: 413 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-----TGTYRWMAPEVIEHKPYD 467
HRD+K AN+ +D N V+K+ DFG A + E GT +MAPEVI
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181
Query: 468 HK---ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELL 522
AD++S G V+ E+ TGK P+ L + V G +P IP + Q P+ + L
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFL 241
Query: 523 ERCWQQDPALRPDFSEIIE 541
+RC + DP RP SE+++
Sbjct: 242 DRCLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 83/260 (31%), Positives = 142/260 (54%), Gaps = 13/260 (5%)
Query: 300 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
+ SG++G +Y+G + + VAIK L+ E + KE E ++M V + +V +
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
+G C ++ ++T+ M G + DY+ + K LL + ++KGMNYL + ++H
Sbjct: 74 LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVH 132
Query: 414 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 470
RDL A N+L+ + VK+ DFG+A+ + A AE G +WMA E I H+ Y H++
Sbjct: 133 RDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQS 192
Query: 471 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 529
DV+S+G+ +WEL+T G PY+ + P +++KG R P + ++ +CW D
Sbjct: 193 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 251
Query: 530 PALRPDFSEIIEILQQIAKE 549
RP F E+I ++A++
Sbjct: 252 ADSRPKFRELIIEFSKMARD 271
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 4e-39
Identities = 89/305 (29%), Positives = 144/305 (47%), Gaps = 56/305 (18%)
Query: 288 EIDPKHLKFGSKVASGSYGDLY-RGTYCSQD-----------------VAIKVLKPERIN 329
E + L F K+ G +G+++ QD VA+KVL+P+ +
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD-AS 59
Query: 330 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK------- 382
+ +++F +EV I+ ++ N+ + +G CT P LC++ E+M G + +L K
Sbjct: 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG 119
Query: 383 -LKGVFKLP--SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439
L +LL +A ++ GM YL N +HRDL N L+ +N +K+ADFG++R
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR- 178
Query: 440 KAQSGVMTAETGTY-----------RWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GK 486
+ Y RWMA E + + K+DV++FG+ LWE+LT +
Sbjct: 179 -------NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231
Query: 487 LPYEYLTP---LQAAVGVVQKGLRPTI---PKNSQPKLAELLERCWQQDPALRPDFSEII 540
PYE+LT ++ A + R P N + EL+ CW++D RP F EI
Sbjct: 232 QPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291
Query: 541 EILQQ 545
LQ+
Sbjct: 292 LFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 6e-39
Identities = 83/253 (32%), Positives = 132/253 (52%), Gaps = 27/253 (10%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
VA+K+LK E ++DMQ +F +E +M + H N+V+ +G C +C++ E+M+ G +
Sbjct: 38 VAVKMLK-EEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 96
Query: 378 DYLH-----------------KLKGVFKLP----SLLKVAIDVSKGMNYLHQNNIIHRDL 416
++L + G+ LP L +A V+ GM YL + +HRDL
Sbjct: 97 EFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVF 473
N L+ EN VVK+ADFG++R + A RWM PE I + Y ++DV+
Sbjct: 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVW 216
Query: 474 SFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 532
++G+VLWE+ + G PY Y + + V+ G + P N +L L+ CW + P+
Sbjct: 217 AYGVVLWEIFSYGMQPY-YGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSD 275
Query: 533 RPDFSEIIEILQQ 545
RP F+ I ILQ+
Sbjct: 276 RPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 7e-39
Identities = 88/294 (29%), Positives = 148/294 (50%), Gaps = 41/294 (13%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 337
WE+ L G + G +G + D VA+K+LK + D+ +
Sbjct: 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLS-DLI 71
Query: 338 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------H 381
E+ +M+ + +HKN++ +GACT+ L ++ E+ S G++ +YL
Sbjct: 72 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131
Query: 382 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--- 438
+ L+ A V++GM YL IHRDL A N+L+ E+ V+K+ADFG+AR
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191
Query: 439 -----VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 492
K +G + +WMAPE + + Y H++DV+SFG++LWE+ T G PY +
Sbjct: 192 HIDYYKKTTNGRLPV-----KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246
Query: 493 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
P++ ++++G R P N +L ++ CW P+ RP F +++E L +I
Sbjct: 247 -PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 144 bits (363), Expect = 1e-38
Identities = 90/303 (29%), Positives = 154/303 (50%), Gaps = 43/303 (14%)
Query: 278 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERI 328
++P D WE L G + G +G + D VA+K+LK +
Sbjct: 3 ELPED--PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT 60
Query: 329 NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--- 384
D+ + E+ +M+ + +HKN++ +GACT+ L ++ E+ S G++ +YL +
Sbjct: 61 EKDLS-DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 119
Query: 385 -----GVFKLPS-------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA 432
+ ++P L+ V++GM YL IHRDL A N+L+ EN V+K+A
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 179
Query: 433 DFGVAR--------VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT 484
DFG+AR K +G + +WMAPE + + Y H++DV+SFG+++WE+ T
Sbjct: 180 DFGLARDVNNIDYYKKTTNGRLPV-----KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
Query: 485 -GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 543
G PY + P++ ++++G R P N +L ++ CW P+ RP F +++E L
Sbjct: 235 LGGSPYPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293
Query: 544 QQI 546
+I
Sbjct: 294 DRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 80/259 (30%), Positives = 136/259 (52%), Gaps = 16/259 (6%)
Query: 297 GSKVASGSYGDLYRG-TYCSQDVAIKVLKPERINSDM-QKEFA---QEVFIMRKVRHKNV 351
G + G+YG +Y G T Q +A+K ++ + N +KE+ +EV +++ ++H N+
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
VQ++G C ++ I EF+ GGS+ L++ G P K + G+ YLH N +
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKA-------QSGVMTAETGTYRWMAPEVIEHK 464
+HRD+K N+++ N ++K+ DFG AR A S ++ + GT WMAPEVI
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 465 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA--AVGVVQKGLRPTIPKNSQPKLAELL 522
Y K+D++S G ++E+ TGK P + L A +G +GL P +P + + +
Sbjct: 184 GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-AHRGLMPRLPDSFSAAAIDFV 242
Query: 523 ERCWQQDPALRPDFSEIIE 541
C +D RP +++
Sbjct: 243 TSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 144 bits (363), Expect = 2e-38
Identities = 90/294 (30%), Positives = 152/294 (51%), Gaps = 41/294 (13%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERINSDMQKEFA 337
WE+ L G + G +G + D VA+K+LK + + D+ +
Sbjct: 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS-DLV 65
Query: 338 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK--------GVFK 388
E+ +M+ + +HKN++ +GACT+ L ++ E+ S G++ +YL + K
Sbjct: 66 SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 389 LPS-------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--- 438
LP L+ A V++GM YL IHRDL A N+L+ E+ V+K+ADFG+AR
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH 185
Query: 439 -----VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 492
K +G + +WMAPE + + Y H++DV+SFG++LWE+ T G PY +
Sbjct: 186 NIDYYKKTTNGRLPV-----KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240
Query: 493 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
P++ ++++G R P N +L ++ CW P+ RP F +++E L ++
Sbjct: 241 -PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 3e-38
Identities = 92/293 (31%), Positives = 149/293 (50%), Gaps = 34/293 (11%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFI 342
WE +KF + G++G + R + AIK+LK E + + ++FA E+ +
Sbjct: 1 WE----DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK-EFASENDHRDFAGELEV 55
Query: 343 MRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS---------- 391
+ K+ H N++ +GAC L I E+ G++ D+L K + + P+
Sbjct: 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115
Query: 392 -----LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446
LL+ A DV+ GM YL + IHRDL A N+L+ EN K+ADFG++R +
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175
Query: 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG 505
T RWMA E + + Y K+DV+SFG++LWE+++ G PY +T + + Q G
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-G 234
Query: 506 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERR 558
R P+N ++ EL+ +CW+ P RP F+ QI+ ++ E R+
Sbjct: 235 YRMEKPRNCDDEVYELMRQCWRDRPYERPPFA-------QISVQLSRMLEARK 280
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 4e-38
Identities = 91/291 (31%), Positives = 137/291 (47%), Gaps = 53/291 (18%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQE 339
D T ++E+ + G+YG +Y+ + Q VAIK++ I D ++E +E
Sbjct: 3 DPTGIFEL-------VEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEEIKEE 52
Query: 340 VFIMRKV-RHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSL 392
I+RK H N+ F GA K +V E GGSV D + KG+ K
Sbjct: 53 YNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKR 109
Query: 393 LKVAI------DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGV 445
LK + +G+ YLH+N +IHRD+K N+L+ +N VK+ DFGV+ + + G
Sbjct: 110 LKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR 169
Query: 446 MTAETGTYRWMAPEVI--EHKP---YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 500
GT WMAPEVI + +P YD ++DV+S GI EL GK P + P++A
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF- 228
Query: 501 VVQKGLRPTIPKNSQPKLA----------ELLERCWQQDPALRPDFSEIIE 541
IP+N P L + + C ++ RP E++E
Sbjct: 229 --------KIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 6e-38
Identities = 83/277 (29%), Positives = 141/277 (50%), Gaps = 40/277 (14%)
Query: 300 VASGSYGDLYRGTYCS----QD---VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ G++G ++ G D VA+K LK E ++D +K+F +E ++ +H+N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAELLTNFQHENIV 71
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHK-------------LKGVFKLPSLLKVAIDV 399
+F G CT+ +V E+M G + +L G L LL++A+ +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY------ 453
+ GM YL + +HRDL N L+ + VVK+ DFG++R V T T Y
Sbjct: 132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVYT--TDYYRVGGHT 184
Query: 454 ----RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP 508
RWM PE I ++ + ++DV+SFG+VLWE+ T GK P+ Y + + + +G
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW-YGLSNEEVIECITQGRLL 243
Query: 509 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 545
P+ ++ +++ CW++DP R + +I E LQ+
Sbjct: 244 QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 6e-38
Identities = 87/282 (30%), Positives = 149/282 (52%), Gaps = 23/282 (8%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMR 344
++ +KF + G++G + + D AIK +K E + D ++FA E+ ++
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLC 62
Query: 345 KV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS------------ 391
K+ H N++ +GAC L + E+ G++ D+L K + + P+
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 392 ---LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448
LL A DV++GM+YL Q IHRDL A N+L+ EN V K+ADFG++R + T
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 182
Query: 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR 507
RWMA E + + Y +DV+S+G++LWE+++ G PY +T + + Q G R
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYR 241
Query: 508 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549
P N ++ +L+ +CW++ P RP F++I+ L ++ +E
Sbjct: 242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 81/260 (31%), Positives = 140/260 (53%), Gaps = 13/260 (5%)
Query: 300 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
+ SG++G +Y+G + VAIKVL+ E + KE E ++M V V +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-ENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
+G C ++ +VT+ M G + DY+ + K LL + ++KGM+YL + ++H
Sbjct: 74 LLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVH 132
Query: 414 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 470
RDL A N+L+ VK+ DFG+AR + A+ G +WMA E I H+ + H++
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQS 192
Query: 471 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 529
DV+S+G+ +WEL+T G PY+ + P + +++KG R P + ++ +CW D
Sbjct: 193 DVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMID 251
Query: 530 PALRPDFSEIIEILQQIAKE 549
RP F E+++ ++A++
Sbjct: 252 SECRPRFRELVDEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-37
Identities = 84/254 (33%), Positives = 132/254 (51%), Gaps = 23/254 (9%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
++ GS+G++Y+G + VAIK++ E +++ + QE+ ++ + + ++ G
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYITRYYG 69
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ K L I+ E++ GGS D L G + + + ++ KG++YLH IHRD+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDI 127
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVM-TAETGTYRWMAPEVIEHKPYDHKADVFSF 475
KAAN+L+ E VK+ADFGVA + + GT WMAPEVI+ YD KAD++S
Sbjct: 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSL 187
Query: 476 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL--------AELLERCWQ 527
GI EL G+ P L P++ IPKNS P L E +E C
Sbjct: 188 GITAIELAKGEPPNSDLHPMRVLF---------LIPKNSPPTLEGQYSKPFKEFVEACLN 238
Query: 528 QDPALRPDFSEIIE 541
+DP RP E+++
Sbjct: 239 KDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 80/269 (29%), Positives = 141/269 (52%), Gaps = 14/269 (5%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQEV 340
E+D K +K + +G +G+L RG C + VAI L+ + ++ F E
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRG--CLKLPSKRELPVAIHTLR-AGCSDKQRRGFLAEA 57
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 400
+ + H N+V+ G T+ ++ IVTE+MS G++ +L K +G L+ + ++
Sbjct: 58 LTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLA 117
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG--TYRWMAP 458
GM YL + +H+ L A +L++ + V K++ F + + T +G W AP
Sbjct: 118 SGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAP 177
Query: 459 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 517
E I++ + +DV+SFGIV+WE+++ G+ PY ++ Q + V+ G R P+N
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-QDVIKAVEDGFRLPAPRNCPNL 236
Query: 518 LAELLERCWQQDPALRPDFSEIIEILQQI 546
L +L+ CWQ++ RP FS+I IL ++
Sbjct: 237 LHQLMLDCWQKERGERPRFSQIHSILSKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-37
Identities = 82/246 (33%), Positives = 136/246 (55%), Gaps = 7/246 (2%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ GS+G++++G + VAIK++ E +++ + QE+ ++ + V ++ G
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYG 69
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ K L I+ E++ GGS D L G + + ++ KG++YLH IHRD+
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDI 127
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSF 475
KAAN+L+ E+ VK+ADFGVA + + GT WMAPEVI+ YD KAD++S
Sbjct: 128 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 187
Query: 476 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD 535
GI EL G+ P+ L P++ + ++ K PT+ N L E +E C ++P+ RP
Sbjct: 188 GITAIELAKGEPPHSELHPMK-VLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 246
Query: 536 FSEIIE 541
E+++
Sbjct: 247 AKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 4e-37
Identities = 77/257 (29%), Positives = 131/257 (50%), Gaps = 21/257 (8%)
Query: 310 RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP--SLCIV 367
G + VA+K LKPE + + + +E+ I+R + H+N+V++ G CT+ + ++
Sbjct: 28 EGDNTGEQVAVKSLKPESGGNHIA-DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 86
Query: 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
EF+ GS+ +YL + K L LK A+ + KGM+YL +HRDL A N+L++
Sbjct: 87 MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 146
Query: 428 VVKVADFGVAR-VKAQSGVMTAE---TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL 483
VK+ DFG+ + ++ T + W APE + + +DV+SFG+ L+ELL
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
Query: 484 T--------GKLPYEYLTPLQAA------VGVVQKGLRPTIPKNSQPKLAELLERCWQQD 529
T L + + P V V+++G R P N ++ +L+ +CW+
Sbjct: 207 TYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQ 266
Query: 530 PALRPDFSEIIEILQQI 546
P+ R F +IE + I
Sbjct: 267 PSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 5e-37
Identities = 79/265 (29%), Positives = 129/265 (48%), Gaps = 22/265 (8%)
Query: 297 GSKVASGSYGDLYRGTYCS--QDVAIK-VLKPERINS-------DMQKEFAQEVFIMRKV 346
G + G+YG +Y + + +A+K V P I DM K E+ ++ +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
H N+VQ++G T L I E++ GGS+ L G F+ + V +G+ YL
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT-YGRFEEQLVRFFTEQVLEGLAYL 124
Query: 407 HQNNIIHRDLKAANLLMDENEVVKVADFGVAR----VKAQSGVMTAETGTYRWMAPEVIE 462
H I+HRDLKA NLL+D + + K++DFG+++ + M+ + G+ WMAPEVI
Sbjct: 125 HSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPEVIH 183
Query: 463 --HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL-- 518
+ Y K D++S G V+ E+ G+ P+ + A + K P IP + L
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSP 243
Query: 519 --AELLERCWQQDPALRPDFSEIIE 541
+ L C+ +P RP E+++
Sbjct: 244 VALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 137 bits (345), Expect = 1e-36
Identities = 83/252 (32%), Positives = 139/252 (55%), Gaps = 19/252 (7%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
++ GS+G++++G Q VAIK++ E +++ + QE+ ++ + V ++ G
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYG 69
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ K L I+ E++ GGS D L F++ ++LK ++ KG++YLH IHRD
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSEKKIHRD 126
Query: 416 LKAANLLMDENEVVKVADFGVA------RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 469
+KAAN+L+ E VK+ADFGVA ++K + V GT WMAPEVI+ YD K
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMAPEVIQQSAYDSK 181
Query: 470 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 529
AD++S GI EL G+ P + P++ + ++ K PT+ E ++ C +D
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDMHPMR-VLFLIPKNNPPTLTGEFSKPFKEFIDACLNKD 240
Query: 530 PALRPDFSEIIE 541
P+ RP E+++
Sbjct: 241 PSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 70/247 (28%), Positives = 133/247 (53%), Gaps = 7/247 (2%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
+ G++G+ LYR T V K + R++ +++ E+ I+ ++H N++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 358 CTKPPSLCIVTEFMSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+L I E+ +GG++YD + + +F+ +L + ++Y+H+ I+HRD+
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDI 127
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFS 474
K N+ + + ++K+ DFG++++ M AET GT +M+PE+ + Y+ K+D+++
Sbjct: 128 KTLNIFLTKAGLIKLGDFGISKILGSEYSM-AETVVGTPYYMSPELCQGVKYNFKSDIWA 186
Query: 475 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP 534
G VL+ELLT K ++ PL V +VQ P + S +L L+ QQDP RP
Sbjct: 187 LGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSS-ELISLVHSLLQQDPEKRP 245
Query: 535 DFSEIIE 541
E+++
Sbjct: 246 TADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 82/260 (31%), Positives = 141/260 (54%), Gaps = 13/260 (5%)
Query: 300 VASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
+ SG++G +Y+G + + VAIK+L E EF E IM + H ++V+
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
+G C P ++ +VT+ M G + DY+H+ K LL + ++KGM YL + ++H
Sbjct: 74 LLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVH 132
Query: 414 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKA 470
RDL A N+L+ VK+ DFG+AR ++ A+ G +WMA E I ++ + H++
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQS 192
Query: 471 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 529
DV+S+G+ +WEL+T G PY+ + P + +++KG R P + ++ +CW D
Sbjct: 193 DVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMID 251
Query: 530 PALRPDFSEIIEILQQIAKE 549
RP F E+ ++A++
Sbjct: 252 ADSRPKFKELAAEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 9e-36
Identities = 78/251 (31%), Positives = 129/251 (51%), Gaps = 20/251 (7%)
Query: 309 YRGTYCSQDV------AIKVLKPERINSDMQKEFAQ----EVFIMRKVRHKNVVQFIGAC 358
+ Y ++DV A+K + R S Q+E + E+ +M ++ H ++++ +GA
Sbjct: 13 FSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT 72
Query: 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418
+ + E+M+GGSV L K G FK ++ + +G++YLH+N IIHRD+K
Sbjct: 73 CEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKG 131
Query: 419 ANLLMDEN-EVVKVADFGVARVKAQSGVMTAE-----TGTYRWMAPEVIEHKPYDHKADV 472
ANLL+D + +++ADFG A A G E GT +MAPEV+ + Y DV
Sbjct: 132 ANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDV 191
Query: 473 FSFGIVLWELLTGKLPY---EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 529
+S G V+ E+ T K P+ ++ L + P+IP++ P L ++ RC +
Sbjct: 192 WSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQ 251
Query: 530 PALRPDFSEII 540
P RP E++
Sbjct: 252 PEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 1e-35
Identities = 86/282 (30%), Positives = 143/282 (50%), Gaps = 31/282 (10%)
Query: 292 KHLKFGSKVASGSYGD--LYRGTYCSQD----VAIKVLKPERINSDMQKE-FAQEVFIMR 344
++LK + G +G LY + VA+K LK E + +E+ I++
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILK 61
Query: 345 KVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
+ H+N+V++ G C++ L ++ E++ GS+ DYL K K L LL A + +G
Sbjct: 62 TLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEG 119
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGTYR--WMAP 458
M YLH + IHRDL A N+L+D + +VK+ DFG+A+ + E G W A
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179
Query: 459 EVIEHKPYDHKADVFSFGIVLWELLTGKLPY--------EYLTPLQAAVGVV------QK 504
E ++ + + +DV+SFG+ L+ELLT E + P Q + VV ++
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239
Query: 505 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
G+R PKN ++ L++ CW+ + RP F +I IL+++
Sbjct: 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 83/282 (29%), Positives = 138/282 (48%), Gaps = 29/282 (10%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS-QD-----VAIKVLKPERINSDMQKEFAQEVFIMRK 345
+HLKF ++ G++G + Y QD VA+K L+ ++ ++F +E+ I++
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKS 61
Query: 346 VRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
++H N+V++ G C +L +V E++ GS+ DYL K + LL A + KGM
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGM 121
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTAETGTYR--WMAPE 459
YL +HRDL N+L++ VK+ DFG+ +V Q E G W APE
Sbjct: 122 EYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-----GKLPYEYL------TPLQAAV----GVVQK 504
+ + +DV+SFG+VL+EL T P E++ Q V +++
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241
Query: 505 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
R P ++ +++ CW DP+ RP FSE+ ++ I
Sbjct: 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 83/261 (31%), Positives = 138/261 (52%), Gaps = 23/261 (8%)
Query: 300 VASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF 354
+ G++G + + D AIK +K E + D ++FA E+ ++ K+ H N++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS---------------LLKVAIDV 399
+GAC L + E+ G++ D+L K + + P+ LL A DV
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 459
++GM+YL Q IHRDL A N+L+ EN V K+ADFG++R + T RWMA E
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIE 181
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518
+ + Y +DV+S+G++LWE+++ G PY +T + + Q G R P N ++
Sbjct: 182 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEKPLNCDDEV 240
Query: 519 AELLERCWQQDPALRPDFSEI 539
+L+ +CW++ P RP F++I
Sbjct: 241 YDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 6e-35
Identities = 77/272 (28%), Positives = 138/272 (50%), Gaps = 28/272 (10%)
Query: 294 LKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKV 346
++F ++ ++G +Y+G +Q VAIK LK IN+ Q EF QE +M ++
Sbjct: 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD--INNPQQWGEFQQEASLMAEL 64
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL----------------HKLKGVFKLP 390
H N+V +G T+ +C++ E+++ G ++++L +K
Sbjct: 65 HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 391 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET 450
L +AI ++ GM YL + +H+DL A N+L+ E VK++D G++R + +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184
Query: 451 GTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 507
+ RWM PE I + + +D++SFG+VLWE+ + L Y Q + +V+K
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL 244
Query: 508 PTIPKNSQPKLAELLERCWQQDPALRPDFSEI 539
++ P++ L+ CWQ+ P+ RP F +I
Sbjct: 245 LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 7e-35
Identities = 86/284 (30%), Positives = 144/284 (50%), Gaps = 32/284 (11%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 339
WE+ + + ++ GS+G +Y G VAIK + E + + EF E
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNE 59
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG------VFKLPSL- 392
+M++ +VV+ +G ++ ++ E M+ G + YL L+ V PSL
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 393 --LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VKAQ 442
+++A +++ GM YL+ N +HRDL A N ++ E+ VK+ DFG+ R K
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 501
G++ RWM+PE ++ + +DV+SFG+VLWE+ T + PY+ ++ Q V
Sbjct: 180 KGLLPV-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234
Query: 502 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 545
++ GL P N L EL+ CWQ +P +RP F EII +++
Sbjct: 235 MEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 79/287 (27%), Positives = 146/287 (50%), Gaps = 36/287 (12%)
Query: 294 LKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
L G + G +G + + T VA+K+LK E +S ++ E ++++V
Sbjct: 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQV 60
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-------------------- 386
H +V++ GAC++ L ++ E+ GS+ +L + + V
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 387 ---FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQ 442
+ L+ A +S+GM YL + ++HRDL A N+L+ E +K++DFG++R V +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 443 SGVMTAETG--TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 499
+ G +WMA E + Y ++DV+SFG++LWE++T G PY + P +
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-ERLF 239
Query: 500 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
+++ G R P+N ++ L+ CW+Q+P RP F++I + L+++
Sbjct: 240 NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 76/244 (31%), Positives = 120/244 (49%), Gaps = 27/244 (11%)
Query: 329 NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS--LCIVTEFMSGGS---VYDYLHKL 383
N D+QK+ +E+ I + + +V++ GA S + I E+ GGS +Y + K
Sbjct: 39 NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98
Query: 384 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443
G L K+A V KG++YLH IIHRD+K +N+L+ VK+ DFGV+ S
Sbjct: 99 GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158
Query: 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503
T TGT +MAPE I+ KPY +DV+S G+ L E+ + P+ P + +
Sbjct: 159 LAGTF-TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF----PPEGEPPLGP 213
Query: 504 KGLRPTIPKNSQPKLAE--------------LLERCWQQDPALRPDFSEIIE---ILQQI 546
L I P+L + +++C ++DP RP +++E I Q+
Sbjct: 214 IELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273
Query: 547 AKEV 550
K+V
Sbjct: 274 KKKV 277
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 134 bits (336), Expect = 2e-34
Identities = 79/273 (28%), Positives = 129/273 (47%), Gaps = 27/273 (9%)
Query: 295 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRH-KNVV 352
+ K+ GS+G++Y + VA+KVL + + S + F +E+ I+ + H N+V
Sbjct: 3 RILRKLGEGSFGEVYLA-RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQNN 410
+ SL +V E++ GGS+ D L K+ KG L + + + YLH
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 411 IIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGV-------MTAETGTYRWMAPEVIE 462
IIHRD+K N+L+D + VVK+ DFG+A++ G + GT +MAPEV+
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 463 HK---PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK-----------GLRP 508
+D++S GI L+ELLTG P+E A ++ L P
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241
Query: 509 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
+ P+ ++LL++ +DP R S +
Sbjct: 242 SNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 3e-34
Identities = 76/250 (30%), Positives = 136/250 (54%), Gaps = 12/250 (4%)
Query: 299 KVASGSYGDLYRGTYCSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
++ SG++G + +G Y + DVAIKVLK E S + E +E IM ++ + +V+
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSV-RDEMMREAEIMHQLDNPYIVRM 60
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
IG C + +L +V E SGG + +L K + +++++ VS GM YL N +HR
Sbjct: 61 IGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119
Query: 415 DLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETG---TYRWMAPEVIEHKPYDHKA 470
DL A N+L+ K++DFG+++ + A A + +W APE I + + ++
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRS 179
Query: 471 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 529
DV+S+GI +WE + G+ PY+ + + + +++G R P P++ L++ CW
Sbjct: 180 DVWSYGITMWEAFSYGQKPYKKMKGPE-VMSFIEQGKRLDCPAECPPEMYALMKDCWIYK 238
Query: 530 PALRPDFSEI 539
RP+F+++
Sbjct: 239 WEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 3e-34
Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 7/218 (3%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+KVLK ++I + E E I+ ++ H +V+ A L +V E+ GG ++
Sbjct: 22 AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF 81
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437
+L K +G F A ++ + YLH II+RDLK N+L+D + +K+ DFG+A
Sbjct: 82 SHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLA 140
Query: 438 RVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL 495
+ + S T GT ++APEV+ K Y D +S G++L+E+LTGK P+ Y
Sbjct: 141 KELS-SEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDR 198
Query: 496 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 533
+ + K P+ P+ +L+ Q+DP R
Sbjct: 199 KEIYEKILKD-PLRFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 4e-34
Identities = 79/249 (31%), Positives = 135/249 (54%), Gaps = 13/249 (5%)
Query: 303 GSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361
G+YG +Y S V I + + PER + +Q +E+ + ++H+N+VQ++G+ ++
Sbjct: 19 GTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-LHEEIALHSYLKHRNIVQYLGSDSEN 77
Query: 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKL--PSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
I E + GGS+ L G K +++ + +G+ YLH N I+HRD+K
Sbjct: 78 GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGD 137
Query: 420 NLLMDE-NEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKP--YDHKADVFSF 475
N+L++ + VVK++DFG ++ A T TGT ++MAPEVI+ P Y AD++S
Sbjct: 138 NVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSL 197
Query: 476 GIVLWELLTGKLPYEYLTPLQAA---VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 532
G + E+ TGK P+ L QAA VG+ + P IP++ + + RC++ DP
Sbjct: 198 GCTIVEMATGKPPFIELGEPQAAMFKVGMFKI--HPEIPESLSAEAKNFILRCFEPDPDK 255
Query: 533 RPDFSEIIE 541
R ++++
Sbjct: 256 RASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 1e-33
Identities = 73/264 (27%), Positives = 131/264 (49%), Gaps = 29/264 (10%)
Query: 303 GSYGDLY----RGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
G +G+++ +G V +K L+ + + ++Q EF +E+ + RK+ HKNVV+ +
Sbjct: 16 GEFGEVFLAKAKGIEEEGGETLVLVKALQ-KTKDENLQSEFRRELDMFRKLSHKNVVRLL 74
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKG---VFKLPSL-----LKVAIDVSKGMNYLH 407
G C + ++ E+ G + +L K K P L + + ++ GM++L
Sbjct: 75 GLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS 134
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY-------RWMAPEV 460
+HRDL A N L+ VKV+ +++ S E RW+APE
Sbjct: 135 NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS-----EYYKLRNALIPLRWLAPEA 189
Query: 461 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 519
++ + K+DV+SFG+++WE+ T G+LP+ L+ + + L +P+ +L
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY 249
Query: 520 ELLERCWQQDPALRPDFSEIIEIL 543
+L+ RCW +P RP FSE++ L
Sbjct: 250 KLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 1e-33
Identities = 72/250 (28%), Positives = 138/250 (55%), Gaps = 12/250 (4%)
Query: 299 KVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
++ SG++G + +G Y + VA+K+LK + + ++ E +E +M+++ + +V+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
IG C + S +V E G + +L K K V ++ ++ VS GM YL + N +HR
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHV-TEKNITELVHQVSMGMKYLEETNFVHR 119
Query: 415 DLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET-GTY--RWMAPEVIEHKPYDHKA 470
DL A N+L+ K++DFG+++ + A A+T G + +W APE + + + K+
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKS 179
Query: 471 DVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 529
DV+SFG+++WE + G+ PY+ + + +++ G R P+ P++ +L++ CW
Sbjct: 180 DVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ-MIESGERMECPQRCPPEMYDLMKLCWTYG 238
Query: 530 PALRPDFSEI 539
RP F+ +
Sbjct: 239 VDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 73/263 (27%), Positives = 132/263 (50%), Gaps = 26/263 (9%)
Query: 303 GSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFI 355
G++G ++ G ++V +K +K S++Q QE ++ + H+N++ +
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPIL 74
Query: 356 GACTK---PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS-------LLKVAIDVSKGMNY 405
C + PP + +M+ G++ +L + + L+ +AI ++ GM+Y
Sbjct: 75 HVCIEDGEPPFVLY--PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR---WMAPEVIE 462
LH+ +IH+D+ A N ++DE VK+ D ++R R WMA E +
Sbjct: 133 LHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV 192
Query: 463 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521
+K Y +DV+SFG++LWEL+T G+ PY + P + A ++ G R P N +L +
Sbjct: 193 NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA-AYLKDGYRLAQPINCPDELFAV 251
Query: 522 LERCWQQDPALRPDFSEIIEILQ 544
+ CW DP RP FS++++ L
Sbjct: 252 MACCWALDPEERPSFSQLVQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 82/256 (32%), Positives = 129/256 (50%), Gaps = 36/256 (14%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG------ACTKPPSLCIVTE 369
Q VA+K+LK + +S +EF +E M++ H NV++ IG A + P ++
Sbjct: 28 QKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILP 87
Query: 370 FMSGGSVYDYLHKLK---GVFKLP--SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 424
FM G ++ +L + F LP +L++ ID++ GM YL N IHRDL A N +++
Sbjct: 88 FMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN 147
Query: 425 ENEVVKVADFGVARVKAQSGVM----TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLW 480
EN V VADFG+++ K SG A +W+A E + Y +DV++FG+ +W
Sbjct: 148 ENMTVCVADFGLSK-KIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMW 206
Query: 481 ELLT-GKLP---------YEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 530
E++T G+ P Y YL KG R P + + EL+ +CW +P
Sbjct: 207 EIMTRGQTPYAGVENSEIYNYLI----------KGNRLKQPPDCLEDVYELMCQCWSPEP 256
Query: 531 ALRPDFSEIIEILQQI 546
RP F + + L+ I
Sbjct: 257 KCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 82/291 (28%), Positives = 142/291 (48%), Gaps = 46/291 (15%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKP-----ERINSDM 332
WE+ + + ++ GS+G +Y G ++D VA+K + ERI
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGN--ARDIIKGEAETRVAVKTVNESASLRERI---- 54
Query: 333 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK---- 388
EF E +M+ +VV+ +G +K +V E M+ G + YL L+ +
Sbjct: 55 --EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 112
Query: 389 -----LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR----- 438
L ++++A +++ GM YL+ +HRDL A N ++ + VK+ DFG+ R
Sbjct: 113 RPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET 172
Query: 439 ---VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 494
K G++ RWMAPE ++ + +D++SFG+VLWE+ + + PY+ L+
Sbjct: 173 DYYRKGGKGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227
Query: 495 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 545
Q V+ G P N ++ +L+ CWQ +P +RP F EI+ +L+
Sbjct: 228 EQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 5e-33
Identities = 72/269 (26%), Positives = 138/269 (51%), Gaps = 13/269 (4%)
Query: 291 PKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFIMR 344
L+ + SG +G +++G + + VAIK ++ +R +E + M
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ-DRSGRQTFQEITDHMLAMG 64
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
+ H +V+ +G C SL +VT+ GS+ D++ + + LL + ++KGM
Sbjct: 65 SLDHAYIVRLLGICPGA-SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMY 123
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVI 461
YL ++ ++HR+L A N+L+ + +V++ADFGVA + + + +WMA E I
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 462 EHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 520
Y H++DV+S+G+ +WE+++ G PY + P +++KG R P+ +
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEVPDLLEKGERLAQPQICTIDVYM 242
Query: 521 LLERCWQQDPALRPDFSEIIEILQQIAKE 549
++ +CW D +RP F E+ ++A++
Sbjct: 243 VMVKCWMIDENVRPTFKELANEFTRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 5e-33
Identities = 68/245 (27%), Positives = 131/245 (53%), Gaps = 5/245 (2%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
V G++G ++ R + V IK + E++ D + E +++ + H N++++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ +L IV E+ GG++ +Y+ K + ++L + + ++++H I+HRDL
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDL 127
Query: 417 KAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 475
K N+L+D+++ VVK+ DFG++++ + GT +++PE+ E KPY+ K+D+++
Sbjct: 128 KTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWAL 187
Query: 476 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD 535
G VL+EL + K +E L A V + G I P L +L+ DP+ RP
Sbjct: 188 GCVLYELASLKRAFEAAN-LPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQ 246
Query: 536 FSEII 540
S+I+
Sbjct: 247 LSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 7e-33
Identities = 74/253 (29%), Positives = 137/253 (54%), Gaps = 11/253 (4%)
Query: 299 KVASGSYGDLY--RGTYCSQDVAIKVLKP---ERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
++ GS+G +Y + + +KVLK +N + + QE ++ K+ H +V+
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNN 410
F + + + CI+TE+ G + L +LK + + I + G++Y+HQ
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126
Query: 411 IIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGTYRWMAPEVIEHKPYDHK 469
I+HRDLKA N+ + N ++K+ DFGV+R+ S + T TGT +M+PE ++H+ YD K
Sbjct: 127 ILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSK 185
Query: 470 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 529
+D++S G +L+E+ +E L + +V+ G P++P+ +L +++ +D
Sbjct: 186 SDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-GPTPSLPETYSRQLNSIMQSMLNKD 244
Query: 530 PALRPDFSEIIEI 542
P+LRP +EI+
Sbjct: 245 PSLRPSAAEILRN 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 73/245 (29%), Positives = 128/245 (52%), Gaps = 21/245 (8%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
VA+K LK + +++F +E ++ ++H+++V+F G CT+ L +V E+M G +
Sbjct: 38 VAVKALK--EASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLN 95
Query: 378 DYL-------HKLK-------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
+L L G L +L +A ++ GM YL + +HRDL N L+
Sbjct: 96 RFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV 155
Query: 424 DENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLW 480
+ VVK+ DFG++R + T RWM PE I ++ + ++D++SFG+VLW
Sbjct: 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLW 215
Query: 481 ELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 539
E+ T GK P+ L+ + A+ + +G P+ P++ +++ CWQ++P R +I
Sbjct: 216 EIFTYGKQPWYQLSNTE-AIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
Query: 540 IEILQ 544
LQ
Sbjct: 275 HSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 66/257 (25%), Positives = 123/257 (47%), Gaps = 16/257 (6%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ GS+G + + S + + K + + +++ EV I+R+++H N+V++
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 357 ACTKPPS--LCIVTEFMSGG---SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH---- 407
+ L IV E+ GG + K + + + ++ + + H
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126
Query: 408 -QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHK 464
N ++HRDLK AN+ +D N VK+ DFG+A++ A+T GT +M+PE + H
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-LGHDSSFAKTYVGTPYYMSPEQLNHM 185
Query: 465 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524
YD K+D++S G +++EL P+ LQ A +++G IP +L E+++
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA-SKIKEGKFRRIPYRYSSELNEVIKS 244
Query: 525 CWQQDPALRPDFSEIIE 541
DP RP E+++
Sbjct: 245 MLNVDPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 90/312 (28%), Positives = 138/312 (44%), Gaps = 84/312 (26%)
Query: 293 HLKFGSKVASGSYGDLYRGTYCSQD---------------------VAIKVLKPERINSD 331
HL F K+ G +G+++ C VA+K+L+P+ N +
Sbjct: 6 HLLFKEKLGEGQFGEVH---LCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-ANKN 61
Query: 332 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL--HKLKG---- 385
+ +F +EV I+ +++ N+++ +G C LC++TE+M G + +L H L
Sbjct: 62 ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121
Query: 386 ------------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD 433
SLL VA+ ++ GM YL N +HRDL N L+ EN +K+AD
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 434 FGVARVKAQSGVMTAETGTY-----------RWMAPEVIEHKPYDHKADVFSFGIVLWEL 482
FG++R G Y RWMA E I + +DV++FG+ LWE+
Sbjct: 182 FGMSR--------NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233
Query: 483 LT--GKLPYEYLTPLQAAVGVVQKG-------------LRPTIPKNSQPKLAELLERCWQ 527
L + PY LT Q V++ RP P Q L EL+ +CW
Sbjct: 234 LMLCKEQPYGELTDEQ----VIENAGEFFRDQGRQVYLFRP--PPCPQG-LYELMLQCWS 286
Query: 528 QDPALRPDFSEI 539
+D RP FS+I
Sbjct: 287 RDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 5e-32
Identities = 80/273 (29%), Positives = 132/273 (48%), Gaps = 22/273 (8%)
Query: 294 LKFGSKVASGSYGDLYRGTYCSQD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
L G + G +G + G D VA+K +K ++F E M++ H
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 350 NVVQFIGACTKP------PSLCIVTEFMSGGSVYDYL--HKLKGV-FKLPS--LLKVAID 398
NV++ IG C + PS ++ FM G ++ +L +L LP+ L+K D
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE----TGTYR 454
++ GM YL + IHRDL A N +++EN V VADFG+++ K +G + +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK-KIYNGDYYRQGRIAKMPVK 179
Query: 455 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN 513
W+A E + + Y K+DV+SFG+ +WE+ T G+ PY + + +++G R P +
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-IYDYLRQGNRLKQPPD 238
Query: 514 SQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
L L+ CW +P RP F + L++
Sbjct: 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|153200 cd04928, ACT_TyrKc, Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-32
Identities = 45/68 (66%), Positives = 53/68 (77%)
Query: 179 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLR 238
MHEITF+ DKPKLLSQL++LL D+GLNI EAHAFST DG +LD+FVV GW ET L
Sbjct: 1 MHEITFAAGDKPKLLSQLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRGETAALG 60
Query: 239 AALEKEVL 246
AL+KE+
Sbjct: 61 HALQKEID 68
|
This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 68 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 9e-32
Identities = 68/249 (27%), Positives = 139/249 (55%), Gaps = 7/249 (2%)
Query: 298 SKVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
K+ GS+G L + + IK + +++ ++E +EV ++ ++H N+VQ+
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
+ + +L IV ++ GG +Y ++ +GV F +L + + + ++H I+HR
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHR 125
Query: 415 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADV 472
D+K+ N+ + ++ +K+ DFG+ARV S V A T GT +++PE+ E++PY++K+D+
Sbjct: 126 DIKSQNIFLTKDGTIKLGDFGIARV-LNSTVELARTCIGTPYYLSPEICENRPYNNKSDI 184
Query: 473 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 532
++ G VL+E+ T K +E ++ V + +G P + + L L+ + ++++P
Sbjct: 185 WALGCVLYEMCTLKHAFE-AGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRD 243
Query: 533 RPDFSEIIE 541
RP + I+E
Sbjct: 244 RPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 76/253 (30%), Positives = 132/253 (52%), Gaps = 28/253 (11%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
VA+K LK + + +K+F +E ++ ++H+++V+F G C L +V E+M G +
Sbjct: 38 VAVKALKDPTLAA--RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95
Query: 378 DYLH---------------KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422
+L + KG L +L +A ++ GM YL + +HRDL N L
Sbjct: 96 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 155
Query: 423 MDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVL 479
+ N +VK+ DFG++R + T RWM PE I ++ + ++DV+SFG++L
Sbjct: 156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 215
Query: 480 WELLT-GKLPYEYLTPLQAAVGVVQKGL--RPTI-PKNSQPKLAELLERCWQQDPALRPD 535
WE+ T GK P+ L+ + + Q + RP + PK ++ +++ CWQ++P R +
Sbjct: 216 WEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPK----EVYDIMLGCWQREPQQRLN 271
Query: 536 FSEIIEILQQIAK 548
EI +IL + K
Sbjct: 272 IKEIYKILHALGK 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 81/303 (26%), Positives = 142/303 (46%), Gaps = 53/303 (17%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------------------VAIKVLKPERI 328
E + L+ K+ G +G+++ C + VA+K+L+ + +
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVH---LCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-V 56
Query: 329 NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH------K 382
+ +F +E+ IM ++++ N+++ +G C LC++TE+M G + +L
Sbjct: 57 TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIEST 116
Query: 383 LKGVFKLPS-----LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437
+PS LL +A+ ++ GM YL N +HRDL N L+ + +K+ADFG++
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
Query: 438 RVKAQSGVMTAETG----TYRWMAPEVIEHKPYDHKADVFSFGIVLWEL--LTGKLPYEY 491
R SG G RWMA E I + +DV++FG+ LWE+ L + PY
Sbjct: 177 R-NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235
Query: 492 LTPLQAAVGVVQ----KGLRPTIPKNSQPKLA-----ELLERCWQQDPALRPDFSEIIEI 542
L+ Q + +G + + SQ L +L+ RCW +D RP F++I
Sbjct: 236 LSDEQVIENTGEFFRNQGRQIYL---SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHF 292
Query: 543 LQQ 545
L++
Sbjct: 293 LRE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 86/267 (32%), Positives = 138/267 (51%), Gaps = 37/267 (13%)
Query: 300 VASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356
V +G+YG +Y+G + Q AIKV+ + D ++E QE+ +++K H+N+ + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 357 ACTK--PP----SLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQN 409
A K PP L +V EF GSV D + KG K + + ++ +G+++LHQ+
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130
Query: 410 NIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMAPEVI--EHKP- 465
+IHRD+K N+L+ EN VK+ DFGV A++ G GT WMAPEVI + P
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 190
Query: 466 --YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA---- 519
YD K+D++S GI E+ G P + P++A IP+N P+L
Sbjct: 191 ATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---------LIPRNPAPRLKSKKW 241
Query: 520 -----ELLERCWQQDPALRPDFSEIIE 541
+E C ++ + RP ++++
Sbjct: 242 SKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 4e-31
Identities = 76/247 (30%), Positives = 130/247 (52%), Gaps = 19/247 (7%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
VA+K LK N+ +K+F +E ++ ++H+++V+F G C + L +V E+M G +
Sbjct: 38 VAVKTLKDASDNA--RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 95
Query: 378 DYL--HKLKGVF----------KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 425
+L H V +L +A ++ GM YL + +HRDL N L+ E
Sbjct: 96 KFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 155
Query: 426 NEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWEL 482
N +VK+ DFG++R + T RWM PE I ++ + ++DV+S G+VLWE+
Sbjct: 156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215
Query: 483 LT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
T GK P+ L+ + + +G P+ ++ +L+ CWQ++P +R + EI
Sbjct: 216 FTYGKQPWYQLSN-NEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274
Query: 542 ILQQIAK 548
+LQ +AK
Sbjct: 275 LLQNLAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 77/251 (30%), Positives = 126/251 (50%), Gaps = 14/251 (5%)
Query: 303 GSYGDLYRGTYCSQDVAIKVLK-PERINSDMQKEFAQEVFI-MRKVRHKNVVQFIGACTK 360
G+YG + + + + V + +NS QK ++ I MR V V F GA +
Sbjct: 12 GAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71
Query: 361 PPSLCIVTEFMSGGSVYD-YLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQN-NIIHRDL 416
+ I E M S+ Y +P L K+A+ + K + YLH ++IHRD+
Sbjct: 72 EGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDV 130
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI----EHKPYDHKADV 472
K +N+L++ N VK+ DFG++ S T + G +MAPE I K YD K+DV
Sbjct: 131 KPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDV 190
Query: 473 FSFGIVLWELLTGKLPYE-YLTPLQAAVGVVQKGLRPTIPKNS-QPKLAELLERCWQQDP 530
+S GI + EL TG+ PY+ + TP Q VV + P +P P+ + + +C +++
Sbjct: 191 WSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKFSPEFQDFVNKCLKKNY 249
Query: 531 ALRPDFSEIIE 541
RP++ E+++
Sbjct: 250 KERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 7e-31
Identities = 74/249 (29%), Positives = 136/249 (54%), Gaps = 8/249 (3%)
Query: 299 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ GS+G +Y + S+ IK + ++ ++ +EV ++ K++H N+V F
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ + L IV E+ GG + +++ +GV F +L + +S G+ ++H I+HRD
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRD 126
Query: 416 LKAANLLMDEN-EVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADV 472
+K+ N+ + +N V K+ DFG+AR S + A T GT +++PE+ +++PY++K D+
Sbjct: 127 IKSQNIFLSKNGMVAKLGDFGIARQLNDS-MELAYTCVGTPYYLSPEICQNRPYNNKTDI 185
Query: 473 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 532
+S G VL+EL T K P+E Q + + Q P P S+ L L+ + ++ P
Sbjct: 186 WSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSR-DLRSLISQLFKVSPRD 244
Query: 533 RPDFSEIIE 541
RP + I++
Sbjct: 245 RPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 68/255 (26%), Positives = 112/255 (43%), Gaps = 17/255 (6%)
Query: 302 SGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358
G+YG ++ + AIKV+ K + I + + E I+ + + VV+ +
Sbjct: 3 KGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF 62
Query: 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418
+L +V E++ GG + L + G ++ + YLH N IIHRDLK
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKP 121
Query: 419 ANLLMDENEVVKVADFGVARVKAQS-----GVMTAET----GTYRWMAPEVIEHKPYDHK 469
N+L+D N +K+ DFG+++V E GT ++APEVI + +
Sbjct: 122 DNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKT 181
Query: 470 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIPKNSQPKLAELLERCWQ 527
D +S G +L+E L G P+ TP + + G P + S + +L+ +
Sbjct: 182 VDWWSLGCILYEFLVGIPPFHGETP-EEIFQNILNGKIEWPEDVEVS-DEAIDLISKLLV 239
Query: 528 QDPALRPDFSEIIEI 542
DP R I EI
Sbjct: 240 PDPEKRLGAKSIEEI 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 56/201 (27%), Positives = 102/201 (50%), Gaps = 23/201 (11%)
Query: 299 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ G+YG +Y+ + VA+K ++ + + +E+ ++++++H N+V+ +
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65
Query: 357 ACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
L +V E+ D YL K G + + + +G+ Y H + I+H
Sbjct: 66 VIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILH 121
Query: 414 RDLKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGT--YRWMAPEVI-EHKP 465
RDLK N+L++ + V+K+ADFG+AR ++ T E T YR APE++ K
Sbjct: 122 RDLKPQNILINRDGVLKLADFGLARAFGIPLRT----YTHEVVTLWYR--APEILLGSKH 175
Query: 466 YDHKADVFSFGIVLWELLTGK 486
Y D++S G + E++TGK
Sbjct: 176 YSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 70/272 (25%), Positives = 120/272 (44%), Gaps = 42/272 (15%)
Query: 295 KFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-----R 347
KFG + GS+ + +++ AIK+L ++ +K + V I ++V
Sbjct: 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK-EKKV--KYVKIEKEVLTRLNG 60
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H +++ +L V E+ G + Y+ K G A ++ + YLH
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLH 119
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARV-----------------KAQSGVMTAET 450
IIHRDLK N+L+D++ +K+ DFG A+V +Q
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 451 ----GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP----YEYLTPLQAAVGVV 502
GT +++PE++ KP +D+++ G +++++LTGK P EYLT Q +
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-FQK----I 234
Query: 503 QKGLRPTIPKNSQPKLAELLERCWQQDPALRP 534
K L + P N P +L+E+ DP R
Sbjct: 235 LK-LEYSFPPNFPPDAKDLIEKLLVLDPQDRL 265
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 2e-30
Identities = 80/235 (34%), Positives = 124/235 (52%), Gaps = 28/235 (11%)
Query: 300 VASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356
V +G+YG +Y+G + Q AIKV+ + D ++E E+ +++K H+N+ + G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 357 ACTK--PP----SLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQN 409
A K PP L +V EF GSV D + KG K + + ++ +G+ +LH +
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140
Query: 410 NIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMAPEVI--EHKP- 465
+IHRD+K N+L+ EN VK+ DFGV A++ G GT WMAPEVI + P
Sbjct: 141 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 200
Query: 466 --YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518
YD+++D++S GI E+ G P + P++A IP+N PKL
Sbjct: 201 ATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---------LIPRNPPPKL 246
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 6e-30
Identities = 68/210 (32%), Positives = 112/210 (53%), Gaps = 14/210 (6%)
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
EV IMR +H N+V+ + L +V EF+ GG++ D + + + V +
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLA 123
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMA 457
V K +++LH +IHRD+K+ ++L+ + VK++DFG A+V + + GT WMA
Sbjct: 124 VLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183
Query: 458 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ-- 515
PEVI PY + D++S GI++ E++ G+ PY PLQA K +R +P +
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-----MKRIRDNLPPKLKNL 238
Query: 516 ----PKLAELLERCWQQDPALRPDFSEIIE 541
P+L L+R +DPA R +E++
Sbjct: 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 6e-30
Identities = 72/246 (29%), Positives = 128/246 (52%), Gaps = 6/246 (2%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
V GSYG+ L R + IK L + +K QE ++ +++H N+V + +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 358 CTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPS-LLKVAIDVSKGMNYLHQNNIIHRD 415
L IV F GG +Y L + KG + +++ + ++ + YLH+ +I+HRD
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRD 127
Query: 416 LKAANLLMDENEVVKVADFGVARV-KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 474
LK N+ + ++KV D G+ARV + Q + + GT +M+PE+ +KPY++K+DV++
Sbjct: 128 LKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWA 187
Query: 475 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP 534
G ++E+ T K + + + V + +G P +PK+ P+L EL+ + P RP
Sbjct: 188 LGCCVYEMATLKHAFN-AKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRP 246
Query: 535 DFSEII 540
I+
Sbjct: 247 SVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 78/261 (29%), Positives = 132/261 (50%), Gaps = 13/261 (4%)
Query: 291 PKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRK 345
P + + G + G++G +Y +++A+K ++ + + + KE E+ +++
Sbjct: 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKN 60
Query: 346 VRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+ H+ +VQ+ G P +L I E M GGS+ D L K G K + +G+
Sbjct: 61 LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGV 119
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR---VKAQSGV-MTAETGTYRWMAPE 459
+YLH N I+HRD+K AN+L D VK+ DFG ++ SG M + TGT WM+PE
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179
Query: 460 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 519
VI + Y KAD++S G + E+LT K P+ + A + + P +P +
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCR 239
Query: 520 ELLERCWQQDPALRPDFSEII 540
+ L+R + + LRP E++
Sbjct: 240 DFLKRIFVE-AKLRPSADELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 78/276 (28%), Positives = 137/276 (49%), Gaps = 20/276 (7%)
Query: 276 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQ 333
H++ D +VWEI ++ G++G +Y+ A KV+ E + +
Sbjct: 3 HVRRDLDPNEVWEII-------GELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEEL 53
Query: 334 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+++ E+ I+ H +V+ +GA L I+ EF GG+V + +L P +
Sbjct: 54 EDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 113
Query: 394 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGT 452
+ + + + YLH IIHRDLKA N+L+ + +K+ADFGV+ ++ + GT
Sbjct: 114 VICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGT 173
Query: 453 YRWMAPEVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 507
WMAPEV+ + PYD+KAD++S GI L E+ + P+ L P++ + + K
Sbjct: 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEP 232
Query: 508 PTI--PKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
PT+ P + + L+ + P RP ++++E
Sbjct: 233 PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 84/298 (28%), Positives = 143/298 (47%), Gaps = 42/298 (14%)
Query: 288 EIDPKHLKFGSKVASGSYGDL----------YRGTYCSQD--------VAIKVLKPERIN 329
E K L F K+ G +G++ + S D VA+K+L+ E N
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLR-EDAN 59
Query: 330 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL--HKLKG-- 385
+ + +F +E+ IM +++ N+++ + C LC++TE+M G + +L H+ +
Sbjct: 60 KNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA 119
Query: 386 ------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439
+L+ +A ++ GM YL N +HRDL N L+ +N +K+ADFG++R
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR- 178
Query: 440 KAQSGVMTAETG----TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLPYEYLT 493
SG G RWM+ E I + +DV++FG+ LWE+LT + PY L+
Sbjct: 179 NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238
Query: 494 PLQAAVGVVQ----KGLRPTIPKNSQ-PK-LAELLERCWQQDPALRPDFSEIIEILQQ 545
Q + +G + +PK + P L +L+ CW+++ RP F EI L +
Sbjct: 239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 76/260 (29%), Positives = 133/260 (51%), Gaps = 15/260 (5%)
Query: 290 DP--KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-QEVFIMR 344
DP K+ +F K+ G+ G +Y + Q+VAIK + + +KE E+ +MR
Sbjct: 16 DPKKKYTRF-EKIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMR 71
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
+ +H N+V ++ + L +V E+++GGS+ D + + + V + + +
Sbjct: 72 ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALE 129
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEH 463
+LH N +IHRD+K+ N+L+ + VK+ DFG A++ + + GT WMAPEV+
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 464 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAEL 521
K Y K D++S GI+ E++ G+ PY PL+A + G P + P+ +
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDF 248
Query: 522 LERCWQQDPALRPDFSEIIE 541
L RC + D R E+++
Sbjct: 249 LNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 77/270 (28%), Positives = 142/270 (52%), Gaps = 26/270 (9%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI----NSDMQKEFAQEV 340
+ WEI ++ G++G +Y+ +Q+ VL ++ + + +++ E+
Sbjct: 5 EFWEII-------GELGDGAFGKVYK----AQNKETGVLAAAKVIDTKSEEELEDYMVEI 53
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 400
I+ H N+V+ + A +L I+ EF +GG+V + +L+ P + V
Sbjct: 54 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL 113
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAP 458
+ +NYLH+N IIHRDLKA N+L + +K+ADFGV+ K + ++ GT WMAP
Sbjct: 114 EALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVS-AKNTRTIQRRDSFIGTPYWMAP 172
Query: 459 EVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--P 511
EV+ + +PYD+KADV+S GI L E+ + P+ L P++ + + K PT+ P
Sbjct: 173 EVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTLAQP 231
Query: 512 KNSQPKLAELLERCWQQDPALRPDFSEIIE 541
+ + L++C +++ R +++++
Sbjct: 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 72/236 (30%), Positives = 122/236 (51%), Gaps = 16/236 (6%)
Query: 291 PKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRK 345
P + + G + G++G++Y +++A+K + + + + KE E+ +++
Sbjct: 1 PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKN 60
Query: 346 VRHKNVVQFIGACTKPPS---LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
+RH +VQ+ G C + P L I E+M GGS+ D L K G + + +G
Sbjct: 61 LRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQG 118
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-----TGTYRWMA 457
++YLH N I+HRD+K AN+L D VK+ DFG ++ + Q+ M+ TGT WM+
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK-RIQTICMSGTGIKSVTGTPYWMS 177
Query: 458 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN 513
PEVI + Y KADV+S + E+LT K P+ + A + + +P +P
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG 233
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 53/158 (33%), Positives = 93/158 (58%), Gaps = 4/158 (2%)
Query: 392 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET 450
LL + V+KGM++L N IHRDL A N+L+ + K+ DFG+AR ++ S +
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275
Query: 451 GTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR 507
+WMAPE I + Y ++DV+S+GI+LWE+ + G PY + ++++G R
Sbjct: 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335
Query: 508 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 545
P+ + ++ ++++ CW DP RP F +I+++++Q
Sbjct: 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 4e-28
Identities = 62/167 (37%), Positives = 95/167 (56%), Gaps = 14/167 (8%)
Query: 392 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--------VKAQS 443
L+ + V++GM +L IHRDL A N+L+ EN VVK+ DFG+AR V+ S
Sbjct: 176 LICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235
Query: 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502
+ +WMAPE I K Y ++DV+SFG++LWE+ + G PY + + +
Sbjct: 236 ARL-----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL 290
Query: 503 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549
+ G R P+N+ P++ ++ CWQ DP RP FS ++EIL + +E
Sbjct: 291 KDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 4e-28
Identities = 79/262 (30%), Positives = 132/262 (50%), Gaps = 15/262 (5%)
Query: 291 PKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRK 345
P + + G + G++G +Y +++A K ++ + + + KE + E+ +++
Sbjct: 1 PINWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKN 60
Query: 346 VRHKNVVQFIGACTK---PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
++H+ +VQ+ G C + +L I E+M GGSV D L K G K + +G
Sbjct: 61 LQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEG 118
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR---VKAQSGV-MTAETGTYRWMAP 458
M+YLH N I+HRD+K AN+L D VK+ DFG ++ SG + + TGT WM+P
Sbjct: 119 MSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 459 EVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518
EVI + Y KADV+S G + E+LT K P+ + A + + P +P +
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHA 238
Query: 519 AELLERCWQQDPALRPDFSEII 540
+ L C + RP E++
Sbjct: 239 RDFL-GCIFVEARHRPSAEELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 4e-28
Identities = 77/260 (29%), Positives = 131/260 (50%), Gaps = 13/260 (5%)
Query: 285 DVWEIDPKH-LKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVF 341
D+ +P+H + +V SG+YGD+Y R + + A+K++K E D QE+F
Sbjct: 1 DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIF 58
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
++++ +H N+V + G+ L I E+ GGS+ D H + G + V + +
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQ 117
Query: 402 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMAPEV 460
G+ YLH +HRD+K AN+L+ +N VK+ADFGV A++ A + GT WMAPEV
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177
Query: 461 I---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS--- 514
++ Y+ D+++ GI EL + P L P++A + + +P K+
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKW 237
Query: 515 QPKLAELLERCWQQDPALRP 534
++ ++P RP
Sbjct: 238 SSTFHNFVKISLTKNPKKRP 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 61/165 (36%), Positives = 95/165 (57%), Gaps = 4/165 (2%)
Query: 389 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVM 446
L L+ + V++GM +L IHRDL A N+L+ EN VVK+ DFG+AR K V
Sbjct: 172 LEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 231
Query: 447 TAETG-TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQK 504
+ +WMAPE I K Y ++DV+SFG++LWE+ + G PY + + +++
Sbjct: 232 KGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE 291
Query: 505 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549
G R P+ + P++ ++ CW +P RP FSE++EIL + +E
Sbjct: 292 GTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 71/249 (28%), Positives = 129/249 (51%), Gaps = 12/249 (4%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFI 355
K+ G+ G ++ + Q+VAIK + + +KE E+ +M+++++ N+V F+
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFL 82
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ L +V E+++GGS+ D + + + V + + + +LH N +IHRD
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHANQVIHRD 140
Query: 416 LKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 474
+K+ N+L+ + VK+ DFG A++ + + GT WMAPEV+ K Y K D++S
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 475 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLERCWQQDPAL 532
GI+ E++ G+ PY PL+A + G P + P+ P + L RC + D
Sbjct: 201 LGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSPIFRDFLNRCLEMDVEK 259
Query: 533 RPDFSEIIE 541
R E+++
Sbjct: 260 RGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 9e-28
Identities = 65/195 (33%), Positives = 102/195 (52%), Gaps = 8/195 (4%)
Query: 300 VASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIG 356
+ G +G + S++ A+K +K I Q+E E I+ + H +V+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF-KLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ ++ E+ GG ++ L +G+F + + +A V YLH II+RD
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIACVVL-AFEYLHNRGIIYRD 118
Query: 416 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFS 474
LK NLL+D N VK+ DFG A+ K +SG T GT ++APE+I +K YD D +S
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAK-KLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWS 177
Query: 475 FGIVLWELLTGKLPY 489
GI+L+ELLTG+ P+
Sbjct: 178 LGILLYELLTGRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 90/298 (30%), Positives = 140/298 (46%), Gaps = 33/298 (11%)
Query: 290 DPKHLKFG-SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRK 345
DP+ L ++ GS+G +Y R ++ VAIK + S+ + ++ +EV +++
Sbjct: 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQ 71
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
+RH N +++ G + + +V E+ G S D L K + + + +G+ Y
Sbjct: 72 LRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAY 130
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK--AQSGVMTAETGTYRWMAPEVI-- 461
LH + IHRD+KA N+L+ E VK+ADFG A + A S V GT WMAPEVI
Sbjct: 131 LHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILA 185
Query: 462 -EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS-QPKLA 519
+ YD K DV+S GI EL K P + + A + Q PT+ N
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SPTLSSNDWSDYFR 244
Query: 520 ELLERCWQQDPALRPDFSE---------------IIEILQQIAKEVGE-ENEERRKEK 561
++ C Q+ P RP E II+++Q+ V E +N + RK K
Sbjct: 245 NFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQRTKDAVRELDNLQYRKMK 302
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 79/255 (30%), Positives = 131/255 (51%), Gaps = 18/255 (7%)
Query: 299 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFA---QEVFIMRKVRHKNVVQ 353
++ SG+YGD+Y R + AIKV+K E ++FA QE+ +M+ +H N+V
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
+ G+ + L I EF GGS+ D H + G + V+ + +G+ YLH +H
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHSKGKMH 129
Query: 414 RDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMAPEV--IEHK-PYDHK 469
RD+K AN+L+ +N VK+ADFGV A++ A + GT WMAPEV +E K Y+
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQL 189
Query: 470 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP---KLAELLERCW 526
D+++ GI EL + P L P++A + + +P K+ ++
Sbjct: 190 CDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMAL 249
Query: 527 QQDPALRPDFSEIIE 541
++P RP ++++
Sbjct: 250 TKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 77/253 (30%), Positives = 121/253 (47%), Gaps = 15/253 (5%)
Query: 303 GSYGDLYRGTYCSQDVAIKVLKPERINSDM--QKEFAQEV-FIMRKVRHKNVVQFIGACT 359
G++G + + + + V K R D QK ++ +MR +V+F GA
Sbjct: 15 GAFGTVNKMLHKPSGTIMAV-KRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF 73
Query: 360 KPPSLCIVTEFM--SGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRD 415
+ I E M S Y Y++ LK V L K+A+ K +NYL + IIHRD
Sbjct: 74 REGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRD 133
Query: 416 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE---HKPYDHKADV 472
+K +N+L+D N +K+ DFG++ S T + G +MAPE I+ YD ++DV
Sbjct: 134 VKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDV 193
Query: 473 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG----LRPTIPKNSQPKLAELLERCWQQ 528
+S GI L+E+ TGK PY + + V KG L + + P + C +
Sbjct: 194 WSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIK 253
Query: 529 DPALRPDFSEIIE 541
D + RP + E++E
Sbjct: 254 DESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 68/220 (30%), Positives = 114/220 (51%), Gaps = 20/220 (9%)
Query: 330 SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 389
S ++K+ +E+ IM + R +V F GA ++C+ EFM GS+ D ++K G +
Sbjct: 44 SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPV 102
Query: 390 PSLLKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448
L K+A+ V +G+ YL+ + I+HRD+K +N+L++ +K+ DFGV+ S A
Sbjct: 103 EILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IA 159
Query: 449 ET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL 506
+T GT +M+PE I+ Y K+DV+S GI + EL GK P+ + + + G+
Sbjct: 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF-SNIDDDGQDDPMGI 218
Query: 507 -----------RPTIPKNSQPKLAELL-ERCWQQDPALRP 534
P +P + P+ + C +DP RP
Sbjct: 219 LDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 2e-27
Identities = 79/257 (30%), Positives = 134/257 (52%), Gaps = 9/257 (3%)
Query: 290 DPK-HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 348
DP+ +L K+ GS G + T S + V K + ++ EV IMR +H
Sbjct: 17 DPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 76
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
+NVV+ + L +V EF+ GG++ D + + + V + V K ++ LH
Sbjct: 77 ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLHA 134
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 467
+IHRD+K+ ++L+ + VK++DFG A+V + + GT WMAPE+I PY
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG 194
Query: 468 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ---PKLAELLER 524
+ D++S GI++ E++ G+ PY PL+ A+ +++ L P + KN P L L+R
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPKL-KNLHKVSPSLKGFLDR 252
Query: 525 CWQQDPALRPDFSEIIE 541
+DPA R +E+++
Sbjct: 253 LLVRDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 77/257 (29%), Positives = 129/257 (50%), Gaps = 22/257 (8%)
Query: 306 GDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365
G+ +RG ++ V +K L+ D Q F QEV R++ H NV+Q +G C +
Sbjct: 14 GEAHRGMSKAR-VVVKELR-ASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYL 71
Query: 366 IVTEFMSGGSVYDYLHKLKGVFKLPS----LLKVAIDVSKGMNYLHQNNIIHRDLKAANL 421
+V EF G + +YL +G+ + L ++A +V+ G+ +LHQ + IH DL N
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131
Query: 422 LMDENEVVKVADFGVARVK-AQSGVMTAETGTY--RWMAPEVIEH-----KPYDH--KAD 471
+ + VK+ D+G+A + + +T + RW+APE++E P D K++
Sbjct: 132 QLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSN 191
Query: 472 VFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ----KGLRPTIPKNSQPKLAELLERCW 526
++S G+ +WEL T PY L+ Q VV+ K +P + + E+++ CW
Sbjct: 192 IWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW 251
Query: 527 QQDPALRPDFSEIIEIL 543
DP RP E+ E+L
Sbjct: 252 -LDPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 61/164 (37%), Positives = 93/164 (56%), Gaps = 4/164 (2%)
Query: 384 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKA 441
K V L L+ + V+KGM +L IHRDL A N+L+ EN VVK+ DFG+AR K
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232
Query: 442 QSGVMTAETG-TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 499
V + +WMAPE I + Y ++DV+SFG++LWE+ + G PY + +
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 292
Query: 500 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 543
+++G R P + P++ + + CW +P+ RP FSE++E L
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 42/212 (19%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKE-----FAQEVFIMRKVRHKNV 351
++ G+YG +Y+ + VA+K +I + +KE +E+ +++K+RH N+
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALK-----KIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVY---DYL-HKLKGVFKLPSLLKVAIDVSK------ 401
V+ IVT GS+Y +Y+ H L G+ P + K K
Sbjct: 61 VRLK---------EIVTS-KGKGSIYMVFEYMDHDLTGLLDSPEV-KFTESQIKCYMKQL 109
Query: 402 --GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGT--YRW 455
G+ YLH N I+HRD+K +N+L++ + V+K+ADFG+AR K S T T YR
Sbjct: 110 LEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR- 168
Query: 456 MAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 486
PE++ Y + D++S G +L EL GK
Sbjct: 169 -PPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 65/260 (25%), Positives = 135/260 (51%), Gaps = 13/260 (5%)
Query: 298 SKVASGSYGDLYRG--TYCSQDVAIKVLKP-ERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
K+ G + +Y+ + VA+K ++ E +++ +++ +E+ +++++ H NV+++
Sbjct: 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKY 67
Query: 355 IGACTKPPSLCIVTEFMSGGSV---YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
+ + + L IV E G + + K K + ++ K + + + ++H I
Sbjct: 68 LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRI 127
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHK 469
+HRD+K AN+ + VVK+ D G+ R + S A + GT +M+PE I Y+ K
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIHENGYNFK 186
Query: 470 ADVFSFGIVLWELLTGKLP-YEYLTPLQAAVGVVQKGLRPTIPKN--SQPKLAELLERCW 526
+D++S G +L+E+ + P Y L + ++K P +P + S+ L +L+ RC
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE-LRDLVSRCI 245
Query: 527 QQDPALRPDFSEIIEILQQI 546
DP RPD S ++++ +++
Sbjct: 246 NPDPEKRPDISYVLQVAKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 53/203 (26%), Positives = 104/203 (51%), Gaps = 4/203 (1%)
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAI 397
I ++RH N+V++ + L IV + + G + ++ + LK F + + +
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 398 DVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM 456
+ + YLH + I+HRDL N+++ E++ V + DFG+A+ K +T+ GT +
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYS 180
Query: 457 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 516
PE+++++PY KADV++FG +L+++ T + P+ L A +V+ P
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE 240
Query: 517 KLAELLERCWQQDPALRPDFSEI 539
+ +++ C D RPD ++
Sbjct: 241 DVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 7/194 (3%)
Query: 298 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
K+ G+YG +Y R + VAIK +K + + K +E+ +++++ H N+++ +
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
L +V EFM +Y + + + + +G+ + H + I+HRD
Sbjct: 65 DVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRD 123
Query: 416 LKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWM-APEVI-EHKPYDHKADV 472
LK NLL++ V+K+ADFG+AR T T RW APE++ K Y D+
Sbjct: 124 LKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT-RWYRAPELLLGDKGYSTPVDI 182
Query: 473 FSFGIVLWELLTGK 486
+S G + ELL+ +
Sbjct: 183 WSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 72/266 (27%), Positives = 128/266 (48%), Gaps = 14/266 (5%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRK 345
+ D L+ ++ SG+ G +Y+ + + V + R N + K ++ ++ K
Sbjct: 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK 69
Query: 346 VRH-KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGM 403
+V+ G + I E MS + D L K ++G L K+ + + K +
Sbjct: 70 SHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKAL 127
Query: 404 NYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 462
+YL + +IHRD+K +N+L+D + VK+ DFG++ S T G +MAPE I+
Sbjct: 128 HYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERID 187
Query: 463 HKP----YDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQKGLRPTIP--KNSQ 515
YD +ADV+S GI L EL TG+ PY+ T + ++Q+ P++P +
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP-PSLPPNEGFS 246
Query: 516 PKLAELLERCWQQDPALRPDFSEIIE 541
P ++ C +D RP + E+++
Sbjct: 247 PDFCSFVDLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 4e-27
Identities = 54/159 (33%), Positives = 96/159 (60%), Gaps = 4/159 (2%)
Query: 392 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 451
L+ + V+ GM +L N +HRDL A N+L+ E ++VK+ DFG+AR + ++
Sbjct: 241 LVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGS 300
Query: 452 TY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR 507
T+ +WMAPE I + Y +DV+SFGI+LWE+ T G PY L + +++G R
Sbjct: 301 TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR 360
Query: 508 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
P ++ ++ E++++CW++ +RPDFS+++ ++ +
Sbjct: 361 MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 78/257 (30%), Positives = 133/257 (51%), Gaps = 28/257 (10%)
Query: 299 KVASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKE-----FAQEVFIMRKVRHKNV 351
K+ GS G + R + + VA+K++ D++K+ EV IMR +H+NV
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMM-------DLRKQQRRELLFNEVVIMRDYQHQNV 80
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V+ + L ++ EF+ GG++ D + + + + V V + + YLH +
Sbjct: 81 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLHSQGV 138
Query: 412 IHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 470
IHRD+K+ ++L+ + VK++DFG A++ + GT WMAPEVI PY +
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 471 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP---KNSQ---PKLAELLER 524
D++S GI++ E++ G+ PY +P+QA K LR + P KN+ P L + LER
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDSPVQA-----MKRLRDSPPPKLKNAHKISPVLRDFLER 253
Query: 525 CWQQDPALRPDFSEIIE 541
++P R E+++
Sbjct: 254 MLTREPQERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 73/225 (32%), Positives = 110/225 (48%), Gaps = 16/225 (7%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
+A+KV+ P I ++QK+ E+ I+ K ++ F GA + I TEFM GGS+
Sbjct: 29 LAVKVI-PLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLD 87
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437
Y L ++A+ V KG+ YL I+HRD+K +N+L++ VK+ DFGV+
Sbjct: 88 VY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVS 142
Query: 438 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE------- 490
S + GT +MAPE I + Y +DV+S GI EL G+ PY
Sbjct: 143 TQLVNS-IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG 201
Query: 491 YLTPLQAAVGVVQKGLRPTIPKNS-QPKLAELLERCWQQDPALRP 534
L PLQ +V + P +P K + +C ++ P RP
Sbjct: 202 SLMPLQLLQCIVDED-PPVLPVGQFSEKFVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 72/247 (29%), Positives = 122/247 (49%), Gaps = 16/247 (6%)
Query: 294 LKFGSKVASGSYGD----LYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRH 348
+F + +GS+G ++G+ + A+K+L +I Q E E I++ +RH
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSG--KYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
+V G+ +L +V E++ GG ++ +L K G F P A V + YLH
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHS 119
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 468
+I++RDLK NLL+D + +K+ DFG A+ + + T GT ++APE+I K Y
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAK-RVKGRTYTL-CGTPEYLAPEIILSKGYGK 177
Query: 469 KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIPKNSQPKLAELLERCW 526
D ++ GI+++E+L G P+ P+Q + +K L + P P +L+
Sbjct: 178 AVDWWALGILIYEMLAGYPPFFDDNPIQ----IYEKILEGKVRFPSFFSPDAKDLIRNLL 233
Query: 527 QQDPALR 533
Q D R
Sbjct: 234 QVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 9e-27
Identities = 75/260 (28%), Positives = 133/260 (51%), Gaps = 15/260 (5%)
Query: 290 DPK--HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMR 344
DPK + +F K+ G+ G +Y Q+VAIK + + +KE E+ +MR
Sbjct: 16 DPKKKYTRF-EKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMR 71
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
+ ++ N+V ++ + L +V E+++GGS+ D + + + V + + ++
Sbjct: 72 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALD 129
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEH 463
+LH N +IHRD+K+ N+L+ + VK+ DFG A++ + + GT WMAPEV+
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 464 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAEL 521
K Y K D++S GI+ E++ G+ PY PL+A + G P + P+ +
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSAVFRDF 248
Query: 522 LERCWQQDPALRPDFSEIIE 541
L RC + D R E+++
Sbjct: 249 LNRCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 29/212 (13%)
Query: 295 KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQ---KEFAQEVFIMRKVRHK 349
+ G K+ G+Y +Y+ + VAIK +K +E+ ++++++H
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHP 62
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS-------KG 402
N++ + ++ +V EFM L+ V K S++ D+ +G
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFMET--------DLEKVIKDKSIVLTPADIKSYMLMTLRG 114
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWM-APEV 460
+ YLH N I+HRDLK NLL+ + V+K+ADFG+AR MT + T RW APE+
Sbjct: 115 LEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT-RWYRAPEL 173
Query: 461 I---EHKPYDHKADVFSFGIVLWELLTGKLPY 489
+ H Y D++S G + ELL P+
Sbjct: 174 LFGARH--YGVGVDMWSVGCIFAELLLRV-PF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 78/260 (30%), Positives = 130/260 (50%), Gaps = 34/260 (13%)
Query: 294 LKFGSKVASGSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
L+ +++ SG+ G +Y R T + A+KV+ ++++ +E+ I+R V H
Sbjct: 76 LERVNRIGSGAGGTVYKVIHRPT--GRLYALKVIYGNH-EDTVRRQICREIEILRDVNHP 132
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLH 407
NVV+ + ++ EFM GGS L+G + L VA + G+ YLH
Sbjct: 133 NVVKCHDMFDHNGEIQVLLEFMDGGS-------LEGTHIADEQFLADVARQILSGIAYLH 185
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM---TAETGTYRWMAPEVI--- 461
+ +I+HRD+K +NLL++ + VK+ADFGV+R+ AQ+ M + GT +M+PE I
Sbjct: 186 RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MDPCNSSVGTIAYMSPERINTD 243
Query: 462 -EHKPYDHKA-DVFSFGIVLWELLTGKLPYEY-----LTPLQAAVGVVQKGLRPTIPKNS 514
H YD A D++S G+ + E G+ P+ L A+ + Q P P +
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP---PEAPATA 300
Query: 515 QPKLAELLERCWQQDPALRP 534
+ + C Q++PA R
Sbjct: 301 SREFRHFISCCLQREPAKRW 320
|
Length = 353 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 74/260 (28%), Positives = 131/260 (50%), Gaps = 15/260 (5%)
Query: 290 DPK--HLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMR 344
DPK + +F K+ G+ G +Y Q+VAI+ + + +KE E+ +MR
Sbjct: 17 DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 72
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
+ ++ N+V ++ + L +V E+++GGS+ D + + + V + + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALE 130
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEH 463
+LH N +IHRD+K+ N+L+ + VK+ DFG A++ + + GT WMAPEV+
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 464 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAEL 521
K Y K D++S GI+ E++ G+ PY PL+A + G P + P+ +
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDF 249
Query: 522 LERCWQQDPALRPDFSEIIE 541
L RC D R E+++
Sbjct: 250 LNRCLDMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 51/214 (23%), Positives = 98/214 (45%), Gaps = 7/214 (3%)
Query: 321 KVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL 380
K ++ + + + E I++++ H +V + ++ +V + + GG + +L
Sbjct: 37 KCVEKGSVRNVLN-----ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL 91
Query: 381 HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440
+ K F + ++ + YLH IIHRD+K N+L+DE V + DF +A
Sbjct: 92 SQ-KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV 150
Query: 441 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY-LTPLQAAV 499
+ T+ +GT +MAPEV+ + Y D +S G+ +E L GK PY ++ +
Sbjct: 151 TPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210
Query: 500 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 533
Q+ P + + + + ++DP R
Sbjct: 211 RAKQETADVLYPATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 72/249 (28%), Positives = 110/249 (44%), Gaps = 28/249 (11%)
Query: 300 VASGSYGDLY------RGTYCSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHK-NV 351
++ G++G +Y G Y AIKVLK + + Q E IM V
Sbjct: 4 ISKGAFGSVYLAKKRSTGDY----FAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYV 59
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
+ + L +V E+++GG + L G + +V G+ LHQ I
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKA 470
IHRD+K NLL+D+ +K+ DFG++R G+ + GT ++APE I D +
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRN----GLENKKFVGTPDYLAPETILGVGDDKMS 174
Query: 471 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQ----PKLAELLER 524
D +S G V++E L G P+ TP V L I P+ + P+ +L+ R
Sbjct: 175 DWWSLGCVIFEFLFGYPPFHAETPDA----VFDNILSRRINWPEEVKEFCSPEAVDLINR 230
Query: 525 CWQQDPALR 533
DPA R
Sbjct: 231 LLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 68/278 (24%), Positives = 135/278 (48%), Gaps = 28/278 (10%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEV 340
EI+ ++F ++ +G +Y+G +Q VAIK LK ++ +++EF E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEA 59
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------HKLKG 385
+ +++H N+V +G TK L ++ + S ++++L +K
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 386 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQS- 443
+ + + ++ GM +L ++++H+DL N+L+ + VK++D G+ R V A
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179
Query: 444 -GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGV 501
+M RWM+PE I + + +D++S+G+VLWE+ + G PY + Q + +
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVIEM 238
Query: 502 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 539
++ P + + L+ CW + P+ RP F +I
Sbjct: 239 IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 86/290 (29%), Positives = 128/290 (44%), Gaps = 52/290 (17%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYR--GTYCSQDVAIKVLKPERINSDMQKEFAQE 339
D +D WEI + G+YG +++ A+K+L P D+ +E E
Sbjct: 15 DPSDTWEII-------ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAE 64
Query: 340 VFIMRKVR-HKNVVQFIGACTKPP-----SLCIVTEFMSGGSVYDYLHKLKGVFKL---- 389
I++ + H NVV+F G K L +V E +GGSV D + KG K
Sbjct: 65 YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV---KGFLKRGERM 121
Query: 390 --PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVM 446
P + + + G+ +LH N IHRD+K N+L+ VK+ DFGV A++ +
Sbjct: 122 EEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181
Query: 447 TAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501
GT WMAPEVI YD + DV+S GI EL G P L P++A
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-- 239
Query: 502 VQKGLRPTIPKNSQPKLAE----------LLERCWQQDPALRPDFSEIIE 541
IP+N P L + + +C +D RP S++++
Sbjct: 240 -------KIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 67/245 (27%), Positives = 134/245 (54%), Gaps = 6/245 (2%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
V GS+G L + Q A+K ++ + +S ++ +E ++ K++H N+V F +
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS-RKEAVLLAKMKHPNIVAFKES 66
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
L IV E+ GG + + +G +F ++L+ + + G+ ++H+ ++HRD+
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDI 126
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSF 475
K+ N+ + +N VK+ DFG AR+ G GT ++ PE+ E+ PY++K+D++S
Sbjct: 127 KSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSL 186
Query: 476 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD 535
G +L+EL T K P++ + + V Q +P +P + +L L+++ ++++P RP
Sbjct: 187 GCILYELCTLKHPFQANSWKNLILKVCQGSYKP-LPSHYSYELRSLIKQMFKRNPRSRPS 245
Query: 536 FSEII 540
+ I+
Sbjct: 246 ATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 47/171 (27%), Positives = 87/171 (50%), Gaps = 4/171 (2%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
VA+K + R+ + + +E+ ++ +H VV+ + +V E+M +
Sbjct: 28 VALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLS 86
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437
+ L + + + KG+ Y+H N I+HRDLK ANLL+ + V+K+ADFG+A
Sbjct: 87 EVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLA 146
Query: 438 RV--KAQSGVMTAETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTG 485
R+ + + + + + T + APE++ YD D+++ G + ELL G
Sbjct: 147 RLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 10/195 (5%)
Query: 303 GSYGDL----YRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIG 356
GS+G + +GT + A+KVLK + I D E E ++ +H + Q
Sbjct: 6 GSFGKVLLAELKGT--DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHS 63
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
L V E+++GG + ++ + G F P A ++ G+ +LH+ II+RDL
Sbjct: 64 CFQTKDRLFFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSF 475
K N+L+D +K+ADFG+ + GV T+ GT ++APE++ ++PY D ++
Sbjct: 123 KLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWAL 182
Query: 476 GIVLWELLTGKLPYE 490
G++L+E+L G+ P+E
Sbjct: 183 GVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 77/278 (27%), Positives = 130/278 (46%), Gaps = 38/278 (13%)
Query: 299 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFI 355
V GSYG + + Q VAIK E + M K+ A +E+ +++++RH+N+V I
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFL-ESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ L +V EF+ +V D L K + K + +G+ + H +NIIHRD
Sbjct: 67 EVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRD 125
Query: 416 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM-APEVIEHKP-YDHKADVF 473
+K N+L+ ++ VVK+ DFG AR A G + + RW APE++ Y D++
Sbjct: 126 IKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIW 185
Query: 474 SFGIVLWELLTGK--LPYE------------------------YLTPLQAAVGVVQ---- 503
+ G ++ E+LTG+ P + PL A + + +
Sbjct: 186 AVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEI 245
Query: 504 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
+ L PK S + +L ++C + DP RP S+++
Sbjct: 246 EPLEKRFPKLS-GLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 89/291 (30%), Positives = 130/291 (44%), Gaps = 54/291 (18%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQ 338
D TD WEI + G+YG +Y+ T +D A+K+L P SD+ +E
Sbjct: 19 DPTDTWEII-------ETIGKGTYGKVYKVTN-KKDGSLAAVKILDPI---SDVDEEIEA 67
Query: 339 EVFIMRKV-RHKNVVQFIGACTKPP-----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSL 392
E I++ + H NVV+F G K L +V E +GGSV + + KG+
Sbjct: 68 EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV---KGLLICGQR 124
Query: 393 LKVAI------DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGV 445
L A+ G+ +LH N IIHRD+K N+L+ VK+ DFGV A++ +
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184
Query: 446 MTAETGTYRWMAPEVIEHK-----PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 500
GT WMAPEVI + YD + DV+S GI EL G P + P++
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF- 243
Query: 501 VVQKGLRPTIPKNSQPKL----------AELLERCWQQDPALRPDFSEIIE 541
IP+N P L + +C +D RP + ++E
Sbjct: 244 --------KIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 81/273 (29%), Positives = 135/273 (49%), Gaps = 15/273 (5%)
Query: 277 LKIPNDGTDVWEIDPKHLKFG-SKVASGSYGDLYRGT--YCSQDVAIKVLK--PERINSD 331
+K P ++ DP+ + G ++ GS+G +Y T + ++ VA+K + ++ N
Sbjct: 5 VKDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEK 64
Query: 332 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS 391
Q + +EV +++++H N +++ G K + +V E+ G S D L K +
Sbjct: 65 WQ-DIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVE 122
Query: 392 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 451
+ + +G+ YLH +N+IHRD+KA N+L+ E VK+ADFG A + + G
Sbjct: 123 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF---VG 179
Query: 452 TYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP 508
T WMAPEVI + YD K DV+S GI EL K P + + A + Q P
Sbjct: 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SP 238
Query: 509 TIPKNS-QPKLAELLERCWQQDPALRPDFSEII 540
T+ N ++ C Q+ P RP +E++
Sbjct: 239 TLQSNEWTDSFRGFVDYCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 66/224 (29%), Positives = 112/224 (50%), Gaps = 12/224 (5%)
Query: 299 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358
K+ GS G + T + V K + ++ EV IMR H+NVV +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418
L +V EF+ GG++ D + + + V + V + ++YLH +IHRD+K+
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146
Query: 419 ANLLMDENEVVKVADFG-VARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGI 477
++L+ + +K++DFG A+V + + GT WMAPEVI PY + D++S GI
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGI 206
Query: 478 VLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521
++ E++ G+ PY PLQA + +R +P P++ +
Sbjct: 207 MVIEMIDGEPPYFNEPPLQA-----MRRIRDNLP----PRVKDS 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 298 SKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
V G+YG + + C + VAIK K + D++K +EV ++R++RH+N+V
Sbjct: 7 GVVGEGAYGVVLK---CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIV 63
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
A + L +V E++ ++ + L G ++ + + + Y H +NII
Sbjct: 64 NLKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNII 122
Query: 413 HRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTAETGTYRWM-APEV-IEHKPYDH 468
HRD+K N+L+ E+ V+K+ DFG AR +T T RW APE+ + Y
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVAT-RWYRAPELLVGDTNYGK 181
Query: 469 KADVFSFGIVLWELLTG 485
DV++ G ++ ELL G
Sbjct: 182 PVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 9e-24
Identities = 53/159 (33%), Positives = 88/159 (55%), Gaps = 7/159 (4%)
Query: 392 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 451
LL V++GM +L N +HRDL A N+L+ + ++VK+ DFG+AR ++
Sbjct: 239 LLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGS 298
Query: 452 TY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR 507
T+ +WMAPE I Y +DV+S+GI+LWE+ + G PY + ++ G R
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR 358
Query: 508 PTIPKNSQPKLAELLERCWQQDPALRPDF---SEIIEIL 543
P ++ ++ +++ +CW +P RP F S+I+E L
Sbjct: 359 MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 9e-24
Identities = 56/169 (33%), Positives = 96/169 (56%), Gaps = 16/169 (9%)
Query: 389 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR---------V 439
L LL+ + V++GM++L N IHRD+ A N+L+ + V K+ DFG+AR V
Sbjct: 211 LDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270
Query: 440 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 498
K + + +WMAPE I Y ++DV+S+GI+LWE+ + GK PY +
Sbjct: 271 KGNARL------PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF 324
Query: 499 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA 547
+V++G + + P + P++ +++ CW +P RP FS+I +++Q+
Sbjct: 325 YKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 73/263 (27%), Positives = 129/263 (49%), Gaps = 19/263 (7%)
Query: 294 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKN 350
++ ++ G+YG +Y+ + V +K R+ D K F Q E+ I+ K
Sbjct: 3 IEVLDELGKGNYGSVYKVLHRPTGV-TMAMKEIRLELDESK-FNQIIMELDILHKAVSPY 60
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSV---YDYLHKLKGVFKLPSLLKVAIDVSKGMNYL- 406
+V F GA ++ + E+M GS+ Y +G+ + L ++ V KG+ +L
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE-DVLRRITYAVVKGLKFLK 119
Query: 407 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI----- 461
++NIIHRD+K N+L++ N VK+ DFGV+ S T G +MAPE I
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT-NIGCQSYMAPERIKSGGP 178
Query: 462 -EHKPYDHKADVFSFGIVLWELLTGKLPY--EYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518
++ Y ++DV+S G+ + E+ G+ PY E + A + + G PT+P
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA 238
Query: 519 AELLERCWQQDPALRPDFSEIIE 541
+ + +C + P RP +++++E
Sbjct: 239 QDFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 71/242 (29%), Positives = 122/242 (50%), Gaps = 10/242 (4%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
+ G +G++Y R + A+K L +RI + A IM + FI
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 358 CT----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
T P LC + + M+GG ++ +L + GVF + A ++ G+ ++H +++
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 414 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADV 472
RDLK AN+L+DE+ V+++D G+A A GT+ +MAPEV++ YD AD
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADW 179
Query: 473 FSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 531
FS G +L++LL G P+ ++ T + + + + +P + P+L LLE Q+D +
Sbjct: 180 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVS 239
Query: 532 LR 533
R
Sbjct: 240 KR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-23
Identities = 66/258 (25%), Positives = 134/258 (51%), Gaps = 11/258 (4%)
Query: 299 KVASGSYGDLYRGTYC---SQDVAIKVLKP-ERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
K+ G + ++YR T C + VA+K ++ E +++ +++ +E+ +++++ H NV+++
Sbjct: 9 KIGRGQFSEVYRAT-CLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY 67
Query: 355 IGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
+ + + L IV E G + Y K K + ++ K + + + ++H +
Sbjct: 68 LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV 127
Query: 412 IHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 470
+HRD+K AN+ + VVK+ D G+ R +++ + GT +M+PE I Y+ K+
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKS 187
Query: 471 DVFSFGIVLWELLTGKLP-YEYLTPLQAAVGVVQKGLRPTIPK-NSQPKLAELLERCWQQ 528
D++S G +L+E+ + P Y L + +++ P +P + KL EL+ C
Sbjct: 188 DIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYP 247
Query: 529 DPALRPDFSEIIEILQQI 546
DP RPD + +I +Q+
Sbjct: 248 DPDQRPDIGYVHQIAKQM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 81/274 (29%), Positives = 136/274 (49%), Gaps = 15/274 (5%)
Query: 277 LKIPNDGTDVWEIDPKHLKFGS--KVASGSYGDLY--RGTYCSQDVAIKVLK-PERINSD 331
LK P ++ DP+ L F ++ GS+G +Y R ++ VAIK + + +++
Sbjct: 9 LKDPEIAELFFKEDPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE 67
Query: 332 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS 391
++ +EV +++++H N +++ G + + +V E+ G S D L K +
Sbjct: 68 KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVE 126
Query: 392 LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 451
+ + +G+ YLH +N+IHRD+KA N+L+ E VK+ADFG A + + + G
Sbjct: 127 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF---VG 183
Query: 452 TYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP 508
T WMAPEVI + YD K DV+S GI EL K P + + A + Q P
Sbjct: 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SP 242
Query: 509 TIPKNS-QPKLAELLERCWQQDPALRPDFSEIIE 541
T+ N ++ C Q+ P RP E+++
Sbjct: 243 TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 59/186 (31%), Positives = 93/186 (50%), Gaps = 9/186 (4%)
Query: 309 YRGTYCSQDVAIKVLKPERINSDMQKE---FAQEVF-IMRKVRHKNVVQFIGACTKPPSL 364
Y+ T + AIK LK I + + E + +F RH +V +
Sbjct: 20 YKKT--GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHV 77
Query: 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 424
C V E+ +GG + ++H VF P + A V G+ YLH+N I++RDLK NLL+D
Sbjct: 78 CFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD 135
Query: 425 ENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL 483
VK+ADFG+ + G T+ GT ++APEV+ Y D + G++++E+L
Sbjct: 136 TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195
Query: 484 TGKLPY 489
G+ P+
Sbjct: 196 VGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 4e-23
Identities = 63/225 (28%), Positives = 110/225 (48%), Gaps = 16/225 (7%)
Query: 319 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L +R+ ++ A E I+ KV + +V A LC+V M+GG +
Sbjct: 22 ACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLK 81
Query: 378 DYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
+++ + + F + A + G+ +LHQ I++RDLK N+L+D++ V+++D G+
Sbjct: 82 YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGL 141
Query: 437 A-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL 495
A +K + GT +MAPEV++ + YD D F+ G L+E++ G+ P+
Sbjct: 142 AVELKGGKKI-KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFR----- 195
Query: 496 QAAVGVVQKGLRP-------TIPKNSQPKLAELLERCWQQDPALR 533
Q V ++ L+ P P+ +L E Q+DP R
Sbjct: 196 QRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 7e-23
Identities = 73/228 (32%), Positives = 118/228 (51%), Gaps = 6/228 (2%)
Query: 319 AIKVLKPERI-NSDMQKE-FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
A+KVL+ + + N QK A+ +++ V+H +V + L V +F++GG +
Sbjct: 24 AVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL 83
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
+ +L + + F P A +++ + YLH NI++RDLK N+L+D V + DFG+
Sbjct: 84 FFHLQRER-SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGL 142
Query: 437 ARVK-AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL 495
+ AQS T GT ++APEVI +PYD+ D + G VL+E+L G P+
Sbjct: 143 CKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA 202
Query: 496 QAAVGVVQKGL--RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
+ ++ K L RP + L ELLE+ Q+ + DF EI E
Sbjct: 203 EMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQE 250
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 8e-23
Identities = 77/243 (31%), Positives = 119/243 (48%), Gaps = 12/243 (4%)
Query: 299 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHKNVVQFI 355
++ GS+G +Y R S+ VAIK + S+ + ++ +EV ++K+RH N +Q+
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
G + + +V E+ G S D L K + + V +G+ YLH +N+IHRD
Sbjct: 82 GCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 416 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI---EHKPYDHKADV 472
+KA N+L+ E +VK+ DFG A + A + GT WMAPEVI + YD K DV
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDGKVDV 197
Query: 473 FSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS-QPKLAELLERCWQQDPA 531
+S GI EL K P + + A + Q P + ++ C Q+ P
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPALQSGHWSEYFRNFVDSCLQKIPQ 256
Query: 532 LRP 534
RP
Sbjct: 257 DRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 8e-23
Identities = 70/246 (28%), Positives = 123/246 (50%), Gaps = 18/246 (7%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
+ G +G++Y R + A+K L +RI + A IM + FI
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 358 CT----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
+ P L + + M+GG ++ +L + GVF + A ++ G+ ++H +++
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 414 RDLKAANLLMDENEVVKVADFGVA----RVKAQSGVMTAETGTYRWMAPEVIEHK-PYDH 468
RDLK AN+L+DE+ V+++D G+A + K + V GT+ +MAPEV++ YD
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----GTHGYMAPEVLQKGVAYDS 175
Query: 469 KADVFSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527
AD FS G +L++LL G P+ ++ T + + + + +P + P+L LLE Q
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235
Query: 528 QDPALR 533
+D R
Sbjct: 236 RDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 66/243 (27%), Positives = 126/243 (51%), Gaps = 21/243 (8%)
Query: 303 GSYGDLY-----RGTYCSQDVAIKVLKP------ERINSDMQKEFAQEVFIMRKVRHKNV 351
GS+G ++ G Q A+KVLK +R+ + M+++ I+ +V H +
Sbjct: 7 GSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERD------ILAEVNHPFI 60
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V+ A L ++ +F+ GG ++ L K + +F + +++ +++LH I
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKA 470
I+RDLK N+L+DE +K+ DFG+++ GT +MAPEV+ + + A
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA 179
Query: 471 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 530
D +SFG++++E+LTG LP++ + +++ L +P+ P+ LL ++++P
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL--GMPQFLSPEAQSLLRALFKRNP 237
Query: 531 ALR 533
A R
Sbjct: 238 ANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 58/257 (22%), Positives = 129/257 (50%), Gaps = 9/257 (3%)
Query: 299 KVASGSYGDLYRGTYCSQDVAIKVLKPE---RINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
K+ G + ++YR T V + + K + +++ + + +E+ +++++ H NV+++
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL---PSLLKVAIDVSKGMNYLHQNNII 412
+ + L IV E G + + K +L ++ K + + + ++H ++
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVM 128
Query: 413 HRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKAD 471
HRD+K AN+ + VVK+ D G+ R +++ + GT +M+PE I Y+ K+D
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSD 188
Query: 472 VFSFGIVLWELLTGKLP-YEYLTPLQAAVGVVQKGLRPTIPKNS-QPKLAELLERCWQQD 529
++S G +L+E+ + P Y L + +++ P +P + +L +L+ C D
Sbjct: 189 IWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPD 248
Query: 530 PALRPDFSEIIEILQQI 546
P RPD + + ++ +++
Sbjct: 249 PEKRPDITYVYDVAKRM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 59/247 (23%), Positives = 120/247 (48%), Gaps = 13/247 (5%)
Query: 308 LYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQ----FIGACTKPP 362
+Y+G + +++V I+ K + + E+ +R++ N+++ I P
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 363 SLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAAN 420
L ++ E+ + G + + L K K + FK + L +AID KG+ L++ N +++L + +
Sbjct: 96 RLSLILEYCTRGYLREVLDKEKDLSFK--TKLDMAIDCCKGLYNLYKYTNKPYKNLTSVS 153
Query: 421 LLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIV 478
L+ EN +K+ G+ ++ + Y + +++ Y K D++S G+V
Sbjct: 154 FLVTENYKLKIICHGLEKILSSPPFKNVNFMVYF--SYKMLNDIFSEYTIKDDIYSLGVV 211
Query: 479 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSE 538
LWE+ TGK+P+E LT + ++ K +P + ++ ++E C D RP+ E
Sbjct: 212 LWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKE 271
Query: 539 IIEILQQ 545
I+ L
Sbjct: 272 ILYNLSL 278
|
Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 66/232 (28%), Positives = 111/232 (47%), Gaps = 54/232 (23%)
Query: 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFA-----QEVFIMRK 345
+ K+ G++G++Y+ + VA+K +I +K+ +E+ I++K
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKILKK 63
Query: 346 VRHKNVVQFI--------GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
++H NVV I + K S+ +VT +M H L G+ + PS V +
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD--------HDLSGLLENPS---VKL 112
Query: 398 DVSK----------GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-------- 439
S+ G+NYLH+N+I+HRD+KAAN+L+D ++K+ADFG+AR
Sbjct: 113 TESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172
Query: 440 KAQSGVMTAE-TG--TYRWM-APEVIEH-KPYDHKADVFSFGIVLWELLTGK 486
K G T + T RW PE++ + Y D++ G V E+ T +
Sbjct: 173 KGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 6e-21
Identities = 53/178 (29%), Positives = 99/178 (55%), Gaps = 10/178 (5%)
Query: 319 AIKVLKPERINSDMQKEFAQEVFIMRKV-----RHKNVVQFIGACTKPPSLCIVTEFMSG 373
AIK+LK + I +Q + + + ++V + + Q L V E+++G
Sbjct: 29 AIKILKKDVI---IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 85
Query: 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD 433
G + ++ ++ G FK P + A +++ G+ +LH II+RDLK N+++D +K+AD
Sbjct: 86 GDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIAD 144
Query: 434 FGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
FG+ + G T GT ++APE+I ++PY D ++FG++L+E+L G+ P++
Sbjct: 145 FGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 9e-21
Identities = 57/200 (28%), Positives = 109/200 (54%), Gaps = 6/200 (3%)
Query: 296 FGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNV 351
F + GS+G + D AIK+LK + + + D++ ++ + + + +
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFL 63
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
Q L V E+++GG + ++ ++ G FK P + A ++S G+ +LH+ I
Sbjct: 64 TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGI 122
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKA 470
I+RDLK N+++D +K+ADFG+ + GV T GT ++APE+I ++PY
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 471 DVFSFGIVLWELLTGKLPYE 490
D +++G++L+E+L G+ P++
Sbjct: 183 DWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 62/235 (26%), Positives = 110/235 (46%), Gaps = 24/235 (10%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
V +KVL + +S F + +M ++ HK++V+ G C + ++ +V E++ G +
Sbjct: 33 VVLKVLGSDHRDSL---AFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLD 88
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENE----VVK 430
+LH+ K L L VA ++ ++YL ++H ++ N+L+ NE +K
Sbjct: 89 VFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIK 148
Query: 431 VADFGVARVKAQSGVMTAETGTYR--WMAPEVIE--HKPYDHKADVFSFGIVLWELLT-G 485
++D G+ V++ E R W+APE I AD +SFG L E+ + G
Sbjct: 149 LSDPGIPI-----TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNG 203
Query: 486 KLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII 540
+ P L+ + + +P +LA L+ +CW DP RP F I+
Sbjct: 204 EEPLSTLSSSEKERFYQDQHR---LPMPDCAELANLINQCWTYDPTKRPSFRAIL 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 63/247 (25%), Positives = 127/247 (51%), Gaps = 8/247 (3%)
Query: 300 VASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKE--FAQEVFIMRKVRHKNVVQFI 355
+ GS+G + + +++ A+KVL+ + I +++ ++ +++ V+H +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ L V ++++GG ++ +L + + F P A +++ + YLH NI++RD
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRD 121
Query: 416 LKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 474
LK N+L+D + + DFG+ + + +G + GT ++APEV+ +PYD D +
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWC 181
Query: 475 FGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAELLERCWQQDPAL 532
G VL+E+L G P+ + ++ K L+P I +++ L LL++ +
Sbjct: 182 LGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGA 241
Query: 533 RPDFSEI 539
+ DF EI
Sbjct: 242 KDDFMEI 248
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 46/128 (35%), Positives = 80/128 (62%), Gaps = 2/128 (1%)
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
L V E+++GG + + ++ G FK P + A +++ G+ +LH II+RDLK N+++
Sbjct: 76 LYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 424 DENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWEL 482
D +K+ADFG+ + GV T GT ++APE+I ++PY D ++FG++L+E+
Sbjct: 135 DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 194
Query: 483 LTGKLPYE 490
L G+ P+E
Sbjct: 195 LAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 71/249 (28%), Positives = 120/249 (48%), Gaps = 12/249 (4%)
Query: 300 VASGSYGDLYRGTYCSQDV--AIKVLKPERI-NSDMQKE-FAQEVFIMRKVRHKNVVQFI 355
+ GS+G + + + A+KVL+ + I QK A+ +++ V+H +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ L V ++++GG ++ +L + + F P A +++ + YLH NII+RD
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERS-FPEPRARFYAAEIASALGYLHSLNIIYRD 121
Query: 416 LKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 474
LK N+L+D V + DFG+ + + S + GT ++APEV+ +PYD D +
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWC 181
Query: 475 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR- 533
G VL+E+L G P+ + ++ K LR + N LLE Q+D R
Sbjct: 182 LGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR--LKPNISVSARHLLEGLLQKDRTKRL 239
Query: 534 ---PDFSEI 539
DF EI
Sbjct: 240 GAKDDFLEI 248
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 69/219 (31%), Positives = 105/219 (47%), Gaps = 40/219 (18%)
Query: 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQ----EVFIMRKV 346
+ + SG+YG + + VAIK K + D A+ E+ ++R +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDD--LIDAKRILREIKLLRHL 56
Query: 347 RHKNVVQFIGACTKPPS------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI--- 397
RH+N++ + +PPS + IVTE M D LHK V K P L
Sbjct: 57 RHENIIGLLDI-LRPPSPEDFNDVYIVTELMET----D-LHK---VIKSPQPLTDDHIQY 107
Query: 398 ---DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAET 450
+ +G+ YLH N+IHRDLK +N+L++ N +K+ DFG+AR + + G +T
Sbjct: 108 FLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 451 GT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
T YR APE++ Y D++S G + ELLT K
Sbjct: 168 VTRWYR--APELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 69/264 (26%), Positives = 127/264 (48%), Gaps = 25/264 (9%)
Query: 299 KVASGSYGDLYRGT----YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
++ +G +G + G Y V +K L+ + Q +F +E R ++H N++Q
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE-QMKFLEEAQPYRSLQHSNLLQC 60
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP----SLLKVAIDVSKGMNYLHQNN 410
+G CT+ +V EF G + YL + + +L ++A +++ G+ +LH+NN
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 411 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEH---- 463
IH DL N L+ + VK+ D+G++ K + + RW+APE+++
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGN 180
Query: 464 ---KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV-QKGLRPTIPKNSQP-- 516
+++V+S G+ +WEL G PY +L+ Q V ++ L+ P+ P
Sbjct: 181 LLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS 240
Query: 517 -KLAELLERCWQQDPALRPDFSEI 539
+ E+++ CW Q P RP E+
Sbjct: 241 DRWYEVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 28/217 (12%)
Query: 294 LKFGSKVASGSYGDL----YRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRH 348
+ G + +GS+G + ++GT + AIK LK I Q + AQE I+ ++ H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH 77
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK------- 401
+V + + + + EF+ GG ++ +L K + P+ DV+K
Sbjct: 78 PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG---RFPN------DVAKFYHAELV 128
Query: 402 -GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPE 459
YLH +II+RDLK NLL+D VKV DFG A +V ++ + GT ++APE
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL---CGTPEYLAPE 185
Query: 460 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496
VI+ K + D ++ G++L+E + G P+ TP +
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR 222
|
Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 3e-20
Identities = 54/194 (27%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ G++G L R + A+K+LK E I D E +++ RH +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ LC V E+++GG ++ +L + + VF ++ ++YLH I++RDL
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 417 KAANLLMDENEVVKVADFGVARVK-AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSF 475
K NL++D++ +K+ DFG+ + + M GT ++APEV+E Y D +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181
Query: 476 GIVLWELLTGKLPY 489
G+V++E++ G+LP+
Sbjct: 182 GVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-20
Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 1/145 (0%)
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
E +++ V H +V++ C+V S +Y YL K + L +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAP 458
+ +G+ YLH IIHRD+K N+ +++ + V + D G A+ + GT AP
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAP 225
Query: 459 EVIEHKPYDHKADVFSFGIVLWELL 483
EV+ Y+ KAD++S GIVL+E+L
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 4e-20
Identities = 78/291 (26%), Positives = 128/291 (43%), Gaps = 57/291 (19%)
Query: 295 KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFA--------QEVFIMR 344
K ++ G++G +Y + VAIK +K K+F +EV +R
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMK---------KKFYSWEECMNLREVKSLR 52
Query: 345 KV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKG 402
K+ H N+V+ + L V E+M G ++Y + KG S+++ I + +G
Sbjct: 53 KLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQG 111
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM-APEVI 461
+ ++H++ HRDLK NLL+ EVVK+ADFG+AR T T RW APE++
Sbjct: 112 LAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST-RWYRAPEIL 170
Query: 462 EHKP-YDHKADVFSFGIVLWELLTGKLP--------------YEYL-TP----------L 495
Y D+++ G ++ EL T + P L TP L
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLR-PLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229
Query: 496 QAAVG-----VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
+ +G L IP N+ P+ +L++ + DP RP S+ ++
Sbjct: 230 ASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQ 279
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-20
Identities = 51/175 (29%), Positives = 93/175 (53%), Gaps = 7/175 (4%)
Query: 319 AIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375
A+K+LK E I + + E A E +++ RH + + LC V E+ +GG
Sbjct: 24 AMKILKKEVIIA--KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
++ +L + + VF ++ + YLH ++++RDLK NL++D++ +K+ DFG
Sbjct: 82 LFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFG 140
Query: 436 VARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
+ + G M GT ++APEV+E Y D + G+V++E++ G+LP+
Sbjct: 141 LCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 5e-20
Identities = 61/238 (25%), Positives = 115/238 (48%), Gaps = 7/238 (2%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ G++G L R + A+K+L+ E I D E +++ RH +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
A LC V E+ +GG ++ +L + + VF ++ + YLH ++++RD+
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSF 475
K NL++D++ +K+ DFG+ + G M GT ++APEV+E Y D +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181
Query: 476 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 533
G+V++E++ G+LP+ + ++ + +R P+ P+ LL ++DP R
Sbjct: 182 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 59/215 (27%), Positives = 106/215 (49%), Gaps = 41/215 (19%)
Query: 298 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKE-FA----QEVFIMRKVRHKN 350
+K+ G++G+++ R Q VA+K ++ + +KE F +E+ I++ ++H+N
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALK-----KVLMENEKEGFPITALREIKILQLLKHEN 72
Query: 351 VVQFIGACTKPP--------SLCIVTEFMSGGSVYDYLHKLKGV-------FKLPSLLKV 395
VV I C S +V EF H L G+ F L + KV
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCE--------HDLAGLLSNKNVKFTLSEIKKV 124
Query: 396 AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-----KAQSGVMTAET 450
+ G+ Y+H+N I+HRD+KAAN+L+ ++ ++K+ADFG+AR ++ T
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 451 GTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLT 484
T + PE+ + + Y D++ G ++ E+ T
Sbjct: 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 71/253 (28%), Positives = 119/253 (47%), Gaps = 20/253 (7%)
Query: 300 VASGSYGDLYRGTYCSQDV--AIKVLKPERINSDMQKE--FAQEVFIMRKVRHKNVVQFI 355
+ GS+G + S A+KVL+ + I ++ A+ +++ ++H +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ L V ++++GG ++ +L + + F P A +V+ + YLH NII+RD
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRER-CFLEPRARFYAAEVASAIGYLHSLNIIYRD 121
Query: 416 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAET-----GTYRWMAPEVIEHKPYDHKA 470
LK N+L+D V + DFG+ + GV ET GT ++APEV+ +PYD
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK----EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTV 177
Query: 471 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 530
D + G VL+E+L G P+ Q ++ K L+ +P +LL +D
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQ--LPGGKTVAACDLLVGLLHKDQ 235
Query: 531 ALR----PDFSEI 539
R DF EI
Sbjct: 236 RRRLGAKADFLEI 248
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 56/196 (28%), Positives = 101/196 (51%), Gaps = 11/196 (5%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF-- 354
++ G+YG +YR T + VA+K ++ + + +E+ ++ +RH N+V+
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 355 IGACTKPPSLCIVTEFMSG--GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ S+ +V E+ S+ D + F + + + + +G+ YLH+N II
Sbjct: 74 VVVGKHLDSIFLVMEYCEQDLASLLD---NMPTPFSESQVKCLMLQLLRGLQYLHENFII 130
Query: 413 HRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTYRWMAPEVI-EHKPYDHKA 470
HRDLK +NLL+ + +K+ADFG+AR + MT + T + APE++ Y
Sbjct: 131 HRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAI 190
Query: 471 DVFSFGIVLWELLTGK 486
D+++ G +L ELL K
Sbjct: 191 DMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 51/174 (29%), Positives = 94/174 (54%), Gaps = 2/174 (1%)
Query: 319 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV- 376
A K L+ +RI + A E I+ KV + VV A +LC+V M+GG +
Sbjct: 29 ACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 88
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
+ H + F+ + A ++ G+ LHQ I++RDLK N+L+D++ ++++D G+
Sbjct: 89 FHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGL 148
Query: 437 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
A + + GT +MAPEV++++ Y D ++ G +L+E++ G+ P++
Sbjct: 149 AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 62/198 (31%), Positives = 104/198 (52%), Gaps = 15/198 (7%)
Query: 299 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ G+YG +Y+G Q VA+K ++ E + +E+ ++++++H N+V
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHR 414
+ L ++ EF+S + YL L KG + L+K + + +G+ + H ++HR
Sbjct: 67 VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHR 125
Query: 415 DLKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGTYRWMAPEVIEHKP-YDH 468
DLK NLL+D V+K+ADFG+AR V+ V T E T + APEV+ P Y
Sbjct: 126 DLKPQNLLIDNKGVIKLADFGLARAFGIPVR----VYTHEVVTLWYRAPEVLLGSPRYST 181
Query: 469 KADVFSFGIVLWELLTGK 486
D++S G + E+ T K
Sbjct: 182 PVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 5e-19
Identities = 65/260 (25%), Positives = 123/260 (47%), Gaps = 29/260 (11%)
Query: 306 GDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365
++Y T ++ V +K LK +S Q EF Q+ R ++H N++Q +G C +
Sbjct: 14 SEIYTDTGVAR-VVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYL 71
Query: 366 IVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422
+V E+ G + YL + + +L L ++A +++ G+ ++H++N +H DL N
Sbjct: 72 LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCF 131
Query: 423 MDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVI-----------EHKPYDH 468
+ + VKV D+G+ + + + E RW+APE++ + KP
Sbjct: 132 LTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKP--- 188
Query: 469 KADVFSFGIVLWELL-TGKLPYEYLTPLQAAVGVVQ----KGLRPTIPKNSQPKLAELLE 523
++V++ G+ LWEL PY +L+ + V++ K +P + + E+L+
Sbjct: 189 -SNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQ 247
Query: 524 RCWQQDPALRPDFSEIIEIL 543
CW P R E+ +L
Sbjct: 248 FCWLS-PEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 7e-19
Identities = 59/218 (27%), Positives = 110/218 (50%), Gaps = 6/218 (2%)
Query: 319 AIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+K+LK E I D E +++ RH + + LC V E+ +GG ++
Sbjct: 24 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGV 436
+L + + VF ++ ++YLH + N+++RDLK NL++D++ +K+ DFG+
Sbjct: 84 FHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL 142
Query: 437 ARVKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL 495
+ + G M GT ++APEV+E Y D + G+V++E++ G+LP+
Sbjct: 143 CKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 202
Query: 496 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 533
+ ++ + +R P+ P+ LL ++DP R
Sbjct: 203 KLFELILMEEIR--FPRTLSPEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 7e-19
Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 4/152 (2%)
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV---FKLPSLLKVAID 398
I+ KV + +V A LC+V M+GG + +++ + F P
Sbjct: 46 ILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ 105
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMA 457
+ G+ +LHQ II+RDLK N+L+D + V+++D G+A +K GT +MA
Sbjct: 106 IISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMA 165
Query: 458 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
PE+++ + YD D F+ G+ L+E++ + P+
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 38/208 (18%)
Query: 303 GSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358
GS+G + +GT ++ AIK LK + + D E + R+V +
Sbjct: 6 GSFGKVMLAELKGT--NEFFAIKALKKDVVLEDDDVECT---MVERRV--------LALA 52
Query: 359 TKPPSLC-------------IVTEFMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGM 403
+ P L V E+++GG D + + G F A ++ G+
Sbjct: 53 WEHPFLTHLFCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGL 109
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVI 461
+LH+ II+RDLK N+L+D++ +K+ADFG+ + +G A T GT ++APE++
Sbjct: 110 QFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENM-NGEGKASTFCGTPDYIAPEIL 168
Query: 462 EHKPYDHKADVFSFGIVLWELLTGKLPY 489
+ + Y+ D +SFG++L+E+L G+ P+
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 49/173 (28%), Positives = 91/173 (52%), Gaps = 2/173 (1%)
Query: 319 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L+ +RI + A E I+ KV + VV A +LC+V M+GG +
Sbjct: 29 ACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLK 88
Query: 378 DYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
+++ + F+ L A ++ G+ LH+ N ++RDLK N+L+D+ ++++D G+
Sbjct: 89 FHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGL 148
Query: 437 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
A + + GT +MAPEV+ ++ Y D + G +++E++ G+ P+
Sbjct: 149 AVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 66/250 (26%), Positives = 129/250 (51%), Gaps = 21/250 (8%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 356
+ GSY L R + A+KV+K E +N D ++ Q E + + + + +
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 357 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIH 413
+C + S L V E+++GG + ++ + + KLP + ++S +NYLH+ II+
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIY 119
Query: 414 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADV 472
RDLK N+L+D +K+ D+G+ + + G T+ GT ++APE++ + Y D
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 473 FSFGIVLWELLTGKLPYEYL----TPLQAAVG-----VVQKGLRPTIPKNSQPKLAELLE 523
++ G++++E++ G+ P++ + P Q +++K +R IP++ K A +L+
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLK 237
Query: 524 RCWQQDPALR 533
+DP R
Sbjct: 238 SFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 37/210 (17%)
Query: 298 SKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKE-FA----QEVFIMRKVRHKN 350
+++ G+YG +YR VA+K LK E+ +KE F +E+ I+ K++H N
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEK-----EKEGFPITSLREINILLKLQHPN 65
Query: 351 VVQF--IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK------LPSLLK-VAIDVSK 401
+V + + + +V E++ H LK + + L S +K + + +
Sbjct: 66 IVTVKEVVVGSNLDKIYMVMEYVE--------HDLKSLMETMKQPFLQSEVKCLMLQLLS 117
Query: 402 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVMTAETGT--YRWMA 457
G+ +LH N I+HRDLK +NLL++ ++K+ DFG+AR + S T T YR A
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKPYTQLVVTLWYR--A 174
Query: 458 PEVIEHKP-YDHKADVFSFGIVLWELLTGK 486
PE++ Y D++S G + ELLT K
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 58/235 (24%), Positives = 108/235 (45%), Gaps = 44/235 (18%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-------- 337
I ++++ G+ + G+YG + + T + VAIK +K I++D+ K+
Sbjct: 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64
Query: 338 ----QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+E+ IM +++H+N++ + + + +V + M+ LK V L
Sbjct: 65 FTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS--------DLKKVVDRKIRL 116
Query: 394 KVA------IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-- 445
+ + + G+N LH+ +HRDL AN+ ++ + K+ADFG+AR
Sbjct: 117 TESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176
Query: 446 -------------MTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
MT++ T + APE++ + Y D++S G + ELLTGK
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-18
Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 18/193 (9%)
Query: 397 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS---GVMTAETGTY 453
I V ++++H ++IHRD+K+AN+L+ N +VK+ DFG +++ A + V GT
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209
Query: 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN 513
++APE+ KPY KAD+FS G++L+ELLT K P++ ++ + G +P +
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-MEEVMHKTLAGRYDPLPPS 268
Query: 514 SQPKLAELLERCWQQDPALRPD-------------FSEIIEILQ-QIAKEVGEENEERRK 559
P++ E++ DP RP S ++EI+Q Q + R+
Sbjct: 269 ISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQTQPGFSGPLRDTISRQ 328
Query: 560 EKSSGGFLSVLRR 572
+ + L V RR
Sbjct: 329 IQQTKQLLQVERR 341
|
Length = 496 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 61/196 (31%), Positives = 104/196 (53%), Gaps = 11/196 (5%)
Query: 303 GSYGDLYR-----GTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKNVVQF 354
G YG +++ G + A+KVLK I + QK+ A E I+ V+H +V
Sbjct: 7 GGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRN-QKDTAHTKAERNILEAVKHPFIVDL 65
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
I A L ++ E++SGG ++ +L + +G+F + ++S + +LHQ II+R
Sbjct: 66 IYAFQTGGKLYLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYR 124
Query: 415 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVF 473
DLK N+L+D VK+ DFG+ + G +T GT +MAPE++ + D +
Sbjct: 125 DLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWW 184
Query: 474 SFGIVLWELLTGKLPY 489
S G +++++LTG P+
Sbjct: 185 SLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 62/239 (25%), Positives = 120/239 (50%), Gaps = 12/239 (5%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 356
V +G++G ++ R A+KV+ + Q++ E ++++V H +++
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
L ++ E++ GG ++ YL + G F + L A ++ + YLH I++RDL
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDL 127
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFG 476
K N+L+D+ +K+ DFG A+ K + T GT ++APEVI+ K ++ D ++ G
Sbjct: 128 KPENILLDKEGHIKLTDFGFAK-KLRDRTWTL-CGTPEYLAPEVIQSKGHNKAVDWWALG 185
Query: 477 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLERCWQQDPALR 533
I+++E+L G P+ P G+ +K L + P++ +L+++ D R
Sbjct: 186 ILIYEMLVGYPPFFDDNPF----GIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|153172 cd04900, ACT_UUR-like_1, ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 4e-18
Identities = 29/72 (40%), Positives = 40/72 (55%), Gaps = 6/72 (8%)
Query: 179 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPY---E 232
E+ T D+P L +++ L +GLNI +A F+T DGY+LD FVV DG P E
Sbjct: 1 GTEVFIYTPDRPGLFARIAGALDQLGLNILDARIFTTRDGYALDTFVVLDPDGEPIGERE 60
Query: 233 ETEQLRAALEKE 244
++R ALE
Sbjct: 61 RLARIREALEDA 72
|
This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 73 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-18
Identities = 56/193 (29%), Positives = 98/193 (50%), Gaps = 6/193 (3%)
Query: 303 GSYGD--LYRGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358
GS+G L R + A+KVLK + I + D++ ++ + H + Q
Sbjct: 6 GSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF 65
Query: 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418
P L V EF++GG + ++ K + F A +++ + +LH II+RDLK
Sbjct: 66 QTPDRLFFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEITSALMFLHDKGIIYRDLKL 124
Query: 419 ANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGI 477
N+L+D K+ADFG+ + +G T+ GT ++APE+++ Y D ++ G+
Sbjct: 125 DNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGV 184
Query: 478 VLWELLTGKLPYE 490
+L+E+L G P+E
Sbjct: 185 LLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 49/174 (28%), Positives = 92/174 (52%), Gaps = 2/174 (1%)
Query: 319 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L+ +RI + A E I+ KV + VV A +LC+V M+GG +
Sbjct: 29 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 88
Query: 378 DYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
+++ + F + A +++ G+ LH+ I++RDLK N+L+D+ ++++D G+
Sbjct: 89 FHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGL 148
Query: 437 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
A + + GT +MAPEV++++ Y D + G +++E++ GK P+
Sbjct: 149 AVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 57/203 (28%), Positives = 109/203 (53%), Gaps = 22/203 (10%)
Query: 300 VASGSYGDLY----RGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQ 353
+ GS+G ++ +GT +Q AIK LK + + + D++ ++ + H +
Sbjct: 3 LGKGSFGKVFLAELKGT--NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 410
+L V E+++GG + ++ HK F LP A ++ G+ +LH
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK----FDLPRATFYAAEIICGLQFLHSKG 116
Query: 411 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET----GTYRWMAPEVIEHKPY 466
I++RDLK N+L+D + +K+ADFG+ + ++ + A+T GT ++APE++ + Y
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCGTPDYIAPEILLGQKY 173
Query: 467 DHKADVFSFGIVLWELLTGKLPY 489
+ D +SFG++L+E+L G+ P+
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 65/234 (27%), Positives = 111/234 (47%), Gaps = 21/234 (8%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
V +KVL P + D+ F + +MR+V HK++V G C + +V EF+ G +
Sbjct: 35 VILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM-------DENEVVK 430
++H+ V P KVA ++ ++YL +++H ++ N+L+ + +K
Sbjct: 93 LFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIK 152
Query: 431 VADFGVARVKAQSGVMTAETGTYR--WMAPEVIE-HKPYDHKADVFSFGIVLWEL-LTGK 486
++D G+ V++ + R W+APE +E K AD +SFG LWE+ G+
Sbjct: 153 LSDPGIPIT-----VLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGE 207
Query: 487 LPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII 540
+P + T L + P S +LA+L+ C DP RP F I+
Sbjct: 208 IPLKDKT-LAEKERFYEGQCMLVTP--SCKELADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 52/193 (26%), Positives = 98/193 (50%), Gaps = 6/193 (3%)
Query: 303 GSYGDLYRGTYCSQD--VAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358
GS+G + D AIKVLK + I + D+ ++ + +H +
Sbjct: 6 GSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF 65
Query: 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418
L V E+++GG + + + + F P A +V+ + +LH++ +I+RDLK
Sbjct: 66 QTKDRLFFVMEYVNGGDLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKL 124
Query: 419 ANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGI 477
N+L+D K+ADFG+ + +GV T GT ++APE+++ Y D ++ G+
Sbjct: 125 DNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGV 184
Query: 478 VLWELLTGKLPYE 490
+++E++ G+ P+E
Sbjct: 185 LMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 65/292 (22%), Positives = 120/292 (41%), Gaps = 49/292 (16%)
Query: 295 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
G L + + VA+K + + + + K QE+ R+++H N++ +
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--LPSLLKVAI--DVSKGMNYLHQNN 410
+ + L +V+ M+ GS D LK F LP L I DV ++Y+H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDL---LKTHFPEGLPELAIAFILKDVLNALDYIHSKG 121
Query: 411 IIHRDLKAANLLMDENEVVKVADFGVA--------RVKAQSGVMTAETGTYRWMAPEVIE 462
IHR +KA+++L+ + V ++ + R + + W++PEV++
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181
Query: 463 H--KPYDHKADVFSFGIVLWELLTGKLPYEYLTP----LQAAVGVVQKGL-RPTIP---- 511
+ Y+ K+D++S GI EL G +P++ + L+ G V L + T P
Sbjct: 182 QNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241
Query: 512 --KNSQPKLA---------------------ELLERCWQQDPALRPDFSEII 540
S+ + +E C Q+DP RP S+++
Sbjct: 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 295 KFGSKVASGSYGDLYR------GTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR- 347
K K+ G++ ++ + G Y AIK +K + S Q +E+ +R++
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKY----YAIKCMK-KHFKSLEQVNNLREIQALRRLSP 56
Query: 348 HKNVVQFIGAC--TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
H N+++ I K L +V E M ++Y+ + K + + K +++
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM-APE-VIEH 463
+H+N I HRD+K N+L+ ++++K+ADFG R T T RW APE ++
Sbjct: 116 MHRNGIFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYTEYIST-RWYRAPECLLTD 173
Query: 464 KPYDHKADVFSFGIVLWELLT 484
Y K D+++ G V +E+L+
Sbjct: 174 GYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 27/216 (12%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDL--YRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 343
VWE+ P + S V SG+YG + T + VAIK L ++ K +E+ ++
Sbjct: 10 VWEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLL 68
Query: 344 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYL--HKLKG---VFKLPSL 392
+ + H+NV+ + T SL +VT M G + + + KL F + +
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQI 127
Query: 393 LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 452
L+ G+ Y+H IIHRDLK +N+ ++E+ +K+ DFG+AR MT T
Sbjct: 128 LR-------GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTGYVAT 178
Query: 453 YRW-MAPEVIEHK-PYDHKADVFSFGIVLWELLTGK 486
RW APE++ + Y+ D++S G ++ ELLTGK
Sbjct: 179 -RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 3e-17
Identities = 47/200 (23%), Positives = 96/200 (48%), Gaps = 23/200 (11%)
Query: 299 KVASGSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQEVF---IMRKVRHKNV 351
K+ G +G + + T + K++K + N+ E +M+ + N
Sbjct: 23 KLIDGKFGKVSVLKHKPT--QKLFVQKIIKAKNFNAI-------EPMVHQLMKD--NPNF 71
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
++ + T ++ +++ G ++D L K +G + K+ + + +N LH++NI
Sbjct: 72 IKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK-EGKLSEAEVKKIIRQLVEALNDLHKHNI 130
Query: 412 IHRDLKAANLLMDENEV-VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 470
IH D+K N+L D + + + D+G+ ++ GT + +PE I+ YD
Sbjct: 131 IHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD---GTLDYFSPEKIKGHNYDVSF 187
Query: 471 DVFSFGIVLWELLTGKLPYE 490
D ++ G++ +ELLTGK P++
Sbjct: 188 DWWAVGVLTYELLTGKHPFK 207
|
Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 45/174 (25%), Positives = 93/174 (53%), Gaps = 2/174 (1%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L +R+ ++ A E I+ KV +V A LC+V M+GG +
Sbjct: 22 ACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLK 81
Query: 378 DYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
+++ + ++ ++ + ++ G+ +LH +I++RD+K N+L+D+ +++D G+
Sbjct: 82 YHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGL 141
Query: 437 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
A +T GT +MAPE+++ +PY + D F+ G ++E++ G+ P++
Sbjct: 142 AVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 64/251 (25%), Positives = 127/251 (50%), Gaps = 25/251 (9%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 356
+ GSY L R Q A+KV+K E ++ D ++ Q E + + + +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 357 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIH 413
+C + S L +V E+++GG + ++ + + KLP A ++ +N+LH+ II+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERGIIY 119
Query: 414 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADV 472
RDLK N+L+D + +K+ D+G+ + G T+ GT ++APE++ + Y D
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179
Query: 473 FSFGIVLWELLTGKLPYEYLTP----------LQAAVGVVQKGLRPTIPKNSQPKLAELL 522
++ G++++E++ G+ P++ +T Q +++K +R IP+ K + +L
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV---ILEKPIR--IPRFLSVKASHVL 234
Query: 523 ERCWQQDPALR 533
+ +DP R
Sbjct: 235 KGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 40/213 (18%)
Query: 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKP-ERINSDMQKEFAQ----EVFIMRKVRHKN 350
S + G+YG + T+ VAIK + P E + F Q E+ I+R+ +H+N
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH------QTFCQRTLREIKILRRFKHEN 64
Query: 351 VVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-----DV 399
++ I +PPS IV E M L+K + K L I +
Sbjct: 65 IIG-ILDIIRPPSFESFNDVYIVQELMETD-----LYK---LIKTQHLSNDHIQYFLYQI 115
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ----SGVMTAETGTYRW 455
+G+ Y+H N++HRDLK +NLL++ N +K+ DFG+AR+ +G +T T RW
Sbjct: 116 LRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT-RW 174
Query: 456 M-APEV-IEHKPYDHKADVFSFGIVLWELLTGK 486
APE+ + K Y D++S G +L E+L+ +
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 292 KHLKFGSKVASGSYGDLY----RGTYCSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKV 346
K + ++V G YG ++ + T + VA+K +K + + + E I+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDT--GEIVALKRMKKSLLFKLNEVRHVLTERDILTTT 58
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
+ + +V+ + A L + E++ GG L+ L GV ++ + ++ L
Sbjct: 59 KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDAL 117
Query: 407 HQNNIIHRDLKAANLLMDENEVVKVADFGVAR---VKAQSGVMTAETGTYRWMAPEVIEH 463
H+ IHRDLK N L+D + +K+ DFG+++ A S V G+ +MAPEV+
Sbjct: 118 HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPDYMAPEVLRG 172
Query: 464 KPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494
K YD D +S G +L+E L G P+ TP
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-17
Identities = 53/177 (29%), Positives = 96/177 (54%), Gaps = 13/177 (7%)
Query: 315 SQDVAIK-VLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-PSLCIVTEFMS 372
Q+VAIK ++KP ++ + +E+ +++ +RH+N++ P + VTE +
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENIISLSDIFISPLEDIYFVTELLG 93
Query: 373 GGSVYDYLHKLKGVFKL-PSLLK-VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 430
LH+L L ++ + +G+ Y+H ++HRDLK +N+L++EN +K
Sbjct: 94 TD-----LHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLK 148
Query: 431 VADFGVARVKAQSGVMTAETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGK 486
+ DFG+AR+ Q MT T + APE+ + + YD + D++S G + E+L GK
Sbjct: 149 ICDFGLARI--QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-17
Identities = 52/172 (30%), Positives = 92/172 (53%), Gaps = 6/172 (3%)
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
L V EF++GG + ++ KG F L A ++ G+ +LH II+RDLK N+++
Sbjct: 71 LFFVMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML 129
Query: 424 DENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 481
D + +K+ADFG+ + G A T GT ++APE+++ Y D +SFG++L+E
Sbjct: 130 DRDGHIKIADFGMCKENV-FGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYE 188
Query: 482 LLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 533
+L G+ P+ + + P P+ + ++LE+ +++DP R
Sbjct: 189 MLIGQSPFHGDDEDELFESIRVD--TPHYPRWITKESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 9e-17
Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 294 LKFGSKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFA-QEVFIMRKVRHK 349
F + +GS+G + TY ++D VAIK + +I Q + E I+ + H
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV--AIDVSKGMNYLH 407
V G+ L +V EF+ GG + +L + K + P+ + A + YL
Sbjct: 92 FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQ 148
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD 467
NI++RDLK NLL+D++ +K+ DFG A+V + T GT ++APE++ + +
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYTL-CGTPEYIAPEILLNVGHG 206
Query: 468 HKADVFSFGIVLWELLTGKLPYEYLTPL 495
AD ++ GI ++E+L G P+ PL
Sbjct: 207 KAADWWTLGIFIYEILVGCPPFYANEPL 234
|
Length = 340 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 46/176 (26%), Positives = 92/176 (52%), Gaps = 7/176 (3%)
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
L ++ ++++GG ++ +L++ + F + ++ +++LHQ II+RD+K N+L+
Sbjct: 80 LHLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL 138
Query: 424 DENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP--YDHKADVFSFGIVL 479
D V + DFG+++ A + GT +MAPEVI +D D +S G++
Sbjct: 139 DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLT 198
Query: 480 WELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERCWQQDPALR 533
+ELLTG P+ + + ++ L+ P PK + + +++ ++DP R
Sbjct: 199 FELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 10/177 (5%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL------CIVTE 369
Q+VAIK L N K +E+ +M+ V HKN++ + T SL +V E
Sbjct: 42 QNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME 101
Query: 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 429
M ++ + ++ LL + G+ +LH IIHRDLK +N+++ + +
Sbjct: 102 LMDA-NLCQVIQMDLDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 157
Query: 430 KVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 486
K+ DFG+AR S +MT T + APEVI Y D++S G ++ E++ G
Sbjct: 158 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 66/250 (26%), Positives = 126/250 (50%), Gaps = 21/250 (8%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIG 356
+ GSY L + A+KV+K E +N D ++ Q E + + + +
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 357 ACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIH 413
+C + S L V EF+SGG D + ++ KLP + ++S +N+LH+ II+
Sbjct: 63 SCFQTESRLFFVIEFVSGG---DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIY 119
Query: 414 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEVIEHKPYDHKADV 472
RDLK N+L+D +K+ D+G+ + + G T+ GT ++APE++ + Y D
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 473 FSFGIVLWELLTGKLPYEYLT----PLQAAVG-----VVQKGLRPTIPKNSQPKLAELLE 523
++ G++++E++ G+ P++ + P Q +++K +R IP++ K + +L+
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKASSVLK 237
Query: 524 RCWQQDPALR 533
+DP R
Sbjct: 238 GFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 298 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFI 355
SK+ GSYG ++ R Q VAIK + ++K +E+ ++++++H N+V I
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLL--KVAIDVSKGMNYLHQNNII 412
+ L +V E+ + L++L K +P L K+ + +N+ H++N I
Sbjct: 67 EVFRRKRKLHLVFEYCD----HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCI 122
Query: 413 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM-APEVI-EHKPYDHKA 470
HRD+K N+L+ + +K+ DFG AR+ G + RW APE++ Y
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPV 182
Query: 471 DVFSFGIVLWELLTG 485
DV++ G V ELLTG
Sbjct: 183 DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 38/99 (38%), Positives = 61/99 (61%), Gaps = 3/99 (3%)
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA--QSGVMTAETGTYRWMAP 458
+G+ YLH I+HRD+K NLL++ N V+K+ DFG+ARV+ +S MT E T + AP
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
Query: 459 EVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496
E++ Y D++S G + ELL ++ ++ +P+Q
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-16
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 24/214 (11%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQ 338
VWE+ P+ +V SG+YG + CS + VAIK L + K +
Sbjct: 10 VWEL-PERYTSLKQVGSGAYGSV-----CSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR 63
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDY----LHKLKGV-FKLPSLL 393
E+ +++ ++H+NV+ + T S EF V Y L K+ G +
Sbjct: 64 ELTLLKHMQHENVIGLLDVFTSAVSG---DEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQ 120
Query: 394 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY 453
+ + G+ Y+H IIHRDLK NL ++E+ +K+ DFG+AR MT T
Sbjct: 121 YLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTR 178
Query: 454 RWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGK 486
+ APEVI + Y+ D++S G ++ E+LTGK
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 51/168 (30%), Positives = 90/168 (53%), Gaps = 15/168 (8%)
Query: 328 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 387
I ++ + +E+ ++ + +V F GA + I E M GGS+ D + LK
Sbjct: 38 IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQV--LKKAG 94
Query: 388 KLPS--LLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVA----RVK 440
++P L K++I V +G+ YL + I+HRD+K +N+L++ +K+ DFGV+
Sbjct: 95 RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154
Query: 441 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 488
A S V GT +M+PE ++ Y ++D++S G+ L E+ G+ P
Sbjct: 155 ANSFV-----GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 5e-16
Identities = 70/261 (26%), Positives = 121/261 (46%), Gaps = 37/261 (14%)
Query: 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
G + G YG+L++ +V +KVL ++ + + + F + +M ++ HK++V G
Sbjct: 14 GIRREVGDYGELHK-----TEVLLKVL--DKSHRNYSESFFEAASMMSQLSHKHLVLNYG 66
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
C +V E++ GS+ YL K K + + L+VA ++ +++L + H ++
Sbjct: 67 VCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNV 126
Query: 417 KAANLLMDENE--------VVKVADFGVARVKAQSGVMTAETGTYR--WMAPEVIEH-KP 465
A N+L+ E +K++D G++ V+ E R W+ PE IE+ +
Sbjct: 127 CAKNVLLIREEDRKTGNPPFIKLSDPGISIT-----VLPKEILLERIPWVPPECIENPQN 181
Query: 466 YDHKADVFSFGIVLWELLTG-KLPYEYLTPLQAAVGVVQKGL-----RPTIPKNSQPKLA 519
AD +SFG LWE+ +G P L QK L R +P +LA
Sbjct: 182 LSLAADKWSFGTTLWEIFSGGDKPLSALDS--------QKKLQFYEDRHQLPAPKWTELA 233
Query: 520 ELLERCWQQDPALRPDFSEII 540
L+ +C +P RP F II
Sbjct: 234 NLINQCMDYEPDFRPSFRAII 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 73/266 (27%), Positives = 121/266 (45%), Gaps = 45/266 (16%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSD--MQKEFAQEVFIMRKV----RHKNV 351
+++G+YG +Y R Q A+K +IN + + Q+VF+ R + + V
Sbjct: 9 ISNGAYGAVYLVRHKETRQRFAMK-----KINKQNLILRNQIQQVFVERDILTFAENPFV 63
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP---SLLKVAIDVSKGMNYLHQ 408
V + LC+V E++ GG D LK + LP + + A V + YLH
Sbjct: 64 VSMFCSFETKRHLCMVMEYVEGG---DCATLLKNIGALPVDMARMYFAETVL-ALEYLHN 119
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET------------------ 450
I+HRDLK NLL+ +K+ DFG++++ G+M+ T
Sbjct: 120 YGIVHRDLKPDNLLITSMGHIKLTDFGLSKI----GLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 451 --GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR- 507
GT ++APEVI + Y D ++ GI+L+E L G +P+ TP + V+ +
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 235
Query: 508 PTIPKNSQPKLAELLERCWQQDPALR 533
P + +L+ R +Q+P R
Sbjct: 236 PEGDEALPADAQDLISRLLRQNPLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 6e-16
Identities = 69/252 (27%), Positives = 125/252 (49%), Gaps = 23/252 (9%)
Query: 310 RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368
RG+ + V K + +N + Q +A+ E+ + H +V+ L ++
Sbjct: 88 RGSDPKEKVVAKFVM---LNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144
Query: 369 EFMSGGSVYDYLHKLKGVFK--LP------SLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420
E+ SGG D ++K K LP LL I ++ ++ +H ++HRDLK+AN
Sbjct: 145 EYGSGG---DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLA--LDEVHSRKMMHRDLKSAN 199
Query: 421 LLMDENEVVKVADFGVARVKAQS---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGI 477
+ + ++K+ DFG ++ + S V ++ GT ++APE+ E K Y KAD++S G+
Sbjct: 200 IFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGV 259
Query: 478 VLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFS 537
+L+ELLT P++ + + V+ P P + LL+ ++PALRP
Sbjct: 260 ILYELLTLHRPFKGPSQREIMQQVLYGKYDP-FPCPVSSGMKALLDPLLSKNPALRPTTQ 318
Query: 538 EII--EILQQIA 547
+++ E L+ +A
Sbjct: 319 QLLHTEFLKYVA 330
|
Length = 478 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 48/173 (27%), Positives = 89/173 (51%), Gaps = 2/173 (1%)
Query: 319 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L+ +RI + A E I+ KV + VV A +LC+V M+GG +
Sbjct: 29 ACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLK 88
Query: 378 DYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
+++ + F + A ++ G+ L + I++RDLK N+L+D+ ++++D G+
Sbjct: 89 FHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGL 148
Query: 437 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
A + + GT +MAPEVI ++ Y D + G +++E++ G+ P+
Sbjct: 149 AVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 58/193 (30%), Positives = 105/193 (54%), Gaps = 9/193 (4%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
V G+YG + R + VAIK K N ++++ +E+ ++R ++ +N+V+ A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRD 415
+ L +V E++ ++ + L ++ GV P ++ I + K +++ H+N+I+HRD
Sbjct: 69 FRRRGKLYLVFEYVEK-NMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHKNDIVHRD 125
Query: 416 LKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWM-APEVIEHKPYDHKADVF 473
+K NLL+ N+V+K+ DFG AR + S E RW +PE++ PY D++
Sbjct: 126 IKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMW 185
Query: 474 SFGIVLWELLTGK 486
S G +L EL G+
Sbjct: 186 SVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 343
+WE+ P+ + S V SG+YG + T VA+K L + K +E+ ++
Sbjct: 12 IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLK----- 394
+ ++H+NV+ + T SL EF VY H L + K L
Sbjct: 71 KHMKHENVIGLLDVFTPARSL---EEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 124
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 454
+ + +G+ Y+H +IIHRDLK +NL ++E+ +K+ DFG+AR MT T
Sbjct: 125 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRW 182
Query: 455 WMAPEV-IEHKPYDHKADVFSFGIVLWELLTGK 486
+ APE+ + Y+ D++S G ++ ELLTG+
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 54/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375
++VAIK L N K +E+ +M+ V HKN++ + T SL EF
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL---EEFQD--- 103
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 425
VY + + L ++++ +D + G+ +LH IIHRDLK +N+++
Sbjct: 104 VYIVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 426 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 485
+ +K+ DFG+AR S +MT T + APEVI Y D++S G ++ E++ G
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
Query: 486 KL 487
+
Sbjct: 222 GV 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 55/199 (27%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 299 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQ--KEFA-QEVFIMRKVRHKNVVQFI 355
K+ G+YG +++ + I LK R++ D + A +E+ ++++++HKN+V+
Sbjct: 7 KIGEGTYGTVFKAKN-RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
L +V E+ + Y G + + KG+ + H +N++HRD
Sbjct: 66 DVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRD 124
Query: 416 LKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGTYRWMAPEVI-EHKPYDHK 469
LK NLL+++N +K+ADFG+AR V+ S AE T + P+V+ K Y
Sbjct: 125 LKPQNLLINKNGELKLADFGLARAFGIPVRCYS----AEVVTLWYRPPDVLFGAKLYSTS 180
Query: 470 ADVFSFGIVLWELLTGKLP 488
D++S G + EL P
Sbjct: 181 IDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 16/220 (7%)
Query: 337 AQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 396
A E I+R + H +++Q G T C++ +Y YL + + + +L +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNI-AICDILAIE 188
Query: 397 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA--RVKAQSGVMTAETGTYR 454
V + + YLH+N IIHRD+KA N+ ++ V + DFG A V + GT
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIA 248
Query: 455 WMAPEVIEHKPYDHKADVFSFGIVLWELLTGK--------LPYEYLTPLQAAVGVVQKGL 506
APE++ PY D++S GIVL+E+ T L + + Q + + + G
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT 308
Query: 507 RPT-IPKNSQPKLAELLERCWQQD---PALRPDFSEIIEI 542
P P ++Q L E+ ++ P RP ++ + E+
Sbjct: 309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYEL 348
|
Length = 391 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 47/223 (21%)
Query: 295 KFGSKVASGSYGDLYRG----TYCSQDVAIKVLKPERINSD-MQKEFAQEVFIMRKVRHK 349
+ + G+YG +Y+ ++ AIK K ++ + + +E+ ++R+++H+
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHE 62
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDY----------LHKLKGVFKLP-----SLLK 394
NVV + + + ++ ++DY H+ +P SLL
Sbjct: 63 NVVSLVEVFLEHADKSV---YL----LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAE- 449
++ G++YLH N ++HRDLK AN+L+ E VVK+ D G+AR+ A+
Sbjct: 116 QILN---GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172
Query: 450 -----TGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLT 484
T YR APE++ H Y D+++ G + ELLT
Sbjct: 173 DPVVVTIWYR--APELLLGARH--YTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 53/197 (26%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 299 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ G+YG +Y R + VA+K ++ E + + +E+ +++++ H N+V+ +
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRD 415
L +V EF+ + Y+ P L+K + + +G+ Y H + ++HRD
Sbjct: 66 VVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRD 124
Query: 416 LKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGTYRWMAPEV-IEHKPYDHK 469
LK NLL+D +K+ADFG+AR V+ T E T + APE+ + + Y
Sbjct: 125 LKPQNLLIDREGALKLADFGLARAFGVPVRT----YTHEVVTLWYRAPEILLGSRQYSTP 180
Query: 470 ADVFSFGIVLWELLTGK 486
D++S G + E++ +
Sbjct: 181 VDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 78/325 (24%), Positives = 129/325 (39%), Gaps = 78/325 (24%)
Query: 308 LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367
L R T V +++ E + K EV + RH N++ T L ++
Sbjct: 18 LARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI 77
Query: 368 TEFMSGGSVYDYLHKLKGVFK-------LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420
+ FM+ GS LK F + ++L A+ +G+NYLHQN IHR++KA++
Sbjct: 78 SPFMAYGSAN---SLLKTYFPEGMSEALIGNILFGAL---RGLNYLHQNGYIHRNIKASH 131
Query: 421 LLMDENEVVKVADFGV--------ARVKAQSGVMTAETGTYRWMAPEVIEHK--PYDHKA 470
+L+ + +V ++ + K T W++PE++ Y+ K+
Sbjct: 132 ILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKS 191
Query: 471 DVFSFGIVLWELLTGKLPYEYL---------------TPLQAAV---------------- 499
D++S GI EL TG++P++ + +PL
Sbjct: 192 DIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVD 251
Query: 500 -----GVVQKGLRPTI---------PKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 545
VV G+ T+ K P L+E C QQDP RP S ++
Sbjct: 252 SGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS--HA 309
Query: 546 IAKEVGEENEERRKEKSSGGFLSVL 570
K+V KE++ G LS+L
Sbjct: 310 FFKQV--------KEQTQGSILSLL 326
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 8e-15
Identities = 50/162 (30%), Positives = 88/162 (54%), Gaps = 3/162 (1%)
Query: 328 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 387
I ++ + +E+ ++ + +V F GA + I E M GGS+ D + K G
Sbjct: 42 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRI 100
Query: 388 KLPSLLKVAIDVSKGMNYLHQNN-IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446
L KV+I V KG+ YL + + I+HRD+K +N+L++ +K+ DFGV+ S +
Sbjct: 101 PEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA 159
Query: 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 488
+ GT +M+PE ++ Y ++D++S G+ L E+ G+ P
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 8e-15
Identities = 61/201 (30%), Positives = 93/201 (46%), Gaps = 33/201 (16%)
Query: 310 RGTY---CS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
RG Y CS + VAIK + N K +E+ ++R + H+NV+ I
Sbjct: 15 RGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIA-IKDIM 73
Query: 360 KPPS------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK------VAIDVSKGMNYLH 407
PP + IV E M LH+ + + L + +G+ Y+H
Sbjct: 74 PPPHREAFNDVYIVYELMDTD-----LHQ---IIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVI-EHKP 465
N++HRDLK +NLL++ N +K+ DFG+AR ++ G MT T + APE++
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSE 185
Query: 466 YDHKADVFSFGIVLWELLTGK 486
Y DV+S G + ELL K
Sbjct: 186 YTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 50/164 (30%), Positives = 90/164 (54%), Gaps = 7/164 (4%)
Query: 328 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVF 387
I ++ + +E+ ++ + +V F GA + I E M GGS+ L + K
Sbjct: 42 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--- 98
Query: 388 KLPS--LLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444
++P L KV+I V +G+ YL + + I+HRD+K +N+L++ +K+ DFGV+ S
Sbjct: 99 RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157
Query: 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 488
+ + GT +M+PE ++ Y ++D++S G+ L EL G+ P
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 64/237 (27%), Positives = 111/237 (46%), Gaps = 21/237 (8%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
V +KVL P + D+ F + +M +V H ++ G C + +V EF+ G +
Sbjct: 47 VVLKVLDPS--HRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM-------DENEVVK 430
L K KG + + VA ++ ++YL N++H ++ A N+L+ + +K
Sbjct: 105 VCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIK 164
Query: 431 VADFGVARVKAQSGVMTAETGTYR--WMAPEVIEHKPYDHKA-DVFSFGIVLWEL-LTGK 486
++D GV+ ++ E R W+APE + A D +SFG L E+ G+
Sbjct: 165 LSDPGVS-----FTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE 219
Query: 487 LPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 543
+P + TP + +K R +P+ S +LA L+ +C +P RP F I+ L
Sbjct: 220 VPLKERTPSEKE-RFYEKKHR--LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 51/196 (26%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 299 KVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ G+YG +Y R + VA+K ++ + + +E+ +++++ H N+V+ +
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
L +V EF+ + ++ LP + + +G+ + H + ++HRD
Sbjct: 67 VIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 125
Query: 416 LKAANLLMDENEVVKVADFGVARVKAQSGV----MTAETGTYRWMAPEV-IEHKPYDHKA 470
LK NLL++ +K+ADFG+AR GV T E T + APE+ + K Y
Sbjct: 126 LKPQNLLINTEGAIKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 182
Query: 471 DVFSFGIVLWELLTGK 486
D++S G + E++T +
Sbjct: 183 DIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 54/184 (29%), Positives = 91/184 (49%), Gaps = 18/184 (9%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375
++VAIK L N K +E+ +M+ V HKN++ + T SL EF
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL---EEFQD--- 96
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSK----------GMNYLHQNNIIHRDLKAANLLMDE 425
VY + + L ++++ +D + G+ +LH IIHRDLK +N+++
Sbjct: 97 VYLVMELMDA--NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154
Query: 426 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG 485
+ +K+ DFG+AR S +MT T + APEVI Y D++S G ++ E++
Sbjct: 155 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214
Query: 486 KLPY 489
K+ +
Sbjct: 215 KILF 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 10/180 (5%)
Query: 317 DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEF 370
+VA+K L N K +E+ +++ V HKN++ + T SL +V E
Sbjct: 48 NVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 107
Query: 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 430
M ++ +H ++ LL + G+ +LH IIHRDLK +N+++ + +K
Sbjct: 108 MDA-NLCQVIHMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 163
Query: 431 VADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
+ DFG+AR + +MT T + APEVI Y D++S G ++ EL+ G + ++
Sbjct: 164 ILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 39/131 (29%), Positives = 72/131 (54%), Gaps = 3/131 (2%)
Query: 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420
L +VT++MSGG ++ +L K +G F ++ + +LH+ +I++RDLK N
Sbjct: 68 DSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPEN 126
Query: 421 LLMDENEVVKVADFGVARVKAQSGVMTAE-TGTYRWMAPEV-IEHKPYDHKADVFSFGIV 478
+L+D + + DFG+++ T GT ++APEV ++ K Y D +S G++
Sbjct: 127 ILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVL 186
Query: 479 LWELLTGKLPY 489
++E+ G P+
Sbjct: 187 VFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 63/234 (26%), Positives = 112/234 (47%), Gaps = 28/234 (11%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 343
VWE+ P+ + + V SG+YG + T Q VA+K L + + +E+ ++
Sbjct: 10 VWEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLL 68
Query: 344 RKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
+ ++H+NV+ + T S+ +VT M L + K L +
Sbjct: 69 KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGA--------DLNNIVKCQKLSDEHV 120
Query: 398 D-----VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 452
+ +G+ Y+H IIHRDLK +N+ ++E+ +++ DFG+AR MT T
Sbjct: 121 QFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE--MTGYVAT 178
Query: 453 YRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPY---EYLTPLQAAVGVV 502
+ APE+ + Y+ D++S G ++ ELL GK + +Y+ L+ + VV
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV 232
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 51/195 (26%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSD--MQKEFAQEVFIMRKVRHKNVVQF 354
K+ G+Y +Y+G + VA+K + ++++ +E+ +M++++H+N+V+
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKELKHENIVRL 63
Query: 355 IGACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
L +V E+M Y H ++G ++ + KG+ + H+N ++H
Sbjct: 64 HDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123
Query: 414 RDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVI-EHKPYDHKAD 471
RDLK NLL+++ +K+ADFG+AR + E T + AP+V+ + Y D
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSID 183
Query: 472 VFSFGIVLWELLTGK 486
++S G ++ E++TG+
Sbjct: 184 IWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 52/201 (25%), Positives = 99/201 (49%), Gaps = 13/201 (6%)
Query: 298 SKVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNV 351
+++ G+YG +++ VA+K ++ + M +EV ++R + H NV
Sbjct: 7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 352 VQFIGACT-----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK-VAIDVSKGMNY 405
V+ CT + L +V E + + YL K+ +K + + +G+++
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 465
LH + ++HRDLK N+L+ + +K+ADFG+AR+ + +T+ T + APEV+
Sbjct: 126 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 185
Query: 466 YDHKADVFSFGIVLWELLTGK 486
Y D++S G + E+ K
Sbjct: 186 YATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 53/197 (26%), Positives = 100/197 (50%), Gaps = 16/197 (8%)
Query: 299 KVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 351
K+ G+Y +Y+G D VA+K ++ E +E A +EV +++ ++H N+
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLE------HEEGAPCTAIREVSLLKDLKHANI 66
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V SL +V E++ + YL + ++ + +G+NY H+ +
Sbjct: 67 VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKV 125
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEV-IEHKPYDHK 469
+HRDLK NLL++E +K+ADFG+AR K+ + + E T + P++ + Y +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 470 ADVFSFGIVLWELLTGK 486
D++ G + +E+ TG+
Sbjct: 186 IDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 19/165 (11%)
Query: 334 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
K +E+ I++ + H+ ++ I A ++C+V D + LP L
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK----CDLFTYVDRSGPLP--L 184
Query: 394 KVAIDVSKGM----NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449
+ AI + + + YLH IIHRD+K N+ +DE E + DFG A +
Sbjct: 185 EQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA---CKLDAHPDT 241
Query: 450 TGTYRWM------APEVIEHKPYDHKADVFSFGIVLWELLTGKLP 488
Y W +PE++ PY K D++S G+VL+E+ +
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 70/217 (32%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-------DVAIKVLKPERINSDMQKEFAQ 338
+WE+ P + +V SG+YG T CS VAIK L + K +
Sbjct: 10 IWEV-PDRYRDLKQVGSGAYG-----TVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR 63
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSL------CIVTEFMSGGSVYDYLHKLKGVFKLPS- 391
E+ +++ ++H+NV+ + T SL +V FM L KL KL
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTD-----LGKLMKHEKLSED 118
Query: 392 -LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET 450
+ + + KG+ Y+H IIHRDLK NL ++E+ +K+ DFG+AR + S MT
Sbjct: 119 RIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSE-MTGYV 176
Query: 451 GTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
T + APEVI Y D++S G ++ E+LTGK
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 53/200 (26%), Positives = 98/200 (49%), Gaps = 39/200 (19%)
Query: 314 CSQDVAIKVLKPERINSDMQ--KEFAQEVFIMRKVRHKNVVQF--------------IGA 357
C + VA+K + + +D Q K +E+ I+R++ H N+V+ +G+
Sbjct: 29 CDKRVAVKKI----VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK-----VAIDVSKGMNYLHQNNII 412
T+ S+ IV E+M L V + L + + +G+ Y+H N++
Sbjct: 85 LTELNSVYIVQEYMET--------DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVL 136
Query: 413 HRDLKAANLLMD-ENEVVKVADFGVARV----KAQSGVMTAETGTYRWMAPEVIEH-KPY 466
HRDLK AN+ ++ E+ V+K+ DFG+AR+ + G ++ T + +P ++ Y
Sbjct: 137 HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNY 196
Query: 467 DHKADVFSFGIVLWELLTGK 486
D+++ G + E+LTGK
Sbjct: 197 TKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 66/278 (23%), Positives = 116/278 (41%), Gaps = 51/278 (18%)
Query: 300 VASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQF 354
+ G+YG +Y+ + VA+K ++ + +E+ +++++ H N+V+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 355 IGACTKPP-----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSK----GMN 404
+ C P L +V E + + YL K P L I D+ + G++
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPK----PGLPPETIKDLMRQLLRGVD 121
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT--YRWMAPEVIE 462
+LH + I+HRDLK N+L+ + VK+ADFG+AR+ + +T+ T YR APEV+
Sbjct: 122 FLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYR--APEVLL 179
Query: 463 HKPYDHKADVFSFGIVLWEL---------------------LTGKLPYEYLTPLQAAVGV 501
Y D++S G + EL + G LP E P ++
Sbjct: 180 QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIG-LPSEEEWPRNVSLPR 238
Query: 502 VQKGLRPTIPKNSQ-----PKLAELLERCWQQDPALRP 534
S + +LL++ +P R
Sbjct: 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ G++G+ L R + A+K+L K E I F +E IM VVQ
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
A L +V E+M GG + + + K +V ++ +H +IHRD+
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA--EVVLALDAIHSMGLIHRDV 168
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP----YDHKA 470
K N+L+D++ +K+ADFG ++G++ +T GT +++PEV++ + Y +
Sbjct: 169 KPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228
Query: 471 DVFSFGIVLWELLTGKLPY 489
D +S G+ L+E+L G P+
Sbjct: 229 DWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 49/175 (28%), Positives = 94/175 (53%), Gaps = 6/175 (3%)
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
L ++ +++SGG ++ +L++ + F + + ++ + +LH+ I++RD+K N+L+
Sbjct: 80 LHLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL 138
Query: 424 DENEVVKVADFGVAR--VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA-DVFSFGIVLW 480
D V + DFG+++ + + + GT +MAPE+I K KA D +S GI+++
Sbjct: 139 DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIF 198
Query: 481 ELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERCWQQDPALR 533
ELLTG P+ V ++ L+ P P P+ +LL + ++DP R
Sbjct: 199 ELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 60/216 (27%), Positives = 108/216 (50%), Gaps = 30/216 (13%)
Query: 293 HLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKE-----FAQEVFIMRK 345
++ G+YG +Y R + VA+K ++ D +KE +E+ I+R+
Sbjct: 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALK-----KVRLDNEKEGFPITAIREIKILRQ 62
Query: 346 VRHKNVVQFIGACT-KPPSLCIVTEFMSGGSVYDYL-HKLKGVFK----------LPSLL 393
+ H+N+V T K +L + + V++Y+ H L G+ + + S +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 394 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETG 451
K ++ G+NY H+ N +HRD+K +N+L++ +K+ADFG+AR+ +S T +
Sbjct: 123 KQLLE---GLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 452 TYRWMAPE-VIEHKPYDHKADVFSFGIVLWELLTGK 486
T + PE ++ + Y DV+S G +L EL T K
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 22/200 (11%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 351
K+ G+Y +++G VA+K ++ E +E A +EV +++ ++H N+
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLE------HEEGAPCTAIREVSLLKNLKHANI 65
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI---DVSKGMNYLHQ 408
V L +V E++ D L L S+ V I + +G++Y H+
Sbjct: 66 VTLHDIIHTERCLTLVFEYLDS----DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEV-IEHKPY 466
I+HRDLK NLL++E +K+ADFG+AR K+ + + E T + P+V + Y
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 467 DHKADVFSFGIVLWELLTGK 486
D++ G +L+E+ TG+
Sbjct: 182 STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ G++G+ L R + A+K+L K E I F +E IM VVQ
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
A L +V E+M GG + + + K +V ++ +H IHRD+
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA--EVVLALDAIHSMGFIHRDV 168
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP----YDHKA 470
K N+L+D++ +K+ADFG + G++ +T GT +++PEV++ + Y +
Sbjct: 169 KPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228
Query: 471 DVFSFGIVLWELLTGKLPY 489
D +S G+ L+E+L G P+
Sbjct: 229 DWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 37/94 (39%), Positives = 56/94 (59%), Gaps = 9/94 (9%)
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG------VMTAETGTYR 454
K + Y+H N+IHRDLK +N+L++ + VK+ADFG+AR ++ V+T T R
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT-R 176
Query: 455 WM-APEV-IEHKPYDHKADVFSFGIVLWELLTGK 486
W APE+ + Y D++S G +L E+L GK
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 51/198 (25%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 299 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ G+YG +Y+ ++ +A+K ++ E+ + + +E+ ++++++H N+V+
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRD 415
L +V E++ + ++ K P L+K + + +G+ Y H + ++HRD
Sbjct: 69 VVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRD 127
Query: 416 LKAANLLMDE-NEVVKVADFGVAR-----VKAQSGVMTAETGTYRWMAPEV-IEHKPYDH 468
LK NLL+D +K+ADFG+AR V+ T E T + APE+ + + Y
Sbjct: 128 LKPQNLLIDRRTNALKLADFGLARAFGIPVRT----FTHEVVTLWYRAPEILLGSRHYST 183
Query: 469 KADVFSFGIVLWELLTGK 486
D++S G + E++ K
Sbjct: 184 PVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 300 VASGSYGD--LYRGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ G++G+ L R Q A+K+L K E I F +E IM + +VQ
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110
Query: 357 ACTKPPSLCIVTEFMSGG------SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 410
A L +V E+M GG S YD K + +L A+D +H
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVL--ALDA------IHSMG 162
Query: 411 IIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIE----HK 464
IHRD+K N+L+D++ +K+ADFG +G++ +T GT +++PEV++
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 465 PYDHKADVFSFGIVLWELLTGKLPY 489
Y + D +S G+ L+E+L G P+
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 59/248 (23%), Positives = 122/248 (49%), Gaps = 15/248 (6%)
Query: 300 VASGSYGDLY-----RGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKN-V 351
+ +G+YG ++ G + A+KVLK I + + E ++ +R +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V A L ++ ++++GG ++ +L + + FK + + ++ + +LH+ I
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGI 126
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIE--HKPYD 467
I+RD+K N+L+D N V + DFG+++ + V A + GT +MAP+++ +D
Sbjct: 127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHD 186
Query: 468 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERC 525
D +S G++++ELLTG P+ + + ++ L+ P P+ ++++R
Sbjct: 187 KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRL 246
Query: 526 WQQDPALR 533
+DP R
Sbjct: 247 LMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 18/203 (8%)
Query: 298 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVV 352
+++ G+YG +Y R + VA+K ++ + + +EV +++++ H N+V
Sbjct: 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 353 QFIGACT-----KPPSLCIVTEFMSGGSVYDYLHKLKG----VFKLPSLLKVAIDVSKGM 403
+ + C + + +V E + + YL K+ + L++ + +G+
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL---RGL 121
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH 463
++LH N I+HRDLK N+L+ VK+ADFG+AR+ + +T T + APEV+
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ 181
Query: 464 KPYDHKADVFSFGIVLWELLTGK 486
Y D++S G + E+ K
Sbjct: 182 STYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-13
Identities = 59/248 (23%), Positives = 111/248 (44%), Gaps = 31/248 (12%)
Query: 315 SQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI-VTEFMS 372
+VAIK+L+ + + Q F +E + ++ H N+V + + PP L V E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---V 429
G ++ + L G ++ + V + H I+HRDLK N+++ + V
Sbjct: 63 GRTLREVLAA-DGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 430 KVADFGVARV-----KAQSGVMTAET---GTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 481
KV DFG+ + A +T T GT + APE + +P +D++++G++ E
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181
Query: 482 LLTGK----------LPYEYLTPLQAAVGVVQKG------LRPTIPKNSQPKLAELLERC 525
LTG+ + Y+ L+P+ ++ G LR + K+ + + A
Sbjct: 182 CLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQR-AASAPAL 240
Query: 526 WQQDPALR 533
++ AL
Sbjct: 241 AERFRALE 248
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 37/92 (40%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 402 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGTYRWM 456
G+ Y+H N++HRDLK NLL++ + +K+ DFG+AR +G MT T RW
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT-RWY 175
Query: 457 -APEV-IEHKPYDHKADVFSFGIVLWELLTGK 486
APE+ + + Y DV+S G +L ELL K
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 58/239 (24%), Positives = 111/239 (46%), Gaps = 9/239 (3%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFI 355
+ GS+G + R + A+K ++ I S++ A+ ++ +V +V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERT-VLAQVNCPFIVPLK 59
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ P L +V F++GG ++ +L + +G F L ++ + LH+ N+I+RD
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 416 LKAANLLMDENEVVKVADFGVARVK-AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 474
LK N+L+D + + DFG+ ++ GT ++APE++ Y D ++
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWT 178
Query: 475 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 533
G++L+E+LTG P+ + ++Q+ LR P +LL +DP R
Sbjct: 179 LGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR--FPDGFDRDAKDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 47/192 (24%), Positives = 97/192 (50%), Gaps = 6/192 (3%)
Query: 299 KVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ G+Y +++G + VA+K ++ E +EV +++ ++H N+V
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
SL +V E++ + Y+ + + ++ + +G+ Y H+ ++HRDL
Sbjct: 72 IVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDL 130
Query: 417 KAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEV-IEHKPYDHKADVFS 474
K NLL++E +K+ADFG+AR K+ + + E T + P+V + Y + D++
Sbjct: 131 KPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWG 190
Query: 475 FGIVLWELLTGK 486
G + +E+ +G+
Sbjct: 191 VGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 54/204 (26%), Positives = 101/204 (49%), Gaps = 10/204 (4%)
Query: 299 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFA--QEVFIMRKVRHKNVVQF 354
K+ GSY +Y+G + VA+KV+ R+ + F +E +++ ++H N+V
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVI---RLQEEEGTPFTAIREASLLKGLKHANIVLL 68
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
+L +V E++ + Y+ K G ++ + +G++Y+HQ I+HR
Sbjct: 69 HDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHR 127
Query: 415 DLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEV-IEHKPYDHKADV 472
DLK NLL+ + +K+ADFG+AR K+ S + E T + P+V + Y D+
Sbjct: 128 DLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDM 187
Query: 473 FSFGIVLWELLTGKLPYEYLTPLQ 496
+ G + E++ G + + +Q
Sbjct: 188 WGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 35/90 (38%), Positives = 54/90 (60%), Gaps = 8/90 (8%)
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-----GVMTAETGTYRW 455
+G+ Y+H N+IHRDLK +NLL++E+ +++ DFG+AR + S MT T RW
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT-RW 176
Query: 456 M-APEVIEHKP-YDHKADVFSFGIVLWELL 483
APE++ P Y D++S G + E+L
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 62/276 (22%), Positives = 113/276 (40%), Gaps = 47/276 (17%)
Query: 300 VASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
++ G G Y+G + V + +NS E A M K++H N+V+ IG C
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCR 753
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN---NIIHRDL 416
++ E++ G ++ + L L + K+AI ++K + +LH ++
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVLRNLSWERRR----KIAIGIAKALRFLHCRCSPAVV---- 805
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR--WMAPEVIEHKPYDHKADVFS 474
L E ++ D R+ + T ++APE E K K+D++
Sbjct: 806 --VGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYG 863
Query: 475 FGIVLWELLTGKLPYEYLTPLQAAVGV----------------VQKGLRPTIPKNSQPKL 518
FG++L ELLTGK +P A GV + + P+I +
Sbjct: 864 FGLILIELLTGK------SPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917
Query: 519 AELLE------RCWQQDPALRPDFSEIIEILQQIAK 548
E++E C DP RP +++++ L+ ++
Sbjct: 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953
|
Length = 968 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 80/293 (27%), Positives = 119/293 (40%), Gaps = 68/293 (23%)
Query: 300 VASGSYGDLYRG--TYCSQDVAIKVLKPERIN------SDMQKEFAQEVFIMRKVRHKNV 351
+ GSYG + T+ + VAIK +IN SD + +E+ ++R +RH ++
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIK-----KINDVFEHVSDATR-ILREIKLLRLLRHPDI 61
Query: 352 VQFIGACTKPPS------LCIVTEFMSGG-----SVYDYLHKLKGVFKLPSLLKVAIDVS 400
V+ I PPS + +V E M D L F L LL+
Sbjct: 62 VE-IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR------ 114
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWM- 456
+ Y+H N+ HRDLK N+L + + +K+ DFG+ARV + + + RW
Sbjct: 115 -ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 457 APEVIE--HKPYDHKADVFSFGIVLWELLTGK-------------LPYEYL-TPLQAAVG 500
APE+ Y D++S G + E+LTGK L + L TP +
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233
Query: 501 VVQ--------KGLRPTIP-------KNSQPKLAELLERCWQQDPALRPDFSE 538
V+ +R P N+ P LLER DP RP E
Sbjct: 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 53/194 (27%), Positives = 96/194 (49%), Gaps = 10/194 (5%)
Query: 299 KVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFA--QEVFIMRKVRHKNVVQF 354
K+ GSY +Y+G Q VA+KV+ + ++ F +E +++ ++H N+V
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVIS---MKTEEGVPFTAIREASLLKGLKHANIVLL 68
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
+L V E+M + Y+ + G ++ + +G+ Y+H +I+HR
Sbjct: 69 HDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHR 127
Query: 415 DLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEVI-EHKPYDHKADV 472
DLK NLL+ +K+ADFG+AR K+ S ++E T + P+V+ Y D+
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDI 187
Query: 473 FSFGIVLWELLTGK 486
+ G + E+L G+
Sbjct: 188 WGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|153145 cd04873, ACT_UUR-ACR-like, ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 7e-12
Identities = 24/69 (34%), Positives = 35/69 (50%), Gaps = 2/69 (2%)
Query: 181 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV-DGWPYEETEQLRA 239
+ D+P LL+ +T +LAD+GLNI +A ST +LDVF V D + A
Sbjct: 2 VVEVYAPDRPGLLADITRVLADLGLNIHDAR-ISTTGERALDVFYVTDSDGRPLDPERIA 60
Query: 240 ALEKEVLKL 248
LE+ +
Sbjct: 61 RLEEALEDA 69
|
This ACT domain family, ACT_UUR_ACR-like, includes the two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the four ACT domains of a novel protein composed almost entirely of ACT domain repeats (the ACR protein) and like proteins. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. This CD also includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein and related domains, as well as, the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 70 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 18/194 (9%)
Query: 306 GDLYRGTYCSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364
GD+Y A+KV+K + + F +E I+ + Q A +L
Sbjct: 26 GDIY---------AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNL 76
Query: 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 424
+V E+ GG + L++ + F ++ ++ +HQ +HRD+K N+L+D
Sbjct: 77 YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID 136
Query: 425 ENEVVKVADFG-VARVKAQSGVM-TAETGTYRWMAPEVIE------HKPYDHKADVFSFG 476
+K+ADFG AR+ A V GT ++APEV+ Y + D +S G
Sbjct: 137 RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLG 196
Query: 477 IVLWELLTGKLPYE 490
++ +E++ G+ P+
Sbjct: 197 VIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 9e-12
Identities = 67/292 (22%), Positives = 135/292 (46%), Gaps = 48/292 (16%)
Query: 299 KVASGSYGDLY-------RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351
K+ +G +G+++ + +C + ++ + LK ER S + EV +MR+++HKN+
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKS----QLVIEVNVMRELKHKNI 74
Query: 352 VQFIGACTKPPS--LCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYL 406
V++I + L I+ EF G + + +K+ G + +++ + + + Y
Sbjct: 75 VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 407 HQ-------NNIIHRDLKAANLLM-----------------DENEVVKVADFGVARVKAQ 442
H ++HRDLK N+ + + + K+ DFG+++
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194
Query: 443 SGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 500
+ + GT + +PE++ H K YD K+D+++ G +++EL +GK P+ +
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLIS 254
Query: 501 VVQKGLRPTIP-KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551
+++G P +P K +L L++ RP S + + QI K VG
Sbjct: 255 ELKRG--PDLPIKGKSKELNILIKNLLNLSAKERP--SALQCLGYQIIKNVG 302
|
Length = 1021 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 53/193 (27%), Positives = 95/193 (49%), Gaps = 10/193 (5%)
Query: 299 KVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFA--QEVFIMRKVRHKNVVQF 354
K+ GSY +Y+G Q VA+K + R+ + F +E +++ ++H N+V
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEI---RLEHEEGAPFTAIREASLLKDLKHANIVTL 68
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
+L +V E++ + Y+ G + ++ + +G+ Y HQ ++HR
Sbjct: 69 HDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHR 127
Query: 415 DLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGTYRWMAPEVI-EHKPYDHKADV 472
DLK NLL+ E +K+ADFG+AR K+ S + E T + P+V+ Y D+
Sbjct: 128 DLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDM 187
Query: 473 FSFGIVLWELLTG 485
+ G + +E+ TG
Sbjct: 188 WGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 45/163 (27%), Positives = 73/163 (44%), Gaps = 45/163 (27%)
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK-------VAIDVSKGMNYLHQNNIIHRDL 416
L +V E+M GG + + L + K VF + +A+D +H+ IHRD+
Sbjct: 76 LYLVMEYMPGGDLMNLLIR-KDVFP-EETARFYIAELVLALD------SVHKLGFIHRDI 127
Query: 417 KAANLLMDENEVVKVADFGVA-----------------------------RVKAQSGVMT 447
K N+L+D + +K+ADFG+ R Q V
Sbjct: 128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRA 187
Query: 448 -AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
+ GT ++APEV+ PY + D +S G++L+E+L G P+
Sbjct: 188 NSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 48/206 (23%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
V ++ + E ++M E+ + + H N+V + L +VT FM+ GS
Sbjct: 28 VTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 87
Query: 378 DYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
D + H + G+ +L ++ + V K ++Y+H +HR +KA+++L+ + V ++
Sbjct: 88 DLICTHFMDGMSEL-AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLR 146
Query: 436 V--------ARVKAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTG 485
R++ W++PEV++ + YD K+D++S GI EL G
Sbjct: 147 SNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 206
Query: 486 KLPYEYLTPLQAAVGVVQKGLRPTIP 511
+P++ + Q ++ + L T+P
Sbjct: 207 HVPFKDMPATQ----MLLEKLNGTVP 228
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 6e-11
Identities = 42/144 (29%), Positives = 77/144 (53%), Gaps = 4/144 (2%)
Query: 300 VASGSYGDLY--RGTYCSQDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
++ G++G +Y R S+ A+KV+ K + IN +M + E + + +V
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ ++ +V E++ GG V LH + G F +K +V+ ++YLH++ IIHRDL
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLH-IYGYFDEEMAVKYISEVALALDYLHRHGIIHRDL 130
Query: 417 KAANLLMDENEVVKVADFGVARVK 440
K N+L+ +K+ DFG+++V
Sbjct: 131 KPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-11
Identities = 50/226 (22%), Positives = 94/226 (41%), Gaps = 38/226 (16%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFI 355
+ G G++Y CS+ VA+K ++ + N ++K F +E I + H +V
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK-------------LPSLLKVAIDVSKG 402
C+ + ++ G Y LK V++ + + L + +
Sbjct: 69 SICSDGDPVYYTMPYIEG---YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK------------AQSGVMTAE- 449
+ Y+H ++HRDLK N+L+ V + D+G A K + + +
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 450 ------TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
GT +MAPE + P D+++ G++L+++LT PY
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 30/209 (14%)
Query: 299 KVASGSYGDLYRGTYCSQDVA---IKVLKPERINSD-------------MQKEFAQEVFI 342
K+ G+YG +Y+ ++D + LK R+ D + + ++ ++I
Sbjct: 8 KIGEGTYGKVYK----ARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLP--SLLKVAIDV 399
+R + ++V + G PSL +V E++ + + LP ++ +
Sbjct: 64 VRLLDVEHVEEKNGK----PSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARV-KAQSGVMTAETGTYRWMA 457
KG+ + H++ ++HRDLK NLL+D + ++K+AD G+ R T E T + A
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRA 179
Query: 458 PEV-IEHKPYDHKADVFSFGIVLWELLTG 485
PEV + Y D++S G + E+
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 39/170 (22%), Positives = 68/170 (40%), Gaps = 20/170 (11%)
Query: 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD 433
S+ D L + V + + LH+ K+ N+L+ + ++K+
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQA------KSGNILLTWDGLLKL-- 52
Query: 434 FGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493
G A + Y +MAPEVI+ + Y KAD++S GI L+E L +LPY
Sbjct: 53 DGSV---AFKTPEQSRPDPY-FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108
Query: 494 PLQAAVGVVQKGLRPTIPKNSQPK--------LAELLERCWQQDPALRPD 535
L A + ++ G+ P++ + + C + P R
Sbjct: 109 ELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREA 158
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 67/236 (28%), Positives = 113/236 (47%), Gaps = 28/236 (11%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH 348
K K G+ + +GS+G +Y C S+ VAIK ++ D Q + +E+ IM+ + H
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAI-CIDTSEKVAIK-----KVLQDPQYK-NRELLIMKNLNH 118
Query: 349 KNVV----QFIGACTKPPS----LCIVTEFMSGGSVYDYL-HKLKGVFKLPSLLK--VAI 397
N++ + C K L +V EF+ +V+ Y+ H + LP L +
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVAR--VKAQSGVMTAETGTYR 454
+ + + Y+H I HRDLK NLL+D N +K+ DFG A+ + Q V + YR
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYR 237
Query: 455 WMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT 509
APE+ + Y D++S G ++ E++ G + + + V ++Q PT
Sbjct: 238 --APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291
|
Length = 440 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 40/122 (32%), Positives = 60/122 (49%), Gaps = 13/122 (10%)
Query: 274 PYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGT-------YCSQDVAIKVLKPE 326
P L P D WE+ +L G + SG++G + T + VA+K+LK
Sbjct: 23 PMQL--PYDSA--WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKST 78
Query: 327 RINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG 385
+S+ Q E+ IM + H N+V +GACTK + I+TE+ G + DYLH+ K
Sbjct: 79 ARSSEKQA-LMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKH 137
Query: 386 VF 387
F
Sbjct: 138 TF 139
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 51/203 (25%), Positives = 83/203 (40%), Gaps = 32/203 (15%)
Query: 319 AIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+KVL K E I + K E I+ + H + + LC+V ++ GG ++
Sbjct: 30 ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89
Query: 378 DYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF-- 434
L + G A +V + YLH I++RDLK N+L+ E+ + ++DF
Sbjct: 90 RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDL 149
Query: 435 -------GVARVKAQSG-------------VMTAET--------GTYRWMAPEVIEHKPY 466
KA + E GT ++APEVI +
Sbjct: 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH 209
Query: 467 DHKADVFSFGIVLWELLTGKLPY 489
D ++ GI+L+E+L G P+
Sbjct: 210 GSAVDWWTLGILLYEMLYGTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 5e-09
Identities = 36/136 (26%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIHRDLKAAN 420
+L +V ++ GG + L K + +LP + ++ ++ +HQ + +HRD+K N
Sbjct: 75 NLYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDN 132
Query: 421 LLMDENEVVKVADFGVARVKAQSGVM--TAETGTYRWMAPEVIEHKP-----YDHKADVF 473
+LMD N +++ADFG + G + + GT +++PE+++ Y + D +
Sbjct: 133 ILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWW 192
Query: 474 SFGIVLWELLTGKLPY 489
S G+ ++E+L G+ P+
Sbjct: 193 SLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 3/109 (2%)
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
+Y YL L + VA + ++Y+H IIHRD+K N+L++ E + + DFG
Sbjct: 246 LYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG 305
Query: 436 VA---RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 481
A R + GT APEV+ PY D++S G+V++E
Sbjct: 306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 57/183 (31%)
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRDLKAANLL 422
L V +++ GG + L +L G+F+ L + I +++ + +H+ IHRD+K N+L
Sbjct: 76 LYFVMDYIPGGDMMSLLIRL-GIFE-EDLARFYIAELTCAIESVHKMGFIHRDIKPDNIL 133
Query: 423 MDENEVVKVADFGVA--------------------------------------------- 437
+D + +K+ DFG+
Sbjct: 134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRK 193
Query: 438 ----RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493
R A S V GT ++APEV+ Y D +S G++L+E+L G+ P+ T
Sbjct: 194 RQHQRCLAHSLV-----GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADT 248
Query: 494 PLQ 496
P +
Sbjct: 249 PAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 37/135 (27%), Positives = 74/135 (54%), Gaps = 11/135 (8%)
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPS-LLKVAI-DVSKGMNYLHQNNIIHRDLKAANL 421
L +V ++ GG + L K + +LP + + I ++ ++ +HQ + +HRD+K N+
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133
Query: 422 LMDENEVVKVADFGVARVKAQSGVM--TAETGTYRWMAPEVIEHK-----PYDHKADVFS 474
L+D N +++ADFG Q G + + GT +++PE+++ Y + D +S
Sbjct: 134 LLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWS 193
Query: 475 FGIVLWELLTGKLPY 489
G+ ++E+L G+ P+
Sbjct: 194 LGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 41/122 (33%), Positives = 62/122 (50%), Gaps = 11/122 (9%)
Query: 277 LKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC----SQ---DVAIKVLKPERIN 329
+++P D WE L G + SG++G + GT SQ VA+K+LKP +
Sbjct: 24 MQLPYDSR--WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS 81
Query: 330 SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK 388
S+ Q E+ IM + H N+V +GACTK + I+TE+ G + +YLHK + F
Sbjct: 82 SEKQA-LMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFL 140
Query: 389 LP 390
Sbjct: 141 SR 142
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 56/227 (24%)
Query: 297 GSKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
G KV G+YG +Y+ +D A+K ++ I+ +E A ++R+++H NV+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIA----LLRELKHPNVI 61
Query: 353 QFIGACTKPPSLCIVTEFMSGGS-----VYDY----------LHKLKGVFKLP------- 390
+ F+S ++DY H+ K P
Sbjct: 62 S------------LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 109
Query: 391 --SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSG 444
SLL +D G++YLH N ++HRDLK AN+L+ E VK+AD G AR+
Sbjct: 110 VKSLLYQILD---GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166
Query: 445 VMTAETG----TYRWMAPE-VIEHKPYDHKADVFSFGIVLWELLTGK 486
A+ T+ + APE ++ + Y D+++ G + ELLT +
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 37/168 (22%)
Query: 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422
+L ++ EF+ GG + L K + + + +A + ++ +HQ IHRD+K NLL
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQLGFIHRDIKPDNLL 133
Query: 423 MDENEVVKVADFGV------------------------------ARVKAQS------GVM 446
+D VK++DFG+ ++ KA++ +
Sbjct: 134 LDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLA 193
Query: 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494
+ GT ++APEV Y+ D +S G++++E+L G P+ TP
Sbjct: 194 FSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 37/168 (22%)
Query: 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422
+L ++ EF+ GG + L K + + + +A V ++ +HQ IHRD+K NLL
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL-AIDAIHQLGFIHRDIKPDNLL 133
Query: 423 MDENEVVKVADFGV------------------------------ARVKAQS------GVM 446
+D VK++DFG+ ++ KA++ +
Sbjct: 134 LDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLA 193
Query: 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494
+ GT ++APEV Y+ D +S G++++E+L G P+ TP
Sbjct: 194 YSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 34/216 (15%)
Query: 297 GSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
G KV G+YG +Y+ ++ A+K ++ I+ +E A ++R+++H NV+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIA----LLRELKHPNVI 61
Query: 353 --QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLP-SLLKVAI-DV 399
Q + + ++ ++ +D H +K +LP S++K + +
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAE----HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117
Query: 400 SKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETG---- 451
G++YLH N ++HRDLK AN+L+ E VK+AD G AR+ A+
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 452 TYRWMAPE-VIEHKPYDHKADVFSFGIVLWELLTGK 486
T+ + APE ++ + Y D+++ G + ELLT +
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 52/235 (22%), Positives = 99/235 (42%), Gaps = 54/235 (22%)
Query: 319 AIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+K L K + +N + E I+ + ++ VV+ + +L V +++ GG +
Sbjct: 30 AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89
Query: 378 DYLHKLKGVFKLPSLLK--VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
L ++ VF P +L +++ + +H+ IHRD+K N+L+D + +K+ DFG
Sbjct: 90 SLLIRM-EVF--PEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFG 146
Query: 436 V------------------------------------------------ARVKAQSGVMT 447
+ A + Q +
Sbjct: 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAH 206
Query: 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502
+ GT ++APEV+ K Y D +S G++L+E+L G+ P+ TP + + V+
Sbjct: 207 SLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVI 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|235342 PRK05092, PRK05092, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 1e-07
Identities = 24/73 (32%), Positives = 34/73 (46%), Gaps = 7/73 (9%)
Query: 181 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPYEETEQL 237
E+T D P L S++ A G NI +A F+T DG +LD F + G +E +L
Sbjct: 734 EVTVLAADHPGLFSRIAGACAAAGANIVDARIFTTTDGRALDTFWIQDAFGRDEDEPRRL 793
Query: 238 ---RAALEKEVLK 247
A+E L
Sbjct: 794 ARLAKAIED-ALS 805
|
Length = 931 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 37/135 (27%), Positives = 75/135 (55%), Gaps = 11/135 (8%)
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLP-SLLKVAI-DVSKGMNYLHQNNIIHRDLKAANL 421
L +V ++ GG + L K + +LP + + + ++ ++ +HQ +HRD+K N+
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNV 133
Query: 422 LMDENEVVKVADFGVA-RVKAQSGVMTA-ETGTYRWMAPEVIE-----HKPYDHKADVFS 474
L+D+N +++ADFG R+ A V + GT +++PE+++ Y + D +S
Sbjct: 134 LLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWS 193
Query: 475 FGIVLWELLTGKLPY 489
G+ ++E+L G+ P+
Sbjct: 194 LGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 30/106 (28%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGT---YCSQD----VAIKVLKPERINSDMQKEFA 337
+ WE +L+FG + +G++G + T +D VA+K+LK ++D ++
Sbjct: 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKA-SAHTDEREALM 89
Query: 338 QEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK 382
E+ I+ + +HKN+V +GACT + ++TE+ G + ++L K
Sbjct: 90 SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRK 135
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 32/128 (25%), Positives = 51/128 (39%), Gaps = 49/128 (38%)
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVA---------------------------- 437
+H+ IHRD+K NLL+D +K++DFG+
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176
Query: 438 ----------------RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 481
R A S V GT ++APEV Y+ + D +S G++++E
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTV-----GTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231
Query: 482 LLTGKLPY 489
+L G P+
Sbjct: 232 MLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 47/211 (22%), Positives = 91/211 (43%), Gaps = 53/211 (25%)
Query: 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI-DVSKGMNYLHQNNIIHRDLKAANL 421
+L V +++ GG + L ++ G+F L + I +++ + +H+ IHRD+K N+
Sbjct: 75 NLYFVMDYIPGGDMMSLLIRM-GIFP-EDLARFYIAELTCAVESVHKMGFIHRDIKPDNI 132
Query: 422 LMDENEVVKVADFGV--------------------------------------------- 436
L+D + +K+ DFG+
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPL 192
Query: 437 ---ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493
A + Q + + GT ++APEV+ Y D +S G++L+E+L G+ P+ T
Sbjct: 193 ERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQT 252
Query: 494 PLQAAVGVVQKGLRPTIPKNSQ--PKLAELL 522
PL+ + V+ IP ++ P+ ++L+
Sbjct: 253 PLETQMKVINWQTSLHIPPQAKLSPEASDLI 283
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 32/109 (29%), Positives = 53/109 (48%), Gaps = 8/109 (7%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINSDMQKEFAQE 339
WE LK G + G++G + T + VA+K+LK +S+ + ++
Sbjct: 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 61
Query: 340 VFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF 387
++ H NVV +GACTKP L ++ EF G++ +YL +G F
Sbjct: 62 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEF 110
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|153139 cd02116, ACT, ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 1e-06
Identities = 24/62 (38%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVF-VVDGWPYEETEQLRAA 240
+T S D+P LL+++ ++LA+ G+NI ++ DG D+F VVDG + E+L A
Sbjct: 1 LTVSGPDRPGLLAKVLSVLAEAGINITSIEQRTSGDGGEADIFIVVDGD--GDLEKLLEA 58
Query: 241 LE 242
LE
Sbjct: 59 LE 60
|
Members of this CD belong to the superfamily of ACT regulatory domains. Pairs of ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme. The ACT domain has been detected in a number of diverse proteins; some of these proteins are involved in amino acid and purine biosynthesis, phenylalanine hydroxylation, regulation of bacterial metabolism and transcription, and many remain to be characterized. ACT domain-containing enzymes involved in amino acid and purine synthesis are in many cases allosteric enzymes with complex regulation enforced by the binding of ligands. The ACT domain is commonly involved in the binding of a small regulatory molecule, such as the amino acids L-Ser and L-Phe in the case of D-3-phosphoglycerate dehydrogenase and the bifunctional chorismate mutase-prephenate dehydratase enzyme (P-protein), respectively. Aspartokinases typically consist of two C-terminal ACT domains in a tandem repeat, but the second ACT domain is inserted within the first, resulting in, what is normally the terminal beta strand of ACT2, formed from a region N-terminal of ACT1. ACT domain repeats have been shown to have nonequivalent ligand-binding sites with complex regulatory patterns such as those seen in the bifunctional enzyme, aspartokinase-homoserine dehydrogenase (ThrA). In other enzymes, such as phenylalanine hydroxylases, the ACT domain appears to function as a flexible small module providing allosteric regulation via transmission of conformational changes, these conformational changes are not necessarily initiated by regulatory ligand binding at the ACT domain itself. ACT domains are present either singularly, N- or C-terminal, or in pairs present C-terminal or between two catalytic domains. Unique to cyanobacteria are four ACT domains C-terminal to an aspartokinase domain. A few proteins are composed almost entirely of ACT domain repeats as seen in the four ACT domain protein, the ACR protein, found in higher plants; and the two ACT domain protein, the glycine cleavage system transcriptional repressor (GcvR) protein, found in some bacteria. Also seen are single ACT domain proteins similar to the Streptococcus pneumoniae ACT domain protein (uncharacterized pdb structure 1ZPV) found in both bacteria and archaea. Purportedly, the ACT domain is an evolutionarily mobile ligand binding regulatory module that has been fused to different enzymes at various times. Length = 60 |
| >gnl|CDD|225400 COG2844, GlnD, UTP:GlnB (protein PII) uridylyltransferase [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 30/107 (28%), Positives = 48/107 (44%), Gaps = 9/107 (8%)
Query: 169 VHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV-- 226
V +V+ E+ D+P+L + + A L+ GL+I +A F+T DGY+LD F+V
Sbjct: 674 VLISVRPHSGGTEVFVYAPDRPRLFAVVCAALSRRGLSIVDAQIFTTRDGYALDTFIVLE 733
Query: 227 -DGWPYEETEQLR------AALEKEVLKLERQGWPSHRSSSPTSEPE 266
DG+P EE + AL + R+ + P
Sbjct: 734 PDGFPVEEDRRAALRGELIEALLSGKAQPPRRRRIPRKLRHFPIPPR 780
|
Length = 867 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 35/112 (31%), Positives = 54/112 (48%), Gaps = 14/112 (12%)
Query: 287 WEIDPKHLKFGSKVASGSYG--------DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ 338
WE LK G + G++G + + C + VA+K+LK E + K
Sbjct: 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASC-RTVAVKMLK-EGATASEYKALMT 59
Query: 339 EVFIMRKV-RHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVF 387
E+ I+ + H NVV +GACTKP P + IV E+ G++ +YL + F
Sbjct: 60 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EYCKFGNLSNYLRSKRECF 110
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|190133 pfam01842, ACT, ACT domain | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 5e-06
Identities = 18/64 (28%), Positives = 30/64 (46%), Gaps = 1/64 (1%)
Query: 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRA 239
+ D+P LL+++ LAD G+NI+ ++ D + VV E+ E
Sbjct: 1 TVLEVGVPDRPGLLAEVFGALADRGINIESISQSTSGDKAGIVFIVVVV-DEEDLEAALE 59
Query: 240 ALEK 243
AL+K
Sbjct: 60 ALKK 63
|
This family of domains generally have a regulatory role. ACT domains are linked to a wide range of metabolic enzymes that are regulated by amino acid concentration. Pairs of ACT domains bind specifically to a particular amino acid leading to regulation of the linked enzyme. The ACT domain is found in: D-3-phosphoglycerate dehydrogenase EC:1.1.1.95, which is inhibited by serine. Aspartokinase EC:2.7.2.4, which is regulated by lysine. Acetolactate synthase small regulatory subunit, which is inhibited by valine. Phenylalanine-4-hydroxylase EC:1.14.16.1, which is regulated by phenylalanine. Prephenate dehydrogenase EC:4.2.1.51. formyltetrahydrofolate deformylase EC:3.5.1.10, which is activated by methionine and inhibited by glycine. GTP pyrophosphokinase EC:2.7.6.5. Length = 66 |
| >gnl|CDD|153171 cd04899, ACT_ACR-UUR-like_2, C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains | Back alignment and domain information |
|---|
Score = 43.6 bits (104), Expect = 7e-06
Identities = 27/63 (42%), Positives = 38/63 (60%), Gaps = 6/63 (9%)
Query: 188 DKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPY--EETEQLRAALE 242
D+P LL+ +T +LA++GLNI A +T+ + DVF V DG P E E LRAAL
Sbjct: 9 DRPGLLADVTRVLAELGLNIHSAKI-ATLGERAEDVFYVTDADGQPLDPERQEALRAALG 67
Query: 243 KEV 245
+ +
Sbjct: 68 EAL 70
|
This ACT domain family, ACT_ACR-UUR-like_2, includes the second of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the second and fourth ACT domains of a novel protein composed almost entirely of ACT domain repeats, the ACR protein. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 70 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 32/111 (28%), Positives = 53/111 (47%), Gaps = 12/111 (10%)
Query: 287 WEIDPKHLKFGSKVASGSYGDL--------YRGTYCSQDVAIKVLKPERINSDMQKEFAQ 338
WE L+ G + G++G + + + C VA+K+LK E + K
Sbjct: 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSC-NTVAVKMLK-EGATASEHKALMS 59
Query: 339 EVFIMRKV-RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVF 387
E+ I+ + H NVV +GACTKP L ++ EF G++ ++L + F
Sbjct: 60 ELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFF 110
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 41/171 (23%), Positives = 74/171 (43%), Gaps = 9/171 (5%)
Query: 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422
S+ +V + GG ++ ++ K + + + A ++ ++ LH+ I+ RDL N+L
Sbjct: 59 SVFLVLQHAEGGKLWSHISKFLNI-PEECVKRWAAEMVVALDALHREGIVCRDLNPNNIL 117
Query: 423 MDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWEL 482
+D+ +++ F S A Y APEV D +S G +L+EL
Sbjct: 118 LDDRGHIQLTYFSRWSEVEDSCDGEAVENMY--CAPEVGGISEETEACDWWSLGAILFEL 175
Query: 483 LTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 533
LTGK T ++ + IP+ + LL++ Q +P R
Sbjct: 176 LTGK------TLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTER 220
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 38/144 (26%), Positives = 66/144 (45%), Gaps = 21/144 (14%)
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLL 422
+CIV G + D++ K G F L ++ ++Y H +++H DLK N+L
Sbjct: 207 MCIVMP-KYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENIL 264
Query: 423 MDENEV----------------VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 466
M+ ++ V++ D G + S T YR +PEV+ +
Sbjct: 265 METSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYR--SPEVVLGLGW 322
Query: 467 DHKADVFSFGIVLWELLTGKLPYE 490
+ D++S G +++EL TGKL Y+
Sbjct: 323 MYSTDMWSMGCIIYELYTGKLLYD 346
|
Length = 467 |
| >gnl|CDD|233534 TIGR01693, UTase_glnD, [Protein-PII] uridylyltransferase | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 19/64 (29%), Positives = 31/64 (48%), Gaps = 3/64 (4%)
Query: 181 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPYEETEQL 237
E+ D+P L +++ LA + L++ +A +T DG +LD FVV G P
Sbjct: 670 EVFIYAPDQPGLFAKVAGALAMLSLSVHDAQVNTTKDGVALDTFVVQDLFGSPPAAERVF 729
Query: 238 RAAL 241
+ L
Sbjct: 730 QELL 733
|
This model describes GlnD, the uridylyltransferase/uridylyl-removing enzyme for the nitrogen regulatory protein PII. Not all homologs of PII share the property of uridylyltransferase modification on the characteristic Tyr residue (see Prosite pattern PS00496 and document PDOC00439), but the modification site is preserved in the PII homolog of all species with a member of this family [Central intermediary metabolism, Nitrogen metabolism, Regulatory functions, Protein interactions]. Length = 850 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 32/129 (24%), Positives = 56/129 (43%), Gaps = 8/129 (6%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQE 339
WE L FG + +G++G + T + VA+K+LKP ++ + ++
Sbjct: 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSEL 89
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
+ H N+V +GACT ++TE+ G + ++L + + F P A
Sbjct: 90 KVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAA 149
Query: 400 SKGMNYLHQ 408
N LHQ
Sbjct: 150 LY-KNLLHQ 157
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|235329 PRK05007, PRK05007, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 24/75 (32%), Positives = 41/75 (54%), Gaps = 5/75 (6%)
Query: 174 QFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWP 230
Q +R EI + D+P L + + A L L++ +A F++ DG ++D F+V DG P
Sbjct: 696 QATRGGTEIFIWSPDRPYLFAAVCAELDRRNLSVHDAQIFTSRDGMAMDTFIVLEPDGSP 755
Query: 231 YEET--EQLRAALEK 243
+ + +R ALE+
Sbjct: 756 LSQDRHQVIRKALEQ 770
|
Length = 884 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 43/207 (20%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 314 CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373
C + +A +V R ++ E+ + ++ H+N+++ + ++T+
Sbjct: 192 CERLIAKRVKAGSRAAIQLE----NEILALGRLNHENILKIEEILRSEANTYMITQKYDF 247
Query: 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSK----GMNYLHQNNIIHRDLKAANLLMDENEVV 429
+Y +++ +K LLK + K + Y+H +IHRD+K N+ ++ + +
Sbjct: 248 -DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKI 306
Query: 430 KVADFGVA------RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL 483
+ DFG A R G + GT +PE++ Y D++S G++L ++L
Sbjct: 307 VLGDFGTAMPFEKEREAFDYGWV----GTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
Query: 484 TGKLPYEYLTPLQAAVGVVQKGLRPTI 510
+ P+ G K L I
Sbjct: 363 SHD-----FCPIGDGGGKPGKQLLKII 384
|
Length = 501 |
| >gnl|CDD|234709 PRK00275, glnD, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 16/72 (22%), Positives = 31/72 (43%), Gaps = 7/72 (9%)
Query: 186 TDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWPY----EETEQLR 238
D+ + A + + LNI +A ++ ++LD ++V DG P EQ+R
Sbjct: 711 APDQHDFFAATVAAMDQLNLNIHDARIITSSSQFTLDTYIVLDDDGEPIGDNPARIEQIR 770
Query: 239 AALEKEVLKLER 250
L + + +
Sbjct: 771 EGLTEALRNPDD 782
|
Length = 895 |
| >gnl|CDD|235123 PRK03381, PRK03381, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.002
Identities = 19/62 (30%), Positives = 32/62 (51%), Gaps = 3/62 (4%)
Query: 186 TDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVF-VVDGWPYEETEQLRAALEKE 244
D+P LL++L L G++++ A +T+ +DVF V + RAA+E+
Sbjct: 714 AADRPGLLARLARALERAGVDVRWARV-ATLGADVVDVFYVTGAAGGPLADA-RAAVEQA 771
Query: 245 VL 246
VL
Sbjct: 772 VL 773
|
Length = 774 |
| >gnl|CDD|235123 PRK03381, PRK03381, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 36/135 (26%), Positives = 54/135 (40%), Gaps = 26/135 (19%)
Query: 123 VSSLLDSEVPAQRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRP-MHE 181
++L E P P P ALA D VH + + P M E
Sbjct: 560 CRAVLAGEPLP-----EPEPL---DPAQLALA----------ADGGVHVEIAPADPHMVE 601
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD---GWPYEET---E 235
+T D+ LLS+ +LA L ++ A + DG ++ FVV G P + +
Sbjct: 602 VTVVAPDRRGLLSKAAGVLALHRLRVRSASV-RSHDGVAVLEFVVSPRFGSPPDAALLRQ 660
Query: 236 QLRAALEKEVLKLER 250
LR AL+ ++ L R
Sbjct: 661 DLRRALDGDLDVLAR 675
|
Length = 774 |
| >gnl|CDD|225400 COG2844, GlnD, UTP:GlnB (protein PII) uridylyltransferase [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 25/114 (21%), Positives = 39/114 (34%), Gaps = 14/114 (12%)
Query: 134 QRQSIHPPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLL 193
PP L I V S + D+P LL
Sbjct: 756 LSGKAQPPRRRRIPRKLRHFPIPP----------RVTILPTASNDKTVLEVRALDRPGLL 805
Query: 194 SQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLK 247
+ L + AD+GL++ A +T DVF+V + + L A L + +L+
Sbjct: 806 AALAGVFADLGLSLHSAKI-TTFGERVEDVFIVTD---ADGQALNAELRQSLLQ 855
|
Length = 867 |
| >gnl|CDD|233534 TIGR01693, UTase_glnD, [Protein-PII] uridylyltransferase | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 17/51 (33%), Positives = 27/51 (52%), Gaps = 1/51 (1%)
Query: 176 SRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV 226
SR + D+P LL+++ L ++GL+IQ A +T + DVF V
Sbjct: 776 SRKATIMEVRALDRPGLLARVGRTLEELGLSIQSAK-ITTFGEKAEDVFYV 825
|
This model describes GlnD, the uridylyltransferase/uridylyl-removing enzyme for the nitrogen regulatory protein PII. Not all homologs of PII share the property of uridylyltransferase modification on the characteristic Tyr residue (see Prosite pattern PS00496 and document PDOC00439), but the modification site is preserved in the PII homolog of all species with a member of this family [Central intermediary metabolism, Nitrogen metabolism, Regulatory functions, Protein interactions]. Length = 850 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.004
Identities = 18/73 (24%), Positives = 38/73 (52%), Gaps = 6/73 (8%)
Query: 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 425
IV E++ G + D ++ L+++ ++ + + LH IIH DL +N+++
Sbjct: 76 IVMEYIEGEPLKDLINSNG-----MEELELSREIGRLVGKLHSAGIIHGDLTTSNMILSG 130
Query: 426 NEVVKVADFGVAR 438
++ + DFG+A
Sbjct: 131 GKIY-LIDFGLAE 142
|
Length = 211 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 575 | |||
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.65 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.42 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.39 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.37 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.37 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.34 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.28 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.24 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.23 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.22 | |
| cd04928 | 68 | ACT_TyrKc Uncharacterized, N-terminal ACT domain o | 99.21 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.19 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.18 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.05 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.97 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.83 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.76 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.72 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.7 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.64 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.51 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.49 | |
| cd04900 | 73 | ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, | 98.49 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.43 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.4 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.27 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.24 | |
| PRK05092 | 931 | PII uridylyl-transferase; Provisional | 98.2 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.15 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.15 | |
| PRK04374 | 869 | PII uridylyl-transferase; Provisional | 98.13 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.11 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.11 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.1 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.08 | |
| PRK00275 | 895 | glnD PII uridylyl-transferase; Provisional | 98.06 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.06 | |
| cd04927 | 76 | ACT_ACR-like_2 Second ACT domain, of a novel type | 98.04 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.97 | |
| cd04925 | 74 | ACT_ACR_2 ACT domain-containing protein which is c | 97.96 | |
| PRK03059 | 856 | PII uridylyl-transferase; Provisional | 97.95 | |
| PRK05007 | 884 | PII uridylyl-transferase; Provisional | 97.87 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.81 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.76 | |
| PRK01759 | 854 | glnD PII uridylyl-transferase; Provisional | 97.76 | |
| TIGR01693 | 850 | UTase_glnD [Protein-PII] uridylyltransferase. This | 97.74 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.65 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.61 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.47 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.42 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.41 | |
| cd04897 | 75 | ACT_ACR_3 ACT domain-containing protein which is c | 97.4 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.4 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.36 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.29 | |
| cd04926 | 72 | ACT_ACR_4 C-terminal ACT domain, of a novel type o | 97.2 | |
| cd04896 | 75 | ACT_ACR-like_3 ACT domain-containing protein which | 97.1 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.09 | |
| cd04895 | 72 | ACT_ACR_1 ACT domain-containing protein which is c | 97.08 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.08 | |
| PF01842 | 66 | ACT: ACT domain; InterPro: IPR002912 The ACT domai | 97.01 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.94 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.81 | |
| cd04873 | 70 | ACT_UUR-ACR-like ACT domains of the bacterial sign | 96.73 | |
| cd04899 | 70 | ACT_ACR-UUR-like_2 C-terminal ACT domains of the b | 96.63 |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-54 Score=455.36 Aligned_cols=271 Identities=49% Similarity=0.900 Sum_probs=254.5
Q ss_pred CCCCceeeCCCceeeeeeeeecCceEEEEEEECCcc-EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC
Q 008171 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (575)
Q Consensus 282 ~~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~-VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 360 (575)
.....|.|+...+.+.+.||+|+||+||+|.|.++. ||||++.....+....+.|.+|+.+|.+++|||||+|+|+|.+
T Consensus 31 ~~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 31 DELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred ccccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 344678999999999999999999999999999999 9999999876666557899999999999999999999999999
Q ss_pred CC-CceeEEEeccCCchhhhhhh-ccCcCChHHHHHHHHHHHHHHHHHHHCC-ceecccCCCCEEecCCC-cEEEeeccc
Q 008171 361 PP-SLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRDLKAANLLMDENE-VVKVADFGV 436 (575)
Q Consensus 361 ~~-~l~lV~E~~~ggsL~d~l~~-~~~~l~~~~~~~i~~qI~~aL~yLH~~g-IiHrDLKp~NILl~~~~-~vkL~DFG~ 436 (575)
+. .++||||||++|+|.++++. .+..+++..++.|+.||++||.|||+++ ||||||||+|||++.++ ++||+|||+
T Consensus 111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGL 190 (362)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence 88 79999999999999999988 4788999999999999999999999999 99999999999999997 999999999
Q ss_pred ceecccC-CccccCCCCCCccCccccc--CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 008171 437 ARVKAQS-GVMTAETGTYRWMAPEVIE--HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN 513 (575)
Q Consensus 437 a~~~~~~-~~~~~~~Gt~~y~APE~i~--~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~ 513 (575)
++..... ..++...||+.|||||++. ...|+.|+||||||++||||+||+.||..+.+.+.+..++..+.+|.+|..
T Consensus 191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~ 270 (362)
T KOG0192|consen 191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKE 270 (362)
T ss_pred ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence 9988766 4666789999999999999 679999999999999999999999999999999999999999999999999
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhch
Q 008171 514 SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 552 (575)
Q Consensus 514 ~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~~ 552 (575)
+++.+..+|.+||..||..||+|.+++..|+.+......
T Consensus 271 ~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 271 CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 999999999999999999999999999999999987764
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-52 Score=437.10 Aligned_cols=261 Identities=37% Similarity=0.736 Sum_probs=238.5
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEECCc-cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~-~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
.+.|+|+.+.++++++||+|.||.||.|.|.++ +||+|.++...... ..|.+|+.+|++|+|+|||+++++|..+.
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 578999999999999999999999999999987 89999999765443 67889999999999999999999999988
Q ss_pred CceeEEEeccCCchhhhhhh-ccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 363 SLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~-~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
.+|||||||+.|+|.++|+. ....+...+++.++.||+.||+||+++++|||||.++|||++++..+||+|||+|+...
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999999987 45679999999999999999999999999999999999999999999999999999554
Q ss_pred cCCccc--cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 008171 442 QSGVMT--AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 442 ~~~~~~--~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
++.... ..--...|+|||.+....|+.||||||||++||||+| |+.||.+++..+.... +.++.|...|..||+++
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-le~GyRlp~P~~CP~~v 433 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-LERGYRLPRPEGCPDEV 433 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH-HhccCcCCCCCCCCHHH
Confidence 443222 2223678999999999999999999999999999999 9999999999887655 77899999999999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
.++|..||..+|++||||..+...|+++..
T Consensus 434 Y~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 434 YELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred HHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 999999999999999999999999988865
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=404.16 Aligned_cols=250 Identities=32% Similarity=0.551 Sum_probs=225.7
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCC-c
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-L 364 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~-l 364 (575)
.+..++++.++.||+|+.|+||++.+. ++-+|+|++. ...+....+++.+|+.++++.+||+||.+||+|..+.. +
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 466678888999999999999999874 6779999994 34567778899999999999999999999999999985 9
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHH-CCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
+|+||||.||||.+++.. .+.+++..+.+|+.+|++||.|||. .+||||||||+|||++..|.|||||||.++....+
T Consensus 154 sI~mEYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred EeehhhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 999999999999999987 4889999999999999999999995 89999999999999999999999999999877766
Q ss_pred CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhcCCCCCCCCC-CcHH
Q 008171 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL-----TPLQAAVGVVQKGLRPTIPKN-SQPK 517 (575)
Q Consensus 444 ~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~-----~~~~~~~~v~~~~~~~~~p~~-~~~~ 517 (575)
.-.+.+||..|||||.+.+..|+.++||||||++++||++|+.||... ...+....++. ...|..|.. ++++
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~-~ppP~lP~~~fS~e 310 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD-EPPPRLPEGEFSPE 310 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc-CCCCCCCcccCCHH
Confidence 456789999999999999999999999999999999999999999763 55666555554 456788887 9999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 518 LAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 518 l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+++|+.+||++||.+||++.||++
T Consensus 311 f~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 311 FRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhc
Confidence 999999999999999999999984
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=411.76 Aligned_cols=249 Identities=27% Similarity=0.469 Sum_probs=228.7
Q ss_pred CCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCcee
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~l 366 (575)
...+|+.++.||+|+|+.+|+++. +|+.||+|++..... .........+|++|.+.|+|||||+++++|++.+++||
T Consensus 16 ~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 16 RSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred CcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence 346899999999999999999987 688899999987554 34556789999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-Cc
Q 008171 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GV 445 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~ 445 (575)
|.|+|..++|..+++ ..+.++++.++.+++||+.||.|||+++|||||||..|++++++-+|||+|||+|.....+ ..
T Consensus 96 vLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 96 VLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 999999999999998 4789999999999999999999999999999999999999999999999999999887755 56
Q ss_pred cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 008171 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 525 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~c 525 (575)
..+.+|||.|.|||++....++..+||||+|||||-||+|++||+..+-.++...+..... .+|..++.+.++||.++
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y--~~P~~ls~~A~dLI~~l 252 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY--SMPSHLSAEAKDLIRKL 252 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc--ccccccCHHHHHHHHHH
Confidence 6788999999999999999999999999999999999999999999888888877766543 57889999999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 008171 526 WQQDPALRPDFSEIIE 541 (575)
Q Consensus 526 L~~dP~~RPs~~ell~ 541 (575)
|+.||.+|||+++++.
T Consensus 253 L~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 253 LRPNPSERPSLDEVLD 268 (592)
T ss_pred hcCCcccCCCHHHHhc
Confidence 9999999999999984
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=396.54 Aligned_cols=248 Identities=30% Similarity=0.575 Sum_probs=225.0
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
.+|.+.++||+|+||+||+|++ ++..||||.+....++....+-+..|+.+|+.++|||||.+++++...+.+|+|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 4688889999999999999987 45779999999888888888889999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC------CcEEEeecccceecccC
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN------EVVKVADFGVARVKAQS 443 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~------~~vkL~DFG~a~~~~~~ 443 (575)
||.||+|.+|++. .+.+++..+..++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+.....
T Consensus 90 yC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 90 YCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred eCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 9999999999988 6789999999999999999999999999999999999999864 56999999999999887
Q ss_pred CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-CCCCCCCCCCcHHHHHHH
Q 008171 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK-GLRPTIPKNSQPKLAELL 522 (575)
Q Consensus 444 ~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~-~~~~~~p~~~~~~l~~Li 522 (575)
......+|++.|||||++..+.|+.|+|+||+|+|||+|++|+.||+..++.+....+.+. ...+.++..++..+.+++
T Consensus 169 ~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll 248 (429)
T KOG0595|consen 169 SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELL 248 (429)
T ss_pred hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhh
Confidence 7777889999999999999999999999999999999999999999999998887654432 345667777888888999
Q ss_pred HHhhhcCCCCCCCHHHHH
Q 008171 523 ERCWQQDPALRPDFSEII 540 (575)
Q Consensus 523 ~~cL~~dP~~RPs~~ell 540 (575)
...++.++..|-++.+..
T Consensus 249 ~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 249 ISLLQRNPKDRISFEDFF 266 (429)
T ss_pred hHHHhcCccccCchHHhh
Confidence 999999999998876643
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=413.70 Aligned_cols=267 Identities=38% Similarity=0.745 Sum_probs=239.4
Q ss_pred CCCCceeeCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 282 ~~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
+...+|+|..+++.++.+||+|+||+||+|.|.| +||||+++......+..+.|++|+.++++-+|.||+-|.|+|..+
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 3347899999999999999999999999999987 699999999988888999999999999999999999999999998
Q ss_pred CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
+. .||+.+|+|-+|+.+++..+.+|....++.|+.||++||.|||.++|||||||..||++.+++.|||+|||++....
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 86 99999999999999999988999999999999999999999999999999999999999999999999999997654
Q ss_pred cC---CccccCCCCCCccCccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC---CCC
Q 008171 442 QS---GVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT---IPK 512 (575)
Q Consensus 442 ~~---~~~~~~~Gt~~y~APE~i~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~---~p~ 512 (575)
.- .......|...|||||++. ..+|+..+|||||||++|||++|.+||......+.+..+-+..+++. +..
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s 619 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRS 619 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhc
Confidence 42 2344557889999999994 56899999999999999999999999997777776665555434443 446
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 513 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 513 ~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
+|+.++++|+..||.+++++||.|.+|+..|+.++..+
T Consensus 620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred cCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 78889999999999999999999999999999887643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=388.32 Aligned_cols=245 Identities=28% Similarity=0.477 Sum_probs=222.3
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
.+.+++|++.++||+|+||.||.++. +++-+|+|++++.... ....+....|..||.+++||.||+++..|+++..+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 45678999999999999999999965 5677999999876543 34567889999999999999999999999999999
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|+|+||+.||.|.-+|++ .+.+++..+..++.+|+.||.|||++|||||||||+|||+|.+|+++|+|||+++.....+
T Consensus 101 ylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 999999999999999987 7899999999999999999999999999999999999999999999999999998655544
Q ss_pred -ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 008171 445 -VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 523 (575)
Q Consensus 445 -~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~ 523 (575)
.....+||+.|||||++.+.+|+..+|+||||+++|||++|..||...+..+....+.... .+..|...+.+.+++++
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEEARDLLK 258 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHHHHHHHH
Confidence 4455799999999999999999999999999999999999999999999888888877654 35667779999999999
Q ss_pred HhhhcCCCCCC
Q 008171 524 RCWQQDPALRP 534 (575)
Q Consensus 524 ~cL~~dP~~RP 534 (575)
++|+.||++|.
T Consensus 259 ~LL~rdp~~RL 269 (357)
T KOG0598|consen 259 KLLKRDPRQRL 269 (357)
T ss_pred HHhccCHHHhc
Confidence 99999999995
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=394.36 Aligned_cols=251 Identities=24% Similarity=0.408 Sum_probs=216.0
Q ss_pred CCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCCh-----HHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~-----~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
-.+.|.+.+.||+|+||.|-+|.. +++.||||+++...... .......+|+.||++|+|||||++++++..+.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 346788899999999999999965 67889999998654322 12234679999999999999999999999999
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC---CcEEEeeccccee
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN---EVVKVADFGVARV 439 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~---~~vkL~DFG~a~~ 439 (575)
..||||||++||.|.+.+-. ++.+.+..-..+++||+.|+.|||++||+||||||+|||+..+ ..+||+|||+|+.
T Consensus 250 s~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred ceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999999876 5667888888899999999999999999999999999999866 6899999999999
Q ss_pred cccCCccccCCCCCCccCcccccCCCCC---chHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhcC--CCCCCCCC
Q 008171 440 KAQSGVMTAETGTYRWMAPEVIEHKPYD---HKADVFSFGIVLWELLTGKLPYEYLTPLQ-AAVGVVQKG--LRPTIPKN 513 (575)
Q Consensus 440 ~~~~~~~~~~~Gt~~y~APE~i~~~~~s---~ksDVwSlGviL~eLltG~~Pf~~~~~~~-~~~~v~~~~--~~~~~p~~ 513 (575)
......|.+.+||+.|.|||++.++.+. .+.|+||+||+||-+|+|.+||....... ....+.+.. +-|.....
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~ 408 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR 408 (475)
T ss_pred cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence 9888889999999999999999766533 47899999999999999999998766555 344444332 23455678
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 514 SQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 514 ~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
++.+..+||.+||..||++|||+.|+++
T Consensus 409 Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 409 ISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred hhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 8999999999999999999999999874
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-48 Score=377.59 Aligned_cols=253 Identities=25% Similarity=0.463 Sum_probs=222.9
Q ss_pred CCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEe-eecCCCC-ce
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG-ACTKPPS-LC 365 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~-~~~~~~~-l~ 365 (575)
...+|++.++||+|+||+||++.. ++..+|.|.++-+..+....+....|+.+|++|+|||||++++ .+.+.+. ++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 346799999999999999999965 6788999999988888888899999999999999999999998 4555554 89
Q ss_pred eEEEeccCCchhhhhhhc---cCcCChHHHHHHHHHHHHHHHHHHH--CC--ceecccCCCCEEecCCCcEEEeecccce
Q 008171 366 IVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQ--NN--IIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~---~~~l~~~~~~~i~~qI~~aL~yLH~--~g--IiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
||||||.+|+|...++.. +..+++..+|+++.|++.||..+|+ .. |+||||||.||+|+.+|.|||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 999999999999998643 4669999999999999999999999 44 9999999999999999999999999999
Q ss_pred ecccCC-ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC-CCCcH
Q 008171 439 VKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP-KNSQP 516 (575)
Q Consensus 439 ~~~~~~-~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p-~~~~~ 516 (575)
...... .....+|||.||+||++...+|+.||||||+||++|||+.-..||.+.+-.+...++.+.. -+.+| ..++.
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd-~~~~p~~~YS~ 255 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGD-YPPLPDEHYST 255 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCC-CCCCcHHHhhh
Confidence 877654 3346789999999999999999999999999999999999999999998888887766654 44566 78999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 008171 517 KLAELLERCWQQDPALRPDFSEIIEIL 543 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~RPs~~ell~~L 543 (575)
.+..+|..|+..||+.||+.-.++..+
T Consensus 256 ~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 256 DLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred HHHHHHHHHccCCcccCCCcchHHHHH
Confidence 999999999999999999854444333
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=401.82 Aligned_cols=260 Identities=33% Similarity=0.663 Sum_probs=238.9
Q ss_pred CCCCCceeeCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC
Q 008171 281 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (575)
Q Consensus 281 ~~~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 360 (575)
....+.|+|..+.+.-++-||+|+.|.||+|+..++.||||.++.- -..+++-|++|+||||+.|.|+|..
T Consensus 113 ~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 113 QQQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred hhhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecC
Confidence 3456789999888888899999999999999999999999987621 1237889999999999999999999
Q ss_pred CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
.+.+|||||||..|-|+.+|+. ..+++...+..|..+|+.||.|||.+.|||||||.-||||+.+..|||+|||.++..
T Consensus 184 sPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred CceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhh
Confidence 9999999999999999999987 678899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 008171 441 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 520 (575)
Q Consensus 441 ~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~ 520 (575)
..-..+..+.||..|||||+|...+.+.|.|||||||+|||||||..||.+....-++.++-...+....|..|+..|+-
T Consensus 263 ~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gfkl 342 (904)
T KOG4721|consen 263 SDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKL 342 (904)
T ss_pred hhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHH
Confidence 77777788999999999999999999999999999999999999999999998888888888888888999999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 521 LLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 521 Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
||++||+..|.+||+|.+++.-|.=+-.++
T Consensus 343 L~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 343 LLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred HHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 999999999999999999998877544444
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=401.35 Aligned_cols=327 Identities=28% Similarity=0.494 Sum_probs=276.8
Q ss_pred ccchhhcccccCCCCceeEEEEEcCCChhhHHHHHHHHHHHHHHhhhcCCCCCCCCCCCCCCCCCCCCCCCCccccCCCC
Q 008171 204 GLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDG 283 (575)
Q Consensus 204 ~~~i~~a~~f~t~~g~~ldv~vv~g~~~e~~~~l~~al~~~~~~~~~~~~~~~~s~s~~~~~~~~~~~~~~~~~~~p~~~ 283 (575)
-||++.+.+|+.|..-+|+-+ |....++.+|++++.+....++..+|.+.--....+...... .....| ..
T Consensus 31 ~lnvrr~~hf~yVk~eDLl~I---GMgRp~qRRLrea~kkm~~~~k~kswvkKvf~ga~p~h~~~t-----~~~~~p-~~ 101 (1039)
T KOG0199|consen 31 LLNVRRFDHFSYVKDEDLLEI---GMGRPQQRRLREAIKKMSREMKNKSWVKKVFIGADPSHPAQT-----NSVANP-SI 101 (1039)
T ss_pred HhccCchhhhhhcchhhhhhh---ccCcHHHHHHHHHHHHhhhhccccchHHHHhccCCccccccc-----cCCCCc-CC
Confidence 579999999999999999876 999999999999999877766666665432221111100000 001111 23
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEECC---c--cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeee
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS---Q--DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~---~--~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~ 358 (575)
....-|..+++++.++||+|+||.|++|.|+. + .||||+++.+..+. ....|++|+.+|.+|+|||++++||+.
T Consensus 102 ~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvV 180 (1039)
T KOG0199|consen 102 DLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVV 180 (1039)
T ss_pred CcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeee
Confidence 34557888899999999999999999999964 2 49999999876665 568899999999999999999999999
Q ss_pred cCCCCceeEEEeccCCchhhhhhh-ccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccc
Q 008171 359 TKPPSLCIVTEFMSGGSVYDYLHK-LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (575)
Q Consensus 359 ~~~~~l~lV~E~~~ggsL~d~l~~-~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a 437 (575)
.+ ..+.||||++++|||.+.|++ .+..|....+..++.||+.||.||.++++|||||..+|||+-....|||+|||++
T Consensus 181 l~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLm 259 (1039)
T KOG0199|consen 181 LD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLM 259 (1039)
T ss_pred cc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccce
Confidence 88 668899999999999999988 5677999999999999999999999999999999999999999999999999999
Q ss_pred eecccCCccccCC----CCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 008171 438 RVKAQSGVMTAET----GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK 512 (575)
Q Consensus 438 ~~~~~~~~~~~~~----Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~ 512 (575)
+-......+.... -.+.|||||.+++..|+.++|||+|||+||||++ |..||.+....++...+- .+.+..-|+
T Consensus 260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk 338 (1039)
T KOG0199|consen 260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPK 338 (1039)
T ss_pred eccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCC
Confidence 9877765443222 3678999999999999999999999999999999 999999999999887755 788889999
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 008171 513 NSQPKLAELLERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 513 ~~~~~l~~Li~~cL~~dP~~RPs~~ell~~ 542 (575)
.|+..++++|..||..+|.+||+|..|.+.
T Consensus 339 ~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 339 YCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred CChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 999999999999999999999999999743
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=390.02 Aligned_cols=252 Identities=25% Similarity=0.438 Sum_probs=225.7
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCCh-HHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~-~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~ 363 (575)
.-...+|++++.||.|+|++||+|+. +++.||||++.+..... ...+-+..|-.+|.+| .||.|++|+..|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 44567999999999999999999976 56779999998765533 2345577899999999 79999999999999999
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
+|+|+||+++|.|.++|++ .|.|++..+..++.+|+.||+|||++|||||||||+|||+|.++++||+|||.|+.....
T Consensus 149 LYFvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred eEEEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 9999999999999999988 589999999999999999999999999999999999999999999999999999865542
Q ss_pred Cc--------------cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC
Q 008171 444 GV--------------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT 509 (575)
Q Consensus 444 ~~--------------~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~ 509 (575)
.. ....+||..|++||++.....+..+|+|+||||||.|+.|.+||.+.+...+...++.-. ..
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~--y~ 305 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD--YE 305 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc--cc
Confidence 11 134789999999999999999999999999999999999999999999988888877644 46
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 008171 510 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 510 ~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~ 542 (575)
+|...++.+++|++++|..||.+|+++.||.+-
T Consensus 306 fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 306 FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred CCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 899999999999999999999999999888753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=385.20 Aligned_cols=262 Identities=34% Similarity=0.660 Sum_probs=222.2
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeee
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC 358 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~ 358 (575)
|.+..++|++.++||+|+||.||+|.+. ++.||||+++... .......+.+|+.+++++ +||||++++++|
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 7888899999999999999999999742 3569999987542 333456789999999999 899999999988
Q ss_pred cCC-CCceeEEEeccCCchhhhhhhcc-----------------------------------------------------
Q 008171 359 TKP-PSLCIVTEFMSGGSVYDYLHKLK----------------------------------------------------- 384 (575)
Q Consensus 359 ~~~-~~l~lV~E~~~ggsL~d~l~~~~----------------------------------------------------- 384 (575)
... ..+++||||++||+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 45899999999999999986531
Q ss_pred --------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc---cccCCCCC
Q 008171 385 --------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTY 453 (575)
Q Consensus 385 --------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~Gt~ 453 (575)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .....+++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 2477788899999999999999999999999999999999999999999999975433211 12234568
Q ss_pred CccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 008171 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 532 (575)
Q Consensus 454 ~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~ 532 (575)
.|+|||++.+..++.++|||||||+||||++ |..||......+.....+..+..+..+..+++++.+++.+||+.||.+
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 320 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE 320 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence 8999999999999999999999999999997 999998866555455555556666778889999999999999999999
Q ss_pred CCCHHHHHHHHHHHHHH
Q 008171 533 RPDFSEIIEILQQIAKE 549 (575)
Q Consensus 533 RPs~~ell~~L~~l~~~ 549 (575)
|||+.++++.|++++++
T Consensus 321 RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 321 RPTFSALVEILGDLLQE 337 (338)
T ss_pred CcCHHHHHHHHHHHHhc
Confidence 99999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=379.17 Aligned_cols=251 Identities=29% Similarity=0.524 Sum_probs=218.6
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC--Ccee
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP--SLCI 366 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~--~l~l 366 (575)
..++..++.||+|+||.||++++. ++..|||.+..... ...+.+.+|+.+|++++|||||+++|...... .++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 356777899999999999999886 58899999886522 12567889999999999999999999744433 6899
Q ss_pred EEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC-CCcEEEeecccceeccc---
Q 008171 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKAQ--- 442 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~--- 442 (575)
.|||++||+|.+++.+..+.++++.+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||.+.....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999999999999987668999999999999999999999999999999999999999 79999999999976653
Q ss_pred -CCccccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 008171 443 -SGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEY-LTPLQAAVGVVQKGLRPTIPKNSQPKLA 519 (575)
Q Consensus 443 -~~~~~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~-~~~~~~~~~v~~~~~~~~~p~~~~~~l~ 519 (575)
........||+.|||||++..+ ..+.++|||||||++.||+||+.||.. ....+....+......|.+|..++++.+
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~ 253 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAK 253 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHH
Confidence 2234456899999999999863 333599999999999999999999998 6666777777777777899999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHH
Q 008171 520 ELLERCWQQDPALRPDFSEIIEIL 543 (575)
Q Consensus 520 ~Li~~cL~~dP~~RPs~~ell~~L 543 (575)
+||.+|+.+||.+||||.++++--
T Consensus 254 ~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 254 DFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred HHHHHHhhcCcccCcCHHHHhhCh
Confidence 999999999999999999998653
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=392.71 Aligned_cols=268 Identities=34% Similarity=0.657 Sum_probs=243.8
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEECC-----cc-EEEEEecCC-CCChHHHHHHHHHHHHHHhcCCCCceEEEe
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QD-VAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-----~~-VAvKvl~~~-~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~ 356 (575)
...|++..++..+.++||+|+||.||+|++.- .. ||||..+.+ ........+|.+|+++|++++|||||++||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 45699999999999999999999999998632 23 899999863 366778899999999999999999999999
Q ss_pred eecCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccc
Q 008171 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436 (575)
Q Consensus 357 ~~~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~ 436 (575)
++.....++||||+|.||+|.++|++..+.++......++.+.+.||+|||++++|||||..+|+|++.++.+||+|||+
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccc
Confidence 99999999999999999999999999777899999999999999999999999999999999999999999999999999
Q ss_pred ceecccCCccc-cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 008171 437 ARVKAQSGVMT-AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 514 (575)
Q Consensus 437 a~~~~~~~~~~-~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~ 514 (575)
++......... ..--..+|+|||.+....|+.++|||||||++||+++ |..||.++...+....++..+.+...|...
T Consensus 309 s~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~ 388 (474)
T KOG0194|consen 309 SRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKT 388 (474)
T ss_pred ccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCC
Confidence 97665222222 2235689999999999999999999999999999999 899999999999999988999999999999
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 515 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 515 ~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
+.++..++.+||..+|+.||++.++.+.|+.+.....
T Consensus 389 p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 389 PKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 9999999999999999999999999999999987655
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=383.04 Aligned_cols=249 Identities=29% Similarity=0.570 Sum_probs=224.1
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCC---hHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN---SDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP 362 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~---~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~ 362 (575)
.....|.+++.||+|+||.||+|.. ++..||||++...... ......+.+|+.+++.++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4457899999999999999999976 5788999988765222 133456678999999999 999999999999999
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC-CcEEEeecccceec-
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVK- 440 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~-~~vkL~DFG~a~~~- 440 (575)
.+|+||||+.||.|++++.+ .+++++..+.+++.||+.|++|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999999999999999998 8999999999999999999999999999999999999999999 99999999999988
Q ss_pred ccCCccccCCCCCCccCcccccCCC-CC-chHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC-cHH
Q 008171 441 AQSGVMTAETGTYRWMAPEVIEHKP-YD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS-QPK 517 (575)
Q Consensus 441 ~~~~~~~~~~Gt~~y~APE~i~~~~-~s-~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~-~~~ 517 (575)
.........+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||...+.......+... ...+|..+ +++
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~--~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG--EFKIPSYLLSPE 250 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC--CccCCCCcCCHH
Confidence 4667788899999999999999988 87 6899999999999999999999998877777664433 34688888 999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHH
Q 008171 518 LAELLERCWQQDPALRPDFSEII 540 (575)
Q Consensus 518 l~~Li~~cL~~dP~~RPs~~ell 540 (575)
++.|+.+||..||.+|+++.+++
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHh
Confidence 99999999999999999999998
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=367.18 Aligned_cols=259 Identities=22% Similarity=0.390 Sum_probs=225.6
Q ss_pred eeeCCCceeee--eeeeecCceEEEEEEECCccEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCCceEEEeeecC---
Q 008171 287 WEIDPKHLKFG--SKVASGSYGDLYRGTYCSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTK--- 360 (575)
Q Consensus 287 ~~i~~~~~~i~--~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--- 360 (575)
+.|+.++++.. ..||+|++|.||+|.+.++.||||+++...... ...+.|.+|+.+|++++||||+++++++.+
T Consensus 13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~ 92 (283)
T PHA02988 13 KCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92 (283)
T ss_pred eecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence 34555555555 679999999999999999999999998654332 335778899999999999999999999866
Q ss_pred -CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHC-CceecccCCCCEEecCCCcEEEeecccce
Q 008171 361 -PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 361 -~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~-gIiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
...+++||||++||+|.+++.+ ...+++...+.++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++
T Consensus 93 ~~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 93 DLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEK 171 (283)
T ss_pred CCCceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHh
Confidence 4568999999999999999976 46789999999999999999999984 99999999999999999999999999997
Q ss_pred ecccCCccccCCCCCCccCcccccC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 008171 439 VKAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 516 (575)
Q Consensus 439 ~~~~~~~~~~~~Gt~~y~APE~i~~--~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~ 516 (575)
..... .....||..|+|||++.+ ..++.++|||||||++|||++|..||...+..+....+.....++.+|..+++
T Consensus 172 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 249 (283)
T PHA02988 172 ILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPL 249 (283)
T ss_pred hhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcH
Confidence 54432 234568999999999976 68999999999999999999999999999888877777777777778888999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 517 KLAELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
++.++|.+||+.||.+|||+.++++.|+.+..
T Consensus 250 ~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 250 EIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999988753
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=358.51 Aligned_cols=239 Identities=27% Similarity=0.476 Sum_probs=219.9
Q ss_pred CCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCcee
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~l 366 (575)
..++|.+.+.||.|+||.|.+++. .+..+|+|+++...+ .-...+...+|..+|+.+.||.++++++.|.+...+||
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 346788899999999999999976 467799999987644 33455678899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcc
Q 008171 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 446 (575)
||||++||.|..++++ .++|+++.+..++.||+.||+|||+++|++|||||+|||||.+|.+||+|||+|+..... .
T Consensus 122 vmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T 198 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--T 198 (355)
T ss_pred EEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--E
Confidence 9999999999999988 688999999999999999999999999999999999999999999999999999876654 5
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 526 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL 526 (575)
.+.+|||.|+|||++..++|+.++|+|+||+++|||+.|.+||...++.++..+++...+ .+|...++.+++|+.++|
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v--~fP~~fs~~~kdLl~~LL 276 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV--KFPSYFSSDAKDLLKKLL 276 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc--cCCcccCHHHHHHHHHHH
Confidence 577999999999999999999999999999999999999999999999999999888765 588999999999999999
Q ss_pred hcCCCCC
Q 008171 527 QQDPALR 533 (575)
Q Consensus 527 ~~dP~~R 533 (575)
+.|-.+|
T Consensus 277 ~vD~t~R 283 (355)
T KOG0616|consen 277 QVDLTKR 283 (355)
T ss_pred hhhhHhh
Confidence 9999888
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=369.87 Aligned_cols=257 Identities=32% Similarity=0.534 Sum_probs=226.1
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
...|-++.+.|++.++||.|..++||+|.+ .++.||||++..+..+.+ ...+.+|+..|+.++||||++++..|...
T Consensus 18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 456788899999999999999999999987 578899999998877666 68899999999999999999999999999
Q ss_pred CCceeEEEeccCCchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
..+|+||.||.+||+.+++... ...+.+..+..|++++++||.|||++|.||||||+.||||+.+|.|||+|||++-..
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 9999999999999999999754 566999999999999999999999999999999999999999999999999998765
Q ss_pred ccCCc-----cccCCCCCCccCcccc--cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC------
Q 008171 441 AQSGV-----MTAETGTYRWMAPEVI--EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR------ 507 (575)
Q Consensus 441 ~~~~~-----~~~~~Gt~~y~APE~i--~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~------ 507 (575)
...+. ....+||++|||||++ ....|+.|+||||||++..||.+|..||..+.|.+....-++....
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~ 256 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG 256 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence 55541 1455899999999996 3457999999999999999999999999999999988766654321
Q ss_pred --CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 --PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 --~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.......+..++.++..||++||.+|||++++++
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1122345678999999999999999999999984
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=385.61 Aligned_cols=268 Identities=31% Similarity=0.641 Sum_probs=241.9
Q ss_pred CCCceeeCCCceeeeeeeeecCceEEEEEEECCc------cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEe
Q 008171 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ------DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356 (575)
Q Consensus 283 ~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~------~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~ 356 (575)
+...+++........++||.|.||.||.|.|..- .||||..+.+... +..+.|++|+.+|+.++|||||+++|
T Consensus 380 ~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMrnfdHphIikLIG 458 (974)
T KOG4257|consen 380 TVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMRNFDHPHIIKLIG 458 (974)
T ss_pred CCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHHhCCCcchhheee
Confidence 3456788888899999999999999999998642 2999999976443 34788999999999999999999999
Q ss_pred eecCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccc
Q 008171 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436 (575)
Q Consensus 357 ~~~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~ 436 (575)
+|.+.+ .+||||+++-|.|..||+..+..++...+..+++||+.||.|||+++++||||..+|||+.....|||+|||+
T Consensus 459 v~~e~P-~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 459 VCVEQP-MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred eeeccc-eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccch
Confidence 998764 8999999999999999999889999999999999999999999999999999999999999999999999999
Q ss_pred ceecccCCccccCCC--CCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 008171 437 ARVKAQSGVMTAETG--TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN 513 (575)
Q Consensus 437 a~~~~~~~~~~~~~G--t~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~ 513 (575)
+|...+.....+..| ...|||||.++...++.++|||.||++|||++. |..||.+....+.+ ..+.++.|+..|++
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-~~iEnGeRlP~P~n 616 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-GHIENGERLPCPPN 616 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-EEecCCCCCCCCCC
Confidence 999888776665555 568999999999999999999999999999988 99999998877665 44778899999999
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhchh
Q 008171 514 SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE 553 (575)
Q Consensus 514 ~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~~~ 553 (575)
|||.|+.|+.+||.++|.+||.|.+|...|.+++++-...
T Consensus 617 CPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~ 656 (974)
T KOG4257|consen 617 CPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKIN 656 (974)
T ss_pred CChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhh
Confidence 9999999999999999999999999999999999855443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=399.28 Aligned_cols=265 Identities=31% Similarity=0.601 Sum_probs=234.4
Q ss_pred CCCCceeeCCCceeeeeeeeecCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEE
Q 008171 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354 (575)
Q Consensus 282 ~~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l 354 (575)
......+|...+.++.++||+|+||.||+|+..+ +-||||.++.. .+.+.+++|.+|+.+|..++|||||+|
T Consensus 476 ~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrL 554 (774)
T KOG1026|consen 476 PDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRL 554 (774)
T ss_pred CccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEE
Confidence 3456778999999999999999999999998643 34999999965 345578999999999999999999999
Q ss_pred EeeecCCCCceeEEEeccCCchhhhhhhc-------------cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCE
Q 008171 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKL-------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 421 (575)
Q Consensus 355 ~~~~~~~~~l~lV~E~~~ggsL~d~l~~~-------------~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NI 421 (575)
+|+|..++.+|||+|||..|+|.+||... +.+++..+.+.||.||+.||.||-++.++||||..+|+
T Consensus 555 lGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNC 634 (774)
T KOG1026|consen 555 LGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNC 634 (774)
T ss_pred EEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhc
Confidence 99999999999999999999999999643 12378889999999999999999999999999999999
Q ss_pred EecCCCcEEEeecccceecccCCccc---cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 008171 422 LMDENEVVKVADFGVARVKAQSGVMT---AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 497 (575)
Q Consensus 422 Ll~~~~~vkL~DFG~a~~~~~~~~~~---~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~ 497 (575)
||+++-.|||+|||+++..-....+. ...-..+|||||.|..+.|+.+||||||||+|||+++ |..||.+++..++
T Consensus 635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV 714 (774)
T KOG1026|consen 635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV 714 (774)
T ss_pred eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH
Confidence 99999999999999998544332222 1234689999999999999999999999999999999 9999999999998
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 498 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 498 ~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
+..+-+..+ ...|.+||.++++||..||+.+|.+||+|+||-..|++..+
T Consensus 715 Ie~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 715 IECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 877666555 78999999999999999999999999999999999988754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=359.80 Aligned_cols=249 Identities=27% Similarity=0.415 Sum_probs=216.4
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
+.|+.+.++|+|+||.||+++. +|+-||||.+.....+....+-.++|+++|++++|+|+|.++.+|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4677788999999999999975 67889999998777677777888999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc-cCCcccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~-~~~~~~~ 448 (575)
||.. ++.+-|..+...++...+.+++.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+... .+...+.
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD 160 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD 160 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence 9955 6777777778889999999999999999999999999999999999999999999999999999888 4456778
Q ss_pred CCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-------------------CCCC
Q 008171 449 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK-------------------GLRP 508 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~-------------------~~~~ 508 (575)
.+.|.+|.|||.+.+ ..|+...|||++||++.||++|.+-|.+.+..+....+... +++.
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l 240 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL 240 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence 889999999999977 78999999999999999999999999988776665544311 1111
Q ss_pred CCC----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 TIP----------KNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 ~~p----------~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+-| ...+.-+.+|+++||..||++|++.+|++.
T Consensus 241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111 234567889999999999999999999983
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=374.04 Aligned_cols=250 Identities=23% Similarity=0.367 Sum_probs=217.2
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
+..++|.+++.||+|+||.||+++. +|+.+|+|++++... ..+..+.++.|..+|...+.|+||+++..|++..++|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 3557889999999999999999965 678899999987644 4456678999999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc---
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ--- 442 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~--- 442 (575)
|||||++||++..+|.+ .+.|++..+..++.+++.|++.||+.|||||||||+|+|||..|++||+|||++.-...
T Consensus 218 LiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999999999987 78999999999999999999999999999999999999999999999999999842110
Q ss_pred ------------------CCccc---------------------------cCCCCCCccCcccccCCCCCchHHHHHHHH
Q 008171 443 ------------------SGVMT---------------------------AETGTYRWMAPEVIEHKPYDHKADVFSFGI 477 (575)
Q Consensus 443 ------------------~~~~~---------------------------~~~Gt~~y~APE~i~~~~~s~ksDVwSlGv 477 (575)
..... ..+|||.|||||++.++.|+..+|+|||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 00000 126999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCC---HHHHH
Q 008171 478 VLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAELLERCWQQDPALRPD---FSEII 540 (575)
Q Consensus 478 iL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p--~~~~~~l~~Li~~cL~~dP~~RPs---~~ell 540 (575)
||||||.|.+||...++.++...++.......+| ..++++..+||.+||. ||++|.. +.||.
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 9999999999999999999998887654323333 4678999999999999 9999974 55554
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=355.89 Aligned_cols=256 Identities=30% Similarity=0.579 Sum_probs=222.2
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC-----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~-----~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 363 (575)
|+.++|++.+.||+|+||.||+|++. +..||+|.++... .......|.+|+.++++++||||+++++++...+.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 66788999999999999999999753 4569999998653 33445679999999999999999999999999999
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
.|+||||+++++|.+++....+.+++..++.++.||+.||.|||++|++||||||+|||++.++.++++|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999999876678999999999999999999999999999999999999999999999999987654322
Q ss_pred Cccc--cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 008171 444 GVMT--AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 520 (575)
Q Consensus 444 ~~~~--~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~ 520 (575)
.... ...++..|+|||++.+..++.++|||||||++|||++ |..||...+..+.... +..+..+..+..++..+.+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA-VEDGFRLPAPRNCPNLLHQ 239 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH-HHCCCCCCCCCCCCHHHHH
Confidence 2111 2345678999999999999999999999999999875 9999998887665544 3455566678889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 521 LLERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 521 Li~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
++.+||+.+|.+||++.+|++.|.++
T Consensus 240 li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 240 LMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 99999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=380.33 Aligned_cols=245 Identities=31% Similarity=0.594 Sum_probs=224.0
Q ss_pred CceeeeeeeeecCceEEEEEE--ECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~--~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|.+.+.||+|+||.||+|+ ++.+.||||.+.+..-.....+.+.+|++|+++++|||||.++++|+...++++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 578888999999999999996 456789999998777777778889999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
|+.| +|..++.. .+.++++.+..|++|++.||.|||+++|+|||+||.|||++..+.+|+||||+|+.+.... ..+.
T Consensus 82 ~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts 159 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS 159 (808)
T ss_pred hhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence 9977 99999987 7899999999999999999999999999999999999999999999999999999887765 4456
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 528 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~ 528 (575)
..|||.|||||++.+++|+..+|+||+|||+|||+.|++||...+-.+....++....+ .|...+..+.+|++.+|.+
T Consensus 160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~--~p~~~S~~f~nfl~gLL~k 237 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK--PPSTASSSFVNFLQGLLIK 237 (808)
T ss_pred ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC--CcccccHHHHHHHHHHhhc
Confidence 67999999999999999999999999999999999999999988877777777665543 4568999999999999999
Q ss_pred CCCCCCCHHHHH
Q 008171 529 DPALRPDFSEII 540 (575)
Q Consensus 529 dP~~RPs~~ell 540 (575)
||.+|.+-.+++
T Consensus 238 dP~~RltW~~Ll 249 (808)
T KOG0597|consen 238 DPAQRLTWTDLL 249 (808)
T ss_pred ChhhcccHHHHh
Confidence 999999998887
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=379.59 Aligned_cols=246 Identities=30% Similarity=0.553 Sum_probs=219.9
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
..|.-..+||+|+.|.||.+.. .++.||||.+....... .+-+.+|+.+|+..+|+|||++++.|...+.+++|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 3567778999999999999976 45679999988654433 3457899999999999999999999988899999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
||+||+|.|.+.. ..+++.++..|++++++||+|||.+||||||||.+|||++.+|.+||+|||++....... ....
T Consensus 351 ym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T 428 (550)
T KOG0578|consen 351 YMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST 428 (550)
T ss_pred ecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence 9999999999976 458999999999999999999999999999999999999999999999999998766654 4567
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhh
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~~~~p~~~~~~l~~Li~~cL~ 527 (575)
.+|||+|||||++..+.|+.|.||||||++++||+-|.+||-..+|.++...+...+. +...+..+++.|++|+.+||+
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~ 508 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLV 508 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhh
Confidence 7899999999999999999999999999999999999999999999998877665442 334577899999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 008171 528 QDPALRPDFSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs~~ell~ 541 (575)
.|+++|+++.|||+
T Consensus 509 ~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 509 VDVEQRASAKELLE 522 (550)
T ss_pred cchhcCCCHHHHhc
Confidence 99999999999985
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=382.87 Aligned_cols=246 Identities=31% Similarity=0.543 Sum_probs=226.5
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCC-CCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~-~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
-|++++-||.|+.|.|-+|++ +|+.+|||++... .........+.+|+.||+.+.||||+++|++|++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 467789999999999999987 6889999999765 4445556778899999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccccC
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 449 (575)
|++||.|++++-. +|++++..+.+++.||+.|+.|+|..+|+||||||+|+|++..+.|||+|||+|.....+....+.
T Consensus 93 yv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTS 171 (786)
T KOG0588|consen 93 YVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETS 171 (786)
T ss_pred ecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcccccc
Confidence 9999999999987 799999999999999999999999999999999999999999999999999999998888888999
Q ss_pred CCCCCccCcccccCCCCC-chHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 008171 450 TGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 528 (575)
Q Consensus 450 ~Gt~~y~APE~i~~~~~s-~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~ 528 (575)
||++.|.|||++.|.+|+ .++||||.|||||.||+|++||++.+-.....++.+..+ .+|..+++++.+||++||..
T Consensus 172 CGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f--~MPs~Is~eaQdLLr~ml~V 249 (786)
T KOG0588|consen 172 CGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF--EMPSNISSEAQDLLRRMLDV 249 (786)
T ss_pred CCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc--cCCCcCCHHHHHHHHHHhcc
Confidence 999999999999999996 589999999999999999999998888777777555433 67899999999999999999
Q ss_pred CCCCCCCHHHHHH
Q 008171 529 DPALRPDFSEIIE 541 (575)
Q Consensus 529 dP~~RPs~~ell~ 541 (575)
||.+|.|..||++
T Consensus 250 Dp~~RiT~~eI~k 262 (786)
T KOG0588|consen 250 DPSTRITTEEILK 262 (786)
T ss_pred CccccccHHHHhh
Confidence 9999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=374.79 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=220.6
Q ss_pred CCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCC-Cce
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP-SLC 365 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~-~l~ 365 (575)
-.++|.+.++||.|+||.||+|+. .++.||||.++......+. -.-++|++.|++|+ |||||++.+++.+.. .+|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 357899999999999999999975 5678999999977655433 23467999999999 999999999998887 899
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 445 (575)
+||||| ..+|+++++.++..|++..+..|+.||++||+|+|++|++||||||+|||+.....|||+|||+||.......
T Consensus 87 fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP 165 (538)
T ss_pred eeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC
Confidence 999999 6699999998888999999999999999999999999999999999999999889999999999999888888
Q ss_pred cccCCCCCCccCcccc-cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-------------------
Q 008171 446 MTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG------------------- 505 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i-~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~------------------- 505 (575)
.+.++.|.+|.|||++ ...-|+.+.|||++|||++|+++-++-|.+.+..+.+.+++.--
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn 245 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN 245 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence 9999999999999998 55679999999999999999999999999988887777665211
Q ss_pred CC-C--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 008171 506 LR-P--------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 506 ~~-~--------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~ 542 (575)
++ | .+-.++++++.++|.+|+.+||.+|||+.|.++.
T Consensus 246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 10 0 0113478999999999999999999999998863
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=402.27 Aligned_cols=263 Identities=35% Similarity=0.660 Sum_probs=234.6
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEECC---c----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS---Q----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~~---~----~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 360 (575)
++..+..++.+.||+|+||.||.|.+.+ . .||||.++.. .+.+...+|.+|+.+|++++|||||+++|+|.+
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 3667889999999999999999999853 2 2888888754 345667889999999999999999999999999
Q ss_pred CCCceeEEEeccCCchhhhhhhc------cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeec
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKL------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~------~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DF 434 (575)
....+|++|||+||+|..||++. ...++...++.|+.||++||.||+++++|||||..+|+|++....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999887 567999999999999999999999999999999999999999999999999
Q ss_pred ccceecccCCc--cccC-CCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 008171 435 GVARVKAQSGV--MTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTI 510 (575)
Q Consensus 435 G~a~~~~~~~~--~~~~-~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~ 510 (575)
|+|+..-.... .... .-..+|||||.+..+.|+.|+|||||||+|||+++ |..||...++.+....++..+ |...
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~ 925 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDP 925 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCC
Confidence 99994333221 1122 33579999999999999999999999999999999 999999999999988777766 9999
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhch
Q 008171 511 PKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 552 (575)
Q Consensus 511 p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~~ 552 (575)
|..|+..++++|..||+.+|++||+|..|++.+..+.+....
T Consensus 926 P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 926 PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 999999999999999999999999999999999999886653
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=372.91 Aligned_cols=263 Identities=32% Similarity=0.633 Sum_probs=225.6
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEE
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI 355 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~ 355 (575)
.+.|.+..++|++++.||+|+||.||++.+. +..||||+++... ..+....+.+|+.+++.+ +|+||++++
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 3578888899999999999999999998752 2369999998653 234456788999999999 899999999
Q ss_pred eeecCCCCceeEEEeccCCchhhhhhhcc---------------------------------------------------
Q 008171 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLK--------------------------------------------------- 384 (575)
Q Consensus 356 ~~~~~~~~l~lV~E~~~ggsL~d~l~~~~--------------------------------------------------- 384 (575)
++|...+.+|+||||+++|+|.+++....
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 99999999999999999999999985421
Q ss_pred ------------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcc
Q 008171 385 ------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446 (575)
Q Consensus 385 ------------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 446 (575)
..+++..+++++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 24677889999999999999999999999999999999999999999999999765433221
Q ss_pred ---ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 008171 447 ---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 522 (575)
Q Consensus 447 ---~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li 522 (575)
....++..|+|||++.+..++.++|||||||++|+|++ |..||...............+..+..+...++++.++|
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 348 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIM 348 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHH
Confidence 12235678999999999999999999999999999997 99999887666555566666667777778899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHH
Q 008171 523 ERCWQQDPALRPDFSEIIEILQQIA 547 (575)
Q Consensus 523 ~~cL~~dP~~RPs~~ell~~L~~l~ 547 (575)
.+||+.||.+||++.++++.|++++
T Consensus 349 ~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=373.77 Aligned_cols=262 Identities=30% Similarity=0.612 Sum_probs=224.8
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEE
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI 355 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~ 355 (575)
...|.+..++|+++++||+|+||.||+|++. +..||||+++.... ......+.+|+.+|+.+ +||||++++
T Consensus 27 ~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~ 105 (375)
T cd05104 27 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLL 105 (375)
T ss_pred ccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeee
Confidence 3567888889999999999999999999742 34699999975432 33456788999999999 899999999
Q ss_pred eeecCCCCceeEEEeccCCchhhhhhhcc---------------------------------------------------
Q 008171 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLK--------------------------------------------------- 384 (575)
Q Consensus 356 ~~~~~~~~l~lV~E~~~ggsL~d~l~~~~--------------------------------------------------- 384 (575)
++|......++||||++||+|.+++....
T Consensus 106 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (375)
T cd05104 106 GACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK 185 (375)
T ss_pred eeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence 99999999999999999999999986432
Q ss_pred -----------------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 385 -----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 385 -----------------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 146778889999999999999999999999999999999999999999999997654
Q ss_pred cCCcc---ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 008171 442 QSGVM---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 517 (575)
Q Consensus 442 ~~~~~---~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~ 517 (575)
..... ....++..|+|||++.+..++.++|||||||++|||++ |..||............+..+.++..|...+.+
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSE 345 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHH
Confidence 43221 12234678999999999999999999999999999998 899998877666666667777777777788999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 518 LAELLERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 518 l~~Li~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
+.++|.+||+.||.+||++.++++.|++.
T Consensus 346 l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 346 MYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=376.31 Aligned_cols=260 Identities=38% Similarity=0.726 Sum_probs=237.5
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEECCc--cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ--DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~--~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
+.|+++..++.+..+||-|.||.||.|.|..- .||||.++.+. ....+|+.|+.+|+.+.|||+|+++|+|+.+.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 89999999999999999999999999999754 59999998653 34689999999999999999999999999999
Q ss_pred CceeEEEeccCCchhhhhhhccC-cCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~-~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
.+|||+|||..|+|.+||+.++. .++.-.+++++.||..||.||..+++|||||..+|+|+.++..|||+|||+++.+.
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 99999999999999999998754 46777788999999999999999999999999999999999999999999999876
Q ss_pred cCCccccCCC---CCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 008171 442 QSGVMTAETG---TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 517 (575)
Q Consensus 442 ~~~~~~~~~G---t~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~ 517 (575)
.. .+++..| ...|.|||-+..+.++.|+|||+||++|||+.| |-.||.+.+..+. .+.+.+++|..-|..|++.
T Consensus 417 gD-TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV-Y~LLEkgyRM~~PeGCPpk 494 (1157)
T KOG4278|consen 417 GD-TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YGLLEKGYRMDGPEGCPPK 494 (1157)
T ss_pred CC-ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH-HHHHhccccccCCCCCCHH
Confidence 54 3444444 578999999999999999999999999999999 9999999987765 4678999999999999999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 518 LAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 518 l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
+++||+.||+..|.+||+|.|+-+.++.++++
T Consensus 495 VYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 495 VYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred HHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 99999999999999999999999999998764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=374.50 Aligned_cols=246 Identities=27% Similarity=0.434 Sum_probs=222.2
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEECC--ccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCC
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP 362 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~--~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~ 362 (575)
..+..++|++.++||+|+||.|+++..++ +.+|||+++++.. ..+..+....|.+|+.... ||.+++++..|+...
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 36777899999999999999999998854 5699999998654 5566778888999998886 999999999999999
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc-
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA- 441 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~- 441 (575)
++|+||||+.||++..+.+ .+.|++..+..++..|+.||.|||++||||||||.+|||+|.+|++||+|||+++...
T Consensus 443 ~l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred eEEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 9999999999999655553 4889999999999999999999999999999999999999999999999999998765
Q ss_pred cCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 008171 442 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521 (575)
Q Consensus 442 ~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~L 521 (575)
......+.+||+.|||||++.+..|+.+.|+|+|||+|||||.|..||.+.+..+....++.. .+.+|..++.+..++
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d--~~~yP~~ls~ea~~i 598 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND--EVRYPRFLSKEAIAI 598 (694)
T ss_pred CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCcccHHHHHH
Confidence 444566789999999999999999999999999999999999999999999999988887765 456899999999999
Q ss_pred HHHhhhcCCCCCCCH
Q 008171 522 LERCWQQDPALRPDF 536 (575)
Q Consensus 522 i~~cL~~dP~~RPs~ 536 (575)
|+++|.+||++|..+
T Consensus 599 l~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 599 MRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHhccCcccccCC
Confidence 999999999999754
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=358.49 Aligned_cols=245 Identities=23% Similarity=0.401 Sum_probs=214.6
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|++.++||+|+||.||++... ++.||+|++..... .......+.+|+.++++++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999875 77899999875432 2234566889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 448 (575)
||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~ 157 (291)
T cd05612 81 EYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWT 157 (291)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--ccc
Confidence 99999999999976 567899999999999999999999999999999999999999999999999999765432 234
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 528 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~ 528 (575)
..||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+... ...+|..+++.+.++|++||+.
T Consensus 158 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~ 235 (291)
T cd05612 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--KLEFPRHLDLYAKDLIKKLLVV 235 (291)
T ss_pred ccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcCCCccCCHHHHHHHHHHcCC
Confidence 57999999999999999999999999999999999999999988877766655543 3457778899999999999999
Q ss_pred CCCCCCC-----HHHHHH
Q 008171 529 DPALRPD-----FSEIIE 541 (575)
Q Consensus 529 dP~~RPs-----~~ell~ 541 (575)
||.+||+ +.++++
T Consensus 236 dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 236 DRTRRLGNMKNGADDVKN 253 (291)
T ss_pred CHHHccCCccCCHHHHhc
Confidence 9999995 777763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=350.06 Aligned_cols=247 Identities=37% Similarity=0.723 Sum_probs=211.5
Q ss_pred eeeeeeeecCceEEEEEEEC------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 295 KFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 295 ~i~~~LG~G~fG~Vy~~~~~------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++.+.||.|+||.||+|++. +..|+||+++.. ........|.+|+.++++++||||++++|++...+.+++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccc
Confidence 56789999999999999987 467999999753 34455788999999999999999999999999888899999
Q ss_pred EeccCCchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC---
Q 008171 369 EFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--- 444 (575)
Q Consensus 369 E~~~ggsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~--- 444 (575)
||+++|+|.+++... ...+++..++.|+.||+.||.|||+++|+|++|+++|||++.++.+||+|||++.......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999886 5779999999999999999999999999999999999999999999999999998763221
Q ss_pred ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 008171 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 523 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~ 523 (575)
......+...|+|||.+....++.++||||||+++|||++ |+.||...+..+....+ .++.++.++..++..+.++|.
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~ 239 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSLIQ 239 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHHHH
Confidence 1223456789999999988889999999999999999999 78999999887766665 666677788899999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHH
Q 008171 524 RCWQQDPALRPDFSEIIEIL 543 (575)
Q Consensus 524 ~cL~~dP~~RPs~~ell~~L 543 (575)
+||..||.+||++.++++.|
T Consensus 240 ~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 240 QCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHT-SSGGGS--HHHHHHHH
T ss_pred HHcCCChhhCcCHHHHHhcC
Confidence 99999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=353.46 Aligned_cols=254 Identities=32% Similarity=0.593 Sum_probs=211.1
Q ss_pred CCCceeeeeeeeecCceEEEEEEEC------------------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCc
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTYC------------------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~~------------------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnI 351 (575)
...+|++.++||+|+||.||++.+. +..||+|++.... .......|.+|+.++++++||||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCe
Confidence 4568899999999999999999752 2359999988643 34456789999999999999999
Q ss_pred eEEEeeecCCCCceeEEEeccCCchhhhhhhcc------------------CcCChHHHHHHHHHHHHHHHHHHHCCcee
Q 008171 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413 (575)
Q Consensus 352 v~l~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~------------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiH 413 (575)
+++++++...+..|+||||+.+++|.+++.... ..+++..+++++.||+.||.|||++||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999899999999999999999985421 24677889999999999999999999999
Q ss_pred cccCCCCEEecCCCcEEEeecccceecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc--CCCC
Q 008171 414 RDLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLP 488 (575)
Q Consensus 414 rDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt--G~~P 488 (575)
|||||+|||++.++.+||+|||+++....... .....++..|+|||++.+..++.++||||||+++|+|++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999975433221 122345789999999998899999999999999999986 6788
Q ss_pred CCCCCHHHHHHHHHh---c---CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 008171 489 YEYLTPLQAAVGVVQ---K---GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 544 (575)
Q Consensus 489 f~~~~~~~~~~~v~~---~---~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~ 544 (575)
|...+..+....+.. . ......+..++..+.++|.+||+.||.+|||+.+|.+.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 987776655433221 1 1123345678899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=369.18 Aligned_cols=264 Identities=32% Similarity=0.622 Sum_probs=226.7
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEE
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFI 355 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~ 355 (575)
.+.|+++..+|.++++||+|+||.||+|++.+ ..||||+++... .......+.+|+.+|+++. ||||++++
T Consensus 29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence 36789999999999999999999999998632 259999997542 3344567999999999996 99999999
Q ss_pred eeecCCCCceeEEEeccCCchhhhhhhcc---------------------------------------------------
Q 008171 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLK--------------------------------------------------- 384 (575)
Q Consensus 356 ~~~~~~~~l~lV~E~~~ggsL~d~l~~~~--------------------------------------------------- 384 (575)
++|...+.+|||||||++|+|.+++....
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (400)
T cd05105 108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ 187 (400)
T ss_pred EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence 99999999999999999999999886531
Q ss_pred --------------------------------------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCC
Q 008171 385 --------------------------------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (575)
Q Consensus 385 --------------------------------------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~N 420 (575)
..+++..++.++.||+.||.|||+++|+||||||+|
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N 267 (400)
T cd05105 188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN 267 (400)
T ss_pred cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence 236777889999999999999999999999999999
Q ss_pred EEecCCCcEEEeecccceecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 008171 421 LLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496 (575)
Q Consensus 421 ILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~ 496 (575)
||++.++.+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 9999999999999999976543221 122346788999999999999999999999999999997 999998876655
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 497 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 497 ~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
.....+..+.++..+..+++++.+++.+||+.||++||++.+|.+.|+++++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 5555566666777788899999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=343.24 Aligned_cols=251 Identities=35% Similarity=0.674 Sum_probs=217.4
Q ss_pred eCCCceeeeeeeeecCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~~-~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
++.++|++.++||+|+||.||++.+.. ..+|+|.++..... ...+.+|+.++++++||||+++++++......|+|
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred CCHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 356789999999999999999998854 47999988754332 35688899999999999999999999999999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc--
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-- 445 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-- 445 (575)
|||++||+|.+++....+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||.++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999999999986566789999999999999999999999999999999999999999999999999875433221
Q ss_pred cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 008171 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~ 524 (575)
.....++..|+|||++.+..++.++|+||||+++|+|++ |+.||...+..+....+.. +.++..|...+..+.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHH
Confidence 122345678999999998899999999999999999999 9999998887776655443 44555677788999999999
Q ss_pred hhhcCCCCCCCHHHHHHHH
Q 008171 525 CWQQDPALRPDFSEIIEIL 543 (575)
Q Consensus 525 cL~~dP~~RPs~~ell~~L 543 (575)
||+.+|.+||++.++++.|
T Consensus 237 c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 237 CWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HccCCcccCcCHHHHHHhh
Confidence 9999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=352.30 Aligned_cols=249 Identities=21% Similarity=0.343 Sum_probs=209.5
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
.|++.+.||+|+||.||++.. +++.||+|++...... ......+.+|+.++++++|+||+++++++...+.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367889999999999999976 5788999998755332 2334567899999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcccc
Q 008171 370 FMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 448 (575)
|+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 999999998876533 4689999999999999999999999999999999999999999999999999987554444455
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--hcCCCCCCCCCCcHHHHHHHHHhh
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV--QKGLRPTIPKNSQPKLAELLERCW 526 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~--~~~~~~~~p~~~~~~l~~Li~~cL 526 (575)
..||..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+. .......++..+++++.+|+++||
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 240 (285)
T cd05631 161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL 240 (285)
T ss_pred CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHh
Confidence 679999999999999999999999999999999999999998755422211111 122234567788999999999999
Q ss_pred hcCCCCCCC-----HHHHHH
Q 008171 527 QQDPALRPD-----FSEIIE 541 (575)
Q Consensus 527 ~~dP~~RPs-----~~ell~ 541 (575)
+.||.+||+ ++++++
T Consensus 241 ~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 241 TKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred hcCHHHhcCCCCCCHHHHhc
Confidence 999999997 677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=362.87 Aligned_cols=246 Identities=27% Similarity=0.422 Sum_probs=215.8
Q ss_pred CCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCcee
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~l 366 (575)
..++|++.+.||+|+||.||++++. ++.||||+++.... .......+.+|+.++++++||||+++++++...+.+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 3468999999999999999999874 67799999875432 22345678899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcc
Q 008171 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 446 (575)
||||+.|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 96 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~ 172 (329)
T PTZ00263 96 LLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--T 172 (329)
T ss_pred EEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--c
Confidence 9999999999999976 567899999999999999999999999999999999999999999999999999765433 2
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 526 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL 526 (575)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...++.+....+... ...+|..+++.+.+||.+||
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L 250 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RLKFPNWFDGRARDLVKGLL 250 (329)
T ss_pred ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CcCCCCCCCHHHHHHHHHHh
Confidence 3457999999999999999999999999999999999999999988887766655543 34577789999999999999
Q ss_pred hcCCCCCCC-----HHHHH
Q 008171 527 QQDPALRPD-----FSEII 540 (575)
Q Consensus 527 ~~dP~~RPs-----~~ell 540 (575)
+.||.+||+ +.+++
T Consensus 251 ~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 251 QTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred hcCHHHcCCCCCCCHHHHh
Confidence 999999996 57766
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=362.07 Aligned_cols=241 Identities=26% Similarity=0.462 Sum_probs=209.9
Q ss_pred eeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCC
Q 008171 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~gg 374 (575)
+.||+|+||.||++.. .++.||||+++.... .......+.+|+.++++++||||+++++++...+.+|+||||++|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 467899999985432 2334567889999999999999999999999999999999999999
Q ss_pred chhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-CccccCCCCC
Q 008171 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGTY 453 (575)
Q Consensus 375 sL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~Gt~ 453 (575)
+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||+
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 159 (323)
T cd05571 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence 99999876 567899999999999999999999999999999999999999999999999998753322 2344567999
Q ss_pred CccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 008171 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 533 (575)
Q Consensus 454 ~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~R 533 (575)
.|+|||++.+..++.++|||||||++|||++|..||...+.......+... ...+|..+++++.++|.+||+.||.+|
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 999999999999999999999999999999999999887776655544433 346778899999999999999999999
Q ss_pred C-----CHHHHHH
Q 008171 534 P-----DFSEIIE 541 (575)
Q Consensus 534 P-----s~~ell~ 541 (575)
| ++.++++
T Consensus 238 ~~~~~~~~~~ll~ 250 (323)
T cd05571 238 LGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCCHHHHHc
Confidence 9 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=347.98 Aligned_cols=255 Identities=31% Similarity=0.622 Sum_probs=219.5
Q ss_pred eCCCceeeeeeeeecCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~~-------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
+...+|++.+.||+|+||.||+|...+ ..||+|.++... .......|.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 345678999999999999999998643 359999987543 344567799999999999999999999999998
Q ss_pred CCceeEEEeccCCchhhhhhhcc---------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~---------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~ 426 (575)
...|++|||+++++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 89999999999999999986531 457888999999999999999999999999999999999999
Q ss_pred CcEEEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 008171 427 EVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502 (575)
Q Consensus 427 ~~vkL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~ 502 (575)
+.++|+|||+++...... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.++.+.... +
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~-i 239 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM-I 239 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-H
Confidence 999999999997543322 2233456889999999988899999999999999999998 9999998887665544 4
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 008171 503 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 545 (575)
Q Consensus 503 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~ 545 (575)
.....+..+..+++++.+|+.+||+.||.+||++.++++.|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 4455566788999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=366.99 Aligned_cols=247 Identities=33% Similarity=0.562 Sum_probs=219.5
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
..|...++||+|+||.||+|.+ +++.||||++..+.. .+....+.+|+.+|.+++++||.++|+.+.....++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 3566678999999999999987 467799999997754 3446789999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc-ccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-MTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~ 448 (575)
||.||++.+.+.. .+.+.+..+..++++++.|+.|||..+.+|||||+.|||+..+|.|||+|||++........ ...
T Consensus 92 y~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t 170 (467)
T KOG0201|consen 92 YCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT 170 (467)
T ss_pred HhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence 9999999999976 45558888999999999999999999999999999999999999999999999976655432 367
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 528 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~ 528 (575)
.+||+.|||||++.+..|+.|+||||||++.+||++|.+||....|.....- +.+...|.+...+++.+++|+..||.+
T Consensus 171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-Ipk~~PP~L~~~~S~~~kEFV~~CL~k 249 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-IPKSAPPRLDGDFSPPFKEFVEACLDK 249 (467)
T ss_pred ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-ccCCCCCccccccCHHHHHHHHHHhhc
Confidence 7899999999999999999999999999999999999999999998655433 344556677778999999999999999
Q ss_pred CCCCCCCHHHHHH
Q 008171 529 DPALRPDFSEIIE 541 (575)
Q Consensus 529 dP~~RPs~~ell~ 541 (575)
||+.||+|.+|++
T Consensus 250 ~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 250 NPEFRPSAKELLK 262 (467)
T ss_pred CcccCcCHHHHhh
Confidence 9999999999985
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=364.54 Aligned_cols=251 Identities=26% Similarity=0.419 Sum_probs=217.9
Q ss_pred CCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC--CCce
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLC 365 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~~l~ 365 (575)
..+.|+.+++||+|.||.||+|++ +++.||+|.+..+...........+||.||++|+||||+++.+..... +.+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 345788899999999999999987 567799999998877777778889999999999999999999998766 6899
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~- 444 (575)
||+|||+ .+|.-++....-+|+++++..+++||+.||+|||.+||+|||||.+|||||.+|.+||+|||+|++.....
T Consensus 195 lVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 195 LVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred EEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 9999995 58888887766689999999999999999999999999999999999999999999999999999666543
Q ss_pred -ccccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-----------------
Q 008171 445 -VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG----------------- 505 (575)
Q Consensus 445 -~~~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~----------------- 505 (575)
.++..+-|.+|.|||++.+. .|+.+.|+||.||||.||+.|++.|.+.+..+....+....
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~ 353 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT 353 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence 67888899999999998765 69999999999999999999999999988776665554321
Q ss_pred -CCCCC---------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 506 -LRPTI---------PKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 506 -~~~~~---------p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+++.. ...+++...+|+..+|..||.+|.|+.+.+.
T Consensus 354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111 1455788999999999999999999998873
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=342.33 Aligned_cols=255 Identities=34% Similarity=0.676 Sum_probs=221.1
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
|.|+.++|++.++||+|+||.||+|.+. ++.||+|.+..... ..+.+.+|+.+++.++|+||+++++.+......+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 7788999999999999999999999864 46699999875432 2467899999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 366 IVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
++|||+++++|.+++... ...+++..++.++.||+.||.|||+++++||||||+||+++.++.++|+|||+++......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999999999999754 3568889999999999999999999999999999999999999999999999998654432
Q ss_pred c--cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 008171 445 V--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521 (575)
Q Consensus 445 ~--~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~L 521 (575)
. .....++..|+|||++.+..++.++|||||||++|+|++ |..||........... +....+...+..++.++.++
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l 236 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA-LQRGYRMPRMENCPDELYDI 236 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHHHHH
Confidence 1 122345678999999998999999999999999999998 9999988777665544 34445555666789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHH
Q 008171 522 LERCWQQDPALRPDFSEIIEILQQ 545 (575)
Q Consensus 522 i~~cL~~dP~~RPs~~ell~~L~~ 545 (575)
+.+||..+|++||+++++++.|++
T Consensus 237 i~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 237 MKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHHccCCcccCcCHHHHHHHHhc
Confidence 999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=342.30 Aligned_cols=256 Identities=37% Similarity=0.713 Sum_probs=222.6
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
|+++..+|.+.++||.|+||.||+|.+. ++.||+|+++... .....+.+|+.+++.++||||+++++++...+.+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 6788889999999999999999999874 6779999987542 2346788999999999999999999999999999
Q ss_pred eeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 365 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||++++++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999999999999987543 45889999999999999999999999999999999999999999999999999765433
Q ss_pred Ccc--ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 008171 444 GVM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 520 (575)
Q Consensus 444 ~~~--~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~ 520 (575)
... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+... .......+..+..+++++.+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKGYRMERPEGCPPKVYE 236 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCCCCCCCCCCHHHHH
Confidence 211 11234568999999999999999999999999999998 999998877655443 34556677788899999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 521 LLERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 521 Li~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
++.+||+.||.+||++.++++.|+.+
T Consensus 237 li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 237 LMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHccCCcccCCCHHHHHHHHHhh
Confidence 99999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=360.50 Aligned_cols=248 Identities=24% Similarity=0.359 Sum_probs=213.6
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|++.++||+|+||.||+|.+ +++.||||+++..... ......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 3688999999999999999987 4678999999854322 234567889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 448 (575)
||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 81 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~ 157 (333)
T cd05600 81 EYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANS 157 (333)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCC
Confidence 99999999999976 56789999999999999999999999999999999999999999999999999975543 2345
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC---CCCCC---CCCcHHHHHHH
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL---RPTIP---KNSQPKLAELL 522 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~---~~~~p---~~~~~~l~~Li 522 (575)
..||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+..... .+... ..+++++.++|
T Consensus 158 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li 237 (333)
T cd05600 158 VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLI 237 (333)
T ss_pred cccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHH
Confidence 6799999999999999999999999999999999999999998887766554443221 11111 25689999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 008171 523 ERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 523 ~~cL~~dP~~RPs~~ell~~ 542 (575)
.+||..+|.+||++.++++.
T Consensus 238 ~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 238 TKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHhhChhhhcCCHHHHHhC
Confidence 99999999999999999853
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=359.83 Aligned_cols=262 Identities=33% Similarity=0.639 Sum_probs=222.8
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEee
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGA 357 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~ 357 (575)
.|.+..++|++.+.||.|+||.||+|... ++.||+|+++... .......+.+|+.+++++ +|+||++++++
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 37888899999999999999999999643 2569999987543 233456788899999999 79999999998
Q ss_pred ecC-CCCceeEEEeccCCchhhhhhhcc----------------------------------------------------
Q 008171 358 CTK-PPSLCIVTEFMSGGSVYDYLHKLK---------------------------------------------------- 384 (575)
Q Consensus 358 ~~~-~~~l~lV~E~~~ggsL~d~l~~~~---------------------------------------------------- 384 (575)
|.. ...++++|||+++++|.+++....
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 754 456889999999999999985421
Q ss_pred --------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc---cccCCCCC
Q 008171 385 --------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTY 453 (575)
Q Consensus 385 --------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~Gt~ 453 (575)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....... .....++.
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 2578889999999999999999999999999999999999999999999999976533221 12234567
Q ss_pred CccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 008171 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 532 (575)
Q Consensus 454 ~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~ 532 (575)
.|+|||++.+..++.++|||||||++|||++ |..||......+.....+..+.++..+..+++++.+++.+||+.+|.+
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 319 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPED 319 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhh
Confidence 8999999999999999999999999999998 999998766555555566666677778888999999999999999999
Q ss_pred CCCHHHHHHHHHHHHH
Q 008171 533 RPDFSEIIEILQQIAK 548 (575)
Q Consensus 533 RPs~~ell~~L~~l~~ 548 (575)
||++.|+++.|+++++
T Consensus 320 RPs~~ell~~l~~~~~ 335 (337)
T cd05054 320 RPTFSELVEILGDLLQ 335 (337)
T ss_pred CcCHHHHHHHHHHHHh
Confidence 9999999999999886
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=356.49 Aligned_cols=252 Identities=28% Similarity=0.421 Sum_probs=211.9
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCCh------------HHHHHHHHHHHHHHhcCCCCceEE
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS------------DMQKEFAQEVFIMRKVRHKNVVQF 354 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~------------~~~~~~~~Ev~iL~~L~HpnIv~l 354 (575)
...++|++++.||+|+||.|-+|.. .++.||||++.+..... ...+...+|+.||+++.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4457999999999999999999977 46779999997543221 113578999999999999999999
Q ss_pred EeeecCC--CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEe
Q 008171 355 IGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA 432 (575)
Q Consensus 355 ~~~~~~~--~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~ 432 (575)
+.+..++ ..+|||+|||..|.+...-.. +..+++.++++++.+++.||+|||.+|||||||||+|+|++++|+|||+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 9998765 469999999998887654322 2238999999999999999999999999999999999999999999999
Q ss_pred ecccceecccC------CccccCCCCCCccCcccccCC---CC-CchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 008171 433 DFGVARVKAQS------GVMTAETGTYRWMAPEVIEHK---PY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (575)
Q Consensus 433 DFG~a~~~~~~------~~~~~~~Gt~~y~APE~i~~~---~~-s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~ 502 (575)
|||++...... .......|||.|+|||...++ .| +.+.||||+||+||.|+.|+.||.+....+...+++
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 99999766332 123345899999999998662 23 457899999999999999999999999999999998
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 503 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 503 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
...+.......+.+.+++||.+||.+||++|.+..+|..
T Consensus 333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 887754444567899999999999999999999988754
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=351.61 Aligned_cols=258 Identities=30% Similarity=0.607 Sum_probs=221.1
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE--CCc----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~----~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
+...+|++.+.||+|+||.||+|++ .++ .||||+++.. ........+.+|+.+++.++||||++++++|...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 4567899999999999999999986 333 3899998743 2334557799999999999999999999999764
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
..++|+||+.+|+|.+++......++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 57899999999999999987667789999999999999999999999999999999999999999999999999986543
Q ss_pred CCcc---ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 008171 443 SGVM---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 443 ~~~~---~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
.... ....++..|+|||++.+..++.++||||||+++|||++ |..||.+....+. ..++....+...+..++..+
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPICTIDV 240 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCCCCCCCCCHHH
Confidence 3221 12234678999999999999999999999999999997 9999988776554 34556666666778889999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
.+++.+||..+|.+||++.+++..|..+.++
T Consensus 241 ~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 241 YMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 9999999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=361.82 Aligned_cols=250 Identities=26% Similarity=0.392 Sum_probs=217.9
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEECC---ccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS---QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~---~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
+.+..++|++.++||+|+||.||+|++.+ ..||+|++..... .......+.+|+.+++.++||||+++++++...+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 35677889999999999999999998643 4699999864322 2334567889999999999999999999999999
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
.+|+||||+.||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999999976 56789999999999999999999999999999999999999999999999999976543
Q ss_pred CCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 008171 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 522 (575)
Q Consensus 443 ~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li 522 (575)
. .....||+.|+|||++.+..++.++|||||||++|||++|..||...++......+.... ..+|..+++.+.++|
T Consensus 184 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li 259 (340)
T PTZ00426 184 R--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--IYFPKFLDNNCKHLM 259 (340)
T ss_pred C--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHH
Confidence 2 334579999999999999999999999999999999999999999888876666655433 346788899999999
Q ss_pred HHhhhcCCCCCC-----CHHHHHH
Q 008171 523 ERCWQQDPALRP-----DFSEIIE 541 (575)
Q Consensus 523 ~~cL~~dP~~RP-----s~~ell~ 541 (575)
++||+.||.+|+ +++++++
T Consensus 260 ~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 260 KKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred HHHcccCHHHcCCCCCCCHHHHHc
Confidence 999999999995 7888765
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=379.37 Aligned_cols=262 Identities=33% Similarity=0.624 Sum_probs=237.9
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEEC--C---ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--S---QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~---~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 360 (575)
..+|+.+..+|.++||.|.||+||+|..+ + ..||||.+|... .+....+|+.|+.||-+..||||++|.|+.++
T Consensus 623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 34899999999999999999999999763 3 359999999764 45567899999999999999999999999999
Q ss_pred CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
...+.||+|||++|+|+.||++..+.|+.-++.-+++.|+.||.||-..|++||||.++|||++.+-.+||+|||++|+.
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999977
Q ss_pred ccCC--ccccCC--CCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 008171 441 AQSG--VMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 515 (575)
Q Consensus 441 ~~~~--~~~~~~--Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~ 515 (575)
.++. ..+..- -..+|.|||.|....++.++||||||++|||.++ |..||=.++..+.+.. +.+++|...|-+||
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka-Ie~gyRLPpPmDCP 860 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA-IEQGYRLPPPMDCP 860 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH-HHhccCCCCCCCCc
Confidence 5543 122222 2579999999999999999999999999999988 9999999998887765 66789999999999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 516 PKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 516 ~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
..|.+||..||++|-.+||.|.||+..|.++++.
T Consensus 861 ~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 861 AALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 9999999999999999999999999999998763
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=340.91 Aligned_cols=256 Identities=35% Similarity=0.642 Sum_probs=221.5
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC-----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~-----~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 363 (575)
|+.++|++.+.||+|+||.||+|.+. ...||||+++... .......|.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred CChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 35678999999999999999999874 2369999987543 34445678999999999999999999999999999
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
.++||||+++++|.+++....+.+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++.....
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999999876778999999999999999999999999999999999999999999999999999876421
Q ss_pred -Cccc--cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 008171 444 -GVMT--AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 519 (575)
Q Consensus 444 -~~~~--~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~ 519 (575)
.... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+ ........+..+++.+.
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~ 238 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV-EDGYRLPPPMDCPSALY 238 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHH
Confidence 1111 2344678999999999999999999999999999998 99999887766655443 44455566778899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 520 ELLERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 520 ~Li~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
+++.+||+.+|.+||++.++++.|+++
T Consensus 239 ~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 239 QLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=362.74 Aligned_cols=248 Identities=25% Similarity=0.398 Sum_probs=215.3
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|.+.++||+|+||.||++... ++.||||+++..... ......+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36889999999999999999885 788999999754332 244567889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC----
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---- 444 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~---- 444 (575)
||++|++|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 999999999999874 789999999999999999999999999999999999999999999999999997654432
Q ss_pred --------------------------ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 008171 445 --------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA 498 (575)
Q Consensus 445 --------------------------~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~ 498 (575)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 223456899999999999999999999999999999999999999998877776
Q ss_pred HHHHh--cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-HHHHHH
Q 008171 499 VGVVQ--KGLRPTIPKNSQPKLAELLERCWQQDPALRPD-FSEIIE 541 (575)
Q Consensus 499 ~~v~~--~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs-~~ell~ 541 (575)
..+.. ..........+++++.++|.+||. ||.+||+ +.++++
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 66655 222222223469999999999997 9999999 999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=348.30 Aligned_cols=249 Identities=22% Similarity=0.341 Sum_probs=207.3
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.+.||+|+||.||++++. ++.||+|+++...........+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36889999999999999999884 5679999998665545556778899999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC--ccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMT 447 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~--~~~ 447 (575)
|++++.+..+. .....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 99887665544 445679999999999999999999999999999999999999999999999999997654322 223
Q ss_pred cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-------------------C-C
Q 008171 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-------------------L-R 507 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~-------------------~-~ 507 (575)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.... . .
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07848 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239 (287)
T ss_pred ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence 4578999999999999999999999999999999999999998876544332221100 0 0
Q ss_pred C----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 P----------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 ~----------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+ .....+++++.+||.+||+.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 011236788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=363.67 Aligned_cols=263 Identities=33% Similarity=0.645 Sum_probs=227.6
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEE
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFI 355 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~ 355 (575)
...|++..++|.++++||+|+||.||+|++.+ ..||+|+++... .......+.+|+.+|.++. ||||++++
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~ 107 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLL 107 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence 34599999999999999999999999998643 469999998643 2333457889999999997 99999999
Q ss_pred eeecCCCCceeEEEeccCCchhhhhhhcc---------------------------------------------------
Q 008171 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLK--------------------------------------------------- 384 (575)
Q Consensus 356 ~~~~~~~~l~lV~E~~~ggsL~d~l~~~~--------------------------------------------------- 384 (575)
++|...+..|+||||+++|+|.++++...
T Consensus 108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 99999999999999999999999986532
Q ss_pred ----------------------------------------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCC
Q 008171 385 ----------------------------------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418 (575)
Q Consensus 385 ----------------------------------------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp 418 (575)
..+++..++.++.||+.||.|||+++|+||||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp 267 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA 267 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence 1356677889999999999999999999999999
Q ss_pred CCEEecCCCcEEEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCH
Q 008171 419 ANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 494 (575)
Q Consensus 419 ~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~ 494 (575)
+|||++.++.+||+|||+++...... ......+++.|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999999999999997643322 1123356788999999999999999999999999999998 8999988777
Q ss_pred HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 008171 495 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA 547 (575)
Q Consensus 495 ~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~ 547 (575)
.+.....+..+.++..|..++.++.+++.+||+.+|.+||++++|++.|++++
T Consensus 348 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 66666667777777888889999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=337.83 Aligned_cols=254 Identities=39% Similarity=0.738 Sum_probs=223.3
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCcee
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~l 366 (575)
|.++.++|++.+.||.|+||.||++...++.||+|.++.... ..+.+.+|+.+++.++|+||+++++++......|+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 567778999999999999999999999999999999986532 45778999999999999999999999998889999
Q ss_pred EEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc
Q 008171 367 VTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 445 (575)
||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||.++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 999999999999997643 368999999999999999999999999999999999999999999999999997663322
Q ss_pred cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 008171 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~ 524 (575)
....++..|+|||.+....++.++||||||+++|+|++ |..||...+..+... .+....++..+..+++++.++|.+
T Consensus 157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~ 234 (256)
T cd05039 157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-HVEKGYRMEAPEGCPPEVYKVMKD 234 (256)
T ss_pred -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHhcCCCCCCccCCCHHHHHHHHH
Confidence 23345678999999988889999999999999999997 999998876655443 344555667788899999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHH
Q 008171 525 CWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 525 cL~~dP~~RPs~~ell~~L~~l 546 (575)
||..+|.+||++.++++.|+++
T Consensus 235 ~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 235 CWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HhccChhhCcCHHHHHHHHhcC
Confidence 9999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=339.70 Aligned_cols=252 Identities=36% Similarity=0.685 Sum_probs=217.5
Q ss_pred eCCCceeeeeeeeecCceEEEEEEECCc-cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~~~-~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
|+.++|++.+.||+|+||.||+|.+.+. .+|||.++..... ...+.+|+.++++++||||+++++++.....+++|
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred CChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 3567899999999999999999988654 5999998754332 35689999999999999999999999988889999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcc-
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM- 446 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~- 446 (575)
|||+.+++|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||.++........
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999999999775567899999999999999999999999999999999999999999999999998765443221
Q ss_pred -ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 008171 447 -TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524 (575)
Q Consensus 447 -~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~ 524 (575)
....++..|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+ ....++..+...+..+.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV-SQGLRLYRPHLASEKVYAIMYS 236 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-hcCCCCCCCCCCCHHHHHHHHH
Confidence 12235678999999998889999999999999999998 99999888776655544 3455566677789999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHH
Q 008171 525 CWQQDPALRPDFSEIIEILQ 544 (575)
Q Consensus 525 cL~~dP~~RPs~~ell~~L~ 544 (575)
||+.||.+||++.++++.|+
T Consensus 237 cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 237 CWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HcCCCcccCCCHHHHHHhhC
Confidence 99999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=333.71 Aligned_cols=250 Identities=22% Similarity=0.366 Sum_probs=216.8
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
.+|...++||+|.||.||+|++ +|+.||||.++.............+|++.|+.++|+||+.++++|...+.+-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999987 57889999999887666666778999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
|| ..+|+..++.....++...+..++.++++|++|||++.|+||||||.|+||+.+|.+||+|||+++...... ..+.
T Consensus 82 fm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~ 160 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH 160 (318)
T ss_pred ec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence 99 569999999888889999999999999999999999999999999999999999999999999999877654 3344
Q ss_pred CCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--------------------
Q 008171 449 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-------------------- 507 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~-------------------- 507 (575)
.+-|..|.|||.+.+ +.|+...|+||.|||+.||+-|.+-|.+.+..+....+..--..
T Consensus 161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~ 240 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQ 240 (318)
T ss_pred ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhc
Confidence 578999999998855 67999999999999999999999888888777665554421100
Q ss_pred -C-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 008171 508 -P-----TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 508 -~-----~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~ 542 (575)
| .+...++..+.+|+.+||.+||.+|++++|.++.
T Consensus 241 ~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 241 FPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0 1234557788999999999999999999998753
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=338.50 Aligned_cols=245 Identities=28% Similarity=0.579 Sum_probs=212.8
Q ss_pred eeeecCceEEEEEEE----CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCC
Q 008171 299 KVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (575)
Q Consensus 299 ~LG~G~fG~Vy~~~~----~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~gg 374 (575)
+||+|+||.||+|.+ ++..+|+|+++...........+.+|+.+++.++||||+++++++.. ...++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 689999999999975 35679999998765556667889999999999999999999998864 4679999999999
Q ss_pred chhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc----cccCC
Q 008171 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV----MTAET 450 (575)
Q Consensus 375 sL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~----~~~~~ 450 (575)
+|.+++.. ...+++..++.++.||+.||.|||++||+||||||.||+++.++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 81 PLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 99999975 46789999999999999999999999999999999999999999999999999976543321 12223
Q ss_pred CCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcC
Q 008171 451 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 529 (575)
Q Consensus 451 Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~d 529 (575)
++..|+|||.+....++.++|+|||||++|||++ |..||...+..+... .+..+..+.+|..+++++.++|.+||+.|
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ-MIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 4678999999988889999999999999999998 999999877765544 45566667788899999999999999999
Q ss_pred CCCCCCHHHHHHHHHHH
Q 008171 530 PALRPDFSEIIEILQQI 546 (575)
Q Consensus 530 P~~RPs~~ell~~L~~l 546 (575)
|.+||++.+|.+.|++.
T Consensus 239 p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 239 VDERPGFAVVELRLRNY 255 (257)
T ss_pred chhCcCHHHHHHHHhcc
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=356.39 Aligned_cols=241 Identities=25% Similarity=0.464 Sum_probs=209.0
Q ss_pred eeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCC
Q 008171 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~gg 374 (575)
+.||+|+||.||++.. .++.||+|+++.... .......+.+|+.+++.++||||+++++++.....+|+||||++|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999986 467899999986432 2334566788999999999999999999999999999999999999
Q ss_pred chhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc-CCccccCCCCC
Q 008171 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTY 453 (575)
Q Consensus 375 sL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~~~~Gt~ 453 (575)
+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||+
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 159 (323)
T cd05595 81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence 99988876 56789999999999999999999999999999999999999999999999999875322 22334567999
Q ss_pred CccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 008171 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 533 (575)
Q Consensus 454 ~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~R 533 (575)
.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.... ..+|..+++++.++|.+||+.||.+|
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred CcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 9999999999999999999999999999999999998887766655544433 35678899999999999999999999
Q ss_pred C-----CHHHHHH
Q 008171 534 P-----DFSEIIE 541 (575)
Q Consensus 534 P-----s~~ell~ 541 (575)
| ++.++++
T Consensus 238 ~~~~~~~~~~~l~ 250 (323)
T cd05595 238 LGGGPSDAKEVME 250 (323)
T ss_pred CCCCCCCHHHHHc
Confidence 8 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=338.73 Aligned_cols=253 Identities=36% Similarity=0.702 Sum_probs=219.3
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeee-cCCCCce
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC-TKPPSLC 365 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~-~~~~~l~ 365 (575)
|.++..+|++.+.||+|+||.||++...+..||+|.++... ..+.+.+|+.++++++|+|++++++++ ......|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 66788899999999999999999999999999999987432 245788999999999999999999975 4556789
Q ss_pred eEEEeccCCchhhhhhhccC-cCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 366 IVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~-~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
+||||+++++|.+++.+... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~- 155 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 155 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc-
Confidence 99999999999999976443 4889999999999999999999999999999999999999999999999998754332
Q ss_pred ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 008171 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 523 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~ 523 (575)
.....++..|+|||++.+..++.++|||||||++|+|++ |+.||......+.... +.....+..+..+++.+.+++.
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~ 233 (256)
T cd05082 156 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPVVYDVMK 233 (256)
T ss_pred -CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCCCCCCCCCCHHHHHHHH
Confidence 123345678999999999999999999999999999997 9999987776555443 4445666777889999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHH
Q 008171 524 RCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 524 ~cL~~dP~~RPs~~ell~~L~~l 546 (575)
+||+.+|.+|||+.++++.|+++
T Consensus 234 ~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 234 QCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHhcCChhhCcCHHHHHHHHhcC
Confidence 99999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=337.91 Aligned_cols=255 Identities=37% Similarity=0.678 Sum_probs=220.8
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
|++..++|++.++||+|+||.||+|.+. ++.||+|.++..... ...+.+|+.++++++||||+++++++...+..|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 6788889999999999999999999874 457999998865432 456889999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
+||||+.|++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999999997643 468999999999999999999999999999999999999999999999999998665332
Q ss_pred ccc--cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 008171 445 VMT--AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521 (575)
Q Consensus 445 ~~~--~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~L 521 (575)
... ....+..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+ ........+..++..+.++
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l 236 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-DQGYRMPCPPGCPKELYDI 236 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCcCCHHHHHH
Confidence 111 1123457999999999999999999999999999999 99999988876665544 3444556677889999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHH
Q 008171 522 LERCWQQDPALRPDFSEIIEILQQ 545 (575)
Q Consensus 522 i~~cL~~dP~~RPs~~ell~~L~~ 545 (575)
+.+||+.+|.+||++.++++.|++
T Consensus 237 i~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 237 MLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHHhhcCcccCCCHHHHHHHHhc
Confidence 999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=345.98 Aligned_cols=249 Identities=23% Similarity=0.411 Sum_probs=205.3
Q ss_pred CceeeeeeeeecCceEEEEEEEC---CccEEEEEecCCCCChHHHHHHHHHHHHHHhc---CCCCceEEEeeec-----C
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACT-----K 360 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~---~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L---~HpnIv~l~~~~~-----~ 360 (575)
.+|++.++||+|+||.||+|.+. ++.||||+++...........+.+|+.+++.+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999863 46799999876544443445566787777766 6999999999874 3
Q ss_pred CCCceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
...+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 456899999995 68999886543 4589999999999999999999999999999999999999999999999999987
Q ss_pred cccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-----------
Q 008171 440 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP----------- 508 (575)
Q Consensus 440 ~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~----------- 508 (575)
...........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+......+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (290)
T cd07862 160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239 (290)
T ss_pred ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence 655544455678999999999999999999999999999999999999999887766555443211000
Q ss_pred --------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 --------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 --------------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+...+++.+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 012356788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=352.21 Aligned_cols=247 Identities=23% Similarity=0.489 Sum_probs=223.1
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
-+|.+.+.||+|.||.|-++.. .|+.||||.++.+.. +.+..-.+.+|+.||..|+||||+++|.+|++.+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4788999999999999999965 678899999987655 4455677999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 448 (575)
||.++|.|+||+.. .+.+++..+..|++||+.|+.|+|+++++|||||.+|||+|.++++||+|||++....+....++
T Consensus 133 EYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqT 211 (668)
T KOG0611|consen 133 EYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQT 211 (668)
T ss_pred EecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHH
Confidence 99999999999987 78899999999999999999999999999999999999999999999999999999998889999
Q ss_pred CCCCCCccCcccccCCCCC-chHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 008171 449 ETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s-~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~ 527 (575)
++|++.|.+||++++.+|. +..|-||||++||.|+.|.+||++.+......++....++. +..+....-||+.||.
T Consensus 212 FCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---P~~PSdA~gLIRwmLm 288 (668)
T KOG0611|consen 212 FCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---PETPSDASGLIRWMLM 288 (668)
T ss_pred hcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC---CCCCchHHHHHHHHHh
Confidence 9999999999999999985 67999999999999999999999998877666655554432 2345578899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 008171 528 QDPALRPDFSEIIEI 542 (575)
Q Consensus 528 ~dP~~RPs~~ell~~ 542 (575)
.||++|.|+.+|-.-
T Consensus 289 VNP~RRATieDiAsH 303 (668)
T KOG0611|consen 289 VNPERRATIEDIASH 303 (668)
T ss_pred cCcccchhHHHHhhh
Confidence 999999999988643
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=344.36 Aligned_cols=257 Identities=33% Similarity=0.598 Sum_probs=217.5
Q ss_pred CceeeeeeeeecCceEEEEEEECC--c--cEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCcee
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYCS--Q--DVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~~--~--~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l~l 366 (575)
++|++.+.||+|+||.||+|.... . .+++|.++.. ......+.+.+|+.+++++ +||||+++++++...+.+|+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 578999999999999999997643 2 3788887742 2334456789999999999 69999999999999899999
Q ss_pred EEEeccCCchhhhhhhcc---------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEE
Q 008171 367 VTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV 431 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~---------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL 431 (575)
||||+++++|.+++.... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence 999999999999996532 35888999999999999999999999999999999999999999999
Q ss_pred eecccceecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 008171 432 ADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTI 510 (575)
Q Consensus 432 ~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~ 510 (575)
+|||++..............+..|+|||++.+..++.++|||||||++|+|++ |..||......+....+ ..+..+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~-~~~~~~~~ 239 (297)
T cd05089 161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL-PQGYRMEK 239 (297)
T ss_pred CCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hcCCCCCC
Confidence 99999864332211222233567999999999999999999999999999997 99999988877665543 44556677
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 511 PKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 511 p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
+..+++++.+++.+||+.+|.+||++.++++.|.+++...
T Consensus 240 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 240 PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 8889999999999999999999999999999999888533
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=351.26 Aligned_cols=251 Identities=25% Similarity=0.421 Sum_probs=210.7
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCcee
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~l 366 (575)
+..++|++.++||+|+||.||++.+. +..||+|++.... .......+.+|+.+|++++||||+++++++...+.+++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 45678999999999999999999875 5679999988642 34456779999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHC-CceecccCCCCEEecCCCcEEEeecccceecccCCc
Q 008171 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~-gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 445 (575)
||||++|++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...... .
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 158 (331)
T cd06649 81 CMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M 158 (331)
T ss_pred EeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-c
Confidence 9999999999999976 45689999999999999999999986 6999999999999999999999999998755432 2
Q ss_pred cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------------------------
Q 008171 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV------------------------ 501 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v------------------------ 501 (575)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR 238 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence 34557999999999999999999999999999999999999999765543321110
Q ss_pred ---------------------HhcCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 008171 502 ---------------------VQKGLRPTIP-KNSQPKLAELLERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 502 ---------------------~~~~~~~~~p-~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~ 542 (575)
+....++..+ ..+++++.+||.+||+.||++|||+.++++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1111112222 2467899999999999999999999999753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=337.63 Aligned_cols=250 Identities=36% Similarity=0.684 Sum_probs=216.3
Q ss_pred CCCceeeeeeeeecCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~~~-~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
+..+|++.+.||+|+||.||++.+.+ ..+|+|++...... ...+.+|+.+++.++||||+++++++......|+||
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 45678899999999999999998754 46999998754333 246788999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcc--
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-- 446 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-- 446 (575)
||++|++|.+++....+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++........
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999999999999876667899999999999999999999999999999999999999999999999999765432211
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 525 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~c 525 (575)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.... +....++..+..+++++.+++.+|
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES-VSAGYRLYRPKLAPTEVYTIMYSC 237 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH-HHcCCcCCCCCCCCHHHHHHHHHH
Confidence 11223467999999999999999999999999999999 8999988777665544 445666777888999999999999
Q ss_pred hhcCCCCCCCHHHHHHHH
Q 008171 526 WQQDPALRPDFSEIIEIL 543 (575)
Q Consensus 526 L~~dP~~RPs~~ell~~L 543 (575)
|+.+|++||++.++++.|
T Consensus 238 l~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 238 WHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred hcCChhhCcCHHHHHHHh
Confidence 999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=341.48 Aligned_cols=256 Identities=31% Similarity=0.582 Sum_probs=216.8
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeec
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~ 359 (575)
|++..++|++.++||+|+||.||+|.+.+ ..||||.++... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 67788899999999999999999997643 459999986432 2334567899999999999999999999999
Q ss_pred CCCCceeEEEeccCCchhhhhhhcc---------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEE
Q 008171 360 KPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 430 (575)
Q Consensus 360 ~~~~l~lV~E~~~ggsL~d~l~~~~---------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vk 430 (575)
.....++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 9999999999999999999986532 2356778899999999999999999999999999999999999999
Q ss_pred EeecccceecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCC
Q 008171 431 VADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGL 506 (575)
Q Consensus 431 L~DFG~a~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~ 506 (575)
|+|||+++....... .....+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+....+. ...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~ 238 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EGG 238 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCC
Confidence 999999875433211 112345788999999999999999999999999999999 789998887766554433 344
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 008171 507 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 544 (575)
Q Consensus 507 ~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~ 544 (575)
.+..+..+++.+.+++.+||+.||.+||++.|+++.|+
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 45677888999999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=355.27 Aligned_cols=236 Identities=23% Similarity=0.402 Sum_probs=205.5
Q ss_pred eeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCCch
Q 008171 300 VASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (575)
Q Consensus 300 LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ggsL 376 (575)
||+|+||.||++++. ++.||+|+++.... .......+.+|+.++++++||||+++++++...+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999874 56799999875432 334456788999999999999999999999999999999999999999
Q ss_pred hhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-CccccCCCCCCc
Q 008171 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGTYRW 455 (575)
Q Consensus 377 ~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~Gt~~y 455 (575)
.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||+.|
T Consensus 81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y 159 (312)
T cd05585 81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159 (312)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence 999976 567999999999999999999999999999999999999999999999999999754332 233445799999
Q ss_pred cCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q 008171 456 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD 535 (575)
Q Consensus 456 ~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs 535 (575)
+|||++.+..++.++|||||||++|+|++|..||...+..+....+... ...+|..+++++.++|.+||+.||.+||+
T Consensus 160 ~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred CCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 9999999999999999999999999999999999988777766655543 34577889999999999999999999986
Q ss_pred HHH
Q 008171 536 FSE 538 (575)
Q Consensus 536 ~~e 538 (575)
+..
T Consensus 238 ~~~ 240 (312)
T cd05585 238 YNG 240 (312)
T ss_pred CCC
Confidence 433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=345.41 Aligned_cols=249 Identities=22% Similarity=0.357 Sum_probs=206.7
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
.++|.+.++||.|+||.||+|.. +++.||+|+++.... ......+.+|+.++++++||||+++++++......|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 45799999999999999999976 467799999875432 222356778999999999999999999999988999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-Cccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT 447 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~ 447 (575)
||+.| +|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~ 161 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS 161 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence 99965 999998776667899999999999999999999999999999999999999999999999999764432 2334
Q ss_pred cCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--------------------
Q 008171 448 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-------------------- 506 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~-------------------- 506 (575)
...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL 241 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence 4578999999999865 5689999999999999999999999988776555433322100
Q ss_pred CC--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 507 RP--------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 507 ~~--------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+ .....+++++.+||.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00 011246788999999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=340.28 Aligned_cols=256 Identities=32% Similarity=0.600 Sum_probs=221.1
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeec
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~ 359 (575)
|++..++|.+.+.||+|+||.||+|.+.+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 67888999999999999999999998643 569999987543 3344567889999999999999999999999
Q ss_pred CCCCceeEEEeccCCchhhhhhhcc---------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEE
Q 008171 360 KPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 430 (575)
Q Consensus 360 ~~~~l~lV~E~~~ggsL~d~l~~~~---------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vk 430 (575)
.....|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+||+++.++.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 9999999999999999999986432 2467889999999999999999999999999999999999999999
Q ss_pred EeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCC
Q 008171 431 VADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGL 506 (575)
Q Consensus 431 L~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~ 506 (575)
|+|||+++...... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+. ...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~ 238 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGG 238 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCC
Confidence 99999987544332 1223456789999999988889999999999999999998 999999888776655444 555
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 008171 507 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 544 (575)
Q Consensus 507 ~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~ 544 (575)
.+.+|..++.++.+++.+||+.+|.+|||+.++++.|+
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 66778889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.13 Aligned_cols=241 Identities=25% Similarity=0.453 Sum_probs=209.4
Q ss_pred eeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCC
Q 008171 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~gg 374 (575)
+.||+|+||.||++.. .++.||||+++.... .......+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999999976 467899999986432 3344567889999999999999999999999999999999999999
Q ss_pred chhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc-CCccccCCCCC
Q 008171 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGTY 453 (575)
Q Consensus 375 sL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~~~~Gt~ 453 (575)
+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||+
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 159 (328)
T cd05593 81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP 159 (328)
T ss_pred CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence 99998866 56789999999999999999999999999999999999999999999999999875332 22334567999
Q ss_pred CccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 008171 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 533 (575)
Q Consensus 454 ~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~R 533 (575)
.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+... ...+|..+++++.++|++||+.||.+|
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--DIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred CccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC--CccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 999999999999999999999999999999999999887776655444332 345778899999999999999999999
Q ss_pred C-----CHHHHHH
Q 008171 534 P-----DFSEIIE 541 (575)
Q Consensus 534 P-----s~~ell~ 541 (575)
| ++.++++
T Consensus 238 ~~~~~~~~~~il~ 250 (328)
T cd05593 238 LGGGPDDAKEIMR 250 (328)
T ss_pred CCCCCCCHHHHhc
Confidence 7 8898875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=360.05 Aligned_cols=248 Identities=22% Similarity=0.361 Sum_probs=211.5
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|++.++||+|+||.||+++. +++.||||+++.... .......+.+|+.+|+.++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4688999999999999999987 467899999975432 2334566888999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC----
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---- 444 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~---- 444 (575)
||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 81 EYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 99999999999976 5679999999999999999999999999999999999999999999999999986432211
Q ss_pred -----------------------------------ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 008171 445 -----------------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489 (575)
Q Consensus 445 -----------------------------------~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf 489 (575)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 011236999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 008171 490 EYLTPLQAAVGVVQKGLRPTIPK--NSQPKLAELLERCWQQDPALRPD---FSEIIE 541 (575)
Q Consensus 490 ~~~~~~~~~~~v~~~~~~~~~p~--~~~~~l~~Li~~cL~~dP~~RPs---~~ell~ 541 (575)
...++.+....+........+|. .+++++.++|++||. +|.+|++ +.++++
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99888777666554333333333 468999999999996 9999997 888765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=354.39 Aligned_cols=241 Identities=27% Similarity=0.471 Sum_probs=208.8
Q ss_pred eeeeecCceEEEEEEE-----CCccEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 298 SKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~-----~~~~VAvKvl~~~~~--~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
++||+|+||.||+++. .++.||||+++.... .......+.+|+.+|+.++||||+++++++..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999975 456799999875432 122345678899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-ccccC
Q 008171 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE 449 (575)
Q Consensus 371 ~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 449 (575)
++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus 82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 999999999976 5678889999999999999999999999999999999999999999999999987543332 23345
Q ss_pred CCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcC
Q 008171 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 529 (575)
Q Consensus 450 ~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~d 529 (575)
.||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+... ...+|..+++.+.++|.+||+.|
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~ 238 (323)
T cd05584 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--KLNLPPYLTPEARDLLKKLLKRN 238 (323)
T ss_pred CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHcccC
Confidence 7999999999999999999999999999999999999999988877666555443 34677889999999999999999
Q ss_pred CCCCC-----CHHHHHH
Q 008171 530 PALRP-----DFSEIIE 541 (575)
Q Consensus 530 P~~RP-----s~~ell~ 541 (575)
|.+|| ++.++++
T Consensus 239 p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 239 PSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HhHcCCCCCCCHHHHhc
Confidence 99999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.08 Aligned_cols=264 Identities=32% Similarity=0.632 Sum_probs=224.8
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEECC---------ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEE
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF 354 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~---------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l 354 (575)
..|++..++|.++++||+|+||.||++.+.+ ..+|+|.++... .......+.+|+.+++.+ +||||+++
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 4678888999999999999999999997532 359999998653 333456788899999999 79999999
Q ss_pred EeeecCCCCceeEEEeccCCchhhhhhhcc---------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCC
Q 008171 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419 (575)
Q Consensus 355 ~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~---------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~ 419 (575)
++++......|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 999999999999999999999999997532 24788899999999999999999999999999999
Q ss_pred CEEecCCCcEEEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 008171 420 NLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL 495 (575)
Q Consensus 420 NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~ 495 (575)
||+++.++.+||+|||.++...... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 9999999999999999987543321 1122234578999999999999999999999999999998 89999876654
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 496 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 496 ~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
+.. ..+....+...+..++.++.+++.+||..+|.+||++.++++.|++++...
T Consensus 250 ~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 250 ELF-KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHH-HHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 443 445556666778889999999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=360.28 Aligned_cols=248 Identities=22% Similarity=0.358 Sum_probs=208.7
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
.|+++++||+|+||+||+|.. +++.||||++..... .......+.+|+.++++++||||+++++++.+...+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999987 456799999976433 33455678999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC------
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS------ 443 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~------ 443 (575)
|++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 82 YIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 9999999999976 467899999999999999999999999999999999999999999999999997532100
Q ss_pred ------------------------------------------CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHH
Q 008171 444 ------------------------------------------GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 481 (575)
Q Consensus 444 ------------------------------------------~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~e 481 (575)
......+||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 00123469999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhh--hcCCCCCCCHHHHHH
Q 008171 482 LLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAELLERCW--QQDPALRPDFSEIIE 541 (575)
Q Consensus 482 LltG~~Pf~~~~~~~~~~~v~~~~~~~~~p--~~~~~~l~~Li~~cL--~~dP~~RPs~~ell~ 541 (575)
|++|..||...++.+....+........+| ..+++++.+||.+|+ ..++..||++.+++.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 999999999887766655555433223333 357899999999955 455666999999985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=345.38 Aligned_cols=248 Identities=23% Similarity=0.397 Sum_probs=202.6
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.++||+|+||.||+|+. +++.||||+++..... .....+.+|+.+++.++||||+++++++......|+|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 6799999999999999999987 4678999998754322 223457789999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-Ccccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~ 448 (575)
|+ +++|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 162 (303)
T cd07869 84 YV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN 162 (303)
T ss_pred CC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence 99 56888888776678999999999999999999999999999999999999999999999999999754332 23345
Q ss_pred CCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHhc---C-------------CCCC-
Q 008171 449 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG-VVQK---G-------------LRPT- 509 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~-v~~~---~-------------~~~~- 509 (575)
..||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......... +... . ..+.
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd07869 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER 242 (303)
T ss_pred CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccc
Confidence 678999999999865 4689999999999999999999999987654332211 1110 0 0000
Q ss_pred ----CC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 510 ----IP---------KNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 510 ----~p---------~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+ ...++.+.+|+.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=336.28 Aligned_cols=252 Identities=31% Similarity=0.582 Sum_probs=215.9
Q ss_pred eeeeeeeeecCceEEEEEEECC-----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCC-----
Q 008171 294 LKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS----- 363 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~~~-----~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~----- 363 (575)
|++++.||+|+||.||+|+... ..||||.++...........+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999998642 559999998765555566789999999999999999999998765544
Q ss_pred -ceeEEEeccCCchhhhhhhc-----cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccc
Q 008171 364 -LCIVTEFMSGGSVYDYLHKL-----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (575)
Q Consensus 364 -l~lV~E~~~ggsL~d~l~~~-----~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a 437 (575)
.+++|||+++++|..++... ...+++..++.++.||+.||.|||++||+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 79999999999999988543 236889999999999999999999999999999999999999999999999999
Q ss_pred eecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 008171 438 RVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN 513 (575)
Q Consensus 438 ~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~ 513 (575)
+....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+.... +..+..+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~ 239 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY-LRHGNRLKQPED 239 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCcC
Confidence 86543321 112235678999999998999999999999999999999 9999988877666544 344556677889
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 514 SQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 514 ~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
+++++.+++.+||+.||.+||++.|+++.|+++
T Consensus 240 ~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 240 CLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 999999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=356.33 Aligned_cols=250 Identities=23% Similarity=0.343 Sum_probs=209.5
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|++.++||+|+||+||++.. +++.||||+++.... .......+.+|+.++.+++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 3688999999999999999987 467899999975432 2334467888999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC----
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---- 444 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~---- 444 (575)
||++||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 99999999999976 5679999999999999999999999999999999999999999999999999986432110
Q ss_pred --------------------------------ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 008171 445 --------------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (575)
Q Consensus 445 --------------------------------~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (575)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 012347999999999999999999999999999999999999999988
Q ss_pred CHHHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhh--cCCCCCCCHHHHHHH
Q 008171 493 TPLQAAVGVVQKGLRPTIPK--NSQPKLAELLERCWQ--QDPALRPDFSEIIEI 542 (575)
Q Consensus 493 ~~~~~~~~v~~~~~~~~~p~--~~~~~l~~Li~~cL~--~dP~~RPs~~ell~~ 542 (575)
++.+....+........+|. .+++++.++|.+|+. .++..||++.||++-
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 88777766654333333443 468899999999764 233356899999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=337.38 Aligned_cols=257 Identities=31% Similarity=0.617 Sum_probs=219.2
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC--Cc----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~----~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
+...+|++.++||+|+||+||+|++. ++ .||+|+++... .......+.+|+.+++.+.||||+++++++.. .
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 45678999999999999999999863 33 38999987543 34445778999999999999999999999875 4
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
..++++||+++|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 57899999999999999987667899999999999999999999999999999999999999999999999999986543
Q ss_pred CCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 008171 443 SGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 443 ~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......... ..+.....+..+..+++.+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-DLLEKGERLPQPPICTIDV 240 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcCCCCccCCHHH
Confidence 322 122335678999999999999999999999999999998 99999877765544 3455555666777899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
.+++.+||+.||++||++.++++.|+++.+
T Consensus 241 ~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 241 YMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 999999999999999999999998877754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.70 Aligned_cols=257 Identities=28% Similarity=0.574 Sum_probs=218.3
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE--CCc----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~----~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
+...+|++.+.||.|+||+||+|.+ .++ .+++|.+... .......++..|+.++++++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~ 81 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A 81 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence 3456888999999999999999987 344 3777776532 223344678889999999999999999998864 4
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
..++++||+++|+|.+++....+.+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 57899999999999999987677899999999999999999999999999999999999999999999999999986543
Q ss_pred CC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 008171 443 SG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 443 ~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
.. ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+..+... ...+..+..+..+..++..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLAQPQICTIDV 240 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCCCCCCCCHHH
Confidence 22 1223456778999999999999999999999999999998 9999988776543 44456666667777889999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
.+++.+||..||.+||++.|+++.|..+.+
T Consensus 241 ~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 241 YMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=335.66 Aligned_cols=252 Identities=29% Similarity=0.545 Sum_probs=211.7
Q ss_pred eeeeeeeeecCceEEEEEEECCc----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC------CC
Q 008171 294 LKFGSKVASGSYGDLYRGTYCSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------PS 363 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~~~~----~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~------~~ 363 (575)
|.++++||+|+||.||+|.+... .||+|.++...........+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678999999999999987542 589999887655556677899999999999999999999987432 34
Q ss_pred ceeEEEeccCCchhhhhhh-----ccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccce
Q 008171 364 LCIVTEFMSGGSVYDYLHK-----LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~-----~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
.+++|||+.+|+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 6899999999999988742 22458899999999999999999999999999999999999999999999999998
Q ss_pred ecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 008171 439 VKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 514 (575)
Q Consensus 439 ~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~ 514 (575)
....... .....+++.|++||++.+..++.++||||||+++|+|++ |..||......+.... +..+..+..+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~ 239 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY-LRQGNRLKQPPDC 239 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCC
Confidence 6543321 122345778999999999999999999999999999999 8999988776654443 4444455567788
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 515 QPKLAELLERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 515 ~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
+..+.++|.+||+.||++|||+.++++.|+++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 240 LDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=344.49 Aligned_cols=260 Identities=32% Similarity=0.654 Sum_probs=224.0
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEee
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGA 357 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~ 357 (575)
.|.+..++|.+.+.||+|+||.||+++.. +..||+|+++... .......+.+|+.+++++ +||||++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 57788889999999999999999999752 2369999987543 234456789999999999 79999999999
Q ss_pred ecCCCCceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccc
Q 008171 358 CTKPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436 (575)
Q Consensus 358 ~~~~~~l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~ 436 (575)
+...+..|+||||+.+++|.++++... ..+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999999997643 3489999999999999999999999999999999999999999999999999
Q ss_pred ceecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 008171 437 ARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK 512 (575)
Q Consensus 437 a~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~ 512 (575)
++....... .....++..|+|||++.+..++.++|||||||++|+|++ |..||...............+..+..+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 267 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE 267 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence 975443221 122345788999999999999999999999999999998 9999988776666656666666666677
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 513 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 513 ~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
..++++.+++.+||+.+|++||++.|+++.|+++
T Consensus 268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 8899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=341.83 Aligned_cols=261 Identities=31% Similarity=0.644 Sum_probs=224.8
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEe
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~ 356 (575)
..|+++.++|++.+.||+|+||.||++.+.+ ..+|+|.++... .......+.+|+.+++++ +|+||+++++
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 4678999999999999999999999998642 459999988543 333456788999999999 7999999999
Q ss_pred eecCCCCceeEEEeccCCchhhhhhhc---------------cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCE
Q 008171 357 ACTKPPSLCIVTEFMSGGSVYDYLHKL---------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 421 (575)
Q Consensus 357 ~~~~~~~l~lV~E~~~ggsL~d~l~~~---------------~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NI 421 (575)
++...+.++++|||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999998642 34688999999999999999999999999999999999
Q ss_pred EecCCCcEEEeecccceecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 008171 422 LMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 497 (575)
Q Consensus 422 Ll~~~~~vkL~DFG~a~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~ 497 (575)
+++.++.+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|+|++ |..||......+.
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 999999999999999976543321 122335678999999999999999999999999999998 9999988877665
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 008171 498 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA 547 (575)
Q Consensus 498 ~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~ 547 (575)
... +.....+..+..++..+.+|+.+||..||.+|||+.++++.|++++
T Consensus 244 ~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 FKL-LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHH-HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 543 4455566778888999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=361.34 Aligned_cols=251 Identities=25% Similarity=0.459 Sum_probs=230.9
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCC-ceeE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIV 367 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~-l~lV 367 (575)
.++|..++++|+|+||.+++.+. .++.+++|.+..........+...+|+.++++++|||||.+.+.|..++. +|||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 35788899999999999887755 45679999999888887777889999999999999999999999999888 9999
Q ss_pred EEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-c
Q 008171 368 TEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-V 445 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~ 445 (575)
|+||+||+|.+.+.+.+ ..+++..+++|+.||+.|+.|||+++|+|||||+.||+++.++.|||+|||+|+...... .
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 99999999999998776 569999999999999999999999999999999999999999999999999999888775 5
Q ss_pred cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 008171 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 525 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~c 525 (575)
.....||+.||+||++.+.+|+.|+|||||||++|||++-+.+|...+.......+.+.. -..+|..++.+++.+|..|
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~~~ 241 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLVKSM 241 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHHHHH
Confidence 556789999999999999999999999999999999999999999999888888877654 4578999999999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 008171 526 WQQDPALRPDFSEIIEI 542 (575)
Q Consensus 526 L~~dP~~RPs~~ell~~ 542 (575)
|..+|..||++.+|+..
T Consensus 242 l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 242 LRKNPEHRPSALELLRR 258 (426)
T ss_pred hhcCCccCCCHHHHhhC
Confidence 99999999999999976
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=337.58 Aligned_cols=256 Identities=34% Similarity=0.649 Sum_probs=221.5
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCcee
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~l 366 (575)
+....+|++.++||.|+||.||+|.+. +..+++|+++... ......+..|+.+++.++||||+++++++......++
T Consensus 2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 444567899999999999999999875 4679999987543 2234668899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-
Q 008171 367 VTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~- 444 (575)
||||+++++|.+++.+.. ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999999999997643 468999999999999999999999999999999999999999999999999997654322
Q ss_pred ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 008171 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 523 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~ 523 (575)
......++..|+|||++....++.++||||||+++|+|++ |..||...+..+....+. ...++..+..+++.+.+++.
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKIML 238 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHHHHHH
Confidence 2223346778999999998999999999999999999998 899999888766655544 55666778899999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHH
Q 008171 524 RCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 524 ~cL~~dP~~RPs~~ell~~L~~l 546 (575)
+||+.||.+|||+.+|++.|+.+
T Consensus 239 ~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 239 ECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHcCCCchhCcCHHHHHHHHhcC
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=356.74 Aligned_cols=238 Identities=26% Similarity=0.438 Sum_probs=207.9
Q ss_pred eeeeecCceEEEEEEE-----CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEecc
Q 008171 298 SKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~-----~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ 372 (575)
+.||+|+||.||++.. .++.||+|+++...........+.+|+.++++++||||+++++++..++.+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999998864 46789999998654433344567889999999999999999999999999999999999
Q ss_pred CCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-CccccCCC
Q 008171 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETG 451 (575)
Q Consensus 373 ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~G 451 (575)
|++|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......|
T Consensus 82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 160 (318)
T cd05582 82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160 (318)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence 9999999976 567899999999999999999999999999999999999999999999999999765443 23345679
Q ss_pred CCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCC
Q 008171 452 TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 531 (575)
Q Consensus 452 t~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~ 531 (575)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... ...+|..+++.+.++|++||+.||.
T Consensus 161 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~l~~~P~ 238 (318)
T cd05582 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA--KLGMPQFLSPEAQSLLRALFKRNPA 238 (318)
T ss_pred ChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHh
Confidence 99999999999999999999999999999999999999988877766555443 3457788999999999999999999
Q ss_pred CCCCHHH
Q 008171 532 LRPDFSE 538 (575)
Q Consensus 532 ~RPs~~e 538 (575)
+||++.+
T Consensus 239 ~R~~a~~ 245 (318)
T cd05582 239 NRLGAGP 245 (318)
T ss_pred HcCCCCC
Confidence 9999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=334.92 Aligned_cols=246 Identities=30% Similarity=0.619 Sum_probs=211.6
Q ss_pred eeeecCceEEEEEEEC----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCC
Q 008171 299 KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (575)
Q Consensus 299 ~LG~G~fG~Vy~~~~~----~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~gg 374 (575)
.||+|+||.||+|.+. +..||+|++.... .......+.+|+.++++++||||+++++++.. ...++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 4899999999999764 3359999987553 34445679999999999999999999998864 4689999999999
Q ss_pred chhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc----cccCC
Q 008171 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV----MTAET 450 (575)
Q Consensus 375 sL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~----~~~~~ 450 (575)
+|.+++......+++..+++++.||+.||.|||++|++||||||+|||++.++.+||+|||+++....... .....
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence 99999987677899999999999999999999999999999999999999999999999999975433221 12223
Q ss_pred CCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcC
Q 008171 451 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 529 (575)
Q Consensus 451 Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~d 529 (575)
++..|+|||++.+..++.++||||||+++|+|++ |..||......+.. ..+..+.++..+..+++++.++|.+||..+
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~c~~~~ 238 (257)
T cd05115 160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-SFIEQGKRLDCPAECPPEMYALMKDCWIYK 238 (257)
T ss_pred CCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-HHHHCCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 4678999999998889999999999999999996 99999988776654 345566677888899999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHH
Q 008171 530 PALRPDFSEIIEILQQIA 547 (575)
Q Consensus 530 P~~RPs~~ell~~L~~l~ 547 (575)
|++||++.++.+.|+.++
T Consensus 239 ~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 239 WEDRPNFAKVEERMRTYY 256 (257)
T ss_pred hhhCcCHHHHHHHHhhhc
Confidence 999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=335.10 Aligned_cols=256 Identities=36% Similarity=0.668 Sum_probs=218.0
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
|.+...+|++.++||+|+||.||+|++.+ ..||+|+++..... ...+.+|+.++++++||||+++++.+.. ...|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 56777899999999999999999998754 46999998864432 3568899999999999999999998754 5689
Q ss_pred eEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||.++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 9999999999999997643 458899999999999999999999999999999999999999999999999997654433
Q ss_pred cc--ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 008171 445 VM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521 (575)
Q Consensus 445 ~~--~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~L 521 (575)
.. ....++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+ ........+..++..+.++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l 235 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDL 235 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH-hcCCCCCCccccCHHHHHH
Confidence 21 12345678999999999999999999999999999999 89999887766655443 3334445567789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHH
Q 008171 522 LERCWQQDPALRPDFSEIIEILQQIA 547 (575)
Q Consensus 522 i~~cL~~dP~~RPs~~ell~~L~~l~ 547 (575)
+.+||+.||.+||++.++++.|++.+
T Consensus 236 i~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 236 MCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHccCCcccCCCHHHHHHHHHHhc
Confidence 99999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=344.36 Aligned_cols=266 Identities=31% Similarity=0.626 Sum_probs=225.3
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEEC---------CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceE
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQ 353 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~---------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~ 353 (575)
...|.+...+|+++++||+|+||.||+++.. ...||+|+++... .......+.+|+.+++.+ +||||++
T Consensus 4 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (314)
T cd05099 4 DPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIIN 82 (314)
T ss_pred cccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeee
Confidence 3567888899999999999999999999752 2359999987543 334456788999999999 5999999
Q ss_pred EEeeecCCCCceeEEEeccCCchhhhhhhcc---------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCC
Q 008171 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418 (575)
Q Consensus 354 l~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~---------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp 418 (575)
+++++.....+|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 162 (314)
T cd05099 83 LLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAA 162 (314)
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 9999999889999999999999999996532 3478889999999999999999999999999999
Q ss_pred CCEEecCCCcEEEeecccceecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCH
Q 008171 419 ANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 494 (575)
Q Consensus 419 ~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~ 494 (575)
+|||++.++.+||+|||+++....... .....++..|+|||++.+..++.++||||||+++|+|++ |..||...+.
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999975543211 122234568999999999999999999999999999999 8999988776
Q ss_pred HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 495 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 495 ~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
.+.... +........+..++.++.+++.+||+.+|.+||++.++++.|+++...+.
T Consensus 243 ~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 243 EELFKL-LREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred HHHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 555443 44455566778889999999999999999999999999999999876553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=338.92 Aligned_cols=255 Identities=30% Similarity=0.587 Sum_probs=215.7
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~------~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
++.++|++.++||+|+||.||+|.+ .+..|++|.++... .......+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 3457889999999999999999975 33569999987543 3344567889999999999999999999999999
Q ss_pred CceeEEEeccCCchhhhhhhc----------------cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC
Q 008171 363 SLCIVTEFMSGGSVYDYLHKL----------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~----------------~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~ 426 (575)
..|+||||+.+++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 999999999999999998532 1247888899999999999999999999999999999999999
Q ss_pred CcEEEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 008171 427 EVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502 (575)
Q Consensus 427 ~~vkL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~ 502 (575)
+.+||+|||+++...... ......++..|+|||++.+..++.++||||||+++|||++ |..||...++...... +
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~-~ 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM-V 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-H
Confidence 999999999997643322 1223345778999999998899999999999999999998 9999988776554433 4
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 008171 503 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 545 (575)
Q Consensus 503 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~ 545 (575)
.....+..+..+++++.+++.+||+.||.+||++.++++.|..
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 4444556778899999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=344.70 Aligned_cols=260 Identities=32% Similarity=0.610 Sum_probs=218.0
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC--Cc--cEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ--DVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~--~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~ 363 (575)
+..++|++.+.||+|+||.||+|.+. +. .+++|.++.. ........+.+|+.++.++ +||||+++++++...+.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 45678999999999999999999864 33 3577776632 2344557788999999999 89999999999999999
Q ss_pred ceeEEEeccCCchhhhhhhcc---------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCc
Q 008171 364 LCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~---------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~ 428 (575)
+|+||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 999999999999999996532 25789999999999999999999999999999999999999999
Q ss_pred EEEeecccceecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCC
Q 008171 429 VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLR 507 (575)
Q Consensus 429 vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~ 507 (575)
+||+|||+++............++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+.... .....+
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~~~ 241 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYR 241 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH-HhcCCc
Confidence 99999999864322211222334678999999988889999999999999999998 9999988776655443 344455
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 508 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 508 ~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
+..+..+++.+.+++.+||+.+|++||++.+++..|.+++.+.
T Consensus 242 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 5667778999999999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=355.43 Aligned_cols=249 Identities=21% Similarity=0.331 Sum_probs=214.0
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|.+.++||+|+||.||++.. .++.||||+++.... .......+.+|+.+++.++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3688999999999999999986 467899999986533 2334567888999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc--c
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--M 446 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~--~ 446 (575)
||++|++|.+++.+..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 99999999999988667899999999999999999999999999999999999999999999999999976544332 2
Q ss_pred ccCCCCCCccCccccc------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHH
Q 008171 447 TAETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKL 518 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~------~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p--~~~~~~l 518 (575)
....||+.|+|||++. ...++.++|||||||++|+|++|..||...+.......+........+| ..+++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence 3347899999999986 5668899999999999999999999999888777666655433222333 3578999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+||.+||+ +|.+||++.+++.
T Consensus 241 ~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 241 LDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHHHcc-ChhhCCCHHHHhC
Confidence 999999998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=352.29 Aligned_cols=261 Identities=34% Similarity=0.648 Sum_probs=220.4
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEE-------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeee
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC 358 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~-------~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~ 358 (575)
|++..++|+++++||+|+||.||+|.+ .++.||||+++.... ......+.+|+.++.++ +||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 778888999999999999999999974 346799999986432 33456788999999999 689999999987
Q ss_pred cCC-CCceeEEEeccCCchhhhhhhcc-----------------------------------------------------
Q 008171 359 TKP-PSLCIVTEFMSGGSVYDYLHKLK----------------------------------------------------- 384 (575)
Q Consensus 359 ~~~-~~l~lV~E~~~ggsL~d~l~~~~----------------------------------------------------- 384 (575)
... ..+++||||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 46789999999999999986422
Q ss_pred -------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc---ccc
Q 008171 385 -------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---MTA 448 (575)
Q Consensus 385 -------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~ 448 (575)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 2367778899999999999999999999999999999999999999999999976433211 112
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~ 527 (575)
..+++.|+|||++.+..++.++||||||+++|+|++ |..||............+..+.++..|..+++++.+++.+||+
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~ 320 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 320 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence 345678999999999999999999999999999997 9999987665555555566666777777888999999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHHH
Q 008171 528 QDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 528 ~dP~~RPs~~ell~~L~~l~~ 548 (575)
.||.+||++.++++.|+.+++
T Consensus 321 ~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 321 GEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=349.37 Aligned_cols=247 Identities=25% Similarity=0.359 Sum_probs=199.9
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC-----CCce
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PSLC 365 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~-----~~l~ 365 (575)
+|++.++||+|+||.||+|.. +++.||||.++...........+.+|+.++++++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588899999999999999986 467899999875433334456788999999999999999999987533 2479
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~- 444 (575)
+||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~-~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 81 VVFELM-ESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEecC-CCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 999999 5689988865 5678999999999999999999999999999999999999999999999999997543221
Q ss_pred ---ccccCCCCCCccCcccccC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-----------------
Q 008171 445 ---VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV----------------- 502 (575)
Q Consensus 445 ---~~~~~~Gt~~y~APE~i~~--~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~----------------- 502 (575)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1234578999999999866 678999999999999999999999997765432211110
Q ss_pred ---------hcCCCC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 503 ---------QKGLRP---TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 503 ---------~~~~~~---~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
...... .....+++.+.++|.+||+.||.+||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 011246788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=350.86 Aligned_cols=244 Identities=27% Similarity=0.455 Sum_probs=207.3
Q ss_pred eeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHH---HhcCCCCceEEEeeecCCCCceeE
Q 008171 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIM---RKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL---~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
|++.+.||+|+||.||++.+ +++.||||+++.... .......+.+|+.++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67889999999999999987 467899999975432 223345566676655 566799999999999999999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-Ccc
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVM 446 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~ 446 (575)
|||++|++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence 999999999988854 57999999999999999999999999999999999999999999999999998753322 233
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 526 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL 526 (575)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.... +.+|..+++.+.++|.+||
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~L 236 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE--VRYPRFLSREAISIMRRLL 236 (324)
T ss_pred cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHh
Confidence 45679999999999999999999999999999999999999999888777666555433 4577789999999999999
Q ss_pred hcCCCCCC-----CHHHHHH
Q 008171 527 QQDPALRP-----DFSEIIE 541 (575)
Q Consensus 527 ~~dP~~RP-----s~~ell~ 541 (575)
+.||.+|| ++.++++
T Consensus 237 ~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 237 RRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred hcCHhHcCCCCCCCHHHHhh
Confidence 99999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=336.59 Aligned_cols=256 Identities=33% Similarity=0.629 Sum_probs=219.5
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC--C---ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC--S---QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~--~---~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 363 (575)
|+..+|++.+.||+|+||.||+|... + ..+|+|.++.... ......+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred CCHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 35578999999999999999999763 2 2599999875433 3445788999999999999999999999999999
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
.|+||||++|++|.+++....+.+++..++.++.||+.||.|||++|++||||||+|||++.++.++|+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999999876677899999999999999999999999999999999999999999999999999765433
Q ss_pred Cc--c--ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 008171 444 GV--M--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 444 ~~--~--~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
.. . ....++..|+|||.+.+..++.++|+||||+++|++++ |..||......+.... +....++..+..+++.+
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 238 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA-IEEGYRLPAPMDCPAAL 238 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHH-HhCCCcCCCCCCCCHHH
Confidence 21 1 12233568999999999899999999999999999886 9999988876655444 34445556667789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
.+++.+||+.+|.+||++.++++.|+++
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 239 HQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=359.85 Aligned_cols=249 Identities=20% Similarity=0.301 Sum_probs=208.7
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|++.++||+|+||.||++.. +++.||||++..... .......+.+|+.++++++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688999999999999999976 567899999865322 3344567889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC----
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---- 444 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~---- 444 (575)
||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 99999999999976 5678999999999999999999999999999999999999999999999999986321100
Q ss_pred --------------------------------------------ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHH
Q 008171 445 --------------------------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLW 480 (575)
Q Consensus 445 --------------------------------------------~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~ 480 (575)
.....+||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence 001246999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhhcCCCCC---CCHHHHHHH
Q 008171 481 ELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK--NSQPKLAELLERCWQQDPALR---PDFSEIIEI 542 (575)
Q Consensus 481 eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~--~~~~~l~~Li~~cL~~dP~~R---Ps~~ell~~ 542 (575)
||++|..||...+..+....+........+|. .+++++.+||.+||. +|.+| +++.+++..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999998887666655554332333443 578999999999997 77665 599988753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=334.53 Aligned_cols=255 Identities=24% Similarity=0.454 Sum_probs=214.1
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~-~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|++.++||+|+||.||+|+. +++.||||.++... ........+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4788999999999999999986 57889999887533 34455567899999999999999999999999888999999
Q ss_pred EeccCCchhhhhhhc---cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-
Q 008171 369 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444 (575)
Q Consensus 369 E~~~ggsL~d~l~~~---~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~- 444 (575)
||+++++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 999999999888532 3458889999999999999999999999999999999999999999999999987654332
Q ss_pred ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 008171 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--PLQAAVGVVQKGLRPTIPKNSQPKLAELL 522 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~--~~~~~~~v~~~~~~~~~p~~~~~~l~~Li 522 (575)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.... .......+......+..+..++..+.++|
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELV 241 (267)
T ss_pred HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence 2234568899999999998889999999999999999999999996543 23333332222333333456788999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 523 ERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 523 ~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
.+||+.+|.+||++.++++.|+++
T Consensus 242 ~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 242 SMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHCCCCcccCcCHHHHHHHHHHh
Confidence 999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.74 Aligned_cols=254 Identities=37% Similarity=0.687 Sum_probs=218.6
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
|++..++|++.++||+|+||.||++... +..||+|.++..... ...+.+|+.++++++|+||+++++++.. ...|
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIY 76 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcE
Confidence 6778889999999999999999999864 467999998865443 3568899999999999999999998864 5689
Q ss_pred eEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
++|||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||++++++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 9999999999999997643 458999999999999999999999999999999999999999999999999997654432
Q ss_pred cc--ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 008171 445 VM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521 (575)
Q Consensus 445 ~~--~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~L 521 (575)
.. ....++..|+|||++.+..++.++|+||||+++|+|++ |..||...+..+.... +.....+..+...+..+.++
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ-VERGYRMPCPQDCPISLHEL 235 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCCCCCCCCcCCHHHHHH
Confidence 11 12235678999999998899999999999999999999 9999988877665544 34455666788889999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHH
Q 008171 522 LERCWQQDPALRPDFSEIIEILQQ 545 (575)
Q Consensus 522 i~~cL~~dP~~RPs~~ell~~L~~ 545 (575)
+.+||.++|.+|||+.++.++|++
T Consensus 236 i~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 236 MLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=331.62 Aligned_cols=245 Identities=33% Similarity=0.668 Sum_probs=210.4
Q ss_pred eeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCCc
Q 008171 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ggs 375 (575)
++||+|+||.||+|+. .++.||+|.+... ...+....+.+|+.+++.++||||+++++++......|+||||+.+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 4689999999999987 5778999988743 344556779999999999999999999999999999999999999999
Q ss_pred hhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcc---ccCCCC
Q 008171 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM---TAETGT 452 (575)
Q Consensus 376 L~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~---~~~~Gt 452 (575)
|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......... ....++
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 159 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence 99999765567899999999999999999999999999999999999999999999999998754332111 111234
Q ss_pred CCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCC
Q 008171 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 531 (575)
Q Consensus 453 ~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~ 531 (575)
..|+|||.+.+..++.++||||||+++|+|++ |..||........... +....+...+..++..+.+++.+||+.+|.
T Consensus 160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 238 (252)
T cd05084 160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA-IEQGVRLPCPELCPDAVYRLMERCWEYDPG 238 (252)
T ss_pred eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH-HHcCCCCCCcccCCHHHHHHHHHHcCCChh
Confidence 67999999999999999999999999999997 9999988776554433 444556677888899999999999999999
Q ss_pred CCCCHHHHHHHHH
Q 008171 532 LRPDFSEIIEILQ 544 (575)
Q Consensus 532 ~RPs~~ell~~L~ 544 (575)
+||++.++++.|+
T Consensus 239 ~Rps~~~~~~~l~ 251 (252)
T cd05084 239 QRPSFSTVHQELQ 251 (252)
T ss_pred hCcCHHHHHHHHh
Confidence 9999999998876
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=332.56 Aligned_cols=249 Identities=29% Similarity=0.520 Sum_probs=217.8
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCCh---HHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCcee
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS---DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~l 366 (575)
+.|++.+.||+|++|.||++.. .++.||+|.+....... .....+.+|+.++++++||||+++++++.....+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688889999999999999975 56889999987543322 234578899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc-
Q 008171 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV- 445 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~- 445 (575)
|+||++|++|.+++.. .+.++...+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||+++.......
T Consensus 82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 82 FMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 9999999999999876 46689999999999999999999999999999999999999999999999999875433211
Q ss_pred ---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 008171 446 ---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 522 (575)
Q Consensus 446 ---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li 522 (575)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||...+..............+.++..++..+.++|
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 13346788999999999999999999999999999999999999888777766666666667778889999999999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 008171 523 ERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 523 ~~cL~~dP~~RPs~~ell~ 541 (575)
.+||..+|.+||++.++++
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 241 RRTFVENAKKRPSAEELLR 259 (263)
T ss_pred HHHhhcCcccCCCHHHHhh
Confidence 9999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=349.67 Aligned_cols=241 Identities=25% Similarity=0.417 Sum_probs=208.4
Q ss_pred ceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCC-CceEEEeeecCCCCceeEE
Q 008171 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHK-NVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~Hp-nIv~l~~~~~~~~~l~lV~ 368 (575)
+|++.+.||+|+||.||+|.+. ++.||||+++.... .......+..|+.++..+.|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999875 46799999876432 233456788899999999875 5888999999889999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc-cCCccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMT 447 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~-~~~~~~ 447 (575)
||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR 159 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence 99999999999876 5678999999999999999999999999999999999999999999999999987432 222344
Q ss_pred cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 008171 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~ 527 (575)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... .+.+|..+++++.+++.+||.
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhh
Confidence 567999999999999999999999999999999999999999988877766655443 456778899999999999999
Q ss_pred cCCCCCCCH
Q 008171 528 QDPALRPDF 536 (575)
Q Consensus 528 ~dP~~RPs~ 536 (575)
.||.+|++.
T Consensus 238 ~~P~~R~~~ 246 (324)
T cd05587 238 KHPAKRLGC 246 (324)
T ss_pred cCHHHcCCC
Confidence 999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=339.17 Aligned_cols=259 Identities=29% Similarity=0.571 Sum_probs=218.5
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeec
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~ 359 (575)
|+++.++|++.++||+|+||.||+|... +..||+|.++... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 7889999999999999999999999653 2369999887543 2233456889999999999999999999999
Q ss_pred CCCCceeEEEeccCCchhhhhhhcc---------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEE
Q 008171 360 KPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 430 (575)
Q Consensus 360 ~~~~l~lV~E~~~ggsL~d~l~~~~---------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vk 430 (575)
.....|+||||+++|+|.+++.... ..++...+..++.||+.||.|||++||+||||||+||+++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 9899999999999999999997532 2345678889999999999999999999999999999999999999
Q ss_pred EeecccceecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCC
Q 008171 431 VADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGL 506 (575)
Q Consensus 431 L~DFG~a~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~ 506 (575)
|+|||+++....... .....++..|+|||.+.+..++.++|+|||||++|||++ |..||......+....+. .+.
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~ 238 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM-DGG 238 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCC
Confidence 999999875433221 122345778999999999999999999999999999998 789998877766544433 344
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 008171 507 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA 547 (575)
Q Consensus 507 ~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~ 547 (575)
.+..+..+++.+.+++.+||+.||.+|||+.++++.|++.+
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 239 YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 45567788999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=353.69 Aligned_cols=241 Identities=26% Similarity=0.466 Sum_probs=208.6
Q ss_pred eeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCC
Q 008171 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~gg 374 (575)
+.||+|+||.||++.. +++.||+|+++.... .......+.+|+.+++.++||||+++++++.....+|+||||++|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 567899999986433 2334567788999999999999999999999999999999999999
Q ss_pred chhhhhhhccCcCChHHHHHHHHHHHHHHHHHHH-CCceecccCCCCEEecCCCcEEEeecccceeccc-CCccccCCCC
Q 008171 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT 452 (575)
Q Consensus 375 sL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~~~~Gt 452 (575)
+|.+++.. .+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (325)
T cd05594 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT 159 (325)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence 99998866 5678999999999999999999997 7999999999999999999999999999875332 2233455799
Q ss_pred CCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 008171 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 532 (575)
Q Consensus 453 ~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~ 532 (575)
+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+... ...+|..+++++.++|.+||+.||.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred cccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 9999999999999999999999999999999999999888776655544433 34567889999999999999999999
Q ss_pred CC-----CHHHHHH
Q 008171 533 RP-----DFSEIIE 541 (575)
Q Consensus 533 RP-----s~~ell~ 541 (575)
|+ ++.++++
T Consensus 238 R~~~~~~~~~~il~ 251 (325)
T cd05594 238 RLGGGPDDAKEIMQ 251 (325)
T ss_pred hCCCCCCCHHHHhc
Confidence 96 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=337.33 Aligned_cols=302 Identities=23% Similarity=0.389 Sum_probs=246.7
Q ss_pred CChhhHHHHHHHHHHHHHHhhhcCCCCCCCCCCCC------CCCCCCCCCCCCccccCCCCCCceeeCCCceeeeeeeee
Q 008171 229 WPYEETEQLRAALEKEVLKLERQGWPSHRSSSPTS------EPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVAS 302 (575)
Q Consensus 229 ~~~e~~~~l~~al~~~~~~~~~~~~~~~~s~s~~~------~~~~~~~~~~~~~~~~p~~~~~~~~i~~~~~~i~~~LG~ 302 (575)
-+.++.++|.+|++..-.+++++....... +|.. ...+....+...++..+......-.+..++|.++++||+
T Consensus 100 es~~eRq~W~~AIq~vsn~l~q~e~~~tn~-~p~~~~d~~~~s~s~d~~~e~m~i~~t~~~~~~~kvTm~dFdfLKvLGk 178 (516)
T KOG0690|consen 100 ESAEERQEWIEAIQAVSNRLKQEELMDTNG-NPEGEMDVNMGSPSDDFGSEEMSIAETEEAKRKNKVTMEDFDFLKVLGK 178 (516)
T ss_pred CCHHHHHHHHHHHHHHhhhhhhhhhcccCC-CccccccccCCCCCccccceeeeecccccccccceeccchhhHHHHhcC
Confidence 458899999999988776666544211110 0000 000111112222222223333445677889999999999
Q ss_pred cCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCCchhhh
Q 008171 303 GSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDY 379 (575)
Q Consensus 303 G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ggsL~d~ 379 (575)
|.||.|-+++. +++.+|||+++++.. ..+....-+.|-++|+..+||.+..+...|+...++|+||||..||.|+-+
T Consensus 179 GTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~H 258 (516)
T KOG0690|consen 179 GTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFH 258 (516)
T ss_pred CccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeee
Confidence 99999998865 578899999997754 455667778899999999999999999999999999999999999999999
Q ss_pred hhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-CccccCCCCCCccCc
Q 008171 380 LHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGTYRWMAP 458 (575)
Q Consensus 380 l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~Gt~~y~AP 458 (575)
|.. ...+++.....+...|+.||.|||+++||+||||.+|+|+|.+|++||+|||+++..... ..+...+|||.|.||
T Consensus 259 Lsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAP 337 (516)
T KOG0690|consen 259 LSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAP 337 (516)
T ss_pred hhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCc
Confidence 977 678999999999999999999999999999999999999999999999999999865544 467788999999999
Q ss_pred ccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 008171 459 EVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP 534 (575)
Q Consensus 459 E~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP 534 (575)
|++....|+.+.|+|.+|++||||+||++||...+......-++...+ .+|..++++.+.|+..+|.+||.+|.
T Consensus 338 EVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~--kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 338 EVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL--KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred hhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc--cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 999999999999999999999999999999998887776666655544 58999999999999999999999995
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=330.89 Aligned_cols=248 Identities=25% Similarity=0.486 Sum_probs=218.3
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
+|.+.+.||+|+||.||+++. .++.|++|.+............+.+|+.++++++||||+++++++...+..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477889999999999999987 467899999886655666678899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 371 MSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 371 ~~ggsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
++|++|.+++... ...++...++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 9999999999774 4578999999999999999999999999999999999999999999999999987654432 2334
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 528 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~ 528 (575)
..|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+. ....+.++..++..+.+++.+||+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08529 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPPVSQMYSQQLAQLIDQCLTK 239 (256)
T ss_pred cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCccccCHHHHHHHHHHccC
Confidence 568899999999999999999999999999999999999998887655554443 3455667778899999999999999
Q ss_pred CCCCCCCHHHHHH
Q 008171 529 DPALRPDFSEIIE 541 (575)
Q Consensus 529 dP~~RPs~~ell~ 541 (575)
+|++||++.++++
T Consensus 240 ~p~~Rp~~~~ll~ 252 (256)
T cd08529 240 DYRQRPDTFQLLR 252 (256)
T ss_pred CcccCcCHHHHhh
Confidence 9999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=340.25 Aligned_cols=255 Identities=25% Similarity=0.525 Sum_probs=217.0
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~-------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
|+..+|++.++||+|+||.||+|+.. ++.||||+++... .......+.+|+.++..++||||+++++++...
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 45567889999999999999999864 3569999988543 334456788999999999999999999999999
Q ss_pred CCceeEEEeccCCchhhhhhhc---------------cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKL---------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~---------------~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~ 426 (575)
...++++||+.+++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999998521 2347888899999999999999999999999999999999999
Q ss_pred CcEEEeecccceecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 008171 427 EVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV 502 (575)
Q Consensus 427 ~~vkL~DFG~a~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~ 502 (575)
+.+||+|||+++....... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999875433221 223346789999999988889999999999999999998 889998887776655544
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 008171 503 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 545 (575)
Q Consensus 503 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~ 545 (575)
. .....++..++..+.+++.+||+.+|.+||++.+++..|+.
T Consensus 241 ~-~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 N-RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred c-CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 3 44455678899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=338.24 Aligned_cols=253 Identities=31% Similarity=0.599 Sum_probs=216.4
Q ss_pred CCCceeeeeeeeecCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~~-------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
...+|.+.+.||+|+||.||+|+.. +..||||.++.... .+....+.+|+.++++++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4567889999999999999999753 35699999875432 334578999999999999999999999999999
Q ss_pred CceeEEEeccCCchhhhhhhcc-------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcE
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLK-------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 429 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~-------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~v 429 (575)
..|+||||++|++|.+++.... ..+++..+..++.||+.|+.|||++||+||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999996532 347888999999999999999999999999999999999999999
Q ss_pred EEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcC
Q 008171 430 KVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG 505 (575)
Q Consensus 430 kL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~ 505 (575)
||+|||+++...... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+. .+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~-~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-QG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cC
Confidence 999999997543221 1223345788999999999999999999999999999998 999998877766554433 44
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 008171 506 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 544 (575)
Q Consensus 506 ~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~ 544 (575)
..+..+..++..+.+++.+||+.||.+||++.|+++.|+
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 445567789999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=350.54 Aligned_cols=247 Identities=27% Similarity=0.455 Sum_probs=204.7
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCcee
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~l 366 (575)
....+|++.++||+|+||.||++++. ++.||||++.... .......+.+|+.+++.++|+||+++++++...+.+|+
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 34467888999999999999999874 6789999986543 33445778999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-c
Q 008171 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-V 445 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~ 445 (575)
||||+.+++|.+.. ...+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 150 v~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 150 LLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred EEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 99999999987543 34677888999999999999999999999999999999999999999999998654432 2
Q ss_pred cccCCCCCCccCcccccC-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHhcCCCCCCCCCCcHHH
Q 008171 446 MTAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPL--QAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~-----~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~--~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||...... ............+..+..+++++
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 304 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF 304 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence 345679999999998843 23456899999999999999999999743322 12222223344556777899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+||.+||+.||.+||++.|+++
T Consensus 305 ~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 305 RHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999999999999885
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=334.54 Aligned_cols=255 Identities=32% Similarity=0.608 Sum_probs=218.5
Q ss_pred CCCceeeeeeeeecCceEEEEEEECC-----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~~~-----~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
+..+|++.+.||+|+||.||+|.... ..||||+++... .......|..|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 45678999999999999999998642 249999987543 445567899999999999999999999999999999
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
++||||+++++|.+++....+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 99999999999999998766789999999999999999999999999999999999999999999999999987544322
Q ss_pred cc---ccC---CCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 008171 445 VM---TAE---TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 517 (575)
Q Consensus 445 ~~---~~~---~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~ 517 (575)
.. ... ..+..|+|||.+.+..++.++|||||||++|||++ |..||......+....+ ....+...+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-EQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH-HcCCcCCCcccCCHH
Confidence 11 111 12457999999999999999999999999999886 99999888776655544 344555566788999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 518 LAELLERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 518 l~~Li~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
+.+++.+||+.+|.+||++.+++..|+++
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 99999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=331.46 Aligned_cols=255 Identities=38% Similarity=0.708 Sum_probs=221.0
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
|+++.++|.+.++||+|+||.||++...+ +.||||.+...... ...+.+|+.++++++|+||+++++++......+
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 67888999999999999999999998643 56999998865433 356889999999999999999999999888999
Q ss_pred eEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999999997644 468999999999999999999999999999999999999999999999999987654321
Q ss_pred --ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 008171 445 --VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521 (575)
Q Consensus 445 --~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~L 521 (575)
......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+.......+ ....+...+..++.++.++
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV-ERGYRMPRPPNCPEELYDL 236 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHH
Confidence 1112234678999999999999999999999999999998 99999888776655543 3455556677789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHH
Q 008171 522 LERCWQQDPALRPDFSEIIEILQQ 545 (575)
Q Consensus 522 i~~cL~~dP~~RPs~~ell~~L~~ 545 (575)
+.+||+.+|.+||++.++++.|++
T Consensus 237 i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 237 MLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHcccCcccCCCHHHHHHHHhc
Confidence 999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=337.50 Aligned_cols=258 Identities=29% Similarity=0.584 Sum_probs=219.6
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~-------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
|+..+|.+.+.||.|+||.||++... +..+|+|.+... .......+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 45678999999999999999999741 234889988643 334456799999999999999999999999999
Q ss_pred CCceeEEEeccCCchhhhhhhcc------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcE
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLK------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 429 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~v 429 (575)
+.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999986532 248999999999999999999999999999999999999999999
Q ss_pred EEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcC
Q 008171 430 KVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG 505 (575)
Q Consensus 430 kL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~ 505 (575)
||+|||+++...... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+. .+
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~-~~ 238 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-QG 238 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cC
Confidence 999999997543322 1122345778999999999999999999999999999998 999998887766555544 34
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 506 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 506 ~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
..+..+..+++++.+++.+||+.||.+|||+.++.+.|+++.+.
T Consensus 239 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 239 RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 44456678899999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=341.15 Aligned_cols=249 Identities=22% Similarity=0.374 Sum_probs=209.8
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
.|++.++||+|+||.||++.. +++.||+|++....... .....+.+|+.+++.++||||+++++.+...+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 377889999999999999986 46789999987543322 233557889999999999999999999999899999999
Q ss_pred eccCCchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcccc
Q 008171 370 FMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 448 (575)
|+.|++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||++++++.++|+|||+++..........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 99999999888653 34689999999999999999999999999999999999999999999999999986554434445
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--hcCCCCCCCCCCcHHHHHHHHHhh
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV--QKGLRPTIPKNSQPKLAELLERCW 526 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~--~~~~~~~~p~~~~~~l~~Li~~cL 526 (575)
..|+..|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+.++..+++.+.+||.+||
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 240 (285)
T cd05605 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL 240 (285)
T ss_pred ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHc
Confidence 678999999999999999999999999999999999999998765433221111 112334566778999999999999
Q ss_pred hcCCCCCC-----CHHHHHH
Q 008171 527 QQDPALRP-----DFSEIIE 541 (575)
Q Consensus 527 ~~dP~~RP-----s~~ell~ 541 (575)
+.||.+|| ++.++++
T Consensus 241 ~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 241 TKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cCCHHHhcCCCCCCHHHHhc
Confidence 99999999 7777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=340.77 Aligned_cols=262 Identities=32% Similarity=0.626 Sum_probs=223.8
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEEC---------CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEE
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI 355 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~---------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~ 355 (575)
.|++...+|.+.+.||+|+||.||++++. +..||+|.++... .......+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 47888899999999999999999999752 2359999987542 234457789999999999 799999999
Q ss_pred eeecCCCCceeEEEeccCCchhhhhhhcc---------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCC
Q 008171 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (575)
Q Consensus 356 ~~~~~~~~l~lV~E~~~ggsL~d~l~~~~---------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~N 420 (575)
+++......|+||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 99999999999999999999999987532 347788899999999999999999999999999999
Q ss_pred EEecCCCcEEEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 008171 421 LLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496 (575)
Q Consensus 421 ILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~ 496 (575)
|+++.++.+||+|||+++...... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 999999999999999997654322 1223345678999999998899999999999999999998 889998877666
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 497 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 497 ~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
.... +....+...+..++.++.+++.+||+.+|.+||++.++++.|++++.-
T Consensus 248 ~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 248 LFKL-LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHH-HHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 5544 445556667788999999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=356.34 Aligned_cols=255 Identities=33% Similarity=0.597 Sum_probs=209.6
Q ss_pred CceeeeeeeeecCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC-CceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-SLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~~-~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~-~l~lV~E 369 (575)
+.|.-...||+|+||.||+|...+ ..||||.+....... .++|.+|+.++.+++|||+|+|+|+|.+.+ ..+||+|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence 456666799999999999999876 789999887654332 456999999999999999999999999988 4999999
Q ss_pred eccCCchhhhhhhccC-cCChHHHHHHHHHHHHHHHHHHHCC---ceecccCCCCEEecCCCcEEEeecccceeccc-CC
Q 008171 370 FMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNN---IIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SG 444 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~-~l~~~~~~~i~~qI~~aL~yLH~~g---IiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~-~~ 444 (575)
||++|+|.++|+.... .++|....+|+.++++||+|||... ||||||||+|||+|++...||+|||+|+.... ..
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~ 232 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDT 232 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcccc
Confidence 9999999999988666 8999999999999999999999864 99999999999999999999999999976654 33
Q ss_pred ccccC-CCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhc-----CCCCCCC-
Q 008171 445 VMTAE-TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT------PLQAAVGVVQK-----GLRPTIP- 511 (575)
Q Consensus 445 ~~~~~-~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~------~~~~~~~v~~~-----~~~~~~p- 511 (575)
..... .||..|+|||.+..+..+.|+||||||++|.||++|+.|.+... -.+.....+.. ...+.+.
T Consensus 233 ~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~ 312 (361)
T KOG1187|consen 233 SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKE 312 (361)
T ss_pred ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccC
Confidence 22233 89999999999999999999999999999999999998887532 12222222222 2233333
Q ss_pred CCCc-----HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 512 KNSQ-----PKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 512 ~~~~-----~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
...+ ..+..+..+|++.+|.+||++.|+++.|+.+..
T Consensus 313 ~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 313 GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 2222 236677889999999999999999888866543
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=365.90 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=217.6
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC----
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP---- 362 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~---- 362 (575)
....+|.+.++||+|+||+||++.. +++.||||++.....+......+.+|+.++..++|+||++++..+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457899999999999999999976 5788999999877666666778899999999999999999988764322
Q ss_pred ----CceeEEEeccCCchhhhhhhc---cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecc
Q 008171 363 ----SLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435 (575)
Q Consensus 363 ----~l~lV~E~~~ggsL~d~l~~~---~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG 435 (575)
.+++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 368999999999999998653 3468999999999999999999999999999999999999999999999999
Q ss_pred cceecccC---CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 008171 436 VARVKAQS---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK 512 (575)
Q Consensus 436 ~a~~~~~~---~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~ 512 (575)
+++..... .......||+.|+|||++.+..++.++|||||||+||||++|+.||...+..+....+.. +....++.
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~ 267 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-GRYDPLPP 267 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCC
Confidence 99765432 123345799999999999999999999999999999999999999998877666555443 33445778
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 513 NSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 513 ~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+++++.+++.+||+.||.+||++.++++
T Consensus 268 ~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 268 SISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred CCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 89999999999999999999999999875
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=332.37 Aligned_cols=259 Identities=32% Similarity=0.632 Sum_probs=221.6
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEECC-----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-----~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
++...+|.+.++||.|+||.||+|.+.+ ..|+||...... .....+.+.+|+.++++++||||+++++++.. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 5667789999999999999999998643 358999887543 34456789999999999999999999999876 4
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
..|+||||+++++|.+++......+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 57899999999999999987566789999999999999999999999999999999999999999999999999976544
Q ss_pred CCcc--ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 008171 443 SGVM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 519 (575)
Q Consensus 443 ~~~~--~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~ 519 (575)
.... +...++..|+|||.+....++.++||||||+++|+|++ |..||...+..+.... +..+.++..+..+++.+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 238 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR-IENGERLPMPPNCPPTLY 238 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHcCCcCCCCCCCCHHHH
Confidence 3221 12234568999999998899999999999999999986 9999988877655543 444556677888999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 520 ELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 520 ~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
++|.+||..+|.+|||+.++++.|+++..+
T Consensus 239 ~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 239 SLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=332.51 Aligned_cols=254 Identities=33% Similarity=0.653 Sum_probs=219.0
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEE-CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~-~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
|+|..++|++.++||+|+||.||+|.. .++.||+|.+...... ...+.+|+.++++++||||+++++++.. ...|
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIY 76 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEcc-CCcE
Confidence 678889999999999999999999986 4577999998865433 3568899999999999999999998754 5689
Q ss_pred eEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
++|||+.+++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999999999986533 468899999999999999999999999999999999999999999999999997655322
Q ss_pred cc--ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 008171 445 VM--TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521 (575)
Q Consensus 445 ~~--~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~L 521 (575)
.. ....++..|+|||++....++.++||||||+++|+|++ |+.||...+..+.... +....+...+..++.++.++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN-LERGYRMPRPDNCPEELYEL 235 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH-HHcCCCCCCCCCCCHHHHHH
Confidence 11 22345678999999999999999999999999999998 9999988776655444 44455667778889999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHH
Q 008171 522 LERCWQQDPALRPDFSEIIEILQQ 545 (575)
Q Consensus 522 i~~cL~~dP~~RPs~~ell~~L~~ 545 (575)
+.+||+.+|++||++++++..|++
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 236 MRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHccCChhhCCCHHHHHHHhhc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=330.86 Aligned_cols=254 Identities=38% Similarity=0.698 Sum_probs=216.8
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
|++...+|.+.++||+|+||.||++.+.+ ..+|+|.+..... ....+.+|+.+++.++|||++++++++.. ...|
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIY 76 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcE
Confidence 56777889999999999999999998754 4699998775432 23568889999999999999999998864 5689
Q ss_pred eEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
+||||+.+++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+||++++++.++|+|||+++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 9999999999999997643 347899999999999999999999999999999999999999999999999997654332
Q ss_pred c--cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 008171 445 V--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521 (575)
Q Consensus 445 ~--~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~L 521 (575)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.... ......+..+...+..+.++
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ-VERGYRMPCPQGCPESLHEL 235 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCcccCHHHHHH
Confidence 1 112345678999999999999999999999999999999 9999998877665544 34455566777889999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHH
Q 008171 522 LERCWQQDPALRPDFSEIIEILQQ 545 (575)
Q Consensus 522 i~~cL~~dP~~RPs~~ell~~L~~ 545 (575)
+.+||..||.+||++.++++.|++
T Consensus 236 i~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 236 MKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHccCCcccCcCHHHHHHHHhc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=356.69 Aligned_cols=252 Identities=22% Similarity=0.333 Sum_probs=214.5
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
.+..++|++.++||+|+||.||+++. +++.||+|+++.... .......+.+|+.+++.++||||+++++++.+...+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 55667899999999999999999987 467799999975322 223345578899999999999999999999999999
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999999999865 468899999999999999999999999999999999999999999999999997654432
Q ss_pred c--cccCCCCCCccCcccccCC----CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCC--CCcH
Q 008171 445 V--MTAETGTYRWMAPEVIEHK----PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK--NSQP 516 (575)
Q Consensus 445 ~--~~~~~Gt~~y~APE~i~~~----~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~--~~~~ 516 (575)
. .....||+.|+|||++.+. .++.++|||||||++|||++|..||...+.......+........+|. .++.
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISK 276 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCH
Confidence 2 2345799999999998653 478999999999999999999999998887776666655433334444 5789
Q ss_pred HHHHHHHHhhhcCCCC--CCCHHHHHH
Q 008171 517 KLAELLERCWQQDPAL--RPDFSEIIE 541 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~--RPs~~ell~ 541 (575)
++.++|.+||+.+|.+ |+++.++++
T Consensus 277 ~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 277 QAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred HHHHHHHHHccChhhccCCCCHHHHhc
Confidence 9999999999999987 999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=337.67 Aligned_cols=254 Identities=30% Similarity=0.608 Sum_probs=217.0
Q ss_pred ceeeeeeeeecCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 293 HLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~~-------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
+|++.+.||+|+||.||+|.... ..+++|.+..... ......+.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 46788999999999999998642 3588998875432 333567899999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhcc-----------------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEE
Q 008171 366 IVTEFMSGGSVYDYLHKLK-----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~-----------------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NIL 422 (575)
++|||+.+++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 9999999999999886421 34788899999999999999999999999999999999
Q ss_pred ecCCCcEEEeecccceecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 008171 423 MDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 498 (575)
Q Consensus 423 l~~~~~vkL~DFG~a~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~ 498 (575)
+++++.+||+|||+++....... .....++..|+|||++.+..++.++||||||+++|+|++ |..||....+.+..
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999975433221 122345778999999988899999999999999999998 99999888766544
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 499 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 499 ~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
..+....+...+..++.++.+++.+||+.+|.+||++.++++.|++++.
T Consensus 240 -~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 240 -NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 3455566667788899999999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=358.63 Aligned_cols=249 Identities=21% Similarity=0.332 Sum_probs=208.5
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|++.++||+|+||.||++.. +++.||||++..... .......+.+|+.+|++++||||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3689999999999999999986 467899999875322 2223466888999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-----
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS----- 443 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~----- 443 (575)
||++||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 81 DYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 99999999999976 567899999999999999999999999999999999999999999999999997422100
Q ss_pred ---------------------------------------CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc
Q 008171 444 ---------------------------------------GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT 484 (575)
Q Consensus 444 ---------------------------------------~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt 484 (575)
......+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence 00123469999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcHHHHHHHHHhhhcCCCCCC---CHHHHHHH
Q 008171 485 GKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLERCWQQDPALRP---DFSEIIEI 542 (575)
Q Consensus 485 G~~Pf~~~~~~~~~~~v~~~~~~~~~--p~~~~~~l~~Li~~cL~~dP~~RP---s~~ell~~ 542 (575)
|+.||...++.+....+........+ ...+++++.++|.+|+ .+|.+|+ ++.++++-
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999988877665554432222222 2367899999999977 5999999 88888743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=347.31 Aligned_cols=250 Identities=25% Similarity=0.445 Sum_probs=208.2
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCcee
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~l 366 (575)
+..++|++.++||.|+||.||++.+. +..+|+|+++... .......+.+|+.++++++||||++++++|...+.+|+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 55678999999999999999999874 5679999887642 34445678999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHC-CceecccCCCCEEecCCCcEEEeecccceecccCCc
Q 008171 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~-gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 445 (575)
||||+.|++|.+++.. .+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...... .
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~ 158 (333)
T cd06650 81 CMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M 158 (333)
T ss_pred EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-c
Confidence 9999999999999976 56689999999999999999999985 7999999999999999999999999998654332 2
Q ss_pred cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-------------------------
Q 008171 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG------------------------- 500 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~------------------------- 500 (575)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||......+....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL 238 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence 2345789999999999999999999999999999999999999976543222110
Q ss_pred ------------------HHhcCCCCCCCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 501 ------------------VVQKGLRPTIPK-NSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 501 ------------------v~~~~~~~~~p~-~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+.....+.++. ..+.++.+||.+||++||.+||++.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 011111122222 35788999999999999999999999973
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=334.34 Aligned_cols=260 Identities=27% Similarity=0.556 Sum_probs=221.6
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEECC------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC-
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK- 360 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~~------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~- 360 (575)
.++.++|++.+.||+|+||.||+|.+.. ..|++|.++.. ........+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 3567889999999999999999998754 66999988743 344556778999999999999999999998765
Q ss_pred CCCceeEEEeccCCchhhhhhhcc-------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEee
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKLK-------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD 433 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~~-------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~D 433 (575)
....++++||+++++|.+++.... ..+++..++.++.||+.||.|||+++++|+||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 467899999999999999986542 4588999999999999999999999999999999999999999999999
Q ss_pred cccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCC
Q 008171 434 FGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPT 509 (575)
Q Consensus 434 FG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~ 509 (575)
||+++...... ......++..|+|||++.+..++.++||||||+++|++++ |+.||...++.+... .+....++.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~ 239 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA-YLKDGYRLA 239 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHH-HHHcCCCCC
Confidence 99997543321 1123346778999999999999999999999999999999 999999887766543 344455556
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 510 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 510 ~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
.+..+++++.+++.+||..||++|||+.++++.|+++.++
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 6677899999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=350.07 Aligned_cols=247 Identities=25% Similarity=0.391 Sum_probs=205.3
Q ss_pred ceeeeeeeeecCceEEEEEEE-----CCccEEEEEecCCCC--ChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCCCc
Q 008171 293 HLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSL 364 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~-----~~~~VAvKvl~~~~~--~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~l 364 (575)
+|++.++||+|+||.||++.. .++.||+|+++.... .......+.+|+.+++.++ ||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999875 457799999875322 2233456888999999995 89999999999999999
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 999999999999999876 5678999999999999999999999999999999999999999999999999997543322
Q ss_pred --ccccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCCCCCCCCCCcHHH
Q 008171 445 --VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 445 --~~~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~---~~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
......||+.|+|||++.+. .++.++|||||||++|+|++|..||..... .......+ ....+.++..+++.+
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI-LKCDPPFPSFIGPEA 238 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH-hcCCCCCCCCCCHHH
Confidence 22345799999999999765 478999999999999999999999964321 12221111 234466778899999
Q ss_pred HHHHHHhhhcCCCCCC-----CHHHHHH
Q 008171 519 AELLERCWQQDPALRP-----DFSEIIE 541 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RP-----s~~ell~ 541 (575)
.++|.+||+.||.+|| ++.++++
T Consensus 239 ~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 239 QDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 9999999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=357.53 Aligned_cols=247 Identities=23% Similarity=0.380 Sum_probs=208.7
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
.|.++++||+|+||.||+|.. +++.||||++..... .......+.+|+.++++++||||+++++.+.+...+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999987 457799999875432 23445678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC------
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS------ 443 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~------ 443 (575)
|++||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 82 YIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 9999999999976 467899999999999999999999999999999999999999999999999997522100
Q ss_pred ------------------------------------------CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHH
Q 008171 444 ------------------------------------------GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 481 (575)
Q Consensus 444 ------------------------------------------~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~e 481 (575)
......+||+.|+|||++.+..|+.++|||||||+|||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 00112468999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 008171 482 LLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAELLERCWQQDPALRPD---FSEIIE 541 (575)
Q Consensus 482 LltG~~Pf~~~~~~~~~~~v~~~~~~~~~p--~~~~~~l~~Li~~cL~~dP~~RPs---~~ell~ 541 (575)
|++|..||...++.+....+........+| ..+++++.++|.+|+ .+|.+|++ +.+++.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 999999999988877766665433333333 467899999999976 59999987 777764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=347.37 Aligned_cols=241 Identities=24% Similarity=0.410 Sum_probs=208.1
Q ss_pred ceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCCCceeEE
Q 008171 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~l~lV~ 368 (575)
+|.+.+.||+|+||.||+|... ++.||||+++.... .......+..|..++..+. |++|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999875 46799999886432 2233455777888888774 789999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-Cccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT 447 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~ 447 (575)
||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~ 159 (323)
T cd05616 81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK 159 (323)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence 99999999999876 467899999999999999999999999999999999999999999999999999754322 2334
Q ss_pred cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 008171 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~ 527 (575)
...||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.... ..+|..+++++.+++.+||+
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred cCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCcCCHHHHHHHHHHcc
Confidence 5679999999999999999999999999999999999999999888877666655433 45678899999999999999
Q ss_pred cCCCCCCCH
Q 008171 528 QDPALRPDF 536 (575)
Q Consensus 528 ~dP~~RPs~ 536 (575)
.||.+|+++
T Consensus 238 ~~p~~R~~~ 246 (323)
T cd05616 238 KHPGKRLGC 246 (323)
T ss_pred cCHHhcCCC
Confidence 999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=349.54 Aligned_cols=247 Identities=25% Similarity=0.361 Sum_probs=203.8
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC------
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------ 362 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~------ 362 (575)
.++|++.+.||+|+||.||++.. .++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 47899999999999999999976 4678999999866555555677889999999999999999999886443
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
.+|+||||+.+ +|.+.+. ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 46999999965 6666553 3478899999999999999999999999999999999999999999999999976555
Q ss_pred CCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-----------------
Q 008171 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG----------------- 505 (575)
Q Consensus 443 ~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~----------------- 505 (575)
........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+....
T Consensus 176 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (359)
T cd07876 176 NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN 255 (359)
T ss_pred CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 445556688999999999999999999999999999999999999998765433222111100
Q ss_pred ---CCC--------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 506 ---LRP--------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 506 ---~~~--------------------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.++ ..+...++++++||.+||+.||.+|||+.|++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 111234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=348.44 Aligned_cols=241 Identities=23% Similarity=0.367 Sum_probs=207.4
Q ss_pred eeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCceeEEEeccC
Q 008171 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
++||+|+||.||+|++. ++.||||+++.... ..+....+..|..+++.+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 56799999886432 233456677899998866 799999999999999999999999999
Q ss_pred CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-CccccCCCC
Q 008171 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGT 452 (575)
Q Consensus 374 gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~Gt 452 (575)
++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05591 81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT 159 (321)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence 999998876 567899999999999999999999999999999999999999999999999998754322 233455799
Q ss_pred CCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 008171 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 532 (575)
Q Consensus 453 ~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~ 532 (575)
+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.... ..+|..+++++.++|.+||+.||.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD--VLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred ccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhccCHHH
Confidence 99999999999999999999999999999999999999988877766655433 3466778999999999999999999
Q ss_pred CC-------CHHHHHH
Q 008171 533 RP-------DFSEIIE 541 (575)
Q Consensus 533 RP-------s~~ell~ 541 (575)
|| ++.++++
T Consensus 238 R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 238 RLGCVASQGGEDAIKQ 253 (321)
T ss_pred cCCCCCCCCCHHHHhc
Confidence 99 6777664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=328.88 Aligned_cols=245 Identities=40% Similarity=0.730 Sum_probs=216.4
Q ss_pred eeeeecCceEEEEEEEC-----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEecc
Q 008171 298 SKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~-----~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ 372 (575)
++||+|+||.||++... +..|++|+++...... ....+.+|+.+++.++|+||+++++++.....+++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 47899999999999876 6679999998664433 46788999999999999999999999999999999999999
Q ss_pred CCchhhhhhhc--------cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 373 GGSVYDYLHKL--------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 373 ggsL~d~l~~~--------~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
+++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||.+.......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 99999999875 4779999999999999999999999999999999999999999999999999998665432
Q ss_pred ---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 008171 445 ---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 520 (575)
Q Consensus 445 ---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~ 520 (575)
......++..|+|||.+....++.++||||||+++|+|++ |..||......+....+. .+.+...+..+++++.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 238 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYRLPKPEYCPDELYE 238 (262)
T ss_pred ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCccCChHHHH
Confidence 2234457889999999988899999999999999999999 699999887766655544 45667788889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHH
Q 008171 521 LLERCWQQDPALRPDFSEIIEILQ 544 (575)
Q Consensus 521 Li~~cL~~dP~~RPs~~ell~~L~ 544 (575)
++.+||+.+|.+||++.++++.|+
T Consensus 239 li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 239 LMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHccCCcccCcCHHHHHHhhC
Confidence 999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=347.18 Aligned_cols=240 Identities=25% Similarity=0.442 Sum_probs=204.2
Q ss_pred eeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHh-cCCCCceEEEeeecCCCCceeEEEeccC
Q 008171 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRK-VRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~-L~HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
+.||+|+||.||+|++. ++.||||+++.... .......+..|..++.. .+||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999874 56699999986432 22334455667777765 4799999999999999999999999999
Q ss_pred CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-CccccCCCC
Q 008171 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGT 452 (575)
Q Consensus 374 gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~Gt 452 (575)
|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt 159 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence 999999876 567999999999999999999999999999999999999999999999999999754332 233455799
Q ss_pred CCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 008171 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 532 (575)
Q Consensus 453 ~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~ 532 (575)
+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.. ..+.+|..++.++.++|.+||+.||.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN--DRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred ccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999999999999999999999999999999998887666655433 356678889999999999999999999
Q ss_pred CCCHH-HHH
Q 008171 533 RPDFS-EII 540 (575)
Q Consensus 533 RPs~~-ell 540 (575)
||++. +++
T Consensus 238 R~~~~~~l~ 246 (316)
T cd05592 238 RLGVDGDIR 246 (316)
T ss_pred cCCChHHHH
Confidence 99875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=348.52 Aligned_cols=236 Identities=25% Similarity=0.394 Sum_probs=204.5
Q ss_pred eeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCceeEEEeccC
Q 008171 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
+.||+|+||.||++... ++.||||+++.... .......+..|..++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999874 56799999875432 233456677888888876 699999999999999999999999999
Q ss_pred CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc-CCccccCCCC
Q 008171 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT 452 (575)
Q Consensus 374 gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~~~~Gt 452 (575)
++|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (320)
T cd05590 81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT 159 (320)
T ss_pred chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence 999998876 46789999999999999999999999999999999999999999999999999875432 2234456799
Q ss_pred CCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 008171 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 532 (575)
Q Consensus 453 ~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~ 532 (575)
+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... ...+|..+++++.++|++||+.||.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred ccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999999999999999999999999999999988877766655443 34567788999999999999999999
Q ss_pred CCCH
Q 008171 533 RPDF 536 (575)
Q Consensus 533 RPs~ 536 (575)
||++
T Consensus 238 R~~~ 241 (320)
T cd05590 238 RLGS 241 (320)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=336.54 Aligned_cols=257 Identities=29% Similarity=0.580 Sum_probs=218.9
Q ss_pred CCCceeeeeeeeecCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~~-------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
...+|.+.+.||.|+||.||++... +..+++|.++... ......+.+|+.++++++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 4467888999999999999999753 2348888876432 333467889999999999999999999999999
Q ss_pred CceeEEEeccCCchhhhhhhcc---------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~---------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~ 427 (575)
..++||||+++++|.+++.... +.+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999986532 3478899999999999999999999999999999999999999
Q ss_pred cEEEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 008171 428 VVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (575)
Q Consensus 428 ~vkL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~ 503 (575)
.++|+|||++....... ......++..|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... ..
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~-~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC-IT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-Hh
Confidence 99999999997544322 1223456788999999999999999999999999999998 9999988877665443 44
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 504 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 504 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
.+..+..+..++..+.+++.+||+.+|.+||++.++++.|+++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 4555566778899999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=362.24 Aligned_cols=247 Identities=22% Similarity=0.359 Sum_probs=212.9
Q ss_pred CceeeeeeeeecCceEEEEEEEC---CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~---~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
..|.+.+.||+|+||.||++... ++.||+|.+... .......+.+|+.+|+.++|||||++++++...+.+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 45899999999999999999763 456888876543 2344456788999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhc---cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-
Q 008171 369 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444 (575)
Q Consensus 369 E~~~ggsL~d~l~~~---~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~- 444 (575)
||++||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999999988542 3468899999999999999999999999999999999999999999999999998655432
Q ss_pred --ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 008171 445 --VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 522 (575)
Q Consensus 445 --~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li 522 (575)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.... ...++..+++++.++|
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li 303 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK-YDPFPCPVSSGMKALL 303 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCccCCHHHHHHH
Confidence 2334569999999999999999999999999999999999999999887776665555433 3456778899999999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 008171 523 ERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 523 ~~cL~~dP~~RPs~~ell~ 541 (575)
.+||+.||.+||++.+++.
T Consensus 304 ~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 304 DPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHhccChhhCcCHHHHHh
Confidence 9999999999999999864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=326.50 Aligned_cols=252 Identities=23% Similarity=0.448 Sum_probs=224.4
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEECC--ccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~--~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
..|.+ ++|.+++.||+|-||.||+|.... --||+|++.+... .......+.+|+.|...|+||||+++|++|-+.
T Consensus 17 ~~~~l--~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 17 KTWTL--DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS 94 (281)
T ss_pred cccch--hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence 34444 589999999999999999998754 4599999865433 334567789999999999999999999999999
Q ss_pred CCceeEEEeccCCchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
...|+++||.++|+|+..|... ..++++...+.++.|++.|+.|+|.++||||||||+|+|++..+.+||+|||-+...
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 9999999999999999999844 356999999999999999999999999999999999999999999999999999766
Q ss_pred ccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 008171 441 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 520 (575)
Q Consensus 441 ~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~ 520 (575)
. .+.....+||..|.+||+..+..++...|+|++|++.||++.|..||+..+..++...+..- +..+|..++.++++
T Consensus 175 p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~--~~~~p~~is~~a~d 251 (281)
T KOG0580|consen 175 P-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV--DLKFPSTISGGAAD 251 (281)
T ss_pred C-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc--cccCCcccChhHHH
Confidence 5 55566789999999999999999999999999999999999999999999877777766543 45678999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 008171 521 LLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 521 Li~~cL~~dP~~RPs~~ell~ 541 (575)
+|.+|+.++|.+|.+..|++.
T Consensus 252 lI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 252 LISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred HHHHHhccCccccccHHHHhh
Confidence 999999999999999998875
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=330.66 Aligned_cols=256 Identities=34% Similarity=0.645 Sum_probs=218.7
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC--Cc---cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ---DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~---~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 363 (575)
|..++|+..+.||+|+||.||+|... ++ .+|+|.++... .......+.+|+.++++++||||+++++++.....
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 45667888999999999999999863 33 58999887543 33445678999999999999999999999999999
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
.|+||||+++++|.+++....+.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999999876678999999999999999999999999999999999999999999999999999755432
Q ss_pred Ccc----ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 008171 444 GVM----TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 444 ~~~----~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
... .....+..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+ ........+..++.++
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~~ 239 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-NDGFRLPAPMDCPSAV 239 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH-hcCCCCCCCCCCCHHH
Confidence 211 11223467999999998899999999999999999997 99999887776655444 3344555566789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
.+++.+||+.+|.+||++.++++.|+++
T Consensus 240 ~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 240 YQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=341.05 Aligned_cols=256 Identities=23% Similarity=0.332 Sum_probs=223.1
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEECC--ccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~--~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
.-.+..+.|+++++||.|.-|+||++...+ ..+|+|++.+.... .+...+...|..||+.++||.++.+|..++.+.
T Consensus 71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 346777899999999999999999999866 66999999876553 344566778999999999999999999999999
Q ss_pred CceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
..|+|||||+||+|..+++++. +.|++..+..++.+|+.||+|||..|||+|||||+||||-++|+|.|+||.++....
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 9999999999999999998775 459999999999999999999999999999999999999999999999999863110
Q ss_pred c---------------------------------C-C-----------------------ccccCCCCCCccCcccccCC
Q 008171 442 Q---------------------------------S-G-----------------------VMTAETGTYRWMAPEVIEHK 464 (575)
Q Consensus 442 ~---------------------------------~-~-----------------------~~~~~~Gt~~y~APE~i~~~ 464 (575)
. . . .....+||-.|.|||+|.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 0 00123689999999999999
Q ss_pred CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC----HHHHH
Q 008171 465 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD----FSEII 540 (575)
Q Consensus 465 ~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs----~~ell 540 (575)
..+.+.|+|+|||+||||+.|..||.+.+..++...++.+.+.-.-...++-.+++||+++|.+||.+|.. +.||.
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 99999999999999999999999999999999999999887654444477889999999999999999987 77765
Q ss_pred H
Q 008171 541 E 541 (575)
Q Consensus 541 ~ 541 (575)
+
T Consensus 391 ~ 391 (459)
T KOG0610|consen 391 R 391 (459)
T ss_pred c
Confidence 3
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=339.32 Aligned_cols=254 Identities=26% Similarity=0.399 Sum_probs=213.8
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC--
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-- 360 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~-- 360 (575)
..|++. ..|...+.||.|+||.|+.+.+ +++.||||.+.....+.-..++..+|+++|+.++|+||+.+++++..
T Consensus 16 ~~~~i~-~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~ 94 (359)
T KOG0660|consen 16 ELFEIP-RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS 94 (359)
T ss_pred eEEecc-ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence 344554 4555578999999999999977 56789999988655566667889999999999999999999998755
Q ss_pred ---CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccc
Q 008171 361 ---PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (575)
Q Consensus 361 ---~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a 437 (575)
-..+|+|+|+| +.+|...++. +..++...+..+++||++||.|+|+.||+||||||.|+|++.+..+||+|||+|
T Consensus 95 ~~~f~DvYiV~elM-etDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 95 RDKFNDVYLVFELM-ETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred ccccceeEEehhHH-hhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccce
Confidence 34589999999 7799999876 455999999999999999999999999999999999999999999999999999
Q ss_pred eeccc---CCccccCCCCCCccCcccc-cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh----------
Q 008171 438 RVKAQ---SGVMTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ---------- 503 (575)
Q Consensus 438 ~~~~~---~~~~~~~~Gt~~y~APE~i-~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~---------- 503 (575)
+.... .+.|+..+.|..|.|||++ ....|+.+.||||+||||.||++|+.-|.+.+.......++.
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 98864 5678888999999999987 567899999999999999999999999987665444332221
Q ss_pred --------------cCCCCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 504 --------------KGLRPT-----IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 504 --------------~~~~~~-----~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
....+. +.++.++...+|+++||..||.+|+|++|.++
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111121 22578899999999999999999999999874
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=360.95 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=202.6
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC-----
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP----- 361 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~----- 361 (575)
....+|+++++||+|+||.||+|.. .++.||||.+.... ....+|+.+|+.++||||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 3446899999999999999999987 46789999886432 2235799999999999999998875321
Q ss_pred ---CCceeEEEeccCCchhhhhhh---ccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC-cEEEeec
Q 008171 362 ---PSLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADF 434 (575)
Q Consensus 362 ---~~l~lV~E~~~ggsL~d~l~~---~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~-~vkL~DF 434 (575)
..+++||||++ ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 137 ~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 24679999996 477777643 246789999999999999999999999999999999999999664 7999999
Q ss_pred ccceecccCCccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--------
Q 008171 435 GVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-------- 505 (575)
Q Consensus 435 G~a~~~~~~~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~-------- 505 (575)
|+++............||+.|+|||++.+ ..|+.++|||||||+||||++|..||.+.+..+....+++..
T Consensus 216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295 (440)
T ss_pred ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 99986655444455678999999999865 469999999999999999999999999877665544433211
Q ss_pred -------------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH--HHHHHH
Q 008171 506 -------------------LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII--EILQQI 546 (575)
Q Consensus 506 -------------------~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell--~~L~~l 546 (575)
++..+|...++++.+||.+||++||.+|||+.|++ ..++.+
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 11123456788999999999999999999999998 344444
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=334.10 Aligned_cols=251 Identities=31% Similarity=0.573 Sum_probs=207.3
Q ss_pred eeeeeeeeecCceEEEEEEE------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC--CCce
Q 008171 294 LKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLC 365 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~------~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~~l~ 365 (575)
|++.+.||+|+||+||++.+ .++.||+|+++... .......+.+|+.++++++||||+++++++... ..+|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 48899999999999998764 34569999988653 233456788999999999999999999987653 3578
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 445 (575)
+||||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.......
T Consensus 85 lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 99999999999999965 4689999999999999999999999999999999999999999999999999976543221
Q ss_pred ----cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH--------------HHHHHHHhcCCC
Q 008171 446 ----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL--------------QAAVGVVQKGLR 507 (575)
Q Consensus 446 ----~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~--------------~~~~~v~~~~~~ 507 (575)
.....++..|+|||++....++.++||||||+++|+|++|..||...... ......+.....
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC
Confidence 12234567799999999889999999999999999999999998643211 111122233344
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 008171 508 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA 547 (575)
Q Consensus 508 ~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~ 547 (575)
+..+..++.++.+++.+||+.+|.+|||++++++.|+++.
T Consensus 243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 5567788999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.76 Aligned_cols=241 Identities=24% Similarity=0.419 Sum_probs=207.0
Q ss_pred eeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCceeEEEeccC
Q 008171 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
+.||+|+||.||++.+. ++.||||+++.... .......+..|..+++.+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999874 56799999985432 223445677899999888 699999999999999999999999999
Q ss_pred CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-CccccCCCC
Q 008171 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGT 452 (575)
Q Consensus 374 gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~Gt 452 (575)
++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~ 159 (318)
T cd05570 81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT 159 (318)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence 999998876 467999999999999999999999999999999999999999999999999998753322 223345689
Q ss_pred CCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 008171 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 532 (575)
Q Consensus 453 ~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~ 532 (575)
+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+... .+.+|..+++++.++|++||+.||.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED--EVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred ccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 9999999999999999999999999999999999999988776665554443 34567789999999999999999999
Q ss_pred CCCH-----HHHHH
Q 008171 533 RPDF-----SEIIE 541 (575)
Q Consensus 533 RPs~-----~ell~ 541 (575)
||++ .++++
T Consensus 238 R~s~~~~~~~~ll~ 251 (318)
T cd05570 238 RLGCLPTGEQDIKG 251 (318)
T ss_pred cCCCCCCCHHHHhc
Confidence 9999 66653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=347.89 Aligned_cols=241 Identities=23% Similarity=0.416 Sum_probs=202.2
Q ss_pred eeeeecCceEEEEEEE--CCccEEEEEecCCCCC-hHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCceeEEEeccC
Q 008171 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
+.||+|+||.||++.. +++.||||+++..... ......+..|..+++.+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999987 4677999999865432 23346688899999998 699999999999999999999999999
Q ss_pred CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc-CCccccCCCC
Q 008171 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT 452 (575)
Q Consensus 374 gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~~~~Gt 452 (575)
|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence 999998865 56799999999999999999999999999999999999999999999999999874322 2233456799
Q ss_pred CCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 008171 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--------PLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524 (575)
Q Consensus 453 ~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~--------~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~ 524 (575)
+.|+|||++.+..++.++|||||||++|+|++|+.||.... ........+. .....+|..+++++.++|.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~li~~ 238 (329)
T cd05588 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL-EKQIRIPRSLSVKASSVLKG 238 (329)
T ss_pred ccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH-cCCCCCCCCCCHHHHHHHHH
Confidence 99999999999999999999999999999999999996321 1122222222 22345788899999999999
Q ss_pred hhhcCCCCCCC------HHHHH
Q 008171 525 CWQQDPALRPD------FSEII 540 (575)
Q Consensus 525 cL~~dP~~RPs------~~ell 540 (575)
||+.||.+||+ +.+++
T Consensus 239 ~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 239 FLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred HhccCHHHcCCCCCCCCHHHHh
Confidence 99999999997 55665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=342.39 Aligned_cols=263 Identities=32% Similarity=0.627 Sum_probs=224.3
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEECC---------ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEE
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF 354 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~---------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l 354 (575)
..|++...+|+++++||+|+||.||++.+.+ ..||+|+++.. ........+.+|+.+++++ +||||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 5789999999999999999999999997522 25899988754 2334457889999999999 79999999
Q ss_pred EeeecCCCCceeEEEeccCCchhhhhhhcc---------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCC
Q 008171 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419 (575)
Q Consensus 355 ~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~---------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~ 419 (575)
+++|...+.++++|||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 999999999999999999999999986532 24777888999999999999999999999999999
Q ss_pred CEEecCCCcEEEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 008171 420 NLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL 495 (575)
Q Consensus 420 NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~ 495 (575)
|||++.++.+||+|||+++...... ......++..|+|||++.+..++.++||||||+++|||++ |..||...+..
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999999997654322 1222334578999999999999999999999999999998 89999887766
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 496 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 496 ~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
+.... +.....+..+..++.++.+++.+||+.+|.+||++.++++.|+++...
T Consensus 244 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 244 ELFKL-LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred HHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 65444 444556677788899999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=331.59 Aligned_cols=258 Identities=33% Similarity=0.624 Sum_probs=221.2
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC--Cc----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~----~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
+...+|++.+.||+|+||.||+|.+. +. .||+|.++.... ......+.+|+.++++++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 45578999999999999999999863 22 489998875533 3445678999999999999999999999987 7
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
..++||||+++|+|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 89999999999999999988777899999999999999999999999999999999999999999999999999976543
Q ss_pred CCcc---ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 008171 443 SGVM---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 443 ~~~~---~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
.... ....++..|+|||.+....++.++|+||||+++|||++ |..||......+....+ ..+.....+..++..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 240 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL-EKGERLPQPPICTIDV 240 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-hCCCCCCCCCCCCHHH
Confidence 2211 12224578999999988899999999999999999998 99999988776655443 3444556677889999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
.+++.+||..||..||++.++++.|.++.+.
T Consensus 241 ~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 241 YMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=326.47 Aligned_cols=251 Identities=36% Similarity=0.712 Sum_probs=216.0
Q ss_pred CCCceeeeeeeeecCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
+..+|++.+.||.|+||.||++.+. +..+|+|.++..... ...+.+|+.++++++||||+++++++......|+||
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 5578899999999999999999875 677999998755443 246889999999999999999999999989999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc--c
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--M 446 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~--~ 446 (575)
||+.+++|.+++....+.+++..++.++.|++.|+.|||++|++|+||||+||+++.++.++|+|||+++....... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 99999999999987667789999999999999999999999999999999999999999999999999875533221 1
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 525 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~c 525 (575)
....++..|+|||++.+..++.++||||||+++|+|++ |..||........... ...+.++..+...+..+.+++.+|
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~ 237 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET-INAGFRLYKPRLASQSVYELMQHC 237 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH-HhCCCCCCCCCCCCHHHHHHHHHH
Confidence 22335678999999998899999999999999999998 9999987766554433 344455556677889999999999
Q ss_pred hhcCCCCCCCHHHHHHHHH
Q 008171 526 WQQDPALRPDFSEIIEILQ 544 (575)
Q Consensus 526 L~~dP~~RPs~~ell~~L~ 544 (575)
|+.+|++||++.++++.|+
T Consensus 238 l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 238 WKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred cccChhhCCCHHHHHHhhC
Confidence 9999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=345.00 Aligned_cols=240 Identities=25% Similarity=0.409 Sum_probs=204.0
Q ss_pred eeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCceeEEEeccC
Q 008171 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
++||+|+||.||++.+ +++.||+|+++.... .......+..|..++..+ +||||+++++++...+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999987 456799999986432 122345567788887754 899999999999999999999999999
Q ss_pred CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc-CCccccCCCC
Q 008171 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT 452 (575)
Q Consensus 374 gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~~~~Gt 452 (575)
++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence 999999876 56789999999999999999999999999999999999999999999999999874322 2234456799
Q ss_pred CCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 008171 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 532 (575)
Q Consensus 453 ~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~ 532 (575)
+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.. ..+.+|..+++++.++|.+||+.||.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV--DTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred cCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999999999999999999999999999999988877665544332 245677789999999999999999999
Q ss_pred CCCHH-HHH
Q 008171 533 RPDFS-EII 540 (575)
Q Consensus 533 RPs~~-ell 540 (575)
||++. +++
T Consensus 238 R~~~~~~~~ 246 (316)
T cd05620 238 RLGVVGNIR 246 (316)
T ss_pred cCCChHHHH
Confidence 99974 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=336.02 Aligned_cols=249 Identities=26% Similarity=0.379 Sum_probs=213.7
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeec--CCCCceeE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT--KPPSLCIV 367 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~--~~~~l~lV 367 (575)
++|..+.+|++|+||.||+|+++ ++-||+|.++.+..........++|+.+|.+++|||||.+-.+.. +-+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 57889999999999999999875 566999999987655555566789999999999999999988754 34569999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-Ccc
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVM 446 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~ 446 (575)
||||+ .+|..++..+..+|....+..++.|+++|++|||.+.|+||||||+|+|++..|.+||+|||+||....+ ..+
T Consensus 156 Me~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~ 234 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY 234 (419)
T ss_pred HHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccC
Confidence 99995 4999999998899999999999999999999999999999999999999999999999999999977665 467
Q ss_pred ccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--------------------
Q 008171 447 TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-------------------- 505 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~-------------------- 505 (575)
+..+-|..|.|||.+.+ ..|+.+.|+||+|||+.||+++++-|.+.+..+....+.+.-
T Consensus 235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~ 314 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM 314 (419)
T ss_pred cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence 88889999999999866 569999999999999999999999999887776666555321
Q ss_pred ---------CCCCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 506 ---------LRPTIPKN-SQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 506 ---------~~~~~p~~-~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
++..++.. ++..-.+|+..+|.+||.+|.|++|.++
T Consensus 315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 11112222 4578899999999999999999999874
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=333.99 Aligned_cols=255 Identities=31% Similarity=0.593 Sum_probs=215.8
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~-------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
++.++|++.++||.|+||.||++... +..||+|++.... .......+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45678999999999999999999863 4669999987543 344557799999999999999999999999999
Q ss_pred CCceeEEEeccCCchhhhhhhcc---------------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCC
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLK---------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~---------------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~N 420 (575)
...|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999986432 246788899999999999999999999999999999
Q ss_pred EEecCCCcEEEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 008171 421 LLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496 (575)
Q Consensus 421 ILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~ 496 (575)
|+++.++.++|+|||+++...... .......+..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999987543221 1122345678999999999999999999999999999997 889998888776
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 008171 497 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 545 (575)
Q Consensus 497 ~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~ 545 (575)
....+. .+.....+..++.++.++|.+||+.+|.+||++.|+++.|++
T Consensus 241 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 VIYYVR-DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHh-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 555433 343445567889999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=330.28 Aligned_cols=248 Identities=33% Similarity=0.617 Sum_probs=208.2
Q ss_pred eeeeecCceEEEEEEECC--c--cEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCceeEEEecc
Q 008171 298 SKVASGSYGDLYRGTYCS--Q--DVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMS 372 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~~--~--~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l~lV~E~~~ 372 (575)
+.||+|+||.||+|...+ . .+++|.++.. ........+.+|+.+++++ +||||+++++++...+.+|+||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 368999999999998743 2 4688887743 2344456789999999999 79999999999999999999999999
Q ss_pred CCchhhhhhhcc---------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccc
Q 008171 373 GGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (575)
Q Consensus 373 ggsL~d~l~~~~---------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a 437 (575)
+++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999986532 24788999999999999999999999999999999999999999999999998
Q ss_pred eecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 008171 438 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 516 (575)
Q Consensus 438 ~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~ 516 (575)
..............+..|+|||++....++.++||||||+++|+|++ |..||...+..+.... +....+...+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (270)
T cd05047 160 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYRLEKPLNCDD 238 (270)
T ss_pred cccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH-HhCCCCCCCCCcCCH
Confidence 63322111122234667999999999999999999999999999997 9999988776555443 344455567778889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 008171 517 KLAELLERCWQQDPALRPDFSEIIEILQQIA 547 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~ 547 (575)
++.+++.+||..||.+||++.+++..|++++
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 239 EVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 9999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=343.79 Aligned_cols=240 Identities=24% Similarity=0.416 Sum_probs=203.7
Q ss_pred eeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHh-cCCCCceEEEeeecCCCCceeEEEeccC
Q 008171 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRK-VRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~-L~HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
+.||+|+||.||+|.+. ++.||||+++.... .......+..|..++.. ++||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999874 56799999986432 12234556678888876 4899999999999999999999999999
Q ss_pred CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-CccccCCCC
Q 008171 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGT 452 (575)
Q Consensus 374 gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~Gt 452 (575)
|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence 999999976 467899999999999999999999999999999999999999999999999998753222 233445799
Q ss_pred CCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 008171 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 532 (575)
Q Consensus 453 ~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~ 532 (575)
+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+... .+.+|..++.++.+++.+||+.||.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred ccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHHhccCHhh
Confidence 9999999999999999999999999999999999999988776655544322 34567788999999999999999999
Q ss_pred CCCHH-HHH
Q 008171 533 RPDFS-EII 540 (575)
Q Consensus 533 RPs~~-ell 540 (575)
||++. +++
T Consensus 238 R~~~~~~l~ 246 (316)
T cd05619 238 RLGVKGDIR 246 (316)
T ss_pred cCCChHHHH
Confidence 99997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=331.91 Aligned_cols=254 Identities=32% Similarity=0.592 Sum_probs=213.7
Q ss_pred eCCCceeeeeeeeecCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~~-------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
+..+.|++.+.||+|+||.||+|.+.+ ..||+|.+.... .......|.+|+.+++.++|+||+++++++.+.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 344678999999999999999998744 568889876432 333456789999999999999999999999988
Q ss_pred CCceeEEEeccCCchhhhhhhcc------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC---cEEEe
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVA 432 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~---~vkL~ 432 (575)
...++||||+.|++|.+++.... ..+++..++.++.||+.||.|||+++++||||||+||+++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 89999999999999999987643 2588999999999999999999999999999999999998654 59999
Q ss_pred ecccceecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCC
Q 008171 433 DFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP 508 (575)
Q Consensus 433 DFG~a~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~ 508 (575)
|||+++....... ......+..|+|||++.+..++.++|||||||++|+|++ |..||...+...... .+....++
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~-~~~~~~~~ 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME-FVTGGGRL 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHcCCcC
Confidence 9999976532211 112233568999999998999999999999999999997 999999877665543 34445566
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 008171 509 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 544 (575)
Q Consensus 509 ~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~ 544 (575)
..+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 778889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=353.06 Aligned_cols=253 Identities=21% Similarity=0.327 Sum_probs=212.7
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
.+..++|++.++||+|+||.||++.+. ++.||+|++..... .......+.+|+.+++.++||||+++++++.++..+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 345578999999999999999999874 56799999875322 223345688899999999999999999999999999
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 999999999999999965 458899999999999999999999999999999999999999999999999998654433
Q ss_pred c--cccCCCCCCccCcccccCCC----CCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCC--CCcH
Q 008171 445 V--MTAETGTYRWMAPEVIEHKP----YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK--NSQP 516 (575)
Q Consensus 445 ~--~~~~~Gt~~y~APE~i~~~~----~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~--~~~~ 516 (575)
. .....||+.|+|||++.+.. ++.++|||||||+||+|++|..||...+.......+........+|. .++.
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~ 276 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISK 276 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCH
Confidence 2 23557999999999997643 78899999999999999999999998887777666665444444454 4689
Q ss_pred HHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 008171 517 KLAELLERCWQQDPAL--RPDFSEIIEI 542 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~--RPs~~ell~~ 542 (575)
.+.+++.+||..++.+ |+++.|+++-
T Consensus 277 ~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 277 HAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 9999999999855543 8899998763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=326.86 Aligned_cols=245 Identities=31% Similarity=0.596 Sum_probs=209.8
Q ss_pred eeeeecCceEEEEEEECC-----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEecc
Q 008171 298 SKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~~-----~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ 372 (575)
++||+|+||.||+|.+.. ..+|+|.+...... .....+.+|+.+++.+.||||+++++++.. ...++||||+.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence 479999999999998733 46999998865443 455779999999999999999999998864 46899999999
Q ss_pred CCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcc----cc
Q 008171 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM----TA 448 (575)
Q Consensus 373 ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~----~~ 448 (575)
+++|.+++... ..+++..++.++.|++.||.|||..+++|+||||+|||++.++.+||+|||+++........ ..
T Consensus 79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 79 LGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 99999999763 47899999999999999999999999999999999999999999999999999765433211 11
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~ 527 (575)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.... +........+..+++.+.++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM-LESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 223568999999999999999999999999999998 9999988877655443 44455566788899999999999999
Q ss_pred cCCCCCCCHHHHHHHHHHH
Q 008171 528 QDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 528 ~dP~~RPs~~ell~~L~~l 546 (575)
.+|.+||++.++++.|+++
T Consensus 237 ~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 237 YRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CChhhCcCHHHHHHHHHhc
Confidence 9999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=332.77 Aligned_cols=253 Identities=29% Similarity=0.576 Sum_probs=215.6
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE-------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~-------~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
|+..+|.+.++||+|+||.||++.. .+..+|+|.++.. .......+.+|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 4567889999999999999999964 2346888987743 344567899999999999999999999999998
Q ss_pred CCceeEEEeccCCchhhhhhhcc--------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLK--------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~--------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~ 427 (575)
...+++|||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 99999999999999999987542 3478899999999999999999999999999999999999999
Q ss_pred cEEEeecccceecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 008171 428 VVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (575)
Q Consensus 428 ~vkL~DFG~a~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~ 503 (575)
.+||+|||+++....... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+ .
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~ 238 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI-T 238 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH-H
Confidence 999999999875433221 112235678999999999999999999999999999998 99999887776655443 3
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 008171 504 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 544 (575)
Q Consensus 504 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~ 544 (575)
.+..+..+..+++.+.+++.+||+.||.+||++.++++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 44455677789999999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=346.39 Aligned_cols=237 Identities=27% Similarity=0.431 Sum_probs=202.0
Q ss_pred eeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHH-HHHhcCCCCceEEEeeecCCCCceeEEEeccC
Q 008171 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVF-IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~-iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
+.||+|+||+||+|.. +++.||||++..... .......+..|.. +++.++||||+++++.+.....+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999987 467899999875432 2223344555554 56889999999999999999999999999999
Q ss_pred CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc-CCccccCCCC
Q 008171 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT 452 (575)
Q Consensus 374 gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~~~~Gt 452 (575)
++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (323)
T cd05575 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT 159 (323)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence 999999876 56789999999999999999999999999999999999999999999999999875332 2234455799
Q ss_pred CCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 008171 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 532 (575)
Q Consensus 453 ~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~ 532 (575)
+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.... ..++..+++++.++|.+||+.||.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP--LRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred hhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 99999999999999999999999999999999999999888777666655443 3456678999999999999999999
Q ss_pred CCCHH
Q 008171 533 RPDFS 537 (575)
Q Consensus 533 RPs~~ 537 (575)
||++.
T Consensus 238 R~~~~ 242 (323)
T cd05575 238 RLGAK 242 (323)
T ss_pred CCCCC
Confidence 99874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=328.02 Aligned_cols=251 Identities=34% Similarity=0.701 Sum_probs=216.2
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCcee
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~l 366 (575)
|-+..++|++.+.||+|+||.||++...++.||+|.++... ....+.+|+.+++.++||||+++++++... ..|+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 34456789999999999999999999999999999987532 235788999999999999999999998765 4799
Q ss_pred EEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc
Q 008171 367 VTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 445 (575)
||||+.+++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999999997643 35889999999999999999999999999999999999999999999999998754322
Q ss_pred cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 008171 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~ 524 (575)
......+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+.... ...+.++..+..+++.+.+++.+
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~ 232 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC-VEKGYRMEPPEGCPADVYVLMTS 232 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-HhCCCCCCCCCcCCHHHHHHHHH
Confidence 223344678999999998999999999999999999997 9999988877655443 44556666777889999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHH
Q 008171 525 CWQQDPALRPDFSEIIEILQQ 545 (575)
Q Consensus 525 cL~~dP~~RPs~~ell~~L~~ 545 (575)
||+.+|.+||++.++++.|++
T Consensus 233 ~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 233 CWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HcCCChhhCcCHHHHHHHHcc
Confidence 999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.45 Aligned_cols=240 Identities=26% Similarity=0.437 Sum_probs=202.0
Q ss_pred eeeeecCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHH-HHHHhcCCCCceEEEeeecCCCCceeEEEeccC
Q 008171 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEV-FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~-~~~~~~~~~Ev-~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
+.||+|+||.||++.+. ++.||+|++...... ......+..|. .+++.++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999874 466999998754321 12223444444 457889999999999999999999999999999
Q ss_pred CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc-CCccccCCCC
Q 008171 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT 452 (575)
Q Consensus 374 gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~~~~Gt 452 (575)
++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 159 (325)
T cd05602 81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT 159 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence 999999976 56788999999999999999999999999999999999999999999999999875332 2334456799
Q ss_pred CCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 008171 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 532 (575)
Q Consensus 453 ~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~ 532 (575)
+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.... ..++..+++.+.++|.+||+.||.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred ccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--cCCCCCCCHHHHHHHHHHcccCHHH
Confidence 99999999999999999999999999999999999999888777666555443 3455678999999999999999999
Q ss_pred CCCHHHHH
Q 008171 533 RPDFSEII 540 (575)
Q Consensus 533 RPs~~ell 540 (575)
||++.+.+
T Consensus 238 R~~~~~~~ 245 (325)
T cd05602 238 RLGAKDDF 245 (325)
T ss_pred CCCCCCCH
Confidence 99877433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=330.59 Aligned_cols=250 Identities=21% Similarity=0.398 Sum_probs=223.1
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
.++|.+.+.||+|.|+.||+... +|+.+|+|++....+.....+++.+|+.|.+.|+|||||++...+......|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 36788899999999999998854 6888999999877776667788999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC---CCcEEEeecccceecccCCc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQSGV 445 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~---~~~vkL~DFG~a~~~~~~~~ 445 (575)
|+|.|+.|..-+-. +..+++..+..++.||+.+|.|+|.+||||||+||.|+|+-. ...+||+|||+|........
T Consensus 90 e~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~ 168 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA 168 (355)
T ss_pred ecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence 99999998876654 366788899999999999999999999999999999999953 44699999999988875555
Q ss_pred cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHHHHHH
Q 008171 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLE 523 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--~~~p~~~~~~l~~Li~ 523 (575)
.....|||.|||||++...+|+..+|||+.|+|||-|+.|++||.+.+......++++.... +....+++++.++|++
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lvr 248 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIR 248 (355)
T ss_pred cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHH
Confidence 56778999999999999999999999999999999999999999998888888888776654 3345689999999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 008171 524 RCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 524 ~cL~~dP~~RPs~~ell~ 541 (575)
+||..||.+|.|+.|.++
T Consensus 249 rML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 249 RMLTVNPKKRITADEALK 266 (355)
T ss_pred HHhccChhhhccHHHHhC
Confidence 999999999999999873
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=326.93 Aligned_cols=248 Identities=26% Similarity=0.475 Sum_probs=214.9
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
+|++.++||.|+||.||++.. +++.||+|.++.... ....+.+.+|+.+++.++||||+++++.+...+.+|+||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 478899999999999999986 467799999875432 33456788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc-ccc
Q 008171 371 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-MTA 448 (575)
Q Consensus 371 ~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~ 448 (575)
+++++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||.++....... ...
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence 99999999886533 4589999999999999999999999999999999999999999999999999976654332 234
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 528 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~ 528 (575)
..|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+. .+....++..++..+.++|.+||+.
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~ 238 (255)
T cd08219 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIKQMFKR 238 (255)
T ss_pred ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHHhC
Confidence 568999999999999999999999999999999999999999877766555443 3444557778899999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 008171 529 DPALRPDFSEIIEI 542 (575)
Q Consensus 529 dP~~RPs~~ell~~ 542 (575)
||.+||++.+++..
T Consensus 239 ~P~~Rp~~~~il~~ 252 (255)
T cd08219 239 NPRSRPSATTILSR 252 (255)
T ss_pred CcccCCCHHHHhhc
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=335.63 Aligned_cols=255 Identities=27% Similarity=0.559 Sum_probs=211.4
Q ss_pred eCCCceeeeeeeeecCceEEEEEEECC----------------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCce
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYCS----------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~~----------------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv 352 (575)
+...+|++.++||+|+||.||++...+ ..||+|.++.. ........|.+|+.++++++||||+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcC
Confidence 345689999999999999999986532 23899998754 3344566799999999999999999
Q ss_pred EEEeeecCCCCceeEEEeccCCchhhhhhhcc-----------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCE
Q 008171 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK-----------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 421 (575)
Q Consensus 353 ~l~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~-----------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NI 421 (575)
++++++......++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999986432 1367888999999999999999999999999999999
Q ss_pred EecCCCcEEEeecccceecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc--CCCCCCCCCHHH
Q 008171 422 LMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLPYEYLTPLQ 496 (575)
Q Consensus 422 Ll~~~~~vkL~DFG~a~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt--G~~Pf~~~~~~~ 496 (575)
+++.++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999875433221 122345778999999998899999999999999999988 678998877665
Q ss_pred HHHHHHh------cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 008171 497 AAVGVVQ------KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 544 (575)
Q Consensus 497 ~~~~v~~------~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~ 544 (575)
....... .......+..+++.+.+++.+||+.||.+||++.++++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 5443321 11223445677899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=327.69 Aligned_cols=245 Identities=33% Similarity=0.647 Sum_probs=213.2
Q ss_pred eeeeecCceEEEEEEECC---c--cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEecc
Q 008171 298 SKVASGSYGDLYRGTYCS---Q--DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~~---~--~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ 372 (575)
++||+|+||.||+|.+.. + .||||.+...... ...+.+.+|+.++++++||||+++++.+.. ..+++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998632 2 5899999876544 566789999999999999999999999988 88999999999
Q ss_pred CCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC----ccc
Q 008171 373 GGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----VMT 447 (575)
Q Consensus 373 ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~----~~~ 447 (575)
+++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||+++...... ...
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE 158 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence 999999997754 578999999999999999999999999999999999999999999999999997654421 112
Q ss_pred cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 008171 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 526 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL 526 (575)
...++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+.........+..++..+.+++.+||
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 238 (257)
T cd05040 159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCW 238 (257)
T ss_pred CCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHC
Confidence 3456789999999999999999999999999999998 999999888877666655455555567788899999999999
Q ss_pred hcCCCCCCCHHHHHHHHH
Q 008171 527 QQDPALRPDFSEIIEILQ 544 (575)
Q Consensus 527 ~~dP~~RPs~~ell~~L~ 544 (575)
+.+|.+||++.++++.|.
T Consensus 239 ~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 239 AHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCcccCCCHHHHHHHhc
Confidence 999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=334.67 Aligned_cols=254 Identities=33% Similarity=0.599 Sum_probs=212.9
Q ss_pred CCCceeeeeeeeecCceEEEEEEECC------------------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCc
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTYCS------------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~~~------------------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnI 351 (575)
...+|++.++||+|+||.||+++... ..||+|.+.... .......+.+|+.++++++||||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCE
Confidence 34678999999999999999987643 348999988553 33456789999999999999999
Q ss_pred eEEEeeecCCCCceeEEEeccCCchhhhhhhcc----------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCE
Q 008171 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK----------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 421 (575)
Q Consensus 352 v~l~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~----------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NI 421 (575)
+++++++...+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999997643 2689999999999999999999999999999999999
Q ss_pred EecCCCcEEEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc--CCCCCCCCCHHH
Q 008171 422 LMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLPYEYLTPLQ 496 (575)
Q Consensus 422 Ll~~~~~vkL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt--G~~Pf~~~~~~~ 496 (575)
+++.++.++|+|||+++...... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 99999999999999997543332 1223456788999999988889999999999999999998 788998777655
Q ss_pred HHHHHHhc------CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 008171 497 AAVGVVQK------GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 544 (575)
Q Consensus 497 ~~~~v~~~------~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~ 544 (575)
........ ......+..++.++.+++.+||+.||.+||++.+|++.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 54433321 1112334567899999999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=335.10 Aligned_cols=242 Identities=22% Similarity=0.370 Sum_probs=199.9
Q ss_pred eeecCceEEEEEEE--CCccEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCCch
Q 008171 300 VASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (575)
Q Consensus 300 LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ggsL 376 (575)
||+|+||.||++.. +++.||+|.+....... .....+..|+.++++++||||+++++++.....+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999976 47889999987543322 2234456799999999999999999999999999999999999999
Q ss_pred hhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccccCCCCCCc
Q 008171 377 YDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRW 455 (575)
Q Consensus 377 ~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~Gt~~y 455 (575)
.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.............||..|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence 98886533 35888999999999999999999999999999999999999999999999999766554444556789999
Q ss_pred cCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---CCCCCCCcHHHHHHHHHhhhcCCCC
Q 008171 456 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---PTIPKNSQPKLAELLERCWQQDPAL 532 (575)
Q Consensus 456 ~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~---~~~p~~~~~~l~~Li~~cL~~dP~~ 532 (575)
+|||++.+..++.++|||||||++|+|++|..||...........+...... ......+++++.++|.+||+.||.+
T Consensus 161 ~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~ 240 (277)
T cd05607 161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPED 240 (277)
T ss_pred cCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhh
Confidence 9999999989999999999999999999999999765332221222221111 1223467899999999999999999
Q ss_pred CCCHHHHHH
Q 008171 533 RPDFSEIIE 541 (575)
Q Consensus 533 RPs~~ell~ 541 (575)
||++.|+++
T Consensus 241 R~~~~~~~~ 249 (277)
T cd05607 241 RLGSREKND 249 (277)
T ss_pred CCCCccchh
Confidence 999987663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=330.50 Aligned_cols=254 Identities=30% Similarity=0.562 Sum_probs=209.1
Q ss_pred CCceeeeeeeeecCceEEEEEEE------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC--CC
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PP 362 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~------~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--~~ 362 (575)
..+|++.+.||+|+||.||++.+ .+..||+|.++.. .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 45789999999999999999975 3567999998754 34445778999999999999999999998643 34
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
.+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 68999999999999999987667789999999999999999999999999999999999999999999999999986543
Q ss_pred CCcc----ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHHHHHh
Q 008171 443 SGVM----TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---------------QAAVGVVQ 503 (575)
Q Consensus 443 ~~~~----~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~---------------~~~~~v~~ 503 (575)
.... ....++..|+|||++.+..++.++||||||+++|||++|..|+...... ......+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 3211 1122345699999999999999999999999999999987765432211 01112233
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 504 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 504 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
...+...+..++.++.+++.+||..+|++|||+.++++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 3444556678899999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=345.68 Aligned_cols=248 Identities=25% Similarity=0.333 Sum_probs=205.3
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC------C
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------P 362 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~------~ 362 (575)
.++|++.+.||+|+||.||++.. .++.||||.+............+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 46899999999999999999976 467899999986655555567788999999999999999999987543 3
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
..|+||||+.+ +|.+.+. ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred eeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 46999999955 6766664 3578899999999999999999999999999999999999999999999999987665
Q ss_pred CCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC----------------
Q 008171 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL---------------- 506 (575)
Q Consensus 443 ~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~---------------- 506 (575)
........||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....++....
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T cd07874 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_pred ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHH
Confidence 5555667899999999999999999999999999999999999999987665443322211100
Q ss_pred ------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 008171 507 ------------------------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 507 ------------------------~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~ 542 (575)
....+...+.++++||.+||+.||.+|||+.|+++-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 001122345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=326.49 Aligned_cols=254 Identities=35% Similarity=0.670 Sum_probs=217.8
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
|++..+.|++.++||+|+||.||++.+. +..+|+|.++.. ......+.+|+.++++++|+||+++++.+.. ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 7888899999999999999999999864 456999988753 2234678899999999999999999999887 7789
Q ss_pred eEEEeccCCchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 366 IVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
++|||+++++|.+++.+. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999999764 3457888899999999999999999999999999999999999999999999997654332
Q ss_pred c--cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 008171 445 V--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521 (575)
Q Consensus 445 ~--~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~L 521 (575)
. .....++..|+|||++....++.++|+||||+++|++++ |..||...+....... +........+...+.++.++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 235 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-LERGYRMPRPENCPEELYNI 235 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HhCCCCCCCcccCCHHHHHH
Confidence 1 122345678999999999899999999999999999998 9999998776655443 34455556667888999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHH
Q 008171 522 LERCWQQDPALRPDFSEIIEILQQ 545 (575)
Q Consensus 522 i~~cL~~dP~~RPs~~ell~~L~~ 545 (575)
+.+||+.+|.+||++.++++.|++
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 236 MMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=346.40 Aligned_cols=247 Identities=26% Similarity=0.351 Sum_probs=206.0
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC------C
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------P 362 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~------~ 362 (575)
.++|++.+.||+|+||.||++.. .++.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 47899999999999999999976 467799999986555555567788999999999999999999987543 3
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
.+|+||||+. ++|.+++. ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 103 DVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred eEEEEEeCCC-CCHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 5799999995 47777664 3478889999999999999999999999999999999999999999999999987665
Q ss_pred CCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC----------------
Q 008171 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL---------------- 506 (575)
Q Consensus 443 ~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~---------------- 506 (575)
........||..|+|||++.+..++.++|||||||++|+|++|+.||...+..+....++....
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (364)
T cd07875 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 258 (364)
T ss_pred CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence 5555567899999999999999999999999999999999999999988776555444332110
Q ss_pred ----CC--------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 507 ----RP--------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 507 ----~~--------------------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
++ ......+.++++||.+||+.||.+|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00 011123467899999999999999999999886
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=348.22 Aligned_cols=247 Identities=25% Similarity=0.390 Sum_probs=205.4
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC-----Cce
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-----SLC 365 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~-----~l~ 365 (575)
+|.+.++||+|+||.||++.. +++.||||.+.....+....+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 467889999999999999986 5788999998755444445577899999999999999999999988766 789
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC--
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-- 443 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-- 443 (575)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 9999995 578887755 567899999999999999999999999999999999999999999999999999865432
Q ss_pred CccccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-------------------
Q 008171 444 GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ------------------- 503 (575)
Q Consensus 444 ~~~~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~------------------- 503 (575)
.......+|..|+|||++.+. .++.++|||||||++|||++|+.||...++.+....+..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 238 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence 234455789999999999774 589999999999999999999999988776554333221
Q ss_pred ----cCCCC-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 504 ----KGLRP-------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 504 ----~~~~~-------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
....+ .+....++++.+||.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 11111 133456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=343.96 Aligned_cols=251 Identities=18% Similarity=0.312 Sum_probs=209.0
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~-~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|++.+.||+|+||.||+++.. ++.||||++.... ........+.+|+.+++.++|+||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46899999999999999999874 6779999987432 22233456888999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc--c
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--M 446 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~--~ 446 (575)
||++|++|.+++.+....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99999999999987667899999999999999999999999999999999999999999999999999876544322 2
Q ss_pred ccCCCCCCccCcccccC-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC---CCCCcHHH
Q 008171 447 TAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI---PKNSQPKL 518 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~-----~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~---p~~~~~~l 518 (575)
....||+.|+|||++.. ..++.++|||||||++|+|++|+.||...+..+....+........+ ...+++.+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence 23469999999999863 45788999999999999999999999988877766665543322222 23578999
Q ss_pred HHHHHHhhhcCCCC--CCCHHHHHHH
Q 008171 519 AELLERCWQQDPAL--RPDFSEIIEI 542 (575)
Q Consensus 519 ~~Li~~cL~~dP~~--RPs~~ell~~ 542 (575)
+++|++||..++.+ ||++.++++-
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 241 KDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999998754433 7888888754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=325.74 Aligned_cols=255 Identities=24% Similarity=0.474 Sum_probs=215.7
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|++.+.||.|+||.||+|.. +++.||+|.++.... .......+.+|+.++++++|+||+++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 4788999999999999999987 478899999875333 3344678999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhc---cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-
Q 008171 369 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444 (575)
Q Consensus 369 E~~~ggsL~d~l~~~---~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~- 444 (575)
||+++++|.+++... ...++...++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||+++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 999999999988642 3558899999999999999999999999999999999999999999999999987654332
Q ss_pred ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhcCCCCCCCC-CCcHHHHHHH
Q 008171 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP-LQAAVGVVQKGLRPTIPK-NSQPKLAELL 522 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~-~~~~~~v~~~~~~~~~p~-~~~~~l~~Li 522 (575)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ..........+..+..+. .++..+.++|
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 241 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLV 241 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHH
Confidence 22345688999999999999999999999999999999999999965431 112222233344444554 7888999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 523 ERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 523 ~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
.+||..+|.+||++.+|++.|+++
T Consensus 242 ~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 242 SRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred HHHcCCCcccCCCHHHHHHHHHHh
Confidence 999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=350.35 Aligned_cols=253 Identities=22% Similarity=0.321 Sum_probs=211.5
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
.+..++|++.+.||+|+||.||++... ++.||+|++..... .......+.+|+.+++.++||||+++++++.....+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 556689999999999999999999874 57799999864322 233345678899999999999999999999999999
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 119 ~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 999999999999999865 458899999999999999999999999999999999999999999999999998665433
Q ss_pred c--cccCCCCCCccCcccccCCC----CCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcH
Q 008171 445 V--MTAETGTYRWMAPEVIEHKP----YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQP 516 (575)
Q Consensus 445 ~--~~~~~Gt~~y~APE~i~~~~----~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p--~~~~~ 516 (575)
. .....||+.|+|||++.+.. ++.++|||||||++|||++|..||...+.......+........+| ..++.
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 276 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCH
Confidence 2 23557999999999996543 7899999999999999999999999888777666665443223333 46899
Q ss_pred HHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 008171 517 KLAELLERCWQQDPAL--RPDFSEIIEI 542 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~--RPs~~ell~~ 542 (575)
++.++|.+||..++.+ |+++.++++.
T Consensus 277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 277 EAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 9999999999844432 6788888763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=333.40 Aligned_cols=248 Identities=23% Similarity=0.385 Sum_probs=201.3
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc---CCCCceEEEeeecC-----CC
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACTK-----PP 362 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L---~HpnIv~l~~~~~~-----~~ 362 (575)
+|.+.+.||+|+||.||+|.. +++.||+|.++...........+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 478899999999999999987 467799999886543333334456677777665 69999999998754 34
Q ss_pred CceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
.+++||||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 5799999996 58888886643 458999999999999999999999999999999999999999999999999998765
Q ss_pred cCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC----------------
Q 008171 442 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG---------------- 505 (575)
Q Consensus 442 ~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~---------------- 505 (575)
.........||..|+|||++.+..++.++|||||||++|+|++|..||...........+....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07863 160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239 (288)
T ss_pred CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc
Confidence 5444455678999999999999999999999999999999999999998776655443332210
Q ss_pred --CCC-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 506 --LRP-------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 506 --~~~-------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
..+ .....++.++.++|.+||+.||.+|||+.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 112356788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=322.41 Aligned_cols=245 Identities=35% Similarity=0.666 Sum_probs=211.2
Q ss_pred eeeeecCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCCch
Q 008171 298 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ggsL 376 (575)
++||+|+||.||+|... ++.||+|+++... .......+.+|+.++++++||||+++++++......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36899999999999864 5679999987543 334455789999999999999999999999999999999999999999
Q ss_pred hhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc--cccCCCCCC
Q 008171 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--MTAETGTYR 454 (575)
Q Consensus 377 ~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~--~~~~~Gt~~ 454 (575)
.+++......+++..++.++.|++.+|.|||++|++|+||||+||+++.++.+||+|||++........ .....++..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence 999977666789999999999999999999999999999999999999999999999999975433221 112234677
Q ss_pred ccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 008171 455 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 533 (575)
Q Consensus 455 y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~R 533 (575)
|+|||++.+..++.++||||||+++|+|++ |..||........... +....+...+..++..+.+++.+||+.+|++|
T Consensus 160 y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (250)
T cd05085 160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ-VEKGYRMSCPQKCPDDVYKVMQRCWDYKPENR 238 (250)
T ss_pred ccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 999999998899999999999999999998 9999988877665544 44566667778899999999999999999999
Q ss_pred CCHHHHHHHHH
Q 008171 534 PDFSEIIEILQ 544 (575)
Q Consensus 534 Ps~~ell~~L~ 544 (575)
|++.++++.|.
T Consensus 239 p~~~~l~~~l~ 249 (250)
T cd05085 239 PKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHhc
Confidence 99999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=334.72 Aligned_cols=242 Identities=24% Similarity=0.377 Sum_probs=200.0
Q ss_pred eeecCceEEEEEEE--CCccEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCCch
Q 008171 300 VASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (575)
Q Consensus 300 LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ggsL 376 (575)
||+|+||+||++.. +++.||+|.+....... .....+..|+.+++.++||||+++++++.....+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999976 46789999987543322 2345678899999999999999999999999999999999999999
Q ss_pred hhhhhh---ccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-ccccCCCC
Q 008171 377 YDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGT 452 (575)
Q Consensus 377 ~d~l~~---~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~Gt 452 (575)
.+++.. ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ......||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 888743 23568999999999999999999999999999999999999999999999999997654332 23345789
Q ss_pred CCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--CCCCCCCCCCcHHHHHHHHHhhhcCC
Q 008171 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAELLERCWQQDP 530 (575)
Q Consensus 453 ~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~--~~~~~~p~~~~~~l~~Li~~cL~~dP 530 (575)
+.|+|||++.+..++.++|||||||++|+|++|+.||............... .....++..+++.+.+++.+||+.||
T Consensus 161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 240 (280)
T cd05608 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDP 240 (280)
T ss_pred cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCH
Confidence 9999999999999999999999999999999999999765432111111111 11234567789999999999999999
Q ss_pred CCCC-----CHHHHHH
Q 008171 531 ALRP-----DFSEIIE 541 (575)
Q Consensus 531 ~~RP-----s~~ell~ 541 (575)
.+|| +++++++
T Consensus 241 ~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 241 EKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHhcCCCCCCHHHHhc
Confidence 9999 5566664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=350.51 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=208.1
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|++.+.||+|+||.||++.. +++.||||+++.... .......+.+|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688899999999999999987 467899999975322 2344567888999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC----
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---- 444 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~---- 444 (575)
||++||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 81 EFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred eCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 99999999999976 5678999999999999999999999999999999999999999999999999986432110
Q ss_pred --------------------------------ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 008171 445 --------------------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (575)
Q Consensus 445 --------------------------------~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (575)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 011346999999999999999999999999999999999999999998
Q ss_pred CHHHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhhcCCCCCCC---HHHHH
Q 008171 493 TPLQAAVGVVQKGLRPTIPK--NSQPKLAELLERCWQQDPALRPD---FSEII 540 (575)
Q Consensus 493 ~~~~~~~~v~~~~~~~~~p~--~~~~~l~~Li~~cL~~dP~~RPs---~~ell 540 (575)
++......+........+|. .+++++.++|.+|+ .||.+|++ +.+++
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 291 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIK 291 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence 88777666554332333343 36889999999977 49999985 55554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=330.19 Aligned_cols=247 Identities=33% Similarity=0.612 Sum_probs=208.0
Q ss_pred eeeeeeeeecCceEEEEEEECCc--cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEec
Q 008171 294 LKFGSKVASGSYGDLYRGTYCSQ--DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~~~~--~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~ 371 (575)
|+++++||+|+||+||++...+. .||+|++..............+|+.++++++||||+++++++.....+++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 78899999999999999998654 5999999977554444445567999999999999999999999999999999999
Q ss_pred cCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec-ccCCccccCC
Q 008171 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK-AQSGVMTAET 450 (575)
Q Consensus 372 ~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~-~~~~~~~~~~ 450 (575)
.+++|.+++.. .+.+++..++.++.||+.||.+||++||+|+||||+||+++.++.++|+|||.+... ..........
T Consensus 81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 159 (260)
T PF00069_consen 81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV 159 (260)
T ss_dssp TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred ccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999983 678899999999999999999999999999999999999999999999999999763 3334455678
Q ss_pred CCCCccCccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHhcCCCC--CCCCCCcHHHHHHHHH
Q 008171 451 GTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---QAAVGVVQKGLRP--TIPKNSQPKLAELLER 524 (575)
Q Consensus 451 Gt~~y~APE~i~-~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~---~~~~~v~~~~~~~--~~p~~~~~~l~~Li~~ 524 (575)
++..|+|||++. +..++.++||||||+++|+|++|..||...... ............. ......++.+.++|.+
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 239 (260)
T PF00069_consen 160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKK 239 (260)
T ss_dssp SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHH
Confidence 899999999998 888999999999999999999999999987322 2222222211111 1112234899999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 008171 525 CWQQDPALRPDFSEIIE 541 (575)
Q Consensus 525 cL~~dP~~RPs~~ell~ 541 (575)
||+.||.+||++.++++
T Consensus 240 ~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 240 MLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HSSSSGGGSTTHHHHHT
T ss_pred HccCChhHCcCHHHHhc
Confidence 99999999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=329.39 Aligned_cols=256 Identities=22% Similarity=0.438 Sum_probs=214.1
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~-~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|++.+.||+|+||.||++.. .++.||||.+.... ........+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999986 57789999876533 23344568899999999999999999999999989999999
Q ss_pred EeccCCchhhhhhhc---cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-
Q 008171 369 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444 (575)
Q Consensus 369 E~~~ggsL~d~l~~~---~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~- 444 (575)
||++|++|.+++... ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 999999999988642 3568999999999999999999999999999999999999999999999999987654332
Q ss_pred ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 008171 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL--QAAVGVVQKGLRPTIPKNSQPKLAELL 522 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~--~~~~~v~~~~~~~~~p~~~~~~l~~Li 522 (575)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||...... +....+......+..+..+++++.+++
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 241 (267)
T ss_pred ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHH
Confidence 223457899999999999999999999999999999999999999754432 222222222222333456889999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHH
Q 008171 523 ERCWQQDPALRPDFSEIIEILQQIA 547 (575)
Q Consensus 523 ~~cL~~dP~~RPs~~ell~~L~~l~ 547 (575)
.+||..||.+|||+.++++.++++.
T Consensus 242 ~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 242 NMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHhcCCCcccCCCHHHHHHHHhhhc
Confidence 9999999999999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=327.28 Aligned_cols=248 Identities=30% Similarity=0.579 Sum_probs=212.7
Q ss_pred ceeeeeeeeecCceEEEEEEE-CCccEEEEEecCCCCC----hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 293 HLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERIN----SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~-~~~~VAvKvl~~~~~~----~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
+|++++.||+|+||.||+|.. .++.+|+|.++..... ......+.+|+.++++++|+||+++++++.....+|+|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999976 5677999998754322 23345688999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC----
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS---- 443 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~---- 443 (575)
|||++|++|.+++.+ .+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 81 MEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 999999999999976 467899999999999999999999999999999999999999999999999998754221
Q ss_pred ---CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-CCCCCCCCCCcHHHH
Q 008171 444 ---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK-GLRPTIPKNSQPKLA 519 (575)
Q Consensus 444 ---~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~-~~~~~~p~~~~~~l~ 519 (575)
.......|+..|+|||++.+..++.++||||||+++|+|++|..||...+........... ...+.++..++.++.
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI 239 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHH
Confidence 1223456899999999999999999999999999999999999999887766554443332 445667888999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 008171 520 ELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 520 ~Li~~cL~~dP~~RPs~~ell~ 541 (575)
++|++||+.+|.+||++.+++.
T Consensus 240 ~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 240 DFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHhcCCcccCCCHHHHhc
Confidence 9999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=332.72 Aligned_cols=248 Identities=22% Similarity=0.352 Sum_probs=208.7
Q ss_pred eeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
|+..+.||+|+||+||++++. ++.||+|++....... .....+.+|+.+|+.++|+||+.+++.+...+..|+||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999874 6789999987654332 2345678899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccccC
Q 008171 371 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449 (575)
Q Consensus 371 ~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 449 (575)
+.+++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++............
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR 161 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCC
Confidence 99999998886533 46999999999999999999999999999999999999999999999999999765443334455
Q ss_pred CCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--CCCCCCCCCCcHHHHHHHHHhhh
Q 008171 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 450 ~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~--~~~~~~p~~~~~~l~~Li~~cL~ 527 (575)
.|+..|+|||++.+..++.++|+||||+++|+|++|..||...........+... .....++..+++++.+|+.+||+
T Consensus 162 ~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 241 (285)
T cd05632 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT 241 (285)
T ss_pred CCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHcc
Confidence 7899999999999999999999999999999999999999877654433222221 12234567788999999999999
Q ss_pred cCCCCCCC-----HHHHHH
Q 008171 528 QDPALRPD-----FSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs-----~~ell~ 541 (575)
.||.+||+ +.+++.
T Consensus 242 ~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 242 KDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CCHhHcCCCcccChHHHHc
Confidence 99999999 555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=344.31 Aligned_cols=237 Identities=22% Similarity=0.404 Sum_probs=198.6
Q ss_pred eeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCceeEEEeccC
Q 008171 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
+.||+|+||.||++... ++.||+|+++.... .......+.+|+.++.++ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999874 56799999986533 233455678899988877 799999999999999999999999999
Q ss_pred CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc-CCccccCCCC
Q 008171 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT 452 (575)
Q Consensus 374 gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~~~~Gt 452 (575)
++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence 999988865 56799999999999999999999999999999999999999999999999999875332 2233455799
Q ss_pred CCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 008171 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--------PLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524 (575)
Q Consensus 453 ~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~--------~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~ 524 (575)
+.|+|||++.+..++.++|||||||++|+|++|..||.... .......... .....+|..++.++.++|.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~-~~~~~~p~~~~~~~~~ll~~ 238 (329)
T cd05618 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIRIPRSLSVKAASVLKS 238 (329)
T ss_pred ccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh-cCCCCCCCCCCHHHHHHHHH
Confidence 99999999999999999999999999999999999995321 1111222222 23446788899999999999
Q ss_pred hhhcCCCCCCCH
Q 008171 525 CWQQDPALRPDF 536 (575)
Q Consensus 525 cL~~dP~~RPs~ 536 (575)
||+.||.+||++
T Consensus 239 ~L~~dP~~R~~~ 250 (329)
T cd05618 239 FLNKDPKERLGC 250 (329)
T ss_pred HhcCCHHHcCCC
Confidence 999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=330.95 Aligned_cols=249 Identities=29% Similarity=0.481 Sum_probs=207.9
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
..+|++.++||+|+||.||+|+. +++.||+|++..... .....+.+|+.++++++||||+++++++.....+|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 35789999999999999999986 467799999875432 22356788999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-ccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT 447 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~ 447 (575)
||+++++|.+++.. .+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....... ...
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 86 EYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 99999999999875 5678999999999999999999999999999999999999999999999999997654322 233
Q ss_pred cCCCCCCccCccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC---CCCCcHHHHHH
Q 008171 448 AETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI---PKNSQPKLAEL 521 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~---p~~~~~~l~~L 521 (575)
...|+..|+|||.+. ...++.++|||||||++|+|++|..||....+......+......+.. +..++..+.++
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNF 244 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHH
Confidence 456889999999984 455788999999999999999999999776655443332222222222 23467899999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 008171 522 LERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 522 i~~cL~~dP~~RPs~~ell~~ 542 (575)
|++||+.+|++||+++++++.
T Consensus 245 i~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 245 VKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred HHHHhhCChhhCcCHHHHhcC
Confidence 999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=324.62 Aligned_cols=249 Identities=32% Similarity=0.591 Sum_probs=207.8
Q ss_pred eeeeecCceEEEEEEEC-----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeec-CCCCceeEEEec
Q 008171 298 SKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT-KPPSLCIVTEFM 371 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~-----~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~-~~~~l~lV~E~~ 371 (575)
+.||+|+||.||+|.+. ...||||.+... ........+.+|+.+++.++||||+++++++. .++..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999863 235999987632 23344577889999999999999999999765 455689999999
Q ss_pred cCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-----cc
Q 008171 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----VM 446 (575)
Q Consensus 372 ~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-----~~ 446 (575)
.+++|.+++......+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 9999999998766667888889999999999999999999999999999999999999999999997543321 11
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 525 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~c 525 (575)
....++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+.... +..+..+..+..+++.+.+++.+|
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~c 238 (262)
T cd05058 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY-LLQGRRLLQPEYCPDPLYEVMLSC 238 (262)
T ss_pred ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HhcCCCCCCCCcCCHHHHHHHHHH
Confidence 23345778999999988899999999999999999999 5777887776655444 344445566777889999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHH
Q 008171 526 WQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 526 L~~dP~~RPs~~ell~~L~~l~~ 548 (575)
|+.+|++||++.++++.|++++.
T Consensus 239 l~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 239 WHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred cCCChhhCCCHHHHHHHHHHHhc
Confidence 99999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=326.36 Aligned_cols=247 Identities=32% Similarity=0.610 Sum_probs=212.7
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCCh-------HHHHHHHHHHHHHHhcCCCCceEEEeeecCCCC
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-------DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~-------~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 363 (575)
+|.+++.||.|+||.||+|.. .++.||+|.+....... .....+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 366778999999999999986 45789999887543321 234568899999999999999999999999999
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
.++||||+++++|.+++.. .+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||+++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred cEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 9999999999999999976 467899999999999999999999999999999999999999999999999998765422
Q ss_pred C-------ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 008171 444 G-------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 516 (575)
Q Consensus 444 ~-------~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~ 516 (575)
. ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+. ....+.++..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNISS 238 (267)
T ss_pred cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh-ccCCCcCCcccCH
Confidence 1 1123457889999999999999999999999999999999999999877665554433 3556778888999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 517 KLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+.++|++||+.||.+||++.++++
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 239 EAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHHHHHccCCchhCcCHHHHhh
Confidence 9999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=333.85 Aligned_cols=248 Identities=24% Similarity=0.402 Sum_probs=208.6
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
.|++.+.||+|+||.||++.+ +++.||+|.+...... ......+.+|+.+++.++|+||+++++.+...+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 367788999999999999987 4678999998754332 2334567889999999999999999999999899999999
Q ss_pred eccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcccc
Q 008171 370 FMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 448 (575)
|++|++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 999999999886533 4589999999999999999999999999999999999999999999999999976554434345
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---QAAVGVVQKGLRPTIPKNSQPKLAELLERC 525 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~---~~~~~v~~~~~~~~~p~~~~~~l~~Li~~c 525 (575)
..||..|+|||++.+..++.++||||||+++|+|++|..||...... ....... .......+..+++++.+|+++|
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05630 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDARSLCKML 239 (285)
T ss_pred CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHHHHHHHH
Confidence 57999999999999999999999999999999999999999865432 1222222 2233456678899999999999
Q ss_pred hhcCCCCCCC-----HHHHHH
Q 008171 526 WQQDPALRPD-----FSEIIE 541 (575)
Q Consensus 526 L~~dP~~RPs-----~~ell~ 541 (575)
|+.||.+||| +.|+++
T Consensus 240 l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 240 LCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhcCHHHccCCCCCchHHHHc
Confidence 9999999999 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=341.24 Aligned_cols=241 Identities=24% Similarity=0.427 Sum_probs=207.5
Q ss_pred ceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCC-CCceEEEeeecCCCCceeEE
Q 008171 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~H-pnIv~l~~~~~~~~~l~lV~ 368 (575)
+|.+.+.||+|+||.||++... ++.||||+++.... .......+..|..+++.+.| ++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3678899999999999999874 67899999875432 22334667889999988865 77888999999889999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-ccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT 447 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~ 447 (575)
||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~ 159 (323)
T cd05615 81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR 159 (323)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence 99999999999876 5679999999999999999999999999999999999999999999999999987543322 233
Q ss_pred cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 008171 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~ 527 (575)
...||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.... ..+|..+++++.+++.+||+
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred CccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHHcc
Confidence 4569999999999999999999999999999999999999999988877766665533 45678899999999999999
Q ss_pred cCCCCCCCH
Q 008171 528 QDPALRPDF 536 (575)
Q Consensus 528 ~dP~~RPs~ 536 (575)
.+|.+|++.
T Consensus 238 ~~p~~R~~~ 246 (323)
T cd05615 238 KHPSKRLGC 246 (323)
T ss_pred cCHhhCCCC
Confidence 999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=332.01 Aligned_cols=255 Identities=31% Similarity=0.560 Sum_probs=211.5
Q ss_pred CCceeeeeeeeecCceEEEEEEE------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC--C
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--P 362 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~------~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~ 362 (575)
...|++.++||+|+||.||++++ .+..||+|.++... .......+.+|+.+++.++||||+++++++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 45678999999999999999975 35679999987543 334456799999999999999999999998765 5
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
..++||||++|++|.+++.+....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||+++....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 68899999999999999976556789999999999999999999999999999999999999999999999999976544
Q ss_pred CCc----cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC--------------CHHHHHHHHHhc
Q 008171 443 SGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL--------------TPLQAAVGVVQK 504 (575)
Q Consensus 443 ~~~----~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~--------------~~~~~~~~v~~~ 504 (575)
... .....++..|+|||++.+..++.++||||||+++|+|+++..|+... ............
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 321 12345677899999998889999999999999999999977654211 111222233344
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 505 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 505 ~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
+.+...+..++..+.+|+.+||+.||.+||++.++++.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 445556778999999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=343.60 Aligned_cols=251 Identities=18% Similarity=0.327 Sum_probs=211.1
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|++.++||+|+||.||++.+. ++.||+|++..... .......+.+|+.++..++|+||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36889999999999999999875 46699999864322 2233455888999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc--c
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--M 446 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~--~ 446 (575)
||+.||+|.+++.+....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99999999999987667899999999999999999999999999999999999999999999999999875433322 2
Q ss_pred ccCCCCCCccCccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC---CCCcHHH
Q 008171 447 TAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP---KNSQPKL 518 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p---~~~~~~l 518 (575)
....||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+.....+..+| ..+++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~ 240 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence 2357999999999985 3568899999999999999999999999988887777766544333333 4679999
Q ss_pred HHHHHHhhhcCCCC--CCCHHHHHHH
Q 008171 519 AELLERCWQQDPAL--RPDFSEIIEI 542 (575)
Q Consensus 519 ~~Li~~cL~~dP~~--RPs~~ell~~ 542 (575)
.+||++||..++.+ |+++.++++-
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 241 KDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHccChhhhcCCCCHHHHhCC
Confidence 99999999765544 6889888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=344.07 Aligned_cols=250 Identities=18% Similarity=0.327 Sum_probs=210.1
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~-~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|++.++||+|+||.||+++.. ++.||+|++.... ........+.+|+.++..++|+||+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999874 5679999987532 22333456888999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcc--
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-- 446 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-- 446 (575)
||+.||+|.+++.+..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 999999999999876678999999999999999999999999999999999999999999999999999765543322
Q ss_pred ccCCCCCCccCcccccC-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC---CCCcHHH
Q 008171 447 TAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP---KNSQPKL 518 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~-----~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p---~~~~~~l 518 (575)
....||+.|+|||++.+ ..++.++|||||||+||+|++|+.||...+..+....+.....+..+| ..+++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~ 240 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA 240 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence 23569999999999875 568899999999999999999999999888777766665544333333 3468999
Q ss_pred HHHHHHhhhcCCCC--CCCHHHHHH
Q 008171 519 AELLERCWQQDPAL--RPDFSEIIE 541 (575)
Q Consensus 519 ~~Li~~cL~~dP~~--RPs~~ell~ 541 (575)
.++|.+||..++.+ |+++.++++
T Consensus 241 ~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 241 KDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred HHHHHHHccCchhhcCCCCHHHHhc
Confidence 99999999866544 457877764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=323.43 Aligned_cols=249 Identities=24% Similarity=0.453 Sum_probs=218.0
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
+|++.+.||.|+||.||.++. .++.+++|.+.....+......+.+|+.++++++|+||+++++++.....++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478899999999998887765 567799999887665666677899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 371 MSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 371 ~~ggsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
+++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 9999999999764 3568999999999999999999999999999999999999999999999999997654433 3345
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 528 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~ 528 (575)
..|++.|+|||++.+..++.++||||||+++|+|++|..||......+....+.... ....+..++.++.++|.+||+.
T Consensus 161 ~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08221 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-YTPVVSVYSSELISLVHSLLQQ 239 (256)
T ss_pred cCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCccccCHHHHHHHHHHccc
Confidence 578999999999988889999999999999999999999998877776666555433 3345577899999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 008171 529 DPALRPDFSEIIEI 542 (575)
Q Consensus 529 dP~~RPs~~ell~~ 542 (575)
+|.+||++.++++.
T Consensus 240 ~p~~R~s~~~ll~~ 253 (256)
T cd08221 240 DPEKRPTADEVLDQ 253 (256)
T ss_pred CcccCCCHHHHhhC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=343.46 Aligned_cols=237 Identities=26% Similarity=0.429 Sum_probs=201.1
Q ss_pred eeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHH-HHHHhcCCCCceEEEeeecCCCCceeEEEeccC
Q 008171 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEV-FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev-~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
++||+|+||.||++++ .++.||+|++..... .......+..|. .+++.++||||+++++++...+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999987 467799999875432 222334455555 468889999999999999999999999999999
Q ss_pred CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc-CCccccCCCC
Q 008171 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT 452 (575)
Q Consensus 374 gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~~~~Gt 452 (575)
++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05603 81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT 159 (321)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence 999988865 56789999999999999999999999999999999999999999999999999875322 2233455789
Q ss_pred CCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 008171 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 532 (575)
Q Consensus 453 ~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~ 532 (575)
+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+... ...+|...+.++.++|.+||+.||.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK--PLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred cccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 9999999999999999999999999999999999999988776666555543 34567788999999999999999999
Q ss_pred CCCHH
Q 008171 533 RPDFS 537 (575)
Q Consensus 533 RPs~~ 537 (575)
||++.
T Consensus 238 R~~~~ 242 (321)
T cd05603 238 RLGAK 242 (321)
T ss_pred cCCCC
Confidence 99764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=321.82 Aligned_cols=248 Identities=27% Similarity=0.486 Sum_probs=213.5
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC-CCCceeEEE
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSLCIVTE 369 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~-~~~l~lV~E 369 (575)
.|++.+.||+|++|.||+++. .++.||+|.+............+.+|+.++++++|+|++++++.+.. ...+|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 378899999999999999986 45679999998665555566778999999999999999999988764 445799999
Q ss_pred eccCCchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-ccc
Q 008171 370 FMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT 447 (575)
Q Consensus 370 ~~~ggsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~ 447 (575)
|+++++|.+++... ...+++..++.++.|++.|+.|||++||+|+||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 99999999999764 3458999999999999999999999999999999999999999999999999997654322 233
Q ss_pred cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 008171 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~ 527 (575)
...+++.|+|||++.+..++.++||||||+++|+|++|..||...+......... .+..+..+...++.+.+++.+||+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 239 (257)
T cd08223 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELIATMLS 239 (257)
T ss_pred cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHHHHhc
Confidence 4568999999999999999999999999999999999999998777655544433 344456777889999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 008171 528 QDPALRPDFSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs~~ell~ 541 (575)
.||.+||++.++++
T Consensus 240 ~~p~~Rp~~~~~l~ 253 (257)
T cd08223 240 KRPEKRPSVKSILR 253 (257)
T ss_pred cCcccCCCHHHHhc
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=345.19 Aligned_cols=238 Identities=27% Similarity=0.433 Sum_probs=202.3
Q ss_pred eeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHH-HHHhcCCCCceEEEeeecCCCCceeEEEeccC
Q 008171 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVF-IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~-iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
+.||+|+||.||+++. +++.||||++..... .......+..|.. +++.++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999987 467899999875432 2233445556654 57789999999999999999999999999999
Q ss_pred CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc-CCccccCCCC
Q 008171 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT 452 (575)
Q Consensus 374 gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~~~~Gt 452 (575)
++|..++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (325)
T cd05604 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT 159 (325)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence 999988875 56799999999999999999999999999999999999999999999999999875322 2233455799
Q ss_pred CCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 008171 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 532 (575)
Q Consensus 453 ~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~ 532 (575)
+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.... ..++...+..+.++|++||+.||.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP--LVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred hhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC--ccCCCCCCHHHHHHHHHHhccCHHh
Confidence 99999999999999999999999999999999999999888777666655433 3445578899999999999999999
Q ss_pred CCCHHH
Q 008171 533 RPDFSE 538 (575)
Q Consensus 533 RPs~~e 538 (575)
||++.+
T Consensus 238 R~~~~~ 243 (325)
T cd05604 238 RLGAKE 243 (325)
T ss_pred cCCCCC
Confidence 998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=335.63 Aligned_cols=249 Identities=22% Similarity=0.369 Sum_probs=205.5
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
.++|.+.++||+|+||.||+|+. .++.||+|.++..... .....+.+|+.++++++||||+++++++..++..|+||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 36799999999999999999986 4567999998754322 22345778999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-ccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT 447 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~ 447 (575)
||+. ++|.+++......++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 84 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (309)
T cd07872 84 EYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS 162 (309)
T ss_pred eCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccc
Confidence 9996 48888887766678999999999999999999999999999999999999999999999999997644322 233
Q ss_pred cCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC---------------------
Q 008171 448 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG--------------------- 505 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~--------------------- 505 (575)
...+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+....
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN 242 (309)
T ss_pred cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence 4568999999999865 568999999999999999999999998776544433222100
Q ss_pred CCC-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 506 LRP-------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 506 ~~~-------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
... .....+++++.++|.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000 011346789999999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=324.89 Aligned_cols=248 Identities=32% Similarity=0.541 Sum_probs=213.4
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.++||.|+||.||++.. .++.+++|++..... .....+.+|+.++++++||||+++++++.....+|++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 5788999999999999999987 457799999885532 245778999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
|+++++|.+++......+++..++.++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 999999999998765789999999999999999999999999999999999999999999999999987654332 2344
Q ss_pred CCCCCCccCcccccCC---CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC---CCCCCcHHHHHHH
Q 008171 449 ETGTYRWMAPEVIEHK---PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT---IPKNSQPKLAELL 522 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~---~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~---~p~~~~~~l~~Li 522 (575)
..++..|+|||.+.+. .++.++|+||||+++|+|++|..||...++.+.........+.+. .+...+.++.++|
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFI 240 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHH
Confidence 5788999999999777 899999999999999999999999988877666555444433322 2334578899999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 008171 523 ERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 523 ~~cL~~dP~~RPs~~ell~ 541 (575)
++||..+|.+||++.+++.
T Consensus 241 ~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 241 KKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHcCCChhhCCCHHHHhc
Confidence 9999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=345.14 Aligned_cols=248 Identities=23% Similarity=0.435 Sum_probs=228.7
Q ss_pred CceeeeeeeeecCceEEEEEE--ECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~--~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
.-|.+.+-||+|-|+.|-+++ .+|..||||++.+..++.-....+.+|+++|+.++|||||++|.+......+|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 457778899999999999986 489999999999888877777889999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEec-CCCcEEEeecccceecccCCcccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~-~~~~vkL~DFG~a~~~~~~~~~~~ 448 (575)
+-.+|+|+||+-+....+.+..+.+++.||+.|+.|+|+..++||||||+||.+. .-|-|||.|||++..+......+.
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~T 177 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTT 177 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhc
Confidence 9999999999999888999999999999999999999999999999999999886 568999999999988888888899
Q ss_pred CCCCCCccCcccccCCCCCc-hHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 008171 449 ETGTYRWMAPEVIEHKPYDH-KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~-ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~ 527 (575)
.+|+..|.|||++.+..|+. +.||||||+|||.|+||+.||+..+..+....++.-. ..+|..++.++++||..||.
T Consensus 178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK--YtvPshvS~eCrdLI~sMLv 255 (864)
T KOG4717|consen 178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK--YTVPSHVSKECRDLIQSMLV 255 (864)
T ss_pred ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc--ccCchhhhHHHHHHHHHHHh
Confidence 99999999999999999985 6899999999999999999999888888877766544 46899999999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 008171 528 QDPALRPDFSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs~~ell~ 541 (575)
.||.+|.+.+||..
T Consensus 256 RdPkkRAslEeI~s 269 (864)
T KOG4717|consen 256 RDPKKRASLEEIVS 269 (864)
T ss_pred cCchhhccHHHHhc
Confidence 99999999999863
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=332.05 Aligned_cols=254 Identities=29% Similarity=0.557 Sum_probs=209.4
Q ss_pred CCceeeeeeeeecCceEEEEEEECC------------------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCce
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYCS------------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~~------------------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv 352 (575)
.++|++.++||+|+||.||++.+.+ ..||+|+++... .......+.+|+.+++.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 4579999999999999999985432 248999987542 344457899999999999999999
Q ss_pred EEEeeecCCCCceeEEEeccCCchhhhhhhcc----------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEE
Q 008171 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK----------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422 (575)
Q Consensus 353 ~l~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~----------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NIL 422 (575)
++++++......|+||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 99999999999999999999999999987532 23677889999999999999999999999999999999
Q ss_pred ecCCCcEEEeecccceecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc--CCCCCCCCCHHHH
Q 008171 423 MDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLPYEYLTPLQA 497 (575)
Q Consensus 423 l~~~~~vkL~DFG~a~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt--G~~Pf~~~~~~~~ 497 (575)
++.++.++|+|||+++....... .....++..|++||+..+..++.++|||||||++|||++ |..||...+..+.
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 99999999999999875433221 112234678999999988899999999999999999998 7899987766554
Q ss_pred HHHHHh------cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 008171 498 AVGVVQ------KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 545 (575)
Q Consensus 498 ~~~v~~------~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~ 545 (575)
...... .......+..+++.+.+++.+||+.||.+||++.++++.|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 243 IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 433211 111223456788999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=322.14 Aligned_cols=248 Identities=33% Similarity=0.589 Sum_probs=216.0
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~---~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
+|+..+.||+|+||.||+|.. +++.|++|.+..... .....+.+.+|+.+++.++|+||+++++++.....+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 366778999999999999987 467899999865432 234567799999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccc
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 447 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 447 (575)
+||++|++|.+++.+ .+.+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 159 (258)
T cd06632 81 LELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK 159 (258)
T ss_pred EEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence 999999999999976 4568999999999999999999999999999999999999999999999999997665444345
Q ss_pred cCCCCCCccCcccccCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 008171 448 AETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 526 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~~~-~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL 526 (575)
...|+..|++||.+.... ++.++|+||||+++|+|++|..||......+...........+.++..+++.+.+++.+||
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 239 (258)
T cd06632 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL 239 (258)
T ss_pred ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHh
Confidence 567899999999997776 9999999999999999999999998877666555544434556778889999999999999
Q ss_pred hcCCCCCCCHHHHHH
Q 008171 527 QQDPALRPDFSEIIE 541 (575)
Q Consensus 527 ~~dP~~RPs~~ell~ 541 (575)
+.+|.+||++.+++.
T Consensus 240 ~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 240 QRDPSLRPTAAELLE 254 (258)
T ss_pred hcCcccCcCHHHHhc
Confidence 999999999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=344.95 Aligned_cols=249 Identities=24% Similarity=0.477 Sum_probs=224.0
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCCCcee
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~l~l 366 (575)
...|.+++.||+|.||.||+++. +++.+|+|+++..... ......+.+|+.+|+++. |||||++++++++...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 46789999999999999999976 4678999999866543 234567899999999999 9999999999999999999
Q ss_pred EEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC----CcEEEeecccceeccc
Q 008171 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN----EVVKVADFGVARVKAQ 442 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~----~~vkL~DFG~a~~~~~ 442 (575)
|||++.||.|.+.+... .+++..+..++.||+.++.|||+.||+||||||+|+|+... +.+|++|||++.....
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 99999999999999775 39999999999999999999999999999999999999643 4799999999998887
Q ss_pred CCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--CCCCCCCCcHHHHH
Q 008171 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIPKNSQPKLAE 520 (575)
Q Consensus 443 ~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~--~~~~p~~~~~~l~~ 520 (575)
.......+||+.|+|||++...+|+..+||||+|+++|.|++|..||.+.+.......+....+ .......++..+.+
T Consensus 192 ~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd 271 (382)
T KOG0032|consen 192 GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKD 271 (382)
T ss_pred CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHH
Confidence 6678888999999999999999999999999999999999999999999998888877776554 33445678999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 008171 521 LLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 521 Li~~cL~~dP~~RPs~~ell~ 541 (575)
++++|+..||..|+++.++++
T Consensus 272 ~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 272 FIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HHHHhcccCcccCCCHHHHhc
Confidence 999999999999999999987
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=341.07 Aligned_cols=238 Identities=21% Similarity=0.387 Sum_probs=200.5
Q ss_pred eeeeecCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCceeEEEeccC
Q 008171 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
+.||+|+||.||++... ++.||+|+++..... ......+.+|+.++.++ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999874 567999999865432 33456688899999888 599999999999999999999999999
Q ss_pred CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc-CCccccCCCC
Q 008171 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT 452 (575)
Q Consensus 374 gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~~~~Gt 452 (575)
++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+||
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (327)
T cd05617 81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT 159 (327)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence 999988865 46799999999999999999999999999999999999999999999999999875322 2234456799
Q ss_pred CCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC------CHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 008171 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL------TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 526 (575)
Q Consensus 453 ~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~------~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL 526 (575)
+.|+|||++.+..++.++|||||||+||+|++|..||... ...+........ ....+|..+++.+.++|.+||
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~li~~~L 238 (327)
T cd05617 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-KPIRIPRFLSVKASHVLKGFL 238 (327)
T ss_pred cccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-CCCCCCCCCCHHHHHHHHHHh
Confidence 9999999999999999999999999999999999999632 222233332322 234578889999999999999
Q ss_pred hcCCCCCCCHH
Q 008171 527 QQDPALRPDFS 537 (575)
Q Consensus 527 ~~dP~~RPs~~ 537 (575)
+.||.+|+++.
T Consensus 239 ~~dP~~R~~~~ 249 (327)
T cd05617 239 NKDPKERLGCQ 249 (327)
T ss_pred ccCHHHcCCCC
Confidence 99999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=327.90 Aligned_cols=248 Identities=26% Similarity=0.389 Sum_probs=204.9
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
+|++.++||+|+||.||+|+. +++.||||.++...........+.+|+.++++++||||+++++++..++.+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 478889999999999999987 467899999876544444456788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcc--CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-ccc
Q 008171 371 MSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT 447 (575)
Q Consensus 371 ~~ggsL~d~l~~~~--~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~ 447 (575)
++ ++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 96 58888876533 568999999999999999999999999999999999999999999999999997554322 233
Q ss_pred cCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC---------------------
Q 008171 448 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG--------------------- 505 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~--------------------- 505 (575)
...+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+............
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence 4567899999998865 457899999999999999999999998766544333222110
Q ss_pred ------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 506 ------LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 506 ------~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
........+++++.++|++||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000112357889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=345.11 Aligned_cols=260 Identities=28% Similarity=0.561 Sum_probs=223.5
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
.-++..+.+.|+++||+|.||.|.++...+ ..||||.++.+. .....++|..|+++|.+|+|||||.++|+|..++.+
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 346777889999999999999999998776 889999999763 455578999999999999999999999999999999
Q ss_pred eeEEEeccCCchhhhhhhccCc-CChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~-l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
|+|||||+.|+|.+|+.....+ +.......|+.||+.||+||.+.+++||||.+.|+|++.++++||+|||++|..-..
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999999999876433 355667789999999999999999999999999999999999999999999854433
Q ss_pred Cccc---cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc--CCCCCCCCCHHHHHHHHH---hcC---CCCCCCC
Q 008171 444 GVMT---AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT--GKLPYEYLTPLQAAVGVV---QKG---LRPTIPK 512 (575)
Q Consensus 444 ~~~~---~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt--G~~Pf~~~~~~~~~~~v~---~~~---~~~~~p~ 512 (575)
.... ..+-..+|||||.+..+.+++++|+|+||++|||+++ ...||..++..+...... ..+ .-+..|.
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~ 770 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPP 770 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCC
Confidence 2222 2245789999999999999999999999999999875 789999998877654422 211 2345788
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 513 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 513 ~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
-|+.++.++|-+||..+-.+||+|+++-..|++.
T Consensus 771 ~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 771 ACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 9999999999999999999999999999888764
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=347.44 Aligned_cols=243 Identities=25% Similarity=0.367 Sum_probs=197.3
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCcee
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~l 366 (575)
+....|++.++||+|+||.||++.+ +++.||||.... ..+.+|+.+|++++||||+++++++......|+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 4556899999999999999999987 467799997542 346789999999999999999999998899999
Q ss_pred EEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC--C
Q 008171 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--G 444 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~--~ 444 (575)
|+|++ +++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 161 v~e~~-~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 161 ILPRY-KTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred EEecC-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 99999 5788888866 467899999999999999999999999999999999999999999999999999653322 2
Q ss_pred ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHH---------------
Q 008171 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP-------LQAAVGVV--------------- 502 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~-------~~~~~~v~--------------- 502 (575)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... ......++
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 23345799999999999999999999999999999999999987643210 00000000
Q ss_pred -----------hcCC-CCC-CC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 503 -----------QKGL-RPT-IP-----KNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 503 -----------~~~~-~~~-~p-----~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.... .+. .+ ..++.++.+||.+||+.||.+|||+.|+++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 000 00 134668999999999999999999999984
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=321.15 Aligned_cols=248 Identities=25% Similarity=0.468 Sum_probs=215.5
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC--CCCceeEE
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIVT 368 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--~~~l~lV~ 368 (575)
+|++.+.||+|+||.||++.. .++.||+|+++...........+.+|+.++++++||||+++++++.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999976 45779999998766666666789999999999999999999997753 44579999
Q ss_pred EeccCCchhhhhhhc---cCcCChHHHHHHHHHHHHHHHHHH-----HCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 369 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLH-----QNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 369 E~~~ggsL~d~l~~~---~~~l~~~~~~~i~~qI~~aL~yLH-----~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
||+++++|.+++... ...+++..++.++.||+.||.||| +.+|+|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998654 467899999999999999999999 899999999999999999999999999999876
Q ss_pred ccCCc-cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 008171 441 AQSGV-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 519 (575)
Q Consensus 441 ~~~~~-~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~ 519 (575)
..... .....++..|+|||++.+..++.++|+||||+++|+|++|..||...+..... ..+..+..+.++..++..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 239 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA-SKIKEGKFRRIPYRYSSELN 239 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHH-HHHhcCCCCCCccccCHHHH
Confidence 55433 34457899999999999988999999999999999999999999987754443 34445555677888999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 008171 520 ELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 520 ~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+++.+||+.+|.+||++.++++
T Consensus 240 ~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 240 EVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred HHHHHHccCCcccCCCHHHHhh
Confidence 9999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=320.47 Aligned_cols=245 Identities=35% Similarity=0.683 Sum_probs=211.2
Q ss_pred eeeeecCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCCch
Q 008171 298 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ggsL 376 (575)
++||.|+||.||++.+. ++.||+|.++..... .....+.+|+.++++++|+||+++++++......++||||+.|++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 47999999999999875 788999998765433 4567899999999999999999999999999999999999999999
Q ss_pred hhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcc---ccCCCCC
Q 008171 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM---TAETGTY 453 (575)
Q Consensus 377 ~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~---~~~~Gt~ 453 (575)
.+++......++...+..++.+++.||.|||++|++||||||+||+++.++.+||+|||++......... ....++.
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence 9999776667899999999999999999999999999999999999999999999999999755422111 1223356
Q ss_pred CccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCC
Q 008171 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPAL 532 (575)
Q Consensus 454 ~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~ 532 (575)
.|+|||.+.+..++.++|+||||+++|+|++ |..||........... +........+..++.++.+++.+||+.+|.+
T Consensus 160 ~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 238 (251)
T cd05041 160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-IESGYRMPAPQLCPEEIYRLMLQCWAYDPEN 238 (251)
T ss_pred ccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-HhcCCCCCCCccCCHHHHHHHHHHhccChhh
Confidence 7999999998899999999999999999999 8999988876554443 3344455667788999999999999999999
Q ss_pred CCCHHHHHHHHH
Q 008171 533 RPDFSEIIEILQ 544 (575)
Q Consensus 533 RPs~~ell~~L~ 544 (575)
||++.|+++.|+
T Consensus 239 Rp~~~ell~~l~ 250 (251)
T cd05041 239 RPSFSEIYNELQ 250 (251)
T ss_pred CcCHHHHHHHhh
Confidence 999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=321.07 Aligned_cols=248 Identities=26% Similarity=0.464 Sum_probs=216.4
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
+|.+.+.||.|+||.||++.. .++.+|+|.+............+.+|+.+++.++||||+++++.+...+.+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478899999999999999876 567799999987665666678899999999999999999999999988899999999
Q ss_pred ccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC-CcEEEeecccceecccCCcccc
Q 008171 371 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSGVMTA 448 (575)
Q Consensus 371 ~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~-~~vkL~DFG~a~~~~~~~~~~~ 448 (575)
++|++|.+++.... ..+++..++.++.|++.||.|||++||+|+||+|+||+++.+ +.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence 99999999997653 458999999999999999999999999999999999999855 4689999999987655444444
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 528 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~ 528 (575)
..|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......... .....++..+++++.+++.+||+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~ 239 (256)
T cd08220 161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-GTFAPISDRYSPDLRQLILSMLNL 239 (256)
T ss_pred cccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh-cCCCCCCCCcCHHHHHHHHHHccC
Confidence 5789999999999998899999999999999999999999988777665555443 334456778899999999999999
Q ss_pred CCCCCCCHHHHHH
Q 008171 529 DPALRPDFSEIIE 541 (575)
Q Consensus 529 dP~~RPs~~ell~ 541 (575)
+|.+|||+.|++.
T Consensus 240 ~p~~Rpt~~~ll~ 252 (256)
T cd08220 240 DPSKRPQLSQIMA 252 (256)
T ss_pred ChhhCCCHHHHhh
Confidence 9999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=327.61 Aligned_cols=255 Identities=31% Similarity=0.618 Sum_probs=215.0
Q ss_pred CCceeeeeeeeecCceEEEEEEEC------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC--CC
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PP 362 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--~~ 362 (575)
..+|++.+.||+|+||.||++++. +..||||+++..... .....|.+|+.+++.+.||||+++++++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 457888899999999999999864 467999999865443 346789999999999999999999999877 55
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
..++||||+++++|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 78999999999999999987666799999999999999999999999999999999999999999999999999986653
Q ss_pred CCc----cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH--------------HHHHHHHHhc
Q 008171 443 SGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP--------------LQAAVGVVQK 504 (575)
Q Consensus 443 ~~~----~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~--------------~~~~~~v~~~ 504 (575)
... .....++..|++||.+.+..++.++||||||+++|+|++|..|+..... .......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 221 1123456679999999888999999999999999999999999864321 1122233444
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 505 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 505 ~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
..+...+..++.++.+++.+||+.+|.+||++.|++++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 455555677889999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=331.04 Aligned_cols=258 Identities=31% Similarity=0.625 Sum_probs=217.5
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE--CCc----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~----~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
+...+|++.+.||+|+||.||+|.+ .+. .||+|.+.... .......+.+|+.+++.++||||++++++|...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 4456788999999999999999986 333 47888887543 233345788999999999999999999998754
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
..++++||+++|+|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 57899999999999999987666789999999999999999999999999999999999999999999999999976543
Q ss_pred CCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 008171 443 SGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 443 ~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
... .....++..|+|||++.+..++.++||||||+++|||++ |..||......+. ...+..+..+..+..++..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLEKGERLPQPPICTIDV 240 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCCCCCCCCCCCHHH
Confidence 221 122345678999999999999999999999999999997 9999987765443 44455565666677788999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
.+++.+||..+|++||++.++++.|+.+...
T Consensus 241 ~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 241 YMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=323.41 Aligned_cols=245 Identities=30% Similarity=0.548 Sum_probs=199.8
Q ss_pred eeeeecCceEEEEEEEC-C---ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccC
Q 008171 298 SKVASGSYGDLYRGTYC-S---QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~-~---~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
++||+|+||.||+|... + ..+++|.+.... .......+.+|+.+++.++||||+++++.+.....+|+||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 36899999999999752 2 357888766432 344456788999999999999999999999999999999999999
Q ss_pred CchhhhhhhccC----cCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc---c
Q 008171 374 GSVYDYLHKLKG----VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---M 446 (575)
Q Consensus 374 gsL~d~l~~~~~----~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~---~ 446 (575)
|+|.+++..... ..++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 999999976432 246778889999999999999999999999999999999999999999999865433221 1
Q ss_pred ccCCCCCCccCccccc-------CCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCC----CCCCCCCC
Q 008171 447 TAETGTYRWMAPEVIE-------HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGL----RPTIPKNS 514 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~-------~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~----~~~~p~~~ 514 (575)
....++..|+|||++. ...++.++|||||||++|||++ |..||....+.+.....+.... .+.++..+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKY 239 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccC
Confidence 2234567899999974 3457889999999999999999 8899988877766555444322 23455678
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 008171 515 QPKLAELLERCWQQDPALRPDFSEIIEILQ 544 (575)
Q Consensus 515 ~~~l~~Li~~cL~~dP~~RPs~~ell~~L~ 544 (575)
++.+.+++..|| .||.+||+++++++.|.
T Consensus 240 ~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 240 SDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 899999999999 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=370.58 Aligned_cols=253 Identities=22% Similarity=0.425 Sum_probs=212.2
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC--CCC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPS 363 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--~~~ 363 (575)
+....+|.++++||+|+||+||+++.. ++.||+|++............|..|+.+|++|+|||||+++++|.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 455578999999999999999999874 5669999998766666667789999999999999999999998744 456
Q ss_pred ceeEEEeccCCchhhhhhhc---cCcCChHHHHHHHHHHHHHHHHHHHC-------CceecccCCCCEEecC--------
Q 008171 364 LCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQN-------NIIHRDLKAANLLMDE-------- 425 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~---~~~l~~~~~~~i~~qI~~aL~yLH~~-------gIiHrDLKp~NILl~~-------- 425 (575)
+||||||+.+++|.++|... .+.+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999999753 35799999999999999999999985 4999999999999964
Q ss_pred ---------CCcEEEeecccceecccCCccccCCCCCCccCcccccC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 008171 426 ---------NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (575)
Q Consensus 426 ---------~~~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~--~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (575)
.+.+||+|||++.............||+.|+|||++.+ ..++.++||||||||||+|++|..||.....
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 23599999999986655444455679999999999854 4589999999999999999999999987766
Q ss_pred HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 495 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 495 ~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.......+...... .....++++.+||.+||+.+|.+||++.|++.
T Consensus 249 ~~qli~~lk~~p~l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 249 FSQLISELKRGPDL-PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHHHHhcCCCC-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 55555544443221 22456899999999999999999999999984
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=328.53 Aligned_cols=249 Identities=27% Similarity=0.485 Sum_probs=211.5
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
.+.|++.++||.|+||.||+|+.. ++.|++|++... .......+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 356999999999999999999874 577999998754 3445677899999999999999999999999889999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-Cccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT 447 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~ 447 (575)
||++|++|..++.+....+++..++.++.||+.+|.|||++||+||||||+||+++.++.++|+|||++...... ....
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence 999999999888766677999999999999999999999999999999999999999999999999998653322 2233
Q ss_pred cCCCCCCccCccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHH
Q 008171 448 AETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAEL 521 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~~~~p~~~~~~l~~L 521 (575)
...+++.|+|||++. ...++.++|||||||++|+|++|..||...++.+.......... ....+..++.++.++
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF 248 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHH
Confidence 456889999999984 44578899999999999999999999988777665544432211 123456778899999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 008171 522 LERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 522 i~~cL~~dP~~RPs~~ell~ 541 (575)
|.+||+.+|++||++.++++
T Consensus 249 i~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 249 LKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHhcCCcccCcCHHHHhc
Confidence 99999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=324.80 Aligned_cols=254 Identities=27% Similarity=0.544 Sum_probs=215.0
Q ss_pred CCCceeeeeeeeecCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~~-------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
..++|++.+.||+|+||.||+|+.. .+.|++|.+.... .......+.+|+.++++++|+||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4467889999999999999999853 3459999876532 2334577999999999999999999999999988
Q ss_pred CceeEEEeccCCchhhhhhhcc--------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeec
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLK--------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~--------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DF 434 (575)
..|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999999997643 15899999999999999999999999999999999999999999999999
Q ss_pred ccceecccCC--ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 008171 435 GVARVKAQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIP 511 (575)
Q Consensus 435 G~a~~~~~~~--~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p 511 (575)
|++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....................+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP 241 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence 9986443221 2233456778999999988889999999999999999998 889998777666555544444444456
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 008171 512 KNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 544 (575)
Q Consensus 512 ~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~ 544 (575)
..++..+.+++.+||+.+|.+||++.++++.|.
T Consensus 242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 778999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=322.16 Aligned_cols=248 Identities=29% Similarity=0.525 Sum_probs=210.7
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC--CCc
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSL 364 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~---~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~~l 364 (575)
.+|++.+.||+|+||.||+|.. ++..||||.+..... .......+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5788999999999999999986 467799998864322 123456788999999999999999999988653 457
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS- 443 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~- 443 (575)
++||||++|++|.+++.. .+.+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 899999999999999876 356888999999999999999999999999999999999999999999999998754321
Q ss_pred ---CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 008171 444 ---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 520 (575)
Q Consensus 444 ---~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~ 520 (575)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.||..................+.+|...+..+.+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 12334568999999999988889999999999999999999999998877666655555445556677788899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 008171 521 LLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 521 Li~~cL~~dP~~RPs~~ell~ 541 (575)
+|++||. +|.+||+++++++
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhc
Confidence 9999995 9999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=328.16 Aligned_cols=247 Identities=30% Similarity=0.524 Sum_probs=212.1
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.++||.|+||.||++.+. ++.||+|+++.. .......+.+|+.++++++||||+++++++......|+|||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 46888999999999999999874 677999998754 34445778999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-Ccccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~ 448 (575)
|+++++|.+++.+....+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++...... .....
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 162 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT 162 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccce
Confidence 99999999999876678999999999999999999999999999999999999999999999999988654332 22334
Q ss_pred CCCCCCccCccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHHHH
Q 008171 449 ETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPKLAEL 521 (575)
Q Consensus 449 ~~Gt~~y~APE~i~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~--~~p~~~~~~l~~L 521 (575)
..+++.|+|||++. ...++.++|+||||+++|+|++|..||....+.+....+. ....+ ..+..++.++.++
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l 241 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL-KSEPPTLDQPSKWSSSFNDF 241 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHh-cCCCCCcCCcccCCHHHHHH
Confidence 56899999999974 4557889999999999999999999999887766555443 33222 3456788999999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 008171 522 LERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 522 i~~cL~~dP~~RPs~~ell~ 541 (575)
|.+||+.+|.+||++.++++
T Consensus 242 i~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 242 LKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred HHHHhccChhhCcCHHHHhc
Confidence 99999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=324.59 Aligned_cols=247 Identities=32% Similarity=0.540 Sum_probs=207.1
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCC------C
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP------P 362 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~------~ 362 (575)
..|.+.++||.|+||.||+|.. .++.||+|++.... .....+.+|+.+++++ +||||+++++++... .
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4577888999999999999987 45779999987543 2235678899999998 699999999988642 4
Q ss_pred CceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
.+|+||||+.+++|.+++.... ..+++..+..++.||+.||.|||+++|+|+||||+||++++++.++|+|||++....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 5799999999999999987643 568999999999999999999999999999999999999999999999999997654
Q ss_pred cC-CccccCCCCCCccCccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 008171 442 QS-GVMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 515 (575)
Q Consensus 442 ~~-~~~~~~~Gt~~y~APE~i~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~ 515 (575)
.. .......|++.|+|||++. +..++.++|||||||++|+|++|..||....+............+...+..++
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 242 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcC
Confidence 32 2334557899999999985 34688899999999999999999999987776665554444444444556788
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 516 PKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 516 ~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.++.+||.+||+.||.+||++.++++
T Consensus 243 ~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 243 KKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 99999999999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=325.68 Aligned_cols=248 Identities=29% Similarity=0.508 Sum_probs=208.1
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
.++|++.++||+|+||.||+|.. +++.||+|+++... ......+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 35788899999999999999987 46789999987553 223456788999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-Cccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT 447 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~ 447 (575)
||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...... ....
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06645 86 EFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK 164 (267)
T ss_pred eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence 99999999999876 567999999999999999999999999999999999999999999999999998755432 2233
Q ss_pred cCCCCCCccCccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC---CCCCcHHHHHH
Q 008171 448 AETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI---PKNSQPKLAEL 521 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~---p~~~~~~l~~L 521 (575)
...|+..|+|||++. ...++.++|+|||||++|+|++|..||....+.............+.. ...++..+.++
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHF 244 (267)
T ss_pred cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHH
Confidence 457899999999974 556889999999999999999999999776655444333333332221 12467889999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 008171 522 LERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 522 i~~cL~~dP~~RPs~~ell~ 541 (575)
|.+||+.+|++||++.++++
T Consensus 245 i~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 245 VKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHccCCchhCcCHHHHhc
Confidence 99999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=318.89 Aligned_cols=248 Identities=41% Similarity=0.766 Sum_probs=214.1
Q ss_pred eeeeeeeeecCceEEEEEEECC------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 294 LKFGSKVASGSYGDLYRGTYCS------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~~~------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
+.+.+.||.|+||.||++.+.. ..||+|+++.... ......+.+|+.+++.++|+||+++++++...+..|++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567899999999999998864 6799999976533 22467899999999999999999999999998999999
Q ss_pred EEeccCCchhhhhhhccCc-CChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcc
Q 008171 368 TEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~-l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 446 (575)
|||+++++|.+++...... +++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 9999999999999765444 899999999999999999999999999999999999999999999999999766544222
Q ss_pred c--cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 008171 447 T--AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 523 (575)
Q Consensus 447 ~--~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~ 523 (575)
. ...+++.|+|||.+....++.++||||||+++|+|++ |..||...+..+....+ .....+..+..++.++.+++.
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~ 238 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYL-KKGYRLPKPENCPPEIYKLML 238 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-hcCCCCCCCCcCCHHHHHHHH
Confidence 2 2336789999999988889999999999999999998 89999887776655543 344556677789999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHH
Q 008171 524 RCWQQDPALRPDFSEIIEIL 543 (575)
Q Consensus 524 ~cL~~dP~~RPs~~ell~~L 543 (575)
+||..||.+|||+.++++.|
T Consensus 239 ~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 239 QCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHCcCChhhCcCHHHHHhhC
Confidence 99999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=319.36 Aligned_cols=248 Identities=24% Similarity=0.481 Sum_probs=216.5
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
+|++.++||+|+||.||+++. .++.||+|.+............+.+|+.++++++||||+++++++...+..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478899999999999999876 567899999876555555567899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc-ccc
Q 008171 371 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-MTA 448 (575)
Q Consensus 371 ~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~ 448 (575)
+.+++|.+++.... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 99999999987643 3588999999999999999999999999999999999999999999999999976544322 223
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 528 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~ 528 (575)
..|++.|+|||++.+..++.++|+|||||++|+|++|..||......+....+. .+..+..+..++.++.++|.+||+.
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~ 239 (256)
T cd08218 161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQLFKR 239 (256)
T ss_pred ccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHHHhhC
Confidence 468899999999999999999999999999999999999998877766655544 3445567788899999999999999
Q ss_pred CCCCCCCHHHHHH
Q 008171 529 DPALRPDFSEIIE 541 (575)
Q Consensus 529 dP~~RPs~~ell~ 541 (575)
+|.+||++.++++
T Consensus 240 ~p~~Rp~~~~vl~ 252 (256)
T cd08218 240 NPRDRPSVNSILE 252 (256)
T ss_pred ChhhCcCHHHHhh
Confidence 9999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=325.31 Aligned_cols=243 Identities=29% Similarity=0.510 Sum_probs=202.8
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.++||+|+||.||+|.+ +++.||+|++.... .......+.+|+.++++++||||+++++.+...+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 3678889999999999999986 56779999987542 34455679999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccccC
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 449 (575)
|+++++|..+ ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...... .....
T Consensus 80 ~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~ 153 (279)
T cd06619 80 FMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTY 153 (279)
T ss_pred cCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCC
Confidence 9999998654 34688899999999999999999999999999999999999999999999999755432 33455
Q ss_pred CCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhcCCCCCC-CCCCcHHHHHH
Q 008171 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP-------LQAAVGVVQKGLRPTI-PKNSQPKLAEL 521 (575)
Q Consensus 450 ~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~-------~~~~~~v~~~~~~~~~-p~~~~~~l~~L 521 (575)
.||..|+|||++.+..++.++|+||||+++|+|++|..||..... ......+... ..+.. ....++++.++
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 232 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-DPPVLPVGQFSEKFVHF 232 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-CCCCCCCCcCCHHHHHH
Confidence 789999999999999999999999999999999999999965322 1222222211 22222 34578899999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 008171 522 LERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 522 i~~cL~~dP~~RPs~~ell~~ 542 (575)
+.+||+.+|.+||++.++++.
T Consensus 233 i~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 233 ITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHhhCChhhCCCHHHHhcC
Confidence 999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=322.35 Aligned_cols=245 Identities=28% Similarity=0.511 Sum_probs=198.4
Q ss_pred eeeeecCceEEEEEEECC----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccC
Q 008171 298 SKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~~----~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
+.||+|+||.||+|.+.+ ..+|+|.++.... ......+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 368999999999998643 4589998876543 23345788999999999999999999999998899999999999
Q ss_pred Cchhhhhhhcc----CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc---c
Q 008171 374 GSVYDYLHKLK----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---M 446 (575)
Q Consensus 374 gsL~d~l~~~~----~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~---~ 446 (575)
++|.+++.... ...++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++....... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 99999997532 2456677888999999999999999999999999999999999999999999975433221 1
Q ss_pred ccCCCCCCccCcccccCC-------CCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcC-C---CCCCCCCC
Q 008171 447 TAETGTYRWMAPEVIEHK-------PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG-L---RPTIPKNS 514 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~-------~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~-~---~~~~p~~~ 514 (575)
....++..|+|||++.+. .++.++||||||+++|||++ |..||......+.....+... . .+.+....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL 239 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCC
Confidence 234578889999998642 35789999999999999996 999998877665543322221 1 23333457
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 008171 515 QPKLAELLERCWQQDPALRPDFSEIIEILQ 544 (575)
Q Consensus 515 ~~~l~~Li~~cL~~dP~~RPs~~ell~~L~ 544 (575)
++.+.++|++|| .+|++|||+.+|+..|+
T Consensus 240 ~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 240 SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 789999999999 68999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=320.39 Aligned_cols=246 Identities=32% Similarity=0.548 Sum_probs=212.4
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.++||+|+||.||+|... ++.|++|.++... ....+.+|+.++++++||||+++++.+.....+|+++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 57888999999999999999875 5779999987542 15789999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
|+++++|.+++......+++..++.++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||++....... ....
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 999999999998767789999999999999999999999999999999999999999999999999987654432 2334
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCcHHHHHHHHHhhh
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~-~~~~~p~~~~~~l~~Li~~cL~ 527 (575)
..++..|+|||++.+..++.++||||||+++|+|++|+.||....+.+....+.... .....+..++.++.++|.+||+
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLV 238 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHh
Confidence 568899999999999999999999999999999999999998877665443322211 1122345677899999999999
Q ss_pred cCCCCCCCHHHHHH
Q 008171 528 QDPALRPDFSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs~~ell~ 541 (575)
.||.+||++.|++.
T Consensus 239 ~~P~~Rps~~~il~ 252 (256)
T cd06612 239 KDPEERPSAIQLLQ 252 (256)
T ss_pred cChhhCcCHHHHhc
Confidence 99999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=322.26 Aligned_cols=248 Identities=29% Similarity=0.505 Sum_probs=211.0
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCC---hHHHHHHHHHHHHHHhcCCCCceEEEeeecC--CCCc
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN---SDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSL 364 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--~~~l 364 (575)
..|++.+.||+|+||.||++.. ++..|++|.+...... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4678889999999999999986 4678999998754322 2345678899999999999999999998765 3567
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS- 443 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~- 443 (575)
++++||+++++|.+++.. .+.++...++.++.||+.||.|||+++|+|+||||+||+++.++.+||+|||+++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 899999999999999976 456899999999999999999999999999999999999999999999999998754321
Q ss_pred ---CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 008171 444 ---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 520 (575)
Q Consensus 444 ---~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~ 520 (575)
.......++..|+|||++.+..++.++|||||||++|+|++|+.||......+...........+.++..+++.+.+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence 11223468899999999999999999999999999999999999998887766666555555567778888999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 008171 521 LLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 521 Li~~cL~~dP~~RPs~~ell~ 541 (575)
++ +||..+|++||++.|+++
T Consensus 241 li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhc
Confidence 99 688889999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=322.99 Aligned_cols=238 Identities=27% Similarity=0.502 Sum_probs=196.4
Q ss_pred eeeeecCceEEEEEEECC--------------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCC
Q 008171 298 SKVASGSYGDLYRGTYCS--------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~~--------------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 363 (575)
+.||+|+||.||+|+... ..|++|++.... ......|.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 468999999999998532 248888876542 3445678899999999999999999999999899
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCc-------EEEeeccc
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV-------VKVADFGV 436 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~-------vkL~DFG~ 436 (575)
.++||||+++++|..++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ++++|||+
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 99999999999999998776677999999999999999999999999999999999999987654 89999999
Q ss_pred ceecccCCccccCCCCCCccCccccc-CCCCCchHHHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 008171 437 ARVKAQSGVMTAETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELL-TGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 514 (575)
Q Consensus 437 a~~~~~~~~~~~~~Gt~~y~APE~i~-~~~~s~ksDVwSlGviL~eLl-tG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~ 514 (575)
+..... .....++..|+|||++. +..++.++|||||||++|+|+ .|..||......+... ...... ......
T Consensus 159 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~--~~~~~~ 232 (262)
T cd05077 159 PITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQC--MLVTPS 232 (262)
T ss_pred CccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCc--cCCCCC
Confidence 864432 23446788999999986 567999999999999999998 5899988765544322 122211 223345
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 008171 515 QPKLAELLERCWQQDPALRPDFSEIIEIL 543 (575)
Q Consensus 515 ~~~l~~Li~~cL~~dP~~RPs~~ell~~L 543 (575)
++++.++|.+||+.||.+||++.+|++.|
T Consensus 233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 233 CKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 67899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=362.18 Aligned_cols=263 Identities=32% Similarity=0.668 Sum_probs=234.6
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEEC---------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEE
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFI 355 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~---------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~ 355 (575)
.|+++.+.+++.+.||+|.||.|++|... ...||||.++..... ...+.+..|+.+|+.+. |+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 89999999999999999999999999743 245999999976655 56788999999999996 99999999
Q ss_pred eeecCCCCceeEEEeccCCchhhhhhhcc---------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCC
Q 008171 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (575)
Q Consensus 356 ~~~~~~~~l~lV~E~~~ggsL~d~l~~~~---------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~N 420 (575)
|+|...+.+++|+||+..|+|.++++..+ ..++...++.++.||+.||+||++..+|||||..+|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999998766 348899999999999999999999999999999999
Q ss_pred EEecCCCcEEEeecccceecccCCccc--cCC--CCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 008171 421 LLMDENEVVKVADFGVARVKAQSGVMT--AET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL 495 (575)
Q Consensus 421 ILl~~~~~vkL~DFG~a~~~~~~~~~~--~~~--Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~ 495 (575)
||++.+..+||+|||+++......... ... -...|||||.+....|+.++||||||++|||+++ |..||.+....
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999999998654443332 222 2456999999999999999999999999999999 99999997744
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 496 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 496 ~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
......+..+.+...|..|+++++++|+.||+.+|++||+|.++.+.|...+.+
T Consensus 529 ~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 529 EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 445668899999999999999999999999999999999999999999997654
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=334.90 Aligned_cols=251 Identities=22% Similarity=0.410 Sum_probs=202.6
Q ss_pred eeeeeeec--CceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEec
Q 008171 296 FGSKVASG--SYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (575)
Q Consensus 296 i~~~LG~G--~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~ 371 (575)
++++||+| +||+||++.. +++.||+|.++...........+.+|+.+++.++||||+++++++..++.+|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 6889999976 4678999999876555555667888999999999999999999999999999999999
Q ss_pred cCCchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC------
Q 008171 372 SGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG------ 444 (575)
Q Consensus 372 ~ggsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~------ 444 (575)
++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||.+......+
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 999999999654 3458999999999999999999999999999999999999999999999998654322111
Q ss_pred --ccccCCCCCCccCcccccC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-------------
Q 008171 445 --VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR------------- 507 (575)
Q Consensus 445 --~~~~~~Gt~~y~APE~i~~--~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~------------- 507 (575)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||......+...........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEEL 241 (327)
T ss_pred ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhc
Confidence 1122356788999999976 46899999999999999999999999876654433332211100
Q ss_pred -------------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 008171 508 -------------------------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQI 546 (575)
Q Consensus 508 -------------------------------~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~--~L~~l 546 (575)
......+++.+.+|+.+||+.||.+|||+.|+++ .++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0012235678999999999999999999999986 35444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=356.55 Aligned_cols=259 Identities=24% Similarity=0.410 Sum_probs=218.0
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEECC--ccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeee-c
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGAC-T 359 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~--~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~-~ 359 (575)
+..++|..-++++.+.|.+|+|+.||++...+ ..||+|.+-.. ++...+.+.+|+.+|++|. |+|||.+++.. .
T Consensus 29 G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 29 GQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred ceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 35678999999999999999999999998753 67999988754 6677888999999999997 99999999932 1
Q ss_pred C------CCCceeEEEeccCCchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCC--ceecccCCCCEEecCCCcEE
Q 008171 360 K------PPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVK 430 (575)
Q Consensus 360 ~------~~~l~lV~E~~~ggsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~g--IiHrDLKp~NILl~~~~~vk 430 (575)
. ...++|.||||.||+|-|++..+ ...|++..+++|+.|+++|+.+||... |||||||-+||||+.+|.+|
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence 1 12467999999999999999754 355999999999999999999999998 99999999999999999999
Q ss_pred EeecccceecccCCccc----------cCCCCCCccCcccc---cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 008171 431 VADFGVARVKAQSGVMT----------AETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497 (575)
Q Consensus 431 L~DFG~a~~~~~~~~~~----------~~~Gt~~y~APE~i---~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~ 497 (575)
|||||.+.......... ....|+.|+|||+| .+.+.+.|+|||+|||+||-|+....||+......+
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI 266 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI 266 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE
Confidence 99999997544332111 12469999999998 578899999999999999999999999997654433
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 498 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 498 ~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
+...+.......++..|.+||+.||+.||.+||++.|++..+..+..
T Consensus 267 ----lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 267 ----LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred ----EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 33334333335789999999999999999999999999999888753
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=319.24 Aligned_cols=248 Identities=30% Similarity=0.544 Sum_probs=211.0
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
+|++.+.||+|+||.||+|.. .++.|++|+++...........+.+|+.+++.++|+||+++++.+...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 578889999999999999986 567899999987665555678899999999999999999999999988999999999
Q ss_pred ccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcc----
Q 008171 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM---- 446 (575)
Q Consensus 371 ~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~---- 446 (575)
+++++|.+++.. ...+++..+..++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 999999999976 456889999999999999999999999999999999999999999999999998765443221
Q ss_pred -ccCCCCCCccCcccccCCC---CCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC--cHHHHH
Q 008171 447 -TAETGTYRWMAPEVIEHKP---YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS--QPKLAE 520 (575)
Q Consensus 447 -~~~~Gt~~y~APE~i~~~~---~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~--~~~l~~ 520 (575)
....++..|+|||++.+.. ++.++||||||+++|+|++|..||..................+.+|... ++.+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 1346789999999998766 8899999999999999999999997664332222222234445555554 899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 008171 521 LLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 521 Li~~cL~~dP~~RPs~~ell~ 541 (575)
+|.+||+.+|.+||++.+++.
T Consensus 240 li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHccCCcccCCCHHHHhc
Confidence 999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=324.86 Aligned_cols=246 Identities=28% Similarity=0.504 Sum_probs=208.8
Q ss_pred eeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEec
Q 008171 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~ 371 (575)
|++.++||.|+||.||+|.+. +..+++|.+... .......+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 577889999999999999875 456888888643 2344567899999999999999999999999999999999999
Q ss_pred cCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-CccccCC
Q 008171 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAET 450 (575)
Q Consensus 372 ~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~ 450 (575)
++++|..++......+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... .......
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 164 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 164 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccccc
Confidence 999999988765678999999999999999999999999999999999999999999999999998654332 1233456
Q ss_pred CCCCccCccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCcHHHHHHHHH
Q 008171 451 GTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPKNSQPKLAELLER 524 (575)
Q Consensus 451 Gt~~y~APE~i~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~-~~~~~p~~~~~~l~~Li~~ 524 (575)
++..|+|||++. +..++.++|||||||++|+|++|..||...++.+......... .....+..++.++.++|.+
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 244 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKK 244 (282)
T ss_pred ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHH
Confidence 899999999983 4567889999999999999999999998887766655543322 1223466788999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 008171 525 CWQQDPALRPDFSEIIE 541 (575)
Q Consensus 525 cL~~dP~~RPs~~ell~ 541 (575)
||+.||.+||++.++++
T Consensus 245 ~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 245 CLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HccCChhhCcCHHHHhc
Confidence 99999999999998864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=327.69 Aligned_cols=248 Identities=22% Similarity=0.364 Sum_probs=202.1
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
+|++.++||+|+||.||+|.+ +++.||+|.++...........+.+|+.++++++||||+++++++.+...+|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 478889999999999999987 467899999976544444446678899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-CccccC
Q 008171 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAE 449 (575)
Q Consensus 371 ~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~ 449 (575)
+. ++|.+++....+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..... ......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE 159 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence 96 5888888766678999999999999999999999999999999999999999999999999999754432 223445
Q ss_pred CCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHhc------------------CCCC-
Q 008171 450 TGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYE-YLTPLQAAVGVVQK------------------GLRP- 508 (575)
Q Consensus 450 ~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~-~~~~~~~~~~v~~~------------------~~~~- 508 (575)
.++..|+|||++.+. .++.++|||||||++|+|++|..||. ..+.......+... ...+
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07839 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM 239 (284)
T ss_pred ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCC
Confidence 678999999998664 47999999999999999999988864 33322222111100 0000
Q ss_pred --------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 --------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 --------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.....+++++.++|.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 112356789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=323.68 Aligned_cols=246 Identities=33% Similarity=0.554 Sum_probs=213.8
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.+.||.|+||.||+|.. +++.||+|++.... .......+.+|+.+++.++|+||+++++++.....+|+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 3678889999999999999987 46779999987553 23345678899999999999999999999998899999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-Ccccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~ 448 (575)
|+++++|.+++.. ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+++..... .....
T Consensus 80 ~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 80 YCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred eeCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence 9999999999976 37899999999999999999999999999999999999999999999999999776543 23345
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCC-CcHHHHHHHHHhhh
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN-SQPKLAELLERCWQ 527 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~-~~~~l~~Li~~cL~ 527 (575)
..++..|+|||++.+..++.++||||||+++|+|++|..||...++...... +.....+.++.. +++.+.+++.+||.
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~l~ 236 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL-IPKNNPPSLEGNKFSKPFKDFVSLCLN 236 (274)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH-hhhcCCCCCcccccCHHHHHHHHHHhh
Confidence 5788999999999988899999999999999999999999988776555433 334455555555 88999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 008171 528 QDPALRPDFSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs~~ell~ 541 (575)
.+|++||+++++++
T Consensus 237 ~~p~~Rpt~~~il~ 250 (274)
T cd06609 237 KDPKERPSAKELLK 250 (274)
T ss_pred CChhhCcCHHHHhh
Confidence 99999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=326.11 Aligned_cols=237 Identities=27% Similarity=0.482 Sum_probs=196.6
Q ss_pred eeeecCceEEEEEEECC--------------------------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCce
Q 008171 299 KVASGSYGDLYRGTYCS--------------------------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352 (575)
Q Consensus 299 ~LG~G~fG~Vy~~~~~~--------------------------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv 352 (575)
+||+|+||.||+|.... ..|++|++... .......|.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 69999999999987411 23888888643 233456788999999999999999
Q ss_pred EEEeeecCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC-----
Q 008171 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----- 427 (575)
Q Consensus 353 ~l~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~----- 427 (575)
+++++|......++||||+++++|..++....+.+++..+..++.||+.||.|||++||+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 999999999999999999999999999977677899999999999999999999999999999999999997543
Q ss_pred --cEEEeecccceecccCCccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHHh
Q 008171 428 --VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELL-TGKLPYEYLTPLQAAVGVVQ 503 (575)
Q Consensus 428 --~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLl-tG~~Pf~~~~~~~~~~~v~~ 503 (575)
.+|++|||++..... .....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||....+.+... ...
T Consensus 160 ~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~ 235 (274)
T cd05076 160 SPFIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYE 235 (274)
T ss_pred cceeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHH
Confidence 489999998754322 123457888999998865 56899999999999999995 6999998876654432 222
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 008171 504 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 543 (575)
Q Consensus 504 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L 543 (575)
.. ..++...++.+.++|.+||+.+|.+||++.++++.|
T Consensus 236 ~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 236 KK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred hc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 22 234455668899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.50 Aligned_cols=244 Identities=27% Similarity=0.461 Sum_probs=213.2
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|.+.+.||+|+||.||++.+ .++.||+|++..... .......+.+|+.++++++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 3688999999999999999987 467899999875433 2334567889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 448 (575)
||+++++|.+++.. .+.++...+..++.||+.||.|||++||+|+||+|.||+++.++.+||+|||++...... ...
T Consensus 81 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~ 157 (290)
T cd05580 81 EYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYT 157 (290)
T ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCC
Confidence 99999999999977 467899999999999999999999999999999999999999999999999999765543 334
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 528 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~ 528 (575)
..|++.|+|||.+.+..++.++||||||+++|+|++|..||......+....+. ...+.+|...++.+.++|.+||..
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~ 235 (290)
T cd05580 158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIRNLLQV 235 (290)
T ss_pred CCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHHHHccC
Confidence 568999999999988889999999999999999999999998877655554444 234567788899999999999999
Q ss_pred CCCCCC-----CHHHHH
Q 008171 529 DPALRP-----DFSEII 540 (575)
Q Consensus 529 dP~~RP-----s~~ell 540 (575)
||.+|+ ++.+++
T Consensus 236 ~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 236 DLTKRLGNLKNGVNDIK 252 (290)
T ss_pred CHHHccCcccCCHHHHH
Confidence 999998 777776
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=348.40 Aligned_cols=244 Identities=30% Similarity=0.471 Sum_probs=217.7
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
.|.-++.||.|+||.||-+.+ +.+.||||.+....- ...-...++.|+..|++++|||+|.+-|+|..+...++|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 466678999999999999976 457799999986543 33456789999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccccC
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 449 (575)
|| -||-.|++.-.+.++.+-.+..|+.+.+.||.|||+.+.||||||+.|||+++.|.|||+|||.|...... ..+
T Consensus 107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---nsF 182 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---NSF 182 (948)
T ss_pred HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch---hcc
Confidence 99 67999999888899999999999999999999999999999999999999999999999999999766543 467
Q ss_pred CCCCCccCcccc---cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 008171 450 TGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 526 (575)
Q Consensus 450 ~Gt~~y~APE~i---~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL 526 (575)
+|||+|||||+| ..+.|+-|+||||||+++.||.-.++|+..++...+...+.+..-........+..|+.|+..||
T Consensus 183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CL 262 (948)
T KOG0577|consen 183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCL 262 (948)
T ss_pred cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHH
Confidence 899999999998 45779999999999999999999999999999999998877654333334578999999999999
Q ss_pred hcCCCCCCCHHHHH
Q 008171 527 QQDPALRPDFSEII 540 (575)
Q Consensus 527 ~~dP~~RPs~~ell 540 (575)
++-|.+|||..+++
T Consensus 263 qKipqeRptse~ll 276 (948)
T KOG0577|consen 263 QKIPQERPTSEELL 276 (948)
T ss_pred hhCcccCCcHHHHh
Confidence 99999999999876
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=338.05 Aligned_cols=250 Identities=26% Similarity=0.420 Sum_probs=204.0
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC--
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-- 361 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~-- 361 (575)
.|++ .++|++.+.||+|+||.||++.. +++.||||++............+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 10 VWEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred Hhhh-hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 4444 36899999999999999999976 456799999886544444456688999999999999999999887533
Q ss_pred ----CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccc
Q 008171 362 ----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (575)
Q Consensus 362 ----~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a 437 (575)
...|++++++ |++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence 3468999998 8899888753 56999999999999999999999999999999999999999999999999999
Q ss_pred eecccCCccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC----------
Q 008171 438 RVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL---------- 506 (575)
Q Consensus 438 ~~~~~~~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~---------- 506 (575)
+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.....
T Consensus 166 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 166 RQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred eecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 76543 2345678999999999876 5789999999999999999999999987665444333221100
Q ss_pred -----------CCCC--------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 507 -----------RPTI--------PKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 507 -----------~~~~--------p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+.. ....++.+.+||.+||+.||.+|||+.|++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0011 1245677899999999999999999999984
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=323.70 Aligned_cols=249 Identities=26% Similarity=0.378 Sum_probs=206.1
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.++||+|+||.||+|... ++.||+|++..........+.+.+|+.++++++||||+++++++.....+++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888999999999999999874 6789999987554333344668899999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
|+++++|..++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence 9999888877654 4578999999999999999999999999999999999999999999999999998655433 2334
Q ss_pred CCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-------------------CC-
Q 008171 449 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-------------------LR- 507 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~-------------------~~- 507 (575)
..++..|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+.... ..
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence 567899999999866 568899999999999999999999998877654443322100 00
Q ss_pred CC---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 PT---------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 ~~---------~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+. .....+..+.+|+.+||+.+|++||++.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 01245788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=320.87 Aligned_cols=252 Identities=24% Similarity=0.476 Sum_probs=214.1
Q ss_pred ceeeeeeeeecCceEEEEEEECC---ccEEEEEecCCC--------CChHHHHHHHHHHHHHHh-cCCCCceEEEeeecC
Q 008171 293 HLKFGSKVASGSYGDLYRGTYCS---QDVAIKVLKPER--------INSDMQKEFAQEVFIMRK-VRHKNVVQFIGACTK 360 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~~---~~VAvKvl~~~~--------~~~~~~~~~~~Ev~iL~~-L~HpnIv~l~~~~~~ 360 (575)
.|++.+.||+|+||.||+|...+ +.+|+|.+.... ........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36778899999999999998754 679999876432 223345667889988875 799999999999999
Q ss_pred CCCceeEEEeccCCchhhhhhh---ccCcCChHHHHHHHHHHHHHHHHHHH-CCceecccCCCCEEecCCCcEEEeeccc
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGV 436 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~---~~~~l~~~~~~~i~~qI~~aL~yLH~-~gIiHrDLKp~NILl~~~~~vkL~DFG~ 436 (575)
.+..|+||||++|++|.+++.. ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999998753 24568999999999999999999996 7899999999999999999999999999
Q ss_pred ceecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 008171 437 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 516 (575)
Q Consensus 437 a~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~ 516 (575)
+.............|+..|++||.+.+..++.++|+||||+++|+|++|..||...........+......+.....+++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE 240 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCH
Confidence 98766554445667899999999999988999999999999999999999999877766665555544444433446789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 008171 517 KLAELLERCWQQDPALRPDFSEIIEILQ 544 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~RPs~~ell~~L~ 544 (575)
++.++|.+||+.||++||++.|+...+.
T Consensus 241 ~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 241 DVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 9999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=346.67 Aligned_cols=247 Identities=23% Similarity=0.376 Sum_probs=196.3
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC------CceEEEeeec
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK------NVVQFIGACT 359 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~Hp------nIv~l~~~~~ 359 (575)
++...+|++.++||+|+||.||+|.+ .++.||||+++.. ......+..|+.+++.++|. +++++++++.
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 44567899999999999999999987 4677999999743 12234566688888877654 5888888886
Q ss_pred CC-CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHH-CCceecccCCCCEEecCCC----------
Q 008171 360 KP-PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENE---------- 427 (575)
Q Consensus 360 ~~-~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~gIiHrDLKp~NILl~~~~---------- 427 (575)
.. .++|+|||++ |++|.+++.+ .+.+++..+..|+.||+.||.|||+ .|||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 54 5789999998 7899998876 4679999999999999999999998 5999999999999998765
Q ss_pred ------cEEEeecccceecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 008171 428 ------VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501 (575)
Q Consensus 428 ------~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v 501 (575)
.+||+|||.+.... ...+..+||+.|+|||++.+..|+.++|||||||+||||++|+.||...+..+....+
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred cCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 49999999885432 2344568999999999999999999999999999999999999999877655433222
Q ss_pred HhcC-------------------------CCCCCC---------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 502 VQKG-------------------------LRPTIP---------------KNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 502 ~~~~-------------------------~~~~~p---------------~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.... +++... ....+.+.+||.+||+.||.+|||+.|+++
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 1100 000000 012456789999999999999999999986
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.16 Aligned_cols=246 Identities=27% Similarity=0.503 Sum_probs=210.1
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
.+|++.++||+|+||.||+|.. .++.|++|.+...... ....+.+|+.+++.+.||||+++++.+......|+|||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 5788899999999999999986 4678999998765433 24668899999999999999999999998889999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
|++|++|.+++.. ..++...+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++....... ....
T Consensus 98 ~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (296)
T cd06654 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (296)
T ss_pred ccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence 9999999999854 467899999999999999999999999999999999999999999999999987543322 2234
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhh
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~~~~p~~~~~~l~~Li~~cL~ 527 (575)
..|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+............ ....+..+++.+.++|.+||.
T Consensus 176 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (296)
T cd06654 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255 (296)
T ss_pred ccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCc
Confidence 5789999999999998899999999999999999999999988776554433332221 123456678899999999999
Q ss_pred cCCCCCCCHHHHHH
Q 008171 528 QDPALRPDFSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs~~ell~ 541 (575)
.+|.+||++.+++.
T Consensus 256 ~~p~~Rpt~~eil~ 269 (296)
T cd06654 256 MDVEKRGSAKELLQ 269 (296)
T ss_pred CCcccCcCHHHHhh
Confidence 99999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.86 Aligned_cols=242 Identities=27% Similarity=0.417 Sum_probs=202.8
Q ss_pred ceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC--C---Cce
Q 008171 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--P---SLC 365 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~---~l~ 365 (575)
.|.-.+++|+|+||.||+|... ++.||||..-.+.- .-.+|+.+|+.+.|||||+++.+|... . .+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 4677789999999999999864 57799998765421 123599999999999999999887432 2 456
Q ss_pred eEEEeccCCchhhhhhhc---cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC-CcEEEeecccceecc
Q 008171 366 IVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKA 441 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~---~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~-~~vkL~DFG~a~~~~ 441 (575)
+|||||+ .+|+++++.. +..++.-.+.-+..||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+...
T Consensus 99 lVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 99 LVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 9999994 5999999753 5678888899999999999999999999999999999999965 999999999999988
Q ss_pred cCCccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC---------------
Q 008171 442 QSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG--------------- 505 (575)
Q Consensus 442 ~~~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~--------------- 505 (575)
.+....+...|..|.|||.+.+ ..|+.+.||||.||+|.||+.|++-|.+.+..+....+++--
T Consensus 178 ~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 178 KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence 8877788889999999999865 579999999999999999999999999887766655444210
Q ss_pred -------CC-----CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 506 -------LR-----PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 506 -------~~-----~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+. .-+....++++.+|+.++|+++|.+|.++.|++.
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 00 0144667899999999999999999999999873
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=318.87 Aligned_cols=236 Identities=26% Similarity=0.499 Sum_probs=196.4
Q ss_pred eeeeecCceEEEEEEECCcc------------EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 298 SKVASGSYGDLYRGTYCSQD------------VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~~~~------------VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
+.||+|+||.||+|.+.+.. +++|++...... ...|.+|+.++++++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999885433 778876644221 5778999999999999999999999987 7789
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC-------cEEEeecccce
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-------VVKVADFGVAR 438 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~-------~vkL~DFG~a~ 438 (575)
+||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 99999999999999987555789999999999999999999999999999999999999887 79999999997
Q ss_pred ecccCCccccCCCCCCccCcccccCC--CCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 008171 439 VKAQSGVMTAETGTYRWMAPEVIEHK--PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 515 (575)
Q Consensus 439 ~~~~~~~~~~~~Gt~~y~APE~i~~~--~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~ 515 (575)
.... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||...+......... .. ...+....
T Consensus 157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~--~~~~~~~~ 230 (259)
T cd05037 157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQ--HRLPMPDC 230 (259)
T ss_pred cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cC--CCCCCCCc
Confidence 6443 2234567889999999776 78999999999999999999 688887776443332222 22 12233334
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 008171 516 PKLAELLERCWQQDPALRPDFSEIIEIL 543 (575)
Q Consensus 516 ~~l~~Li~~cL~~dP~~RPs~~ell~~L 543 (575)
..+.++|.+||..+|.+||++.++++.|
T Consensus 231 ~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 231 AELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred hHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 8999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=326.73 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=205.4
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
.++|.+.++||.|+||.||+|.+. ++.||+|.++..... .....+.+|+.+++.++||||+++++++.....+|+||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 367999999999999999999874 677999998754322 22345778999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-ccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT 447 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~ 447 (575)
||+. ++|.+++......+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....... ...
T Consensus 84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (301)
T cd07873 84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS 162 (301)
T ss_pred eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccc
Confidence 9996 59999988766778999999999999999999999999999999999999999999999999997544322 233
Q ss_pred cCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC----------------C-C--
Q 008171 448 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG----------------L-R-- 507 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~----------------~-~-- 507 (575)
...+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.... . .
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN 242 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccc
Confidence 4567899999999865 458899999999999999999999998776544332221100 0 0
Q ss_pred -C--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 -P--------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 -~--------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+ .....+++.+.+||.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 012356888999999999999999999999885
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=321.98 Aligned_cols=248 Identities=24% Similarity=0.406 Sum_probs=209.4
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
+|++.+.||.|+||.||+|++ .++.||+|++............+.+|+.++++++||||+++++++.....+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 488999999999999999987 467899999987655455567899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC--cccc
Q 008171 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTA 448 (575)
Q Consensus 371 ~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~--~~~~ 448 (575)
+ |++|.+++......+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 9 999999997766789999999999999999999999999999999999999999999999999997665433 2344
Q ss_pred CCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-------------------
Q 008171 449 ETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP------------------- 508 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~------------------- 508 (575)
..|+..|+|||++.+. .++.++||||||+++|+|++|..||...........+......+
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence 5789999999998654 46899999999999999999998887766544433322211000
Q ss_pred ---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 ---------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 ---------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
......+..+.++|.+||+.+|.+||++++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111345789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=326.89 Aligned_cols=251 Identities=25% Similarity=0.396 Sum_probs=212.6
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC-ceEEEeeecCCC-----
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPP----- 362 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~Hpn-Iv~l~~~~~~~~----- 362 (575)
...|...++||+|+||+||+|.. +|+.||+|.+..+...+.......+|+.+|+.|+|+| ||.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45678888999999999999975 5778999999876554445566789999999999999 999999987766
Q ss_pred -CceeEEEeccCCchhhhhhhcc---CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccce
Q 008171 363 -SLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 363 -~l~lV~E~~~ggsL~d~l~~~~---~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
.+++|+||+ .-+|..++.... ..++...+..++.||+.||+|||+++|+||||||.||||++.|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 789999999 569999998765 357778999999999999999999999999999999999999999999999999
Q ss_pred ecccC-CccccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--------
Q 008171 439 VKAQS-GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-------- 508 (575)
Q Consensus 439 ~~~~~-~~~~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~-------- 508 (575)
....+ ...+.+++|..|+|||++.+. .|+...||||+|||++||++++.-|.+.+..+....+.+.-..|
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 76644 357788999999999999776 79999999999999999999999999988877666655321111
Q ss_pred --------CCC------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 008171 509 --------TIP------------KNSQPKLAELLERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 509 --------~~p------------~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~ 542 (575)
.++ +...+...+++.+||+.+|.+|.|++..++.
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111 1222578899999999999999999998764
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=322.79 Aligned_cols=246 Identities=22% Similarity=0.354 Sum_probs=213.4
Q ss_pred ceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
+|++.++||.|+||.||++... ++.||+|++...... ....+.+.+|+.++++++||||+++++.+.....+|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788999999999999999874 688999998765432 2456789999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccccC
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 449 (575)
|+.|++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++............
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 159 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST 159 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccccc
Confidence 99999999999763 68899999999999999999999999999999999999999999999999999766554444556
Q ss_pred CCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 008171 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP--LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 450 ~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~--~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~ 527 (575)
.|+..|+|||++.+..++.++|+||||+++|+|++|..||...+. ......... ...+..|..++..+.++|.+||+
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~ 238 (258)
T cd05578 160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE-TADVLYPATWSTEAIDAINKLLE 238 (258)
T ss_pred CCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc-cccccCcccCcHHHHHHHHHHcc
Confidence 789999999999888899999999999999999999999987764 222222222 24566778889999999999999
Q ss_pred cCCCCCCCH--HHHH
Q 008171 528 QDPALRPDF--SEII 540 (575)
Q Consensus 528 ~dP~~RPs~--~ell 540 (575)
.||.+||++ +|++
T Consensus 239 ~~p~~R~~~~~~~l~ 253 (258)
T cd05578 239 RDPQKRLGDNLKDLK 253 (258)
T ss_pred CChhHcCCccHHHHh
Confidence 999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=321.50 Aligned_cols=245 Identities=38% Similarity=0.683 Sum_probs=207.2
Q ss_pred eeeeecCceEEEEEEECC--------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 298 SKVASGSYGDLYRGTYCS--------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~~--------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
+.||+|+||.||+|+... +.+|||.+.... .......+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999998643 469999886542 22345678899999999999999999999999899999999
Q ss_pred eccCCchhhhhhhc------cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC-----cEEEeecccce
Q 008171 370 FMSGGSVYDYLHKL------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-----VVKVADFGVAR 438 (575)
Q Consensus 370 ~~~ggsL~d~l~~~------~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~-----~vkL~DFG~a~ 438 (575)
|++|++|.+++... ...+++..++.++.||+.||.|||+++++|+||||+||+++.++ .++|+|||+++
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 99999999999652 23478899999999999999999999999999999999999877 89999999987
Q ss_pred ecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 008171 439 VKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 514 (575)
Q Consensus 439 ~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~ 514 (575)
...... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+.... +........+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (269)
T cd05044 160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH-VTAGGRLQKPENC 238 (269)
T ss_pred ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH-HhcCCccCCcccc
Confidence 543321 1122345788999999999999999999999999999998 9999988777665443 3344455677788
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 008171 515 QPKLAELLERCWQQDPALRPDFSEIIEILQ 544 (575)
Q Consensus 515 ~~~l~~Li~~cL~~dP~~RPs~~ell~~L~ 544 (575)
+..+.++|.+||..+|.+||++.++++.|+
T Consensus 239 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 239 PDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred hHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 999999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=324.88 Aligned_cols=248 Identities=26% Similarity=0.472 Sum_probs=209.1
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.+.||+|+||.||++.+. ++.||+|.++.. ........+.+|+.++++++||||+++++.+...+.+|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 36888999999999999999874 778999998754 234445778999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhc--cCcCChHHHHHHHHHHHHHHHHHHH-CCceecccCCCCEEecCCCcEEEeecccceecccCCcc
Q 008171 370 FMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446 (575)
Q Consensus 370 ~~~ggsL~d~l~~~--~~~l~~~~~~~i~~qI~~aL~yLH~-~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 446 (575)
|++|++|..++... ...+++..+..++.||+.||.|||. .||+|+||||+||+++.++.+||+|||++...... ..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~ 158 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LA 158 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-cc
Confidence 99999999988653 2478999999999999999999996 59999999999999999999999999998754332 23
Q ss_pred ccCCCCCCccCcccccCC------CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--HHhcCCCCCCCCCCcHHH
Q 008171 447 TAETGTYRWMAPEVIEHK------PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG--VVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~------~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~--v~~~~~~~~~p~~~~~~l 518 (575)
....+++.|+|||++.+. .++.++|+|||||++|+|++|..||........... .......+.++..+++++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA 238 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHH
Confidence 345688899999998544 358899999999999999999999976554333221 122344566777899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.++|.+||+.+|.+||++.+++.
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 239 QDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHHHcccCcccCCCHHHHhc
Confidence 99999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=347.01 Aligned_cols=243 Identities=28% Similarity=0.436 Sum_probs=204.0
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-C-----CCceEEEeeecCCCCc
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-H-----KNVVQFIGACTKPPSL 364 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-H-----pnIv~l~~~~~~~~~l 364 (575)
+|.+.+.||+|+||.|.++.+ +++.||||+++.. .....+...|+.+|..|+ | -|+|+++++|...+++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 789999999999999999987 4678999999964 344566777999999998 4 3899999999999999
Q ss_pred eeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC--CCcEEEeecccceecc
Q 008171 365 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE--NEVVKVADFGVARVKA 441 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~--~~~vkL~DFG~a~~~~ 441 (575)
|||+|.+ +.+|+++++..+ ..+++..+..|+.||+.||.+||+.||||+||||+|||+.. ...|||+|||.++...
T Consensus 264 ciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred eeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 9999999 779999997653 56999999999999999999999999999999999999974 3479999999998776
Q ss_pred cCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh------------------
Q 008171 442 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ------------------ 503 (575)
Q Consensus 442 ~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~------------------ 503 (575)
+.-. ..+.+..|.|||+|.+.+|+.+.||||||||++||++|.+-|.+.+..+....+++
T Consensus 343 q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~k 420 (586)
T KOG0667|consen 343 QRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHK 420 (586)
T ss_pred Ccce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccce
Confidence 5432 67789999999999999999999999999999999999988887766555443331
Q ss_pred ---c-C----------------------------CCCCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 008171 504 ---K-G----------------------------LRPTIP-----------KNSQPKLAELLERCWQQDPALRPDFSEII 540 (575)
Q Consensus 504 ---~-~----------------------------~~~~~p-----------~~~~~~l~~Li~~cL~~dP~~RPs~~ell 540 (575)
. . .....| ......+.++|.+||..||.+|+|..|.+
T Consensus 421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal 500 (586)
T KOG0667|consen 421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQAL 500 (586)
T ss_pred ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHh
Confidence 0 0 000011 12235689999999999999999999987
Q ss_pred H
Q 008171 541 E 541 (575)
Q Consensus 541 ~ 541 (575)
+
T Consensus 501 ~ 501 (586)
T KOG0667|consen 501 N 501 (586)
T ss_pred c
Confidence 4
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=327.66 Aligned_cols=250 Identities=22% Similarity=0.350 Sum_probs=212.4
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|++.+.||+|+||.||++... ++.||+|.+....... .....+.+|+.+++.++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36889999999999999999874 5789999998654432 34567899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc--
Q 008171 369 EFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-- 445 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-- 445 (575)
||+.|++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 9999999999987543 5689999999999999999999999999999999999999999999999999864322110
Q ss_pred ----------------------------cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 008171 446 ----------------------------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497 (575)
Q Consensus 446 ----------------------------~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~ 497 (575)
.....||..|+|||++.+..++.++||||||+++|+|++|..||...+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 1123678899999999999999999999999999999999999998887766
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC----HHHHHH
Q 008171 498 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD----FSEIIE 541 (575)
Q Consensus 498 ~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs----~~ell~ 541 (575)
...+.............++.+.++|.+||..||.+||+ +.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 66655544333333347899999999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=321.88 Aligned_cols=246 Identities=30% Similarity=0.521 Sum_probs=210.6
Q ss_pred ceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
+|++.++||.|+||.||++... ++.||+|.+..... ......+.+|+.+++.++||||+++++.+.....+++++||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 5778899999999999999885 67899999876533 34567789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHH-CCceecccCCCCEEecCCCcEEEeecccceecccCCccccC
Q 008171 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449 (575)
Q Consensus 371 ~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 449 (575)
+++++|.+++......+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+......... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~ 159 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-TF 159 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-cc
Confidence 99999999998766789999999999999999999999 99999999999999999999999999998655433222 26
Q ss_pred CCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhcCCCCCCCCC-CcHHHHHHHH
Q 008171 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL-----TPLQAAVGVVQKGLRPTIPKN-SQPKLAELLE 523 (575)
Q Consensus 450 ~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~-----~~~~~~~~v~~~~~~~~~p~~-~~~~l~~Li~ 523 (575)
.++..|+|||.+.+..++.++||||||+++|+|++|..||... ...+..... .....+..+.. +++++.++|.
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~ 238 (265)
T cd06605 160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI-VNEPPPRLPSGKFSPDFQDFVN 238 (265)
T ss_pred cCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH-hcCCCCCCChhhcCHHHHHHHH
Confidence 7889999999999999999999999999999999999999754 222222222 22334455555 8899999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 008171 524 RCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 524 ~cL~~dP~~RPs~~ell~ 541 (575)
+||..||.+||++.+++.
T Consensus 239 ~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 239 LCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHcCCCchhCcCHHHHhh
Confidence 999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=322.31 Aligned_cols=247 Identities=31% Similarity=0.535 Sum_probs=202.1
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHH-HHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI-MRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~i-L~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|++.+.||+|+||.||++.+ +++.||||.++....... ...+..|+.+ ++.++||||+++++++...+..|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 3688999999999999999987 467899999886543333 3455556664 67778999999999999999999999
Q ss_pred EeccCCchhhhhhhc---cCcCChHHHHHHHHHHHHHHHHHHHC-CceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 369 EFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 369 E~~~ggsL~d~l~~~---~~~l~~~~~~~i~~qI~~aL~yLH~~-gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
||++ ++|.+++... ...+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||+++......
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9995 6888877542 35689999999999999999999997 99999999999999999999999999997655443
Q ss_pred ccccCCCCCCccCcccccC----CCCCchHHHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhcCCCCCCC-CCCcHHH
Q 008171 445 VMTAETGTYRWMAPEVIEH----KPYDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQKGLRPTIP-KNSQPKL 518 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~----~~~s~ksDVwSlGviL~eLltG~~Pf~~~-~~~~~~~~v~~~~~~~~~p-~~~~~~l 518 (575)
..+...|+..|+|||++.+ ..++.++|+|||||++|+|++|..||... ...+....... ...+.++ ..++.++
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 237 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQLPAEKFSPEF 237 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh-cCCCCCCccccCHHH
Confidence 3344578999999998864 55788999999999999999999999753 33333333333 3334444 4578999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.++|.+||..+|.+||++.++++
T Consensus 238 ~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 238 QDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=318.14 Aligned_cols=248 Identities=34% Similarity=0.569 Sum_probs=211.9
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++++.||.|+||+||+|.. .+..+++|++....... ....+.+|+.+++.++|+||+++++.+......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4688999999999999999986 45679999987654444 56779999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhc--cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc--
Q 008171 370 FMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-- 445 (575)
Q Consensus 370 ~~~ggsL~d~l~~~--~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-- 445 (575)
+++|++|.+++... .+.+++..+..++.||+.||.|||++||+|+||+|+||++++++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999999999764 25689999999999999999999999999999999999999999999999999875544322
Q ss_pred ---cccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC-----CCCcH
Q 008171 446 ---MTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP-----KNSQP 516 (575)
Q Consensus 446 ---~~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p-----~~~~~ 516 (575)
.....|+..|+|||++... .++.++|+||||+++|+|++|..||...++.+.......... +.++ ..+++
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 238 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP-PSLETGADYKKYSK 238 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCC-CCcCCccccccccH
Confidence 1334689999999998776 789999999999999999999999988877666555544321 2222 25678
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 517 KLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+.+++.+||+.||.+||++.++++
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhh
Confidence 9999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=351.20 Aligned_cols=241 Identities=30% Similarity=0.558 Sum_probs=211.8
Q ss_pred eeeecCceEEEEEEECCcc--EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCCch
Q 008171 299 KVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (575)
Q Consensus 299 ~LG~G~fG~Vy~~~~~~~~--VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ggsL 376 (575)
+||+|.||+||-|++.... .|||.+... ++...+-+.+|+.+.++|+|.|||+++|.|.+++.+-|.||-++||||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 6999999999999886554 688877643 344456788999999999999999999999999999999999999999
Q ss_pred hhhhhhccCcC--ChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEec-CCCcEEEeecccceecccCC-ccccCCCC
Q 008171 377 YDYLHKLKGVF--KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSG-VMTAETGT 452 (575)
Q Consensus 377 ~d~l~~~~~~l--~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~-~~~~vkL~DFG~a~~~~~~~-~~~~~~Gt 452 (575)
.++|+..-|++ .+..+..+.+||+.||.|||.+.|+|||||-+||||+ ..|.+||+|||.++....-. ...+.+||
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGT 739 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGT 739 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccc
Confidence 99999888888 7888999999999999999999999999999999996 58999999999998766544 44577999
Q ss_pred CCccCcccccCC--CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHhcCCCCCCCCCCcHHHHHHHHHhhhcC
Q 008171 453 YRWMAPEVIEHK--PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV-GVVQKGLRPTIPKNSQPKLAELLERCWQQD 529 (575)
Q Consensus 453 ~~y~APE~i~~~--~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~-~v~~~~~~~~~p~~~~~~l~~Li~~cL~~d 529 (575)
..|||||+|..+ .|+.++|||||||++.||.||++||-.+...+++. ++---...|++|..++.+.+.+|.+|+.+|
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd 819 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPD 819 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCC
Confidence 999999999765 59999999999999999999999998776666553 333334578999999999999999999999
Q ss_pred CCCCCCHHHHHH
Q 008171 530 PALRPDFSEIIE 541 (575)
Q Consensus 530 P~~RPs~~ell~ 541 (575)
|.+||++++++.
T Consensus 820 ~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 820 PCDRPSAKDLLQ 831 (1226)
T ss_pred cccCccHHHhcc
Confidence 999999999874
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=327.74 Aligned_cols=248 Identities=24% Similarity=0.432 Sum_probs=206.2
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.++||+|+||.||++.+. +..+|+|.++.. ........+.+|+.++++++||||+++++.+...+.+|+|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 36889999999999999999874 567899988754 234455678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHH-CCceecccCCCCEEecCCCcEEEeecccceecccCCcccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 448 (575)
|++|++|.+++.+ .+.+++..+..++.||+.||.|||+ .+++|+||||+|||++.++.+||+|||++...... ....
T Consensus 80 y~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~ 157 (308)
T cd06615 80 HMDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANS 157 (308)
T ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-cccc
Confidence 9999999999976 4778999999999999999999997 59999999999999999999999999998654332 2234
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--------------------------
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV-------------------------- 502 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~-------------------------- 502 (575)
..|+..|+|||++.+..++.++|+||||+++|+|++|..||...+........-
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence 578999999999988889999999999999999999999997544322211110
Q ss_pred ---------hcCCCCCCCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 008171 503 ---------QKGLRPTIPK-NSQPKLAELLERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 503 ---------~~~~~~~~p~-~~~~~l~~Li~~cL~~dP~~RPs~~ell~~ 542 (575)
.....+..|. .+++++++++.+||..+|++||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111122222 367889999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=318.72 Aligned_cols=252 Identities=30% Similarity=0.560 Sum_probs=210.1
Q ss_pred eeeeeeeeecCceEEEEEEEC-----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC------
Q 008171 294 LKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------ 362 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~~-----~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~------ 362 (575)
|++.+.||+|+||.||+|.+. ++.||||+++...........+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999753 467999999876666666778999999999999999999999875432
Q ss_pred CceeEEEeccCCchhhhhhhc-----cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKL-----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~-----~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a 437 (575)
..++++||+.+|+|.+++... ...++...++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 237889999999999887432 124788899999999999999999999999999999999999999999999999
Q ss_pred eecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 008171 438 RVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN 513 (575)
Q Consensus 438 ~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~ 513 (575)
+...... ......+++.|++||.+....++.++|||||||++|+|++ |..||...+..+....+. .......+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 239 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-KGNRLKQPPD 239 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-cCCcCCCCCC
Confidence 7553322 1123345678999999999999999999999999999999 899998877655544433 3334455667
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 514 SQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 514 ~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
+++.+.+++.+||+.+|++||++.++++.|+++
T Consensus 240 ~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 240 CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 889999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=325.44 Aligned_cols=250 Identities=29% Similarity=0.498 Sum_probs=210.4
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCcee
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~l 366 (575)
+..++|++.++||+|+||.||++.+. ++.||+|++.... .......+.+|+.+++.++||||+++++.+...+.+|+
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 44578999999999999999999875 7789999987543 23446788999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHH-CCceecccCCCCEEecCCCcEEEeecccceecccCCc
Q 008171 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 445 (575)
||||+++++|.+++.+ .+.+++..+..++.+++.||.|||+ .+|+|+||||+||+++.++.++|+|||++...... .
T Consensus 81 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~ 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-I 158 (284)
T ss_pred EEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-c
Confidence 9999999999999876 5678999999999999999999997 59999999999999999999999999998654322 2
Q ss_pred cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH-----------HHHHHHHhcCCCCCCCCC-
Q 008171 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL-----------QAAVGVVQKGLRPTIPKN- 513 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~-----------~~~~~v~~~~~~~~~p~~- 513 (575)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||...... .....+.. ...+.++..
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 237 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPPPRLPSSD 237 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-ccCCCCCchh
Confidence 23457899999999998889999999999999999999999999865542 11222222 222333333
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 008171 514 SQPKLAELLERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 514 ~~~~l~~Li~~cL~~dP~~RPs~~ell~~ 542 (575)
++.++.+|+.+||+.||.+||++.|+++.
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 238 FPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 78899999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=338.64 Aligned_cols=239 Identities=23% Similarity=0.379 Sum_probs=197.6
Q ss_pred eeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhc---CCCCceEEEeeecCCCCceeEEEeccC
Q 008171 300 VASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV---RHKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 300 LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L---~HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
||+|+||+||+|+. .++.||||++..... .......+..|..++..+ +||||+++++.+.....+|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999987 467899999864322 222334556677777665 699999999999999999999999999
Q ss_pred CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-CccccCCCC
Q 008171 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGT 452 (575)
Q Consensus 374 gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~Gt 452 (575)
|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt 159 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT 159 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence 999999876 577999999999999999999999999999999999999999999999999998753322 233456799
Q ss_pred CCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC-CCCcHHHHHHHHHhhhcCC
Q 008171 453 YRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP-KNSQPKLAELLERCWQQDP 530 (575)
Q Consensus 453 ~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p-~~~~~~l~~Li~~cL~~dP 530 (575)
+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+..... .++ ..+++++.++|.+||+.||
T Consensus 160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~~L~~~P 237 (330)
T cd05586 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV--RFPKNVLSDEGRQFVKGLLNRNP 237 (330)
T ss_pred ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcCCCH
Confidence 999999998654 589999999999999999999999988777666555443332 233 3578999999999999999
Q ss_pred CCCC----CHHHHHH
Q 008171 531 ALRP----DFSEIIE 541 (575)
Q Consensus 531 ~~RP----s~~ell~ 541 (575)
.+|| ++.++++
T Consensus 238 ~~R~~~~~~~~~ll~ 252 (330)
T cd05586 238 QHRLGAHRDAVELKE 252 (330)
T ss_pred HHCCCCCCCHHHHhc
Confidence 9998 4555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=318.03 Aligned_cols=241 Identities=27% Similarity=0.439 Sum_probs=210.3
Q ss_pred eeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCCch
Q 008171 300 VASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (575)
Q Consensus 300 LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ggsL 376 (575)
||.|+||.||+++.. ++.||+|++..... .....+.+.+|+.+++.++||||+++++.+.++..+|+||||++|++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999986 78899999876543 234557799999999999999999999999999999999999999999
Q ss_pred hhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccccCCCCCCcc
Q 008171 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM 456 (575)
Q Consensus 377 ~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~ 456 (575)
.+++.+ ...++...+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.............++..|+
T Consensus 81 ~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
T cd05572 81 WTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYV 159 (262)
T ss_pred HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCcc
Confidence 999976 4568999999999999999999999999999999999999999999999999998665543334457899999
Q ss_pred CcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 008171 457 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--PLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP 534 (575)
Q Consensus 457 APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~--~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP 534 (575)
+||.+....++.++|+||||+++|+|++|..||.... +.+....+......+.+|..+++++.++|.+||+.+|.+||
T Consensus 160 ~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 239 (262)
T cd05572 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERL 239 (262)
T ss_pred ChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCc
Confidence 9999988889999999999999999999999998776 55555555544556677778899999999999999999999
Q ss_pred C-----HHHHHH
Q 008171 535 D-----FSEIIE 541 (575)
Q Consensus 535 s-----~~ell~ 541 (575)
+ +.|+++
T Consensus 240 ~~~~~~~~~l~~ 251 (262)
T cd05572 240 GNLKGGIKDIKK 251 (262)
T ss_pred CCcccCHHHHhc
Confidence 9 777664
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=322.62 Aligned_cols=238 Identities=26% Similarity=0.488 Sum_probs=198.9
Q ss_pred eeeeecCceEEEEEEECC---------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 298 SKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~~---------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
+.||+|+||.||+|.... ..|++|.+... .......+.+|+.+++.+.||||+++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 368999999999997632 34888887543 2334567889999999999999999999999988999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCc--------EEEeecccceec
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--------VKVADFGVARVK 440 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~--------vkL~DFG~a~~~ 440 (575)
||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++. ++++|||++...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 999999999999876667899999999999999999999999999999999999987654 699999988644
Q ss_pred ccCCccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 008171 441 AQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTG-KLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 441 ~~~~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG-~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
.. .....++..|+|||++.+ ..++.++||||||+++|+|++| ..||...++..... ... .+..+|...+.++
T Consensus 159 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~ 232 (258)
T cd05078 159 LP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYE--DRHQLPAPKWTEL 232 (258)
T ss_pred CC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHH--ccccCCCCCcHHH
Confidence 32 233467889999999976 4589999999999999999998 57777666554332 222 2345677778999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIEIL 543 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~~L 543 (575)
.++|.+||+.||++|||+.++++.|
T Consensus 233 ~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 233 ANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHHhccChhhCCCHHHHHHhc
Confidence 9999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=325.72 Aligned_cols=254 Identities=25% Similarity=0.388 Sum_probs=213.3
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|++.+.||+|+||.||++... ++.|++|.+...... ......+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999874 567999998765322 234567889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC----
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---- 444 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~---- 444 (575)
||++|++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 81 EYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred ecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 99999999999976 4678999999999999999999999999999999999999999999999999986421110
Q ss_pred ------------ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCC
Q 008171 445 ------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIP 511 (575)
Q Consensus 445 ------------~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~~~~p 511 (575)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||.+.++.+.......... .+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 11123578899999999988999999999999999999999999998877766555444322 23334
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 512 KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 512 ~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
..+++++.++|.+||+.||.+||++.++.+.|+.-
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 46789999999999999999999987777777763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=321.34 Aligned_cols=247 Identities=33% Similarity=0.581 Sum_probs=213.7
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
..|+..++||.|+||.||+|.+ .++.||||+++.... ......+.+|+.++++++||||+++++.+.+....|+|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 3567788999999999999986 467899999875432 3445789999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
|++|++|.+++.. +.+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 83 ~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 83 YLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred cCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence 9999999999864 568899999999999999999999999999999999999999999999999997654332 2233
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 528 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~ 528 (575)
..++..|+|||++.+..++.++|+||||+++|+|++|..||...++...... ......+.++..++..+.+++.+||+.
T Consensus 161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-IPKNNPPTLTGEFSKPFKEFIDACLNK 239 (277)
T ss_pred ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-hhcCCCCCCchhhhHHHHHHHHHHccc
Confidence 4678899999999998999999999999999999999999988877655443 334445667778889999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 008171 529 DPALRPDFSEIIEI 542 (575)
Q Consensus 529 dP~~RPs~~ell~~ 542 (575)
+|.+||++.+++..
T Consensus 240 ~p~~Rp~~~~il~~ 253 (277)
T cd06640 240 DPSFRPTAKELLKH 253 (277)
T ss_pred CcccCcCHHHHHhC
Confidence 99999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=347.81 Aligned_cols=245 Identities=29% Similarity=0.520 Sum_probs=214.3
Q ss_pred eeeeeeeeecCceEEEEEEECCcc--EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEec
Q 008171 294 LKFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~~~~~--VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~ 371 (575)
+.|+..||.|+||.||++...... .|-|++... .......|+-|+.||..+.||+||+++++|..++.++|+.|||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 455678999999999999765433 577777643 3556788999999999999999999999999999999999999
Q ss_pred cCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee-cccCCccccCC
Q 008171 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-KAQSGVMTAET 450 (575)
Q Consensus 372 ~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~-~~~~~~~~~~~ 450 (575)
.||-...++-.....+++.++..+++|++.||.|||+++|||||||+.|||++-+|.|+|+|||++-. .........++
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFI 191 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFI 191 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcccc
Confidence 99999999888889999999999999999999999999999999999999999999999999998742 22223455789
Q ss_pred CCCCccCcccc-----cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCcHHHHHHHHH
Q 008171 451 GTYRWMAPEVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPKNSQPKLAELLER 524 (575)
Q Consensus 451 Gt~~y~APE~i-----~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~-~~~~~p~~~~~~l~~Li~~ 524 (575)
|||+|||||++ ...+|+.++||||||++|.||..+.+|...+++...+..+.... .....|...+..+.+++.+
T Consensus 192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~ 271 (1187)
T KOG0579|consen 192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKR 271 (1187)
T ss_pred CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHH
Confidence 99999999987 45689999999999999999999999999999999888765432 2234577889999999999
Q ss_pred hhhcCCCCCCCHHHHH
Q 008171 525 CWQQDPALRPDFSEII 540 (575)
Q Consensus 525 cL~~dP~~RPs~~ell 540 (575)
||.+||..||++.+|+
T Consensus 272 cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 272 CLVKNPRNRPPAAQLL 287 (1187)
T ss_pred HHhcCCccCCCHHHHh
Confidence 9999999999999987
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=322.94 Aligned_cols=246 Identities=28% Similarity=0.519 Sum_probs=211.5
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
.+|++.++||.|+||.||+|.. .++.|++|.+...... ....+.+|+.+++.++||||+++++++.....+|+|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 5699999999999999999975 5788999998754332 34678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
|+.|++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++....... ....
T Consensus 97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 174 (296)
T cd06655 97 YLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST 174 (296)
T ss_pred ecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence 9999999998864 468999999999999999999999999999999999999999999999999987544332 2234
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhh
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~~~~p~~~~~~l~~Li~~cL~ 527 (575)
..++..|+|||.+.+..++.++|||||||++|+|++|..||...++......+..... ....+..+++.+.++|++||.
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 254 (296)
T cd06655 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLE 254 (296)
T ss_pred cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhh
Confidence 5688999999999999999999999999999999999999998877665544333221 223566788999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 008171 528 QDPALRPDFSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs~~ell~ 541 (575)
.||.+||++.+++.
T Consensus 255 ~dp~~Rpt~~~il~ 268 (296)
T cd06655 255 MDVEKRGSAKELLQ 268 (296)
T ss_pred cChhhCCCHHHHhh
Confidence 99999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=361.15 Aligned_cols=258 Identities=21% Similarity=0.375 Sum_probs=211.1
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
.+|++.++||+|+||.||+|.+ +++.||||+++.... .......+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5789999999999999999987 467899999976433 2344567999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhc----------cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccce
Q 008171 369 EFMSGGSVYDYLHKL----------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 369 E~~~ggsL~d~l~~~----------~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
||++|++|.+++... ...++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999998642 1235567788999999999999999999999999999999999999999999997
Q ss_pred ecccCC-------------------ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 008171 439 VKAQSG-------------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV 499 (575)
Q Consensus 439 ~~~~~~-------------------~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~ 499 (575)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|..||..........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~ 241 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY 241 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence 652110 0112469999999999999999999999999999999999999998755443322
Q ss_pred HH-HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHHH
Q 008171 500 GV-VQKGLRPTIPKNSQPKLAELLERCWQQDPALRP-DFSEIIEILQQIAKE 549 (575)
Q Consensus 500 ~v-~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP-s~~ell~~L~~l~~~ 549 (575)
.. ............+++.+.+++.+||+.||.+|| ++.++++.|+..++.
T Consensus 242 ~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 242 RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 21 111111111246789999999999999999996 577788888887753
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=321.52 Aligned_cols=247 Identities=30% Similarity=0.522 Sum_probs=204.7
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecC------CC
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTK------PP 362 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~------~~ 362 (575)
..|++.++||.|+||.||+|.+ .++.||+|++... ......+..|+.+++++ +|+||+++++++.. ..
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 5778889999999999999987 4577999998643 23345688899999998 69999999998853 45
Q ss_pred CceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
.+|++|||+++++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 6799999999999999987643 458888899999999999999999999999999999999999999999999987543
Q ss_pred cC-CccccCCCCCCccCccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 008171 442 QS-GVMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 515 (575)
Q Consensus 442 ~~-~~~~~~~Gt~~y~APE~i~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~ 515 (575)
.. .......|+..|+|||++. ...++.++|||||||++|+|++|..||....+......+............++
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (282)
T cd06636 173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWS 252 (282)
T ss_pred ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccC
Confidence 22 2233456899999999985 45688899999999999999999999987776555544333333333445688
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 516 PKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 516 ~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.++.++|.+||+.||.+||++.||++
T Consensus 253 ~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 253 KKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 99999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=312.66 Aligned_cols=248 Identities=29% Similarity=0.551 Sum_probs=220.0
Q ss_pred ceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
+|++.+.||+|+||.||++.+. ++.|++|++............+.+|+.+++.++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999886 77899999987766656677899999999999999999999999888999999999
Q ss_pred ccCCchhhhhhhcc---CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cc
Q 008171 371 MSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VM 446 (575)
Q Consensus 371 ~~ggsL~d~l~~~~---~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~ 446 (575)
+++++|.+++.... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 99999999997753 779999999999999999999999999999999999999999999999999997655443 23
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 526 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL 526 (575)
....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....... ...+.++..++..+.+++.+||
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l 239 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK-GQYPPIPSQYSSELRNLVSSLL 239 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHc
Confidence 345688999999999999999999999999999999999999988877666655544 3355677789999999999999
Q ss_pred hcCCCCCCCHHHHHH
Q 008171 527 QQDPALRPDFSEIIE 541 (575)
Q Consensus 527 ~~dP~~RPs~~ell~ 541 (575)
..+|.+||++.++++
T Consensus 240 ~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 240 QKDPEERPSIAQILQ 254 (258)
T ss_pred CCChhhCcCHHHHhc
Confidence 999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=337.24 Aligned_cols=245 Identities=23% Similarity=0.406 Sum_probs=199.7
Q ss_pred eCCCceeeeeeeeecCceEEEEEEECC----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~~----~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
+...+|.++++||+|+||.||++...+ ..||+|.+... ..+.+|+.+|++++||||+++++++.....+
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 345689999999999999999997643 56899987643 2346799999999999999999999988999
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|+|||++ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 162 ~lv~e~~-~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 162 CMVMPKY-KCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEEehhc-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9999999 5688888843 5789999999999999999999999999999999999999999999999999997544332
Q ss_pred ---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHh---------------
Q 008171 445 ---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---QAAVGVVQ--------------- 503 (575)
Q Consensus 445 ---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~---~~~~~v~~--------------- 503 (575)
......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.... .....++.
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 123457999999999999999999999999999999999999999654321 11111110
Q ss_pred ----------cCCCCCC--C-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 008171 504 ----------KGLRPTI--P-----KNSQPKLAELLERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 504 ----------~~~~~~~--p-----~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~ 542 (575)
...++.. + ...+.++.++|.+||..||++||++.|++..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0011111 1 2346788999999999999999999998853
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=322.38 Aligned_cols=246 Identities=33% Similarity=0.585 Sum_probs=212.0
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
+.|+..+.||+|+||.||+|.+ .++.||+|+++.... ......+.+|+.++++++||||+++++.+...+..|+|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 3467788999999999999976 457799999875432 3345678999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
|+++++|.+++.. +.+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++....... ....
T Consensus 83 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 83 YLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred ccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence 9999999998854 578999999999999999999999999999999999999999999999999997654332 2223
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 528 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~ 528 (575)
..|+..|+|||++.+..++.++|+|||||++|+|++|..||....+...... ......+.++..++..+.+++.+||+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL-IPKNSPPTLEGQYSKPFKEFVEACLNK 239 (277)
T ss_pred ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh-hhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 4688999999999999999999999999999999999999987766554433 334445566677889999999999999
Q ss_pred CCCCCCCHHHHHH
Q 008171 529 DPALRPDFSEIIE 541 (575)
Q Consensus 529 dP~~RPs~~ell~ 541 (575)
+|.+||++.++++
T Consensus 240 ~p~~Rp~~~~il~ 252 (277)
T cd06642 240 DPRFRPTAKELLK 252 (277)
T ss_pred CcccCcCHHHHHH
Confidence 9999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=319.42 Aligned_cols=251 Identities=29% Similarity=0.485 Sum_probs=204.9
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeec-----C
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACT-----K 360 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~-----~ 360 (575)
...++|++.+.||+|+||.||++.. .++.+|+|+++... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 3457889999999999999999976 46779999976432 2235677899999999 6999999999873 3
Q ss_pred CCCceeEEEeccCCchhhhhhh---ccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccc
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~---~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a 437 (575)
.+.+|+||||++|++|.+++.. ....+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 4568999999999999998753 2356888999999999999999999999999999999999999999999999999
Q ss_pred eecccCC-ccccCCCCCCccCccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-CCCCC
Q 008171 438 RVKAQSG-VMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTI 510 (575)
Q Consensus 438 ~~~~~~~-~~~~~~Gt~~y~APE~i~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~-~~~~~ 510 (575)
+...... ......|++.|+|||++. +..++.++|||||||++|+|++|..||....+........... .....
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (286)
T cd06638 172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQ 251 (286)
T ss_pred eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccC
Confidence 7654332 223456899999999985 3458899999999999999999999998877655443322211 11223
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 008171 511 PKNSQPKLAELLERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 511 p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~ 542 (575)
+..++..+.++|.+||+.||++||++.|+++-
T Consensus 252 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 252 PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 45578899999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=323.79 Aligned_cols=249 Identities=26% Similarity=0.382 Sum_probs=207.5
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC--CCceeE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIV 367 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~~l~lV 367 (575)
++|++.+.||.|+||.||+|++. ++.+++|.++...........+.+|+.++++++||||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47888999999999999999984 67799999986554444445678899999999999999999998776 889999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-Ccc
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVM 446 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~ 446 (575)
|||+. ++|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...... ...
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 163 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence 99996 5999998776667999999999999999999999999999999999999999999999999999865543 233
Q ss_pred ccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---------------------
Q 008171 447 TAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--------------------- 504 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~--------------------- 504 (575)
....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+...
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (293)
T cd07843 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK 243 (293)
T ss_pred ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccc
Confidence 445678999999998654 4689999999999999999999999877665544332211
Q ss_pred --------CCCCCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 505 --------GLRPTIPKN-SQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 505 --------~~~~~~p~~-~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+...++.. +++.+.++|++||+.+|++|||+.|++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 244 TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 011223333 5888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.39 Aligned_cols=243 Identities=24% Similarity=0.400 Sum_probs=196.0
Q ss_pred CCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
....|++.+.||+|+||.||+|+.. ++.||+|+.... ....|+.++++++||||+++++++......|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 3356999999999999999999885 457999985432 234699999999999999999999999999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccc
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 447 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 447 (575)
||++ .++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 136 ~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 214 (357)
T PHA03209 136 LPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214 (357)
T ss_pred EEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccc
Confidence 9999 568999987767789999999999999999999999999999999999999999999999999997654444444
Q ss_pred cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCC-CCCCCCHH---------HHHHHHHhc-CCC-CCCC----
Q 008171 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKL-PYEYLTPL---------QAAVGVVQK-GLR-PTIP---- 511 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~-Pf~~~~~~---------~~~~~v~~~-~~~-~~~p---- 511 (575)
...||+.|+|||++.+..++.++|||||||++|||+++.. +|...... .....++.. +.. ..++
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 294 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG 294 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence 5679999999999999999999999999999999998544 44332110 011111110 000 0011
Q ss_pred --------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 512 --------------------------KNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 512 --------------------------~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
..++..+.+||.+||+.||.+|||+.|+++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 144667788999999999999999999875
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=317.77 Aligned_cols=248 Identities=30% Similarity=0.543 Sum_probs=209.4
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCC----hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCcee
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN----SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~----~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~l 366 (575)
+|++++.||+|+||.||++.. +++.||+|++...... ......+.+|+.+++.++|+||+++++++...+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 367789999999999999976 5678999998754321 2245678999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC-cEEEeecccceecccCC-
Q 008171 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSG- 444 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~~~- 444 (575)
||||+.|++|.+++.. .+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||.+.......
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 9999999999999976 56789999999999999999999999999999999999998775 69999999987654321
Q ss_pred ----ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCCCCCCCCCCcHH
Q 008171 445 ----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQKGLRPTIPKNSQPK 517 (575)
Q Consensus 445 ----~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~---~~~~~~v~~~~~~~~~p~~~~~~ 517 (575)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||..... .............+.++...+++
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 11234678999999999988999999999999999999999999975432 22222333334456777888999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 518 LAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 518 l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+.+++.+||..+|.+||++.++++
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhc
Confidence 999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=309.93 Aligned_cols=248 Identities=32% Similarity=0.581 Sum_probs=217.5
Q ss_pred ceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC--CCceeEE
Q 008171 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVT 368 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~~l~lV~ 368 (575)
+|++.+.||+|++|.||+|... ++.|++|++............+.+|+.++++++||||+++++.+... ..+++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999885 77899999887655455677899999999999999999999999887 7899999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc---
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--- 445 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~--- 445 (575)
||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 81 EYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 999999999999874 4899999999999999999999999999999999999999999999999999987666543
Q ss_pred cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 008171 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT-PLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~-~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~ 524 (575)
.....++..|+|||.+....++.++||||||+++|+|++|..||.... ..............+.++...+..+.++|.+
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~ 239 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK 239 (260)
T ss_pred ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHH
Confidence 445678999999999988889999999999999999999999998766 3333333333345567788889999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 008171 525 CWQQDPALRPDFSEIIE 541 (575)
Q Consensus 525 cL~~dP~~RPs~~ell~ 541 (575)
||+.||.+||++.+++.
T Consensus 240 ~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 240 CLRRDPKKRPTADELLQ 256 (260)
T ss_pred hCcCChhhCCCHHHHhh
Confidence 99999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=314.89 Aligned_cols=248 Identities=28% Similarity=0.504 Sum_probs=213.2
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCC---CChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC--CCc
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER---INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSL 364 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~---~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~~l 364 (575)
..|++.+.||+|+||.||+|.. +++.||+|++.... ........+.+|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5688999999999999999986 46789999875432 1234456788999999999999999999988653 458
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS- 443 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~- 443 (575)
+++|||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 899999999999999876 456889999999999999999999999999999999999999999999999999754321
Q ss_pred ---CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 008171 444 ---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 520 (575)
Q Consensus 444 ---~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~ 520 (575)
.......++..|+|||++.+..++.++|+|||||++|+|++|+.||.................++.+|..+++++.+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 12234568999999999998889999999999999999999999999887777766666666677889999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 008171 521 LLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 521 Li~~cL~~dP~~RPs~~ell~ 541 (575)
+|.+||+ +|..||++.+++.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHhc-CcccCccHHHHhc
Confidence 9999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=312.85 Aligned_cols=247 Identities=31% Similarity=0.534 Sum_probs=213.7
Q ss_pred ceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
+|++.+.||.|++|.||+++.. ++.|+||++...... .....+.+|+.++.+++|+||+++++++.....+++||||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 6788899999999999999874 678999998865432 4567899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHH-CCceecccCCCCEEecCCCcEEEeecccceecccCCcc-cc
Q 008171 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-TA 448 (575)
Q Consensus 371 ~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~ 448 (575)
+++++|.+++.. ...+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++......... ..
T Consensus 81 ~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 159 (264)
T cd06623 81 MDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT 159 (264)
T ss_pred cCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccc
Confidence 999999999976 3778999999999999999999999 99999999999999999999999999999866543322 24
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhcCCCCCCCCC-CcHHHHHHHHHh
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--PLQAAVGVVQKGLRPTIPKN-SQPKLAELLERC 525 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~--~~~~~~~v~~~~~~~~~p~~-~~~~l~~Li~~c 525 (575)
..++..|+|||.+....++.++|+||||+++|+|++|..||.... ........+.....+.++.. ++..+.++|.+|
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 239 (264)
T cd06623 160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISAC 239 (264)
T ss_pred eeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHH
Confidence 568899999999999999999999999999999999999998774 22222233334444556666 899999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 008171 526 WQQDPALRPDFSEIIE 541 (575)
Q Consensus 526 L~~dP~~RPs~~ell~ 541 (575)
|..+|.+||++.++++
T Consensus 240 l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 240 LQKDPKKRPSAAELLQ 255 (264)
T ss_pred ccCChhhCCCHHHHHh
Confidence 9999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=316.16 Aligned_cols=245 Identities=25% Similarity=0.491 Sum_probs=198.4
Q ss_pred eeeeecCceEEEEEEEC-Cc---cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccC
Q 008171 298 SKVASGSYGDLYRGTYC-SQ---DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~-~~---~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
++||+|+||.||+|... +. .+++|.++... .......+.+|+.+++.++||||+++++.|......|+||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 36899999999999753 32 35566655432 233457899999999999999999999999999999999999999
Q ss_pred Cchhhhhhhcc---CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC---ccc
Q 008171 374 GSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMT 447 (575)
Q Consensus 374 gsL~d~l~~~~---~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~ 447 (575)
++|.+++.+.. ..++...++.++.||+.||.|||+++|+||||||+|||++.++.++|+|||++....... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 159 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED 159 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence 99999997632 345677788999999999999999999999999999999999999999999985432211 123
Q ss_pred cCCCCCCccCcccccC-------CCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcC----CCCCCCCCCc
Q 008171 448 AETGTYRWMAPEVIEH-------KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG----LRPTIPKNSQ 515 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~-------~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~----~~~~~p~~~~ 515 (575)
...++..|+|||++.. ..++.++||||||+++|||++ |..||...+..+....+.... .++.++..++
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd05086 160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYS 239 (268)
T ss_pred CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCc
Confidence 4467899999999843 345789999999999999997 678998877766555544332 3455666788
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 008171 516 PKLAELLERCWQQDPALRPDFSEIIEILQ 544 (575)
Q Consensus 516 ~~l~~Li~~cL~~dP~~RPs~~ell~~L~ 544 (575)
+.+.+++.+|| .+|++||++.++++.|.
T Consensus 240 ~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 240 ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 99999999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=315.36 Aligned_cols=252 Identities=29% Similarity=0.488 Sum_probs=207.0
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
+++.+.+.....||+|+||.||+|++. +..|++|.+.... ....+.+.+|+.++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 344444555568999999999999864 4569999887542 334567899999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhccCcC--ChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC-CCcEEEeecccceeccc
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVF--KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKAQ 442 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l--~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~ 442 (575)
+|+||+++++|.+++......+ +...+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 9999999999999998654555 78888999999999999999999999999999999986 67999999999875433
Q ss_pred CC-ccccCCCCCCccCcccccCC--CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHhcCCCCCCCCCCcHHH
Q 008171 443 SG-VMTAETGTYRWMAPEVIEHK--PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA-AVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 443 ~~-~~~~~~Gt~~y~APE~i~~~--~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~-~~~v~~~~~~~~~p~~~~~~l 518 (575)
.. ......|+..|+|||++.+. .++.++|+||||+++|+|++|..||........ ..........+.+|..+++++
T Consensus 162 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (268)
T cd06624 162 INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEA 241 (268)
T ss_pred CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHH
Confidence 22 23345689999999998654 388999999999999999999999976543222 222222234466788899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+++.+||+.+|.+||++.+++.
T Consensus 242 ~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 242 KNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred HHHHHHHcCCCchhCCCHHHHHh
Confidence 99999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=320.21 Aligned_cols=249 Identities=25% Similarity=0.397 Sum_probs=207.4
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.++||+|+||.||+|.+. ++.||+|+++...........+.+|+.++++++|+||+++++++...+..|+|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999874 6789999988655555556789999999999999999999999999889999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC--ccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMT 447 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~--~~~ 447 (575)
|++++.+..+..+ ...++...++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++....... ...
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 9988666655544 5668999999999999999999999999999999999999999999999999987655443 334
Q ss_pred cCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-------------------C--
Q 008171 448 AETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK-------------------G-- 505 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~-------------------~-- 505 (575)
...++..|+|||++... .++.++||||||+++|+|++|..||......+........ .
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence 45788999999999887 8999999999999999999999999876554433221110 0
Q ss_pred C---------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 506 L---------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 506 ~---------~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
. ....+..+++++.++|++||..+|++||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 00123345889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=324.52 Aligned_cols=246 Identities=28% Similarity=0.504 Sum_probs=209.6
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
.+|++.++||+|+||.||++.. .++.||+|.+...... ....+.+|+.+++.++||||+++++++......|+|||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 6788999999999999999986 5788999998754332 24668899999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
|++|++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++....... ....
T Consensus 97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 174 (297)
T cd06656 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (297)
T ss_pred ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence 9999999999864 567889999999999999999999999999999999999999999999999987654332 2234
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhh
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~~~~p~~~~~~l~~Li~~cL~ 527 (575)
..+++.|+|||.+.+..++.++|+||||+++|+|++|..||...++..........+. ....+..+++.+.+++.+||.
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 254 (297)
T cd06656 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLE 254 (297)
T ss_pred ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHcc
Confidence 5688999999999999999999999999999999999999987665444332222111 123456778899999999999
Q ss_pred cCCCCCCCHHHHHH
Q 008171 528 QDPALRPDFSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs~~ell~ 541 (575)
.+|.+||++.++++
T Consensus 255 ~~p~~Rps~~~il~ 268 (297)
T cd06656 255 MDVDRRGSAKELLQ 268 (297)
T ss_pred CChhhCcCHHHHhc
Confidence 99999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=316.43 Aligned_cols=248 Identities=31% Similarity=0.542 Sum_probs=206.8
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCC--------hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN--------SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~--------~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
+|.+.+.||.|+||.||+|.. +++.||+|.++..... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467789999999999999975 5678999988643211 122456888999999999999999999999999
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
..++||||+.|++|.+++... +.++...+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||+++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 999999999999999999774 6789999999999999999999999999999999999999999999999999975433
Q ss_pred CC---ccccCCCCCCccCcccccCCC--CCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC----CC
Q 008171 443 SG---VMTAETGTYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP----KN 513 (575)
Q Consensus 443 ~~---~~~~~~Gt~~y~APE~i~~~~--~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p----~~ 513 (575)
.. ......|+..|+|||++.... ++.++|+||||+++|+|++|..||..................+.++ ..
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMN 240 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccccc
Confidence 21 123346889999999987654 8899999999999999999999998766655544433333333333 35
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 514 SQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 514 ~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
++.++.++|.+||+.+|.+||++.++++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 241 LSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 6889999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=320.54 Aligned_cols=249 Identities=26% Similarity=0.389 Sum_probs=205.6
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.++||+|+||.||+|.+. ++.||+|++............+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888999999999999999874 6789999987654444455678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-Ccccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~ 448 (575)
|+.+++|.++... ...+++..++.++.||+.||.|||+.||+|+||+|+||++++++.++|+|||++...... .....
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07846 81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD 159 (286)
T ss_pred cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence 9999888887654 456899999999999999999999999999999999999999999999999998765433 23334
Q ss_pred CCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--------------------CCC
Q 008171 449 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--------------------GLR 507 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~--------------------~~~ 507 (575)
..++..|+|||++.+ ..++.++||||||+++|+|++|..||......+....+... ...
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence 568899999999865 45788999999999999999999999766544332222110 000
Q ss_pred C---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 P---------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 ~---------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+ .....++..+.+++.+||+.+|.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 012356788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=313.78 Aligned_cols=255 Identities=28% Similarity=0.490 Sum_probs=221.1
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEECC--ccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecC
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTK 360 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~--~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~ 360 (575)
+..+..+.++++++..||+|+.|.|++.++.. .-.|||.+.... ++...++++..+.++.+.. +|+||+.+|+|..
T Consensus 84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~ 162 (391)
T KOG0983|consen 84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT 162 (391)
T ss_pred CcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence 44556777888999999999999999998855 779999998653 5555677888888776665 8999999999999
Q ss_pred CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHC-CceecccCCCCEEecCCCcEEEeeccccee
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~-gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
+...+|.||.| +..+..++...++++++..+-++...+++||.||..+ ||||||+||+|||+|+.|++||||||.+..
T Consensus 163 n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGr 241 (391)
T KOG0983|consen 163 NTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGR 241 (391)
T ss_pred CchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccce
Confidence 99999999999 6678888888889999999999999999999999865 999999999999999999999999999998
Q ss_pred cccCCccccCCCCCCccCcccccC---CCCCchHHHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhcCCCCCCCC--C
Q 008171 440 KAQSGVMTAETGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQKGLRPTIPK--N 513 (575)
Q Consensus 440 ~~~~~~~~~~~Gt~~y~APE~i~~---~~~s~ksDVwSlGviL~eLltG~~Pf~~~-~~~~~~~~v~~~~~~~~~p~--~ 513 (575)
..++...+...|.+.|||||.+.- ..|+.++||||||++++||.||..||.+- +..+....+++ ...|.+|. .
T Consensus 242 lvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~g 320 (391)
T KOG0983|consen 242 LVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMG 320 (391)
T ss_pred eecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccC
Confidence 888877788889999999999953 46999999999999999999999999884 44555555555 44466654 3
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 514 SQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 514 ~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.++.+.+|+..||++|+.+||.+.+|++
T Consensus 321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 321 FSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 7999999999999999999999999885
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=312.95 Aligned_cols=248 Identities=29% Similarity=0.530 Sum_probs=212.3
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
+|.+.+.||+|+||.||++.. .+..||+|.+............+.+|+.++++++|+||+++++.+......|+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 478899999999999999987 457799999876544444456788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhccC-cCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC-cEEEeecccceecccCCc-cc
Q 008171 371 MSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGV-MT 447 (575)
Q Consensus 371 ~~ggsL~d~l~~~~~-~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~~~~-~~ 447 (575)
+++++|.+++....+ .+++..+..++.||+.||.|||+++|+|+||||+||++++++ .+||+|||.+........ ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 999999999876433 578999999999999999999999999999999999999876 469999999876544321 22
Q ss_pred cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 008171 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~ 527 (575)
...|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....... ...+.++...+..+.++|.+||.
T Consensus 161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~ 239 (257)
T cd08225 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-GYFAPISPNFSRDLRSLISQLFK 239 (257)
T ss_pred ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-ccCCCCCCCCCHHHHHHHHHHhc
Confidence 34689999999999888899999999999999999999999988776665554443 33445566788999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 008171 528 QDPALRPDFSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs~~ell~ 541 (575)
.+|.+||++.++++
T Consensus 240 ~~p~~Rpt~~~ll~ 253 (257)
T cd08225 240 VSPRDRPSITSILK 253 (257)
T ss_pred cChhhCcCHHHHhh
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=307.42 Aligned_cols=246 Identities=35% Similarity=0.637 Sum_probs=213.2
Q ss_pred ceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
+|.+.+.||+|++|.||++... ++.+++|++..... .....+.+|+.++++++|+||+++++.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 3677899999999999999885 67799999986543 3457889999999999999999999999988999999999
Q ss_pred ccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccccCC
Q 008171 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET 450 (575)
Q Consensus 371 ~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 450 (575)
++|++|.+++......+++..++.++.|++.||.|||.+|++|+||+|+||+++.++.++|+|||.+.............
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence 99999999998765789999999999999999999999999999999999999999999999999997665543234557
Q ss_pred CCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC--cHHHHHHHHHhhhc
Q 008171 451 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS--QPKLAELLERCWQQ 528 (575)
Q Consensus 451 Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~--~~~l~~Li~~cL~~ 528 (575)
++..|++||.+.+..++.++|+||||+++|+|++|..||...+..+....... ...+..+... +..+.++|.+||+.
T Consensus 159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~ 237 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQK 237 (253)
T ss_pred cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHHccC
Confidence 89999999999888899999999999999999999999988766555544333 3333344333 88999999999999
Q ss_pred CCCCCCCHHHHHH
Q 008171 529 DPALRPDFSEIIE 541 (575)
Q Consensus 529 dP~~RPs~~ell~ 541 (575)
||.+|||+.++++
T Consensus 238 ~p~~R~t~~~~l~ 250 (253)
T cd05122 238 NPEKRPTAEQLLK 250 (253)
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.70 Aligned_cols=255 Identities=21% Similarity=0.357 Sum_probs=214.6
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCC
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP 362 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~ 362 (575)
..+.+....|.+.++||+|+.+.||++...+ +.||+|.+.....+.....-|.+|+..|.+|+ |.+||++|+|-..++
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 4668889999999999999999999998754 56888888777778888899999999999996 899999999999999
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
.+||||||= ..+|..+|++....++...+..++.||+.++.++|+.||||.||||+|+|+- .|.+||+|||.|.....
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 999999987 6799999998777777678999999999999999999999999999999997 57899999999976654
Q ss_pred CC---ccccCCCCCCccCcccccCCC-----------CCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCC
Q 008171 443 SG---VMTAETGTYRWMAPEVIEHKP-----------YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV-QKGLR 507 (575)
Q Consensus 443 ~~---~~~~~~Gt~~y~APE~i~~~~-----------~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~-~~~~~ 507 (575)
.. .....+||+.||+||.+.... .+.++||||||||||+|+.|+.||............+ ..+..
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE 591 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence 42 345678999999999985433 4568999999999999999999998766444433333 33233
Q ss_pred CCCCCCCcHH-HHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 PTIPKNSQPK-LAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 ~~~p~~~~~~-l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.++|..-+.. +.++|+.||..||.+||++.+||+
T Consensus 592 Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 592 IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 3444443333 999999999999999999999984
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=322.70 Aligned_cols=251 Identities=25% Similarity=0.358 Sum_probs=207.0
Q ss_pred CCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC--CCce
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLC 365 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~~l~ 365 (575)
..++|++.+.||.|+||.||+|.+ +++.||+|+++...........+.+|+.++++++|+||+++++++... +.++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 346799999999999999999987 467899999876544333344567899999999999999999998654 4689
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-C
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-G 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~ 444 (575)
+||||+. ++|.+++......+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 9999995 5898888776678999999999999999999999999999999999999999999999999999865543 2
Q ss_pred ccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC----------------
Q 008171 445 VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---------------- 507 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~---------------- 507 (575)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+......
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 3334456888999999865 56899999999999999999999999988877665544431100
Q ss_pred -CCC-----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 -PTI-----------PKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 -~~~-----------p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
..+ ....++++.++|.+||+.||.+|||+.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 0125788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.58 Aligned_cols=246 Identities=29% Similarity=0.455 Sum_probs=208.1
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~-~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
+.|++.++||+|+||.||+|+. .++.||+|++.... ........+.+|+.+++.++||||++++++|......|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4588889999999999999986 46789999986443 23344567899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 448 (575)
||+. |+|.+++......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++...... ..
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~ 170 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NS 170 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---CC
Confidence 9995 5787877665677999999999999999999999999999999999999999999999999998754332 34
Q ss_pred CCCCCCccCccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 008171 449 ETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 525 (575)
Q Consensus 449 ~~Gt~~y~APE~i~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~c 525 (575)
..+++.|+|||++. ...++.++||||||+++|+|++|..||...+.......+.........+..++..+.++|.+|
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 250 (307)
T cd06607 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSC 250 (307)
T ss_pred ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHH
Confidence 56889999999884 456889999999999999999999999888776655443332222222345788999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 008171 526 WQQDPALRPDFSEIIE 541 (575)
Q Consensus 526 L~~dP~~RPs~~ell~ 541 (575)
|+.+|.+||++.+++.
T Consensus 251 l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 251 LQKIPQDRPSSEELLK 266 (307)
T ss_pred hcCChhhCcCHHHHhc
Confidence 9999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=341.85 Aligned_cols=249 Identities=28% Similarity=0.484 Sum_probs=226.8
Q ss_pred CCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
....|.+.+.||+|.|+.|.+++. ++..||||++.....+....+.+.+|+++|+.|+|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 345788999999999999999976 678899999998888887777799999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccc
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 447 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 447 (575)
|||+.+|.+++++.+ .+.+.+..+..++.|++.|++|||+++|+|||||++|||++.+-++||+|||++..........
T Consensus 134 ~eya~~ge~~~yl~~-~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lq 212 (596)
T KOG0586|consen 134 MEYASGGELFDYLVK-HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQ 212 (596)
T ss_pred EEeccCchhHHHHHh-cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccccc
Confidence 999999999999988 5677779999999999999999999999999999999999999999999999999998888888
Q ss_pred cCCCCCCccCcccccCCCCC-chHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 008171 448 AETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 526 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~~~~s-~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL 526 (575)
..+|++.|.|||++.+..|+ +.+|+||+|++||-|++|.+||++.+-.+.-..++...+ .+|..++.++.++|+++|
T Consensus 213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~--rIp~~ms~dce~lLrk~l 290 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY--RIPFYMSCDCEDLLRKFL 290 (596)
T ss_pred ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee--cccceeechhHHHHHHhh
Confidence 99999999999999998886 679999999999999999999998776665555555544 477788889999999999
Q ss_pred hcCCCCCCCHHHHHH
Q 008171 527 QQDPALRPDFSEIIE 541 (575)
Q Consensus 527 ~~dP~~RPs~~ell~ 541 (575)
..+|.+|++.+++.+
T Consensus 291 vl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 291 VLNPSKRGPCDQIMK 305 (596)
T ss_pred ccCccccCCHHHhhh
Confidence 999999999999864
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=320.63 Aligned_cols=248 Identities=29% Similarity=0.499 Sum_probs=201.6
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCCCceeE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~l~lV 367 (575)
.++|...++||+|+||.||++.+ .++.||+|.+...... .....+.+|+.++.++. ||||+++++++..++..+++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 34677788999999999999987 4577999998754333 44567889999999996 99999999999998899999
Q ss_pred EEeccCCchhhhhh---h-ccCcCChHHHHHHHHHHHHHHHHHHHC-CceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 368 TEFMSGGSVYDYLH---K-LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 368 ~E~~~ggsL~d~l~---~-~~~~l~~~~~~~i~~qI~~aL~yLH~~-gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
|||+. ++|.++.. . ....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 99985 46555432 2 236789999999999999999999975 999999999999999999999999999976554
Q ss_pred CCccccCCCCCCccCcccccCC---CCCchHHHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhcCCCCC----CCCCC
Q 008171 443 SGVMTAETGTYRWMAPEVIEHK---PYDHKADVFSFGIVLWELLTGKLPYEYLTPL-QAAVGVVQKGLRPT----IPKNS 514 (575)
Q Consensus 443 ~~~~~~~~Gt~~y~APE~i~~~---~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~-~~~~~v~~~~~~~~----~p~~~ 514 (575)
........|+..|+|||++.+. .++.++|||||||++|+|++|+.||...... +....... ...+. .+..+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK-GDPPILSNSEEREF 239 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcC-CCCCcCCCcCCCcc
Confidence 4444455789999999999766 6899999999999999999999999765532 22222221 22222 22357
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 515 QPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 515 ~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
++++.+||.+||+.||.+||++.++++
T Consensus 240 ~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 240 SPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 899999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=314.90 Aligned_cols=245 Identities=22% Similarity=0.339 Sum_probs=200.4
Q ss_pred eeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCC--CCceeEE
Q 008171 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKP--PSLCIVT 368 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~--~~l~lV~ 368 (575)
|++.++||+|+||.||+|+. +++.||+|.++....... .....+|+.+++++. |+||+++++++.+. +.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 57789999999999999987 467799999876533332 234557888999886 99999999999877 8899999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 448 (575)
||+. ++|.+++......+++..++.++.||+.||.|||++||+||||+|+||+++. +.+||+|||+++..........
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~ 157 (282)
T cd07831 80 ELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTE 157 (282)
T ss_pred ecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCC
Confidence 9996 5888888765677999999999999999999999999999999999999999 9999999999986655444445
Q ss_pred CCCCCCccCccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC----------------CCCCC-
Q 008171 449 ETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG----------------LRPTI- 510 (575)
Q Consensus 449 ~~Gt~~y~APE~i~-~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~----------------~~~~~- 510 (575)
..++..|+|||++. +..++.++|||||||++|+|++|..||...+..+......... ....+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07831 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237 (282)
T ss_pred CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence 67899999999764 4567889999999999999999999998876654333221100 00001
Q ss_pred ----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 511 ----------PKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 511 ----------p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
...++.++.++|.+||+++|.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 1356789999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.38 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=205.7
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCC---hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN---SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
+|++.+.||.|+||.||+|.+ .++.||||.++..... ......+..|+.+++.++|+||+++++++.....+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477889999999999999987 4678999999865443 33445678899999999999999999999998999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cc
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VM 446 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~ 446 (575)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++...... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 899999997744479999999999999999999999999999999999999999999999999997655432 33
Q ss_pred ccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC------------------
Q 008171 447 TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR------------------ 507 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~------------------ 507 (575)
....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+......
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence 34467889999998854 56789999999999999999998888776654433332211000
Q ss_pred ---C-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 ---P-----TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 ---~-----~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+ ......+.++.++|.+||+.||.+||++.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0 012345788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.31 Aligned_cols=247 Identities=25% Similarity=0.363 Sum_probs=203.8
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC------C
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP------P 362 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~------~ 362 (575)
.++|++.+.||+|+||.||++.. +++.||||++............+.+|+.++++++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 36799999999999999999986 567899999876544455556788999999999999999999987543 3
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
..|+||||+. ++|.+.+.. .++...+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred cEEEEEeccC-CCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 4699999995 588887754 288999999999999999999999999999999999999999999999999987655
Q ss_pred CCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC----------------
Q 008171 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL---------------- 506 (575)
Q Consensus 443 ~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~---------------- 506 (575)
........++..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...-.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (353)
T cd07850 171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN 250 (353)
T ss_pred CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence 5444556789999999999999999999999999999999999999987654333222211000
Q ss_pred ----CC---------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 507 ----RP---------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 507 ----~~---------------------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
++ ..+...++++.++|.+||+.||.+||++.|++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 001234667899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=313.98 Aligned_cols=248 Identities=33% Similarity=0.528 Sum_probs=204.9
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCC-----
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP----- 362 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~----- 362 (575)
.++|++.+.||.|+||.||+|... ++.+++|++..... ....+.+|+.+++++ .|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 367889999999999999999874 56799999875432 346788999999999 6999999999986544
Q ss_pred -CceeEEEeccCCchhhhhhhc---cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccce
Q 008171 363 -SLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 363 -~l~lV~E~~~ggsL~d~l~~~---~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
.+|+||||+++++|.+++... ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 489999999999999998653 3678999999999999999999999999999999999999999999999999987
Q ss_pred ecccC-CccccCCCCCCccCcccccC-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-CCCC
Q 008171 439 VKAQS-GVMTAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-PTIP 511 (575)
Q Consensus 439 ~~~~~-~~~~~~~Gt~~y~APE~i~~-----~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~-~~~p 511 (575)
..... .......|+..|+|||++.. ..++.++||||||++||+|++|..||....+......+...... ...+
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSP 241 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCch
Confidence 54432 22334568999999998753 35778999999999999999999999877665555444332211 1122
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 512 KNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 512 ~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
..++.++.++|.+||..||.+|||+.++++
T Consensus 242 ~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 242 ENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 346789999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=322.10 Aligned_cols=240 Identities=23% Similarity=0.388 Sum_probs=185.8
Q ss_pred eeeeeecCceEEEEEEEC----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC--CCCceeEEEe
Q 008171 297 GSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIVTEF 370 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~----~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--~~~l~lV~E~ 370 (575)
+++||+|+||.||+|... ++.||+|.+...... ..+.+|+.+|++++||||+++++++.. ...+|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999853 366999998754322 346789999999999999999998854 4567899999
Q ss_pred ccCCchhhhhhhc--------cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEe----cCCCcEEEeecccce
Q 008171 371 MSGGSVYDYLHKL--------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVAR 438 (575)
Q Consensus 371 ~~ggsL~d~l~~~--------~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl----~~~~~vkL~DFG~a~ 438 (575)
+ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 A-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred c-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 9 55888877532 2358889999999999999999999999999999999999 456789999999998
Q ss_pred ecccCC----ccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---------HHHHHHHhc
Q 008171 439 VKAQSG----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---------QAAVGVVQK 504 (575)
Q Consensus 439 ~~~~~~----~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~---------~~~~~v~~~ 504 (575)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 654321 2334578999999999976 45899999999999999999999999643210 001011000
Q ss_pred -----------------------CCCC-------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 505 -----------------------GLRP-------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 505 -----------------------~~~~-------------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.... ......+.++.+||.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 001123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=314.11 Aligned_cols=245 Identities=34% Similarity=0.593 Sum_probs=212.3
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
-|++.++||+|+||.||+|.. .+..||||++..... ......+.+|+.++++++||||+++++++......|+||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 467788999999999999976 467899999865432 33456788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-ccccC
Q 008171 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE 449 (575)
Q Consensus 371 ~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 449 (575)
+++++|.+++.. +.+++..+..++.|++.|+.|||++|++|+||+|.||+++.++.++|+|||++....... .....
T Consensus 84 ~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06641 84 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence 999999999864 568999999999999999999999999999999999999999999999999987554322 22345
Q ss_pred CCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcC
Q 008171 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 529 (575)
Q Consensus 450 ~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~d 529 (575)
.++..|+|||.+.+..++.++|+|||||++|+|++|..||....+...... +.....+.++..++.++.+++.+||+.+
T Consensus 162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 240 (277)
T cd06641 162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL-IPKNNPPTLEGNYSKPLKEFVEACLNKE 240 (277)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH-HhcCCCCCCCcccCHHHHHHHHHHccCC
Confidence 688999999999888899999999999999999999999988776555443 3444456677788999999999999999
Q ss_pred CCCCCCHHHHHH
Q 008171 530 PALRPDFSEIIE 541 (575)
Q Consensus 530 P~~RPs~~ell~ 541 (575)
|.+||++.++++
T Consensus 241 p~~Rp~~~~~l~ 252 (277)
T cd06641 241 PSFRPTAKELLK 252 (277)
T ss_pred hhhCcCHHHHHh
Confidence 999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=317.07 Aligned_cols=248 Identities=21% Similarity=0.387 Sum_probs=204.3
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
+|++.+.||.|+||.||+|++ +++.||||.++...........+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 378889999999999999987 467899999876544444456788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 371 MSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 371 ~~ggsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
+. ++|.+++... .+.+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 95 6888888653 3568999999999999999999999999999999999999999999999999987544322 2334
Q ss_pred CCCCCCccCcccccCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-------------------
Q 008171 449 ETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP------------------- 508 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~-~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~------------------- 508 (575)
..++..|+|||++.+.. ++.++||||||+++|+|++|+.||...+..............+
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence 45788999999886644 6889999999999999999999998766554443332211000
Q ss_pred --------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 --------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 --------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+...++++++++|.+||+.||.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 112356788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=311.70 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=218.7
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC------ChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCC
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI------NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP 362 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~------~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~ 362 (575)
..|.-.+.||.|..+.|.++.. +++.+|+|++..... .....+.-.+|+.||+++ .||+|+++.++++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 3566677899999999988754 678899998864321 224456678899999999 4999999999999999
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
.+++|+|.|+.|.|.|+|.. .-.+++....+|++|++.|+.|||.++|+||||||+|||++++-++||+|||+++....
T Consensus 97 F~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999999999999987 66789999999999999999999999999999999999999999999999999999888
Q ss_pred CCccccCCCCCCccCccccc------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--CCCCCCCC
Q 008171 443 SGVMTAETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIPKNS 514 (575)
Q Consensus 443 ~~~~~~~~Gt~~y~APE~i~------~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~--~~~~p~~~ 514 (575)
+......+|||+|.|||.+. +..|+...|+|++|+|||.|+.|.+||-.....-....+++..+ +.+-..++
T Consensus 176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadi 255 (411)
T KOG0599|consen 176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADI 255 (411)
T ss_pred chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhc
Confidence 88888999999999999984 44688899999999999999999999977666655555555443 44455688
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHH
Q 008171 515 QPKLAELLERCWQQDPALRPDFSEIIE--ILQQIA 547 (575)
Q Consensus 515 ~~~l~~Li~~cL~~dP~~RPs~~ell~--~L~~l~ 547 (575)
+...++||.+||+.||.+|.|++|.+. ++..+.
T Consensus 256 s~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 256 SATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred cccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 999999999999999999999999984 344444
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=306.52 Aligned_cols=247 Identities=35% Similarity=0.637 Sum_probs=217.3
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
+|++.++||+|++|.||+++. .++.|++|.+............+.+|+.++++++|||++++++++......+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 477889999999999999976 457899999987765555667899999999999999999999999988899999999
Q ss_pred ccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc-cccC
Q 008171 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-MTAE 449 (575)
Q Consensus 371 ~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~ 449 (575)
+++++|.+++.. .+.+++..++.++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (254)
T cd06627 81 AENGSLRQIIKK-FGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV 159 (254)
T ss_pred CCCCcHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence 999999999876 37799999999999999999999999999999999999999999999999999986654332 2345
Q ss_pred CCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcC
Q 008171 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 529 (575)
Q Consensus 450 ~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~d 529 (575)
.++..|+|||...+..++.++|||+||+++|+|++|..||...+......... ....+.++..+++.+.+++.+||..+
T Consensus 160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~ 238 (254)
T cd06627 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQKD 238 (254)
T ss_pred ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHHhCC
Confidence 68899999999988889999999999999999999999998877655554443 34456678889999999999999999
Q ss_pred CCCCCCHHHHHH
Q 008171 530 PALRPDFSEIIE 541 (575)
Q Consensus 530 P~~RPs~~ell~ 541 (575)
|++||++.+++.
T Consensus 239 p~~R~~~~~~l~ 250 (254)
T cd06627 239 PNLRPTAKQLLK 250 (254)
T ss_pred hhhCcCHHHHhc
Confidence 999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.36 Aligned_cols=242 Identities=23% Similarity=0.344 Sum_probs=196.0
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
...|.+.++||+|+||.||++.+. ++.||||.... ..+.+|+.+|++++|+|||++++++...+..|+||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 347899999999999999999875 56799996432 33568999999999999999999999888999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc---
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV--- 445 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~--- 445 (575)
|++ .++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 240 e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 240 PKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred Ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 999 5689998877566799999999999999999999999999999999999999999999999999976543221
Q ss_pred cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC------H-HHHHHHHHhcC-CC-CCCC-----
Q 008171 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT------P-LQAAVGVVQKG-LR-PTIP----- 511 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~------~-~~~~~~v~~~~-~~-~~~p----- 511 (575)
.....||..|+|||++.+..++.++|||||||+||||++|..|+.... + ......+++.. .. ..++
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 223469999999999999999999999999999999999876553221 0 11122222111 00 0000
Q ss_pred --------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 512 --------------------------KNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 512 --------------------------~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
...++.+.+||.+||+.||.+|||+.|+++
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 134568999999999999999999999986
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=309.46 Aligned_cols=247 Identities=30% Similarity=0.525 Sum_probs=215.8
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
+|++.++||.|+||.||+++. +++.+++|.+............+.+|+.+++.++|+||+++++++......|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999976 467799999886655555567788999999999999999999999988999999999
Q ss_pred ccCCchhhhhhhc---cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccc
Q 008171 371 MSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 447 (575)
Q Consensus 371 ~~ggsL~d~l~~~---~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 447 (575)
+++++|.+++... ...+++..++.++.|++.||.|||++|++|+||+|.||+++.++.+||+|||++...... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~ 159 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAK 159 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Ccc
Confidence 9999999998653 356889999999999999999999999999999999999999999999999999766544 333
Q ss_pred cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 008171 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~ 527 (575)
...+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+ .....+.++..++.++.+++.+||+
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08530 160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV-QRGKYPPIPPIYSQDLQNFIRSMLQ 238 (256)
T ss_pred cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hcCCCCCCchhhCHHHHHHHHHHcC
Confidence 456899999999999999999999999999999999999999988776554443 3344556677889999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 008171 528 QDPALRPDFSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs~~ell~ 541 (575)
.+|++||++.++++
T Consensus 239 ~~p~~Rp~~~~~l~ 252 (256)
T cd08530 239 VKPKLRPNCDKILA 252 (256)
T ss_pred CCcccCCCHHHHhc
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.60 Aligned_cols=255 Identities=26% Similarity=0.496 Sum_probs=208.9
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCC
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKP 361 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~ 361 (575)
..|.++.++|++.++||+|+||.||+|.+. ++.||||.++..... .....+..|+.++.++. ||||+++++++...
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 456778889999999999999999999986 788999999754332 33455667777666665 99999999999999
Q ss_pred CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHH-CCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
...|+||||+ +++|.+++....+.+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++...
T Consensus 87 ~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 87 SDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred CeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 9999999999 557888777666789999999999999999999997 59999999999999999999999999998765
Q ss_pred ccCCccccCCCCCCccCcccccCCC----CCchHHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhcCCCCCCC--CC
Q 008171 441 AQSGVMTAETGTYRWMAPEVIEHKP----YDHKADVFSFGIVLWELLTGKLPYEYLTP-LQAAVGVVQKGLRPTIP--KN 513 (575)
Q Consensus 441 ~~~~~~~~~~Gt~~y~APE~i~~~~----~s~ksDVwSlGviL~eLltG~~Pf~~~~~-~~~~~~v~~~~~~~~~p--~~ 513 (575)
..........++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..... .+....+.... .+..+ ..
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 244 (296)
T cd06618 166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-PPSLPPNEG 244 (296)
T ss_pred cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-CCCCCCCCC
Confidence 5444444556888999999986553 88999999999999999999999976433 23333333322 22333 24
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 008171 514 SQPKLAELLERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 514 ~~~~l~~Li~~cL~~dP~~RPs~~ell~~ 542 (575)
++.++.+++.+||+.||.+||++.+++..
T Consensus 245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 245 FSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 78999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=314.02 Aligned_cols=248 Identities=29% Similarity=0.475 Sum_probs=204.6
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCC-----C
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP-----P 362 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~-----~ 362 (575)
.++|.+.+.||+|+||.||++.. .++.+|+|++.... .....+.+|+.+++++ +||||+++++++... .
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 46799999999999999999987 46789999987532 2235677899999999 799999999988643 3
Q ss_pred CceeEEEeccCCchhhhhhh---ccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 363 SLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~---~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
.+|+||||++|++|.++++. ....+++..++.++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 58999999999999998863 245689999999999999999999999999999999999999999999999999875
Q ss_pred cccCC-ccccCCCCCCccCcccccCC-----CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCC
Q 008171 440 KAQSG-VMTAETGTYRWMAPEVIEHK-----PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPK 512 (575)
Q Consensus 440 ~~~~~-~~~~~~Gt~~y~APE~i~~~-----~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~~~~p~ 512 (575)
..... ......|+..|+|||++... .++.++|||||||++|+|++|+.||....+.+....+..... ....+.
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE 257 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCccc
Confidence 44322 22345688999999998543 368899999999999999999999998877666554433211 112345
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 513 NSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 513 ~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
..+..+.++|.+||+.+|++||++.++++
T Consensus 258 ~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 258 KWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 66788999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=315.55 Aligned_cols=247 Identities=33% Similarity=0.593 Sum_probs=211.7
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
+.|.+.+.||+|+||.||+|.+. ++.|++|+++.... ....+.+|+.+++.++|+||+++++.+......|+|+|
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 45777889999999999999885 77899999875433 45678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
|++|++|.+++......+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ....
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 175 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS 175 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhcc
Confidence 999999999998755489999999999999999999999999999999999999999999999999886543321 2234
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-CCCCCCcHHHHHHHHHhhh
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-TIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~-~~p~~~~~~l~~Li~~cL~ 527 (575)
..++..|++||++.+..++.++|+||||+++|+|++|..||....+......+....... ..+..++..+.++|.+||+
T Consensus 176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (286)
T cd06614 176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLV 255 (286)
T ss_pred ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhc
Confidence 457889999999998899999999999999999999999999887766555444333222 1223478999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 008171 528 QDPALRPDFSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs~~ell~ 541 (575)
.+|.+||++.+++.
T Consensus 256 ~~p~~Rpt~~~il~ 269 (286)
T cd06614 256 KDPEKRPSAEELLQ 269 (286)
T ss_pred cChhhCcCHHHHhh
Confidence 99999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=313.27 Aligned_cols=245 Identities=32% Similarity=0.564 Sum_probs=207.1
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC---CCCceEEEeeecCCCCceeE
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~---HpnIv~l~~~~~~~~~l~lV 367 (575)
.|++.+.||+|+||.||+|.+ .++.||+|+++... .......+.+|+.+++.++ |||++++++++......|+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 477788999999999999987 46779999987543 2334567888999999997 99999999999998999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cc
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VM 446 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~ 446 (575)
|||+.|++|.+++.. +.+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 81 MEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence 999999999999865 478999999999999999999999999999999999999999999999999997654432 23
Q ss_pred ccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCC-CcHHHHHHHHH
Q 008171 447 TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN-SQPKLAELLER 524 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~-~~~~l~~Li~~ 524 (575)
....|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||........... ......+.++.. ++.++.++|.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~ 237 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-IPKSKPPRLEDNGYSKLLREFVAA 237 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-cccCCCCCCCcccCCHHHHHHHHH
Confidence 34578999999998864 4578999999999999999999999988776554432 222223344443 78899999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 008171 525 CWQQDPALRPDFSEIIE 541 (575)
Q Consensus 525 cL~~dP~~RPs~~ell~ 541 (575)
||+.||.+||++.++++
T Consensus 238 ~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 238 CLDEEPKERLSAEELLK 254 (277)
T ss_pred HcCCCcccCcCHHHHhh
Confidence 99999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=318.67 Aligned_cols=247 Identities=29% Similarity=0.456 Sum_probs=211.2
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
..|...+.||+|+||.||+++. .+..||+|++..... ..+....+.+|+.++++++|||++++++++......++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 4577889999999999999986 467799999875432 3345567899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 448 (575)
||+. |+|.+++......+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++..... ...
T Consensus 105 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~ 180 (317)
T cd06635 105 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANS 180 (317)
T ss_pred eCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---ccc
Confidence 9996 588888766667799999999999999999999999999999999999999999999999999864432 234
Q ss_pred CCCCCCccCccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 008171 449 ETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 525 (575)
Q Consensus 449 ~~Gt~~y~APE~i~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~c 525 (575)
..|++.|+|||++. ...++.++|||||||++|+|++|..||...........+......+..+..+++.+.+++.+|
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 260 (317)
T cd06635 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC 260 (317)
T ss_pred ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHH
Confidence 56889999999973 456899999999999999999999999887776666655554444444557889999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 008171 526 WQQDPALRPDFSEIIEI 542 (575)
Q Consensus 526 L~~dP~~RPs~~ell~~ 542 (575)
|+.+|.+||++.++++.
T Consensus 261 l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 261 LQKIPQDRPTSEELLKH 277 (317)
T ss_pred ccCCcccCcCHHHHHhC
Confidence 99999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=313.98 Aligned_cols=247 Identities=23% Similarity=0.383 Sum_probs=204.8
Q ss_pred eeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEec
Q 008171 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~ 371 (575)
|++.++||.|++|.||+|.+ +++.||+|++............+.+|+.++++++||||+++++++...+..|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56778999999999999986 5788999998866544444567889999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-ccccC
Q 008171 372 SGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE 449 (575)
Q Consensus 372 ~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 449 (575)
+++|.+++.... ..+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||+++...... .....
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 159 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence 568999987643 368999999999999999999999999999999999999999999999999997543321 22334
Q ss_pred CCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---------------------
Q 008171 450 TGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--------------------- 507 (575)
Q Consensus 450 ~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--------------------- 507 (575)
.++..|+|||++.+. .++.++||||||+++|+|++|+.||...+.......+.+....
T Consensus 160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd07835 160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK 239 (283)
T ss_pred ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccc
Confidence 578899999988654 5789999999999999999999999877765544333221100
Q ss_pred ------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 ------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 ------~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
......+++.+.++|.+||+.||.+||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 1123456789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=317.79 Aligned_cols=254 Identities=17% Similarity=0.246 Sum_probs=191.8
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEECCc-----cEEEEEecCCCCChHH---------HHHHHHHHHHHHhcCCCCceE
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDM---------QKEFAQEVFIMRKVRHKNVVQ 353 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~-----~VAvKvl~~~~~~~~~---------~~~~~~Ev~iL~~L~HpnIv~ 353 (575)
++..++|++.++||+|+||.||+|.+.+. .+|+|+.......... ......+...+..+.|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 56668999999999999999999987543 5677764432211100 012233445566778999999
Q ss_pred EEeeecCCC----CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcE
Q 008171 354 FIGACTKPP----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 429 (575)
Q Consensus 354 l~~~~~~~~----~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~v 429 (575)
+++.+.... ..++++|++ ..++.+.+.. ....++..+..++.||+.||.|||+++|+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 998765433 236778877 4466666654 3446788899999999999999999999999999999999999999
Q ss_pred EEeecccceecccCC--------ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-
Q 008171 430 KVADFGVARVKAQSG--------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG- 500 (575)
Q Consensus 430 kL~DFG~a~~~~~~~--------~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~- 500 (575)
+|+|||+++...... ......||+.|+|||++.+..++.++|||||||+||||++|..||...........
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 999999997653221 12234699999999999999999999999999999999999999987743221111
Q ss_pred ----HHhcCCCC-CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 008171 501 ----VVQKGLRP-TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 543 (575)
Q Consensus 501 ----v~~~~~~~-~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L 543 (575)
...+-..+ .....+++++.++++.||..+|++||++.+|++.|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 246 AKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11111111 12346789999999999999999999999999876
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=314.87 Aligned_cols=249 Identities=21% Similarity=0.333 Sum_probs=202.4
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCCC-----
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS----- 363 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~----- 363 (575)
++|++.+.||+|+||.||+|.+ +++.||||+++...........+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3688899999999999999987 4678999998765444334567888999999996 6999999998876555
Q ss_pred ceeEEEeccCCchhhhhhhcc----CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC-CCcEEEeecccce
Q 008171 364 LCIVTEFMSGGSVYDYLHKLK----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVAR 438 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~----~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~-~~~vkL~DFG~a~ 438 (575)
.|+||||+++ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 7999999975 8888876432 35899999999999999999999999999999999999998 8899999999987
Q ss_pred ecccC-CccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--------
Q 008171 439 VKAQS-GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-------- 508 (575)
Q Consensus 439 ~~~~~-~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~-------- 508 (575)
..... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+...-..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 54332 22334467889999998865 567999999999999999999999998877666554433211000
Q ss_pred ------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 ------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 ------------------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.....+++++.++|.+||..||.+||++.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 011357889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=305.78 Aligned_cols=261 Identities=21% Similarity=0.337 Sum_probs=211.8
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC-
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP- 361 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~- 361 (575)
+...|+.++|+|.++||.|+|+-||+++. ++..||+|.+.... .+..+...+|+...++++||||++++++....
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE 91 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence 44579999999999999999999999975 56779999988654 45567889999999999999999999886433
Q ss_pred ----CCceeEEEeccCCchhhhhhhcc---CcCChHHHHHHHHHHHHHHHHHHHCC--ceecccCCCCEEecCCCcEEEe
Q 008171 362 ----PSLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVA 432 (575)
Q Consensus 362 ----~~l~lV~E~~~ggsL~d~l~~~~---~~l~~~~~~~i~~qI~~aL~yLH~~g--IiHrDLKp~NILl~~~~~vkL~ 432 (575)
...||+++|...|||.+.+...+ ..+++.++++|+.+|++||.+||... ++||||||.|||+++.+.++|.
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence 34899999999999999987553 36999999999999999999999998 9999999999999999999999
Q ss_pred ecccceecccCC----------ccccCCCCCCccCccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH--HH
Q 008171 433 DFGVARVKAQSG----------VMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL--QA 497 (575)
Q Consensus 433 DFG~a~~~~~~~----------~~~~~~Gt~~y~APE~i~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~--~~ 497 (575)
|||.++.....- ....+..|..|.|||.+. +...+.++|||||||+||.|+.|..||+..-.. ..
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl 251 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL 251 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence 999987533211 122346789999999995 445788999999999999999999999642211 11
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 008171 498 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA 547 (575)
Q Consensus 498 ~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~ 547 (575)
+..+......-.-...++..+.++++.||+.||.+||++.+++..++++.
T Consensus 252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11112111111112238899999999999999999999999999988764
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=314.34 Aligned_cols=241 Identities=25% Similarity=0.405 Sum_probs=200.6
Q ss_pred eeecCceEEEEEEE--CCccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCCch
Q 008171 300 VASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (575)
Q Consensus 300 LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ggsL 376 (575)
||+|+||+||++.. +++.||+|++...... ......+..|+.++++++||||+++++.+...+..|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999976 4678999998754332 22345677899999999999999999999999999999999999999
Q ss_pred hhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccccCCCCCCc
Q 008171 377 YDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRW 455 (575)
Q Consensus 377 ~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~Gt~~y 455 (575)
.+++.+.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.............++..|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence 99987643 36899999999999999999999999999999999999999999999999998765544344455788999
Q ss_pred cCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 008171 456 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV--QKGLRPTIPKNSQPKLAELLERCWQQDPALR 533 (575)
Q Consensus 456 ~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~--~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~R 533 (575)
+|||++.+..++.++||||||+++|+|++|+.||...........+. ........+..+++.+.++|.+||+.||.+|
T Consensus 161 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 240 (277)
T cd05577 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR 240 (277)
T ss_pred CCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHc
Confidence 99999988889999999999999999999999997654311111111 1123345667789999999999999999999
Q ss_pred C-----CHHHHH
Q 008171 534 P-----DFSEII 540 (575)
Q Consensus 534 P-----s~~ell 540 (575)
| ++.+++
T Consensus 241 ~~~~~~~~~~ll 252 (277)
T cd05577 241 LGCRGGSADEVR 252 (277)
T ss_pred cCCCcccHHHHH
Confidence 9 555565
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=314.33 Aligned_cols=248 Identities=25% Similarity=0.415 Sum_probs=199.4
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
+.|.+.++||+|+||.||+|.. .++.||||.+...... .....+.+|+.+++.++||||+++++++......|+|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 5789999999999999999987 4678999998754322 223456789999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
|+.+ +|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... ....
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN 162 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence 9964 9999987766788999999999999999999999999999999999999999999999999987543221 2223
Q ss_pred CCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHh---cC------------------
Q 008171 449 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLT-PLQAAVGVVQ---KG------------------ 505 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~-~~~~~~~v~~---~~------------------ 505 (575)
..++..|+|||++.+ ..++.++||||||+++|+|++|..||.... ..+....+.. ..
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence 457889999999865 568999999999999999999999997655 2221111110 00
Q ss_pred CC---C----CCCCCCc--HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 506 LR---P----TIPKNSQ--PKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 506 ~~---~----~~p~~~~--~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.. + ......+ .++.+++.+||+.+|.+||++.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 0 0001233 78899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=313.51 Aligned_cols=248 Identities=23% Similarity=0.377 Sum_probs=198.6
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
+.|++.+.||+|+||.||+|.. +++.||+|++..... ......+.+|+.+++.++|+||+++++++......|+|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 5788999999999999999976 467899999875432 2223467789999999999999999999999889999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
|+. ++|.+++......+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++...... ....
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 162 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS 162 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence 995 67777776555678888999999999999999999999999999999999999999999999987543322 2234
Q ss_pred CCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHhc----------------CCCCC-
Q 008171 449 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA-VGVVQK----------------GLRPT- 509 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~-~~v~~~----------------~~~~~- 509 (575)
..+++.|+|||++.+ ..++.++||||||+++|+|++|..||......... ...... ...+.
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07870 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW 242 (291)
T ss_pred ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchh
Confidence 467899999999875 45889999999999999999999999866543221 111100 00000
Q ss_pred ----CC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 510 ----IP---------KNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 510 ----~p---------~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+ ...++.+.+++.+||..||.+|||+.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00 112578999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.38 Aligned_cols=243 Identities=29% Similarity=0.501 Sum_probs=205.2
Q ss_pred eeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEec
Q 008171 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~ 371 (575)
|....+||.|+||.||++.. .+..||||.+.... ......+.+|+.+++.++||||+++++.+...+..|+||||+
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 44456899999999999986 46789999986432 334567889999999999999999999999999999999999
Q ss_pred cCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-ccccCC
Q 008171 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAET 450 (575)
Q Consensus 372 ~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~ 450 (575)
++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ......
T Consensus 102 ~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 179 (292)
T cd06658 102 EGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV 179 (292)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceee
Confidence 99999998854 568999999999999999999999999999999999999999999999999986543221 223456
Q ss_pred CCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcHHHHHHHHHhhhc
Q 008171 451 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLERCWQQ 528 (575)
Q Consensus 451 Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~--p~~~~~~l~~Li~~cL~~ 528 (575)
|+..|+|||.+.+..++.++||||||+++|||++|..||....+.+....+. ....+.+ ...++..+.+++.+||..
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~ 258 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR-DNLPPRVKDSHKVSSVLRGFLDLMLVR 258 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcCCCccccccccCHHHHHHHHHHccC
Confidence 8999999999999899999999999999999999999998877766544322 2222222 235788999999999999
Q ss_pred CCCCCCCHHHHHH
Q 008171 529 DPALRPDFSEIIE 541 (575)
Q Consensus 529 dP~~RPs~~ell~ 541 (575)
||.+|||+.++++
T Consensus 259 ~P~~Rpt~~~il~ 271 (292)
T cd06658 259 EPSQRATAQELLQ 271 (292)
T ss_pred ChhHCcCHHHHhh
Confidence 9999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=311.51 Aligned_cols=252 Identities=29% Similarity=0.469 Sum_probs=205.0
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC--CCCceeE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIV 367 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--~~~l~lV 367 (575)
+.|.+.++||.|++|.||++.+ .++.+|+|.+..... ......+.+|+.++++++||||+++++++.. .+.+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 3578889999999999999987 467799999875432 3445778999999999999999999998754 3468999
Q ss_pred EEeccCCchhhhhhh---ccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 368 TEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~---~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|||++|++|.+++.. ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999999999988753 24568899999999999999999999999999999999999999999999999986544322
Q ss_pred ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhcCCCCCCC------CC
Q 008171 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL-----TPLQAAVGVVQKGLRPTIP------KN 513 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~-----~~~~~~~~v~~~~~~~~~p------~~ 513 (575)
.....++..|+|||.+.+..++.++|||||||++|+|++|..||... .+.+....+.. ...+.++ ..
T Consensus 160 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 237 (287)
T cd06621 160 -AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKDEPGNGIK 237 (287)
T ss_pred -cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhccCCCCCCc
Confidence 22446788999999999999999999999999999999999999765 22333322222 1112222 23
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 008171 514 SQPKLAELLERCWQQDPALRPDFSEIIE--ILQQI 546 (575)
Q Consensus 514 ~~~~l~~Li~~cL~~dP~~RPs~~ell~--~L~~l 546 (575)
.++.+.++|.+||..+|.+|||+.|+++ .+++.
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 238 WSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred hHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 4678999999999999999999999987 44443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=318.06 Aligned_cols=240 Identities=23% Similarity=0.396 Sum_probs=185.1
Q ss_pred eeeeeecCceEEEEEEEC----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeec--CCCCceeEEEe
Q 008171 297 GSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT--KPPSLCIVTEF 370 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~----~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~--~~~~l~lV~E~ 370 (575)
+++||+|+||.||+|+.. +..||+|.+..... ...+.+|+.++++++||||+++++++. ....+|+||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 468999999999999863 35699999875432 245778999999999999999999874 35568999999
Q ss_pred ccCCchhhhhhhc--------cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEe----cCCCcEEEeecccce
Q 008171 371 MSGGSVYDYLHKL--------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVAR 438 (575)
Q Consensus 371 ~~ggsL~d~l~~~--------~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl----~~~~~vkL~DFG~a~ 438 (575)
+. ++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 95 5787776421 2357888999999999999999999999999999999999 456789999999998
Q ss_pred ecccCC----ccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---------HHHHHHHh-
Q 008171 439 VKAQSG----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---------QAAVGVVQ- 503 (575)
Q Consensus 439 ~~~~~~----~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~---------~~~~~v~~- 503 (575)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||...... .....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 654332 2234578999999999876 45899999999999999999999999643210 00000000
Q ss_pred ----------------------cCC-C------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 504 ----------------------KGL-R------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 504 ----------------------~~~-~------------~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
... . .......+..+.+||.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 000 0 0011123567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=308.90 Aligned_cols=242 Identities=27% Similarity=0.390 Sum_probs=199.9
Q ss_pred eeeeecCceEEEEEEE--CCccEEEEEecCCCCC-hHHHHHHHHHHHH-HHhcCCCCceEEEeeecCCCCceeEEEeccC
Q 008171 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFI-MRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~-~~~~~~~~~Ev~i-L~~L~HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
+.||.|+||.||+|.. .++.||||++...... ......+..|..+ ....+|+||+++++++.....+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5789999999999987 5678999998754322 2223344555544 4455899999999999999999999999999
Q ss_pred CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccccCCCCC
Q 008171 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY 453 (575)
Q Consensus 374 gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~Gt~ 453 (575)
++|.+++.. .+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||+++.... .....|+.
T Consensus 82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~ 157 (260)
T cd05611 82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTP 157 (260)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCc
Confidence 999999976 46789999999999999999999999999999999999999999999999999875433 23446889
Q ss_pred CccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--CCCCCCCCcHHHHHHHHHhhhcCCC
Q 008171 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIPKNSQPKLAELLERCWQQDPA 531 (575)
Q Consensus 454 ~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~--~~~~p~~~~~~l~~Li~~cL~~dP~ 531 (575)
.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..... .......+++.+.+++.+||+.+|+
T Consensus 158 ~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 237 (260)
T cd05611 158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPA 237 (260)
T ss_pred CccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHH
Confidence 99999999888899999999999999999999999988877665544433322 2334456889999999999999999
Q ss_pred CCCCHHHHHHHH
Q 008171 532 LRPDFSEIIEIL 543 (575)
Q Consensus 532 ~RPs~~ell~~L 543 (575)
+||++.++.+.|
T Consensus 238 ~R~~~~~~~~~l 249 (260)
T cd05611 238 KRLGANGYQEIK 249 (260)
T ss_pred HccCCCcHHHHH
Confidence 999776554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=314.89 Aligned_cols=250 Identities=26% Similarity=0.416 Sum_probs=199.5
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCC-----
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS----- 363 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~----- 363 (575)
.++|++.++||.|+||.||++.. +++.||||.+............+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 35799999999999999999987 46789999987554333334556789999999999999999998865543
Q ss_pred ---ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 364 ---LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 364 ---l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
.|+||||+. ++|.+++......+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++...
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 499999995 5888888765567999999999999999999999999999999999999999999999999999755
Q ss_pred ccCC-----ccccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--CCCC----
Q 008171 441 AQSG-----VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRP---- 508 (575)
Q Consensus 441 ~~~~-----~~~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~--~~~~---- 508 (575)
.... ......++..|+|||++.+. .++.++||||||+++|+|++|..||...++......+..- ...+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP 249 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 4322 12234578899999988664 4789999999999999999999999877654332211110 0000
Q ss_pred -----------CC-------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 -----------TI-------------PKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 -----------~~-------------p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+ +...++.+.++|.+||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 1123567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=309.13 Aligned_cols=242 Identities=26% Similarity=0.426 Sum_probs=206.0
Q ss_pred eeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCCch
Q 008171 300 VASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (575)
Q Consensus 300 LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ggsL 376 (575)
||.|+||.||++.+. ++.|++|++..... .......+.+|+.++++++||||+++++.+......|++|||+.|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999885 78899999876543 224456788999999999999999999999999999999999999999
Q ss_pred hhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC---------ccc
Q 008171 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---------VMT 447 (575)
Q Consensus 377 ~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~---------~~~ 447 (575)
.+++.+. +.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 159 (265)
T cd05579 81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159 (265)
T ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence 9999773 478999999999999999999999999999999999999999999999999987544331 223
Q ss_pred cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC--cHHHHHHHHHh
Q 008171 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS--QPKLAELLERC 525 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~--~~~l~~Li~~c 525 (575)
...++..|++||.+....++.++||||||+++|+|++|..||....+.+....+..... ..+..+ ++.+.+++.+|
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~ 237 (265)
T cd05579 160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI--EWPEDVEVSDEAIDLISKL 237 (265)
T ss_pred CcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc--CCCccccCCHHHHHHHHHH
Confidence 34678899999999888899999999999999999999999988887776655544332 334444 89999999999
Q ss_pred hhcCCCCCCCHHHHHHHHH
Q 008171 526 WQQDPALRPDFSEIIEILQ 544 (575)
Q Consensus 526 L~~dP~~RPs~~ell~~L~ 544 (575)
|+.+|.+||++..+.+.|+
T Consensus 238 l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 238 LVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred hcCCHhhcCCCccHHHHhc
Confidence 9999999999965555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=310.94 Aligned_cols=247 Identities=24% Similarity=0.392 Sum_probs=208.3
Q ss_pred eeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEec
Q 008171 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~ 371 (575)
|++.+.||.|++|.||++.. .++.+++|.++...........+.+|+.++++++|+||+++++++......++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 46678999999999999987 4677999998876555455677889999999999999999999999999999999999
Q ss_pred cCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-ccccCC
Q 008171 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAET 450 (575)
Q Consensus 372 ~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~ 450 (575)
++ +|.+++......+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~ 159 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV 159 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence 65 8888887766789999999999999999999999999999999999999999999999999997665543 333456
Q ss_pred CCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC----------------------
Q 008171 451 GTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---------------------- 507 (575)
Q Consensus 451 Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~---------------------- 507 (575)
++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+......
T Consensus 160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05118 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239 (283)
T ss_pred CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc
Confidence 88899999998776 7899999999999999999999999887765544333221100
Q ss_pred ------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 ------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 ------~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
......++.++.++|.+||+.||.+||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0112346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=312.56 Aligned_cols=243 Identities=30% Similarity=0.521 Sum_probs=205.9
Q ss_pred eeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEec
Q 008171 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~ 371 (575)
|.-.++||.|++|.||++.. .++.+++|.+... .....+.+.+|+.+++.++||||+++++++...+..|+|+||+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 44457999999999999976 4577999988643 2233456889999999999999999999999999999999999
Q ss_pred cCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-ccccCC
Q 008171 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAET 450 (575)
Q Consensus 372 ~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~ 450 (575)
.|++|.+++.. ++++...+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....... ......
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 176 (285)
T cd06648 99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV 176 (285)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence 99999999876 568999999999999999999999999999999999999999999999999886543322 223456
Q ss_pred CCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcHHHHHHHHHhhhc
Q 008171 451 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLERCWQQ 528 (575)
Q Consensus 451 Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~--p~~~~~~l~~Li~~cL~~ 528 (575)
|++.|+|||.+.+..++.++||||||+++|+|++|..||...++......+.. ...+.+ +..+++.+.++|++||+.
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~ 255 (285)
T cd06648 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD-NLPPKLKNLHKVSPRLRSFLDRMLVR 255 (285)
T ss_pred CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHh-cCCCCCcccccCCHHHHHHHHHHccc
Confidence 89999999999988999999999999999999999999988777665554333 222222 334788999999999999
Q ss_pred CCCCCCCHHHHHH
Q 008171 529 DPALRPDFSEIIE 541 (575)
Q Consensus 529 dP~~RPs~~ell~ 541 (575)
+|.+||++.++++
T Consensus 256 ~p~~Rpt~~~il~ 268 (285)
T cd06648 256 DPAQRATAAELLN 268 (285)
T ss_pred ChhhCcCHHHHcc
Confidence 9999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=309.88 Aligned_cols=247 Identities=25% Similarity=0.402 Sum_probs=204.8
Q ss_pred eeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC--CCceeEEE
Q 008171 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTE 369 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~~l~lV~E 369 (575)
|++.++||.|+||.||+|... ++.+|+|.+............+.+|+.+++.++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567899999999999999875 57899999987643344456788999999999999999999999887 78999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC--ccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMT 447 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~--~~~ 447 (575)
|++ ++|.+++......+++..++.++.||+.||.|||+.|++|+||+|+||++++++.++|+|||++....... ..+
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 996 58998887655689999999999999999999999999999999999999999999999999997665443 233
Q ss_pred cCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-------------------
Q 008171 448 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR------------------- 507 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~------------------- 507 (575)
...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+......
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK 239 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence 4567889999998764 46889999999999999999999999877765444333221000
Q ss_pred ----------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 ----------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 ----------~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
..+...+++.+.+++++||+.+|.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0011223889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=311.89 Aligned_cols=249 Identities=22% Similarity=0.380 Sum_probs=202.9
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.++||.|++|.||+|.. +++.||+|.+............+.+|+.++++++||||+++++++......|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 5789999999999999999986 46779999987654444445678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC-CCcEEEeecccceecccC-Ccc
Q 008171 370 FMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKAQS-GVM 446 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~~-~~~ 446 (575)
|++ ++|.+++.... ..+++..++.++.||+.||.|||++||+|+||+|+||+++. ++.+||+|||++...... ...
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence 995 58888775433 23678889999999999999999999999999999999985 567999999999754332 222
Q ss_pred ccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC------------------
Q 008171 447 TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR------------------ 507 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~------------------ 507 (575)
....+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+......
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T PLN00009 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA 240 (294)
T ss_pred ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence 34467899999999865 46889999999999999999999999887765554443221000
Q ss_pred -CC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 -PT--------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 -~~--------~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+. .....++++.+++.+||+.+|.+||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 12356788999999999999999999999885
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=317.53 Aligned_cols=244 Identities=28% Similarity=0.478 Sum_probs=205.8
Q ss_pred eeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEec
Q 008171 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~ 371 (575)
|....+||.|+||.||++.. .++.||+|++..... .....+.+|+.+++.++||||+++++.+...+..|+||||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 33455899999999999976 578899999865432 23456889999999999999999999999999999999999
Q ss_pred cCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-ccccCC
Q 008171 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAET 450 (575)
Q Consensus 372 ~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~ 450 (575)
++++|.+++.. ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....... ......
T Consensus 101 ~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 178 (297)
T cd06659 101 QGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 178 (297)
T ss_pred CCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence 99999988754 568999999999999999999999999999999999999999999999999986443322 223456
Q ss_pred CCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCcHHHHHHHHHhhhcC
Q 008171 451 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPKNSQPKLAELLERCWQQD 529 (575)
Q Consensus 451 Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~-~~~~~p~~~~~~l~~Li~~cL~~d 529 (575)
|+..|+|||++.+..++.++|||||||++|+|++|..||....+.+....+.... .....+..+++.+.++|++||+.+
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~ 258 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTRE 258 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCC
Confidence 8999999999999899999999999999999999999998877666554432211 112234567889999999999999
Q ss_pred CCCCCCHHHHHH
Q 008171 530 PALRPDFSEIIE 541 (575)
Q Consensus 530 P~~RPs~~ell~ 541 (575)
|.+||++.++++
T Consensus 259 P~~Rps~~~ll~ 270 (297)
T cd06659 259 PQERATAQELLD 270 (297)
T ss_pred cccCcCHHHHhh
Confidence 999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=314.55 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=204.2
Q ss_pred CCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC-----
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP----- 362 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~----- 362 (575)
..++|++.++||+|+||.||+|+. .++.||||+++...........+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 346788999999999999999987 4678999999765433334456788999999999999999999887654
Q ss_pred -----CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccc
Q 008171 363 -----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (575)
Q Consensus 363 -----~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a 437 (575)
.+|+|+||+++ +|.+++......+++..++.++.||+.||.|||++||+|+||||+||++++++.+||+|||++
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 78999999965 777777765667999999999999999999999999999999999999999999999999999
Q ss_pred eecccCC--ccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC------
Q 008171 438 RVKAQSG--VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP------ 508 (575)
Q Consensus 438 ~~~~~~~--~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~------ 508 (575)
....... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP 243 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 7654432 2223356888999998865 457899999999999999999999998766555443332211000
Q ss_pred ----------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 ----------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 ----------------------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.....+++.+.+++.+||+.||.+||++.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 012246889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=321.67 Aligned_cols=245 Identities=31% Similarity=0.522 Sum_probs=215.8
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
+-|.++.+||+|+||.||++.+ .|+-+|||.+..+ . ..+++..|+.||+++..|++|++||.+.....++||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---T-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---c-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3577889999999999999965 6788999998754 2 35788999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-Ccccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~ 448 (575)
||..|++.|+++..+.++++..+..+++.-++||+|||-..-||||||..|||++.+|..||+|||+|....+. .....
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT 188 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT 188 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence 99999999999998899999999999999999999999999999999999999999999999999999755442 12345
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHHHHHHHhh
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPKLAELLERCW 526 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~--~~p~~~~~~l~~Li~~cL 526 (575)
..||+.|||||++..-.|+.++||||||++..||..|++||....|..++..+-. ...| ..|...+.++.+++++||
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT-~PPPTF~KPE~WS~~F~DFi~~CL 267 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT-KPPPTFKKPEEWSSEFNDFIRSCL 267 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC-CCCCCCCChHhhhhHHHHHHHHHh
Confidence 6899999999999999999999999999999999999999999998876644322 2222 235567889999999999
Q ss_pred hcCCCCCCCHHHHHH
Q 008171 527 QQDPALRPDFSEIIE 541 (575)
Q Consensus 527 ~~dP~~RPs~~ell~ 541 (575)
.++|++|-|+.+|++
T Consensus 268 iK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 268 IKKPEERKTALRLCE 282 (502)
T ss_pred cCCHHHHHHHHHHhh
Confidence 999999999999874
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=309.60 Aligned_cols=247 Identities=22% Similarity=0.373 Sum_probs=204.5
Q ss_pred eeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhc---CCCCceEEEeeecCCCC-----
Q 008171 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACTKPPS----- 363 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L---~HpnIv~l~~~~~~~~~----- 363 (575)
|++.++||+|+||.||+|++. ++.||+|+++...........+.+|+.+++++ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 577899999999999999984 67899999986554444455677788887776 59999999999987766
Q ss_pred ceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 364 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
++++|||+. ++|.+++.... ..+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 899999996 48988887643 3689999999999999999999999999999999999999999999999999987655
Q ss_pred CCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---------------
Q 008171 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--------------- 507 (575)
Q Consensus 443 ~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--------------- 507 (575)
........++..|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+......
T Consensus 160 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07838 160 EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS 239 (287)
T ss_pred CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchh
Confidence 54444556889999999999999999999999999999999999999887766655444331100
Q ss_pred ----------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 ----------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 ----------~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.......++.+.++|.+||+.||.+||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 240 SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0001234577899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=310.20 Aligned_cols=247 Identities=25% Similarity=0.449 Sum_probs=202.8
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
+|++.++||.|++|.||+|+. +++.||||+++..... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 478899999999999999987 4678999998765332 2235677899999999999999999999999999999999
Q ss_pred ccCCchhhhhhhcc--CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-ccc
Q 008171 371 MSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT 447 (575)
Q Consensus 371 ~~ggsL~d~l~~~~--~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~ 447 (575)
+++ +|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||++++++.++|+|||+++...... ...
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence 975 8888886543 468999999999999999999999999999999999999999999999999997544321 223
Q ss_pred cCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC----------------CCCC-
Q 008171 448 AETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG----------------LRPT- 509 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~----------------~~~~- 509 (575)
...++..|++||++.+ ..++.++||||||+++|+|++|..||...+..+....+.... +...
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence 4567899999999865 457899999999999999999999998776554443332210 0011
Q ss_pred ----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 510 ----------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 510 ----------~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+...+++.+.+++.+||+.||.+||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11345788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=311.99 Aligned_cols=241 Identities=28% Similarity=0.449 Sum_probs=194.7
Q ss_pred eeeecCceEEEEEEE--CCccEEEEEecCCCCChH-HHHHHHHHHHHHHh---cCCCCceEEEeeecCCCCceeEEEecc
Q 008171 299 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD-MQKEFAQEVFIMRK---VRHKNVVQFIGACTKPPSLCIVTEFMS 372 (575)
Q Consensus 299 ~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~-~~~~~~~Ev~iL~~---L~HpnIv~l~~~~~~~~~l~lV~E~~~ 372 (575)
.||+|+||.||++.. +++.||+|++........ ....+.+|..+++. .+||||+.+++++...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999987 467899999876543322 22334455544443 479999999999998889999999999
Q ss_pred CCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccccCCCC
Q 008171 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 452 (575)
Q Consensus 373 ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~Gt 452 (575)
|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... ......||
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~ 158 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGT 158 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccCcCCC
Confidence 9999998876 567999999999999999999999999999999999999999999999999998754432 22345689
Q ss_pred CCccCccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCC
Q 008171 453 YRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ-AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 530 (575)
Q Consensus 453 ~~y~APE~i~-~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~-~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP 530 (575)
..|+|||.+. +..++.++|||||||++|+|++|..||....... .............++..+++++.++|.+||+.||
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 238 (279)
T cd05633 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDV 238 (279)
T ss_pred cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCH
Confidence 9999999986 4668999999999999999999999997543211 1111122234456778899999999999999999
Q ss_pred CCCC-----CHHHHHH
Q 008171 531 ALRP-----DFSEIIE 541 (575)
Q Consensus 531 ~~RP-----s~~ell~ 541 (575)
.+|| +++++++
T Consensus 239 ~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 239 SKRLGCLGRGAQEVKE 254 (279)
T ss_pred HHhcCCCCCCHHHHHh
Confidence 9999 5887765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=315.74 Aligned_cols=246 Identities=28% Similarity=0.510 Sum_probs=206.7
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
.+|++.+.||+|+||.||++.. +++.||+|.+..... .....+.+|+.++++++||||+++++.+......|+|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 6788999999999999999975 567799999864422 234678899999999999999999999999899999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
|+++++|.+++.+ ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred cCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence 9999999999865 457889999999999999999999999999999999999999999999999886544322 2234
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhh
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~~~~p~~~~~~l~~Li~~cL~ 527 (575)
..|++.|+|||.+.+..++.++|+||||+++|+|++|..||...++......+..... ....+..++..+.++|++||.
T Consensus 175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 254 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 254 (293)
T ss_pred ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHcc
Confidence 4688999999999888899999999999999999999999987765544322221111 112334567889999999999
Q ss_pred cCCCCCCCHHHHHH
Q 008171 528 QDPALRPDFSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs~~ell~ 541 (575)
.+|.+||++.+++.
T Consensus 255 ~~p~~Rp~~~~il~ 268 (293)
T cd06647 255 MDVEKRGSAKELLQ 268 (293)
T ss_pred CChhhCcCHHHHhc
Confidence 99999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=309.49 Aligned_cols=247 Identities=25% Similarity=0.483 Sum_probs=212.5
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCCCceeE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~l~lV 367 (575)
++|.+.+.||+|+||.||+++. +++.||+|++..... .......+.+|+.++++++ ||||+++++++......++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4688999999999999999987 578899999876433 2334467889999999999 99999999999999999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc--
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-- 445 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-- 445 (575)
|||+.+++|.+++.+ .+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 81 LEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 999999999999977 45799999999999999999999999999999999999999999999999999875443221
Q ss_pred -------------------cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC
Q 008171 446 -------------------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL 506 (575)
Q Consensus 446 -------------------~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~ 506 (575)
.....++..|+|||++....++.++|+||||+++|+|++|..||...+.......+.. .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~ 237 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK--L 237 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh--c
Confidence 1223578899999999888899999999999999999999999998776555544442 3
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCH----HHHHH
Q 008171 507 RPTIPKNSQPKLAELLERCWQQDPALRPDF----SEIIE 541 (575)
Q Consensus 507 ~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~----~ell~ 541 (575)
...++..+++.+.++|++||+.+|.+||++ .++++
T Consensus 238 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 238 EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 345777889999999999999999999999 77653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=319.23 Aligned_cols=252 Identities=25% Similarity=0.449 Sum_probs=202.1
Q ss_pred eeeeec--CceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccC
Q 008171 298 SKVASG--SYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 298 ~~LG~G--~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
..||.| +||+||++++ .++.||+|++..........+.+.+|+.+++.++||||+++++++...+..|+|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 9999999987 678899999987655555567889999999999999999999999999999999999999
Q ss_pred Cchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc-------
Q 008171 374 GSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV------- 445 (575)
Q Consensus 374 gsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~------- 445 (575)
++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++++||+.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 99999987643 4588999999999999999999999999999999999999999999999986533221111
Q ss_pred -cccCCCCCCccCcccccCC--CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-----------------
Q 008171 446 -MTAETGTYRWMAPEVIEHK--PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG----------------- 505 (575)
Q Consensus 446 -~~~~~Gt~~y~APE~i~~~--~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~----------------- 505 (575)
.....++..|+|||++.+. .++.++|||||||++|+|++|..||......+.........
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence 1112356779999999763 57899999999999999999999998776544433322110
Q ss_pred ----------------------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH--HHHHHHHHH
Q 008171 506 ----------------------------LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII--EILQQIAKE 549 (575)
Q Consensus 506 ----------------------------~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell--~~L~~l~~~ 549 (575)
++...+..+++.+.+||++||+.||++|||+.|++ ..+..+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 11112334677899999999999999999999997 345555544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=317.01 Aligned_cols=248 Identities=22% Similarity=0.396 Sum_probs=203.4
Q ss_pred eeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccC
Q 008171 294 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
+.+++.+|.|+++.||+++.+++.||||+++...........+.+|+.+++.++||||+++++++......|++|||+++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 45666777788888888888899999999987655555667899999999999999999999999999999999999999
Q ss_pred Cchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC--------
Q 008171 374 GSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-------- 444 (575)
Q Consensus 374 gsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-------- 444 (575)
++|.+++... ...+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||.+.......
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9999999764 3568999999999999999999999999999999999999999999999999886443221
Q ss_pred ccccCCCCCCccCcccccC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC----------------
Q 008171 445 VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL---------------- 506 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~--~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~---------------- 506 (575)
......++..|+|||++.+ ..++.++|+|||||++|+|++|..||.................
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 1233457788999999866 4588999999999999999999999987665444332221110
Q ss_pred ----------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 507 ----------------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 507 ----------------~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
....+...++++.+++.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00111233567899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=321.40 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=205.0
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC-----CCc
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PSL 364 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~-----~~l 364 (575)
.+|++.+.||+|+||.||++.. +++.||||.++...........+.+|+.+++.++||||+++++++... ..+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 4799999999999999999986 467899999876543444456678899999999999999999987543 347
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS- 443 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~- 443 (575)
|+|+||+ +++|.+++.. .+.+++..++.++.||+.||.|||+++++||||||+||+++.++.+||+|||++......
T Consensus 85 ~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 85 YIVYELM-DTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEeCC-CCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 9999999 4689888875 567999999999999999999999999999999999999999999999999999765443
Q ss_pred CccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-------------------
Q 008171 444 GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ------------------- 503 (575)
Q Consensus 444 ~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~------------------- 503 (575)
.......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence 23445578999999998864 5689999999999999999999999976553322211110
Q ss_pred ----c-C--CC---CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHH
Q 008171 504 ----K-G--LR---PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI--LQQI 546 (575)
Q Consensus 504 ----~-~--~~---~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~--L~~l 546 (575)
. . .+ ......+++++.++|++||+.+|.+||++.++++- +..+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 0 00 01234678999999999999999999999999865 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=314.78 Aligned_cols=248 Identities=23% Similarity=0.385 Sum_probs=196.1
Q ss_pred ceeeeeeeeecCceEEEEEEE----CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC--CCce
Q 008171 293 HLKFGSKVASGSYGDLYRGTY----CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLC 365 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~----~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~~l~ 365 (575)
.|++.++||+|+||.||+|.. .++.||+|++..... .......+.+|+.++++++||||+++++++... ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 478889999999999999987 457899999886431 222345678899999999999999999999887 7899
Q ss_pred eEEEeccCCchhhhhhhc----cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC----CCcEEEeecccc
Q 008171 366 IVTEFMSGGSVYDYLHKL----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE----NEVVKVADFGVA 437 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~----~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~----~~~vkL~DFG~a 437 (575)
+||||++ ++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999996 4677766432 236889999999999999999999999999999999999999 999999999998
Q ss_pred eecccCCc----cccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH---------HHHHH--
Q 008171 438 RVKAQSGV----MTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ---------AAVGV-- 501 (575)
Q Consensus 438 ~~~~~~~~----~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~---------~~~~v-- 501 (575)
........ .....++..|+|||++.+ ..++.++||||||+++|+|++|..||....... ....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 76543321 223467889999998866 468999999999999999999999997544321 00000
Q ss_pred -H---------------------hcCCCCCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 502 -V---------------------QKGLRPTIP-----------KNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 502 -~---------------------~~~~~~~~p-----------~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+ +.......+ ...+.++.+++.+||+.||.+|||+.|++.
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 000011111 156678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=312.56 Aligned_cols=244 Identities=29% Similarity=0.455 Sum_probs=206.9
Q ss_pred eeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
|...++||+|+||.||+|+. +++.|++|++..... .......+.+|+.+++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999986 567899999875433 334456788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccccCC
Q 008171 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET 450 (575)
Q Consensus 371 ~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 450 (575)
+. ++|.+++......+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++.... ......
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~~~~~ 178 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSFV 178 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CCCCcc
Confidence 95 58888887666779999999999999999999999999999999999999999999999999985432 233457
Q ss_pred CCCCccCccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 008171 451 GTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 451 Gt~~y~APE~i~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~ 527 (575)
|+..|+|||++. ...++.++||||||+++|+|++|..||...+.......+............++..+.+++.+||+
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 258 (313)
T cd06633 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQ 258 (313)
T ss_pred ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHcc
Confidence 899999999984 46688999999999999999999999988877666655544433333345677889999999999
Q ss_pred cCCCCCCCHHHHHH
Q 008171 528 QDPALRPDFSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs~~ell~ 541 (575)
.+|.+||++.+++.
T Consensus 259 ~~P~~Rp~~~~~l~ 272 (313)
T cd06633 259 KIPQERPASAELLR 272 (313)
T ss_pred CChhhCcCHHHHhc
Confidence 99999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.73 Aligned_cols=247 Identities=30% Similarity=0.451 Sum_probs=207.6
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
..|...+.||+|+||.||+|.. +++.+|+|.+..... .......+.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 4577788999999999999987 467799999875322 3344567889999999999999999999999989999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 448 (575)
||+. ++|.+++......+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++..... ...
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---~~~ 170 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANX 170 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC---ccc
Confidence 9995 688888766566789999999999999999999999999999999999999999999999999875543 234
Q ss_pred CCCCCCccCccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 008171 449 ETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 525 (575)
Q Consensus 449 ~~Gt~~y~APE~i~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~c 525 (575)
..++..|+|||++. ...++.++|||||||++|+|++|..||...+..+....+.........+..++..+.++|.+|
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 250 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHH
Confidence 56889999999974 456888999999999999999999999887766555544433332233457888999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 008171 526 WQQDPALRPDFSEIIEI 542 (575)
Q Consensus 526 L~~dP~~RPs~~ell~~ 542 (575)
|+.+|.+||++.++++.
T Consensus 251 l~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 251 LQKIPQDRPTSEVLLKH 267 (308)
T ss_pred hhCCcccCCCHHHHhhC
Confidence 99999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.55 Aligned_cols=252 Identities=26% Similarity=0.373 Sum_probs=210.4
Q ss_pred ceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC-----Cce
Q 008171 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-----SLC 365 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~-----~l~ 365 (575)
+|++.+.||.|+||.||+|+.. ++.||||.+..........+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788999999999999999874 578999998865443455678999999999999999999999987765 789
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~- 444 (575)
+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||.|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 81 IVTELME-TDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEecchh-hhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 9999996 589888866 4589999999999999999999999999999999999999999999999999998765542
Q ss_pred ---ccccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-------------
Q 008171 445 ---VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR------------- 507 (575)
Q Consensus 445 ---~~~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~------------- 507 (575)
......++..|+|||++.+. .++.++|+||||+++|+|++|..||...+..+....+......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 24455789999999999887 8999999999999999999999999887765544333321100
Q ss_pred ----------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHH
Q 008171 508 ----------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI--LQQI 546 (575)
Q Consensus 508 ----------------~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~--L~~l 546 (575)
......+++.+.++|.+||+.+|.+||++.+++.. ++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 01123467889999999999999999999999863 5544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=304.31 Aligned_cols=247 Identities=29% Similarity=0.523 Sum_probs=208.1
Q ss_pred ceeeeeeeeecCceEEEEEEECC--ccEEEEEecCCC---CChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 293 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPER---INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~~--~~VAvKvl~~~~---~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
+|.+.++||+|+||.||++.+.. ..+++|+++... ........+..|+.++++++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999998753 456777766432 2233345677899999999999999999999999999999
Q ss_pred EEeccCCchhhhhhh---ccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 368 TEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~---~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|||+++++|.+++.. ....+++..++.++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999998864 2456899999999999999999999999999999999999975 579999999987654332
Q ss_pred -ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 008171 445 -VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 523 (575)
Q Consensus 445 -~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~ 523 (575)
......|++.|+|||.+.+..++.++|+||||+++|+|++|..||............. .+..+..+..++.++.++|.
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 238 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSIMQ 238 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHHHHH
Confidence 2334568899999999988889999999999999999999999998776655554433 35556677888999999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 008171 524 RCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 524 ~cL~~dP~~RPs~~ell~ 541 (575)
+||+.+|.+||++.++++
T Consensus 239 ~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 239 SMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHhcCChhhCcCHHHHhh
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=353.30 Aligned_cols=251 Identities=21% Similarity=0.351 Sum_probs=218.9
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
.+..++|.|++.||+|+||.|.+++. +++-||+|++.+-.. ......-|..|..+|..-+.+.|++++.+|+++.++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 45667899999999999999999976 467799999875322 122345688999999999999999999999999999
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|+|||||+||+|..++.+.. ++++.++..++..|+-||+.||+.|+|||||||+|||||..|+|||+|||.+-.....+
T Consensus 151 YlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred EEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 99999999999999999866 99999999999999999999999999999999999999999999999999987666555
Q ss_pred c--cccCCCCCCccCccccc----C-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCc
Q 008171 445 V--MTAETGTYRWMAPEVIE----H-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQ 515 (575)
Q Consensus 445 ~--~~~~~Gt~~y~APE~i~----~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p--~~~~ 515 (575)
. ....+|||.|.+||++. + +.|+..+|+||+||++|||++|..||...+-.+++..++.......+| ..+|
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VS 309 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVS 309 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccC
Confidence 3 34568999999999983 3 579999999999999999999999999999889988888775555666 5689
Q ss_pred HHHHHHHHHhhhcCCCCCCC---HHHHH
Q 008171 516 PKLAELLERCWQQDPALRPD---FSEII 540 (575)
Q Consensus 516 ~~l~~Li~~cL~~dP~~RPs---~~ell 540 (575)
++.++||++.+. +|+.|.. +.++.
T Consensus 310 eeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 310 EEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred HHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 999999999875 6777876 77765
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=337.24 Aligned_cols=258 Identities=32% Similarity=0.603 Sum_probs=228.5
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--C----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--S----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~----~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
...++..++||+|+||+||+|.|- + -+||||++..... ...-.+++.|+.+|.+|+|||+++++++|.... +
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 345667789999999999999873 2 3599999875533 334578999999999999999999999998765 8
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
-||++||++|+|.|+++..++.+....++.|..||++||.|||.++++||||..+|||+.+-..+||.|||+++......
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999998766543
Q ss_pred -ccccCCC--CCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 008171 445 -VMTAETG--TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 520 (575)
Q Consensus 445 -~~~~~~G--t~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~ 520 (575)
...+..| .+.|||=|.+....|++++|||||||++||++| |..||.++...++ .+.++++.|...|+.|+.++..
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-~dlle~geRLsqPpiCtiDVy~ 931 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-PDLLEKGERLSQPPICTIDVYM 931 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-hHHHhccccCCCCCCccHHHHH
Confidence 2333333 578999999999999999999999999999999 9999999887654 5678889999999999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 521 LLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 521 Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
+|.+||..|+..||+|+++...+.+..++.+
T Consensus 932 ~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 932 VMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred HHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 9999999999999999999999998876543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=313.86 Aligned_cols=244 Identities=25% Similarity=0.433 Sum_probs=216.5
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEECC--ccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCCC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS 363 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~~--~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~ 363 (575)
.|...+|.++.+||+|+||.|.++...| +.+|||+++.+.. ..+..+--..|-++|.... -|.+++++..|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 6777899999999999999999998765 4599999997644 2222333445777777664 5789999999999999
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
+|+||||+.||+|.-.+++ -+++.++.+..++..|+.||-|||++|||+||||.+|||++.+|+|||+|||+++.....
T Consensus 425 LyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred eeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence 9999999999999988877 688999999999999999999999999999999999999999999999999999865554
Q ss_pred C-ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 008171 444 G-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 522 (575)
Q Consensus 444 ~-~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li 522 (575)
+ ...+.+||+.|+|||++..++|+.++|+||+|++||||+.|+.||++.+..+....+..... .+|+.++.+..+++
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv--syPKslSkEAv~ic 581 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV--SYPKSLSKEAVAIC 581 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC--cCcccccHHHHHHH
Confidence 4 44577999999999999999999999999999999999999999999999999988887764 58999999999999
Q ss_pred HHhhhcCCCCCC
Q 008171 523 ERCWQQDPALRP 534 (575)
Q Consensus 523 ~~cL~~dP~~RP 534 (575)
...|.+.|.+|.
T Consensus 582 kg~ltK~P~kRL 593 (683)
T KOG0696|consen 582 KGLLTKHPGKRL 593 (683)
T ss_pred HHHhhcCCcccc
Confidence 999999999995
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=306.41 Aligned_cols=246 Identities=26% Similarity=0.413 Sum_probs=202.4
Q ss_pred eeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCCCceeEEEe
Q 008171 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
|++.+.||+|+||.||+|+. +++.|+||.+........ .....+|+..+++++ ||||+++++++...+..|+||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 57789999999999999998 457799999876543322 234567999999999 99999999999999999999999
Q ss_pred ccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccccC
Q 008171 371 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449 (575)
Q Consensus 371 ~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 449 (575)
+ +++|.+++.... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++............
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY 158 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence 9 889999887644 47899999999999999999999999999999999999999999999999999876554444556
Q ss_pred CCCCCccCccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-----------------CC----
Q 008171 450 TGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-----------------LR---- 507 (575)
Q Consensus 450 ~Gt~~y~APE~i~-~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~-----------------~~---- 507 (575)
.++..|+|||++. ...++.++|+||||+++|+|++|+.||...+.......+..-. ..
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP 238 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence 7899999999884 4568899999999999999999999998776544433222100 00
Q ss_pred -------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 -------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 -------~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.......+..+.++|++||+.+|.+||++.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0011223688999999999999999999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=309.28 Aligned_cols=247 Identities=23% Similarity=0.400 Sum_probs=202.4
Q ss_pred ceeeeeeeeecCceEEEEEEE-----CCccEEEEEecCCCC--ChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCc
Q 008171 293 HLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~-----~~~~VAvKvl~~~~~--~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l 364 (575)
.|++.+.||.|+||.||++.. +++.||+|+++.... .......+.+|+.+++++ +|+||+++++.+.....+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 377889999999999999976 567899999875432 122346688899999999 589999999999988889
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||+|+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 999999999999999976 4678999999999999999999999999999999999999999999999999997654322
Q ss_pred --ccccCCCCCCccCcccccCC--CCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHhcCCCCCCCCCCcHH
Q 008171 445 --VMTAETGTYRWMAPEVIEHK--PYDHKADVFSFGIVLWELLTGKLPYEYLTPL---QAAVGVVQKGLRPTIPKNSQPK 517 (575)
Q Consensus 445 --~~~~~~Gt~~y~APE~i~~~--~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~---~~~~~v~~~~~~~~~p~~~~~~ 517 (575)
......|+..|+|||.+.+. .++.++||||||+++|+|++|..||...... ......+.. ..+.++..+++.
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSAL 238 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc-cCCCCCccCCHH
Confidence 22245689999999998653 4788999999999999999999999643221 112121211 234567788999
Q ss_pred HHHHHHHhhhcCCCCCC-----CHHHHHH
Q 008171 518 LAELLERCWQQDPALRP-----DFSEIIE 541 (575)
Q Consensus 518 l~~Li~~cL~~dP~~RP-----s~~ell~ 541 (575)
+.+++++||+.||.+|| ++.+++.
T Consensus 239 ~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 239 AKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 99999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=320.26 Aligned_cols=248 Identities=23% Similarity=0.361 Sum_probs=214.9
Q ss_pred eeCCCceeeeeeeeecCceEEEEEE--ECCccEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~--~~~~~VAvKvl~~~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
.+..+.|+.-++||+|+||.||-+. .+|+-||+|.+.+.+... ......++|..||.+++.+.||.+-.+|+..+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 4566778888999999999999664 578889999887665533 2334578899999999999999999999999999
Q ss_pred eeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 365 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
|+|+..|.||+|.-+|.+.. ..|++..+..++.+|+.||++||+.+|++|||||+|||+|+.|+|.|+|+|+|......
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999999887754 46999999999999999999999999999999999999999999999999999988888
Q ss_pred CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhcCCCCCCCCCCcHHHH
Q 008171 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT----PLQAAVGVVQKGLRPTIPKNSQPKLA 519 (575)
Q Consensus 444 ~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~----~~~~~~~v~~~~~~~~~p~~~~~~l~ 519 (575)
......+||.+|||||++.+..|+...|+|||||+||||+.|+.||.... ..+.-..++. ....++...+++++
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~kFS~eak 418 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSDKFSEEAK 418 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhcccccCHHHH
Confidence 77778899999999999999999999999999999999999999996533 2222222222 23457789999999
Q ss_pred HHHHHhhhcCCCCCCCHH
Q 008171 520 ELLERCWQQDPALRPDFS 537 (575)
Q Consensus 520 ~Li~~cL~~dP~~RPs~~ 537 (575)
++++.+|++||.+|....
T Consensus 419 slc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 419 SLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHHHccCHHHhccCC
Confidence 999999999999997544
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=335.84 Aligned_cols=250 Identities=17% Similarity=0.299 Sum_probs=189.0
Q ss_pred CCceeeeeeeeecCceEEEEEEECC---ccEEEEEe---------------cCCCCChHHHHHHHHHHHHHHhcCCCCce
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYCS---QDVAIKVL---------------KPERINSDMQKEFAQEVFIMRKVRHKNVV 352 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~~---~~VAvKvl---------------~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv 352 (575)
..+|+++++||+|+||+||++.... ..+++|.+ +...........+.+|+.+|++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3689999999999999999986532 11222211 11111223456688999999999999999
Q ss_pred EEEeeecCCCCceeEEEeccCCchhhhhhhc----cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCc
Q 008171 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKL----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428 (575)
Q Consensus 353 ~l~~~~~~~~~l~lV~E~~~ggsL~d~l~~~----~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~ 428 (575)
++++++...+..|+|+|++ +++|.+++... ........+..|+.||+.||.|||++||+||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 9999999999999999999 56777776432 223445677889999999999999999999999999999999999
Q ss_pred EEEeecccceecccCC--ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCC-CCCCC--CHHHHHHHHHh
Q 008171 429 VKVADFGVARVKAQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKL-PYEYL--TPLQAAVGVVQ 503 (575)
Q Consensus 429 vkL~DFG~a~~~~~~~--~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~-Pf~~~--~~~~~~~~v~~ 503 (575)
+||+|||+++...... ......||..|+|||++.+..|+.++|||||||+||||++|.. ||... .+......++.
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~ 385 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID 385 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence 9999999998665432 2234579999999999999999999999999999999999775 45332 22222222111
Q ss_pred cC------C---------------CCCC---------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 504 KG------L---------------RPTI---------PKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 504 ~~------~---------------~~~~---------p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.. + .... ...++..+.++|.+||+.||.+|||+.|++.
T Consensus 386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 0 0000 1134567888899999999999999999985
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=307.22 Aligned_cols=241 Identities=28% Similarity=0.435 Sum_probs=195.3
Q ss_pred eeeecCceEEEEEEE--CCccEEEEEecCCCCCh-HHHHHHHHHHH---HHHhcCCCCceEEEeeecCCCCceeEEEecc
Q 008171 299 KVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-DMQKEFAQEVF---IMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (575)
Q Consensus 299 ~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~-~~~~~~~~Ev~---iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ 372 (575)
.||+|+||.||++.. +++.||||++....... .....+..|.. +++...||||+.+++++...+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999876 46789999987654332 21223444444 4444579999999999999999999999999
Q ss_pred CCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccccCCCC
Q 008171 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 452 (575)
Q Consensus 373 ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~Gt 452 (575)
|++|.+++.. .+.+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++...... ......|+
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~ 158 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGT 158 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcCCC
Confidence 9999998865 567999999999999999999999999999999999999999999999999998754332 22345789
Q ss_pred CCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCC
Q 008171 453 YRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA-AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 530 (575)
Q Consensus 453 ~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~-~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP 530 (575)
..|+|||++.+. .++.++||||+|+++|+|++|+.||........ ..........+.++..+++++.+++.+||..+|
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p 238 (278)
T cd05606 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV 238 (278)
T ss_pred cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCH
Confidence 999999999744 689999999999999999999999976532111 111122234556777889999999999999999
Q ss_pred CCCC-----CHHHHHH
Q 008171 531 ALRP-----DFSEIIE 541 (575)
Q Consensus 531 ~~RP-----s~~ell~ 541 (575)
.+|| ++.++++
T Consensus 239 ~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 239 NRRLGCLGRGAQEVKE 254 (278)
T ss_pred HhccCCCCCCHHHHHh
Confidence 9999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=310.66 Aligned_cols=250 Identities=25% Similarity=0.389 Sum_probs=199.9
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC------
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------ 362 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~------ 362 (575)
.++|++.++||+|+||.||+|++. ++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 368999999999999999999874 677999998755433333356778999999999999999998874433
Q ss_pred --CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 363 --SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 363 --~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
.+|+||||+. ++|...+......+++..+..++.||+.||.|||++||+|+||||+||++++++.++|+|||+++..
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 4699999995 5777777665668999999999999999999999999999999999999999999999999999754
Q ss_pred ccCCc------------cccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC
Q 008171 441 AQSGV------------MTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 507 (575)
Q Consensus 441 ~~~~~------------~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~ 507 (575)
..... .+...+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 43221 122356888999998865 45899999999999999999999999887765544333221100
Q ss_pred ---------------------CCC-------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 ---------------------PTI-------PKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 ---------------------~~~-------p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
... .....+.+.++|.+||+.||.+|||+.+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000 1234478999999999999999999998874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=315.79 Aligned_cols=251 Identities=26% Similarity=0.448 Sum_probs=199.4
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC-----CCc
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PSL 364 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~-----~~l 364 (575)
++|++.++||+|+||.||+|.+ +++.||||+++... .......+.+|+.++++++||||+++++++... ...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 5799999999999999999976 56789999987432 233456688899999999999999999876543 347
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|+|+||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 84 YIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 99999995 588877743 578999999999999999999999999999999999999999999999999987644322
Q ss_pred ----ccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---------------c
Q 008171 445 ----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ---------------K 504 (575)
Q Consensus 445 ----~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~---------------~ 504 (575)
......||..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+.. .
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 2233568999999998754 5689999999999999999999999976544322211110 0
Q ss_pred ---------CCCCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHH
Q 008171 505 ---------GLRPT-----IPKNSQPKLAELLERCWQQDPALRPDFSEIIEI--LQQI 546 (575)
Q Consensus 505 ---------~~~~~-----~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~--L~~l 546 (575)
...+. .....++++.++|.+||+.+|.+||++.|+++. ++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00000 113457889999999999999999999999864 5444
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.75 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=201.6
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC----CCCce
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----PPSLC 365 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~----~~~l~ 365 (575)
.+|.+.+.||.|+||.||+|.. +++.||+|++............+.+|+.+|++++||||+++++++.. ...+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6788889999999999999976 47789999988654444455678889999999999999999988753 34689
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~- 444 (575)
+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 85 lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 85 VVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 9999995 689988865 4569999999999999999999999999999999999999999999999999997543322
Q ss_pred ----ccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---------------
Q 008171 445 ----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--------------- 504 (575)
Q Consensus 445 ----~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~--------------- 504 (575)
......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 1234578999999999865 56899999999999999999999999876543322111110
Q ss_pred ---------CCCCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 505 ---------GLRPT-----IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 505 ---------~~~~~-----~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
..... .....++++.++|.+||+.+|.+||++.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00111 12456889999999999999999999998875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=298.40 Aligned_cols=236 Identities=28% Similarity=0.424 Sum_probs=205.6
Q ss_pred eeecCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCCch
Q 008171 300 VASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (575)
Q Consensus 300 LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ggsL 376 (575)
||.|+||.||++... ++.+++|++...... ......+..|+.++++++||||+++++.+......|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999874 678999998765432 23556789999999999999999999999999999999999999999
Q ss_pred hhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-CccccCCCCCCc
Q 008171 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGTYRW 455 (575)
Q Consensus 377 ~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~Gt~~y 455 (575)
.+++.. ...+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++...... .......++..|
T Consensus 81 ~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05123 81 FSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159 (250)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence 999976 356899999999999999999999999999999999999999999999999999765443 233455789999
Q ss_pred cCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q 008171 456 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPD 535 (575)
Q Consensus 456 ~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs 535 (575)
++||.+.+..++.++|+||||+++|+|++|..||......+....+.. ....++...+..+.++|++||..||++||+
T Consensus 160 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred cChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 999999988899999999999999999999999987776554444443 345678888999999999999999999999
Q ss_pred HHH
Q 008171 536 FSE 538 (575)
Q Consensus 536 ~~e 538 (575)
+.+
T Consensus 238 ~~~ 240 (250)
T cd05123 238 SGG 240 (250)
T ss_pred ccc
Confidence 954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=308.19 Aligned_cols=251 Identities=24% Similarity=0.382 Sum_probs=207.0
Q ss_pred ceeeeeeeeecCceEEEEEEE-----CCccEEEEEecCCCCC--hHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCc
Q 008171 293 HLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERIN--SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~-----~~~~VAvKvl~~~~~~--~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l 364 (575)
+|++.+.||+|+||.||+++. .++.||||+++..... ......+.+|+.+++++ +||||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 378889999999999999875 3467999998754321 22345688999999999 599999999999988899
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|+||||+.+++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|.||+++.++.++|+|||+++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 999999999999999876 4678999999999999999999999999999999999999999999999999987644332
Q ss_pred c--cccCCCCCCccCcccccCCC--CCchHHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhcCCCCCCCCCCcH
Q 008171 445 V--MTAETGTYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLTP----LQAAVGVVQKGLRPTIPKNSQP 516 (575)
Q Consensus 445 ~--~~~~~Gt~~y~APE~i~~~~--~s~ksDVwSlGviL~eLltG~~Pf~~~~~----~~~~~~v~~~~~~~~~p~~~~~ 516 (575)
. .....|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||..... .+....+. ...+..+..+++
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 237 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL--KSKPPFPKTMSA 237 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH--ccCCCCCcccCH
Confidence 1 22346899999999987655 78899999999999999999999964322 12222222 223456777899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 517 KLAELLERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
.+.+++.+||+.||++|||+.++.+.|+..
T Consensus 238 ~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 238 EARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 999999999999999999998888777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=312.99 Aligned_cols=249 Identities=27% Similarity=0.431 Sum_probs=204.5
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC-
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP- 362 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~- 362 (575)
.|.+ .++|++.+.||+|+||.||++.. +++.||||++............+.+|+.+|++++||||+++++++....
T Consensus 10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 10 IWEV-PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhcc-ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 4555 36799999999999999999976 4678999998755444445567889999999999999999999886554
Q ss_pred -----CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccc
Q 008171 363 -----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (575)
Q Consensus 363 -----~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a 437 (575)
.+|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 358999999 7899888754 56899999999999999999999999999999999999999999999999999
Q ss_pred eecccCCccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---------
Q 008171 438 RVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--------- 507 (575)
Q Consensus 438 ~~~~~~~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--------- 507 (575)
...... .....++..|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+......
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 166 RQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 754332 234467899999999865 45889999999999999999999999876654433332211100
Q ss_pred --------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 008171 508 --------------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEII 540 (575)
Q Consensus 508 --------------------~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell 540 (575)
..+...+++.+.++|.+||+.||.+||++.+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 012246788899999999999999999999988
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=314.67 Aligned_cols=255 Identities=26% Similarity=0.406 Sum_probs=204.6
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
..|++. .+|.+.+.||+|+||.||+|.. +++.||||+++...........+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 87 (342)
T cd07879 9 TVWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV 87 (342)
T ss_pred hhhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence 456664 5799999999999999999986 4788999998765444444566889999999999999999999886543
Q ss_pred ------CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccc
Q 008171 363 ------SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436 (575)
Q Consensus 363 ------~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~ 436 (575)
.+|+|+||+. .+|..++ ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 88 SGDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred cCCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4589999995 4666654 34689999999999999999999999999999999999999999999999999
Q ss_pred ceecccCCccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC---------
Q 008171 437 ARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--------- 506 (575)
Q Consensus 437 a~~~~~~~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~--------- 506 (575)
++.... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+.....
T Consensus 164 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 164 ARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 875432 2334567889999999866 4689999999999999999999999988765544333221000
Q ss_pred ------------CCCC--------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHH--HHHHHH
Q 008171 507 ------------RPTI--------PKNSQPKLAELLERCWQQDPALRPDFSEII--EILQQI 546 (575)
Q Consensus 507 ------------~~~~--------p~~~~~~l~~Li~~cL~~dP~~RPs~~ell--~~L~~l 546 (575)
.+.+ ....++++.++|.+||+.||.+||++.+++ ..++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0001 124678899999999999999999999998 346554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=326.15 Aligned_cols=246 Identities=26% Similarity=0.407 Sum_probs=228.4
Q ss_pred eCCCceeeeeeeeecCceEEEEEEECCcc--EEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQD--VAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~--VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
+..++++++.-||-|+||.|-++...++. +|+|++++... +......+..|-.||..++.|.||++|..|.+...+|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 44567888889999999999999988776 89999987654 5566778899999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 445 (575)
++||-|-||.|+..|++ ++.|....+..++..++.|++|||++|||+|||||+|++++.+|.+||.|||+|+....+..
T Consensus 497 mLmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hhHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 99999999999999988 78999999999999999999999999999999999999999999999999999998888887
Q ss_pred cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 008171 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 525 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~c 525 (575)
.-+.+||+.|.|||++..+..+.++|.|+||+++|||++|.+||.+.++..++..++.......+|..++....+||+++
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~L 655 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKL 655 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHH
Confidence 88899999999999999999999999999999999999999999999999999888876666789999999999999999
Q ss_pred hhcCCCCCCC
Q 008171 526 WQQDPALRPD 535 (575)
Q Consensus 526 L~~dP~~RPs 535 (575)
...+|.+|..
T Consensus 656 Cr~~P~ERLG 665 (732)
T KOG0614|consen 656 CRDNPTERLG 665 (732)
T ss_pred HhcCcHhhhc
Confidence 9999999975
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=330.53 Aligned_cols=243 Identities=27% Similarity=0.536 Sum_probs=205.0
Q ss_pred eeeeeeeeecCceEEEEEEECCc--cEEEEEecCCC--CChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCC--ceeE
Q 008171 294 LKFGSKVASGSYGDLYRGTYCSQ--DVAIKVLKPER--INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS--LCIV 367 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~~~~--~VAvKvl~~~~--~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~--l~lV 367 (575)
+++..+||+|+|-+||+|.+... .||--.++... .++...++|..|+.+|+.|+|||||++|.+|.+..+ +.+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 46678999999999999977543 35533333222 234556889999999999999999999999987666 7789
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHC--CceecccCCCCEEec-CCCcEEEeecccceecccCC
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--NIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~--gIiHrDLKp~NILl~-~~~~vkL~DFG~a~~~~~~~ 444 (575)
+|++..|+|..|+.+ .+.++...+..|++||++||.|||++ -|||||||-+||+|+ ..|.|||+|+|+|.....+.
T Consensus 122 TEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 122 TELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred eecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 999999999999987 56788899999999999999999998 599999999999997 56899999999998877664
Q ss_pred ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCC-CCCCCCcHHHHHHH
Q 008171 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY-LTPLQAAVGVVQKGLRP-TIPKNSQPKLAELL 522 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~-~~~~~~~~~v~~~~~~~-~~p~~~~~~l~~Li 522 (575)
... .+|||.|||||++. ..|+...||||||++|.||+|+..||.. .++.+++.++.. +..| .+.+--.|++++||
T Consensus 201 aks-vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S-GiKP~sl~kV~dPevr~fI 277 (632)
T KOG0584|consen 201 AKS-VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS-GIKPAALSKVKDPEVREFI 277 (632)
T ss_pred cce-eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc-CCCHHHhhccCCHHHHHHH
Confidence 433 78999999999998 7799999999999999999999999964 667777777655 4443 44555579999999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 008171 523 ERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 523 ~~cL~~dP~~RPs~~ell~ 541 (575)
.+||.. ..+|||+.|||+
T Consensus 278 ekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 278 EKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHhcC-chhccCHHHHhh
Confidence 999999 899999999984
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=303.40 Aligned_cols=247 Identities=25% Similarity=0.429 Sum_probs=205.4
Q ss_pred eeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEec
Q 008171 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~ 371 (575)
|++.++||+|.||.||+|+.. ++.||+|++............+.+|+.++++++|+||+++++++......++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456789999999999999874 688999999876434444567888999999999999999999999999999999999
Q ss_pred cCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-ccccCC
Q 008171 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAET 450 (575)
Q Consensus 372 ~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~ 450 (575)
+ ++|.+++......+++..++.++.|++.||.|||++||+|+||+|+||+++.++.++|+|||+++...... ......
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence 6 59999998755679999999999999999999999999999999999999999999999999997654432 333456
Q ss_pred CCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC----------------CC---C--
Q 008171 451 GTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG----------------LR---P-- 508 (575)
Q Consensus 451 Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~----------------~~---~-- 508 (575)
++..|+|||.+.+. .++.++||||||+++|+|++|..||...+.......+.... .. +
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd07829 160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKF 239 (282)
T ss_pred cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccccc
Confidence 68889999998766 88999999999999999999999998776554433322110 00 0
Q ss_pred ------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 ------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 ------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
......+..+.++|++||..||.+||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred CccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 011234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=306.92 Aligned_cols=242 Identities=30% Similarity=0.490 Sum_probs=204.1
Q ss_pred eeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEecc
Q 008171 295 KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (575)
Q Consensus 295 ~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ 372 (575)
....+||+|+||.||++.. +++.||||.+... .......+.+|+.+++.++|+||+++++.+...+..|+||||++
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 3346899999999999987 4678999987643 22345678899999999999999999999999999999999999
Q ss_pred CCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-ccccCCC
Q 008171 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETG 451 (575)
Q Consensus 373 ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~G 451 (575)
+++|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ......|
T Consensus 101 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 101 GGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 9999998754 568999999999999999999999999999999999999999999999999986543321 2234568
Q ss_pred CCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHHHHHHhhhcC
Q 008171 452 TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPKLAELLERCWQQD 529 (575)
Q Consensus 452 t~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~--~p~~~~~~l~~Li~~cL~~d 529 (575)
++.|+|||.+.+..++.++|+||||+++|+|++|..||......+.... ......+. ....+++.+.+++.+||+.+
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 257 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-IRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhhCCcccCCcccCCHHHHHHHHHHHhCC
Confidence 9999999999888899999999999999999999999988766554433 22233222 23457889999999999999
Q ss_pred CCCCCCHHHHHH
Q 008171 530 PALRPDFSEIIE 541 (575)
Q Consensus 530 P~~RPs~~ell~ 541 (575)
|.+||++.+++.
T Consensus 258 P~~R~~~~~ll~ 269 (292)
T cd06657 258 PAQRATAAELLK 269 (292)
T ss_pred cccCcCHHHHhc
Confidence 999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=302.18 Aligned_cols=238 Identities=21% Similarity=0.403 Sum_probs=192.5
Q ss_pred ceeeeeee--eecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCceeE
Q 008171 293 HLKFGSKV--ASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 293 ~~~i~~~L--G~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l~lV 367 (575)
.|.+.+.+ |+|+||.||++.. ++..+|+|++........ |+.....+ +||||+++++.+...+.+|+|
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 45555555 9999999999976 467799999875433221 22222222 699999999999999999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC-cEEEeecccceecccCCcc
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVM 446 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~~~~~ 446 (575)
|||++|++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||+++.....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 88 MDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--- 163 (267)
T ss_pred EEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence 9999999999999763 4899999999999999999999999999999999999999988 9999999998765432
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-h-cCCCCCCCCCCcHHHHHHHHH
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV-Q-KGLRPTIPKNSQPKLAELLER 524 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~-~-~~~~~~~p~~~~~~l~~Li~~ 524 (575)
....++..|+|||++.+..++.++||||||+++|+|++|..||............+ . .......+..+++.+.++|.+
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 243 (267)
T PHA03390 164 SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQS 243 (267)
T ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHH
Confidence 23468999999999999999999999999999999999999998554322111111 1 122334556789999999999
Q ss_pred hhhcCCCCCCC-HHHHHH
Q 008171 525 CWQQDPALRPD-FSEIIE 541 (575)
Q Consensus 525 cL~~dP~~RPs-~~ell~ 541 (575)
||+.+|.+||+ ++++++
T Consensus 244 ~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 244 MLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HhccChhhCCchHHHHhc
Confidence 99999999995 688873
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=313.93 Aligned_cols=247 Identities=23% Similarity=0.377 Sum_probs=200.2
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCC--CCcee
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP--PSLCI 366 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~--~~l~l 366 (575)
++|.+.+.||+|+||.||+|.+ .++.+|+|.+............+.+|+.+++++ +||||+++++++... ..+|+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 5788899999999999999987 467899998865433334456677899999999 999999999987543 35899
Q ss_pred EEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC--
Q 008171 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-- 444 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-- 444 (575)
||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 87 v~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 87 VFEYME-TDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred Eecccc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 999996 599888865 378888999999999999999999999999999999999999999999999997544322
Q ss_pred ----ccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-------------
Q 008171 445 ----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL------------- 506 (575)
Q Consensus 445 ----~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~------------- 506 (575)
......||..|+|||++.+ ..++.++||||||+++|+|++|+.||...........+.....
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence 2233468999999998754 5688999999999999999999999987655443322211100
Q ss_pred ----------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 507 ----------------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 507 ----------------~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.......++.++.++|.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 01122347889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=311.13 Aligned_cols=246 Identities=25% Similarity=0.392 Sum_probs=199.6
Q ss_pred eeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChH------------HHHHHHHHHHHHHhcCCCCceEEEeeec
Q 008171 294 LKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD------------MQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~------------~~~~~~~Ev~iL~~L~HpnIv~l~~~~~ 359 (575)
+.+.+.||.|+||.||+|.+ .++.||||+++....... ....+.+|+.++++++||||+++++++.
T Consensus 11 ~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 90 (335)
T PTZ00024 11 IQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYV 90 (335)
T ss_pred hhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEe
Confidence 34567899999999999976 467899999875432210 1125778999999999999999999999
Q ss_pred CCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 360 ~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
.....|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||.++.
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~ 168 (335)
T PTZ00024 91 EGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARR 168 (335)
T ss_pred cCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceee
Confidence 9999999999996 689998865 56789999999999999999999999999999999999999999999999999976
Q ss_pred cccC---------------CccccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 008171 440 KAQS---------------GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (575)
Q Consensus 440 ~~~~---------------~~~~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~ 503 (575)
.... .......++..|+|||.+.+. .++.++|||||||++|+|++|..||...+..+....+..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~ 248 (335)
T PTZ00024 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248 (335)
T ss_pred cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 5411 122234568899999998764 478999999999999999999999988776655433322
Q ss_pred cCCCC--------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 504 KGLRP--------------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 504 ~~~~~--------------------------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
....+ .....++.++.++|.+||+.+|.+||++.+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11000 012345788999999999999999999999884
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=355.74 Aligned_cols=248 Identities=30% Similarity=0.489 Sum_probs=212.3
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
++..+.+||.|.||.||-+.. +|...|+|.++...........+.+|..++..++|||+|+++|+-.....++|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 345567899999999999975 567799998876544444556788999999999999999999999998999999999
Q ss_pred ccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-----Cc
Q 008171 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-----GV 445 (575)
Q Consensus 371 ~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-----~~ 445 (575)
|.||+|.+.+.. .+-.++.....+..|++.|+.|||+.||+||||||+||+++.+|.+|++|||.|.....+ +.
T Consensus 1316 C~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1316 CEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred hccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 999999999975 555677777888999999999999999999999999999999999999999999765443 23
Q ss_pred cccCCCCCCccCcccccC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 008171 446 MTAETGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 522 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~---~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li 522 (575)
.....||+-|||||+|.+ +....++|||||||++.||+||+.||..++..=++.--+..+-.|.+|..++++-++||
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHH
Confidence 345579999999999964 45677899999999999999999999877655444444566778999999999999999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 008171 523 ERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 523 ~~cL~~dP~~RPs~~ell~ 541 (575)
.+||..||..|.++.||++
T Consensus 1475 e~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HHHHhcCchhhhHHHHHHH
Confidence 9999999999988887654
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.91 Aligned_cols=246 Identities=25% Similarity=0.362 Sum_probs=197.0
Q ss_pred ceeeeeeeeecCceEEEEEEEC----CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeec----CCCC
Q 008171 293 HLKFGSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACT----KPPS 363 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~----~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~----~~~~ 363 (575)
+|++.+.||+|+||.||++.+. ++.||||.+..........+.+.+|+.+++++ .||||+++++.+. ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999885 44799999875443444456788899999999 4999999998643 2245
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
+|+++||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 81 LYLYEELM-EADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred EEEEEecc-cCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 78899998 4689988865 567899999999999999999999999999999999999999999999999999754432
Q ss_pred C-----ccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-------------
Q 008171 444 G-----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK------------- 504 (575)
Q Consensus 444 ~-----~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~------------- 504 (575)
. ......||..|+|||++.+ ..++.++||||||+++|+|++|..||...+.......++..
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 1 1233468999999998765 56899999999999999999999999876543332221110
Q ss_pred -------------CCC---CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 008171 505 -------------GLR---PTIPKNSQPKLAELLERCWQQDPALRPDFSEII 540 (575)
Q Consensus 505 -------------~~~---~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell 540 (575)
... ......++..+.+++.+||+.||.+|||+.+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000 112234578999999999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=308.90 Aligned_cols=250 Identities=26% Similarity=0.398 Sum_probs=201.7
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC-CCC
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPS 363 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~-~~~ 363 (575)
|.+. ++|.+.+.||.|+||.||++.. +++.||||.+............+.+|+.++++++||||+++++++.. ...
T Consensus 6 ~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 6 FEIT-NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eccc-cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 4444 5699999999999999999976 46779999887554444445678899999999999999999998865 557
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
.|+||||+ +++|.+++.. ..++...+..++.||+.||.|||++||+||||+|.||+++.++.++|+|||.+.....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~- 160 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP- 160 (328)
T ss_pred EEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-
Confidence 89999999 6689888754 5678888999999999999999999999999999999999999999999999875432
Q ss_pred CccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-------------------
Q 008171 444 GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ------------------- 503 (575)
Q Consensus 444 ~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~------------------- 503 (575)
......++..|+|||++.+ ..++.++||||||+++|+|++|..||....+......+..
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 161 -QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred -CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 2234567889999998865 6789999999999999999999999987665332211110
Q ss_pred ----c-CCCCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 008171 504 ----K-GLRPT-----IPKNSQPKLAELLERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 504 ----~-~~~~~-----~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~ 542 (575)
. ..... ....+++++.++|++||+.+|.+||++.+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00001 113567899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=314.08 Aligned_cols=250 Identities=27% Similarity=0.426 Sum_probs=205.4
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCC
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 363 (575)
.|++. ++|.+.+.||+|+||.||+|... ++.||||++............+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~~-~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 10 VWEVP-DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred eeccc-CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 34453 57999999999999999999874 6779999987654444445678889999999999999999987765544
Q ss_pred ------ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccc
Q 008171 364 ------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (575)
Q Consensus 364 ------l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a 437 (575)
+|+|+||+ |++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999999 7799998865 56899999999999999999999999999999999999999999999999999
Q ss_pred eecccCCccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---------
Q 008171 438 RVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--------- 507 (575)
Q Consensus 438 ~~~~~~~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--------- 507 (575)
...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+....+......
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 166 RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 765432 345578899999999865 46889999999999999999999999877665544332221000
Q ss_pred -----------------C---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 -----------------P---TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 -----------------~---~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+ ......++++.++|.+||+.||.+|||+.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0 111345889999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.10 Aligned_cols=251 Identities=25% Similarity=0.402 Sum_probs=202.5
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC--
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-- 361 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~-- 361 (575)
.|.+. ++|.+.+.||+|+||.||++.. +++.||+|+++...........+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~-~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 12 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred Hhhcc-CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 34443 6799999999999999999975 567899999886543444456788899999999999999999987532
Q ss_pred ----CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccc
Q 008171 362 ----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437 (575)
Q Consensus 362 ----~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a 437 (575)
...|++++++ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~ 167 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 167 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccc
Confidence 3468888887 8899888754 46899999999999999999999999999999999999999999999999998
Q ss_pred eecccCCccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC----------
Q 008171 438 RVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL---------- 506 (575)
Q Consensus 438 ~~~~~~~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~---------- 506 (575)
+.... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 168 RHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred ccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 75433 2344578899999999865 5789999999999999999999999987665443332221100
Q ss_pred --------------CC-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 008171 507 --------------RP-----TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 507 --------------~~-----~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~ 542 (575)
.+ ......++++.++|.+||+.||.+||++.+++.-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 0112457889999999999999999999998743
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=320.83 Aligned_cols=244 Identities=25% Similarity=0.416 Sum_probs=214.3
Q ss_pred eeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCC
Q 008171 297 GSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGG 374 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~gg 374 (575)
.+.||+|.||+||-|+. +|++||||++.+.++.......+.+|+.||+++.||.||.+...|+.+..+++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 36899999999999865 6899999999988887766688999999999999999999999999999999999999776
Q ss_pred chhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC---CCcEEEeecccceecccCCccccCCC
Q 008171 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQSGVMTAETG 451 (575)
Q Consensus 375 sL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~---~~~vkL~DFG~a~~~~~~~~~~~~~G 451 (575)
-|.-+|...++.+++.....++.||+.||.|||-+||+|+||||+|||+.. -..+||||||+|++..........+|
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVG 728 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVG 728 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcC
Confidence 677777777899999999999999999999999999999999999999964 34799999999999988877888899
Q ss_pred CCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCC
Q 008171 452 TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 531 (575)
Q Consensus 452 t~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~ 531 (575)
|+.|.|||++..+.|...-|+||+|+|+|--++|..||..........+...--+.+.....++++..+||..+|+..-.
T Consensus 729 TPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~ 808 (888)
T KOG4236|consen 729 TPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMR 808 (888)
T ss_pred CccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999755433322222222344556678899999999999999999
Q ss_pred CCCCHHHHH
Q 008171 532 LRPDFSEII 540 (575)
Q Consensus 532 ~RPs~~ell 540 (575)
+|.|....+
T Consensus 809 kRysvdk~l 817 (888)
T KOG4236|consen 809 KRYSVDKSL 817 (888)
T ss_pred HhcchHhhc
Confidence 999988755
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.76 Aligned_cols=245 Identities=23% Similarity=0.378 Sum_probs=197.8
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC--------
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-------- 361 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~-------- 361 (575)
.+|.+.+.||.|+||.||+|.. +++.||+|.+..... ...+.+.+|+.++++++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 6899999999999999999987 467899999875533 3346788999999999999999999776543
Q ss_pred ------CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC-CCcEEEeec
Q 008171 362 ------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADF 434 (575)
Q Consensus 362 ------~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~-~~~vkL~DF 434 (575)
..+|+||||++ ++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+||
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 35789999996 588888753 56899999999999999999999999999999999999974 567899999
Q ss_pred ccceecccCC----ccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC----
Q 008171 435 GVARVKAQSG----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG---- 505 (575)
Q Consensus 435 G~a~~~~~~~----~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~---- 505 (575)
|.++...... ......++..|+|||++.. ..++.++|||||||++|+|++|..||...++...........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9997643321 1223467889999998754 568899999999999999999999998777655444332211
Q ss_pred -------------------CCC-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 506 -------------------LRP-----TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 506 -------------------~~~-----~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
..+ .+....+.++.++|.+||+.||.+||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 012356788999999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=335.14 Aligned_cols=147 Identities=28% Similarity=0.481 Sum_probs=133.5
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~-~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
.++|++.++||+|+||.||+|.+. ++.||||+++... ........+..|+.+++.++||||+++++++.....+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367999999999999999999986 7789999997543 3445567788999999999999999999999988999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccce
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
|||+.|++|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999976 4678999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=302.96 Aligned_cols=259 Identities=26% Similarity=0.435 Sum_probs=214.2
Q ss_pred CCCCceeeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHH-HHhcCCCCceEEEeee
Q 008171 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI-MRKVRHKNVVQFIGAC 358 (575)
Q Consensus 282 ~~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~i-L~~L~HpnIv~l~~~~ 358 (575)
+....|++...+++-...||.|+||+|++-.. .|+..|||.++.... ...+++++.|... ++.-++||||++||++
T Consensus 54 ~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 54 DDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred CcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 34456788888999999999999999998765 577899999987654 3446778888875 5555789999999999
Q ss_pred cCCCCceeEEEeccCCchhhhhh----hccCcCChHHHHHHHHHHHHHHHHHHHC-CceecccCCCCEEecCCCcEEEee
Q 008171 359 TKPPSLCIVTEFMSGGSVYDYLH----KLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVAD 433 (575)
Q Consensus 359 ~~~~~l~lV~E~~~ggsL~d~l~----~~~~~l~~~~~~~i~~qI~~aL~yLH~~-gIiHrDLKp~NILl~~~~~vkL~D 433 (575)
..++.++|.||+| ..||..+.. ..+..+++..+..|+.-.+.||.||... .|||||+||+|||++..|.|||||
T Consensus 133 F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCD 211 (361)
T KOG1006|consen 133 FSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCD 211 (361)
T ss_pred hcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeec
Confidence 9999999999999 567766543 2356799999999999999999999865 999999999999999999999999
Q ss_pred cccceecccCCccccCCCCCCccCccccc--CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--
Q 008171 434 FGVARVKAQSGVMTAETGTYRWMAPEVIE--HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT-- 509 (575)
Q Consensus 434 FG~a~~~~~~~~~~~~~Gt~~y~APE~i~--~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~-- 509 (575)
||.+.....+-..+...|...|||||.+. ...|+.++||||||++|||+.||..||...+..-.....+..+-.|.
T Consensus 212 FGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~ 291 (361)
T KOG1006|consen 212 FGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILL 291 (361)
T ss_pred ccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeec
Confidence 99998777776777888999999999994 44699999999999999999999999998765432223333333222
Q ss_pred CCC---CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 008171 510 IPK---NSQPKLAELLERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 510 ~p~---~~~~~l~~Li~~cL~~dP~~RPs~~ell~~ 542 (575)
.+. +.+..+..+|.-||.+|-..||.+.+|++.
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 222 368899999999999999999999998764
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=298.96 Aligned_cols=237 Identities=25% Similarity=0.405 Sum_probs=198.2
Q ss_pred eeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecC----CCCceeEEEe
Q 008171 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTK----PPSLCIVTEF 370 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~----~~~l~lV~E~ 370 (575)
++||-|-.|.|..+.. +++.+|+|++... ...++|+.+.... .|||||.+++++.+ ...+.||||.
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~ 140 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC 140 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence 5799999999988855 6788999998732 3467788886665 59999999998754 3457899999
Q ss_pred ccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC---CCcEEEeecccceecccCCcc
Q 008171 371 MSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQSGVM 446 (575)
Q Consensus 371 ~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~---~~~vkL~DFG~a~~~~~~~~~ 446 (575)
|+||.|...++.+. ..|++..+..|+.||..|+.|||+.+|.||||||+|+|... +..+||+|||+|+.......+
T Consensus 141 meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L 220 (400)
T KOG0604|consen 141 MEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDL 220 (400)
T ss_pred ccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccc
Confidence 99999999998753 35999999999999999999999999999999999999974 557999999999988878888
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh----cC--CCCCCCCCCcHHHHH
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ----KG--LRPTIPKNSQPKLAE 520 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~----~~--~~~~~p~~~~~~l~~ 520 (575)
.+.+-|++|+|||++....|+..+|+||+|++||-|++|.+||......-...++.. .. +..+-...++...++
T Consensus 221 ~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKd 300 (400)
T KOG0604|consen 221 MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKD 300 (400)
T ss_pred cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHH
Confidence 889999999999999999999999999999999999999999976544322222211 11 122223467889999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 008171 521 LLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 521 Li~~cL~~dP~~RPs~~ell~ 541 (575)
+|+++|..+|.+|.|+.+++.
T Consensus 301 lIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 301 LIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred HHHHHhcCCchhheeHHHhhc
Confidence 999999999999999999873
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=337.08 Aligned_cols=245 Identities=26% Similarity=0.462 Sum_probs=194.1
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC--------
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-------- 361 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~-------- 361 (575)
.+|...+.||+|+||.||+++. +|..||||.+.... +......+.+|+.+|.+|+|||||+++.+|.+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 4577788999999999999976 68999999998765 555667899999999999999999987543000
Q ss_pred --------------------------------------------------------------------------------
Q 008171 362 -------------------------------------------------------------------------------- 361 (575)
Q Consensus 362 -------------------------------------------------------------------------------- 361 (575)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCC
Q 008171 362 -------------------------------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 410 (575)
Q Consensus 362 -------------------------------~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~g 410 (575)
..+||-||||+..+|.++++.....-....+|+++.+|+.||.|+|+.|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0258899999988888888653221146789999999999999999999
Q ss_pred ceecccCCCCEEecCCCcEEEeecccceecc-------------------cCCccccCCCCCCccCcccccCC---CCCc
Q 008171 411 IIHRDLKAANLLMDENEVVKVADFGVARVKA-------------------QSGVMTAETGTYRWMAPEVIEHK---PYDH 468 (575)
Q Consensus 411 IiHrDLKp~NILl~~~~~vkL~DFG~a~~~~-------------------~~~~~~~~~Gt~~y~APE~i~~~---~~s~ 468 (575)
||||||||.||++++++.|||+|||+|.... ..+..+..+||..|+|||++.+. .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999997511 11245567899999999999654 4999
Q ss_pred hHHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCC---CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 469 KADVFSFGIVLWELLTGKLPYEY-LTPLQAAVGVVQKGLRPTI---PKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 469 ksDVwSlGviL~eLltG~~Pf~~-~~~~~~~~~v~~~~~~~~~---p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
|+|+||||+||+||+. ||.. +....++.. ++++.-|.. +..-.+.-+.+|+.|++.||.+||||.|||+
T Consensus 798 KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~-LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTSMERASILTN-LRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCchHHHHHHHHh-cccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 9999999999999986 5643 333333333 333332322 3344567889999999999999999999984
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.87 Aligned_cols=252 Identities=26% Similarity=0.462 Sum_probs=204.8
Q ss_pred eeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC------CceeEEE
Q 008171 298 SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------SLCIVTE 369 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~------~l~lV~E 369 (575)
+.||+|+||.||+|+. +|+.||||.++... .....+..-+|+.+|++++|||||+++++-+... ...+|||
T Consensus 19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 7899999999999975 68889999998754 3344577889999999999999999998765433 3579999
Q ss_pred eccCCchhhhhhhc--cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEec--CCC--cEEEeecccceecccC
Q 008171 370 FMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD--ENE--VVKVADFGVARVKAQS 443 (575)
Q Consensus 370 ~~~ggsL~d~l~~~--~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~--~~~--~vkL~DFG~a~~~~~~ 443 (575)
||.||+|+..+++. ...+++..++.+..+++.||.|||.+||+||||||.||++- ++| ..||+|||.|+...++
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~ 177 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN 177 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCC
Confidence 99999999999764 34699999999999999999999999999999999999994 333 5899999999999999
Q ss_pred CccccCCCCCCccCccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHhcC-------------
Q 008171 444 GVMTAETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL----QAAVGVVQKG------------- 505 (575)
Q Consensus 444 ~~~~~~~Gt~~y~APE~i~-~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~----~~~~~v~~~~------------- 505 (575)
...+...||..|.+||++. .+.|+..+|.|||||++|++.||..||...... +....+..+.
T Consensus 178 s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eN 257 (732)
T KOG4250|consen 178 SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEEN 257 (732)
T ss_pred CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccC
Confidence 8999999999999999998 588999999999999999999999999543222 2222222111
Q ss_pred ------CCCCCCCCCcHH----HHHHHHHhhhcCCCCCC--CHHHHHHHHHHHHHHh
Q 008171 506 ------LRPTIPKNSQPK----LAELLERCWQQDPALRP--DFSEIIEILQQIAKEV 550 (575)
Q Consensus 506 ------~~~~~p~~~~~~----l~~Li~~cL~~dP~~RP--s~~ell~~L~~l~~~~ 550 (575)
...++|.+.++. +..++..+|..+|.+|- .+.+.-..+.+|++..
T Consensus 258 gpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 258 GPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred CceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 111234444433 55778888999999998 8888888888877643
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=286.40 Aligned_cols=218 Identities=22% Similarity=0.266 Sum_probs=182.8
Q ss_pred cCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCCchhhhh
Q 008171 303 GSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL 380 (575)
Q Consensus 303 G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ggsL~d~l 380 (575)
|.||.||++.+ +++.||+|.++... .+.+|...+....||||+++++++......|+||||++|++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 88999999987 56779999987542 2334555556667999999999999999999999999999999998
Q ss_pred hhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccccCCCCCCccCccc
Q 008171 381 HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 460 (575)
Q Consensus 381 ~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~ 460 (575)
.+ ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||.+...... .....++..|+|||.
T Consensus 77 ~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~ 153 (237)
T cd05576 77 SK-FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEV 153 (237)
T ss_pred HH-hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcc
Confidence 76 456899999999999999999999999999999999999999999999999987654432 233456778999999
Q ss_pred ccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 008171 461 IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 536 (575)
Q Consensus 461 i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~ 536 (575)
+.+..++.++|+||+|+++|+|++|..|+...... ........+|..+++.++++|.+||+.||.+||++
T Consensus 154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 98888999999999999999999999887643211 11122335677889999999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=277.25 Aligned_cols=236 Identities=35% Similarity=0.563 Sum_probs=202.3
Q ss_pred CceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCCchhhhhh
Q 008171 304 SYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH 381 (575)
Q Consensus 304 ~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ggsL~d~l~ 381 (575)
+||.||+|.+. ++.+++|++........ ...+.+|+..+++++|+||+++++.+......++++||+.+++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999985 47899999886543322 5789999999999999999999999998889999999999999999987
Q ss_pred hccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccccCCCCCCccCcccc
Q 008171 382 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 461 (575)
Q Consensus 382 ~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i 461 (575)
... .++...++.++.+++.++.|||+.+|+|+||+|.||+++.++.++|+|||.+.............++..|++||.+
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 633 3899999999999999999999999999999999999999999999999999877665455667789999999999
Q ss_pred cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCC--CcHHHHHHHHHhhhcCCCCCCCHHHH
Q 008171 462 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN--SQPKLAELLERCWQQDPALRPDFSEI 539 (575)
Q Consensus 462 ~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~--~~~~l~~Li~~cL~~dP~~RPs~~el 539 (575)
.+..++.++|||+||+++|+|++|..||.....................+.. ++.++.+++.+||..+|++||++.++
T Consensus 159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 238 (244)
T smart00220 159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEA 238 (244)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHH
Confidence 9888999999999999999999999999874444444444444433322222 88999999999999999999999999
Q ss_pred HH
Q 008171 540 IE 541 (575)
Q Consensus 540 l~ 541 (575)
++
T Consensus 239 ~~ 240 (244)
T smart00220 239 LQ 240 (244)
T ss_pred hh
Confidence 86
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.77 Aligned_cols=245 Identities=22% Similarity=0.368 Sum_probs=205.0
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
.++.+.|..++.||-|+||+|.++.. +...||+|.+.+..+ ..+.......|..||..-+.+.||+||..|.+.+.+
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 57778899999999999999999965 445699999876433 445567788899999999999999999999999999
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec---c
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK---A 441 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~---~ 441 (575)
|+||+|++||++..+|-+ .+-|.+..+..++..+..|+++.|..|+|||||||+|||||.+|+|||.|||++.-+ .
T Consensus 705 YFVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EEEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999999999877 688999999999999999999999999999999999999999999999999998411 0
Q ss_pred cC-----C------cc-----------------------------ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHH
Q 008171 442 QS-----G------VM-----------------------------TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 481 (575)
Q Consensus 442 ~~-----~------~~-----------------------------~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~e 481 (575)
.+ + .| ...+||+.|+|||++....|+..+|+||.|+||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 00 0 00 11369999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHHHh--cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 008171 482 LLTGKLPYEYLTPLQAAVGVVQ--KGLRPTIPKNSQPKLAELLERCWQQDPALRP 534 (575)
Q Consensus 482 LltG~~Pf~~~~~~~~~~~v~~--~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP 534 (575)
|+.|+.||-..++.++...++. ..+......++++++.++|.++. .+++.|.
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhh
Confidence 9999999998888777655543 33333444678999999998754 3445553
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=296.60 Aligned_cols=251 Identities=32% Similarity=0.648 Sum_probs=204.3
Q ss_pred CCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHh--cCCCCceEEEeeecCCC----Cc
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--VRHKNVVQFIGACTKPP----SL 364 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~--L~HpnIv~l~~~~~~~~----~l 364 (575)
..+..+.+.||+|.||+||+|.|.|+.||||++... ....+.+|..|.+. |+|+||+.|+++-.... ++
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 367889999999999999999999999999998743 13557777777775 48999999999865433 58
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHC--------CceecccCCCCEEecCCCcEEEeeccc
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--------NIIHRDLKAANLLMDENEVVKVADFGV 436 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~--------gIiHrDLKp~NILl~~~~~vkL~DFG~ 436 (575)
++|++|.+.|||+|||.. ..++....++++..++.||++||.. .|.|||||.+|||+..++...|+|+|+
T Consensus 285 wLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 999999999999999976 7889999999999999999999953 599999999999999999999999999
Q ss_pred ceecccC-----CccccCCCCCCccCcccccCC----CCC--chHHHHHHHHHHHHHHc----C------CCCCCCCCH-
Q 008171 437 ARVKAQS-----GVMTAETGTYRWMAPEVIEHK----PYD--HKADVFSFGIVLWELLT----G------KLPYEYLTP- 494 (575)
Q Consensus 437 a~~~~~~-----~~~~~~~Gt~~y~APE~i~~~----~~s--~ksDVwSlGviL~eLlt----G------~~Pf~~~~~- 494 (575)
|-..... ......+||.+|||||++... .|+ ..+||||||.+|||+.. | .+||.+..+
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 9654432 134456899999999998543 222 35899999999999975 2 378865432
Q ss_pred ----HHHHHHHHhcCCCCCCCCCCc-----HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 495 ----LQAAVGVVQKGLRPTIPKNSQ-----PKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 495 ----~~~~~~v~~~~~~~~~p~~~~-----~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
.+...-+..+.+||.+|.... ..+..+|+.||..||.-|.|+--+.+.|.++.+
T Consensus 443 DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 443 DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 233333456778898887553 347788999999999999999999999988864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=267.90 Aligned_cols=248 Identities=23% Similarity=0.387 Sum_probs=211.6
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
.|+-.++||+|.||+||+|+. +++-||+|.++.+..++......++|+.+|+.++|.|||++++....++.+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 455678999999999999976 457799999998777776777889999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-ccccC
Q 008171 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE 449 (575)
Q Consensus 371 ~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 449 (575)
| .-.|..+....++.++...+..++.|+++||.|+|+.++.||||||.|+||+.+|.+|++|||+++-+..+- ...++
T Consensus 83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysae 161 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE 161 (292)
T ss_pred h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeece
Confidence 9 568999999999999999999999999999999999999999999999999999999999999999776654 56778
Q ss_pred CCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCC------CC------------C
Q 008171 450 TGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGL------RP------------T 509 (575)
Q Consensus 450 ~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~------~~------------~ 509 (575)
+-|..|.+|.++.+. -|+...|+||.|||+.|+.. |++-|.+.+-.+....+...-. +| .
T Consensus 162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ 241 (292)
T KOG0662|consen 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPI 241 (292)
T ss_pred eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCC
Confidence 899999999998664 58999999999999999998 8888888777666655543211 11 1
Q ss_pred CC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 510 IP---------KNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 510 ~p---------~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+| +..+..=+++++++|.-+|.+|.++++.++
T Consensus 242 ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 242 YPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11 122344679999999999999999987653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=290.77 Aligned_cols=262 Identities=25% Similarity=0.498 Sum_probs=224.2
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 360 (575)
.+...+++....+-+|.||.||+|.|.. +.|-+|.++.. .+.-....+++|..++..+.|||+.++.+++..
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 4555677777889999999999996532 34777877743 334446779999999999999999999998754
Q ss_pred -CCCceeEEEeccCCchhhhhhhcc-------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEe
Q 008171 361 -PPSLCIVTEFMSGGSVYDYLHKLK-------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA 432 (575)
Q Consensus 361 -~~~l~lV~E~~~ggsL~d~l~~~~-------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~ 432 (575)
....+.++.++.-|+|..+|..++ ..++..++..++.|++.||+|||+.||||.||..+|.+|++.-.|||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 455678889999999999998443 346677888899999999999999999999999999999999999999
Q ss_pred ecccceecccC---CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCC
Q 008171 433 DFGVARVKAQS---GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP 508 (575)
Q Consensus 433 DFG~a~~~~~~---~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~ 508 (575)
|=.++|..... +.-..+.....||+||.+.+..|+.++|+||||++||||+| |+.||...+|.+.. ..+.++.|.
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~-~ylkdGyRl 517 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME-HYLKDGYRL 517 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-HHHhcccee
Confidence 99999854432 23334566889999999999999999999999999999999 99999999999876 457789999
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 509 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 509 ~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
..|.+||+++..+|..||...|++||+|+|+...|.++..++.
T Consensus 518 aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 518 AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999999999999877654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=309.91 Aligned_cols=238 Identities=24% Similarity=0.377 Sum_probs=199.6
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCceeE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l~lV 367 (575)
...|.+...+|.|+|+.|-.+.. +++..++|++.....+ -.+|+.++... +||||+++++.+.+..+.|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceeeee
Confidence 46788888999999999998865 5677999999865221 23466554444 699999999999999999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEe-cCCCcEEEeecccceecccCCcc
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM-DENEVVKVADFGVARVKAQSGVM 446 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl-~~~~~vkL~DFG~a~~~~~~~~~ 446 (575)
||++.|+-|.+.+... ..+. ..+..|+.+|+.|+.|||.+|||||||||+|||+ +..+.++|+|||.++..... .
T Consensus 395 ~e~l~g~ell~ri~~~-~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~ 470 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSK-PEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--C 470 (612)
T ss_pred ehhccccHHHHHHHhc-chhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--h
Confidence 9999999888887652 2233 6777899999999999999999999999999999 68999999999999876655 4
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 526 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL 526 (575)
...+-|..|+|||+....+|+.++||||||++||+||+|+.||..-.....+.. .-..+.+...+|..+++|+++||
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~---~i~~~~~s~~vS~~AKdLl~~LL 547 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT---RIQMPKFSECVSDEAKDLLQQLL 547 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH---hhcCCccccccCHHHHHHHHHhc
Confidence 455678899999999999999999999999999999999999987665533333 23345566899999999999999
Q ss_pred hcCCCCCCCHHHHHH
Q 008171 527 QQDPALRPDFSEIIE 541 (575)
Q Consensus 527 ~~dP~~RPs~~ell~ 541 (575)
+.||.+||++.++..
T Consensus 548 ~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 548 QVDPALRLGADEIGA 562 (612)
T ss_pred cCChhhCcChhhhcc
Confidence 999999999999863
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=289.17 Aligned_cols=241 Identities=23% Similarity=0.425 Sum_probs=199.6
Q ss_pred eeeeeecCceEEEEEE--ECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCCCceeEEEeccC
Q 008171 297 GSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~--~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
.+.||+|+|+.|-.+. +++..||||++.+.. .....++.+|+.++.+.+ |+||++++++|+++..+|+|||.|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 3579999999998764 578899999998763 344678899999999996 99999999999999999999999999
Q ss_pred CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC---cEEEeecccceecccC-------
Q 008171 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARVKAQS------- 443 (575)
Q Consensus 374 gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~---~vkL~DFG~a~~~~~~------- 443 (575)
|+|...+++ ...|++..+.++.++|+.||.|||.+||.||||||+|||..... .||||||.+..-....
T Consensus 161 GplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 161 GPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred chHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 999999987 67799999999999999999999999999999999999997543 5999999887532221
Q ss_pred -CccccCCCCCCccCccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH--------------HHHHHHHHh
Q 008171 444 -GVMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTP--------------LQAAVGVVQ 503 (575)
Q Consensus 444 -~~~~~~~Gt~~y~APE~i~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~--------------~~~~~~v~~ 503 (575)
....+.+|+..|||||+.. ...|+.++|+||||+|||-||+|.+||.+.-. .+....-++
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 1233557889999999873 34599999999999999999999999975321 122333344
Q ss_pred cCCCCCCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 504 KGLRPTIP----KNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 504 ~~~~~~~p----~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+. .++| .+++.+.++++..+|..|+.+|-++.+++.
T Consensus 320 EGk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 320 EGK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 443 2444 367899999999999999999999998876
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=286.12 Aligned_cols=247 Identities=21% Similarity=0.404 Sum_probs=211.9
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHH-HHHHHHHHHHHhc-CCCCceEEEeeecC
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQ-KEFAQEVFIMRKV-RHKNVVQFIGACTK 360 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~-~~~~~Ev~iL~~L-~HpnIv~l~~~~~~ 360 (575)
..|.+...+|.++++||+|+|+.|.++.. +.+-||+|+++++.++.+.- .-...|-.+..+- +||.+|-++..|+.
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 56788889999999999999999998876 45669999999887765432 3344466665554 68999999999999
Q ss_pred CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
+..+++|.||++||+|.-+++. ..+++++.+..+...|+-||.|||++|||+||||..|||+|..|++||.|+|+++..
T Consensus 323 esrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred cceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999999999988876 678999999999999999999999999999999999999999999999999999876
Q ss_pred ccCC-ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCC-------CCHHHHHHH-HHhcCCCCCCC
Q 008171 441 AQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY-------LTPLQAAVG-VVQKGLRPTIP 511 (575)
Q Consensus 441 ~~~~-~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~-------~~~~~~~~~-v~~~~~~~~~p 511 (575)
..++ ...+.+|||.|.|||++.+..|....|+|+||++|+||+.|+.||+. .+..+-... ++.+.. .+|
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--rip 479 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--RIP 479 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--ccc
Confidence 6655 45578999999999999999999999999999999999999999963 233333333 334443 588
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCC
Q 008171 512 KNSQPKLAELLERCWQQDPALRP 534 (575)
Q Consensus 512 ~~~~~~l~~Li~~cL~~dP~~RP 534 (575)
..++-....+++..|++||.+|.
T Consensus 480 rslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 480 RSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ceeehhhHHHHHHhhcCCcHHhc
Confidence 89999999999999999999985
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=338.34 Aligned_cols=242 Identities=23% Similarity=0.407 Sum_probs=192.2
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
.++..+.||+|+||.||+|.. .+..||||.++..... ...|+.++++++|||||+++++|.+....|+||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 455667899999999999986 5678999998743211 13468899999999999999999999999999999
Q ss_pred ccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHH---HCCceecccCCCCEEecCCCcEEEeecccceecccCCccc
Q 008171 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH---QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 447 (575)
Q Consensus 371 ~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH---~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 447 (575)
+++|+|.++++. +++..+.+++.||+.||+||| +.+|+||||||+||+++.++..++. ||....... ..
T Consensus 765 ~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~ 836 (968)
T PLN00113 765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DT 836 (968)
T ss_pred CCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CC
Confidence 999999999964 789999999999999999999 6799999999999999998887775 665543222 22
Q ss_pred cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHH-----hcCCCCCC------C
Q 008171 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP-----LQAAVGVV-----QKGLRPTI------P 511 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~-----~~~~~~v~-----~~~~~~~~------p 511 (575)
...||+.|+|||++.+..|+.++|||||||++|||++|+.||..... .+...... .....+.+ +
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916 (968)
T ss_pred CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence 34688999999999999999999999999999999999999853211 11111000 00111111 1
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 512 KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 512 ~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
.....++.+++.+||+.||.+||++.|+++.|+++.+
T Consensus 917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 1223467889999999999999999999999998875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=292.09 Aligned_cols=251 Identities=32% Similarity=0.535 Sum_probs=206.6
Q ss_pred CCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhc--CCCCceEEEeeecCCC----Cc
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV--RHKNVVQFIGACTKPP----SL 364 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L--~HpnIv~l~~~~~~~~----~l 364 (575)
...+++.+.||+|.||.||+|++.++.||||++.. ...+.|.+|..|.+.. +|+||++|+++-.... .+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 45667788999999999999999999999999874 3456788888887754 6999999999875554 78
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHC---------CceecccCCCCEEecCCCcEEEeecc
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN---------NIIHRDLKAANLLMDENEVVKVADFG 435 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~---------gIiHrDLKp~NILl~~~~~vkL~DFG 435 (575)
+||+||.+.|+|.+||.. ..+++....+++..|++||+|||.. .|+|||||.+|||+.+|+...|+|||
T Consensus 284 wLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999999975 7799999999999999999999953 69999999999999999999999999
Q ss_pred cceecccC---CccccCCCCCCccCcccccCCC-CC-----chHHHHHHHHHHHHHHcCC------------CCCC----
Q 008171 436 VARVKAQS---GVMTAETGTYRWMAPEVIEHKP-YD-----HKADVFSFGIVLWELLTGK------------LPYE---- 490 (575)
Q Consensus 436 ~a~~~~~~---~~~~~~~Gt~~y~APE~i~~~~-~s-----~ksDVwSlGviL~eLltG~------------~Pf~---- 490 (575)
+|...... +.....+||.+|||||++.+.- +. .+.||||+|.+||||++.. +||+
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 99866543 2334578999999999997642 22 3589999999999999843 2332
Q ss_pred -CCCHHHHHHHHHhcCCCCCCCCCC-----cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 491 -YLTPLQAAVGVVQKGLRPTIPKNS-----QPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 491 -~~~~~~~~~~v~~~~~~~~~p~~~-----~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
.-+-.+...-++++..||.+|... ..-+++.++.||..|++-|.|+.=+-+.+.++..
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 112234444567888899888643 3568899999999999999999988888887764
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=284.35 Aligned_cols=249 Identities=24% Similarity=0.391 Sum_probs=194.9
Q ss_pred CceeeeeeeeecCceEEEEEEEC------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC-CCCc
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSL 364 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~-~~~l 364 (575)
..|+...+||+|.||.||++... ...+|||.++.+...........+|+.+++.++||||+.+..++.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 56888899999999999999532 2369999998764433444567889999999999999999999876 7789
Q ss_pred eeEEEeccCCchhhhhhhc----cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC----CcEEEeeccc
Q 008171 365 CIVTEFMSGGSVYDYLHKL----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN----EVVKVADFGV 436 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~----~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~----~~vkL~DFG~ 436 (575)
++++||.+ .+|+++++.. ...++...+..|+.||+.|+.|||++-|+||||||.|||+..+ |.|||+|||+
T Consensus 104 ~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 104 WLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 99999995 4899888643 2468999999999999999999999999999999999999877 8999999999
Q ss_pred ceecccCC----ccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCC-------CHHHH-----HH
Q 008171 437 ARVKAQSG----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYL-------TPLQA-----AV 499 (575)
Q Consensus 437 a~~~~~~~----~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~-------~~~~~-----~~ 499 (575)
+|.....- .....+-|..|.|||.+.+ ..|+.+.|||+.|||+.||++-.+-|.+. +|.+. +.
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 99776542 2233456999999999876 56999999999999999999988777432 12111 11
Q ss_pred HHHhc---CCCCC-----------------C------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 500 GVVQK---GLRPT-----------------I------------PKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 500 ~v~~~---~~~~~-----------------~------------p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.++-. ..+|. . ...-++...+|+.+||+.||.+|.|+++.++
T Consensus 263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 11100 00000 0 0112455889999999999999999998774
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=290.00 Aligned_cols=245 Identities=25% Similarity=0.393 Sum_probs=197.9
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--C----CceEEEeeecCCC
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--K----NVVQFIGACTKPP 362 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~H--p----nIv~l~~~~~~~~ 362 (575)
..+|.+.+.+|+|.||.|-.+.+. +..||||+++.- ..+.+..+-|+.+|+++.+ | .+|++.++|.-.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 578999999999999999998764 567999999843 3344556679999999953 3 3788899999999
Q ss_pred CceeEEEeccCCchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC----------------
Q 008171 363 SLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---------------- 425 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~---------------- 425 (575)
+.|||+|.+ |.|+++++... ..+++...+..++.|++.+|.|||.++++|.||||+|||+.+
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence 999999999 88999999763 356999999999999999999999999999999999999942
Q ss_pred ----CCcEEEeecccceecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH---
Q 008171 426 ----NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA--- 498 (575)
Q Consensus 426 ----~~~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~--- 498 (575)
+..|+|+|||.|+...+.. +..+.|..|.|||++.+-+++.++||||+||||+||++|..-|..-+..+-.
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMM 321 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMM 321 (415)
T ss_pred ccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHH
Confidence 2259999999998765543 5667899999999999999999999999999999999999999766543321
Q ss_pred HHHHh--------cC-----C---CC-----------------CCC--------CCCcHHHHHHHHHhhhcCCCCCCCHH
Q 008171 499 VGVVQ--------KG-----L---RP-----------------TIP--------KNSQPKLAELLERCWQQDPALRPDFS 537 (575)
Q Consensus 499 ~~v~~--------~~-----~---~~-----------------~~p--------~~~~~~l~~Li~~cL~~dP~~RPs~~ 537 (575)
..++. +. + +. ..| .....+|.+||++||.+||.+|+|+.
T Consensus 322 erIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~ 401 (415)
T KOG0671|consen 322 ERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLR 401 (415)
T ss_pred HHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHH
Confidence 11111 00 0 00 000 11134689999999999999999999
Q ss_pred HHHH
Q 008171 538 EIIE 541 (575)
Q Consensus 538 ell~ 541 (575)
|++.
T Consensus 402 EAL~ 405 (415)
T KOG0671|consen 402 EALS 405 (415)
T ss_pred HHhc
Confidence 9874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=267.03 Aligned_cols=217 Identities=31% Similarity=0.477 Sum_probs=188.5
Q ss_pred ceeeCCCceeeeeeeeecCceEE--EEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHH-hcCCCCceEEEeeecCCC
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDL--YRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR-KVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~V--y~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~-~L~HpnIv~l~~~~~~~~ 362 (575)
.+++..+.+.-+..||+|+||.| |+-.+.|+-.|+|.++.. ++.+.+++.++|+.+.. ...+|.+|.|||...++.
T Consensus 40 ~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t-vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 40 NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT-VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh-cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 37888889999999999999975 566678899999999854 55666788888998755 556999999999999999
Q ss_pred CceeEEEeccCCchhhhhhh---ccCcCChHHHHHHHHHHHHHHHHHHHC-CceecccCCCCEEecCCCcEEEeecccce
Q 008171 363 SLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~---~~~~l~~~~~~~i~~qI~~aL~yLH~~-gIiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
..+|.||.| ..||..+..+ ..+.+++..+-+|+..++.||.|||++ .+||||+||+||||+.+|.||+||||.+.
T Consensus 119 dvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999999 6688877643 367899999999999999999999976 99999999999999999999999999998
Q ss_pred ecccCCccccCCCCCCccCccccc----CCCCCchHHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhc
Q 008171 439 VKAQSGVMTAETGTYRWMAPEVIE----HKPYDHKADVFSFGIVLWELLTGKLPYEY-LTPLQAAVGVVQK 504 (575)
Q Consensus 439 ~~~~~~~~~~~~Gt~~y~APE~i~----~~~~s~ksDVwSlGviL~eLltG~~Pf~~-~~~~~~~~~v~~~ 504 (575)
...++-..+...|...|||||.+. ...|+.|+||||||+++.||.+++.||+. .++.+...+++..
T Consensus 198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 887776666678999999999984 44799999999999999999999999975 5788877776654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=308.59 Aligned_cols=246 Identities=32% Similarity=0.545 Sum_probs=208.6
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeec-----CCCCc
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACT-----KPPSL 364 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~-----~~~~l 364 (575)
.+.|.+.||.|.+|.||+++. .++.+|+|++.... +...++..|..||+.+. |||++.++|++. .++.+
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 455668999999999998864 67889999988653 33456777889988775 899999999984 35679
Q ss_pred eeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 365 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
++|||||.|||..|++++.. ..+.+..+..|++.++.|+.+||++.+||||||-.|||++.++.|||+|||++...+..
T Consensus 97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST 176 (953)
T ss_pred EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence 99999999999999997654 56999999999999999999999999999999999999999999999999998765543
Q ss_pred -CccccCCCCCCccCcccccCC-----CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcH
Q 008171 444 -GVMTAETGTYRWMAPEVIEHK-----PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQP 516 (575)
Q Consensus 444 -~~~~~~~Gt~~y~APE~i~~~-----~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~~~~p~~~~~ 516 (575)
+...+.+||+.|||||++... .|+..+|+||||++..||--|.+|+-++.|..+...+-+... +...|...+.
T Consensus 177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~ 256 (953)
T KOG0587|consen 177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSK 256 (953)
T ss_pred cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHH
Confidence 345567899999999999543 478899999999999999999999999999888766443321 1223667889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 517 KLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
++-++|..||.+|..+||+..++++
T Consensus 257 ~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 257 KFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred HHHHHHHHHHhhccccCcchhhhcc
Confidence 9999999999999999999999873
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=275.50 Aligned_cols=251 Identities=26% Similarity=0.419 Sum_probs=203.6
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC------
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK------ 360 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~------ 360 (575)
++.+.|.-..+||+|.||+||+++. .++.||+|.+..+..........++|+.+|..|.|+|++.++..|..
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 4456777788999999999998864 56779998766544444445667899999999999999999998843
Q ss_pred --CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccce
Q 008171 361 --PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 361 --~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
...+|+||.+|+ .+|.-+|.+..-++++..+.+++.++..||.|+|++.|+|||+||+||||+.+|.+||+|||+++
T Consensus 94 r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 94 RDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred cccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 234899999995 58999998877889999999999999999999999999999999999999999999999999998
Q ss_pred ecccCC-----ccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc------CC
Q 008171 439 VKAQSG-----VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK------GL 506 (575)
Q Consensus 439 ~~~~~~-----~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~------~~ 506 (575)
....+. ..+..+-|..|.+||.+.+ ..|+.+.|||..||||.||.++.+-+.+.+..+....+-+- ..
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 665542 2344566999999998865 57999999999999999999999999887776654432211 11
Q ss_pred CCC--------------CC-------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 008171 507 RPT--------------IP-------------KNSQPKLAELLERCWQQDPALRPDFSEII 540 (575)
Q Consensus 507 ~~~--------------~p-------------~~~~~~l~~Li~~cL~~dP~~RPs~~ell 540 (575)
+|. +| -.-.++..+|+.++|..||.+|+++++.+
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al 313 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL 313 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence 111 11 11135788999999999999999999987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=291.64 Aligned_cols=254 Identities=19% Similarity=0.275 Sum_probs=185.3
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE------------------CCccEEEEEecCCCCCh------------HHHHHHH
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY------------------CSQDVAIKVLKPERINS------------DMQKEFA 337 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~------------------~~~~VAvKvl~~~~~~~------------~~~~~~~ 337 (575)
.+..++|++.++||+|+||.||+|.+ .++.||||.++...... ...+.+.
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 34677999999999999999999964 23569999987542110 0112234
Q ss_pred HHHHHHHhcCCCCc-----eEEEeeecC--------CCCceeEEEeccCCchhhhhhhccC-------------------
Q 008171 338 QEVFIMRKVRHKNV-----VQFIGACTK--------PPSLCIVTEFMSGGSVYDYLHKLKG------------------- 385 (575)
Q Consensus 338 ~Ev~iL~~L~HpnI-----v~l~~~~~~--------~~~l~lV~E~~~ggsL~d~l~~~~~------------------- 385 (575)
.|+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++...+
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57778888876554 667777643 3467999999999999999864321
Q ss_pred ----cCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccc--cCCCCCCccCcc
Q 008171 386 ----VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT--AETGTYRWMAPE 459 (575)
Q Consensus 386 ----~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~--~~~Gt~~y~APE 459 (575)
.+++..++.++.||+.+|.|||+++|+||||||+|||++.++.+||+|||++.......... ...+|+.|+|||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 23566788899999999999999999999999999999999999999999997544332222 234588999999
Q ss_pred cccCCC--------------------CC--chHHHHHHHHHHHHHHcCCC-CCCCCCHHHHHHH-----------HHhcC
Q 008171 460 VIEHKP--------------------YD--HKADVFSFGIVLWELLTGKL-PYEYLTPLQAAVG-----------VVQKG 505 (575)
Q Consensus 460 ~i~~~~--------------------~s--~ksDVwSlGviL~eLltG~~-Pf~~~~~~~~~~~-----------v~~~~ 505 (575)
++.... |+ .+.||||+||++|+|++|.. ||........... +....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 985432 11 24799999999999999875 7764332221111 11112
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCC---CCCCCHHHHHH
Q 008171 506 LRPTIPKNSQPKLAELLERCWQQDP---ALRPDFSEIIE 541 (575)
Q Consensus 506 ~~~~~p~~~~~~l~~Li~~cL~~dP---~~RPs~~ell~ 541 (575)
.........++...+|+.+||..+| .+|+|+.|+++
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 2223345678999999999999866 68999999874
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-33 Score=284.68 Aligned_cols=251 Identities=20% Similarity=0.378 Sum_probs=200.5
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCC-----hHHHHHHHHHHHHHHhcCCCCceEEEeeec-C
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-----SDMQKEFAQEVFIMRKVRHKNVVQFIGACT-K 360 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~-----~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~-~ 360 (575)
.-.++|-++..||+|+|+.||++-+ ..+.||||+-...... ..+.+...+|..|.+.|.||.||++|+++. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3346677888999999999999965 4567999987643322 234456788999999999999999999985 5
Q ss_pred CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHC--CceecccCCCCEEec---CCCcEEEeecc
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--NIIHRDLKAANLLMD---ENEVVKVADFG 435 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~--gIiHrDLKp~NILl~---~~~~vkL~DFG 435 (575)
...+|-|+|||+|.+|.-||+. ...+++..+..|+.||+.||.||... -|||-||||.|||+- ..|.+||.|||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 6678999999999999988876 67789999999999999999999977 599999999999994 46789999999
Q ss_pred cceecccCCc--------cccCCCCCCccCcccccC----CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--H
Q 008171 436 VARVKAQSGV--------MTAETGTYRWMAPEVIEH----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG--V 501 (575)
Q Consensus 436 ~a~~~~~~~~--------~~~~~Gt~~y~APE~i~~----~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~--v 501 (575)
+++++..... .....||++|++||++.- ...+.|.||||+|+|+|.++.|+.||...-..+.+.. .
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 9998776432 234579999999999832 3468899999999999999999999976544443321 0
Q ss_pred HhcCCCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 008171 502 VQKGLRPTI--PKNSQPKLAELLERCWQQDPALRPDFSEII 540 (575)
Q Consensus 502 ~~~~~~~~~--p~~~~~~l~~Li~~cL~~dP~~RPs~~ell 540 (575)
+.+...-.+ .+.++++..+||++||++--++|.+..+|-
T Consensus 699 IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 699 ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111111122 246789999999999999999998877754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=296.84 Aligned_cols=246 Identities=16% Similarity=0.217 Sum_probs=168.5
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEee----
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA---- 357 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~---- 357 (575)
.+..++|.+.++||+|+||.||+|++. +..||||.+...... ..+..+ .++...+.++..++..
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 345578999999999999999999874 457999987643211 111111 1112222223222221
Q ss_pred --ecCCCCceeEEEeccCCchhhhhhhccCc-------------------CChHHHHHHHHHHHHHHHHHHHCCceeccc
Q 008171 358 --CTKPPSLCIVTEFMSGGSVYDYLHKLKGV-------------------FKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416 (575)
Q Consensus 358 --~~~~~~l~lV~E~~~ggsL~d~l~~~~~~-------------------l~~~~~~~i~~qI~~aL~yLH~~gIiHrDL 416 (575)
+.....+++|+||+.+++|.+++...... .....+..++.||+.||.|||++||+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 24566789999999999999998653211 112345679999999999999999999999
Q ss_pred CCCCEEecC-CCcEEEeecccceecccC--CccccCCCCCCccCcccccCC----------------------CCCchHH
Q 008171 417 KAANLLMDE-NEVVKVADFGVARVKAQS--GVMTAETGTYRWMAPEVIEHK----------------------PYDHKAD 471 (575)
Q Consensus 417 Kp~NILl~~-~~~vkL~DFG~a~~~~~~--~~~~~~~Gt~~y~APE~i~~~----------------------~~s~ksD 471 (575)
||+|||++. ++.+||+|||+++..... .......+|+.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 579999999999754332 233456789999999976322 2445679
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----------CCCCC----------CCCCCcHHHHHHHHHhhhcCCC
Q 008171 472 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK----------GLRPT----------IPKNSQPKLAELLERCWQQDPA 531 (575)
Q Consensus 472 VwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~----------~~~~~----------~p~~~~~~l~~Li~~cL~~dP~ 531 (575)
||||||+||||+++..|+... .......+.. ...+. +.........+||.+||++||.
T Consensus 362 VwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 999999999999987665421 1111111111 00000 1111223456899999999999
Q ss_pred CCCCHHHHHH
Q 008171 532 LRPDFSEIIE 541 (575)
Q Consensus 532 ~RPs~~ell~ 541 (575)
+|||+.|+++
T Consensus 440 kR~ta~e~L~ 449 (566)
T PLN03225 440 QRISAKAALA 449 (566)
T ss_pred cCCCHHHHhC
Confidence 9999999985
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=275.58 Aligned_cols=133 Identities=24% Similarity=0.417 Sum_probs=113.6
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-----C---CCceEEEee
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-----H---KNVVQFIGA 357 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-----H---pnIv~l~~~ 357 (575)
.+...+|.+.++||+|-|++||++.++ ++.||+|+.+.. ..+.+....|+++|++++ | .+||+|++.
T Consensus 74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 345589999999999999999999875 567999999853 345566788999999995 2 479999998
Q ss_pred ec----CCCCceeEEEeccCCchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHC-CceecccCCCCEEec
Q 008171 358 CT----KPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMD 424 (575)
Q Consensus 358 ~~----~~~~l~lV~E~~~ggsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~-gIiHrDLKp~NILl~ 424 (575)
|. .+.++|||+|++ |.+|..+|... ...++...+.+|++||+.||.|||.. ||||.||||+|||+.
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 84 455799999999 88999988765 35699999999999999999999975 999999999999994
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=255.54 Aligned_cols=243 Identities=20% Similarity=0.378 Sum_probs=195.9
Q ss_pred CCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCC--Cc
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP--SL 364 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~--~l 364 (575)
..++|++.+++|+|-|++||.|.. +++.++||++++- -.+.+.+|+.||+.|. ||||++++++..++. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 447899999999999999999974 6788999999864 2467899999999998 999999999987653 46
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC-CCcEEEeecccceecccC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKAQS 443 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~~ 443 (575)
.+|+||+.+.+...+. ..++...+..++.++++||.|+|+.||+|||+||.|++||. ...++|+|||+|.+....
T Consensus 111 aLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 7999999876655443 45788899999999999999999999999999999999985 557999999999887776
Q ss_pred CccccCCCCCCccCcccc-cCCCCCchHHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHH-------------------
Q 008171 444 GVMTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEY-LTPLQAAVGVV------------------- 502 (575)
Q Consensus 444 ~~~~~~~Gt~~y~APE~i-~~~~~s~ksDVwSlGviL~eLltG~~Pf~~-~~~~~~~~~v~------------------- 502 (575)
......+.+..|-.||.+ .-+.|+..-|+|||||+|..|+..+.||.. .+..+....+.
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 666667788899999988 556799999999999999999999888843 22222222111
Q ss_pred --------hcCCC--------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 503 --------QKGLR--------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 503 --------~~~~~--------~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
....+ +.-..-.+++..+|+.++|..|-.+|+|++|.+.
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 01000 0111223699999999999999999999999864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=295.70 Aligned_cols=252 Identities=26% Similarity=0.423 Sum_probs=196.2
Q ss_pred eeeeeeeecCceE-EEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCCCceeEEEecc
Q 008171 295 KFGSKVASGSYGD-LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMS 372 (575)
Q Consensus 295 ~i~~~LG~G~fG~-Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~l~lV~E~~~ 372 (575)
.-.+.+|.|+.|+ ||+|.+.++.||||.+-.+. .....+|+..|+.-+ |||||++++.-.+....||..|.|
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 3345689999986 89999999999999877442 344667999999885 999999999999999999999999
Q ss_pred CCchhhhhhhc--cCc-CChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC---C--CcEEEeecccceecccCC
Q 008171 373 GGSVYDYLHKL--KGV-FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---N--EVVKVADFGVARVKAQSG 444 (575)
Q Consensus 373 ggsL~d~l~~~--~~~-l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~---~--~~vkL~DFG~a~~~~~~~ 444 (575)
..+|.+++... ... ...-..+.+..|++.||++||+.+||||||||.||||+. + ..++|+|||+++......
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 66999999763 111 111345778899999999999999999999999999975 2 479999999998655543
Q ss_pred ----ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCC-CCCCCCcHHH
Q 008171 445 ----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP-TIPKNSQPKL 518 (575)
Q Consensus 445 ----~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~-~~p~~~~~~l 518 (575)
......||.+|+|||++....-..++|||||||++|+.++ |..||...-..+... +...... .+......+.
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI--l~~~~~L~~L~~~~d~eA 743 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI--LTGNYTLVHLEPLPDCEA 743 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh--hcCccceeeeccCchHHH
Confidence 2335579999999999998888889999999999999999 589998765544332 2221110 0111111289
Q ss_pred HHHHHHhhhcCCCCCCCHHHHH------------HHHHHHHHHhchhh
Q 008171 519 AELLERCWQQDPALRPDFSEII------------EILQQIAKEVGEEN 554 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell------------~~L~~l~~~~~~~~ 554 (575)
.+||.+|++++|..||++.+++ .+|+++-.++..++
T Consensus 744 ~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e~ 791 (903)
T KOG1027|consen 744 KDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKEN 791 (903)
T ss_pred HHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhhh
Confidence 9999999999999999999986 45666655555443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=267.00 Aligned_cols=244 Identities=26% Similarity=0.435 Sum_probs=198.4
Q ss_pred eeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC-----CceeEE
Q 008171 296 FGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-----SLCIVT 368 (575)
Q Consensus 296 i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~-----~l~lV~ 368 (575)
-.+.||.|+||.||-.++ .++.||+|.+..-..+-...+.+.+|+++|...+|.|++..+++..-.. .+|+++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 347899999999999987 5788999988754434445678999999999999999999888765432 368999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC--Ccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS--GVM 446 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~--~~~ 446 (575)
|+| ..+|..++-. ...++...+.-+.+||++||.|||+.||.||||||.|+|++.+..+||||||+++..... ..|
T Consensus 137 ELm-QSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM 214 (449)
T KOG0664|consen 137 ELM-QSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM 214 (449)
T ss_pred HHH-Hhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence 999 4577777765 677888999999999999999999999999999999999999999999999999976543 478
Q ss_pred ccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-----------------------
Q 008171 447 TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV----------------------- 502 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~----------------------- 502 (575)
+.++-|.+|.|||++.+ ..|+.+.||||+|||+.||+..+.-|...+|.+...-+.
T Consensus 215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~L 294 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVL 294 (449)
T ss_pred HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhh
Confidence 88899999999999876 569999999999999999999999998877766544332
Q ss_pred hcCCCC-C--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 503 QKGLRP-T--------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 503 ~~~~~~-~--------~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+.+.++ . -+..-..+...++.+++.+||++|.+..+.+.
T Consensus 295 R~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 295 RAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred ccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 112211 1 11233456788899999999999998877654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=244.09 Aligned_cols=209 Identities=37% Similarity=0.686 Sum_probs=186.6
Q ss_pred eeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCCchh
Q 008171 300 VASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377 (575)
Q Consensus 300 LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ggsL~ 377 (575)
||+|++|.||++... ++.+++|++....... ....+.+|+..++.+.|++|+++++++......++++||+.|++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999987 7889999998664332 3467899999999999999999999999988999999999999999
Q ss_pred hhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC-CCcEEEeecccceecccCC-ccccCCCCCCc
Q 008171 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKAQSG-VMTAETGTYRW 455 (575)
Q Consensus 378 d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~~~-~~~~~~Gt~~y 455 (575)
+++......++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+....... ......+...|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY 159 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence 999774457899999999999999999999999999999999999999 8999999999997665542 23445678899
Q ss_pred cCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 008171 456 MAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP 534 (575)
Q Consensus 456 ~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP 534 (575)
++||.+... .++.++|+|++|+++++| ..+.+++.+||+.+|.+||
T Consensus 160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~R~ 206 (215)
T cd00180 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEKRP 206 (215)
T ss_pred cChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcccCc
Confidence 999999887 889999999999999999 6899999999999999999
Q ss_pred CHHHHHHH
Q 008171 535 DFSEIIEI 542 (575)
Q Consensus 535 s~~ell~~ 542 (575)
++.++++.
T Consensus 207 ~~~~l~~~ 214 (215)
T cd00180 207 SAKEILEH 214 (215)
T ss_pred CHHHHhhC
Confidence 99999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=263.03 Aligned_cols=248 Identities=24% Similarity=0.311 Sum_probs=203.6
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC----
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP---- 362 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~---- 362 (575)
..+.+|.-.+.+|.|.- .|.-+-+ .+++||+|.+.....+....++..+|..++..+.|+||++++.++.-..
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 34467777888999988 5555533 5789999988777666666788899999999999999999999986543
Q ss_pred --CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 363 --SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 363 --~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
..|+|||+| ..+|...+. -.++...+.+|..|++.|+.|||+.||+||||||+||++..++.+||+|||+++..
T Consensus 93 ~~e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 93 FQEVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHhHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 469999999 568888876 45678889999999999999999999999999999999999999999999999877
Q ss_pred ccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--------------
Q 008171 441 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-------------- 506 (575)
Q Consensus 441 ~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~-------------- 506 (575)
...-.++..+.|..|.|||++.+..|...+||||+||++.||++|+.-|.+....+...++++.-.
T Consensus 169 ~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 169 DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 776678888999999999999988899999999999999999999999987655444333221100
Q ss_pred ------------------------C--CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 507 ------------------------R--PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 507 ------------------------~--~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
. .+.+..-...+++++.+||..||++|.++.++|.
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0 0011122356899999999999999999999874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=286.65 Aligned_cols=247 Identities=29% Similarity=0.496 Sum_probs=216.2
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
.+|....++|+|+||.||++++ +++..|+|+++.+..+ ...-..+|+.+++..+|||||.++|.+.....++|+||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 5788889999999999999976 5788999999976432 34567789999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-Ccccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~ 448 (575)
||.||+|.+..+- .+.+++-++..+++..++|+.|||+.|-+|||||-.|||+++.|.+|++|||.+-..... .....
T Consensus 93 ycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks 171 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS 171 (829)
T ss_pred ecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence 9999999998876 789999999999999999999999999999999999999999999999999998544332 23446
Q ss_pred CCCCCCccCcccc---cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC---CCCCcHHHHHHH
Q 008171 449 ETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI---PKNSQPKLAELL 522 (575)
Q Consensus 449 ~~Gt~~y~APE~i---~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~---p~~~~~~l~~Li 522 (575)
..||++|||||+. ..+.|...+|||++|++..|+-.-+.|...+.+.++..-+-..++.|.. +...++.|-+|+
T Consensus 172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fv 251 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFV 251 (829)
T ss_pred ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHH
Confidence 7899999999987 5678999999999999999999889999999999988776666655432 345688999999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 008171 523 ERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 523 ~~cL~~dP~~RPs~~ell~ 541 (575)
+.||.++|++||++..++.
T Consensus 252 K~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 252 KGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHhcCCCccCCChhhhee
Confidence 9999999999999998764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=277.42 Aligned_cols=248 Identities=24% Similarity=0.398 Sum_probs=203.3
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC------CCceEEEeeecC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH------KNVVQFIGACTK 360 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~H------pnIv~l~~~~~~ 360 (575)
+-..+|.+..-.|.|-|++|.+|.+. ++.||||+|... +-+.+.=+.|+.||++|+. -++++++..|..
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 34467888888899999999999874 678999999853 4566777889999999973 379999999999
Q ss_pred CCCceeEEEeccCCchhhhhhhccC--cCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC-CcEEEeecccc
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVA 437 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~~~--~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~-~~vkL~DFG~a 437 (575)
.+++|||+|.+ ..+|.++|.++.. .|....+..++.|++.||..|-..||+|.||||.|||+++. ..+||||||.|
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence 99999999999 7799999988653 47788899999999999999999999999999999999975 56999999999
Q ss_pred eecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-----------cC-
Q 008171 438 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ-----------KG- 505 (575)
Q Consensus 438 ~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~-----------~~- 505 (575)
.....+. .+.+.-+..|.|||+|.+.+|++..|+||+||+||||+||+.-|.+.+..+++.-.+. ++
T Consensus 585 ~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgq 663 (752)
T KOG0670|consen 585 SFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQ 663 (752)
T ss_pred ccccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcc
Confidence 7666543 3444556789999999999999999999999999999999999998877666543221 00
Q ss_pred -------------------------------CCC------------CCCCC---CcHHHHHHHHHhhhcCCCCCCCHHHH
Q 008171 506 -------------------------------LRP------------TIPKN---SQPKLAELLERCWQQDPALRPDFSEI 539 (575)
Q Consensus 506 -------------------------------~~~------------~~p~~---~~~~l~~Li~~cL~~dP~~RPs~~el 539 (575)
..| .+|.. .-..|++||.+||..||.+|.|..|.
T Consensus 664 F~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqA 743 (752)
T KOG0670|consen 664 FKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQA 743 (752)
T ss_pred hhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHH
Confidence 001 01111 12458899999999999999999987
Q ss_pred HH
Q 008171 540 IE 541 (575)
Q Consensus 540 l~ 541 (575)
|+
T Consensus 744 L~ 745 (752)
T KOG0670|consen 744 LK 745 (752)
T ss_pred hc
Confidence 64
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-29 Score=242.25 Aligned_cols=212 Identities=33% Similarity=0.580 Sum_probs=182.2
Q ss_pred eeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEec
Q 008171 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~ 371 (575)
|.+.+.||.|++|.||++... ++.+++|.+...... .....+.+|+..+++++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 467789999999999999885 578999999865433 24678899999999999999999999999888999999999
Q ss_pred cCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC--ccccC
Q 008171 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTAE 449 (575)
Q Consensus 372 ~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~--~~~~~ 449 (575)
.+++|.+++......+++..++.++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+....... .....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV 159 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence 9999999997744338999999999999999999999999999999999999999999999999998765543 33455
Q ss_pred CCCCCccCcccc-cCCCCCchHHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCC
Q 008171 450 TGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEY-LTPLQAAVGVVQKGL 506 (575)
Q Consensus 450 ~Gt~~y~APE~i-~~~~~s~ksDVwSlGviL~eLltG~~Pf~~-~~~~~~~~~v~~~~~ 506 (575)
.++..|++||.+ ....++.++|+|+||+++|+|++|+.||.. .++.....+.+..+.
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 678899999999 777888899999999999999999999977 555555555555443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-28 Score=240.53 Aligned_cols=266 Identities=20% Similarity=0.317 Sum_probs=221.3
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCCCc
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSL 364 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~l 364 (575)
.+-.-.|+++++||+|+||.++.|+. .+++||||.-....... .+.-|.+..+.|. .++|.++|.+.....+.
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP----QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP----QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEeccccCCcc----hHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 45556899999999999999999974 78999999866543333 3556777777775 69999999999999999
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC-----CCcEEEeeccccee
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-----NEVVKVADFGVARV 439 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~-----~~~vkL~DFG~a~~ 439 (575)
.||+|++ |.||.|++.-+..+|+..+++.+|+|++.-++|+|.+.+|+|||||+|+||+. ...|.|+|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999999 99999999999999999999999999999999999999999999999999974 34699999999987
Q ss_pred cccCCc--------cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHhcCCC-
Q 008171 440 KAQSGV--------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ---AAVGVVQKGLR- 507 (575)
Q Consensus 440 ~~~~~~--------~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~---~~~~v~~~~~~- 507 (575)
..++.. .....||.+||+=....+.+.+.+.|+-|||-+++++|-|.+||.++.... ...++-...-.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 655432 234579999999999999999999999999999999999999999875433 23332221111
Q ss_pred --CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhchhhHHHh
Q 008171 508 --PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERR 558 (575)
Q Consensus 508 --~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~~~~~~~~ 558 (575)
..+...+|.++...|+..-..+..+-|+++-+..++.+++..++.......
T Consensus 259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~y 311 (449)
T KOG1165|consen 259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEY 311 (449)
T ss_pred CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccc
Confidence 123456788999999999999999999999999999999998875444333
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=266.92 Aligned_cols=198 Identities=27% Similarity=0.446 Sum_probs=173.5
Q ss_pred CceeeeeeeeecCceEEEEEEECC--ccEEEEEecCCCCChHHH------HHHHHHHHHHHhcC---CCCceEEEeeecC
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ------KEFAQEVFIMRKVR---HKNVVQFIGACTK 360 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~~--~~VAvKvl~~~~~~~~~~------~~~~~Ev~iL~~L~---HpnIv~l~~~~~~ 360 (575)
.+|...+.||.|+||.|+++.++. ..|+||.+.+++.-.+.. -.+-.|+.||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 468999999999999999998864 459999998776533322 12567999999998 9999999999999
Q ss_pred CCCceeEEEec-cCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 361 PPSLCIVTEFM-SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 361 ~~~l~lV~E~~-~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
.+.+||+||-. +|.+|.+++.. +..+++..+..|++||+.|+++||..||||||||-+||.++.+|.+||+|||.+..
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 99999999975 46689999976 67899999999999999999999999999999999999999999999999999854
Q ss_pred cccCCccccCCCCCCccCcccccCCCCCc-hHHHHHHHHHHHHHHcCCCCCCC
Q 008171 440 KAQSGVMTAETGTYRWMAPEVIEHKPYDH-KADVFSFGIVLWELLTGKLPYEY 491 (575)
Q Consensus 440 ~~~~~~~~~~~Gt~~y~APE~i~~~~~s~-ksDVwSlGviL~eLltG~~Pf~~ 491 (575)
. .++.....+||..|.|||++.+.+|-- .-|||++|++||.++....||..
T Consensus 720 ~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 720 T-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred h-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 3 456777889999999999999998854 57999999999999999999854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-27 Score=244.42 Aligned_cols=255 Identities=24% Similarity=0.356 Sum_probs=206.0
Q ss_pred ceeeeeeeeecCceEEEEEEECCc---cEEEEEecCCCCChHHHHHHHHHHHHHHhcCC----CCceEEEeee-cCCCCc
Q 008171 293 HLKFGSKVASGSYGDLYRGTYCSQ---DVAIKVLKPERINSDMQKEFAQEVFIMRKVRH----KNVVQFIGAC-TKPPSL 364 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~~~---~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~H----pnIv~l~~~~-~~~~~l 364 (575)
+|++.++||+|+||.||.+..... .+|+|+......... ..+..|+.++..+.. +++..+++.+ ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 799999999999999999997654 599998775422211 156778899888873 6899999999 577788
Q ss_pred eeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC-----CcEEEeecccce
Q 008171 365 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-----EVVKVADFGVAR 438 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~-----~~vkL~DFG~a~ 438 (575)
||||+.+ |.+|.++..... +.++..+++.++.|++.+|.+||+.|++||||||.|++++.. ..+.|.|||+++
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999999 999999886655 789999999999999999999999999999999999999865 469999999998
Q ss_pred --ecc-cCC-------c-cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--
Q 008171 439 --VKA-QSG-------V-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-- 505 (575)
Q Consensus 439 --~~~-~~~-------~-~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~-- 505 (575)
... ..+ . .....||.+|+++.+..+...+.+.|+||++.++.+|+.|.+||...........+....
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~ 255 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK 255 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence 321 111 1 223459999999999999999999999999999999999999998766432222222221
Q ss_pred -CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 506 -LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 506 -~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
.........+.++..++..+-..+...+|.+..+...|+++....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 111134456778889888888899999999999999998887754
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=240.01 Aligned_cols=253 Identities=31% Similarity=0.644 Sum_probs=220.9
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
.|+.+++.+..+|...-.|+.|+|+|.+.+++.|+++.........+.|..|.-.|+-..||||+.++++|..++++.++
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred CcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 46778888899999999999999999999999999998777777778899999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhhccC-cCChHHHHHHHHHHHHHHHHHHHCC--ceecccCCCCEEecCCCcEEEe--ecccceeccc
Q 008171 368 TEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVA--DFGVARVKAQ 442 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~-~l~~~~~~~i~~qI~~aL~yLH~~g--IiHrDLKp~NILl~~~~~vkL~--DFG~a~~~~~ 442 (575)
..||+-|||+..++...+ ..+..++.+++.+|++||+|||+.. |----|....|+||++-..+|+ |--++. +
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf---q 342 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF---Q 342 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee---e
Confidence 999999999999987544 3778899999999999999999974 3344588899999998776653 332221 1
Q ss_pred CCccccCCCCCCccCcccccCCCCC---chHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 008171 443 SGVMTAETGTYRWMAPEVIEHKPYD---HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 519 (575)
Q Consensus 443 ~~~~~~~~Gt~~y~APE~i~~~~~s---~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~ 519 (575)
.....-.+.||+||.+..++-+ .++|+|||++++|||.|...||...++.+.-.++.-+++++.+|+.+++.+.
T Consensus 343 ---e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~ 419 (448)
T KOG0195|consen 343 ---EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMN 419 (448)
T ss_pred ---ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHH
Confidence 1122347899999999877755 4799999999999999999999999999998899999999999999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 520 ELLERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 520 ~Li~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
.||.-|++.||.+||.|..++-.|++.
T Consensus 420 klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 420 KLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred HHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 999999999999999999999988875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=225.04 Aligned_cols=164 Identities=24% Similarity=0.374 Sum_probs=134.3
Q ss_pred CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccccCCCCC
Q 008171 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY 453 (575)
Q Consensus 374 gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~Gt~ 453 (575)
|+|.+++...+..+++..++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||+++..... ...||+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcc
Confidence 6899999876677999999999999999999999999 999999999999999 9999766543 236899
Q ss_pred CccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC------CCCCCcH--HHHHHHHHh
Q 008171 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT------IPKNSQP--KLAELLERC 525 (575)
Q Consensus 454 ~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~------~p~~~~~--~l~~Li~~c 525 (575)
.|||||++.+..|+.++|||||||++|||++|..||............+.....+. .+...+. ++.++|.+|
T Consensus 69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~c 148 (176)
T smart00750 69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVC 148 (176)
T ss_pred cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHH
Confidence 99999999999999999999999999999999999976654333222222222211 1222333 699999999
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 526 WQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 526 L~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
|..+|.+||++.|+++.+..+..+
T Consensus 149 l~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 149 ASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HhcccccccCHHHHHHHHHHHHHH
Confidence 999999999999999988776543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=282.64 Aligned_cols=193 Identities=17% Similarity=0.237 Sum_probs=144.4
Q ss_pred hcCC-CCceEEEeee-------cCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceeccc
Q 008171 345 KVRH-KNVVQFIGAC-------TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416 (575)
Q Consensus 345 ~L~H-pnIv~l~~~~-------~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDL 416 (575)
.++| .||++++++| .....+++++||+ +++|.+++......+++..++.++.||+.||.|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3455 5788888876 2334577889988 67999999875667999999999999999999999999999999
Q ss_pred CCCCEEecCC-------------------CcEEEeecccceecccCC-----------------ccccCCCCCCccCccc
Q 008171 417 KAANLLMDEN-------------------EVVKVADFGVARVKAQSG-----------------VMTAETGTYRWMAPEV 460 (575)
Q Consensus 417 Kp~NILl~~~-------------------~~vkL~DFG~a~~~~~~~-----------------~~~~~~Gt~~y~APE~ 460 (575)
||+||||+.. +.+||+|||+++...... ......||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 9999999654 455666666665321100 0112358899999999
Q ss_pred ccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 008171 461 IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII 540 (575)
Q Consensus 461 i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell 540 (575)
+.+..|+.++|||||||+||||++|..|+..... .... +.....+.......+....++.+||+++|.+||++.|++
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSS-LRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHH-HHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 9999999999999999999999999888754321 1111 111122222122346678999999999999999999997
Q ss_pred H
Q 008171 541 E 541 (575)
Q Consensus 541 ~ 541 (575)
+
T Consensus 264 ~ 264 (793)
T PLN00181 264 Q 264 (793)
T ss_pred h
Confidence 4
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-27 Score=225.10 Aligned_cols=258 Identities=23% Similarity=0.326 Sum_probs=215.5
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC-CCceEEEeeecCCCCc
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSL 364 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~H-pnIv~l~~~~~~~~~l 364 (575)
.|....|+++++||+|+||.+|+|.. .|..||||+-....-.+ .+..|.++.+.|++ ..|..+..++.+...-
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 45567899999999999999999976 57889999977554333 35678899999986 7888888888888889
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC---CCcEEEeecccceecc
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKA 441 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~---~~~vkL~DFG~a~~~~ 441 (575)
.+||+++ |.||.+++.-+...++..+++-++-|++.-++|+|.+++|||||||+|+|++- ...+.++|||+|+..-
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999999 99999999999999999999999999999999999999999999999999973 4579999999997543
Q ss_pred cCC--------ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHhcCCCC--
Q 008171 442 QSG--------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---QAAVGVVQKGLRP-- 508 (575)
Q Consensus 442 ~~~--------~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~---~~~~~v~~~~~~~-- 508 (575)
+.. .....+||.+|.+-....+...+.+.|+-|+|.+|.++.-|.+||+++... |....+..+....
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 321 223457999999988888888899999999999999999999999987644 4444444443322
Q ss_pred -CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 509 -TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 509 -~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
.+....|.++...+..|-..--++-|++.-|.+.+.-++..+
T Consensus 246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 234677899999999999999999999999888888776654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=227.14 Aligned_cols=249 Identities=20% Similarity=0.303 Sum_probs=189.6
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEe-eecCCCCceeE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG-ACTKPPSLCIV 367 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~-~~~~~~~l~lV 367 (575)
+.|.|.+.||.|.||.+-++.+. ++.+++|.+..... ..++|.+|..---.| .|.||+.-|+ +|+..+.++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 57889999999999999999875 45699999876533 357788887654445 4899998776 46777788899
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC--CCcEEEeecccceecccCCc
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE--NEVVKVADFGVARVKAQSGV 445 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~--~~~vkL~DFG~a~~~~~~~~ 445 (575)
+||++-|+|..-+.. ..+-+....+++.|+++|+.|||+++++|||||.+||||-. .-.|||||||..+..+.--
T Consensus 101 qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV- 177 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV- 177 (378)
T ss_pred eccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee-
Confidence 999999999988754 56788888999999999999999999999999999999953 3479999999986543321
Q ss_pred cccCCCCCCccCcccccCC-----CCCchHHHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhcCCCCCCCC---CC
Q 008171 446 MTAETGTYRWMAPEVIEHK-----PYDHKADVFSFGIVLWELLTGKLPYEYL---TPLQAAVGVVQKGLRPTIPK---NS 514 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~-----~~s~ksDVwSlGviL~eLltG~~Pf~~~---~~~~~~~~v~~~~~~~~~p~---~~ 514 (575)
...--+..|.+||+.... ...+.+|+|.||+++|.+++|+.||+.. .+.-+......++..+..|. ..
T Consensus 178 -~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~f 256 (378)
T KOG1345|consen 178 -KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPF 256 (378)
T ss_pred -hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhccc
Confidence 111235678999986432 2456799999999999999999999742 23333333344455555554 56
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 008171 515 QPKLAELLERCWQQDPALRPDFSEIIEILQQIA 547 (575)
Q Consensus 515 ~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~ 547 (575)
++.+..+.++-|..++++|=-..+..+.-...+
T Consensus 257 s~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 257 SEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred CHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence 788999999999999999955555555444433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-24 Score=216.70 Aligned_cols=248 Identities=30% Similarity=0.497 Sum_probs=204.9
Q ss_pred eeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChH-HHHHHHHHHHHHHhcCCC-CceEEEeeecCCCCceeEEEec
Q 008171 294 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD-MQKEFAQEVFIMRKVRHK-NVVQFIGACTKPPSLCIVTEFM 371 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~-~~~~~~~Ev~iL~~L~Hp-nIv~l~~~~~~~~~l~lV~E~~ 371 (575)
|.+.+.||.|+||.||++... ..+++|.+........ ....+.+|+.+++.+.|+ +|+++++.+......+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 677889999999999999887 7899999987665543 578899999999999988 7999999997777789999999
Q ss_pred cCCchhhhhhhcc--CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC-cEEEeecccceecccCC----
Q 008171 372 SGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSG---- 444 (575)
Q Consensus 372 ~ggsL~d~l~~~~--~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~~~---- 444 (575)
.++++.+++.... ..++......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.++......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS 160 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccc
Confidence 9999997776533 2789999999999999999999999999999999999999988 79999999998555433
Q ss_pred ---ccccCCCCCCccCcccccC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCCCC----CCC
Q 008171 445 ---VMTAETGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQKGLRP----TIP 511 (575)
Q Consensus 445 ---~~~~~~Gt~~y~APE~i~~---~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~---~~~~~~v~~~~~~~----~~p 511 (575)
......||..|++||.+.+ ..++...|+|++|++++++++|..||..... .......+.....+ ...
T Consensus 161 ~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (384)
T COG0515 161 IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240 (384)
T ss_pred ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccC
Confidence 2456689999999999987 6788999999999999999999999877763 23333333333222 122
Q ss_pred CCC----cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 008171 512 KNS----QPKLAELLERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 512 ~~~----~~~l~~Li~~cL~~dP~~RPs~~ell~~ 542 (575)
... ...+.+++.+|+..+|..|.+..+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 241 PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 222 2579999999999999999988877654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=236.02 Aligned_cols=242 Identities=23% Similarity=0.373 Sum_probs=186.9
Q ss_pred CceeeeeeeeecCceEEEEEEEC-----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCCCce
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~-----~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~l~ 365 (575)
+.|+.+++||.|+|+.||+++.. .+.||+|.+..... ...+..|+.+|..+. +.||+++.+.+..+++.+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 56788899999999999999753 35699998875421 355889999999996 799999999999999999
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC-CCcEEEeecccceecccC-
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKAQS- 443 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~~- 443 (575)
+|+||++.....+++.. ++...+..++..++.||.++|.+|||||||||.|+|.+. .+.-.|+|||+|......
T Consensus 112 ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred EEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 99999999888887765 678999999999999999999999999999999999984 577899999998611000
Q ss_pred -----Cc---------c------------------------------ccCCCCCCccCcccccC-CCCCchHHHHHHHHH
Q 008171 444 -----GV---------M------------------------------TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIV 478 (575)
Q Consensus 444 -----~~---------~------------------------------~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGvi 478 (575)
.. + ....||++|.|||++.. ...++++||||.|+|
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 00 0 01249999999999854 457889999999999
Q ss_pred HHHHHcCCCCCCCCCHH-HHHHH---------------------HHh-----------------------cC----CCCC
Q 008171 479 LWELLTGKLPYEYLTPL-QAAVG---------------------VVQ-----------------------KG----LRPT 509 (575)
Q Consensus 479 L~eLltG~~Pf~~~~~~-~~~~~---------------------v~~-----------------------~~----~~~~ 509 (575)
+..++++..||-..... ..... +.+ +. ....
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 99999999999421100 00000 000 00 0111
Q ss_pred C-CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 510 I-PKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 510 ~-p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
. ....+..+.+|+.+||..||.+|.|+++.|+
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 1 1223458999999999999999999999874
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=222.29 Aligned_cols=165 Identities=19% Similarity=0.197 Sum_probs=129.5
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE---CCccEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCceE-EEeeecC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY---CSQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQ-FIGACTK 360 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~---~~~~VAvKvl~~~~~---~~~~~~~~~~Ev~iL~~L~HpnIv~-l~~~~~~ 360 (575)
..-...|.+.+.||+|+||+||+|.+ .++.||||++..... .......|.+|+.+|++++|+||+. ++..
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 34457799999999999999999976 356689998763311 2334567999999999999999985 5442
Q ss_pred CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceeccc-CCCCEEecCCCcEEEeeccccee
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL-KAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDL-Kp~NILl~~~~~vkL~DFG~a~~ 439 (575)
+..|+||||++|++|... .. .. ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+++.
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 357999999999999632 11 11 1467899999999999999999999 99999999999999999999986
Q ss_pred cccCCcc---------ccCCCCCCccCcccccCC
Q 008171 440 KAQSGVM---------TAETGTYRWMAPEVIEHK 464 (575)
Q Consensus 440 ~~~~~~~---------~~~~Gt~~y~APE~i~~~ 464 (575)
....+.. +...+++.|+|||.+...
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 5544321 234678899999998543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-23 Score=226.85 Aligned_cols=233 Identities=26% Similarity=0.420 Sum_probs=196.2
Q ss_pred eeecCceEEEEEE-----ECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCCCceeEEEeccC
Q 008171 300 VASGSYGDLYRGT-----YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 300 LG~G~fG~Vy~~~-----~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
+|.|+||.|+++. +.+.-+|+|+++..............|..++..++ ||.+|+++..++.+..+++++++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6899999998653 44566999998876554433346677899999998 99999999999999999999999999
Q ss_pred CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccccCCCCC
Q 008171 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY 453 (575)
Q Consensus 374 gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~Gt~ 453 (575)
|.|...+.+ ...+.+.....+...++-+++++|+.+|+|||+|++||+++.+|++++.|||+++........ +||+
T Consensus 82 g~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt~ 157 (612)
T KOG0603|consen 82 GDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGTY 157 (612)
T ss_pred chhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccch
Confidence 999988876 566788888899999999999999999999999999999999999999999999876654332 8999
Q ss_pred CccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 008171 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 533 (575)
Q Consensus 454 ~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~R 533 (575)
.|||||+++ ....++|+||||++++||++|..||.. +....+.. ..+..|...+..+.+++.+++..+|.+|
T Consensus 158 eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~--~~~~~p~~l~~~a~~~~~~l~~r~p~nr 229 (612)
T KOG0603|consen 158 EYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK--AELEMPRELSAEARSLFRQLFKRNPENR 229 (612)
T ss_pred hhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh--hccCCchhhhHHHHHHHHHHHhhCHHHH
Confidence 999999998 678899999999999999999999987 33333333 2356888999999999999999999999
Q ss_pred CCH--HHHHHHHH
Q 008171 534 PDF--SEIIEILQ 544 (575)
Q Consensus 534 Ps~--~ell~~L~ 544 (575)
-.. ..+.+..+
T Consensus 230 Lg~~~~~~~eik~ 242 (612)
T KOG0603|consen 230 LGAGPDGVDEIKQ 242 (612)
T ss_pred hccCcchhHHHhc
Confidence 754 34444433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.7e-23 Score=230.68 Aligned_cols=245 Identities=22% Similarity=0.349 Sum_probs=188.6
Q ss_pred eeeeeeeecCceEEEEEEEC--CccEEEEEec----CCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 295 KFGSKVASGSYGDLYRGTYC--SQDVAIKVLK----PERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 295 ~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~----~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
+....+|.|++|.|+..... ....+.|... ......+....+..|+.+-..+.|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 56678999999977766542 2223333322 22222223333777888899999999988887777666666669
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC----
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---- 444 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~---- 444 (575)
|||++ +|+.++.. .+.++...+..++.|++.|+.|||..||.|||+|++|++++.+|.+||+|||.+.......
T Consensus 401 E~~~~-Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred hcccH-HHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence 99999 99999876 4678889999999999999999999999999999999999999999999999998765543
Q ss_pred -ccccCCCCCCccCcccccCCCCCch-HHHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHhcCC------CCCCCCCCc
Q 008171 445 -VMTAETGTYRWMAPEVIEHKPYDHK-ADVFSFGIVLWELLTGKLPYEYLTPLQAA-VGVVQKGL------RPTIPKNSQ 515 (575)
Q Consensus 445 -~~~~~~Gt~~y~APE~i~~~~~s~k-sDVwSlGviL~eLltG~~Pf~~~~~~~~~-~~v~~~~~------~~~~p~~~~ 515 (575)
.....+|+..|+|||++.+..|++. .||||.|+++..|++|+.||..-...+.. ........ ...+...++
T Consensus 479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp 558 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLP 558 (601)
T ss_pred hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhch
Confidence 2345679999999999999999975 79999999999999999999755443321 11111000 011234567
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 516 PKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 516 ~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+.+.+|.+||+.||.+|.|+.+|++
T Consensus 559 ~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 559 RETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hhHHHHHHHHccCChhheecHHHHhh
Confidence 78999999999999999999999874
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.5e-22 Score=190.78 Aligned_cols=141 Identities=17% Similarity=0.183 Sum_probs=108.9
Q ss_pred eeeeeecCceEEEEEEE-CCccEEEEEecCCCCChHH------------------------HHHHHHHHHHHHhcCCCCc
Q 008171 297 GSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDM------------------------QKEFAQEVFIMRKVRHKNV 351 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~-~~~~VAvKvl~~~~~~~~~------------------------~~~~~~Ev~iL~~L~HpnI 351 (575)
...||+|+||.||+|.. +|+.||||+++........ .....+|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46899999999999987 5789999999865321111 1122459999999988776
Q ss_pred eEEEeeecCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHH-HHCCceecccCCCCEEecCCCcEE
Q 008171 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL-HQNNIIHRDLKAANLLMDENEVVK 430 (575)
Q Consensus 352 v~l~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yL-H~~gIiHrDLKp~NILl~~~~~vk 430 (575)
.....+... ..+|||||++|+++...... .+.++...+..++.||+.+|.|| |+.||+||||||+|||++ ++.++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 433222222 24899999988777655333 46789999999999999999999 799999999999999998 47899
Q ss_pred Eeecccceecc
Q 008171 431 VADFGVARVKA 441 (575)
Q Consensus 431 L~DFG~a~~~~ 441 (575)
|+|||++....
T Consensus 158 LiDFG~a~~~~ 168 (190)
T cd05147 158 IIDVSQSVEHD 168 (190)
T ss_pred EEEccccccCC
Confidence 99999996443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.2e-22 Score=194.62 Aligned_cols=174 Identities=14% Similarity=0.199 Sum_probs=137.2
Q ss_pred eCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChH-HHHH------HHHHHHHHHhcCCCCceEEEeeecC-
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD-MQKE------FAQEVFIMRKVRHKNVVQFIGACTK- 360 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~-~~~~------~~~Ev~iL~~L~HpnIv~l~~~~~~- 360 (575)
+-..+|++.+.||.|+||.||+....+..+|||++........ .... +.+|+..+.++.|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 3457899999999999999999888788899999986644332 2222 5789999999999999998887542
Q ss_pred -------CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEee
Q 008171 361 -------PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD 433 (575)
Q Consensus 361 -------~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~D 433 (575)
.+..+|||||++|.+|.++.. ++. ....+|+.+|..||+.|++|||+||+||+++.+| ++|+|
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 235789999999999988742 222 2456999999999999999999999999999988 99999
Q ss_pred cccceecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHH
Q 008171 434 FGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL 483 (575)
Q Consensus 434 FG~a~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLl 483 (575)
||............ ..+....|+.++|+|+||+++..+.
T Consensus 178 fg~~~~~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence 99886543322111 1345556788999999999987664
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-21 Score=197.24 Aligned_cols=195 Identities=23% Similarity=0.361 Sum_probs=147.8
Q ss_pred CCCCceEEEeeecC---------------------------CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHH
Q 008171 347 RHKNVVQFIGACTK---------------------------PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399 (575)
Q Consensus 347 ~HpnIv~l~~~~~~---------------------------~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI 399 (575)
+|||||.+.++|.+ +..+|+||..+ ..+|..++-. ...+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~--~~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT--RHRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc--CCCchHHHHHHHHHH
Confidence 59999999987643 23578999888 4588888854 455677778899999
Q ss_pred HHHHHHHHHCCceecccCCCCEEec--C--CCcEEEeecccceecccCC-------ccccCCCCCCccCcccccCCC---
Q 008171 400 SKGMNYLHQNNIIHRDLKAANLLMD--E--NEVVKVADFGVARVKAQSG-------VMTAETGTYRWMAPEVIEHKP--- 465 (575)
Q Consensus 400 ~~aL~yLH~~gIiHrDLKp~NILl~--~--~~~vkL~DFG~a~~~~~~~-------~~~~~~Gt~~y~APE~i~~~~--- 465 (575)
+.|+.|||++||.|||||.+|||+. + -..+.|+|||++--....+ ..-..-|.-..||||+.+..+
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~ 430 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN 430 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence 9999999999999999999999993 2 3468999999873222211 111234778899999986543
Q ss_pred ---CCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 008171 466 ---YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 466 ---~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~ 542 (575)
--.|+|.|+.|.+.||++....||.............++..-|..|..+++.+++++..+|+.||.+|++..-.-..
T Consensus 431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred eeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhH
Confidence 12489999999999999999999976332222222244555678999999999999999999999999987655444
Q ss_pred HH
Q 008171 543 LQ 544 (575)
Q Consensus 543 L~ 544 (575)
|+
T Consensus 511 l~ 512 (598)
T KOG4158|consen 511 LN 512 (598)
T ss_pred HH
Confidence 44
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=182.27 Aligned_cols=142 Identities=16% Similarity=0.158 Sum_probs=110.8
Q ss_pred eeeeeecCceEEEEEEE-CCccEEEEEecCCCCChH------------------------HHHHHHHHHHHHHhcCCCCc
Q 008171 297 GSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSD------------------------MQKEFAQEVFIMRKVRHKNV 351 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~-~~~~VAvKvl~~~~~~~~------------------------~~~~~~~Ev~iL~~L~HpnI 351 (575)
.+.||+|+||.||+|.. +|+.||||+++....... ....+..|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 56899999999999987 488999999986532100 01234579999999999987
Q ss_pred eEEEeeecCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHH-CCceecccCCCCEEecCCCcEE
Q 008171 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVK 430 (575)
Q Consensus 352 v~l~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~gIiHrDLKp~NILl~~~~~vk 430 (575)
.....+... ..||||||++|+++...... ...++...+..++.|++.+|.+||+ +||+||||||+|||++ ++.++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 443333322 24899999988765443222 3567888999999999999999999 9999999999999999 88999
Q ss_pred Eeecccceeccc
Q 008171 431 VADFGVARVKAQ 442 (575)
Q Consensus 431 L~DFG~a~~~~~ 442 (575)
|+|||++.....
T Consensus 158 liDFG~a~~~~~ 169 (190)
T cd05145 158 IIDVSQAVELDH 169 (190)
T ss_pred EEEcccceecCC
Confidence 999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-21 Score=195.42 Aligned_cols=232 Identities=17% Similarity=0.278 Sum_probs=151.9
Q ss_pred ceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCC----------CCceEEEeee-
Q 008171 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRH----------KNVVQFIGAC- 358 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~H----------pnIv~l~~~~- 358 (575)
.+..++.||.|+++.||++++. ++.+|+|+...... .....+.+.+|......+.+ -.++.-++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 5778899999999999999985 58899998765442 22345667777655555332 1122111111
Q ss_pred -----------cCCC-----CceeEEEeccCCchhhhhhhcc---C---cCChHHHHHHHHHHHHHHHHHHHCCceeccc
Q 008171 359 -----------TKPP-----SLCIVTEFMSGGSVYDYLHKLK---G---VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416 (575)
Q Consensus 359 -----------~~~~-----~l~lV~E~~~ggsL~d~l~~~~---~---~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDL 416 (575)
.+.. +.+++|+-+ -++|.+++.... . .+.......+..|+++.+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1111 347788888 568888764321 1 1223334556789999999999999999999
Q ss_pred CCCCEEecCCCcEEEeecccceecccCCccccCCCCCCccCcccccC--------CCCCchHHHHHHHHHHHHHHcCCCC
Q 008171 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH--------KPYDHKADVFSFGIVLWELLTGKLP 488 (575)
Q Consensus 417 Kp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~--------~~~s~ksDVwSlGviL~eLltG~~P 488 (575)
+|+|++++.+|.++|+||+........... ...+..|.+||.... -.++.+.|.|+||+++|.|.||..|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 999999999999999999988655543222 445678999998743 2578899999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 008171 489 YEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 533 (575)
Q Consensus 489 f~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~R 533 (575)
|....+...... .+. ... ++|+.++.||+.+|+.||.+|
T Consensus 250 f~~~~~~~~~~~----~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 250 FGLSSPEADPEW----DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TCCCGGGSTSGG----GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCccccccc----cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 987654322111 122 233 888999999999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=180.83 Aligned_cols=183 Identities=14% Similarity=0.126 Sum_probs=140.8
Q ss_pred eeeeeeecCceEEEEEEECCccEEEEEecCCCCChH--HHHHHHHHHHHHHhcCC-CCceEEEeeecCCCCceeEEEecc
Q 008171 296 FGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD--MQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSLCIVTEFMS 372 (575)
Q Consensus 296 i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~--~~~~~~~Ev~iL~~L~H-pnIv~l~~~~~~~~~l~lV~E~~~ 372 (575)
....|++|+||+||.+...+.+++.+.+........ ....+.+|+.+|++|.| ++|++++++ ...|++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 346899999999999888888888887775433211 12357899999999964 889999886 34699999999
Q ss_pred CCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceeccc-CCCCEEecCCCcEEEeecccceecccCCcc-----
Q 008171 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL-KAANLLMDENEVVKVADFGVARVKAQSGVM----- 446 (575)
Q Consensus 373 ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDL-Kp~NILl~~~~~vkL~DFG~a~~~~~~~~~----- 446 (575)
|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~ 153 (218)
T PRK12274 82 GAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLA 153 (218)
T ss_pred CccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHH
Confidence 9998754421 1 1357789999999999999999999 799999999999999999999855543310
Q ss_pred ---------ccCCCCCCccCcccccCC-CCC-chHHHHHHHHHHHHHHcCCCCCC
Q 008171 447 ---------TAETGTYRWMAPEVIEHK-PYD-HKADVFSFGIVLWELLTGKLPYE 490 (575)
Q Consensus 447 ---------~~~~Gt~~y~APE~i~~~-~~s-~ksDVwSlGviL~eLltG~~Pf~ 490 (575)
.-...++.|++|+...-. ..+ ...++++.|+-+|.++|+..|+-
T Consensus 154 ~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 154 REDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 011357788888765322 344 56788899999999999887763
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=220.77 Aligned_cols=239 Identities=20% Similarity=0.269 Sum_probs=181.5
Q ss_pred ceeeeeeeeecCceEEEEEEECCccEEEEEecCCC--CChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPER--INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~--~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
++...+.||++.|=.|.++++....|+||++-... .+-....+-+.|++ ....++||++++.-+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 67888999999999999999877779999975432 22222333344555 5667899999999988888888999999
Q ss_pred ccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc----CCcc
Q 008171 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ----SGVM 446 (575)
Q Consensus 371 ~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~----~~~~ 446 (575)
. ..+|+|.+.. +.-+.+-....|+.|++.||.-+|..||+|+|||.+||||+.-+.+.|+||..-+..-- +...
T Consensus 103 v-khnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf 180 (1431)
T KOG1240|consen 103 V-KHNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF 180 (1431)
T ss_pred H-hhhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence 9 5699999976 45567778888999999999999999999999999999999999999999987642211 1122
Q ss_pred ccC----CCCCCccCcccccCC----------C-CCchHHHHHHHHHHHHHHc-CCCCCCCCCHH-------HHHHHHHh
Q 008171 447 TAE----TGTYRWMAPEVIEHK----------P-YDHKADVFSFGIVLWELLT-GKLPYEYLTPL-------QAAVGVVQ 503 (575)
Q Consensus 447 ~~~----~Gt~~y~APE~i~~~----------~-~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~-------~~~~~v~~ 503 (575)
+.. ..-.+|.|||.+... + .+++-||||+||+++||++ |++||....-. ......+.
T Consensus 181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le 260 (1431)
T KOG1240|consen 181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLE 260 (1431)
T ss_pred eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHH
Confidence 222 234579999998432 2 5678999999999999998 89888521100 00011111
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 008171 504 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 504 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~ 542 (575)
+ + ....++++|..|++.||.+|.++++.++.
T Consensus 261 ~-----I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 261 K-----I---EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred h-----C---cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1 1 12379999999999999999999999876
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-19 Score=208.29 Aligned_cols=249 Identities=20% Similarity=0.295 Sum_probs=192.2
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEE-CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC---CCCceEEEeeecC
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQFIGACTK 360 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~-~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~---HpnIv~l~~~~~~ 360 (575)
..+++....|.|.+.||.|+||.||+|+. .++.||+|+-++....+- .=-.+++.+|+ -+.|..+..+..-
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf-----YI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF-----YICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee-----eehHHHHHhhchhhhcchHHHHHHHcc
Confidence 46788899999999999999999999976 467899999887654432 22233444444 2456666666666
Q ss_pred CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC-------CCcEEEee
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-------NEVVKVAD 433 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~-------~~~vkL~D 433 (575)
.+..++|+||.+-|+|.++++. .+.+++..+..|+.||+.-++.||..+|||+||||+|+||.. ...++|+|
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred CCcceeeeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 6778999999999999999984 677899999999999999999999999999999999999952 34699999
Q ss_pred cccceec---ccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC----
Q 008171 434 FGVARVK---AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL---- 506 (575)
Q Consensus 434 FG~a~~~---~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~---- 506 (575)
||.+..+ ..........+|-.+-.+|+..+++++..+|.|.|+.+++-||.|+. .. +..+.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y-----------~q-~~~g~~~~~ 912 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY-----------ME-VKNGSSWMV 912 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH-----------HH-hcCCcceec
Confidence 9998533 23334566778999999999999999999999999999999999962 11 11111
Q ss_pred CCCCCCCCcH-HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 507 RPTIPKNSQP-KLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 507 ~~~~p~~~~~-~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
...++..... -+.+++..+|+.|-..=|...+|...|+.++.+-.
T Consensus 913 ~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~ 958 (974)
T KOG1166|consen 913 KTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHF 958 (974)
T ss_pred cccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHH
Confidence 1112333322 36678889998555555888888888888886554
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-19 Score=174.36 Aligned_cols=136 Identities=23% Similarity=0.399 Sum_probs=115.4
Q ss_pred eeeeecCceEEEEEEECCccEEEEEecCCCCChH------HHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEec
Q 008171 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD------MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~------~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~ 371 (575)
+.||+|++|.||+|.+.+..|++|+......... ....+.+|+.++..+.|++|+....++......++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5799999999999999999999998775443211 1245788999999999999877666666667889999999
Q ss_pred cCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 372 ~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
+|++|.+++.... . ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||.++.
T Consensus 82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999986521 2 7888999999999999999999999999999999 78899999998853
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-20 Score=209.69 Aligned_cols=203 Identities=28% Similarity=0.414 Sum_probs=155.8
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
.+|..++.|-.|+||.||..++. .+.+|+|+-+... +++- |+.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l--------ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL--------ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccch--------hhhc--cccccCCccee-----------------
Confidence 56788899999999999999765 6778886533211 1110 22222233332
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-----
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG----- 444 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~----- 444 (575)
|+....++. -++++... +.+++|||+.||+|||+||+|++|+.-|++|+.|||+++......
T Consensus 136 ----gDc~tllk~-~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 ----GDCATLLKN-IGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred ----chhhhhccc-CCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 444444443 34555443 778999999999999999999999999999999999986432211
Q ss_pred -----------ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 008171 445 -----------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK-GLRPTIPK 512 (575)
Q Consensus 445 -----------~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~-~~~~~~p~ 512 (575)
.....+||+.|.|||++..+.|+...|+|++|+|+||.+-|+.||.+.++.+.+..++.. ..+++-..
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~de 282 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDE 282 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCc
Confidence 011237999999999999999999999999999999999999999999999888766643 34566677
Q ss_pred CCcHHHHHHHHHhhhcCCCCCC
Q 008171 513 NSQPKLAELLERCWQQDPALRP 534 (575)
Q Consensus 513 ~~~~~l~~Li~~cL~~dP~~RP 534 (575)
..+++++++|.++|+.+|..|-
T Consensus 283 a~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 283 ALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred CCCHHHHHHHHHHHHhChHhhc
Confidence 7899999999999999999994
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2e-19 Score=194.00 Aligned_cols=206 Identities=32% Similarity=0.573 Sum_probs=167.2
Q ss_pred HHhcCCCCceEEEeeecCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCc-eecccCCCCE
Q 008171 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI-IHRDLKAANL 421 (575)
Q Consensus 343 L~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gI-iHrDLKp~NI 421 (575)
|+.+.|.|+.+|+|.+.+.+..++|.+||+.|+|.|.+....-.+++.....++++|+.||.|||.--| .|+.++..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 467899999999999999999999999999999999998866778888888899999999999998866 9999999999
Q ss_pred EecCCCcEEEeecccceecccC---CccccCCCCCCccCcccccCCC-------CCchHHHHHHHHHHHHHHcCCCCCCC
Q 008171 422 LMDENEVVKVADFGVARVKAQS---GVMTAETGTYRWMAPEVIEHKP-------YDHKADVFSFGIVLWELLTGKLPYEY 491 (575)
Q Consensus 422 Ll~~~~~vkL~DFG~a~~~~~~---~~~~~~~Gt~~y~APE~i~~~~-------~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (575)
+++....+||+|||+....... .......-...|.|||.+.... .+.+.|+||||++++|+++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 9999999999999998766421 1111222456799999996542 45679999999999999999999975
Q ss_pred ----CCHHHHHHHHHh---cCCCCCCCC--CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 492 ----LTPLQAAVGVVQ---KGLRPTIPK--NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 492 ----~~~~~~~~~v~~---~~~~~~~p~--~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
..+.+....+.. ..++|.+.. ..++++..+++.||..+|..||++.++...++.+..
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 233344444332 224555542 456689999999999999999999999888877665
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.9e-19 Score=172.42 Aligned_cols=134 Identities=16% Similarity=0.229 Sum_probs=103.8
Q ss_pred eeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-----CCCCceEEEeeecCCC---Cce-eE
Q 008171 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-----RHKNVVQFIGACTKPP---SLC-IV 367 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-----~HpnIv~l~~~~~~~~---~l~-lV 367 (575)
.+.||+|+||.||.-..... .+||++..... ...+.+.+|+.+++.+ .||||++++|++.++. .++ +|
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEECCCCcC-eEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 46899999999997332333 47888875432 2346789999999999 5799999999998763 333 78
Q ss_pred EEe--ccCCchhhhhhhccCcCChHHHHHHHHHHHHHH-HHHHHCCceecccCCCCEEecC----CCcEEEeecccc
Q 008171 368 TEF--MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM-NYLHQNNIIHRDLKAANLLMDE----NEVVKVADFGVA 437 (575)
Q Consensus 368 ~E~--~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL-~yLH~~gIiHrDLKp~NILl~~----~~~vkL~DFG~a 437 (575)
||| +.+++|.+++.+ +.+++. ..++.|++.++ .|||+++|+||||||+|||++. ++.++|+||+.+
T Consensus 84 ~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999 447999999965 346655 35677888777 9999999999999999999974 337999995444
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=167.41 Aligned_cols=132 Identities=20% Similarity=0.362 Sum_probs=107.9
Q ss_pred eeeecCceEEEEEEECCccEEEEEecCCCCCh------HHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEecc
Q 008171 299 KVASGSYGDLYRGTYCSQDVAIKVLKPERINS------DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (575)
Q Consensus 299 ~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~------~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ 372 (575)
.||+|+||.||+|.+.+..|++|+........ .....+.+|+.+++.+.|+++.....++......++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 37999999999999999999999976432211 113567889999999998875544444445566799999999
Q ss_pred CCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 373 ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
|++|.+++..... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||+++.
T Consensus 81 g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988754211 7899999999999999999999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.2e-18 Score=171.47 Aligned_cols=143 Identities=16% Similarity=0.187 Sum_probs=112.2
Q ss_pred ceeeeeeeeecCceEEEEEE---ECCccEEEEEecCCCCCh----------------------HHHHHHHHHHHHHHhcC
Q 008171 293 HLKFGSKVASGSYGDLYRGT---YCSQDVAIKVLKPERINS----------------------DMQKEFAQEVFIMRKVR 347 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~---~~~~~VAvKvl~~~~~~~----------------------~~~~~~~~Ev~iL~~L~ 347 (575)
-|.+.+.||+|+||.||+|. ..++.||||+++...... .....+..|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778899999999999998 367899999987543210 01234668999999998
Q ss_pred CC--CceEEEeeecCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCC-ceecccCCCCEEec
Q 008171 348 HK--NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN-IIHRDLKAANLLMD 424 (575)
Q Consensus 348 Hp--nIv~l~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~g-IiHrDLKp~NILl~ 424 (575)
+. .++++++. ...++||||++|.+|...... ...+....+..++.||+.++.+||+.| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 63 34555543 235899999999888776533 345666677899999999999999999 99999999999999
Q ss_pred CCCcEEEeecccceecc
Q 008171 425 ENEVVKVADFGVARVKA 441 (575)
Q Consensus 425 ~~~~vkL~DFG~a~~~~ 441 (575)
++.++|+|||.+....
T Consensus 184 -~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 -DGKVVIIDVSQSVELD 199 (237)
T ss_pred -CCCEEEEEChhhhccC
Confidence 8899999999986433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.3e-19 Score=190.58 Aligned_cols=168 Identities=26% Similarity=0.465 Sum_probs=136.7
Q ss_pred CCceeEEEeccCCchhhhhhhc--cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKL--KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~--~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
..+||.|++|.-.+|.+|+... ....++...+.++.|++.|++| +|.+|+|+||.||++..+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 3589999999999999999643 2456778889999999999999 9999999999999999999999999999976
Q ss_pred cccCC-------ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 008171 440 KAQSG-------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIP 511 (575)
Q Consensus 440 ~~~~~-------~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p 511 (575)
..... .++..+||..||+||.+.+..|+.|+|||+||++|+||+. =..+++ .......++.+..|+..
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----r~~t~~d~r~g~ip~~~ 481 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----RIATLTDIRDGIIPPEF 481 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----HHHhhhhhhcCCCChHH
Confidence 66554 5677899999999999999999999999999999999998 222222 22223334555444333
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCH
Q 008171 512 KNSQPKLAELLERCWQQDPALRPDF 536 (575)
Q Consensus 512 ~~~~~~l~~Li~~cL~~dP~~RPs~ 536 (575)
..-.|+-+.|+.+++.+.|.+||++
T Consensus 482 ~~d~p~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 482 LQDYPEEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred hhcCcHHHHHHHHhcCCCcccCchH
Confidence 3445677899999999999999943
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.8e-18 Score=187.49 Aligned_cols=136 Identities=21% Similarity=0.335 Sum_probs=114.1
Q ss_pred eeeeeeeeecCceEEEEEEECCccEEEEEecCCCCC-h-----HHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 294 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN-S-----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~-~-----~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
|...++||+|+||+||+|.+.+..+++|+....... . .....+.+|+.+++.++|++++..+.++......++|
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 345789999999999999998888777764332211 1 1235688999999999999998887777777778999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
|||++|++|.+++. ....++.+++.+|.|||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 415 ~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 415 MEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999885 346789999999999999999999999999999 577899999999964
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-17 Score=160.79 Aligned_cols=137 Identities=19% Similarity=0.237 Sum_probs=108.2
Q ss_pred eeeeeeeeecCceEEEEEEE-CCccEEEEEecCCCCCh--------------------HHHHHHHHHHHHHHhcCCC--C
Q 008171 294 LKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINS--------------------DMQKEFAQEVFIMRKVRHK--N 350 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~-~~~~VAvKvl~~~~~~~--------------------~~~~~~~~Ev~iL~~L~Hp--n 350 (575)
|.+.+.||.|+||.||++.. .++.||||++....... .....+..|..++.++.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 66678999999999999987 57889999976543110 0112367799999999887 4
Q ss_pred ceEEEeeecCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEE
Q 008171 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 430 (575)
Q Consensus 351 Iv~l~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vk 430 (575)
++..++. ...++||||++|++|...... .....++.+|+.++.++|+.||+|+||||+||+++.++.++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 5555543 345899999999998765431 34567889999999999999999999999999999999999
Q ss_pred Eeecccceecc
Q 008171 431 VADFGVARVKA 441 (575)
Q Consensus 431 L~DFG~a~~~~ 441 (575)
|+|||.+....
T Consensus 166 liDfg~~~~~~ 176 (198)
T cd05144 166 IIDWPQMVSTD 176 (198)
T ss_pred EEECCccccCC
Confidence 99999995443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=151.07 Aligned_cols=138 Identities=21% Similarity=0.286 Sum_probs=100.4
Q ss_pred eeeeeecCceEEEEEEEC-CccEEEEEecCCCCChHHHHH----------------------HHHHHHHHHhcCCCC--c
Q 008171 297 GSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKE----------------------FAQEVFIMRKVRHKN--V 351 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~----------------------~~~Ev~iL~~L~Hpn--I 351 (575)
++.||+|+||.||+|... ++.||||+++........... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 568999999999999876 788999998764322211111 135666666665443 4
Q ss_pred eEEEeeecCCCCceeEEEeccCCchhh-hhhhccCcCChHHHHHHHHHHHHHHHHHHH-CCceecccCCCCEEecCCCcE
Q 008171 352 VQFIGACTKPPSLCIVTEFMSGGSVYD-YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVV 429 (575)
Q Consensus 352 v~l~~~~~~~~~l~lV~E~~~ggsL~d-~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~gIiHrDLKp~NILl~~~~~v 429 (575)
.+.++.. ..++||||++|+.+.. .+..... ...+..++.+++.++.++|. .||+|+||||+||+++ ++.+
T Consensus 82 ~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~~---~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 82 PKPIDLN----RHVLVMEFIGGDGIPAPRLKDVRL---LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CceEecC----CCEEEEEEeCCCCccChhhhhhhh---cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 5555432 3699999999854432 1221111 16678899999999999999 9999999999999999 8899
Q ss_pred EEeecccceeccc
Q 008171 430 KVADFGVARVKAQ 442 (575)
Q Consensus 430 kL~DFG~a~~~~~ 442 (575)
+|+|||.+.....
T Consensus 154 ~liDfg~a~~~~~ 166 (187)
T cd05119 154 YIIDVPQAVEIDH 166 (187)
T ss_pred EEEECcccccccC
Confidence 9999999964443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.4e-16 Score=140.26 Aligned_cols=132 Identities=17% Similarity=0.219 Sum_probs=114.2
Q ss_pred eeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CCceEEEeeecCCCCceeEEEeccC
Q 008171 296 FGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 296 i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~H--pnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
+.+.||.|.++.||+++..+..+++|+...... ...+.+|+.+++.+++ .++++++.+....+..+++|||+.|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 357899999999999999888999999875432 4568899999999987 5899999998888889999999988
Q ss_pred CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHC---CceecccCCCCEEecCCCcEEEeeccccee
Q 008171 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN---NIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 374 gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~---gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
+.+..+ +......++.+++.+|.+||.. +++|+|++|+||++++.+.++++|||.++.
T Consensus 78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 877654 4456677899999999999985 799999999999999989999999998853
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=1e-15 Score=153.56 Aligned_cols=136 Identities=14% Similarity=0.156 Sum_probs=106.6
Q ss_pred eeee-ecCceEEEEEEECCccEEEEEecCCCC-----------ChHHHHHHHHHHHHHHhcCCCCc--eEEEeeecCCC-
Q 008171 298 SKVA-SGSYGDLYRGTYCSQDVAIKVLKPERI-----------NSDMQKEFAQEVFIMRKVRHKNV--VQFIGACTKPP- 362 (575)
Q Consensus 298 ~~LG-~G~fG~Vy~~~~~~~~VAvKvl~~~~~-----------~~~~~~~~~~Ev~iL~~L~HpnI--v~l~~~~~~~~- 362 (575)
..|| .|+.|+||.+...+..++||.+..... .......+.+|+.++.+|.|++| +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4677 888999999988899999998864321 11223567889999999998875 67776643322
Q ss_pred C---ceeEEEeccC-CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccce
Q 008171 363 S---LCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 363 ~---l~lV~E~~~g-gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
. .++|||+++| .+|.+++.. ..++.. .+.+|+.+|.+||++||+||||||.|||++.++.++|+|||.++
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 2 2599999997 689888754 344443 35789999999999999999999999999998999999999985
Q ss_pred e
Q 008171 439 V 439 (575)
Q Consensus 439 ~ 439 (575)
.
T Consensus 191 ~ 191 (239)
T PRK01723 191 L 191 (239)
T ss_pred c
Confidence 4
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1e-17 Score=187.94 Aligned_cols=249 Identities=25% Similarity=0.413 Sum_probs=197.8
Q ss_pred CceeeeeeeeecCceEEEEEEECC---ccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCCCceeE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYCS---QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~~---~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~l~lV 367 (575)
..|.+.+-||+|+|+.|-.....+ ..+|+|.+...............|..+-+.+. |+|++.+++........+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456677789999999988775533 33666666554433444555666888888887 99999999999999999999
Q ss_pred EEeccCCchhhhh-hhccCcCChHHHHHHHHHHHHHHHHHH-HCCceecccCCCCEEecCCC-cEEEeecccceeccc-C
Q 008171 368 TEFMSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQ-S 443 (575)
Q Consensus 368 ~E~~~ggsL~d~l-~~~~~~l~~~~~~~i~~qI~~aL~yLH-~~gIiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~-~ 443 (575)
++|..|+++.+.+ .......+...+-.++.|+..++.|+| ..++.|+|+||+|.+++..+ .++++|||+|..... .
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 9999999999998 443336777888899999999999999 99999999999999999999 999999999986655 3
Q ss_pred C---ccccCCC-CCCccCcccccCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHhcC--CCCCCCCCCc
Q 008171 444 G---VMTAETG-TYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA-VGVVQKG--LRPTIPKNSQ 515 (575)
Q Consensus 444 ~---~~~~~~G-t~~y~APE~i~~~~-~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~-~~v~~~~--~~~~~p~~~~ 515 (575)
+ .....+| ++.|+|||...+.. .....|+||.|+++.-+++|..||......... ....... .........+
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSIS 259 (601)
T ss_pred CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCC
Confidence 3 3345578 99999999998854 456789999999999999999999765443322 1112211 1244556788
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHH
Q 008171 516 PKLAELLERCWQQDPALRPDFSEII 540 (575)
Q Consensus 516 ~~l~~Li~~cL~~dP~~RPs~~ell 540 (575)
....+++.+++..+|..|.+.+++.
T Consensus 260 ~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 260 DQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred hhhhhcccccccCCchhcccccccc
Confidence 8999999999999999999988874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.6e-14 Score=156.41 Aligned_cols=246 Identities=23% Similarity=0.289 Sum_probs=188.4
Q ss_pred Cceeeeeeeee--cCceEEEEEEE----CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCCCc
Q 008171 292 KHLKFGSKVAS--GSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSL 364 (575)
Q Consensus 292 ~~~~i~~~LG~--G~fG~Vy~~~~----~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~l 364 (575)
..+.+.+.+|+ |.+|.||.+.. .+..+|+|.-+...........=.+|+...++++ |+|.++.+..+...+.+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45666778999 99999998865 4566888874433222222233455777777775 89999999999999999
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHH----HHHHHHHCCceecccCCCCEEecCC-CcEEEeeccccee
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK----GMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARV 439 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~----aL~yLH~~gIiHrDLKp~NILl~~~-~~vkL~DFG~a~~ 439 (575)
|+-+|++ |.+|..+.+.....++...++.+..+... |+.++|+.+|+|-|+||.||++..+ ...+++|||+...
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~ 272 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK 272 (524)
T ss_pred eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence 9999999 68999998886677899999999999999 9999999999999999999999999 8899999999987
Q ss_pred cccCCc-cc-----cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-CCCCCCC
Q 008171 440 KAQSGV-MT-----AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPK 512 (575)
Q Consensus 440 ~~~~~~-~~-----~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~-~~~~~p~ 512 (575)
...... .. ...|...|++||..++. ++.+.|+|++|.++.+..++..+........+. ..++. ...++..
T Consensus 273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~--~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWS--QLRQGYIPLEFCE 349 (524)
T ss_pred ccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcc--ccccccCchhhhc
Confidence 666541 11 12578899999998665 788999999999999998876555332111111 01111 2223444
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 513 NSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 513 ~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
..+.++...+..|+..+|..|+++..++.
T Consensus 350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 350 GGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 55677888999999999999999887654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.9e-13 Score=146.26 Aligned_cols=139 Identities=17% Similarity=0.274 Sum_probs=99.5
Q ss_pred eeeeecCceEEEEEEE-CCccEEEEEecCCCCCh---H-------------------------H----------HHHHHH
Q 008171 298 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERINS---D-------------------------M----------QKEFAQ 338 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~-~~~~VAvKvl~~~~~~~---~-------------------------~----------~~~~~~ 338 (575)
+.||+|++|.||+|+. .|+.||||+.++..... + . .-.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 4799999999999987 68899999987642110 0 0 012556
Q ss_pred HHHHHHhcC-----CCCc--eEEEeeecCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHH-HHHHHHHCC
Q 008171 339 EVFIMRKVR-----HKNV--VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK-GMNYLHQNN 410 (575)
Q Consensus 339 Ev~iL~~L~-----HpnI--v~l~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~-aL~yLH~~g 410 (575)
|+..+.+++ +++| .+++. ......++||||++|++|.++........ ....++.+++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence 676666663 2332 23332 22334699999999999998875422222 23456666666 468899999
Q ss_pred ceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 411 IIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 411 IiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
++|+|++|.||+++.++.++|+|||++....
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.42 E-value=9e-13 Score=123.80 Aligned_cols=127 Identities=17% Similarity=0.193 Sum_probs=98.2
Q ss_pred eeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCc-eEEEeeecCCCCceeEEEeccCCc
Q 008171 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVTEFMSGGS 375 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnI-v~l~~~~~~~~~l~lV~E~~~ggs 375 (575)
.+.|+.|.++.||+++..++.|++|+...... ....+..|+.+++.+.+.++ ++++.... ...++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 35789999999999999999999999765421 12346789999999876554 44555443 34589999999988
Q ss_pred hhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCc-----eecccCCCCEEecCCCcEEEeecccce
Q 008171 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI-----IHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 376 L~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gI-----iHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
+.+.. . ....++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 78 l~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 76531 1 112456799999999999985 9999999999999 6689999999884
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=8.8e-12 Score=137.89 Aligned_cols=141 Identities=18% Similarity=0.263 Sum_probs=91.5
Q ss_pred ceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC---------------------------C-h----HHHH----
Q 008171 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI---------------------------N-S----DMQK---- 334 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~---------------------------~-~----~~~~---- 334 (575)
.|.. +.||+|++|.||+|+.. |+.||||++++... + . +..+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3444 68999999999999873 78999999986521 0 0 1111
Q ss_pred --HHHHHHHHHHhcC----CCCceEEEeee-cCCCCceeEEEeccCCchhhhhhhc-cC----cCChHHHHHHHHHHHHH
Q 008171 335 --EFAQEVFIMRKVR----HKNVVQFIGAC-TKPPSLCIVTEFMSGGSVYDYLHKL-KG----VFKLPSLLKVAIDVSKG 402 (575)
Q Consensus 335 --~~~~Ev~iL~~L~----HpnIv~l~~~~-~~~~~l~lV~E~~~ggsL~d~l~~~-~~----~l~~~~~~~i~~qI~~a 402 (575)
++.+|+..+.+++ +.+.+.+-.++ .-....+|||||+.|+.+.++-.-. .+ .+....+..++.||+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-- 277 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-- 277 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence 2444555555443 22222222222 1133568999999999998753211 12 233333444444443
Q ss_pred HHHHHHCCceecccCCCCEEecCCC----cEEEeecccceecc
Q 008171 403 MNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKA 441 (575)
Q Consensus 403 L~yLH~~gIiHrDLKp~NILl~~~~----~vkL~DFG~a~~~~ 441 (575)
..|++|+|+||.||+++.++ .++++|||++....
T Consensus 278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 58999999999999999888 99999999996553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.9e-13 Score=151.70 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=192.0
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCC
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~-~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 363 (575)
+....+.+.+.+-+-+|+++.++.++-. +...++|+..... ......+....+-.++-..++|-++.....+.-...
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 4556677778888999999999987643 3345555543221 111123334445555555567878877766666677
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc-c
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-Q 442 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~-~ 442 (575)
++++++|+.|++|...+++ -+..+......++..+..+++|||...+.|+|++|.|+|+..++..++.|||...... .
T Consensus 879 ~~L~~~~~~~~~~~Skl~~-~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHN-SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred cchhhHHhccCCchhhhhc-CCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence 8999999999999999987 3456666777788899999999999999999999999999999999999998432100 0
Q ss_pred --------------------C-----------CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 008171 443 --------------------S-----------GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY 491 (575)
Q Consensus 443 --------------------~-----------~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~ 491 (575)
. .......||+.|.+||...+......+|+|++|++++|.++|..||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 001233689999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHhcC-CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 008171 492 LTPLQAAVGVVQKG-LRPTIPKNSQPKLAELLERCWQQDPALRPDFS 537 (575)
Q Consensus 492 ~~~~~~~~~v~~~~-~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ 537 (575)
..+.+....+.... -++..+...+++..+++.+.+..+|.+|-.+.
T Consensus 1038 ~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99998887665433 34567778899999999999999999997655
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.6e-11 Score=134.56 Aligned_cols=162 Identities=15% Similarity=0.251 Sum_probs=125.0
Q ss_pred CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCCchhhhhhhccCcCChHHHH
Q 008171 314 CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 393 (575)
Q Consensus 314 ~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~ 393 (575)
.+.+|.|++.+.... .......+-++.|+.++||||++++..+...+.+|||+|.+. .|..++.. +....+.
T Consensus 36 ~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKEEVC 107 (690)
T ss_pred cCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHHHHH
Confidence 567788888875533 333456778889999999999999999999999999999983 56666765 3366777
Q ss_pred HHHHHHHHHHHHHH-HCCceecccCCCCEEecCCCcEEEeecccceecccCCcc-ccCCCCCCccCcccccCCCCCchHH
Q 008171 394 KVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-TAETGTYRWMAPEVIEHKPYDHKAD 471 (575)
Q Consensus 394 ~i~~qI~~aL~yLH-~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~Gt~~y~APE~i~~~~~s~ksD 471 (575)
..+.||+.||.||| ..+++|++|.-..|+++..|..||++|.++........+ ....--..|..|+.+.... -..|
T Consensus 108 ~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D 185 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSID 185 (690)
T ss_pred HHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchh
Confidence 78999999999998 668999999999999999999999999988654433211 1111122355666554333 4579
Q ss_pred HHHHHHHHHHHHcC
Q 008171 472 VFSFGIVLWELLTG 485 (575)
Q Consensus 472 VwSlGviL~eLltG 485 (575)
.|.|||++||++.|
T Consensus 186 ~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 186 SWGLGCLIEELFNG 199 (690)
T ss_pred hhhHHHHHHHHhCc
Confidence 99999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.1e-11 Score=120.19 Aligned_cols=137 Identities=17% Similarity=0.202 Sum_probs=99.9
Q ss_pred eeeeecCceEEEEEEEC--------CccEEEEEecCCCC--------------------ChHHHHHH----HHHHHHHHh
Q 008171 298 SKVASGSYGDLYRGTYC--------SQDVAIKVLKPERI--------------------NSDMQKEF----AQEVFIMRK 345 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--------~~~VAvKvl~~~~~--------------------~~~~~~~~----~~Ev~iL~~ 345 (575)
..||.|--+.||.|... +..+|||+.+.... .......+ .+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999754 26799999863211 01112223 379999999
Q ss_pred cCC--CCceEEEeeecCCCCceeEEEeccCCchhh-hhhhccCcCChHHHHHHHHHHHHHHHHH-HHCCceecccCCCCE
Q 008171 346 VRH--KNVVQFIGACTKPPSLCIVTEFMSGGSVYD-YLHKLKGVFKLPSLLKVAIDVSKGMNYL-HQNNIIHRDLKAANL 421 (575)
Q Consensus 346 L~H--pnIv~l~~~~~~~~~l~lV~E~~~ggsL~d-~l~~~~~~l~~~~~~~i~~qI~~aL~yL-H~~gIiHrDLKp~NI 421 (575)
+.. -++++++++ ...+|||||+.+..+.. .+.. ..++...+..+..+++.+|..| |+.||+|+||++.||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 964 467777765 35689999997653322 2222 2345556777889999999999 899999999999999
Q ss_pred EecCCCcEEEeecccceecc
Q 008171 422 LMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 422 Ll~~~~~vkL~DFG~a~~~~ 441 (575)
|++ ++.+.|+|||.+....
T Consensus 157 L~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEE-CCcEEEEECCCceeCC
Confidence 997 4679999999886544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.4e-11 Score=113.27 Aligned_cols=134 Identities=22% Similarity=0.347 Sum_probs=104.2
Q ss_pred eeeeecCceEEEEEEECCccEEEEEecCCCC-ChHH-----HHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEec
Q 008171 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERI-NSDM-----QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~-~~~~-----~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~ 371 (575)
..+++|+-+.+|.+.+.+.++++|.=.++.. .+.. .....+|++++.+++--.|.--+=+..+++...|+|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 3578999999999999888888886443332 2221 245778999999998655544444455666788999999
Q ss_pred cCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 372 ~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
+|..|.+.+... ...++..+-.-+.-||..||+|+||.++||++..++ +.++|||++...
T Consensus 82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999888763 245677788888899999999999999999998765 999999999643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.9e-12 Score=137.24 Aligned_cols=243 Identities=21% Similarity=0.220 Sum_probs=180.8
Q ss_pred CCceeeeeeeeecCceEEEEEEEC---CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCCCcee
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~---~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~l~l 366 (575)
..+|..+.+||.|.|+.|+..... +-.|++|.+............-..|+.+...+. |.+++..+..|....+.||
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 356788899999999999987653 345888887765544433344556777777665 8899998888888888899
Q ss_pred EEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC-CcEEEeecccceecccCCc
Q 008171 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSGV 445 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~-~~vkL~DFG~a~~~~~~~~ 445 (575)
--|||.++++...+ .....+.+...+++..|++.++.++|+..++|+|+||+||++..+ +..++.|||......-. .
T Consensus 344 p~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~-~ 421 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS-S 421 (524)
T ss_pred chhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee-c
Confidence 99999999887766 335567888899999999999999999999999999999999886 78899999988642211 1
Q ss_pred cccCCCCCCc-cCcccccCCCCCchHHHHHHHHHHHHHHcCCC-CCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 008171 446 MTAETGTYRW-MAPEVIEHKPYDHKADVFSFGIVLWELLTGKL-PYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 523 (575)
Q Consensus 446 ~~~~~Gt~~y-~APE~i~~~~~s~ksDVwSlGviL~eLltG~~-Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~ 523 (575)
.....++..| .+|......++..+.|+||||..+.+.+++.. ++.+..- ..+..+..+..+... ..+..+.+
T Consensus 422 ~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-----~~i~~~~~p~~~~~~-~~~q~~~k 495 (524)
T KOG0601|consen 422 GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-----LTIRSGDTPNLPGLK-LQLQVLLK 495 (524)
T ss_pred ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc-----eeeecccccCCCchH-Hhhhhhhh
Confidence 1122233344 35556677788899999999999999999763 3322111 112333334444443 78889999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 008171 524 RCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 524 ~cL~~dP~~RPs~~ell~ 541 (575)
.+...++..||.+-++..
T Consensus 496 v~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 496 VMINPDRKRRPSAVELSL 513 (524)
T ss_pred hhcCCccccchhhhhhcc
Confidence 999999999999887654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=9.6e-12 Score=125.84 Aligned_cols=191 Identities=20% Similarity=0.329 Sum_probs=138.2
Q ss_pred HHHhcCCCCceEEEeeecCC-----CCceeEEEeccCCchhhhhhhc---cCcCChHHHHHHHHHHHHHHHHHHHC--Cc
Q 008171 342 IMRKVRHKNVVQFIGACTKP-----PSLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQN--NI 411 (575)
Q Consensus 342 iL~~L~HpnIv~l~~~~~~~-----~~l~lV~E~~~ggsL~d~l~~~---~~~l~~~~~~~i~~qI~~aL~yLH~~--gI 411 (575)
-|-++-|.|||+++.||.+. ....+++|||+.|+|..+|++. ...+......+|+.||+.||.|||+. -|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 34455799999999998654 3478999999999999999754 34577788889999999999999998 59
Q ss_pred eecccCCCCEEecCCCcEEEeecccce--eccc---CCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCC
Q 008171 412 IHRDLKAANLLMDENEVVKVADFGVAR--VKAQ---SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 486 (575)
Q Consensus 412 iHrDLKp~NILl~~~~~vkL~DFG~a~--~~~~---~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~ 486 (575)
+|+++..+.|++..+|-||+.---... .... .......++-++|.+||.=.....+.++|||+||....+|.-+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 999999999999999988875322111 0000 01122346778999999876667778899999999999998776
Q ss_pred CCC-CCCC---HHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 008171 487 LPY-EYLT---PLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII 540 (575)
Q Consensus 487 ~Pf-~~~~---~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell 540 (575)
.-- ...+ ..+....+ +-....+.=+.++.+|++..|..||++.+++
T Consensus 280 iq~tnseS~~~~ee~ia~~--------i~~len~lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIANV--------IIGLENGLQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred eccCCCcceeehhhhhhhh--------eeeccCccccCcCcccccCCCCCCcchhhhh
Confidence 432 1111 11111111 1111123346789999999999999999876
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.1e-10 Score=113.89 Aligned_cols=139 Identities=19% Similarity=0.288 Sum_probs=107.2
Q ss_pred eeeeecCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CCceEEEeeecCC---CCceeEEEec
Q 008171 298 SKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKP---PSLCIVTEFM 371 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~~-~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~H--pnIv~l~~~~~~~---~~l~lV~E~~ 371 (575)
+.|+.|.++.||+++..+ +.+++|+....... .....+.+|+.+++.+.+ .++++++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 578999999999998776 88999997654321 124567889999999986 3467788777654 3678999999
Q ss_pred cCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 008171 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ------------------------------------------- 408 (575)
Q Consensus 372 ~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~------------------------------------------- 408 (575)
+|.++.+.+.. ..++......++.+++++|.+||+
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99988876532 345666677777777777777773
Q ss_pred -------------CCceecccCCCCEEecC--CCcEEEeeccccee
Q 008171 409 -------------NNIIHRDLKAANLLMDE--NEVVKVADFGVARV 439 (575)
Q Consensus 409 -------------~gIiHrDLKp~NILl~~--~~~vkL~DFG~a~~ 439 (575)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24699999999999998 67789999998853
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd04928 ACT_TyrKc Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.3e-11 Score=97.14 Aligned_cols=67 Identities=67% Similarity=1.026 Sum_probs=64.6
Q ss_pred ccceeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCceeEEEEEcCCChhhHHHHHHHHHHHH
Q 008171 179 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEV 245 (575)
Q Consensus 179 ~~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ldv~vv~g~~~e~~~~l~~al~~~~ 245 (575)
|+||++.+.|+|+|+++++.+|+..||||..|.+|+|.||+.||+|+|.+|..++++.|.+++++.+
T Consensus 1 ~~eI~V~~~Dr~gLFa~iag~L~~~~LnI~~A~i~tt~dG~~LDtF~V~d~~~~~~~~~~~~~~~~~ 67 (68)
T cd04928 1 MHEITFAAGDKPKLLSQLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRGETAALGHALQKEI 67 (68)
T ss_pred CEEEEEEECCCcchHHHHHHHHHHCCCceEEEEEEEcCCCeEEEEEEEecCCccchHHHHHHHHHhh
Confidence 5799999999999999999999999999999999999999999999999999999999999998764
|
This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.1e-10 Score=108.32 Aligned_cols=144 Identities=23% Similarity=0.298 Sum_probs=108.3
Q ss_pred eeeeeecCceEEEEEEECCccEEEEEecCCCC-----Ch-HHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERI-----NS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~-----~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
...|-+|+-+.|+++.+.|+...||.=..+.. +. -...+..+|+++|.++.--.|.--.=++.+...-+|+|||
T Consensus 12 l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred ceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 45788999999999999999999886433322 11 2245688999999999755554333334555567899999
Q ss_pred ccC-Cchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC---cEEEeecccceec
Q 008171 371 MSG-GSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARVK 440 (575)
Q Consensus 371 ~~g-gsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~---~vkL~DFG~a~~~ 440 (575)
++| .++.+++.... ..........++.+|-..+.-||.++|||+||..+||++..++ .+.++|||++...
T Consensus 92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 977 47888876543 3333344478999999999999999999999999999997554 4589999998644
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.2e-09 Score=114.04 Aligned_cols=251 Identities=18% Similarity=0.303 Sum_probs=172.0
Q ss_pred eeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEee------ecCC-CCcee
Q 008171 295 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGA------CTKP-PSLCI 366 (575)
Q Consensus 295 ~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~------~~~~-~~l~l 366 (575)
..++.||+|+-+.+|-.-.-+..|| |+......... .+.+..|... .||-+-.-+.+ ..+. ....+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~-----aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQ-----AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchhhchhh-eeecCCCchHH-----HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 3457899999999996544444444 66554322111 1122333333 35533221111 1222 23678
Q ss_pred EEEeccCCc-hhhhhh-----hccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 367 VTEFMSGGS-VYDYLH-----KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 367 V~E~~~ggs-L~d~l~-----~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
+|..++|.. +..+++ .....+.|..+++.++.++.+.+.||..|..-+|+.++|+|+++++.|.|.|-..-.+.
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec
Confidence 888887753 222221 11245788899999999999999999999999999999999999999999997766655
Q ss_pred ccCCccccCCCCCCccCccccc-----CCCCCchHHHHHHHHHHHHHHcC-CCCCCCC-------CHHHHHHHH------
Q 008171 441 AQSGVMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTG-KLPYEYL-------TPLQAAVGV------ 501 (575)
Q Consensus 441 ~~~~~~~~~~Gt~~y~APE~i~-----~~~~s~ksDVwSlGviL~eLltG-~~Pf~~~-------~~~~~~~~v------ 501 (575)
.........+|...|.+||.-+ +..-+...|.|.||+++|+|+.| +.||.+. ++.++.+.-
T Consensus 168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya 247 (637)
T COG4248 168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYA 247 (637)
T ss_pred cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeec
Confidence 5555666788999999999764 44556779999999999999985 9999764 333322211
Q ss_pred --HhcCCCCC---CC-CCCcHHHHHHHHHhhhc--CCCCCCCHHHHHHHHHHHHHHhc
Q 008171 502 --VQKGLRPT---IP-KNSQPKLAELLERCWQQ--DPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 502 --~~~~~~~~---~p-~~~~~~l~~Li~~cL~~--dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
-+.++++. +| ..+++.+..|+.+|+.. ++.-||+++-++..|..+.+++.
T Consensus 248 ~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 248 SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 11122221 12 34678999999999974 46789999999999999888775
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.3e-09 Score=109.33 Aligned_cols=135 Identities=15% Similarity=0.073 Sum_probs=98.1
Q ss_pred CceEEEEEEECCccEEEEEecCCCCCh---------HHHHHHHHHHHHHHhcCCCCc--eEEEeeecC-----CCCceeE
Q 008171 304 SYGDLYRGTYCSQDVAIKVLKPERINS---------DMQKEFAQEVFIMRKVRHKNV--VQFIGACTK-----PPSLCIV 367 (575)
Q Consensus 304 ~fG~Vy~~~~~~~~VAvKvl~~~~~~~---------~~~~~~~~Ev~iL~~L~HpnI--v~l~~~~~~-----~~~l~lV 367 (575)
....|++..+.|+.|.||......... .....+.+|...+.+|..-+| +..++++.. ....+||
T Consensus 34 ~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 34 EGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 334477888888899999775432111 001147789998888854333 334444432 2346899
Q ss_pred EEeccCC-chhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC-------CCcEEEeecccce
Q 008171 368 TEFMSGG-SVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-------NEVVKVADFGVAR 438 (575)
Q Consensus 368 ~E~~~gg-sL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~-------~~~vkL~DFG~a~ 438 (575)
||++++. +|.+++... ....+......++.+++..+.-||..||+|+|+++.|||++. +..+.|+||+.++
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999876 799888532 244556677789999999999999999999999999999975 4689999999885
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.3e-08 Score=98.39 Aligned_cols=127 Identities=20% Similarity=0.274 Sum_probs=84.2
Q ss_pred EEEEEEE-CCccEEEEEecCCCCC------------------------hHHHHHHHHHHHHHHhcCCC--CceEEEeeec
Q 008171 307 DLYRGTY-CSQDVAIKVLKPERIN------------------------SDMQKEFAQEVFIMRKVRHK--NVVQFIGACT 359 (575)
Q Consensus 307 ~Vy~~~~-~~~~VAvKvl~~~~~~------------------------~~~~~~~~~Ev~iL~~L~Hp--nIv~l~~~~~ 359 (575)
.||.|.. .+..+|||+.+....+ ........+|...|.++..- ++++++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4898876 5778999998643111 01124567899999999865 567777553
Q ss_pred CCCCceeEEEecc--CCchhhhhhhccCcCChHHHHHHHHHHHHHHHH-HHHCCceecccCCCCEEecCCCcEEEeeccc
Q 008171 360 KPPSLCIVTEFMS--GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY-LHQNNIIHRDLKAANLLMDENEVVKVADFGV 436 (575)
Q Consensus 360 ~~~~l~lV~E~~~--ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~y-LH~~gIiHrDLKp~NILl~~~~~vkL~DFG~ 436 (575)
..+|||||++ |..+..+... .++......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+|||.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~---~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV---DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC---GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ---CCEEEEEecCCCccchhhHHhc---cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3589999998 6555443322 12244566788888886655 579999999999999999987 899999998
Q ss_pred ceecc
Q 008171 437 ARVKA 441 (575)
Q Consensus 437 a~~~~ 441 (575)
+....
T Consensus 153 av~~~ 157 (188)
T PF01163_consen 153 AVDSS 157 (188)
T ss_dssp EEETT
T ss_pred ceecC
Confidence 86544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.4e-07 Score=101.20 Aligned_cols=212 Identities=17% Similarity=0.215 Sum_probs=153.4
Q ss_pred ceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeec----CCCCceeEEEeccC-Cchh
Q 008171 305 YGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT----KPPSLCIVTEFMSG-GSVY 377 (575)
Q Consensus 305 fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~----~~~~l~lV~E~~~g-gsL~ 377 (575)
..+.|++.. +|..|++|.+...+... ......-+.+++++.|+|||+|..++. ....+++|++|+++ ++|+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 356888864 57789999985433221 122344578899999999999998875 34468999999875 5788
Q ss_pred hhhhhc--------------cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 378 DYLHKL--------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 378 d~l~~~--------------~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
++.... +.+.++..+|.++.|+..||.++|+.|...+-|.|.+||++.+-+++|+..|...+...+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 765221 234678899999999999999999999999999999999998889999988887655443
Q ss_pred CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 008171 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP-YEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 522 (575)
Q Consensus 444 ~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~P-f~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li 522 (575)
. + |-+. --.+-|.=.||.+++.|.||..- +......+.... .+-..++.++++++
T Consensus 447 ~------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~--------~I~~~yS~D~rn~v 502 (655)
T KOG3741|consen 447 P------T-------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT--------RITTTYSTDLRNVV 502 (655)
T ss_pred C------C-------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHH--------HhhhhhhHHHHHHH
Confidence 2 0 1111 12357899999999999998642 333333222122 23456788999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHH
Q 008171 523 ERCWQQDPALRPDFSEIIEIL 543 (575)
Q Consensus 523 ~~cL~~dP~~RPs~~ell~~L 543 (575)
......++++ -++.+++..+
T Consensus 503 ~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 503 EYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHHhcCccc-ccHHHHHHHH
Confidence 9999988887 6777776553
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.76 E-value=4.6e-08 Score=95.95 Aligned_cols=106 Identities=17% Similarity=0.278 Sum_probs=82.8
Q ss_pred HHHHHHHHHHHhcCCCC--ceEEEeeecCC----CCceeEEEeccCC-chhhhhhhccCcCChHHHHHHHHHHHHHHHHH
Q 008171 334 KEFAQEVFIMRKVRHKN--VVQFIGACTKP----PSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406 (575)
Q Consensus 334 ~~~~~Ev~iL~~L~Hpn--Iv~l~~~~~~~----~~l~lV~E~~~gg-sL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yL 406 (575)
....+|...+..|..-+ ++..+++.... ...++|||+++|. +|.+++..... .+......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 45777888888776433 34455554432 2358999999885 79998876322 66677788999999999999
Q ss_pred HHCCceecccCCCCEEecCCC---cEEEeecccceec
Q 008171 407 HQNNIIHRDLKAANLLMDENE---VVKVADFGVARVK 440 (575)
Q Consensus 407 H~~gIiHrDLKp~NILl~~~~---~vkL~DFG~a~~~ 440 (575)
|.+||+|+|+++.|||++.++ .+.++||+-++..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999999887 8999999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=9.1e-08 Score=95.96 Aligned_cols=135 Identities=19% Similarity=0.264 Sum_probs=100.9
Q ss_pred eeeeeeeecCceEEEEEEEC-CccEEEEEecCCCCC--------------------hHHHHHHHHHHHHHHhcCCC--Cc
Q 008171 295 KFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERIN--------------------SDMQKEFAQEVFIMRKVRHK--NV 351 (575)
Q Consensus 295 ~i~~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~--------------------~~~~~~~~~Ev~iL~~L~Hp--nI 351 (575)
.++.+||-|--+.||.|... +.++|||.-+....+ .-......+|..+|.+|... .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 45678999999999999874 889999986533211 11233466799999998755 66
Q ss_pred eEEEeeecCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEE
Q 008171 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV 431 (575)
Q Consensus 352 v~l~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL 431 (575)
++.+++ +..++||||++|-.|+..- ++....-.++..|+.-+.-+-..||||+|+.+-||+++++|.+.+
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 666643 4568999999997776543 133444556666666666666999999999999999999999999
Q ss_pred eeccccee
Q 008171 432 ADFGVARV 439 (575)
Q Consensus 432 ~DFG~a~~ 439 (575)
+||--+..
T Consensus 244 IDwPQ~v~ 251 (304)
T COG0478 244 IDWPQAVP 251 (304)
T ss_pred EeCccccc
Confidence 99976643
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=8.4e-07 Score=98.03 Aligned_cols=139 Identities=18% Similarity=0.268 Sum_probs=94.7
Q ss_pred eeeeecCceEEEEEEEC-CccEEEEEecCCCCC---------------------------h-HHH----------HHHHH
Q 008171 298 SKVASGSYGDLYRGTYC-SQDVAIKVLKPERIN---------------------------S-DMQ----------KEFAQ 338 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~---------------------------~-~~~----------~~~~~ 338 (575)
+.|+.++-|.||+|+.. |+.||||+..+.-.. . ... -.+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 47899999999999986 899999998754210 0 000 12555
Q ss_pred HHHHHHhcC-----CCCc--eEEEeeecCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHH-HHHHHHCC
Q 008171 339 EVFIMRKVR-----HKNV--VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG-MNYLHQNN 410 (575)
Q Consensus 339 Ev~iL~~L~-----HpnI--v~l~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~a-L~yLH~~g 410 (575)
|+..+.+++ .++| ++++ ++-.+.-.++|||+.|-.+.+........++...+ +..++.+ +.-+=..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~--we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~i---a~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVY--WEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKEL---AELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceee--hhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHH---HHHHHHHHHHHHHhcC
Confidence 666666664 2333 2333 33334568999999999999985433344553333 3333333 23333589
Q ss_pred ceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 411 IIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 411 IiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
++|.|..|.||+++.+|.+.+.|||++....
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999986443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=9.2e-09 Score=113.62 Aligned_cols=144 Identities=19% Similarity=0.302 Sum_probs=106.4
Q ss_pred HHHHHHHHHHHHC-CceecccCCCCEEecCCCcEEEeecccceecccCCc-----c-----ccCCCCCCccCcccccCCC
Q 008171 397 IDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV-----M-----TAETGTYRWMAPEVIEHKP 465 (575)
Q Consensus 397 ~qI~~aL~yLH~~-gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-----~-----~~~~Gt~~y~APE~i~~~~ 465 (575)
.+++.||.|+|+. ++||+.|.|++|.++..+.+||+.|+++.....+.. . ........|.|||++.+..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 4455999999975 999999999999999999999999998854333111 1 1113456899999999988
Q ss_pred CCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH--hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 008171 466 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVV--QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEII 540 (575)
Q Consensus 466 ~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~--~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell 540 (575)
.+.++|+||+|+++|.++. |+.-+............. ...-....+..+++++++-|.+++..++.-||++.++.
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 8999999999999999994 555554432222111111 11112235578899999999999999999999777664
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.3e-06 Score=85.53 Aligned_cols=139 Identities=12% Similarity=0.079 Sum_probs=101.7
Q ss_pred eecCceEEEEEEECCccEEEEEecCCCC---C-hHHHHHHHHHHHHHHhcCCC--CceEEEeeec--CC--CCceeEEEe
Q 008171 301 ASGSYGDLYRGTYCSQDVAIKVLKPERI---N-SDMQKEFAQEVFIMRKVRHK--NVVQFIGACT--KP--PSLCIVTEF 370 (575)
Q Consensus 301 G~G~fG~Vy~~~~~~~~VAvKvl~~~~~---~-~~~~~~~~~Ev~iL~~L~Hp--nIv~l~~~~~--~~--~~l~lV~E~ 370 (575)
|+|+.+-|++-.+.|+.+-+|.-..... . +.-...|.+|+..+++|..- .+++.+.... .+ -.-+||+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 6688888999888888888887541110 0 22356799999999999642 2445442221 11 135799998
Q ss_pred ccC-Cchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCc--EEEeeccccee
Q 008171 371 MSG-GSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--VKVADFGVARV 439 (575)
Q Consensus 371 ~~g-gsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~--vkL~DFG~a~~ 439 (575)
+.| -+|.+++... -.+.+......++.+|+..+.-||..|+.|+|+.+.|||++.++. ++++||.-++.
T Consensus 107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 854 4788887542 234566667789999999999999999999999999999986677 99999987753
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.4e-06 Score=86.79 Aligned_cols=134 Identities=17% Similarity=0.253 Sum_probs=85.6
Q ss_pred eeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC--ceEEEeeecCCCCceeEEEeccCCc
Q 008171 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGACTKPPSLCIVTEFMSGGS 375 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~Hpn--Iv~l~~~~~~~~~l~lV~E~~~ggs 375 (575)
..||.|..+.||+. .+..+++|+..... . .....+|.++++.+..-. +.+.++++...+..++|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-D---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC-C---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 47899999999984 35678889876532 1 234678999999987543 4677888877777899999998863
Q ss_pred -hhhhh---------------------hhcc-CcCChHHHH-HHHH----------HHHH-HHHHHH----HCCceeccc
Q 008171 376 -VYDYL---------------------HKLK-GVFKLPSLL-KVAI----------DVSK-GMNYLH----QNNIIHRDL 416 (575)
Q Consensus 376 -L~d~l---------------------~~~~-~~l~~~~~~-~i~~----------qI~~-aL~yLH----~~gIiHrDL 416 (575)
+...+ +... ...+..... .+.. .+.. ...+|. ...++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 1100 011111111 1110 1111 122332 125789999
Q ss_pred CCCCEEecCCCcEEEeecccce
Q 008171 417 KAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 417 Kp~NILl~~~~~vkL~DFG~a~ 438 (575)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd04900 ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.5e-07 Score=75.37 Aligned_cols=66 Identities=35% Similarity=0.536 Sum_probs=53.3
Q ss_pred cceeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCceeEEEEEcCCChh--hHHHHHHHHHHHH
Q 008171 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYE--ETEQLRAALEKEV 245 (575)
Q Consensus 180 ~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ldv~vv~g~~~e--~~~~l~~al~~~~ 245 (575)
.||.+.+.|+|+||++++.+|++.|+||..|.+|.+.+|+.+|+|.|..+... ..++.++.+++.+
T Consensus 2 ~~i~v~~~Dr~gLl~~i~~~l~~~~l~I~~A~i~T~~~~~v~D~F~v~~~~~~~~~~~~~~~~l~~~L 69 (73)
T cd04900 2 TEVFIYTPDRPGLFARIAGALDQLGLNILDARIFTTRDGYALDTFVVLDPDGEPIGERERLARIREAL 69 (73)
T ss_pred EEEEEEecCCCCHHHHHHHHHHHCCCCeEEeEEEEeCCCeEEEEEEEECCCCCCCChHHHHHHHHHHH
Confidence 48999999999999999999999999999999999999999999999654321 1233334455444
|
This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.7e-06 Score=83.24 Aligned_cols=139 Identities=21% Similarity=0.282 Sum_probs=85.0
Q ss_pred eeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC--ceEEEeeec---CCCCceeEEEec
Q 008171 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGACT---KPPSLCIVTEFM 371 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~Hpn--Iv~l~~~~~---~~~~l~lV~E~~ 371 (575)
++.|+.|..+.||+.+..+..+++|+.... .....+.+|..+++.+.... +.+++..+. .....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 468999999999999998889999997643 34567788999998886433 556666432 223468999999
Q ss_pred cCCchhh----------------hh---hhccCc---CChHH---------HHHH------------HHHHHH-HHHHHH
Q 008171 372 SGGSVYD----------------YL---HKLKGV---FKLPS---------LLKV------------AIDVSK-GMNYLH 407 (575)
Q Consensus 372 ~ggsL~d----------------~l---~~~~~~---l~~~~---------~~~i------------~~qI~~-aL~yLH 407 (575)
+|..+.. .+ +..... +.... .... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988877 11 111000 01000 0000 111222 233333
Q ss_pred -------HCCceecccCCCCEEec-CCCcEEEeeccccee
Q 008171 408 -------QNNIIHRDLKAANLLMD-ENEVVKVADFGVARV 439 (575)
Q Consensus 408 -------~~gIiHrDLKp~NILl~-~~~~vkL~DFG~a~~ 439 (575)
...++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 24699999999999999 666678999998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.5e-06 Score=82.96 Aligned_cols=140 Identities=16% Similarity=0.184 Sum_probs=94.6
Q ss_pred eCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChH-HHHH------HHHHHHHHHhcCC---CCceEEEeee
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD-MQKE------FAQEVFIMRKVRH---KNVVQFIGAC 358 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~-~~~~------~~~Ev~iL~~L~H---pnIv~l~~~~ 358 (575)
+-..+|++.+.+-......|.+....++.+++|..+......+ .... ..+.+..+.+++. -....++-+.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4456788888888877788888888999999999876532211 1111 2234444444432 2223323222
Q ss_pred -----cCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEee
Q 008171 359 -----TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD 433 (575)
Q Consensus 359 -----~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~D 433 (575)
.-....+++|||++|..|.++.. +++ .++..|..+|.-||+.|++|+|..|.|++++.++ ++++|
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID 177 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIID 177 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEE
Confidence 22234568999999988877642 122 2456777889999999999999999999999655 99999
Q ss_pred cccce
Q 008171 434 FGVAR 438 (575)
Q Consensus 434 FG~a~ 438 (575)
|+..+
T Consensus 178 ~~~k~ 182 (229)
T PF06176_consen 178 TQGKR 182 (229)
T ss_pred Ccccc
Confidence 98765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.27 E-value=8.6e-06 Score=81.51 Aligned_cols=135 Identities=17% Similarity=0.156 Sum_probs=86.0
Q ss_pred eeeecCc-eEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCCCceeEEEeccCCch
Q 008171 299 KVASGSY-GDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSGGSV 376 (575)
Q Consensus 299 ~LG~G~f-G~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~l~lV~E~~~ggsL 376 (575)
.|..|.+ ..||+....+..+.+|+..... ...+.+|+.+++.+. +--++++++++...+..++|||+++|.+|
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 4555655 6799998777788889876442 234667898888885 34466788877766678999999999877
Q ss_pred hhhh-------------------hhccC-cCChH----HHHHHHH--------------------HHHHHHHHHH-----
Q 008171 377 YDYL-------------------HKLKG-VFKLP----SLLKVAI--------------------DVSKGMNYLH----- 407 (575)
Q Consensus 377 ~d~l-------------------~~~~~-~l~~~----~~~~i~~--------------------qI~~aL~yLH----- 407 (575)
.... +.... ..+.. ....... .+...+..|-
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 6432 11000 00100 0000000 0111122221
Q ss_pred --HCCceecccCCCCEEecCCCcEEEeecccce
Q 008171 408 --QNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 408 --~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2358999999999999998888999999774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.5e-05 Score=79.36 Aligned_cols=137 Identities=18% Similarity=0.165 Sum_probs=91.5
Q ss_pred eeeecCceEEEEEEE-CCccEEEEEecCCCCChHH----------------------HHHHHHHHHHHHhcCC--CCceE
Q 008171 299 KVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDM----------------------QKEFAQEVFIMRKVRH--KNVVQ 353 (575)
Q Consensus 299 ~LG~G~fG~Vy~~~~-~~~~VAvKvl~~~~~~~~~----------------------~~~~~~Ev~iL~~L~H--pnIv~ 353 (575)
.|.+|--+.||+|.. .+..+|+|+.+........ ..-...|..-|+++.. =.+++
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 456666677999875 5788999998754321111 0113346666776643 33444
Q ss_pred EEeeecCCCCceeEEEeccCC-chhhhhhhccCcCChHHHHHHHHHHHHHHHHHHH-CCceecccCCCCEEecCCCcEEE
Q 008171 354 FIGACTKPPSLCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKV 431 (575)
Q Consensus 354 l~~~~~~~~~l~lV~E~~~gg-sL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~gIiHrDLKp~NILl~~~~~vkL 431 (575)
-+.+.. ..+||||+... .-.-.|.. -.+.......+..++++.|.-|-. .+++|+||..-|||+. ++.+.|
T Consensus 135 Pi~~~~----nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i 207 (268)
T COG1718 135 PIAFRN----NVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI 207 (268)
T ss_pred ceeecC----CeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence 454432 47999999543 11111211 223333677788899999988887 8999999999999999 889999
Q ss_pred eecccceeccc
Q 008171 432 ADFGVARVKAQ 442 (575)
Q Consensus 432 ~DFG~a~~~~~ 442 (575)
+|||-|.....
T Consensus 208 ID~~QaV~~~h 218 (268)
T COG1718 208 IDVSQAVTIDH 218 (268)
T ss_pred EECccccccCC
Confidence 99998865543
|
|
| >PRK05092 PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=98.20 E-value=1e-05 Score=96.21 Aligned_cols=119 Identities=29% Similarity=0.369 Sum_probs=92.4
Q ss_pred HHHHHHHhccCCcccccccCCCchhhHHhHHHHHHHhcCCCCCCeEEEEEEEeeeCCCCCCcccccCCCCCccccCCCCC
Q 008171 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDSEVPAQRQSIHP 140 (575)
Q Consensus 61 ~~~l~~hf~rlp~~y~~d~~~~~~edvl~h~~ll~~a~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (575)
.+++.++|.+||.+|-+-.. ++++.-|-+++....+....|++.++.-. .
T Consensus 680 ~~~~~~~~~~~~~~yf~~~~---~~~i~~h~~~~~~~~~~~~~~~v~~~~~~---~------------------------ 729 (931)
T PRK05092 680 KADRDAYLARHYPAYWLAVD---LDTQARHARFIRDADDAGRPLATEVRPDP---A------------------------ 729 (931)
T ss_pred HHHHHHHHHhCCcHHhcCCC---HHHHHHHHHHHHhccccCCCcEEEEEecC---C------------------------
Confidence 35678899999999999865 55999999999887664455666553310 0
Q ss_pred CCCCCCChhhHHHHHHhhcCCCCCCCCcccccccccCcccceeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCce
Q 008171 141 PPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYS 220 (575)
Q Consensus 141 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ 220 (575)
.-.-+|+|.+.|+|+|+++++.+|+..|+||..|.+|.|.||+.
T Consensus 730 ------------------------------------~~~t~v~I~~~Dr~GLfa~i~~~L~~~glnI~~A~I~t~~dg~a 773 (931)
T PRK05092 730 ------------------------------------RGVTEVTVLAADHPGLFSRIAGACAAAGANIVDARIFTTTDGRA 773 (931)
T ss_pred ------------------------------------CCeEEEEEEeCCCCcHHHHHHHHHHHCCCcEEEEEEEEecCCeE
Confidence 01339999999999999999999999999999999999999999
Q ss_pred eEEEEE---cCCC---hhhHHHHHHHHHHHH
Q 008171 221 LDVFVV---DGWP---YEETEQLRAALEKEV 245 (575)
Q Consensus 221 ldv~vv---~g~~---~e~~~~l~~al~~~~ 245 (575)
+|+|.| +|.+ .+..+.++++|...+
T Consensus 774 lD~F~V~~~~g~~~~~~~~~~~l~~~L~~~l 804 (931)
T PRK05092 774 LDTFWIQDAFGRDEDEPRRLARLAKAIEDAL 804 (931)
T ss_pred EEEEEEECCCCCCCCCHHHHHHHHHHHHHHH
Confidence 999999 5543 234455566665544
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.1e-05 Score=76.44 Aligned_cols=136 Identities=19% Similarity=0.237 Sum_probs=99.0
Q ss_pred CceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCce-EEEeeecCCCCceeEEEe
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV-QFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv-~l~~~~~~~~~l~lV~E~ 370 (575)
-..+..+.||+|.+|.||+|.|.+..+|+|+-+.+. ....+..|+++|..+.-.++. ++|.+..+ ++.|||
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~ 93 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEY 93 (201)
T ss_pred hhhhhhhhhhcccccEEEEeeccCceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhh
Confidence 344556789999999999999999999999977543 245688899999999877664 45555443 566999
Q ss_pred ccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccC-CCCEEecCCCcEEEeecccceecccC
Q 008171 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK-AANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 371 ~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLK-p~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
+.|-.|.+.-... +- +-...++..---|-..||-|..|. |...+|..++.+.|+||..|+....+
T Consensus 94 i~G~~L~~~~~~~----~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~p 159 (201)
T COG2112 94 IDGRPLGKLEIGG----DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKKP 159 (201)
T ss_pred hcCcchhhhhhcc----cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhccCC
Confidence 9998887765421 22 233455555556778899999986 55555555668999999999755444
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.8e-05 Score=74.36 Aligned_cols=100 Identities=17% Similarity=0.301 Sum_probs=81.8
Q ss_pred HHHHHHHHhcCC-CCceEEEeeecCCCCceeEEEeccCCchhhh---hhhccCcCChHHHHHHHHHHHHHHHHHHH---C
Q 008171 337 AQEVFIMRKVRH-KNVVQFIGACTKPPSLCIVTEFMSGGSVYDY---LHKLKGVFKLPSLLKVAIDVSKGMNYLHQ---N 409 (575)
Q Consensus 337 ~~Ev~iL~~L~H-pnIv~l~~~~~~~~~l~lV~E~~~ggsL~d~---l~~~~~~l~~~~~~~i~~qI~~aL~yLH~---~ 409 (575)
..|.-+|+.+++ +++++++|+|.. ++|+||...+++... +.. -...++....+|+.+++..+.+|+. .
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358889999987 699999999964 679999987766532 111 1235899999999999999999998 4
Q ss_pred CceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 410 NIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 410 gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
.+.-.|++++|+-+++++.+|++|...+....
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 68899999999999999999999998875443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK04374 PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=98.13 E-value=2.1e-05 Score=92.53 Aligned_cols=119 Identities=20% Similarity=0.248 Sum_probs=86.9
Q ss_pred hHHHHHHHhccCCcccccccCCCchhhHHhHHHHHHHhcCCCCCCeEEEEEEEeeeCCCCCCcccccCCCCCccccCCCC
Q 008171 60 FDDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDSEVPAQRQSIH 139 (575)
Q Consensus 60 f~~~l~~hf~rlp~~y~~d~~~~~~edvl~h~~ll~~a~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (575)
=.+++.++|++||.||-+--. ++++.-|-+++.... ...|.+-++-..
T Consensus 638 ~~~~~~~~~~~l~~~Y~~~~~---~~~I~~h~~~~~~~~--~~~~~v~~~~~~--------------------------- 685 (869)
T PRK04374 638 DDATIDRQFAGMPDENFLRFR---PEQLAWQAASLIEVE--IGQTLVKARRAV--------------------------- 685 (869)
T ss_pred CHHHHHHHHHhCCchhhcCCC---HHHHHHHHHHHHhcC--CCCCeEEEeeec---------------------------
Confidence 356788899999999998755 569999999997653 222322111100
Q ss_pred CCCCCCCChhhHHHHHHhhcCCCCCCCCcccccccccCcccceeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCc
Q 008171 140 PPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGY 219 (575)
Q Consensus 140 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~ 219 (575)
| .+..-||++.+.|+|+|+++++.+|+..|+||..|.+|+|.||+
T Consensus 686 --~---------------------------------~~~~~~v~v~~~d~~gLFa~i~g~l~~~~lnI~~A~i~t~~~g~ 730 (869)
T PRK04374 686 --P---------------------------------DNDALEVFVYSPDRDGLFAAIVATLDRKGYGIHRARVLDAPHDA 730 (869)
T ss_pred --c---------------------------------CCCeEEEEEEeCCCccHHHHHHHHHHHCCCeEEEEEEEEcCCCE
Confidence 0 00133999999999999999999999999999999999999999
Q ss_pred eeEEEEEcCCCh---hhHHHHHHHHHHHH
Q 008171 220 SLDVFVVDGWPY---EETEQLRAALEKEV 245 (575)
Q Consensus 220 ~ldv~vv~g~~~---e~~~~l~~al~~~~ 245 (575)
.+|+|+|..... +..+.++++|++.+
T Consensus 731 ~ld~f~V~~~~~~~~~~~~~i~~~l~~~l 759 (869)
T PRK04374 731 IFDVFEVLPQDTYADGDPQRLAAALRQVL 759 (869)
T ss_pred EEEEEEEeCCCCCChHHHHHHHHHHHHHH
Confidence 999999964333 33333444444444
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.11 E-value=6.9e-07 Score=98.11 Aligned_cols=183 Identities=21% Similarity=0.210 Sum_probs=133.6
Q ss_pred eeeeeeeecCceEEEEEEECCcc-EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC-ceEEEeeecCCCCceeEEEecc
Q 008171 295 KFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPPSLCIVTEFMS 372 (575)
Q Consensus 295 ~i~~~LG~G~fG~Vy~~~~~~~~-VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~Hpn-Iv~l~~~~~~~~~l~lV~E~~~ 372 (575)
.+...+++|+++.+|+.+...+. ...+.+... ....-++.+|.+++||| .+..++-++.+....++++++.
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 34456789999999987654332 223333322 34456889999999999 7777777888888999999998
Q ss_pred CC-chhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccccCCC
Q 008171 373 GG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 451 (575)
Q Consensus 373 gg-sL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~G 451 (575)
++ +-........-.+...+...+.+.-.+++++||+.--+|+| ||+..+ +..+..||+...............+
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~ 392 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIG 392 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccccccCCC
Confidence 87 32222221122234445566777788899999998778998 777765 6799999999876555444556789
Q ss_pred CCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 008171 452 TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489 (575)
Q Consensus 452 t~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf 489 (575)
|+.|+|||++....++.+.|.|++|.--.+|--|-.|-
T Consensus 393 ~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 393 TPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 99999999999999999999999998766666666554
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.4e-05 Score=88.25 Aligned_cols=141 Identities=18% Similarity=0.254 Sum_probs=93.4
Q ss_pred eeeeecCceEEEEEEE-CCccEEEEEecCCCCCh-----------------------------HHH------HHHHHHHH
Q 008171 298 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERINS-----------------------------DMQ------KEFAQEVF 341 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~-~~~~VAvKvl~~~~~~~-----------------------------~~~------~~~~~Ev~ 341 (575)
+.||.-+.|.||+|+. .|+.||||+-++.-... +.. -.|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 4689999999999986 46789999987542110 001 13556665
Q ss_pred HHHhc----CCCC------ceEEEeeecCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCc
Q 008171 342 IMRKV----RHKN------VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411 (575)
Q Consensus 342 iL~~L----~Hpn------Iv~l~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gI 411 (575)
-..+. .|-+ |+++|-.+. ..-.++||||.|..+.|.-.-....++...+..-+.++..-+ |=..|+
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q--If~~Gf 322 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ--IFKTGF 322 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH--HHhcCC
Confidence 55544 3444 455554343 345899999999988887543345566664444333332222 224579
Q ss_pred eecccCCCCEEecC----CCcEEEeecccceeccc
Q 008171 412 IHRDLKAANLLMDE----NEVVKVADFGVARVKAQ 442 (575)
Q Consensus 412 iHrDLKp~NILl~~----~~~vkL~DFG~a~~~~~ 442 (575)
+|+|=.|.||++.. ++.+.+.|||+......
T Consensus 323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 99999999999984 66899999999865443
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.10 E-value=9.1e-05 Score=72.15 Aligned_cols=127 Identities=19% Similarity=0.307 Sum_probs=92.1
Q ss_pred CceeeeeeeeecCc-eEEEEEEECCccEEEEEecC---CC-------CCh---------HHHHHHHHHHHHHHhcC---C
Q 008171 292 KHLKFGSKVASGSY-GDLYRGTYCSQDVAIKVLKP---ER-------INS---------DMQKEFAQEVFIMRKVR---H 348 (575)
Q Consensus 292 ~~~~i~~~LG~G~f-G~Vy~~~~~~~~VAvKvl~~---~~-------~~~---------~~~~~~~~Ev~iL~~L~---H 348 (575)
.++++++.||.|.- |.||+++..|+.+|+|+.+. .. ... ....-|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67899999999999 99999999999999999321 10 000 12235788888777775 4
Q ss_pred CCc--eEEEeeecC------------------CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHH
Q 008171 349 KNV--VQFIGACTK------------------PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408 (575)
Q Consensus 349 pnI--v~l~~~~~~------------------~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~ 408 (575)
.++ |+.+||..- .....||.||++... .+ ...-+.+|.+-|..+|.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~----~~~~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PL----QIRDIPQMLRDLKILHK 182 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------cc----chhHHHHHHHHHHHHHH
Confidence 556 899988621 112357888876533 12 22345678888899999
Q ss_pred CCceecccCCCCEEecCCCcEEEeecccc
Q 008171 409 NNIIHRDLKAANLLMDENEVVKVADFGVA 437 (575)
Q Consensus 409 ~gIiHrDLKp~NILl~~~~~vkL~DFG~a 437 (575)
.||+-+|+++.|.. + -||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc---C--CEEEecccC
Confidence 99999999999987 2 389999865
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.08 E-value=4.8e-05 Score=89.68 Aligned_cols=144 Identities=16% Similarity=0.306 Sum_probs=91.9
Q ss_pred eeeeeecCceEEEEEEECC----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCc--eEEEeeecCC---CCcee
Q 008171 297 GSKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNV--VQFIGACTKP---PSLCI 366 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~~----~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnI--v~l~~~~~~~---~~l~l 366 (575)
.+.|+.|.+..+|+.+..+ ..+++|......... ....+.+|+.+|+.+. |.+| ++++.+|.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 4678999999999987654 357777765432211 2346789999999996 6655 8888888765 46789
Q ss_pred EEEeccCCchhhh-----------------------hhhccC-c--C-----C----hHHHHHHHH--------------
Q 008171 367 VTEFMSGGSVYDY-----------------------LHKLKG-V--F-----K----LPSLLKVAI-------------- 397 (575)
Q Consensus 367 V~E~~~ggsL~d~-----------------------l~~~~~-~--l-----~----~~~~~~i~~-------------- 397 (575)
||||++|..+.+. |+.... . + + ...+..+..
T Consensus 122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 201 (822)
T PLN02876 122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN 201 (822)
T ss_pred EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence 9999988654321 111100 0 0 0 112222111
Q ss_pred -HHHHHHHHHHH-----------CCceecccCCCCEEecCC--CcEEEeecccceecc
Q 008171 398 -DVSKGMNYLHQ-----------NNIIHRDLKAANLLMDEN--EVVKVADFGVARVKA 441 (575)
Q Consensus 398 -qI~~aL~yLH~-----------~gIiHrDLKp~NILl~~~--~~vkL~DFG~a~~~~ 441 (575)
.+...+.+|.. ..+||+|+++.|||++.+ ..+-|.||+++...+
T Consensus 202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 12234566642 259999999999999853 346899999986543
|
|
| >PRK00275 glnD PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.6e-05 Score=92.21 Aligned_cols=104 Identities=19% Similarity=0.331 Sum_probs=80.6
Q ss_pred HHHHHHHhccCCcccccccCCCchhhHHhHHHHHHHhcCCCCCCeEEEEEEEeeeCCCCCCcccccCCCCCccccCCCCC
Q 008171 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDSEVPAQRQSIHP 140 (575)
Q Consensus 61 ~~~l~~hf~rlp~~y~~d~~~~~~edvl~h~~ll~~a~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (575)
.+++.++|.+||.||-+--. ++++.-|-+++....++.. |.+-++. .+ +
T Consensus 650 ~~~~~~~~~~~~~~Y~l~~~---~~~I~~h~~~~~~~~~~~~-~~v~~~~---~~--~---------------------- 698 (895)
T PRK00275 650 PDDAEQLWSQLGDDYFLRHT---AGDIAWHTEAILQHPDDGG-PLVLIKE---TT--Q---------------------- 698 (895)
T ss_pred HHHHHHHHHhCCcHHhcCCC---HHHHHHHHHHHHhcccCCC-CeEEEEe---cC--c----------------------
Confidence 46788899999999999865 4599999999987644333 3332321 10 0
Q ss_pred CCCCCCChhhHHHHHHhhcCCCCCCCCcccccccccCcccceeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCce
Q 008171 141 PPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYS 220 (575)
Q Consensus 141 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ 220 (575)
++. .-.-||++.+.|+|+|++.++.+|+..|+||..|.+|+|.||+.
T Consensus 699 -~~~--------------------------------~~~t~V~V~~~DrpgLFa~i~g~L~~~~lnI~~A~I~Tt~dg~a 745 (895)
T PRK00275 699 -REF--------------------------------EGGTQIFIYAPDQHDFFAATVAAMDQLNLNIHDARIITSSSQFT 745 (895)
T ss_pred -cCC--------------------------------CCeEEEEEEeCCCCcHHHHHHHHHHHCCCeEEEEEEEEcCCCeE
Confidence 000 01229999999999999999999999999999999999999999
Q ss_pred eEEEEEcC
Q 008171 221 LDVFVVDG 228 (575)
Q Consensus 221 ldv~vv~g 228 (575)
+|+|+|..
T Consensus 746 lD~F~V~d 753 (895)
T PRK00275 746 LDTYIVLD 753 (895)
T ss_pred EEEEEEeC
Confidence 99999953
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.7e-05 Score=92.64 Aligned_cols=196 Identities=19% Similarity=0.234 Sum_probs=147.3
Q ss_pred HHHHHHHHHHhcCCCCceEEEeeecCCC----CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCC
Q 008171 335 EFAQEVFIMRKVRHKNVVQFIGACTKPP----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 410 (575)
Q Consensus 335 ~~~~Ev~iL~~L~HpnIv~l~~~~~~~~----~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~g 410 (575)
...-|...+.++.|+|++.++.+..... .+.+..+++++.++...+.. -+.++...++.+..++..||.|+|+..
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 3444777888899999999998864432 23455688988888888876 678899999999999999999999997
Q ss_pred ceecccCCC---CEEecCCCcEEEe--ecccceecccCCccccCCCCCCccCcccccCCCCCch--HHHHHHHHHHHHHH
Q 008171 411 IIHRDLKAA---NLLMDENEVVKVA--DFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK--ADVFSFGIVLWELL 483 (575)
Q Consensus 411 IiHrDLKp~---NILl~~~~~vkL~--DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~k--sDVwSlGviL~eLl 483 (575)
..|.-|... +..++..+.+.++ ||+.+.............-+..|.+||......++.+ .|+|++|.....+.
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~ 386 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS 386 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence 666665555 5555667777777 9999887777766666667788899999877776654 79999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 008171 484 TGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 484 tG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~ 542 (575)
.|..+-..... .. ...+.....++.++..+|+..++++|+++.+++..
T Consensus 387 ~~~~i~~~~~~-------~~----~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 387 QGEDISEKSAV-------PV----SLLDVLSTSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred hcCcccccccc-------hh----hhhccccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 87644221111 00 11222222378899999999999999999998864
|
|
| >cd04927 ACT_ACR-like_2 Second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=98.04 E-value=9.5e-06 Score=66.70 Aligned_cols=48 Identities=27% Similarity=0.457 Sum_probs=44.2
Q ss_pred eeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCceeEEEEEcCC
Q 008171 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGW 229 (575)
Q Consensus 182 i~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ldv~vv~g~ 229 (575)
+-+.+.|+|+|+++++.+|++.|+||..|.++.|.+|+.+|+|.|...
T Consensus 3 ~ei~~~Dr~gLfa~i~~~l~~~~l~I~~A~I~Tt~~~~v~D~F~V~d~ 50 (76)
T cd04927 3 LKLFCSDRKGLLHDVTEVLYELELTIERVKVSTTPDGRVLDLFFITDA 50 (76)
T ss_pred EEEEECCCCCHHHHHHHHHHHCCCeEEEEEEEECCCCEEEEEEEEeCC
Confidence 456788999999999999999999999999999999999999999543
|
This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.97 E-value=7.2e-05 Score=74.63 Aligned_cols=74 Identities=15% Similarity=0.214 Sum_probs=48.4
Q ss_pred eeeeecCce-EEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC---CceEEEeeecCC---CCceeEEEe
Q 008171 298 SKVASGSYG-DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK---NVVQFIGACTKP---PSLCIVTEF 370 (575)
Q Consensus 298 ~~LG~G~fG-~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~Hp---nIv~l~~~~~~~---~~l~lV~E~ 370 (575)
+.|+.|+.. .||+. +..+++|+.+... ....+.+|+.+++.+... -+.++++.+... +..+++|++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 467777666 58875 3467788755321 234688899999888632 355566555432 235889999
Q ss_pred ccCCchhh
Q 008171 371 MSGGSVYD 378 (575)
Q Consensus 371 ~~ggsL~d 378 (575)
++|.++.+
T Consensus 76 i~G~~l~~ 83 (235)
T cd05155 76 LEGETATA 83 (235)
T ss_pred ecCCCCCc
Confidence 99977753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd04925 ACT_ACR_2 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=97.96 E-value=1.9e-05 Score=64.53 Aligned_cols=45 Identities=40% Similarity=0.536 Sum_probs=41.6
Q ss_pred eeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCceeEEEEEc
Q 008171 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD 227 (575)
Q Consensus 182 i~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ldv~vv~ 227 (575)
|.+.+.|+|+|++.++.+|++.|+||..|+++ |.+|+.+|+|.|.
T Consensus 3 ~~v~~~Dr~gLl~~i~~~l~~~~lnI~~A~i~-t~~~~~~d~f~V~ 47 (74)
T cd04925 3 IELTGTDRPGLLSEVFAVLADLHCNVVEARAW-THNGRLACVIYVR 47 (74)
T ss_pred EEEEECCCCCHHHHHHHHHHHCCCcEEEEEEE-EECCEEEEEEEEE
Confidence 56778899999999999999999999999999 5699999999995
|
This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >PRK03059 PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=97.95 E-value=6.3e-05 Score=88.62 Aligned_cols=101 Identities=29% Similarity=0.449 Sum_probs=79.9
Q ss_pred HHHHHHHhccCCcccccccCCCchhhHHhHHHHHHHhcCCCCCCeEEEEEEEeeeCCCCCCcccccCCCCCccccCCCCC
Q 008171 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDSEVPAQRQSIHP 140 (575)
Q Consensus 61 ~~~l~~hf~rlp~~y~~d~~~~~~edvl~h~~ll~~a~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (575)
.+.+.++|.+||.+|-+-- .++++.-|-+++....+.. .|.+-+|. .+.
T Consensus 627 ~~~~~~~~~~~~~~Yf~~~---~~~~I~~h~~~~~~~~~~~-~~~v~~~~---~~~------------------------ 675 (856)
T PRK03059 627 DDAHEALWDQLDVGYFLRH---DAADIAWHTRHLYRHVDTD-TPIVRARL---SPA------------------------ 675 (856)
T ss_pred HHHHHHHHHhCChHHhccC---CHHHHHHHHHHHHhcccCC-CCeEEEEe---cCC------------------------
Confidence 4568889999999999875 4569999999997754322 23332221 100
Q ss_pred CCCCCCChhhHHHHHHhhcCCCCCCCCcccccccccCcccceeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCce
Q 008171 141 PPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYS 220 (575)
Q Consensus 141 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ 220 (575)
+-.-||++.+.|+|+|+++++.+|+..|+||..|.+|+|.||+.
T Consensus 676 ------------------------------------~~~~~v~i~~~d~~gLFa~i~g~l~~~~l~I~~A~i~t~~~g~~ 719 (856)
T PRK03059 676 ------------------------------------GEGLQVMVYTPDQPDLFARICGYFDRAGFSILDARVHTTRHGYA 719 (856)
T ss_pred ------------------------------------CCeEEEEEEecCCCcHHHHHHHHHHHCCCceeeeEEEEcCCCeE
Confidence 01239999999999999999999999999999999999999999
Q ss_pred eEEEEEcC
Q 008171 221 LDVFVVDG 228 (575)
Q Consensus 221 ldv~vv~g 228 (575)
+|+|+|..
T Consensus 720 ld~f~V~~ 727 (856)
T PRK03059 720 LDTFQVLD 727 (856)
T ss_pred EEEEEEeC
Confidence 99999943
|
|
| >PRK05007 PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00011 Score=87.00 Aligned_cols=117 Identities=24% Similarity=0.384 Sum_probs=87.5
Q ss_pred HHHHHHHhccCCcccccccCCCchhhHHhHHHHHHHhcCCCCCCeEEEEEEEeeeCCCCCCcccccCCCCCccccCCCCC
Q 008171 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDSEVPAQRQSIHP 140 (575)
Q Consensus 61 ~~~l~~hf~rlp~~y~~d~~~~~~edvl~h~~ll~~a~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (575)
.+.+.++|.++|.+|-+-- .++++.-|-+++..+.. ..|.+.++. . ..
T Consensus 651 ~~~~~~~~~~~~~~yf~~~---~~~~I~~h~~~~~~~~~--~~p~V~i~~---~-----~~------------------- 698 (884)
T PRK05007 651 EEALHQIWSRCRADYFLRH---TPNQLAWHARHLLQHDL--DKPLVLLSK---Q-----AT------------------- 698 (884)
T ss_pred HHHHHHHHHhCChHHhcCC---CHHHHHHHHHHHHhccC--CCCeEEEEe---c-----CC-------------------
Confidence 4567889999999999875 45699999999987642 334443211 0 00
Q ss_pred CCCCCCChhhHHHHHHhhcCCCCCCCCcccccccccCcccceeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCce
Q 008171 141 PPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYS 220 (575)
Q Consensus 141 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ 220 (575)
...-+|++.+.|+|+|+++++.+|+..|+||..|.+|.+.||+.
T Consensus 699 ------------------------------------~~~t~V~V~a~DrpGLfa~Ia~~La~~~L~I~~A~I~T~~dg~a 742 (884)
T PRK05007 699 ------------------------------------RGGTEIFIWSPDRPYLFAAVCAELDRRNLSVHDAQIFTSRDGMA 742 (884)
T ss_pred ------------------------------------CCeEEEEEEecCCcCHHHHHHHHHHHCCCEEEEEEEEEcCCCeE
Confidence 01239999999999999999999999999999999999999999
Q ss_pred eEEEEEcCCC---h--hhHHHHHHHHHHHH
Q 008171 221 LDVFVVDGWP---Y--EETEQLRAALEKEV 245 (575)
Q Consensus 221 ldv~vv~g~~---~--e~~~~l~~al~~~~ 245 (575)
+|+|.|.... . +..+.+++.|.+.+
T Consensus 743 lD~F~V~d~~g~~~~~~~~~~I~~~L~~aL 772 (884)
T PRK05007 743 MDTFIVLEPDGSPLSQDRHQVIRKALEQAL 772 (884)
T ss_pred EEEEEEECCCCCCCCHHHHHHHHHHHHHHH
Confidence 9999994322 2 23344556665555
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00029 Score=68.83 Aligned_cols=132 Identities=21% Similarity=0.394 Sum_probs=93.0
Q ss_pred eeeeecCceEEEEEEECCccEEEEEecCCC--------------CChHHHHHHHHHHHHHHhcC------CCCceEEEee
Q 008171 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPER--------------INSDMQKEFAQEVFIMRKVR------HKNVVQFIGA 357 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~--------------~~~~~~~~~~~Ev~iL~~L~------HpnIv~l~~~ 357 (575)
..||+|+.=.||.-- .+....||++.... ......+++.+|+.-...+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 478999999898732 23457889988765 11112355666776666665 7889999999
Q ss_pred ecCCCCceeEEEeccC------CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC----
Q 008171 358 CTKPPSLCIVTEFMSG------GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---- 427 (575)
Q Consensus 358 ~~~~~~l~lV~E~~~g------gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~---- 427 (575)
.+++--..+|+|.+.+ .+|.+++.. +.++. .+...+-.-..||-..+|+.+||+|.||++....
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~ 159 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEF 159 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCce
Confidence 9988888999998753 367777743 44554 3334444556788999999999999999996432
Q ss_pred cEEEee-ccc
Q 008171 428 VVKVAD-FGV 436 (575)
Q Consensus 428 ~vkL~D-FG~ 436 (575)
.+.|+| ||.
T Consensus 160 ~lvlIDG~G~ 169 (199)
T PF10707_consen 160 RLVLIDGLGE 169 (199)
T ss_pred EEEEEeCCCC
Confidence 467776 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00046 Score=71.61 Aligned_cols=76 Identities=14% Similarity=0.125 Sum_probs=57.9
Q ss_pred eeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC---CCceEEEeeecC---CCCceeEEEe
Q 008171 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH---KNVVQFIGACTK---PPSLCIVTEF 370 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~H---pnIv~l~~~~~~---~~~l~lV~E~ 370 (575)
.+.||.|..+.||+....+..+.+|..+... . ...+..|+..|+.|.- -.+++++++|.. .+..+||||+
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~-~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGNPMPLMARSFS-T---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeecCCccceeEEEEEcCCCCEEEEEecccc-c---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 4579999999999988766678888865311 1 2468889999998863 367888887754 3568999999
Q ss_pred ccCCch
Q 008171 371 MSGGSV 376 (575)
Q Consensus 371 ~~ggsL 376 (575)
++|.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >PRK01759 glnD PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00026 Score=83.56 Aligned_cols=117 Identities=25% Similarity=0.365 Sum_probs=86.2
Q ss_pred hHHHHHHHhccCCcccccccCCCchhhHHhHHHHHHHhcCCCCCCeEEEEEEEeeeCCCCCCcccccCCCCCccccCCCC
Q 008171 60 FDDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDSEVPAQRQSIH 139 (575)
Q Consensus 60 f~~~l~~hf~rlp~~y~~d~~~~~~edvl~h~~ll~~a~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (575)
=.+.+.++|.++|.+|-+- ..+|+++-|-+++..... .|.+.+ .+. ..
T Consensus 627 ~~~~~~~~~~~~~~~yf~~---~~~~~I~~h~~~~~~~~~---~~~V~i-----~~~---~~------------------ 674 (854)
T PRK01759 627 SETQIEQLWQRCPEDYFLR---NTPKQIAWHALLLLDFRG---DLLVKI-----SNR---FS------------------ 674 (854)
T ss_pred CHHHHHHHHHhCCcHHhcC---CCHHHHHHHHHHHHhcCC---CCEEEE-----Eec---CC------------------
Confidence 3556888999999999995 456799999999866432 233322 100 00
Q ss_pred CCCCCCCChhhHHHHHHhhcCCCCCCCCcccccccccCcccceeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCc
Q 008171 140 PPPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGY 219 (575)
Q Consensus 140 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~ 219 (575)
...-+|++.+.|+|+|+++++.+|+..|+||..|.+|.|.+|+
T Consensus 675 -------------------------------------~~~t~V~V~~~DrpGLfa~Ia~~L~~~~L~I~~A~I~T~~~g~ 717 (854)
T PRK01759 675 -------------------------------------RGGTEIFIYCQDQANLFLKVVSTIGAKKLSIHDAQIITSQDGY 717 (854)
T ss_pred -------------------------------------CCeEEEEEEecCCccHHHHHHHHHHHCCCeEEEEEEEEccCCE
Confidence 0123999999999999999999999999999999999999999
Q ss_pred eeEEEEEc---CCCh--hhHHHHHHHHHHHH
Q 008171 220 SLDVFVVD---GWPY--EETEQLRAALEKEV 245 (575)
Q Consensus 220 ~ldv~vv~---g~~~--e~~~~l~~al~~~~ 245 (575)
.+|+|.|. |-+. +..+.++++|.+.+
T Consensus 718 alD~F~V~d~~g~~~~~~~~~~l~~~L~~aL 748 (854)
T PRK01759 718 VLDSFIVTELNGKLLEFDRRRQLEQALTKAL 748 (854)
T ss_pred EEEEEEEeCCCCCCCCHHHHHHHHHHHHHHH
Confidence 99999994 3222 23334555555555
|
|
| >TIGR01693 UTase_glnD [Protein-PII] uridylyltransferase | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.0002 Score=84.72 Aligned_cols=119 Identities=22% Similarity=0.272 Sum_probs=88.2
Q ss_pred HHHHHHHhccCCcccccccCCCchhhHHhHHHHHHHhcCCCCCCeEEEEEEEeeeCCCCCCcccccCCCCCccccCCCCC
Q 008171 61 DDELWTHFNRLPTRYALDVNVERAEDVLMHKRLLHLAHDPRNRPAIEVRLVQVHPVSDRNSAVSSLLDSEVPAQRQSIHP 140 (575)
Q Consensus 61 ~~~l~~hf~rlp~~y~~d~~~~~~edvl~h~~ll~~a~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (575)
.+++..++.++|.+|-+-..+ +++.-|-+++..+.+... |.+.+. . . .
T Consensus 617 ~~~~~~~~~~~~~~y~~~~~~---~~I~~h~~~~~~~~~~~~-~~v~~~--~---~----~------------------- 664 (850)
T TIGR01693 617 SNEAEVLWLRAYDDYFLRFTH---KEIAWHAESLRRALSSGG-PLALID--G---T----R------------------- 664 (850)
T ss_pred HHHHHHHHHhCCchhhcCCCH---HHHHHHHHHHHhcccCCC-CEEEEe--c---c----C-------------------
Confidence 356788999999999998764 599999999988644222 222111 0 0 0
Q ss_pred CCCCCCChhhHHHHHHhhcCCCCCCCCcccccccccCcccceeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCce
Q 008171 141 PPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYS 220 (575)
Q Consensus 141 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ 220 (575)
....-+|++.+.|+|+||++++.+|+..|+||..|.+|+|.+|+.
T Consensus 665 -----------------------------------~~~~t~i~V~~~DrpgLla~i~~~L~~~~l~I~~A~I~tt~~g~~ 709 (850)
T TIGR01693 665 -----------------------------------PSGGTEVFIYAPDQPGLFAKVAGALAMLSLSVHDAQVNTTKDGVA 709 (850)
T ss_pred -----------------------------------CCCeEEEEEEeCCCCcHHHHHHHHHHHCCCeEEEEEEEEecCCEE
Confidence 001339999999999999999999999999999999999999999
Q ss_pred eEEEEEcCCC---h---hhHHHHHHHHHHHHH
Q 008171 221 LDVFVVDGWP---Y---EETEQLRAALEKEVL 246 (575)
Q Consensus 221 ldv~vv~g~~---~---e~~~~l~~al~~~~~ 246 (575)
+|+|.|.... . +..+.++++|...+.
T Consensus 710 lD~F~V~~~~g~~~~~~~~~~~i~~~L~~~L~ 741 (850)
T TIGR01693 710 LDTFVVQDLFGSPPAAERVFQELLQGLVDVLA 741 (850)
T ss_pred EEEEEEECCCCCCCCcHHHHHHHHHHHHHHHc
Confidence 9999995432 1 124456666666553
|
This model describes GlnD, the uridylyltransferase/uridylyl-removing enzyme for the nitrogen regulatory protein PII. Not all homologs of PII share the property of uridylyltransferase modification on the characteristic Tyr residue (see Prosite pattern PS00496 and document PDOC00439), but the modification site is preserved in the PII homolog of all species with a member of this family. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.65 E-value=4.6e-05 Score=78.50 Aligned_cols=134 Identities=18% Similarity=0.238 Sum_probs=96.3
Q ss_pred eeeeeeeeecCceEEEEEEEC-CccEEEEEecCCCCCh------------------H--HHHHHHHHHHHHHhcCC--CC
Q 008171 294 LKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINS------------------D--MQKEFAQEVFIMRKVRH--KN 350 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~------------------~--~~~~~~~Ev~iL~~L~H--pn 350 (575)
+.+++.||-|--+.||.+-+. |++.++|+-+..+.+- - ..-...+|...|+.|.. --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 345678999999999999875 8888888754332211 0 11235568888888753 23
Q ss_pred ceEEEeeecCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEE
Q 008171 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 430 (575)
Q Consensus 351 Iv~l~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vk 430 (575)
+++.+++ +..|+|||++.|..|...-+- ...-.+...+..-+.-|...|+||+|..-=||+|++++.++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV-------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeec-------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 4555543 356899999999888765432 12233455666667788899999999999999999999999
Q ss_pred Eeecccce
Q 008171 431 VADFGVAR 438 (575)
Q Consensus 431 L~DFG~a~ 438 (575)
++||--+.
T Consensus 243 vIDFPQmv 250 (465)
T KOG2268|consen 243 VIDFPQMV 250 (465)
T ss_pred EeechHhh
Confidence 99997654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00028 Score=71.23 Aligned_cols=133 Identities=14% Similarity=0.149 Sum_probs=79.4
Q ss_pred eeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCc-eEEEeeecCCCCceeEEEeccCCchh
Q 008171 299 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVTEFMSGGSVY 377 (575)
Q Consensus 299 ~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnI-v~l~~~~~~~~~l~lV~E~~~ggsL~ 377 (575)
.+..|-...+|+.+..++.+++|+....... ......+|..+++.+....+ +++++.+. -++||||++|..+.
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKA--LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCccccc--ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 3456777889998877888999985532111 10134678889988865433 44555443 37899999987664
Q ss_pred hh-----------------hhhcc---CcCChH-HHHHHHHHH---------HHHHHHHHH--------CCceecccCCC
Q 008171 378 DY-----------------LHKLK---GVFKLP-SLLKVAIDV---------SKGMNYLHQ--------NNIIHRDLKAA 419 (575)
Q Consensus 378 d~-----------------l~~~~---~~l~~~-~~~~i~~qI---------~~aL~yLH~--------~gIiHrDLKp~ 419 (575)
.. ++... .+++.. .+..+..++ ...+..+-. ..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 31 11111 011111 111221111 111222222 25899999999
Q ss_pred CEEecCCCcEEEeecccce
Q 008171 420 NLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 420 NILl~~~~~vkL~DFG~a~ 438 (575)
||+++.++ +.|+||..+.
T Consensus 157 Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred cEEEeCCC-CEEEeccccC
Confidence 99999877 7899999884
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0011 Score=65.88 Aligned_cols=73 Identities=12% Similarity=0.178 Sum_probs=48.6
Q ss_pred eeeeecCceEEEEEEEC---CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC-ceEEEeeecCCCCceeEEEeccC
Q 008171 298 SKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~---~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~Hpn-Iv~l~~~~~~~~~l~lV~E~~~g 373 (575)
+.|..|-...+|+.+.. ++.|++|+....... .....+|+.+++.+...+ .+++++.+. -.++|||++|
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G 76 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPG 76 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCC
Confidence 56788888899998765 467999987643211 122346888888886433 445555443 2489999999
Q ss_pred Cchh
Q 008171 374 GSVY 377 (575)
Q Consensus 374 gsL~ 377 (575)
.++.
T Consensus 77 ~~l~ 80 (235)
T cd05157 77 RTLE 80 (235)
T ss_pred CcCC
Confidence 7763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0017 Score=67.44 Aligned_cols=138 Identities=22% Similarity=0.265 Sum_probs=83.4
Q ss_pred eeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC--CceEEEeee------cCCCCceeEE
Q 008171 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK--NVVQFIGAC------TKPPSLCIVT 368 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~Hp--nIv~l~~~~------~~~~~l~lV~ 368 (575)
.+.++.|....+|+....+..+++|+..... . ......|..++..|... .+++++... ...+..++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 4567788778899987666678899876421 1 23345567777777432 244554432 1234568999
Q ss_pred EeccCCchhhh--------------hhhccCcCC--------hHH---HH------------HHHHHHHHHHHHHHH---
Q 008171 369 EFMSGGSVYDY--------------LHKLKGVFK--------LPS---LL------------KVAIDVSKGMNYLHQ--- 408 (575)
Q Consensus 369 E~~~ggsL~d~--------------l~~~~~~l~--------~~~---~~------------~i~~qI~~aL~yLH~--- 408 (575)
+|++|..+... ++.....++ ... .. .....+...++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 99998654311 111111110 010 00 001123345555542
Q ss_pred ----CCceecccCCCCEEecCCCcEEEeecccce
Q 008171 409 ----NNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 409 ----~gIiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 589999999999999988877899999873
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.002 Score=66.33 Aligned_cols=137 Identities=18% Similarity=0.181 Sum_probs=85.5
Q ss_pred eeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC--CceEEEeee------cCCCCceeEE
Q 008171 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK--NVVQFIGAC------TKPPSLCIVT 368 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~Hp--nIv~l~~~~------~~~~~l~lV~ 368 (575)
.+.|..|....+|+....+..+++|+... .. ......|+.+++.+.+. .+++++... ...+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~--~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK--VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC--CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 34677787788999877777899998764 11 24466788888888543 245554421 2234568999
Q ss_pred EeccCCchhhh----h----------hhccCcCCh--------HHHH------------HHHHHHHHHHHHHHH------
Q 008171 369 EFMSGGSVYDY----L----------HKLKGVFKL--------PSLL------------KVAIDVSKGMNYLHQ------ 408 (575)
Q Consensus 369 E~~~ggsL~d~----l----------~~~~~~l~~--------~~~~------------~i~~qI~~aL~yLH~------ 408 (575)
+|++|..+... . +.....+.. .... .....+..++.++.+
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 99998776431 0 111000100 0000 011122334455543
Q ss_pred -CCceecccCCCCEEecCCCcEEEeecccce
Q 008171 409 -NNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 409 -~gIiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998878999999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd04897 ACT_ACR_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00049 Score=56.30 Aligned_cols=64 Identities=23% Similarity=0.340 Sum_probs=50.8
Q ss_pred eeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCceeEEEEE---cCCC---hhhHHHHHHHHHHHHH
Q 008171 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVV---DGWP---YEETEQLRAALEKEVL 246 (575)
Q Consensus 182 i~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ldv~vv---~g~~---~e~~~~l~~al~~~~~ 246 (575)
|.+.+.|+|+||..++..|.++|++|.-|++ +|..+...|+|-| +|.+ .+..+.++++|...+.
T Consensus 4 veV~~~DRpGLL~~i~~~l~~~~l~I~~A~I-~T~gera~D~FyV~d~~g~kl~~~~~~~~l~~~L~~al~ 73 (75)
T cd04897 4 VTVQCRDRPKLLFDVVCTLTDMDYVVFHATI-DTDGDDAHQEYYIRHKDGRTLSTEGERQRVIKCLEAAIE 73 (75)
T ss_pred EEEEeCCcCcHHHHHHHHHHhCCeEEEEEEE-eecCceEEEEEEEEcCCCCccCCHHHHHHHHHHHHHHHh
Confidence 5678999999999999999999999999976 4555689999999 4533 3345667777776654
|
This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.40 E-value=3.2e-05 Score=92.08 Aligned_cols=233 Identities=11% Similarity=0.053 Sum_probs=148.5
Q ss_pred eEEEEEEECCc---cEEEEEecCC---CCChHHHHHHHHHHHHHHhcCCCCceEEEeeec--CCCCceeEEEeccCCchh
Q 008171 306 GDLYRGTYCSQ---DVAIKVLKPE---RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT--KPPSLCIVTEFMSGGSVY 377 (575)
Q Consensus 306 G~Vy~~~~~~~---~VAvKvl~~~---~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~--~~~~l~lV~E~~~ggsL~ 377 (575)
+..+++++-+. .+.+|+.+.- ...+...+....|...++...|+++.....-.. .....+++++|+.+|.+.
T Consensus 1240 ~~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f 1319 (2724)
T KOG1826|consen 1240 HFHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLF 1319 (2724)
T ss_pred ceeeccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHH
Confidence 33445554332 2455555432 222333455666777777888998877655432 223468999999999999
Q ss_pred hhhhhccC---cCChHHHHHHHHHHHHHHHHHHHC-----CceecccCCCCEEecCCCcEEEeecccceecccC-Ccccc
Q 008171 378 DYLHKLKG---VFKLPSLLKVAIDVSKGMNYLHQN-----NIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA 448 (575)
Q Consensus 378 d~l~~~~~---~l~~~~~~~i~~qI~~aL~yLH~~-----gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~ 448 (575)
+.+-+.-. .+....+.....+.+....-+|+. -.+|++||+.|.+|..+..+|++++|+.++.... .....
T Consensus 1320 ~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl 1399 (2724)
T KOG1826|consen 1320 SIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGL 1399 (2724)
T ss_pred HHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhh
Confidence 99865322 233333333344435666666643 2699999999999999999999999999844433 23445
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 528 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~ 528 (575)
..+++.|+.|++.+.-.++.++|+|..|+.+|++..|..+|...... ...+.++.+..-.++.-.|.+.-.....+|-.
T Consensus 1400 ~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~-~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~ 1478 (2724)
T KOG1826|consen 1400 ELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQP-ALKGIIDNHTFFSIEKLKPGDANVEALHRLLW 1478 (2724)
T ss_pred hhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHH-HHcCcccccccccccccCCCcccHHHHHHHHH
Confidence 67889999999999999999999999999999998888776432211 11222333333344444444444444455555
Q ss_pred CCCCCCCHHHH
Q 008171 529 DPALRPDFSEI 539 (575)
Q Consensus 529 dP~~RPs~~el 539 (575)
....||.-...
T Consensus 1479 K~~~rp~q~is 1489 (2724)
T KOG1826|consen 1479 KYMERPGQYIS 1489 (2724)
T ss_pred Hhhhcchhhhh
Confidence 55566654443
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0025 Score=66.37 Aligned_cols=136 Identities=17% Similarity=0.242 Sum_probs=76.7
Q ss_pred eeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC--CceEEEee------ecCCCCceeEEE
Q 008171 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK--NVVQFIGA------CTKPPSLCIVTE 369 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~Hp--nIv~l~~~------~~~~~~l~lV~E 369 (575)
+.|+.|....+|+.+..+..+++|+.. .... .....|+.+++.|... .+++.+.. ....+..+++++
T Consensus 28 ~~l~~G~~n~~y~v~t~~g~~vLK~~~--~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQGEYVLTLFE--RLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred chhccccccceEEEEeCCCcEEEEEec--cCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 457778778899988767789999876 2222 2233455666655321 23343321 122345689999
Q ss_pred eccCCchhh-----------hh---hhccCcC--------Ch---HHHH-H-----------HHHH-HHHHHHHHH----
Q 008171 370 FMSGGSVYD-----------YL---HKLKGVF--------KL---PSLL-K-----------VAID-VSKGMNYLH---- 407 (575)
Q Consensus 370 ~~~ggsL~d-----------~l---~~~~~~l--------~~---~~~~-~-----------i~~q-I~~aL~yLH---- 407 (575)
|++|..+.. .+ +.....+ .. .... + ...+ +...+..+.
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 999875421 11 1110111 10 0000 0 1111 111223332
Q ss_pred ---HCCceecccCCCCEEecCCCcEEEeecccce
Q 008171 408 ---QNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 408 ---~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
..++||+|+.|.||+++.+...-|+||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2389999999999999977666899999884
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.005 Score=66.47 Aligned_cols=76 Identities=13% Similarity=0.002 Sum_probs=53.7
Q ss_pred eeeeecCceEEEEEEECCc--cEEEEEecCCC----C-ChHHHHHHHHHHHHHHhcC---CCCceEEEeeecCCCCceeE
Q 008171 298 SKVASGSYGDLYRGTYCSQ--DVAIKVLKPER----I-NSDMQKEFAQEVFIMRKVR---HKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~~~--~VAvKvl~~~~----~-~~~~~~~~~~Ev~iL~~L~---HpnIv~l~~~~~~~~~l~lV 367 (575)
+.||.|.+..||+++..+. .|+||.-.+.. . ..-...++..|...|+.+. ..++++++.+.. ...++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence 5789999999999988653 79999854221 0 0123456777888888764 246778887744 557899
Q ss_pred EEeccCCc
Q 008171 368 TEFMSGGS 375 (575)
Q Consensus 368 ~E~~~ggs 375 (575)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >cd04926 ACT_ACR_4 C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.00075 Score=54.71 Aligned_cols=47 Identities=26% Similarity=0.467 Sum_probs=43.1
Q ss_pred ceeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCceeEEEEEcC
Q 008171 181 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDG 228 (575)
Q Consensus 181 ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ldv~vv~g 228 (575)
+|++.+.|+|.+|+.++.+|++.|+||..|.+|.+ +|+.+|+|.|..
T Consensus 3 ri~V~~~D~~Gll~~i~~~l~~~~lnI~sa~i~t~-~~~~~d~f~v~~ 49 (72)
T cd04926 3 RLELRTEDRVGLLSDVTRVFRENGLTVTRAEISTQ-GDMAVNVFYVTD 49 (72)
T ss_pred EEEEEECCccCHHHHHHHHHHHCCcEEEEEEEecC-CCeEEEEEEEEC
Confidence 78899999999999999999999999999999855 889999999953
|
This CD includes the C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >cd04896 ACT_ACR-like_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0017 Score=53.10 Aligned_cols=64 Identities=20% Similarity=0.203 Sum_probs=49.8
Q ss_pred eeeecCChhhHHHHHHHHHHhcccchhhccccc-CCCCceeEEEEEcCCC-----hhhHHHHHHHHHHHH
Q 008171 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFS-TVDGYSLDVFVVDGWP-----YEETEQLRAALEKEV 245 (575)
Q Consensus 182 i~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~-t~~g~~ldv~vv~g~~-----~e~~~~l~~al~~~~ 245 (575)
|-+.+.|+|+||..++.++.++|++|+-|++=+ |..+...|+|.|+... .+..+.|+++|...+
T Consensus 3 lev~a~DRpGLL~~i~~~l~~~~l~i~~AkI~~~T~Gerv~D~Fyv~~~g~kl~d~~~~~~L~~~L~~~l 72 (75)
T cd04896 3 LQIRCVDQKGLLYDILRTSKDCNIQISYGRFSSKVKGYREVDLFIVQSDGKKIMDPKKQAALCARLREEM 72 (75)
T ss_pred EEEEeCCcccHHHHHHHHHHHCCeEEEEEEEecCcccCEEEEEEEEeCCCCccCCHHHHHHHHHHHHHHh
Confidence 456789999999999999999999999998764 5656677999997654 233456666666544
|
This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0039 Score=64.40 Aligned_cols=74 Identities=15% Similarity=0.318 Sum_probs=48.2
Q ss_pred eeeeecCceEEEEEEEC--------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCc-eEEEeeecCCCCceeEE
Q 008171 298 SKVASGSYGDLYRGTYC--------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVT 368 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnI-v~l~~~~~~~~~l~lV~ 368 (575)
+.|..|-...+|+.+.. ++.+++|+...... ......+|..+++.+...++ .++++++.. .+|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~ 76 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE 76 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence 45666767788888764 36799999664321 12345678888888864333 456665542 3689
Q ss_pred EeccCCchhh
Q 008171 369 EFMSGGSVYD 378 (575)
Q Consensus 369 E~~~ggsL~d 378 (575)
||++|.++..
T Consensus 77 e~i~G~~l~~ 86 (302)
T cd05156 77 EFIPSRTLTT 86 (302)
T ss_pred heeCCCcCCH
Confidence 9999877653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd04895 ACT_ACR_1 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0011 Score=53.74 Aligned_cols=46 Identities=30% Similarity=0.496 Sum_probs=40.7
Q ss_pred eeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCceeEEEEEcC
Q 008171 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDG 228 (575)
Q Consensus 182 i~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ldv~vv~g 228 (575)
|-+.+.|+|+||..++.+|.++|++|+-|++ +|..+...|+|-|..
T Consensus 4 iev~a~DRpGLL~~i~~~l~~~gl~I~~AkI-sT~Gerv~DvFyV~d 49 (72)
T cd04895 4 VKVDSARKPGILLEAVQVLTDLDLCITKAYI-SSDGGWFMDVFHVTD 49 (72)
T ss_pred EEEEECCcCCHHHHHHHHHHHCCcEEEEEEE-eecCCeEEEEEEEEC
Confidence 5678899999999999999999999999976 666779999999943
|
This CD includes the N-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0079 Score=62.90 Aligned_cols=143 Identities=19% Similarity=0.298 Sum_probs=85.0
Q ss_pred eeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CCceEEEeeecCCC--CceeEEEeccCC
Q 008171 299 KVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPP--SLCIVTEFMSGG 374 (575)
Q Consensus 299 ~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~H--pnIv~l~~~~~~~~--~l~lV~E~~~gg 374 (575)
.+-.|..-.+|.....++.+++. ...............+|..+++.+.- --+...++.|..+. ..|.||+|+.|.
T Consensus 32 ~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe 110 (321)
T COG3173 32 EISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGE 110 (321)
T ss_pred eccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecce
Confidence 33333333466665567778888 33222333445667788888888753 23455677776665 679999999884
Q ss_pred chhhhhhh------------------cc----------C---cCChHHHHHHHH--------------HHHHHHHHHHHC
Q 008171 375 SVYDYLHK------------------LK----------G---VFKLPSLLKVAI--------------DVSKGMNYLHQN 409 (575)
Q Consensus 375 sL~d~l~~------------------~~----------~---~l~~~~~~~i~~--------------qI~~aL~yLH~~ 409 (575)
.+.+.+.. .. + .....++..+.. .+..-..||+.+
T Consensus 111 ~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~ 190 (321)
T COG3173 111 VVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN 190 (321)
T ss_pred eccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence 32222111 00 0 001111111111 122234555543
Q ss_pred --------CceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 410 --------NIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 410 --------gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
.++|+|+.+.||+++.++.+-|+||+.+...+.
T Consensus 191 ~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 191 RPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred CCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 489999999999999998899999999865543
|
|
| >PF01842 ACT: ACT domain; InterPro: IPR002912 The ACT domain is found in a variety of contexts and is proposed to be a conserved regulatory binding fold | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.00093 Score=52.29 Aligned_cols=63 Identities=33% Similarity=0.410 Sum_probs=51.2
Q ss_pred cceeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCceeEEEEEcCCChhhHHHHHHHHHH
Q 008171 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEK 243 (575)
Q Consensus 180 ~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ldv~vv~g~~~e~~~~l~~al~~ 243 (575)
|.|++...|+|++|..++++|++.|+||..++.+++.++ .-.++++......+.+.+.++|++
T Consensus 1 ~~v~v~~~drpG~l~~v~~~la~~~inI~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~ 63 (66)
T PF01842_consen 1 YRVRVIVPDRPGILADVTEILADHGINIDSISQSSDKDG-VGIVFIVIVVDEEDLEKLLEELEA 63 (66)
T ss_dssp EEEEEEEETSTTHHHHHHHHHHHTTEEEEEEEEEEESST-TEEEEEEEEEEGHGHHHHHHHHHH
T ss_pred CEEEEEcCCCCCHHHHHHHHHHHcCCCHHHeEEEecCCC-ceEEEEEEECCCCCHHHHHHHHHc
Confidence 467888999999999999999999999999999999985 444444445556677777777765
|
ACT domains are linked to a wide range of metabolic enzymes that are regulated by amino acid concentration. The archetypical ACT domain is the C-terminal regulatory domain of 3-phosphoglycerate dehydrogenase (3PGDH), which folds with a ferredoxin-like topology. A pair of ACT domains form an eight-stranded antiparallel sheet with two molecules of allosteric inhibitor serine bound in the interface. Biochemical exploration of a few other proteins containing ACT domains supports the suggestions that these domains contain the archetypical ACT structure [].; GO: 0016597 amino acid binding, 0008152 metabolic process; PDB: 3L76_B 2F06_B 3NRB_C 1Y7P_C 2QMX_A 2DT9_A 2ZHO_D 3K5P_A 3TVI_K 3C1M_C .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0016 Score=70.88 Aligned_cols=155 Identities=23% Similarity=0.295 Sum_probs=94.5
Q ss_pred HHHHHHHHHHHhcCCCCceEEEeeecC-CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCce
Q 008171 334 KEFAQEVFIMRKVRHKNVVQFIGACTK-PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412 (575)
Q Consensus 334 ~~~~~Ev~iL~~L~HpnIv~l~~~~~~-~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIi 412 (575)
..++-...+++.+.|+|..+.+.+-.. .....+|||++ +.||++++.... +...... .+|+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~s~~--------------~~~~~ 89 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDESLL--------------AHGVL 89 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchhhhc--------------ccccc
Confidence 456778889999999999999987643 34578899999 889999986633 2221111 22222
Q ss_pred ecccCCCCEEecCCCcEEEeecccceecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 008171 413 HRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (575)
Q Consensus 413 HrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (575)
|- |+ ++++| -++ ... |-. ..+|+||||+|.++.++.-|..-|...
T Consensus 90 ~~-----~~-------~~~td-~~~---t~~--------------~~~-----~~pKsdVwsl~~i~~el~L~~~l~~~~ 134 (725)
T KOG1093|consen 90 HL-----NI-------IYITD-HFL---TKY--------------PSP-----IGPKSDVWSLGFIILELYLGISLEAEL 134 (725)
T ss_pred ee-----hh-------hhccc-ccc---ccC--------------CCC-----CCcchhhhhHHHHHHHHHHhhHHHHHH
Confidence 21 22 22333 000 000 111 114999999999999999988766554
Q ss_pred CHHHHHHHHHhcCCCC----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 008171 493 TPLQAAVGVVQKGLRP----------TIPKNSQPKLAELLERCWQQDPALRPDFSEII 540 (575)
Q Consensus 493 ~~~~~~~~v~~~~~~~----------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell 540 (575)
...+....+..-...+ .+-..++..+.++..+|+-..|..||.+.++.
T Consensus 135 ~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 135 TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 4433333222111110 12234566788889999999998888666654
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.012 Score=61.97 Aligned_cols=140 Identities=17% Similarity=0.210 Sum_probs=91.5
Q ss_pred eeeeecCceEEEEEEE-CCccEEEEEecCCCC----------------------C-hHHHHH-HHHHHHHHHhcCCCCce
Q 008171 298 SKVASGSYGDLYRGTY-CSQDVAIKVLKPERI----------------------N-SDMQKE-FAQEVFIMRKVRHKNVV 352 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~-~~~~VAvKvl~~~~~----------------------~-~~~~~~-~~~Ev~iL~~L~HpnIv 352 (575)
-.|..|--+.||.++. .|..+|||+++...+ + ..+.+- ...|++-|++++...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 4567777788999976 467799999874311 1 112222 33477788888655443
Q ss_pred EEEeeecCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHH-CCceecccCCCCEEecCCCcEEE
Q 008171 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKV 431 (575)
Q Consensus 353 ~l~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~gIiHrDLKp~NILl~~~~~vkL 431 (575)
-.--+.. ....|||+|+.+ .=+-.=.-..-.++...+..+-.|++.-|.-|-+ ++.+|.||.--|+|+. +|.+.|
T Consensus 230 ~PePIlL--k~hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~lyi 305 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKLYI 305 (520)
T ss_pred CCCceee--ecceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEEEE
Confidence 2111111 134799999953 2111111113457777888888899998888764 6899999999999997 568999
Q ss_pred eecccceecc
Q 008171 432 ADFGVARVKA 441 (575)
Q Consensus 432 ~DFG~a~~~~ 441 (575)
+|.+-+....
T Consensus 306 IDVSQSVE~D 315 (520)
T KOG2270|consen 306 IDVSQSVEHD 315 (520)
T ss_pred EEccccccCC
Confidence 9998775443
|
|
| >cd04873 ACT_UUR-ACR-like ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.004 Score=49.23 Aligned_cols=48 Identities=40% Similarity=0.598 Sum_probs=43.5
Q ss_pred ceeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCceeEEEEEcCC
Q 008171 181 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGW 229 (575)
Q Consensus 181 ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ldv~vv~g~ 229 (575)
+|++...|+|++++.++.+|++.|+||..+..+++-+ +..++|.|++.
T Consensus 2 ~l~i~~~d~~g~l~~i~~~l~~~~~~I~~~~~~~~~~-~~~~~~~v~~~ 49 (70)
T cd04873 2 VVEVYAPDRPGLLADITRVLADLGLNIHDARISTTGE-RALDVFYVTDS 49 (70)
T ss_pred EEEEEeCCCCCHHHHHHHHHHHCCCeEEEEEEeecCC-EEEEEEEEECC
Confidence 6889999999999999999999999999999988866 89999988653
|
This ACT domain family, ACT_UUR_ACR-like, includes the two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the four ACT domains of a novel protein composed almost entirely of ACT domain repeats (the ACR protein) and like proteins. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. This CD also includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein and related domains, as well as, the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted t |
| >cd04899 ACT_ACR-UUR-like_2 C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.0051 Score=48.93 Aligned_cols=45 Identities=36% Similarity=0.572 Sum_probs=40.5
Q ss_pred eeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCceeEEEEEc
Q 008171 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD 227 (575)
Q Consensus 182 i~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ldv~vv~ 227 (575)
|.+.+.|+|+++.+++.++++.|+||..+.++.+ .++.+|.|.+.
T Consensus 3 l~v~~~d~~gll~~i~~~l~~~~~~I~~~~~~~~-~~~~~~~f~i~ 47 (70)
T cd04899 3 LELTALDRPGLLADVTRVLAELGLNIHSAKIATL-GERAEDVFYVT 47 (70)
T ss_pred EEEEEcCCccHHHHHHHHHHHCCCeEEEEEEEec-CCEEEEEEEEE
Confidence 6778899999999999999999999999998755 46999999885
|
This ACT domain family, ACT_ACR-UUR-like_2, includes the second of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the second and fourth ACT domains of a novel protein composed almost entirely of ACT domain repeats, the ACR protein. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. Members of this CD belong to the superfamily of ACT regulatory domains. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 575 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-59 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-59 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-49 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-49 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-48 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-48 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-48 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-48 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-48 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-48 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-47 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-47 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-47 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-47 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-47 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-47 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-46 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-46 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-46 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-46 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-46 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-46 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-46 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-45 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-45 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-45 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-45 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-45 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-45 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-45 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-45 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-45 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-45 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-45 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-45 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-45 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-45 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-45 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-45 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-44 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-44 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-44 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-44 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-44 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-44 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-44 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-44 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-44 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-44 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-44 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-44 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-44 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-44 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-44 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-44 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-43 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-43 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-43 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-43 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-43 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-43 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-43 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-43 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-43 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-43 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-43 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-43 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-43 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-43 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-43 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-43 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-42 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-42 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-42 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-42 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-42 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-42 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-42 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-42 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-41 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-41 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-41 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-41 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-41 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-40 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-40 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-38 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-38 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-38 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-38 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-38 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-38 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-38 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-38 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-38 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-38 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-38 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-38 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-38 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-38 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-38 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-38 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-38 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-37 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-37 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-37 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-37 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-37 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-37 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-37 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-37 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-37 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-37 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-37 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-37 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-37 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-37 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-36 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-36 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-36 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-36 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-36 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-36 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-36 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-36 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-36 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-36 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-36 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-36 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-35 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-35 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-35 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-35 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-35 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-35 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-35 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-35 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-35 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-35 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-35 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-35 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-35 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-35 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-35 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-35 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-35 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-35 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-35 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-35 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-35 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-35 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-35 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-35 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-35 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-35 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-35 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-35 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-35 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-35 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-35 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-35 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-35 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-35 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-35 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-35 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-35 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-35 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-35 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-35 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-35 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-34 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-34 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-34 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-34 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-34 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-34 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-34 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-34 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-34 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-34 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-34 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-34 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-34 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-34 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-34 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-34 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-33 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-33 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-33 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-33 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-33 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-33 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-33 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-33 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-33 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-33 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-33 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-33 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-33 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-33 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-33 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-33 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-33 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-33 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-32 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-32 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-32 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-32 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-32 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-32 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-32 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-32 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-32 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-32 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-32 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-32 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-32 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-32 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-32 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-32 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-32 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-32 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-32 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-32 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-32 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-32 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-32 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-32 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-32 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-32 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-32 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-32 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-32 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-32 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-32 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-32 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-32 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-32 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-32 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-32 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-32 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-32 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-32 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-32 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-32 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-32 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-32 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-32 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-31 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-31 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-31 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-31 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-31 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-31 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-31 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-31 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-31 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-31 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-30 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-30 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-30 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-30 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-30 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-30 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-30 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-30 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-30 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-30 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-30 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-30 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-30 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-30 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-30 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-30 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-30 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-30 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-30 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-30 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-30 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-30 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-30 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-30 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-30 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-30 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-30 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-30 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-30 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-30 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-30 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-30 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-30 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-29 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-29 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-29 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-29 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-29 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-29 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-29 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-29 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-29 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-29 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-29 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-29 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-29 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-29 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-29 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-29 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-29 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-28 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-28 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-28 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-28 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-28 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-28 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-28 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-28 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-28 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-28 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-28 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-28 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-28 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-28 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-27 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-27 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-27 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-27 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-27 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-27 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-27 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-27 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-26 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-26 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-26 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-26 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-26 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-26 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-26 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-26 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-26 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-26 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-25 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-25 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-25 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-25 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-25 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-25 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-25 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-25 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-25 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-25 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-25 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-25 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-25 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-25 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-25 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-25 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-25 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-25 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-25 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-25 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-25 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-25 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-25 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-25 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-25 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-25 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-25 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-25 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-25 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-25 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-25 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-24 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-24 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-24 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-24 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-24 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-24 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-24 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-24 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-24 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-24 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-24 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-24 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-24 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-24 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-24 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-24 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-24 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-24 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-24 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-24 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-24 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-24 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-24 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-24 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-24 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-24 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-24 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-24 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-24 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-24 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-24 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-24 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-24 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-24 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-24 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-24 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-24 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-24 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-24 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-24 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-24 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-24 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-24 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-24 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-24 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-24 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-24 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-23 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-23 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-23 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-23 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-23 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-23 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-23 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-23 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-23 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-23 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-23 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-23 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-23 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-23 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-23 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-23 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-23 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-23 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-23 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-23 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-23 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-23 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-23 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-23 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-23 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-23 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-23 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-23 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-23 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-23 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-23 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-23 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-23 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-23 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-23 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-23 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-23 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-23 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-23 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-23 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-22 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-22 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-22 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-22 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-22 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-22 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-22 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-22 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-22 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-22 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-22 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-22 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-22 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-22 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-22 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-22 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-22 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-21 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-21 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-21 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-21 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-21 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-21 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-21 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-21 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-21 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-21 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-20 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-20 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-20 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-20 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-20 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-20 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-20 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-20 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-20 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-20 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-20 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-20 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-20 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-20 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-20 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-20 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-20 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-20 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-20 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-20 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-20 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-20 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-20 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-20 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-20 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-20 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-20 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-20 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-20 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-20 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-20 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-20 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-19 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-19 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-19 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-19 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-19 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-19 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-19 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-19 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-19 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-19 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-19 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-19 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-19 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-19 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-19 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-19 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-19 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-19 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-19 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-19 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-19 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-19 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-19 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-19 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-19 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-19 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-19 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-19 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-19 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-19 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-19 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-19 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-18 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-18 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-18 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-18 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-18 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-18 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-18 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-18 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-18 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-18 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-18 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-18 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-18 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-18 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-18 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-18 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-18 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-18 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-18 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-18 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-18 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-18 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-18 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-18 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-18 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-18 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-18 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-18 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-18 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-18 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-18 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-18 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-18 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-18 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-18 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-18 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-18 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-18 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-18 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-18 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-18 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-18 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-18 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-18 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-18 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-18 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-18 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-18 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-18 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-18 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-17 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-17 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-17 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-17 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-17 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-17 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-17 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-17 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-17 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-17 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-17 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-17 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-17 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-17 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-17 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-17 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-17 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-17 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-16 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-16 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-16 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-16 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-16 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-16 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-16 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-16 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-16 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-16 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-16 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-16 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-16 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-16 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-16 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-16 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-16 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-16 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-16 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-16 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-16 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-16 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-16 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-16 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-16 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-16 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-16 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-16 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-16 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-16 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-16 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-16 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-16 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-16 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-16 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-16 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-16 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-16 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-16 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-16 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-16 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-16 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-16 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-15 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-15 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-15 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-15 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-15 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-15 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-15 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-15 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-15 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-15 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-15 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-15 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-15 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-15 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-15 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-15 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-15 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-15 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-15 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-15 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-15 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-15 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-15 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-15 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-15 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-15 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-15 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-15 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-15 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-15 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-15 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-15 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-15 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-15 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-15 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-15 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-15 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-15 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-14 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-14 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-14 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-14 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-14 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-14 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-13 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-13 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-13 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-13 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-13 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-13 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-13 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-13 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-13 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-13 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-13 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-13 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-13 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-13 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-13 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-13 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-13 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-13 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-13 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-13 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-13 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-13 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-13 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-13 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-13 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-13 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-13 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-13 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-13 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-13 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-13 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-13 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-13 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-13 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-13 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-13 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-13 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-13 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-13 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-12 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-11 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-11 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-11 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-11 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-11 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 3e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-11 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 454 bits (1169), Expect = e-158
Identities = 117/300 (39%), Positives = 182/300 (60%), Gaps = 8/300 (2%)
Query: 256 HRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS 315
H P S+ + ++ + + D +I L K+ +GS+G ++R +
Sbjct: 4 HHHHHPMSDYDIPTTENLYFQGAMDGD---DMDIPWCDLNIKEKIGAGSFGTVHRAEWHG 60
Query: 316 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375
DVA+K+L + +++ EF +EV IM+++RH N+V F+GA T+PP+L IVTE++S GS
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 376 VYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKV 431
+Y LHK +L L +A DV+KGMNYLH N I+HR+LK+ NLL+D+ VKV
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV 180
Query: 432 ADFGVARVKAQSGV-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
DFG++R+KA + + + GT WMAPEV+ +P + K+DV+SFG++LWEL T + P+
Sbjct: 181 CDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240
Query: 491 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550
L P Q V K R IP+N P++A ++E CW +P RP F+ I+++L+ + K
Sbjct: 241 NLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 433 bits (1115), Expect = e-150
Identities = 101/289 (34%), Positives = 164/289 (56%), Gaps = 12/289 (4%)
Query: 271 KSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINS 330
K H +H D D WEI + G ++ SGS+G +Y+G + DVA+K+L
Sbjct: 3 KGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH-GDVAVKMLNVTAPTP 61
Query: 331 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP 390
+ F EV ++RK RH N++ F+G T P L IVT++ G S+Y +LH + F++
Sbjct: 62 QQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMK 120
Query: 391 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ---SGVMT 447
L+ +A ++GM+YLH +IIHRDLK+ N+ + E+ VK+ DFG+A K++ S
Sbjct: 121 KLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180
Query: 448 AETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
+G+ WMAPEVI + PY ++DV++FGIVL+EL+TG+LPY + + +V +
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240
Query: 505 GLR----PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549
G + N ++ L+ C ++ RP F I+ ++++A+E
Sbjct: 241 GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 428 bits (1102), Expect = e-149
Identities = 95/274 (34%), Positives = 147/274 (53%), Gaps = 16/274 (5%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN--SDMQKEFAQEVFIM 343
+ EID L + G +G +YR + +VA+K + + S + QE +
Sbjct: 1 LLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
++H N++ G C K P+LC+V EF GG + L + L+ A+ +++GM
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGM 118
Query: 404 NYLHQNN---IIHRDLKAANLLMDE--------NEVVKVADFGVARVKAQSGVMTAETGT 452
NYLH IIHRDLK++N+L+ + N+++K+ DFG+AR ++ M+A G
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGA 177
Query: 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK 512
Y WMAPEVI + +DV+S+G++LWELLTG++P+ + L A GV L IP
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237
Query: 513 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
A+L+E CW DP RP F+ I++ L I
Sbjct: 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 429 bits (1106), Expect = e-149
Identities = 92/304 (30%), Positives = 137/304 (45%), Gaps = 17/304 (5%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
P L G + G +G + T+ + + + R + + Q+ F +EV +MR +
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
H NV++FIG K L +TE++ GG++ + + + + A D++ GM YL
Sbjct: 65 EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 407 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA---------------QSGVMTAETG 451
H NIIHRDL + N L+ EN+ V VADFG+AR+ G
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 452 TYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV-VQKGLRPTI 510
WMAPE+I + YD K DVFSFGIVL E++ P G+ V+ L
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244
Query: 511 PKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRK-EKSSGGFLSV 569
P N P + RC DP RP F ++ L+ + + + E+ GF
Sbjct: 245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWET 304
Query: 570 LRRG 573
RRG
Sbjct: 305 YRRG 308
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 422 bits (1088), Expect = e-146
Identities = 83/271 (30%), Positives = 149/271 (54%), Gaps = 12/271 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
ID K L F +K+ G+L++G + D+ +KVLK ++ ++F +E +R
Sbjct: 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 347 RHKNVVQFIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGM 403
H NV+ +GAC PP+ ++T +M GS+Y+ LH+ V +K A+D+++GM
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 404 NYLH--QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 461
+LH + I L + ++++DE+ +++ V W+APE +
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF----QSPGRMYAPAWVAPEAL 180
Query: 462 EHKPYD---HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518
+ KP D AD++SF ++LWEL+T ++P+ L+ ++ + V +GLRPTIP P +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240
Query: 519 AELLERCWQQDPALRPDFSEIIEILQQIAKE 549
++L++ C +DPA RP F I+ IL+++ +
Sbjct: 241 SKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 419 bits (1080), Expect = e-145
Identities = 83/305 (27%), Positives = 150/305 (49%), Gaps = 19/305 (6%)
Query: 261 PTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAI 320
P +S P + W+I + L+ G + G +G +Y G + +VAI
Sbjct: 2 PEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH-GEVAI 60
Query: 321 KVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL 380
+++ ER N D K F +EV R+ RH+NVV F+GAC PP L I+T G ++Y +
Sbjct: 61 RLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV 120
Query: 381 HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440
K V + ++A ++ KGM YLH I+H+DLK+ N+ D V + DFG+ +
Sbjct: 121 RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNG-KVVITDFGLFSIS 179
Query: 441 A------QSGVMTAETGTYRWMAPEVI---------EHKPYDHKADVFSFGIVLWELLTG 485
+ + + G +APE+I + P+ +DVF+ G + +EL
Sbjct: 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR 239
Query: 486 KLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK-LAELLERCWQQDPALRPDFSEIIEILQ 544
+ P++ + + G++P + + K ++++L CW + RP F++++++L+
Sbjct: 240 EWPFKTQPAEA-IIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298
Query: 545 QIAKE 549
++ K
Sbjct: 299 KLPKR 303
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 412 bits (1062), Expect = e-142
Identities = 85/285 (29%), Positives = 150/285 (52%), Gaps = 22/285 (7%)
Query: 280 PNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ---- 333
+ + + +++ ++ G +G +++G VAIK L + +
Sbjct: 7 EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 334 -KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL 392
+EF +EVFIM + H N+V+ G PP +V EF+ G +Y L K
Sbjct: 67 FQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVK 124
Query: 393 LKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENE-----VVKVADFGVARVKAQSGV 445
L++ +D++ G+ Y+ N I+HRDL++ N+ + + KVADFG+++ S
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-- 182
Query: 446 MTAETGTYRWMAPEVI--EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV--GV 501
++ G ++WMAPE I E + Y KAD +SF ++L+ +LTG+ P++ + + +
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242
Query: 502 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
++GLRPTIP++ P+L ++E CW DP RP FS I++ L ++
Sbjct: 243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 409 bits (1053), Expect = e-141
Identities = 94/285 (32%), Positives = 149/285 (52%), Gaps = 15/285 (5%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
+ ID K ++ V G++G + + + ++DVAIK ++ E +K F E+ + +
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSR 57
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGM 403
V H N+V+ GAC P +C+V E+ GGS+Y+ LH + + + + S+G+
Sbjct: 58 VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 404 NYLHQ---NNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 459
YLH +IHRDLK NLL+ V+K+ DFG A MT G+ WMAPE
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPE 173
Query: 460 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQKGLRPTIPKNSQPKL 518
V E Y K DVFS+GI+LWE++T + P++ + P + V G RP + KN +
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 519 AELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKSS 563
L+ RCW +DP+ RP EI++I+ + + +E +
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQH 278
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 361 bits (929), Expect = e-122
Identities = 81/307 (26%), Positives = 137/307 (44%), Gaps = 48/307 (15%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
V K ++ ++ G YG+++ G + + VA+KV S ++ E++
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRE---TEIYQTVL 87
Query: 346 VRHKNVVQFIGACTKP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
+RH+N++ FI A K L ++T++ GS+YDYL S+LK+A
Sbjct: 88 MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVS 145
Query: 402 GMNYLH--------QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----VMTA 448
G+ +LH + I HRDLK+ N+L+ +N +AD G+A
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 449 ETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTG----------KLPYEYL 492
GT R+M PEV++ H AD++SFG++LWE+ +LPY L
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265
Query: 493 TPLQAAVG-----VVQKGLRPTIPKNSQ-----PKLAELLERCWQQDPALRPDFSEIIEI 542
P + V K LRP+ P ++ +L+ CW +PA R + +
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325
Query: 543 LQQIAKE 549
L ++++
Sbjct: 326 LAKMSES 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 350 bits (900), Expect = e-118
Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 48/298 (16%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351
+ + V G YG+++RG++ ++VA+K+ S ++ E++ +RH+N+
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE---TELYNTVMLRHENI 64
Query: 352 VQFIGACTK----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
+ FI + L ++T + GS+YDYL S L++ + ++ G+ +LH
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLH 122
Query: 408 --------QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM-----TAETGTYR 454
+ I HRDLK+ N+L+ +N +AD G+A + +QS GT R
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 455 WMAPEVIEHKP------YDHKADVFSFGIVLWELLTG----------KLPYEYLTPLQAA 498
+MAPEV++ + D+++FG+VLWE+ K P+ + P +
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242
Query: 499 V-----GVVQKGLRPTIPKNSQ-----PKLAELLERCWQQDPALRPDFSEIIEILQQI 546
V RP IP LA+L++ CW Q+P+ R I + L +I
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 345 bits (888), Expect = e-115
Identities = 79/309 (25%), Positives = 145/309 (46%), Gaps = 48/309 (15%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
V + + + G +G+++RG + ++VA+K+ S ++ E++
Sbjct: 36 VQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVM 92
Query: 346 VRHKNVVQFIGACTK----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
+RH+N++ FI A K L +V+++ GS++DYL++ + ++K+A+ +
Sbjct: 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTAS 150
Query: 402 GMNYLHQN--------NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----VMTA 448
G+ +LH I HRDLK+ N+L+ +N +AD G+A +
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 449 ETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTG----------KLPYEYL 492
GT R+MAPEV++ H +AD+++ G+V WE+ +LPY L
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270
Query: 493 TPLQAAVG-----VVQKGLRPTIPKNSQ-----PKLAELLERCWQQDPALRPDFSEIIEI 542
P +V V ++ LRP IP Q +A+++ CW + A R I +
Sbjct: 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330
Query: 543 LQQIAKEVG 551
L Q++++ G
Sbjct: 331 LSQLSQQEG 339
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 337 bits (867), Expect = e-112
Identities = 82/309 (26%), Positives = 139/309 (44%), Gaps = 48/309 (15%)
Query: 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFI 342
GT+ L+ A G +G +++ ++ VA+K+ + + EV+
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ---DKQSWQNEYEVYS 71
Query: 343 MRKVRHKNVVQFIGACTKPPS----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
+ ++H+N++QFIGA + S L ++T F GS+ D+L V L +A
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAET 129
Query: 399 VSKGMNYLHQN----------NIIHRDLKAANLLMDENEVVKVADFGVARVK---AQSGV 445
+++G+ YLH++ I HRD+K+ N+L+ N +ADFG+A +G
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 446 MTAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPY-----EYLTPL 495
+ GT R+MAPEV+E + + D+++ G+VLWEL + EY+ P
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 496 QAAVG-----------VVQKGLRPTIPKNSQP-----KLAELLERCWQQDPALRPDFSEI 539
+ +G VV K RP + Q L E +E CW D R +
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309
Query: 540 IEILQQIAK 548
E + Q+ +
Sbjct: 310 GERITQMQR 318
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 308 bits (790), Expect = e-101
Identities = 74/320 (23%), Positives = 129/320 (40%), Gaps = 63/320 (19%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQE--VFIMR 344
+D +LK + G YG +Y+G+ + VA+KV + Q F E ++ +
Sbjct: 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFA----NRQ-NFINEKNIYRVP 62
Query: 345 KVRHKNVVQFIGACTKPPS-----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
+ H N+ +FI + + +V E+ GS+ YL S ++A V
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSSCRLAHSV 120
Query: 400 SKGMNYLH---------QNNIIHRDLKAANLLMDENEVVKVADFGVARVKA--------- 441
++G+ YLH + I HRDL + N+L+ + ++DFG++
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 442 QSGVMTAETGTYRWMAPEVIE-------HKPYDHKADVFSFGIVLWELLTGK---LPYEY 491
+ +E GT R+MAPEV+E + + D+++ G++ WE+ P E
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240
Query: 492 LTPLQAA---------------VGVVQKGLRPTIPKN------SQPKLAELLERCWQQDP 530
+ Q A V V ++ RP P+ + L E +E CW QD
Sbjct: 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300
Query: 531 ALRPDFSEIIEILQQIAKEV 550
R E + ++
Sbjct: 301 EARLTAQXAEERMAELMMIW 320
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 1e-92
Identities = 93/272 (34%), Positives = 147/272 (54%), Gaps = 10/272 (3%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 342
D W ++ + L G ++ G++G+++ G + VA+K + E + D++ +F QE I
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARI 165
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
+++ H N+V+ IG CT+ + IV E + GG +L ++ +LL++ D + G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT----YRWMAP 458
M YL IHRDL A N L+ E V+K++DFG++R GV A G +W AP
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE-EADGVYAASGGLRQVPVKWTAP 284
Query: 459 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 517
E + + Y ++DV+SFGI+LWE + G PY L+ Q V+KG R P+
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-TREFVEKGGRLPCPELCPDA 343
Query: 518 LAELLERCWQQDPALRPDFSEIIEILQQIAKE 549
+ L+E+CW +P RP FS I + LQ I K
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 2e-91
Identities = 96/267 (35%), Positives = 156/267 (58%), Gaps = 10/267 (3%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 345
W IDP L F ++ SG +G ++ G + ++ VAIK ++ + +++F +E +M K
Sbjct: 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMK 59
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
+ H +VQ G C + +C+VTEFM G + DYL +G+F +LL + +DV +GM Y
Sbjct: 60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIE 462
L + +IHRDL A N L+ EN+V+KV+DFG+ R T+ TGT +W +PEV
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS 178
Query: 463 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521
Y K+DV+SFG+++WE+ + GK+PYE + V + G R P+ + + ++
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFRLYKPRLASTHVYQI 237
Query: 522 LERCWQQDPALRPDFSEIIEILQQIAK 548
+ CW++ P RP FS ++ L +IA+
Sbjct: 238 MNHCWRERPEDRPAFSRLLRQLAEIAE 264
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 5e-91
Identities = 94/271 (34%), Positives = 145/271 (53%), Gaps = 16/271 (5%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 344
W ++ K LK + G +GD+ G Y VA+K +K + F E +M
Sbjct: 14 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----DATAQAFLAEASVMT 69
Query: 345 KVRHKNVVQFIGACTK-PPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 402
++RH N+VQ +G + L IVTE+M+ GS+ DYL V LLK ++DV +
Sbjct: 70 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 459
M YL NN +HRDL A N+L+ E+ V KV+DFG+ + + + +W APE
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPE 184
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518
+ K + K+DV+SFGI+LWE+ + G++PY + L+ V V+KG + P P +
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKMDAPDGCPPAV 243
Query: 519 AELLERCWQQDPALRPDFSEIIEILQQIAKE 549
E+++ CW D A+RP F ++ E L+ I
Sbjct: 244 YEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 6e-91
Identities = 102/292 (34%), Positives = 162/292 (55%), Gaps = 14/292 (4%)
Query: 280 PNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFA 337
PN D WE++ + K+ G YG++Y G + S VA+K LK ++ +EF
Sbjct: 3 PNY--DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFL 57
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVA 396
+E +M++++H N+VQ +G CT+ P I+TEFM+ G++ DYL + LL +A
Sbjct: 58 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 397 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---Y 453
+S M YL + N IHRDL A N L+ EN +VKVADFG++R+ TA G
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPI 176
Query: 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK 512
+W APE + + + K+DV++FG++LWE+ T G PY + Q +++K R P+
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRMERPE 235
Query: 513 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKSSG 564
K+ EL+ CWQ +P+ RP F+EI + + + +E +E ++ G
Sbjct: 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRG 287
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 8e-91
Identities = 90/270 (33%), Positives = 150/270 (55%), Gaps = 10/270 (3%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 343
WEIDPK L F ++ +G +G + G + Q DVAIK++K S + EF +E +M
Sbjct: 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVM 73
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+ H+ +VQ G CTK + I+TE+M+ G + +YL +++ F+ LL++ DV + M
Sbjct: 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 133
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEV 460
YL +HRDL A N L+++ VVKV+DFG++R T+ G+ RW PEV
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEV 192
Query: 461 IEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 519
+ + + K+D+++FG+++WE+ + GK+PYE T + +GLR P + K+
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIAQGLRLYRPHLASEKVY 251
Query: 520 ELLERCWQQDPALRPDFSEIIEILQQIAKE 549
++ CW + RP F ++ + + E
Sbjct: 252 TIMYSCWHEKADERPTFKILLSNILDVMDE 281
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 277 bits (712), Expect = 4e-90
Identities = 87/268 (32%), Positives = 145/268 (54%), Gaps = 10/268 (3%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIMRK 345
E+ + + ++ SG +G + G + Q DVA+K++K S + EF QE M K
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKE---GSMSEDEFFQEAQTMMK 59
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
+ H +V+F G C+K + IVTE++S G + +YL + LL++ DV +GM +
Sbjct: 60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIE 462
L + IHRDL A N L+D + VKV+DFG+ R + GT +W APEV
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVFH 178
Query: 463 HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521
+ Y K+DV++FGI++WE+ + GK+PY+ T V V +G R P + + ++
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT-NSEVVLKVSQGHRLYRPHLASDTIYQI 237
Query: 522 LERCWQQDPALRPDFSEIIEILQQIAKE 549
+ CW + P RP F +++ ++ + ++
Sbjct: 238 MYSCWHELPEKRPTFQQLLSSIEPLREK 265
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 9e-90
Identities = 83/277 (29%), Positives = 140/277 (50%), Gaps = 12/277 (4%)
Query: 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQ-KEFA 337
+ I K L+ K+ GS+G + RG + + VA+K LKP+ ++ +F
Sbjct: 10 SLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 69
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
+EV M + H+N+++ G PP + +VTE GS+ D L K +G F L +L + A+
Sbjct: 70 REVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---Y 453
V++GM YL IHRDL A NLL+ ++VK+ DFG+ R + + +
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188
Query: 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK 512
W APE ++ + + H +D + FG+ LWE+ T G+ P+ L Q + ++G R P+
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 248
Query: 513 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549
+ + ++ +CW P RP F + + L +
Sbjct: 249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 2e-89
Identities = 82/282 (29%), Positives = 140/282 (49%), Gaps = 11/282 (3%)
Query: 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFA 337
G + I + + + G +G++Y G Y + VA+K K + D +++F
Sbjct: 3 GGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFM 61
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
E IM+ + H ++V+ IG + P I+ E G + YL + K K+ +L+ ++
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RW 455
+ K M YL N +HRD+ N+L+ E VK+ DFG++R A +W
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 180
Query: 456 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 514
M+PE I + + +DV+ F + +WE+L+ GK P+ +L +GV++KG R P
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-VIGVLEKGDRLPKPDLC 239
Query: 515 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEE 556
P L L+ RCW DP+ RP F+E++ L + + + E
Sbjct: 240 PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAME 281
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 2e-89
Identities = 93/271 (34%), Positives = 145/271 (53%), Gaps = 16/271 (5%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 344
W ++ K LK + G +GD+ G Y VA+K +K + + F E +M
Sbjct: 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMT 241
Query: 345 KVRHKNVVQFIGACTK-PPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 402
++RH N+VQ +G + L IVTE+M+ GS+ DYL V LLK ++DV +
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 459
M YL NN +HRDL A N+L+ E+ V KV+DFG+ + + + +W APE
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPE 356
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518
+ K + K+DV+SFGI+LWE+ + G++PY + L+ V V+KG + P P +
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKMDAPDGCPPAV 415
Query: 519 AELLERCWQQDPALRPDFSEIIEILQQIAKE 549
++++ CW D A RP F ++ E L+ I
Sbjct: 416 YDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 2e-88
Identities = 100/301 (33%), Positives = 164/301 (54%), Gaps = 12/301 (3%)
Query: 271 KSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI 328
K + + + D WE++ + K+ G YG++Y G + S VA+K LK
Sbjct: 199 KRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--- 255
Query: 329 NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VF 387
++ +EF +E +M++++H N+VQ +G CT+ P I+TEFM+ G++ DYL +
Sbjct: 256 DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV 315
Query: 388 KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 447
LL +A +S M YL + N IHR+L A N L+ EN +VKVADFG++R+ T
Sbjct: 316 SAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYT 374
Query: 448 AETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503
A G +W APE + + + K+DV++FG++LWE+ T G PY + L +++
Sbjct: 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLE 433
Query: 504 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKSS 563
K R P+ K+ EL+ CWQ +P+ RP F+EI + + + +E +E ++
Sbjct: 434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKR 493
Query: 564 G 564
G
Sbjct: 494 G 494
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 3e-88
Identities = 88/268 (32%), Positives = 151/268 (56%), Gaps = 12/268 (4%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 343
D WE+ + LK ++ +G +G+++ G Y VA+K LK S F E +M
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPDAFLAEANLM 62
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 402
++++H+ +V+ T+ P + I+TE+M GS+ D+L G + LL +A +++G
Sbjct: 63 KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 459
M ++ + N IHRDL+AAN+L+ + K+ADFG+AR+ + TA G +W APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPE 180
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518
I + + K+DV+SFGI+L E++T G++PY +T + +++G R P N +L
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNLERGYRMVRPDNCPEEL 239
Query: 519 AELLERCWQQDPALRPDFSEIIEILQQI 546
+L+ CW++ P RP F + +L+
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 273 bits (701), Expect = 8e-88
Identities = 84/281 (29%), Positives = 144/281 (51%), Gaps = 16/281 (5%)
Query: 280 PNDGTDVWE-IDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDM 332
PN + + K + SG++G +Y+G + + VAIK L+
Sbjct: 4 PNQA--LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN 61
Query: 333 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL 392
KE E ++M V + +V + +G C + ++T+ M G + DY+ + K L
Sbjct: 62 -KEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 393 LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETG 451
L + ++KGMNYL ++HRDL A N+L+ + VK+ DFG+A+ + A+ AE G
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 452 TY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP 508
+WMA E I H+ Y H++DV+S+G+ +WEL+T G PY+ + + +++KG R
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERL 238
Query: 509 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549
P + ++ +CW D RP F E+I ++A++
Sbjct: 239 PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 1e-87
Identities = 88/275 (32%), Positives = 145/275 (52%), Gaps = 11/275 (4%)
Query: 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFA 337
T +EI + ++ G + G +GD+++G Y S + VAIK K + ++++F
Sbjct: 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFL 64
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
QE MR+ H ++V+ IG T+ P + I+ E + G + +L K L SL+ A
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 123
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--RW 455
+S + YL +HRD+ A N+L+ N+ VK+ DFG++R S A G +W
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 183
Query: 456 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 514
MAPE I + + +DV+ FG+ +WE+L G P++ + +G ++ G R +P N
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIENGERLPMPPNC 242
Query: 515 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549
P L L+ +CW DP+ RP F+E+ L I +E
Sbjct: 243 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 6e-87
Identities = 79/286 (27%), Positives = 140/286 (48%), Gaps = 13/286 (4%)
Query: 285 DVWEIDPKHLKFGSKV-ASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQE 339
+D K L K SG++G + +G Y + VA+K+LK E + ++ E E
Sbjct: 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 68
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
+M+++ + +V+ IG C +V E G + YL + K +++++ V
Sbjct: 69 ANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQV 126
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---YRW 455
S GM YL ++N +HRDL A N+L+ K++DFG+++ ++A A+T +W
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186
Query: 456 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 514
APE I + + K+DV+SFG+++WE + G+ PY + +++KG R P
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-GSEVTAMLEKGERMGCPAGC 245
Query: 515 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKE 560
++ +L+ CW D RP F+ + L+ +V E
Sbjct: 246 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHHH 291
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 271 bits (694), Expect = 1e-86
Identities = 72/274 (26%), Positives = 137/274 (50%), Gaps = 15/274 (5%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQ-KEFAQE 339
L+ + SG +G +++G + + V IKV++ + + +
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTDH 65
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
+ + + H ++V+ +G C L +VT+++ GS+ D++ + +G LL + +
Sbjct: 66 MLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI 124
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWM 456
+KGM YL ++ ++HR+L A N+L+ V+VADFGVA + + +WM
Sbjct: 125 AKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184
Query: 457 APEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 515
A E I Y H++DV+S+G+ +WEL+T G PY L + +++KG R P+
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-VPDLLEKGERLAQPQICT 243
Query: 516 PKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549
+ ++ +CW D +RP F E+ ++A++
Sbjct: 244 IDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 8e-86
Identities = 89/274 (32%), Positives = 137/274 (50%), Gaps = 12/274 (4%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQE 339
EI+ + + SG G++ G VAIK LK +++F E
Sbjct: 42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-RRDFLSE 100
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
IM + H N+++ G T+ IVTE+M GS+ +L G F + L+ + V
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---YRW 455
GM YL +HRDL A N+L+D N V KV+DFG++R ++ TG RW
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220
Query: 456 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 514
APE I + + +DV+SFG+V+WE+L G+ PY +T + + V++G R P
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT-NRDVISSVEEGYRLPAPMGC 279
Query: 515 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548
L +L+ CW +D A RP FS+I+ +L + +
Sbjct: 280 PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 1e-85
Identities = 86/275 (31%), Positives = 146/275 (53%), Gaps = 13/275 (4%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 338
EI P + + +G +G++Y+G VAIK LK + +F
Sbjct: 37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ-RVDFLG 95
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
E IM + H N+++ G +K + I+TE+M G++ +L + G F + L+ +
Sbjct: 96 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---YR 454
++ GM YL N +HRDL A N+L++ N V KV+DFG++R ++ +G R
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215
Query: 455 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN 513
W APE I ++ + +DV+SFGIV+WE++T G+ PY L+ + + G R P +
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKAINDGFRLPTPMD 274
Query: 514 SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548
+ +L+ +CWQQ+ A RP F++I+ IL ++ +
Sbjct: 275 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 3e-85
Identities = 97/278 (34%), Positives = 155/278 (55%), Gaps = 12/278 (4%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIM 343
D WEI + LK K+ +G +G+++ TY VA+K +KP S + F E +M
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP---GSMSVEAFLAEANVM 237
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 402
+ ++H +V+ TK P + I+TEFM+ GS+ D+L +G LP L+ + +++G
Sbjct: 238 KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 296
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 459
M ++ Q N IHRDL+AAN+L+ + V K+ADFG+ARV + TA G +W APE
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPE 355
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518
I + K+DV+SFGI+L E++T G++PY ++ + +++G R P+N +L
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-NPEVIRALERGYRMPRPENCPEEL 414
Query: 519 AELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEE 556
++ RCW+ P RP F I +L + EE
Sbjct: 415 YNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEE 452
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 5e-85
Identities = 76/284 (26%), Positives = 137/284 (48%), Gaps = 15/284 (5%)
Query: 285 DVWEIDPKHLKFG-SKVASGSYGDLYRGTYCSQ----DVAIKVLKPERINSDMQK-EFAQ 338
+ +L ++ G++G + +G Y + DVAIKVLK E +
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMR 59
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
E IM ++ + +V+ IG C L +V E GG ++ +L + + ++ ++
Sbjct: 60 EAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---YR 454
VS GM YL + N +HRDL A N+L+ K++DFG+++ + A TA + +
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 455 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN 513
W APE I + + ++DV+S+G+ +WE L+ G+ PY+ + + +++G R P
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRMECPPE 237
Query: 514 SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEER 557
P+L L+ CW RPDF + + ++ + + E
Sbjct: 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 6e-85
Identities = 73/292 (25%), Positives = 132/292 (45%), Gaps = 31/292 (10%)
Query: 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEF 336
G+D + + +HLKF ++ G++G + Y + VA+K L+ + ++F
Sbjct: 1 GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDF 58
Query: 337 AQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK 394
+E+ I++ ++H N+V++ G C +L ++ E++ GS+ DYL K K LL+
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT- 452
+ KGM YL IHRDL N+L++ VK+ DFG+ + + +
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 453 --YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT----------------GKLPYEYLTP 494
W APE + + +DV+SFG+VL+EL T G +
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 495 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
+ +++ R P ++ ++ CW + RP F ++ + QI
Sbjct: 239 FH-LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 2e-84
Identities = 79/303 (26%), Positives = 134/303 (44%), Gaps = 28/303 (9%)
Query: 270 MKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVL 323
M H +H D + +HLK+ S++ G++G + Y VA+K L
Sbjct: 1 MGHHHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL 60
Query: 324 KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGSVYDYLH 381
+ D Q++F +E+ I++ + +V++ G P SL +V E++ G + D+L
Sbjct: 61 QHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ 118
Query: 382 KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VK 440
+ + LL + + KGM YL +HRDL A N+L++ VK+ADFG+A+ +
Sbjct: 119 RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178
Query: 441 AQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496
W APE + + ++DV+SFG+VL+EL T
Sbjct: 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL 238
Query: 497 AAVGV-------------VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 543
+G +++G R P ++ EL++ CW P RP FS + L
Sbjct: 239 RMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298
Query: 544 QQI 546
+
Sbjct: 299 DML 301
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 4e-84
Identities = 74/323 (22%), Positives = 137/323 (42%), Gaps = 31/323 (9%)
Query: 256 HRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-- 313
H + T + + D + + +HLKF ++ G++G + Y
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDP 64
Query: 314 ----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIV 367
+ VA+K L+ + ++F +E+ I++ ++H N+V++ G C +L ++
Sbjct: 65 LQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122
Query: 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
E++ GS+ DYL K K LL+ + KGM YL IHRDL N+L++
Sbjct: 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN 182
Query: 428 VVKVADFGVAR-VKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELL 483
VK+ DFG+ + + + W APE + + +DV+SFG+VL+EL
Sbjct: 183 RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 242
Query: 484 T----------------GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527
T G + + +++ R P ++ ++ CW
Sbjct: 243 TYIEKSKSPPAEFMRMIGNDKQGQMIVFH-LIELLKNNGRLPRPDGCPDEIYMIMTECWN 301
Query: 528 QDPALRPDFSEIIEILQQIAKEV 550
+ RP F ++ + QI ++
Sbjct: 302 NNVNQRPSFRDLALRVDQIRDQM 324
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 8e-84
Identities = 99/280 (35%), Positives = 156/280 (55%), Gaps = 12/280 (4%)
Query: 273 HPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSD 331
+ D WEI + L+ K+ G +G+++ GT+ VAIK LKP +
Sbjct: 165 PTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTM 221
Query: 332 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLP 390
+ F QE +M+K+RH+ +VQ ++ P + IVTE+MS GS+ D+L G +LP
Sbjct: 222 SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLP 280
Query: 391 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET 450
L+ +A ++ GM Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+ + TA
Sbjct: 281 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQ 339
Query: 451 GT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGL 506
G +W APE + + K+DV+SFGI+L EL T G++PY + + + V++G
Sbjct: 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGY 398
Query: 507 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
R P L +L+ +CW+++P RP F + L+
Sbjct: 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 1e-83
Identities = 100/357 (28%), Positives = 173/357 (48%), Gaps = 20/357 (5%)
Query: 206 NIQEAHAFST-VDGY----SLDVFVVDGWPYEETEQLRAALEKEVLKLERQGWPSHRSSS 260
++ A + +DGY + P +E E+ ++ K ++ S S
Sbjct: 303 SLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVS 362
Query: 261 PTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD--- 317
T + + + Y +P+ +EI + ++ G + G +GD+++G Y S +
Sbjct: 363 ETDDYAEIIDEEDTY--TMPST--RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPA 418
Query: 318 --VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375
VAIK K + ++++F QE MR+ H ++V+ IG T+ P + I+ E + G
Sbjct: 419 MAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGE 476
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
+ +L K L SL+ A +S + YL +HRD+ A N+L+ N+ VK+ DFG
Sbjct: 477 LRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 536
Query: 436 VARVKAQSGVMTAETGTY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 492
++R S A G +WMAPE I + + +DV+ FG+ +WE+L G P++ +
Sbjct: 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596
Query: 493 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549
+G ++ G R +P N P L L+ +CW DP+ RP F+E+ L I +E
Sbjct: 597 KNND-VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 1e-83
Identities = 86/274 (31%), Positives = 141/274 (51%), Gaps = 12/274 (4%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQE 339
E+D ++ V +G +G++ G VAIK LK +++F E
Sbjct: 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGE 96
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
IM + H N+++ G TK + IVTE+M GS+ +L K F + L+ + +
Sbjct: 97 ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT---YRW 455
+ GM YL +HRDL A N+L++ N V KV+DFG+ R ++ G RW
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216
Query: 456 MAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 514
+PE I ++ + +DV+S+GIVLWE+++ G+ PY ++ Q + V +G R P +
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-NQDVIKAVDEGYRLPPPMDC 275
Query: 515 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548
L +L+ CWQ+D RP F +I+ IL ++ +
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 8e-83
Identities = 81/291 (27%), Positives = 139/291 (47%), Gaps = 29/291 (9%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQ 338
D + + LK + G +G + Y + VA+K LKPE + + +
Sbjct: 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKK 72
Query: 339 EVFIMRKVRHKNVVQFIGACTKPP--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVA 396
E+ I+R + H+N+V++ G CT+ + ++ EF+ GS+ +YL K K L LK A
Sbjct: 73 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA 132
Query: 397 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGT--- 452
+ + KGM+YL +HRDL A N+L++ VK+ DFG+ + ++ T +
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192
Query: 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT---------------GKLPYEYLTPLQA 497
W APE + + +DV+SFG+ L ELLT + +T +
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR- 251
Query: 498 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548
V +++G R P N ++ +L+ +CW+ P+ R F +IE + + K
Sbjct: 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 2e-82
Identities = 84/281 (29%), Positives = 144/281 (51%), Gaps = 16/281 (5%)
Query: 280 PNDGTDVWE-IDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDM 332
PN + + K + SG++G +Y+G + + VAIK L+
Sbjct: 4 PNQA--LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN 61
Query: 333 QKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL 392
KE E ++M V + +V + +G C + ++T+ M G + DY+ + K L
Sbjct: 62 -KEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 393 LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETG 451
L + ++KGMNYL ++HRDL A N+L+ + VK+ DFG+A+ + A+ AE G
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 452 TY--RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP 508
+WMA E I H+ Y H++DV+S+G+ +WEL+T G PY+ + + +++KG R
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERL 238
Query: 509 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549
P + ++ +CW D RP F E+I ++A++
Sbjct: 239 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 6e-82
Identities = 99/268 (36%), Positives = 155/268 (57%), Gaps = 12/268 (4%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-DVAIKVLKPERINSDMQKEFAQEVFIM 343
D WEI + L+ K+ G +G+++ GT+ VAIK LKP + + F QE +M
Sbjct: 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVM 316
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 402
+K+RH+ +VQ ++ P + IVTE+MS GS+ D+L G +LP L+ +A ++ G
Sbjct: 317 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPE 459
M Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+ + TA G +W APE
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 434
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518
+ + K+DV+SFGI+L EL T G++PY + + + V++G R P L
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYRMPCPPECPESL 493
Query: 519 AELLERCWQQDPALRPDFSEIIEILQQI 546
+L+ +CW+++P RP F + L+
Sbjct: 494 HDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 1e-81
Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 35/283 (12%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY---------CSQDVAIKVLKPERINSDMQKEFA 337
+I + L F + G++ +++G +V +KVL + + + F
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFF 60
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
+ +M K+ HK++V G C +V EF+ GS+ YL K K + L+VA
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMD--------ENEVVKVADFGVARVKAQSGVMTAE 449
++ M++L +N +IH ++ A N+L+ +K++D G++
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-------VLP 173
Query: 450 TGTY----RWMAPEVIEH-KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503
W+ PE IE+ K + D +SFG LWE+ + G P L Q + +
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-SQRKLQFYE 232
Query: 504 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
+ +P +LA L+ C +P RP F II L +
Sbjct: 233 DRHQ--LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 252 bits (647), Expect = 4e-80
Identities = 78/294 (26%), Positives = 142/294 (48%), Gaps = 29/294 (9%)
Query: 281 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQ 333
+ G V I + + ++ G++G ++ VA+K LK +
Sbjct: 4 HSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAAR 61
Query: 334 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL------------- 380
K+F +E ++ ++H+++V+F G C L +V E+M G + +L
Sbjct: 62 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 121
Query: 381 --HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438
+ KG L +L +A ++ GM YL + +HRDL N L+ N +VK+ DFG++R
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
Query: 439 VKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 494
+ T RWM PE I ++ + ++DV+SFG++LWE+ T GK P+ L+
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241
Query: 495 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548
+ + + +G P+ ++ +++ CWQ++P R + EI +IL + K
Sbjct: 242 TE-VIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 7e-80
Identities = 74/293 (25%), Positives = 134/293 (45%), Gaps = 21/293 (7%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQE 339
+ I + G + G +G + +D VA+K+LK + I S +EF +E
Sbjct: 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 340 VFIMRKVRHKNVVQFIGACTK------PPSLCIVTEFMSGGSVYDYLHKLK-----GVFK 388
M++ H +V + +G + P ++ FM G ++ +L +
Sbjct: 76 AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 389 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448
L +L++ +D++ GM YL N IHRDL A N ++ E+ V VADFG++R
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ 195
Query: 449 ETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQK 504
+ +W+A E + Y +DV++FG+ +WE++T G+ PY + + +
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-IYNYLIG 254
Query: 505 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEER 557
G R P ++ +L+ +CW DP RP F+ + L+ I + + +
Sbjct: 255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 9e-80
Identities = 78/281 (27%), Positives = 133/281 (47%), Gaps = 20/281 (7%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQE 339
+ ID L G + G +G + G +D VA+K +K + + +EF E
Sbjct: 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 340 VFIMRKVRHKNVVQFIGACTK-----PPSLCIVTEFMSGGSVYDYLHKLK-----GVFKL 389
M+ H NV++ +G C + P ++ FM G ++ YL + L
Sbjct: 87 AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146
Query: 390 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449
+LLK +D++ GM YL N +HRDL A N ++ ++ V VADFG+++
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206
Query: 450 TGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG 505
+W+A E + + Y K+DV++FG+ +WE+ T G PY + + + G
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-MYDYLLHG 265
Query: 506 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
R P++ +L E++ CW+ DP RP FS + L+++
Sbjct: 266 HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 1e-79
Identities = 83/312 (26%), Positives = 144/312 (46%), Gaps = 38/312 (12%)
Query: 273 HPYHLKIPNDG---------TDVWEIDPKHLKFGSKVASGSYGDLYRGTY------CSQD 317
H +H + G D ++LK + G +G + Y +
Sbjct: 3 HHHHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEM 62
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSLCIVTEFMSGGS 375
VA+K LK + + + QE+ I+R + H++++++ G C SL +V E++ GS
Sbjct: 63 VAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS 121
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
+ DYL + L LL A + +GM YLH + IHRDL A N+L+D + +VK+ DFG
Sbjct: 122 LRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG 179
Query: 436 VAR-VKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 490
+A+ V W APE ++ + + +DV+SFG+ L+ELLT
Sbjct: 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239
Query: 491 YLTPLQAAVGV-------------VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFS 537
T +G+ +++G R P ++ L++ CW+ + + RP F
Sbjct: 240 PPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFE 299
Query: 538 EIIEILQQIAKE 549
+I IL+ + ++
Sbjct: 300 NLIPILKTVHEK 311
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 3e-79
Identities = 80/273 (29%), Positives = 127/273 (46%), Gaps = 14/273 (5%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEV 340
V + F + G +G +Y GT D A+K L + +F E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEG 77
Query: 341 FIMRKVRHKNVVQFIGACTKP-PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
IM+ H NV+ +G C + S +V +M G + +++ + L+ + V
Sbjct: 78 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY-----R 454
+KGM YL +HRDL A N ++DE VKVADFG+AR + T +
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197
Query: 455 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN 513
WMA E ++ + + K+DV+SFG++LWEL+T G PY + + +G R P+
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGRRLLQPEY 256
Query: 514 SQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
L E++ +CW +RP FSE++ + I
Sbjct: 257 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 4e-79
Identities = 81/305 (26%), Positives = 144/305 (47%), Gaps = 32/305 (10%)
Query: 278 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINS 330
++P D WE L FG + +G++G + T + VA+K+LK +
Sbjct: 11 QLPYD--HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHL 67
Query: 331 DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL--------- 380
++ E+ ++ + H N+V +GACT ++TE+ G + ++L
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 381 --------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA 432
+ L LL + V+KGM +L N IHRDL A N+L+ + K+
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187
Query: 433 DFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLP 488
DFG+AR + +WMAPE I + Y ++DV+S+GI LWEL + G P
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
Query: 489 YEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548
Y + ++++G R P+++ ++ ++++ CW DP RP F +I++++++
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
Query: 549 EVGEE 553
E
Sbjct: 308 ESTNH 312
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 5e-79
Identities = 93/315 (29%), Positives = 154/315 (48%), Gaps = 29/315 (9%)
Query: 273 HPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC----SQDVAIKVLKPERI 328
H +H K D T +D +KF + G++G + + D AIK +K E
Sbjct: 6 HHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYA 64
Query: 329 NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL------- 380
+ D ++FA E+ ++ K+ H N++ +GAC L + E+ G++ D+L
Sbjct: 65 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 124
Query: 381 --------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA 432
+ LL A DV++GM+YL Q IHRDL A N+L+ EN V K+A
Sbjct: 125 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 184
Query: 433 DFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLP 488
DFG++R V +T RWMA E + + Y +DV+S+G++LWE+++ G P
Sbjct: 185 DFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
Query: 489 YEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548
Y +T + +G R P N ++ +L+ +CW++ P RP F++I+ L ++ +
Sbjct: 242 YCGMTC-AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300
Query: 549 EVGEENEERRKEKSS 563
E EK +
Sbjct: 301 ERKTYVNTTLYEKFT 315
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 5e-79
Identities = 86/318 (27%), Positives = 150/318 (47%), Gaps = 30/318 (9%)
Query: 258 SSSPTSEPEDTGMKSHPYHLKIPN--DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-- 313
S S S E G + ++ P V I + + ++ G++G ++
Sbjct: 5 SGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHN 64
Query: 314 -----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368
VA+K LK + +++F +E ++ ++H+++V+F G CT+ L +V
Sbjct: 65 LLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVF 122
Query: 369 EFMSGGSVYDYL--------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
E+M G + +L G L LL VA V+ GM YL + +HR
Sbjct: 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHR 182
Query: 415 DLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKAD 471
DL N L+ + VVK+ DFG++R + T RWM PE I ++ + ++D
Sbjct: 183 DLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESD 242
Query: 472 VFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDP 530
V+SFG+VLWE+ T GK P+ L+ + A+ + +G P+ P++ ++ CWQ++P
Sbjct: 243 VWSFGVVLWEIFTYGKQPWYQLSNTE-AIDCITQGRELERPRACPPEVYAIMRGCWQREP 301
Query: 531 ALRPDFSEIIEILQQIAK 548
R ++ LQ +A+
Sbjct: 302 QQRHSIKDVHARLQALAQ 319
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 5e-79
Identities = 88/322 (27%), Positives = 151/322 (46%), Gaps = 37/322 (11%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 313
SH + +P G+ ++P D WE L G + G++G +
Sbjct: 3 SSHHHHHHSQDPMLAGVS----EYELPED--PKWEFPRDKLTLGKPLGEGAFGQVVMAEA 56
Query: 314 C---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363
+ VA+K+LK + + E+ +M+ + +HKN++ +GACT+
Sbjct: 57 VGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 115
Query: 364 LCIVTEFMSGGSVYDYL---------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
L ++ E+ S G++ +YL + L+ +++GM YL
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKP 465
IHRDL A N+L+ EN V+K+ADFG+AR T +WMAPE + +
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 235
Query: 466 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524
Y H++DV+SFG+++WE+ T G PY + + ++++G R P N +L ++
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-LFKLLKEGHRMDKPANCTNELYMMMRD 294
Query: 525 CWQQDPALRPDFSEIIEILQQI 546
CW P+ RP F +++E L +I
Sbjct: 295 CWHAVPSQRPTFKQLVEDLDRI 316
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 7e-79
Identities = 79/274 (28%), Positives = 134/274 (48%), Gaps = 16/274 (5%)
Query: 287 WEI--DPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQE 339
I + + G +G +Y G Y Q AIK L ++ F +E
Sbjct: 14 VLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVE-AFLRE 72
Query: 340 VFIMRKVRHKNVVQFIGACTKP-PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
+MR + H NV+ IG P ++ +M G + ++ + + L+ +
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY----- 453
V++GM YL + +HRDL A N ++DE+ VKVADFG+AR + + +
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK 512
+W A E ++ + K+DV+SFG++LWELLT G PY ++ P + +G R P+
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLAQGRRLPQPE 251
Query: 513 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
L +++++CW+ DPA+RP F ++ ++QI
Sbjct: 252 YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 2e-78
Identities = 84/306 (27%), Positives = 144/306 (47%), Gaps = 30/306 (9%)
Query: 272 SHPYHLKIPN--------DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQ 316
+H +H PN +D+ E+ K++ + G++G++Y G
Sbjct: 2 AHHHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPL 61
Query: 317 DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
VA+K L E + + +F E I+ K H+N+V+ IG + I+ E M+GG +
Sbjct: 62 QVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDL 120
Query: 377 YDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENE 427
+L + + + LL VA D++ G YL +N+ IHRD+ A N L+
Sbjct: 121 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180
Query: 428 VVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT 484
V K+ DFG+AR ++ +WM PE + K D +SFG++LWE+ +
Sbjct: 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
Query: 485 -GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 543
G +PY + + + V G R PKN + ++ +CWQ P RP+F+ I+E +
Sbjct: 241 LGYMPYPSKSNQE-VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299
Query: 544 QQIAKE 549
+ ++
Sbjct: 300 EYCTQD 305
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 2e-78
Identities = 91/329 (27%), Positives = 153/329 (46%), Gaps = 33/329 (10%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 313
P R ++ S DT M + ++P D WE L G + G +G +
Sbjct: 45 PLVRITTRLSSTADTPMLAGVSEYELPED--PKWEFPRDKLTLGKPLGEGCFGQVVMAEA 102
Query: 314 C---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363
+ VA+K+LK + + E+ +M+ + +HKN++ +GACT+
Sbjct: 103 VGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161
Query: 364 LCIVTEFMSGGSVYDYL---------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
L ++ E+ S G++ +YL + L+ +++GM YL
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKP 465
IHRDL A N+L+ EN V+K+ADFG+AR T +WMAPE + +
Sbjct: 222 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 281
Query: 466 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524
Y H++DV+SFG+++WE+ T G PY + + ++++G R P N +L ++
Sbjct: 282 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-LFKLLKEGHRMDKPANCTNELYMMMRD 340
Query: 525 CWQQDPALRPDFSEIIEILQQIAKEVGEE 553
CW P+ RP F +++E L +I E
Sbjct: 341 CWHAVPSQRPTFKQLVEDLDRILTLTTNE 369
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 247 bits (634), Expect = 3e-78
Identities = 71/285 (24%), Positives = 135/285 (47%), Gaps = 28/285 (9%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQ 338
+ EI ++F ++ +G +Y+G +Q VAIK LK + +++EF
Sbjct: 3 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK-AEGPLREEFRH 61
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------------HKL 383
E + +++H NVV +G TK L ++ + S G ++++L +
Sbjct: 62 EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 384 KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443
K + P + + ++ GM YL ++++H+DL N+L+ + VK++D G+ R +
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 444 GVMTAETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 499
+ RWMAPE I + + +D++S+G+VLWE+ + G PY + V
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-VV 240
Query: 500 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 544
+++ P + + L+ CW + P+ RP F +I L+
Sbjct: 241 EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 4e-78
Identities = 93/325 (28%), Positives = 147/325 (45%), Gaps = 38/325 (11%)
Query: 260 SPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY------ 313
P P D + PY WE LK G + G++G +
Sbjct: 2 DPDELPLDEHCERLPYD-------ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKT 54
Query: 314 -CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP-PSLCIVTEF 370
+ VA+K+LK E + E+ I+ + H NVV +GACTKP L ++ EF
Sbjct: 55 ATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 113
Query: 371 MSGGSVYDYL---------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415
G++ YL K L L+ + V+KGM +L IHRD
Sbjct: 114 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 173
Query: 416 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADV 472
L A N+L+ E VVK+ DFG+AR + + +WMAPE I + Y ++DV
Sbjct: 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 233
Query: 473 FSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 531
+SFG++LWE+ + G PY + + +++G R P + P++ + + CW +P+
Sbjct: 234 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 293
Query: 532 LRPDFSEIIEILQQIAKEVGEENEE 556
RP FSE++E L + + ++
Sbjct: 294 QRPTFSELVEHLGNLLQA--NAQQD 316
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 250 bits (639), Expect = 6e-78
Identities = 79/273 (28%), Positives = 128/273 (46%), Gaps = 14/273 (5%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEV 340
V + F + G +G +Y GT D A+K L ++ +F E
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEG 141
Query: 341 FIMRKVRHKNVVQFIGACTKP-PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
IM+ H NV+ +G C + S +V +M G + +++ + L+ + V
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY-----R 454
+KGM +L +HRDL A N ++DE VKVADFG+AR + T +
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 261
Query: 455 WMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKN 513
WMA E ++ + + K+DV+SFG++LWEL+T G PY + + +G R P+
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGRRLLQPEY 320
Query: 514 SQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
L E++ +CW +RP FSE++ + I
Sbjct: 321 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 247 bits (634), Expect = 6e-78
Identities = 82/282 (29%), Positives = 140/282 (49%), Gaps = 22/282 (7%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFA 337
D WE+ + + ++ GS+G +Y G VAIK + E + + EF
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 76
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------GVFK 388
E +M++ +VV+ +G ++ ++ E M+ G + YL L+
Sbjct: 77 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 389 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448
L ++++A +++ GM YL+ N +HRDL A N ++ E+ VK+ DFG+ R ++
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 449 ETGTY---RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQK 504
RWM+PE ++ + +DV+SFG+VLWE+ T + PY+ L+ Q + V +
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-VLRFVME 255
Query: 505 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
G P N L EL+ CWQ +P +RP F EII +++
Sbjct: 256 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 1e-77
Identities = 82/303 (27%), Positives = 149/303 (49%), Gaps = 38/303 (12%)
Query: 278 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINS 330
KI D WE K+L G + G +G + + T VA+K+LK E +
Sbjct: 11 KILED--PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-ENASP 67
Query: 331 DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---------- 380
++ E ++++V H +V++ GAC++ L ++ E+ GS+ +L
Sbjct: 68 SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 381 -------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
H + + L+ A +S+GM YL + ++HRDL A N+L+ E
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR 187
Query: 428 VVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT 484
+K++DFG++R + + +WMA E + Y ++DV+SFG++LWE++T
Sbjct: 188 KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 485 -GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 543
G PY + P + +++ G R P N ++ L+ +CW+Q+P RP F++I + L
Sbjct: 248 LGGNPYPGIPPER-LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306
Query: 544 QQI 546
+++
Sbjct: 307 EKM 309
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 3e-77
Identities = 81/314 (25%), Positives = 145/314 (46%), Gaps = 14/314 (4%)
Query: 253 WPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKV-ASGSYGDLYRG 311
P P DT + P+ + +L G++G + +G
Sbjct: 297 ARITSPDKPRPMPMDTSVFESPFSDPEELKDKK-LFLKRDNLLIADIELGCGNFGSVRQG 355
Query: 312 TYCSQ----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367
Y + DVAIKVLK +D +E +E IM ++ + +V+ IG C L +V
Sbjct: 356 VYRMRKKQIDVAIKVLKQGTEKAD-TEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLV 413
Query: 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
E GG ++ +L + + ++ ++ VS GM YL + N +HR+L A N+L+
Sbjct: 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH 473
Query: 428 VVKVADFGVAR-VKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELL 483
K++DFG+++ + A TA + +W APE I + + ++DV+S+G+ +WE L
Sbjct: 474 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533
Query: 484 T-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEI 542
+ G+ PY+ + + +++G R P P+L L+ CW RPDF + +
Sbjct: 534 SYGQKPYKKMK-GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR 592
Query: 543 LQQIAKEVGEENEE 556
++ + + E
Sbjct: 593 MRACYYSLASKVEG 606
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 4e-77
Identities = 84/316 (26%), Positives = 147/316 (46%), Gaps = 22/316 (6%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 313
P ++ S + T + + +D+ E+ K++ + G++G++Y G
Sbjct: 33 PEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQV 92
Query: 314 -------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366
VA+K L E + + +F E I+ K H+N+V+ IG + I
Sbjct: 93 SGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 151
Query: 367 VTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420
+ E M+GG + +L + + + LL VA D++ G YL +N+ IHRD+ A N
Sbjct: 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 211
Query: 421 LLMD---ENEVVKVADFGVARVKAQSGVMTAETGTY---RWMAPEVIEHKPYDHKADVFS 474
L+ V K+ DFG+AR ++G +WM PE + K D +S
Sbjct: 212 CLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 271
Query: 475 FGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 533
FG++LWE+ + G +PY + + + V G R PKN + ++ +CWQ P R
Sbjct: 272 FGVLLWEIFSLGYMPYPSKSNQE-VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 330
Query: 534 PDFSEIIEILQQIAKE 549
P+F+ I+E ++ ++
Sbjct: 331 PNFAIILERIEYCTQD 346
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 7e-77
Identities = 84/303 (27%), Positives = 148/303 (48%), Gaps = 28/303 (9%)
Query: 278 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINS 330
++P + + WE +L+FG + +G++G + T VA+K+LK ++
Sbjct: 34 QLPYN--EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHA 90
Query: 331 DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK- 388
D ++ E+ IM + +H+N+V +GACT + ++TE+ G + ++L + V +
Sbjct: 91 DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLET 150
Query: 389 ------------LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
LL + V++GM +L N IHRD+ A N+L+ V K+ DFG+
Sbjct: 151 DPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 210
Query: 437 ARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 492
AR + +WMAPE I Y ++DV+S+GI+LWE+ + G PY +
Sbjct: 211 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270
Query: 493 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 552
+V+ G + P + + +++ CW +P RP F +I LQ+ A+E
Sbjct: 271 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR 330
Query: 553 ENE 555
E +
Sbjct: 331 ERD 333
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 1e-76
Identities = 93/322 (28%), Positives = 153/322 (47%), Gaps = 34/322 (10%)
Query: 255 SHRSSSPTSE-PEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 313
H PT+E GM + ++P D WE+ L G + G++G +
Sbjct: 33 HHDYDIPTTENLYFQGMLAGVSEYELPED--PRWELPRDRLVLGKPLGEGAFGQVVLAEA 90
Query: 314 ---------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363
VA+K+LK + E+ +M+ + +HKN++ +GACT+
Sbjct: 91 IGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 149
Query: 364 LCIVTEFMSGGSVYDYL---------------HKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
L ++ E+ S G++ +YL H + L+ A V++GM YL
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKP 465
IHRDL A N+L+ E+ V+K+ADFG+AR T +WMAPE + +
Sbjct: 210 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 269
Query: 466 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524
Y H++DV+SFG++LWE+ T G PY + + ++++G R P N +L ++
Sbjct: 270 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-LFKLLKEGHRMDKPSNCTNELYMMMRD 328
Query: 525 CWQQDPALRPDFSEIIEILQQI 546
CW P+ RP F +++E L +I
Sbjct: 329 CWHAVPSQRPTFKQLVEDLDRI 350
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 2e-76
Identities = 83/303 (27%), Positives = 139/303 (45%), Gaps = 37/303 (12%)
Query: 278 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINS 330
+ D WE ++L+FG + SG++G + T S VA+K+LK E+ +S
Sbjct: 33 EYEYD--LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADS 89
Query: 331 DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL 389
++ E+ +M ++ H+N+V +GACT + ++ E+ G + +YL + F
Sbjct: 90 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 149
Query: 390 PS----------------------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
LL A V+KGM +L + +HRDL A N+L+ +
Sbjct: 150 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK 209
Query: 428 VVKVADFGVARVKAQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT 484
VVK+ DFG+AR +WMAPE + Y K+DV+S+GI+LWE+ +
Sbjct: 210 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
Query: 485 -GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 543
G PY + ++Q G + P + ++ +++ CW D RP F + L
Sbjct: 270 LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329
Query: 544 QQI 546
Sbjct: 330 GCQ 332
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 3e-75
Identities = 87/337 (25%), Positives = 156/337 (46%), Gaps = 39/337 (11%)
Query: 250 RQGWPSHRSSSPTSEPEDTGMKSHPYHLKIP---NDGTDVWEIDPKHLKFGSKVASGSYG 306
+ ++ SE + +P + ++P N E ++++ + G++G
Sbjct: 2 AMESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFG 61
Query: 307 DLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
+++ VA+K+LK E ++DMQ +F +E +M + + N+V+ +G C
Sbjct: 62 RVFQARAPGLLPYEPFTMVAVKMLK-EEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKG-----------------------VFKLPSLLKVA 396
+C++ E+M+ G + ++L + L +A
Sbjct: 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 180
Query: 397 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTY--- 453
V+ GM YL + +HRDL N L+ EN VVK+ADFG++R + A+
Sbjct: 181 RQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPI 240
Query: 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPK 512
RWM PE I + Y ++DV+++G+VLWE+ + G PY + + + V+ G P+
Sbjct: 241 RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE-VIYYVRDGNILACPE 299
Query: 513 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549
N +L L+ CW + PA RP F I ILQ++ +
Sbjct: 300 NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 6e-70
Identities = 76/272 (27%), Positives = 133/272 (48%), Gaps = 15/272 (5%)
Query: 279 IPNDGTDVWEIDP--KHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQK 334
I T + + LKF ++ GS+ +Y+G T + +VA L+ ++ ++
Sbjct: 11 IEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ 70
Query: 335 EFAQEVFIMRKVRHKNVVQFIGA----CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP 390
F +E +++ ++H N+V+F + + +VTE M+ G++ YL + V K+
Sbjct: 71 RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIK 129
Query: 391 SLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMT 447
L + KG+ +LH IIHRDLK N+ + VK+ D G+A +K S
Sbjct: 130 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA 189
Query: 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 507
GT +MAPE+ E K YD DV++FG+ + E+ T + PY V G++
Sbjct: 190 -VIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 247
Query: 508 P-TIPKNSQPKLAELLERCWQQDPALRPDFSE 538
P + K + P++ E++E C +Q+ R +
Sbjct: 248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 7e-64
Identities = 60/311 (19%), Positives = 133/311 (42%), Gaps = 16/311 (5%)
Query: 257 RSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG--TYC 314
+S P + + + I K+ G + ++YR
Sbjct: 4 QSQGMQGPPVPQFQPQKALRPDMGYNTLANFRI-------EKKIGRGQFSEVYRAACLLD 56
Query: 315 SQDVAIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373
VA+K ++ + + +E+ +++++ H NV+++ + + L IV E
Sbjct: 57 GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 116
Query: 374 GSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 430
G + + K + ++ K + + + ++H ++HRD+K AN+ + VVK
Sbjct: 117 GDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVK 176
Query: 431 VADFGVARV-KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
+ D G+ R +++ + GT +M+PE I Y+ K+D++S G +L+E+ + P+
Sbjct: 177 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236
Query: 490 EY-LTPLQAAVGVVQKGLRPTIPKNSQ-PKLAELLERCWQQDPALRPDFSEIIEILQQIA 547
L + +++ P +P + +L +L+ C DP RPD + + ++ +++
Sbjct: 237 YGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296
Query: 548 KEVGEENEERR 558
E
Sbjct: 297 ACTASSLEHHH 307
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-63
Identities = 75/277 (27%), Positives = 148/277 (53%), Gaps = 10/277 (3%)
Query: 273 HPYHLKIPNDGTDVWEIDPKHLK---FGSKVASGSYGD--LYRGTYCSQDVAIKVLKPER 327
H +H + + ++ K+ GS+G L + T + IK + R
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR 61
Query: 328 INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV- 386
++S ++E +EV ++ ++H N+VQ+ + + SL IV ++ GG ++ ++ KGV
Sbjct: 62 MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL 121
Query: 387 FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446
F+ +L + + + ++H I+HRD+K+ N+ + ++ V++ DFG+ARV S V
Sbjct: 122 FQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV-LNSTVE 180
Query: 447 TAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
A GT +++PE+ E+KPY++K+D+++ G VL+EL T K +E + ++ V +
Sbjct: 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLVLKIIS 239
Query: 505 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
G P + + L L+ + ++++P RP + I+E
Sbjct: 240 GSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 4e-62
Identities = 65/299 (21%), Positives = 117/299 (39%), Gaps = 19/299 (6%)
Query: 246 LKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSY 305
L + W S + PE + K+ + E + + +V GS+
Sbjct: 13 LASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYRE-EVHWMTHQPRVGRGSF 71
Query: 306 GDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363
G+++R A+K + ++ +E+ + +V GA + P
Sbjct: 72 GEVHRMKDKQTGFQCAVKKV-------RLEVFRVEELVACAGLSSPRIVPLYGAVREGPW 124
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
+ I E + GGS+ + K G L +G+ YLH I+H D+KA N+L+
Sbjct: 125 VNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL 183
Query: 424 DEN-EVVKVADFGVARVKAQSGVMTAET------GTYRWMAPEVIEHKPYDHKADVFSFG 476
+ + DFG A G+ + GT MAPEV+ KP D K D++S
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC 243
Query: 477 IVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPKNSQPKLAELLERCWQQDPALRP 534
++ +L G P+ + + + IP + P A+ ++ +++P R
Sbjct: 244 CMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA 302
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 1e-61
Identities = 67/291 (23%), Positives = 125/291 (42%), Gaps = 38/291 (13%)
Query: 289 IDPKHLK---FGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIM 343
+D + + SG +G +++ + + IK +K ++ +EV +
Sbjct: 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKAL 58
Query: 344 RKVRHKNVVQFIGA----------------CTKPPSLCIVTEFMSGGSVYDYLHKLKGV- 386
K+ H N+V + G +K L I EF G++ ++ K +G
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 387 FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446
L++ ++KG++Y+H +I+RDLK +N+ + + + VK+ DFG+ G
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG 505
T GT R+M+PE I + Y + D+++ G++L ELL +E
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-------TSKFFTDL 231
Query: 506 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQIAKEVGEEN 554
I K LL++ + P RP+ SEI+ + + + E E +
Sbjct: 232 RDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERH 282
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 6e-61
Identities = 56/250 (22%), Positives = 97/250 (38%), Gaps = 8/250 (3%)
Query: 295 KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNV 351
+ S++ GSYG++++ + A+K + EV KV +H
Sbjct: 60 QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC 119
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V+ A + L + TE G S+ + + D + +LH +
Sbjct: 120 VRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGL 178
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKAD 471
+H D+K AN+ + K+ DFG+ +G + G R+MAPE+++ Y AD
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ-GSYGTAAD 237
Query: 472 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 531
VFS G+ + E+ Q + Q L P +L +L + DP
Sbjct: 238 VFSLGLTILEVACNMELPHGGEGWQQ---LRQGYLPPEFTAGLSSELRSVLVMMLEPDPK 294
Query: 532 LRPDFSEIIE 541
LR ++
Sbjct: 295 LRATAEALLA 304
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 2e-60
Identities = 86/285 (30%), Positives = 131/285 (45%), Gaps = 43/285 (15%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMR 344
W I+ + + SG+ + + VAIK + E+ + M E +E+ M
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMS 68
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYD-YLHKLKGVFKLPSLLK---VAI--- 397
+ H N+V + + L +V + +SGGSV D H + +L +A
Sbjct: 69 QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET------G 451
+V +G+ YLH+N IHRD+KA N+L+ E+ V++ADFGV+ A G +T G
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 452 TYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI 510
T WMAPEV+E + YD KAD++SFGI EL TG PY P++
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---------MLT 239
Query: 511 PKNSQPKLA-----------------ELLERCWQQDPALRPDFSE 538
+N P L +++ C Q+DP RP +E
Sbjct: 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE 284
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 2e-60
Identities = 91/282 (32%), Positives = 143/282 (50%), Gaps = 36/282 (12%)
Query: 270 MKSHPYHLKIPNDGTDVWEIDPKHL-KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPE 326
M P +P G + DP+ L K+ GS+G++++G + VAIK++ E
Sbjct: 1 MAHSPVQSGLP--GMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE 58
Query: 327 RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV 386
+++ + QE+ ++ + V ++ G+ K L I+ E++ GGS D L G
Sbjct: 59 EAEDEIE-DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GP 115
Query: 387 FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA------RVK 440
+ + ++ KG++YLH IHRD+KAAN+L+ E+ VK+ADFGVA ++K
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175
Query: 441 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 500
+ V GT WMAPEVI+ YD KAD++S GI EL G+ P+ L P++
Sbjct: 176 RNTFV-----GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF- 229
Query: 501 VVQKGLRPTIPKNSQPKLA--------ELLERCWQQDPALRP 534
IPKN+ P L E +E C ++P+ RP
Sbjct: 230 --------LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 263
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 4e-60
Identities = 73/247 (29%), Positives = 127/247 (51%), Gaps = 11/247 (4%)
Query: 297 GSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQF 354
+ G+YG +Y G S +AIK + +S + +E+ + + ++HKN+VQ+
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP-SLLKV-AIDVSKGMNYLHQNNII 412
+G+ ++ + I E + GGS+ L G K + + +G+ YLH N I+
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 413 HRDLKAANLLMDENE-VVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKP--YDH 468
HRD+K N+L++ V+K++DFG + R+ + TGT ++MAPE+I+ P Y
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGK 204
Query: 469 KADVFSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527
AD++S G + E+ TGK P+ E P A V + P IP++ + + +C++
Sbjct: 205 AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFE 264
Query: 528 QDPALRP 534
DP R
Sbjct: 265 PDPDKRA 271
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 7e-59
Identities = 58/281 (20%), Positives = 119/281 (42%), Gaps = 35/281 (12%)
Query: 297 GSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQ 353
K+ SG +G +++ AIK K S ++ +EV+ + +H +VV+
Sbjct: 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 410
+ A + + I E+ +GGS+ D + +++ FK L + + V +G+ Y+H +
Sbjct: 76 YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 135
Query: 411 IIHRDLKAANLLMDEN-------------------EVVKVADFGVARVKAQSGVMTAETG 451
++H D+K +N+ + + K+ D G + E G
Sbjct: 136 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISSPQVEEG 192
Query: 452 TYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI 510
R++A EV+ E+ + KAD+F+ + + + +++G P I
Sbjct: 193 DSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE----IRQGRLPRI 248
Query: 511 PKNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQIAKE 549
P+ + ELL+ DP RP +++ +L +++
Sbjct: 249 PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 9e-58
Identities = 80/273 (29%), Positives = 123/273 (45%), Gaps = 37/273 (13%)
Query: 285 DVWEIDPKHL-KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVF 341
D P+ + K+ GSYG +Y+ + Q VAIK + E +E +E+
Sbjct: 21 DSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEIS 76
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
IM++ +VV++ G+ K L IV E+ GSV D + + + K
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 136
Query: 402 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA------RVKAQSGVMTAETGTYRW 455
G+ YLH IHRD+KA N+L++ K+ADFGVA K + + GT W
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GTPFW 191
Query: 456 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 515
MAPEVI+ Y+ AD++S GI E+ GK PY + P++A IP N
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF---------MIPTNPP 242
Query: 516 PKLA----------ELLERCWQQDPALRPDFSE 538
P + +++C + P R ++
Sbjct: 243 PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQ 275
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-57
Identities = 80/289 (27%), Positives = 136/289 (47%), Gaps = 46/289 (15%)
Query: 276 HLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ 333
H++ D +VWEI ++ G++G +Y+ A KV++ + + +
Sbjct: 10 HVRRDLDPNEVWEIV-------GELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEEL 60
Query: 334 KEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+++ E+ I+ H +V+ +GA L I+ EF GG+V + +L P +
Sbjct: 61 EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120
Query: 394 KVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA------RVKAQSGVMT 447
V + + +N+LH IIHRDLKA N+LM +++ADFGV+ K S +
Sbjct: 121 VVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-- 178
Query: 448 AETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502
GT WMAPEV+ PYD+KAD++S GI L E+ + P+ L P++ +
Sbjct: 179 ---GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL--- 232
Query: 503 QKGLRPTIPKNSQPKLA----------ELLERCWQQDPALRPDFSEIIE 541
I K+ P L + L+ ++P RP ++++E
Sbjct: 233 ------KIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 2e-56
Identities = 68/250 (27%), Positives = 121/250 (48%), Gaps = 20/250 (8%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ G+ G +Y + Q+VAI+ + + ++ E+ +MR+ ++ N+V ++
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ L +V E+++GGS+ D + + + V + + + +LH N +IHRD+
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDI 142
Query: 417 KAANLLMDENEVVKVADFGVA------RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 470
K+ N+L+ + VK+ DFG + K + V GT WMAPEV+ K Y K
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAPEVVTRKAYGPKV 197
Query: 471 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQ 528
D++S GI+ E++ G+ PY PL+A + G P + + + L RC +
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLEM 256
Query: 529 DPALRPDFSE 538
D R E
Sbjct: 257 DVEKRGSAKE 266
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-55
Identities = 54/308 (17%), Positives = 124/308 (40%), Gaps = 21/308 (6%)
Query: 252 GWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRG 311
G ++ + D+ K + + + + ++ SG +++
Sbjct: 16 GMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV 75
Query: 312 TYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGACTKPPSLCIVT 368
Q AIK + E ++ + E+ + K++ + +++ + +V
Sbjct: 76 LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135
Query: 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428
E + +L K K ++ + ++ +HQ+ I+H DLK AN L+ + +
Sbjct: 136 EC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-M 192
Query: 429 VKVADFGVAR-VKAQSGVMTAET--GTYRWMAPEVIEHKP-----------YDHKADVFS 474
+K+ DFG+A ++ + + ++ G +M PE I+ K+DV+S
Sbjct: 193 LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 252
Query: 475 FGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 533
G +L+ + GK P+ + + + ++ P + L ++L+ C ++DP R
Sbjct: 253 LGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 312
Query: 534 PDFSEIIE 541
E++
Sbjct: 313 ISIPELLA 320
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-55
Identities = 62/311 (19%), Positives = 125/311 (40%), Gaps = 33/311 (10%)
Query: 269 GMKSHPYHLKIPNDGTD----VWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKV 322
G H +H + + ID KH F K+ G + + G + A+K
Sbjct: 2 GSSHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKR 61
Query: 323 LKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPS----LCIVTEFMSGGSVY 377
+ + +E A +E + R H N+++ + C + ++ F G+++
Sbjct: 62 I---LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118
Query: 378 DYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434
+ + +LK +L + + + +G+ +H HRDLK N+L+ + + D
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDL 178
Query: 435 GVARVK----------AQSGVMTAETGTYRWMAPEVIEHKPY---DHKADVFSFGIVLWE 481
G A+ T + APE+ + + D + DV+S G VL+
Sbjct: 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYA 238
Query: 482 LLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQDPALRPDFSEI 539
++ G+ PY+ + +V + + + +IP++ + L +LL DP RP +
Sbjct: 239 MMFGEGPYDMVFQKGDSVALAVQN-QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297
Query: 540 IEILQQIAKEV 550
+ L+ +
Sbjct: 298 LSQLEALQPPA 308
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-55
Identities = 59/289 (20%), Positives = 116/289 (40%), Gaps = 35/289 (12%)
Query: 302 SGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC- 358
G +G + + AIK ++ +++ +EV + K+ H +V++ A
Sbjct: 15 RGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWL 73
Query: 359 -----------TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNY 405
+ L I + ++ D+++ + + L + + +++ + +
Sbjct: 74 EKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEF 133
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-------------KAQSGVMTAETGT 452
LH ++HRDLK +N+ ++VVKV DFG+ T + GT
Sbjct: 134 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGT 193
Query: 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK 512
+M+PE I Y HK D+FS G++L+ELL P+ + V+ P +
Sbjct: 194 KLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFT 250
Query: 513 NSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQIAKEVGEENEERRK 559
P +++ P RP+ IIE + + + +R +
Sbjct: 251 QKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSR 299
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-55
Identities = 72/250 (28%), Positives = 119/250 (47%), Gaps = 20/250 (8%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ GS G + + VA+K++ ++ EV IMR +H NVV+
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ L ++ EF+ GG++ D + + + V V + + YLH +IHRD+
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDI 167
Query: 417 KAANLLMDENEVVKVADFGVA------RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 470
K+ ++L+ + VK++DFG K +S V GT WMAPEVI Y +
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISRSLYATEV 222
Query: 471 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQ 528
D++S GI++ E++ G+ PY +P+QA + P + + + P L + LER +
Sbjct: 223 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNSHKVSPVLRDFLERMLVR 281
Query: 529 DPALRPDFSE 538
DP R E
Sbjct: 282 DPQERATAQE 291
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-55
Identities = 78/271 (28%), Positives = 142/271 (52%), Gaps = 21/271 (7%)
Query: 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQ--KEFAQEVFIMRKVRHKNVVQF 354
G+K+ G +G +Y+G + VA+K L + + ++F QE+ +M K +H+N+V+
Sbjct: 36 GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKL--PSLLKVAIDVSKGMNYLHQNNII 412
+G + LC+V +M GS+ D L L G L K+A + G+N+LH+N+ I
Sbjct: 96 LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 155
Query: 413 HRDLKAANLLMDENEVVKVADFGVAR---VKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 469
HRD+K+AN+L+DE K++DFG+AR AQ+ + + GT +MAPE + + K
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITP-K 214
Query: 470 ADVFSFGIVLWELLTGKLPY----------EYLTPLQAAVGVVQKGLRPTI---PKNSQP 516
+D++SFG+VL E++TG + ++ ++ + + S
Sbjct: 215 SDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVE 274
Query: 517 KLAELLERCWQQDPALRPDFSEIIEILQQIA 547
+ + +C + RPD ++ ++LQ++
Sbjct: 275 AMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 3e-55
Identities = 52/265 (19%), Positives = 114/265 (43%), Gaps = 21/265 (7%)
Query: 295 KFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--V 351
++ SG +++ Q AIK + E ++ + E+ + K++ + +
Sbjct: 12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
++ + +V E + +L K K ++ + ++ +HQ+ I
Sbjct: 72 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGI 129
Query: 412 IHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAET--GTYRWMAPEVIEHKP--- 465
+H DLK AN L+ + ++K+ DFG+A ++ + + ++ GT +M PE I+
Sbjct: 130 VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188
Query: 466 --------YDHKADVFSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTIPKNSQP 516
K+DV+S G +L+ + GK P+ + + + ++ P +
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 248
Query: 517 KLAELLERCWQQDPALRPDFSEIIE 541
L ++L+ C ++DP R E++
Sbjct: 249 DLQDVLKCCLKRDPKQRISIPELLA 273
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 5e-55
Identities = 66/254 (25%), Positives = 119/254 (46%), Gaps = 16/254 (6%)
Query: 302 SGSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA-- 357
+GSYG R + + K L + ++ EV ++R+++H N+V++
Sbjct: 16 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQ-----N 409
+L IV E+ GG + + K +L+V ++ + H+ +
Sbjct: 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 135
Query: 410 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYD 467
++HRDLK AN+ +D + VK+ DFG+AR+ A+T GT +M+PE + Y+
Sbjct: 136 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKTFVGTPYYMSPEQMNRMSYN 194
Query: 468 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527
K+D++S G +L+EL P+ + + G +++G IP +L E++ R
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIREGKFRRIPYRYSDELNEIITRMLN 253
Query: 528 QDPALRPDFSEIIE 541
RP EI+E
Sbjct: 254 LKDYHRPSVEEILE 267
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 8e-55
Identities = 54/271 (19%), Positives = 114/271 (42%), Gaps = 21/271 (7%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
+ + ++ SG +++ Q AIK + E ++ + E+ + K++
Sbjct: 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 84
Query: 348 HKN--VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
+ +++ + +V E + +L K K ++ + ++
Sbjct: 85 QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHT 142
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIE 462
+HQ+ I+H DLK AN L+ + ++K+ DFG+A S V ++ GT +M PE I+
Sbjct: 143 IHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 463 HKP-----------YDHKADVFSFGIVLWELLTGKLPY-EYLTPLQAAVGVVQKGLRPTI 510
K+DV+S G +L+ + GK P+ + + + ++
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261
Query: 511 PKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
P + L ++L+ C ++DP R E++
Sbjct: 262 PDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 8e-55
Identities = 79/287 (27%), Positives = 135/287 (47%), Gaps = 19/287 (6%)
Query: 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQE 339
W+ + LK ++ G+YG + + + Q +A+K ++ ++ QK+ +
Sbjct: 12 SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST-VDEKEQKQLLMD 70
Query: 340 V-FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDY---LHKLKGVFKLPSLLKV 395
+ +MR +VQF GA + I E MS Y L V L K+
Sbjct: 71 LDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKI 130
Query: 396 AIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 454
+ K +N+L +N IIHRD+K +N+L+D + +K+ DFG++ S T + G
Sbjct: 131 TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRP 190
Query: 455 WMAPEVIE----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI 510
+MAPE I+ + YD ++DV+S GI L+EL TG+ PY + + V KG P +
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250
Query: 511 PKNSQ----PKLAELLERCWQQDPALRPDFSEIIE---ILQQIAKEV 550
+ + P + C +D + RP + E+++ IL + V
Sbjct: 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-54
Identities = 83/301 (27%), Positives = 130/301 (43%), Gaps = 29/301 (9%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHL-KFGSKVASGSYGDLYRGT 312
P+ + + LK P+ ++ DP+ L ++ GS+G +Y
Sbjct: 15 PTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFAR 74
Query: 313 YCS--QDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369
+ VAIK + S + ++ +EV ++K+RH N +Q+ G + + +V E
Sbjct: 75 DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134
Query: 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 429
+ GS D L K + + V +G+ YLH +N+IHRD+KA N+L+ E +V
Sbjct: 135 YC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLV 193
Query: 430 KVADFGVARVKAQSGVMTAETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGK 486
K+ DFG A + + GT WMAPEVI + YD K DV+S GI EL K
Sbjct: 194 KLGDFGSA---SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
Query: 487 LPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA---------ELLERCWQQDPALRPDFS 537
P + + A I +N P L ++ C Q+ P RP
Sbjct: 251 PPLFNMNAMSALY---------HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 301
Query: 538 E 538
Sbjct: 302 V 302
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 3e-54
Identities = 66/277 (23%), Positives = 122/277 (44%), Gaps = 15/277 (5%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEV-FIMR 344
E+ L+ ++ G+YG + + + Q +A+K ++ +NS QK ++ MR
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMR 61
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGG--SVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
V V F GA + + I E M Y + L K+A+ + K
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 403 MNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 461
+ +LH ++IHRD+K +N+L++ VK+ DFG++ + G +MAPE I
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERI 181
Query: 462 E----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS-QP 516
K Y K+D++S GI + EL + PY+ + V + P +P +
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA 241
Query: 517 KLAELLERCWQQDPALRPDFSEIIE---ILQQIAKEV 550
+ + +C +++ RP + E+++ +K
Sbjct: 242 EFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 187 bits (475), Expect = 7e-54
Identities = 51/329 (15%), Positives = 108/329 (32%), Gaps = 38/329 (11%)
Query: 255 SHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASG--SYGDLYRGT 312
+H GM S + + + + G +
Sbjct: 2 AHHHHHHMENLYFQGMSSFL--------------PEGGCYELLTVIGKGFEDLMTVNLAR 47
Query: 313 YCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370
Y + V ++ + E +++M E+ + + H N+V + L +VT F
Sbjct: 48 YKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 107
Query: 371 MSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 429
M+ GS D + ++ + V K ++Y+H +HR +KA+++L+ + V
Sbjct: 108 MAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKV 167
Query: 430 KVADFGVA--------RVKAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVL 479
++ R + W++PEV++ + YD K+D++S GI
Sbjct: 168 YLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITA 227
Query: 480 WELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 539
EL G +P++ + Q + + P L + ++
Sbjct: 228 CELANGHVPFKDMPATQMLL---------EKLNGTVPCLLDTSTIPAEELTMSPSRSVAN 278
Query: 540 IEILQQIAKEVGEENEERRKEKSSGGFLS 568
+ + + S
Sbjct: 279 SGLSDSLTTSTPRPSNGDSPSHPYHRTFS 307
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 1e-53
Identities = 69/301 (22%), Positives = 132/301 (43%), Gaps = 25/301 (8%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEV-FIM 343
++ + L+ ++ SG+ G +++ + +A+K ++ N + K ++ ++
Sbjct: 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMDLDVVL 78
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+ +VQ G + I E M + +++G L K+ + + K +
Sbjct: 79 KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKK-RMQGPIPERILGKMTVAIVKAL 137
Query: 404 NYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 462
YL ++ +IHRD+K +N+L+DE +K+ DFG++ G +MAPE I+
Sbjct: 138 YYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERID 197
Query: 463 -----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ-- 515
YD +ADV+S GI L EL TG+ PY+ + V + P +P +
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFS 257
Query: 516 PKLAELLERCWQQDPALRPDFSEIIE------------ILQQIAKEVGEENEERRKEKSS 563
++ C +D RP +++++E + K+V + E R SS
Sbjct: 258 GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRSGPSS 317
Query: 564 G 564
G
Sbjct: 318 G 318
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-53
Identities = 58/278 (20%), Positives = 114/278 (41%), Gaps = 34/278 (12%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ + + G++G + + + AIK ++ + EV ++ + H+ VV
Sbjct: 9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNHQYVV 65
Query: 353 QFIGA-------------CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
++ A K +L I E+ G++YD +H + ++ +
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV---------------KAQSG 444
+ ++Y+H IIHRDLK N+ +DE+ VK+ DFG+A+ S
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 445 VMTAETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503
+T+ GT ++A EV++ Y+ K D++S GI+ +E++ + + V
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVS 245
Query: 504 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
P N +++ DP RP ++
Sbjct: 246 IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-53
Identities = 68/272 (25%), Positives = 121/272 (44%), Gaps = 9/272 (3%)
Query: 281 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQ 338
V E+ + S++ +G+ G +++ ++ +A K++ E I ++ + +
Sbjct: 22 TQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIR 80
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
E+ ++ + +V F GA + I E M GGS+ L K G L KV+I
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSIA 139
Query: 399 VSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMA 457
V KG+ YL + I+HRD+K +N+L++ +K+ DFGV+ S + GT +M+
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRSYMS 198
Query: 458 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 517
PE ++ Y ++D++S G+ L E+ G+ P P A + G + P
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI---PPPDAKELELMFGCQVEGDAAETPP 255
Query: 518 LAELLERCWQQDPALRPDFSEIIEILQQIAKE 549
R + I E+L I E
Sbjct: 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE 287
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-53
Identities = 87/311 (27%), Positives = 146/311 (46%), Gaps = 49/311 (15%)
Query: 290 DPKHL-KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
DP + + V +G+YG +Y+G + Q AIKV+ D ++E QE+ +++K
Sbjct: 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKY 77
Query: 347 -RHKNVVQFIGA------CTKPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAID 398
H+N+ + GA L +V EF GSV D + K K + + +
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 137
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV-ARVKAQSGVMTAETGTYRWMA 457
+ +G+++LHQ+ +IHRD+K N+L+ EN VK+ DFGV A++ G GT WMA
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197
Query: 458 PEVIEHK-----PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK 512
PEVI YD K+D++S GI E+ G P + P++A IP+
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---------LIPR 248
Query: 513 NSQPKLA---------ELLERCWQQDPALRPDFSEIIE-----------ILQQIAKEVGE 552
N P+L +E C ++ + RP ++++ ++ K+ +
Sbjct: 249 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHID 308
Query: 553 ENEERRKEKSS 563
+++R EK
Sbjct: 309 RTKKKRGEKDE 319
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-51
Identities = 72/270 (26%), Positives = 126/270 (46%), Gaps = 30/270 (11%)
Query: 302 SGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQ--KEFAQEVFIMRKVRHKNVVQFIGAC 358
G +G +Y+G VA+K PE Q +EF E+ + RH ++V IG C
Sbjct: 49 HGVFGKVYKGVLRDGAKVALKRRTPE----SSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 359 TKPPSLCIVTEFMSGGSVYDYLH-KLKGVFKL--PSLLKVAIDVSKGMNYLHQNNIIHRD 415
+ + ++ ++M G++ +L+ + L++ I ++G++YLH IIHRD
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRD 164
Query: 416 LKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPE-VIEHKPYDHKAD 471
+K+ N+L+DEN V K+ DFG+++ + + T GT ++ PE I+ + + K+D
Sbjct: 165 VKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTE-KSD 223
Query: 472 VFSFGIVLWELLTGKLPYEYLTPLQA------AVGVVQKG---------LRPTIPKNSQP 516
V+SFG+VL+E+L + P + AV G L I S
Sbjct: 224 VYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLR 283
Query: 517 KLAELLERCWQQDPALRPDFSEIIEILQQI 546
K + +C RP +++ L+
Sbjct: 284 KFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 5e-50
Identities = 64/292 (21%), Positives = 111/292 (38%), Gaps = 46/292 (15%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ G+ +++RG + AIKV + + +E +++K+ HKN+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIV 70
Query: 353 QFIGA--CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQ 408
+ T ++ EF GS+Y L + + LP L V DV GMN+L +
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 409 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-- 462
N I+HR++K N++ D V K+ DFG AR + GT ++ P++ E
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190
Query: 463 ------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--------- 507
K Y D++S G+ + TG LP+ + V+ K +
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 508 ------------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
++ + Q L +L + D F +
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 5e-49
Identities = 65/297 (21%), Positives = 112/297 (37%), Gaps = 46/297 (15%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ G+ +++RG + AIKV + + +E +++K+ HKN+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIV 70
Query: 353 QFIGA--CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMNYLHQ 408
+ T ++ EF GS+Y L + + LP L V DV GMN+L +
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 409 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-- 462
N I+HR++K N++ D V K+ DFG AR + GT ++ P++ E
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190
Query: 463 ------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--------- 507
K Y D++S G+ + TG LP+ + V+ K +
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 508 ------------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
++ + Q L +L + D F + I
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-47
Identities = 71/260 (27%), Positives = 127/260 (48%), Gaps = 10/260 (3%)
Query: 289 IDPKHLK---FGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERI-NSDMQKEFAQEVFI 342
+DP+ + G + G + + + + A K++ + +++ + E+ I
Sbjct: 9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 68
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
R + H++VV F G + +V E S+ + K + P + G
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLG 127
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVI 461
YLH+N +IHRDLK NL ++E+ VK+ DFG+A +V+ GT ++APEV+
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL 187
Query: 462 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521
K + + DV+S G +++ LL GK P+E + L+ ++K +IPK+ P A L
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKN-EYSIPKHINPVAASL 245
Query: 522 LERCWQQDPALRPDFSEIIE 541
+++ Q DP RP +E++
Sbjct: 246 IQKMLQTDPTARPTINELLN 265
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-47
Identities = 72/324 (22%), Positives = 133/324 (41%), Gaps = 51/324 (15%)
Query: 259 SSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQ 316
+ P S +G + G V E+ L+ +A G + +Y + +
Sbjct: 2 AGPGSLGGASGRDQSDF------VGQTV-ELGELRLRVRRVLAEGGFAFVYEAQDVGSGR 54
Query: 317 DVAIK-VLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS--------LCI 366
+ A+K +L + + QEV M+K+ H N+VQF A + +
Sbjct: 55 EYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLL 111
Query: 367 VTEFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLL 422
+TE G + ++L + +G ++LK+ + + ++H+ IIHRDLK NLL
Sbjct: 112 LTEL-CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLL 170
Query: 423 MDENEVVKVADFGVARVKAQSGVMTAET-------------GTYRWMAPEVIE---HKPY 466
+ +K+ DFG A + + T + PE+I+ + P
Sbjct: 171 LSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI 230
Query: 467 DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLER 524
K D+++ G +L+ L + P+E L+ + G + +IP + L+
Sbjct: 231 GEKQDIWALGCILYLLCFRQHPFEDGAKLR-----IVNG-KYSIPPHDTQYTVFHSLIRA 284
Query: 525 CWQQDPALRPDFSEIIEILQQIAK 548
Q +P R +E++ LQ+IA
Sbjct: 285 MLQVNPEERLSIAEVVHQLQEIAA 308
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 3e-47
Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 29/290 (10%)
Query: 299 KVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357
+ G +G +Y+G VA+K LK ER + +F EV ++ H+N+++ G
Sbjct: 37 ILGRGGFGKVYKGRLADGTLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGF 95
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLH-KLKGVFKL--PSLLKVAIDVSKGMNYLHQN---NI 411
C P +V +M+ GSV L + + L P ++A+ ++G+ YLH + I
Sbjct: 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 155
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGTYRWMAPEVIEHKPYDHK 469
IHRD+KAAN+L+DE V DFG+A++ + V TA GT +APE + K
Sbjct: 156 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 215
Query: 470 ADVFSFGIVLWELLTGKLPYEYLTPLQA-----------------AVGVVQKGLRPTIPK 512
DVF +G++L EL+TG+ ++ +V L+
Sbjct: 216 TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKD 275
Query: 513 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRKEKS 562
+L ++ C Q P RP SE++ +L+ + E EE +KE+
Sbjct: 276 EEVEQLIQVALLCTQSSPMERPKMSEVVRMLE--GDGLAERWEEWQKEEM 323
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 7e-47
Identities = 75/295 (25%), Positives = 132/295 (44%), Gaps = 12/295 (4%)
Query: 254 PSHRSSSPTSEPEDTGMKSH---PYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYR 310
P+ P + P +IP D + G + G + +
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSR--RRYVRGRFLGKGGFAKCFE 59
Query: 311 GT--YCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367
+ + A K++ + +++ + E+ I R + H++VV F G + +V
Sbjct: 60 ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119
Query: 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
E S+ + K + P + G YLH+N +IHRDLK NL ++E+
Sbjct: 120 LELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 178
Query: 428 VVKVADFGVA-RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 486
VK+ DFG+A +V+ GT ++APEV+ K + + DV+S G +++ LL GK
Sbjct: 179 EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
Query: 487 LPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
P+E + L+ ++K +IPK+ P A L+++ Q DP RP +E++
Sbjct: 239 PPFE-TSCLKETYLRIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 7e-46
Identities = 60/244 (24%), Positives = 114/244 (46%), Gaps = 8/244 (3%)
Query: 303 GSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
GS+ +YR +VAIK++ K + M + EV I +++H ++++
Sbjct: 22 GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
+ +V E G + YL F + GM YLH + I+HRDL +
Sbjct: 82 DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLS 141
Query: 420 NLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGI 477
NLL+ N +K+ADFG+A + + T GT +++PE+ + ++DV+S G
Sbjct: 142 NLLLTRNMNIKIADFGLA-TQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGC 200
Query: 478 VLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFS 537
+ + LL G+ P++ ++ + V +P + +L+ + +++PA R S
Sbjct: 201 MFYTLLIGRPPFDT-DTVKNTLNKVVLA-DYEMPSFLSIEAKDLIHQLLRRNPADRLSLS 258
Query: 538 EIIE 541
+++
Sbjct: 259 SVLD 262
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-45
Identities = 70/260 (26%), Positives = 125/260 (48%), Gaps = 10/260 (3%)
Query: 303 GSYGDLY--RGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
G +G++Y R +A+KVL ++ + ++ + +EV I +RH N+++ G
Sbjct: 20 GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
+ ++ E+ G+VY L K F +++ ++Y H +IHRD+K
Sbjct: 80 DATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 138
Query: 420 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 479
NLL+ +K+ADFG + S GT ++ PE+IE + +D K D++S G++
Sbjct: 139 NLLLGSAGELKIADFGWSVHAPSSRRTDL-CGTLDYLPPEMIEGRMHDEKVDLWSLGVLC 197
Query: 480 WELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 539
+E L GK P+E T Q + + T P +L+ R + +P+ RP E+
Sbjct: 198 YEFLVGKPPFEANTY-QETYKRISRV-EFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 255
Query: 540 IE---ILQQIAKEVGEENEE 556
+E I +K +N+E
Sbjct: 256 LEHPWITANSSKPSNCQNKE 275
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 4e-45
Identities = 61/236 (25%), Positives = 106/236 (44%), Gaps = 14/236 (5%)
Query: 295 KFGSKVASGSYGDLYRGT--YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ ++ +G +G + R + VAIK + E + ++ + E+ IM+K+ H NVV
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNVV 75
Query: 353 QFI------GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP--SLLKVAIDVSKGMN 404
+ E+ GG + YL++ + L + + D+S +
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 405 YLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI 461
YLH+N IIHRDLK N+++ + K+ D G A+ Q + T GT +++APE++
Sbjct: 136 YLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL 195
Query: 462 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 517
E K Y D +SFG + +E +TG P+ G V++ I
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 6e-45
Identities = 60/242 (24%), Positives = 112/242 (46%), Gaps = 7/242 (2%)
Query: 303 GSYGDLY--RGTYCSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
G +G++Y R +A+KVL ++ ++ + +E+ I +RH N+++
Sbjct: 25 GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
+ ++ EF G +Y L K G F +++ ++Y H+ +IHRD+K
Sbjct: 85 DRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPE 143
Query: 420 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 479
NLLM +K+ADFG + T GT ++ PE+IE K +D K D++ G++
Sbjct: 144 NLLMGYKGELKIADFGWSVHAPSLRRRTM-CGTLDYLPPEMIEGKTHDEKVDLWCAGVLC 202
Query: 480 WELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 539
+E L G P++ + + +V L+ P +L+ + + P R +
Sbjct: 203 YEFLVGMPPFDSPSHTETHRRIVNVDLK--FPPFLSDGSKDLISKLLRYHPPQRLPLKGV 260
Query: 540 IE 541
+E
Sbjct: 261 ME 262
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-44
Identities = 67/297 (22%), Positives = 125/297 (42%), Gaps = 34/297 (11%)
Query: 259 SSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGD-LYRGTYCSQD 317
SSP+ E +D ++ T V + + G+ G +YRG + ++D
Sbjct: 3 SSPSLEQDD------------GDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRD 50
Query: 318 VAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
VA+K RI + +EV ++R+ H NV+++ I E ++
Sbjct: 51 VAVK-----RILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATL 104
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-----VVKV 431
+Y+ + + + + G+ +LH NI+HRDLK N+L+ +
Sbjct: 105 QEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMI 164
Query: 432 ADFGVARV----KAQSGVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLT 484
+DFG+ + + + GT W+APE++ + + D+FS G V + +++
Sbjct: 165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
Query: 485 -GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA-ELLERCWQQDPALRPDFSEI 539
G P+ QA + + L P+ + +A EL+E+ DP RP +
Sbjct: 225 EGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 7e-44
Identities = 57/173 (32%), Positives = 92/173 (53%), Gaps = 4/173 (2%)
Query: 381 HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440
K L L+ + V+KGM +L IHRDL A N+L+ E VVK+ DFG+AR
Sbjct: 184 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 441 AQSGVMTAETGT---YRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496
+ + +WMAPE I + Y ++DV+SFG++LWE+ + G PY + +
Sbjct: 244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303
Query: 497 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549
+++G R P + P++ + + CW +P+ RP FSE++E L + +
Sbjct: 304 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 3e-20
Identities = 39/156 (25%), Positives = 61/156 (39%), Gaps = 15/156 (9%)
Query: 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------VAIKVLKPERINSDMQKEF 336
WE LK G + G++G + D VA+K+LK E +
Sbjct: 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRAL 72
Query: 337 AQEVFIMRKV-RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK 394
E+ I+ + H NVV +GACTKP L ++ EF G++ YL + F
Sbjct: 73 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKG 132
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVK 430
+G +Y+ I DLK + ++
Sbjct: 133 A--RFRQGKDYV---GAIPVDLKRRLDSITSSQSSA 163
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 51/248 (20%), Positives = 100/248 (40%), Gaps = 18/248 (7%)
Query: 309 YRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368
++ + + + + ++ M KN V + + L I
Sbjct: 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140
Query: 369 EFMSGGSVYDYLHKLKGVFKLPS--LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
+ ++ D++++ + L + I +++ + +LH ++HRDLK +N+ +
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD 200
Query: 427 EVVKVADFGVARV-------------KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 473
+VVKV DFG+ T + GT +M+PE I Y HK D+F
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIF 260
Query: 474 SFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 533
S G++L+ELL + + V+ P + P+ +++ P R
Sbjct: 261 SLGLILFELLY---SFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317
Query: 534 PDFSEIIE 541
P+ ++IIE
Sbjct: 318 PEATDIIE 325
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-43
Identities = 54/314 (17%), Positives = 120/314 (38%), Gaps = 47/314 (14%)
Query: 295 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI---------------NSDMQKEFAQE 339
+ + G + + ++ A+K + + +F E
Sbjct: 34 RIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNE 93
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-------KGVFKLPSL 392
+ I+ ++++ + G T + I+ E+M S+ + + +
Sbjct: 94 LQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 393 LKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG 451
+ V +Y+H + NI HRD+K +N+LMD+N VK++DFG + + G
Sbjct: 154 KCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES-EYMVDKKIKGSRG 212
Query: 452 TYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYE----------------YLT 493
TY +M PE ++ K D++S GI L+ + +P+
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEY 272
Query: 494 PLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQDPALRPDFSEIIE---ILQQIAK 548
PL + + + N+ + + L+ +++PA R + ++ + +
Sbjct: 273 PLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIE 332
Query: 549 EVGEENEERRKEKS 562
++ E ++E K++
Sbjct: 333 DLREFSKELYKKRK 346
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-42
Identities = 72/242 (29%), Positives = 123/242 (50%), Gaps = 6/242 (2%)
Query: 303 GSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360
G++ + + ++VAIK++ ++N ++ +EV IM+ + H N+V+
Sbjct: 26 GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET 85
Query: 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420
+L ++ E+ SGG V+DYL G K + + Y HQ I+HRDLKA N
Sbjct: 86 EKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAEN 144
Query: 421 LLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIVL 479
LL+D + +K+ADFG + G + A G + APE+ + K YD + DV+S G++L
Sbjct: 145 LLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 204
Query: 480 WELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEI 539
+ L++G LP++ L+ V +G + IP LL+R +P R +I
Sbjct: 205 YTLVSGSLPFDGQN-LKELRERVLRG-KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQI 262
Query: 540 IE 541
++
Sbjct: 263 MK 264
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 8e-42
Identities = 52/334 (15%), Positives = 115/334 (34%), Gaps = 67/334 (20%)
Query: 235 EQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHL 294
++L L L P SS P + + + +K + +++ K +
Sbjct: 24 DKLIFKL------LSGLSKPV--SSYPNTFEWQCKLPA----IKPKTE----FQLGSKLV 67
Query: 295 KFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
+ G++ +Y T Q +KV KP + Q + ++
Sbjct: 68 YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW-EFYIGT-QLMERLKPSM 125
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK----GVFKLPSLLKVAIDVSKGM 403
++F A +V E S G++ + ++ K V ++ A+ + +
Sbjct: 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185
Query: 404 NYLHQNNIIHRDLKAANLLM-----------DENEVVKVADFGVA---RVKAQSGVMTAE 449
+H IIH D+K N ++ D + + + D G + ++ + + TA+
Sbjct: 186 EQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT 509
T + E++ +KP++++ D F ++ +L G
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM-------------------KV 286
Query: 510 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEIL 543
+ + K L R D ++E ++
Sbjct: 287 KNEGGECKPEGLFRRLPHLDM-----WNEFFHVM 315
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-41
Identities = 67/266 (25%), Positives = 127/266 (47%), Gaps = 18/266 (6%)
Query: 297 GSKVASGSYGDLYRG--TYCSQDVAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQ 353
K+ G +Y T + VAIK + R + K F +EV ++ H+N+V
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
I + +V E++ G ++ +Y+ G + + + + G+ + H I+H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVH 134
Query: 414 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKAD 471
RD+K N+L+D N+ +K+ DFG+A+ +++ + GT ++ +PE + + D D
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTD 194
Query: 472 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ-------KGLRPTIPKNSQPKLAELLER 524
++S GIVL+E+L G+ P+ T + A+ +Q +R IP L+ ++ R
Sbjct: 195 IYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIP----QSLSNVILR 250
Query: 525 CWQQDPALRP-DFSEIIEILQQIAKE 549
++D A R E+ + L + E
Sbjct: 251 ATEKDKANRYKTIQEMKDDLSSVLHE 276
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 9e-41
Identities = 66/243 (27%), Positives = 127/243 (52%), Gaps = 7/243 (2%)
Query: 303 GSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
G++G + G + VA+K+L ++I S D+ + +E+ ++ RH ++++ +
Sbjct: 22 GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
P +V E++SGG ++DY+ K G + ++ + ++Y H++ ++HRDLK
Sbjct: 82 TPTDFFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPE 140
Query: 420 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIV 478
N+L+D + K+ADFG++ + + + G+ + APEVI + Y + D++S G++
Sbjct: 141 NVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVI 200
Query: 479 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSE 538
L+ LL G LP++ + ++ G IP+ +A LL Q DP R +
Sbjct: 201 LYALLCGTLPFDDEH-VPTLFKKIRGG-VFYIPEYLNRSVATLLMHMLQVDPLKRATIKD 258
Query: 539 IIE 541
I E
Sbjct: 259 IRE 261
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-40
Identities = 71/269 (26%), Positives = 124/269 (46%), Gaps = 23/269 (8%)
Query: 297 GSKVASGSYGDLYRG--TYCSQDVAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQ 353
G + G +++ +DVA+KVL+ + + F +E + H +V
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 354 F--IGACTKPPSLC--IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
G P IV E++ G ++ D +H +G ++V D + +N+ HQN
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQN 135
Query: 410 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET----GTYRWMAPEVIEHKP 465
IIHRD+K AN+++ VKV DFG+AR A SG +T GT ++++PE
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195
Query: 466 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ------KGLRPTIPKNSQPKLA 519
D ++DV+S G VL+E+LTG+ P+ +P+ A V+ + L
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS----ADLD 251
Query: 520 ELLERCWQQDPALRP-DFSEIIEILQQIA 547
++ + ++P R +E+ L ++
Sbjct: 252 AVVLKALAKNPENRYQTAAEMRADLVRVH 280
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-40
Identities = 64/247 (25%), Positives = 118/247 (47%), Gaps = 9/247 (3%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
G+YG++ + VA+K++ +R D + +E+ I + + H+NVV+F G
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
+ + E+ SGG ++D + P + + G+ YLH I HRD+K
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134
Query: 420 NLLMDENEVVKVADFG---VARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSF 475
NLL+DE + +K++DFG V R + ++ GT ++APE+++ + + DV+S
Sbjct: 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194
Query: 476 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE-LLERCWQQDPALRP 534
GIVL +L G+LP++ + ++ P LL + ++P+ R
Sbjct: 195 GIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI 254
Query: 535 DFSEIIE 541
+I +
Sbjct: 255 TIPDIKK 261
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-40
Identities = 69/284 (24%), Positives = 118/284 (41%), Gaps = 44/284 (15%)
Query: 295 KFGSKVASGSYGD--LYRGTYCSQDVAIKVLKPERI------------------------ 328
++ GSYG L + A+KVL +++
Sbjct: 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 329 NSDMQKEFAQEVFIMRKVRHKNVVQF---IGACTKPPSLCIVTEFMSGGSVYDYLHKLKG 385
++ QE+ I++K+ H NVV+ + + L +V E ++ G V +
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVPTL--K 132
Query: 386 VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445
D+ KG+ YLH IIHRD+K +NLL+ E+ +K+ADFGV+ S
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 446 MTAET-GTYRWMAPEVI--EHKPYD-HKADVFSFGIVLWELLTGKLPY--EYLTPLQAAV 499
+ + T GT +MAPE + K + DV++ G+ L+ + G+ P+ E + L +
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK- 251
Query: 500 GVVQKGLRPTIPKNSQ--PKLAELLERCWQQDPALRPDFSEIIE 541
++ P L +L+ R ++P R EI
Sbjct: 252 --IKSQ-ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 64/247 (25%), Positives = 118/247 (47%), Gaps = 9/247 (3%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
G+YG++ + VA+K++ +R D + +E+ I + + H+NVV+F G
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
+ + E+ SGG ++D + P + + G+ YLH I HRD+K
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134
Query: 420 NLLMDENEVVKVADFG---VARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSF 475
NLL+DE + +K++DFG V R + ++ GT ++APE+++ + + DV+S
Sbjct: 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194
Query: 476 GIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE-LLERCWQQDPALRP 534
GIVL +L G+LP++ + ++ P LL + ++P+ R
Sbjct: 195 GIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI 254
Query: 535 DFSEIIE 541
+I +
Sbjct: 255 TIPDIKK 261
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 71/243 (29%), Positives = 120/243 (49%), Gaps = 8/243 (3%)
Query: 303 GSYGDLYRGTYCS--QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
GS+G + T+ Q VA+K + + + SDM +E+ ++ +RH ++++ T
Sbjct: 20 GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
P + +V E+ +GG ++DY+ + K + + + Y H++ I+HRDLK
Sbjct: 80 TPTDIVMVIEY-AGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPE 137
Query: 420 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIV 478
NLL+D+N VK+ADFG++ + + G+ + APEVI K Y + DV+S GIV
Sbjct: 138 NLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIV 197
Query: 479 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSE 538
L+ +L G+LP++ + V +P P L+ R DP R E
Sbjct: 198 LYVMLVGRLPFDDEF-IPNLFKKVNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQE 255
Query: 539 IIE 541
I
Sbjct: 256 IRR 258
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 58/202 (28%), Positives = 106/202 (52%), Gaps = 7/202 (3%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
+ + GS+G++ + Q+ A+KV+ + +EV +++K+ H
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
N+++ S IV E +GG ++D + K + F ++ V G+ Y+H++
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 410 NIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 466
NI+HRDLK N+L+ +++ +K+ DFG++ Q+ M GT ++APEV+ Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTY 199
Query: 467 DHKADVFSFGIVLWELLTGKLP 488
D K DV+S G++L+ LL+G P
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-38
Identities = 47/199 (23%), Positives = 101/199 (50%), Gaps = 6/199 (3%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
++ G++ + R + + + A K++ +++++ ++ +E I RK++H N+V
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ + + +V + ++GG +++ + + + + + + Y H N I+
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIV 127
Query: 413 HRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 469
HR+LK NLL+ + VK+ADFG+A S GT +++PEV++ PY
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 187
Query: 470 ADVFSFGIVLWELLTGKLP 488
D+++ G++L+ LL G P
Sbjct: 188 VDIWACGVILYILLVGYPP 206
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-38
Identities = 61/239 (25%), Positives = 115/239 (48%), Gaps = 21/239 (8%)
Query: 270 MKSHPYHLKIPNDGTDVWEIDP--------------KHLKFGSKVASGSYGDLYRGTYCS 315
M H +H + ++ + + K+ SG+YG++
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 316 --QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSG 373
+ AIK+++ +++ + +EV +++ + H N+++ + +V E G
Sbjct: 61 THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVK 430
G ++D + + F + V G+ YLH++NI+HRDLK NLL+ +++ ++K
Sbjct: 121 GELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIK 179
Query: 431 VADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPY 489
+ DFG++ V M GT ++APEV+ K YD K DV+S G++L+ LL G P+
Sbjct: 180 IVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYDEKCDVWSIGVILFILLAGYPPF 237
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-38
Identities = 63/261 (24%), Positives = 116/261 (44%), Gaps = 19/261 (7%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS--DMQKEFAQEVFIMRKVRHKN 350
G + GSYG + A+K+LK +++ + + +E+ ++R++RHKN
Sbjct: 8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKN 67
Query: 351 VVQF---IGACTKPPSLCIVTEFMSGGS--VYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
V+Q + K + +V E+ G + D + + F + + G+ Y
Sbjct: 68 VIQLVDVLYNEEKQ-KMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEY 124
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIE 462
LH I+H+D+K NLL+ +K++ GVA A G+ + PE+
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 463 -HKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 520
+ K D++S G+ L+ + TG P+E + + KG IP + P L++
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKG-SYAIPGDCGPPLSD 242
Query: 521 LLERCWQQDPALRPDFSEIIE 541
LL+ + +PA R +I +
Sbjct: 243 LLKGMLEYEPAKRFSIRQIRQ 263
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 9e-38
Identities = 58/202 (28%), Positives = 106/202 (52%), Gaps = 7/202 (3%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
+ + GS+G++ + Q+ A+KV+ + +EV +++K+ H
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
N+++ S IV E +GG ++D + K + F ++ V G+ Y+H++
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 410 NIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 466
NI+HRDLK N+L+ +++ +K+ DFG++ Q+ M GT ++APEV+ Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTY 199
Query: 467 DHKADVFSFGIVLWELLTGKLP 488
D K DV+S G++L+ LL+G P
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-37
Identities = 66/243 (27%), Positives = 127/243 (52%), Gaps = 7/243 (2%)
Query: 303 GSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
G++G + G + VA+K+L ++I S D+ + +E+ ++ RH ++++ +
Sbjct: 27 GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
P + +V E++SGG ++DY+ K G ++ + G++Y H++ ++HRDLK
Sbjct: 87 TPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPE 145
Query: 420 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIV 478
N+L+D + K+ADFG++ + + + G+ + APEVI + Y + D++S G++
Sbjct: 146 NVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVI 205
Query: 479 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSE 538
L+ LL G LP++ + + G P+ P + LL+ Q DP R +
Sbjct: 206 LYALLCGTLPFDDDH-VPTLFKKICDG-IFYTPQYLNPSVISLLKHMLQVDPMKRATIKD 263
Query: 539 IIE 541
I E
Sbjct: 264 IRE 266
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-37
Identities = 39/348 (11%), Positives = 97/348 (27%), Gaps = 49/348 (14%)
Query: 237 LRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKF 296
+R L++E + + + + E + + + + + LK
Sbjct: 11 MRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQ----GERKLKL 66
Query: 297 GSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
+ G ++ +D A+KV + + + F ++ ++ +
Sbjct: 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126
Query: 354 FIGAC--------------------------TKPPSLCIVTEFMSG-----GSVYDYLHK 382
+ ++ S S D+++
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186
Query: 383 LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442
+G + +L + + + L ++H NL + + + + D
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 443 SGVMTAETGTYRWMAPEVIEHK--PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG 500
G ++ TY E + + H + + G+ ++ + LP+ +TP
Sbjct: 247 RGPASSVPVTY--APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW 304
Query: 501 VVQKGLRPTIPKNSQPKLA-------ELLERCWQQDPALRPDFSEIIE 541
P + L+ R D R E +E
Sbjct: 305 KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 68/250 (27%), Positives = 115/250 (46%), Gaps = 15/250 (6%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359
SG++G + VA+K ++ + + +E+ R +RH N+V+F
Sbjct: 30 SGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
P L I+ E+ SGG +Y+ + G F + G++Y H I HRDLK
Sbjct: 87 TPTHLAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLE 145
Query: 420 NLLMDENEV--VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFG 476
N L+D + +K+ DFG ++ + GT ++APEV+ + YD ADV+S G
Sbjct: 146 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCG 205
Query: 477 IVLWELLTGKLPYE---YLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQDPA 531
+ L+ +L G P+E + + + + +IP + + P+ L+ R + DPA
Sbjct: 206 VTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV-KYSIPDDIRISPECCHLISRIFVADPA 264
Query: 532 LRPDFSEIIE 541
R EI
Sbjct: 265 TRISIPEIKT 274
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 56/257 (21%), Positives = 109/257 (42%), Gaps = 19/257 (7%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA------QEVFIMRKV 346
S + SG++G ++ ++V +K +K E++ D E E+ I+ +V
Sbjct: 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 347 RHKNVVQFIGACTKPPSLCIVTEF-MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
H N+++ + +V E SG ++ ++ + P + + + Y
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGY 145
Query: 406 LHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 465
L +IIHRD+K N+++ E+ +K+ DFG A + + GT + APEV+ P
Sbjct: 146 LRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNP 205
Query: 466 YD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524
Y + +++S G+ L+ L+ + P+ L A P +L L+
Sbjct: 206 YRGPELEMWSLGVTLYTLVFEENPFCELEETVEA--------AIHPPYLVSKELMSLVSG 257
Query: 525 CWQQDPALRPDFSEIIE 541
Q P R +++
Sbjct: 258 LLQPVPERRTTLEKLVT 274
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-37
Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 10/205 (4%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
F K+ SG++GD++ S + IK + +R M++ E+ +++ + H
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ-IEAEIEVLKSLDHP 80
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYL---HKLKGVFKLPSLLKVAIDVSKGMNYL 406
N+++ ++ IV E GG + + + + ++ + + Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 407 HQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH 463
H +++H+DLK N+L + +K+ DFG+A + T GT +MAPEV
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-K 199
Query: 464 KPYDHKADVFSFGIVLWELLTGKLP 488
+ K D++S G+V++ LLTG LP
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-37
Identities = 52/249 (20%), Positives = 97/249 (38%), Gaps = 17/249 (6%)
Query: 297 GSKVASGSYGDLYRG--TYCSQDVAIKVLKPE-RINSDMQKEFAQEVFIMRKVRHKNVVQ 353
V G GD+Y T + VA+K++ + + +E +++ +VV
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
L + ++G + L + +G P + + + ++ H H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATH 157
Query: 414 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKAD 471
RD+K N+L+ ++ + DFG+A + GT +MAPE ++AD
Sbjct: 158 RDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRAD 217
Query: 472 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ------KGLRPTIPKNSQPKLAELLERC 525
+++ VL+E LTG PY+ L + +RP IP ++ R
Sbjct: 218 IYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGIP----VAFDAVIARG 272
Query: 526 WQQDPALRP 534
++P R
Sbjct: 273 MAKNPEDRY 281
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-37
Identities = 68/298 (22%), Positives = 122/298 (40%), Gaps = 21/298 (7%)
Query: 255 SHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC 314
H S P + M E + G + SG +G +Y G
Sbjct: 6 HHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRV 65
Query: 315 S--QDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHK--NVVQFIGACTKPPSLCI 366
S VAIK ++ +RI+ EV +++KV V++ + +P S +
Sbjct: 66 SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 125
Query: 367 VTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 425
+ E ++D++ + +G + V + + + H ++HRD+K N+L+D
Sbjct: 126 ILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL 184
Query: 426 NEV-VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELL 483
N +K+ DFG + + V T GT + PE I + Y A V+S GI+L++++
Sbjct: 185 NRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243
Query: 484 TGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
G +P+E + +G + + + L+ C P+ RP F EI
Sbjct: 244 CGDIPFE-------HDEEIIRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-36
Identities = 57/204 (27%), Positives = 106/204 (51%), Gaps = 8/204 (3%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRH 348
K + GS+G++ Q+ A+KV+ K + ++ +EV +++++ H
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
N+++ +V E +GG ++D + + F ++ V G+ Y+H+
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHK 144
Query: 409 NNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 465
N I+HRDLK NLL+ ++ +++ DFG++ S M + GT ++APEV+ H
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGT 203
Query: 466 YDHKADVFSFGIVLWELLTGKLPY 489
YD K DV+S G++L+ LL+G P+
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPF 227
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 52/208 (25%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI------NSDMQKEFAQEVFIMRKV 346
+ SG+ G++ + VAI+++ + +D E+ I++K+
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
H +++ IV E M GG ++D + K + + + YL
Sbjct: 198 NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYL 255
Query: 407 HQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE- 462
H+N IIHRDLK N+L+ +E+ ++K+ DFG +++ ++ +M GT ++APEV+
Sbjct: 256 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 315
Query: 463 --HKPYDHKADVFSFGIVLWELLTGKLP 488
Y+ D +S G++L+ L+G P
Sbjct: 316 VGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 9/202 (4%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
++ + + GS+G++ A K + + F QE+ IM+ + H
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHP 66
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
N+++ + +V E +GG +++ + K VF+ ++ DV + Y H+
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 410 NIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPY 466
N+ HRDLK N L + +K+ DFG+A +M + GT +++P+V+ Y
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-EGLY 184
Query: 467 DHKADVFSFGIVLWELLTGKLP 488
+ D +S G++++ LL G P
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPP 206
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-36
Identities = 47/199 (23%), Positives = 101/199 (50%), Gaps = 6/199 (3%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
++ G++ + R + + + A K++ +++++ ++ +E I RK++H N+V
Sbjct: 32 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ + + +V + ++GG +++ + + + + + + Y H N I+
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIV 150
Query: 413 HRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 469
HR+LK NLL+ + VK+ADFG+A S GT +++PEV++ PY
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 210
Query: 470 ADVFSFGIVLWELLTGKLP 488
D+++ G++L+ LL G P
Sbjct: 211 VDIWACGVILYILLVGYPP 229
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 57/200 (28%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVRHKNV 351
F + SG++ +++ + A+K + K E+ +++K++H+N+
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS---LENEIAVLKKIKHENI 68
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V +V + +SGG ++D + + +GV+ V V + YLH+N I
Sbjct: 69 VTLEDIYESTTHYYLVMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 412 IHRDLKAANLL---MDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 468
+HRDLK NLL +EN + + DFG+++++ Q+G+M+ GT ++APEV+ KPY
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAPEVLAQKPYSK 186
Query: 469 KADVFSFGIVLWELLTGKLP 488
D +S G++ + LL G P
Sbjct: 187 AVDCWSIGVITYILLCGYPP 206
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 59/287 (20%), Positives = 120/287 (41%), Gaps = 43/287 (14%)
Query: 292 KHLKFGSKVASGSYGDL-YRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHK 349
+ + GS G + ++G++ + VA+K R+ D E+ ++ + H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVK-----RMLIDFCDIALMEIKLLTESDDHP 69
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYL------HKLKGVFKLPSLLKVAIDVSKGM 403
NV+++ + T L I E ++ D + + + K + + + ++ G+
Sbjct: 70 NVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 404 NYLHQNNIIHRDLKAANLLMD-------------ENEVVKVADFGVARV-----KAQSGV 445
+LH IIHRDLK N+L+ EN + ++DFG+ + +
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 446 MTAETGTYRWMAPEVIE-------HKPYDHKADVFSFGIVLWELLT-GKLPY--EYLTPL 495
+ +GT W APE++E + D+FS G V + +L+ GK P+ +Y
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248
Query: 496 QAAVGVVQ-KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
G+ ++ ++ + +L+ + DP RP +++
Sbjct: 249 NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 61/260 (23%), Positives = 104/260 (40%), Gaps = 23/260 (8%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS----DMQKEFAQEVFIMRKVR- 347
+ G + G +G ++ G + VAIKV+ R+ EV ++ KV
Sbjct: 34 RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 348 ---HKNVVQFIGACTKPPSLCIVTEF-MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
H V++ + +V E + ++DY+ + KG V +
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAI 152
Query: 404 NYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 462
+ H ++HRD+K N+L+D K+ DFG + T GT + PE I
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDFDGTRVYSPPEWIS 211
Query: 463 HKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521
Y A V+S GI+L++++ G +P+E + + P + P L
Sbjct: 212 RHQYHALPATVWSLGILLYDMVCGDIPFE-------RDQEILEA-ELHFPAHVSPDCCAL 263
Query: 522 LERCWQQDPALRPDFSEIIE 541
+ RC P+ RP EI+
Sbjct: 264 IRRCLAPKPSSRPSLEEILL 283
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 55/247 (22%), Positives = 95/247 (38%), Gaps = 53/247 (21%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVL---KPERINSDMQKEFAQEVFIMRKVRHK 349
+ GSYG + AIK++ K +IN + EV +M+K+ H
Sbjct: 29 HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLL---------------- 393
N+ + +C+V E GG + D L+ +
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 394 -----------------------KVAIDVSKGMNYLHQNNIIHRDLKAANLLM--DENEV 428
+ + ++YLH I HRD+K N L +++
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFE 208
Query: 429 VKVADFGVARV-----KAQSGVMTAETGTYRWMAPEVIE--HKPYDHKADVFSFGIVLWE 481
+K+ DFG+++ + MT + GT ++APEV+ ++ Y K D +S G++L
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 482 LLTGKLP 488
LL G +P
Sbjct: 269 LLMGAVP 275
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-35
Identities = 43/200 (21%), Positives = 101/200 (50%), Gaps = 7/200 (3%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ ++ G++ + R Q+ A ++ +++++ ++ +E I R ++H N+V
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ + ++ ++ + ++GG +++ + + + + + + + HQ ++
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVV 132
Query: 413 HRDLKAANLLM---DENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDH 468
HR+LK NLL+ + VK+ADFG+A V+ + GT +++PEV+ PY
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGK 192
Query: 469 KADVFSFGIVLWELLTGKLP 488
D+++ G++L+ LL G P
Sbjct: 193 PVDLWACGVILYILLVGYPP 212
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-35
Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI------NSDMQKEFAQEVFIMRKV 346
+ SG+ G++ + VAIK++ + +D E+ I++K+
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
H +++ IV E M GG ++D + K + + + YL
Sbjct: 73 NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYL 130
Query: 407 HQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE- 462
H+N IIHRDLK N+L+ +E+ ++K+ DFG +++ ++ +M GT ++APEV+
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 190
Query: 463 --HKPYDHKADVFSFGIVLWELLTGKLP 488
Y+ D +S G++L+ L+G P
Sbjct: 191 VGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 58/247 (23%), Positives = 111/247 (44%), Gaps = 14/247 (5%)
Query: 247 KLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYG 306
L + SS T+ P + ++ + + S++ G+
Sbjct: 12 DLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDAL----SDFFEVESELGRGATS 67
Query: 307 DLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364
+YR + A+KVLK ++ E+ ++ ++ H N+++ P +
Sbjct: 68 IVYRCKQKGTQKPYALKVLKKTVDKKIVR----TEIGVLLRLSHPNIIKLKEIFETPTEI 123
Query: 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM- 423
+V E ++GG ++D + + KG + + + + YLH+N I+HRDLK NLL
Sbjct: 124 SLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYA 182
Query: 424 --DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 481
+ +K+ADFG++++ +M GT + APE++ Y + D++S GI+ +
Sbjct: 183 TPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYI 242
Query: 482 LLTGKLP 488
LL G P
Sbjct: 243 LLCGFEP 249
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 52/201 (25%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 348
+ G ++ SG + + + ++ A K +K R++S + +E +EV I+R++RH
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
N++ + ++ E +SGG ++D+L + K + + G++YLH
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHS 126
Query: 409 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 464
I H DLK N+++ N +K+ DFG+A GT ++APE++ ++
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 186
Query: 465 PYDHKADVFSFGIVLWELLTG 485
P +AD++S G++ + LL+G
Sbjct: 187 PLGLEADMWSIGVITYILLSG 207
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-------DMQKEFAQEVFIMRK 345
+ + G + R + ++ A+K++ S ++++ +EV I+RK
Sbjct: 20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 346 V-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
V H N++Q +V + M G ++DYL + K K+ + + +
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVIC 138
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-- 462
LH+ NI+HRDLK N+L+D++ +K+ DFG + + GT ++APE+IE
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 198
Query: 463 ----HKPYDHKADVFSFGIVLWELLTGKLP 488
H Y + D++S G++++ LL G P
Sbjct: 199 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 14/207 (6%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSD---MQKEFAQEVFIMRKVRHK 349
+ + G + + R Q A+K++ + S ++ +E I ++H
Sbjct: 27 ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK----GMNY 405
++V+ + + L +V EFM G + + K + VA + + Y
Sbjct: 87 HIVELLETYSSDGMLYMVFEFMDGADLCFEIVK-RADAGFVYSEAVASHYMRQILEALRY 145
Query: 406 LHQNNIIHRDLKAANLLM---DENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVI 461
H NNIIHRD+K +L+ + + VK+ FGVA + V GT +MAPEV+
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 462 EHKPYDHKADVFSFGIVLWELLTGKLP 488
+ +PY DV+ G++L+ LL+G LP
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 48/194 (24%), Positives = 93/194 (47%), Gaps = 7/194 (3%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGAC 358
G + + + S Q+ A K LK R D + E E+ ++ + V+
Sbjct: 39 RGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98
Query: 359 TKPPSLCIVTEFMSGGSVYDYL-HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 417
+ ++ E+ +GG ++ +L + ++++ + +G+ YLHQNNI+H DLK
Sbjct: 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLK 158
Query: 418 AANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 474
N+L+ +K+ DFG++R + + GT ++APE++ + P D+++
Sbjct: 159 PQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWN 218
Query: 475 FGIVLWELLTGKLP 488
GI+ + LLT P
Sbjct: 219 IGIIAYMLLTHTSP 232
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ----KEFAQEVFIMRKVRH 348
G ++ SG + + + S + A K +K + + + +E +EV I+R+V H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
NV+ + ++ E +SGG ++D+L + K + G+NYLH
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHT 133
Query: 409 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 464
I H DLK N+++ +K+ DFG+A GT ++APE++ ++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 465 PYDHKADVFSFGIVLWELLTGKLP 488
P +AD++S G++ + LL+G P
Sbjct: 194 PLGLEADMWSIGVITYILLSGASP 217
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 52/250 (20%), Positives = 114/250 (45%), Gaps = 18/250 (7%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 313
+ + E+ +S ++P+ E + + G + R +
Sbjct: 58 AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAK-EFY-QKYDPKDVIGRGVSSVVRRCVH 115
Query: 314 CS--QDVAIKVLK------PERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSL 364
+ + A+K+++ ++++ +E I+R+V H +++ I + +
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175
Query: 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD 424
+V + M G ++DYL + K + + + +++LH NNI+HRDLK N+L+D
Sbjct: 176 FLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD 234
Query: 425 ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE------HKPYDHKADVFSFGIV 478
+N ++++DFG + + GT ++APE+++ H Y + D+++ G++
Sbjct: 235 DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294
Query: 479 LWELLTGKLP 488
L+ LL G P
Sbjct: 295 LFTLLAGSPP 304
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 8e-34
Identities = 54/213 (25%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLK-----------PERINSDMQKEFAQ 338
+ K+ SG+YG++ + + AIKV+K + +E
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
E+ +++ + H N+++ +VTEF GG +++ + + F +
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQ 154
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRW 455
+ G+ YLH++NI+HRD+K N+L+ + +K+ DFG++ ++ + GT +
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214
Query: 456 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP 488
+APEV+ K Y+ K DV+S G++++ LL G P
Sbjct: 215 IAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-34
Identities = 42/198 (21%), Positives = 88/198 (44%), Gaps = 7/198 (3%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ G +G ++R S + K +K + + + K +E+ I+ RH+N++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNIL 64
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ L ++ EF+SG +++ ++ ++ V + + +LH +NI
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 413 HRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 470
H D++ N++ + +K+ +FG AR + APEV +H
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 471 DVFSFGIVLWELLTGKLP 488
D++S G +++ LL+G P
Sbjct: 185 DMWSLGTLVYVLLSGINP 202
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLK----PERINSDMQKEFAQEVFIMRKVRH 348
G ++ SG + + + S + A K +K ++E +EV I+R+V H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
N++ + ++ E +SGG ++D+L + K + G+NYLH
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHT 133
Query: 409 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 464
I H DLK N+++ +K+ DFG+A GT ++APE++ ++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 465 PYDHKADVFSFGIVLWELLTGKLP 488
P +AD++S G++ + LL+G P
Sbjct: 194 PLGLEADMWSIGVITYILLSGASP 217
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-33
Identities = 60/268 (22%), Positives = 113/268 (42%), Gaps = 14/268 (5%)
Query: 230 PYEETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTD-VWE 288
P E T + ++ + R+G+ Y I E
Sbjct: 93 PCEPTAPVLIPGDE---RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149
Query: 289 IDPKHLK----FGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFI 342
I H+ ++ +G++G ++R T + + A K + + ++ +E+
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQT 207
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
M +RH +V A + ++ EFMSGG +++ + ++ V KG
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 267
Query: 403 MNYLHQNNIIHRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 460
+ ++H+NN +H DLK N++ + +K+ DFG+ + TGT + APEV
Sbjct: 268 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 327
Query: 461 IEHKPYDHKADVFSFGIVLWELLTGKLP 488
E KP + D++S G++ + LL+G P
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-33
Identities = 55/264 (20%), Positives = 95/264 (35%), Gaps = 28/264 (10%)
Query: 297 GSKVASGSYGDLYRGT---YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
+A G G +Y + V +K L +++ Q E + +V H ++VQ
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 354 FI-----GACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
P IV E++ G S+ + + +++ ++YLH
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLHS 200
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 468
+++ DLK N+++ E + +K+ D G G + GT + APE++ P
Sbjct: 201 IGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYL---YGTPGFQAPEIVRTGP-TV 255
Query: 469 KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK-LAELLERCWQ 527
D+++ G L L G GL P LL R
Sbjct: 256 ATDIYTVGRTLAALTLDLPTRN---------GRYVDGLPEDDPVLKTYDSYGRLLRRAID 306
Query: 528 QDPALRP-DFSEIIEILQQIAKEV 550
DP R E+ L + +EV
Sbjct: 307 PDPRQRFTTAEEMSAQLTGVLREV 330
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 50/204 (24%), Positives = 96/204 (47%), Gaps = 11/204 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQK----EFAQEVFIMRKVRH 348
G ++ SG + + + S A K +K R S + + +EV I+++++H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
NV+ + ++ E ++GG ++D+L + K + + G+ YLH
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS 132
Query: 409 NNIIHRDLKAANLLM----DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 464
I H DLK N+++ +K+ DFG+A GT ++APE++ ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 465 PYDHKADVFSFGIVLWELLTGKLP 488
P +AD++S G++ + LL+G P
Sbjct: 193 PLGLEADMWSIGVITYILLSGASP 216
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 41/198 (20%), Positives = 93/198 (46%), Gaps = 6/198 (3%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
++ SG++G ++R + + K + + E+ IM ++ H ++
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLI 111
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
A + ++ EF+SGG ++D + ++ +G+ ++H+++I+
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 171
Query: 413 HRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 470
H D+K N++ + VK+ DFG+A ++ T T + APE+++ +P
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYT 231
Query: 471 DVFSFGIVLWELLTGKLP 488
D+++ G++ + LL+G P
Sbjct: 232 DMWAIGVLGYVLLSGLSP 249
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 45/299 (15%), Positives = 93/299 (31%), Gaps = 59/299 (19%)
Query: 291 PKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRKVR 347
P+ L G+ + T + + V ER S+ K+ +EV +R +R
Sbjct: 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131
Query: 348 -------------------------HKNVVQFIGACTKPPSLCIVTEFM----SGGSVYD 378
K +++ L + + + +
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191
Query: 379 YLHKLKGVFKLPSL---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
L K L++ + V + + LH ++H L+ ++++D+ V + F
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 251
Query: 436 VARVKAQSGVMTAETGTYRWMAPEVI-----------EHKPYDHKADVFSFGIVLWELLT 484
+ G + + + PE+ D ++ G+V++ +
Sbjct: 252 HLV---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 485 GKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
LP AA+G + R IP + LLE + R + +E
Sbjct: 309 ADLPIT----KDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 359
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 47/194 (24%), Positives = 93/194 (47%), Gaps = 13/194 (6%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGAC 358
GS+ + + Q A+K+ I+ M+ +E+ ++ H N+V+
Sbjct: 21 EGSFSICRKCVHKKSNQAFAVKI-----ISKRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418
+V E ++GG +++ + K K F + + ++++H ++HRDLK
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKP 134
Query: 419 ANLLM---DENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFS 474
NLL ++N +K+ DFG AR + + T + APE++ YD D++S
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWS 194
Query: 475 FGIVLWELLTGKLP 488
G++L+ +L+G++P
Sbjct: 195 LGVILYTMLSGQVP 208
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 39/294 (13%), Positives = 91/294 (30%), Gaps = 50/294 (17%)
Query: 291 PKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVL-KPERINSDMQKEFAQEVFIMRK-- 345
P+ L G+ + T + + V ER S+ K+ +EV +R
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136
Query: 346 --------------------VRHKNVVQFIGACTKPPSLCIVTEF-------MSGGSVYD 378
V+ + I + +++ F + + +
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196
Query: 379 YLHKLKGVFKLPSL---LKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
L K L++ + V + + LH ++H L+ ++++D+ V + F
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 436 VARVKAQSGVMTAETGTY---RWMAPEVIEHKP-----YDHKADVFSFGIVLWELLTGKL 487
+ + ++ + A ++ D ++ G+ ++ + L
Sbjct: 257 HLV-RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 488 PYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
P L + + + IP + LLE + R + +E
Sbjct: 316 PNTDDAALGGSEWIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 51/247 (20%), Positives = 106/247 (42%), Gaps = 14/247 (5%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSK--------VASGSY 305
S+ + + + + P D + K S + G +
Sbjct: 43 WSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRF 102
Query: 306 GDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363
G +++ + +A K++K + ++E E+ +M ++ H N++Q A
Sbjct: 103 GQVHKCEETATGLKLAAKIIKTRGMKD--KEEVKNEISVMNQLDHANLIQLYDAFESKND 160
Query: 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
+ +V E++ GG ++D + + + +G+ ++HQ I+H DLK N+L
Sbjct: 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILC 220
Query: 424 --DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWE 481
+ + +K+ DFG+AR + GT ++APEV+ + D++S G++ +
Sbjct: 221 VNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYM 280
Query: 482 LLTGKLP 488
LL+G P
Sbjct: 281 LLSGLSP 287
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 53/202 (26%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRK-VRHKNV 351
+ + GSY R + + + A+K++ +++ +E+ I+ + +H N+
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTEEIEILLRYGQHPNI 78
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
+ + +VTE M GG + D + + + F V ++K + YLH +
Sbjct: 79 ITLKDVYDDGKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 412 IHRDLKAANLLM----DENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPY 466
+HRDLK +N+L E +++ DFG A+ ++A++G++ T ++APEV+E + Y
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197
Query: 467 DHKADVFSFGIVLWELLTGKLP 488
D D++S G++L+ +LTG P
Sbjct: 198 DAACDIWSLGVLLYTMLTGYTP 219
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 58/241 (24%), Positives = 108/241 (44%), Gaps = 17/241 (7%)
Query: 303 GSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGA 357
GS+ + T S++ AIK+L+ I + + + E +M ++ H V+
Sbjct: 41 GSFSTVVLARELAT--SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT 98
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 417
L + G + Y+ K G F ++ + YLH IIHRDLK
Sbjct: 99 FQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLK 157
Query: 418 AANLLMDENEVVKVADFGVA-RVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFS 474
N+L++E+ +++ DFG A + +S A + GT ++++PE++ K +D+++
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWA 217
Query: 475 FGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPKNSQPKLAELLERCWQQDPAL 532
G ++++L+ G P+ + QK L P+ PK +L+E+ D
Sbjct: 218 LGCIIYQLVAGLPPFRAGNEYL----IFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATK 273
Query: 533 R 533
R
Sbjct: 274 R 274
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 66/234 (28%), Positives = 111/234 (47%), Gaps = 8/234 (3%)
Query: 303 GSYG--DLYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFIGACT 359
GS+G L + A+K+L +++ Q E E I++ V +V+ +
Sbjct: 52 GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
+L +V E+++GG ++ +L + G F P A + YLH ++I+RDLK
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 420 NLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVL 479
NLL+D+ ++V DFG A K G GT +APE+I K Y+ D ++ G+++
Sbjct: 171 NLLIDQQGYIQVTDFGFA--KRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228
Query: 480 WELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 533
+E+ G P+ P+Q +V +R P + L +LL Q D R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-30
Identities = 57/230 (24%), Positives = 109/230 (47%), Gaps = 9/230 (3%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L+ +RI + A E I+ KV + VV A +LC+V M+GG +
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272
Query: 378 DYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
+++ + + F + A ++ G+ LH+ I++RDLK N+L+D++ ++++D G+
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL 332
Query: 437 ARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496
A + + GT +MAPEV++++ Y D ++ G +L+E++ G+ P++
Sbjct: 333 AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI 392
Query: 497 AAVGVVQKGLR--PTIPKNSQPKLAELLERCWQQDPALR-----PDFSEI 539
V + + P+ L + +DPA R E+
Sbjct: 393 KREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREV 442
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-29
Identities = 63/223 (28%), Positives = 109/223 (48%), Gaps = 9/223 (4%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A K L +R+ + A E I+ KV + +V A LC+V M+GG +
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR 273
Query: 378 DYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434
+++ + F+ P + + G+ +LHQ NII+RDLK N+L+D++ V+++D
Sbjct: 274 YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDL 333
Query: 435 GVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492
G+A V+ ++G + GT +MAPE++ + YD D F+ G+ L+E++ + P+
Sbjct: 334 GLA-VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392
Query: 493 TPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERCWQQDPALR 533
+ Q+ L T P P + E Q+DP R
Sbjct: 393 GEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKR 435
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 55/228 (24%), Positives = 105/228 (46%), Gaps = 9/228 (3%)
Query: 319 AIKVLKPERINSDMQKEFA-QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+K + ++ + +E+ IM+ + H +V + + +V + + GG +
Sbjct: 44 AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR 103
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437
+L + FK ++ ++ ++YL IIHRD+K N+L+DE+ V + DF +A
Sbjct: 104 YHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA 162
Query: 438 RVKAQSGVMTAETGTYRWMAPEVIEHKP---YDHKADVFSFGIVLWELLTGKLPYEYL-- 492
+ + +T GT +MAPE+ + Y D +S G+ +ELL G+ PY
Sbjct: 163 AMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222
Query: 493 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR-PDFSEI 539
T + V + T P ++ LL++ + +P R S++
Sbjct: 223 TSSKEIVHTFETT-VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDV 269
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 56/226 (24%), Positives = 111/226 (49%), Gaps = 13/226 (5%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
A+KV+K E +N D ++ Q E + + H +V L V E+++GG +
Sbjct: 38 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 97
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
++ + + + ++S +NYLH+ II+RDLK N+L+D +K+ D+G+
Sbjct: 98 MFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 156
Query: 437 ARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494
+ + G T+ T GT ++APE++ + Y D ++ G++++E++ G+ P++ +
Sbjct: 157 CKEGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 215
Query: 495 LQAAVGVVQKGL-------RPTIPKNSQPKLAELLERCWQQDPALR 533
+ L + IP++ K A +L+ +DP R
Sbjct: 216 SDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 58/248 (23%), Positives = 105/248 (42%), Gaps = 39/248 (15%)
Query: 256 HRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS 315
H S E G + Y + TD +++ + L G G G + +
Sbjct: 5 HHHHSSGLEVLFQGPEPKKYAV------TDDYQLSKQVL--GL----GVNGKVLECFHRR 52
Query: 316 --QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC----TKPPSLCIVT 368
Q A+K+L + QEV + ++V + L I+
Sbjct: 53 TGQKCALKLL-------YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105
Query: 369 EFMSGGSVYDYLHKLKGVFKLP-----SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423
E M GG ++ + + +G +++ D+ + +LH +NI HRD+K NLL
Sbjct: 106 ECMEGGELFSRIQE-RGDQAFTEREAAEIMR---DIGTAIQFLHSHNIAHRDVKPENLLY 161
Query: 424 ---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLW 480
+++ V+K+ DFG A+ + + T ++APEV+ + YD D++S G++++
Sbjct: 162 TSKEKDAVLKLTDFGFAK-ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 220
Query: 481 ELLTGKLP 488
LL G P
Sbjct: 221 ILLCGFPP 228
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 56/250 (22%), Positives = 101/250 (40%), Gaps = 26/250 (10%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 313
P+ P ++P + P I + + G G + +
Sbjct: 24 PTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFN 83
Query: 314 CS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC----TKPPSLCI 366
+ A+K+L D K +EV + + + ++V+ + L I
Sbjct: 84 KRTQEKFALKML------QDCPKAR-REVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136
Query: 367 VTEFMSGGSVYDYLHKLKGVFKLP-----SLLKVAIDVSKGMNYLHQNNIIHRDLKAANL 421
V E + GG ++ + +G ++K + + + YLH NI HRD+K NL
Sbjct: 137 VMECLDGGELFSRIQD-RGDQAFTEREASEIMK---SIGEAIQYLHSINIAHRDVKPENL 192
Query: 422 LM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIV 478
L N ++K+ DFG A+ +T T ++APEV+ + YD D++S G++
Sbjct: 193 LYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 252
Query: 479 LWELLTGKLP 488
++ LL G P
Sbjct: 253 MYILLCGYPP 262
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 61/240 (25%), Positives = 105/240 (43%), Gaps = 32/240 (13%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVL--KPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIG 356
G++ + Q+ A+K++ +P I S + +EV ++ + + H+NV++ I
Sbjct: 23 EGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF----REVEMLYQCQGHRNVLELIE 78
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ +V E M GGS+ ++HK + F V DV+ +++LH I HRDL
Sbjct: 79 FFEEEDRFYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 417 KAANLLM---DENEVVKVADFGVARV--------KAQSGVMTAETGTYRWMAPEVIE--- 462
K N+L ++ VK+ DF + + + G+ +MAPEV+E
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 463 --HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 520
YD + D++S G++L+ LL+G P G R Q L E
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGY------PPFVGRCGSDCGWDRGEACPACQNMLFE 251
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 55/226 (24%), Positives = 111/226 (49%), Gaps = 13/226 (5%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
A++V+K E +N D ++ Q E + + H +V L V E+++GG +
Sbjct: 81 AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 140
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
++ + + + ++S +NYLH+ II+RDLK N+L+D +K+ D+G+
Sbjct: 141 MFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 199
Query: 437 ARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494
+ + G T+ T GT ++APE++ + Y D ++ G++++E++ G+ P++ +
Sbjct: 200 CKEGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 258
Query: 495 LQAAVGVVQKGL-------RPTIPKNSQPKLAELLERCWQQDPALR 533
+ L + IP++ K A +L+ +DP R
Sbjct: 259 SDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 58/229 (25%), Positives = 111/229 (48%), Gaps = 12/229 (5%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+K+L+ E I + + E +++ RH + A LC V E+ +GG ++
Sbjct: 34 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 93
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437
+L + + VF ++ + YLH ++++RD+K NL++D++ +K+ DFG+
Sbjct: 94 FHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152
Query: 438 RVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL 495
+ G T GT ++APEV+E Y D + G+V++E++ G+LP+
Sbjct: 153 KEGISDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211
Query: 496 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR-----PDFSEI 539
+ ++ + +R P+ P+ LL ++DP R D E+
Sbjct: 212 RLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 52/174 (29%), Positives = 95/174 (54%), Gaps = 4/174 (2%)
Query: 319 AIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYD 378
A+KVLK + + E I+ +V H +V+ A L ++ +F+ GG ++
Sbjct: 56 AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 115
Query: 379 YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438
L K + +F + +++ +++LH II+RDLK N+L+DE +K+ DFG+++
Sbjct: 116 RLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK 174
Query: 439 VKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
+ GT +MAPEV+ + + AD +SFG++++E+LTG LP++
Sbjct: 175 ESIDHEKKAY-SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 66/216 (30%), Positives = 108/216 (50%), Gaps = 6/216 (2%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+KVLK E + Q E E ++ V H +++ G + ++ +++ GG ++
Sbjct: 35 AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELF 94
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437
L K F P A +V + YLH +II+RDLK N+L+D+N +K+ DFG A
Sbjct: 95 SLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 153
Query: 438 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497
K V GT ++APEV+ KPY+ D +SFGI+++E+L G P+ ++
Sbjct: 154 --KYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211
Query: 498 AVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 533
++ LR P + +LL R +D + R
Sbjct: 212 YEKILNAELR--FPPFFNEDVKDLLSRLITRDLSQR 245
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 57/194 (29%), Positives = 96/194 (49%), Gaps = 9/194 (4%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
V GSYG + + + VAIK + ++K +E+ +++++RH+N+V +
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
C K +V EF+ ++ D L + K + G+ + H +NIIHRD+
Sbjct: 92 VCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDI 150
Query: 417 KAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT--YRWMAPEVI-EHKPYDHKADV 472
K N+L+ ++ VVK+ DFG AR A V E T YR APE++ Y DV
Sbjct: 151 KPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR--APELLVGDVKYGKAVDV 208
Query: 473 FSFGIVLWELLTGK 486
++ G ++ E+ G+
Sbjct: 209 WAIGCLVTEMFMGE 222
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 36/209 (17%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQ--------EVFIMRKVRH 348
+ G + +Y+ +Q VAIK +I + E E+ +++++ H
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIK-----KIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS-------K 401
N++ + A ++ +V +FM L+ + K SL+ + +
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFME--------TDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 402 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT--YRWMAP 458
G+ YLHQ+ I+HRDLK NLL+DEN V+K+ADFG+A+ + T + T YR AP
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYR--AP 181
Query: 459 EVIEH-KPYDHKADVFSFGIVLWELLTGK 486
E++ + Y D+++ G +L ELL
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 74/321 (23%), Positives = 146/321 (45%), Gaps = 25/321 (7%)
Query: 232 EETEQLRAALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDP 291
EE E+ A++ L++Q + S +++G + L P +
Sbjct: 94 EEREEWTTAIQTVADGLKKQ-AAAEMDFRSGSPSDNSGAEEMEVSLAKPKH-----RVTM 147
Query: 292 KHLKFGSKVASGSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKV 346
++ + G++G + + T + A+K+LK E I + + E +++
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKAT--GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
RH + + LC V E+ +GG ++ +L + + VF ++ ++YL
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYL 264
Query: 407 H-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEH 463
H + N+++RDLK NL++D++ +K+ DFG+ + + G T GT ++APEV+E
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK-TFCGTPEYLAPEVLED 323
Query: 464 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 523
Y D + G+V++E++ G+LP+ + ++ + +R P+ P+ LL
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLS 381
Query: 524 RCWQQDPALR-----PDFSEI 539
++DP R D EI
Sbjct: 382 GLLKKDPKQRLGGGSEDAKEI 402
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 24/201 (11%)
Query: 299 KVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNVV 352
K+ G+YG +Y+ + A+K +I + + E +E+ I+++++H N+V
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALK-----KIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
+ L +V E + D L +G + + + + G+ Y H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 410 NIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT--YRWMAPEVI-EHKP 465
++HRDLK NLL++ +K+ADFG+AR T E T YR AP+V+ K
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR--APDVLMGSKK 177
Query: 466 YDHKADVFSFGIVLWELLTGK 486
Y D++S G + E++ G
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGT 198
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-27
Identities = 65/222 (29%), Positives = 110/222 (49%), Gaps = 10/222 (4%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKN---VVQFIGACTKPPSLCIVTEFMSGG 374
A+K L +RI + A E ++ V + +V A P L + + M+GG
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277
Query: 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434
++ +L + GVF + A ++ G+ ++H +++RDLK AN+L+DE+ V+++D
Sbjct: 278 DLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDL 336
Query: 435 GVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLT 493
G+A A GT+ +MAPEV++ YD AD FS G +L++LL G P+
Sbjct: 337 GLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF-RQH 394
Query: 494 PLQAAVGVVQKGLR--PTIPKNSQPKLAELLERCWQQDPALR 533
+ + + L +P + P+L LLE Q+D R
Sbjct: 395 KTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 436
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 57/176 (32%), Positives = 89/176 (50%), Gaps = 6/176 (3%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
A+KVLK + I D E E I+ H + Q P L V EF++GG +
Sbjct: 52 AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL 111
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
++ K F A ++ + +LH II+RDLK N+L+D K+ADFG+
Sbjct: 112 MFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM 170
Query: 437 ARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
+ +GV TA T GT ++APE+++ Y D ++ G++L+E+L G P+E
Sbjct: 171 CKEGICNGVTTA-TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 55/177 (31%), Positives = 97/177 (54%), Gaps = 8/177 (4%)
Query: 319 AIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375
A+KVLK I + K+ A E I+ +V+H +V I A L ++ E++SGG
Sbjct: 49 AMKVLKKAMIVRN-AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGE 107
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
++ L + +G+F + ++S + +LHQ II+RDLK N++++ VK+ DFG
Sbjct: 108 LFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFG 166
Query: 436 VARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
+ + G +T T GT +MAPE++ ++ D +S G +++++LTG P+
Sbjct: 167 LCKESIHDGTVT-HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT 222
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 37/214 (17%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKE-F----AQEVFIMRKVRHKNV 351
K+ G++G++++ Q VA+K ++ + +KE F +E+ I++ ++H+NV
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQLLKHENV 78
Query: 352 VQFIGACT--------KPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVS 400
V I C S+ +V +F +D L + F L + +V +
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR-----VKAQSGVMTAETGT--Y 453
G+ Y+H+N I+HRD+KAAN+L+ + V+K+ADFG+AR +Q T T Y
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194
Query: 454 RWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
R PE++ + Y D++ G ++ E+ T
Sbjct: 195 R--PPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 7e-27
Identities = 53/194 (27%), Positives = 97/194 (50%), Gaps = 9/194 (4%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
K+ GSYG +++ Q VAIK + ++K +E+ ++++++H N+V +
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
+ L +V E+ +V L + + + + + +N+ H++N IHRD+
Sbjct: 70 VFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDV 128
Query: 417 KAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT--YRWMAPEVIEH-KPYDHKADV 472
K N+L+ ++ V+K+ DFG AR+ S E T YR +PE++ Y DV
Sbjct: 129 KPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR--SPELLVGDTQYGPPVDV 186
Query: 473 FSFGIVLWELLTGK 486
++ G V ELL+G
Sbjct: 187 WAIGCVFAELLSGV 200
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-27
Identities = 60/250 (24%), Positives = 116/250 (46%), Gaps = 12/250 (4%)
Query: 249 ERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDL 308
+ + + + + ++ + + F + GS+G +
Sbjct: 298 GNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKV 357
Query: 309 ----YRGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPP 362
+GT + A+K+LK + + D E E ++ + + Q
Sbjct: 358 MLSERKGT--DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415
Query: 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422
L V E+++GG + ++ + G FK P + A +++ G+ +L II+RDLK N++
Sbjct: 416 RLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM 474
Query: 423 MDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLW 480
+D +K+ADFG+ + GV T T GT ++APE+I ++PY D ++FG++L+
Sbjct: 475 LDSEGHIKIADFGMCKENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 533
Query: 481 ELLTGKLPYE 490
E+L G+ P+E
Sbjct: 534 EMLAGQAPFE 543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 54/176 (30%), Positives = 96/176 (54%), Gaps = 6/176 (3%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
A+K+LK + + D E E ++ + + Q L V E+++GG +
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 108
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
++ + G FK P + A +++ G+ +L II+RDLK N+++D +K+ADFG+
Sbjct: 109 MYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM 167
Query: 437 ARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
+ GV T T GT ++APE+I ++PY D ++FG++L+E+L G+ P+E
Sbjct: 168 CKENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 299 KVASGSYGDLYRG---TYCSQDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKN 350
KV G+YG +Y+ + VA+K RI D + E +E+ +++++ H N
Sbjct: 28 KVGEGTYGVVYKAKDSQ--GRIVALK-----RIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
+V I L +V EFM D L + K + + + +G+ + H
Sbjct: 81 IVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT--YRWMAPEVI-EH 463
Q+ I+HRDLK NLL++ + +K+ADFG+AR T E T YR AP+V+
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR--APDVLMGS 194
Query: 464 KPYDHKADVFSFGIVLWELLTGK 486
K Y D++S G + E++TGK
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK 217
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 2e-26
Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 10/220 (4%)
Query: 319 AIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGS 375
AIK LK + + D E V H + +L V E+++GG
Sbjct: 46 AIKALKKDVVLMDDDVECTMVEKRVL-SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGD 104
Query: 376 VYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
+ ++ F L A ++ G+ +LH I++RDLK N+L+D++ +K+ADFG
Sbjct: 105 LMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 163
Query: 436 VARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493
+ + T T GT ++APE++ + Y+H D +SFG++L+E+L G+ P+
Sbjct: 164 MCKENMLGDAKTN-TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222
Query: 494 PLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR 533
+ + P+ + + +LL + + ++P R
Sbjct: 223 EEELFHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKR 260
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 351
K+ G+YG +++ + VA+K R+ D E +E+ ++++++HKN+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALK-----RVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
V+ L +V EF D Y G + + KG+ + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SGVMTAETGT--YRWMAPEVI-EHK 464
N++HRDLK NLL++ N +K+A+FG+AR +AE T YR P+V+ K
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR--PPDVLFGAK 177
Query: 465 PYDHKADVFSFGIVLWELLTGKLPY 489
Y D++S G + EL P
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 58/338 (17%), Positives = 111/338 (32%), Gaps = 87/338 (25%)
Query: 269 GMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS------QDVAIKV 322
GM++ + + + ++SGSYG C+ VAIK
Sbjct: 1 GMQAKGEAAMRDLIAE-LHAMQSPY-TVQRFISSGSYG-----AVCAGVDSEGIPVAIKR 53
Query: 323 LKPERINSDMQKEF-----AQ----EVFIMRKVRHKNVVQFIGACTKPPSLC------IV 367
+ + + E+ ++ H N++ + +V
Sbjct: 54 VFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG-LRDIFVHFEEPAMHKLYLV 112
Query: 368 TEFMSGGSVYDYLHKL--KGVFKLPS---------LLKVAIDVSKGMNYLHQNNIIHRDL 416
TE M D L ++ + +L G++ LH+ ++HRDL
Sbjct: 113 TELMR----TD-LAQVIHDQRIVISPQHIQYFMYHILL-------GLHVLHEAGVVHRDL 160
Query: 417 KAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVF 473
N+L+ +N + + DF +AR T YR APE++ + K + D++
Sbjct: 161 HPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYR--APELVMQFKGFTKLVDMW 218
Query: 474 SFGIVLWELLTGK-------------LPYEYL-TPLQAAVGVVQ--------KGLRPTIP 511
S G V+ E+ K E + TP V + + +P
Sbjct: 219 SAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVP 278
Query: 512 K--------NSQPKLAELLERCWQQDPALRPDFSEIIE 541
+ P +L+ + + +P R + +
Sbjct: 279 ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 43/197 (21%), Positives = 92/197 (46%), Gaps = 10/197 (5%)
Query: 303 GSYGD--LYRGTYCSQDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNVVQFIGACT 359
G++G+ + + + A+K+L + + F +E ++ K + A
Sbjct: 85 GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144
Query: 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419
+L +V ++ GG + L K + ++ ++ +HQ + +HRD+K
Sbjct: 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPD 204
Query: 420 NLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP-----YDHKADV 472
N+LMD N +++ADFG + G + + GT +++PE+++ Y + D
Sbjct: 205 NILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDW 264
Query: 473 FSFGIVLWELLTGKLPY 489
+S G+ ++E+L G+ P+
Sbjct: 265 WSLGVCMYEMLYGETPF 281
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 35/212 (16%)
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQ--------EVFIMRKVR- 347
++ G+YG +Y+ + VA+K + EV ++R++
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALK-----SVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 348 --HKNVVQFIGACT-----KPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLK-VA 396
H NVV+ + C + + +V E + D YL K +K +
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDLM 126
Query: 397 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT--YR 454
+G+++LH N I+HRDLK N+L+ VK+ADFG+AR+ + +T T YR
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYR 186
Query: 455 WMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 486
APEV+ Y D++S G + E+ K
Sbjct: 187 --APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 52/203 (25%), Positives = 98/203 (48%), Gaps = 28/203 (13%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKE------FAQEVFIMRKVRHKN 350
K+ G+Y +Y+G VA+K ++ ++ E +EV +++ ++H N
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEIR-------LEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
+V SL +V E++ D YL + + ++ + +G+ Y H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT--YRWMAPEVI-EH 463
+ ++HRDLK NLL++E +K+ADFG+AR K+ + E T YR P+++
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR--PPDILLGS 175
Query: 464 KPYDHKADVFSFGIVLWELLTGK 486
Y + D++ G + +E+ TG+
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGR 198
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 64/229 (27%), Positives = 113/229 (49%), Gaps = 12/229 (5%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIM-RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSV 376
A+KVL+ + I +++ E ++ + V+H +V + L V ++++GG +
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126
Query: 377 YDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
+ +L + + F P A +++ + YLH NI++RDLK N+L+D + + DFG+
Sbjct: 127 FYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL 185
Query: 437 ARVKAQSGVMTAET--GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494
+ + T+ T GT ++APEV+ +PYD D + G VL+E+L G P+
Sbjct: 186 CKENIEHNSTTS-TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 244
Query: 495 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR----PDFSEI 539
+ ++ K L+ + N LLE Q+D R DF EI
Sbjct: 245 AEMYDNILNKPLQ--LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 39/211 (18%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 351
K+ +G+Y +Y+G + VA+K +K + +E +E+ +M++++H+N+
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLD------SEEGTPSTAIREISLMKELKHENI 65
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS----------- 400
V+ L +V EFM + LK ++ +
Sbjct: 66 VRLYDVIHTENKLTLVFEFMD--------NDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 401 -KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA-QSGVMTAETGT--YRWM 456
+G+ + H+N I+HRDLK NLL+++ +K+ DFG+AR ++E T YR
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR-- 175
Query: 457 APEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
AP+V+ + Y D++S G +L E++TGK
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 32/263 (12%), Positives = 79/263 (30%), Gaps = 46/263 (17%)
Query: 297 GSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRHKNVVQ 353
++ T + VA+ + P+ + D+ +E + ++ V +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
+ +V E++ GGS+ + ++ ++ + H+ +
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVAD---TSPSPVGAIRAMQSLAAAADAAHRAGVAL 152
Query: 414 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 473
+ + + + V +A + + D+
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPATMP--------------------------DANPQDDIR 186
Query: 474 SFGIVLWELLTGKLPYE---YLTPLQAAVGVVQ------KGLRPTIPKNSQPKLAELLER 524
G L+ LL + P + L A + IP +++ + R
Sbjct: 187 GIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP----FQISAVAAR 242
Query: 525 CWQQDPALRPDFSEIIEILQQIA 547
Q D +R S ++ ++QQ
Sbjct: 243 SVQGDGGIRSA-STLLNLMQQAT 264
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 33/210 (15%)
Query: 299 KVASGSYGDLYRGTYCSQD---VAIKVLKPERINSDMQKEFA-----QEVFIMRKVR--- 347
++ G+YG +++ VA+K R+ +E +EV ++R +
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALK-----RVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 348 HKNVVQFI-----GACTKPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLK-VAID 398
H NVV+ + L +V E + D YL K+ +K +
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT--YRWM 456
+ +G+++LH + ++HRDLK N+L+ + +K+ADFG+AR+ + +T+ T YR
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYR-- 186
Query: 457 APEVIEHKPYDHKADVFSFGIVLWELLTGK 486
APEV+ Y D++S G + E+ K
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 65/308 (21%), Positives = 130/308 (42%), Gaps = 26/308 (8%)
Query: 254 PSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYG------- 306
+S + + + L+ N ++ ++ + + +G+YG
Sbjct: 16 GGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRK 75
Query: 307 DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQ---EVFIMRKVRHKN-VVQFIGACTKPP 362
T + A+KVLK I K E ++ +R +V A
Sbjct: 76 ISGHDT--GKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132
Query: 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422
L ++ ++++GG ++ +L + + F + ++ + +LH+ II+RD+K N+L
Sbjct: 133 KLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 191
Query: 423 MDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVI--EHKPYDHKADVFSFGIV 478
+D N V + DFG+++ A GT +MAP+++ +D D +S G++
Sbjct: 192 LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 251
Query: 479 LWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERCWQQDPALR--- 533
++ELLTG P+ + + ++ L+ P P+ +L++R +DP R
Sbjct: 252 MYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGC 311
Query: 534 --PDFSEI 539
D EI
Sbjct: 312 GPRDADEI 319
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 38/201 (18%), Positives = 85/201 (42%), Gaps = 16/201 (7%)
Query: 303 GSYGDLY----RGTYCSQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGA 357
G++ ++ + T Q A+K++ + + + E ++ + + Q A
Sbjct: 72 GAFSEVAVVKMKQT--GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129
Query: 358 CTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLK 417
L +V E+ GG + L K ++ ++ +H+ +HRD+K
Sbjct: 130 FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIK 189
Query: 418 AANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIE-------HKPYDH 468
N+L+D +++ADFG G + + GT +++PE+++ Y
Sbjct: 190 PDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGP 249
Query: 469 KADVFSFGIVLWELLTGKLPY 489
+ D ++ G+ +E+ G+ P+
Sbjct: 250 ECDWWALGVFAYEMFYGQTPF 270
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 45/218 (20%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIM 343
W + K+ G Y +++ + + V +K+LKP + +K+ +E+ I+
Sbjct: 31 EWGN-QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKIL 84
Query: 344 RKVR-HKNVVQ----FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI- 397
+R N++ ++ P+L + + D +L +L I
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPAL-VFEHVNN----TD-FKQL-----YQTLTDYDIR 133
Query: 398 ----DVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTAETGT 452
++ K ++Y H I+HRD+K N+++D E+ +++ D+G+A +
Sbjct: 134 FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 193
Query: 453 YRWM-APEVI-EHKPYDHKADVFSFGIVLWELLTGKLP 488
R+ PE++ +++ YD+ D++S G +L ++ K P
Sbjct: 194 -RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 37/221 (16%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQ----E 339
+ + ++ + + SG+ G + ++VAIK K R + + A+ E
Sbjct: 57 TFTVLKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQN--QTHAKRAYRE 111
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+ +M+ V HKN++ + T +L +V E M + L ++ + L
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----AN-LCQV-----IQMEL 161
Query: 394 K------VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 447
+ + G+ +LH IIHRDLK +N+++ + +K+ DFG+AR S +MT
Sbjct: 162 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 221
Query: 448 AETGT--YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 486
T YR APEVI Y D++S G ++ E++ K
Sbjct: 222 PYVVTRYYR--APEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 67/255 (26%), Positives = 112/255 (43%), Gaps = 43/255 (16%)
Query: 256 HRSSSPTSEPEDTGMKSHPYHLKIP-NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC 314
S++P + + + +K+ +DG + + + + +GS+G +++
Sbjct: 4 TMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNC-KVIGNGSFGVVFQAKLV 62
Query: 315 -SQDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPS-------LC 365
S +VAIK ++ D K F E+ IMR V+H NVV + A L
Sbjct: 63 ESDEVAIK-----KVLQD--KRFKNRELQIMRIVKHPNVVD-LKAFFYSNGDKKDEVFLN 114
Query: 366 IVTEFMSGGSVYDYL-HKLKGVFKLPS---------LLKVAIDVSKGMNYLHQNNIIHRD 415
+V E++ +VY H K +P LL+ + Y+H I HRD
Sbjct: 115 LVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLR-------SLAYIHSIGICHRD 166
Query: 416 LKAANLLMDENE-VVKVADFGVARVKAQSGVMTAE--TGTYRWMAPEVI-EHKPYDHKAD 471
+K NLL+D V+K+ DFG A++ + + YR APE+I Y D
Sbjct: 167 IKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR--APELIFGATNYTTNID 224
Query: 472 VFSFGIVLWELLTGK 486
++S G V+ EL+ G+
Sbjct: 225 IWSTGCVMAELMQGQ 239
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 40/211 (18%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
+ +GS+G +Y+ C + VAIK ++ D + + +E+ IMRK+ H N+V+ +
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIK-----KVLQDKRFKN-RELQIMRKLDHCNIVR-LR 113
Query: 357 ACTKPPS-------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS--------- 400
L +V +++ + V + S K + V
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVP--------ETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 401 -KGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSGVMTAETGT--YRWM 456
+ + Y+H I HRD+K NLL+D + V+K+ DFG A+ + + + YR
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR-- 223
Query: 457 APEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
APE+I Y DV+S G VL ELL G+
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 45/225 (20%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQ----E 339
+ + ++ + + SG+ G + ++VAIK K R + + A+ E
Sbjct: 20 TFTVLKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQN--QTHAKRAYRE 74
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLP--- 390
+ +M+ V HKN++ + T SL IV E M + L + V ++
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----AN-LCQ---VIQMELDH 126
Query: 391 --------SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442
+L G+ +LH IIHRDLK +N+++ + +K+ DFG+AR
Sbjct: 127 ERMSYLLYQMLC-------GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179
Query: 443 SGVMTAETGTYRWM-APEVIEHKPYDHKADVFSFGIVLWELLTGK 486
S +MT T R+ APEVI Y D++S G ++ E++ G
Sbjct: 180 SFMMTPYVVT-RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 45/220 (20%), Positives = 98/220 (44%), Gaps = 43/220 (19%)
Query: 298 SKVASGSYG------DLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---- 347
K+ G + D+ T+ VA+K+++ + + E+ ++++V
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTH----VAMKIVRG---DKVYTEAAEDEIKLLQRVNDADN 77
Query: 348 -------HKNVVQ------FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLL 393
++++ G + +V E + G ++ + K + L +
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVH--VVMVFEVL-GENLLALIKKYEHRGIPLIYVK 134
Query: 394 KVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENE------VVKVADFGVARVKAQSGVM 446
+++ + G++Y+H+ IIH D+K N+LM+ + +K+AD G A +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 194
Query: 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 486
+ +T YR +PEV+ P+ AD++S +++EL+TG
Sbjct: 195 SIQTREYR--SPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 69/220 (31%), Positives = 102/220 (46%), Gaps = 35/220 (15%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQ----E 339
WE+ + V SG+YG + VAIK K R + FA+ E
Sbjct: 20 AWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQS--ELFAKRAYRE 74
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+ +++ +RH+NV+ + T +L +V FM D L K + K L
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG----TD-LGK---LMKHEKLG 126
Query: 394 KVAID-----VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448
+ I + KG+ Y+H IIHRDLK NL ++E+ +K+ DFG+AR MT
Sbjct: 127 EDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ--ADSEMTG 184
Query: 449 ETGTYRWM-APEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
T RW APEVI Y D++S G ++ E++TGK
Sbjct: 185 YVVT-RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 33/221 (14%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQEVFIM 343
V+++ P++ S + G+YG + VAIK + P + Q+ +E+ I+
Sbjct: 22 VFDVGPRY-TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKIL 79
Query: 344 RKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
+ RH+N++ P++ IV + M D L+K + K L I
Sbjct: 80 LRFRHENIIGINDIIR-APTIEQMKDVYIVQDLME----TD-LYK---LLKTQHLSNDHI 130
Query: 398 D-----VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTA 448
+ +G+ Y+H N++HRDLK +NLL++ +K+ DFG+ARV +G +T
Sbjct: 131 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 449 ETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
T YR APE++ K Y D++S G +L E+L+ +
Sbjct: 191 YVATRWYR--APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 9/178 (5%)
Query: 319 AIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVY 377
A+K+L + F E IM VVQ A L +V E+M GG +
Sbjct: 98 AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV 157
Query: 378 DYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVA 437
+ + +V ++ +H IHRD+K N+L+D++ +K+ADFG
Sbjct: 158 NLMSNYD--VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 215
Query: 438 RVKAQSGVMTAET--GTYRWMAPEVIEHKP----YDHKADVFSFGIVLWELLTGKLPY 489
+ G++ +T GT +++PEV++ + Y + D +S G+ L+E+L G P+
Sbjct: 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 28/216 (12%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQ----E 339
WE+ PK + V SG+YG + + VAIK K R + FA+ E
Sbjct: 19 AWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQS--EIFAKRAYRE 73
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+ +++ ++H+NV+ + T SL +V FM D L K+ G+ +
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TD-LQKIMGLKFSEEKI 128
Query: 394 KVAI-DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 452
+ + + KG+ Y+H ++HRDLK NL ++E+ +K+ DFG+AR MT T
Sbjct: 129 QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH--ADAEMTGYVVT 186
Query: 453 YRW-MAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
RW APEVI Y+ D++S G ++ E+LTGK
Sbjct: 187 -RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 37/210 (17%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA-----QEVFIMRKVRHKNV 351
K+ G+YG++Y+ + VAIK RI + ++E +EV ++++++H+N+
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIK-----RIRLEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS------KGMNY 405
++ L ++ E+ + LK + + + S G+N+
Sbjct: 96 IELKSVIHHNHRLHLIFEYAE--------NDLKKYMDKNPDVSMRVIKSFLYQLINGVNF 147
Query: 406 LHQNNIIHRDLKAANLLMDENE-----VVKVADFGVARVKA-QSGVMTAETGT--YRWMA 457
H +HRDLK NLL+ ++ V+K+ DFG+AR T E T YR
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR--P 205
Query: 458 PEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
PE++ + Y D++S + E+L
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-23
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 48/218 (22%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFA----QEVFIMRKVRHKNVV 352
G++G + G S VAIK ++ D F Q + + + H N+V
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIK-----KVIQD--PRFRNRELQIMQDLAVLHHPNIV 82
Query: 353 QFIGACTKPPS--------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS---- 400
Q + + L +V E++ D LH+ + +VA
Sbjct: 83 Q-LQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHR---CCRNYYRRQVAPPPILIKV 133
Query: 401 ------KGMNYLHQN--NIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTAETG 451
+ + LH N+ HRD+K N+L++ + +K+ DFG A+ + S A
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 452 T--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
+ YR APE+I ++ Y D++S G + E++ G+
Sbjct: 194 SRYYR--APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 46/208 (22%), Positives = 81/208 (38%), Gaps = 47/208 (22%)
Query: 296 FGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVV 352
+ G G + + + A+K+L D K +EV + + + ++V
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPK-ARREVELHWRASQCPHIV 74
Query: 353 QFIGAC----TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLP-----SLLKVAIDVSKGM 403
+ + L IV E + GG ++ + +G ++K + + +
Sbjct: 75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMK---SIGEAI 130
Query: 404 NYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 460
YLH NI HRD+K NLL N ++K+ DFG A E
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKET 170
Query: 461 IEHKPYDHKADVFSFGIVLWELLTGKLP 488
+ YD D++S G++++ LL G P
Sbjct: 171 T-GEKYDKSCDMWSLGVIMYILLCGYPP 197
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 1e-22
Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 44/223 (19%)
Query: 295 KFGSKVASGSYGDLYRG----TYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 350
G KV G+YG +Y+ +D A+K ++ I+ +E + ++R+++H N
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPN 79
Query: 351 VVQFIGACT--KPPSLCIVTEFMSGGSVYD---YLHKLKGVFKLPSLLKVAIDVSK---- 401
V+ + ++ ++ +D + + +++ + K
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 402 ----GMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVAR-----VKAQSGVMTA 448
G++YLH N ++HRDLK AN+L+ E VK+AD G AR +K + +
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD-LDP 194
Query: 449 ETGT--YRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGK 486
T YR APE++ H Y D+++ G + ELLT +
Sbjct: 195 VVVTFWYR--APELLLGARH--YTKAIDIWAIGCIFAELLTSE 233
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 50/233 (21%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQ 338
V+ I + S + G+YG CS + VAIK ++P + +
Sbjct: 6 VYNISSDF-QLKSLLGEGAYG-----VVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-R 58
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSL 392
E+ I++ +H+N++ I +P S I+ E M D LH+ V L
Sbjct: 59 EIKILKHFKHENIIT-IFNIQRPDSFENFNEVYIIQELMQ----TD-LHR---VISTQML 109
Query: 393 LKVAI-----DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-------- 439
I + + LH +N+IHRDLK +NLL++ N +KV DFG+AR+
Sbjct: 110 SDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 440 ---KAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
Q M T YR APEV+ Y DV+S G +L EL +
Sbjct: 170 SEPTGQQSGMVEFVATRWYR--APEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 65/220 (29%), Positives = 108/220 (49%), Gaps = 35/220 (15%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQ----E 339
+WE+ ++ + S V SG+YG + T VA+K K R A+ E
Sbjct: 24 IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQS--IIHAKRTYRE 78
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLL 393
+ +++ ++H+NV+ + T SL +VT M D L+ + K L
Sbjct: 79 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----AD-LNN---IVKCQKLT 130
Query: 394 KVAID-----VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448
+ + +G+ Y+H +IIHRDLK +NL ++E+ +K+ DFG+AR + MT
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH--TADEMTG 188
Query: 449 ETGTYRW-MAPEVI-EHKPYDHKADVFSFGIVLWELLTGK 486
T RW APE++ Y+ D++S G ++ ELLTG+
Sbjct: 189 YVAT-RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 64/311 (20%), Positives = 115/311 (36%), Gaps = 80/311 (25%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQ 338
+++ ++ + G G S + VAIK + ++ +
Sbjct: 6 GFDLGSRY-MDLKPLGCGGNG-----LVFSAVDNDCDKRVAIKKIVLTDP-QSVKHAL-R 57
Query: 339 EVFIMRKVRHKNVVQFIGACTKPPSLC--------------IVTEFMSGGSVYDYLHKLK 384
E+ I+R++ H N+V+ S IV E+M D L
Sbjct: 58 EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME----TD-LAN-- 110
Query: 385 GVFKLPSLLKVAID-----VSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVAR 438
V + LL+ + +G+ Y+H N++HRDLK ANL ++ E+ V+K+ DFG+AR
Sbjct: 111 -VLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169
Query: 439 V----KAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGK----- 486
+ + G ++ T YR +P ++ Y D+++ G + E+LTGK
Sbjct: 170 IMDPHYSHKGHLSEGLVTKWYR--SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAG 227
Query: 487 --------LPYEYL-TPLQAAVGVVQKGLR------PTIPK--------NSQPKLAELLE 523
L E + + + + T P + + LE
Sbjct: 228 AHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLE 287
Query: 524 RCWQQDPALRP 534
+ P R
Sbjct: 288 QILTFSPMDRL 298
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 1e-20
Identities = 56/188 (29%), Positives = 92/188 (48%), Gaps = 31/188 (16%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK------NVVQFIGACTKPPSLCIVTE 369
Q VA+K+++ ++ A+E+ I+ +R + NV+ + T +C+ E
Sbjct: 123 QHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE 179
Query: 370 FMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
+S ++Y+ + +K +G F LP + K A + + ++ LH+N IIH DLK N+L+ +
Sbjct: 180 LLSM-NLYELIKKNKFQG-FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG 237
Query: 428 --VVKVADFGVARVKAQSGVMTAETGT-------YRWMAPEVIEHKPYDHKADVFSFGIV 478
+KV DFG S + YR APEVI Y D++S G +
Sbjct: 238 RSGIKVIDFG-------SSCYEHQRVYTYIQSRFYR--APEVILGARYGMPIDMWSLGCI 288
Query: 479 LWELLTGK 486
L ELLTG
Sbjct: 289 LAELLTGY 296
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 71/307 (23%), Positives = 114/307 (37%), Gaps = 70/307 (22%)
Query: 281 NDGTDVWEIDPKHLKFGSKVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKEFAQ 338
G + + + GSYG +Y ++VAIK K R+ D +
Sbjct: 16 FQGIKNVHVPDNY-IIKHLIGRGSYGYVYLAYDKNTEKNVAIK--KVNRMFED--LIDCK 70
Query: 339 ----EVFIMRKVRHKNVVQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFK 388
E+ I+ +++ +++ P L IV E D L K +FK
Sbjct: 71 RILREITILNRLKSDYIIRLYDLI-IPDDLLKFDELYIVLEIAD----SD-LKK---LFK 121
Query: 389 LPSLLK------VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--- 439
P L + ++ G N++H++ IIHRDLK AN L++++ VKV DFG+AR
Sbjct: 122 TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181
Query: 440 --------------------KAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVFSFG 476
K +T+ T YR APE+I + Y D++S G
Sbjct: 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYR--APELILLQENYTKSIDIWSTG 239
Query: 477 IVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDF 536
+ ELL + P P +S L+ + + R
Sbjct: 240 CIFAELLNMLQSHINDPT----------NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQL 289
Query: 537 SEIIEIL 543
+ I I+
Sbjct: 290 NIIFNII 296
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 3e-20
Identities = 68/296 (22%), Positives = 111/296 (37%), Gaps = 68/296 (22%)
Query: 239 AALEKEVLKLERQGWPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGS 298
++ E + G S S + S +P +D W+I ++ +
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSD-WQIPDRY-EIRH 59
Query: 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERINSDMQKE-FAQ----EVFIMRKVRHKNV 351
+ +GSYG + + VAIK +I + + E+ I+ ++ H +V
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIK-----KILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 352 VQFIGACTKPPSLC------IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI------DV 399
V+ + P + +V E D K +F+ P L ++
Sbjct: 115 VK-VLDIVIPKDVEKFDELYVVLEIAD----SD-FKK---LFRTPVYLTELHIKTLLYNL 165
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-------------------- 439
G+ Y+H I+HRDLK AN L++++ VKV DFG+AR
Sbjct: 166 LVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 440 --------KAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELLT 484
K +T T YR APE+I + Y DV+S G + ELL
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYR--APELILLQENYTEAIDVWSIGCIFAELLN 279
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 46/243 (18%), Positives = 91/243 (37%), Gaps = 72/243 (29%)
Query: 299 KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHKNVVQ-- 353
+ +GS+G + + A+K ++ D + E+ IM+ + H N+++
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALK-----KVLQD--PRYKNRELDIMKVLDHVNIIKLV 66
Query: 354 ------------------------------FIGACTKPPS------LCIVTEFMSGGSVY 377
+ + L ++ E++ +++
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLH 125
Query: 378 DYL-HKLKGVFKLPS---------LLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-EN 426
L ++ +P L + + ++H I HRD+K NLL++ ++
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFR-------AVGFIHSLGICHRDIKPQNLLVNSKD 178
Query: 427 EVVKVADFGVARVKAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWELL 483
+K+ DFG A+ S A + YR APE++ Y D++S G V EL+
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYICSRFYR--APELMLGATEYTPSIDLWSIGCVFGELI 236
Query: 484 TGK 486
GK
Sbjct: 237 LGK 239
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 66/245 (26%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQ- 338
+ K+ + K+ G+YG + VA+K K + AQ
Sbjct: 5 RHVLRKY-ELVKKLGKGAYG-----IVWKSIDRRTGEVVAVK--KIFDAFQN--STDAQR 54
Query: 339 ---EVFIMRKVR-HKNVVQFIGACTKPPS---LCIVTEFMSGGSVYDYLHKLKGVFKLPS 391
E+ I+ ++ H+N+V + + + + +V ++M D LH V +
Sbjct: 55 TFREIMILTELSGHENIVNLLNVL-RADNDRDVYLVFDYME----TD-LHA---VIRANI 105
Query: 392 LLKVAI-----DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV------- 439
L V + K + YLH ++HRD+K +N+L++ VKVADFG++R
Sbjct: 106 LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 440 ---------------KAQSGVMTAETGT--YRWMAPEVI-EHKPYDHKADVFSFGIVLWE 481
++T T YR APE++ Y D++S G +L E
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYR--APEILLGSTKYTKGIDMWSLGCILGE 223
Query: 482 LLTGK 486
+L GK
Sbjct: 224 ILCGK 228
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-19
Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 19/183 (10%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH------KNVVQFIGACTKPPSLCIVTE 369
+ VAIK++K + EV ++ + +V LC+V E
Sbjct: 80 EWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE 136
Query: 370 FMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQN--NIIHRDLKAANLLM-- 423
+S ++YD L +G L K A + + +L +IIH DLK N+L+
Sbjct: 137 MLSY-NLYDLLRNTNFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN 194
Query: 424 DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELL 483
+ +K+ DFG + Q ++ YR +PEV+ PYD D++S G +L E+
Sbjct: 195 PKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SPEVLLGMPYDLAIDMWSLGCILVEMH 252
Query: 484 TGK 486
TG+
Sbjct: 253 TGE 255
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 71/285 (24%), Positives = 120/285 (42%), Gaps = 31/285 (10%)
Query: 293 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-K 349
+ G K+ SGS+GD+Y GT + ++VAIK+ E + + + E I + ++
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQ-LHIESKIYKMMQGGV 65
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
+ + +V E + G S+ D + F L ++L +A + + Y+H
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 410 NIIHRDLKAANLLM---DENEVVKVADFGVAR--VKAQSGVMTAE------TGTYRWM-- 456
N IHRD+K N LM + +V + DFG+A+ A++ TGT R+
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184
Query: 457 -APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL---TPLQAAVGVVQKGLRPTIP- 511
IE D D+ S G VL G LP++ L T Q + +K + I
Sbjct: 185 NTHLGIEQSRRD---DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241
Query: 512 --KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEEN 554
K + A L C +PD+S + ++ + + G
Sbjct: 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 51/206 (24%), Positives = 82/206 (39%), Gaps = 48/206 (23%)
Query: 315 SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK------NVVQFIGACTKPPSLCIVT 368
+ VA+K++K + E+ ++ + VQ + +CIV
Sbjct: 40 GRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVF 96
Query: 369 EFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
E + G S YD++ + F+L + K+A + K +N+LH N + H DLK N+L ++
Sbjct: 97 ELL-GLSTYDFIKENGFLP-FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQS 154
Query: 427 EV-------------------VKVADFGVARVKAQSGVMTAETGT-------YRWMAPEV 460
+ +KV DFG S E + YR APEV
Sbjct: 155 DYTEAYNPKIKRDERTLINPDIKVVDFG-------SATYDDEHHSTLVSTRHYR--APEV 205
Query: 461 IEHKPYDHKADVFSFGIVLWELLTGK 486
I + DV+S G +L E G
Sbjct: 206 ILALGWSQPCDVWSIGCILIEYYLGF 231
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 49/206 (23%), Positives = 85/206 (41%), Gaps = 50/206 (24%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRHK------NVVQFIGACTKPPSLCIVT 368
VA+K+++ N +E A+ E+ +++K++ K V +CI
Sbjct: 46 SQVALKIIR----NVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101
Query: 369 EFMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426
E + G + +++L + + + LP + +A + + +LH+N + H DLK N+L +
Sbjct: 102 ELL-GKNTFEFLKENNFQP-YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNS 159
Query: 427 EV-------------------VKVADFGVARVKAQSGVMTAETGT-------YRWMAPEV 460
E ++VADFG S E T YR PEV
Sbjct: 160 EFETLYNEHKSCEEKSVKNTSIRVADFG-------SATFDHEHHTTIVATRHYR--PPEV 210
Query: 461 IEHKPYDHKADVFSFGIVLWELLTGK 486
I + DV+S G +L+E G
Sbjct: 211 ILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 52/211 (24%), Positives = 93/211 (44%), Gaps = 55/211 (26%)
Query: 316 QDVAIKVLKPERINSDMQKEFAQ-EVFIMRKVRH-----KNVVQFIGACTKPPSLCIVTE 369
+ A+KV++ N A+ E I++K+++ N+V++ G +C++ E
Sbjct: 61 KYYAVKVVR----NIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE 116
Query: 370 FMSGGSVYDYL--HKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427
+ G S+Y+ + + G F + + I++ K +NYL + ++ H DLK N+L+D+
Sbjct: 117 PL-GPSLYEIITRNNYNG-FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPY 174
Query: 428 V-------------------------VKVADFGVARVKAQSGVMTAETGT-------YRW 455
+K+ DFG ++ YR
Sbjct: 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-------CATFKSDYHGSIINTRQYR- 226
Query: 456 MAPEVIEHKPYDHKADVFSFGIVLWELLTGK 486
APEVI + +D +D++SFG VL EL TG
Sbjct: 227 -APEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 61/285 (21%), Positives = 118/285 (41%), Gaps = 30/285 (10%)
Query: 293 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-K 349
+ + G K+ G++G+L G + VAIK+ E + S + E +++
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAPQLH-LEYRFYKQLGSGD 65
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
+ Q +V E + G S+ D F L ++L +AI + M Y+H
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 410 NIIHRDLKAANLLM-----DENEVVKVADFGVAR--VKAQSG--VMTAE----TGTYRWM 456
N+I+RD+K N L+ +V+ + DF +A+ + ++ + E TGT R+M
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184
Query: 457 APEVIEHKPYDH--KADVFSFGIVLWELLTGKLPYEYL---TPLQAAVGVVQKGLRPTIP 511
+ + H + + D+ + G + L G LP++ L T + + I
Sbjct: 185 S--INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE 242
Query: 512 K--NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEEN 554
+ P++A L + D +PD+ + ++ + G
Sbjct: 243 VLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMF 287
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 52/286 (18%), Positives = 107/286 (37%), Gaps = 31/286 (10%)
Query: 293 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-K 349
H K G ++ GS+G ++ GT Q VAIK E SD + E + +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAP-QLRDEYRTYKLLAGCT 66
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
+ + +V + + G S+ D L F + ++ A + + +H+
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 410 NIIHRDLKAANLLM-----DENEVVKVADFGVAR--VKAQSGVMTAE------TGTYRWM 456
++++RD+K N L+ ++ V DFG+ + + +GT R+M
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185
Query: 457 APEVIEHKPYDH--KADVFSFGIVLWELLTGKLPYEYL---TPLQAAVGVVQKGLRPTIP 511
+ + H + + D+ + G V L G LP++ L T Q + +K +
Sbjct: 186 S--INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243
Query: 512 ---KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEEN 554
+ + + PD+ + + ++ + +
Sbjct: 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 289
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 60/349 (17%), Positives = 114/349 (32%), Gaps = 56/349 (16%)
Query: 253 WPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGT 312
H SS E+ +S L+ GT + + + K S + G LY
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAA 62
Query: 313 ----------YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362
Q ++K+ + + + E F R + V P
Sbjct: 63 PTSTLTCDSGPQKQKFSLKL---DAKDGRLFNEQN---FFQRAAKPLQV-NKWKKLYSTP 115
Query: 363 SLCIVTEFMSGGSVYDY-----------LHKL-----KGVFKLPSLLKVAIDVSKGMNYL 406
L I T G Y L K V S+L+VA + + +L
Sbjct: 116 LLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFL 175
Query: 407 HQNNIIHRDLKAANLLMDENEVVKV--ADFGVAR--------VKAQSGVMTAETGTYRWM 456
H+N +H ++ A N+ +D + +V A +G A V G + G ++
Sbjct: 176 HENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235
Query: 457 APEVIEHKPYDH--KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK-- 512
+ + HK ++D+ S G + + L G LP+ P + ++
Sbjct: 236 S--MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFV 293
Query: 513 ------NSQPK-LAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEEN 554
+ L + L+ +P ++ + L+ + +++
Sbjct: 294 GPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSP 342
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 54/258 (20%), Positives = 95/258 (36%), Gaps = 71/258 (27%)
Query: 298 SKVASGSYGDLY--RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-------- 347
K+ G + ++ + VA+KV+K + E+ +++ VR
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVK---SAEHYTETALDEIRLLKSVRNSDPNDPN 99
Query: 348 HKNVVQFIGACT-KPPS---LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKG 402
+ VVQ + + +C+V E + G + ++ K LP + K+ V +G
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158
Query: 403 MNYLH-QNNIIHRDLKAANLLM-------------------------------------- 423
++YLH + IIH D+K N+L+
Sbjct: 159 LDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 424 -----------DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADV 472
E VK+AD G A + +T YR + EV+ Y+ AD+
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYR--SLEVLIGSGYNTPADI 276
Query: 473 FSFGIVLWELLTGKLPYE 490
+S + +EL TG +E
Sbjct: 277 WSTACMAFELATGDYLFE 294
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 68/339 (20%), Positives = 126/339 (37%), Gaps = 51/339 (15%)
Query: 255 SHRSSSPTSEPEDTGMKSHPYHLKIP-NDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY 313
H SS + Y +P +G + +++ G K+ SG +G +Y
Sbjct: 4 HHHHSSGVDLGTENL-----YFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFP 58
Query: 314 --CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371
+ A V+K E + E+ ++V K+ ++ + L I +
Sbjct: 59 TNKPEKDARHVVKVEYQENGPLF---SELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115
Query: 372 SGGSVY---DY--------------LHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414
SG + + Y + G FK ++L++ I + + Y+H+N +H
Sbjct: 116 SGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHG 175
Query: 415 DLKAANLLMDENEVVKV--ADFGVARVKAQSGVM--------TAETGTYRWMAPEVIEHK 464
D+KAANLL+ +V AD+G++ +G GT + + + HK
Sbjct: 176 DIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTS--LDAHK 233
Query: 465 PYDH--KADVFSFGIVLWELLTGKLPYEYLTPLQAAV--------GVVQKGLRPTIPKNS 514
++DV G + L GKLP+E AV + + + P S
Sbjct: 234 GVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGS 293
Query: 515 QPK-LAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 552
+A+ L +P++ + +IL +G
Sbjct: 294 SCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGP 332
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 54/301 (17%), Positives = 108/301 (35%), Gaps = 44/301 (14%)
Query: 295 KFGSKVASGSYGDLYRGT-YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
K G + G +G +Y S+ V ++ E+ ++ +Q
Sbjct: 38 KVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQ 97
Query: 354 FIGACTKPPSLCI-------------------VTEFMSGGSVYDYLHKLKGVFKLPSLLK 394
K L + + + G + F ++L+
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQ 156
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKV--ADFGVARVKAQSGVMTAE--- 449
+++ + + Y+H++ +H D+KA+NLL++ +V D+G+A GV A
Sbjct: 157 LSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216
Query: 450 -----TGTYRWMAPEVIEHKPYDH--KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502
GT + + + H + D+ G + + LTG LP+E V
Sbjct: 217 PKRCHDGTIEFTS--IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDS 274
Query: 503 QKGLRPTIP---------KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE 553
+ R I N+ ++A+ +E D +P + + +IL Q K +G +
Sbjct: 275 KIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334
Query: 554 N 554
+
Sbjct: 335 D 335
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 63/285 (22%), Positives = 114/285 (40%), Gaps = 31/285 (10%)
Query: 293 HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HK 349
+ G K+ SGS+G++Y GT +++VAIK+ E + + + E I R ++
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHP-QLLYESKIYRILQGGT 63
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
+ + +V + + G S+ D + L ++L +A + + ++H
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 410 NIIHRDLKAANLLMDENE---VVKVADFGVAR--VKAQSGVMTAE------TGTYRWM-- 456
+ +HRD+K N LM V + DFG+A+ + TGT R+
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASV 182
Query: 457 -APEVIEHKPYDHKADVFSFGIVLWELLTGKLP---YEYLTPLQAAVGVVQKGLRPTIP- 511
IE D D+ S G VL L G LP + T Q + +K + +I
Sbjct: 183 NTHLGIEQSRRD---DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239
Query: 512 --KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEEN 554
+ + A C +PD+S + + + + G +
Sbjct: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQF 284
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 4e-12
Identities = 33/186 (17%), Positives = 63/186 (33%), Gaps = 48/186 (25%)
Query: 299 KVASGSYGDLYRGTYCSQDVAIKVL---KPERINSDMQK---EFAQEVFIMRKV------ 346
K+ G +G++++ VAIK++ P+ +N QK E E+ I +++
Sbjct: 27 KIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 347 ---RHKNVVQFIGAC----TKPPSLC--------------------------IVTEFMSG 373
R + + + PP L IV EF G
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVA 432
G D + L + + ++ + + HRDL N+L+ + + K+
Sbjct: 147 GI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLH 204
Query: 433 DFGVAR 438
+
Sbjct: 205 YTLNGK 210
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 4e-08
Identities = 48/436 (11%), Positives = 120/436 (27%), Gaps = 118/436 (27%)
Query: 208 QEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLK------------------LE 249
+ + + + D FV + + + ++ L KE + L
Sbjct: 13 EHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLL 72
Query: 250 RQG-----------------WPSHRSSSPTSEPEDTGMKSHPYHLKIPNDGT-----DVW 287
+ + + +P ++ ND +V
Sbjct: 73 SKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS 132
Query: 288 EIDPKH--------LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQE 339
+ P L+ V G L G VA+ V ++ Q + +
Sbjct: 133 RLQPYLKLRQALLELRPAKNVL--IDGVLGSGKTW---VALDVCLSYKV----QCKMDFK 183
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
+F + + C P ++ + + + ++ + + + +
Sbjct: 184 IFWLN----------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH---SI 230
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQSGVMTAETGTYRWM 456
+ L + + + L++ + + ++ + T ++
Sbjct: 231 QAELRRL----LKSKPYENCLLVLLNVQNAKAWNAFNLS-CKIL----LTTRFKQVTDFL 281
Query: 457 APEVIEHKPYDHKADVFS-------FGIVLWELLTGKLPYEYLT--PLQAAVGVVQKGLR 507
+ H DH + + L + LP E LT P + ++ + +R
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKSLLLKYL-DCRPQDLPREVLTTNPR--RLSIIAESIR 338
Query: 508 --PTIPKNSQ----PKLAELLERCW-QQDPA-LRPDF-------------SEIIEIL-QQ 545
N + KL ++E +PA R F + ++ ++
Sbjct: 339 DGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFD 398
Query: 546 IAKEVGEE--NEERRK 559
+ K N+ +
Sbjct: 399 VIKSDVMVVVNKLHKY 414
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 2e-07
Identities = 77/529 (14%), Positives = 142/529 (26%), Gaps = 202/529 (38%)
Query: 22 SSPPPQHQSRQHRQKL------GVY-----------NEVLGRLKESNNDEAIQPRFDDEL 64
S P + RQ +L + +V +Q + D ++
Sbjct: 132 SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVC-------LSYKVQCKMDFKI 184
Query: 65 -WTHFNRLPTRYALDVNVERAEDVL-MHKRLLHLA---------HDPRNRPAIEV----- 108
W + N E VL M ++LL+ H + I
Sbjct: 185 FWLNLK----------NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL 234
Query: 109 -RLVQVHP----------VSD-----------------RNSAVSSLLDSEVPAQRQSIHP 140
RL++ P V + R V+ L + H
Sbjct: 235 RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHH 294
Query: 141 PPAFGSSPNLEALAIEANNSHNLDGDNSVHANVQFSRPMHEITFSTDDKPKLLSQLTAL- 199
L + D P+ +
Sbjct: 295 SMTLTPDEVKSLLLKYLDCR-------------------------PQDLPREVLTTNPRR 329
Query: 200 LADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLKLE----RQGW-- 253
L+ I +I++ A D W + ++L +E + LE R+ +
Sbjct: 330 LSIIAESIRDGLATW------------DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDR 377
Query: 254 ----------PSHR-----SSSPTSEPEDTGMKSHPYHL--KIPNDGTDVWEIDPKHLKF 296
P+ S+ K H Y L K P + T I +L+
Sbjct: 378 LSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKEST--ISIPSIYLEL 435
Query: 297 GSKVAS---------GSYGDLYRGTYCSQDVAIKV------------LKPERINSDMQKE 335
K+ + Y ++ + + S D+ LK + +
Sbjct: 436 KVKLENEYALHRSIVDHY-NIPKT-FDSDDLIPPYLDQYFYSHIGHHLKNIE-HPERMTL 492
Query: 336 FAQEV----FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--- 388
F F+ +K+RH + A GS+ + L +LK +K
Sbjct: 493 FRMVFLDFRFLEQKIRHDST-----AWNAS------------GSILNTLQQLK-FYKPYI 534
Query: 389 ---LPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANL----LMDENEVV 429
P ++ + +++L + + K +L LM E+E +
Sbjct: 535 CDNDPKYERLVNAI---LDFLPKIEENLICS-KYTDLLRIALMAEDEAI 579
|
| >1u8s_A Glycine cleavage system transcriptional repressor, putative; structural genomics, protein structure initiative (PSI), domain swapping; 2.45A {Vibrio cholerae} SCOP: d.58.18.5 d.58.18.5 Length = 192 | Back alignment and structure |
|---|
Score = 40.1 bits (93), Expect = 7e-04
Identities = 11/84 (13%), Positives = 27/84 (32%), Gaps = 2/84 (2%)
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL 241
IT D+P + +++ L+ G NI ++ ++L + + ++ L
Sbjct: 9 ITAVGTDRPGICNEVVRLVTQAGCNIIDSRIAMFGKEFTLLMLI--SGSPSNITRVETTL 66
Query: 242 EKEVLKLERQGWPSHRSSSPTSEP 265
+ + S
Sbjct: 67 PLLGQQHDLITMMKRTSPHDHQTH 90
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 575 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.18 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.11 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.83 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.6 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.54 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.45 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.39 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.28 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.24 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.15 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.03 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.81 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.76 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.61 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.48 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.45 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.28 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.24 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.06 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.96 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.73 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.7 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.7 | |
| 1u8s_A | 192 | Glycine cleavage system transcriptional repressor, | 96.52 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.12 | |
| 1zpv_A | 91 | ACT domain protein; structural genomics, PSI, prot | 95.74 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.71 | |
| 2nyi_A | 195 | Unknown protein; protein structure initiative, PSI | 95.6 | |
| 2ko1_A | 88 | CTR148A, GTP pyrophosphokinase; homodimer, alpha+b | 94.45 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.98 | |
| 2f1f_A | 164 | Acetolactate synthase isozyme III small subunit; f | 92.57 | |
| 2nyi_A | 195 | Unknown protein; protein structure initiative, PSI | 91.91 | |
| 2pc6_A | 165 | Probable acetolactate synthase isozyme III (small; | 90.73 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 90.65 | |
| 1u8s_A | 192 | Glycine cleavage system transcriptional repressor, | 90.14 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.41 | |
| 3n0v_A | 286 | Formyltetrahydrofolate deformylase; formyl transfe | 85.17 | |
| 3nrb_A | 287 | Formyltetrahydrofolate deformylase; N-terminal ACT | 84.74 | |
| 3obi_A | 288 | Formyltetrahydrofolate deformylase; structural gen | 84.35 | |
| 3lou_A | 292 | Formyltetrahydrofolate deformylase; structural gen | 83.05 | |
| 2fgc_A | 193 | Acetolactate synthase, small subunit; regulatory s | 82.07 | |
| 3o1l_A | 302 | Formyltetrahydrofolate deformylase; structural gen | 81.51 | |
| 3p96_A | 415 | Phosphoserine phosphatase SERB; ssgcid, structural | 80.92 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=479.02 Aligned_cols=266 Identities=36% Similarity=0.685 Sum_probs=230.4
Q ss_pred CCCCceeeCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 282 ~~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
+....|+|+.++++++++||+|+||+||+|++.+ .||||+++....+....+.|.+|+.+|++++|||||+++++|.+
T Consensus 26 ~~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~- 103 (307)
T 3omv_A 26 DSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK- 103 (307)
T ss_dssp ---CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred CCCcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-
Confidence 3456899999999999999999999999998765 69999998776677778899999999999999999999999865
Q ss_pred CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
+.+|||||||+||+|.++++...+.+++..+..|+.||+.||.|||+++||||||||+|||+++++.+||+|||+|+...
T Consensus 104 ~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 104 DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 56899999999999999998877889999999999999999999999999999999999999999999999999998654
Q ss_pred cC---CccccCCCCCCccCcccccC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC----CCCC
Q 008171 442 QS---GVMTAETGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR----PTIP 511 (575)
Q Consensus 442 ~~---~~~~~~~Gt~~y~APE~i~~---~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~----~~~p 511 (575)
.. ......+||+.|||||++.+ .+|+.++|||||||+||||+||+.||.+.+........+..+.. +.++
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 263 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLY 263 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSC
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Confidence 32 23456689999999999953 46999999999999999999999999988877666665655433 2456
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 512 KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 512 ~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
..+++++.+||.+||+.||.+|||+.|+++.|+.+...
T Consensus 264 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 264 KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 78999999999999999999999999999999877543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-57 Score=474.25 Aligned_cols=261 Identities=31% Similarity=0.577 Sum_probs=227.4
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEee
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~ 357 (575)
..+.|+.++|.+.++||+|+||+||+|++. ++.||||+++.. +....++|.+|+.+|++++|||||+++|+
T Consensus 34 ~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~ 111 (329)
T 4aoj_A 34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGV 111 (329)
T ss_dssp CSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 346788889999999999999999999874 467999999853 45566889999999999999999999999
Q ss_pred ecCCCCceeEEEeccCCchhhhhhhc--------------cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEe
Q 008171 358 CTKPPSLCIVTEFMSGGSVYDYLHKL--------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423 (575)
Q Consensus 358 ~~~~~~l~lV~E~~~ggsL~d~l~~~--------------~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl 423 (575)
|.+.+.+|||||||+||+|.+++++. .+++++..++.|+.||+.||.|||+++||||||||+|||+
T Consensus 112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl 191 (329)
T 4aoj_A 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 191 (329)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence 99999999999999999999999753 2468999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 008171 424 DENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 499 (575)
Q Consensus 424 ~~~~~vkL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~ 499 (575)
+.++.+||+|||+++...... ..+...||+.|||||++.+..|+.++|||||||+||||+| |+.||...+..+...
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999998654432 2234579999999999999999999999999999999999 999999999887765
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 500 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 500 ~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
.+ ..+.++..|..+++++.+||.+||+.||.+|||+.||++.|+.+.+
T Consensus 272 ~i-~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 272 CI-TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HH-HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HH-HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 54 4567788999999999999999999999999999999999998865
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=469.44 Aligned_cols=259 Identities=29% Similarity=0.573 Sum_probs=230.0
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeec
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~ 359 (575)
+.|+.++|.+.++||+|+||+||+|++. +..||||+++.. +....++|.+|+.+|++++|||||+++|+|.
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 4688889999999999999999999864 456999999853 4556788999999999999999999999999
Q ss_pred CCCCceeEEEeccCCchhhhhhhcc------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC
Q 008171 360 KPPSLCIVTEFMSGGSVYDYLHKLK------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427 (575)
Q Consensus 360 ~~~~l~lV~E~~~ggsL~d~l~~~~------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~ 427 (575)
+++.+|||||||+||+|.++|+... ..+++..++.|+.||+.||.|||+++||||||||+|||++.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 9999999999999999999997632 4699999999999999999999999999999999999999999
Q ss_pred cEEEeecccceecccCCcc---ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 008171 428 VVKVADFGVARVKAQSGVM---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (575)
Q Consensus 428 ~vkL~DFG~a~~~~~~~~~---~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~ 503 (575)
.+||+|||+|+........ ....||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+....+.
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~- 244 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT- 244 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 9999999999865443221 23458999999999999999999999999999999998 999999999887766644
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 504 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 504 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
.+.++..|..+++++.+||.+||+.||.+|||+.||.+.|+++.+
T Consensus 245 ~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 245 QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 466778899999999999999999999999999999999998765
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-57 Score=467.55 Aligned_cols=258 Identities=27% Similarity=0.549 Sum_probs=229.0
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeee
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~ 358 (575)
.++|..+++++.++||+|+||+||+|.+. ++.||||+++... .....++|.+|+.+|++++|||||+++|+|
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 44788889999999999999999999873 4679999998543 344567899999999999999999999999
Q ss_pred cCCCCceeEEEeccCCchhhhhhhc---------------cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEe
Q 008171 359 TKPPSLCIVTEFMSGGSVYDYLHKL---------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM 423 (575)
Q Consensus 359 ~~~~~l~lV~E~~~ggsL~d~l~~~---------------~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl 423 (575)
.+.+.+|||||||++|+|.++|... ...+++..++.|+.||+.||.|||+++||||||||+||||
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 9999999999999999999999643 2468999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 008171 424 DENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 499 (575)
Q Consensus 424 ~~~~~vkL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~ 499 (575)
++++.+||+|||+++...... ..+...||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..+...
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999998654332 3345679999999999999999999999999999999998 899999999877665
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 008171 500 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 545 (575)
Q Consensus 500 ~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~ 545 (575)
. +..+.++..|..+++++.+||.+||+.||.+||||.||++.|+.
T Consensus 259 ~-i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 259 M-IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp H-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred H-HHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 5 44566778899999999999999999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-56 Score=470.96 Aligned_cols=264 Identities=33% Similarity=0.629 Sum_probs=236.0
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC-CCceEEEe
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIG 356 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~H-pnIv~l~~ 356 (575)
+.|+|+.++|+++++||+|+||+||+|++.+ +.||||+++... .....+.|.+|+.+|++++| ||||+++|
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 5799999999999999999999999998754 459999998653 34456789999999999976 89999999
Q ss_pred eecCC-CCceeEEEeccCCchhhhhhhcc---------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCC
Q 008171 357 ACTKP-PSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (575)
Q Consensus 357 ~~~~~-~~l~lV~E~~~ggsL~d~l~~~~---------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~N 420 (575)
+|..+ ..+|||||||+||+|.++|++.. ..+++..+..|+.||+.||.|||+++||||||||+|
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N 215 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence 99764 56899999999999999997532 348899999999999999999999999999999999
Q ss_pred EEecCCCcEEEeecccceecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 008171 421 LLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496 (575)
Q Consensus 421 ILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~ 496 (575)
||++.++.+||+|||+|+....... .....||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..+
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999986654332 234568999999999999999999999999999999998 999999988777
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 497 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 497 ~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
.....+..+.++.+|..+++++.++|.+||+.||.+||||.||++.|+++++.
T Consensus 296 ~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 296 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 77777888889999999999999999999999999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-56 Score=469.58 Aligned_cols=251 Identities=26% Similarity=0.475 Sum_probs=222.3
Q ss_pred CCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
..++|+++++||+|+||+||+|++. ++.||||+++....+....+.+.+|+.+|++|+|||||++++++.+.+.+|||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 3468999999999999999999874 78899999988777777788899999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-c
Q 008171 368 TEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-V 445 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~ 445 (575)
||||+||+|.+++...+ ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+...... .
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 99999999999997644 457899999999999999999999999999999999999999999999999998765432 2
Q ss_pred cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 008171 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 525 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~c 525 (575)
.+..+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+....++... .+.++..+++++.+||.+|
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~~~~~~s~~~~~li~~~ 260 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-FPPVSLHYSYDLRSLVSQL 260 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCCTTSCHHHHHHHHHH
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCCccCCHHHHHHHHHH
Confidence 345679999999999999999999999999999999999999999999888887776654 4567889999999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 008171 526 WQQDPALRPDFSEIIE 541 (575)
Q Consensus 526 L~~dP~~RPs~~ell~ 541 (575)
|++||.+|||+.|+++
T Consensus 261 L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 261 FKRNPRDRPSVNSILE 276 (350)
T ss_dssp TCSSGGGSCCHHHHHT
T ss_pred ccCChhHCcCHHHHhc
Confidence 9999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=461.67 Aligned_cols=258 Identities=24% Similarity=0.379 Sum_probs=225.8
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
+..+...|++.++||+|+||.||+|++. ++.||||+++.+... .+|+.+|++++|||||++++++.+.+.+
T Consensus 53 ~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~ 125 (336)
T 4g3f_A 53 YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWV 125 (336)
T ss_dssp CCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred hhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3445578999999999999999999874 678999999865332 4699999999999999999999999999
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC-cEEEeecccceecccC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQS 443 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~~ 443 (575)
|||||||+||+|.+++.+ .+.+++..+..|+.||+.||.|||++|||||||||+||||+.+| .+||+|||+|+.....
T Consensus 126 ~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999999999976 57899999999999999999999999999999999999999987 6999999999876543
Q ss_pred Cc------cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCCcH
Q 008171 444 GV------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-PTIPKNSQP 516 (575)
Q Consensus 444 ~~------~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~-~~~p~~~~~ 516 (575)
.. ....+||+.|||||++.+.+|+.++|||||||+||||++|+.||.+.+..+....+...... ..+|..+++
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~ 284 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAP 284 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCH
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCH
Confidence 21 12347999999999999999999999999999999999999999987776666666554432 257889999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhch
Q 008171 517 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 552 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~~ 552 (575)
++.+||.+||++||.+|||+.||++.|..+++++..
T Consensus 285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 999999999999999999999999999999987764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=456.76 Aligned_cols=248 Identities=23% Similarity=0.419 Sum_probs=223.1
Q ss_pred CCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCcee
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~l 366 (575)
..++|+++++||+|+||+||+|++ +++.||||++..... +....+.+.+|+.+|++++|||||++++++.+++.+||
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 346799999999999999999987 467899999975432 22335679999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC--
Q 008171 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-- 444 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-- 444 (575)
|||||+||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 110 vmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 9999999999999976 5789999999999999999999999999999999999999999999999999998765332
Q ss_pred -ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 008171 445 -VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 523 (575)
Q Consensus 445 -~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~ 523 (575)
.....+||+.|||||++.+..|+.++|||||||+||+|++|..||.+.+..+....+.... +.+|..+++++++||.
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~ 266 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE--YDFPEKFFPKARDLVE 266 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCTTCCHHHHHHHH
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCcccCHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999998888877776654 4678899999999999
Q ss_pred HhhhcCCCCCCCHHHHH
Q 008171 524 RCWQQDPALRPDFSEII 540 (575)
Q Consensus 524 ~cL~~dP~~RPs~~ell 540 (575)
+||++||.+|||+.|++
T Consensus 267 ~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 267 KLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHSCSSGGGSTTSGGGT
T ss_pred HHccCCHhHCcChHHHc
Confidence 99999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-55 Score=446.51 Aligned_cols=245 Identities=29% Similarity=0.563 Sum_probs=214.8
Q ss_pred eeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC----CCCceeE
Q 008171 294 LKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----PPSLCIV 367 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~----~~~l~lV 367 (575)
|++.++||+|+||+||+|.+. +..||||++..........+.|.+|+.+|++++|||||+++++|.. ...+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 578889999999999999985 5679999998777777777889999999999999999999999854 3568999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCC--ceecccCCCCEEecC-CCcEEEeecccceecccCC
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDE-NEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~g--IiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~~~ 444 (575)
||||+||+|.+++.+ .+.+++..+..|+.||+.||.|||++| ||||||||+||||+. ++.+||+|||+|+.... .
T Consensus 108 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-~ 185 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-S 185 (290)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-T
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-C
Confidence 999999999999976 578999999999999999999999998 999999999999984 78999999999975443 3
Q ss_pred ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-CCCCCCcHHHHHHHH
Q 008171 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-TIPKNSQPKLAELLE 523 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~-~~p~~~~~~l~~Li~ 523 (575)
.....+||+.|||||++.+ .|+.++|||||||+||||+||+.||...+........+..+..+ .++..+++++.+||.
T Consensus 186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~ 264 (290)
T 3fpq_A 186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 264 (290)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHH
Confidence 4456789999999999875 59999999999999999999999998776655555555555443 466778999999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 008171 524 RCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 524 ~cL~~dP~~RPs~~ell~ 541 (575)
+||+.||.+|||+.|+++
T Consensus 265 ~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 265 GCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHSCSSGGGSCCHHHHHT
T ss_pred HHccCChhHCcCHHHHhc
Confidence 999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-55 Score=457.10 Aligned_cols=245 Identities=29% Similarity=0.480 Sum_probs=218.5
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
+.|++.++||+|+||+||+|++. ++.||||+++...... .+.+.+|+.+|++++|||||++++++.+.+.+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46999999999999999999984 6789999997543322 3568899999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-Ccccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~ 448 (575)
||+||+|.+++.+ +.+++..+..|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+..... ...+.
T Consensus 152 y~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 152 FLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp CCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred CCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence 9999999999965 67999999999999999999999999999999999999999999999999999876554 34567
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHHHHHHHhh
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPKLAELLERCW 526 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~--~~p~~~~~~l~~Li~~cL 526 (575)
.+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+....+.. ...+ ..+..+++++.+||.+||
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~-~~~~~~~~~~~~s~~~~dli~~~L 308 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPRLKNLHKVSPSLKGFLDRLL 308 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SSCCCCSCGGGSCHHHHHHHHHHS
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-CCCCCCCccccCCHHHHHHHHHHc
Confidence 7899999999999999999999999999999999999999999988887766544 3333 344578999999999999
Q ss_pred hcCCCCCCCHHHHHH
Q 008171 527 QQDPALRPDFSEIIE 541 (575)
Q Consensus 527 ~~dP~~RPs~~ell~ 541 (575)
++||.+|||+.|+++
T Consensus 309 ~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 309 VRDPAQRATAAELLK 323 (346)
T ss_dssp CSSTTTSCCHHHHTT
T ss_pred CCChhHCcCHHHHhc
Confidence 999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=442.32 Aligned_cols=246 Identities=27% Similarity=0.488 Sum_probs=204.8
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|+++++||+|+||+||+|.+ +++.||||+++..... .+....+.+|+.+|++++|||||++++++.+++.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999987 4788999999865443 344567999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 448 (575)
||+ +|+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..........
T Consensus 93 Ey~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 170 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT 170 (275)
T ss_dssp ECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred eCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCC
Confidence 999 7899999976 67899999999999999999999999999999999999999999999999999987776666677
Q ss_pred CCCCCCccCcccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 008171 449 ETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~ 527 (575)
.+||+.|||||++.+..| +.++|||||||++|+|++|+.||.+.+..+....+... .+.+|..+++++.+||.+||+
T Consensus 171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~ 248 (275)
T 3hyh_A 171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--VYTLPKFLSPGAAGLIKRMLI 248 (275)
T ss_dssp ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHHHHHSC
T ss_pred eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHcc
Confidence 899999999999999887 57999999999999999999999998877766665543 346788999999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 008171 528 QDPALRPDFSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs~~ell~ 541 (575)
.||.+|||+.|+++
T Consensus 249 ~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 249 VNPLNRISIHEIMQ 262 (275)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhHCcCHHHHHc
Confidence 99999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=456.16 Aligned_cols=246 Identities=26% Similarity=0.435 Sum_probs=214.5
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE-----CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~-----~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
.+++++|+++++||+|+||+||+|+. +++.||||+++...........+.+|+.+|++++|||||++++++.+++
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 56778999999999999999999986 3467999999865444333456888999999999999999999999999
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
.+|||||||+||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999999987 57899999999999999999999999999999999999999999999999999986544
Q ss_pred C-CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 008171 443 S-GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521 (575)
Q Consensus 443 ~-~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~L 521 (575)
. ......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+....+.... +.+|..+++++.+|
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~l 256 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSL 256 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHH
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC--CCCCCcCCHHHHHH
Confidence 3 34556789999999999999999999999999999999999999999999888877776643 46788999999999
Q ss_pred HHHhhhcCCCCCCCH
Q 008171 522 LERCWQQDPALRPDF 536 (575)
Q Consensus 522 i~~cL~~dP~~RPs~ 536 (575)
|.+||++||.+|||+
T Consensus 257 i~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 257 LRMLFKRNPANRLGA 271 (304)
T ss_dssp HHHHTCSSGGGSTTC
T ss_pred HHHHcccCHHHCCCC
Confidence 999999999999985
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-54 Score=458.95 Aligned_cols=246 Identities=29% Similarity=0.459 Sum_probs=219.4
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
+.|++.++||+|+||.||+|++. ++.||||++....... .+.+.+|+.+|++++|||||+++++|.+.+.+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 46999999999999999999984 6789999997653322 3568899999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-Ccccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~ 448 (575)
||+||+|.+++.. +.+++..+..|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+..... .....
T Consensus 229 y~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 229 FLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp CCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred CCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence 9999999999964 67999999999999999999999999999999999999999999999999999876554 34566
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCcHHHHHHHHHhhh
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~-~~~~~p~~~~~~l~~Li~~cL~ 527 (575)
.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.... .....+..+++++.+||.+||+
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~ 386 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV 386 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSC
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcC
Confidence 789999999999999999999999999999999999999999998888776655432 1234456889999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 008171 528 QDPALRPDFSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs~~ell~ 541 (575)
.||.+|||+.|+++
T Consensus 387 ~dP~~R~ta~ell~ 400 (423)
T 4fie_A 387 RDPAQRATAAELLK 400 (423)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred CChhHCcCHHHHhc
Confidence 99999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-53 Score=435.47 Aligned_cols=253 Identities=27% Similarity=0.520 Sum_probs=207.5
Q ss_pred CceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC----CceeE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP----SLCIV 367 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~----~l~lV 367 (575)
++|.+.++||+|+||+||+|++.|+.||||+++... .....+..|+..+.+++|||||+++++|..++ .+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 468899999999999999999999999999997532 21223345677778899999999999997653 47999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHC--------CceecccCCCCEEecCCCcEEEeeccccee
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--------NIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~--------gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
||||+||+|.++++. ..+++..+.+++.|++.||.|||++ +||||||||+|||++.++.+||+|||+++.
T Consensus 80 ~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999975 5689999999999999999999987 999999999999999999999999999987
Q ss_pred cccCCc-----cccCCCCCCccCcccccCC------CCCchHHHHHHHHHHHHHHcCCCCCC----------CC-----C
Q 008171 440 KAQSGV-----MTAETGTYRWMAPEVIEHK------PYDHKADVFSFGIVLWELLTGKLPYE----------YL-----T 493 (575)
Q Consensus 440 ~~~~~~-----~~~~~Gt~~y~APE~i~~~------~~s~ksDVwSlGviL~eLltG~~Pf~----------~~-----~ 493 (575)
...... ....+||+.|||||++.+. .|+.++|||||||+||||+||..||. .. .
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 654432 2235799999999999764 46789999999999999999976553 22 1
Q ss_pred HHHHHHHHHhcCCCCCCCCCC-----cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 494 PLQAAVGVVQKGLRPTIPKNS-----QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 494 ~~~~~~~v~~~~~~~~~p~~~-----~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
..+....+....++|.+|... +..+.+||.+||+.||.+||||.|+++.|+++.++
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 233344455667788777543 35789999999999999999999999999988753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-52 Score=426.01 Aligned_cols=246 Identities=24% Similarity=0.407 Sum_probs=193.3
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC-------
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------- 362 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~------- 362 (575)
++|++++.||+|+||+||+|++. ++.||||+++... .....+.+.+|+.+|++++|||||+++++|...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 36899999999999999999874 7789999997543 3445577999999999999999999999986433
Q ss_pred -----CceeEEEeccCCchhhhhhhcc--CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecc
Q 008171 363 -----SLCIVTEFMSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435 (575)
Q Consensus 363 -----~l~lV~E~~~ggsL~d~l~~~~--~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG 435 (575)
.+|||||||+||+|.+++.... ...+...++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 3699999999999999997632 234556788999999999999999999999999999999999999999999
Q ss_pred cceecccCC-------------ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 008171 436 VARVKAQSG-------------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV 502 (575)
Q Consensus 436 ~a~~~~~~~-------------~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~ 502 (575)
+|+...... ..+..+||+.|||||++.+..|+.++|||||||+||||++ ||............+
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~ 240 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV 240 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHH
Confidence 998654432 1234579999999999999999999999999999999996 776432222222222
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 503 QKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 503 ~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.....|..+...++.+.+||.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 241 RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 333233333455677899999999999999999999876
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=433.87 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=213.3
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC------CCC
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK------PPS 363 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~------~~~ 363 (575)
++|+++++||+|+||+||+|.+ +++.||||+++.........+.+.+|+.+|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999987 47889999998776666667889999999999999999999998753 367
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
+|||||||+ |+|.+++.+ .+.+++..+..|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 134 ~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 899999995 689999976 678999999999999999999999999999999999999999999999999999865432
Q ss_pred -----CccccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--------
Q 008171 444 -----GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT-------- 509 (575)
Q Consensus 444 -----~~~~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~-------- 509 (575)
......+||+.|||||++.+. .|+.++||||+||++|||++|+.||.+.+..+....+......+.
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 234567899999999998775 569999999999999999999999999888777665543221111
Q ss_pred ---------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 510 ---------------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 510 ---------------------~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+...+++++.+||.+||+.||.+|||+.|+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 12356899999999999999999999999875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=404.53 Aligned_cols=269 Identities=42% Similarity=0.739 Sum_probs=231.9
Q ss_pred CCCceeeCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 283 ~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
..+.+++...+|++.++||+|+||.||+|++.++.||||++............+.+|+.++++++||||+++++++...+
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 34567888999999999999999999999999999999999887777777788999999999999999999999999999
Q ss_pred CceeEEEeccCCchhhhhhhcc--CcCChHHHHHHHHHHHHHHHHHHHCC--ceecccCCCCEEecCCCcEEEeecccce
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~--~~l~~~~~~~i~~qI~~aL~yLH~~g--IiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
.+|+||||+.|++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 9999999999999999997643 24999999999999999999999999 9999999999999999999999999997
Q ss_pred ecccCC-ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 008171 439 VKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 517 (575)
Q Consensus 439 ~~~~~~-~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~ 517 (575)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.....+..++..++++
T Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (309)
T 3p86_A 188 LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ 267 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred cccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence 554432 2345679999999999999999999999999999999999999999999888877776677778889999999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 518 LAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 518 l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
+.++|.+||+.||.+|||+.++++.|+.+++...
T Consensus 268 l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 268 VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999999986543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=439.22 Aligned_cols=248 Identities=23% Similarity=0.368 Sum_probs=224.6
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|+++++||+|+||.||+|.. +++.||||+++... ......+.+|+.+|+.++|||||++++++.+...+|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 5799999999999999999987 46789999997543 3345678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC--CcEEEeecccceecccCCccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN--EVVKVADFGVARVKAQSGVMT 447 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~--~~vkL~DFG~a~~~~~~~~~~ 447 (575)
||+||+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.........
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~ 314 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence 999999999998767889999999999999999999999999999999999999854 899999999999887776677
Q ss_pred cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHHHHHHHh
Q 008171 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERC 525 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--~~~p~~~~~~l~~Li~~c 525 (575)
..+||+.|||||++.+..|+.++|||||||+||+|++|..||.+.+..+....+...... ...+..+++++.+||.+|
T Consensus 315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~ 394 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 394 (573)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTT
T ss_pred eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence 789999999999999999999999999999999999999999999988887776655433 234467899999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 008171 526 WQQDPALRPDFSEIIE 541 (575)
Q Consensus 526 L~~dP~~RPs~~ell~ 541 (575)
|+.||.+|||+.|+++
T Consensus 395 L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 395 LLADPNTRMTIHQALE 410 (573)
T ss_dssp SCSSGGGSCCHHHHHH
T ss_pred ccCChhHCcCHHHHhc
Confidence 9999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=409.62 Aligned_cols=242 Identities=22% Similarity=0.359 Sum_probs=198.1
Q ss_pred CceeeeeeeeecCceEEEEEEEC-----CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCce
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~-----~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l~ 365 (575)
++|++.++||+|+||+||+|+.. ++.||||.+.... ....+.+|+.+|+.+ +|||||++++++.+.+++|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 56999999999999999999762 4679999987542 235678899999998 6999999999999999999
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC-CcEEEeecccceecccCC
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQSG 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~-~~vkL~DFG~a~~~~~~~ 444 (575)
||||||+||+|.+++. .+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+......
T Consensus 97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 9999999999999984 48999999999999999999999999999999999999876 899999999997543321
Q ss_pred -----------------------------ccccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCC-
Q 008171 445 -----------------------------VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLT- 493 (575)
Q Consensus 445 -----------------------------~~~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~- 493 (575)
..+..+||+.|||||++.+. .|+.++||||+||++|||++|+.||...+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 23345799999999999775 58999999999999999999999995433
Q ss_pred HHHHHHHHHh------------------------------------c----------------CCCCCCCCCCcHHHHHH
Q 008171 494 PLQAAVGVVQ------------------------------------K----------------GLRPTIPKNSQPKLAEL 521 (575)
Q Consensus 494 ~~~~~~~v~~------------------------------------~----------------~~~~~~p~~~~~~l~~L 521 (575)
..+....+.. . .........+++++.+|
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 2222221110 0 00011234678999999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 008171 522 LERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 522 i~~cL~~dP~~RPs~~ell~ 541 (575)
|.+||+.||.+|||+.|+++
T Consensus 333 l~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHCcCChhHCcCHHHHhc
Confidence 99999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=383.50 Aligned_cols=261 Identities=35% Similarity=0.717 Sum_probs=231.9
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEE-CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~-~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
.+.|.++.++|++.++||+|+||.||+|.+ .++.||+|++....... +.+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 78 (269)
T 4hcu_A 2 SGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA 78 (269)
T ss_dssp ---CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 457899999999999999999999999998 56779999998654443 56889999999999999999999999999
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
..|+||||+++++|.+++....+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 99999999999999999987778899999999999999999999999999999999999999999999999999975543
Q ss_pred CC--ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 008171 443 SG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 519 (575)
Q Consensus 443 ~~--~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~ 519 (575)
.. ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+ .....+..+..+++.+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 237 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRLYKPRLASTHVY 237 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCCCCTTSCHHHH
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-hcCccCCCCCcCCHHHH
Confidence 32 2234456788999999999999999999999999999999 99999998887766554 44566777888999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 520 ELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 520 ~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
+++.+||+.||.+||++.++++.|+++..
T Consensus 238 ~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 238 QIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=433.69 Aligned_cols=249 Identities=27% Similarity=0.412 Sum_probs=210.6
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC----ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI----NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~----~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
+..++|+++++||+|+||.||+|+. +++.||||+++.... ..........++.+++.++|||||++++++.+..
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 3446899999999999999999987 467899999975432 1222233344567777889999999999999999
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
.+|||||||+||+|.+++.+ .+.+++..+..|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 266 ~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999999987 67899999999999999999999999999999999999999999999999999987654
Q ss_pred CCccccCCCCCCccCccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhcCCCCCCCCCCcHHH
Q 008171 443 SGVMTAETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLT---PLQAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 443 ~~~~~~~~Gt~~y~APE~i~-~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~---~~~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
. .....+||+.|||||++. +..|+.++|||||||+||||++|..||.+.+ ..+....+.. ..+.+|..+++++
T Consensus 345 ~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~--~~~~~p~~~S~~a 421 (689)
T 3v5w_A 345 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPEL 421 (689)
T ss_dssp C-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH--CCCCCCTTSCHHH
T ss_pred C-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC--CCCCCCccCCHHH
Confidence 4 345678999999999996 4689999999999999999999999997532 3333333333 3456788999999
Q ss_pred HHHHHHhhhcCCCCCCC-----HHHHHH
Q 008171 519 AELLERCWQQDPALRPD-----FSEIIE 541 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs-----~~ell~ 541 (575)
.+||.+||++||.+|++ +.|+++
T Consensus 422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 422 RSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 99999999999999998 677653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=405.50 Aligned_cols=264 Identities=34% Similarity=0.653 Sum_probs=234.2
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
.+.|.++.++|++.++||+|+||.||+|++. ++.||||+++.. ........|.+|+.+|++++||||+++++++...
T Consensus 106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 184 (377)
T 3cbl_A 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 184 (377)
T ss_dssp CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence 3578999999999999999999999999985 678999998854 3445566799999999999999999999999999
Q ss_pred CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
..+|+||||++||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 99999999999999999998766779999999999999999999999999999999999999999999999999998654
Q ss_pred cCCcc---ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 008171 442 QSGVM---TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 517 (575)
Q Consensus 442 ~~~~~---~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~ 517 (575)
..... ....+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+... .+..+.+...|..++++
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 343 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE-FVEKGGRLPCPELCPDA 343 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH-HHHTTCCCCCCTTCCHH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCCCCCCCHH
Confidence 43211 11234678999999998899999999999999999998 999999988776554 45566777888999999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 518 LAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 518 l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
+.++|.+||+.||.+|||+.++++.|+++.+.
T Consensus 344 l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 99999999999999999999999999998753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=379.49 Aligned_cols=257 Identities=32% Similarity=0.622 Sum_probs=234.0
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC--CCc
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP--PSL 364 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~~l 364 (575)
+.++.++|++.++||+|+||.||+|++.++.||||+++.........+.+.+|+.++++++||||+++++++... ...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 467788999999999999999999999999999999998776777778899999999999999999999999877 788
Q ss_pred eeEEEeccCCchhhhhhhccC-cCChHHHHHHHHHHHHHHHHHHHCC--ceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 365 CIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~-~l~~~~~~~i~~qI~~aL~yLH~~g--IiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
++||||++|++|.+++....+ .+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999999987543 5899999999999999999999999 9999999999999999999999999875432
Q ss_pred cCCccccCCCCCCccCcccccCCCCCc---hHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 008171 442 QSGVMTAETGTYRWMAPEVIEHKPYDH---KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 442 ~~~~~~~~~Gt~~y~APE~i~~~~~s~---ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
.....||+.|+|||++.+..++. ++||||||+++|+|++|..||...+..+....+.....++.++..+++++
T Consensus 165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (271)
T 3kmu_A 165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240 (271)
T ss_dssp ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHH
T ss_pred ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHH
Confidence 23457899999999998765544 89999999999999999999999999888888888888889999999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIEILQQIA 547 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~~L~~l~ 547 (575)
.++|.+||+.||.+|||+.++++.|+++.
T Consensus 241 ~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 241 SKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 99999999999999999999999999874
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=398.66 Aligned_cols=265 Identities=31% Similarity=0.624 Sum_probs=232.6
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEECC---------ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEE
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF 354 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~---------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l 354 (575)
..|++..++|++++.||+|+||.||+|.+.+ ..||||+++... .......+.+|+.+|+++ +||||+++
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~ 152 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 152 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 3567888999999999999999999998632 359999998653 344567899999999999 89999999
Q ss_pred EeeecCCCCceeEEEeccCCchhhhhhhcc---------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCC
Q 008171 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419 (575)
Q Consensus 355 ~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~---------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~ 419 (575)
+++|...+.+|+||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 232 (370)
T 2psq_A 153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 232 (370)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence 999999999999999999999999997643 34789999999999999999999999999999999
Q ss_pred CEEecCCCcEEEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 008171 420 NLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL 495 (575)
Q Consensus 420 NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~ 495 (575)
|||++.++.+||+|||+++...... ......+|+.|+|||++.+..|+.++|||||||++|||++ |..||.+....
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999999998655432 2234467889999999999999999999999999999999 99999988766
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 496 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 496 ~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
+... .+..+.++..|..+++++.++|.+||+.||.+||++.|+++.|++++....
T Consensus 313 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 313 ELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp GHHH-HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHH-HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 6544 455566778889999999999999999999999999999999999987553
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=394.27 Aligned_cols=248 Identities=28% Similarity=0.493 Sum_probs=226.8
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
..+|++.+.||+|+||.||+|.+ +++.||||++.....+......+.+|+.+|+.++||||+++++++...+.+|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 36899999999999999999987 5788999999877667777788999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 448 (575)
||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 94 e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 172 (328)
T 3fe3_A 94 EYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA 172 (328)
T ss_dssp CCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGT
T ss_pred ECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcccc
Confidence 99999999999976 57799999999999999999999999999999999999999999999999999987766666777
Q ss_pred CCCCCCccCcccccCCCCC-chHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 008171 449 ETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s-~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~ 527 (575)
.+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+.... ..+|..+++++.+||++||+
T Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~ 250 (328)
T 3fe3_A 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK--YRIPFYMSTDCENLLKRFLV 250 (328)
T ss_dssp TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHCC
T ss_pred ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHCC
Confidence 8899999999999888875 79999999999999999999999998887776666543 35778899999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 008171 528 QDPALRPDFSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs~~ell~ 541 (575)
.||.+|||+.|+++
T Consensus 251 ~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 251 LNPIKRGTLEQIMK 264 (328)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred CChhHCcCHHHHhc
Confidence 99999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=382.14 Aligned_cols=263 Identities=33% Similarity=0.678 Sum_probs=231.4
Q ss_pred CCCceeeCCCceeeeeeeeecCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 283 ~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
+...|+++.++|++.++||+|+||.||++.+.+ ..||||+++...... ..+.+|+.++++++||||+++++++...
T Consensus 15 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 15 GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp -CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 346789999999999999999999999998865 479999998665443 5688999999999999999999999999
Q ss_pred CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
..+|+||||+.|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 99999999999999999998877889999999999999999999999999999999999999999999999999997554
Q ss_pred cCC--ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 008171 442 QSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 442 ~~~--~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+ ....+...+..+++.+
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 250 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRLYRPHLASEKV 250 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTTCCCCCCTTCCHHH
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH-hcccCCCCCCcCCHHH
Confidence 332 2233456788999999999999999999999999999998 99999998887766554 4456677788899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
.++|.+||+.||.+|||+.++++.|++++.+
T Consensus 251 ~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 251 YTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 9999999999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=391.60 Aligned_cols=263 Identities=34% Similarity=0.602 Sum_probs=231.0
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEEC-----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-----~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 360 (575)
.+++..++|++.++||+|+||.||+|.+. +..||||+++... .....+.+.+|+.++++++||||+++++++.+
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 34778889999999999999999999874 2349999998543 45556789999999999999999999999999
Q ss_pred CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
...+|+||||++|++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999999876788999999999999999999999999999999999999999999999999999876
Q ss_pred ccCC----ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 008171 441 AQSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 515 (575)
Q Consensus 441 ~~~~----~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~ 515 (575)
.... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+ ....+...+..++
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 280 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV-EEGYRLPAPMGCP 280 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-HTTCCCCCCTTCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-HcCCCCCCCCCcC
Confidence 5432 1223356788999999999999999999999999999999 99999998887766554 4456677888999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 516 PKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 516 ~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
+.+.++|.+||..||.+|||+.++++.|+.+++..
T Consensus 281 ~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 281 HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 99999999999999999999999999999998643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=408.63 Aligned_cols=257 Identities=35% Similarity=0.687 Sum_probs=228.7
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC-C
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP-S 363 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~-~ 363 (575)
..|+++.++|++.++||+|+||.||+|.+.++.||||+++... ..+.|.+|+.+|++++||||+++++++.... .
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 4689999999999999999999999999999999999998653 3467899999999999999999999986654 7
Q ss_pred ceeEEEeccCCchhhhhhhccC-cCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~-~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
+||||||+++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 8999999999999999987543 379999999999999999999999999999999999999999999999999985443
Q ss_pred CCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 008171 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521 (575)
Q Consensus 443 ~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~L 521 (575)
. .....+|+.|+|||++.+..++.++|||||||+||||++ |..||...+..+.... +..+.++..|..+++++.++
T Consensus 342 ~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~p~~~~~~l~~l 418 (450)
T 1k9a_A 342 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPAVYDV 418 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH-HHTTCCCCCCTTCCHHHHHH
T ss_pred c--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCcCCHHHHHH
Confidence 2 223467899999999999999999999999999999998 9999998877665544 45677888899999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 522 LERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 522 i~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
|.+||+.||.+|||+.++++.|+++..
T Consensus 419 i~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 419 MKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 999999999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=383.47 Aligned_cols=264 Identities=36% Similarity=0.732 Sum_probs=217.8
Q ss_pred CCCceeeCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 283 ~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
+.+.++|..++|++.++||+|+||.||+|++.+ .||||+++.........+.+.+|+.++++++||||+++++++. ..
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~ 92 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-AP 92 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CC
Confidence 456779999999999999999999999998755 5999999987777777788999999999999999999999664 45
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
.+++||||+.|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 68999999999999999987778899999999999999999999999999999999999999999999999999975443
Q ss_pred C---CccccCCCCCCccCccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-C---CCCC
Q 008171 443 S---GVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-P---TIPK 512 (575)
Q Consensus 443 ~---~~~~~~~Gt~~y~APE~i~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~-~---~~p~ 512 (575)
. .......||+.|+|||++. +..++.++||||||+++|+|++|..||......+.....+..... + ..+.
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS 252 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCT
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccc
Confidence 2 2334457999999999996 677899999999999999999999999887766655555544332 2 2345
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 513 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 513 ~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
.+++.+.++|.+||+.||.+|||+.++++.|+++.+
T Consensus 253 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 253 NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 789999999999999999999999999999998753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=383.64 Aligned_cols=263 Identities=28% Similarity=0.532 Sum_probs=221.5
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEE------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~------~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 360 (575)
.++..++|++.++||+|+||.||++++ .++.||||++... .....+.+.+|+.++++++||||+++++++..
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 367778999999999999999999986 4677999999854 45556789999999999999999999998854
Q ss_pred --CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccce
Q 008171 361 --PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 361 --~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
...+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 456899999999999999998877779999999999999999999999999999999999999999999999999998
Q ss_pred ecccCC----ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHH
Q 008171 439 VKAQSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---------------QAAV 499 (575)
Q Consensus 439 ~~~~~~----~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~---------------~~~~ 499 (575)
...... ......+|..|+|||++.+..++.++||||||+++|+|++|..||...... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 654432 223345778899999999999999999999999999999999998643211 1222
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 500 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 500 ~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
..+....+...+..+++++.++|.+||+.||.+|||+.|+++.|+++.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 3345566677888999999999999999999999999999999999987653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=380.84 Aligned_cols=267 Identities=30% Similarity=0.621 Sum_probs=236.9
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEE-------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEE
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI 355 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~-------~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~ 355 (575)
...|++..++|++++.||+|+||.||+|++ .++.||||+++... .......+.+|+.+++++ +||||++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 457899999999999999999999999986 23679999998653 334567899999999999 899999999
Q ss_pred eeecCCCCceeEEEeccCCchhhhhhhccC-----------------cCChHHHHHHHHHHHHHHHHHHHCCceecccCC
Q 008171 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKG-----------------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKA 418 (575)
Q Consensus 356 ~~~~~~~~l~lV~E~~~ggsL~d~l~~~~~-----------------~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp 418 (575)
+++...+..++||||+++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 999999999999999999999999976433 489999999999999999999999999999999
Q ss_pred CCEEecCCCcEEEeecccceecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCH
Q 008171 419 ANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTP 494 (575)
Q Consensus 419 ~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~ 494 (575)
+|||++.++.+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 999999999999999999986654432 223456789999999999999999999999999999999 9999998877
Q ss_pred HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 495 LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 495 ~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
.......+....++..+..+++.+.++|.+||+.||.+|||+.|+++.|++++.+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred hhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 666677777777777888999999999999999999999999999999999987654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=392.47 Aligned_cols=265 Identities=32% Similarity=0.631 Sum_probs=232.5
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEE
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI 355 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~ 355 (575)
...|++..++|+++++||+|+||.||+|++.+ +.||||+++... .....+.+.+|+.+++++ +||||++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 45789999999999999999999999998532 569999998543 344567799999999999 789999999
Q ss_pred eeecCCCC-ceeEEEeccCCchhhhhhhccC-------------------------------------------------
Q 008171 356 GACTKPPS-LCIVTEFMSGGSVYDYLHKLKG------------------------------------------------- 385 (575)
Q Consensus 356 ~~~~~~~~-l~lV~E~~~ggsL~d~l~~~~~------------------------------------------------- 385 (575)
+++...+. +++||||++||+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99877554 8999999999999999976432
Q ss_pred ----------------cCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC---cc
Q 008171 386 ----------------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VM 446 (575)
Q Consensus 386 ----------------~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~---~~ 446 (575)
.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 252 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence 18899999999999999999999999999999999999999999999999998654332 22
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 525 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~c 525 (575)
....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+.....+.....+..+..+++++.++|.+|
T Consensus 253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 332 (359)
T 3vhe_A 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 332 (359)
T ss_dssp --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHH
T ss_pred cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 34567899999999999999999999999999999998 99999988777777677777778888999999999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 526 WQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 526 L~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
|+.||.+|||+.|+++.|+++++.
T Consensus 333 l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 333 WHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCChhhCCCHHHHHHHHHHHHHH
Confidence 999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=375.57 Aligned_cols=256 Identities=36% Similarity=0.713 Sum_probs=218.4
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERIN--SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
+++.++|++.++||+|+||.||+|.+.++.||||+++..... ....+.+.+|+.+++.++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 567789999999999999999999999999999998754322 233567899999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCC---ceecccCCCCEEecC--------CCcEEEeec
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN---IIHRDLKAANLLMDE--------NEVVKVADF 434 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~g---IiHrDLKp~NILl~~--------~~~vkL~DF 434 (575)
+||||++|++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999999853 67999999999999999999999999 999999999999986 778999999
Q ss_pred ccceecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 008171 435 GVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 514 (575)
Q Consensus 435 G~a~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~ 514 (575)
|+++...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+................++..+
T Consensus 161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3dtc_A 161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239 (271)
T ss_dssp CC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred Cccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence 9997654432 234579999999999999999999999999999999999999999999888888777777778888999
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 515 QPKLAELLERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 515 ~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
++.+.++|.+||+.||.+|||+.|+++.|+++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999999999999754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=374.69 Aligned_cols=258 Identities=32% Similarity=0.613 Sum_probs=229.5
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
.|++..++|++.++||+|+||.||++.+.+ ..||+|+++...... ..+.+|+.++++++||||+++++++......
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 467888999999999999999999998865 469999998654443 5688999999999999999999999999999
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|+||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999999998866779999999999999999999999999999999999999999999999999998665543
Q ss_pred c--cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 008171 445 V--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521 (575)
Q Consensus 445 ~--~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~L 521 (575)
. .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .......+..+++.+.++
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l 237 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIYQI 237 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSCHHHHHH
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcChHHHHHH
Confidence 2 223456778999999999899999999999999999999 999999888877665543 455666778889999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHH
Q 008171 522 LERCWQQDPALRPDFSEIIEILQQIA 547 (575)
Q Consensus 522 i~~cL~~dP~~RPs~~ell~~L~~l~ 547 (575)
|.+||+.||.+|||+.++++.|+.+.
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 238 MYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 99999999999999999999998774
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=377.84 Aligned_cols=263 Identities=32% Similarity=0.604 Sum_probs=219.4
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEECC-----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeec
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-----~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~ 359 (575)
..|++..++|++.+.||+|+||.||+|.+.. ..||+|+++.. ........+.+|+.++++++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 4678889999999999999999999998743 34999998754 24455678999999999999999999999985
Q ss_pred CCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 360 ~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
.+..|+||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 4578999999999999999987666899999999999999999999999999999999999999999999999999986
Q ss_pred cccCCc--cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 008171 440 KAQSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 516 (575)
Q Consensus 440 ~~~~~~--~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~ 516 (575)
...... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+ ....++.++..+++
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i-~~~~~~~~~~~~~~ 244 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPP 244 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCCCCCCTTCCH
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH-HcCCCCCCCCCCCH
Confidence 654332 233456789999999999999999999999999999997 99999988776655443 34555678889999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 517 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
.+.++|.+||+.||.+|||+.++++.|++++.+.
T Consensus 245 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 245 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999998643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=389.55 Aligned_cols=264 Identities=33% Similarity=0.541 Sum_probs=224.7
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
+.+..++|+++++||+|+||+||++.+. ++.||+|++.. .+......+.+|+.++++++||||+++++++.+....
T Consensus 5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 4577889999999999999999999985 67799998864 3456678899999999999999999999999999999
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|+||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999999999998877889999999999999999999999999999999999999999999999999998654432
Q ss_pred cc---------------ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHhcCCCC
Q 008171 445 VM---------------TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG-VVQKGLRP 508 (575)
Q Consensus 445 ~~---------------~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~-v~~~~~~~ 508 (575)
.. ....||+.|+|||++.+..++.++||||||+++|+|++|..||....+...... ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 21 145799999999999999999999999999999999999999875432111000 00011112
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhch
Q 008171 509 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 552 (575)
Q Consensus 509 ~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~~ 552 (575)
..+..+++.+.++|.+||+.||.+|||+.++++.|+++...+..
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 35678889999999999999999999999999999999877653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=372.04 Aligned_cols=259 Identities=36% Similarity=0.728 Sum_probs=230.7
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEE-CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~-~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
.|.++.++|++.+.||+|+||.||++.+ .++.||+|+++..... .+.+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 5889999999999999999999999998 4567999999865443 35788999999999999999999999999999
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|+||||++|++|.+++....+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 99999999999999998867789999999999999999999999999999999999999999999999999997654321
Q ss_pred --ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 008171 445 --VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521 (575)
Q Consensus 445 --~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~L 521 (575)
......+|..|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... +..+.++..+..+++.+.++
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~~~l~~l 237 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-ISTGFRLYKPRLASTHVYQI 237 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCCTTSCHHHHHH
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH-HhcCCcCCCCccCcHHHHHH
Confidence 2234457889999999999999999999999999999999 8999998887766554 44456667788899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 522 LERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 522 i~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
+.+||+.||.+||++.++++.|+++..
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 238 MNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=390.18 Aligned_cols=267 Identities=30% Similarity=0.573 Sum_probs=231.0
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEE-------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEE
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI 355 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~-------~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~ 355 (575)
...|++..++|++++.||+|+||.||+|++ .+..||||+++... .......+.+|+.+++++ +||||++++
T Consensus 37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 115 (344)
T 1rjb_A 37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLL 115 (344)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 346899999999999999999999999987 23469999998543 333457799999999999 899999999
Q ss_pred eeecCCCCceeEEEeccCCchhhhhhhccC----------------------cCChHHHHHHHHHHHHHHHHHHHCCcee
Q 008171 356 GACTKPPSLCIVTEFMSGGSVYDYLHKLKG----------------------VFKLPSLLKVAIDVSKGMNYLHQNNIIH 413 (575)
Q Consensus 356 ~~~~~~~~l~lV~E~~~ggsL~d~l~~~~~----------------------~l~~~~~~~i~~qI~~aL~yLH~~gIiH 413 (575)
+++...+.+|+||||++||+|.+++..... .+++..++.++.||+.||.|||++||+|
T Consensus 116 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 195 (344)
T 1rjb_A 116 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 195 (344)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 999999999999999999999999976443 3789999999999999999999999999
Q ss_pred cccCCCCEEecCCCcEEEeecccceecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCC
Q 008171 414 RDLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPY 489 (575)
Q Consensus 414 rDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf 489 (575)
|||||+|||++.++.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999976544322 223456889999999999999999999999999999998 99999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 490 EYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 490 ~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
............+.....+..+..+++++.++|.+||..||.+|||+.++++.|+.++....
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 276 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp TTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred ccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 98887777777777788888889999999999999999999999999999999999877554
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=391.53 Aligned_cols=266 Identities=32% Similarity=0.625 Sum_probs=235.7
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEECC---------ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEE
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF 354 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~---------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l 354 (575)
..|++..++|.++++||+|+||.||+|++.+ ..||||+++.. ........+.+|+.+++++ +||||+++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 4678899999999999999999999998743 45999999865 3445567899999999999 89999999
Q ss_pred EeeecCCCCceeEEEeccCCchhhhhhhcc---------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCC
Q 008171 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419 (575)
Q Consensus 355 ~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~---------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~ 419 (575)
++++...+.+|+||||+.||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 999999999999999999999999997643 35899999999999999999999999999999999
Q ss_pred CEEecCCCcEEEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 008171 420 NLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL 495 (575)
Q Consensus 420 NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~ 495 (575)
|||++.++.+||+|||+++...... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+..
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998655432 2334567889999999999999999999999999999999 99999988876
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhch
Q 008171 496 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 552 (575)
Q Consensus 496 ~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~~ 552 (575)
+... .+..+.++..+..+++++.++|.+||+.||.+|||+.|+++.|++++.....
T Consensus 301 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 301 ELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp HHHH-HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred HHHH-HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 6554 4556667788899999999999999999999999999999999999876653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=387.51 Aligned_cols=263 Identities=31% Similarity=0.591 Sum_probs=229.5
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeee
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~ 358 (575)
.+++..++|++.+.||+|+||.||+|++.+ +.||||+++... .......+.+|+.++++++||||+++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 356778899999999999999999999864 679999998543 455567899999999999999999999999
Q ss_pred cCCCCceeEEEeccCCchhhhhhhcc-----------------------CcCChHHHHHHHHHHHHHHHHHHHCCceecc
Q 008171 359 TKPPSLCIVTEFMSGGSVYDYLHKLK-----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415 (575)
Q Consensus 359 ~~~~~l~lV~E~~~ggsL~d~l~~~~-----------------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrD 415 (575)
...+.+|+||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 99999999999999999999997642 5689999999999999999999999999999
Q ss_pred cCCCCEEecCCCcEEEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 008171 416 LKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEY 491 (575)
Q Consensus 416 LKp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~ 491 (575)
|||+|||++.++.+||+|||+++...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999997544322 2234567899999999999999999999999999999999 9999999
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 492 LTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 492 ~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
.+..+....+ ..+..+.++..+++.+.++|.+||+.||.+||++.++++.|+++....
T Consensus 280 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 280 MAHEEVIYYV-RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp SCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CChHHHHHHH-hCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 8877766554 445556778899999999999999999999999999999999987644
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=377.16 Aligned_cols=268 Identities=29% Similarity=0.539 Sum_probs=229.8
Q ss_pred CceeeCCCceeeee-eeeecCceEEEEEEEC----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeec
Q 008171 285 DVWEIDPKHLKFGS-KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (575)
Q Consensus 285 ~~~~i~~~~~~i~~-~LG~G~fG~Vy~~~~~----~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~ 359 (575)
..+.++.++|++.+ .||+|+||.||+|.+. ++.||||+++.........+.+.+|+.++++++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 45577888999998 9999999999999653 46799999987665566678899999999999999999999999
Q ss_pred CCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 360 ~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
..+.+|+||||+.+++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 45678999999999999999976 56799999999999999999999999999999999999999999999999999986
Q ss_pred cccCCc----cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 008171 440 KAQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 514 (575)
Q Consensus 440 ~~~~~~----~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~ 514 (575)
...... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... +..+.++..+..+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~ 245 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEKGERMGCPAGC 245 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTC
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCCCCCCCCCC
Confidence 654332 223356789999999998899999999999999999999 9999999887665444 4556677788899
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhchhhH
Q 008171 515 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENE 555 (575)
Q Consensus 515 ~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~~~~~ 555 (575)
++.+.++|.+||+.||.+||++.++++.|++++.....+++
T Consensus 246 ~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~ 286 (291)
T 1xbb_A 246 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 286 (291)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhccc
Confidence 99999999999999999999999999999999988775543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=378.23 Aligned_cols=263 Identities=29% Similarity=0.599 Sum_probs=231.5
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEee
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~ 357 (575)
..|++..++|++.+.||+|+||.||++++. ++.||||+++.. ......+.+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 467888899999999999999999999862 267999999854 345556789999999999999999999999
Q ss_pred ecCCCCceeEEEeccCCchhhhhhhcc-----------------------CcCChHHHHHHHHHHHHHHHHHHHCCceec
Q 008171 358 CTKPPSLCIVTEFMSGGSVYDYLHKLK-----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414 (575)
Q Consensus 358 ~~~~~~l~lV~E~~~ggsL~d~l~~~~-----------------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHr 414 (575)
+...+.+|+||||+.|++|.+++.... ..+++..++.++.||+.||.|||++||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 999999999999999999999997643 248899999999999999999999999999
Q ss_pred ccCCCCEEecCCCcEEEeecccceecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 008171 415 DLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 490 (575)
Q Consensus 415 DLKp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~ 490 (575)
||||+|||++.++.+||+|||+++....... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986654332 233457889999999999999999999999999999999 999999
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 491 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 491 ~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
.....+... .+.....+..+..+++.+.++|.+||+.||.+||++.++++.|++++.+
T Consensus 255 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 255 GIPPERLFN-LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp TCCGGGHHH-HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCHHHHHH-HhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 888766554 3455566778889999999999999999999999999999999998763
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=393.11 Aligned_cols=262 Identities=32% Similarity=0.602 Sum_probs=220.4
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEEC-----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-----~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
.+++..+|++.+.||+|+||.||+|++. +..||||+++... .....+.|.+|+.+|++++||||+++++++...
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 4677889999999999999999999864 4569999998643 455567899999999999999999999999999
Q ss_pred CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
..+|+||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999999998866789999999999999999999999999999999999999999999999999998655
Q ss_pred cCCc----cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 008171 442 QSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 516 (575)
Q Consensus 442 ~~~~----~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~ 516 (575)
.... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||...+..+.... +..+.+...+..+++
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~-i~~~~~~~~~~~~~~ 277 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA-VDEGYRLPPPMDCPA 277 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH-HHTTEECCCCTTCBH
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCccccH
Confidence 4321 122345788999999999999999999999999999998 9999998887766544 445556667788999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 517 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
.+.++|.+||+.||.+||++.++++.|+++++..
T Consensus 278 ~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 278 ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred HHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 9999999999999999999999999999998744
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=387.57 Aligned_cols=250 Identities=24% Similarity=0.451 Sum_probs=221.2
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
+..++|++.+.||+|+||.||+++.. ++.||||+++.... .......+.+|+.+|+.++||||+++++++.....+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 45578999999999999999999874 67899999975421 1223567889999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc-CC
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-SG 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~-~~ 444 (575)
+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ..
T Consensus 82 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 99999999999999976 57799999999999999999999999999999999999999999999999999976433 33
Q ss_pred ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 008171 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~ 524 (575)
.....+||+.|+|||++.+..|+.++|||||||++|||++|..||...+..+....+.... ..+|..+++++.+||.+
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~ 238 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHH
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHH
Confidence 4556789999999999999999999999999999999999999999888877776666543 45778899999999999
Q ss_pred hhhcCCCCCC-----CHHHHHH
Q 008171 525 CWQQDPALRP-----DFSEIIE 541 (575)
Q Consensus 525 cL~~dP~~RP-----s~~ell~ 541 (575)
||+.||.+|| ++.|+++
T Consensus 239 lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 239 LLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHT
T ss_pred HhhcCHHHhcCCCCCCHHHHHc
Confidence 9999999999 8998875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=368.84 Aligned_cols=265 Identities=31% Similarity=0.614 Sum_probs=231.4
Q ss_pred CCCceeeCCCceeeeeeeeecCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 283 ~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
..+.|++..++|++.+.||+|+||.||+|.+.+ +.||||+++..... ...+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 79 (279)
T 1qpc_A 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (279)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred chhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-
Confidence 346799999999999999999999999999865 57999999865433 4678899999999999999999999875
Q ss_pred CCceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
+..++||||+.|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 46899999999999999997643 36999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCc--cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 008171 441 AQSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 517 (575)
Q Consensus 441 ~~~~~--~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~ 517 (575)
..... .....+|..|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... +..+..+..+..++++
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 238 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCPEE 238 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTCCHH
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH-HhcccCCCCcccccHH
Confidence 54432 223456889999999998899999999999999999999 9999998887766544 4455667778899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhch
Q 008171 518 LAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 552 (575)
Q Consensus 518 l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~~ 552 (575)
+.+++.+||..||.+|||+.++++.|++++.....
T Consensus 239 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred HHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 99999999999999999999999999999876653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=380.16 Aligned_cols=266 Identities=30% Similarity=0.596 Sum_probs=234.5
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEE
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI 355 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~ 355 (575)
...|++..++|++.+.||+|+||.||+|.+.+ ..||+|+++... .......+.+|+.+++++ +||||++++
T Consensus 38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 34689999999999999999999999998743 359999998653 344567899999999999 899999999
Q ss_pred eeecCCCCceeEEEeccCCchhhhhhhc-------------cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEE
Q 008171 356 GACTKPPSLCIVTEFMSGGSVYDYLHKL-------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLL 422 (575)
Q Consensus 356 ~~~~~~~~l~lV~E~~~ggsL~d~l~~~-------------~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NIL 422 (575)
+++...+.+|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196 (333)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence 9999999999999999999999999754 235799999999999999999999999999999999999
Q ss_pred ecCCCcEEEeecccceecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 008171 423 MDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAA 498 (575)
Q Consensus 423 l~~~~~vkL~DFG~a~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~ 498 (575)
++.++.+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 99999999999999986544322 223456789999999999999999999999999999998 99999988776666
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 499 VGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 499 ~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
...+.....+..+..+++.+.++|.+||+.||.+|||+.++++.|+++..+.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 6777777777788889999999999999999999999999999999988654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=403.16 Aligned_cols=303 Identities=23% Similarity=0.390 Sum_probs=229.0
Q ss_pred CCChhhHHHHHHHHHHHHHHhhhcCCCCCC--CCCCCCCCCCCCCCCCCCccccCCCCCCceeeCCCceeeeeeeeecCc
Q 008171 228 GWPYEETEQLRAALEKEVLKLERQGWPSHR--SSSPTSEPEDTGMKSHPYHLKIPNDGTDVWEIDPKHLKFGSKVASGSY 305 (575)
Q Consensus 228 g~~~e~~~~l~~al~~~~~~~~~~~~~~~~--s~s~~~~~~~~~~~~~~~~~~~p~~~~~~~~i~~~~~~i~~~LG~G~f 305 (575)
....++.++|..++...+..++.+...... +.++........ ... ......+.+..++|++.++||+|+|
T Consensus 90 ~~~~ee~e~W~~ai~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-----~~~~~~~~~~~~~y~~~~~lG~G~~ 161 (446)
T 4ejn_A 90 VETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEE---MEV-----SLAKPKHRVTMNEFEYLKLLGKGTF 161 (446)
T ss_dssp CSSHHHHHHHHHHHHHHCCC------------------------------------------CCCGGGEEEEEEEEEETT
T ss_pred cCCHHHHHHHHHHHHhhhhhhhcccccccccCCCCCcccccccc---ccc-----cccCcccCCChHHcEEeEEEeeCcC
Confidence 456789999999999887555544321111 111111000000 000 0111234566688999999999999
Q ss_pred eEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEeccCCchhhhhhh
Q 008171 306 GDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK 382 (575)
Q Consensus 306 G~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ggsL~d~l~~ 382 (575)
|.||++.. +++.||||+++.... .......+.+|+.+++.++||||+++++++...+.+|+||||++|++|.+++..
T Consensus 162 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 241 (446)
T 4ejn_A 162 GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR 241 (446)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHH
T ss_pred EEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHh
Confidence 99999987 467899999975432 233456788999999999999999999999999999999999999999999976
Q ss_pred ccCcCChHHHHHHHHHHHHHHHHHHH-CCceecccCCCCEEecCCCcEEEeecccceecccC-CccccCCCCCCccCccc
Q 008171 383 LKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAETGTYRWMAPEV 460 (575)
Q Consensus 383 ~~~~l~~~~~~~i~~qI~~aL~yLH~-~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~Gt~~y~APE~ 460 (575)
.+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++..... .......||+.|+|||+
T Consensus 242 -~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~ 320 (446)
T 4ejn_A 242 -ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 320 (446)
T ss_dssp -HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHH
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhh
Confidence 5679999999999999999999998 99999999999999999999999999999764332 34556789999999999
Q ss_pred ccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----C
Q 008171 461 IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRP-----D 535 (575)
Q Consensus 461 i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RP-----s 535 (575)
+.+..|+.++|||||||+||||++|..||...+..+....+.... ..+|..+++++.+||.+||+.||.+|| +
T Consensus 321 ~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t 398 (446)
T 4ejn_A 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSED 398 (446)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTT
T ss_pred cCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCC
Confidence 999999999999999999999999999999988887777666554 357788999999999999999999999 9
Q ss_pred HHHHHH
Q 008171 536 FSEIIE 541 (575)
Q Consensus 536 ~~ell~ 541 (575)
+.|+++
T Consensus 399 ~~ell~ 404 (446)
T 4ejn_A 399 AKEIMQ 404 (446)
T ss_dssp HHHHHT
T ss_pred HHHHHh
Confidence 999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=402.33 Aligned_cols=261 Identities=34% Similarity=0.664 Sum_probs=230.6
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
.+.|++..++|++.++||+|+||.||+|.+. +..||||+++..... .+.|.+|+.+|++++||||+++++++. ..
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 4678999999999999999999999999986 567999999865432 567999999999999999999999987 56
Q ss_pred CceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
.+|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 7899999999999999997643 368999999999999999999999999999999999999999999999999998654
Q ss_pred cCC--ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 008171 442 QSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 442 ~~~--~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
... ......+|..|+|||++....++.++|||||||+||||++ |..||.+.+..+.... +..+.+...|..+++++
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~~~~~~~~l 414 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-LERGYRMPRPENCPEEL 414 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHHTCCCCCCTTSCHHH
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHH
Confidence 322 1223346788999999999999999999999999999999 9999999888776655 44567777889999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
.++|.+||+.||.+|||+.+|++.|+++...
T Consensus 415 ~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 415 YNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999987653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=377.80 Aligned_cols=246 Identities=27% Similarity=0.506 Sum_probs=217.7
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.++||+|+||.||+|.+ .++.||||++....... ...+.+|+.++++++||||+++++++...+.+|+|||
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 5789999999999999999976 56789999987554332 4668899999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
|+.|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 98 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 175 (297)
T 3fxz_A 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (297)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred CCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCC
Confidence 9999999999975 468999999999999999999999999999999999999999999999999998665443 3445
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhh
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~~~~p~~~~~~l~~Li~~cL~ 527 (575)
..||+.|+|||++.+..++.++|||||||++|+|++|..||...++......+..... ....+..+++.+.+||.+||+
T Consensus 176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 255 (297)
T 3fxz_A 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 255 (297)
T ss_dssp CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSC
T ss_pred ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHcc
Confidence 6799999999999999999999999999999999999999999888776665554432 344567889999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 008171 528 QDPALRPDFSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs~~ell~ 541 (575)
.||.+|||+.|+++
T Consensus 256 ~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 256 MDVEKRGSAKELLQ 269 (297)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred CChhHCcCHHHHhh
Confidence 99999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=385.08 Aligned_cols=263 Identities=29% Similarity=0.464 Sum_probs=219.9
Q ss_pred CCCCceeeCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 282 ~~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
+++..|.++.++|++.++||+|+||.||+|++.++.||||+++.. ......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp CCCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred cCccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 456678899999999999999999999999999999999999753 23345566799999999999999999998765
Q ss_pred CC----ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHC----------CceecccCCCCEEecCCC
Q 008171 362 PS----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN----------NIIHRDLKAANLLMDENE 427 (575)
Q Consensus 362 ~~----l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~----------gIiHrDLKp~NILl~~~~ 427 (575)
.. +|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred CCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence 43 6999999999999999965 5599999999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecccCC---ccccCCCCCCccCcccccCC-----CCCchHHHHHHHHHHHHHHcCCCCCCCCC------
Q 008171 428 VVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHK-----PYDHKADVFSFGIVLWELLTGKLPYEYLT------ 493 (575)
Q Consensus 428 ~vkL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~-----~~s~ksDVwSlGviL~eLltG~~Pf~~~~------ 493 (575)
.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..
T Consensus 169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 248 (322)
T 3soc_A 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248 (322)
T ss_dssp CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence 99999999997655432 23345799999999999863 56678999999999999999999996532
Q ss_pred ----------HHHHHHHHHhcCCCCCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 494 ----------PLQAAVGVVQKGLRPTIPKN-----SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 494 ----------~~~~~~~v~~~~~~~~~p~~-----~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
.......+.....++.++.. +++++.+||.+||+.||.+|||+.|+++.|+++.+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 22222233344444444432 345699999999999999999999999999998753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=372.47 Aligned_cols=265 Identities=28% Similarity=0.549 Sum_probs=232.3
Q ss_pred ceeeCCCceeeee-eeeecCceEEEEEEE----CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC
Q 008171 286 VWEIDPKHLKFGS-KVASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (575)
Q Consensus 286 ~~~i~~~~~~i~~-~LG~G~fG~Vy~~~~----~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 360 (575)
.|.+..++|.+.+ .||+|+||.||+|.+ .+..||||+++... .......+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 80 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ- 80 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-
Confidence 4577788898887 999999999999986 45679999998653 4455678999999999999999999999994
Q ss_pred CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
.+.+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 45689999999999999999876778999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCc----cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 008171 441 AQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 515 (575)
Q Consensus 441 ~~~~~----~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~ 515 (575)
..... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... +..+.++.++..++
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~ 239 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRMECPPECP 239 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-HHTTCCCCCCTTCC
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HhcCCcCCCCCCcC
Confidence 54322 223456899999999998899999999999999999998 9999998877665544 44566678889999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhchh
Q 008171 516 PKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE 553 (575)
Q Consensus 516 ~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~~~ 553 (575)
+++.++|.+||+.||.+||++.++++.|++++.+....
T Consensus 240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 240 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 99999999999999999999999999999999876543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=386.63 Aligned_cols=249 Identities=20% Similarity=0.388 Sum_probs=221.9
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.++||+|+||.||++.+. ++.||+|++............+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 57999999999999999999874 6789999998777666667889999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC---CcEEEeecccceecccCCcc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN---EVVKVADFGVARVKAQSGVM 446 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~---~~vkL~DFG~a~~~~~~~~~ 446 (575)
|+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.........
T Consensus 109 ~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~ 187 (362)
T 2bdw_A 109 LVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187 (362)
T ss_dssp CCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCccc
Confidence 9999999999876 5679999999999999999999999999999999999999865 45999999999877665556
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcHHHHHHHHH
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLER 524 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~--p~~~~~~l~~Li~~ 524 (575)
....||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..+....+......... ...+++++.+||.+
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 267 (362)
T 2bdw_A 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 267 (362)
T ss_dssp CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHH
T ss_pred ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHH
Confidence 6678999999999999999999999999999999999999999988877776665554433222 24678999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 008171 525 CWQQDPALRPDFSEIIE 541 (575)
Q Consensus 525 cL~~dP~~RPs~~ell~ 541 (575)
||+.||.+||++.|+++
T Consensus 268 ~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 268 MLTVNPKKRITADQALK 284 (362)
T ss_dssp HSCSSGGGSCCHHHHTT
T ss_pred HcCCChhhCcCHHHHhc
Confidence 99999999999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=378.26 Aligned_cols=263 Identities=33% Similarity=0.626 Sum_probs=225.9
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEECCc------cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQ------DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~------~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 360 (575)
+++..++|++.+.||+|+||.||+|.+... .||||+++... .......+.+|+.++++++||||+++++++..
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 478889999999999999999999987432 49999998543 44556779999999999999999999999999
Q ss_pred CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
...+++||||++|++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999999999876778999999999999999999999999999999999999999999999999999865
Q ss_pred ccCC----ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 008171 441 AQSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 515 (575)
Q Consensus 441 ~~~~----~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~ 515 (575)
.... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+.... +..+.++..+..++
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~ 276 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-INDGFRLPTPMDCP 276 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCCTTCB
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHCCCcCCCcccCC
Confidence 4432 1223356789999999999999999999999999999999 9999998887666544 44556667788999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 516 PKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 516 ~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
+.+.++|.+||+.||.+||++.++++.|++++....
T Consensus 277 ~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 277 SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 999999999999999999999999999999987543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=388.66 Aligned_cols=263 Identities=30% Similarity=0.565 Sum_probs=228.4
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeee
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~ 358 (575)
.+++..++|+++++||+|+||.||+|++. ++.||||+++.. ........+.+|+.++++++||||+++++++
T Consensus 65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 45677889999999999999999999854 346999999743 3445566799999999999999999999999
Q ss_pred cCCCCceeEEEeccCCchhhhhhhcc------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC---cE
Q 008171 359 TKPPSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VV 429 (575)
Q Consensus 359 ~~~~~l~lV~E~~~ggsL~d~l~~~~------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~---~v 429 (575)
......|+||||+.||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999999997643 3589999999999999999999999999999999999999554 59
Q ss_pred EEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcC
Q 008171 430 KVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG 505 (575)
Q Consensus 430 kL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~ 505 (575)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++ |..||......+.... +..+
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~-i~~~ 302 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-VTSG 302 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHTT
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcC
Confidence 999999997543221 2234567999999999999999999999999999999998 9999999887766554 4455
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 506 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 506 ~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
.++..+..+++.+.+||.+||+.||.+||++.++++.|+.+.+..
T Consensus 303 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 567778899999999999999999999999999999999987644
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=372.41 Aligned_cols=265 Identities=36% Similarity=0.666 Sum_probs=234.6
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
+.|++..++|++.++||+|+||.||+|.+. +..||||+++... .....+.+|+.++++++||||+++++++....
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 578999999999999999999999999986 6779999998542 33577899999999999999999999999999
Q ss_pred CceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
.+|+||||+.|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999999999999997643 458999999999999999999999999999999999999999999999999997655
Q ss_pred cCC--ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 008171 442 QSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 442 ~~~--~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... +....++..+..+++.+
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 241 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKDYRMERPEGCPEKV 241 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-HHTTCCCCCCTTCCHHH
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhccCCCCCCCCCCHHH
Confidence 433 2223456789999999999999999999999999999999 9999998877665443 55566777888999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhchh
Q 008171 519 AELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE 553 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~~~ 553 (575)
.++|.+||..||.+|||+.++++.|++++.+....
T Consensus 242 ~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~~ 276 (288)
T 3kfa_A 242 YELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 276 (288)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 99999999999999999999999999999876543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=387.28 Aligned_cols=249 Identities=22% Similarity=0.395 Sum_probs=220.4
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~----~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
+.|++++.||+|+||.||++... ++.||||+++...... .....+.+|+.+|++++||||+++++++.+...+|
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 57999999999999999999884 6789999998654322 13467899999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC----cEEEeecccceecc
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKA 441 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~----~vkL~DFG~a~~~~ 441 (575)
+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 92 lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 92 LILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 99999999999999976 56799999999999999999999999999999999999998776 79999999998776
Q ss_pred cCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHH
Q 008171 442 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLA 519 (575)
Q Consensus 442 ~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--~~~p~~~~~~l~ 519 (575)
.........||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+...... +..+..+++++.
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 250 (361)
T 2yab_A 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK 250 (361)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred CCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHH
Confidence 665566778999999999999999999999999999999999999999998887777665544322 123367899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 008171 520 ELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 520 ~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+||.+||..||.+|||+.|+++
T Consensus 251 ~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 251 DFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHCCCChhHCcCHHHHhc
Confidence 9999999999999999999984
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=369.24 Aligned_cols=262 Identities=29% Similarity=0.581 Sum_probs=226.0
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEECCc-----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeec
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~-----~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~ 359 (575)
..|.+..++|++.+.||+|+||.||+|.+.+. .||+|+++... .......+.+|+.++++++||||+++++++.
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE 83 (281)
T ss_dssp CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 45678889999999999999999999987532 39999988653 4455678999999999999999999999987
Q ss_pred CCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 360 ~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
+ +..|+||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 84 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 84 E-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred C-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 5 457899999999999999988677799999999999999999999999999999999999999999999999999976
Q ss_pred cccCC--ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 008171 440 KAQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 516 (575)
Q Consensus 440 ~~~~~--~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~ 516 (575)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+.... +.....+..+..+++
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 241 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-LEKGDRLPKPDLCPP 241 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH-HHHTCCCCCCTTCCH
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH-HhcCCCCCCCCCCCH
Confidence 54432 2234457889999999999999999999999999999998 9999987776655443 444556677888999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 517 KLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
.+.++|.+||..||.+||++.|+++.|+++++.
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 242 VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999999999998764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=379.33 Aligned_cols=265 Identities=28% Similarity=0.514 Sum_probs=213.8
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEECCc-----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~-----~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 360 (575)
.+.+..++|++++.||+|+||.||+|.+... .||||+++.........+.+.+|+.++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 4567788999999999999999999986432 69999998776666667889999999999999999999999977
Q ss_pred CCCc------eeEEEeccCCchhhhhhhcc-----CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcE
Q 008171 361 PPSL------CIVTEFMSGGSVYDYLHKLK-----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVV 429 (575)
Q Consensus 361 ~~~l------~lV~E~~~ggsL~d~l~~~~-----~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~v 429 (575)
.... ++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence 6655 99999999999999986532 258999999999999999999999999999999999999999999
Q ss_pred EEeecccceecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcC
Q 008171 430 KVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG 505 (575)
Q Consensus 430 kL~DFG~a~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~ 505 (575)
||+|||+++....... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+. ..
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~ 255 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI-GG 255 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TT
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh-cC
Confidence 9999999976544322 223456789999999999999999999999999999999 999999888777665544 34
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 506 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 506 ~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
..+..+..+++++.++|.+||+.||.+|||+.++++.|++++....
T Consensus 256 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 256 NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 4567788899999999999999999999999999999999987554
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=377.34 Aligned_cols=265 Identities=31% Similarity=0.619 Sum_probs=232.8
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEEC---------CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEE
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF 354 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~---------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l 354 (575)
..|++..++|++++.||+|+||.||+|.+. +..||||+++... .......+.+|+.+++++ +||||+++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 567899999999999999999999999874 3569999998543 445567899999999999 89999999
Q ss_pred EeeecCCCCceeEEEeccCCchhhhhhhcc---------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCC
Q 008171 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419 (575)
Q Consensus 355 ~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~---------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~ 419 (575)
++++...+.+|+||||+.|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 999999999999999999999999997643 24889999999999999999999999999999999
Q ss_pred CEEecCCCcEEEeecccceecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 008171 420 NLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL 495 (575)
Q Consensus 420 NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~ 495 (575)
|||++.++.+||+|||+++....... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 99999999999999999986654332 234457889999999998899999999999999999999 99999988776
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 496 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 496 ~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
+.... +..+.++..+..+++++.++|.+||+.||.+||++.++++.|++++....
T Consensus 267 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 267 ELFKL-LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHHHH-HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHH-HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 65544 44556677888999999999999999999999999999999999987654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=370.01 Aligned_cols=255 Identities=33% Similarity=0.675 Sum_probs=221.3
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHH-----HHHHHHHHHHHhcCCCCceEEEeeecC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQ-----KEFAQEVFIMRKVRHKNVVQFIGACTK 360 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~-----~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 360 (575)
.+..++|++.+.||+|+||.||+|++ +++.||||++.......... +.+.+|+.++++++||||+++++++.+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 45668899999999999999999998 46789999987654332211 678999999999999999999999976
Q ss_pred CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCC--ceecccCCCCEEecCCCc-----EEEee
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEV-----VKVAD 433 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~g--IiHrDLKp~NILl~~~~~-----vkL~D 433 (575)
.. ++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 54 7999999999999999876778999999999999999999999999 999999999999988776 99999
Q ss_pred cccceecccCCccccCCCCCCccCcccc--cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHhcCCCCC
Q 008171 434 FGVARVKAQSGVMTAETGTYRWMAPEVI--EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA--AVGVVQKGLRPT 509 (575)
Q Consensus 434 FG~a~~~~~~~~~~~~~Gt~~y~APE~i--~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~--~~~v~~~~~~~~ 509 (575)
||+++.... ......||+.|+|||++ ....++.++|||||||++|+|++|..||........ ...+......+.
T Consensus 173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 4f0f_A 173 FGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250 (287)
T ss_dssp CTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred CCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence 999975433 34456799999999999 456688999999999999999999999987654333 455566677888
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 510 IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 510 ~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
++..+++.+.++|.+||+.||.+|||+.++++.|+++
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 9999999999999999999999999999999998753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=375.56 Aligned_cols=266 Identities=32% Similarity=0.621 Sum_probs=231.6
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEe
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~ 356 (575)
..|++..++|++.+.||+|+||.||+|.+. ++.||||+++... .......+.+|+.+++++ +||||+++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 467888899999999999999999999853 3679999998653 344557799999999999 6899999999
Q ss_pred eecCCC-CceeEEEeccCCchhhhhhhccCc---------------CChHHHHHHHHHHHHHHHHHHHCCceecccCCCC
Q 008171 357 ACTKPP-SLCIVTEFMSGGSVYDYLHKLKGV---------------FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (575)
Q Consensus 357 ~~~~~~-~l~lV~E~~~ggsL~d~l~~~~~~---------------l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~N 420 (575)
++...+ .+|+||||++|++|.+++...... +++..++.++.||+.||.|||++||+||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 987654 489999999999999999764332 7899999999999999999999999999999999
Q ss_pred EEecCCCcEEEeecccceecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 008171 421 LLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQ 496 (575)
Q Consensus 421 ILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~ 496 (575)
|+++.++.+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|+|++ |..||......+
T Consensus 179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 9999999999999999976544321 223457889999999999999999999999999999998 999998877666
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 497 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 497 ~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
.....+..+.....+..+++++.++|.+||+.||.+|||+.++++.|+++++...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 259 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 6666666677777888999999999999999999999999999999999987543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=374.22 Aligned_cols=259 Identities=25% Similarity=0.442 Sum_probs=222.0
Q ss_pred CCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCcee
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~l 366 (575)
-.++|++.++||+|+||.||++.+. ++.||+|++..... .....+.+.+|+.++++++||||+++++++...+.+|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 3478999999999999999999874 67899999865433 44556789999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC--
Q 008171 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-- 444 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-- 444 (575)
||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 89 v~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp EEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 9999999999999976 5679999999999999999999999999999999999999999999999999997654432
Q ss_pred ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CCCCCCcHHHHHH
Q 008171 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP---TIPKNSQPKLAEL 521 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~---~~p~~~~~~l~~L 521 (575)
......||+.|+|||++.+..++.++||||||+++|+|++|..||...+........+...... ..+..+++.+.++
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 247 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNV 247 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHH
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHH
Confidence 2234569999999999999999999999999999999999999999998887766665544321 2456789999999
Q ss_pred HHHhhhcCCCCCC-CHHHHHHHHHHHHHH
Q 008171 522 LERCWQQDPALRP-DFSEIIEILQQIAKE 549 (575)
Q Consensus 522 i~~cL~~dP~~RP-s~~ell~~L~~l~~~ 549 (575)
|.+||..||.+|| ++.++.+.|+.++.+
T Consensus 248 i~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 248 ILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred HHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 9999999999998 899999988887653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=380.53 Aligned_cols=247 Identities=19% Similarity=0.315 Sum_probs=220.9
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|+++++||+|+||.||++.+. ++.||+|+++.. ......+.+|+.+|+.++||||+++++++.+...+|+|||
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 68999999999999999999884 677999998754 3345678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC--CCcEEEeecccceecccCCccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE--NEVVKVADFGVARVKAQSGVMT 447 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~--~~~vkL~DFG~a~~~~~~~~~~ 447 (575)
|++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 161 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccc
Confidence 99999999999876668999999999999999999999999999999999999987 7899999999998876665566
Q ss_pred cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHHHHHHh
Q 008171 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPKLAELLERC 525 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~--~p~~~~~~l~~Li~~c 525 (575)
...||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+........ ....+++++.+||.+|
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 241 (321)
T 1tki_A 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHH
Confidence 67899999999999999999999999999999999999999999888877776665543322 2247899999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 008171 526 WQQDPALRPDFSEIIE 541 (575)
Q Consensus 526 L~~dP~~RPs~~ell~ 541 (575)
|..||.+|||+.|+++
T Consensus 242 L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 242 LVKERKSRMTASEALQ 257 (321)
T ss_dssp SCSSGGGSCCHHHHHH
T ss_pred cCCChhHCcCHHHHhc
Confidence 9999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=398.47 Aligned_cols=262 Identities=36% Similarity=0.662 Sum_probs=227.1
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
.+.|++..++|++.++||+|+||.||+|.+.+ ..||||+++..... .+.|.+|+.+|++++||||+++++++.. .
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 46799999999999999999999999999875 56999999865433 3678999999999999999999999977 6
Q ss_pred CceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 7899999999999999997643 458999999999999999999999999999999999999999999999999998654
Q ss_pred cCC--ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 008171 442 QSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 442 ~~~--~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
... ......+|..|+|||++.+..++.++||||||++||||++ |..||.+....+.... +..+.++..|..+++.+
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~~~~~~~~l 410 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESL 410 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTSCHHH
T ss_pred CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHH
Confidence 432 1223456789999999999999999999999999999999 9999999888776654 45567778889999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 519 AELLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
.++|.+||+.||.+|||+.+|++.|++++...
T Consensus 411 ~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 99999999999999999999999999887543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=372.94 Aligned_cols=259 Identities=30% Similarity=0.559 Sum_probs=222.1
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~------~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
.+....|++.++||+|+||.||++.+ .++.||||+++... .......+.+|+.++++++||||+++++++...
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 55667899999999999999999985 46779999998653 223357789999999999999999999999776
Q ss_pred --CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 362 --PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 362 --~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
..+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 668999999999999999987778899999999999999999999999999999999999999999999999999987
Q ss_pred cccCC----ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCC--------------CCHHHHHHHH
Q 008171 440 KAQSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY--------------LTPLQAAVGV 501 (575)
Q Consensus 440 ~~~~~----~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~--------------~~~~~~~~~v 501 (575)
..... ......||..|+|||++.+..++.++||||||+++|+|++|..|+.. ..........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 65543 22345688889999999999999999999999999999999987632 2233334445
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 008171 502 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA 547 (575)
Q Consensus 502 ~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~ 547 (575)
+....+...+..+++.+.++|.+||+.||.+|||+.++++.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 5666677788899999999999999999999999999999999886
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=404.26 Aligned_cols=262 Identities=36% Similarity=0.689 Sum_probs=233.2
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
.+.|++...+|++.++||+|+||.||+|.+. +..||||+++..... ...|.+|+.+|++++||||++++++|...
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4678999999999999999999999999986 677999999865433 46799999999999999999999999999
Q ss_pred CCceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
..+||||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 99999999999999999997643 56899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCc--cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 008171 441 AQSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 517 (575)
Q Consensus 441 ~~~~~--~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~ 517 (575)
..... .....+|..|+|||++.+..++.++|||||||+||||++ |..||.+.+..+... .+....+...|..++++
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 447 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGCPEK 447 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-HHHTTCCCCCCTTCCHH
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCCCCCCCHH
Confidence 54321 223346789999999999999999999999999999999 999999888766543 45667778889999999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 518 LAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 518 l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
+.+||.+||+.||.+|||+.+|++.|+.++++
T Consensus 448 l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 448 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999988653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=369.24 Aligned_cols=258 Identities=36% Similarity=0.690 Sum_probs=219.4
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC-CC
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PP 362 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~-~~ 362 (575)
...|.++.++|++.+.||+|+||.||++++.++.||||+++... ..+.+.+|+.++++++||||+++++++.. .+
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence 34678889999999999999999999999999999999988543 34678999999999999999999998654 45
Q ss_pred CceeEEEeccCCchhhhhhhccC-cCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~-~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
.+|+||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 78999999999999999976433 38999999999999999999999999999999999999999999999999997554
Q ss_pred cCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 008171 442 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 520 (575)
Q Consensus 442 ~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~ 520 (575)
.. .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.... +..+.++..+..+++.+.+
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~ 245 (278)
T 1byg_A 169 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPAVYE 245 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-HTTTCCCCCCTTCCHHHHH
T ss_pred cc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCCCCCcccCCHHHHH
Confidence 33 233467899999999999999999999999999999998 9999998776655443 4456677788899999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 521 LLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 521 Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
+|.+||+.||.+||++.++++.|+++..
T Consensus 246 li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 246 VMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 9999999999999999999999999865
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=365.25 Aligned_cols=250 Identities=20% Similarity=0.384 Sum_probs=224.1
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
.++|++.++||+|+||.||+|.+. ++.||+|++............+.+|+.++++++||||+++++++...+..|+||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 368999999999999999999874 678999999877777777788999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCc---EEEeecccceecccCCc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---VKVADFGVARVKAQSGV 445 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~---vkL~DFG~a~~~~~~~~ 445 (575)
||+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++........
T Consensus 85 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 85 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 99999999999876 567999999999999999999999999999999999999986655 99999999987776666
Q ss_pred cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHHHHH
Q 008171 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPKLAELLE 523 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~--~p~~~~~~l~~Li~ 523 (575)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+........ ....+++++.++|.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 243 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHH
T ss_pred ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHH
Confidence 6677899999999999999999999999999999999999999999888777766655544322 23578999999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 008171 524 RCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 524 ~cL~~dP~~RPs~~ell~ 541 (575)
+||+.||.+|||+.|+++
T Consensus 244 ~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 244 SMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHSCSSTTTSCCHHHHTT
T ss_pred HHcccChhhCCCHHHHhc
Confidence 999999999999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=371.12 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=211.1
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCCh------------------------HHHHHHHHHHHH
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS------------------------DMQKEFAQEVFI 342 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~------------------------~~~~~~~~Ev~i 342 (575)
+..++|++.++||+|+||.||+|.. .++.||||++....... .....+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 3447899999999999999999987 46779999987653211 123568899999
Q ss_pred HHhcCCCCceEEEeeecC--CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCC
Q 008171 343 MRKVRHKNVVQFIGACTK--PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (575)
Q Consensus 343 L~~L~HpnIv~l~~~~~~--~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~N 420 (575)
|++++||||+++++++.. ...+|+||||+++++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999999999999999876 567899999999999998764 3579999999999999999999999999999999999
Q ss_pred EEecCCCcEEEeecccceecccCC-ccccCCCCCCccCcccccCCC---CCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 008171 421 LLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKP---YDHKADVFSFGIVLWELLTGKLPYEYLTPLQ 496 (575)
Q Consensus 421 ILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~Gt~~y~APE~i~~~~---~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~ 496 (575)
||++.++.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.......
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 247 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence 999999999999999998765433 344567999999999997765 4789999999999999999999999888776
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 497 AAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 497 ~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
....+.........+..+++++.++|.+||+.||.+||++.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 248 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 666655555444445678999999999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=388.86 Aligned_cols=265 Identities=20% Similarity=0.308 Sum_probs=214.6
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC-------CccEEEEEecCCCCChHH---------HHHHHHHHHHHHhcCCCCc
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDM---------QKEFAQEVFIMRKVRHKNV 351 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------~~~VAvKvl~~~~~~~~~---------~~~~~~Ev~iL~~L~HpnI 351 (575)
++..++|+++++||+|+||.||+|.+. ++.||||++......... ...+.+|+..++.++||||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 466789999999999999999999874 367999998754311100 1124456677788889999
Q ss_pred eEEEeeecCC----CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEec--C
Q 008171 352 VQFIGACTKP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD--E 425 (575)
Q Consensus 352 v~l~~~~~~~----~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~--~ 425 (575)
+++++++... ...||||||+ |++|.+++....+.+++..++.|+.||+.||.|||++||+||||||+|||++ .
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 9999998664 4589999999 9999999988668899999999999999999999999999999999999999 8
Q ss_pred CCcEEEeecccceecccCCc--------cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 008171 426 NEVVKVADFGVARVKAQSGV--------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQA 497 (575)
Q Consensus 426 ~~~vkL~DFG~a~~~~~~~~--------~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~ 497 (575)
++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||+||||++|..||........
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 89999999999986544321 1234599999999999999999999999999999999999999986432222
Q ss_pred HHHHHhcCCCCC---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhchh
Q 008171 498 AVGVVQKGLRPT---------IPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE 553 (575)
Q Consensus 498 ~~~v~~~~~~~~---------~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~~~ 553 (575)
..........+. .+..+++++.++|.+||+.||.+||++.+|++.|++++++.+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 221111111101 12577899999999999999999999999999999999987643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=373.38 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=210.6
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE-CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~-~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
--.++|++.++||+|+||+||+|.+ .++.||+|+++...........+.+|+.++++++||||+++++++.....+|+|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 3457899999999999999999998 467899999987655555567889999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-Ccc
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVM 446 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~ 446 (575)
|||++ ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 98 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 176 (311)
T 3niz_A 98 FEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY 176 (311)
T ss_dssp EECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred EcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccc
Confidence 99996 5888888876777999999999999999999999999999999999999999999999999999876543 334
Q ss_pred ccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-----------------
Q 008171 447 TAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP----------------- 508 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~----------------- 508 (575)
....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 256 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR 256 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSC
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhc
Confidence 55678999999999876 568999999999999999999999998776655544433211000
Q ss_pred -----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 -----------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 -----------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+...+++++.+||.+||+.||.+|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 012356789999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=378.63 Aligned_cols=259 Identities=30% Similarity=0.608 Sum_probs=220.1
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--Ccc----EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~----VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
.+..++|++.++||+|+||.||+|.+. ++. ||+|.++... .....+.+.+|+.++++++||||++++++|...
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 466789999999999999999999874 333 5888776432 334457899999999999999999999999875
Q ss_pred CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
..++|+||+.+|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 90 -~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp -SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred -CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 4889999999999999998877889999999999999999999999999999999999999999999999999998654
Q ss_pred cCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 008171 442 QSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 517 (575)
Q Consensus 442 ~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~ 517 (575)
.... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||...+..+.. ..+....+...+..++..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 247 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPICTID 247 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHHTTCCCCCCTTBCHH
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-HHHHcCCCCCCCccCCHH
Confidence 4332 223456889999999999999999999999999999999 99999988776554 445556667788899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 518 LAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 518 l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
+.+++.+||+.||.+||++.++++.|+.+.+.
T Consensus 248 ~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 99999999999999999999999999998753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=373.26 Aligned_cols=268 Identities=28% Similarity=0.507 Sum_probs=222.8
Q ss_pred CCCceeeCCCceeeeeeeeecCceEEEEEEECC-----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEee
Q 008171 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357 (575)
Q Consensus 283 ~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-----~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~ 357 (575)
....+.++.++|++++.||+|+||.||+|.+.. ..||||+++...........+.+|+.++++++||||++++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 345668888999999999999999999998643 369999998776666777889999999999999999999999
Q ss_pred ecCCC-----CceeEEEeccCCchhhhhhh-----ccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC
Q 008171 358 CTKPP-----SLCIVTEFMSGGSVYDYLHK-----LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427 (575)
Q Consensus 358 ~~~~~-----~l~lV~E~~~ggsL~d~l~~-----~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~ 427 (575)
+.... ..|+||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence 87654 35999999999999999843 235699999999999999999999999999999999999999999
Q ss_pred cEEEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 008171 428 VVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (575)
Q Consensus 428 ~vkL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~ 503 (575)
.+||+|||+++...... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+ .
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~ 263 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL-L 263 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-H
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH-H
Confidence 99999999997654332 2233457889999999999999999999999999999999 99999988776665543 4
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 504 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 504 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
.+.++..+..+++++.++|.+||..||.+||++.++++.|+++++.+.
T Consensus 264 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 264 HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 455677888999999999999999999999999999999999988764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=392.78 Aligned_cols=249 Identities=19% Similarity=0.361 Sum_probs=220.2
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.++||+|+||.||++.. .++.||+|++............+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 5799999999999999999987 56789999998776666667789999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEec---CCCcEEEeecccceecccCC-c
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSG-V 445 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~---~~~~vkL~DFG~a~~~~~~~-~ 445 (575)
|+.||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...... .
T Consensus 91 ~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~ 169 (444)
T 3soa_A 91 LVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169 (444)
T ss_dssp CCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred eCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence 9999999999977 56799999999999999999999999999999999999998 46789999999997665433 3
Q ss_pred cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHHHHH
Q 008171 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPKLAELLE 523 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~--~p~~~~~~l~~Li~ 523 (575)
.....||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..+....+........ ....+++++.+||.
T Consensus 170 ~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 249 (444)
T 3soa_A 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 249 (444)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHH
T ss_pred eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHH
Confidence 4556899999999999999999999999999999999999999999888777776665544322 22478999999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 008171 524 RCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 524 ~cL~~dP~~RPs~~ell~ 541 (575)
+||+.||.+|||+.|+++
T Consensus 250 ~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 250 KMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHSCSSTTTSCCHHHHHH
T ss_pred HHcCCChhHCCCHHHHhc
Confidence 999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=376.39 Aligned_cols=249 Identities=22% Similarity=0.395 Sum_probs=219.3
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~----~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
+.|++.+.||+|+||.||++... ++.||+|+++...... .....+.+|+.+|++++||||+++++++.....+|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 57999999999999999999984 6789999997654321 13567899999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC----cEEEeecccceecc
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKA 441 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~----~vkL~DFG~a~~~~ 441 (575)
+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 91 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999999999999976 56799999999999999999999999999999999999999877 79999999998776
Q ss_pred cCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHH
Q 008171 442 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPKLA 519 (575)
Q Consensus 442 ~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~--~~p~~~~~~l~ 519 (575)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....... ..+..+++.+.
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (326)
T 2y0a_A 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249 (326)
T ss_dssp TTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHH
Confidence 6555566789999999999999999999999999999999999999999888777666555433221 22357889999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 008171 520 ELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 520 ~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+||.+||+.||.+|||+.|+++
T Consensus 250 ~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 250 DFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhhCCCHHHHhc
Confidence 9999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=375.90 Aligned_cols=251 Identities=25% Similarity=0.435 Sum_probs=210.9
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE-----CCccEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCceEEEeeecC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERIN--SDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~-----~~~~VAvKvl~~~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 360 (575)
.+..++|++.++||+|+||.||+++. .++.||||+++..... ......+.+|+.+|++++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 56678999999999999999999987 4677999999865432 2334568889999999999999999999999
Q ss_pred CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
.+.+|+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred CCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 9999999999999999999976 567899999999999999999999999999999999999999999999999999754
Q ss_pred ccCC-ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 008171 441 AQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 519 (575)
Q Consensus 441 ~~~~-~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~ 519 (575)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.... ..+|..+++++.
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~ 249 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK--LNLPPYLTQEAR 249 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--CCCCTTSCHHHH
T ss_pred ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHH
Confidence 4332 3445679999999999999999999999999999999999999999988877776666543 457788999999
Q ss_pred HHHHHhhhcCCCCCC-----CHHHHHH
Q 008171 520 ELLERCWQQDPALRP-----DFSEIIE 541 (575)
Q Consensus 520 ~Li~~cL~~dP~~RP-----s~~ell~ 541 (575)
++|.+||+.||.+|| ++.|+++
T Consensus 250 ~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 250 DLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 999999999999999 6777764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=370.19 Aligned_cols=249 Identities=23% Similarity=0.394 Sum_probs=210.2
Q ss_pred CceeeeeeeeecCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
++|++.++||+|+||.||+|++. ++.||||+++...........+.+|+.++++++||||+++++++...+.+|+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999884 67899999986654444456788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-CccccC
Q 008171 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTAE 449 (575)
Q Consensus 371 ~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~ 449 (575)
+.+ +|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ......
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccc
Confidence 965 999999877788999999999999999999999999999999999999999999999999999765432 233455
Q ss_pred CCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC----------------CC----
Q 008171 450 TGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL----------------RP---- 508 (575)
Q Consensus 450 ~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~----------------~~---- 508 (575)
.||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+..... .+
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T 1ob3_A 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240 (288)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred cccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccccc
Confidence 78999999999976 4589999999999999999999999998887666555443110 00
Q ss_pred -------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 -------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 -------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.....+++++.+||.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 122457899999999999999999999999874
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=386.64 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=214.8
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~ 363 (575)
.+..++|++.++||+|+||.||++++. ++.||||+++.... .......+.+|..+++.+ +||||+++++++.+...
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 466689999999999999999999874 67899999975422 223346688899999988 69999999999999999
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
+|+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 9999999999999999976 577999999999999999999999999999999999999999999999999999754333
Q ss_pred -CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 008171 444 -GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 522 (575)
Q Consensus 444 -~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li 522 (575)
......+||+.|+|||++.+..|+.++|||||||++|||++|..||...+..+....+.... ..+|..+++.+.++|
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li 255 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--VVYPTWLHEDATGIL 255 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHH
Confidence 23445689999999999999999999999999999999999999999999888877776654 456788999999999
Q ss_pred HHhhhcCCCCCCCH------HHHHH
Q 008171 523 ERCWQQDPALRPDF------SEIIE 541 (575)
Q Consensus 523 ~~cL~~dP~~RPs~------~ell~ 541 (575)
.+||+.||.+||++ .|+++
T Consensus 256 ~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 256 KSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHhhhCHHHccCCcccCCHHHHhh
Confidence 99999999999998 66654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=372.52 Aligned_cols=263 Identities=31% Similarity=0.573 Sum_probs=229.3
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEe
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIG 356 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~ 356 (575)
.+.|++..++|++.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.++++++||||+++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 3578899999999999999999999999764 4679999998543 3445567999999999999999999999
Q ss_pred eecCCCCceeEEEeccCCchhhhhhhcc---------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC
Q 008171 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427 (575)
Q Consensus 357 ~~~~~~~l~lV~E~~~ggsL~d~l~~~~---------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~ 427 (575)
++......|+||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 9999999999999999999999997643 4578999999999999999999999999999999999999999
Q ss_pred cEEEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 008171 428 VVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQ 503 (575)
Q Consensus 428 ~vkL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~ 503 (575)
.+||+|||+++...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 255 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence 99999999997554432 1223456889999999999999999999999999999999 8999999888776655444
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 504 KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 504 ~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
...+..+..+++.+.++|.+||+.||.+|||+.|+++.|++++.
T Consensus 256 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 256 -GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 44456778899999999999999999999999999999987653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=369.14 Aligned_cols=261 Identities=18% Similarity=0.275 Sum_probs=221.9
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCc
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l 364 (575)
.+..++|++.+.||+|+||.||+|.. .++.||||++...... ..+.+|+.+++.+ +|+|++++++++......
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 45567899999999999999999995 5788999998754322 3477899999999 799999999999999999
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCc-----EEEeeccccee
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV-----VKVADFGVARV 439 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~-----vkL~DFG~a~~ 439 (575)
|+||||+ |++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999999 99999999876677999999999999999999999999999999999999987765 99999999986
Q ss_pred cccCCc--------cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhc---C
Q 008171 440 KAQSGV--------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT---PLQAAVGVVQK---G 505 (575)
Q Consensus 440 ~~~~~~--------~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~---~~~~~~~v~~~---~ 505 (575)
...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+ ..+....+... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 654322 234579999999999999999999999999999999999999998743 33333332222 1
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhchh
Q 008171 506 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEE 553 (575)
Q Consensus 506 ~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~~~ 553 (575)
..+.....+++++.++|.+||+.||.+||++.+|++.|++++++....
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 112334578999999999999999999999999999999999877543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=377.79 Aligned_cols=259 Identities=28% Similarity=0.563 Sum_probs=221.1
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--Ccc----EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~----VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
.+..++|++.++||+|+||.||+|.+. ++. ||+|++..... ......+.+|+.++++++||||+++++++. .
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 456789999999999999999999874 333 78887764322 222355778999999999999999999986 4
Q ss_pred CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
...++||||+.+|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 56899999999999999998877789999999999999999999999999999999999999999999999999998654
Q ss_pred cCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 008171 442 QSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 517 (575)
Q Consensus 442 ~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~ 517 (575)
... ......||..|+|||++.+..++.++|||||||++|+|++ |..||......+.... +....++..+..++++
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 245 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL-LEKGERLAQPQICTID 245 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH-HHTTCBCCCCTTBCTT
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH-HHcCCCCCCCCcCcHH
Confidence 432 2344567889999999999999999999999999999999 9999998776665443 4555667778889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 518 LAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 518 l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
+.++|.+||+.||.+||++.++++.|+.+.+.
T Consensus 246 ~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 246 VYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999988653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=366.61 Aligned_cols=249 Identities=22% Similarity=0.359 Sum_probs=211.4
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.++||+|+||+||+|.+. ++.||||+++...........+.+|+.++++++||||+++++++.+...+|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999984 6779999998776666667889999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-Ccccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~ 448 (575)
|+.+ +|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence 9965 777777666788999999999999999999999999999999999999999999999999999876543 23455
Q ss_pred CCCCCCccCcccccCCC-CCchHHHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHHhcCCC-------------------
Q 008171 449 ETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLP-YEYLTPLQAAVGVVQKGLR------------------- 507 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~-~s~ksDVwSlGviL~eLltG~~P-f~~~~~~~~~~~v~~~~~~------------------- 507 (575)
..||+.|+|||++.+.. ++.++|||||||++|+|++|..| |...+..+....+......
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T 3o0g_A 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccc
Confidence 67899999999997765 89999999999999999998777 4555555444443321100
Q ss_pred --------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 --------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 --------~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
......+++++.+||.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 1122357899999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=405.22 Aligned_cols=265 Identities=27% Similarity=0.545 Sum_probs=228.0
Q ss_pred CceeeCCCceeeee-eeeecCceEEEEEEEC----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeec
Q 008171 285 DVWEIDPKHLKFGS-KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (575)
Q Consensus 285 ~~~~i~~~~~~i~~-~LG~G~fG~Vy~~~~~----~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~ 359 (575)
..|.+...++.+.+ +||+|+||.||+|.+. +..||||+++... .....+.|.+|+.+|++++|||||+++++|.
T Consensus 328 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 406 (613)
T 2ozo_A 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 406 (613)
T ss_dssp CCSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEec
Confidence 34667777888777 8999999999999873 3459999998653 2334678999999999999999999999997
Q ss_pred CCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 360 ~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
. +.+||||||+.||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 407 ~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 407 A-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp S-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred c-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 6 569999999999999999987677899999999999999999999999999999999999999999999999999976
Q ss_pred cccCCc----cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 008171 440 KAQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 514 (575)
Q Consensus 440 ~~~~~~----~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~ 514 (575)
...... .....+|+.|+|||++.+..++.++|||||||+||||++ |..||...+..+.... +..+.++..|..+
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-i~~~~~~~~p~~~ 564 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRMECPPEC 564 (613)
T ss_dssp CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH-HHTTCCCCCCTTC
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCCCCCCcC
Confidence 543321 123345789999999999999999999999999999998 9999999887766544 5556778889999
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhch
Q 008171 515 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 552 (575)
Q Consensus 515 ~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~~ 552 (575)
++++.++|.+||+.||.+||++.+|++.|++++..+..
T Consensus 565 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 565 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 99999999999999999999999999999999877653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=375.99 Aligned_cols=248 Identities=26% Similarity=0.453 Sum_probs=220.0
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
+..++|++.+.||+|+||.||+++.. ++.||+|+++..... ......+.+|+.+++.++||||+++++++.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 34578999999999999999999874 678999999754221 123466888999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 445 (575)
+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus 83 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--~ 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--V 159 (318)
T ss_dssp EEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--C
T ss_pred EEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--c
Confidence 99999999999999976 56799999999999999999999999999999999999999999999999999986543 2
Q ss_pred cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 008171 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 525 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~c 525 (575)
....+||+.|+|||++.+..|+.++|||||||++|||++|..||...+..+....++... ..+|..+++++.++|.+|
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~l 237 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLLSRL 237 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHH
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHH
Confidence 345689999999999999999999999999999999999999999988888777776654 457788999999999999
Q ss_pred hhcCCCCCC-----CHHHHHH
Q 008171 526 WQQDPALRP-----DFSEIIE 541 (575)
Q Consensus 526 L~~dP~~RP-----s~~ell~ 541 (575)
|+.||.+|| ++.++++
T Consensus 238 L~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 238 ITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp TCSCTTTCTTSSTTTTHHHHT
T ss_pred hccCHHHcCCCcCCCHHHHhc
Confidence 999999999 8888873
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=373.88 Aligned_cols=262 Identities=29% Similarity=0.522 Sum_probs=224.8
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeec--
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT-- 359 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~------~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~-- 359 (575)
-++.++|++.++||+|+||.||++++ .++.||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 46678999999999999999999985 4567999999854 3455677999999999999999999999875
Q ss_pred CCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 360 ~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
+...+|+||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 45568999999999999999988677899999999999999999999999999999999999999999999999999987
Q ss_pred cccCC----ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH--------------HHHHHHH
Q 008171 440 KAQSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP--------------LQAAVGV 501 (575)
Q Consensus 440 ~~~~~----~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~--------------~~~~~~v 501 (575)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... .......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 65433 22344678889999999999999999999999999999999999854322 2334445
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 502 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 502 ~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
+....++..+..+++.+.++|.+||+.||.+|||+.++++.|+.++....
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 56667778889999999999999999999999999999999999987554
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=383.90 Aligned_cols=257 Identities=20% Similarity=0.382 Sum_probs=216.3
Q ss_pred CceeeCCCceeeeeeeeec--CceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC
Q 008171 285 DVWEIDPKHLKFGSKVASG--SYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G--~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 360 (575)
..+..+.++|+++++||+| +||.||++++. ++.||||+++...........+.+|+.++++++||||+++++++..
T Consensus 18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 97 (389)
T 3gni_B 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA 97 (389)
T ss_dssp CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence 3455667899999999999 99999999985 6789999998877677777889999999999999999999999999
Q ss_pred CCCceeEEEeccCCchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
.+.+|+||||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+..
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999999999999999764 36699999999999999999999999999999999999999999999999999865
Q ss_pred cccCC--------ccccCCCCCCccCcccccC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC---
Q 008171 440 KAQSG--------VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--- 506 (575)
Q Consensus 440 ~~~~~--------~~~~~~Gt~~y~APE~i~~--~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~--- 506 (575)
....+ ......||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+.....+....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 43221 2223478999999999987 6799999999999999999999999987665544433222111
Q ss_pred -----------------------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 507 -----------------------------------------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 507 -----------------------------------------~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
....+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11244567899999999999999999999999984
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=369.70 Aligned_cols=256 Identities=35% Similarity=0.686 Sum_probs=216.2
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
.++.++|++.+.||+|+||.||++++.++.||||++... ...+.|.+|+.++++++||||+++++++.+ ..|+|
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence 467789999999999999999999999999999998743 345779999999999999999999999874 48999
Q ss_pred EEeccCCchhhhhhhccC--cCChHHHHHHHHHHHHHHHHHHH---CCceecccCCCCEEecCCCc-EEEeecccceecc
Q 008171 368 TEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQ---NNIIHRDLKAANLLMDENEV-VKVADFGVARVKA 441 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~--~l~~~~~~~i~~qI~~aL~yLH~---~gIiHrDLKp~NILl~~~~~-vkL~DFG~a~~~~ 441 (575)
|||++|++|.+++..... .++...++.++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 999999999999976432 47888999999999999999999 89999999999999998886 7999999997544
Q ss_pred cCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhcCCCCCCCCCCcHHHHH
Q 008171 442 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ-AAVGVVQKGLRPTIPKNSQPKLAE 520 (575)
Q Consensus 442 ~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~-~~~~v~~~~~~~~~p~~~~~~l~~ 520 (575)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ..........++..+..+++.+.+
T Consensus 158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
T 2eva_A 158 TH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHH
T ss_pred cc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHH
Confidence 32 334569999999999999999999999999999999999999998653322 222334456667788899999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 521 LLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 521 Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
+|.+||+.||.+|||+.++++.|+.+.+...
T Consensus 236 li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 236 LMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred HHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 9999999999999999999999999987654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=385.51 Aligned_cols=247 Identities=21% Similarity=0.378 Sum_probs=210.9
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCCh-HHHHHHHHHHHHHHhc-CCCCceEEEeeecCCC
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS-DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP 362 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~-~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~ 362 (575)
..+..++|+++++||+|+||.||++++. ++.||||+++...... .....+.+|..+++++ +||||+++++++.+..
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 3566789999999999999999999875 5679999998654432 3345678899999887 8999999999999999
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc-
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA- 441 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~- 441 (575)
.+|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999999999976 5779999999999999999999999999999999999999999999999999998633
Q ss_pred cCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC---------HHHHHHHHHhcCCCCCCCC
Q 008171 442 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT---------PLQAAVGVVQKGLRPTIPK 512 (575)
Q Consensus 442 ~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~---------~~~~~~~v~~~~~~~~~p~ 512 (575)
........+||+.|+|||++.+..|+.++|||||||++|||++|..||.... .......+.. ....+|.
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~ 283 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPR 283 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH--CCCCCCT
T ss_pred CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc--cccCCCC
Confidence 3334556789999999999999999999999999999999999999996432 1122222333 3456788
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCH
Q 008171 513 NSQPKLAELLERCWQQDPALRPDF 536 (575)
Q Consensus 513 ~~~~~l~~Li~~cL~~dP~~RPs~ 536 (575)
.+++++.+||++||+.||.+||++
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCC
Confidence 999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=379.35 Aligned_cols=267 Identities=29% Similarity=0.586 Sum_probs=223.0
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCC
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 363 (575)
...|++..++|++.+.||+|+||.||+|.+.+ .||+|+++.........+.+.+|+.++++++||||+++++++...+.
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 35788999999999999999999999999865 59999998765544445667889999999999999999999999999
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
+++||||+.|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 9999999999999999987666899999999999999999999999999999999999998 679999999998654321
Q ss_pred ------CccccCCCCCCccCcccccC---------CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC
Q 008171 444 ------GVMTAETGTYRWMAPEVIEH---------KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP 508 (575)
Q Consensus 444 ------~~~~~~~Gt~~y~APE~i~~---------~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~ 508 (575)
.......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.......
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 262 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN 262 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence 22334468999999999864 458999999999999999999999999888777665544433323
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhch
Q 008171 509 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 552 (575)
Q Consensus 509 ~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~~ 552 (575)
..+..+++++.++|.+||..||.+|||+.++++.|+++......
T Consensus 263 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 33447889999999999999999999999999999998875543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=375.72 Aligned_cols=257 Identities=21% Similarity=0.319 Sum_probs=217.2
Q ss_pred CCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCcee
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l~l 366 (575)
-.++|++.++||+|+||.||+|+. +++.||||++...... ..+.+|+.+++++ +||||+++++++......|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 347899999999999999999986 5778999998754322 3578899999999 89999999999999999999
Q ss_pred EEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCc-----EEEeecccceecc
Q 008171 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV-----VKVADFGVARVKA 441 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~-----vkL~DFG~a~~~~ 441 (575)
||||+ |++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999 99999999876788999999999999999999999999999999999999998887 9999999998654
Q ss_pred cCCc--------cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCCC---
Q 008171 442 QSGV--------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQKGLR--- 507 (575)
Q Consensus 442 ~~~~--------~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~---~~~~~~v~~~~~~--- 507 (575)
.... .....||+.|+|||++.+..++.++|||||||++|||++|..||...+. .+....+......
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 4322 2356799999999999999999999999999999999999999987543 2222222211111
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhch
Q 008171 508 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 552 (575)
Q Consensus 508 ~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~~ 552 (575)
......++ ++.++|.+||+.||.+||++.+|++.|++++.+.+.
T Consensus 242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 242 EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 11123355 999999999999999999999999999999987754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=363.77 Aligned_cols=257 Identities=31% Similarity=0.587 Sum_probs=221.1
Q ss_pred ceeeeeeeeecCceEEEEEEECC--c---cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc-ee
Q 008171 293 HLKFGSKVASGSYGDLYRGTYCS--Q---DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL-CI 366 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~~--~---~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l-~l 366 (575)
.|++.++||+|+||.||+|.+.+ + .||+|++... ......+.+.+|+.++++++||||+++++++...... ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 46677999999999999998632 2 5999998753 3445567899999999999999999999999776655 99
Q ss_pred EEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC--
Q 008171 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-- 444 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-- 444 (575)
||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 999999999999998867789999999999999999999999999999999999999999999999999997543321
Q ss_pred ---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 008171 445 ---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 520 (575)
Q Consensus 445 ---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~ 520 (575)
......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||...+..+... .+........+..+++.+.+
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~ 259 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH-FLAQGRRLPQPEYCPDSLYQ 259 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHH-HHHTTCCCCCCTTCCHHHHH
T ss_pred ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHH-HhhcCCCCCCCccchHHHHH
Confidence 2234467899999999999999999999999999999999 555666666555443 44555566778889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 521 LLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 521 Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
+|.+||+.||.+|||+.++++.|++++..+.
T Consensus 260 li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 260 VMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999998775
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=376.29 Aligned_cols=245 Identities=22% Similarity=0.399 Sum_probs=212.5
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCc
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l 364 (575)
+..++|++.+.||+|+||.||++++. ++.||||+++.... .......+.+|+.+++++ +||||+++++++.+...+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 45578999999999999999999985 67799999986544 344566788999999988 899999999999999999
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc-C
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ-S 443 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~-~ 443 (575)
|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus 86 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 999999999999999976 56799999999999999999999999999999999999999999999999999986433 2
Q ss_pred CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC---------CHHHHHHHHHhcCCCCCCCCCC
Q 008171 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYL---------TPLQAAVGVVQKGLRPTIPKNS 514 (575)
Q Consensus 444 ~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~---------~~~~~~~~v~~~~~~~~~p~~~ 514 (575)
......+||+.|+|||++.+..|+.++|||||||++|||++|..||... ........+... ...+|..+
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~~ 242 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSL 242 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--CCCCCTTS
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--CCCCCCCC
Confidence 3445668999999999999999999999999999999999999999752 122222233332 34678899
Q ss_pred cHHHHHHHHHhhhcCCCCCCCH
Q 008171 515 QPKLAELLERCWQQDPALRPDF 536 (575)
Q Consensus 515 ~~~l~~Li~~cL~~dP~~RPs~ 536 (575)
++++.+||.+||+.||.+||++
T Consensus 243 s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 243 SVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTC
T ss_pred CHHHHHHHHHHhcCCHhHCCCC
Confidence 9999999999999999999996
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=402.81 Aligned_cols=262 Identities=36% Similarity=0.662 Sum_probs=231.4
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
.+.|+|..++|++.++||+|+||.||+|.+.+ ..||||+++..... .+.|.+|+.+|++++||||+++++++.+ .
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 46799999999999999999999999999875 56999999875433 3678999999999999999999999977 6
Q ss_pred CceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
.+||||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 7999999999999999997643 458999999999999999999999999999999999999999999999999997654
Q ss_pred cCC--ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 008171 442 QSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 442 ~~~--~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
... ......++..|+|||++.+..++.++|||||||+||||++ |..||.+....+.... +..+.+...+..+++.+
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~~~~~~~~l 493 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESL 493 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTCCHHH
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHH
Confidence 321 1223456789999999999999999999999999999999 9999999888776554 45567777888999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 519 AELLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
.+||.+||+.||.+|||+.+|++.|++++...
T Consensus 494 ~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 494 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 99999999999999999999999999887544
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=366.32 Aligned_cols=258 Identities=31% Similarity=0.561 Sum_probs=220.4
Q ss_pred CceeeeeeeeecCceEEEEEEECCc-----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeee-cCCCCce
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC-TKPPSLC 365 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~~~-----~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~-~~~~~l~ 365 (575)
.+|++.++||+|+||.||+|++... .||+|.++.. ........+.+|+.++++++||||+++++++ ...+..|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4688999999999999999986432 3899998753 3445567899999999999999999999985 4556789
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~- 444 (575)
+||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 9999999999999998767789999999999999999999999999999999999999999999999999997654432
Q ss_pred ----ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 008171 445 ----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 519 (575)
Q Consensus 445 ----~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~ 519 (575)
......||+.|+|||++.+..++.++||||||+++|+|++ |.+||...+..+....+ ........+..+++.+.
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~ 262 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQPEYCPDPLY 262 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH-HTTCCCCCCTTCCHHHH
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-hcCCCCCCCccCCHHHH
Confidence 2233457789999999999999999999999999999999 67788777666555443 34555667888999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 520 ELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 520 ~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
++|.+||+.||.+|||+.++++.|++++.++.
T Consensus 263 ~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 263 EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 99999999999999999999999999988654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=366.08 Aligned_cols=261 Identities=32% Similarity=0.624 Sum_probs=219.9
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEECC---c--cEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecC
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS---Q--DVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~---~--~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 360 (575)
..+..++|++.++||+|+||.||+|++.. + .||||+++.... .....+.+.+|+.++++++||||+++++++..
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 36677899999999999999999998632 2 489999886543 33556789999999999999999999999987
Q ss_pred CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
.. .++||||+.+++|.+++....+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++...
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 54 89999999999999999887778999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCc----cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 008171 441 AQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 515 (575)
Q Consensus 441 ~~~~~----~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~ 515 (575)
..... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+......+..+..++
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 251 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence 54332 223457889999999999899999999999999999999 9999999998888777777666777788999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 516 PKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 516 ~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
+++.++|.+||..||.+|||+.++++.|+++..
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 999999999999999999999999999988754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=385.17 Aligned_cols=252 Identities=23% Similarity=0.398 Sum_probs=217.3
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCC
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 363 (575)
..+..++|++.+.||+|+||.||++.+. ++.||||++..... .......+.+|+.+|+.++|||||++++++.+...
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 4677789999999999999999999875 56799999875321 22234678899999999999999999999999999
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
+|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999999999976 567999999999999999999999999999999999999999999999999999887766
Q ss_pred CccccCCCCCCccCccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhcCCCCCCCCCCcHH
Q 008171 444 GVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLT---PLQAAVGVVQKGLRPTIPKNSQPK 517 (575)
Q Consensus 444 ~~~~~~~Gt~~y~APE~i~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~---~~~~~~~v~~~~~~~~~p~~~~~~ 517 (575)
......+||+.|+|||++. +..|+.++|||||||++|+|++|..||.... ..+....+. .....+|..++++
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~p~~~s~~ 246 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--TTVVTYPSAWSQE 246 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH--HCCCCCCTTSCHH
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--hcccCCCCcCCHH
Confidence 6667788999999999996 4568999999999999999999999997533 222222222 2335678889999
Q ss_pred HHHHHHHhhhcCCCCCCC-HHHHHH
Q 008171 518 LAELLERCWQQDPALRPD-FSEIIE 541 (575)
Q Consensus 518 l~~Li~~cL~~dP~~RPs-~~ell~ 541 (575)
+.+||.+||+.||.+||+ +.++++
T Consensus 247 ~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 247 MVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHHHHHhcCCHhHhcccHHHHHc
Confidence 999999999999999998 666653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=365.03 Aligned_cols=254 Identities=25% Similarity=0.407 Sum_probs=204.0
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
+++..++|++.++||+|+||.||++.+ .++.||||+++...........+.++...++.++||||+++++++...+..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 467788999999999999999999998 578899999986644444445556666678899999999999999999999
Q ss_pred eeEEEeccCCchhhhhhh---ccCcCChHHHHHHHHHHHHHHHHHHHC-CceecccCCCCEEecCCCcEEEeecccceec
Q 008171 365 CIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~---~~~~l~~~~~~~i~~qI~~aL~yLH~~-gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
|+||||++ ++|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999996 588887754 356799999999999999999999998 9999999999999999999999999999876
Q ss_pred ccCCccccCCCCCCccCcccc----cCCCCCchHHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCCCCCCc
Q 008171 441 AQSGVMTAETGTYRWMAPEVI----EHKPYDHKADVFSFGIVLWELLTGKLPYEY-LTPLQAAVGVVQKGLRPTIPKNSQ 515 (575)
Q Consensus 441 ~~~~~~~~~~Gt~~y~APE~i----~~~~~s~ksDVwSlGviL~eLltG~~Pf~~-~~~~~~~~~v~~~~~~~~~p~~~~ 515 (575)
..........||+.|+|||++ .+..++.++||||||+++|+|++|..||.. ..+................+..++
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS 240 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence 665555556899999999996 566799999999999999999999999987 345555555555554444456789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 516 PKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 516 ~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+++.++|.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 241 AEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 99999999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=378.79 Aligned_cols=250 Identities=28% Similarity=0.439 Sum_probs=202.0
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
..+.++|++.++||+|+||.||+++. +++.||||++....... ..+.+|+.++++++||||+++++++.....+|
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 34567899999999999999999998 46789999997653322 55789999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCc--EEEeecccceecccC
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--VKVADFGVARVKAQS 443 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~--vkL~DFG~a~~~~~~ 443 (575)
+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 93 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 93 IIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999999999999976 567999999999999999999999999999999999999987665 999999999865555
Q ss_pred CccccCCCCCCccCcccccCCCCCch-HHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhcCCCCCCCCCCcHHH
Q 008171 444 GVMTAETGTYRWMAPEVIEHKPYDHK-ADVFSFGIVLWELLTGKLPYEYLTP----LQAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 444 ~~~~~~~Gt~~y~APE~i~~~~~s~k-sDVwSlGviL~eLltG~~Pf~~~~~----~~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
.......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..... ......+.........+..+++++
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 251 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPEC 251 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHH
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHH
Confidence 55556789999999999988888766 8999999999999999999987543 233333333333333344689999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+||.+||+.||.+|||+.|+++
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 252 CHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHccCChhHCcCHHHHHh
Confidence 99999999999999999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=381.47 Aligned_cols=250 Identities=24% Similarity=0.424 Sum_probs=217.8
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~ 363 (575)
.+..++|++.+.||+|+||.||+|++. ++.||||+++.... .......+..|..+++.+ +||||+++++++.+...
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 456789999999999999999999984 67799999975421 112345678899999887 89999999999999999
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc-
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ- 442 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~- 442 (575)
+|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 9999999999999999976 56799999999999999999999999999999999999999999999999999976433
Q ss_pred CCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 008171 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 522 (575)
Q Consensus 443 ~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li 522 (575)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||...+..+....+... .+.+|..+++++.+||
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li 249 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLL 249 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CCCCCcccCHHHHHHH
Confidence 23445668999999999999999999999999999999999999999998887777666554 3567888999999999
Q ss_pred HHhhhcCCCCCCCHH-HHH
Q 008171 523 ERCWQQDPALRPDFS-EII 540 (575)
Q Consensus 523 ~~cL~~dP~~RPs~~-ell 540 (575)
.+||+.||.+||++. +++
T Consensus 250 ~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 250 VKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHSCSSGGGSBTTBSCGG
T ss_pred HHHhcCCHhHcCCChHHHH
Confidence 999999999999997 654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=382.15 Aligned_cols=248 Identities=19% Similarity=0.369 Sum_probs=220.4
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
+.|++.++||+|+||.||+|... ++.||+|++.... ......+.+|+.+|++++||||+++++++.+...+|+|||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 57999999999999999999884 6779999987542 3334678999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC--CCcEEEeecccceecccCCccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE--NEVVKVADFGVARVKAQSGVMT 447 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~--~~~vkL~DFG~a~~~~~~~~~~ 447 (575)
|+.|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.........
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 208 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCccee
Confidence 99999999999876668999999999999999999999999999999999999974 4679999999998776655556
Q ss_pred cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--CCCCCCCCcHHHHHHHHHh
Q 008171 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIPKNSQPKLAELLERC 525 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~--~~~~p~~~~~~l~~Li~~c 525 (575)
...||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..... .+..+..+++++.+||.+|
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 288 (387)
T 1kob_A 209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 288 (387)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTT
T ss_pred eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHH
Confidence 66899999999999999999999999999999999999999999888777666655433 2334567899999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 008171 526 WQQDPALRPDFSEIIE 541 (575)
Q Consensus 526 L~~dP~~RPs~~ell~ 541 (575)
|+.||.+|||+.|+++
T Consensus 289 L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 289 LQKEPRKRLTVHDALE 304 (387)
T ss_dssp SCSSGGGSCCHHHHHT
T ss_pred cCCChhHCcCHHHHhh
Confidence 9999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=368.27 Aligned_cols=253 Identities=28% Similarity=0.494 Sum_probs=217.3
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEECC---------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeee
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~~---------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~ 358 (575)
++..++|++.+.||+|+||.||+|.+.. ..||+|++.... ....+.+.+|+.++++++||||+++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 5777899999999999999999997643 359999987542 34457799999999999999999999999
Q ss_pred cCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCc--------EE
Q 008171 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--------VK 430 (575)
Q Consensus 359 ~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~--------vk 430 (575)
...+..|+||||+.|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999999999886666999999999999999999999999999999999999998876 99
Q ss_pred EeecccceecccCCccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCC
Q 008171 431 VADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP 508 (575)
Q Consensus 431 L~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~ 508 (575)
|+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|+|++ |..||........... ... ..
T Consensus 162 l~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~-~~~--~~ 235 (289)
T 4fvq_A 162 LSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF-YED--RH 235 (289)
T ss_dssp ECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-HHT--TC
T ss_pred eccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH-hhc--cC
Confidence 9999998644322 23457889999999987 779999999999999999999 5566666665444332 222 34
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 509 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 509 ~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
.++...++++.++|.+||+.||.+|||+.++++.|++++.
T Consensus 236 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 236 QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 5667778899999999999999999999999999999876
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=374.56 Aligned_cols=261 Identities=32% Similarity=0.601 Sum_probs=223.6
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--Ccc--EEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQD--VAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP 362 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~--VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~ 362 (575)
.++.++|++.+.||+|+||.||+|++. +.. ||||.++... .......+.+|+.+++++ +||||+++++++...+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 466689999999999999999999864 443 5999887432 334456789999999999 8999999999999999
Q ss_pred CceeEEEeccCCchhhhhhhcc---------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~---------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~ 427 (575)
.+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997643 4689999999999999999999999999999999999999999
Q ss_pred cEEEeecccceecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCC
Q 008171 428 VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGL 506 (575)
Q Consensus 428 ~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~ 506 (575)
.+||+|||+++............+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+..+.... +..+.
T Consensus 180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~-~~~~~ 258 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGY 258 (327)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-GGGTC
T ss_pred eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH-hhcCC
Confidence 999999999975444333445567899999999999999999999999999999998 9999999887766544 44556
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 507 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 507 ~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
++..+..+++.+.++|.+||+.||.+|||+.++++.|++++.+.
T Consensus 259 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 259 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 67788899999999999999999999999999999999998754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=370.80 Aligned_cols=261 Identities=30% Similarity=0.553 Sum_probs=223.3
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC-
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK- 360 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~------~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~- 360 (575)
.++...|+++++||+|+||.||++.+ .++.||||+++.. ........+.+|+.++++++||||+++++++..
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 34545569999999999999999876 4677999999865 344556789999999999999999999999876
Q ss_pred -CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 361 -PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 361 -~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
...+++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CCceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 4568999999999999999965 4589999999999999999999999999999999999999999999999999987
Q ss_pred cccCC----ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH--------------HHHHHH
Q 008171 440 KAQSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL--------------QAAVGV 501 (575)
Q Consensus 440 ~~~~~----~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~--------------~~~~~v 501 (575)
..... ......||..|+|||++.+..++.++||||||+++|+|++|..||...... ......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 65543 223446788999999999999999999999999999999999999653211 122334
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 502 VQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 502 ~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
+....+...+..+++++.+||.+||+.||.+|||+.|+++.|+.+.....
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 55666777888999999999999999999999999999999999987765
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=380.14 Aligned_cols=251 Identities=24% Similarity=0.397 Sum_probs=218.3
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPS 363 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~ 363 (575)
.+..++|++.+.||+|+||.||+++.. ++.||||+++.... .......+..|..++..+ +||||+++++++.....
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 456789999999999999999999986 46799999975422 122346688899999988 79999999999999999
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
+|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 9999999999999999976 567999999999999999999999999999999999999999999999999999864332
Q ss_pred -CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 008171 444 -GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 522 (575)
Q Consensus 444 -~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li 522 (575)
......+||+.|+|||++.+..|+.++|||||||++|||++|..||...+..+....+.... ..+|..+++++.+||
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li 252 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSMSKEAVAIC 252 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHH
Confidence 34456689999999999999999999999999999999999999999988888777766654 457789999999999
Q ss_pred HHhhhcCCCCCCC-----HHHHHH
Q 008171 523 ERCWQQDPALRPD-----FSEIIE 541 (575)
Q Consensus 523 ~~cL~~dP~~RPs-----~~ell~ 541 (575)
.+||+.||.+||+ +.++++
T Consensus 253 ~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 253 KGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhc
Confidence 9999999999995 466653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=379.44 Aligned_cols=247 Identities=25% Similarity=0.386 Sum_probs=219.3
Q ss_pred CCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCcee
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~l 366 (575)
..++|++.+.||+|+||.||++++. ++.||||+++.... .......+.+|+.+|+.++||||+++++++.+...+|+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 4468999999999999999999984 67899999875422 12234678899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcc
Q 008171 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 446 (575)
||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 119 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~ 195 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--T 195 (350)
T ss_dssp EEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--B
T ss_pred EEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--c
Confidence 9999999999999976 467999999999999999999999999999999999999999999999999999865433 3
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 526 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL 526 (575)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.... ..+|..+++++.++|.+||
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~lL 273 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLL 273 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTCCHHHHHHHHHHS
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHh
Confidence 45679999999999999999999999999999999999999999988888777766543 4577889999999999999
Q ss_pred hcCCCCCCC-----HHHHHH
Q 008171 527 QQDPALRPD-----FSEIIE 541 (575)
Q Consensus 527 ~~dP~~RPs-----~~ell~ 541 (575)
+.||.+||+ +.++++
T Consensus 274 ~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 274 QVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHT
T ss_pred hcCHHhccCCccCCHHHHHh
Confidence 999999998 777764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=373.60 Aligned_cols=248 Identities=26% Similarity=0.439 Sum_probs=209.6
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.++||+|+||.||+|.+. ++.||||++...... .....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 68999999999999999999874 678999998754332 234668899999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC---cc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VM 446 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~---~~ 446 (575)
|++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred cCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 9999999999976 5679999999999999999999999999999999999999999999999999997654322 33
Q ss_pred ccCCCCCCccCcccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 008171 447 TAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQA-AVGVVQKGLRPTIPKNSQPKLAELLER 524 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~-~~~v~~~~~~~~~p~~~~~~l~~Li~~ 524 (575)
....||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ................+++.+.+||.+
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 244 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHH
T ss_pred CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHH
Confidence 45679999999999988776 7789999999999999999999987655422 223333333333346789999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 008171 525 CWQQDPALRPDFSEIIE 541 (575)
Q Consensus 525 cL~~dP~~RPs~~ell~ 541 (575)
||+.||.+|||+.|+++
T Consensus 245 ~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 245 ILVENPSARITIPDIKK 261 (323)
T ss_dssp HSCSSTTTSCCHHHHTT
T ss_pred HccCChhhCcCHHHHhh
Confidence 99999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=405.94 Aligned_cols=264 Identities=29% Similarity=0.540 Sum_probs=227.7
Q ss_pred CceeeCCCceeeee-eeeecCceEEEEEEEC----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeec
Q 008171 285 DVWEIDPKHLKFGS-KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (575)
Q Consensus 285 ~~~~i~~~~~~i~~-~LG~G~fG~Vy~~~~~----~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~ 359 (575)
..|.++...+.+.. +||+|+||.||+|.+. ++.||||+++....+....+.+.+|+.+|++++|||||++++++.
T Consensus 361 ~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 440 (635)
T 4fl3_A 361 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE 440 (635)
T ss_dssp SSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 35667767776654 8999999999999763 466999999876666666788999999999999999999999997
Q ss_pred CCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 360 ~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
. +.+++||||+.+|+|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 441 ~-~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 518 (635)
T 4fl3_A 441 A-ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 518 (635)
T ss_dssp S-SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred c-CCEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence 5 458999999999999999976 56799999999999999999999999999999999999999999999999999986
Q ss_pred cccCC----ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 008171 440 KAQSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 514 (575)
Q Consensus 440 ~~~~~----~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~ 514 (575)
..... ......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+.+..+.... +..+.++..|..+
T Consensus 519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-i~~~~~~~~p~~~ 597 (635)
T 4fl3_A 519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEKGERMGCPAGC 597 (635)
T ss_dssp TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTC
T ss_pred cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCC
Confidence 54432 2233456889999999999999999999999999999998 9999999888766544 5556677889999
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 515 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 515 ~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
++++.+||.+||+.||.+||++.+|++.|++++.++.
T Consensus 598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~ 634 (635)
T 4fl3_A 598 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634 (635)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999999987653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=372.96 Aligned_cols=258 Identities=30% Similarity=0.606 Sum_probs=218.6
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--Ccc----EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQD----VAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~----VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
.+...+|++.++||+|+||.||+|.+. ++. ||+|.+.... .......+.+|+.++++++||||+++++++...
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 466789999999999999999999874 444 4777765432 233457799999999999999999999999875
Q ss_pred CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
. .++|+||+.+|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 4 889999999999999998877889999999999999999999999999999999999999999999999999998654
Q ss_pred cCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 008171 442 QSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 517 (575)
Q Consensus 442 ~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~ 517 (575)
... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+... .+........+..++++
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 247 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQPPICTID 247 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-HHHTTCCCCCCTTBCHH
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-HHHcCCCCCCCccCCHH
Confidence 432 2233456889999999999999999999999999999999 999999887766544 45556667788899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 518 LAELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 518 l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
+.++|.+||+.||.+||++.|+++.|+++..
T Consensus 248 l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=366.75 Aligned_cols=251 Identities=31% Similarity=0.597 Sum_probs=207.1
Q ss_pred eCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHh--cCCCCceEEEeeecC----CC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--VRHKNVVQFIGACTK----PP 362 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~--L~HpnIv~l~~~~~~----~~ 362 (575)
+-.++|++.++||+|+||.||+|++.++.||||++... ....+..|..++.. ++||||+++++++.. ..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 34578999999999999999999999999999998743 23556667777776 789999999998543 34
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHH--------HCCceecccCCCCEEecCCCcEEEeec
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH--------QNNIIHRDLKAANLLMDENEVVKVADF 434 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH--------~~gIiHrDLKp~NILl~~~~~vkL~DF 434 (575)
.+|+||||+++|+|.++++. ..+++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+||
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred eeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 58999999999999999954 57999999999999999999999 999999999999999999999999999
Q ss_pred ccceecccCCc-----cccCCCCCCccCcccccCC------CCCchHHHHHHHHHHHHHHcC----------CCCCCCCC
Q 008171 435 GVARVKAQSGV-----MTAETGTYRWMAPEVIEHK------PYDHKADVFSFGIVLWELLTG----------KLPYEYLT 493 (575)
Q Consensus 435 G~a~~~~~~~~-----~~~~~Gt~~y~APE~i~~~------~~s~ksDVwSlGviL~eLltG----------~~Pf~~~~ 493 (575)
|+++....... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 99976554432 2234799999999999877 455799999999999999999 88886532
Q ss_pred H----HHHHHH-HHhcCCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 494 P----LQAAVG-VVQKGLRPTIPK-----NSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 494 ~----~~~~~~-v~~~~~~~~~p~-----~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
+ ...... ......++.++. .+++++.++|.+||+.||.+|||+.++++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2 222222 223334444443 3567899999999999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=373.67 Aligned_cols=258 Identities=27% Similarity=0.469 Sum_probs=216.3
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
...++|++.+.||+|+||.||+|.+. ++.||||++.... ......+.+|+.++++++||||+++++++...+.+|+|
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 34578999999999999999999874 6789999987653 33457799999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhhcc---CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 368 TEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~---~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 193 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD 193 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 99999999999996543 358999999999999999999999999999999999999999999999999998644322
Q ss_pred ---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHh---------cCC
Q 008171 445 ---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ------AAVGVVQ---------KGL 506 (575)
Q Consensus 445 ---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~------~~~~v~~---------~~~ 506 (575)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....+.+ ....... ...
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (321)
T 2qkw_B 194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL 273 (321)
T ss_dssp CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSC
T ss_pred ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhh
Confidence 2234468999999999998999999999999999999999999997644321 1111111 111
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 507 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 507 ~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
...++..++..+.+++.+||+.||.+|||+.|+++.|+.+++
T Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 223344556789999999999999999999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=383.37 Aligned_cols=248 Identities=25% Similarity=0.429 Sum_probs=210.4
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHH-HHhcCCCCceEEEeeecCCCC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFI-MRKVRHKNVVQFIGACTKPPS 363 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~-~~~~~~~~~Ev~i-L~~L~HpnIv~l~~~~~~~~~ 363 (575)
.+..++|++.+.||+|+||.||++++. ++.||||+++..... ......+.+|..+ ++.++||||+++++++.+...
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 345678999999999999999999985 567999999865442 2334566777776 577899999999999999999
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc-
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ- 442 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~- 442 (575)
+|+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999999999999976 56799999999999999999999999999999999999999999999999999976433
Q ss_pred CCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 008171 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 522 (575)
Q Consensus 443 ~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li 522 (575)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||...+..+....++... ..++..+++++.+||
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li 270 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQLKPNITNSARHLL 270 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC--CCCCSSSCHHHHHHH
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Confidence 334456689999999999999999999999999999999999999999988888777776654 356778999999999
Q ss_pred HHhhhcCCCCCCCHHH
Q 008171 523 ERCWQQDPALRPDFSE 538 (575)
Q Consensus 523 ~~cL~~dP~~RPs~~e 538 (575)
.+||+.||.+||++.+
T Consensus 271 ~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 271 EGLLQKDRTKRLGAKD 286 (373)
T ss_dssp HHHTCSSGGGSTTTTT
T ss_pred HHHcccCHHhCCCCCC
Confidence 9999999999999753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=368.78 Aligned_cols=246 Identities=22% Similarity=0.276 Sum_probs=207.7
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCceeE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l~lV 367 (575)
.++|++.++||+|+||+||+|.+. ++.||||++............+..|+..+.++ +||||++++++|.+.+.+|+|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 368999999999999999999985 67899999887655555556666777766666 899999999999999999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccc
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 447 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 447 (575)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 214 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE 214 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCc
Confidence 9999 779999998877789999999999999999999999999999999999999999999999999998776665666
Q ss_pred cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 008171 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~ 527 (575)
...||+.|+|||++.+ .++.++|||||||++|||++|..|+..... ...+......+.++..+++++.++|.+||+
T Consensus 215 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 290 (311)
T 3p1a_A 215 VQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMMLE 290 (311)
T ss_dssp CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHHSC
T ss_pred ccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHHcC
Confidence 6779999999999886 699999999999999999999766654322 222233333444567889999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 008171 528 QDPALRPDFSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs~~ell~ 541 (575)
.||.+|||+.|+++
T Consensus 291 ~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 291 PDPKLRATAEALLA 304 (311)
T ss_dssp SSTTTSCCHHHHHT
T ss_pred CChhhCcCHHHHHh
Confidence 99999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=372.78 Aligned_cols=252 Identities=21% Similarity=0.379 Sum_probs=215.4
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CCceEEEeeecCCCC
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPPS 363 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~H--pnIv~l~~~~~~~~~ 363 (575)
..+...+|++.++||+|+||.||++.+. ++.||||++............+.+|+.+|++++| |||+++++++.....
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 4677789999999999999999999874 5679999998777677777889999999999987 999999999999999
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
+|+|||+ .+++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 84 ~~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEEECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEEeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 9999995 58899999987 56799999999999999999999999999999999999997 678999999999865443
Q ss_pred C---ccccCCCCCCccCcccccC-----------CCCCchHHHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhcCCCC
Q 008171 444 G---VMTAETGTYRWMAPEVIEH-----------KPYDHKADVFSFGIVLWELLTGKLPYEYLT-PLQAAVGVVQKGLRP 508 (575)
Q Consensus 444 ~---~~~~~~Gt~~y~APE~i~~-----------~~~s~ksDVwSlGviL~eLltG~~Pf~~~~-~~~~~~~v~~~~~~~ 508 (575)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......++......
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence 2 2335679999999999864 678999999999999999999999998754 334455555556667
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 ~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.++...++++.+||.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 788889999999999999999999999999974
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=370.63 Aligned_cols=258 Identities=23% Similarity=0.373 Sum_probs=214.7
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC--Cc
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP--SL 364 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~--~l 364 (575)
+...+|++.++||+|+||.||+|.+. ++.||||+++..... .....+.+|+.++++++||||+++++++.... .+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 44578999999999999999999986 678999999854322 22466789999999999999999999987655 77
Q ss_pred eeEEEeccCCchhhhhhhccC--cCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEe----cCCCcEEEeecccce
Q 008171 365 CIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVAR 438 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~--~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl----~~~~~vkL~DFG~a~ 438 (575)
|+||||++|++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999999976433 38999999999999999999999999999999999999 778889999999998
Q ss_pred ecccCCccccCCCCCCccCccccc--------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhcCC
Q 008171 439 VKAQSGVMTAETGTYRWMAPEVIE--------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTP----LQAAVGVVQKGL 506 (575)
Q Consensus 439 ~~~~~~~~~~~~Gt~~y~APE~i~--------~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~----~~~~~~v~~~~~ 506 (575)
............||+.|+|||++. +..++.++|||||||++|||++|..||..... .+....++....
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 877666666778999999999986 57899999999999999999999999975332 233333333211
Q ss_pred C-----------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 008171 507 R-----------------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA 547 (575)
Q Consensus 507 ~-----------------------~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~ 547 (575)
. ..++..+++.+.++|++||+.||.+|||+.|+++-..+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 0 1222345678999999999999999999999998777643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=377.17 Aligned_cols=249 Identities=25% Similarity=0.405 Sum_probs=210.3
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCcee
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~---~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~l 366 (575)
+.|++.+.||+|+||.||++.+. ++.||||++..... .......+.+|+.+++.++||||+++++++...+.+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 57999999999999999999874 67899999864321 11134678999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhhcc---CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCc---EEEeecccceec
Q 008171 367 VTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---VKVADFGVARVK 440 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~---~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~---vkL~DFG~a~~~ 440 (575)
||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 999999999998886532 35899999999999999999999999999999999999986654 999999999876
Q ss_pred ccCCc-cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHH
Q 008171 441 AQSGV-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPK 517 (575)
Q Consensus 441 ~~~~~-~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~--~~p~~~~~~ 517 (575)
..... .....||+.|+|||++.+..|+.++|||||||++|+|++|..||.... .+....+....... .....++++
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~ 262 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISES 262 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCHH
Confidence 65443 445679999999999999999999999999999999999999998753 33344444333221 122578899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 518 LAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 518 l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+.+||.+||+.||.+|||+.|+++
T Consensus 263 ~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 263 AKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHCCCChhHCcCHHHHhc
Confidence 999999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=382.18 Aligned_cols=258 Identities=30% Similarity=0.553 Sum_probs=214.2
Q ss_pred CceeeeeeeeecCceEEEEEEECC-----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeec-CCCCce
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT-KPPSLC 365 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~~-----~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~-~~~~l~ 365 (575)
..|++.++||+|+||.||+|++.+ ..||||.++.. ........|.+|+.++++++||||+++++++. ..+..|
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 357888999999999999998632 24899998753 34455678999999999999999999999865 456789
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~- 444 (575)
+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 9999999999999998767778999999999999999999999999999999999999999999999999997554322
Q ss_pred ----ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 008171 445 ----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 519 (575)
Q Consensus 445 ----~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~ 519 (575)
......+|+.|+|||++.+..++.++|||||||++|||++ |..||...+..+.... +..+.++..|..+++.+.
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~-~~~~~~~~~p~~~~~~l~ 326 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-LLQGRRLLQPEYCPDPLY 326 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH-HHTTCCCCCCTTCCHHHH
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHHH
Confidence 1233457889999999999999999999999999999999 7889987766555444 344556677889999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 520 ELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 520 ~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
++|.+||+.||.+||++.++++.|++++..+.
T Consensus 327 ~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 327 EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 99999999999999999999999999988665
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=377.99 Aligned_cols=250 Identities=20% Similarity=0.343 Sum_probs=215.1
Q ss_pred eeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEecc
Q 008171 295 KFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMS 372 (575)
Q Consensus 295 ~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~~ 372 (575)
...+.||+|+||.||+|.. .++.||+|+++... ......+.+|+.+|++++||||+++++++...+.+|+||||++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 3367899999999999987 46789999998643 3445789999999999999999999999999999999999999
Q ss_pred CCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEe--cCCCcEEEeecccceecccCCccccCC
Q 008171 373 GGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAET 450 (575)
Q Consensus 373 ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl--~~~~~vkL~DFG~a~~~~~~~~~~~~~ 450 (575)
|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++............
T Consensus 170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~ 249 (373)
T 2x4f_A 170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF 249 (373)
T ss_dssp TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCC
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccccc
Confidence 999999998766789999999999999999999999999999999999999 567889999999998776665556678
Q ss_pred CCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHHHHHHHhhhc
Q 008171 451 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPKLAELLERCWQQ 528 (575)
Q Consensus 451 Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~--~~p~~~~~~l~~Li~~cL~~ 528 (575)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....... .....+++++.+||.+||+.
T Consensus 250 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 329 (373)
T 2x4f_A 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIK 329 (373)
T ss_dssp SSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCS
T ss_pred CCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCC
Confidence 9999999999999999999999999999999999999999988887777766654332 22357899999999999999
Q ss_pred CCCCCCCHHHHHH--HHHHH
Q 008171 529 DPALRPDFSEIIE--ILQQI 546 (575)
Q Consensus 529 dP~~RPs~~ell~--~L~~l 546 (575)
||.+||++.|+++ .+++.
T Consensus 330 dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 330 EKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp SGGGSCCHHHHHHSHHHHCH
T ss_pred ChhhCCCHHHHhcCcCcCCC
Confidence 9999999999986 55544
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=382.06 Aligned_cols=246 Identities=29% Similarity=0.496 Sum_probs=213.1
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|++.+.||+|+||.||+|.+ +++.||||++...... .+....+.+|+.+++.++||||+++++++.....+|+||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999998 5678999998743221 122356889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 448 (575)
||+ +|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 89 E~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~ 166 (336)
T 3h4j_B 89 EYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT 166 (336)
T ss_dssp CCC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCC
T ss_pred ECC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccccc
Confidence 999 7899999876 56799999999999999999999999999999999999999999999999999987766666667
Q ss_pred CCCCCCccCcccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 008171 449 ETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~ 527 (575)
.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+ ......+|..+++++.+||++||+
T Consensus 167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li~~~L~ 244 (336)
T 3h4j_B 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLIRRMIV 244 (336)
T ss_dssp CTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHHHHHTTSC
T ss_pred ccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHHHHHHHcC
Confidence 789999999999988876 78999999999999999999999865433221111 122345678899999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 008171 528 QDPALRPDFSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs~~ell~ 541 (575)
.||.+|||+.|+++
T Consensus 245 ~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 245 ADPMQRITIQEIRR 258 (336)
T ss_dssp SSGGGSCCHHHHTT
T ss_pred CChhHCcCHHHHHh
Confidence 99999999999974
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=369.09 Aligned_cols=262 Identities=27% Similarity=0.539 Sum_probs=224.3
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~------~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
.+...+|+++++||+|+||.||++++ .++.||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 56678899999999999999999986 4677999999864 345567899999999999999999999998664
Q ss_pred C--CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 362 P--SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 362 ~--~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
+ .+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 4 78999999999999999988767899999999999999999999999999999999999999999999999999987
Q ss_pred cccCCc----cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH---------------HHHHHH
Q 008171 440 KAQSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---------------LQAAVG 500 (575)
Q Consensus 440 ~~~~~~----~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~---------------~~~~~~ 500 (575)
...... .....+|..|+|||++.+..++.++||||||+++|+|++|..||..... ......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 654432 2234577889999999988999999999999999999999998863211 011223
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 501 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 501 v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
.+....++..+..+++++.++|.+||+.||.+|||+.++++.|+++.+++.
T Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 344555667788999999999999999999999999999999999987653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=393.33 Aligned_cols=254 Identities=19% Similarity=0.327 Sum_probs=218.7
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
.+..++|++.++||+|+||+||+|++. ++.||||+++..... ......+.+|+.++..++||||++++++|.+...+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 455678999999999999999999985 567999998742211 11123488899999999999999999999999999
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|+|||||+||+|.+++.+..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 99999999999999998867889999999999999999999999999999999999999999999999999997665543
Q ss_pred c--cccCCCCCCccCccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---CCCCCCC
Q 008171 445 V--MTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---PTIPKNS 514 (575)
Q Consensus 445 ~--~~~~~Gt~~y~APE~i~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~---~~~p~~~ 514 (575)
. ....+||+.|+|||++. ...|+.++|||||||+||||++|+.||...+..+....++....+ |.....+
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 309 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence 3 23468999999999996 567999999999999999999999999999888887776643322 3333568
Q ss_pred cHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 008171 515 QPKLAELLERCWQQDPAL--RPDFSEIIE 541 (575)
Q Consensus 515 ~~~l~~Li~~cL~~dP~~--RPs~~ell~ 541 (575)
++++.+||++||..+|++ ||++.|+++
T Consensus 310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 310 SENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred CHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 999999999999888887 999999875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=366.60 Aligned_cols=249 Identities=22% Similarity=0.398 Sum_probs=218.9
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~----~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
++|++.+.||+|+||.||++.+. ++.||||+++...... .....+.+|+.++++++||||+++++++.....+|
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 57999999999999999999884 6789999997654322 13567899999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC----cEEEeecccceecc
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKA 441 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~----~vkL~DFG~a~~~~ 441 (575)
+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 92 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 99999999999999976 56789999999999999999999999999999999999999887 79999999998776
Q ss_pred cCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHH
Q 008171 442 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLA 519 (575)
Q Consensus 442 ~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--~~~p~~~~~~l~ 519 (575)
.........||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+...... +.++..+++.+.
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (321)
T 2a2a_A 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK 250 (321)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHH
T ss_pred ccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHH
Confidence 655556678999999999999999999999999999999999999999988877766555443221 122357889999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 008171 520 ELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 520 ~Li~~cL~~dP~~RPs~~ell~ 541 (575)
++|.+||+.||.+|||+.|+++
T Consensus 251 ~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 251 DFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHhc
Confidence 9999999999999999999985
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=373.11 Aligned_cols=246 Identities=30% Similarity=0.458 Sum_probs=217.6
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
+.|++.+.||+|+||.||+|.. .++.||||++...... ......+.+|+.++++++||||+++++++......|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4589999999999999999986 5678999999765433 344577999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 448 (575)
||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ...
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~~ 209 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANS 209 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCC
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---CCc
Confidence 9996 688888877678899999999999999999999999999999999999999999999999999976543 235
Q ss_pred CCCCCCccCccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 008171 449 ETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 525 (575)
Q Consensus 449 ~~Gt~~y~APE~i~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~c 525 (575)
..||+.|+|||++. ...++.++|||||||++|||++|..||...+.......+.........+..+++.+.+||.+|
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 289 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 289 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHH
T ss_pred ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 57999999999984 577999999999999999999999999998887777766665554455678899999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 008171 526 WQQDPALRPDFSEIIE 541 (575)
Q Consensus 526 L~~dP~~RPs~~ell~ 541 (575)
|+.||.+|||+.++++
T Consensus 290 l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 290 LQKIPQDRPTSEVLLK 305 (348)
T ss_dssp TCSSGGGSCCHHHHTT
T ss_pred cccChhhCcCHHHHhh
Confidence 9999999999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=369.99 Aligned_cols=257 Identities=27% Similarity=0.444 Sum_probs=212.8
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc---
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL--- 364 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l--- 364 (575)
.++|++.++||+|+||.||++.+ .++.||||+++.... +......+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999996 467899999987544 345567899999999999999999999998765544
Q ss_pred -eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 365 -CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 365 -~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
|+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred cEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 999999999999999976 567999999999999999999999999999999999999999999999999999765443
Q ss_pred C----ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHH
Q 008171 444 G----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPK 517 (575)
Q Consensus 444 ~----~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~--~p~~~~~~ 517 (575)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+...........+. .+..++++
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 249 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHH
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHH
Confidence 2 22334689999999999999999999999999999999999999999988887766666543332 23568999
Q ss_pred HHHHHHHhhhcCCCCCCCHHH-HHHHHHHHHH
Q 008171 518 LAELLERCWQQDPALRPDFSE-IIEILQQIAK 548 (575)
Q Consensus 518 l~~Li~~cL~~dP~~RPs~~e-ll~~L~~l~~ 548 (575)
+.++|.+||+.||.+||++.+ +...|..+..
T Consensus 250 l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 250 LDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 999999999999999996554 5555655543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=377.06 Aligned_cols=253 Identities=21% Similarity=0.373 Sum_probs=216.1
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC--CCCceEEEeeecCCC
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR--HKNVVQFIGACTKPP 362 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~--HpnIv~l~~~~~~~~ 362 (575)
...+....|++.++||+|+||.||++... ++.||||++............+.+|+.+|++++ ||||+++++++....
T Consensus 50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 50 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp CEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred cccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 34666778999999999999999999874 667999999877667777788999999999997 499999999999999
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
.+||||| +.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred EEEEEEe-cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9999999 558899999987 46789999999999999999999999999999999999996 58899999999986544
Q ss_pred CC---ccccCCCCCCccCcccccC-----------CCCCchHHHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhcCCC
Q 008171 443 SG---VMTAETGTYRWMAPEVIEH-----------KPYDHKADVFSFGIVLWELLTGKLPYEYLT-PLQAAVGVVQKGLR 507 (575)
Q Consensus 443 ~~---~~~~~~Gt~~y~APE~i~~-----------~~~s~ksDVwSlGviL~eLltG~~Pf~~~~-~~~~~~~v~~~~~~ 507 (575)
.. ......||+.|+|||++.+ ..|+.++|||||||+||+|++|..||.... .......++.....
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~ 286 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence 32 2345679999999999865 468999999999999999999999998754 34455555655666
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 ~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
..++...++++.+||.+||+.||.+||++.|+++
T Consensus 287 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 6778888999999999999999999999999974
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=367.57 Aligned_cols=262 Identities=30% Similarity=0.565 Sum_probs=223.2
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEE-------CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeee
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY-------CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~-------~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~ 358 (575)
..++..++|++.+.||+|+||.||+|++ .++.||||++... ........+.+|+.++++++||||+++++++
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (327)
T 2yfx_A 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVS 102 (327)
T ss_dssp SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence 3467788999999999999999999984 3456999999743 3445567899999999999999999999999
Q ss_pred cCCCCceeEEEeccCCchhhhhhhcc------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC---CCcE
Q 008171 359 TKPPSLCIVTEFMSGGSVYDYLHKLK------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVV 429 (575)
Q Consensus 359 ~~~~~l~lV~E~~~ggsL~d~l~~~~------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~---~~~v 429 (575)
......|+||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. +..+
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999999997643 35889999999999999999999999999999999999984 4469
Q ss_pred EEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcC
Q 008171 430 KVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKG 505 (575)
Q Consensus 430 kL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~ 505 (575)
||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++ |..||......+.... +...
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~ 261 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-VTSG 261 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHTT
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH-HhcC
Confidence 999999997543322 2234467899999999999999999999999999999998 9999998877665544 4445
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 506 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 506 ~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
.++..+..+++.+.++|.+||+.||.+||++.++++.|..+...
T Consensus 262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 56677889999999999999999999999999999999988753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=363.47 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=208.4
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.++||+|+||.||+|.+. ++.||||++............+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57999999999999999999985 6789999998776666667889999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
|+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 83 ~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (311)
T 4agu_A 83 YCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD 161 (311)
T ss_dssp CCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred eCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence 9999999988765 5679999999999999999999999999999999999999999999999999998765432 3445
Q ss_pred CCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-------------------CCCC
Q 008171 449 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK-------------------GLRP 508 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~-------------------~~~~ 508 (575)
..||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+... ....
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (311)
T 4agu_A 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI 241 (311)
T ss_dssp ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCC
T ss_pred CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcC
Confidence 679999999999976 67899999999999999999999999988776655433221 0000
Q ss_pred CC----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 TI----------PKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 ~~----------p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.. ...+++.+.+||.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred CCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 1357889999999999999999999999974
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=373.56 Aligned_cols=246 Identities=24% Similarity=0.402 Sum_probs=196.9
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
.+.|++.++||+|+||.||+|++. ++.||||+++... ..+.+.+|+.++++++||||+++++++.....+|+||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 467999999999999999999985 5679999998542 2356788999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC---CCcEEEeecccceecccCCc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQSGV 445 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~---~~~vkL~DFG~a~~~~~~~~ 445 (575)
||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.......
T Consensus 128 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 128 ELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp CCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 99999999999976 567999999999999999999999999999999999999975 88999999999987665555
Q ss_pred cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHhcCCC--CCCCCCCcHHHHHHH
Q 008171 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV-GVVQKGLR--PTIPKNSQPKLAELL 522 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~-~v~~~~~~--~~~p~~~~~~l~~Li 522 (575)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||......+... .+...... ......+++++.+||
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 286 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLV 286 (349)
T ss_dssp ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHH
Confidence 566789999999999999999999999999999999999999998776655333 33332221 223357899999999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 008171 523 ERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 523 ~~cL~~dP~~RPs~~ell~ 541 (575)
.+||+.||.+|||+.|+++
T Consensus 287 ~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 287 RKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HTTSCSSGGGSCCHHHHHH
T ss_pred HHHccCChhhCcCHHHHhc
Confidence 9999999999999999985
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=365.54 Aligned_cols=244 Identities=29% Similarity=0.461 Sum_probs=213.7
Q ss_pred ceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
.|...++||+|+||.||+|+.. ++.||||++...... ....+.+|+.++++++||||+++++++...+..|+||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 4677789999999999999874 788999999765332 346788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-ccccC
Q 008171 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE 449 (575)
Q Consensus 371 ~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 449 (575)
++|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 124 ~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 201 (321)
T 2c30_A 124 LQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 201 (321)
T ss_dssp CCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred CCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence 999999999864 569999999999999999999999999999999999999999999999999998665432 33456
Q ss_pred CCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHHHHHHhhh
Q 008171 450 TGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 450 ~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~--~p~~~~~~l~~Li~~cL~ 527 (575)
.||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+... ..+. .+..+++.+.++|.+||+
T Consensus 202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~ 280 (321)
T 2c30_A 202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKNSHKVSPVLRDFLERMLV 280 (321)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-SCCCCTTGGGSCHHHHHHHHHHSC
T ss_pred cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCcCccccCCHHHHHHHHHHcc
Confidence 7999999999999999999999999999999999999999988887766554433 2222 234678999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 008171 528 QDPALRPDFSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs~~ell~ 541 (575)
.||.+|||+.|+++
T Consensus 281 ~dp~~Rps~~ell~ 294 (321)
T 2c30_A 281 RDPQERATAQELLD 294 (321)
T ss_dssp SSTTTSCCHHHHHT
T ss_pred CChhhCcCHHHHhc
Confidence 99999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=360.45 Aligned_cols=261 Identities=21% Similarity=0.423 Sum_probs=211.2
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPER-INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~-~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
..+|++.++||+|+||.||+|.. .++.||||+++... ........+.+|+.++++++||||+++++++...+.+++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999986 47789999998643 3455667899999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhhc---cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 368 TEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~---~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 9999999999998652 4568999999999999999999999999999999999999999999999999997654432
Q ss_pred -ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 008171 445 -VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT--PLQAAVGVVQKGLRPTIPKNSQPKLAEL 521 (575)
Q Consensus 445 -~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~--~~~~~~~v~~~~~~~~~p~~~~~~l~~L 521 (575)
......||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......+......+..+..+++++.++
T Consensus 191 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 270 (310)
T 2wqm_A 191 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 270 (310)
T ss_dssp --------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHH
T ss_pred ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHH
Confidence 2334578999999999999999999999999999999999999997543 3333333333333334446789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 522 LERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 522 i~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
|.+||..||.+|||+.++++.|+++.....
T Consensus 271 i~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 271 VNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 999999999999999999999999987654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=356.27 Aligned_cols=246 Identities=24% Similarity=0.406 Sum_probs=216.4
Q ss_pred CceeeeeeeeecCceEEEEEEECC--ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~~--~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.++||+|+||.||+|.+.+ ..||+|++....... ...+.+|+.++++++||||+++++++......|+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 579999999999999999999854 569999987643322 4678999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEe---cCCCcEEEeecccceecccCCcc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVM 446 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl---~~~~~vkL~DFG~a~~~~~~~~~ 446 (575)
|++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.........
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 87 LCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp CCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred ccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence 9999999999876 5679999999999999999999999999999999999999 78889999999999877766666
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcHHHHHHHHH
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLER 524 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~--p~~~~~~l~~Li~~ 524 (575)
....||+.|+|||++.+. ++.++||||||+++|+|++|..||...+..+....+......... ...+++.+.++|.+
T Consensus 166 ~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 244 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244 (277)
T ss_dssp CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHH
T ss_pred hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHH
Confidence 677899999999998765 899999999999999999999999998887777665554332211 12688999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 008171 525 CWQQDPALRPDFSEIIE 541 (575)
Q Consensus 525 cL~~dP~~RPs~~ell~ 541 (575)
||+.||.+||++.++++
T Consensus 245 ~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 245 LLTKSPKQRITSLQALE 261 (277)
T ss_dssp HTCSSTTTSCCHHHHTT
T ss_pred HccCChhhCcCHHHHhc
Confidence 99999999999999875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=388.71 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=216.9
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
.+..++|++.++||+|+||.||++++. ++.||+|+++.... .......+.+|+.+++.++||||+++++++.+...+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 455678999999999999999999984 56799999874211 111123478899999999999999999999999999
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 145 ~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 999999999999999965 568999999999999999999999999999999999999999999999999998766544
Q ss_pred c--cccCCCCCCccCcccccCCC----CCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcH
Q 008171 445 V--MTAETGTYRWMAPEVIEHKP----YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQP 516 (575)
Q Consensus 445 ~--~~~~~Gt~~y~APE~i~~~~----~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~--p~~~~~ 516 (575)
. ....+||+.|+|||++.+.. |+.++|||||||+||||++|..||...+..+....++.......+ +..+++
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~ 302 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 302 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCH
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccH
Confidence 2 33668999999999998765 889999999999999999999999999888877776654322233 347899
Q ss_pred HHHHHHHHhhhcCCCC--CCCHHHHHH
Q 008171 517 KLAELLERCWQQDPAL--RPDFSEIIE 541 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~--RPs~~ell~ 541 (575)
++.+||.+||+.+|.+ ||++.|+++
T Consensus 303 ~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 303 EAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 9999999999988988 999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=376.09 Aligned_cols=247 Identities=22% Similarity=0.380 Sum_probs=200.5
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCC--Ccee
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPP--SLCI 366 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~--~l~l 366 (575)
++|++.++||+|+||.||+|.+ +++.||||++............+.+|+.+++++. ||||+++++++...+ .+|+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 6899999999999999999987 4678999999866556666788899999999998 999999999986543 6899
Q ss_pred EEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc----
Q 008171 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ---- 442 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~---- 442 (575)
|||||. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 89 v~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 999996 689998865 5789999999999999999999999999999999999999999999999999986432
Q ss_pred ------------------CCccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 008171 443 ------------------SGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ 503 (575)
Q Consensus 443 ------------------~~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~ 503 (575)
....+..+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+.......++.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 112345679999999999976 6799999999999999999999999998887766555442
Q ss_pred cCCCC---------------------------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 008171 504 KGLRP---------------------------------------------TIPKNSQPKLAELLERCWQQDPALRPDFSE 538 (575)
Q Consensus 504 ~~~~~---------------------------------------------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~e 538 (575)
....| ..+..+++++.+||.+||+.||.+|||+.|
T Consensus 246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e 325 (388)
T 3oz6_A 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325 (388)
T ss_dssp HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence 11111 012367899999999999999999999999
Q ss_pred HHH
Q 008171 539 IIE 541 (575)
Q Consensus 539 ll~ 541 (575)
+++
T Consensus 326 ~l~ 328 (388)
T 3oz6_A 326 ALK 328 (388)
T ss_dssp HTT
T ss_pred HhC
Confidence 875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=359.76 Aligned_cols=251 Identities=25% Similarity=0.423 Sum_probs=217.3
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeee--cCCCCcee
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC--TKPPSLCI 366 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~--~~~~~l~l 366 (575)
.++|++.+.||+|+||.||++.+. ++.||+|++..........+.+.+|+.++++++||||+++++++ .....+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 358999999999999999999984 67899999987766677778899999999999999999999987 44667899
Q ss_pred EEEeccCCchhhhhhhcc---CcCChHHHHHHHHHHHHHHHHHHHCC-----ceecccCCCCEEecCCCcEEEeecccce
Q 008171 367 VTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNN-----IIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~---~~l~~~~~~~i~~qI~~aL~yLH~~g-----IiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
||||++|++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999997642 34899999999999999999999999 9999999999999999999999999997
Q ss_pred ecccCC-ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 008171 439 VKAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 517 (575)
Q Consensus 439 ~~~~~~-~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~ 517 (575)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+ ..+..+.++..++++
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~ 243 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIPYRYSDE 243 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHTCCCCCCTTSCHH
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHH-hhcccccCCcccCHH
Confidence 654432 223456899999999999999999999999999999999999999988876655443 445556788899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 008171 518 LAELLERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 518 l~~Li~~cL~~dP~~RPs~~ell~~ 542 (575)
+.++|.+||+.||.+||++.|+++.
T Consensus 244 l~~li~~~l~~~p~~Rps~~~ll~~ 268 (279)
T 2w5a_A 244 LNEIITRMLNLKDYHRPSVEEILEN 268 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCCcccCCCHHHHHhC
Confidence 9999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=370.60 Aligned_cols=260 Identities=27% Similarity=0.447 Sum_probs=207.2
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHH--HHhcCCCCceEEEeee-----c
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFI--MRKVRHKNVVQFIGAC-----T 359 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~i--L~~L~HpnIv~l~~~~-----~ 359 (575)
+.++.++|++.++||+|+||.||+|++.++.||||++.... ...+..|..+ +..++||||+++++.+ .
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 46778899999999999999999999999999999987432 2334444444 5568999999999743 3
Q ss_pred CCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHC---------CceecccCCCCEEecCCCcEE
Q 008171 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN---------NIIHRDLKAANLLMDENEVVK 430 (575)
Q Consensus 360 ~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~---------gIiHrDLKp~NILl~~~~~vk 430 (575)
....+|+||||++||+|.+++.. ...++..++.++.||+.||.|||++ ||+||||||+|||++.++.+|
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred CCceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 34457899999999999999965 4458889999999999999999999 999999999999999999999
Q ss_pred EeecccceecccCC---------ccccCCCCCCccCcccccC-------CCCCchHHHHHHHHHHHHHHcCCCCCCCCC-
Q 008171 431 VADFGVARVKAQSG---------VMTAETGTYRWMAPEVIEH-------KPYDHKADVFSFGIVLWELLTGKLPYEYLT- 493 (575)
Q Consensus 431 L~DFG~a~~~~~~~---------~~~~~~Gt~~y~APE~i~~-------~~~s~ksDVwSlGviL~eLltG~~Pf~~~~- 493 (575)
|+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998654321 2234579999999999987 456778999999999999999976653211
Q ss_pred -----------------HHHHHHHHHhcCCCCCCCCC------CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 494 -----------------PLQAAVGVVQKGLRPTIPKN------SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 494 -----------------~~~~~~~v~~~~~~~~~p~~------~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
.......+.....++.+|.. +++++.+||.+||+.||.+|||+.|+++.|++++..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 11112222334445555554 4458999999999999999999999999999999866
Q ss_pred chh
Q 008171 551 GEE 553 (575)
Q Consensus 551 ~~~ 553 (575)
...
T Consensus 321 ~~~ 323 (336)
T 3g2f_A 321 ERN 323 (336)
T ss_dssp CC-
T ss_pred Hhc
Confidence 543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=365.19 Aligned_cols=252 Identities=23% Similarity=0.366 Sum_probs=208.6
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCC---hHHHHHHHHHHHHHHhcC---CCCceEEEeeecC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN---SDMQKEFAQEVFIMRKVR---HKNVVQFIGACTK 360 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~---~~~~~~~~~Ev~iL~~L~---HpnIv~l~~~~~~ 360 (575)
+..++|++.++||+|+||+||+|.+ +++.||||+++..... ......+.+|+.+++.++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4457899999999999999999985 5678999998743321 112245667777777665 9999999999876
Q ss_pred CC-----CceeEEEeccCCchhhhhhhccC-cCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeec
Q 008171 361 PP-----SLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434 (575)
Q Consensus 361 ~~-----~l~lV~E~~~ggsL~d~l~~~~~-~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DF 434 (575)
.. .+++||||+. ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 54 4799999995 599999976543 4999999999999999999999999999999999999999999999999
Q ss_pred ccceecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC-----
Q 008171 435 GVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT----- 509 (575)
Q Consensus 435 G~a~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~----- 509 (575)
|+++............||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+......+.
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred ccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 999877666566677899999999999999999999999999999999999999999888776665543211100
Q ss_pred --------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 510 --------------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 510 --------------------~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
....+++++.+||.+||+.||.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 12357899999999999999999999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=358.95 Aligned_cols=248 Identities=23% Similarity=0.408 Sum_probs=207.2
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|.+.++||+|+||.||++... +..||+|++...... .....+.+|+.++++++||||+++++++.....+|+|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 57999999999999999999874 677999998765432 235678999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhc---cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEe---cCCCcEEEeecccceecccC
Q 008171 370 FMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 370 ~~~ggsL~d~l~~~---~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl---~~~~~vkL~DFG~a~~~~~~ 443 (575)
|++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 99999999998643 3679999999999999999999999999999999999999 45678999999999876665
Q ss_pred CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-CCCCCCcHHHHHHH
Q 008171 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-TIPKNSQPKLAELL 522 (575)
Q Consensus 444 ~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~-~~p~~~~~~l~~Li 522 (575)
.......||+.|+|||++. ..++.++||||||+++|+|++|..||...+..+............ .....+++++.+||
T Consensus 181 ~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 259 (285)
T 3is5_A 181 EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLL 259 (285)
T ss_dssp ------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHH
T ss_pred ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHH
Confidence 5556678999999999986 468999999999999999999999999988776665544433222 22244789999999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 008171 523 ERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 523 ~~cL~~dP~~RPs~~ell~ 541 (575)
.+||+.||.+|||+.|+++
T Consensus 260 ~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 260 KQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHTCSCTTTSCCHHHHHT
T ss_pred HHHccCChhhCcCHHHHhc
Confidence 9999999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=389.10 Aligned_cols=250 Identities=26% Similarity=0.518 Sum_probs=221.6
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
+...+|.+++.||+|+||.||+|++. ++.||||++...... .+....+.+|+.+|+.++||||+++++++.....+|
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34468999999999999999999874 788999999754221 123467889999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 445 (575)
+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 93 lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 93 MVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 99999999999999976 57799999999999999999999999999999999999999999999999999988766656
Q ss_pred cccCCCCCCccCcccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 008171 446 MTAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~ 524 (575)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+.... ...|..+++++.+||.+
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~Li~~ 249 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI--FYTPQYLNPSVISLLKH 249 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC--CCCCTTCCHHHHHHHHH
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--cCCCccCCHHHHHHHHH
Confidence 667789999999999988876 689999999999999999999999887766666555432 35677899999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 008171 525 CWQQDPALRPDFSEIIE 541 (575)
Q Consensus 525 cL~~dP~~RPs~~ell~ 541 (575)
||+.||.+|||+.|+++
T Consensus 250 ~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 250 MLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HTCSSTTTSCCHHHHHT
T ss_pred HcCCCchhCcCHHHHHh
Confidence 99999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=358.64 Aligned_cols=256 Identities=26% Similarity=0.386 Sum_probs=214.5
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeee-cCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC-TKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~-~~~~~l~lV~ 368 (575)
++|++.+.||+|+||.||+|++ .++.||||++...... ..+.+|+.+++.++|++++..+..+ ......++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 6899999999999999999996 5788999998765433 3578899999999998876666554 5566789999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEe---cCCCcEEEeecccceecccCCc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGV 445 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl---~~~~~vkL~DFG~a~~~~~~~~ 445 (575)
||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 999 999999998767789999999999999999999999999999999999999 4888999999999986654422
Q ss_pred --------cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCC---CCCCC
Q 008171 446 --------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQKGL---RPTIP 511 (575)
Q Consensus 446 --------~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~---~~~~~~v~~~~~---~~~~p 511 (575)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .+....+..... .+..+
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 243 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHH
Confidence 2455799999999999999999999999999999999999999986432 122222222111 12234
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhch
Q 008171 512 KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 552 (575)
Q Consensus 512 ~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~~ 552 (575)
..+++++.++|.+||+.||.+|||+.++++.|++++.+.+.
T Consensus 244 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 67899999999999999999999999999999999887653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=388.04 Aligned_cols=253 Identities=26% Similarity=0.444 Sum_probs=216.2
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|+++++||+|+||.||+|.+. +..||||+++...........+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 47999999999999999999984 6779999998665444445778999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC---CCcEEEeecccceecccCCcc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQSGVM 446 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~---~~~vkL~DFG~a~~~~~~~~~ 446 (575)
|+.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++........
T Consensus 117 ~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~ 195 (494)
T 3lij_A 117 CYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195 (494)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence 9999999998876 567999999999999999999999999999999999999976 455999999999887766666
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcHHHHHHHHH
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNSQPKLAELLER 524 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~--p~~~~~~l~~Li~~ 524 (575)
....||+.|+|||++. ..|+.++|||||||++|+|++|..||...+..+....+......... ...+++.+.+||.+
T Consensus 196 ~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 274 (494)
T 3lij_A 196 KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274 (494)
T ss_dssp CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHH
T ss_pred cccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHH
Confidence 7778999999999986 46999999999999999999999999999888777776655443322 25789999999999
Q ss_pred hhhcCCCCCCCHHHHHH--HHHHH
Q 008171 525 CWQQDPALRPDFSEIIE--ILQQI 546 (575)
Q Consensus 525 cL~~dP~~RPs~~ell~--~L~~l 546 (575)
||+.||.+|||+.|+++ .+++.
T Consensus 275 ~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 275 MLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HCCCChhhCccHHHHhcCcccccC
Confidence 99999999999999984 34443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=387.16 Aligned_cols=253 Identities=17% Similarity=0.301 Sum_probs=215.7
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
.+..++|++.++||+|+||.||+++. +++.||||+++.... .......+.+|+.++..++||||+++++++.+...+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 45567899999999999999999998 477899999974321 112234578899999999999999999999999999
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|+||||++||+|.+++.+....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 99999999999999998766689999999999999999999999999999999999999999999999999998765544
Q ss_pred c--cccCCCCCCccCccccc-------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC---CCCCCCC
Q 008171 445 V--MTAETGTYRWMAPEVIE-------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG---LRPTIPK 512 (575)
Q Consensus 445 ~--~~~~~Gt~~y~APE~i~-------~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~---~~~~~p~ 512 (575)
. ....+||+.|+|||++. ...|+.++|||||||++|||++|+.||...+..+....++... ..+..+.
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 296 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE 296 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence 3 23458999999999997 4678999999999999999999999999988887776665422 2233456
Q ss_pred CCcHHHHHHHHHhhhcCCCCC---CCHHHHHH
Q 008171 513 NSQPKLAELLERCWQQDPALR---PDFSEIIE 541 (575)
Q Consensus 513 ~~~~~l~~Li~~cL~~dP~~R---Ps~~ell~ 541 (575)
.+++++.+||++||. +|.+| |++.|+++
T Consensus 297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 899999999999999 99998 58888864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=376.99 Aligned_cols=259 Identities=22% Similarity=0.323 Sum_probs=205.6
Q ss_pred eeeCCCceeeeeeeeecCceEEEEEEEC-----CccEEEEEecCCCCChH---------HHHHHHHHHHHHHhcCCCCce
Q 008171 287 WEIDPKHLKFGSKVASGSYGDLYRGTYC-----SQDVAIKVLKPERINSD---------MQKEFAQEVFIMRKVRHKNVV 352 (575)
Q Consensus 287 ~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-----~~~VAvKvl~~~~~~~~---------~~~~~~~Ev~iL~~L~HpnIv 352 (575)
.++..++|+++++||+|+||.||+|.+. +..||||++........ ....+.+|+.+++.++||||+
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 3466789999999999999999999984 46699999876532110 112467888999999999999
Q ss_pred EEEeeecC----CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC-
Q 008171 353 QFIGACTK----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE- 427 (575)
Q Consensus 353 ~l~~~~~~----~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~- 427 (575)
++++++.. ...+|+||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence 99999876 67899999999 99999999873 4899999999999999999999999999999999999999877
Q ss_pred -cEEEeecccceecccCC--------ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 008171 428 -VVKVADFGVARVKAQSG--------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAA 498 (575)
Q Consensus 428 -~vkL~DFG~a~~~~~~~--------~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~ 498 (575)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 99999999998654322 124457999999999999999999999999999999999999999653221111
Q ss_pred HHHHhcCCCCCCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 008171 499 VGVVQKGLRPTIP---------KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA 547 (575)
Q Consensus 499 ~~v~~~~~~~~~p---------~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~ 547 (575)
.........+.++ ..+++++.++|.+||..||.+||++.+|++.|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 1111111112222 278899999999999999999999999999988753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=388.83 Aligned_cols=248 Identities=26% Similarity=0.478 Sum_probs=216.2
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.++||+|+||+||++.+. ++.||||++............+.+|+.+|++++||||+++++++.....+|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 67999999999999999999984 6789999986543323335778999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEec---CCCcEEEeecccceecccCCcc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSGVM 446 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~---~~~~vkL~DFG~a~~~~~~~~~ 446 (575)
|+.|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++........
T Consensus 102 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 180 (486)
T 3mwu_A 102 LYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (486)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCcc
Confidence 9999999999876 46799999999999999999999999999999999999995 4567999999999876666566
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHH
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAELLER 524 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p--~~~~~~l~~Li~~ 524 (575)
....||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+....+.........+ ..+++++.+||.+
T Consensus 181 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 259 (486)
T 3mwu_A 181 KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259 (486)
T ss_dssp -CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHH
T ss_pred CCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHH
Confidence 67789999999999976 49999999999999999999999999998888777766654443333 4688999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 008171 525 CWQQDPALRPDFSEIIE 541 (575)
Q Consensus 525 cL~~dP~~RPs~~ell~ 541 (575)
||+.||.+|||+.|+++
T Consensus 260 ~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 260 MLTFHPSLRITATQCLE 276 (486)
T ss_dssp HTCSSTTTSCCHHHHHH
T ss_pred HcCCChhhCcCHHHHhc
Confidence 99999999999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=366.89 Aligned_cols=249 Identities=24% Similarity=0.405 Sum_probs=197.3
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
.++|++.++||+|+||.||+|.+. ++.||||+++.... ......+.+|+.++++++||||+++++++...+.+|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 357899999999999999999864 67899999976532 223356889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhcc-----CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 369 EFMSGGSVYDYLHKLK-----GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~-----~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
||++ ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 9997 59999986542 45899999999999999999999999999999999999999999999999999876543
Q ss_pred -CccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC---------------
Q 008171 444 -GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--------------- 506 (575)
Q Consensus 444 -~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~--------------- 506 (575)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (317)
T 2pmi_A 162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241 (317)
T ss_dssp CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence 23445678999999999976 4689999999999999999999999998887666554432110
Q ss_pred -----------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 507 -----------------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 507 -----------------~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+..+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 01122357889999999999999999999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=356.03 Aligned_cols=254 Identities=24% Similarity=0.450 Sum_probs=216.0
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~----~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
++|++.++||+|+||.||++.+. ++.||+|+++...... .....+.+|+.++++++||||+++++++......|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 57999999999999999999985 6789999987654322 13577899999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC----cEEEeecccceecc
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKA 441 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~----~vkL~DFG~a~~~~ 441 (575)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 85 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999976 56799999999999999999999999999999999999998877 89999999998766
Q ss_pred cCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHH
Q 008171 442 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLA 519 (575)
Q Consensus 442 ~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--~~~p~~~~~~l~ 519 (575)
.........||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+...... +..+..+++.+.
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (283)
T 3bhy_A 164 AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK 243 (283)
T ss_dssp --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHH
T ss_pred CCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHH
Confidence 555555667999999999999999999999999999999999999999988877665554433221 122357789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 008171 520 ELLERCWQQDPALRPDFSEIIE--ILQQI 546 (575)
Q Consensus 520 ~Li~~cL~~dP~~RPs~~ell~--~L~~l 546 (575)
++|.+||..||.+||++.++++ .++.+
T Consensus 244 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 244 DFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 9999999999999999999986 45554
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=387.20 Aligned_cols=248 Identities=25% Similarity=0.433 Sum_probs=215.4
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCCh-----------HHHHHHHHHHHHHHhcCCCCceEEEeee
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS-----------DMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~-----------~~~~~~~~Ev~iL~~L~HpnIv~l~~~~ 358 (575)
++|+++++||+|+||+||+|... ++.||||+++...... .....+.+|+.+|++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 67999999999999999999974 5779999997654321 2356789999999999999999999999
Q ss_pred cCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC---cEEEeecc
Q 008171 359 TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADFG 435 (575)
Q Consensus 359 ~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~---~vkL~DFG 435 (575)
.+...+|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 194 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred EcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence 999999999999999999999976 57799999999999999999999999999999999999998776 69999999
Q ss_pred cceecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC--CCC
Q 008171 436 VARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKN 513 (575)
Q Consensus 436 ~a~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~--p~~ 513 (575)
+++............||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+....+......... ...
T Consensus 195 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 273 (504)
T 3q5i_A 195 LSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKN 273 (504)
T ss_dssp TCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTT
T ss_pred CCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCC
Confidence 9988776666677789999999999874 6999999999999999999999999999888877776655433222 257
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 514 SQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 514 ~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+++++.+||.+||+.||.+|||+.|+++
T Consensus 274 ~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 274 ISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 8999999999999999999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=366.00 Aligned_cols=246 Identities=24% Similarity=0.411 Sum_probs=200.6
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC-------
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------- 362 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~------- 362 (575)
++|++.++||+|+||.||+|++. ++.||||+++... .....+.+.+|+.+|++++||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 47899999999999999999984 6789999998654 3344678999999999999999999999875433
Q ss_pred --------------------------------------------------CceeEEEeccCCchhhhhhhcc--CcCChH
Q 008171 363 --------------------------------------------------SLCIVTEFMSGGSVYDYLHKLK--GVFKLP 390 (575)
Q Consensus 363 --------------------------------------------------~l~lV~E~~~ggsL~d~l~~~~--~~l~~~ 390 (575)
.+|+||||++|++|.+++.... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 2799999999999999997643 235566
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-------------ccccCCCCCCccC
Q 008171 391 SLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-------------VMTAETGTYRWMA 457 (575)
Q Consensus 391 ~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-------------~~~~~~Gt~~y~A 457 (575)
.++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ......||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 789999999999999999999999999999999999999999999998765532 2234579999999
Q ss_pred cccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 008171 458 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFS 537 (575)
Q Consensus 458 PE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ 537 (575)
||++.+..++.++|||||||++|+|++|..|+.. .............+..+...++++.++|.+||+.||.+|||+.
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 321 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT 321 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHH
Confidence 9999999999999999999999999998766421 1111222223333333345678899999999999999999999
Q ss_pred HHHH
Q 008171 538 EIIE 541 (575)
Q Consensus 538 ell~ 541 (575)
|+++
T Consensus 322 ~~l~ 325 (332)
T 3qd2_B 322 DIIE 325 (332)
T ss_dssp HHHH
T ss_pred HHhh
Confidence 9885
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=368.30 Aligned_cols=250 Identities=26% Similarity=0.429 Sum_probs=210.8
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCC---CChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCcee
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPER---INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~---~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~l 366 (575)
++|++.++||+|+||.||+|.+. ++.||||++.... ........+.+|+.++++++||||+++++++.+.+..|+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 78999999999999999999874 5679999987532 233446789999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhhc---------------------------------------cCcCChHHHHHHHHHHHHHHHHHH
Q 008171 367 VTEFMSGGSVYDYLHKL---------------------------------------KGVFKLPSLLKVAIDVSKGMNYLH 407 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~---------------------------------------~~~l~~~~~~~i~~qI~~aL~yLH 407 (575)
||||++||+|.+++... ...+++..++.++.||+.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999998521 112456778899999999999999
Q ss_pred HCCceecccCCCCEEecCCC--cEEEeecccceecccCC-----ccccCCCCCCccCcccccC--CCCCchHHHHHHHHH
Q 008171 408 QNNIIHRDLKAANLLMDENE--VVKVADFGVARVKAQSG-----VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIV 478 (575)
Q Consensus 408 ~~gIiHrDLKp~NILl~~~~--~vkL~DFG~a~~~~~~~-----~~~~~~Gt~~y~APE~i~~--~~~s~ksDVwSlGvi 478 (575)
++||+||||||+|||++.++ .+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||+
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 99999999999999998776 89999999998654321 2345679999999999965 679999999999999
Q ss_pred HHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 479 LWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 479 L~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p--~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+|+|++|..||...+..+....+.........+ ..+++++.+||.+||+.||.+||++.++++
T Consensus 266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 999999999999999888887777665543333 247899999999999999999999999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=357.70 Aligned_cols=249 Identities=27% Similarity=0.468 Sum_probs=214.5
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
+..++|++.+.||+|+||.||+|.+. ++.||||++...... ......+.+|+.++++++||||+++++++.+....|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 34568999999999999999999885 456999998653221 122466889999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 445 (575)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 86 lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~ 163 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-R 163 (279)
T ss_dssp EEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-c
Confidence 99999999999999976 467999999999999999999999999999999999999999999999999998544332 2
Q ss_pred cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 008171 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 525 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~c 525 (575)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+... ...+|..+++.+.+||.+|
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~ 241 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDFVTEGARDLISRL 241 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHHHHH
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC--CCCCCCcCCHHHHHHHHHH
Confidence 34557899999999999999999999999999999999999999988877766554443 3457788999999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 008171 526 WQQDPALRPDFSEIIE 541 (575)
Q Consensus 526 L~~dP~~RPs~~ell~ 541 (575)
|+.||.+|||+.|+++
T Consensus 242 l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 242 LKHNPSQRPMLREVLE 257 (279)
T ss_dssp CCSSGGGSCCHHHHHH
T ss_pred hccChhhCCCHHHHhh
Confidence 9999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=354.12 Aligned_cols=243 Identities=23% Similarity=0.380 Sum_probs=211.2
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|++.++||+|+||.||+|.+. ++.||||+++...........+.+|+.++..+ +||||+++++++...+.+|+||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999984 78899999987666666678899999999999 8999999999999999999999
Q ss_pred EeccCCchhhhhhhcc---CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC-------------------
Q 008171 369 EFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN------------------- 426 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~---~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~------------------- 426 (575)
||++|++|.+++.... +.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 9999999999997642 568999999999999999999999999999999999999844
Q ss_pred CcEEEeecccceecccCCccccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC
Q 008171 427 EVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG 505 (575)
Q Consensus 427 ~~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~ 505 (575)
..+||+|||.+...... ....||+.|+|||++.+. .++.++|||||||++|+|++|..|+...... ..+...
T Consensus 171 ~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~----~~~~~~ 243 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW----HEIRQG 243 (289)
T ss_dssp CCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH----HHHHTT
T ss_pred eEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH----HHHHcC
Confidence 47999999999876543 234699999999999776 6678999999999999999998777554332 223445
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 506 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 506 ~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
..+.++..+++++.++|.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 244 RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 567788899999999999999999999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=381.29 Aligned_cols=253 Identities=24% Similarity=0.330 Sum_probs=193.4
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeec----
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT---- 359 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~---- 359 (575)
.|.+. ++|+++++||+|+||.||+|.+ +++.||||++.....+....+.+.+|+.+|++++||||+++++++.
T Consensus 48 ~~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 48 DWQIP-DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp SCCSC-TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred cCccC-CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 34443 7899999999999999999976 4678999999876556666788999999999999999999999984
Q ss_pred -CCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccce
Q 008171 360 -KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 360 -~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
....+|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 127 EKFDELYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp TTCCCEEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred ccCceEEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccch
Confidence 335689999998 6799999876 5679999999999999999999999999999999999999999999999999998
Q ss_pred ecccCC----------------------------ccccCCCCCCccCcccc-cCCCCCchHHHHHHHHHHHHHHc-----
Q 008171 439 VKAQSG----------------------------VMTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLT----- 484 (575)
Q Consensus 439 ~~~~~~----------------------------~~~~~~Gt~~y~APE~i-~~~~~s~ksDVwSlGviL~eLlt----- 484 (575)
...... ..+..+||+.|+|||++ .+..|+.++|||||||+||||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 654221 23455789999999986 56779999999999999999998
Q ss_pred ------CCCCCCCCCHH--------------------HHHHHHHh----------------------cCCC-------CC
Q 008171 485 ------GKLPYEYLTPL--------------------QAAVGVVQ----------------------KGLR-------PT 509 (575)
Q Consensus 485 ------G~~Pf~~~~~~--------------------~~~~~v~~----------------------~~~~-------~~ 509 (575)
|..+|.+.... .....+.. ..+. ..
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 66777654311 11111100 0000 01
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 510 IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 510 ~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
....+++++.+||.+||+.||.+|||+.|+++
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 22456899999999999999999999999876
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=357.09 Aligned_cols=256 Identities=26% Similarity=0.387 Sum_probs=211.5
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeee-cCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC-TKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~-~~~~~l~lV~ 368 (575)
++|++.+.||+|+||.||+|++ .++.||||++...... ..+.+|+.+++.++|++++..++.+ ......++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 6799999999999999999985 5678999987654322 3478899999999998877766655 5667789999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEe---cCCCcEEEeecccceecccCCc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGV 445 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl---~~~~~vkL~DFG~a~~~~~~~~ 445 (575)
||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 999 999999998767789999999999999999999999999999999999999 7889999999999986654322
Q ss_pred --------cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHhcCC---CCCCC
Q 008171 446 --------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---QAAVGVVQKGL---RPTIP 511 (575)
Q Consensus 446 --------~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~---~~~~~v~~~~~---~~~~p 511 (575)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.. +....+..... .+...
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 243 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhh
Confidence 23457899999999999999999999999999999999999999764322 22222221111 11233
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhch
Q 008171 512 KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 552 (575)
Q Consensus 512 ~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~~ 552 (575)
..+++++.++|.+||+.||.+|||+.++++.|++++.+.+.
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 67789999999999999999999999999999999987753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=370.27 Aligned_cols=251 Identities=27% Similarity=0.409 Sum_probs=210.0
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
..|++. ++|++.+.||+|+||.||+|.+ +++.||||++..........+.+.+|+.+|++++||||+++++++....
T Consensus 19 ~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 19 TAWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp SEECCB-SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred ceeeec-ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence 345554 7899999999999999999987 4678999999766556666788999999999999999999999987653
Q ss_pred ------CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccc
Q 008171 363 ------SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436 (575)
Q Consensus 363 ------~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~ 436 (575)
.+|+||||+ |++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 8899999875 5789999999999999999999999999999999999999999999999999
Q ss_pred ceecccCCccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--------
Q 008171 437 ARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-------- 507 (575)
Q Consensus 437 a~~~~~~~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~-------- 507 (575)
++.... ..+...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 175 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 175 ARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp CEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 987543 3456689999999999977 78999999999999999999999999988776655444321110
Q ss_pred ---------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 ---------------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 ---------------------~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
..+...+++.+.+||.+||+.||.+|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 1234567899999999999999999999999886
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=365.80 Aligned_cols=248 Identities=27% Similarity=0.455 Sum_probs=220.1
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
..+|.+++.||+|+||.||++.+. ++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 468999999999999999999985 56799999876543 345567789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cc
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VM 446 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~ 446 (575)
|||+.|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 120 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 198 (335)
T 2owb_A 120 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198 (335)
T ss_dssp ECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence 999999999998876 5679999999999999999999999999999999999999999999999999998765332 34
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 526 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL 526 (575)
....||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+... ...++..+++.+.+||.+||
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l 276 (335)
T 2owb_A 199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKML 276 (335)
T ss_dssp CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHHHHHT
T ss_pred cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--CCCCCccCCHHHHHHHHHHc
Confidence 4567999999999999999999999999999999999999999988877666555443 34567889999999999999
Q ss_pred hcCCCCCCCHHHHHH
Q 008171 527 QQDPALRPDFSEIIE 541 (575)
Q Consensus 527 ~~dP~~RPs~~ell~ 541 (575)
+.||.+||++.|+++
T Consensus 277 ~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 277 QTDPTARPTINELLN 291 (335)
T ss_dssp CSSGGGSCCGGGGGG
T ss_pred cCChhHCcCHHHHhc
Confidence 999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=356.11 Aligned_cols=251 Identities=29% Similarity=0.547 Sum_probs=215.5
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC----C
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----P 361 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~----~ 361 (575)
..+...|++.++||+|+||.||+|.+. +..||+|++............+.+|+.++++++||||+++++++.. .
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 344567899999999999999999885 4669999998777777778889999999999999999999998754 4
Q ss_pred CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCC--ceecccCCCCEEec-CCCcEEEeecccce
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMD-ENEVVKVADFGVAR 438 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~g--IiHrDLKp~NILl~-~~~~vkL~DFG~a~ 438 (575)
..+|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred ceEEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 558999999999999999976 467999999999999999999999999 99999999999998 78999999999996
Q ss_pred ecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCCcHH
Q 008171 439 VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-PTIPKNSQPK 517 (575)
Q Consensus 439 ~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~-~~~p~~~~~~ 517 (575)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||............+..... ..++...+++
T Consensus 181 ~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (290)
T 1t4h_A 181 LKRAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258 (290)
T ss_dssp GCCTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred ccccc-ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHH
Confidence 54433 3345679999999998875 4999999999999999999999999886655555444444433 3456677899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 518 LAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 518 l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+.++|.+||+.||.+|||+.++++
T Consensus 259 l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 259 VKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHccCChhhCCCHHHHhh
Confidence 999999999999999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=387.47 Aligned_cols=249 Identities=24% Similarity=0.458 Sum_probs=221.1
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
.++|++.++||+|+||.||++.. +++.||||++...... ......+.+|+.++++++||||+++++++...+.+|+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 36899999999999999999988 4678999999765432 33457789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEe---cCCCcEEEeecccceecccCC
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl---~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|||+.|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 105 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 183 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183 (484)
T ss_dssp ECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence 999999999999976 5679999999999999999999999999999999999999 567899999999998776666
Q ss_pred ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHH
Q 008171 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAELL 522 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p--~~~~~~l~~Li 522 (575)
......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+....+.........+ ..+++++.+||
T Consensus 184 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 262 (484)
T 3nyv_A 184 KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLI 262 (484)
T ss_dssp SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHH
T ss_pred ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHH
Confidence 6666789999999999976 69999999999999999999999999999888877776655444333 46899999999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 008171 523 ERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 523 ~~cL~~dP~~RPs~~ell~ 541 (575)
.+||+.||.+|||+.|+++
T Consensus 263 ~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 263 RKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHTCSSGGGSCCHHHHHT
T ss_pred HHHCCCChhHCcCHHHHhh
Confidence 9999999999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=368.07 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=209.3
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-----CCCceEEEeeecC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-----HKNVVQFIGACTK 360 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-----HpnIv~l~~~~~~ 360 (575)
.+-.++|++.++||+|+||.||+|++ .++.||||+++.. ......+..|+.+++.+. ||||+++++++..
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 44567999999999999999999998 5677999999742 344567888999999997 9999999999999
Q ss_pred CCCceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC--------------
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-------------- 425 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~-------------- 425 (575)
.+.+|+||||+ |++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 99999999999 999999997643 45999999999999999999999999999999999999975
Q ss_pred -----------CCcEEEeecccceecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 008171 426 -----------NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP 494 (575)
Q Consensus 426 -----------~~~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~ 494 (575)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 264 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH 264 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence 789999999999865432 3456799999999999999999999999999999999999999988776
Q ss_pred HHHHHHHHhcCCC------------------------CCCC--------------------CCCcHHHHHHHHHhhhcCC
Q 008171 495 LQAAVGVVQKGLR------------------------PTIP--------------------KNSQPKLAELLERCWQQDP 530 (575)
Q Consensus 495 ~~~~~~v~~~~~~------------------------~~~p--------------------~~~~~~l~~Li~~cL~~dP 530 (575)
.+....+...... ...| ...++.+.+||.+||+.||
T Consensus 265 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 344 (360)
T 3llt_A 265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344 (360)
T ss_dssp HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCCh
Confidence 6554433221100 0011 1123778899999999999
Q ss_pred CCCCCHHHHHH
Q 008171 531 ALRPDFSEIIE 541 (575)
Q Consensus 531 ~~RPs~~ell~ 541 (575)
.+|||+.|+++
T Consensus 345 ~~Rpta~elL~ 355 (360)
T 3llt_A 345 TLRPSPAELLK 355 (360)
T ss_dssp GGSCCHHHHTT
T ss_pred hhCCCHHHHhc
Confidence 99999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=367.87 Aligned_cols=249 Identities=22% Similarity=0.364 Sum_probs=201.6
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
.++|++.++||+|+||.||+|.+ .++.||||+++...........+.+|+.++++++||||+++++++.....+|+||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 46899999999999999999986 4678999999876655555677889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEec-----CCCcEEEeecccceecccC
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-----ENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~-----~~~~vkL~DFG~a~~~~~~ 443 (575)
||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.....
T Consensus 113 e~~~-~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 113 EYAE-NDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp ECCS-EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred ecCC-CCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 9996 599999976 56699999999999999999999999999999999999994 5556999999999765433
Q ss_pred -CccccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC------------
Q 008171 444 -GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT------------ 509 (575)
Q Consensus 444 -~~~~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~------------ 509 (575)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+......+.
T Consensus 191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (329)
T 3gbz_A 191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD 270 (329)
T ss_dssp ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhh
Confidence 234456789999999999774 589999999999999999999999999888776666543211110
Q ss_pred ----C------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 510 ----I------------PKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 510 ----~------------p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
. +..+++++.+||.+||+.||.+|||+.|+++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 271 WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 1126789999999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=363.88 Aligned_cols=259 Identities=18% Similarity=0.314 Sum_probs=211.1
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
.++|++.++||+|+||.||++.+. ++.||||++..... .......+.+|+.++++++||||+++++++...+.+|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999874 67799999986543 344557899999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC--c
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--V 445 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~--~ 445 (575)
|||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 113 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 113 MRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp EECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence 999999999999976 5679999999999999999999999999999999999999999999999999997655432 2
Q ss_pred cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHHHHHH
Q 008171 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLE 523 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--~~~p~~~~~~l~~Li~ 523 (575)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||......... ..+..... ...+..+++++.++|.
T Consensus 192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~ 270 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG-AHINQAIPRPSTVRPGIPVAFDAVIA 270 (309)
T ss_dssp -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH-HHHHSCCCCGGGTSTTCCTHHHHHHH
T ss_pred ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH-HHhccCCCCccccCCCCCHHHHHHHH
Confidence 33557899999999999999999999999999999999999999887655333 22332221 2356788999999999
Q ss_pred HhhhcCCCCCC-CHHHHHHHHHHHHHHhc
Q 008171 524 RCWQQDPALRP-DFSEIIEILQQIAKEVG 551 (575)
Q Consensus 524 ~cL~~dP~~RP-s~~ell~~L~~l~~~~~ 551 (575)
+||+.||.+|| ++.++++.|++++....
T Consensus 271 ~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 271 RGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp HHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred HhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 99999999999 99999999998876543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=354.70 Aligned_cols=251 Identities=26% Similarity=0.501 Sum_probs=209.8
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
.+..++|++++.||+|+||.||+|.+. ++.||||++..... ..+....+.+|+.+++.++||||+++++++......
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 344578999999999999999999884 78899999875321 122346788999999999999999999999999999
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 999999999999999976 4678999999999999999999999999999999999999999999999999998766554
Q ss_pred ccccCCCCCCccCcccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 008171 445 VMTAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 523 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~ 523 (575)
......||+.|+|||++.+..+ +.++||||||+++|+|++|..||......+....+... ...+|..+++.+.++|.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~ 243 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEYLNRSVATLLM 243 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHH
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--cccCchhcCHHHHHHHH
Confidence 4556679999999999988776 68999999999999999999999988776655544332 34567788999999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 008171 524 RCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 524 ~cL~~dP~~RPs~~ell~ 541 (575)
+||+.||.+|||+.++++
T Consensus 244 ~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 244 HMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHccCChhhCCCHHHHHh
Confidence 999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=363.72 Aligned_cols=250 Identities=20% Similarity=0.377 Sum_probs=214.7
Q ss_pred Cceeee-eeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCCCceeE
Q 008171 292 KHLKFG-SKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 292 ~~~~i~-~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~l~lV 367 (575)
+.|.+. ++||+|+||.||+|... ++.||||+++...........+.+|+.+++.+. ||||+++++++.....+|+|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 467776 89999999999999885 778999999876555555678999999999995 69999999999999999999
Q ss_pred EEeccCCchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC---CCcEEEeecccceecccC
Q 008171 368 TEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQS 443 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~---~~~vkL~DFG~a~~~~~~ 443 (575)
|||+.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 9999999999998643 467999999999999999999999999999999999999987 789999999999877666
Q ss_pred CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--CCCCCCCCcHHHHHH
Q 008171 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIPKNSQPKLAEL 521 (575)
Q Consensus 444 ~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~--~~~~p~~~~~~l~~L 521 (575)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+..... ....+..+++.+.++
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 267 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDF 267 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHH
Confidence 555667899999999999999999999999999999999999999999888777666554433 334456789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 008171 522 LERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 522 i~~cL~~dP~~RPs~~ell~ 541 (575)
|.+||+.||.+|||+.++++
T Consensus 268 i~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 268 IQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHcCCChhhCcCHHHHhC
Confidence 99999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=372.70 Aligned_cols=256 Identities=18% Similarity=0.251 Sum_probs=212.4
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC----------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceE----
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC----------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ---- 353 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~----------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~---- 353 (575)
....++|++.+.||+|+||.||+|.+. ++.||||++... ..+.+|+.++++++||||++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~ 110 (352)
T 2jii_A 38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKK 110 (352)
T ss_dssp CTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred cccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhh
Confidence 344689999999999999999999874 578999998754 35788999999999999988
Q ss_pred -----------EEeeecC-CCCceeEEEeccCCchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCC
Q 008171 354 -----------FIGACTK-PPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 420 (575)
Q Consensus 354 -----------l~~~~~~-~~~l~lV~E~~~ggsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~N 420 (575)
+++++.. ...+|+||||+ |++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 189 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189 (352)
T ss_dssp HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 4555544 66789999999 99999999874 3679999999999999999999999999999999999
Q ss_pred EEecCCC--cEEEeecccceecccCC--------ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 008171 421 LLMDENE--VVKVADFGVARVKAQSG--------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490 (575)
Q Consensus 421 ILl~~~~--~vkL~DFG~a~~~~~~~--------~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~ 490 (575)
||++.++ .+||+|||+++...... ......||+.|+|||++.+..++.++|||||||+||+|++|..||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999988 89999999997654332 1234479999999999999999999999999999999999999998
Q ss_pred CCC-HHHHHHHHH---hcCCCCCCC------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhch
Q 008171 491 YLT-PLQAAVGVV---QKGLRPTIP------KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 552 (575)
Q Consensus 491 ~~~-~~~~~~~v~---~~~~~~~~p------~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~~ 552 (575)
... ......... .... +.++ ..+++++.++|.+||+.||.+||++.++++.|+++++..+.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKP-GPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSC-CCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cCCcCHHHHHHHHHhccCCh-hhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 764 222222211 1111 1121 25689999999999999999999999999999999987653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=359.52 Aligned_cols=248 Identities=25% Similarity=0.429 Sum_probs=192.4
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|++.+.||+|+||.||+|+. .++.||||++..... .......+.+|+.++++++||||+++++++...+..|+||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5799999999999999999987 577899999874321 1123467899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-ccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMT 447 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~ 447 (575)
||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 170 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY 170 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcce
Confidence 9999999999998766789999999999999999999999999999999999999999999999999998655332 233
Q ss_pred cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 008171 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~ 527 (575)
...||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+... ....|..+++++.++|.+||+
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~ 248 (278)
T 3cok_A 171 TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA--DYEMPSFLSIEAKDLIHQLLR 248 (278)
T ss_dssp ---------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS--CCCCCTTSCHHHHHHHHHHSC
T ss_pred eccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc--ccCCccccCHHHHHHHHHHcc
Confidence 457899999999999999999999999999999999999999876654443332222 234677889999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 008171 528 QDPALRPDFSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs~~ell~ 541 (575)
.||.+|||+.++++
T Consensus 249 ~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 249 RNPADRLSLSSVLD 262 (278)
T ss_dssp SSGGGSCCHHHHTT
T ss_pred cCHhhCCCHHHHhc
Confidence 99999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=360.41 Aligned_cols=253 Identities=30% Similarity=0.529 Sum_probs=210.9
Q ss_pred eeeeeeeeecCceEEEEEEECCccEEEEEecCCC--CChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEec
Q 008171 294 LKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPER--INSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~--~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~ 371 (575)
|..+++||+|+||.||+|.+.++.||||++.... ........+.+|+.++++++||||+++++++......|+||||+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 4456899999999999999999999999987543 23345678999999999999999999999999999999999999
Q ss_pred cCCchhhhhhhcc--CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC---cc
Q 008171 372 SGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VM 446 (575)
Q Consensus 372 ~ggsL~d~l~~~~--~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~---~~ 446 (575)
+|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... ..
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 192 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence 9999999987543 458999999999999999999999999999999999999999999999999998655432 12
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---Hhc----------CCCCCCCCC
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV---VQK----------GLRPTIPKN 513 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v---~~~----------~~~~~~p~~ 513 (575)
....||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+ ... ...+..+..
T Consensus 193 ~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (307)
T 2nru_A 193 SRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADST 271 (307)
T ss_dssp SSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHH
T ss_pred cccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchH
Confidence 34578999999999875 4899999999999999999999999765432211111 110 111223445
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 008171 514 SQPKLAELLERCWQQDPALRPDFSEIIEILQQIA 547 (575)
Q Consensus 514 ~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~ 547 (575)
+++.+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 272 ~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 272 SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 5678999999999999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=355.51 Aligned_cols=248 Identities=27% Similarity=0.455 Sum_probs=219.7
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
.++|.+.+.||+|+||.||++.+. ++.||+|++..... .......+.+|+.++++++||||+++++++...+..|+|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467999999999999999999985 56799999876543 345567789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cc
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VM 446 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~ 446 (575)
|||+.|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 94 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 172 (294)
T 2rku_A 94 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 172 (294)
T ss_dssp EECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcccc
Confidence 999999999998876 5679999999999999999999999999999999999999999999999999998765332 34
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 526 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL 526 (575)
....||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+... ...++..+++.+.++|.+||
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l 250 (294)
T 2rku_A 173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKML 250 (294)
T ss_dssp CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTSCHHHHHHHHHHT
T ss_pred ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc--cCCCccccCHHHHHHHHHHc
Confidence 4567999999999999999999999999999999999999999988877665554433 34577889999999999999
Q ss_pred hcCCCCCCCHHHHHH
Q 008171 527 QQDPALRPDFSEIIE 541 (575)
Q Consensus 527 ~~dP~~RPs~~ell~ 541 (575)
+.||.+|||+.++++
T Consensus 251 ~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 251 QTDPTARPTINELLN 265 (294)
T ss_dssp CSSGGGSCCGGGGGG
T ss_pred ccChhhCcCHHHHhh
Confidence 999999999999886
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=361.98 Aligned_cols=261 Identities=26% Similarity=0.428 Sum_probs=203.0
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeee--
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGAC-- 358 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~-- 358 (575)
...+++...+|++.++||+|+||.||++.+ .++.||||++... .......+.+|+.+++++. ||||+++++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 356788889999999999999999999998 6778999998644 3445677899999999996 99999999988
Q ss_pred ------cCCCCceeEEEeccCCchhhhhhh--ccCcCChHHHHHHHHHHHHHHHHHHHCC--ceecccCCCCEEecCCCc
Q 008171 359 ------TKPPSLCIVTEFMSGGSVYDYLHK--LKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMDENEV 428 (575)
Q Consensus 359 ------~~~~~l~lV~E~~~ggsL~d~l~~--~~~~l~~~~~~~i~~qI~~aL~yLH~~g--IiHrDLKp~NILl~~~~~ 428 (575)
.....+++||||+. |+|.+++.. ..+.+++..++.++.||+.||.|||++| |+||||||+|||++.++.
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC
T ss_pred cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC
Confidence 34445799999994 799998865 2456999999999999999999999999 999999999999999999
Q ss_pred EEEeecccceecccCCcc-------------ccCCCCCCccCcccc---cCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 008171 429 VKVADFGVARVKAQSGVM-------------TAETGTYRWMAPEVI---EHKPYDHKADVFSFGIVLWELLTGKLPYEYL 492 (575)
Q Consensus 429 vkL~DFG~a~~~~~~~~~-------------~~~~Gt~~y~APE~i---~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~ 492 (575)
+||+|||+++........ ....||+.|+|||++ .+..++.++|||||||++|+|++|..||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 999999999865543211 134589999999998 5777899999999999999999999999865
Q ss_pred CHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 493 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 493 ~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
..... .........+..+++.+.+||.+||+.||.+||++.|+++.|+.+.....
T Consensus 257 ~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 257 AKLRI----VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp -------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred hHHHh----hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 54432 33334445566778899999999999999999999999999999987554
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=382.91 Aligned_cols=247 Identities=25% Similarity=0.363 Sum_probs=204.0
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC------
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------ 362 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~------ 362 (575)
.++|+++++||+|+||.||+|.+. ++.||||++..........+.+.+|+.+|+.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999874 678999999876556666788999999999999999999999986554
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
.+|+||||+.+ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 141 ~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred eEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 45999999965 5666663 3489999999999999999999999999999999999999999999999999988776
Q ss_pred CCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--------------
Q 008171 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-------------- 508 (575)
Q Consensus 443 ~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~-------------- 508 (575)
....+..+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+....++.....+
T Consensus 217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~ 296 (464)
T 3ttj_A 217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 296 (464)
T ss_dssp CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence 666777899999999999999999999999999999999999999999988766655544321110
Q ss_pred ------CC---------CCC-----------CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 ------TI---------PKN-----------SQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 ------~~---------p~~-----------~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.. +.. .++++.+||.+||+.||.+|||+.|+++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 000 1567999999999999999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=367.56 Aligned_cols=249 Identities=22% Similarity=0.421 Sum_probs=217.0
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC--Ch----HHHHHHHHHHHHHHhc-CCCCceEEEeeecCCC
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI--NS----DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP 362 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~--~~----~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~ 362 (575)
.+|++.+.||+|+||.||+|.+. ++.||||++..... .. .....+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 57999999999999999999984 78899999976532 11 2345688999999999 7999999999999999
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
..|+||||++|++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999999999999976 56799999999999999999999999999999999999999999999999999987766
Q ss_pred CCccccCCCCCCccCccccc------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCC
Q 008171 443 SGVMTAETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI--PKNS 514 (575)
Q Consensus 443 ~~~~~~~~Gt~~y~APE~i~------~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~--p~~~ 514 (575)
........||+.|+|||++. ...++.++|||||||++|+|++|..||...+.......+......... ...+
T Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 332 (365)
T 2y7j_A 253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR 332 (365)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSS
T ss_pred CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccC
Confidence 65566778999999999985 346889999999999999999999999988877766655554433222 2467
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 515 QPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 515 ~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
++.+.++|.+||+.||.+|||+.++++
T Consensus 333 ~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 333 SSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 899999999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=361.56 Aligned_cols=252 Identities=31% Similarity=0.595 Sum_probs=207.2
Q ss_pred CceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHh--cCCCCceEEEeeecCC----CCce
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--VRHKNVVQFIGACTKP----PSLC 365 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~--L~HpnIv~l~~~~~~~----~~l~ 365 (575)
++|++.++||+|+||.||+|++.++.||||++.... ...+..|..++.. ++||||+++++++... ..+|
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 689999999999999999999999999999986431 2344555555554 4899999999998766 6789
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHC--------CceecccCCCCEEecCCCcEEEeecccc
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--------NIIHRDLKAANLLMDENEVVKVADFGVA 437 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~--------gIiHrDLKp~NILl~~~~~vkL~DFG~a 437 (575)
+||||++||+|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 112 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 189 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189 (337)
T ss_dssp EEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence 99999999999999965 4689999999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCc-----cccCCCCCCccCcccccCCCCCch------HHHHHHHHHHHHHHcC----------CCCCCCCCH--
Q 008171 438 RVKAQSGV-----MTAETGTYRWMAPEVIEHKPYDHK------ADVFSFGIVLWELLTG----------KLPYEYLTP-- 494 (575)
Q Consensus 438 ~~~~~~~~-----~~~~~Gt~~y~APE~i~~~~~s~k------sDVwSlGviL~eLltG----------~~Pf~~~~~-- 494 (575)
+....... .....||+.|+|||++.+..++.+ +|||||||++|||++| ..||....+
T Consensus 190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 269 (337)
T 3mdy_A 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269 (337)
T ss_dssp EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence 76544321 124579999999999988776654 9999999999999999 777765322
Q ss_pred ---HHHHHHHHhcCCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 495 ---LQAAVGVVQKGLRPTIPK-----NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 495 ---~~~~~~v~~~~~~~~~p~-----~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
......+.....++.++. .+++++.++|.+||+.||.+|||+.++++.|+++.+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 222222334445555554 56788999999999999999999999999999998643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=354.84 Aligned_cols=250 Identities=23% Similarity=0.430 Sum_probs=218.6
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
.+..++|++.+.||+|+||.||+|.+. ++.||||++...... ......+.+|+.++++++||||+++++++...+.+
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 345578999999999999999999985 567999998643221 12246788999999999999999999999999999
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 999999999999999976 467999999999999999999999999999999999999999999999999999755432
Q ss_pred ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 008171 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~ 524 (575)
......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+... ...+|..+++.+.++|.+
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~ 245 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DLKFPPFLSDGSKDLISK 245 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc--ccCCCCcCCHHHHHHHHH
Confidence 234567999999999999999999999999999999999999999988877666555443 345778899999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 008171 525 CWQQDPALRPDFSEIIE 541 (575)
Q Consensus 525 cL~~dP~~RPs~~ell~ 541 (575)
||+.||.+||++.++++
T Consensus 246 ~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 246 LLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HSCSSGGGSCCHHHHHT
T ss_pred HhhcCHhhCCCHHHHhh
Confidence 99999999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=369.64 Aligned_cols=242 Identities=22% Similarity=0.396 Sum_probs=211.4
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChH------HHHHHHHHHHHHHhcCCCCceEEEeeecCCCC
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSD------MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~------~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 363 (575)
++|++.++||+|+||.||+|.+ .++.||||+++....... ....+.+|+.++++++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 5799999999999999999986 467799999986543221 23457789999999999999999999999999
Q ss_pred ceeEEEeccCC-chhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 364 LCIVTEFMSGG-SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 364 l~lV~E~~~gg-sL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
+++||||+.+| +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 99999999766 99999976 56799999999999999999999999999999999999999999999999999988776
Q ss_pred CCccccCCCCCCccCcccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 008171 443 SGVMTAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521 (575)
Q Consensus 443 ~~~~~~~~Gt~~y~APE~i~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~L 521 (575)
........||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... . ......+..+++++.+|
T Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~--~~~~~~~~~~~~~l~~l 254 (335)
T 3dls_A 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------V--EAAIHPPYLVSKELMSL 254 (335)
T ss_dssp TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------T--TTCCCCSSCCCHHHHHH
T ss_pred CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------H--hhccCCCcccCHHHHHH
Confidence 666666789999999999988887 88999999999999999999999763321 1 12234566789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 008171 522 LERCWQQDPALRPDFSEIIEI 542 (575)
Q Consensus 522 i~~cL~~dP~~RPs~~ell~~ 542 (575)
|.+||+.||.+|||+.++++-
T Consensus 255 i~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 255 VSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=352.44 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=218.5
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC---C----hHHHHHHHHHHHHHHhcC-CCCceEEEeeecC
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI---N----SDMQKEFAQEVFIMRKVR-HKNVVQFIGACTK 360 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~---~----~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~ 360 (575)
.++|++.+.||+|+||.||+|.+ +++.||||+++.... . ......+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 47899999999999999999998 457899999976532 1 123467889999999996 9999999999999
Q ss_pred CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
....|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++...
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 9999999999999999999976 567999999999999999999999999999999999999999999999999999877
Q ss_pred ccCCccccCCCCCCccCccccc------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--C
Q 008171 441 AQSGVMTAETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--K 512 (575)
Q Consensus 441 ~~~~~~~~~~Gt~~y~APE~i~------~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p--~ 512 (575)
..........||+.|+|||++. ...++.++||||||+++|+|++|..||...+.......+.........+ .
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (298)
T 1phk_A 175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 254 (298)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccccc
Confidence 6655566678999999999984 5678999999999999999999999999888777666655554433322 4
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 513 NSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 513 ~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+++.+.++|.+||+.||.+|||+.|+++
T Consensus 255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 255 DYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp GSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 68899999999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=367.45 Aligned_cols=251 Identities=25% Similarity=0.433 Sum_probs=213.4
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
++..++|++.++||+|+||.||++.+. ++.||+|++... ........+.+|+.++++++||||+++++++...+.+|
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 556678999999999999999999986 678999999865 34555678999999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHC-CceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~-gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 108 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp EEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999999999976 56799999999999999999999996 9999999999999999999999999998654332
Q ss_pred ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH-------------------------
Q 008171 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV------------------------- 499 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~------------------------- 499 (575)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+...
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 2345579999999999999999999999999999999999999998766543221
Q ss_pred -----------------HHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 500 -----------------GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 500 -----------------~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+.........+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 111112222223457899999999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=358.65 Aligned_cols=250 Identities=31% Similarity=0.520 Sum_probs=209.5
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecC-----
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTK----- 360 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~----- 360 (575)
...++|++.+.||+|+||.||+|++ .++.||||++...... ...+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 3457899999999999999999998 5788999998754332 35688999999999 79999999999865
Q ss_pred -CCCceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccce
Q 008171 361 -PPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 361 -~~~l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
...+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 457899999999999999997643 578999999999999999999999999999999999999999999999999997
Q ss_pred ecccC-CccccCCCCCCccCccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 008171 439 VKAQS-GVMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK 512 (575)
Q Consensus 439 ~~~~~-~~~~~~~Gt~~y~APE~i~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~ 512 (575)
..... .......||+.|+|||++. +..++.++|||||||++|+|++|..||...........+.........+.
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 2x7f_A 178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK 257 (326)
T ss_dssp -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCS
T ss_pred ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCcc
Confidence 65433 2234557999999999996 56789999999999999999999999999888777666555544444567
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 513 NSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 513 ~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+++.+.++|.+||..||.+||++.++++
T Consensus 258 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 258 KWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 88999999999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=374.56 Aligned_cols=243 Identities=22% Similarity=0.366 Sum_probs=195.2
Q ss_pred Cceeee-eeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHH-hcCCCCceEEEeeecC----CCC
Q 008171 292 KHLKFG-SKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMR-KVRHKNVVQFIGACTK----PPS 363 (575)
Q Consensus 292 ~~~~i~-~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~-~L~HpnIv~l~~~~~~----~~~ 363 (575)
++|.+. ++||+|+||.||++.+. ++.||||+++.. ..+.+|+.++. ..+||||+++++++.. ...
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 456665 78999999999999884 677999998732 35677888874 4589999999998754 567
Q ss_pred ceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC---CCcEEEeeccccee
Q 008171 364 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARV 439 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~---~~~vkL~DFG~a~~ 439 (575)
+||||||+.||+|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 899999999999999997643 46999999999999999999999999999999999999997 78999999999987
Q ss_pred cccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHhcCCCC--CCCCC
Q 008171 440 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ----AAVGVVQKGLRP--TIPKN 513 (575)
Q Consensus 440 ~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~----~~~~v~~~~~~~--~~p~~ 513 (575)
..........+||+.|+|||++.+..|+.++|||||||+||+|++|..||....... ....+....... .....
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 293 (400)
T 1nxk_A 214 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293 (400)
T ss_dssp CC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTT
T ss_pred cCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccccc
Confidence 766555667789999999999999999999999999999999999999997654321 122222222221 22357
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 514 SQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 514 ~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+++++.+||.+||+.||.+|||+.|+++
T Consensus 294 ~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 294 VSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 8999999999999999999999999985
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=362.86 Aligned_cols=253 Identities=29% Similarity=0.583 Sum_probs=214.8
Q ss_pred CCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHh--cCCCCceEEEeeecCCC----Cc
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRK--VRHKNVVQFIGACTKPP----SL 364 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~--L~HpnIv~l~~~~~~~~----~l 364 (575)
.++|++.+.||+|+||.||+|++.++.||||++... ....+.+|+.+++. ++||||+++++++.... .+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 368999999999999999999999999999998743 24567889999888 78999999999998765 78
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHH--------HCCceecccCCCCEEecCCCcEEEeeccc
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH--------QNNIIHRDLKAANLLMDENEVVKVADFGV 436 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH--------~~gIiHrDLKp~NILl~~~~~vkL~DFG~ 436 (575)
|+||||+++++|.+++.+ ..+++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+|||+
T Consensus 116 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 999999999999999965 56899999999999999999999 89999999999999999999999999999
Q ss_pred ceecccCC-----ccccCCCCCCccCcccccCCC------CCchHHHHHHHHHHHHHHcC----------CCCCCCCC--
Q 008171 437 ARVKAQSG-----VMTAETGTYRWMAPEVIEHKP------YDHKADVFSFGIVLWELLTG----------KLPYEYLT-- 493 (575)
Q Consensus 437 a~~~~~~~-----~~~~~~Gt~~y~APE~i~~~~------~s~ksDVwSlGviL~eLltG----------~~Pf~~~~-- 493 (575)
++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++| ..||....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 98665543 224457999999999997763 34789999999999999999 78997653
Q ss_pred ---HHHHHHHHHhcCCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 494 ---PLQAAVGVVQKGLRPTIPK-----NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 494 ---~~~~~~~v~~~~~~~~~p~-----~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
.......+.....++.++. .+++.+.++|.+||+.||.+|||+.++++.|+++.++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 2233333445556666654 34568999999999999999999999999999997643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=355.24 Aligned_cols=246 Identities=34% Similarity=0.591 Sum_probs=219.2
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
+.|++.++||+|+||.||+|.+. ++.||||++...... .....+.+|+.++++++||||+++++++.....+|+|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 56999999999999999999874 678999999765432 345779999999999999999999999999899999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
|++|++|.+++.. +.+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....... ....
T Consensus 101 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 178 (303)
T 3a7i_A 101 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178 (303)
T ss_dssp CCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence 9999999999864 679999999999999999999999999999999999999999999999999997655433 3345
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 528 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~ 528 (575)
..||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+ .....+.++..+++.+.++|.+||+.
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~ 257 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI-PKNNPPTLEGNYSKPLKEFVEACLNK 257 (303)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-HHSCCCCCCSSCCHHHHHHHHHHCCS
T ss_pred cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh-hcCCCCCCccccCHHHHHHHHHHcCC
Confidence 67899999999999999999999999999999999999999988877665543 34556677889999999999999999
Q ss_pred CCCCCCCHHHHHH
Q 008171 529 DPALRPDFSEIIE 541 (575)
Q Consensus 529 dP~~RPs~~ell~ 541 (575)
||.+|||+.++++
T Consensus 258 dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 258 EPSFRPTAKELLK 270 (303)
T ss_dssp SGGGSCCHHHHTT
T ss_pred ChhhCcCHHHHhh
Confidence 9999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=394.92 Aligned_cols=262 Identities=32% Similarity=0.610 Sum_probs=227.4
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEECC-----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeec
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-----~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~ 359 (575)
..|++..++|++++.||+|+||.||+|.+.. ..||||.++.. ........+.+|+.+|++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 4678888999999999999999999998843 34899998754 24455678999999999999999999999985
Q ss_pred CCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 360 ~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
+ +.+|+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 462 ~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 462 E-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred c-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 4 568999999999999999987666799999999999999999999999999999999999999999999999999986
Q ss_pred cccCCc--cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 008171 440 KAQSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 516 (575)
Q Consensus 440 ~~~~~~--~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~ 516 (575)
...... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+ ..+.++.++..+++
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i-~~~~~~~~~~~~~~ 619 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPP 619 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HHTCCCCCCTTCCH
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HcCCCCCCCccccH
Confidence 654332 223457789999999999999999999999999999997 99999998887766554 44556678889999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 517 KLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
.+.++|.+||..||.+||++.++++.|++++.+
T Consensus 620 ~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 620 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=364.55 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=207.3
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCCh---HHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS---DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
.++|++.+.||+|+||.||+|.+. ++.||||+++...... .....+.+|+.++++++||||+++++++.....+|
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 468999999999999999999874 6789999987543221 12346889999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-C
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-G 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~ 444 (575)
+||||+.+ +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence 99999965 899998876678999999999999999999999999999999999999999999999999999865433 2
Q ss_pred ccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---------------
Q 008171 445 VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--------------- 508 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~--------------- 508 (575)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T 1ua2_A 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 247 (346)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccc
Confidence 4456689999999999965 458999999999999999999999999988877766655421111
Q ss_pred ------C-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 ------T-----IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 ------~-----~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
. +...+++++.+||.+||+.||.+|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 248 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 11456789999999999999999999999885
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=366.95 Aligned_cols=255 Identities=25% Similarity=0.392 Sum_probs=213.2
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCC
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 363 (575)
.+....++|++.+.||+|+||.||++.+. ++.||||++............+.+|+.++++++||||+++++++.....
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 98 (331)
T 4aaa_A 19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR 98 (331)
T ss_dssp CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence 34455679999999999999999999985 6789999998776666667788999999999999999999999999999
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
+|+||||+.+++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEEEECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEEecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999999888887654 567999999999999999999999999999999999999999999999999999765443
Q ss_pred -CccccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC----------------
Q 008171 444 -GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG---------------- 505 (575)
Q Consensus 444 -~~~~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~---------------- 505 (575)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+....
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 234456799999999999775 78999999999999999999999999888766554433210
Q ss_pred ---CC-CC---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 506 ---LR-PT---------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 506 ---~~-~~---------~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.. +. ....+++.+.+||.+||+.||.+|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 00 11357899999999999999999999999885
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=371.39 Aligned_cols=259 Identities=30% Similarity=0.511 Sum_probs=211.9
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEE-CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~-~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
.+.+..++|++.+.||+|+||.||+|.. .++.||||+++...... ....+.+|+.++++++||||+++++++......
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 4566778999999999999999999986 46789999998653222 223688999999999999999999999999999
Q ss_pred eeEEEeccCCchhhhhhhcc---CcCChHHHHHHHHHHHHHHHHHHHC---CceecccCCCCEEecCCCcEEEeecccce
Q 008171 365 CIVTEFMSGGSVYDYLHKLK---GVFKLPSLLKVAIDVSKGMNYLHQN---NIIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~---~~l~~~~~~~i~~qI~~aL~yLH~~---gIiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
++||||+.|++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 99999999999999997643 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ecccCC--ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhc--------
Q 008171 439 VKAQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT----PLQAAVGVVQK-------- 504 (575)
Q Consensus 439 ~~~~~~--~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~----~~~~~~~v~~~-------- 504 (575)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ........+..
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (326)
T 3uim_A 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 262 (326)
T ss_dssp ECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCST
T ss_pred ccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhh
Confidence 765432 3344569999999999998899999999999999999999999995211 00001111111
Q ss_pred -----CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 008171 505 -----GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQ 545 (575)
Q Consensus 505 -----~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~ 545 (575)
......+...++.+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 263 ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 11122333445789999999999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=354.17 Aligned_cols=246 Identities=26% Similarity=0.420 Sum_probs=212.2
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC---------
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--------- 360 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--------- 360 (575)
.+|++.+.||+|+||.||+|.+. ++.||+|+++... ..+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 57999999999999999999985 7889999997542 346789999999999999999998743
Q ss_pred -------CCCceeEEEeccCCchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEe
Q 008171 361 -------PPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA 432 (575)
Q Consensus 361 -------~~~l~lV~E~~~ggsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~ 432 (575)
...+|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 34579999999999999999764 3579999999999999999999999999999999999999999999999
Q ss_pred ecccceecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 008171 433 DFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK 512 (575)
Q Consensus 433 DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~ 512 (575)
|||++.............||+.|+|||++.+..++.++||||||+++|+|++|..||.... . ....+. ...++.
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~-~~~~~~---~~~~~~ 238 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--K-FFTDLR---DGIISD 238 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--H-HHHHHH---TTCCCT
T ss_pred cchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--H-HHHHhh---cccccc
Confidence 9999987766655566789999999999999999999999999999999999998874321 1 111122 234567
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 513 NSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 513 ~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
.+++.+.++|.+||+.||.+||++.|+++.|..+.+.
T Consensus 239 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 239 IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 7899999999999999999999999999999887643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=362.82 Aligned_cols=262 Identities=21% Similarity=0.352 Sum_probs=215.1
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeec--
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT-- 359 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~-- 359 (575)
...+.++.++|++.++||+|+||.||++.. .++.||||++... .......+.+|+.++++++||||+++++++.
T Consensus 21 g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 21 GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp EEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred ccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 346788889999999999999999999986 5678999998653 3455678999999999999999999999986
Q ss_pred --CCCCceeEEEeccCCchhhhhhhc---cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeec
Q 008171 360 --KPPSLCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434 (575)
Q Consensus 360 --~~~~l~lV~E~~~ggsL~d~l~~~---~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DF 434 (575)
.....|+||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~df 178 (317)
T 2buj_A 99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDL 178 (317)
T ss_dssp ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEec
Confidence 345789999999999999998763 467999999999999999999999999999999999999999999999999
Q ss_pred ccceecccCC----------ccccCCCCCCccCcccccCCC---CCchHHHHHHHHHHHHHHcCCCCCCCCCHH-HHHHH
Q 008171 435 GVARVKAQSG----------VMTAETGTYRWMAPEVIEHKP---YDHKADVFSFGIVLWELLTGKLPYEYLTPL-QAAVG 500 (575)
Q Consensus 435 G~a~~~~~~~----------~~~~~~Gt~~y~APE~i~~~~---~s~ksDVwSlGviL~eLltG~~Pf~~~~~~-~~~~~ 500 (575)
|++....... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||...... .....
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 258 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH
Confidence 9987543211 112345799999999997654 789999999999999999999999542110 01112
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 008171 501 VVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA 547 (575)
Q Consensus 501 v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~ 547 (575)
..........+..+++++.++|.+||+.||.+||++.++++.|+.+.
T Consensus 259 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 259 AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 23334444556688999999999999999999999999999998764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=366.04 Aligned_cols=248 Identities=23% Similarity=0.375 Sum_probs=203.6
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.++||+|+||.||+|.+. ++.||||+++..... .....+.+|+.++++++||||+++++++.....+|+|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 57999999999999999999984 677999999754321 112245679999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
|+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 159 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence 996 59999998877789999999999999999999999999999999999999999999999999997655332 3445
Q ss_pred CCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-------------------
Q 008171 449 ETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP------------------- 508 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~------------------- 508 (575)
..||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence 578999999999876 678999999999999999999999999988776655544321111
Q ss_pred ---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 ---------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 ---------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
..+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 012356889999999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=379.96 Aligned_cols=260 Identities=23% Similarity=0.371 Sum_probs=216.4
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC--Cc
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP--SL 364 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~--~l 364 (575)
+...+|++.++||+|+||.||+|.+. ++.||||+++..... .....+.+|+.++++++||||+++++++.... ..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 44578999999999999999999985 678999999854322 22466789999999999999999999987655 67
Q ss_pred eeEEEeccCCchhhhhhhccC--cCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEe----cCCCcEEEeecccce
Q 008171 365 CIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVADFGVAR 438 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~--~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl----~~~~~vkL~DFG~a~ 438 (575)
|+||||++|++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999999976433 38999999999999999999999999999999999999 777889999999998
Q ss_pred ecccCCccccCCCCCCccCcccccC--------CCCCchHHHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhcCC
Q 008171 439 VKAQSGVMTAETGTYRWMAPEVIEH--------KPYDHKADVFSFGIVLWELLTGKLPYEYLT----PLQAAVGVVQKGL 506 (575)
Q Consensus 439 ~~~~~~~~~~~~Gt~~y~APE~i~~--------~~~s~ksDVwSlGviL~eLltG~~Pf~~~~----~~~~~~~v~~~~~ 506 (575)
............||+.|+|||++.+ ..++.++|||||||++|||++|..||.... ..+....++....
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 7766655666789999999999865 567889999999999999999999996432 2333344333211
Q ss_pred C-----------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 507 R-----------------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 507 ~-----------------------~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
. ..++..+++.+.++|.+||+.||.+||++.++++.+.+++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 0 012234567899999999999999999999999999998864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=355.25 Aligned_cols=246 Identities=24% Similarity=0.456 Sum_probs=213.4
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.+.||+|+||.||+++.. ++.||||+++.... .....+.+|+.++++++||||+++++++.....+|+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 57999999999999999999874 77899999985432 223568899999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEe---cCCCcEEEeecccceecccCCcc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSGVM 446 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl---~~~~~vkL~DFG~a~~~~~~~~~ 446 (575)
|++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...... ..
T Consensus 87 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~ 164 (304)
T 2jam_A 87 LVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IM 164 (304)
T ss_dssp CCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TT
T ss_pred cCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-cc
Confidence 9999999999876 5679999999999999999999999999999999999999 77889999999999754432 33
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHHHHHHH
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLER 524 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--~~~p~~~~~~l~~Li~~ 524 (575)
....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+...... ...+..+++++.++|.+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 244 (304)
T 2jam_A 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICH 244 (304)
T ss_dssp HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHH
T ss_pred ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHH
Confidence 4456899999999999999999999999999999999999999988877766655554332 23446789999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 008171 525 CWQQDPALRPDFSEIIE 541 (575)
Q Consensus 525 cL~~dP~~RPs~~ell~ 541 (575)
||+.||.+||++.|+++
T Consensus 245 ~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 245 LLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHCSSTTTSCCHHHHHT
T ss_pred HcCCChhHCcCHHHHhc
Confidence 99999999999999985
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=349.13 Aligned_cols=248 Identities=26% Similarity=0.439 Sum_probs=211.0
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.+.||+|+||.||+|.+. ++.||||++...... .....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 47899999999999999999884 678999999755432 345778999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC---cc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VM 446 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~---~~ 446 (575)
|++|++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....... ..
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred ecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 9999999999976 5679999999999999999999999999999999999999999999999999997654322 23
Q ss_pred ccCCCCCCccCcccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 008171 447 TAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQA-AVGVVQKGLRPTIPKNSQPKLAELLER 524 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~-~~~v~~~~~~~~~p~~~~~~l~~Li~~ 524 (575)
....||+.|+|||++.+..+ +.++||||||+++|+|++|..||........ ................+++.+.++|.+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 244 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHH
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHH
Confidence 45678999999999988775 7799999999999999999999987654322 222232222223345688999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 008171 525 CWQQDPALRPDFSEIIE 541 (575)
Q Consensus 525 cL~~dP~~RPs~~ell~ 541 (575)
||+.||.+|||+.|+++
T Consensus 245 ~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 245 ILVENPSARITIPDIKK 261 (276)
T ss_dssp HSCSSTTTSCCHHHHTT
T ss_pred HCCCCchhCCCHHHHhc
Confidence 99999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=357.22 Aligned_cols=256 Identities=24% Similarity=0.463 Sum_probs=199.5
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
...|.+..++|++.+.||+|+||.||+|.+. ++.||||++..........+.+.++..+++.++||||+++++++...
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 96 (318)
T 2dyl_A 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN 96 (318)
T ss_dssp SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence 4567888899999999999999999999984 77899999987654444445556666788899999999999999999
Q ss_pred CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHC-CceecccCCCCEEecCCCcEEEeecccceec
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~-gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
+.+|+||||+ ++.+..+.....+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 97 ~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 97 TDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp SEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred CcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 9999999999 6667666665567899999999999999999999995 9999999999999999999999999999766
Q ss_pred ccCCccccCCCCCCccCccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhcCCCCCCC--C
Q 008171 441 AQSGVMTAETGTYRWMAPEVIE-----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTP-LQAAVGVVQKGLRPTIP--K 512 (575)
Q Consensus 441 ~~~~~~~~~~Gt~~y~APE~i~-----~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~-~~~~~~v~~~~~~~~~p--~ 512 (575)
..........||+.|+|||++. ...++.++||||||+++|+|++|..||..... .+....+. ....+.++ .
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~ 254 (318)
T 2dyl_A 176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL-QEEPPLLPGHM 254 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH-HSCCCCCCSSS
T ss_pred cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh-ccCCCCCCccC
Confidence 5555555667999999999994 56789999999999999999999999987543 33333333 33344444 4
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 513 NSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 513 ~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+++++.++|.+||+.||.+||++.++++
T Consensus 255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 58999999999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=353.78 Aligned_cols=248 Identities=26% Similarity=0.478 Sum_probs=216.7
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.++||+|+||.||+++. .++.||||++............+.+|+.++++++||||+++++++.....+|+|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 5899999999999999999998 46789999997655544456789999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC---CcEEEeecccceecccCCcc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN---EVVKVADFGVARVKAQSGVM 446 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~---~~vkL~DFG~a~~~~~~~~~ 446 (575)
|+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++.........
T Consensus 102 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~ 180 (287)
T 2wei_A 102 LYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (287)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc
Confidence 9999999999876 4679999999999999999999999999999999999999754 46999999999866555444
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHH
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIP--KNSQPKLAELLER 524 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p--~~~~~~l~~Li~~ 524 (575)
....||+.|+|||++.+. ++.++||||||+++|+|++|..||...+..+....+.........+ ..+++++.++|.+
T Consensus 181 ~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 259 (287)
T 2wei_A 181 KDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259 (287)
T ss_dssp SCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHH
T ss_pred ccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHH
Confidence 455689999999998765 8999999999999999999999999988877666655544333333 5789999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 008171 525 CWQQDPALRPDFSEIIE 541 (575)
Q Consensus 525 cL~~dP~~RPs~~ell~ 541 (575)
||+.||.+|||+.|+++
T Consensus 260 ~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 260 MLTFHPSLRITATQCLE 276 (287)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HcccChhhCcCHHHHhc
Confidence 99999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=355.78 Aligned_cols=243 Identities=19% Similarity=0.359 Sum_probs=204.2
Q ss_pred CCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecC--CCCc
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTK--PPSL 364 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~--~~~l 364 (575)
..++|+++++||+|+||.||+|.+ .++.||||+++... ...+.+|+.++++++ ||||+++++++.. ....
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 347899999999999999999987 56789999997432 367889999999997 9999999999987 5678
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC-cEEEeecccceecccC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQS 443 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~~ 443 (575)
++||||+.+++|.+++.. +++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 109 ~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EEEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EEEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 999999999999998854 88999999999999999999999999999999999999776 8999999999877666
Q ss_pred CccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHH------------hcC----
Q 008171 444 GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLT-PLQAAVGVV------------QKG---- 505 (575)
Q Consensus 444 ~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~-~~~~~~~v~------------~~~---- 505 (575)
.......||..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+....+. ...
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 66667789999999999977 679999999999999999999999995432 222211111 000
Q ss_pred -------------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 506 -------------------LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 506 -------------------~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.....+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011122337899999999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=365.14 Aligned_cols=247 Identities=25% Similarity=0.353 Sum_probs=200.2
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC------
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------ 362 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~------ 362 (575)
.++|++.+.||+|+||.||+|.. .++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 37899999999999999999987 4678999999876656666788999999999999999999999987654
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
.+|+||||+. ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred ceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 6799999996 57888774 4589999999999999999999999999999999999999999999999999987665
Q ss_pred CCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--------------
Q 008171 443 SGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-------------- 508 (575)
Q Consensus 443 ~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~-------------- 508 (575)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....++.....+
T Consensus 180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 259 (371)
T 2xrw_A 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 259 (371)
T ss_dssp ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 555566789999999999999999999999999999999999999999888776655544321111
Q ss_pred ------CC--------------CC------CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 ------TI--------------PK------NSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 ------~~--------------p~------~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.. |. ..++++.+||.+||+.||.+|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00 00 11578999999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=370.84 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=202.5
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC--
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-- 361 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~-- 361 (575)
.|.+ .++|++.++||+|+||.||+|.+. ++.||||+++.........+.+.+|+.+|++++||||+++++++...
T Consensus 21 ~~~i-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 21 NVHV-PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL 99 (432)
T ss_dssp GCCC-CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred ccee-cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence 3444 378999999999999999999874 57799999987655666678899999999999999999999998765
Q ss_pred ---CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccce
Q 008171 362 ---PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 362 ---~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
..+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 100 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 100 LKFDELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CcCCeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 56899999995 699999976 5679999999999999999999999999999999999999999999999999998
Q ss_pred ecccCC-----------------------ccccCCCCCCccCcccc-cCCCCCchHHHHHHHHHHHHHHcCCCC------
Q 008171 439 VKAQSG-----------------------VMTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGKLP------ 488 (575)
Q Consensus 439 ~~~~~~-----------------------~~~~~~Gt~~y~APE~i-~~~~~s~ksDVwSlGviL~eLltG~~P------ 488 (575)
...... .++..+||+.|+|||++ ....|+.++|||||||++|||++|..|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 257 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence 654432 23567899999999986 566799999999999999999985444
Q ss_pred -----CCCCCH-----------------HHHHHHH-----------------------Hhc-CCCCC-----CCCCCcHH
Q 008171 489 -----YEYLTP-----------------LQAAVGV-----------------------VQK-GLRPT-----IPKNSQPK 517 (575)
Q Consensus 489 -----f~~~~~-----------------~~~~~~v-----------------------~~~-~~~~~-----~p~~~~~~ 517 (575)
|.+.+. ......+ +.. ..... ....++++
T Consensus 258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 337 (432)
T 3n9x_A 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD 337 (432)
T ss_dssp GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence 433221 0111010 100 00111 11467899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 518 LAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 518 l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+.+||++||+.||.+|||+.|+++
T Consensus 338 ~~dLl~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 338 GINLLESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHhcCCcccCCCHHHHhc
Confidence 999999999999999999999885
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=364.10 Aligned_cols=250 Identities=26% Similarity=0.415 Sum_probs=209.7
Q ss_pred CCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC--------
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-------- 360 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~-------- 360 (575)
.++|+++++||+|+||.||+|.+ +++.||||++............+.+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36899999999999999999998 46789999987665555445678899999999999999999999865
Q ss_pred CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
.+.+|+||||+. ++|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 346899999996 5888888776778999999999999999999999999999999999999999999999999999865
Q ss_pred ccC-----CccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--CCCCCCCC
Q 008171 441 AQS-----GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK--GLRPTIPK 512 (575)
Q Consensus 441 ~~~-----~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~--~~~~~~p~ 512 (575)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+... ...+....
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 254 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 422 23345678999999999976 56899999999999999999999999998876665544332 11111111
Q ss_pred C----------------------------CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 513 N----------------------------SQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 513 ~----------------------------~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
. .++.+.+||.+||+.||.+|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 1 2678999999999999999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=364.64 Aligned_cols=243 Identities=24% Similarity=0.439 Sum_probs=207.0
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|++.+.||+|+||.||++.+. ++.||||+++..... +.+|+.++.++ +||||+++++++.+...+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 57999999999999999999884 677999999765322 34688888888 7999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC----CcEEEeecccceecccC-
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN----EVVKVADFGVARVKAQS- 443 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~----~~vkL~DFG~a~~~~~~- 443 (575)
||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+..+ +.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 96 ELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred eCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 99999999999976 5679999999999999999999999999999999999998543 35999999999865543
Q ss_pred CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHHhcCCC--CCCCCCCcHHH
Q 008171 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEY---LTPLQAAVGVVQKGLR--PTIPKNSQPKL 518 (575)
Q Consensus 444 ~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~---~~~~~~~~~v~~~~~~--~~~p~~~~~~l 518 (575)
......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.. .+..+....+...... ...+..+++++
T Consensus 175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 254 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA 254 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHH
T ss_pred CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHH
Confidence 344566899999999999988899999999999999999999999975 3444444444443322 22346789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+||.+||..||.+||++.++++
T Consensus 255 ~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 255 KDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHCCCChhHCcCHHHHhc
Confidence 99999999999999999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=355.47 Aligned_cols=249 Identities=28% Similarity=0.496 Sum_probs=211.3
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
.++|++.+.||+|+||.||+|.+. ++.||+|++.... ......+.+|+.++++++||||+++++++...+.+|+||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 367999999999999999999985 6779999987543 233567899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-Cccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMT 447 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~ 447 (575)
||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 175 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD 175 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC--
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccc
Confidence 999999999999876788999999999999999999999999999999999999999999999999987543221 1223
Q ss_pred cCCCCCCccCcccc-----cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCCcHHHHHH
Q 008171 448 AETGTYRWMAPEVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-PTIPKNSQPKLAEL 521 (575)
Q Consensus 448 ~~~Gt~~y~APE~i-----~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~-~~~p~~~~~~l~~L 521 (575)
...||+.|+|||++ .+..++.++||||||+++|+|++|..||...+.......+...... ...+..+++.+.++
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF 255 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHH
Confidence 45789999999998 4678999999999999999999999999998887776665544322 23456788999999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 008171 522 LERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 522 i~~cL~~dP~~RPs~~ell~ 541 (575)
|.+||+.||.+|||+.++++
T Consensus 256 i~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 256 LKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHcccChhhCCCHHHHhc
Confidence 99999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=373.30 Aligned_cols=251 Identities=23% Similarity=0.403 Sum_probs=210.1
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE-----CCccEEEEEecCCCC--ChHHHHHHHHHHHHHHhc-CCCCceEEEeeec
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACT 359 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~-----~~~~VAvKvl~~~~~--~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~ 359 (575)
.+..++|++.++||+|+||.||+++. .++.||||+++.... .......+.+|+.+|+++ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 45567999999999999999999987 567899999875432 112234577899999999 5999999999999
Q ss_pred CCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 360 KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 360 ~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
....+|+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eCceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999999999976 46799999999999999999999999999999999999999999999999999986
Q ss_pred cccCC--ccccCCCCCCccCcccccC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhcCCCCCCC
Q 008171 440 KAQSG--VMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLT----PLQAAVGVVQKGLRPTIP 511 (575)
Q Consensus 440 ~~~~~--~~~~~~Gt~~y~APE~i~~--~~~s~ksDVwSlGviL~eLltG~~Pf~~~~----~~~~~~~v~~~~~~~~~p 511 (575)
..... ......||+.|+|||++.+ ..++.++|||||||+||+|++|..||.... .......+.. ..+.++
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~ 286 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYP 286 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--CCCCCC
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc--cCCCCC
Confidence 54332 2334579999999999985 457899999999999999999999997432 2222222222 345678
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 008171 512 KNSQPKLAELLERCWQQDPALRP-----DFSEIIE 541 (575)
Q Consensus 512 ~~~~~~l~~Li~~cL~~dP~~RP-----s~~ell~ 541 (575)
..+++.+.+||.+||..||.+|| ++.|+++
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 88999999999999999999999 8888875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=364.27 Aligned_cols=257 Identities=17% Similarity=0.262 Sum_probs=215.7
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEE-------ECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC---CCCceE
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGT-------YCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQ 353 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~-------~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~---HpnIv~ 353 (575)
...+++..++|.+.++||+|+||.||+|. ..++.||||+++... ..++..|+.+++.++ |+||++
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhh
Confidence 35678888999999999999999999993 356789999998542 356778888888887 899999
Q ss_pred EEeeecCCCCceeEEEeccCCchhhhhhhc----cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC----
Q 008171 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKL----KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---- 425 (575)
Q Consensus 354 l~~~~~~~~~l~lV~E~~~ggsL~d~l~~~----~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~---- 425 (575)
+++++...+..|+||||++||+|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++.
T Consensus 132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence 999999999999999999999999999752 456999999999999999999999999999999999999998
Q ss_pred -------CCcEEEeecccceecc---cCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Q 008171 426 -------NEVVKVADFGVARVKA---QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPL 495 (575)
Q Consensus 426 -------~~~vkL~DFG~a~~~~---~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~ 495 (575)
++.+||+|||+++... .........||+.|+|||++.+..|+.++|||||||++|||++|+.||......
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 8999999999997543 233455678999999999999999999999999999999999999999643321
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC-CCHHHHHHHHHHHHHHhc
Q 008171 496 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALR-PDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 496 ~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~R-Ps~~ell~~L~~l~~~~~ 551 (575)
... .. .... ....++.+.+++.+||+.+|.+| |++.++.+.|++++....
T Consensus 292 ~~~---~~-~~~~--~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 292 ECK---PE-GLFR--RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp EEE---EC-SCCT--TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred cee---ec-hhcc--ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 100 00 1111 11347789999999999999998 689999999999887643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=375.50 Aligned_cols=249 Identities=24% Similarity=0.413 Sum_probs=199.2
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCC------hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN------SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~------~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
.++|.+.++||+|+||.||+|.+. ++.||||++...... ......+.+|+.+|++++||||+++++++...
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~- 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 368999999999999999999874 578999998754321 12233588999999999999999999998654
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC---cEEEeeccccee
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARV 439 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~---~vkL~DFG~a~~ 439 (575)
.+|+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred ceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 58999999999999999876 56799999999999999999999999999999999999997544 599999999987
Q ss_pred cccCCccccCCCCCCccCccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CCCCC
Q 008171 440 KAQSGVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP---TIPKN 513 (575)
Q Consensus 440 ~~~~~~~~~~~Gt~~y~APE~i~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~---~~p~~ 513 (575)
...........||+.|+|||++. ...|+.++|||||||++|+|++|..||............+..+... .....
T Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 371 (419)
T 3i6u_A 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 371 (419)
T ss_dssp CC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTT
T ss_pred cCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcc
Confidence 76665666778999999999985 3678899999999999999999999998654433333333333222 22356
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 514 SQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 514 ~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+++.+.+||.+||+.||.+||++.|+++
T Consensus 372 ~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 372 VSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 8899999999999999999999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=367.35 Aligned_cols=253 Identities=22% Similarity=0.349 Sum_probs=209.7
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC-----
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----- 360 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~----- 360 (575)
+...++|+++++||+|+||.||+|.+ +++.||||++...... ..+|+.+|+.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 45667899999999999999999987 5678999998754321 2369999999999999999998833
Q ss_pred ---------------------------------CCCceeEEEeccCCchhhhhhh---ccCcCChHHHHHHHHHHHHHHH
Q 008171 361 ---------------------------------PPSLCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMN 404 (575)
Q Consensus 361 ---------------------------------~~~l~lV~E~~~ggsL~d~l~~---~~~~l~~~~~~~i~~qI~~aL~ 404 (575)
...+++||||++ ++|.+.+.. ....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 334889999996 588877753 2467999999999999999999
Q ss_pred HHHHCCceecccCCCCEEec-CCCcEEEeecccceecccCCccccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHH
Q 008171 405 YLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWEL 482 (575)
Q Consensus 405 yLH~~gIiHrDLKp~NILl~-~~~~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eL 482 (575)
|||++||+||||||+|||++ .++.+||+|||+++............||+.|+|||++.+. .++.++|||||||++|+|
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 99999999999999999998 6889999999999877666666677899999999998765 499999999999999999
Q ss_pred HcCCCCCCCCCHHHHHHHHHhcCC---------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q 008171 483 LTGKLPYEYLTPLQAAVGVVQKGL---------------------------RPTIPKNSQPKLAELLERCWQQDPALRPD 535 (575)
Q Consensus 483 ltG~~Pf~~~~~~~~~~~v~~~~~---------------------------~~~~p~~~~~~l~~Li~~cL~~dP~~RPs 535 (575)
++|..||.+.+..+....++.... ...++..+++++.+||.+||+.||.+|||
T Consensus 236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (383)
T 3eb0_A 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN 315 (383)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 999999999887776665543111 11145678899999999999999999999
Q ss_pred HHHHHH--HHHHHH
Q 008171 536 FSEIIE--ILQQIA 547 (575)
Q Consensus 536 ~~ell~--~L~~l~ 547 (575)
+.|+++ .++++.
T Consensus 316 ~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 316 PYEAMAHPFFDHLR 329 (383)
T ss_dssp HHHHHTSGGGHHHH
T ss_pred HHHHhcCHHHHHHH
Confidence 999984 455443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=390.64 Aligned_cols=251 Identities=24% Similarity=0.389 Sum_probs=217.0
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
+..++|++.+.||+|+||.||++++ +++.||||++...... ......+.+|+.+|++++||||+++++++.+...+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 4557899999999999999999998 4778999998754221 123456889999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 366 IVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
+||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 9999999999999987643 349999999999999999999999999999999999999999999999999998776655
Q ss_pred ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 008171 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT----PLQAAVGVVQKGLRPTIPKNSQPKLAE 520 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~----~~~~~~~v~~~~~~~~~p~~~~~~l~~ 520 (575)
.....+||+.|+|||++.+..|+.++|||||||++|||++|..||.... ..+....+. .....++..+++++.+
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~--~~~~~~p~~~s~~~~d 418 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK--EVPEEYSERFSPQARS 418 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH--HCCCCCCTTSCHHHHH
T ss_pred cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh--cccccCCccCCHHHHH
Confidence 5566789999999999999999999999999999999999999998753 223332222 2345677889999999
Q ss_pred HHHHhhhcCCCCCC-----CHHHHHH
Q 008171 521 LLERCWQQDPALRP-----DFSEIIE 541 (575)
Q Consensus 521 Li~~cL~~dP~~RP-----s~~ell~ 541 (575)
||.+||+.||.+|| ++.|+++
T Consensus 419 LI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 419 LCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred HHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 99999999999999 7788764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=353.76 Aligned_cols=250 Identities=30% Similarity=0.468 Sum_probs=211.5
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
....++|++.+.||+|+||.||+|.+. ++.||||++..... ...+.+|+.++++++||||+++++++.....+|
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 345578999999999999999999885 67899999986432 356889999999999999999999999989999
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG- 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~- 444 (575)
+||||+++++|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 9999999999999998667789999999999999999999999999999999999999999999999999997655432
Q ss_pred ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHH
Q 008171 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLE 523 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~~~~p~~~~~~l~~Li~ 523 (575)
......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+..... ....+..+++.+.++|.
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 260 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVK 260 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHH
Confidence 33455789999999999999999999999999999999999999998887766554333221 12235567899999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 008171 524 RCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 524 ~cL~~dP~~RPs~~ell~ 541 (575)
+||..||.+|||+.++++
T Consensus 261 ~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 261 QCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHTCSCTTTSCCHHHHTT
T ss_pred HHccCChhhCcCHHHHHh
Confidence 999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=396.48 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=218.9
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCC
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP 361 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~ 361 (575)
...+..++|+++++||+|+||.||++.+. ++.||||+++.... .......+..|..++..+ +||+|+++++++.+.
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence 34567789999999999999999999985 56699999975421 122345678899999987 699999999999999
Q ss_pred CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
..+||||||++||+|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred CEEEEEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999999999987 5779999999999999999999999999999999999999999999999999998643
Q ss_pred cC-CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 008171 442 QS-GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 520 (575)
Q Consensus 442 ~~-~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~ 520 (575)
.. ......+||+.|+|||++.+..|+.++|||||||+||||++|..||.+.+..+....++... ..+|..+++++.+
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~ 571 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSMSKEAVA 571 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC--CCCCTTSCHHHHH
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHH
Confidence 33 34556789999999999999999999999999999999999999999998888877776543 4678899999999
Q ss_pred HHHHhhhcCCCCCCCH-----HHHH
Q 008171 521 LLERCWQQDPALRPDF-----SEII 540 (575)
Q Consensus 521 Li~~cL~~dP~~RPs~-----~ell 540 (575)
||++||+.||.+||++ .||+
T Consensus 572 li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 572 ICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp HHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred HHHHHccCCHHHCCCCCCCcHHHHh
Confidence 9999999999999997 5555
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=358.21 Aligned_cols=255 Identities=33% Similarity=0.566 Sum_probs=197.3
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCC
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 363 (575)
.|.+..++|++.+.||+|+||.||+|.+ .++.||||++..... ......+.+|+.++++++||||+++++++...+.
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 4678889999999999999999999976 578899999875432 2335678899999999999999999999999999
Q ss_pred ceeEEEeccCCchhhhhhh-------ccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccc
Q 008171 364 LCIVTEFMSGGSVYDYLHK-------LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~-------~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~ 436 (575)
.|+||||++|++|.+++.. ..+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999999864 245689999999999999999999999999999999999999999999999999
Q ss_pred ceecccCC------ccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--
Q 008171 437 ARVKAQSG------VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-- 507 (575)
Q Consensus 437 a~~~~~~~------~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~-- 507 (575)
+....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||..................
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 87554322 1234578999999999965 56899999999999999999999999988776665544433211
Q ss_pred ------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 ------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 ------~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+.....+++++.++|.+||+.||.+||++.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 2234577899999999999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=376.12 Aligned_cols=249 Identities=16% Similarity=0.195 Sum_probs=199.5
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHH---HHHHhcCCCCceEEE-------
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEV---FIMRKVRHKNVVQFI------- 355 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev---~iL~~L~HpnIv~l~------- 355 (575)
...++|++.++||+|+||.||+|++ +++.||||++..... .....+.+.+|+ .++++++|||||+++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 3456899999999999999999985 478899999975432 344567899999 555566899999998
Q ss_pred eeecCCC-----------------CceeEEEeccCCchhhhhhhccCcCCh-------HHHHHHHHHHHHHHHHHHHCCc
Q 008171 356 GACTKPP-----------------SLCIVTEFMSGGSVYDYLHKLKGVFKL-------PSLLKVAIDVSKGMNYLHQNNI 411 (575)
Q Consensus 356 ~~~~~~~-----------------~l~lV~E~~~ggsL~d~l~~~~~~l~~-------~~~~~i~~qI~~aL~yLH~~gI 411 (575)
+++...+ ..||||||+ +|+|.+++... +.+++ ..++.|+.||+.||.|||++||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 227 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 227 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 5554443 378999999 68999999763 33444 7888899999999999999999
Q ss_pred eecccCCCCEEecCCCcEEEeecccceecccCCccccCCCCCCccCcccccCC-----------CCCchHHHHHHHHHHH
Q 008171 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-----------PYDHKADVFSFGIVLW 480 (575)
Q Consensus 412 iHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~~-----------~~s~ksDVwSlGviL~ 480 (575)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .|+.++|||||||+||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 9999999999999999999999999986433 3445677 999999999887 8999999999999999
Q ss_pred HHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHH
Q 008171 481 ELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQIAK 548 (575)
Q Consensus 481 eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~--~L~~l~~ 548 (575)
||++|+.||...+.......+. ..+..+++++.+||.+||+.||.+||++.|+++ .++++..
T Consensus 305 elltg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 305 WIWCADLPITKDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368 (377)
T ss_dssp HHHHSSCCC------CCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred HHHHCCCCCcccccccchhhhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence 9999999997655433221111 223678899999999999999999999999986 5555544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=359.11 Aligned_cols=248 Identities=25% Similarity=0.422 Sum_probs=204.2
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCC------hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCC
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN------SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~------~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 363 (575)
++|++.+.||+|+||.||+|.+. ++.||||++...... ......+.+|+.++++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 57999999999999999999884 577999999764321 122345889999999999999999999987654
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCc---EEEeecccceec
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---VKVADFGVARVK 440 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~---vkL~DFG~a~~~ 440 (575)
+|+||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 89 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 8999999999999999876 567999999999999999999999999999999999999987654 999999999876
Q ss_pred ccCCccccCCCCCCccCccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---CCCCCCC
Q 008171 441 AQSGVMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---PTIPKNS 514 (575)
Q Consensus 441 ~~~~~~~~~~Gt~~y~APE~i~---~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~---~~~p~~~ 514 (575)
..........||+.|+|||++. ...++.++|||||||++|+|++|..||............+..+.. +..+..+
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 247 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTS
T ss_pred ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhc
Confidence 6554445567999999999973 567899999999999999999999999765443222222322222 2233578
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 515 QPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 515 ~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
++++.++|.+||+.||.+||++.++++
T Consensus 248 ~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 248 SEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 899999999999999999999999984
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=361.99 Aligned_cols=237 Identities=22% Similarity=0.428 Sum_probs=182.5
Q ss_pred eeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCCCceeEEEeccCC
Q 008171 298 SKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFMSGG 374 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~l~lV~E~~~gg 374 (575)
++||+|+||.||++.+. ++.||||++... ....+.+|+.+++.+. ||||+++++++.+....|+||||++|+
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 78999999999999985 678999998743 3466788999999997 999999999999999999999999999
Q ss_pred chhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC---cEEEeecccceecccCC-ccccCC
Q 008171 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE---VVKVADFGVARVKAQSG-VMTAET 450 (575)
Q Consensus 375 sL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~---~vkL~DFG~a~~~~~~~-~~~~~~ 450 (575)
+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...... ......
T Consensus 92 ~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 170 (325)
T 3kn6_A 92 ELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170 (325)
T ss_dssp BHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccC
Confidence 99999987 57799999999999999999999999999999999999998765 89999999998655432 345567
Q ss_pred CCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhcCCCCC--CCCCCcHHHHHH
Q 008171 451 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP-------LQAAVGVVQKGLRPT--IPKNSQPKLAEL 521 (575)
Q Consensus 451 Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~-------~~~~~~v~~~~~~~~--~p~~~~~~l~~L 521 (575)
||+.|+|||++.+..|+.++|||||||++|+|++|..||..... .+....+........ ....+++++.+|
T Consensus 171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 250 (325)
T 3kn6_A 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL 250 (325)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHH
T ss_pred CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHH
Confidence 89999999999999999999999999999999999999976443 233333222221111 113578999999
Q ss_pred HHHhhhcCCCCCCCHHHHH
Q 008171 522 LERCWQQDPALRPDFSEII 540 (575)
Q Consensus 522 i~~cL~~dP~~RPs~~ell 540 (575)
|.+||+.||.+|||+.|++
T Consensus 251 i~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 251 IQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp HHHHHCCCTTTCCCTTTST
T ss_pred HHHHCCCChhHCCCHHHHh
Confidence 9999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=367.51 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=196.5
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC-
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP- 361 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~- 361 (575)
..|++. ++|++.+.||+|+||.||+|.+ .++.||||++.....+......+.+|+.+|+.++||||+++++++...
T Consensus 23 ~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 101 (367)
T 2fst_X 23 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 101 (367)
T ss_dssp EEEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 456665 7899999999999999999986 467899999987655666678899999999999999999999998654
Q ss_pred -----CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccc
Q 008171 362 -----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436 (575)
Q Consensus 362 -----~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~ 436 (575)
..+|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 102 SLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp SGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred ccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999999 7899999865 6799999999999999999999999999999999999999999999999999
Q ss_pred ceecccCCccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--------
Q 008171 437 ARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-------- 507 (575)
Q Consensus 437 a~~~~~~~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~-------- 507 (575)
++.... ..+...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 179 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 179 ARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred cccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 976543 2455689999999999977 68999999999999999999999999988876655444321100
Q ss_pred -------------CC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 -------------PT--------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 -------------~~--------~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+. ....+++.+.+||.+||+.||.+|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00 12356889999999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=350.34 Aligned_cols=254 Identities=28% Similarity=0.491 Sum_probs=211.9
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCC
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 363 (575)
.+.+...++.....||+|+||.||+|.+ .++.||||++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 3455556666677999999999999997 45679999987543 3345778999999999999999999999999999
Q ss_pred ceeEEEeccCCchhhhhhhccC--cCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC-CCcEEEeecccceec
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKG--VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVK 440 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~--~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~-~~~vkL~DFG~a~~~ 440 (575)
+++||||+++++|.+++....+ .+++..++.++.||+.||.|||++||+|+||||+||+++. ++.+||+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 9999999999999999976543 4568889999999999999999999999999999999987 899999999999865
Q ss_pred ccCC-ccccCCCCCCccCcccccCCC--CCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhcCCCCCCCCCCcH
Q 008171 441 AQSG-VMTAETGTYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLTPLQ-AAVGVVQKGLRPTIPKNSQP 516 (575)
Q Consensus 441 ~~~~-~~~~~~Gt~~y~APE~i~~~~--~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~-~~~~v~~~~~~~~~p~~~~~ 516 (575)
.... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||....... ...........+.++..+++
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (295)
T 2clq_A 174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA 253 (295)
T ss_dssp CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCH
T ss_pred CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCH
Confidence 5432 234557999999999997643 8999999999999999999999997654333 22333344566778889999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 517 KLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
++.++|.+||+.||.+||++.++++
T Consensus 254 ~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 254 EAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHccCChhhCCCHHHHhc
Confidence 9999999999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=356.68 Aligned_cols=250 Identities=23% Similarity=0.397 Sum_probs=211.0
Q ss_pred CCceeeeeeeeecCceEEEEEEEC---CccEEEEEecCCCCChHHHHHHHHHHHHHHhc---CCCCceEEEeeec-----
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACT----- 359 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~---~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L---~HpnIv~l~~~~~----- 359 (575)
.++|++.+.||+|+||.||+|.+. ++.||||+++...........+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 368999999999999999999873 56799999875443332234566777777776 8999999999986
Q ss_pred CCCCceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccce
Q 008171 360 KPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 360 ~~~~l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
....+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 5667899999996 69999997643 459999999999999999999999999999999999999999999999999998
Q ss_pred ecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-----------
Q 008171 439 VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR----------- 507 (575)
Q Consensus 439 ~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~----------- 507 (575)
............||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......++.....
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (326)
T 1blx_A 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248 (326)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccc
Confidence 766555556678999999999999999999999999999999999999999988877666555431100
Q ss_pred --------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 --------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 --------------~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
..++..+++.+.+||.+||..||.+||++.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1234568899999999999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=360.53 Aligned_cols=256 Identities=30% Similarity=0.504 Sum_probs=190.7
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHH-HHHhcCCCCceEEEeeecC
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVF-IMRKVRHKNVVQFIGACTK 360 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~-iL~~L~HpnIv~l~~~~~~ 360 (575)
...|.+..++|++.+.||+|+||.||+|.+. ++.||||+++.... ......+..|+. +++.++||||+++++++..
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 4678899999999999999999999999985 78899999986533 333455566665 7788899999999999999
Q ss_pred CCCceeEEEeccCCchhhhhhh----ccCcCChHHHHHHHHHHHHHHHHHHHC-CceecccCCCCEEecCCCcEEEeecc
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHK----LKGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENEVVKVADFG 435 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~----~~~~l~~~~~~~i~~qI~~aL~yLH~~-gIiHrDLKp~NILl~~~~~vkL~DFG 435 (575)
.+..|+||||+.| +|.+++.. ....+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999999965 88887753 256789999999999999999999999 99999999999999999999999999
Q ss_pred cceecccCCccccCCCCCCccCcccc----cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC-
Q 008171 436 VARVKAQSGVMTAETGTYRWMAPEVI----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI- 510 (575)
Q Consensus 436 ~a~~~~~~~~~~~~~Gt~~y~APE~i----~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~- 510 (575)
+++............||+.|+|||++ .+..++.++||||||+++|+|++|..||...............+..+.+
T Consensus 172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T 3aln_A 172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS 251 (327)
T ss_dssp SSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCC
T ss_pred CceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence 99876655445555799999999999 5667999999999999999999999999875433222111122222222
Q ss_pred ---CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 511 ---PKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 511 ---p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+..+++.+.+||.+||+.||.+||++.++++
T Consensus 252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 2468999999999999999999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=384.34 Aligned_cols=246 Identities=25% Similarity=0.411 Sum_probs=212.5
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
+..++|.+.+.||+|+||.||+++. +++.||||++...... ......+.+|+.+|++++||||+++++++.....+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 4457899999999999999999998 4778999999754321 123467889999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhc---cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 366 IVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~---~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
+||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999998764 34699999999999999999999999999999999999999999999999999987655
Q ss_pred CCc-cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhcCCCCCCCCCCcHH
Q 008171 443 SGV-MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT----PLQAAVGVVQKGLRPTIPKNSQPK 517 (575)
Q Consensus 443 ~~~-~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~----~~~~~~~v~~~~~~~~~p~~~~~~ 517 (575)
... ....+||+.|+|||++.+..|+.++|||||||++|||++|..||.... ..+....+... ...+|..+++.
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~--~~~~p~~~s~~ 419 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--AVTYPDKFSPA 419 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC--CCCCCTTSCHH
T ss_pred CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc--ccCCCcccCHH
Confidence 433 334589999999999999999999999999999999999999998653 33444444433 34577889999
Q ss_pred HHHHHHHhhhcCCCCCCCH
Q 008171 518 LAELLERCWQQDPALRPDF 536 (575)
Q Consensus 518 l~~Li~~cL~~dP~~RPs~ 536 (575)
+.+||.+||+.||.+||++
T Consensus 420 ~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 420 SKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp HHHHHHHHSCSSGGGSCCC
T ss_pred HHHHHHHhccCCHhHCCCC
Confidence 9999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=351.74 Aligned_cols=254 Identities=21% Similarity=0.377 Sum_probs=215.1
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CCceEEEeeecCC
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKP 361 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~H--pnIv~l~~~~~~~ 361 (575)
....+..++|++.+.||+|+||.||++.+. ++.||||++............+.+|+.++++++| |||+++++++...
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 456788889999999999999999999874 5679999998776667777889999999999984 9999999999999
Q ss_pred CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
..+|+||| +.+++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred CEEEEEEe-cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence 99999999 558899999986 56789999999999999999999999999999999999996 4899999999997654
Q ss_pred cCC---ccccCCCCCCccCcccccC-----------CCCCchHHHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhcCC
Q 008171 442 QSG---VMTAETGTYRWMAPEVIEH-----------KPYDHKADVFSFGIVLWELLTGKLPYEYLT-PLQAAVGVVQKGL 506 (575)
Q Consensus 442 ~~~---~~~~~~Gt~~y~APE~i~~-----------~~~s~ksDVwSlGviL~eLltG~~Pf~~~~-~~~~~~~v~~~~~ 506 (575)
... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.... .............
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 257 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 257 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc
Confidence 432 2234578999999999875 478899999999999999999999998764 3344445555556
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 507 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 507 ~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
...++..+++++.++|.+||+.||.+||++.|+++
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 66778888999999999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=356.47 Aligned_cols=245 Identities=24% Similarity=0.407 Sum_probs=200.2
Q ss_pred Cceeee-eeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCceeE
Q 008171 292 KHLKFG-SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 292 ~~~~i~-~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l~lV 367 (575)
+.|++. +.||+|+||.||++.+ .++.||||++..... .....+.+|+.+++++ +||||+++++++...+.+|+|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 567774 7899999999999986 577899999976532 2356788999999985 799999999999999999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCc---EEEeecccceecccCC
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---VKVADFGVARVKAQSG 444 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~---vkL~DFG~a~~~~~~~ 444 (575)
|||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 90 FEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred EEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 999999999999977 467999999999999999999999999999999999999988765 9999999987543221
Q ss_pred --------ccccCCCCCCccCcccccC-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCCH---------------HH
Q 008171 445 --------VMTAETGTYRWMAPEVIEH-----KPYDHKADVFSFGIVLWELLTGKLPYEYLTP---------------LQ 496 (575)
Q Consensus 445 --------~~~~~~Gt~~y~APE~i~~-----~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~---------------~~ 496 (575)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ..
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 248 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence 1224469999999999975 5688999999999999999999999976542 11
Q ss_pred HHHHHHhcCCCCCCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 497 AAVGVVQKGLRPTIP----KNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 497 ~~~~v~~~~~~~~~p----~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
....+.... ..++ ..+++++.+||.+||+.||.+|||+.|+++
T Consensus 249 ~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 249 LFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 222222222 2233 468899999999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=362.22 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=211.4
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
...|++. ++|.+.++||+|+||.||+|.+. ++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 35 ~~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 113 (371)
T 4exu_A 35 KTAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 113 (371)
T ss_dssp TEEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence 4556665 78999999999999999999874 67899999987766666678899999999999999999999999877
Q ss_pred CCc------eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecc
Q 008171 362 PSL------CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435 (575)
Q Consensus 362 ~~l------~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG 435 (575)
... |+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 114 ~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp SSSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred CCcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecC
Confidence 655 99999995 68887773 459999999999999999999999999999999999999999999999999
Q ss_pred cceecccCCccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC------
Q 008171 436 VARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP------ 508 (575)
Q Consensus 436 ~a~~~~~~~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~------ 508 (575)
+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+......+
T Consensus 190 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 190 LARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp CC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 9975543 2445678999999999977 789999999999999999999999999888766655544311110
Q ss_pred -----------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 -----------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 -----------------------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
..+..+++.+.+||.+||+.||.+|||+.|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 123467899999999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=362.09 Aligned_cols=250 Identities=21% Similarity=0.381 Sum_probs=213.8
Q ss_pred eCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCCh---------------HHHHHHHHHHHHHHhcCCCCceE
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINS---------------DMQKEFAQEVFIMRKVRHKNVVQ 353 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~---------------~~~~~~~~Ev~iL~~L~HpnIv~ 353 (575)
+..++|++.+.||+|+||.||+|.+.++.||||++....... .....+.+|+.++++++||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 345789999999999999999999989999999987542211 11277899999999999999999
Q ss_pred EEeeecCCCCceeEEEeccCCchhhh------hhhc-cCcCChHHHHHHHHHHHHHHHHHHH-CCceecccCCCCEEecC
Q 008171 354 FIGACTKPPSLCIVTEFMSGGSVYDY------LHKL-KGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDE 425 (575)
Q Consensus 354 l~~~~~~~~~l~lV~E~~~ggsL~d~------l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~-~gIiHrDLKp~NILl~~ 425 (575)
+++++...+.+|+||||++|++|.++ +... ...+++..++.++.||+.||.|||+ +||+||||||+||+++.
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 99999999999999999999999998 5442 4679999999999999999999999 99999999999999999
Q ss_pred CCcEEEeecccceecccCCccccCCCCCCccCcccccCC-CCCc-hHHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHH
Q 008171 426 NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDH-KADVFSFGIVLWELLTGKLPYEYLTP-LQAAVGVV 502 (575)
Q Consensus 426 ~~~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~~-~~s~-ksDVwSlGviL~eLltG~~Pf~~~~~-~~~~~~v~ 502 (575)
++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|+|++|..||..... .+....+.
T Consensus 188 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~ 266 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266 (348)
T ss_dssp TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHT
T ss_pred CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Confidence 999999999999865443 44566799999999999887 6776 99999999999999999999988776 44433333
Q ss_pred hcCCCCCCC-------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 503 QKGLRPTIP-------------------KNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 503 ~~~~~~~~p-------------------~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
. . ...++ ..+++++.+||.+||+.||.+||++.|+++
T Consensus 267 ~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 267 T-K-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp S-C-CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred c-c-CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2 2 22333 678999999999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=369.92 Aligned_cols=243 Identities=25% Similarity=0.334 Sum_probs=201.8
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC------CCC
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK------PPS 363 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~------~~~ 363 (575)
.+|++.++||+|+||.||+|++ .++.||||++.... ..+.+|+.+|++++||||+++++++.. ...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 4799999999999999999998 46789999987542 123469999999999999999998732 223
Q ss_pred ceeEEEeccCCchhhhhhh---ccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC-CcEEEeeccccee
Q 008171 364 LCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARV 439 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~---~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~-~~vkL~DFG~a~~ 439 (575)
+++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 6799999965 67666643 35679999999999999999999999999999999999999965 6789999999987
Q ss_pred cccCCccccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC------------
Q 008171 440 KAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL------------ 506 (575)
Q Consensus 440 ~~~~~~~~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~------------ 506 (575)
...........||+.|+|||++.+. .|+.++|||||||+||||++|+.||.+.+..+....++....
T Consensus 207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~ 286 (420)
T 1j1b_A 207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286 (420)
T ss_dssp CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS
T ss_pred cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 6655555667899999999999764 799999999999999999999999998887666555443100
Q ss_pred ------CCC---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 507 ------RPT---------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 507 ------~~~---------~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+. ++..+++++.+||.+||+.||.+||++.|+++
T Consensus 287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 010 23467899999999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=375.55 Aligned_cols=256 Identities=23% Similarity=0.361 Sum_probs=215.5
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC-CCceEEEeeecCCCCceeE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~H-pnIv~l~~~~~~~~~l~lV 367 (575)
.++|+++++||+|+||.||+|.+. ++.||||++...... ..+.+|+.+++.++| ++|+.+..++......|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 468999999999999999999974 788999998765433 247789999999987 5566666667777788999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEe---cCCCcEEEeecccceecccCC
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM---DENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl---~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|||+ |++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++......
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 9999 999999998777889999999999999999999999999999999999999 588999999999998765433
Q ss_pred c--------cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCC---CCCC
Q 008171 445 V--------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQKGL---RPTI 510 (575)
Q Consensus 445 ~--------~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~---~~~~~~v~~~~~---~~~~ 510 (575)
. .....||+.|+|||++.+..++.++|||||||+||||++|+.||..... .+....+..... ...+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence 2 1255799999999999999999999999999999999999999987543 232322222211 1223
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 511 PKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 511 p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
+..+++++.+||.+||+.||.+||++.+|++.|++++...+
T Consensus 241 ~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 46788999999999999999999999999999999987654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=362.67 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=202.1
Q ss_pred CCCceeeeeeeeecCceEEEEEEE-CCccEEEEEecCCCC---------ChHHHHHHHHHHHHHHhcCCCCceEEEeee-
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERI---------NSDMQKEFAQEVFIMRKVRHKNVVQFIGAC- 358 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~-~~~~VAvKvl~~~~~---------~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~- 358 (575)
-.++|++.++||+|+||.||+|.. .++.||||++..... +....+.+.+|+.++++++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 346899999999999999999976 467799999865322 223357899999999999999999999988
Q ss_pred ----cCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeec
Q 008171 359 ----TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434 (575)
Q Consensus 359 ----~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DF 434 (575)
.....+|+||||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 33446799999996 6898888876778999999999999999999999999999999999999999999999999
Q ss_pred ccceecccCCccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-----
Q 008171 435 GVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP----- 508 (575)
Q Consensus 435 G~a~~~~~~~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~----- 508 (575)
|+++............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+......+
T Consensus 179 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 258 (362)
T 3pg1_A 179 NLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV 258 (362)
T ss_dssp TC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHh
Confidence 99986666555666789999999999977 779999999999999999999999999887766655543311111
Q ss_pred -------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 -------------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 -------------------------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
..+..+++.+.+||.+||+.||.+|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 123456889999999999999999999999875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=348.63 Aligned_cols=247 Identities=24% Similarity=0.425 Sum_probs=208.4
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCceEEEeee--cCCCCce
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERIN--SDMQKEFAQEVFIMRKVRHKNVVQFIGAC--TKPPSLC 365 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~--~~~~~l~ 365 (575)
++|++++.||+|+||.||++.+ .++.||+|+++..... ......+.+|+.++++++||||+++++++ .....+|
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 5799999999999999999987 4567999999754221 23457799999999999999999999998 4556789
Q ss_pred eEEEeccCCchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-
Q 008171 366 IVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS- 443 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~- 443 (575)
+||||+.++ |.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 999999766 77776543 456999999999999999999999999999999999999999999999999999865432
Q ss_pred --CccccCCCCCCccCcccccCCC--CCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 008171 444 --GVMTAETGTYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 519 (575)
Q Consensus 444 --~~~~~~~Gt~~y~APE~i~~~~--~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~ 519 (575)
.......||+.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+... ...++..+++.+.
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~~~~~~~~l~ 241 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGDCGPPLS 241 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--CCCCCSSSCHHHH
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC--CCCCCCccCHHHH
Confidence 2334557999999999997654 378999999999999999999999988877665554443 3457788999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 008171 520 ELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 520 ~Li~~cL~~dP~~RPs~~ell~ 541 (575)
++|.+||+.||.+|||+.|+++
T Consensus 242 ~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHccCChhhCCCHHHHhc
Confidence 9999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=369.49 Aligned_cols=255 Identities=13% Similarity=0.133 Sum_probs=192.6
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhc--CCCCceEEEe-------ee
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKV--RHKNVVQFIG-------AC 358 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L--~HpnIv~l~~-------~~ 358 (575)
..+|++.++||+|+||.||+|++. ++.||||+++..... ......+.+|+.+++.+ +||||++++. ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 346999999999999999999974 677999999876553 34456677886555555 5999888653 33
Q ss_pred cCC-----------------CCceeEEEeccCCchhhhhhhccCcCChHHH------HHHHHHHHHHHHHHHHCCceecc
Q 008171 359 TKP-----------------PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSL------LKVAIDVSKGMNYLHQNNIIHRD 415 (575)
Q Consensus 359 ~~~-----------------~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~------~~i~~qI~~aL~yLH~~gIiHrD 415 (575)
... ..+||||||++ ++|.+++......++.... +.++.||+.||.|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 221 23799999997 8999999876566666666 78889999999999999999999
Q ss_pred cCCCCEEecCCCcEEEeecccceecccCCccccCCCCCCccCcccccC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 008171 416 LKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYEYLT 493 (575)
Q Consensus 416 LKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~--~~~s~ksDVwSlGviL~eLltG~~Pf~~~~ 493 (575)
|||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..|+.++|||||||+||+|++|+.||....
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 297 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence 9999999999999999999999866432 224567799999999987 789999999999999999999999998764
Q ss_pred HHHHHH-------HHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHH
Q 008171 494 PLQAAV-------GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQIAK 548 (575)
Q Consensus 494 ~~~~~~-------~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~--~L~~l~~ 548 (575)
+..... ...........+..+++.+.+||.+||+.||.+|||+.++++ .++++..
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp TTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred cccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence 321100 000111222233578999999999999999999999999975 4444433
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=353.94 Aligned_cols=250 Identities=27% Similarity=0.423 Sum_probs=209.2
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
..|++. ++|.+.+.||+|+||.||+|.+. ++.||||++............+.+|+.++++++||||+++++++....
T Consensus 18 ~~~~l~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 96 (353)
T 3coi_A 18 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 96 (353)
T ss_dssp EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cccccC-ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence 345554 68999999999999999999874 678999999876666666788999999999999999999999998765
Q ss_pred C------ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccc
Q 008171 363 S------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436 (575)
Q Consensus 363 ~------l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~ 436 (575)
. +|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 97 SLRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp SGGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred ccccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeeccc
Confidence 4 499999996 68888874 3589999999999999999999999999999999999999999999999999
Q ss_pred ceecccCCccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC----------
Q 008171 437 ARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG---------- 505 (575)
Q Consensus 437 a~~~~~~~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~---------- 505 (575)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 173 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 173 ARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred ccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 9765432 345678999999999977 679999999999999999999999999887665544433210
Q ss_pred -------------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 506 -------------------LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 506 -------------------~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.....+..+++++.+||.+||+.||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 011234577899999999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=358.20 Aligned_cols=246 Identities=24% Similarity=0.391 Sum_probs=207.2
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC-----CCc
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PSL 364 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~-----~~l 364 (575)
.+|++.++||+|+||.||++.+. ++.||||++.... .......+.+|+.++++++||||+++++++... ...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 68999999999999999999874 6679999998532 444567899999999999999999999998654 368
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 106 ~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 99999995 599998865 569999999999999999999999999999999999999999999999999998665432
Q ss_pred c----cccCCCCCCccCccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-----------
Q 008171 445 V----MTAETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP----------- 508 (575)
Q Consensus 445 ~----~~~~~Gt~~y~APE~i~-~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~----------- 508 (575)
. .....||+.|+|||++. ...++.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 2 34457999999999875 4568999999999999999999999998877665554433211000
Q ss_pred ------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 ------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 ------------------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+...+++++.+||.+||+.||.+|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 122467899999999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=365.88 Aligned_cols=246 Identities=26% Similarity=0.405 Sum_probs=208.4
Q ss_pred CCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhc------CCCCceEEEeeecCC
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV------RHKNVVQFIGACTKP 361 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L------~HpnIv~l~~~~~~~ 361 (575)
...+|++.++||+|+||.||+|.+. ++.||||+++.. ......+.+|+.+++.+ +|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 3467999999999999999999874 577999999853 34456788899999888 467999999999999
Q ss_pred CCceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCc--EEEeecccce
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV--VKVADFGVAR 438 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~--vkL~DFG~a~ 438 (575)
..+|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999999995 69999987644 45999999999999999999999999999999999999999887 9999999997
Q ss_pred ecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC----------
Q 008171 439 VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP---------- 508 (575)
Q Consensus 439 ~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~---------- 508 (575)
..... .....||+.|+|||++.+..|+.++|||||||+||||++|..||.+.+..+....++.....+
T Consensus 251 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~ 328 (429)
T 3kvw_A 251 YEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKR 328 (429)
T ss_dssp ETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTT
T ss_pred ecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhh
Confidence 65432 345689999999999999999999999999999999999999999887766554433210000
Q ss_pred -----------------------------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 -----------------------------------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 -----------------------------------------------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.++...++.+.+||.+||+.||.+|||+.|+++
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 329 AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR 408 (429)
T ss_dssp HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence 012344788999999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=364.79 Aligned_cols=244 Identities=25% Similarity=0.365 Sum_probs=201.7
Q ss_pred CCceeeeeeeeecCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC------C
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP------S 363 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~------~ 363 (575)
..+|++.++||+|+||.||+|++. +..||+|.+...... ..+|+.+|+.++||||+++++++.... .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 357999999999999999999984 455888887643211 236999999999999999999984433 3
Q ss_pred ceeEEEeccCCchhhhhh---hccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEec-CCCcEEEeeccccee
Q 008171 364 LCIVTEFMSGGSVYDYLH---KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARV 439 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~---~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~-~~~~vkL~DFG~a~~ 439 (575)
+|+||||++++ +.+.+. .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 113 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 113 LNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 78999999764 444332 2356799999999999999999999999999999999999999 799999999999988
Q ss_pred cccCCccccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-----------
Q 008171 440 KAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR----------- 507 (575)
Q Consensus 440 ~~~~~~~~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~----------- 507 (575)
...........||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+....++.....
T Consensus 192 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 192 LIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271 (394)
T ss_dssp CCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred ccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 7666666677899999999999765 5999999999999999999999999998877665554431100
Q ss_pred -------C---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 -------P---------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 -------~---------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+ .++..+++++.+||.+||+.||.+|||+.|+++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0 133458899999999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=351.85 Aligned_cols=247 Identities=26% Similarity=0.350 Sum_probs=205.8
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC-----CC
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP-----PS 363 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~-----~~ 363 (575)
.++|++.+.||+|+||.||+|.+. ++.||||+++.. ........+.+|+.++++++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 378999999999999999999985 778999999753 2344567788999999999999999999987654 67
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
.|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 899999995 699998865 57999999999999999999999999999999999999999999999999999865432
Q ss_pred C-----------ccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---
Q 008171 444 G-----------VMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--- 508 (575)
Q Consensus 444 ~-----------~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~--- 508 (575)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 1 1223478999999998754 779999999999999999999999999887655443332210000
Q ss_pred ---------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 ---------------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 ---------------------------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
..+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 012467899999999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=348.37 Aligned_cols=247 Identities=24% Similarity=0.370 Sum_probs=207.1
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE---CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC------ceEEEeeec
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY---CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN------VVQFIGACT 359 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~---~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~Hpn------Iv~l~~~~~ 359 (575)
+-.++|++.++||+|+||.||++.+ .++.||||+++.. ......+.+|+.+++.++|++ |+++++++.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 3457899999999999999999987 4677999999743 344577889999999998765 999999999
Q ss_pred CCCCceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC-------------
Q 008171 360 KPPSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE------------- 425 (575)
Q Consensus 360 ~~~~l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~------------- 425 (575)
..+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999999 889999997643 36899999999999999999999999999999999999987
Q ss_pred ------CCcEEEeecccceecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 008171 426 ------NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV 499 (575)
Q Consensus 426 ------~~~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~ 499 (575)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+...
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred ccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 668999999999865432 345679999999999999999999999999999999999999999877655433
Q ss_pred HHHhcCC------------------------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 008171 500 GVVQKGL------------------------------------------RPTIPKNSQPKLAELLERCWQQDPALRPDFS 537 (575)
Q Consensus 500 ~v~~~~~------------------------------------------~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ 537 (575)
.+..... ....+..+++++.+||.+||+.||.+|||+.
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 324 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR 324 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence 3211000 0011223467899999999999999999999
Q ss_pred HHHH
Q 008171 538 EIIE 541 (575)
Q Consensus 538 ell~ 541 (575)
|+++
T Consensus 325 ell~ 328 (339)
T 1z57_A 325 EALK 328 (339)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=359.22 Aligned_cols=245 Identities=24% Similarity=0.374 Sum_probs=200.8
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC--------CCCceEEEeeec-
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR--------HKNVVQFIGACT- 359 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~--------HpnIv~l~~~~~- 359 (575)
.++|++.++||+|+||.||+|.+. ++.||||+++.. ......+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 578999999999999999999874 677999999743 445677899999999996 788999999987
Q ss_pred ---CCCCceeEEEeccCCchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHC-CceecccCCCCEEecCCC-------
Q 008171 360 ---KPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMDENE------- 427 (575)
Q Consensus 360 ---~~~~l~lV~E~~~ggsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~-gIiHrDLKp~NILl~~~~------- 427 (575)
....+|+||||+ +++|.+++... .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 566799999999 56666666543 36799999999999999999999998 999999999999999775
Q ss_pred ------------------------------------------cEEEeecccceecccCCccccCCCCCCccCcccccCCC
Q 008171 428 ------------------------------------------VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 465 (575)
Q Consensus 428 ------------------------------------------~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~~~ 465 (575)
.+||+|||+++..... .....||+.|+|||++.+..
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC
Confidence 7999999999876543 44567999999999999999
Q ss_pred CCchHHHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhc-CC--------------------------------
Q 008171 466 YDHKADVFSFGIVLWELLTGKLPYEYLTP------LQAAVGVVQK-GL-------------------------------- 506 (575)
Q Consensus 466 ~s~ksDVwSlGviL~eLltG~~Pf~~~~~------~~~~~~v~~~-~~-------------------------------- 506 (575)
++.++|||||||+||+|++|..||...+. ......+... +.
T Consensus 270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (397)
T 1wak_A 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG 349 (397)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence 99999999999999999999999976442 1111111110 00
Q ss_pred -------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 507 -------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 507 -------~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
....+...++.+.+||.+||+.||.+|||+.|+++
T Consensus 350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00123344678999999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=342.98 Aligned_cols=244 Identities=24% Similarity=0.446 Sum_probs=198.1
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC---------
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--------- 360 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--------- 360 (575)
++|++.+.||+|+||.||+|+. .++.||||++... ......+.+|+.++++++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 4789999999999999999987 4678999998642 3455778999999999999999999998744
Q ss_pred ----CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccc
Q 008171 361 ----PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436 (575)
Q Consensus 361 ----~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~ 436 (575)
...+|+||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 3467999999999999999987666788999999999999999999999999999999999999999999999999
Q ss_pred ceecccC---------------CccccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCH-HHHHH
Q 008171 437 ARVKAQS---------------GVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTP-LQAAV 499 (575)
Q Consensus 437 a~~~~~~---------------~~~~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~-~~~~~ 499 (575)
+...... .......||+.|+|||++.+. .++.++|||||||++|+|++ ||..... .+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~ 239 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence 9765421 123345689999999999765 78999999999999999998 5543222 22222
Q ss_pred HHHh--cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 500 GVVQ--KGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 500 ~v~~--~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+.. ..+.+.++..+++.+.++|.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 2221 12334556677889999999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=345.69 Aligned_cols=246 Identities=24% Similarity=0.370 Sum_probs=201.0
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeec---------
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT--------- 359 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~--------- 359 (575)
.++|++.++||+|+||.||+|.+. ++.||||++... +....+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 378999999999999999999985 678999998754 3455678999999999999999999998873
Q ss_pred -----CCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEec-CCCcEEEee
Q 008171 360 -----KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVAD 433 (575)
Q Consensus 360 -----~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~-~~~~vkL~D 433 (575)
....+|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 3456799999996 699999864 6789999999999999999999999999999999999997 567999999
Q ss_pred cccceecccC----CccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-
Q 008171 434 FGVARVKAQS----GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR- 507 (575)
Q Consensus 434 FG~a~~~~~~----~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~- 507 (575)
||+++..... .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+......
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999865432 22334567999999998865 77999999999999999999999999988876665544432110
Q ss_pred ----------------------C-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 ----------------------P-----TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 ----------------------~-----~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+ ..+..+++++.++|.+||+.||.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0 122468899999999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=355.05 Aligned_cols=250 Identities=20% Similarity=0.224 Sum_probs=196.4
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCC--
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-- 363 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~-- 363 (575)
....++|++.++||+|+||.||+|++. ++.||||++...... ...+.+++..++.++||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 344578999999999999999999985 678999988654322 2356778888999999999999999854332
Q ss_pred -----ceeEEEeccCCchhhhhhh---ccCcCChHHHHHHHHHHHHHHHHHH--HCCceecccCCCCEEecC-CCcEEEe
Q 008171 364 -----LCIVTEFMSGGSVYDYLHK---LKGVFKLPSLLKVAIDVSKGMNYLH--QNNIIHRDLKAANLLMDE-NEVVKVA 432 (575)
Q Consensus 364 -----l~lV~E~~~ggsL~d~l~~---~~~~l~~~~~~~i~~qI~~aL~yLH--~~gIiHrDLKp~NILl~~-~~~vkL~ 432 (575)
+|+||||+.+ +|.+.+.. ....+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 7899999976 55544432 3567899999999999999999999 999999999999999996 8999999
Q ss_pred ecccceecccCCccccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC------
Q 008171 433 DFGVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG------ 505 (575)
Q Consensus 433 DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~------ 505 (575)
|||+++............||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+....
T Consensus 175 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3e3p_A 175 DFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254 (360)
T ss_dssp CCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred eCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence 99999877766666677899999999998665 48999999999999999999999999988776665554311
Q ss_pred ------------------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 506 ------------------------LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 506 ------------------------~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
..+..+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 012233446889999999999999999999999885
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=344.74 Aligned_cols=244 Identities=25% Similarity=0.462 Sum_probs=200.1
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCCh----HHHHHHHHHHHHHHhc----CCCCceEEEee
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS----DMQKEFAQEVFIMRKV----RHKNVVQFIGA 357 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~----~~~~~~~~Ev~iL~~L----~HpnIv~l~~~ 357 (575)
+.-.++|++.++||+|+||.||+|.+ .++.||||++....... .....+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 44567899999999999999999987 46779999997654322 1234466799999999 89999999999
Q ss_pred ecCCCCceeEEEe-ccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEec-CCCcEEEeecc
Q 008171 358 CTKPPSLCIVTEF-MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFG 435 (575)
Q Consensus 358 ~~~~~~l~lV~E~-~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~-~~~~vkL~DFG 435 (575)
+...+..++|||| +.+++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 9999999999999 789999999977 56799999999999999999999999999999999999999 88999999999
Q ss_pred cceecccCCccccCCCCCCccCcccccCCCCC-chHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 008171 436 VARVKAQSGVMTAETGTYRWMAPEVIEHKPYD-HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNS 514 (575)
Q Consensus 436 ~a~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s-~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~ 514 (575)
+++..... ......||..|+|||++.+..+. .++||||||+++|+|++|+.||..... +... ...++..+
T Consensus 186 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~--~~~~~~~~ 256 (312)
T 2iwi_A 186 SGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEA--ELHFPAHV 256 (312)
T ss_dssp SCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHT--CCCCCTTS
T ss_pred hhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhh--ccCCcccC
Confidence 99876543 34456799999999999777664 589999999999999999999975321 1222 34567889
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 515 QPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 515 ~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
++.+.++|.+||+.||.+|||+.|+++
T Consensus 257 ~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 257 SPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999999999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=358.24 Aligned_cols=244 Identities=23% Similarity=0.392 Sum_probs=183.4
Q ss_pred ceee-eeeeeecCceEEEEEEEC----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeee--cCCCCce
Q 008171 293 HLKF-GSKVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC--TKPPSLC 365 (575)
Q Consensus 293 ~~~i-~~~LG~G~fG~Vy~~~~~----~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~--~~~~~l~ 365 (575)
.|.+ +++||+|+||.||+|.+. ++.||||++...... ..+.+|+.+|++++||||+++++++ .....+|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 4555 568999999999999964 567999999865433 4578899999999999999999998 4567899
Q ss_pred eEEEeccCCchhhhhhhcc--------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEe----cCCCcEEEee
Q 008171 366 IVTEFMSGGSVYDYLHKLK--------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----DENEVVKVAD 433 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~--------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl----~~~~~vkL~D 433 (575)
+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9999995 58888875322 248999999999999999999999999999999999999 6778999999
Q ss_pred cccceecccC----CccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---------HHHH
Q 008171 434 FGVARVKAQS----GVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPL---------QAAV 499 (575)
Q Consensus 434 FG~a~~~~~~----~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~---------~~~~ 499 (575)
||+++..... .......||+.|+|||++.+ ..++.++|||||||+||+|++|..||...... +...
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 9999865543 23345679999999999987 45999999999999999999999999754431 2222
Q ss_pred HHHhcCCCCC------------------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 500 GVVQKGLRPT------------------------------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 500 ~v~~~~~~~~------------------------------------~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.++.....+. .....++.+.+||.+||+.||.+|||+.|+++
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 2111100000 01122678999999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=348.32 Aligned_cols=243 Identities=23% Similarity=0.377 Sum_probs=175.2
Q ss_pred Cceeeee-eeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC----CCCc
Q 008171 292 KHLKFGS-KVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----PPSL 364 (575)
Q Consensus 292 ~~~~i~~-~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~----~~~l 364 (575)
++|.+.+ .||+|+||.||+|.+. ++.||||++... .. ...+....++.++||||+++++++.. ...+
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 5788855 6999999999999985 788999998743 21 12223344667789999999999865 4458
Q ss_pred eeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC---CCcEEEeecccceec
Q 008171 365 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVK 440 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~---~~~vkL~DFG~a~~~ 440 (575)
|+||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 99999999999999998754 46999999999999999999999999999999999999976 455999999999765
Q ss_pred ccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH------hcCCCCCCCCCC
Q 008171 441 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV------QKGLRPTIPKNS 514 (575)
Q Consensus 441 ~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~------~~~~~~~~p~~~ 514 (575)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||............. ...........+
T Consensus 182 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (336)
T 3fhr_A 182 TQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 260 (336)
T ss_dssp -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTC
T ss_pred ccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccC
Confidence 533 3345678999999999999999999999999999999999999997665443321111 111222233578
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 515 QPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 515 ~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
++++.+||.+||+.||.+|||+.|+++
T Consensus 261 ~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 261 SEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 999999999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=343.02 Aligned_cols=245 Identities=23% Similarity=0.401 Sum_probs=203.7
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--C-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC------ceEEEeeecCC
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--S-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN------VVQFIGACTKP 361 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~-~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~Hpn------Iv~l~~~~~~~ 361 (575)
.++|++.++||+|+||.||++.+. + +.||||+++.. ......+.+|+.++++++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 579999999999999999999874 3 57999999743 344577889999999998766 89999999999
Q ss_pred CCceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEe-----------------
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLM----------------- 423 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl----------------- 423 (575)
+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999999 667777775543 579999999999999999999999999999999999999
Q ss_pred --cCCCcEEEeecccceecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 008171 424 --DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGV 501 (575)
Q Consensus 424 --~~~~~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v 501 (575)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM 251 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 56789999999999865432 34567999999999999999999999999999999999999999987765544332
Q ss_pred HhcCCC-C-----------------------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHH
Q 008171 502 VQKGLR-P-----------------------------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEI 539 (575)
Q Consensus 502 ~~~~~~-~-----------------------------------------~~p~~~~~~l~~Li~~cL~~dP~~RPs~~el 539 (575)
...... | ......++++.+||.+||+.||.+|||+.|+
T Consensus 252 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~ 331 (355)
T 2eu9_A 252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA 331 (355)
T ss_dssp HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence 211000 0 0112235689999999999999999999998
Q ss_pred HH
Q 008171 540 IE 541 (575)
Q Consensus 540 l~ 541 (575)
++
T Consensus 332 l~ 333 (355)
T 2eu9_A 332 LL 333 (355)
T ss_dssp TT
T ss_pred hc
Confidence 74
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=348.31 Aligned_cols=244 Identities=25% Similarity=0.465 Sum_probs=208.1
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCCh----HHHHHHHHHHHHHHhcC--CCCceEEEeeec
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVR--HKNVVQFIGACT 359 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~----~~~~~~~~Ev~iL~~L~--HpnIv~l~~~~~ 359 (575)
+.-.++|++.+.||+|+||.||+|.+ .++.||||+++...... .....+.+|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 45568899999999999999999987 46789999997654322 12245678999999996 599999999999
Q ss_pred CCCCceeEEEeccC-CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEec-CCCcEEEeecccc
Q 008171 360 KPPSLCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVA 437 (575)
Q Consensus 360 ~~~~l~lV~E~~~g-gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~-~~~~vkL~DFG~a 437 (575)
..+..++|||++.+ ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 99999999999976 899999976 57799999999999999999999999999999999999999 7889999999999
Q ss_pred eecccCCccccCCCCCCccCcccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 008171 438 RVKAQSGVMTAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 516 (575)
Q Consensus 438 ~~~~~~~~~~~~~Gt~~y~APE~i~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~ 516 (575)
+..... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||..... +... ...++..+++
T Consensus 198 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~--~~~~~~~~~~ 268 (320)
T 3a99_A 198 ALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG--QVFFRQRVSS 268 (320)
T ss_dssp EECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC--CCCCSSCCCH
T ss_pred cccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc--cccccccCCH
Confidence 876543 3445679999999999977766 6889999999999999999999975321 1222 2346678899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 517 KLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
++.++|.+||+.||.+|||+.++++
T Consensus 269 ~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 269 ECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=349.87 Aligned_cols=245 Identities=24% Similarity=0.354 Sum_probs=204.2
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CC-----CceEEEeeecCCC
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HK-----NVVQFIGACTKPP 362 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-Hp-----nIv~l~~~~~~~~ 362 (575)
.++|++.++||+|+||.||+|.+. ++.||||+++.. ......+..|+.+++.++ |+ +|+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 478999999999999999999874 677999999843 344567788999999886 44 4999999999989
Q ss_pred CceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHH--HCCceecccCCCCEEec--CCCcEEEeecccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLH--QNNIIHRDLKAANLLMD--ENEVVKVADFGVA 437 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH--~~gIiHrDLKp~NILl~--~~~~vkL~DFG~a 437 (575)
.+|+||||+. ++|.+++.... +.+++..+..++.||+.||.||| +.||+||||||+|||++ .++.+||+|||++
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 9999999995 59999997654 56999999999999999999999 57999999999999995 4778999999999
Q ss_pred eecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--------
Q 008171 438 RVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT-------- 509 (575)
Q Consensus 438 ~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~-------- 509 (575)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......+.
T Consensus 209 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (382)
T 2vx3_A 209 CQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAP 286 (382)
T ss_dssp EETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCT
T ss_pred eecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhH
Confidence 876432 4456899999999999999999999999999999999999999998887766555443210000
Q ss_pred --------CCC----------------------------------------------CCcHHHHHHHHHhhhcCCCCCCC
Q 008171 510 --------IPK----------------------------------------------NSQPKLAELLERCWQQDPALRPD 535 (575)
Q Consensus 510 --------~p~----------------------------------------------~~~~~l~~Li~~cL~~dP~~RPs 535 (575)
++. ...+++.+||.+||+.||.+|||
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt 366 (382)
T 2vx3_A 287 KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ 366 (382)
T ss_dssp THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC
T ss_pred HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCC
Confidence 000 01147899999999999999999
Q ss_pred HHHHHH
Q 008171 536 FSEIIE 541 (575)
Q Consensus 536 ~~ell~ 541 (575)
+.|+++
T Consensus 367 a~e~L~ 372 (382)
T 2vx3_A 367 PYYALQ 372 (382)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=349.75 Aligned_cols=248 Identities=20% Similarity=0.376 Sum_probs=202.4
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-----------CCCceEE
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-----------HKNVVQF 354 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-----------HpnIv~l 354 (575)
.+...+|++.++||+|+||.||+|++ .++.||||++... ......+.+|+.++++++ ||||+++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 56678999999999999999999987 5678999999743 334567889999999887 8899999
Q ss_pred EeeecCCC----CceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHC-CceecccCCCCEEec----
Q 008171 355 IGACTKPP----SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQN-NIIHRDLKAANLLMD---- 424 (575)
Q Consensus 355 ~~~~~~~~----~l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~-gIiHrDLKp~NILl~---- 424 (575)
++++...+ .+++||||+ |++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99987543 689999999 999999997643 5599999999999999999999998 999999999999994
Q ss_pred --CCCcEEEeecccceecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH------HH
Q 008171 425 --ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP------LQ 496 (575)
Q Consensus 425 --~~~~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~------~~ 496 (575)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+. ..
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 3448999999999866543 3455799999999999999999999999999999999999999986542 11
Q ss_pred HHHHHHhc-C---------------------------------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 008171 497 AAVGVVQK-G---------------------------------------LRPTIPKNSQPKLAELLERCWQQDPALRPDF 536 (575)
Q Consensus 497 ~~~~v~~~-~---------------------------------------~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~ 536 (575)
....+... + ....++..+++++.+||.+||+.||.+|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 11111110 0 0112344567889999999999999999999
Q ss_pred HHHHH
Q 008171 537 SEIIE 541 (575)
Q Consensus 537 ~ell~ 541 (575)
.|+++
T Consensus 329 ~ell~ 333 (373)
T 1q8y_A 329 GGLVN 333 (373)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=358.61 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=199.3
Q ss_pred CCceeeCCCceeeeeeeeecCceE-EEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCC
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGD-LYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKP 361 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~-Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~ 361 (575)
.+.+.+...+|.+.+.||+|+||+ ||++.+.++.||||++..... ..+.+|+.+|+++ +|||||++++++.+.
T Consensus 16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 16 TSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp --CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred CCcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 345678888999999999999998 567777899999999975432 2356799999999 799999999999999
Q ss_pred CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC-----CCcEEEeeccc
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-----NEVVKVADFGV 436 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~-----~~~vkL~DFG~ 436 (575)
..+||||||+. |+|.+++......+....++.++.||+.||.|||++||+||||||+|||++. ...+||+|||+
T Consensus 91 ~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 91 QFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp TEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred CEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 99999999995 6999999876666777778899999999999999999999999999999953 23588999999
Q ss_pred ceecccCC----ccccCCCCCCccCccccc---CCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCC
Q 008171 437 ARVKAQSG----VMTAETGTYRWMAPEVIE---HKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRP 508 (575)
Q Consensus 437 a~~~~~~~----~~~~~~Gt~~y~APE~i~---~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~ 508 (575)
++...... ......||+.|+|||++. ...++.++|||||||++|||++ |..||......+............
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 249 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTT
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccc
Confidence 98655432 334567999999999997 4667889999999999999999 999997665544332221111111
Q ss_pred -CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 008171 509 -TIPKNSQPKLAELLERCWQQDPALRPDFSEII 540 (575)
Q Consensus 509 -~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell 540 (575)
..+...++.+.+||.+||+.||.+|||+.+++
T Consensus 250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cCccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 11233466789999999999999999999998
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=349.04 Aligned_cols=242 Identities=22% Similarity=0.378 Sum_probs=188.6
Q ss_pred CceeeeeeeeecCceEEE-EEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLY-RGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy-~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
+.|.+.+.||+|+||+|| .+...++.||||++... ....+.+|+.+|+++ +||||+++++++.....+|||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 456667899999999996 44567899999998753 235678899999987 89999999999999999999999
Q ss_pred eccCCchhhhhhhccCc------CChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC-------------CcEE
Q 008171 370 FMSGGSVYDYLHKLKGV------FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN-------------EVVK 430 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~------l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~-------------~~vk 430 (575)
|+. |+|.+++...... .++..++.++.||+.||.|||++||+||||||+|||++.+ +.+|
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 995 6999999764221 1334567899999999999999999999999999999754 4899
Q ss_pred EeecccceecccCC-----ccccCCCCCCccCcccccC-------CCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 008171 431 VADFGVARVKAQSG-----VMTAETGTYRWMAPEVIEH-------KPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQA 497 (575)
Q Consensus 431 L~DFG~a~~~~~~~-----~~~~~~Gt~~y~APE~i~~-------~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~ 497 (575)
|+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||......+.
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~ 248 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence 99999998765432 1234579999999999965 678999999999999999999 9999976654432
Q ss_pred HHHHHhcCCCCC-C----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 498 AVGVVQKGLRPT-I----PKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 498 ~~~v~~~~~~~~-~----p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.++....... . +..+++++.++|.+||+.||.+|||+.++++
T Consensus 249 --~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 --NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 2233222211 1 1234688999999999999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=329.36 Aligned_cols=231 Identities=13% Similarity=0.166 Sum_probs=193.3
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
+-.++|++.++||+|+||.||+|.+. ++.||||++...... ......+.+|+.++++++||||+++++++...+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 44578999999999999999999985 688999999876543 455678999999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV 445 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 445 (575)
+||||++|++|.+++.. + .....+.+++.||+.||.|||++||+||||||+|||++.++.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 99999999999999954 3 3556788999999999999999999999999999999999999998543
Q ss_pred cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHhcCCCC--CCCCCCcHHHHH
Q 008171 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV---GVVQKGLRP--TIPKNSQPKLAE 520 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~---~v~~~~~~~--~~p~~~~~~l~~ 520 (575)
|++ +++.++|||||||++|+|++|+.||...+..+... ........+ ..+..+++++.+
T Consensus 175 ---------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (286)
T 3uqc_A 175 ---------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238 (286)
T ss_dssp ---------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHH
T ss_pred ---------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHH
Confidence 333 37899999999999999999999998765432110 001111110 234678999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 521 LLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 521 Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
+|.+||+.||.+| |+.|+++.|+++...
T Consensus 239 li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 239 VAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp HHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred HHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 9999999999999 999999999998653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=347.36 Aligned_cols=242 Identities=17% Similarity=0.194 Sum_probs=188.9
Q ss_pred CCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCC-CCce-------------
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRH-KNVV------------- 352 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~H-pnIv------------- 352 (575)
...+|+++++||+|+||.||+|++. ++.||||+++.... .....+.+.+|+.+++.++| +|..
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3456889999999999999999986 78899999884332 22335678999999999987 2211
Q ss_pred --------EEEeeecC-----CCCceeEEEeccCCchhhhhhhc------cCcCChHHHHHHHHHHHHHHHHHHHCCcee
Q 008171 353 --------QFIGACTK-----PPSLCIVTEFMSGGSVYDYLHKL------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413 (575)
Q Consensus 353 --------~l~~~~~~-----~~~l~lV~E~~~ggsL~d~l~~~------~~~l~~~~~~~i~~qI~~aL~yLH~~gIiH 413 (575)
.++.++.. ...++++|+++ +++|.+++... ...+++..++.++.||+.||.|||++||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 11111111 22457777776 78999998532 455788899999999999999999999999
Q ss_pred cccCCCCEEecCCCcEEEeecccceecccCCccccCCCCCCccCcccc----------cCCCCCchHHHHHHHHHHHHHH
Q 008171 414 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVI----------EHKPYDHKADVFSFGIVLWELL 483 (575)
Q Consensus 414 rDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i----------~~~~~s~ksDVwSlGviL~eLl 483 (575)
|||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ ....|+.++|||||||++|||+
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 999999999999999999999999865543 455678 999999999 6667899999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 484 TGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 484 tG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+|+.||...+..+....+.. ....+++++.+||.+||+.||.+||++.++++
T Consensus 312 tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HSSCCCCTTGGGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HCCCCCCCcchhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999987665433222111 22367899999999999999999999888753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=363.31 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=207.0
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC------CCC
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK------PPS 363 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~------~~~ 363 (575)
++|++.++||+|+||.||+|.+ .++.||||+++.. ........+.+|+.++++++||||+++++++.. ...
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 6789999999999999999986 4678999998764 345556789999999999999999999998765 677
Q ss_pred ceeEEEeccCCchhhhhhhcc--CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCc---EEEeecccce
Q 008171 364 LCIVTEFMSGGSVYDYLHKLK--GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV---VKVADFGVAR 438 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~--~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~---vkL~DFG~a~ 438 (575)
.|+||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 899999999999999997643 26899999999999999999999999999999999999997664 9999999998
Q ss_pred ecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH---------HH-HhcC---
Q 008171 439 VKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV---------GV-VQKG--- 505 (575)
Q Consensus 439 ~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~---------~v-~~~~--- 505 (575)
............||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .. ....
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g 252 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSS
T ss_pred ccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcc
Confidence 7766666667789999999999999999999999999999999999999997643221100 00 0000
Q ss_pred ---C------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH-----HHHHHHHHHH
Q 008171 506 ---L------RPTIPKNSQPKLAELLERCWQQDPALRPDFSE-----IIEILQQIAK 548 (575)
Q Consensus 506 ---~------~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~e-----ll~~L~~l~~ 548 (575)
+ ...++..+++.+.++|.+||..||.+|||+.+ +.+.+.+++.
T Consensus 253 ~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp SCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred ccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0 01123346789999999999999999999988 4566666553
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=361.87 Aligned_cols=245 Identities=21% Similarity=0.256 Sum_probs=202.4
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC---CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCC--
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-- 363 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~---~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~-- 363 (575)
+-.++|++.++||+|+||.||++.+. ++.||||++... ........+.+|+.++++++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 34478999999999999999999874 678999998753 344556788999999999999999999999977655
Q ss_pred ---ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 364 ---LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 364 ---l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
.||||||++|++|.+++.. .+++..++.|+.||+.||.|||++||+||||||+|||++.+ .+||+|||+++..
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp CEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred CceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 6999999999999988744 79999999999999999999999999999999999999975 8999999999866
Q ss_pred ccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC-CCCCCcHHHH
Q 008171 441 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT-IPKNSQPKLA 519 (575)
Q Consensus 441 ~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~-~p~~~~~~l~ 519 (575)
... ....||+.|+|||++.+. ++.++|||||||+||+|++|..||..... ...... .....++.+.
T Consensus 232 ~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~l~ 298 (681)
T 2pzi_A 232 NSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV---------DGLPEDDPVLKTYDSYG 298 (681)
T ss_dssp TCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC---------SSCCTTCHHHHHCHHHH
T ss_pred ccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc---------ccccccccccccCHHHH
Confidence 543 456799999999999765 48999999999999999999988864211 011000 0112357899
Q ss_pred HHHHHhhhcCCCCCC-CHHHHHHHHHHHHHHhc
Q 008171 520 ELLERCWQQDPALRP-DFSEIIEILQQIAKEVG 551 (575)
Q Consensus 520 ~Li~~cL~~dP~~RP-s~~ell~~L~~l~~~~~ 551 (575)
++|.+||+.||.+|| ++.++...|..+++++.
T Consensus 299 ~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~ 331 (681)
T 2pzi_A 299 RLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVV 331 (681)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHHH
T ss_pred HHHhhhccCChhhCCCHHHHHHHHHHHHHHHhh
Confidence 999999999999999 57788888888887664
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=322.47 Aligned_cols=222 Identities=23% Similarity=0.414 Sum_probs=180.7
Q ss_pred Cceeee-eeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHH-HhcCCCCceEEEeeecC----CCC
Q 008171 292 KHLKFG-SKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIM-RKVRHKNVVQFIGACTK----PPS 363 (575)
Q Consensus 292 ~~~~i~-~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL-~~L~HpnIv~l~~~~~~----~~~ 363 (575)
++|.+. +.||+|+||.||++.+ +++.||||+++.. ..+.+|+.++ +.++||||+++++++.. ...
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 456666 7899999999999987 4678999998742 4567888887 56689999999998865 667
Q ss_pred ceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC---CCcEEEeeccccee
Q 008171 364 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARV 439 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~---~~~vkL~DFG~a~~ 439 (575)
+|+||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 899999999999999998753 36999999999999999999999999999999999999998 78899999999864
Q ss_pred cccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--CCCCC----CC
Q 008171 440 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIP----KN 513 (575)
Q Consensus 440 ~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~--~~~~p----~~ 513 (575)
.. +..++.++|||||||++|+|++|..||................. ....+ ..
T Consensus 170 ~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (299)
T 3m2w_A 170 TT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 228 (299)
T ss_dssp CT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTT
T ss_pred cc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhccc
Confidence 32 24578899999999999999999999987655433221111111 11222 56
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 514 SQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 514 ~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+++++.++|.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 229 VSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 8899999999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=338.14 Aligned_cols=240 Identities=16% Similarity=0.239 Sum_probs=190.2
Q ss_pred eCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCC------ChHHHHHHHHHHHHHHhcC---------CCCceE
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERI------NSDMQKEFAQEVFIMRKVR---------HKNVVQ 353 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~------~~~~~~~~~~Ev~iL~~L~---------HpnIv~ 353 (575)
+..++|++.++||+|+||+||+|+++++.||||+++.... .......+.+|+.+|+.++ ||||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 4557899999999999999999999999999999986532 2233467889999999986 666666
Q ss_pred EEee-----------------ec-------------CCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHH
Q 008171 354 FIGA-----------------CT-------------KPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403 (575)
Q Consensus 354 l~~~-----------------~~-------------~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL 403 (575)
++++ +. ....+||||||+.+|++.+.+.+ +.+++..++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 6554 33 26789999999999987777743 6689999999999999999
Q ss_pred HHHH-HCCceecccCCCCEEecCCC--------------------cEEEeecccceecccCCccccCCCCCCccCccccc
Q 008171 404 NYLH-QNNIIHRDLKAANLLMDENE--------------------VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE 462 (575)
Q Consensus 404 ~yLH-~~gIiHrDLKp~NILl~~~~--------------------~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~ 462 (575)
.||| ++||+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||++.
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence 9999 99999999999999999887 8999999999866543 347999999999998
Q ss_pred CCCCCchHHHHHHHHH-HHHHHcCCCCCCCCCHHHHH-HHHHhcC-CCC----CCCCCCcHHHHHHHHHhhhcCCCCCCC
Q 008171 463 HKPYDHKADVFSFGIV-LWELLTGKLPYEYLTPLQAA-VGVVQKG-LRP----TIPKNSQPKLAELLERCWQQDPALRPD 535 (575)
Q Consensus 463 ~~~~s~ksDVwSlGvi-L~eLltG~~Pf~~~~~~~~~-~~v~~~~-~~~----~~p~~~~~~l~~Li~~cL~~dP~~RPs 535 (575)
+.. +.++|||||+++ .+++++|..||......... ..+.... ... ..+..+++++.+||++||+.| |
T Consensus 251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s 324 (336)
T 2vuw_A 251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S 324 (336)
T ss_dssp CCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S
T ss_pred CCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C
Confidence 776 999999998777 77788899998543221111 1222111 111 112357889999999999977 8
Q ss_pred HHHHH
Q 008171 536 FSEII 540 (575)
Q Consensus 536 ~~ell 540 (575)
+.|++
T Consensus 325 a~e~l 329 (336)
T 2vuw_A 325 ATDLL 329 (336)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-32 Score=301.60 Aligned_cols=183 Identities=14% Similarity=0.127 Sum_probs=131.9
Q ss_pred eeeecCceEEEEE--EECCccEEEEEecCCCCC--------hHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCCCceeE
Q 008171 299 KVASGSYGDLYRG--TYCSQDVAIKVLKPERIN--------SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 299 ~LG~G~fG~Vy~~--~~~~~~VAvKvl~~~~~~--------~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~l~lV 367 (575)
..+.|++|.+..+ .+.|+.|+||++...... ....++|.+|+.+|+++ .|+||++++++++++..+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3566777766644 457999999999765321 23346799999999999 699999999999999999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cc
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VM 446 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~ 446 (575)
|||++|++|.+++.. .+.++.. +|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+...... ..
T Consensus 321 MEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~ 396 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP 396 (569)
T ss_dssp EECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred EecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence 999999999999976 5667654 588999999999999999999999999999999999999999998765443 34
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCC
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK 486 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~ 486 (575)
...+||+.|||||++.+. +..++|+||+|+++++|.++.
T Consensus 397 ~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp HHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred cCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence 556899999999999765 677899999999988776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=272.84 Aligned_cols=184 Identities=20% Similarity=0.251 Sum_probs=148.2
Q ss_pred eeeeeeecCceEEEEEEECCccEEEEEecCCCCChH------HHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 296 FGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSD------MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 296 i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~------~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
..++||+|+||.||++++.++.+++|.......... ..+.+.+|+.+|++++||||+++..++......|||||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 356899999999999999999999998765443221 23558999999999999999955555556667899999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCc----
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGV---- 445 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~---- 445 (575)
|++|++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|||+++.......
T Consensus 420 ~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~ 488 (540)
T 3en9_A 420 YINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVD 488 (540)
T ss_dssp CCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHH
T ss_pred CCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccc
Confidence 9999999999975 5689999999999999999999999999999998 999999999987655322
Q ss_pred ----cccCCCCCCccCcccccC--CCCCchHHHHHHHHHHHHHHcCCCCCC
Q 008171 446 ----MTAETGTYRWMAPEVIEH--KPYDHKADVFSFGIVLWELLTGKLPYE 490 (575)
Q Consensus 446 ----~~~~~Gt~~y~APE~i~~--~~~s~ksDVwSlGviL~eLltG~~Pf~ 490 (575)
.....||+.|||||++.. ..|+..+|+|+..+-..+-+.++-+|.
T Consensus 489 ~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 489 LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 135579999999999977 678888999999988888887776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.3e-24 Score=218.51 Aligned_cols=146 Identities=14% Similarity=0.132 Sum_probs=116.7
Q ss_pred CceeeeeeeeecCceEEEEEEE-CCccEEEEEecCCCCCh----------------HHHHHHHHHHHHHHhcCCCCceEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINS----------------DMQKEFAQEVFIMRKVRHKNVVQF 354 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~-~~~~VAvKvl~~~~~~~----------------~~~~~~~~Ev~iL~~L~HpnIv~l 354 (575)
..|.+++.||+|+||.||+|.+ .++.||||+++...... .....+.+|+.+|++++| +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence 3466789999999999999998 46789999997543211 135678999999999994 444
Q ss_pred EeeecCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeec
Q 008171 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434 (575)
Q Consensus 355 ~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DF 434 (575)
.+++.. +..|+||||++|++|.+ +.. .....++.||+.||.|||++||+||||||+|||++ ++.+||+||
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 444433 56799999999999998 421 33557999999999999999999999999999999 999999999
Q ss_pred ccceecccCCccccCCCCCCccCccccc
Q 008171 435 GVARVKAQSGVMTAETGTYRWMAPEVIE 462 (575)
Q Consensus 435 G~a~~~~~~~~~~~~~Gt~~y~APE~i~ 462 (575)
|+++. +..++|||++.
T Consensus 237 G~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 237 PQSVE------------VGEEGWREILE 252 (282)
T ss_dssp TTCEE------------TTSTTHHHHHH
T ss_pred CCCeE------------CCCCCHHHHHH
Confidence 99963 34578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.6e-20 Score=188.55 Aligned_cols=138 Identities=16% Similarity=0.198 Sum_probs=108.2
Q ss_pred ceeeeeeeeecCceEEEEEEE--CCcc--EEEEEecCCCCCh----------------------HHHHHHHHHHHHHHhc
Q 008171 293 HLKFGSKVASGSYGDLYRGTY--CSQD--VAIKVLKPERINS----------------------DMQKEFAQEVFIMRKV 346 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~--~~~~--VAvKvl~~~~~~~----------------------~~~~~~~~Ev~iL~~L 346 (575)
-|.+.+.||+|+||.||+|.+ .++. ||||+++...... .....+.+|+.+|+.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999987 7888 9999986542110 1123678899999999
Q ss_pred CCCCc--eEEEeeecCCCCceeEEEeccC-C----chhhhhhhccCcCChHHHHHHHHHHHHHHHHHH-HCCceecccCC
Q 008171 347 RHKNV--VQFIGACTKPPSLCIVTEFMSG-G----SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRDLKA 418 (575)
Q Consensus 347 ~HpnI--v~l~~~~~~~~~l~lV~E~~~g-g----sL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH-~~gIiHrDLKp 418 (575)
.|+++ +.++.. ...+|||||+.+ | +|.++... .++..+..++.||+.||.||| +.||+||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 98754 445543 357999999942 4 55554322 345678899999999999999 99999999999
Q ss_pred CCEEecCCCcEEEeecccceec
Q 008171 419 ANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 419 ~NILl~~~~~vkL~DFG~a~~~ 440 (575)
+|||++. .++|+|||+|...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999998 8999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=6.4e-18 Score=178.85 Aligned_cols=136 Identities=16% Similarity=0.210 Sum_probs=99.7
Q ss_pred eeeeeeeeecCceEEEEEEE-CCccEEEEEecCCCCC------------hHHH--------HHHHHHHHHHHhcCCCCc-
Q 008171 294 LKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERIN------------SDMQ--------KEFAQEVFIMRKVRHKNV- 351 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~-~~~~VAvKvl~~~~~~------------~~~~--------~~~~~Ev~iL~~L~HpnI- 351 (575)
|.++++||.|+||.||+|.. .|+.||||+++....+ .... .....|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 78899999999999999986 5788999998753211 0000 112346666666654433
Q ss_pred -eEEEeeecCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC---
Q 008171 352 -VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE--- 427 (575)
Q Consensus 352 -v~l~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~--- 427 (575)
...++. ...+|||||+.|++|.++.. .+....++.||+.+|.|||++|||||||||.|||+++++
T Consensus 177 vp~p~~~----~~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 177 VPEPIAQ----SRHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CCCEEEE----ETTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCeeeec----cCceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 222322 13479999999988876542 234567889999999999999999999999999998776
Q ss_pred -------cEEEeecccceec
Q 008171 428 -------VVKVADFGVARVK 440 (575)
Q Consensus 428 -------~vkL~DFG~a~~~ 440 (575)
.+.|+||+-+...
T Consensus 246 d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CTTSEEEEEEECCCTTCEET
T ss_pred cccccccceEEEEeCCcccC
Confidence 3899999987543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=2.1e-12 Score=128.39 Aligned_cols=138 Identities=12% Similarity=0.090 Sum_probs=111.6
Q ss_pred ceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCCCceeEEEec
Q 008171 293 HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFM 371 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~l~lV~E~~ 371 (575)
.|++...++.|+++.||+....++.+++|+........ ...+.+|+.+++.+. +..++++++++...+..|+||||+
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 47777888889999999998778899999987532111 235788999999995 677889999988888899999999
Q ss_pred cCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 008171 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ------------------------------------------- 408 (575)
Q Consensus 372 ~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~------------------------------------------- 408 (575)
+|.+|.+.+. +......++.++..+|..||+
T Consensus 93 ~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 93 DGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred CCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 9999887632 122345788999999999998
Q ss_pred ----------------CCceecccCCCCEEecCCCcEEEeecccce
Q 008171 409 ----------------NNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 409 ----------------~gIiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876667799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.19 E-value=3.7e-11 Score=118.24 Aligned_cols=132 Identities=12% Similarity=0.135 Sum_probs=97.5
Q ss_pred eeeeeeeeecCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC--ceEEEeeecCCCCceeEEEe
Q 008171 294 LKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~Hpn--Iv~l~~~~~~~~~l~lV~E~ 370 (575)
+.+....+.|+.+.||+.... ++.+++|+..... ...+.+|+.+++.+.+.+ ++++++++...+..++||||
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 343333345666999999754 4679999977541 234678999999997544 56688888887788999999
Q ss_pred ccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCC----------------------------------------
Q 008171 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN---------------------------------------- 410 (575)
Q Consensus 371 ~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~g---------------------------------------- 410 (575)
++|.+|. ... .. ...++.+++..|..||+..
T Consensus 97 i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 97 VPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp CSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred cCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 9998884 211 11 2256677777777887643
Q ss_pred ------------------ceecccCCCCEEecCCCcEEEeeccccee
Q 008171 411 ------------------IIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 411 ------------------IiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
++|+|++|.|||++.++.+.|+|||.+..
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999998853
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.18 E-value=9e-11 Score=122.43 Aligned_cols=140 Identities=14% Similarity=0.238 Sum_probs=107.7
Q ss_pred eeeeeecCceEEEEEEECCccEEEEEec--CCCCChHHHHHHHHHHHHHHhcCC--CCceEEEeeecCC---CCceeEEE
Q 008171 297 GSKVASGSYGDLYRGTYCSQDVAIKVLK--PERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKP---PSLCIVTE 369 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~~~~VAvKvl~--~~~~~~~~~~~~~~Ev~iL~~L~H--pnIv~l~~~~~~~---~~l~lV~E 369 (575)
.+.|+.|.++.||+.+..+..+++|+.. ..... .....+.+|+.+++.+.. ..+++++.++.+. +..|+|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4678999999999998888889999876 43211 123467889999999974 5678899988776 45799999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ----------------------------------------- 408 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~----------------------------------------- 408 (575)
|++|..+.+.. ...++......++.+++..|..||+
T Consensus 122 ~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 122 FVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp CCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred ecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 99998885522 2336777888899999999999997
Q ss_pred -----------------CCceecccCCCCEEecCCCc--EEEeecccceec
Q 008171 409 -----------------NNIIHRDLKAANLLMDENEV--VKVADFGVARVK 440 (575)
Q Consensus 409 -----------------~gIiHrDLKp~NILl~~~~~--vkL~DFG~a~~~ 440 (575)
.+++|+|+++.|||++.++. +.|+||+.+...
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 36899999999999997653 699999998643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.11 E-value=2e-10 Score=117.01 Aligned_cols=182 Identities=17% Similarity=0.201 Sum_probs=123.5
Q ss_pred eeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CC--CceEEEeeecCCC---CceeEEEec
Q 008171 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HK--NVVQFIGACTKPP---SLCIVTEFM 371 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-Hp--nIv~l~~~~~~~~---~l~lV~E~~ 371 (575)
+.++.|.+..||+.. +.+++|+.... .....+.+|+.+|+.+. +. .+.+++..+.... ..|+||+++
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 458999999999863 67999986532 34567889999999884 32 2456666554433 348899999
Q ss_pred cCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 008171 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ------------------------------------------- 408 (575)
Q Consensus 372 ~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~------------------------------------------- 408 (575)
+|.+|.+... ..++......++.+++..|..||+
T Consensus 99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 9988875332 346677777788888888888885
Q ss_pred ---------------CCceecccCCCCEEecC--CCcEEEeecccceecccCCccccCCCCCCccCcccccC-----CCC
Q 008171 409 ---------------NNIIHRDLKAANLLMDE--NEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-----KPY 466 (575)
Q Consensus 409 ---------------~gIiHrDLKp~NILl~~--~~~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~-----~~~ 466 (575)
..++|+|++|.||+++. .+.+.|+||+.+.................-..|+.... ...
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 24799999999999998 56689999999876543211111110000022332110 111
Q ss_pred ---------CchHHHHHHHHHHHHHHcCCCCC
Q 008171 467 ---------DHKADVFSFGIVLWELLTGKLPY 489 (575)
Q Consensus 467 ---------s~ksDVwSlGviL~eLltG~~Pf 489 (575)
....++|+++.++|.+.+|..+|
T Consensus 256 ~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 256 DIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 12368999999999999998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=6.7e-07 Score=91.28 Aligned_cols=134 Identities=16% Similarity=0.163 Sum_probs=93.4
Q ss_pred eeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC---CceEEEeeec-CCCCceeEEEeccC
Q 008171 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK---NVVQFIGACT-KPPSLCIVTEFMSG 373 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~Hp---nIv~l~~~~~-~~~~l~lV~E~~~g 373 (575)
+.++.|....||+. +..+++|+-.. ......+.+|+.+|+.|.+. .+.+++.++. ..+..|+||||++|
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eecCCCcceeEEEE---CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 46788998999987 78899998532 33456789999999999752 3566777663 44567899999999
Q ss_pred CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHC--------------------------------------------
Q 008171 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN-------------------------------------------- 409 (575)
Q Consensus 374 gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~-------------------------------------------- 409 (575)
.+|.+..- ..++......++.++...|..||+.
T Consensus 98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 88876311 1223334444444444444444432
Q ss_pred ----------------CceecccCCCCEEecC---CCc-EEEeecccceecc
Q 008171 410 ----------------NIIHRDLKAANLLMDE---NEV-VKVADFGVARVKA 441 (575)
Q Consensus 410 ----------------gIiHrDLKp~NILl~~---~~~-vkL~DFG~a~~~~ 441 (575)
.++|+|++|.|||++. ++. +.|+||+.+....
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 4599999999999987 344 5899999886543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.6e-06 Score=85.96 Aligned_cols=131 Identities=17% Similarity=0.232 Sum_probs=92.9
Q ss_pred eeeecCce-EEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC-CCceEEEeeecCCCCceeEEEeccCC
Q 008171 299 KVASGSYG-DLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSLCIVTEFMSGG 374 (575)
Q Consensus 299 ~LG~G~fG-~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~H-pnIv~l~~~~~~~~~l~lV~E~~~gg 374 (575)
.+..|..| .||+.... +..+++|+-... ....+.+|..+|+.+.. --+.+++.++.+.+..|+|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 45556655 68987653 457999986632 34568889999998852 23678888888888899999999998
Q ss_pred chhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHC---------------------------------------------
Q 008171 375 SVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN--------------------------------------------- 409 (575)
Q Consensus 375 sL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~--------------------------------------------- 409 (575)
++.+.... .......++.++...|.-||+.
T Consensus 106 ~~~~~~~~-----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 106 TAFQVLEE-----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EHHHHHHH-----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccccC-----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 87765432 1122233444555555555521
Q ss_pred -------------CceecccCCCCEEecCCCcEEEeeccccee
Q 008171 410 -------------NIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 410 -------------gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 279999999999999887778999998854
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=7.5e-07 Score=92.32 Aligned_cols=81 Identities=15% Similarity=0.102 Sum_probs=57.1
Q ss_pred eeeee-eecCceEEEEEEEC--------CccEEEEEecCCC---CChHHHHHHHHHHHHHHhcCC---CCceEEEeeecC
Q 008171 296 FGSKV-ASGSYGDLYRGTYC--------SQDVAIKVLKPER---INSDMQKEFAQEVFIMRKVRH---KNVVQFIGACTK 360 (575)
Q Consensus 296 i~~~L-G~G~fG~Vy~~~~~--------~~~VAvKvl~~~~---~~~~~~~~~~~Ev~iL~~L~H---pnIv~l~~~~~~ 360 (575)
..+.| +.|....+|+.+.. ++.+++|+..... ... ...+.+|+.+++.+.. -.+.+++.++.+
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~--~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP--TYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS--CCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc--hhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 34677 88888999988765 6679999866432 100 1346778888888853 357778888765
Q ss_pred C---CCceeEEEeccCCchhh
Q 008171 361 P---PSLCIVTEFMSGGSVYD 378 (575)
Q Consensus 361 ~---~~l~lV~E~~~ggsL~d 378 (575)
. +..|+||||++|.++.+
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp STTTSSCEEEEECCCCBCCCB
T ss_pred CCccCCceEEEEecCCCChhh
Confidence 5 35689999999877654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.24 E-value=7.3e-06 Score=83.60 Aligned_cols=135 Identities=18% Similarity=0.223 Sum_probs=79.9
Q ss_pred eeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CCceEEEee------ecCCCCceeEEE
Q 008171 298 SKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGA------CTKPPSLCIVTE 369 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~H--pnIv~l~~~------~~~~~~l~lV~E 369 (575)
+.|+.|..+.||+....+..+++|+.... . ..+..|+.+++.|.. -.+++++.. ....+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 45666778899999877777999998752 2 233445566655542 133444431 123456789999
Q ss_pred eccCCchh-----------h---hhhhccCcC-------------ChHH-------------------------------
Q 008171 370 FMSGGSVY-----------D---YLHKLKGVF-------------KLPS------------------------------- 391 (575)
Q Consensus 370 ~~~ggsL~-----------d---~l~~~~~~l-------------~~~~------------------------------- 391 (575)
|++|.++. . .++.....+ .+..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99987653 0 112111111 1110
Q ss_pred HHHHHHHHHHHHHHHH-------------HCCceecccCCCCEEecCCCcEEEeecccce
Q 008171 392 LLKVAIDVSKGMNYLH-------------QNNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 392 ~~~i~~qI~~aL~yLH-------------~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
+..+..++..++.+|+ ..+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111123344566665 3589999999999999888899999999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=7.1e-06 Score=86.42 Aligned_cols=76 Identities=12% Similarity=-0.017 Sum_probs=49.9
Q ss_pred eeeeeecCceEEEEEEE--CCccEEEEEecCCCC--Ch---HHHHHHHHHHHHHHhcCC--C-CceEEEeeecCCCCcee
Q 008171 297 GSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI--NS---DMQKEFAQEVFIMRKVRH--K-NVVQFIGACTKPPSLCI 366 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~--~~---~~~~~~~~Ev~iL~~L~H--p-nIv~l~~~~~~~~~l~l 366 (575)
.+.||.|.++.||+++. .++.++||....... .. .....+..|+.+|+.+.. + .+++++.+. ....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 35789999999999953 567899998764311 00 112456778899888753 3 345666543 345689
Q ss_pred EEEeccCC
Q 008171 367 VTEFMSGG 374 (575)
Q Consensus 367 V~E~~~gg 374 (575)
|||+++|.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999774
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.03 E-value=1.1e-05 Score=85.91 Aligned_cols=78 Identities=15% Similarity=0.197 Sum_probs=49.4
Q ss_pred HHCCceecccCCCCEEecCCCcEEEeecccceecccCCccccCCC--CCCccCcccccCCC---CCchHHHHHHHHHHHH
Q 008171 407 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETG--TYRWMAPEVIEHKP---YDHKADVFSFGIVLWE 481 (575)
Q Consensus 407 H~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~G--t~~y~APE~i~~~~---~s~ksDVwSlGviL~e 481 (575)
+...++|+|++|.|||++.++ ++|+||+.+.............. ...|++|+...... -....++..+...+|+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 356899999999999999877 99999999875543211111111 23456666553211 1223555677788888
Q ss_pred HHcC
Q 008171 482 LLTG 485 (575)
Q Consensus 482 LltG 485 (575)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.81 E-value=0.00017 Score=69.81 Aligned_cols=140 Identities=14% Similarity=0.156 Sum_probs=97.8
Q ss_pred CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHH-HCCceecccCCCCEEecCCCcEEEeecccceecccCCccccCCCC
Q 008171 374 GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH-QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGT 452 (575)
Q Consensus 374 gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH-~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~Gt 452 (575)
-||.++|...+.++++.++|.++.|.+.+|.-+- ++.-..+=+.|..|++..+|.|.+.+ +.+. ...
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~ 100 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGE 100 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------ccc
Confidence 3899999999999999999999999999987762 22222344567899999999988763 1110 123
Q ss_pred CCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcC---
Q 008171 453 YRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD--- 529 (575)
Q Consensus 453 ~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~d--- 529 (575)
..+.+||... ...+.+.=|||||++||..+-- ++.+..+..+++.|-.||..|..-+
T Consensus 101 ~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy-------------------gL~e~eE~eLS~~LE~LL~~Mt~~~~d~ 160 (229)
T 2yle_A 101 PPPVAGKLGY-SQCMETEVIESLGIIIYKALDY-------------------GLKENEERELSPPLEQLIDHMANTVEAD 160 (229)
T ss_dssp ------CCSS-SSSCHHHHHHHHHHHHHHHHTT-------------------TCCTTEEECCCHHHHHHHHHHTTCCC--
T ss_pred cCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc-------------------CCCcccchhhCHHHHHHHHHHHhccccc
Confidence 3466888763 3456889999999999998763 3334556678899999999997652
Q ss_pred ----------------------CCCCCCHHHHHHHHHH
Q 008171 530 ----------------------PALRPDFSEIIEILQQ 545 (575)
Q Consensus 530 ----------------------P~~RPs~~ell~~L~~ 545 (575)
+..|++++++++.=..
T Consensus 161 ~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~ 198 (229)
T 2yle_A 161 GSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAA 198 (229)
T ss_dssp ------------------CCSCCCCCCSHHHHHHHHHT
T ss_pred ccccccccccccccccccccccccCcCCHHHHHHHHHh
Confidence 3578899988765443
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00012 Score=75.09 Aligned_cols=75 Identities=16% Similarity=0.129 Sum_probs=61.2
Q ss_pred eeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC---CCCceEEEeeecCCCCceeEEEeccC
Q 008171 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR---HKNVVQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~---HpnIv~l~~~~~~~~~l~lV~E~~~g 373 (575)
.+.|+.|.+..+|+.+..+..+++|+.... ....+..|+..|+.|. ...+++++.++...+..++||||++|
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 357899999999999877788999987643 2456888999999885 25688899888877889999999998
Q ss_pred Cch
Q 008171 374 GSV 376 (575)
Q Consensus 374 gsL 376 (575)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00014 Score=73.78 Aligned_cols=140 Identities=14% Similarity=0.141 Sum_probs=81.5
Q ss_pred eeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC--ceEEEeee------cCCCCceeE
Q 008171 296 FGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGAC------TKPPSLCIV 367 (575)
Q Consensus 296 i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~Hpn--Iv~l~~~~------~~~~~l~lV 367 (575)
-.+.|+.|....+|+....+..+++|+...... ...+..|+.+++.|...+ +.+++... ...+..+++
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred EeeccCCCcccceEEEEeCCccEEEEEeCCCCC----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 345788888899999987777899999875311 123556777777775322 33343221 112456899
Q ss_pred EEeccCCchhhh--------------hhhccCcC--------ChHHHHH---------------HHHHHHHHHHHHHH--
Q 008171 368 TEFMSGGSVYDY--------------LHKLKGVF--------KLPSLLK---------------VAIDVSKGMNYLHQ-- 408 (575)
Q Consensus 368 ~E~~~ggsL~d~--------------l~~~~~~l--------~~~~~~~---------------i~~qI~~aL~yLH~-- 408 (575)
|+|++|..+... ++.....+ ....... +...+...+.++..
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 999998654321 11110011 1000000 01123445556653
Q ss_pred -----CCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 409 -----NNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 409 -----~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
.+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3799999999999999876668999998753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00038 Score=70.23 Aligned_cols=134 Identities=17% Similarity=0.193 Sum_probs=77.1
Q ss_pred eeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCc-eEEEeeecCCCCceeEEEec-cCC
Q 008171 297 GSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVTEFM-SGG 374 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnI-v~l~~~~~~~~~l~lV~E~~-~gg 374 (575)
.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+...++ .++++.+.+ .-++++||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCc
Confidence 468889999999998 77999997753111 1123458877777753333 466665433 457899999 776
Q ss_pred chhhh------------------hhhccCcCC----h-HHHHHHHH--------------HHHHHHHHH----HH----C
Q 008171 375 SVYDY------------------LHKLKGVFK----L-PSLLKVAI--------------DVSKGMNYL----HQ----N 409 (575)
Q Consensus 375 sL~d~------------------l~~~~~~l~----~-~~~~~i~~--------------qI~~aL~yL----H~----~ 409 (575)
+|... ++.....+. . ..+..+.. .+...+..| .. .
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 55421 111111111 0 11111111 111112222 11 2
Q ss_pred CceecccCCCCEEecCCCcEEEeecccceec
Q 008171 410 NIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 410 gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
.++|+|+.+.||+ ..++.+.|+||..+...
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 4899999999999 55667899999988644
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00028 Score=72.14 Aligned_cols=137 Identities=15% Similarity=0.115 Sum_probs=73.6
Q ss_pred eeeecCceE-EEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC--CCceEEEeeecCCCCceeEEEeccCC
Q 008171 299 KVASGSYGD-LYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH--KNVVQFIGACTKPPSLCIVTEFMSGG 374 (575)
Q Consensus 299 ~LG~G~fG~-Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~H--pnIv~l~~~~~~~~~l~lV~E~~~gg 374 (575)
.|+.|.... +|+.+.. +..+++|....... ..+..|+.+++.+.. -.+++++.+....+ +++||++.|.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 455554443 6676653 66677776544310 223456777776643 23566777654433 7899999776
Q ss_pred chhhhhhhcc-------------------------CcCChHHHH-------H-H------------HHHHHHHHHHH---
Q 008171 375 SVYDYLHKLK-------------------------GVFKLPSLL-------K-V------------AIDVSKGMNYL--- 406 (575)
Q Consensus 375 sL~d~l~~~~-------------------------~~l~~~~~~-------~-i------------~~qI~~aL~yL--- 406 (575)
++.+++.... ..+...... . + ...+...+..|
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 6654332100 011111110 0 0 01112223333
Q ss_pred ---HHCCceecccCCCCEEecCC----CcEEEeecccceeccc
Q 008171 407 ---HQNNIIHRDLKAANLLMDEN----EVVKVADFGVARVKAQ 442 (575)
Q Consensus 407 ---H~~gIiHrDLKp~NILl~~~----~~vkL~DFG~a~~~~~ 442 (575)
+...++|+|+.+.|||++.+ +.+.|+||+.+.....
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~ 220 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR 220 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence 23479999999999999874 6899999999875543
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0021 Score=64.29 Aligned_cols=78 Identities=14% Similarity=0.103 Sum_probs=55.8
Q ss_pred ceeeeeeeeecCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC---CCceEEEeeecCCCCceeEE
Q 008171 293 HLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH---KNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~H---pnIv~l~~~~~~~~~l~lV~ 368 (575)
.+.-.+.+|.|..+.||+.+.. |+.|.+|+........ ...|..|+..|+.|.- --+++++++.. -++||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~----~~lv~ 89 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWDD----RTLAM 89 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEET----TEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEeccC----ceEEE
Confidence 4455678999999999999874 6889999866443221 2357789999998852 23566666543 48999
Q ss_pred EeccCCch
Q 008171 369 EFMSGGSV 376 (575)
Q Consensus 369 E~~~ggsL 376 (575)
||+.++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0011 Score=70.72 Aligned_cols=73 Identities=12% Similarity=0.233 Sum_probs=50.5
Q ss_pred eeeeeecCceEEEEEEEC---------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCc-eEEEeeecCCCCcee
Q 008171 297 GSKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCI 366 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~---------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnI-v~l~~~~~~~~~l~l 366 (575)
.+.|+.|....+|+.... ++.+++|+..... . ...+..|..+++.+...++ +++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 357888888999999874 3679999985321 1 1344579999988864444 667776653 38
Q ss_pred EEEeccCCchh
Q 008171 367 VTEFMSGGSVY 377 (575)
Q Consensus 367 V~E~~~ggsL~ 377 (575)
|+||++|.+|.
T Consensus 150 v~e~l~G~~l~ 160 (429)
T 1nw1_A 150 LEEYIPSRPLS 160 (429)
T ss_dssp EECCCCEEECC
T ss_pred EEEEeCCcccC
Confidence 99999875543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0015 Score=67.90 Aligned_cols=72 Identities=13% Similarity=0.180 Sum_probs=44.8
Q ss_pred eeeeecCceEEEEEEECC----------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC-ceEEEeeecCCCCcee
Q 008171 298 SKVASGSYGDLYRGTYCS----------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPPSLCI 366 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~~----------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~Hpn-Iv~l~~~~~~~~~l~l 366 (575)
+.|+.|..-.+|+....+ +.+++|+..... ........|..+++.+...+ ++++++... -++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~ 111 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGR 111 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEecC----CcE
Confidence 467888888999988754 578888865421 11112356888888886434 446766552 378
Q ss_pred EEEeccCCch
Q 008171 367 VTEFMSGGSV 376 (575)
Q Consensus 367 V~E~~~ggsL 376 (575)
||||++|.++
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999988654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0032 Score=66.19 Aligned_cols=135 Identities=13% Similarity=0.217 Sum_probs=80.5
Q ss_pred eeeeecCceEEEEEEEC---------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC-ceEEEeeecCCCCceeE
Q 008171 298 SKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPPSLCIV 367 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~---------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~Hpn-Iv~l~~~~~~~~~l~lV 367 (575)
+.|..|....+|+.+.. ++.+++|+..... .....+.+|..+++.|.--+ ..++++.+.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 45666777788888763 3568888853211 12345568999998886322 3667777764 389
Q ss_pred EEeccCCchhhh-----------------hhhccC----cCC--hHHHHHHHHHHHH-------------------HHHH
Q 008171 368 TEFMSGGSVYDY-----------------LHKLKG----VFK--LPSLLKVAIDVSK-------------------GMNY 405 (575)
Q Consensus 368 ~E~~~ggsL~d~-----------------l~~~~~----~l~--~~~~~~i~~qI~~-------------------aL~y 405 (575)
|||++|.+|..- |+...- ... +..+.++..++-. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999998766421 111111 111 2344445444322 2333
Q ss_pred HH----H----CCceecccCCCCEEecCC----CcEEEeeccccee
Q 008171 406 LH----Q----NNIIHRDLKAANLLMDEN----EVVKVADFGVARV 439 (575)
Q Consensus 406 LH----~----~gIiHrDLKp~NILl~~~----~~vkL~DFG~a~~ 439 (575)
|. . ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 33 2 258999999999999876 7899999998853
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0079 Score=60.85 Aligned_cols=136 Identities=15% Similarity=0.148 Sum_probs=78.3
Q ss_pred eeeecCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC--ceEEEee-----ecCCCCceeEEEe
Q 008171 299 KVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN--VVQFIGA-----CTKPPSLCIVTEF 370 (575)
Q Consensus 299 ~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~Hpn--Iv~l~~~-----~~~~~~l~lV~E~ 370 (575)
.|+ |....||+.... ++.+++|+........ ..+..|..+++.+.... +++++.. ....+..+++|+|
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 456 777889988654 4579999987543332 44566888888775322 4444443 0112345789999
Q ss_pred ccCCchhh-----------h---hhhcc--------CcCChHHH----HHH---------------HHHHHHHHHHHH--
Q 008171 371 MSGGSVYD-----------Y---LHKLK--------GVFKLPSL----LKV---------------AIDVSKGMNYLH-- 407 (575)
Q Consensus 371 ~~ggsL~d-----------~---l~~~~--------~~l~~~~~----~~i---------------~~qI~~aL~yLH-- 407 (575)
++|.++.. . ++... ..+..... ..+ ...+-..+..+.
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 98865431 0 11110 01111110 001 111111223332
Q ss_pred -----HCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 408 -----QNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 408 -----~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
...++|+|+++.|||++ + .+.|+||+.+...
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 34689999999999999 4 8999999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.70 E-value=0.005 Score=63.36 Aligned_cols=33 Identities=21% Similarity=0.412 Sum_probs=28.7
Q ss_pred CCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 409 ~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
..++|+|+.+.||+++.++.+.|+||+.+....
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 468999999999999988889999998886543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0098 Score=64.01 Aligned_cols=74 Identities=19% Similarity=0.119 Sum_probs=49.5
Q ss_pred eeeeeecCceEEEEEEECC--ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCc-eEEEeeecCCCCceeEEEeccC
Q 008171 297 GSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIVTEFMSG 373 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~~~--~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnI-v~l~~~~~~~~~l~lV~E~~~g 373 (575)
.+.|+.|-...+|+....+ ..+++|+....... .....+|..+++.|...++ +++++.+.. .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCC
Confidence 3578888889999999876 78999987543111 0112578999998875554 567777742 469999988
Q ss_pred Cchh
Q 008171 374 GSVY 377 (575)
Q Consensus 374 gsL~ 377 (575)
.+|.
T Consensus 186 ~~l~ 189 (458)
T 2qg7_A 186 YALS 189 (458)
T ss_dssp EECC
T ss_pred ccCC
Confidence 6553
|
| >1u8s_A Glycine cleavage system transcriptional repressor, putative; structural genomics, protein structure initiative (PSI), domain swapping; 2.45A {Vibrio cholerae} SCOP: d.58.18.5 d.58.18.5 | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0025 Score=60.27 Aligned_cols=64 Identities=17% Similarity=0.277 Sum_probs=53.2
Q ss_pred cceeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCceeEEEEEcCCChhhHHHHHHHHHHHH
Q 008171 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEV 245 (575)
Q Consensus 180 ~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ldv~vv~g~~~e~~~~l~~al~~~~ 245 (575)
+.|++++.|+|+++++++.+|++.|+||.++..|.+.+++.+ .++|++ +.+..++|+++|....
T Consensus 7 ~~itv~~~DrpGiva~vt~~La~~g~NI~d~~~~~~~~~f~~-~~~v~~-~~~~~~~l~~~L~~~~ 70 (192)
T 1u8s_A 7 LVITAVGTDRPGICNEVVRLVTQAGCNIIDSRIAMFGKEFTL-LMLISG-SPSNITRVETTLPLLG 70 (192)
T ss_dssp EEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTEEEE-EEEEEE-CHHHHHHHHHHHHHHH
T ss_pred EEEEEEcCCCCcHHHHHHHHHHHCCCCEEeeeeeecCCceEE-EEEEec-CCCCHHHHHHHHHHHH
Confidence 579999999999999999999999999999999998888887 566654 3356677777777644
|
| >1zpv_A ACT domain protein; structural genomics, PSI, protein structure INIT midwest center for structural genomics, MCSG, unknown funct; 1.90A {Streptococcus pneumoniae} SCOP: d.58.18.7 | Back alignment and structure |
|---|
Probab=95.74 E-value=0.015 Score=47.53 Aligned_cols=67 Identities=22% Similarity=0.219 Sum_probs=53.6
Q ss_pred cceeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCceeEEEEEcCCChhhHHHHHHHHHHHHHH
Q 008171 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLK 247 (575)
Q Consensus 180 ~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ldv~vv~g~~~e~~~~l~~al~~~~~~ 247 (575)
..|++...|+|++|+.++.+|++.|.||.....+... |...-.+.|+....+..+++.++|++.-..
T Consensus 6 ~~l~v~~~DrpGila~vt~~la~~~~NI~~i~~~~~~-~~~~~~i~v~~~~~~~l~~l~~~L~~~~~~ 72 (91)
T 1zpv_A 6 AIITVVGKDKSGIVAGVSGKIAELGLNIDDISQTVLD-EYFTMMAVVSSDEKQDFTYLRNEFEAFGQT 72 (91)
T ss_dssp EEEEEEESCCTTHHHHHHHHHHHTTCEEEEEEEEEET-TEEEEEEEEEESSCCCHHHHHHHHHHHHHH
T ss_pred EEEEEEECCCCCHHHHHHHHHHHcCCCEEEEEeEEEc-CEEEEEEEEEeCCCCCHHHHHHHHHHHHHH
Confidence 5799999999999999999999999999998887665 666666666544456778888888765443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.71 E-value=0.026 Score=60.07 Aligned_cols=72 Identities=14% Similarity=0.203 Sum_probs=47.4
Q ss_pred eeeeecCceEEEEEEEC---------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCC-ceEEEeeecCCCCceeE
Q 008171 298 SKVASGSYGDLYRGTYC---------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN-VVQFIGACTKPPSLCIV 367 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~---------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~Hpn-Iv~l~~~~~~~~~l~lV 367 (575)
+.|..|....+|+.... ++.+++++..... .......+|..+++.+.-.+ ..++++.+. -++|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence 46677778889998876 5779999865421 11112356888888875323 455666443 3789
Q ss_pred EEeccCCch
Q 008171 368 TEFMSGGSV 376 (575)
Q Consensus 368 ~E~~~ggsL 376 (575)
|||++|.+|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998765
|
| >2nyi_A Unknown protein; protein structure initiative, PSI, center for eukaryotic structural genomics, CESG, structural genomics; 1.80A {Galdieria sulphuraria} | Back alignment and structure |
|---|
Probab=95.60 E-value=0.008 Score=57.02 Aligned_cols=47 Identities=11% Similarity=0.298 Sum_probs=43.2
Q ss_pred cceeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCceeEEEEEc
Q 008171 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVD 227 (575)
Q Consensus 180 ~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ldv~vv~ 227 (575)
..|++++.|+|++.++++.+|++.|+||.++..|.+.++|.+ .+.|+
T Consensus 6 ~~ltv~~~DrpGiva~vs~~La~~g~NI~da~q~~~~~~f~m-~~~v~ 52 (195)
T 2nyi_A 6 FVVSVAGSDRVGIVHDFSWALKNISANVESSRMACLGGDFAM-IVLVS 52 (195)
T ss_dssp EEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTEEEE-EEEEE
T ss_pred EEEEEEeCCCCcHHHHHHHHHHHCCCCEEEEEeEEECCeEEE-EEEEE
Confidence 589999999999999999999999999999999999999999 55554
|
| >2ko1_A CTR148A, GTP pyrophosphokinase; homodimer, alpha+beta, transferase, structural genomics, PSI-2, protein structure initiative; NMR {Chlorobaculum tepidum} PDB: 3ibw_A | Back alignment and structure |
|---|
Probab=94.45 E-value=0.036 Score=44.70 Aligned_cols=62 Identities=16% Similarity=0.147 Sum_probs=44.7
Q ss_pred ccceeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCceeEEEEEcCCChhhHHHHHHHH
Q 008171 179 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL 241 (575)
Q Consensus 179 ~~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ldv~vv~g~~~e~~~~l~~al 241 (575)
...|.+...|+|++|.+++++|++.|.||......... +...-+|.++....+..+++.++|
T Consensus 5 ~~~l~v~~~Dr~G~L~~I~~~la~~~inI~~i~~~~~~-~~~~~~i~v~~~~~~~l~~l~~~L 66 (88)
T 2ko1_A 5 LAGIRIVGEDKNGMTNQITGVISKFDTNIRTIVLNAKD-GIFTCNLMIFVKNTDKLTTLMDKL 66 (88)
T ss_dssp EEEEEEEEECCTTHHHHHHHHHTTSSSCEEEEEEEECS-SEEEEEEEEEESSHHHHHHHHHHH
T ss_pred EEEEEEEEECCCcHHHHHHHHHHHCCCCeEEEEEEEcC-CEEEEEEEEEECCHHHHHHHHHHH
Confidence 34788899999999999999999999999987776544 344455555554444444444444
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.98 E-value=0.08 Score=55.57 Aligned_cols=29 Identities=24% Similarity=0.469 Sum_probs=25.1
Q ss_pred ceecccCCCCEEe------cCCCcEEEeeccccee
Q 008171 411 IIHRDLKAANLLM------DENEVVKVADFGVARV 439 (575)
Q Consensus 411 IiHrDLKp~NILl------~~~~~vkL~DFG~a~~ 439 (575)
++|+|+.+.|||+ ++++.+.|+||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567899999998853
|
| >2f1f_A Acetolactate synthase isozyme III small subunit; ferredoxin fold, ACT domain, transferase; HET: P33 1PE; 1.75A {Escherichia coli} SCOP: d.58.18.6 d.58.18.6 | Back alignment and structure |
|---|
Probab=92.57 E-value=0.19 Score=46.26 Aligned_cols=63 Identities=22% Similarity=0.243 Sum_probs=50.8
Q ss_pred cceeeecCChhhHHHHHHHHHHhcccchhhcccccCCC-CceeEEEEEcCCChhhHHHHHHHHHH
Q 008171 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEETEQLRAALEK 243 (575)
Q Consensus 180 ~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~-g~~ldv~vv~g~~~e~~~~l~~al~~ 243 (575)
|.|.+-..|+|+.|++++.++++-|.||.-..+..|.+ |.+-=.|+|++ ..+..+++..++.+
T Consensus 4 ~~IsV~v~NrpGvLarIt~lfs~rg~NI~Sl~v~~t~d~~~sriti~V~~-d~~~leqI~kqL~K 67 (164)
T 2f1f_A 4 RILSVLLENESGALSRVIGLFSQRGYNIESLTVAPTDDPTLSRMTIQTVG-DEKVLEQIEKQLHK 67 (164)
T ss_dssp EEEEEEEECCTTHHHHHHHHHHTTTCCCSEEEEEECSCSSEEEEEEEEES-CHHHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcHHHHHHHHHHHCCCCeeeceeeecCCCCEEEEEEEEec-cHHHHHHHHHHHcC
Confidence 78888899999999999999999999999988887775 88877788884 34455555555543
|
| >2nyi_A Unknown protein; protein structure initiative, PSI, center for eukaryotic structural genomics, CESG, structural genomics; 1.80A {Galdieria sulphuraria} | Back alignment and structure |
|---|
Probab=91.91 E-value=0.13 Score=48.44 Aligned_cols=68 Identities=19% Similarity=0.101 Sum_probs=48.0
Q ss_pred ccceeeecCChhhHHHHHHHHHHhcccchhhcccccCC------CCceeEEEEEcCCChhhHHHHHHHHHHHHHHh
Q 008171 179 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTV------DGYSLDVFVVDGWPYEETEQLRAALEKEVLKL 248 (575)
Q Consensus 179 ~~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~------~g~~ldv~vv~g~~~e~~~~l~~al~~~~~~~ 248 (575)
-+-|++++.|+|++++.++.+|++.|+||.++..|..- +-|.+.+ .++.-.... ++|+++|.....++
T Consensus 93 ~~iltv~g~DrpGiva~Vt~~La~~g~nI~~~~~~t~~~~~~~~~~F~m~~-~~~~~~~~~-~~l~~~l~~~a~~l 166 (195)
T 2nyi_A 93 EYELYVEGPDSEGIVEAVTAVLAKKGANIVELETETLPAPFAGFTLFRMGS-RVAFPFPLY-QEVVTALSRVEEEF 166 (195)
T ss_dssp EEEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEEECSSTTCEEEEEEE-EEEEEGGGH-HHHHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcCHHHHHHHHHHHcCCCEEEceeeecccccCCCCeEEEEE-EEEcCCCcc-HHHHHHHHHHHHHc
Confidence 46799999999999999999999999999999988543 2222222 222112334 77888887655443
|
| >2pc6_A Probable acetolactate synthase isozyme III (small; regulatory subunit, structural genomi protein structure initiative; HET: MSE; 2.50A {Nitrosomonas europaea atcc 19718} SCOP: d.58.18.6 d.58.18.6 | Back alignment and structure |
|---|
Probab=90.73 E-value=0.35 Score=44.52 Aligned_cols=63 Identities=30% Similarity=0.413 Sum_probs=49.6
Q ss_pred cceeeecCChhhHHHHHHHHHHhcccchhhcccccCCC-CceeEEEEEcCCChhhHHHHHHHHHH
Q 008171 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEETEQLRAALEK 243 (575)
Q Consensus 180 ~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~-g~~ldv~vv~g~~~e~~~~l~~al~~ 243 (575)
|.|.+-..|+|+.|++++.++++-|.||.-..+..|-| |.+-=.|+|++ ..+..+++..++.+
T Consensus 5 ~~IsV~veNrpGvL~rI~~lfs~rg~NI~Sl~v~~t~d~g~sritivV~~-d~~~leql~kQL~K 68 (165)
T 2pc6_A 5 HIISLLMENEAGALSRVAGLFSARGYNIESLSVAPTEDPTLSRMTLVTNG-PDEIVEQITKQLNK 68 (165)
T ss_dssp EEEEEEEECSTTHHHHHHHHHHHHTCCCCEEEEEECSSTTEEEEEEEEEE-CHHHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcHHHHHHHHHHHCCCcEEEEEEEecCCCCEEEEEEEEec-cHHHHHHHHHHhcC
Confidence 67888889999999999999999999999988887774 77777778873 34445555555443
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=90.65 E-value=0.02 Score=61.69 Aligned_cols=60 Identities=8% Similarity=0.035 Sum_probs=16.5
Q ss_pred eeeeeeecCceEEEEEEECC--ccEEE------EEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeee
Q 008171 296 FGSKVASGSYGDLYRGTYCS--QDVAI------KVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (575)
Q Consensus 296 i~~~LG~G~fG~Vy~~~~~~--~~VAv------Kvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~ 358 (575)
+.++|| ||+||+|.+.+ .+||| |..+......+....|.+|..+++.++|||+++.+++.
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 345676 99999999875 47888 77766555555566789999999999999999988764
|
| >1u8s_A Glycine cleavage system transcriptional repressor, putative; structural genomics, protein structure initiative (PSI), domain swapping; 2.45A {Vibrio cholerae} SCOP: d.58.18.5 d.58.18.5 | Back alignment and structure |
|---|
Probab=90.14 E-value=0.41 Score=44.70 Aligned_cols=70 Identities=16% Similarity=0.075 Sum_probs=49.7
Q ss_pred ccceeeecCChhhHHHHHHHHHHhcccchhhcccccCC-------CCceeEEEEEcCCChhhHHHHHHHHHHHHHHh
Q 008171 179 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTV-------DGYSLDVFVVDGWPYEETEQLRAALEKEVLKL 248 (575)
Q Consensus 179 ~~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~-------~g~~ldv~vv~g~~~e~~~~l~~al~~~~~~~ 248 (575)
.+-|++.+.|+|+++..++.+|++.|+||.++..|... .+...--+.|+.-...+.++|+++|.....++
T Consensus 93 ~~~l~v~~~D~~Gil~~v~~~l~~~~~nI~~~~~~t~~~~~~~~~~~~F~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 169 (192)
T 1u8s_A 93 TVEVYVESDDKLGLTEKFTQFFAQRQIGMASLSAQTISKDKLHSEQNQFHIAISARVDSGCNLMQLQEEFDALCTAL 169 (192)
T ss_dssp EEEEEEEESCCTTHHHHHHHHHHHTTCCEEEEEEEEEC--------CEEEEEEEEEECTTSCHHHHHHHHHHHHHHH
T ss_pred eEEEEEEeCCCccHHHHHHHHHHHcCCcHHHhhhhcccCCccCCCCCEEEEEEEEeCCCCCCHHHHHHHHHHHHHHh
Confidence 56899999999999999999999999999999988543 12222222233222336788888888655443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.41 E-value=2 Score=41.11 Aligned_cols=116 Identities=9% Similarity=0.080 Sum_probs=76.1
Q ss_pred CCCCceEEEeeecCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC
Q 008171 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN 426 (575)
Q Consensus 347 ~HpnIv~l~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~ 426 (575)
.||+++.. .+-..++.+.|.++.-+ +...+-. -..++....++++.+|+....+++ .-+|--|.|+||+++.+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~--ik~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~~ 115 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN--IKSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTRD 115 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG--GGGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECTT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH--HHhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcCC
Confidence 57888865 34455555555554433 2233221 134688889999999998875443 34778899999999999
Q ss_pred CcEEEeecccceecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 008171 427 EVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490 (575)
Q Consensus 427 ~~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~ 490 (575)
+.+++.-.|+-... +|. .++...=+-.+=|++..+++++..|+
T Consensus 116 ~~p~i~~RGik~~l----------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 116 GLPIAKTRGLQNVV----------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp SCEEESCCEETTTB----------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CCEEEEEccCccCC----------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999877764211 111 22333334457889999999988764
|
| >3n0v_A Formyltetrahydrofolate deformylase; formyl transferase, ACT domain, structural genomics, joint C structural genomics, JCSG; HET: MSE; 2.25A {Pseudomonas putida} | Back alignment and structure |
|---|
Probab=85.17 E-value=0.92 Score=45.43 Aligned_cols=65 Identities=15% Similarity=0.080 Sum_probs=48.4
Q ss_pred cceeeecCChhhHHHHHHHHHHhcccchhhccccc-CCCCceeEEEEEcCCChhhHHHHHHHHHHH
Q 008171 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFS-TVDGYSLDVFVVDGWPYEETEQLRAALEKE 244 (575)
Q Consensus 180 ~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~-t~~g~~ldv~vv~g~~~e~~~~l~~al~~~ 244 (575)
+-+|+++.|+|++..++|..|++.|.||.+...|. ...|...=...++.-...+.++|+++|...
T Consensus 9 ~vLtv~c~DrpGIVa~Vs~~La~~g~NI~d~~q~~d~~~g~Ffmr~~~~~~~~~~~~~L~~~f~~l 74 (286)
T 3n0v_A 9 WILTADCPSMLGTVDVVTRYLFEQRCYVTEHHSFDDRQSGRFFIRVEFRQPDDFDEAGFRAGLAER 74 (286)
T ss_dssp EEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTTTEEEEEEEEECCSSCCHHHHHHHHHHH
T ss_pred EEEEEEeCCCCCHHHHHHHHHHHCCCCeeeeeeeccCCCCeeEEEEEEecCCCCCHHHHHHHHHHH
Confidence 46999999999999999999999999999999984 234544444445432223567788877653
|
| >3nrb_A Formyltetrahydrofolate deformylase; N-terminal ACT domain, structural genomics, joint center for structural genomics, JCSG; HET: MSE FLC; 2.05A {Pseudomonas putida} | Back alignment and structure |
|---|
Probab=84.74 E-value=0.69 Score=46.39 Aligned_cols=63 Identities=22% Similarity=0.342 Sum_probs=45.6
Q ss_pred cceeeecCChhhHHHHHHHHHHhcccchhhcccccC-CCCceeEEEEEcCCChhhHHHHHHHHHH
Q 008171 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFST-VDGYSLDVFVVDGWPYEETEQLRAALEK 243 (575)
Q Consensus 180 ~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t-~~g~~ldv~vv~g~~~e~~~~l~~al~~ 243 (575)
+=+|+++.|+|++...+|..|++.|.||.+...|.+ ..|+..=...++. +..+.++|+++|+.
T Consensus 8 ~vLtv~c~Dr~GIVa~Vs~~La~~g~NI~d~~q~~d~~~g~Ffmr~~~~~-~~~~~~~L~~~f~~ 71 (287)
T 3nrb_A 8 YVLSLACQDAPGIVSEVSTFLFNNGANIVEAEQFNDEDSSKFFMRVSVEI-PVAGVNDFNSAFGK 71 (287)
T ss_dssp EEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTTTEEEEEEEEEC-CC---CHHHHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHHHHHCCCCEEeeeeeecCCCCeEEEEEEEEc-CCCCHHHHHHHHHH
Confidence 358999999999999999999999999999999953 3555544444443 22234467666654
|
| >3obi_A Formyltetrahydrofolate deformylase; structural genomics, joint center for structural genomics, J protein structure initiative; HET: MSE; 1.95A {Rhodopseudomonas palustris} | Back alignment and structure |
|---|
Probab=84.35 E-value=1.1 Score=44.92 Aligned_cols=65 Identities=20% Similarity=0.248 Sum_probs=49.6
Q ss_pred cceeeecCChhhHHHHHHHHHHhcccchhhcccccC-CCCceeEEEEEcCCCh--hhHHHHHHHHHHHH
Q 008171 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFST-VDGYSLDVFVVDGWPY--EETEQLRAALEKEV 245 (575)
Q Consensus 180 ~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t-~~g~~ldv~vv~g~~~--e~~~~l~~al~~~~ 245 (575)
+-+|+++.|+|++..++|..|++.|.||.+...|.+ ..|+..=...++ ++. .+.++|+++|+..-
T Consensus 7 ~iLtv~g~DrpGIVa~Vs~~La~~g~NI~d~~q~~d~~~g~Ffmr~~~~-~~~~~~~~~~L~~~f~~la 74 (288)
T 3obi_A 7 YVLTLSCPDRAGIVSAVSTFLFENGQNILDAQQYNDTESGHFFMRVVFN-AAAKVIPLASLRTGFGVIA 74 (288)
T ss_dssp EEEEEEEECCTTHHHHHHHHHHHTTEEEEEEEEEEETTTTEEEEEEEEE-ESSCCCCHHHHHHHHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHHHHHCCCcEEeeeeeecCCCCceEEEEEEE-cCCCCCCHHHHHHHHHHHH
Confidence 459999999999999999999999999999999954 355554444444 332 35778888887543
|
| >3lou_A Formyltetrahydrofolate deformylase; structural genomics, JOI for structural genomics, JCSG, protein structure initiative hydrolase; HET: MSE; 1.90A {Burkholderia mallei} | Back alignment and structure |
|---|
Probab=83.05 E-value=1.3 Score=44.51 Aligned_cols=67 Identities=15% Similarity=0.128 Sum_probs=48.9
Q ss_pred cceeeecCChhhHHHHHHHHHHhcccchhhccccc-CCCCceeEEEEEcCC--C-hhhHHHHHHHHHHHHH
Q 008171 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFS-TVDGYSLDVFVVDGW--P-YEETEQLRAALEKEVL 246 (575)
Q Consensus 180 ~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~-t~~g~~ldv~vv~g~--~-~e~~~~l~~al~~~~~ 246 (575)
+-+|+++.|+|++..++|..|++-|.||.+...|. ...|...=...++.- . ..+.++|+++|+..-.
T Consensus 11 ~vLtv~c~Dr~GIVa~Vs~~La~~g~NI~d~~q~~d~~~g~Ffmr~~~~~~~~~~~~~~~~L~~~f~~la~ 81 (292)
T 3lou_A 11 FVLTLSCPSAAGQVAAVVGLLDRHRCYVDELTVFDDDLSARFFVRCVFHATDDADALRVDALRREFEPIAE 81 (292)
T ss_dssp EEEEEEEESCSCHHHHHHHHHHHTTEEEEEEEEEEETTTTEEEEEEEEEECC----CCHHHHHHHHHHHHH
T ss_pred EEEEEEcCCCCCHHHHHHHHHHHCCCCEEeeEEEecCCCCceEEEEEEEccCcccCCCHHHHHHHHHHHHH
Confidence 45999999999999999999999999999999984 234544444444432 1 2356778888865433
|
| >2fgc_A Acetolactate synthase, small subunit; regulatory subunit, structural genomi protein structure initiative; 2.30A {Thermotoga maritima} SCOP: d.58.18.6 d.58.18.6 | Back alignment and structure |
|---|
Probab=82.07 E-value=1.1 Score=42.00 Aligned_cols=62 Identities=24% Similarity=0.326 Sum_probs=48.5
Q ss_pred cceeeecCChhhHHHHHHHHHHhcccchhhcccccCCC-CceeEEEEEcCCChhhHHHHHHHHH
Q 008171 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEETEQLRAALE 242 (575)
Q Consensus 180 ~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~-g~~ldv~vv~g~~~e~~~~l~~al~ 242 (575)
|-|++-..|+|+.|++++.++++-|+||.--.+..|.| |.+-=.++|++- ....+++..++.
T Consensus 30 ~~LsVlVeN~pGvLaRItglfsrRG~NI~SLtV~~ted~gisRitIvV~g~-e~~ieqL~kQL~ 92 (193)
T 2fgc_A 30 HLVSMLVHNKPGVMRKVANLFARRGFNISSITVGESETPGLSRLVIMVKGD-DKTIEQIEKQAY 92 (193)
T ss_dssp EEEEEEEECCTTHHHHHHHHHHTTTCEEEEEEEEECSSTTEEEEEEEEEEC-TTHHHHHHHHHT
T ss_pred EEEEEEECCCChHHHHHHHHHHHCCceEEEEEeeccCCCCEEEEEEEEECC-HHHHHHHHHHhc
Confidence 78888889999999999999999999999888887766 666666788765 334555555443
|
| >3o1l_A Formyltetrahydrofolate deformylase; structural genomics, joint center for structural genomics, J protein structure initiative; HET: MSE; 2.20A {Pseudomonas syringae PV} | Back alignment and structure |
|---|
Probab=81.51 E-value=1.7 Score=43.76 Aligned_cols=66 Identities=15% Similarity=0.178 Sum_probs=49.7
Q ss_pred cceeeecCChhhHHHHHHHHHHhcccchhhcccccC-CCCceeEEEEEcCCCh--hhHHHHHHHHHHHHH
Q 008171 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFST-VDGYSLDVFVVDGWPY--EETEQLRAALEKEVL 246 (575)
Q Consensus 180 ~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t-~~g~~ldv~vv~g~~~--e~~~~l~~al~~~~~ 246 (575)
+=+|+++.|+|++...+|..|++.|.||.+...|.. ..|+..=...++ ++. .+.++|+++|+..-.
T Consensus 23 ~iLtv~c~DrpGIVa~VS~~La~~g~NI~d~~q~~d~~~g~FfMr~~~~-~~~~~~~~~~L~~~l~~la~ 91 (302)
T 3o1l_A 23 FRLVIACPDRVGIVAKVSNFLASHNGWITEASHHSDNLSGWFFMRHEIR-ADTLPFDLDGFREAFTPIAE 91 (302)
T ss_dssp EEEEEEEECCTTHHHHHHHHHHHTTCCEEEEEEEEETTTTEEEEEEEEE-GGGSSSCHHHHHHHHHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHHHHHCCCCEEEeeEEecCCCCeEEEEEEEe-cCCCCCCHHHHHHHHHHHHH
Confidence 359999999999999999999999999999999853 346555444454 222 356788888865433
|
| >3p96_A Phosphoserine phosphatase SERB; ssgcid, structural genomics, structural genomics center for infectious disease, hydrolas; 2.05A {Mycobacterium avium} | Back alignment and structure |
|---|
Probab=80.92 E-value=0.91 Score=47.52 Aligned_cols=63 Identities=22% Similarity=0.335 Sum_probs=46.3
Q ss_pred ceeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCceeEEEEEcCCChh--hHHHHHHHHHHHH
Q 008171 181 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYE--ETEQLRAALEKEV 245 (575)
Q Consensus 181 ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ldv~vv~g~~~e--~~~~l~~al~~~~ 245 (575)
=||+++.|+|++.+.+|.+|++.|.||.+...+....-|++-+ .|+. +.. ..++|+++|...-
T Consensus 14 ~lt~~g~Dr~Giv~~vs~~l~~~~~nI~d~~q~~~~~~f~~~~-~~~~-~~~~~~~~~l~~~l~~~~ 78 (415)
T 3p96_A 14 LITVTGVDQPGVTATLFEVLSRHGVELLNVEQVVIRHRLTLGV-LVCC-PADVADGPALRHDVEAAI 78 (415)
T ss_dssp EEEEEEECCTTHHHHHHHHHTTTTCEEEEEEEEEETTEEEEEE-EEEE-CHHHHTSHHHHHHHHHHH
T ss_pred EEEEEcCCCCCHHHHHHHHHHHCCCCEEEeeeEEECCEeEEEE-EEEe-cCCcCCHHHHHHHHHHHH
Confidence 5999999999999999999999999999998886443334433 3332 222 3367888776543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 575 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-91 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-82 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-77 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-76 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-76 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-75 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-74 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-74 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-73 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-73 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-72 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-72 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-71 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-71 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-71 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-71 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-70 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-70 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-69 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-69 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-68 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-68 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-67 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-66 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-66 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-65 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-65 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-64 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-63 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-62 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-62 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-62 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-61 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-60 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-59 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-58 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-58 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-56 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-55 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-53 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-52 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-52 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-50 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-50 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-50 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-47 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-45 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-44 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-44 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-44 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-43 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-40 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-38 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-38 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-37 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-17 | |
| d1ygya3 | 78 | d.58.18.1 (A:452-529) Phosphoglycerate dehydrogena | 1e-04 | |
| d1u8sa1 | 86 | d.58.18.5 (A:2-87) putative transcriptional repres | 1e-04 | |
| d1sc6a3 | 84 | d.58.18.1 (A:327-410) Phosphoglycerate dehydrogena | 2e-04 | |
| d1y7pa2 | 77 | d.58.18.12 (A:2-78) Hypothetical protein AF1403, N | 5e-04 | |
| d1zpva1 | 83 | d.58.18.7 (A:1-83) UPF0237 protein SP0238 {Strepto | 9e-04 | |
| d2pc6a2 | 77 | d.58.18.6 (A:1-77) Acetolactate synthase small sub | 0.001 | |
| d2f06a1 | 71 | d.58.18.11 (A:71-141) Hypothetical protein BT0572 | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 279 bits (716), Expect = 3e-91
Identities = 97/276 (35%), Positives = 160/276 (57%), Gaps = 12/276 (4%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMR 344
D WEI + G ++ SGS+G +Y+G + DVA+K+L + F EV ++R
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
K RH N++ F+G T P L IVT++ G S+Y +LH ++ F++ L+ +A ++GM+
Sbjct: 60 KTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ---SGVMTAETGTYRWMAPEVI 461
YLH +IIHRDLK+ N+ + E+ VK+ DFG+A VK++ S +G+ WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 462 EHK---PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR----PTIPKNS 514
+ PY ++DV++FGIVL+EL+TG+LPY + + +V +G + N
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 515 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550
+ L+ C ++ RP F +I+ ++ +A+ +
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 257 bits (657), Expect = 1e-82
Identities = 93/262 (35%), Positives = 143/262 (54%), Gaps = 8/262 (3%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
W ++ K LK + G +GD+ G Y VA+K +K N + F E +M ++
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 57
Query: 347 RHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLH-KLKGVFKLPSLLKVAIDVSKGMN 404
RH N+VQ +G + L IVTE+M+ GS+ DYL + + V LLK ++DV + M
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 464
YL NN +HRDL A N+L+ E+ V KV+DFG+ + + + +W APE + K
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK 175
Query: 465 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524
+ K+DV+SFGI+LWE+ + PL+ V V+KG + P P + E+++
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN 235
Query: 525 CWQQDPALRPDFSEIIEILQQI 546
CW D A+RP F ++ E L+ I
Sbjct: 236 CWHLDAAMRPSFLQLREQLEHI 257
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (618), Expect = 6e-77
Identities = 84/262 (32%), Positives = 145/262 (55%), Gaps = 8/262 (3%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
IDPK L F ++ +G +G + G + DVAIK++K ++ + EF +E +M +
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLS 57
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H+ +VQ G CTK + I+TE+M+ G + +YL +++ F+ LL++ DV + M YL
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTAETGTYRWMAPEVIEHKP 465
+HRDL A N L+++ VVKV+DFG++R RW PEV+ +
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 466 YDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524
+ K+D+++FG+++WE+ + GK+PYE T + A + +GLR P + K+ ++
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-EHIAQGLRLYRPHLASEKVYTIMYS 236
Query: 525 CWQQDPALRPDFSEIIEILQQI 546
CW + RP F ++ + +
Sbjct: 237 CWHEKADERPTFKILLSNILDV 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (616), Expect = 1e-76
Identities = 86/263 (32%), Positives = 146/263 (55%), Gaps = 6/263 (2%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-VAIKVLKPERINSDMQKEFAQEVFIMRKVR 347
IDP L F ++ SG +G ++ G + ++D VAIK ++ ++ +++F +E +M K+
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLS 58
Query: 348 HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
H +VQ G C + +C+V EFM G + DYL +G+F +LL + +DV +GM YL
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 408 QNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPEVIEHKP 465
+ +IHRDL A N L+ EN+V+KV+DFG+ R ++ +W +PEV
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 466 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERC 525
Y K+DV+SFG+++WE+ + V + G R P+ + + +++ C
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238
Query: 526 WQQDPALRPDFSEIIEILQQIAK 548
W++ P RP FS ++ L +IA+
Sbjct: 239 WKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (613), Expect = 6e-76
Identities = 80/266 (30%), Positives = 143/266 (53%), Gaps = 8/266 (3%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIM 343
D WE+ + LK ++ +G +G+++ G Y VA+K LK ++ F E +M
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLM 62
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV-FKLPSLLKVAIDVSKG 402
++++H+ +V+ T+ P + I+TE+M GS+ D+L G+ + LL +A +++G
Sbjct: 63 KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGTYRWMAPEV 460
M ++ + N IHRDL+AAN+L+ + K+ADFG+AR+ + +W APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 461 IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 520
I + + K+DV+SFGI+L E++T + +++G R P N +L +
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241
Query: 521 LLERCWQQDPALRPDFSEIIEILQQI 546
L+ CW++ P RP F + +L+
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (606), Expect = 9e-75
Identities = 93/266 (34%), Positives = 147/266 (55%), Gaps = 8/266 (3%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIM 343
D WEI + L+ K+ G +G+++ GT+ VAIK LKP ++ + F QE +M
Sbjct: 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVM 66
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKG 402
+K+RH+ +VQ ++ P + IVTE+MS GS+ D+L G +LP L+ +A ++ G
Sbjct: 67 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV--KAQSGVMTAETGTYRWMAPEV 460
M Y+ + N +HRDL+AAN+L+ EN V KVADFG+AR+ + +W APE
Sbjct: 126 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185
Query: 461 IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 520
+ + K+DV+SFGI+L EL T + + V++G R P L +
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245
Query: 521 LLERCWQQDPALRPDFSEIIEILQQI 546
L+ +CW+++P RP F + L+
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (599), Expect = 6e-74
Identities = 83/269 (30%), Positives = 139/269 (51%), Gaps = 12/269 (4%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINS-DMQKEFAQEVFI 342
I K L+ K+ GS+G + RG + + VA+K LKP+ ++ + +F +EV
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
M + H+N+++ G PP + +VTE GS+ D L K +G F L +L + A+ V++G
Sbjct: 65 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWMAP 458
M YL IHRDL A NLL+ ++VK+ DFG+ R + + W AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 459 EVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 517
E ++ + + H +D + FG+ LWE+ T G+ P+ L Q + ++G R P++
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 518 LAELLERCWQQDPALRPDFSEIIEILQQI 546
+ ++ +CW P RP F + + L +
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 235 bits (600), Expect = 7e-74
Identities = 93/280 (33%), Positives = 154/280 (55%), Gaps = 8/280 (2%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFI 342
D WE++ + K+ G YG++Y G + S VA+K LK + + +EF +E +
Sbjct: 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAV 66
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSK 401
M++++H N+VQ +G CT+ P I+TEFM+ G++ DYL + + LL +A +S
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126
Query: 402 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--VMTAETGTYRWMAPE 459
M YL + N IHRDL A N L+ EN +VKVADFG++R+ +W APE
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 460 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 519
+ + + K+DV++FG++LWE+ T + L +++K R P+ K+
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 246
Query: 520 ELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEERRK 559
EL+ CWQ +P+ RP F+EI + + + +E +E ++
Sbjct: 247 ELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 286
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 5e-73
Identities = 74/263 (28%), Positives = 132/263 (50%), Gaps = 13/263 (4%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
D + LKF ++ GS+ +Y+G +VA L+ ++ ++ F +E +++ +
Sbjct: 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65
Query: 347 RHKNVVQFIGACTKP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
+H N+V+F + + +VTE M+ G++ YL + V K+ L + KG
Sbjct: 66 QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKG 124
Query: 403 MNYLHQNN--IIHRDLKAAN-LLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPE 459
+ +LH IIHRDLK N + VK+ D G+A +K ++ A GT +MAPE
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVIGTPEFMAPE 183
Query: 460 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP-TIPKNSQPKL 518
+ E K YD DV++FG+ + E+ T + PY V G++P + K + P++
Sbjct: 184 MYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242
Query: 519 AELLERCWQQDPALRPDFSEIIE 541
E++E C +Q+ R +++
Sbjct: 243 KEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 9e-73
Identities = 82/292 (28%), Positives = 137/292 (46%), Gaps = 35/292 (11%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRG-------TYCSQDVAIKVLKPERINSDMQKEFAQE 339
WE ++L+FG + SG++G + T S VA+K+LK E+ +S ++ E
Sbjct: 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSE 90
Query: 340 VFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK-------------- 384
+ +M ++ H+N+V +GACT + ++ E+ G + +YL +
Sbjct: 91 LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 385 --------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
V LL A V+KGM +L + +HRDL A N+L+ +VVK+ DFG+
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 437 ARVKAQSGVMTAET---GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYL 492
AR +WMAPE + Y K+DV+S+GI+LWE+ + G PY +
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 493 TPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 544
++Q G + P + ++ +++ CW D RP F + L
Sbjct: 271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (591), Expect = 1e-72
Identities = 78/277 (28%), Positives = 138/277 (49%), Gaps = 13/277 (4%)
Query: 289 IDPKHLKFGSKV-ASGSYGDLYRGTY----CSQDVAIKVLKPERINSDMQKEFAQEVFIM 343
+D K L K SG++G + +G Y + VA+K+LK E + ++ E E +M
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+++ + +V+ IG C S +V E G + YL + K +++++ VS GM
Sbjct: 63 QQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGM 120
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWMAPE 459
YL ++N +HRDL A N+L+ K++DFG+++ + T +W APE
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518
I + + K+DV+SFG+++WE + G+ PY + + +++KG R P ++
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TAMLEKGERMGCPAGCPREM 239
Query: 519 AELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENE 555
+L+ CW D RP F+ + L+ +V E
Sbjct: 240 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 276
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (588), Expect = 2e-72
Identities = 68/258 (26%), Positives = 125/258 (48%), Gaps = 9/258 (3%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIM 343
W ++ + G + G +G++Y +A+KVL ++ ++ + +EV I
Sbjct: 3 WALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60
Query: 344 RKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+RH N+++ G + ++ E+ G+VY L K F +++ +
Sbjct: 61 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANAL 119
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH 463
+Y H +IHRD+K NLL+ +K+ADFG + A S T GT ++ PE+IE
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 178
Query: 464 KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 523
+ +D K D++S G++ +E L GK P+E T + + + + T P +L+
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLIS 236
Query: 524 RCWQQDPALRPDFSEIIE 541
R + +P+ RP E++E
Sbjct: 237 RLLKHNPSQRPMLREVLE 254
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 1e-71
Identities = 82/272 (30%), Positives = 141/272 (51%), Gaps = 11/272 (4%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEV 340
EI P + + +G +G++Y+G + VAIK LK + +F E
Sbjct: 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEA 60
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 400
IM + H N+++ G +K + I+TE+M G++ +L + G F + L+ + ++
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWM 456
GM YL N +HRDL A N+L++ N V KV+DFG++RV + + RW
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 457 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 516
APE I ++ + +DV+SFGIV+WE++T + + + G R P +
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240
Query: 517 KLAELLERCWQQDPALRPDFSEIIEILQQIAK 548
+ +L+ +CWQQ+ A RP F++I+ IL ++ +
Sbjct: 241 AIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 4e-71
Identities = 84/270 (31%), Positives = 139/270 (51%), Gaps = 9/270 (3%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQEVF 341
+EI + ++ G + G +GD+++G Y S + VAIK K + ++++F QE
Sbjct: 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEAL 60
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
MR+ H ++V+ IG T+ P + I+ E + G + +L K L SL+ A +S
Sbjct: 61 TMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 402 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET--GTYRWMAPE 459
+ YL +HRD+ A N+L+ N+ VK+ DFG++R S A +WMAPE
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 460 VIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 519
I + + +DV+ FG+ +WE+L + +G ++ G R +P N P L
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239
Query: 520 ELLERCWQQDPALRPDFSEIIEILQQIAKE 549
L+ +CW DP+ RP F+E+ L I +E
Sbjct: 240 SLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 5e-71
Identities = 74/279 (26%), Positives = 136/279 (48%), Gaps = 13/279 (4%)
Query: 287 WEIDPKHLKFGS-KVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVF 341
+ +L ++ G++G + +G Y DVAIKVLK +E +E
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQ 61
Query: 342 IMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSK 401
IM ++ + +V+ IG C L +V E GG ++ +L + + ++ ++ VS
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120
Query: 402 GMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWMA 457
GM YL + N +HRDL A N+L+ K++DFG+++ + +A +W A
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 458 PEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 516
PE I + + ++DV+S+G+ +WE L+ G+ PY+ + + + +++G R P P
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-MAFIEQGKRMECPPECPP 239
Query: 517 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENE 555
+L L+ CW RPDF + + ++ + + E
Sbjct: 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 227 bits (580), Expect = 8e-71
Identities = 90/289 (31%), Positives = 147/289 (50%), Gaps = 16/289 (5%)
Query: 274 PYHLKIPNDGTD--VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPE 326
P+ + PN+ EID +K + +G +G++ G VAIK LK
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 327 RINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGV 386
+++F E IM + H NV+ G TK + I+TEFM GS+ +L + G
Sbjct: 66 Y-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ 124
Query: 387 FKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVM 446
F + L+ + ++ GM YL N +HRDL A N+L++ N V KV+DFG++R
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 447 TAET------GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAV 499
T RW APE I+++ + +DV+S+GIV+WE+++ G+ PY +T Q +
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVI 243
Query: 500 GVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548
+++ R P + L +L+ CWQ+D RP F +I+ L ++ +
Sbjct: 244 NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (573), Expect = 7e-70
Identities = 72/264 (27%), Positives = 136/264 (51%), Gaps = 12/264 (4%)
Query: 288 EIDPK-HLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMR 344
+++P+ + ++ G++G +Y+ S A KV+ + + + +++ E+ I+
Sbjct: 7 DLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILA 64
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
H N+V+ + A +L I+ EF +GG+V + +L+ + V +N
Sbjct: 65 SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 124
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVI-- 461
YLH N IIHRDLKA N+L + +K+ADFGV+ ++ + GT WMAPEV+
Sbjct: 125 YLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184
Query: 462 ---EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ-KGLRPTIPKNSQPK 517
+ +PYD+KADV+S GI L E+ + P+ L P++ + + + + P
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244
Query: 518 LAELLERCWQQDPALRPDFSEIIE 541
+ L++C +++ R S++++
Sbjct: 245 FKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 9e-70
Identities = 82/301 (27%), Positives = 145/301 (48%), Gaps = 32/301 (10%)
Query: 278 KIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINS 330
++P D WE L FG + +G++G + T VA+K+LKP +
Sbjct: 11 QLPYD--HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HL 67
Query: 331 DMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLK----- 384
++ E+ ++ + H N+V +GACT ++TE+ G + ++L + +
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 385 ------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVA 432
L LL + V+KGM +L N IHRDL A N+L+ + K+
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187
Query: 433 DFGVARVKAQSGVMTAET---GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLP 488
DFG+AR + +WMAPE I + Y ++DV+S+GI LWEL + G P
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
Query: 489 YEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548
Y + ++++G R P+++ ++ ++++ CW DP RP F +I++++++
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
Query: 549 E 549
E
Sbjct: 308 E 308
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 224 bits (571), Expect = 3e-69
Identities = 82/305 (26%), Positives = 136/305 (44%), Gaps = 27/305 (8%)
Query: 280 PNDGTDVWEIDPKHL-KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ-KE 335
P+ ++ DP+ L ++ GS+G +Y + VAIK + S+ + ++
Sbjct: 2 PDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 336 FAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKV 395
+EV ++K+RH N +Q+ G + + +V E+ G + K + + V
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAV 120
Query: 396 AIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRW 455
+G+ YLH +N+IHRD+KA N+L+ E +VK+ DFG A + A + GT W
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYW 177
Query: 456 MAPEVIE---HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPK 512
MAPEVI YD K DV+S GI EL K P + + A + Q
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 237
Query: 513 NSQPKLAELLERCWQQDPALRPDFSEI---------------IEILQQIAKEVGE-ENEE 556
+ ++ C Q+ P RP + ++++Q+ V E +N +
Sbjct: 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQ 297
Query: 557 RRKEK 561
RK K
Sbjct: 298 YRKMK 302
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 3e-69
Identities = 81/282 (28%), Positives = 138/282 (48%), Gaps = 21/282 (7%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIM 343
+D +KF + G++G + + D AIK +K + D ++FA E+ ++
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVL 64
Query: 344 RKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHK---------------LKGVF 387
K+ H N++ +GAC L + E+ G++ D+L K
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 388 KLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 447
LL A DV++GM+YL Q IHRDL A N+L+ EN V K+ADFG++R + T
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184
Query: 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 507
RWMA E + + Y +DV+S+G++LWE+++ + +G R
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244
Query: 508 PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549
P N ++ +L+ +CW++ P RP F++I+ L ++ +E
Sbjct: 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 222 bits (565), Expect = 1e-68
Identities = 81/295 (27%), Positives = 141/295 (47%), Gaps = 34/295 (11%)
Query: 287 WEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQE 339
E ++++ + G++G +++ VA+K+LK E ++DMQ +F +E
Sbjct: 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQRE 66
Query: 340 VFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKG-------------- 385
+M + + N+V+ +G C +C++ E+M+ G + ++L +
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 386 ---------VFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436
L +A V+ GM YL + +HRDL N L+ EN VVK+ADFG+
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 437 ARVKAQSGVMTAET---GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLT 493
+R + A+ RWM PE I + Y ++DV+++G+VLWE+ + L Y
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246
Query: 494 PLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548
+ + V+ G P+N +L L+ CW + PA RP F I ILQ++ +
Sbjct: 247 AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 2e-68
Identities = 66/260 (25%), Positives = 123/260 (47%), Gaps = 14/260 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ + +GSYG + S + + K L + ++ EV ++R+++H N+V
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 353 QFIGACTKPPS--LCIVTEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLH 407
++ + L IV E+ GG + + K + +L+V ++ + H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 408 Q-----NNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVI 461
+ + ++HRDLK AN+ +D + VK+ DFG+AR + + A GT +M+PE +
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186
Query: 462 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521
Y+ K+D++S G +L+EL P+ + + A G +++G IP +L E+
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-GKIREGKFRRIPYRYSDELNEI 245
Query: 522 LERCWQQDPALRPDFSEIIE 541
+ R RP EI+E
Sbjct: 246 ITRMLNLKDYHRPSVEEILE 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (560), Expect = 1e-67
Identities = 80/281 (28%), Positives = 126/281 (44%), Gaps = 14/281 (4%)
Query: 287 WEIDPKHLK--FGSKVASGSYGDLYRGTYCSQD-----VAIKVLKPERINSDMQKEFAQE 339
I P L F + G +G +Y GT D A+K L + +F E
Sbjct: 20 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTE 78
Query: 340 VFIMRKVRHKNVVQFIGACTKPP-SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAID 398
IM+ H NV+ +G C + S +V +M G + +++ + L+ +
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 399 VSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----VMTAETGTY 453
V+KGM +L +HRDL A N ++DE VKVADFG+AR T
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198
Query: 454 RWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKN 513
+WMA E ++ + + K+DV+SFG++LWEL+T P + +G R P+
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 258
Query: 514 SQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEEN 554
L E++ +CW +RP FSE++ + I E+
Sbjct: 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 4e-66
Identities = 69/257 (26%), Positives = 124/257 (48%), Gaps = 9/257 (3%)
Query: 290 DP-KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV 346
DP K K+ G+ G +Y + Q+VAI+ + + ++ E+ +MR+
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMREN 74
Query: 347 RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
++ N+V ++ + L +V E+++GGS+ D + + + V + + + +L
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFL 132
Query: 407 HQNNIIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKP 465
H N +IHRD+K+ N+L+ + VK+ DFG + + + GT WMAPEV+ K
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 466 YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG-LRPTIPKNSQPKLAELLER 524
Y K D++S GI+ E++ G+ PY PL+A + G P+ + L R
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 525 CWQQDPALRPDFSEIIE 541
C D R E+++
Sbjct: 253 CLDMDVEKRGSAKELLQ 269
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 4e-66
Identities = 66/254 (25%), Positives = 121/254 (47%), Gaps = 9/254 (3%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ G+YG++ + VA+K++ +R D + +E+ I + + H+NVV
Sbjct: 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVV 66
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+F G + + E+ SGG ++D + P + + G+ YLH I
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGIT 125
Query: 413 HRDLKAANLLMDENEVVKVADFGVARV---KAQSGVMTAETGTYRWMAPEVIEHKPYD-H 468
HRD+K NLL+DE + +K++DFG+A V + ++ GT ++APE+++ + +
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 469 KADVFSFGIVLWELLTGKLPYEYLTP-LQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527
DV+S GIVL +L G+LP++ + Q +K K LL +
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILV 245
Query: 528 QDPALRPDFSEIIE 541
++P+ R +I +
Sbjct: 246 ENPSARITIPDIKK 259
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 2e-65
Identities = 88/297 (29%), Positives = 142/297 (47%), Gaps = 28/297 (9%)
Query: 279 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD-------VAIKVLKPERINSD 331
+P D WE LK G + G++G + D VA+K+LK +S+
Sbjct: 1 LPYD-ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 59
Query: 332 MQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS-LCIVTEFMSGGSVYDYLHK-------- 382
+ ++ ++ H NVV +GACTKP L ++ EF G++ YL
Sbjct: 60 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 119
Query: 383 -------LKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFG 435
K L L+ + V+KGM +L IHRDL A N+L+ E VVK+ DFG
Sbjct: 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 436 VARVKAQSGVMTAET---GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG-KLPYEY 491
+AR + + +WMAPE I + Y ++DV+SFG++LWE+ + PY
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239
Query: 492 LTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548
+ + +++G R P + P++ + + CW +P+ RP FSE++E L + +
Sbjct: 240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 3e-65
Identities = 85/296 (28%), Positives = 144/296 (48%), Gaps = 31/296 (10%)
Query: 279 IPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQD---------VAIKVLKPERIN 329
+P D WE+ L G + G++G + D VA+K+LK +
Sbjct: 2 LPED--PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE 59
Query: 330 SDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLH------- 381
D+ + E+ +M+ + +HKN++ +GACT+ L ++ E+ S G++ +YL
Sbjct: 60 KDL-SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118
Query: 382 --------KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVAD 433
+ L+ A V++GM YL IHRDL A N+L+ E+ V+K+AD
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 178
Query: 434 FGVARVKAQSGVMTA---ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE 490
FG+AR +WMAPE + + Y H++DV+SFG++LWE+ T
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238
Query: 491 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
P++ ++++G R P N +L ++ CW P+ RP F +++E L +I
Sbjct: 239 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 2e-64
Identities = 79/271 (29%), Positives = 138/271 (50%), Gaps = 13/271 (4%)
Query: 289 IDPKHLKFGSKVASGSYGDLYRGTYCSQD------VAIKVLKPERINSDMQKEFAQEVFI 342
+ K + SG++G +Y+G + + VAIK L+ E + KE E ++
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYV 64
Query: 343 MRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKG 402
M V + +V + +G C ++ ++T+ M G + DY+ + K LL + ++KG
Sbjct: 65 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 403 MNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPE 459
MNYL ++HRDL A N+L+ + VK+ DFG+A++ +WMA E
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 460 VIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518
I H+ Y H++DV+S+G+ +WEL+T G PY+ + +++KG R P +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKGERLPQPPICTIDV 242
Query: 519 AELLERCWQQDPALRPDFSEIIEILQQIAKE 549
++ +CW D RP F E+I ++A++
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIEFSKMARD 273
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 5e-64
Identities = 65/299 (21%), Positives = 129/299 (43%), Gaps = 48/299 (16%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRK 345
E+ + S++ +G+ G +++ ++ +A K++ E I ++ + +E+ ++ +
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHE 60
Query: 346 VRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNY 405
+V F GA + I E M GGS+ L K G L KV+I V KG+ Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 119
Query: 406 LHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 464
L + + I+HRD+K +N+L++ +K+ DFGV+ + + + GT +M+PE ++
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGT 178
Query: 465 PYDHKADVFSFGIVLWELLTGKLPYEYLTP--LQAAVGVVQKGLRPTIPKNSQ------- 515
Y ++D++S G+ L E+ G+ P L+ G +G P +
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238
Query: 516 ---------------------------------PKLAELLERCWQQDPALRPDFSEIIE 541
+ + + +C ++PA R D +++
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 3e-63
Identities = 77/281 (27%), Positives = 133/281 (47%), Gaps = 20/281 (7%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFA 337
D WE+ + + ++ GS+G +Y G VAIK + + + EF
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE-RIEFL 71
Query: 338 QEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK--------- 388
E +M++ +VV+ +G ++ ++ E M+ G + YL L+
Sbjct: 72 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 389 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---V 445
L ++++A +++ GM YL+ N +HRDL A N ++ E+ VK+ DFG+ R ++
Sbjct: 132 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191
Query: 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG 505
RWM+PE ++ + +DV+SFG+VLWE+ T + + V +G
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251
Query: 506 LRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQI 546
P N L EL+ CWQ +P +RP F EII +++
Sbjct: 252 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 5e-63
Identities = 72/303 (23%), Positives = 135/303 (44%), Gaps = 48/303 (15%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV 351
+ + + G +G+++RG + ++VA+K+ + E++ +RH+N+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENI 59
Query: 352 VQFIGACTKP----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLH 407
+ FI A K L +V+++ GS++DYL++ + ++K+A+ + G+ +LH
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLH 117
Query: 408 Q--------NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-----VMTAETGTYR 454
I HRDLK+ N+L+ +N +AD G+A + GT R
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 455 WMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV--------- 499
+MAPEV++ H +AD+++ G+V WE+ Q
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 500 ------GVVQKGLRPTIPKNSQP-----KLAELLERCWQQDPALRPDFSEIIEILQQIAK 548
V ++ LRP IP Q +A+++ CW + A R I + L Q+++
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
Query: 549 EVG 551
+ G
Sbjct: 298 QEG 300
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 207 bits (528), Expect = 1e-62
Identities = 59/265 (22%), Positives = 113/265 (42%), Gaps = 12/265 (4%)
Query: 287 WEIDPKHL----KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEV 340
EI H+ ++ +G++G ++R T + + A K + + ++ +E+
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEI 74
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 400
M +RH +V A + ++ EFMSGG +++ + ++ V
Sbjct: 75 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134
Query: 401 KGMNYLHQNNIIHRDLKAANLLM--DENEVVKVADFGVARVKAQSGVMTAETGTYRWMAP 458
KG+ ++H+NN +H DLK N++ + +K+ DFG+ + TGT + AP
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 194
Query: 459 EVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--P 516
EV E KP + D++S G++ + LL+G P+ + V S
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254
Query: 517 KLAELLERCWQQDPALRPDFSEIIE 541
+ + + DP R + +E
Sbjct: 255 DGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 205 bits (523), Expect = 3e-62
Identities = 64/298 (21%), Positives = 136/298 (45%), Gaps = 23/298 (7%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
F + +G++ ++ + VAIK + + + + E+ ++ K++H N+V
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIV 70
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
L ++ + +SGG ++D + + KG + ++ V + YLH I+
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIV 129
Query: 413 HRDLKAANLL---MDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 469
HRDLK NLL +DE+ + ++DFG+++++ V++ GT ++APEV+ KPY
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 189
Query: 470 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQ 527
D +S G++ + LL G P+ + +++ P + + +
Sbjct: 190 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLME 249
Query: 528 QDPALRPDFSEIIE-------------ILQQIAKEVGEENEERRKEKSSGGFLSVLRR 572
+DP R + ++ I Q +++++ ++N + K K + +V+R
Sbjct: 250 KDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQI-KKNFAKSKWKQAFNATAVVRH 306
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 206 bits (524), Expect = 6e-62
Identities = 49/255 (19%), Positives = 114/255 (44%), Gaps = 8/255 (3%)
Query: 293 HLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKN 350
+ ++ SG++G ++R + + K + + E+ IM ++ H
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPK 87
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 410
++ A + ++ EF+SGG ++D + ++ +G+ ++H+++
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 147
Query: 411 IIHRDLKAANLLMDENE--VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 468
I+H D+K N++ + + VK+ DFG+A ++ T T + APE+++ +P
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 207
Query: 469 KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCW 526
D+++ G++ + LL+G P+ L+ V + S P+ + ++
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL 267
Query: 527 QQDPALRPDFSEIIE 541
Q++P R + +E
Sbjct: 268 QKEPRKRLTVHDALE 282
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 5e-61
Identities = 58/258 (22%), Positives = 114/258 (44%), Gaps = 9/258 (3%)
Query: 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSD-MQKEFAQEVFIMR 344
+ P+ KFG + GS+ + + ++ AIK+L+ I + +E +M
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 345 KVRHKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
++ H V+ L + G + Y+ K G F ++ +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALE 122
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVI 461
YLH IIHRDLK N+L++E+ +++ DFG A+V + + GT ++++PE++
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 462 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAEL 521
K +D+++ G ++++L+ G P+ +++ L P+ PK +L
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDL 240
Query: 522 LERCWQQDPALRPDFSEI 539
+E+ D R E+
Sbjct: 241 VEKLLVLDATKRLGCEEM 258
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 1e-60
Identities = 51/280 (18%), Positives = 115/280 (41%), Gaps = 15/280 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ G +G ++R S + K +K + Q +E+ I+ RH+N++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNIL 64
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ L ++ EF+SG +++ ++ ++ V + + +LH +NI
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 413 HRDLKAANLLMD--ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 470
H D++ N++ + +K+ +FG AR + APEV +H
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 471 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--PKLAELLERCWQQ 528
D++S G +++ LL+G P+ T Q ++ + + + ++R +
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK 244
Query: 529 DPALRPDFSEII------EILQQIAKEVGEENEERRKEKS 562
+ R SE + + +++++ +V + RR +
Sbjct: 245 ERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHT 284
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 197 bits (503), Expect = 1e-59
Identities = 60/265 (22%), Positives = 117/265 (44%), Gaps = 19/265 (7%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-------DMQKEFAQEVFIMRK 345
+ + G + R + ++ A+K++ S ++++ +EV I+RK
Sbjct: 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65
Query: 346 VR-HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
V H N++Q +V + M G ++DYL + K K+ + + +
Sbjct: 66 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVIC 124
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIE-- 462
LH+ NI+HRDLK N+L+D++ +K+ DFG + + GT ++APE+IE
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 184
Query: 463 ----HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ--P 516
H Y + D++S G++++ LL G P+ + + ++ + P+
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 244
Query: 517 KLAELLERCWQQDPALRPDFSEIIE 541
+ +L+ R P R E +
Sbjct: 245 TVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 3e-58
Identities = 59/255 (23%), Positives = 118/255 (46%), Gaps = 10/255 (3%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRHKN 350
+ GS+G ++ + Q AIK LK + + + D++ ++ + H
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 351 VVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN 410
+ +L V E+++GG + ++ F L A ++ G+ +LH
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 411 IIHRDLKAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVIEHKPYDHK 469
I++RDLK N+L+D++ +K+ADFG+ + GT ++APE++ + Y+H
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS 183
Query: 470 ADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQD 529
D +SFG++L+E+L G+ P+ + + P P+ + + +LL + + ++
Sbjct: 184 VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLVKLFVRE 241
Query: 530 PALRPDFSEIIEILQ 544
P R +I Q
Sbjct: 242 PEKRLGVRG--DIRQ 254
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 193 bits (491), Expect = 4e-58
Identities = 74/274 (27%), Positives = 129/274 (47%), Gaps = 19/274 (6%)
Query: 291 PKHL----KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIM 343
P HL + G + G +++ +DVA+KVL+ + F +E
Sbjct: 2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA 61
Query: 344 RKVRHKNVVQFIGAC----TKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
+ H +V P IV E++ G ++ D +H +G ++V D
Sbjct: 62 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADA 120
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAET----GTYRW 455
+ +N+ HQN IIHRD+K AN+++ VKV DFG+AR A SG +T GT ++
Sbjct: 121 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 456 MAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 515
++PE D ++DV+S G VL+E+LTG+ P+ +P+ A V++ P ++
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240
Query: 516 --PKLAELLERCWQQDPALRP-DFSEIIEILQQI 546
L ++ + ++P R +E+ L ++
Sbjct: 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 3e-56
Identities = 60/259 (23%), Positives = 117/259 (45%), Gaps = 13/259 (5%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSD----MQKEFAQEVFIMRKVRH 348
G ++ SG + + + S A K +K R S +++ +EV I+++++H
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
NV+ + ++ E ++GG ++D+L + K + + G+ YLH
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS 131
Query: 409 NNIIHRDLKAANLLMDENEV----VKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHK 464
I H DLK N+++ + V +K+ DFG+A GT ++APE++ ++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 465 PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ--AAVGVVQKGLRPTIPKNSQPKLAELL 522
P +AD++S G++ + LL+G P+ T + A V V N+ + +
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251
Query: 523 ERCWQQDPALRPDFSEIIE 541
R +DP R + ++
Sbjct: 252 RRLLVKDPKKRMTIQDSLQ 270
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (473), Expect = 3e-55
Identities = 62/280 (22%), Positives = 112/280 (40%), Gaps = 23/280 (8%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ G K+ SGS+GD+Y GT + ++VAIK+ + + E I + ++ +
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGI 65
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
I C ++ + G S+ D + F L ++L +A + + Y+H N I
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 125
Query: 413 HRDLKAANLLM---DENEVVKVADFGVARVKAQSGV--------MTAETGTYRWMAPEVI 461
HRD+K N LM + +V + DFG+A+ + TGT R+ +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 462 EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR------PTIPKNSQ 515
+ D+ S G VL G LP++ L + + + K
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245
Query: 516 PKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENE 555
+ A L C +PD+S + ++ + + G +
Sbjct: 246 SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 181 bits (460), Expect = 4e-53
Identities = 66/258 (25%), Positives = 120/258 (46%), Gaps = 10/258 (3%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRH 348
+ + + +GS+G ++ + A+KVLK E + Q E E ++ V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
+++ G + ++ +++ GG ++ L K F P A +V + YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDH 468
+II+RDLK N+L+D+N +K+ DFG A+ V GT ++APEV+ KPY+
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYTLCGTPDYIAPEVVSTKPYNK 180
Query: 469 KADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 528
D +SFGI+++E+L G P+ ++ ++ P + +LL R +
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITR 238
Query: 529 DPALRPDFSE--IIEILQ 544
D + R + ++
Sbjct: 239 DLSQRLGNLQNGTEDVKN 256
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 180 bits (457), Expect = 6e-53
Identities = 46/287 (16%), Positives = 101/287 (35%), Gaps = 25/287 (8%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK 349
H K G ++ GS+G ++ GT Q VAIK + E + +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLAGC 60
Query: 350 NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQN 409
+ + + ++ + G S+ D L F + ++ A + + +H+
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 410 NIIHRDLKAANLLMDE-----NEVVKVADFGVARVKAQSGV--------MTAETGTYRWM 456
++++RD+K N L+ ++ V DFG+ + +GT R+M
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 457 APEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR------PTI 510
+ + + D+ + G V L G LP++ L + G + +
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 511 PKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGEENEER 557
+ + + PD+ + + ++ + + +E
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDEN 287
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-52
Identities = 61/257 (23%), Positives = 110/257 (42%), Gaps = 19/257 (7%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQ----KEFAQEVFIMRKVR- 347
+ G + SG +G +Y G S VAIK ++ +RI+ + EV +++KV
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 348 -HKNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYL 406
V++ + +P S ++ E +G + V + + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 407 HQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKP 465
H ++HRD+K N+L+D N +K+ DFG + + V T GT + PE I +
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 185
Query: 466 Y-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524
Y A V+S GI+L++++ G +P+E+ + + + + L+
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG--------QVFFRQRVSSECQHLIRW 237
Query: 525 CWQQDPALRPDFSEIIE 541
C P+ RP F EI
Sbjct: 238 CLALRPSDRPTFEEIQN 254
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 181 bits (459), Expect = 2e-52
Identities = 66/260 (25%), Positives = 121/260 (46%), Gaps = 12/260 (4%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQ----EVFIMRKVRH 348
+ G +G++Y + A+K L +RI + A + ++
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
+V A P L + + M+GG ++ +L + GVF + A ++ G+ ++H
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHN 125
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYD 467
+++RDLK AN+L+DE+ V+++D G+A ++ A GT+ +MAPEV++ YD
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYD 184
Query: 468 HKADVFSFGIVLWELLTGKLPYEYLTPL-QAAVGVVQKGLRPTIPKNSQPKLAELLERCW 526
AD FS G +L++LL G P+ + + + + +P + P+L LLE
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 244
Query: 527 QQDPALRPDFSE--IIEILQ 544
Q+D R E+ +
Sbjct: 245 QRDVNRRLGCLGRGAQEVKE 264
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-50
Identities = 60/259 (23%), Positives = 121/259 (46%), Gaps = 9/259 (3%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINS-DMQKEFAQEVFIMRKVRH 348
+ + G++G + + + A+K+L+ E I + D E +++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 349 KNVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ 408
+ A LC V E+ +GG ++ +L + + VF ++ + YLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHS 123
Query: 409 NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPYD 467
++++RD+K NL++D++ +K+ DFG+ + G M GT ++APEV+E Y
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 468 HKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQ 527
D + G+V++E++ G+LP+ + ++ + P+ P+ LL +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLK 241
Query: 528 QDPALRP--DFSEIIEILQ 544
+DP R S+ E+++
Sbjct: 242 KDPKQRLGGGPSDAKEVME 260
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-50
Identities = 54/257 (21%), Positives = 105/257 (40%), Gaps = 24/257 (9%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGAC 358
G G + + + A+K+L+ + +EV + + + ++V+ +
Sbjct: 22 LGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVY 74
Query: 359 ----TKPPSLCIVTEFMSGGSVYDYLHKLKG-VFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
L IV E + GG ++ + F ++ + + + YLH NI H
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 134
Query: 414 RDLKAANLLMD---ENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKA 470
RD+K NLL N ++K+ DFG A+ +T T ++APEV+ + YD
Sbjct: 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC 194
Query: 471 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTI------PKNSQPKLAELLER 524
D++S G++++ LL G P+ L + G+ + ++ L+
Sbjct: 195 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 254
Query: 525 CWQQDPALRPDFSEIIE 541
+ +P R +E +
Sbjct: 255 LLKTEPTQRMTITEFMN 271
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 9e-50
Identities = 55/286 (19%), Positives = 114/286 (39%), Gaps = 36/286 (12%)
Query: 292 KHLKFGSKVASGSYGDLYRGTYCS---QDVAIKVLKPERINSDMQKEFAQEVFIMRK--- 345
+ + +++ G+YG +++ + VA+K ++ + M +EV ++R
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 346 VRHKNVVQFIGACTKPPS-----LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVS 400
H NVV+ CT + L +V E + + ++ + +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 401 KGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEV 460
+G+++LH + ++HRDLK N+L+ + +K+ADFG+AR+ + +T+ T + APEV
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 186
Query: 461 IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT----------- 509
+ Y D++S G + E+ K + + + ++ P
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 510 --------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
+ +LL +C +PA R +
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 7e-47
Identities = 60/273 (21%), Positives = 118/273 (43%), Gaps = 34/273 (12%)
Query: 302 SGSYGDLYRGTYCS--QDVAIKVLKPERI---NSDMQKEFAQEVFIMRKVRHKNVVQFIG 356
G + +Y+ + Q VAIK +K + + +E+ +++++ H N++ +
Sbjct: 8 EGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLD 67
Query: 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDL 416
A ++ +V +FM + + V + + +G+ YLHQ+ I+HRDL
Sbjct: 68 AFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDL 126
Query: 417 KAANLLMDENEVVKVADFGVAR-VKAQSGVMTAETGTYRWMAPEVI-EHKPYDHKADVFS 474
K NLL+DEN V+K+ADFG+A+ + + T + T + APE++ + Y D+++
Sbjct: 127 KPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWA 186
Query: 475 FGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT------------------------- 509
G +L ELL + L + + PT
Sbjct: 187 VGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLH 246
Query: 510 -IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
I + L +L++ + +P R ++ ++
Sbjct: 247 HIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 3e-46
Identities = 53/278 (19%), Positives = 106/278 (38%), Gaps = 31/278 (11%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ K+ G+YG +Y+ + VA+K ++ + + +E+ +++++ H N+V
Sbjct: 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ + L +V EF+ LP + + +G+ + H + ++
Sbjct: 65 KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 413 HRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIEHKPY-DHKA 470
HRDLK NLL++ +K+ADFG+AR T E T + APE++ Y
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 471 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--------------------- 509
D++S G + E++T + + + + + + P
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 510 ------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
+ LL + DP R +
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 161 bits (409), Expect = 3e-46
Identities = 55/277 (19%), Positives = 108/277 (38%), Gaps = 31/277 (11%)
Query: 295 KFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ 353
K+ G+YG +Y+ + A+K ++ E+ + + +E+ I+++++H N+V+
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 354 FIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIH 413
L +V E + L +G + + + + G+ Y H ++H
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQDL-KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 414 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRW-MAPEVIE-HKPYDHKAD 471
RDLK NLL++ +K+ADFG+AR W AP+V+ K Y D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 472 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT---------------------- 509
++S G + E++ G + ++ + + + P
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 510 -----IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
K +LL + + DP R + +E
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 3e-45
Identities = 60/296 (20%), Positives = 119/296 (40%), Gaps = 44/296 (14%)
Query: 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIM 343
V+++ P++ S + G+YG + VAIK + P + + +E+ I+
Sbjct: 3 VFDVGPRY-TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKIL 60
Query: 344 RKVRHKNVVQFIGACTKPP----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDV 399
+ RH+N++ P + + G +Y L + +
Sbjct: 61 LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQI 118
Query: 400 SKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRW 455
+G+ Y+H N++HRDLK +NLL++ +K+ DFG+ARV +G +T T +
Sbjct: 119 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 456 MAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT----- 509
APE++ + Y D++S G +L E+L+ + + L ++ P+
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 510 ------------------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
+ N+ K +LL++ +P R + + +
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-44
Identities = 64/293 (21%), Positives = 119/293 (40%), Gaps = 47/293 (16%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ +K+ G++G++++ + Q VA+K + E +E+ I++ ++H+NVV
Sbjct: 13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72
Query: 353 QFIGACTKPPS--------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMN 404
I C S + +V +F + L F L + +V + G+
Sbjct: 73 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLY 131
Query: 405 YLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV-----KAQSGVMTAETGTYRWMAPE 459
Y+H+N I+HRD+KAAN+L+ + V+K+ADFG+AR +Q T T + PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 460 VI-EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--------- 509
++ + Y D++ G ++ E+ T + T + Q T
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 510 ---------------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
P +L+++ DPA R D + +
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (402), Expect = 2e-44
Identities = 63/243 (25%), Positives = 112/243 (46%), Gaps = 8/243 (3%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKE-FAQEVFIMRKVRHKNV 351
+ +GS+G + + A+K+L +++ Q E E I++ V +
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 352 VQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNI 411
V+ + +L +V E+++GG ++ +L + G F P A + YLH ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 412 IHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKAD 471
I+RDLK NLL+D+ ++V DFG A+ G GT +APE+I K Y+ D
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWTLCGTPEALAPEIILSKGYNKAVD 220
Query: 472 VFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPA 531
++ G++++E+ G P+ P+Q +V + P + L +LL Q D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 532 LRP 534
R
Sbjct: 279 KRF 281
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 4e-44
Identities = 62/284 (21%), Positives = 130/284 (45%), Gaps = 17/284 (5%)
Query: 277 LKIPNDGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSD 331
L+ N ++ ++ + + +G+YG ++ S + A+KVLK I
Sbjct: 9 LRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK 68
Query: 332 MQ--KEFAQEVFIMRKVRHK-NVVQFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFK 388
+ + E ++ +R +V A L ++ ++++GG ++ +L + + F
Sbjct: 69 AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFT 127
Query: 389 LPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVAR--VKAQSGVM 446
+ ++ + +LH+ II+RD+K N+L+D N V + DFG+++ V ++
Sbjct: 128 EHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 187
Query: 447 TAETGTYRWMAPEVIEHKP--YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQK 504
GT +MAP+++ +D D +S G++++ELLTG P+ + + ++
Sbjct: 188 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 247
Query: 505 GLR--PTIPKNSQPKLAELLERCWQQDPALRPDFSE--IIEILQ 544
L+ P P+ +L++R +DP R EI +
Sbjct: 248 ILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 7e-43
Identities = 55/279 (19%), Positives = 110/279 (39%), Gaps = 33/279 (11%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ K+ G+YG +++ + VA+K ++ + + + +E+ ++++++HKN+V
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 353 QFIGACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNII 412
+ L +V EF + G + + KG+ + H N++
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123
Query: 413 HRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAETGTYRWMAPEVIE-HKPYDHKA 470
HRDLK NLL++ N +K+A+FG+AR +AE T + P+V+ K Y
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 471 DVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP---------------------- 508
D++S G + EL P + + + + L
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243
Query: 509 ------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
+ +LL+ + +P R E ++
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-42
Identities = 72/295 (24%), Positives = 116/295 (39%), Gaps = 40/295 (13%)
Query: 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEV 340
WE+ + V SG+YG + VAIK L + K +E+
Sbjct: 10 TKTAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYREL 68
Query: 341 FIMRKVRHKNVVQFIGACTKPPSLCIVTEFM----SGGSVYDYLHKLKGVFKLPSLLKVA 396
+++ +RH+NV+ + T +L T+F G+ L K + +
Sbjct: 69 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLV 127
Query: 397 IDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWM 456
+ KG+ Y+H IIHRDLK NL ++E+ +K+ DFG+AR MT T +
Sbjct: 128 YQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYR 185
Query: 457 APEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP------- 508
APEVI Y D++S G ++ E++TGK ++ L +++ P
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245
Query: 509 ----------------------TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
+I N+ P LLE+ D R E +
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-40
Identities = 59/286 (20%), Positives = 106/286 (37%), Gaps = 45/286 (15%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
+ +GS+G +Y+ C + VAIK + ++ + +E+ IMRK+ H N+V
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIV 76
Query: 353 QFIGACTKPPS------LCIVTEFMSGGSVYDYLH--KLKGVFKLPSLLKVAIDVSKGMN 404
+ L +V +++ H + K + + + + +
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 405 YLHQNNIIHRDLKAANL-LMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAP-EVIE 462
Y+H I HRD+K NL L + V+K+ DFG A+ + + + + AP +
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 463 HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT------------- 509
Y DV+S G VL ELL G+ + + + V +++ PT
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 510 --------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
+ P+ L R + P R E
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (357), Expect = 4e-38
Identities = 63/307 (20%), Positives = 116/307 (37%), Gaps = 53/307 (17%)
Query: 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEV 340
G + + K + + SG+ G + ++VAIK L N K +E+
Sbjct: 9 GDSTFTV-LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 341 FIMRKVRHKNVVQFIGACTKPPS------LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLK 394
+M+ V HKN++ + T + + +V E M ++ +
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSY 123
Query: 395 VAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYR 454
+ + G+ +LH IIHRDLK +N+++ + +K+ DFG+AR S +MT T
Sbjct: 124 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 183
Query: 455 WMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT----- 509
+ APEVI Y D++S G ++ E++ K+ + + V+++ P
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243
Query: 510 -----------------------------------IPKNSQPKLAELLERCWQQDPALRP 534
K + +LL + DPA R
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303
Query: 535 DFSEIIE 541
+ ++
Sbjct: 304 SVDDALQ 310
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 140 bits (353), Expect = 8e-38
Identities = 52/310 (16%), Positives = 119/310 (38%), Gaps = 60/310 (19%)
Query: 283 GTDVWEIDPKHLKFGS--------KVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDM 332
+ W+ + +++G+ K+ G Y +++ + + V +K+LKP +
Sbjct: 18 PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----- 72
Query: 333 QKEFAQEVFIMRKVR-HKNVVQFIGACTKPPS--LCIVTEFMSGGSVYDYLHKLKGVFKL 389
+K+ +E+ I+ +R N++ P S +V E ++ +L
Sbjct: 73 KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD----FKQLYQTLTD 128
Query: 390 PSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQSGVMTA 448
+ ++ K ++Y H I+HRD+K N+++D E+ +++ D+G+A
Sbjct: 129 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 188
Query: 449 ETGTYRWMAPEV-IEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL- 506
+ + PE+ ++++ YD+ D++S G +L ++ K P+ + + + K L
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248
Query: 507 -----------------------------------RPTIPKNSQPKLAELLERCWQQDPA 531
P+ + L++ + D
Sbjct: 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308
Query: 532 LRPDFSEIIE 541
R E +E
Sbjct: 309 SRLTAREAME 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-37
Identities = 57/293 (19%), Positives = 116/293 (39%), Gaps = 40/293 (13%)
Query: 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFI 342
+WE+ P+ + S V SG+YG + VA+K L + K +E+ +
Sbjct: 12 TIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 343 MRKVRHKNVVQFIGACTKPPSLC-----IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
++ ++H+NV+ + T SL + + G + + + + +
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIY 128
Query: 398 DVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMA 457
+ +G+ Y+H +IIHRDLK +NL ++E+ +K+ DFG+AR + +
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTGYVATRWYRAP 187
Query: 458 PEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT-------- 509
++ Y+ D++S G ++ ELLTG+ + + +++ P
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 510 ---------------------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541
+ + P +LLE+ D R ++ +
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (267), Expect = 5e-26
Identities = 47/317 (14%), Positives = 108/317 (34%), Gaps = 75/317 (23%)
Query: 295 KFGSKVASGSYGDLYRGTYCS--QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVV 352
K+ G + ++ VA+K+++ +++ + E+ ++++V +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNT 72
Query: 353 QFIGACTKPP---------------SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAI 397
+ + +V E + + L + +++
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 398 DVSKGMNYLH-QNNIIHRDLKAANLLMDENEV------VKVADFGVARVKAQSGVMTAET 450
+ G++Y+H + IIH D+K N+LM+ + +K+AD G A + +
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS--I 190
Query: 451 GTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYE-------------------- 490
T + +PEV+ P+ AD++S +++EL+TG +E
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 491 -----------------YLTPLQAAVGVVQKGLRPT---------IPKNSQPKLAELLER 524
+ + + P K+ ++++ L
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310
Query: 525 CWQQDPALRPDFSEIIE 541
Q DP R D ++
Sbjct: 311 MLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.5 bits (190), Expect = 4e-17
Identities = 22/195 (11%), Positives = 58/195 (29%), Gaps = 32/195 (16%)
Query: 297 GSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQK--------EFAQEVFIMRKVR 347
G + G ++ + +K K + K F+ +
Sbjct: 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 348 HKNVVQFIGACTKPP----SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGM 403
+ + + G ++ E + +Y ++ + +V + + +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEV 116
Query: 404 NYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV----KAQSGVMTAETGTYRWMAPE 459
+ I+H DL N+L+ E + + DF + + + + +
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIITYFS-- 173
Query: 460 VIEHKPYDHKADVFS 474
+ Y + D+ S
Sbjct: 174 ----RTYRTEKDINS 184
|
| >d1ygya3 d.58.18.1 (A:452-529) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 78 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 38.7 bits (90), Expect = 1e-04
Identities = 12/62 (19%), Positives = 23/62 (37%), Gaps = 2/62 (3%)
Query: 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWP-YEETEQL 237
+ D+P L ++ LL G+NIQ A + + + +D + +
Sbjct: 4 INLIIHYVDRPGALGKIGTLLGTAGVNIQAAQLSEDAEGPGATILLRLDQDVPDDVRTAI 63
Query: 238 RA 239
A
Sbjct: 64 AA 65
|
| >d1u8sa1 d.58.18.5 (A:2-87) putative transcriptional repressor VC2159 {Vibrio cholerae [TaxId: 666]} Length = 86 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Glycine cleavage system transcriptional repressor domain: putative transcriptional repressor VC2159 species: Vibrio cholerae [TaxId: 666]
Score = 38.6 bits (90), Expect = 1e-04
Identities = 10/62 (16%), Positives = 22/62 (35%), Gaps = 2/62 (3%)
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL 241
IT D+P + +++ L+ G NI + + ++ G ++ L
Sbjct: 8 ITAVGTDRPGICNEVVRLVTQAGCNI-IDSRIAMFGKEFTLLMLISG-SPSNITRVETTL 65
Query: 242 EK 243
Sbjct: 66 PL 67
|
| >d1sc6a3 d.58.18.1 (A:327-410) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Escherichia coli [TaxId: 562]} Length = 84 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain species: Escherichia coli [TaxId: 562]
Score = 38.5 bits (90), Expect = 2e-04
Identities = 12/62 (19%), Positives = 29/62 (46%), Gaps = 2/62 (3%)
Query: 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEET-EQL 237
+ +++P +L+ L + A+ G+NI + ++ GY + D E+ + +
Sbjct: 12 RRLMHIHENRPGVLTALNKIFAEQGVNIAAQYLQTSAQMGYVVIDIEADEDVAEKALQAM 71
Query: 238 RA 239
+A
Sbjct: 72 KA 73
|
| >d1y7pa2 d.58.18.12 (A:2-78) Hypothetical protein AF1403, N-terminal domain {Archaeon Archaeoglobus fulgidus [TaxId: 2234]} Length = 77 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: AF1403 N-terminal domain-like domain: Hypothetical protein AF1403, N-terminal domain species: Archaeon Archaeoglobus fulgidus [TaxId: 2234]
Score = 36.7 bits (85), Expect = 5e-04
Identities = 13/73 (17%), Positives = 32/73 (43%), Gaps = 3/73 (4%)
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYE-ETEQLRAA 240
+ ++K +L LT ++A+ G NI A F G ++ + E++
Sbjct: 4 LRIIAENKIGVLRDLTTIIAEEGGNITFAQTFLIKHGEHEGKALIYFEIEGGDFEKILER 63
Query: 241 LEK--EVLKLERQ 251
++ ++++E +
Sbjct: 64 VKTFDYIIEIEEE 76
|
| >d1zpva1 d.58.18.7 (A:1-83) UPF0237 protein SP0238 {Streptococcus pneumoniae [TaxId: 1313]} Length = 83 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: SP0238-like domain: UPF0237 protein SP0238 species: Streptococcus pneumoniae [TaxId: 1313]
Score = 36.3 bits (84), Expect = 9e-04
Identities = 13/62 (20%), Positives = 27/62 (43%), Gaps = 1/62 (1%)
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL 241
IT DK +++ ++ +A++GLNI + + +++ V + LR
Sbjct: 5 ITVVGKDKSGIVAGVSGKIAELGLNIDDISQTVLDEYFTMMAVVSSDEKQDF-TYLRNEF 63
Query: 242 EK 243
E
Sbjct: 64 EA 65
|
| >d2pc6a2 d.58.18.6 (A:1-77) Acetolactate synthase small subunit, IlvH {Nitrosomonas europaea [TaxId: 915]} Length = 77 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: IlvH-like domain: Acetolactate synthase small subunit, IlvH species: Nitrosomonas europaea [TaxId: 915]
Score = 35.8 bits (83), Expect = 0.001
Identities = 23/73 (31%), Positives = 34/73 (46%), Gaps = 4/73 (5%)
Query: 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSLDVFVVDGWPYEETEQLR 238
H I+ +++ LS++ L + G NI+ T D S V +G P E EQ+
Sbjct: 3 HIISLLMENEAGALSRVAGLFSARGYNIESLSVAPTEDPTLSRMTLVTNG-PDEIVEQIT 61
Query: 239 AALEK--EVLKLE 249
L K EV+KL
Sbjct: 62 KQLNKLIEVVKLI 74
|
| >d2f06a1 d.58.18.11 (A:71-141) Hypothetical protein BT0572 {Bacteroides thetaiotaomicron [TaxId: 818]} Length = 71 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: BT0572-like domain: Hypothetical protein BT0572 species: Bacteroides thetaiotaomicron [TaxId: 818]
Score = 34.2 bits (79), Expect = 0.004
Identities = 9/63 (14%), Positives = 27/63 (42%), Gaps = 6/63 (9%)
Query: 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAAL 241
+ S + P L+++ L+ G+ I+ ++F+ + + V ++ L
Sbjct: 2 VGISCPNVPGALAKVLGFLSAEGVFIEYMYSFANNN-VANVVIRPS-----NMDKCIEVL 55
Query: 242 EKE 244
+++
Sbjct: 56 KEK 58
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 575 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.47 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.93 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.52 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.73 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.34 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.27 | |
| d1u8sa1 | 86 | putative transcriptional repressor VC2159 {Vibrio | 96.16 | |
| d1zpva1 | 83 | UPF0237 protein SP0238 {Streptococcus pneumoniae [ | 96.1 | |
| d1u8sa2 | 93 | putative transcriptional repressor VC2159 {Vibrio | 93.19 | |
| d1ygya3 | 78 | Phosphoglycerate dehydrogenase, regulatory (C-term | 91.71 | |
| d1sc6a3 | 84 | Phosphoglycerate dehydrogenase, regulatory (C-term | 91.07 | |
| d2f06a1 | 71 | Hypothetical protein BT0572 {Bacteroides thetaiota | 90.31 | |
| d1y7pa2 | 77 | Hypothetical protein AF1403, N-terminal domain {Ar | 89.11 | |
| d2f06a2 | 70 | Hypothetical protein BT0572 {Bacteroides thetaiota | 88.82 | |
| d2pc6a2 | 77 | Acetolactate synthase small subunit, IlvH {Nitroso | 80.76 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-57 Score=459.98 Aligned_cols=264 Identities=36% Similarity=0.710 Sum_probs=230.4
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
++|+|+.++|+++++||+|+||+||+|++.+ .||||+++....+....+.|.+|+.+|++++|||||++++++.. +.+
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence 5799999999999999999999999998654 69999998776667777899999999999999999999998865 568
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS- 443 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~- 443 (575)
|||||||+||+|.+++...++.+++..+..|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999999999877788999999999999999999999999999999999999999999999999999765543
Q ss_pred --CccccCCCCCCccCcccccC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC----CCCCCC
Q 008171 444 --GVMTAETGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP----TIPKNS 514 (575)
Q Consensus 444 --~~~~~~~Gt~~y~APE~i~~---~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~----~~p~~~ 514 (575)
.......||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+.++.......+..+..+ .++..+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 238 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence 23445679999999999964 458999999999999999999999999988776666656555432 356789
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 515 QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 515 ~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
++++.+||.+||+.||.+|||+.||++.|+.+.+.+
T Consensus 239 ~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 999999999999999999999999999999887643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-55 Score=439.30 Aligned_cols=256 Identities=35% Similarity=0.717 Sum_probs=220.1
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
|++++|+++++||+|+||+||+|.+. ++.||||+++..... .++|.+|+.++++++|||||+++|+|..++.+|+|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 67889999999999999999999985 567999999865433 36799999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC--c
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--V 445 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~--~ 445 (575)
|||+++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99999999999998877889999999999999999999999999999999999999999999999999998665443 2
Q ss_pred cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 008171 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~ 524 (575)
.....||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..+.... +..+.++..|..+++++.+||.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~-i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-ISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH-HHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH-HHhcCCCCCccccCHHHHHHHHH
Confidence 234578999999999999999999999999999999999 5777777776665544 55677888899999999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 525 CWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 525 cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
||+.||.+|||++|+++.|+++.+
T Consensus 238 cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHHHHHHHh
Confidence 999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-55 Score=449.05 Aligned_cols=263 Identities=35% Similarity=0.660 Sum_probs=232.5
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
.+.|+|+.++|++.++||+|+||+||+|.+. ++.||||+++..... .+.|.+|+.+|++++|||||+++++|.+.
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 4679999999999999999999999999984 677999999865433 46799999999999999999999999999
Q ss_pred CCceeEEEeccCCchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
+.+||||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence 9999999999999999999753 467899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCc--cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 008171 441 AQSGV--MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 441 ~~~~~--~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
..... .....||+.|+|||++.+..|+.++|||||||++|||++|..||............+..+.++.+|..+++++
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 245 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 245 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHH
Confidence 54432 2334578999999999999999999999999999999997666554444445556677788899999999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
.+||.+||+.||.+|||+.|+++.|+.++++
T Consensus 246 ~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 246 YELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999999887653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-55 Score=440.02 Aligned_cols=261 Identities=31% Similarity=0.619 Sum_probs=229.8
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
.+.|+|+.++|+++++||+|+||+||+|.+.+ +.||||+++..... .+.|.+|+.+|++++|||||++++++.+ +
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 47899999999999999999999999999864 67999999865433 3679999999999999999999998865 5
Q ss_pred CceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
.+||||||+++|+|.+++.... .++++..++.|+.||+.||.|||++||+||||||+||||++++.+||+|||+|+...
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 6899999999999999876543 369999999999999999999999999999999999999999999999999998765
Q ss_pred cCC--ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 008171 442 QSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG-KLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 442 ~~~--~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG-~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
... ......||+.|||||++.+..|+.++|||||||+||||+|| .+||...+..+.. ..+..+.++..|..+++++
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~-~~i~~~~~~~~p~~~~~~l 239 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLERGYRMVRPDNCPEEL 239 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTTCCCCCCTTCCHHH
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHH-HHHHhcCCCCCcccChHHH
Confidence 543 33455789999999999999999999999999999999995 5556666655544 4456678888999999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
.+||.+||+.||++|||++||++.|++++..
T Consensus 240 ~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 9999999999999999999999999998753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-54 Score=444.03 Aligned_cols=259 Identities=33% Similarity=0.609 Sum_probs=221.6
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEECC--c---cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS--Q---DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~~--~---~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
+++.++|++.++||+|+||+||+|.+.. + .||||.+.... .....+.|.+|+.+|++++|||||+++++|...+
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 5777899999999999999999998742 2 38888877543 4455678999999999999999999999999999
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
.+|+|||||+||+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999999999988778899999999999999999999999999999999999999999999999999986554
Q ss_pred CCc------cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 008171 443 SGV------MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQ 515 (575)
Q Consensus 443 ~~~------~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~ 515 (575)
... .....||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..+.... +..+.++..|..++
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~-i~~~~~~~~~~~~~ 259 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA-IEQDYRLPPPMDCP 259 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCCTTCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCccch
Confidence 321 122457899999999999999999999999999999998 8999999988776554 45577788899999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 516 PKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 516 ~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
+++.+||.+||+.||.+|||+.|+++.|+++++
T Consensus 260 ~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 260 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 999999999999999999999999999999876
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-54 Score=436.98 Aligned_cols=262 Identities=29% Similarity=0.561 Sum_probs=224.5
Q ss_pred CCCceeee-eeeeecCceEEEEEEECC----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCc
Q 008171 290 DPKHLKFG-SKVASGSYGDLYRGTYCS----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSL 364 (575)
Q Consensus 290 ~~~~~~i~-~~LG~G~fG~Vy~~~~~~----~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l 364 (575)
+.+.+.+. ++||+|+||+||+|.+.+ +.||||+++....+....+.|.+|+.+|++++|||||+++++|..+ ..
T Consensus 4 d~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~ 82 (277)
T d1xbba_ 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SW 82 (277)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SE
T ss_pred chhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CE
Confidence 34445554 469999999999998742 4699999987666666678899999999999999999999999754 57
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
||||||++||+|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 83 MLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161 (277)
T ss_dssp EEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence 899999999999999976 5779999999999999999999999999999999999999999999999999998655432
Q ss_pred ----ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 008171 445 ----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLA 519 (575)
Q Consensus 445 ----~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~ 519 (575)
......||+.|||||++.+..|+.++|||||||++|||++ |..||.+.+..+... .+..+.++.+|..+++++.
T Consensus 162 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~-~i~~~~~~~~p~~~~~~~~ 240 (277)
T d1xbba_ 162 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGERMGCPAGCPREMY 240 (277)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-HHHTTCCCCCCTTCCHHHH
T ss_pred cccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHH-HHHcCCCCCCCcccCHHHH
Confidence 2234568999999999999999999999999999999998 999999988776554 4556778889999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhchhh
Q 008171 520 ELLERCWQQDPALRPDFSEIIEILQQIAKEVGEEN 554 (575)
Q Consensus 520 ~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~~~~ 554 (575)
+||.+||+.||.+|||+.+|++.|++.+.++..++
T Consensus 241 ~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~e~ 275 (277)
T d1xbba_ 241 DLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcCCCC
Confidence 99999999999999999999999999887766544
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-54 Score=435.03 Aligned_cols=259 Identities=32% Similarity=0.615 Sum_probs=223.1
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEECC------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~~------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
||++++|++.+.||+|+||.||+|.+.+ ..||||+++... .......|.+|+.+|++++|||||+++|++.+.
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 7888999999999999999999998753 259999997543 444566799999999999999999999999999
Q ss_pred CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
+.+++||||+.++++.+++....+.+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++...
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999999999999988877889999999999999999999999999999999999999999999999999998654
Q ss_pred cCC----ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 008171 442 QSG----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP-YEYLTPLQAAVGVVQKGLRPTIPKNSQP 516 (575)
Q Consensus 442 ~~~----~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~P-f~~~~~~~~~~~v~~~~~~~~~p~~~~~ 516 (575)
... ......||+.|||||++.+..|+.++|||||||+||||++|..| |...+..+ ....+..+.++..|..+++
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~ 240 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-VMKAINDGFRLPTPMDCPS 240 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTTCCCCCCTTCBH
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-HHHHHhccCCCCCchhhHH
Confidence 432 22344689999999999999999999999999999999996554 55555544 4455677888899999999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 517 KLAELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
++.+||.+||+.||++|||+.|+++.|+++++
T Consensus 241 ~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 241 AIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 99999999999999999999999999998875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=448.81 Aligned_cols=259 Identities=31% Similarity=0.594 Sum_probs=228.9
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEe
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~ 356 (575)
..|+|+.++|+++++||+|+||+||+|++.+ ..||+|.+.... .......+.+|+.+|+++ +|||||++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 5689999999999999999999999998743 248999987543 233456789999999998 8999999999
Q ss_pred eecCCCCceeEEEeccCCchhhhhhhcc----------------------CcCChHHHHHHHHHHHHHHHHHHHCCceec
Q 008171 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLK----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHR 414 (575)
Q Consensus 357 ~~~~~~~l~lV~E~~~ggsL~d~l~~~~----------------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHr 414 (575)
++.+.+.+|||||||+||+|.++++... +.+++..++.|+.||+.||.|||++|||||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 9999999999999999999999997643 348889999999999999999999999999
Q ss_pred ccCCCCEEecCCCcEEEeecccceecccCCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 008171 415 DLKAANLLMDENEVVKVADFGVARVKAQSGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYE 490 (575)
Q Consensus 415 DLKp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~ 490 (575)
||||+|||++.++.+||+|||+|+....... .....||+.|||||++.+..|+.++|||||||+||||++ |..||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986555432 234467999999999999999999999999999999998 899999
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 008171 491 YLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQ 544 (575)
Q Consensus 491 ~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~ 544 (575)
+.+..+....++..+.++..|..+++++.+||.+||+.||.+|||++||++.|.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 988878788888888999999999999999999999999999999999999885
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-54 Score=436.80 Aligned_cols=263 Identities=28% Similarity=0.560 Sum_probs=232.0
Q ss_pred eeeCCCceeeee-eeeecCceEEEEEEEC----CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 287 WEIDPKHLKFGS-KVASGSYGDLYRGTYC----SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 287 ~~i~~~~~~i~~-~LG~G~fG~Vy~~~~~----~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
|.+..++|.+.+ +||+|+||+||+|.+. +..||||+++... .....+.|.+|+.+|++++|||||+++++|..
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 80 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-
Confidence 456677888888 4999999999999763 3359999998653 45556789999999999999999999999976
Q ss_pred CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
+.+|||||||+||+|.+++...++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 46899999999999999987767889999999999999999999999999999999999999999999999999998765
Q ss_pred cCCc----cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 008171 442 QSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 516 (575)
Q Consensus 442 ~~~~----~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~ 516 (575)
.... .....||+.|+|||++.+..|+.++|||||||++|||+| |..||...+..+... .+..+.++.+|..+++
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~-~i~~~~~~~~p~~~~~ 239 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-FIEQGKRMECPPECPP 239 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH-HHHTTCCCCCCTTCCH
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCCCCcCCH
Confidence 4332 234568999999999999999999999999999999998 999999988766554 4566778899999999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhch
Q 008171 517 KLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 552 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~~ 552 (575)
++.+||.+||+.||++||||.++++.|+.++..+..
T Consensus 240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~ 275 (285)
T d1u59a_ 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275 (285)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence 999999999999999999999999999998876543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-54 Score=430.97 Aligned_cols=253 Identities=33% Similarity=0.667 Sum_probs=229.7
Q ss_pred eCCCceeeeeeeeecCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeE
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
+++++|+++++||+|+||+||+|++. ++.||||+++...... .+|.+|+.++++++||||++++|+|.+.+.+++|
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 46789999999999999999999985 4579999998765443 5799999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC--c
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG--V 445 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~--~ 445 (575)
|||+++|+|.+++......+++..+++++.||++||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 99999999999988778889999999999999999999999999999999999999999999999999998655443 2
Q ss_pred cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 008171 446 MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524 (575)
Q Consensus 446 ~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~ 524 (575)
.....||+.|+|||++.+..|+.++|||||||++|||+| |+.||...+..+....+ ..+.++..|..+++++.+||.+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH-HhCCCCCCcccccHHHHHHHHH
Confidence 334678999999999999999999999999999999998 89999999988776554 5577888999999999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHH
Q 008171 525 CWQQDPALRPDFSEIIEILQQ 545 (575)
Q Consensus 525 cL~~dP~~RPs~~ell~~L~~ 545 (575)
||+.||.+|||+.++++.|.+
T Consensus 237 cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCSSGGGSCCHHHHHHHHHC
T ss_pred HccCCHhHCcCHHHHHHHhhC
Confidence 999999999999999998864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-54 Score=432.18 Aligned_cols=261 Identities=32% Similarity=0.613 Sum_probs=222.1
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEECC-----ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-----~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 360 (575)
+|+|+.++|++++.||+|+||.||+|++.. ..||||.++.. ........|.+|+.+|++++|||||++++++.+
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 79 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 79 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 589999999999999999999999998753 23788887643 344556789999999999999999999999964
Q ss_pred CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
+.+|+||||+++|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 80 -~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 80 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred -CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 6789999999999999998877788999999999999999999999999999999999999999999999999999865
Q ss_pred ccCC--ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 008171 441 AQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPK 517 (575)
Q Consensus 441 ~~~~--~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~ 517 (575)
.... ..+...||+.|+|||++.+..|+.++|||||||++|||++ |..||...+..+....+ ..+.++.+|..++++
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~~~ 237 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPPT 237 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCCCCCCTTCCHH
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHH
Confidence 5432 3344568999999999999999999999999999999998 89999998887776554 456677889999999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 518 LAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 518 l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
+.+||.+||+.||.+|||+.||++.|++++++
T Consensus 238 ~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 238 LYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999998864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-54 Score=432.48 Aligned_cols=249 Identities=26% Similarity=0.431 Sum_probs=211.4
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC--CCCceeE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--PPSLCIV 367 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--~~~l~lV 367 (575)
++|++.+.||+|+||+||+|++. ++.||||+++....+....+.+.+|+.+|++++|||||++++++.+ .+.+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999874 6789999998877777777889999999999999999999998854 4568999
Q ss_pred EEeccCCchhhhhhhc---cCcCChHHHHHHHHHHHHHHHHHHHCC-----ceecccCCCCEEecCCCcEEEeeccccee
Q 008171 368 TEFMSGGSVYDYLHKL---KGVFKLPSLLKVAIDVSKGMNYLHQNN-----IIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~---~~~l~~~~~~~i~~qI~~aL~yLH~~g-----IiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
||||+||+|.+++.+. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998643 467999999999999999999999876 99999999999999999999999999987
Q ss_pred cccCC-ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 008171 440 KAQSG-VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 440 ~~~~~-~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
..... ......||+.|||||++.+..|+.++|||||||++|||++|..||...+..+....+.. +..+.+|..+++++
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l 242 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDEL 242 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCCCCTTSCHHH
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHH
Confidence 65443 34567899999999999999999999999999999999999999999888877666554 44456888999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.+||.+||+.||.+|||+.|+++
T Consensus 243 ~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 243 NEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCChhHCcCHHHHHh
Confidence 99999999999999999999874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-54 Score=431.96 Aligned_cols=246 Identities=27% Similarity=0.481 Sum_probs=220.5
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|++++.||+|+||+||+|++. ++.||||++..... .......+.+|+.+|++++|||||++++++.+++.+||||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999984 67799999875432 1233567899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 448 (575)
|||+||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 86 Ey~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~ 163 (263)
T d2j4za1 86 EYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTT 163 (263)
T ss_dssp ECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCEE
T ss_pred eecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-cccc
Confidence 99999999999976 577999999999999999999999999999999999999999999999999999765543 3445
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 528 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~ 528 (575)
..||+.|||||++.+..|+.++|||||||+||+|++|+.||.+.+..+....+... .+.+|..+++++.+||.+||+.
T Consensus 164 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~ 241 (263)
T d2j4za1 164 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDFVTEGARDLISRLLKH 241 (263)
T ss_dssp TTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTSCHHHHHHHHHHTCS
T ss_pred cCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCccCCHHHHHHHHHHccC
Confidence 68999999999999999999999999999999999999999998887776665543 3567889999999999999999
Q ss_pred CCCCCCCHHHHHH
Q 008171 529 DPALRPDFSEIIE 541 (575)
Q Consensus 529 dP~~RPs~~ell~ 541 (575)
||.+|||+.|+++
T Consensus 242 dp~~R~t~~eil~ 254 (263)
T d2j4za1 242 NPSQRPMLREVLE 254 (263)
T ss_dssp SGGGSCCHHHHHT
T ss_pred CHhHCcCHHHHHc
Confidence 9999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-53 Score=432.22 Aligned_cols=246 Identities=27% Similarity=0.505 Sum_probs=219.6
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|++.++||+|+||+||+|.+ +++.||||+++...... .+.+.+|+.+|++++|||||++++++.+.+.+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 4689999999999999999986 47889999987554322 4678999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
||+||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence 9999999998764 579999999999999999999999999999999999999999999999999998765443 4456
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhh
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELLERCWQ 527 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~~~~p~~~~~~l~~Li~~cL~ 527 (575)
.+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+..... ....+..+++++.+||.+||+
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 255 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTC
T ss_pred cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHcc
Confidence 6899999999999999999999999999999999999999999888877766655433 345667899999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 008171 528 QDPALRPDFSEIIE 541 (575)
Q Consensus 528 ~dP~~RPs~~ell~ 541 (575)
.||.+|||+.|+++
T Consensus 256 ~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 256 MDVEKRGSAKELLQ 269 (293)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred CChhHCcCHHHHhc
Confidence 99999999999874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=429.46 Aligned_cols=248 Identities=26% Similarity=0.441 Sum_probs=211.1
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|+++++||+|+||+||+|++. ++.||||+++.... .+..+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 47999999999999999999874 67899999976543 2334678999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC---cc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---VM 446 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~---~~ 446 (575)
|++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 84 y~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 84 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred ccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 9999999999976 5789999999999999999999999999999999999999999999999999998754432 34
Q ss_pred ccCCCCCCccCcccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 008171 447 TAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQ-AAVGVVQKGLRPTIPKNSQPKLAELLER 524 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~~~~~~-~~~~v~~~~~~~~~p~~~~~~l~~Li~~ 524 (575)
+..+||+.|||||++.+..+ +.++|||||||++|||++|+.||...+... ..............+..+++++.+||.+
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 242 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHH
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHH
Confidence 56689999999999988886 578999999999999999999997755433 3333333333344456789999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 008171 525 CWQQDPALRPDFSEIIE 541 (575)
Q Consensus 525 cL~~dP~~RPs~~ell~ 541 (575)
||+.||.+|||+.|+++
T Consensus 243 ~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 243 ILVENPSARITIPDIKK 259 (271)
T ss_dssp HSCSSTTTSCCHHHHTT
T ss_pred HcCCChhHCcCHHHHhc
Confidence 99999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-53 Score=426.10 Aligned_cols=256 Identities=36% Similarity=0.697 Sum_probs=222.4
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC-CCCc
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSL 364 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~-~~~l 364 (575)
.|+|+.++|+++++||+|+||.||+|.+.++.||||+++.+. ..+.|.+|+.++++++||||++++|+|.+ .+.+
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred CCccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence 489999999999999999999999999999999999997543 34678999999999999999999999854 4668
Q ss_pred eeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 365 CIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
|+||||+++|+|.+++.+.. ..+++..+++++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 99999999999999997643 45899999999999999999999999999999999999999999999999999865433
Q ss_pred CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 008171 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELL 522 (575)
Q Consensus 444 ~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li 522 (575)
.....+|..|+|||++.+..++.++|||||||++|||++ |+.||...+..+.... +..+.++.+|..+++++.+||
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~li 233 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPAVYEVM 233 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-HTTTCCCCCCTTCCHHHHHHH
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCCCCCccCCHHHHHHH
Confidence 334568999999999999999999999999999999998 7999998877766655 556788999999999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 523 ERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 523 ~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
.+||..||.+|||+.++++.|+++..
T Consensus 234 ~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 234 KNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999998864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=433.63 Aligned_cols=248 Identities=29% Similarity=0.490 Sum_probs=219.3
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
+.|+++++||+|+||.||+|.+. ++.||||+++... ....+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 35899999999999999999984 6679999997543 3345678999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
||+||+|.+++.+..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...... ....
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence 999999999988767789999999999999999999999999999999999999999999999999997654432 3446
Q ss_pred CCCCCCccCcccc-----cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHH
Q 008171 449 ETGTYRWMAPEVI-----EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-RPTIPKNSQPKLAELL 522 (575)
Q Consensus 449 ~~Gt~~y~APE~i-----~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~-~~~~p~~~~~~l~~Li 522 (575)
..||+.|||||++ ....|+.++|||||||++|||++|+.||.+.++.+....+..... ....+..+++++.+||
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li 249 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 249 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence 7899999999998 356789999999999999999999999999998888777665432 2345678899999999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 008171 523 ERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 523 ~~cL~~dP~~RPs~~ell~ 541 (575)
.+||+.||.+|||+.|+++
T Consensus 250 ~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 250 KKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHSCSSTTTSCCHHHHTT
T ss_pred HHHccCChhHCcCHHHHhc
Confidence 9999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=428.09 Aligned_cols=263 Identities=35% Similarity=0.629 Sum_probs=223.3
Q ss_pred CCCCceeeCCCceeeeeeeeecCceEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC
Q 008171 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (575)
Q Consensus 282 ~~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 360 (575)
...+.|+|+.++|+++++||+|+||+||+|++.+ +.||||+++....+ .+.|.+|+.+|++++|||||+++++|.+
T Consensus 7 ~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 83 (285)
T d1fmka3 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE 83 (285)
T ss_dssp SSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec
Confidence 4467899999999999999999999999999855 56999999865443 3679999999999999999999999865
Q ss_pred CCCceeEEEeccCCchhhhhhhc-cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKL-KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
+.+++||||+++|+|..++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 84 -~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 84 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred -CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhh
Confidence 5689999999999999988654 35699999999999999999999999999999999999999999999999999986
Q ss_pred cccCC--ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 008171 440 KAQSG--VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLP-YEYLTPLQAAVGVVQKGLRPTIPKNSQP 516 (575)
Q Consensus 440 ~~~~~--~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~P-f~~~~~~~~~~~v~~~~~~~~~p~~~~~ 516 (575)
..... ......||+.|+|||++....++.++|||||||+||||++|..| |......+. ...+..+.++.++..+++
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~-~~~i~~~~~~~~~~~~~~ 241 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LDQVERGYRMPCPPECPE 241 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HHHHHTTCCCCCCTTSCH
T ss_pred ccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHH-HHHHHhcCCCCCCcccCH
Confidence 64433 33456789999999999999999999999999999999996544 555555444 444566778889999999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 517 KLAELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
++.++|.+||+.||++||++++|++.|++.+..
T Consensus 242 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 999999999999999999999999998887643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=423.25 Aligned_cols=246 Identities=29% Similarity=0.554 Sum_probs=213.7
Q ss_pred ceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC----CCCcee
Q 008171 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK----PPSLCI 366 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~----~~~l~l 366 (575)
.|++.++||+|+||+||+|++. ++.||+|++..........+.|.+|+.+|++++|||||++++++.. ...+||
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 4578889999999999999985 5679999998776677777889999999999999999999999854 345899
Q ss_pred EEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCC--ceecccCCCCEEec-CCCcEEEeecccceecccC
Q 008171 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNN--IIHRDLKAANLLMD-ENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~g--IiHrDLKp~NILl~-~~~~vkL~DFG~a~~~~~~ 443 (575)
||||++||+|.+++.+ .+.+++..+..++.||+.||.|||++| |+||||||+|||++ +++.+||+|||+++.....
T Consensus 90 vmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 9999999999999976 577999999999999999999999998 99999999999996 5789999999999764433
Q ss_pred CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCCcHHHHHHH
Q 008171 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR-PTIPKNSQPKLAELL 522 (575)
Q Consensus 444 ~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~-~~~p~~~~~~l~~Li 522 (575)
.....+||+.|||||++.+ .|+.++|||||||++|||++|+.||............+..+.. +.++..+++++.+||
T Consensus 169 -~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li 246 (270)
T d1t4ha_ 169 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246 (270)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred -ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHH
Confidence 3446689999999999876 5999999999999999999999999877665555554544443 346677899999999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 008171 523 ERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 523 ~~cL~~dP~~RPs~~ell~ 541 (575)
.+||++||++|||+.|+++
T Consensus 247 ~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 247 EGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHSCSSGGGSCCHHHHHT
T ss_pred HHHccCCHhHCcCHHHHhC
Confidence 9999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-53 Score=425.87 Aligned_cols=258 Identities=32% Similarity=0.620 Sum_probs=221.7
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEECC-----ccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS-----QDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKP 361 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-----~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 361 (575)
-|+.++|++.+.||+|+||+||+|++.+ ..||||+++.... ..+..+.|.+|+.+|++++|||||+++|+|.+
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~- 82 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT- 82 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence 4677899999999999999999998743 2589999876544 33456789999999999999999999999976
Q ss_pred CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
+.+++||||+++|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 46899999999999999998877889999999999999999999999999999999999999999999999999998765
Q ss_pred cCCc----cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 008171 442 QSGV----MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQP 516 (575)
Q Consensus 442 ~~~~----~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~ 516 (575)
.... .....||..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+...+.++..+..+++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 242 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccH
Confidence 5432 223457889999999999999999999999999999998 89999999999988888888888999999999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 008171 517 KLAELLERCWQQDPALRPDFSEIIEILQQI 546 (575)
Q Consensus 517 ~l~~Li~~cL~~dP~~RPs~~ell~~L~~l 546 (575)
++.+||.+||+.||++|||+.||++.|+++
T Consensus 243 ~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 243 DIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 999999999999999999999999888764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=432.90 Aligned_cols=249 Identities=23% Similarity=0.420 Sum_probs=219.3
Q ss_pred CCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCcee
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~l 366 (575)
.+++|++++.||+|+||+||+|.+. ++.||||+++.... .......+.+|+.+|++++|||||++++++.+.+.+||
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 4467999999999999999999884 67899999875432 22335678999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC--
Q 008171 367 VTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-- 444 (575)
Q Consensus 367 V~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-- 444 (575)
||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 86 vmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 9999999999999876 6789999999999999999999999999999999999999999999999999998765432
Q ss_pred -ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 008171 445 -VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 523 (575)
Q Consensus 445 -~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~ 523 (575)
.....+||+.|||||++.+..|+.++|||||||+||+|++|..||...+..+....+... .+.+|..+++++.+||.
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~ 242 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--EYDFPEKFFPKARDLVE 242 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--CCCCCTTCCHHHHHHHH
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC--CCCCCccCCHHHHHHHH
Confidence 334567999999999999999999999999999999999999999998888877766654 35678899999999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 008171 524 RCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 524 ~cL~~dP~~RPs~~ell~ 541 (575)
+||+.||.+|||+.|++.
T Consensus 243 ~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 243 KLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp TTSCSSGGGSTTSGGGTC
T ss_pred HHccCCHhHCcCHHHHcC
Confidence 999999999999999754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-52 Score=431.91 Aligned_cols=248 Identities=22% Similarity=0.443 Sum_probs=203.7
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
+.|++.+.||+|+||+||+|++. ++.||||++....... ....+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 56999999999999999999884 6779999998654433 24568899999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEec---CCCcEEEeecccceecccCCcc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD---ENEVVKVADFGVARVKAQSGVM 446 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~---~~~~vkL~DFG~a~~~~~~~~~ 446 (575)
||+||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+. +++.+||+|||+++........
T Consensus 88 ~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~ 166 (307)
T d1a06a_ 88 LVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 166 (307)
T ss_dssp CCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred ccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence 9999999999976 67899999999999999999999999999999999999995 5789999999999877666666
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHHHHHHH
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPKLAELLER 524 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~--~~p~~~~~~l~~Li~~ 524 (575)
...+||+.|||||++.+..|+.++|||||||+||+|++|..||.+.+..+....+....... ..+..+++++.+||.+
T Consensus 167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 246 (307)
T d1a06a_ 167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246 (307)
T ss_dssp ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHH
Confidence 67789999999999999999999999999999999999999999988888777766655433 3446889999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 008171 525 CWQQDPALRPDFSEIIE 541 (575)
Q Consensus 525 cL~~dP~~RPs~~ell~ 541 (575)
||++||.+|||+.|+++
T Consensus 247 ~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 247 LMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HSCSSGGGSCCHHHHHH
T ss_pred HccCCHhHCcCHHHHhc
Confidence 99999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-52 Score=425.64 Aligned_cols=264 Identities=32% Similarity=0.619 Sum_probs=223.4
Q ss_pred CCceeeCCCceeeeeeeeecCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEE
Q 008171 284 TDVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFI 355 (575)
Q Consensus 284 ~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~ 355 (575)
.+.|+|..++|+++++||+|+||.||+|++.+ +.||||+++... .....+.+.+|..++.++ +|+||+.++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 35799999999999999999999999998743 469999987543 344456788888888877 588999999
Q ss_pred eeecCC-CCceeEEEeccCCchhhhhhhcc---------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCC
Q 008171 356 GACTKP-PSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419 (575)
Q Consensus 356 ~~~~~~-~~l~lV~E~~~ggsL~d~l~~~~---------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~ 419 (575)
+++... ..+++|||||+||+|.++++... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 987654 56899999999999999997532 34889999999999999999999999999999999
Q ss_pred CEEecCCCcEEEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcC-CCCCCCCCHH
Q 008171 420 NLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG-KLPYEYLTPL 495 (575)
Q Consensus 420 NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG-~~Pf~~~~~~ 495 (575)
|||++.++.+||+|||+|+...... ......||+.|||||++.+..|+.++|||||||++|||++| ..||...+..
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998654432 23345799999999999999999999999999999999986 5789888777
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 496 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 496 ~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
+.....+..+.++.+|..+++++.++|.+||+.||.+|||+.|+++.|+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 77777788888999999999999999999999999999999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-52 Score=430.01 Aligned_cols=245 Identities=29% Similarity=0.434 Sum_probs=218.8
Q ss_pred ceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN-SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
.|++.++||+|+||+||+|++. ++.||||+++..... ....+.+.+|+.+|++++|||||++++++.+.+.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 5899999999999999999874 677999999866543 3445679999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCccccC
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAE 449 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 449 (575)
||.||+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ....
T Consensus 96 ~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~~~ 171 (309)
T d1u5ra_ 96 YCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSF 171 (309)
T ss_dssp CCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCC
T ss_pred ecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CCcc
Confidence 9999998766654 67899999999999999999999999999999999999999999999999999976543 3456
Q ss_pred CCCCCccCcccccC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 008171 450 TGTYRWMAPEVIEH---KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 526 (575)
Q Consensus 450 ~Gt~~y~APE~i~~---~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL 526 (575)
.||+.|||||++.+ ..|+.++|||||||++|||++|..||.+.+..+....+.........+..+++++.+||.+||
T Consensus 172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L 251 (309)
T d1u5ra_ 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251 (309)
T ss_dssp CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHT
T ss_pred ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHC
Confidence 79999999999853 468999999999999999999999999999888887777766655566789999999999999
Q ss_pred hcCCCCCCCHHHHHH
Q 008171 527 QQDPALRPDFSEIIE 541 (575)
Q Consensus 527 ~~dP~~RPs~~ell~ 541 (575)
+.||.+|||+.|+++
T Consensus 252 ~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 252 QKIPQDRPTSEVLLK 266 (309)
T ss_dssp CSSGGGSCCHHHHTT
T ss_pred cCChhHCcCHHHHHh
Confidence 999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.5e-52 Score=433.90 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=223.6
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|+++++||+|+||.||+|++. ++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+.+|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 47999999999999999999874 7789999997543 3445778999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC--CCcEEEeecccceecccCCccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE--NEVVKVADFGVARVKAQSGVMT 447 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~--~~~vkL~DFG~a~~~~~~~~~~ 447 (575)
||+||+|.+++.+..+.+++..++.|+.||+.||.|||++|||||||||+|||++. ++.+||+|||+++.........
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 183 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence 99999999999776788999999999999999999999999999999999999964 6789999999999877766667
Q ss_pred cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHHHHHHHh
Q 008171 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPKLAELLERC 525 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~--~~p~~~~~~l~~Li~~c 525 (575)
...||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+....... .....+++++.+||.+|
T Consensus 184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 263 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 263 (350)
T ss_dssp EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHH
T ss_pred eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence 7889999999999999999999999999999999999999999998888877766654432 23356899999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 008171 526 WQQDPALRPDFSEIIE 541 (575)
Q Consensus 526 L~~dP~~RPs~~ell~ 541 (575)
|+.||.+|||+.|+++
T Consensus 264 L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 264 LLADPNTRMTIHQALE 279 (350)
T ss_dssp CCSSGGGSCCHHHHHH
T ss_pred ccCChhHCcCHHHHhc
Confidence 9999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-52 Score=422.36 Aligned_cols=249 Identities=22% Similarity=0.399 Sum_probs=222.5
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~----~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
++|+++++||+|+||+||+|.+. ++.||||+++...... ...+.+.+|+.+|++++|||||++++++.+...+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57999999999999999999974 6789999997654322 23577999999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC----cEEEeecccceecc
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE----VVKVADFGVARVKA 441 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~----~vkL~DFG~a~~~~ 441 (575)
||||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 90 iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999976 56899999999999999999999999999999999999998776 59999999998877
Q ss_pred cCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHH
Q 008171 442 QSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLA 519 (575)
Q Consensus 442 ~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--~~~p~~~~~~l~ 519 (575)
.........||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+....+...... +..+..+++++.
T Consensus 169 ~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 248 (293)
T d1jksa_ 169 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248 (293)
T ss_dssp TSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred CCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHH
Confidence 666667778999999999999999999999999999999999999999999888877766554432 223468899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 008171 520 ELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 520 ~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+||.+||+.||.+|||+.|+++
T Consensus 249 ~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 249 DFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 9999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=432.22 Aligned_cols=256 Identities=25% Similarity=0.445 Sum_probs=214.8
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
+|..++|++.++||+|+||+||+|.+. ++.||||+++... .......+.+|+.+|++++|||||+++++|.+++++|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 466788999999999999999999984 6789999998653 3444578999999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHH-CCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
||||||+||+|.+++.+ .+.+++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+|+.....
T Consensus 81 iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 99999999999999976 5679999999999999999999997 59999999999999999999999999999865432
Q ss_pred ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH------------------------
Q 008171 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVG------------------------ 500 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~------------------------ 500 (575)
..+..+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..+....
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 33456899999999999999999999999999999999999999976543221100
Q ss_pred -----------------HHhcCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 008171 501 -----------------VVQKGLRPTIP-KNSQPKLAELLERCWQQDPALRPDFSEIIE--ILQQI 546 (575)
Q Consensus 501 -----------------v~~~~~~~~~p-~~~~~~l~~Li~~cL~~dP~~RPs~~ell~--~L~~l 546 (575)
.......+..+ ..+++++.+||.+||+.||.+|||+.|+++ .+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 01111122222 246889999999999999999999999987 45543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-51 Score=431.62 Aligned_cols=248 Identities=19% Similarity=0.374 Sum_probs=224.1
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
+.|+++++||+|+||.||+|.+ +++.||||+++... ......+.+|+.+|++++|||||++++++.++..+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4699999999999999999997 46789999997643 3335678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEec--CCCcEEEeecccceecccCCccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMD--ENEVVKVADFGVARVKAQSGVMT 447 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~--~~~~vkL~DFG~a~~~~~~~~~~ 447 (575)
||+||+|.+++.....++++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.........
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~ 186 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence 9999999998877677899999999999999999999999999999999999998 57899999999999887766677
Q ss_pred cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHHHHHHHh
Q 008171 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--PTIPKNSQPKLAELLERC 525 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--~~~p~~~~~~l~~Li~~c 525 (575)
...||+.|+|||++.+..|+.++|||||||+||+|++|..||.+.+..+....+...... ...+..+++++.+||.+|
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 266 (352)
T d1koba_ 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 266 (352)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTT
T ss_pred eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence 778999999999999999999999999999999999999999999988877776665443 334568999999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 008171 526 WQQDPALRPDFSEIIE 541 (575)
Q Consensus 526 L~~dP~~RPs~~ell~ 541 (575)
|+.||.+|||+.|+++
T Consensus 267 L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 267 LQKEPRKRLTVHDALE 282 (352)
T ss_dssp SCSSGGGSCCHHHHHT
T ss_pred ccCChhHCcCHHHHhc
Confidence 9999999999999976
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=419.89 Aligned_cols=262 Identities=32% Similarity=0.638 Sum_probs=228.5
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEECC---------ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEE
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQF 354 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~---------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l 354 (575)
..|+|+.++|.++++||+|+||.||+|++.+ ..||||+++... ......++.+|+..+.++ +|||||++
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 3599999999999999999999999998643 259999998654 444567899999999888 79999999
Q ss_pred EeeecCCCCceeEEEeccCCchhhhhhhcc---------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCC
Q 008171 355 IGACTKPPSLCIVTEFMSGGSVYDYLHKLK---------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419 (575)
Q Consensus 355 ~~~~~~~~~l~lV~E~~~ggsL~d~l~~~~---------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~ 419 (575)
+++|.+++.+++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++|||||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 999999999999999999999999997543 35899999999999999999999999999999999
Q ss_pred CEEecCCCcEEEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 008171 420 NLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL 495 (575)
Q Consensus 420 NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~ 495 (575)
|||++.++.+||+|||+++...... ......||+.|+|||++.++.|+.++|||||||++|||++ |..||...+..
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 9999999999999999998665543 2344578999999999999999999999999999999998 79999988876
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 008171 496 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAK 548 (575)
Q Consensus 496 ~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~ 548 (575)
+.. ..+..+.++..|..+++++.+||.+||+.||.+|||+.|+++.|++++.
T Consensus 245 ~~~-~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 ELF-KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHH-HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH-HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 654 5566788899999999999999999999999999999999999999865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=422.70 Aligned_cols=265 Identities=31% Similarity=0.626 Sum_probs=237.1
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEe
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIG 356 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~ 356 (575)
..|+|+.++|+++++||+|+||.||+|++.+ +.||||+++... .......|.+|+.+++++ +|||||++++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 4799999999999999999999999998732 469999998654 344566899999999999 6999999999
Q ss_pred eecCCCCceeEEEeccCCchhhhhhhcc-----------------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCC
Q 008171 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLK-----------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAA 419 (575)
Q Consensus 357 ~~~~~~~l~lV~E~~~ggsL~d~l~~~~-----------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~ 419 (575)
+|.+...+|+|||||+||+|.++++... ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 9999999999999999999999987532 25889999999999999999999999999999999
Q ss_pred CEEecCCCcEEEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 008171 420 NLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPL 495 (575)
Q Consensus 420 NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~ 495 (575)
|||++.++.+||+|||+++...... ......||+.|+|||++....++.++|||||||++|||++ |.+||...+..
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998655432 2234578999999999999999999999999999999998 77778888877
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 496 QAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 496 ~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
.....++..+.++..|..+++++.+||.+||+.||.+|||+.||++.|++++.+.
T Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 7777888889999999999999999999999999999999999999999988763
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-51 Score=422.40 Aligned_cols=260 Identities=31% Similarity=0.583 Sum_probs=227.9
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEECC-------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeee
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYCS-------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGAC 358 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~~-------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~ 358 (575)
.|++..++|++.++||+|+||+||+|++.+ +.||||+++.. ...+..+.|.+|+.+|++++||||++++++|
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 357777899999999999999999999754 56999998754 3455677899999999999999999999999
Q ss_pred cCCCCceeEEEeccCCchhhhhhhcc-----------------------CcCChHHHHHHHHHHHHHHHHHHHCCceecc
Q 008171 359 TKPPSLCIVTEFMSGGSVYDYLHKLK-----------------------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRD 415 (575)
Q Consensus 359 ~~~~~l~lV~E~~~ggsL~d~l~~~~-----------------------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrD 415 (575)
......++||||+++|+|.+++.... ..+++..++.|+.||+.||+|||+++|||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999999999999986432 2478889999999999999999999999999
Q ss_pred cCCCCEEecCCCcEEEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCC-CCCCC
Q 008171 416 LKAANLLMDENEVVKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK-LPYEY 491 (575)
Q Consensus 416 LKp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~-~Pf~~ 491 (575)
|||+|||++.++.+||+|||+++...... ..+...||+.|+|||++.+..|+.++|||||||+||||++|. .||.+
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 99999999999999999999997554332 233457889999999999999999999999999999999985 68888
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 008171 492 LTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA 547 (575)
Q Consensus 492 ~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~ 547 (575)
.+..+.... +..+.++.+|..+++++.+||.+||+.||.+||||.||++.|+++.
T Consensus 246 ~~~~e~~~~-v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 246 MAHEEVIYY-VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp SCHHHHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCHHHHHHH-HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 888877665 4556678889999999999999999999999999999999998864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=428.99 Aligned_cols=250 Identities=24% Similarity=0.448 Sum_probs=223.3
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCce
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 365 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~ 365 (575)
|..++|++++.||+|+||.||+|+. +++.||||+++.... .......+.+|+.+|++++||||+++++++.+...+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 4557899999999999999999987 467899999975432 2233567889999999999999999999999999999
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-C
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-G 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~ 444 (575)
+|||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+..... .
T Consensus 82 iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred cceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 99999999999999877 678999999999999999999999999999999999999999999999999999865443 3
Q ss_pred ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 008171 445 VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLER 524 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~ 524 (575)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.... +.+|..+++++.+||.+
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC--CCCCccCCHHHHHHHHh
Confidence 4556789999999999999999999999999999999999999999999887776665543 56889999999999999
Q ss_pred hhhcCCCCCCC-----HHHHHH
Q 008171 525 CWQQDPALRPD-----FSEIIE 541 (575)
Q Consensus 525 cL~~dP~~RPs-----~~ell~ 541 (575)
||++||.+||+ +.|+++
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHT
T ss_pred hccCCchhhcccccccHHHHHc
Confidence 99999999995 788775
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=423.61 Aligned_cols=258 Identities=30% Similarity=0.613 Sum_probs=222.9
Q ss_pred eCCCceeeeeeeeecCceEEEEEEECC--c----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTYCS--Q----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP 362 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~~~--~----~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 362 (575)
+...+|+++++||+|+||+||+|.+.. + .||+|.++... +....+.|.+|+.+|++++|||||+++++|.++
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 445679999999999999999998743 2 48888887542 334467899999999999999999999999874
Q ss_pred CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceeccc
Q 008171 363 SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQ 442 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 442 (575)
..++++||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 57888999999999999988788899999999999999999999999999999999999999999999999999987554
Q ss_pred CCc---cccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 008171 443 SGV---MTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT-GKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKL 518 (575)
Q Consensus 443 ~~~---~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l 518 (575)
... .....||+.|+|||++.++.|+.++|||||||+||||+| |..||.+.+..+.. ..+..+.++..|..+++++
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-~~i~~~~~~~~p~~~~~~~ 242 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPICTIDV 242 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-HHHHHTCCCCCCTTBCHHH
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHcCCCCCCCcccCHHH
Confidence 322 233468999999999999999999999999999999998 89999988776654 4566778888999999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 008171 519 AELLERCWQQDPALRPDFSEIIEILQQIAKE 549 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~ 549 (575)
.+||.+||+.||.+|||+.|+++.|..+.++
T Consensus 243 ~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 243 YMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 9999999999999999999999999887653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=423.68 Aligned_cols=261 Identities=32% Similarity=0.589 Sum_probs=225.5
Q ss_pred eeCCCceeeeeeeeecCceEEEEEEECC--c--cEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecCCC
Q 008171 288 EIDPKHLKFGSKVASGSYGDLYRGTYCS--Q--DVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTKPP 362 (575)
Q Consensus 288 ~i~~~~~~i~~~LG~G~fG~Vy~~~~~~--~--~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~ 362 (575)
.|+.++|++.++||+|+||+||+|++.+ . .||||.++... ..+..+.|.+|+.+|+++ +|||||+++++|.+.+
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 4778899999999999999999998743 3 37788776433 333456799999999999 7999999999999999
Q ss_pred CceeEEEeccCCchhhhhhhc---------------cCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC
Q 008171 363 SLCIVTEFMSGGSVYDYLHKL---------------KGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE 427 (575)
Q Consensus 363 ~l~lV~E~~~ggsL~d~l~~~---------------~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~ 427 (575)
.+|+||||++||+|.++++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999653 35689999999999999999999999999999999999999999
Q ss_pred cEEEeecccceecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCC-CCCCCCCHHHHHHHHHhcCC
Q 008171 428 VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGK-LPYEYLTPLQAAVGVVQKGL 506 (575)
Q Consensus 428 ~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~-~Pf~~~~~~~~~~~v~~~~~ 506 (575)
.+||+|||+++............||..|+|||.+.+..|+.++|||||||++|||++|. .||.+.+..+.... +..+.
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~-i~~~~ 243 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGY 243 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-GGGTC
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH-HHhcC
Confidence 99999999998766555555667999999999999999999999999999999999964 67888887776655 45577
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 507 RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 507 ~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
++.+|..+++++.+||.+||+.||++|||+.|+++.|++++++.
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 88999999999999999999999999999999999999998643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.7e-51 Score=410.77 Aligned_cols=255 Identities=27% Similarity=0.448 Sum_probs=218.1
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC----Cc
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP----SL 364 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~----~l 364 (575)
++|++.+.||+|+||+||+|++. ++.||||+++.... +......|.+|+.+|++++|||||++++++.... .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 57999999999999999999874 78899999987654 3455678999999999999999999999986544 37
Q ss_pred eeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC
Q 008171 365 CIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG 444 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 444 (575)
||||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||.+.......
T Consensus 87 ~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 899999999999998876 5789999999999999999999999999999999999999999999999999987554332
Q ss_pred ----ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHH
Q 008171 445 ----VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPKL 518 (575)
Q Consensus 445 ----~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~--~~p~~~~~~l 518 (575)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.++.+.....+.....+ ..+..+|+++
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l 245 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245 (277)
T ss_dssp -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHH
T ss_pred ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHH
Confidence 3445679999999999999999999999999999999999999999999888887777665443 2456789999
Q ss_pred HHHHHHhhhcCCCCCC-CHHHHHHHHHHHH
Q 008171 519 AELLERCWQQDPALRP-DFSEIIEILQQIA 547 (575)
Q Consensus 519 ~~Li~~cL~~dP~~RP-s~~ell~~L~~l~ 547 (575)
.++|.+||++||.+|| |+++++..|.++.
T Consensus 246 ~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 246 DAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 9999999999999999 8999998888764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.4e-51 Score=419.69 Aligned_cols=245 Identities=26% Similarity=0.459 Sum_probs=220.3
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|+++++||+|+||+||+|++. ++.||||+++.... .....+.+.+|+.+|++++|||||++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999974 67899999975432 1233567899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 448 (575)
|||.||+|..++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+..... ...
T Consensus 84 E~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~ 160 (316)
T d1fota_ 84 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYT 160 (316)
T ss_dssp CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCC
T ss_pred eecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--ccc
Confidence 99999999998876 677899999999999999999999999999999999999999999999999999876543 446
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 528 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~ 528 (575)
.+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+.... ..+|..+++++.++|.+||++
T Consensus 161 ~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~ 238 (316)
T d1fota_ 161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLLSRLITR 238 (316)
T ss_dssp CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCS
T ss_pred ccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhh
Confidence 789999999999999999999999999999999999999999999888877766653 457788999999999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 008171 529 DPALRP-----DFSEIIE 541 (575)
Q Consensus 529 dP~~RP-----s~~ell~ 541 (575)
||.+|+ |++++++
T Consensus 239 dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 239 DLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CTTTCTTSSTTTTHHHHT
T ss_pred CHHhccccchhhHHHHHc
Confidence 999996 8999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=416.55 Aligned_cols=261 Identities=31% Similarity=0.568 Sum_probs=230.6
Q ss_pred CceeeCCCceeeeeeeeecCceEEEEEEEC-------CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEee
Q 008171 285 DVWEIDPKHLKFGSKVASGSYGDLYRGTYC-------SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGA 357 (575)
Q Consensus 285 ~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~-------~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~ 357 (575)
+.|+|+.++|+++++||+|+||+||+|.+. ++.||||+++.. ........|.+|+.++++++|||||+++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 579999999999999999999999999874 356999999754 344556779999999999999999999999
Q ss_pred ecCCCCceeEEEeccCCchhhhhhhcc---------CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCc
Q 008171 358 CTKPPSLCIVTEFMSGGSVYDYLHKLK---------GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 428 (575)
Q Consensus 358 ~~~~~~l~lV~E~~~ggsL~d~l~~~~---------~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~ 428 (575)
|..++..++||||+.+|+|.+++.... ..+++..+.+++.||+.||.|||+++|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 999999999999999999999986532 24688899999999999999999999999999999999999999
Q ss_pred EEEeecccceecccCC---ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHhc
Q 008171 429 VKVADFGVARVKAQSG---VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTG-KLPYEYLTPLQAAVGVVQK 504 (575)
Q Consensus 429 vkL~DFG~a~~~~~~~---~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG-~~Pf~~~~~~~~~~~v~~~ 504 (575)
+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++| ..||.+.+..+....+. .
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~-~ 250 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-E 250 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-T
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-h
Confidence 9999999998654432 22344689999999999999999999999999999999997 58999988888776544 5
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 008171 505 GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIA 547 (575)
Q Consensus 505 ~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~ 547 (575)
+.++.+|..+++.+.++|.+||+.||.+|||+.+|++.|++.+
T Consensus 251 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 251 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 6678889999999999999999999999999999999887653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.2e-50 Score=407.88 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=221.0
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCCh-------HHHHHHHHHHHHHHhcC-CCCceEEEeeecCC
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS-------DMQKEFAQEVFIMRKVR-HKNVVQFIGACTKP 361 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~-------~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~ 361 (575)
++|++.++||+|+||+||+|+. +++.||||+++...... .....+.+|+.+|++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999987 56889999997654321 23456889999999997 99999999999999
Q ss_pred CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
+.+|||||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 999999999999999999976 6789999999999999999999999999999999999999999999999999999877
Q ss_pred cCCccccCCCCCCccCccccc------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--CCCC
Q 008171 442 QSGVMTAETGTYRWMAPEVIE------HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPT--IPKN 513 (575)
Q Consensus 442 ~~~~~~~~~Gt~~y~APE~i~------~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~--~p~~ 513 (575)
.....+...||+.|+|||++. ...++.++||||+||++|+|++|+.||.+.+.......+......+. ...+
T Consensus 162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (277)
T d1phka_ 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241 (277)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence 766666778999999999984 34578899999999999999999999999988877766666554332 3347
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 514 SQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 514 ~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+++++++||.+||+.||.+|||+.|+++
T Consensus 242 ~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 242 YSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 8999999999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-50 Score=416.37 Aligned_cols=247 Identities=19% Similarity=0.312 Sum_probs=220.8
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|+++++||+|+||+||+|.+. ++.||||+++... .....+.+|+.+|+.++|||||++++++.+.+.+|||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 57999999999999999999874 6789999998653 234568899999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCC--CcEEEeecccceecccCCccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDEN--EVVKVADFGVARVKAQSGVMT 447 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~--~~vkL~DFG~a~~~~~~~~~~ 447 (575)
||+||+|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++.+ ..+||+|||+++.........
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~ 161 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence 999999999998766689999999999999999999999999999999999999854 489999999998876665566
Q ss_pred cCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHHHHHHHh
Q 008171 448 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--TIPKNSQPKLAELLERC 525 (575)
Q Consensus 448 ~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~--~~p~~~~~~l~~Li~~c 525 (575)
...||+.|+|||.+.+..|+.++|||||||++|+|++|..||...+..+....+....... ..+..+++++.+||.+|
T Consensus 162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 241 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHH
Confidence 6789999999999999999999999999999999999999999999888877776654332 12347899999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 008171 526 WQQDPALRPDFSEIIE 541 (575)
Q Consensus 526 L~~dP~~RPs~~ell~ 541 (575)
|..||.+|||+.|+++
T Consensus 242 L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 242 LVKERKSRMTASEALQ 257 (321)
T ss_dssp SCSSGGGSCCHHHHHH
T ss_pred ccCChhHCcCHHHHhc
Confidence 9999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-50 Score=420.45 Aligned_cols=245 Identities=25% Similarity=0.391 Sum_probs=219.9
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERI-NSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~ 368 (575)
++|+++++||+|+||.||+|.+. ++.||||+++.... .......+.+|+.+|+.++|||||++++++.....+++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 58999999999999999999874 78899999875322 2233467899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCCcccc
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMTA 448 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 448 (575)
||+.||+|.+++.+ .+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++..... ...
T Consensus 121 e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~ 197 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWT 197 (350)
T ss_dssp ECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCC
T ss_pred ccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--ccc
Confidence 99999999999976 567999999999999999999999999999999999999999999999999999876533 445
Q ss_pred CCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc
Q 008171 449 ETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCWQQ 528 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL~~ 528 (575)
..||+.|||||++.+..|+.++|||||||+||+|++|..||.+.+.......+.... +.+|..+++++.+||++||+.
T Consensus 198 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~ 275 (350)
T d1rdqe_ 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQV 275 (350)
T ss_dssp CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTCCHHHHHHHHHHSCS
T ss_pred ccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC--CCCCccCCHHHHHHHHHHhhh
Confidence 689999999999999999999999999999999999999999998888777766554 456789999999999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 008171 529 DPALRP-----DFSEIIE 541 (575)
Q Consensus 529 dP~~RP-----s~~ell~ 541 (575)
||.+|+ |+.++++
T Consensus 276 dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 276 DLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CTTTCTTSSTTTTHHHHT
T ss_pred CHHhccccccccHHHHHc
Confidence 999994 8999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=410.50 Aligned_cols=256 Identities=29% Similarity=0.516 Sum_probs=218.4
Q ss_pred eeeeeeeecCceEEEEEEECCc-----cEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC-CCCceeEE
Q 008171 295 KFGSKVASGSYGDLYRGTYCSQ-----DVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK-PPSLCIVT 368 (575)
Q Consensus 295 ~i~~~LG~G~fG~Vy~~~~~~~-----~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~-~~~l~lV~ 368 (575)
.+.++||+|+||+||+|++... .||||.++.. .+.....+|.+|+.+|++++|||||+++|++.. ++.+++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 4468999999999999997432 4899998743 355567889999999999999999999999764 56789999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC----
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG---- 444 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~---- 444 (575)
|||++|+|.+++......+++..++.++.||+.||.|||+.+|+||||||+|||+++++.+||+|||+++......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 9999999999998877788899999999999999999999999999999999999999999999999998654432
Q ss_pred -ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 008171 445 -VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLE 523 (575)
Q Consensus 445 -~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~ 523 (575)
......||+.|+|||.+....++.++||||||++||||++|..||............+..+.++..|..+++++.+||.
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~ 268 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 268 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHH
Confidence 2223468999999999999999999999999999999999777775543333334445567788899999999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 524 RCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 524 ~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
+||+.||++||++.|+++.|+++++...
T Consensus 269 ~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 269 KCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 9999999999999999999999987544
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-50 Score=413.70 Aligned_cols=247 Identities=24% Similarity=0.430 Sum_probs=217.0
Q ss_pred CceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCC-ChHHHHHHHHHHHHHH-hcCCCCceEEEeeecCCCCceeE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERI-NSDMQKEFAQEVFIMR-KVRHKNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~-~~~~~~~~~~Ev~iL~-~L~HpnIv~l~~~~~~~~~l~lV 367 (575)
++|.++++||+|+||+||+|++ +++.||||+++.... .......+..|..++. .++|||||++++++.+.+.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999998 567899999975322 1222355666777655 78999999999999999999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-Ccc
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVM 446 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~ 446 (575)
||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~ 160 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 160 (320)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence 999999999999976 677999999999999999999999999999999999999999999999999999865443 345
Q ss_pred ccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 008171 447 TAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAELLERCW 526 (575)
Q Consensus 447 ~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~Li~~cL 526 (575)
+...||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+... .+.+|..+++++.+||.+||
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli~~~L 238 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLVKLF 238 (320)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHS
T ss_pred cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCccCCHHHHHHHHHhc
Confidence 5678999999999999999999999999999999999999999999988877666544 46788899999999999999
Q ss_pred hcCCCCCCCHH-HHHH
Q 008171 527 QQDPALRPDFS-EIIE 541 (575)
Q Consensus 527 ~~dP~~RPs~~-ell~ 541 (575)
+.||.+||++. ++++
T Consensus 239 ~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 239 VREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CSSGGGSBTTBSCGGG
T ss_pred ccCCCCCcCHHHHHHh
Confidence 99999999985 6753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.3e-49 Score=415.47 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=209.9
Q ss_pred CCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCC----hHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCC
Q 008171 290 DPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERIN----SDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPS 363 (575)
Q Consensus 290 ~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~----~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 363 (575)
..++|+++++||+|+||.||+|++. ++.||||++...... ........+|+.+++.++|||||++++++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 3568999999999999999999984 678999998743321 1112233345677778889999999999999999
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
+|||||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 9999999999999999976 577899999999999999999999999999999999999999999999999999866543
Q ss_pred CccccCCCCCCccCccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHhcCCCCCCCCCCcHHHHHH
Q 008171 444 GVMTAETGTYRWMAPEVIE-HKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAV-GVVQKGLRPTIPKNSQPKLAEL 521 (575)
Q Consensus 444 ~~~~~~~Gt~~y~APE~i~-~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~-~v~~~~~~~~~p~~~~~~l~~L 521 (575)
......||+.|+|||++. +..|+.++|||||||+||||++|+.||...+...... ........+.+|..+++++.+|
T Consensus 161 -~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (364)
T d1omwa3 161 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 239 (364)
T ss_dssp -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHH
T ss_pred -cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHH
Confidence 345568999999999996 4579999999999999999999999998755432221 1122334556788999999999
Q ss_pred HHHhhhcCCCCCCC-----HHHHHH
Q 008171 522 LERCWQQDPALRPD-----FSEIIE 541 (575)
Q Consensus 522 i~~cL~~dP~~RPs-----~~ell~ 541 (575)
|.+||+.||.+||| ++|+++
T Consensus 240 i~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 240 LEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHHHcccCHHHhCCCcccCHHHHHc
Confidence 99999999999999 688874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=403.63 Aligned_cols=250 Identities=22% Similarity=0.358 Sum_probs=212.7
Q ss_pred CceeeeeeeeecCceEEEEEEEC---CccEEEEEecCCCCChHHHHHHHHHHHHHHhc---CCCCceEEEeeec-----C
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC---SQDVAIKVLKPERINSDMQKEFAQEVFIMRKV---RHKNVVQFIGACT-----K 360 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~---~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L---~HpnIv~l~~~~~-----~ 360 (575)
++|+++++||+|+||+||+|.+. ++.||||+++...........+.+|+.+|+.| +||||++++++|. .
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 68999999999999999999874 45699999976544443334566788877766 7999999999884 3
Q ss_pred CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
...+|++|||+.++.+..........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 45689999999888777666665678999999999999999999999999999999999999999999999999999877
Q ss_pred ccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--------------
Q 008171 441 AQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL-------------- 506 (575)
Q Consensus 441 ~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~-------------- 506 (575)
..........||+.|+|||++.+.+|+.++|||||||++|||++|+.||.+.+..+....++....
T Consensus 167 ~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 246 (305)
T d1blxa_ 167 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246 (305)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSC
T ss_pred cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccch
Confidence 766667788999999999999999999999999999999999999999999888776655543110
Q ss_pred -----------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 507 -----------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 507 -----------~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
...++..+++.+.+||.+||++||.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 01234567899999999999999999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-49 Score=400.35 Aligned_cols=244 Identities=24% Similarity=0.349 Sum_probs=202.4
Q ss_pred eeeeeecCceEEEEEEE--CCccEEEEEecCCCCCh---HHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEec
Q 008171 297 GSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINS---DMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEFM 371 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~~ 371 (575)
+++||+|+||+||+|.+ +++.||||+++...... ...+.+.+|+.+|++++|||||++++++...+.+||||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999987 46789999997654322 22356889999999999999999999999999999999999
Q ss_pred cCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-ccccCC
Q 008171 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAET 450 (575)
Q Consensus 372 ~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~ 450 (575)
.|+++..+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .....+
T Consensus 83 ~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 161 (299)
T d1ua2a_ 83 ETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV 161 (299)
T ss_dssp SEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred cchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence 8877665554 36779999999999999999999999999999999999999999999999999997655433 344568
Q ss_pred CCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---------------------
Q 008171 451 GTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP--------------------- 508 (575)
Q Consensus 451 Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~--------------------- 508 (575)
||+.|+|||++.. ..|+.++|||||||++|||++|..||.+.+..+....+......+
T Consensus 162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (299)
T d1ua2a_ 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241 (299)
T ss_dssp CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence 9999999999864 568999999999999999999999999988877665554321000
Q ss_pred C-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 T-----IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 ~-----~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
. +...+++++.+||.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0 11356789999999999999999999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-49 Score=401.34 Aligned_cols=250 Identities=21% Similarity=0.356 Sum_probs=207.5
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|+++++||+|+||.||+|++. ++.||||+++...........+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999984 6789999998665554556789999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC-Ccccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS-GVMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~ 448 (575)
|+.++.+..........+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+++..... .....
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~ 161 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTC
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccccee
Confidence 99654444343444567999999999999999999999999999999999999999999999999999876543 34455
Q ss_pred CCCCCCccCcccccCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC----------------CCC--
Q 008171 449 ETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL----------------RPT-- 509 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~-~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~----------------~~~-- 509 (575)
..||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+....+..... ...
T Consensus 162 ~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T d1gz8a_ 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241 (298)
T ss_dssp CBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSC
T ss_pred ecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccc
Confidence 68999999999987766 47899999999999999999999998887766555432110 001
Q ss_pred ---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 510 ---------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 510 ---------~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
....+++++.+||.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11356789999999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=409.58 Aligned_cols=243 Identities=23% Similarity=0.409 Sum_probs=203.3
Q ss_pred Cceeeee-eeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhc-CCCCceEEEeeecC----CCC
Q 008171 292 KHLKFGS-KVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKV-RHKNVVQFIGACTK----PPS 363 (575)
Q Consensus 292 ~~~~i~~-~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~----~~~ 363 (575)
++|++.. .||+|+||.||+|++ +++.||||+++.. ..+.+|+.++.++ +|||||++++++.+ ...
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 4788765 599999999999987 4678999998742 4567899987655 79999999998854 466
Q ss_pred ceeEEEeccCCchhhhhhhcc-CcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC---CCcEEEeeccccee
Q 008171 364 LCIVTEFMSGGSVYDYLHKLK-GVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARV 439 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~---~~~vkL~DFG~a~~ 439 (575)
+|||||||+||+|.+++.+.. ..+++..++.|+.||+.||.|||++||+||||||+|||++. .+.+||+|||+++.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence 899999999999999997643 46999999999999999999999999999999999999985 56799999999998
Q ss_pred cccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--CCCCC----CC
Q 008171 440 KAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIP----KN 513 (575)
Q Consensus 440 ~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~--~~~~p----~~ 513 (575)
...........||+.|||||++.+..|+.++|||||||+||+|++|+.||.+.+.......+..... ...+| ..
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 243 (335)
T d2ozaa1 164 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243 (335)
T ss_dssp CCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHH
T ss_pred ccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCccccc
Confidence 7777677778999999999999999999999999999999999999999987665444333322221 11222 25
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 514 SQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 514 ~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+++++.+||.+||+.||.+|||+.|+++
T Consensus 244 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 244 VSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 7899999999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.2e-48 Score=393.59 Aligned_cols=249 Identities=22% Similarity=0.354 Sum_probs=209.4
Q ss_pred CceeeeeeeeecCceEEEEEEEC-CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEEe
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC-SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTEF 370 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~-~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E~ 370 (575)
++|++.++||+|+||+||+|++. ++.||||+++....+....+.+.+|+.+|++++|||||++++++...+..|++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 58999999999999999999875 57899999987655555567899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-ccccC
Q 008171 371 MSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTAE 449 (575)
Q Consensus 371 ~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 449 (575)
+.++.+..+.. ..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||.+....... .....
T Consensus 82 ~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (286)
T d1ob3a_ 82 LDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160 (286)
T ss_dssp CSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred ehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence 97766555544 46889999999999999999999999999999999999999999999999999997655433 33455
Q ss_pred CCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---------------------
Q 008171 450 TGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR--------------------- 507 (575)
Q Consensus 450 ~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~--------------------- 507 (575)
.|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+..+....+......
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T d1ob3a_ 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240 (286)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccccc
Confidence 78999999999865 45789999999999999999999999988877765554321000
Q ss_pred ------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 ------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 ------~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
...+..+++++.+||.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1234567899999999999999999999999873
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=396.51 Aligned_cols=240 Identities=25% Similarity=0.477 Sum_probs=205.2
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCCh----HHHHHHHHHHHHHHhcC--CCCceEEEeeecCCCC
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINS----DMQKEFAQEVFIMRKVR--HKNVVQFIGACTKPPS 363 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~----~~~~~~~~Ev~iL~~L~--HpnIv~l~~~~~~~~~ 363 (575)
++|+++++||+|+||+||+|.+. ++.||||+++...... .....+.+|+.+|++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999984 6789999997654322 11234678999999997 8999999999999999
Q ss_pred ceeEEEeccC-CchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC-CCcEEEeecccceecc
Q 008171 364 LCIVTEFMSG-GSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-NEVVKVADFGVARVKA 441 (575)
Q Consensus 364 l~lV~E~~~g-gsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~ 441 (575)
+|+||||+.+ +++.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 9999999976 577777765 578999999999999999999999999999999999999985 4799999999998654
Q ss_pred cCCccccCCCCCCccCcccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 008171 442 QSGVMTAETGTYRWMAPEVIEHKPY-DHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTIPKNSQPKLAE 520 (575)
Q Consensus 442 ~~~~~~~~~Gt~~y~APE~i~~~~~-s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~~~p~~~~~~l~~ 520 (575)
.. ..+...||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+ .+... ...++..+++++.+
T Consensus 163 ~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~--~~~~~~~~s~~~~~ 233 (273)
T d1xwsa_ 163 DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--QVFFRQRVSSECQH 233 (273)
T ss_dssp SS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--CCCCSSCCCHHHHH
T ss_pred cc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc--ccCCCCCCCHHHHH
Confidence 43 4456789999999999987765 567899999999999999999997632 12222 24577889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 008171 521 LLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 521 Li~~cL~~dP~~RPs~~ell~ 541 (575)
||.+||+.||.+|||+.|+++
T Consensus 234 li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 234 LIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHccCCHhHCcCHHHHhc
Confidence 999999999999999999976
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=396.88 Aligned_cols=254 Identities=27% Similarity=0.509 Sum_probs=206.2
Q ss_pred CceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC----CceeE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP----SLCIV 367 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~----~l~lV 367 (575)
.+|.+.++||+|+||+||+|++.++.||||+++... .....+..|+..+.+++|||||+++++|.... .+|+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 468899999999999999999999999999987432 21122334555667889999999999986543 57999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHH--------CCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ--------NNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~--------~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
||||++|+|.+++++ ..+++..++.++.|++.||.|||+ +||+||||||+||||+.++.+||+|||+++.
T Consensus 80 ~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999999976 468999999999999999999996 5999999999999999999999999999986
Q ss_pred cccCC-----ccccCCCCCCccCcccccCCC------CCchHHHHHHHHHHHHHHcCCCCCCC---------------CC
Q 008171 440 KAQSG-----VMTAETGTYRWMAPEVIEHKP------YDHKADVFSFGIVLWELLTGKLPYEY---------------LT 493 (575)
Q Consensus 440 ~~~~~-----~~~~~~Gt~~y~APE~i~~~~------~s~ksDVwSlGviL~eLltG~~Pf~~---------------~~ 493 (575)
..... ......||+.|+|||++.... ++.++|||||||+||||+||..||.. ..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 65432 233457999999999987643 67799999999999999999887632 12
Q ss_pred HHHHHHHHHhcCCCCCCCCCC-----cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q 008171 494 PLQAAVGVVQKGLRPTIPKNS-----QPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEV 550 (575)
Q Consensus 494 ~~~~~~~v~~~~~~~~~p~~~-----~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~ 550 (575)
.......+.....+|.++... ...+.+|+.+||+.||.+|||+.||++.|+++.++-
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 233333445556677666543 346999999999999999999999999999887654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-47 Score=394.08 Aligned_cols=253 Identities=27% Similarity=0.398 Sum_probs=210.5
Q ss_pred CCCceeeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC
Q 008171 283 GTDVWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK 360 (575)
Q Consensus 283 ~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 360 (575)
+...|++ .++|+++++||+|+||+||+|.+. ++.||||+++....+....+.+.+|+.+|++++|||||+++++|..
T Consensus 10 ~~~~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~ 88 (346)
T d1cm8a_ 10 TKTAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTP 88 (346)
T ss_dssp SSSEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECS
T ss_pred cCceeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEecc
Confidence 3456787 479999999999999999999974 7889999998776677777889999999999999999999999876
Q ss_pred CC------CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeec
Q 008171 361 PP------SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434 (575)
Q Consensus 361 ~~------~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DF 434 (575)
.+ .+|+||||+ |.+|..+++. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 89 DETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred CccccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccc
Confidence 54 479999999 7788877654 67999999999999999999999999999999999999999999999999
Q ss_pred ccceecccCCccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-------
Q 008171 435 GVARVKAQSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL------- 506 (575)
Q Consensus 435 G~a~~~~~~~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~------- 506 (575)
|+++.... ..+...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.............
T Consensus 166 g~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 166 GLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp TTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 99986654 3566789999999999876 4578999999999999999999999988776555433221100
Q ss_pred ----------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 507 ----------------------RPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 507 ----------------------~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
...+...+++++.+||.+||..||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 11234567899999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-46 Score=384.38 Aligned_cols=255 Identities=25% Similarity=0.349 Sum_probs=208.2
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceE-EEeeecCCCCceeEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQ-FIGACTKPPSLCIVT 368 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~-l~~~~~~~~~l~lV~ 368 (575)
++|+++++||+|+||+||+|++. ++.||||++...... .++..|+.+++.++|+|++. +.+++...+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 47999999999999999999975 678999998765332 34778999999998776554 555567777889999
Q ss_pred EeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC---CCcEEEeecccceecccCC-
Q 008171 369 EFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE---NEVVKVADFGVARVKAQSG- 444 (575)
Q Consensus 369 E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~---~~~vkL~DFG~a~~~~~~~- 444 (575)
||+ +++|.+.+....+.+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+|||+|+......
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 999 66787877776788999999999999999999999999999999999999864 5579999999998765432
Q ss_pred -------ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---hc---CCCCCCC
Q 008171 445 -------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVV---QK---GLRPTIP 511 (575)
Q Consensus 445 -------~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~---~~---~~~~~~p 511 (575)
......||+.|||||++.+..|+.++|||||||++|||++|..||......+....+. .. ...+..+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHT
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhc
Confidence 2234579999999999999999999999999999999999999998765544332211 11 1122345
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhc
Q 008171 512 KNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVG 551 (575)
Q Consensus 512 ~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~ 551 (575)
..+|+++.++|.+||+.||.+||++.++.+.|++++...+
T Consensus 242 ~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 6889999999999999999999999999999999876543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.7e-46 Score=380.47 Aligned_cols=257 Identities=18% Similarity=0.282 Sum_probs=216.3
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCC-CCceEEEeeecCCCCceeE
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTKPPSLCIV 367 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~H-pnIv~l~~~~~~~~~l~lV 367 (575)
.++|+++++||+|+||+||+|++. ++.||||++...... ..+.+|+.+++.+.| +|++.+++++......|+|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 468999999999999999999974 678999998754322 346678899999976 8999999999999999999
Q ss_pred EEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecC-----CCcEEEeecccceeccc
Q 008171 368 TEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE-----NEVVKVADFGVARVKAQ 442 (575)
Q Consensus 368 ~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~-----~~~vkL~DFG~a~~~~~ 442 (575)
|||+ |++|.+++......++...+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+....
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9999 78999999887778999999999999999999999999999999999999974 57899999999987544
Q ss_pred CC--------ccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhc---CCCC
Q 008171 443 SG--------VMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTP---LQAAVGVVQK---GLRP 508 (575)
Q Consensus 443 ~~--------~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~---~~~~~~v~~~---~~~~ 508 (575)
.. ......||+.|||||++.+..++.++|||||||++|||++|..||.+... .+....+... ....
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence 31 22345799999999999999999999999999999999999999976533 2222222211 1122
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhch
Q 008171 509 TIPKNSQPKLAELLERCWQQDPALRPDFSEIIEILQQIAKEVGE 552 (575)
Q Consensus 509 ~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~~L~~l~~~~~~ 552 (575)
.++..+|+++.+++..||..+|++||+++.+.+.|++++++.+.
T Consensus 239 ~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~ 282 (293)
T d1csna_ 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282 (293)
T ss_dssp HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence 34567899999999999999999999999999999999876653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-46 Score=386.76 Aligned_cols=252 Identities=23% Similarity=0.382 Sum_probs=205.0
Q ss_pred ceeeCCCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCC-
Q 008171 286 VWEIDPKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPP- 362 (575)
Q Consensus 286 ~~~i~~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~- 362 (575)
.|+|. ++|+++++||+|+||+||+|.+. ++.||||+++... .....+.+.+|+.+|++++||||+++++++....
T Consensus 3 ~~~i~-~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 3 VFDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp CCCCC-TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred ccCcC-CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 45665 45999999999999999999874 7889999997543 4555678999999999999999999999986543
Q ss_pred ---CceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccccee
Q 008171 363 ---SLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 363 ---~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
..+++++|+.||+|.+++.. +.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 81 EQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp TTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cccceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 23455566779999999965 5799999999999999999999999999999999999999999999999999986
Q ss_pred cccCC----ccccCCCCCCccCcccc-cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-------
Q 008171 440 KAQSG----VMTAETGTYRWMAPEVI-EHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR------- 507 (575)
Q Consensus 440 ~~~~~----~~~~~~Gt~~y~APE~i-~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~------- 507 (575)
..... .....+||+.|+|||++ ....++.++||||+||++|+|++|+.||...+..............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 54432 23455799999999998 5566899999999999999999999999887765444333211000
Q ss_pred -----------------C-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 -----------------P-----TIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 -----------------~-----~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
. .....+++++.+||.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 123467789999999999999999999999985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-46 Score=381.49 Aligned_cols=249 Identities=25% Similarity=0.369 Sum_probs=201.6
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC--------C
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK--------P 361 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--------~ 361 (575)
++|+++++||+|+||+||+|++. ++.||||++............+.+|+.+|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 68999999999999999999974 6789999987665555556778999999999999999999998754 3
Q ss_pred CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecc
Q 008171 362 PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKA 441 (575)
Q Consensus 362 ~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 441 (575)
..+|+||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 4689999999776655444 446779999999999999999999999999999999999999999999999999997654
Q ss_pred cCC-----ccccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--CCCCC--
Q 008171 442 QSG-----VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGL--RPTIP-- 511 (575)
Q Consensus 442 ~~~-----~~~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~--~~~~p-- 511 (575)
... .....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+.......+..... .+...
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 322 22345799999999998765 689999999999999999999999998887666544332111 11100
Q ss_pred --------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 512 --------------------------KNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 512 --------------------------~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
...++.+.+||.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 012567889999999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-46 Score=387.95 Aligned_cols=243 Identities=25% Similarity=0.324 Sum_probs=201.5
Q ss_pred ceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC------CCCc
Q 008171 293 HLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK------PPSL 364 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~------~~~l 364 (575)
+|+.+++||+|+||+||+|++. ++.||||+++..... +.+|+.+|++++||||++++++|.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 6899999999999999999984 678999999765322 3469999999999999999998742 3347
Q ss_pred eeEEEeccCCchhhhhh--hccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC-cEEEeecccceecc
Q 008171 365 CIVTEFMSGGSVYDYLH--KLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKA 441 (575)
Q Consensus 365 ~lV~E~~~ggsL~d~l~--~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~ 441 (575)
|||||||+++.+..+.. .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 89999997654443332 2355799999999999999999999999999999999999999775 89999999998877
Q ss_pred cCCccccCCCCCCccCcccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC---------------
Q 008171 442 QSGVMTAETGTYRWMAPEVIEH-KPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKG--------------- 505 (575)
Q Consensus 442 ~~~~~~~~~Gt~~y~APE~i~~-~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~--------------- 505 (575)
.........||+.|+|||++.+ ..|+.++|||||||++|||++|..||...+..+....+....
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 254 (350)
T d1q5ka_ 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254 (350)
T ss_dssp TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence 6666677789999999998865 579999999999999999999999999887766655443210
Q ss_pred CC------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 506 LR------------PTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 506 ~~------------~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.. ......+++++.+||.+||+.||.+|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0123457899999999999999999999999885
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-46 Score=375.03 Aligned_cols=249 Identities=21% Similarity=0.322 Sum_probs=211.2
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecCCCCceeEEE
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLCIVTE 369 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~l~lV~E 369 (575)
++|+++++||+|+||+||+|++. ++.||||+++...........+.+|+.+|++++||||+++++++.....+++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999984 5679999998776666677889999999999999999999999999999999999
Q ss_pred eccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccCC-cccc
Q 008171 370 FMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSG-VMTA 448 (575)
Q Consensus 370 ~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 448 (575)
++.|++|..++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||.++...... ....
T Consensus 82 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~ 160 (292)
T d1unla_ 82 FCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp CCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred ecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence 9999888877765 6788999999999999999999999999999999999999999999999999998766543 3344
Q ss_pred CCCCCCccCcccccCCC-CCchHHHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhc----------------------
Q 008171 449 ETGTYRWMAPEVIEHKP-YDHKADVFSFGIVLWELLTGKLPYEYL-TPLQAAVGVVQK---------------------- 504 (575)
Q Consensus 449 ~~Gt~~y~APE~i~~~~-~s~ksDVwSlGviL~eLltG~~Pf~~~-~~~~~~~~v~~~---------------------- 504 (575)
..+++.|+|||++.... ++.++|||||||++|||++|+.||... +..+....+...
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccc
Confidence 56788999999987665 689999999999999999999886543 433333322210
Q ss_pred -----CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 505 -----GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 505 -----~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
......+..+++.+.+||.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111234567889999999999999999999999874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.9e-45 Score=377.86 Aligned_cols=242 Identities=19% Similarity=0.342 Sum_probs=201.3
Q ss_pred CCceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecC--CCCce
Q 008171 291 PKHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTK--PPSLC 365 (575)
Q Consensus 291 ~~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~--~~~l~ 365 (575)
.++|+++++||+|+||+||+|++. ++.||||+++... .+.+.+|+.+|+++. ||||+++++++.. ...+|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 357999999999999999999974 6789999997542 356889999999996 9999999999864 45689
Q ss_pred eEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCC-cEEEeecccceecccCC
Q 008171 366 IVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENE-VVKVADFGVARVKAQSG 444 (575)
Q Consensus 366 lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~~~ 444 (575)
+||||+.+++|..+. +.+++..+..++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++......
T Consensus 109 ~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred EEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999999987764 4589999999999999999999999999999999999998654 69999999998877666
Q ss_pred ccccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHh------------c------
Q 008171 445 VMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ-AAVGVVQ------------K------ 504 (575)
Q Consensus 445 ~~~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~-~~~~v~~------------~------ 504 (575)
......||+.|+|||++.+. .++.++||||+||++|+|++|+.||....... ....+.. .
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 66777899999999998765 58999999999999999999999997654322 1111100 0
Q ss_pred -----------------CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 505 -----------------GLRPTIPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 505 -----------------~~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
.........+++++.+||++||+.||.+|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111122346889999999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=388.11 Aligned_cols=252 Identities=23% Similarity=0.392 Sum_probs=210.6
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE-----CCccEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCC-CCceEEEeeecC
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY-----CSQDVAIKVLKPERI--NSDMQKEFAQEVFIMRKVRH-KNVVQFIGACTK 360 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~-----~~~~VAvKvl~~~~~--~~~~~~~~~~Ev~iL~~L~H-pnIv~l~~~~~~ 360 (575)
+..++|+++++||+|+||+||+|.. +++.||||+++.... +....+.+.+|+.+|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 3457899999999999999999976 356799999875433 12234568889999999987 899999999999
Q ss_pred CCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceec
Q 008171 361 PPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVK 440 (575)
Q Consensus 361 ~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 440 (575)
...+++||||+.||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred CCceeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 9999999999999999999977 567789999999999999999999999999999999999999999999999999865
Q ss_pred ccC--CccccCCCCCCccCcccccCC--CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--cCCCCCCCCCC
Q 008171 441 AQS--GVMTAETGTYRWMAPEVIEHK--PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQ--KGLRPTIPKNS 514 (575)
Q Consensus 441 ~~~--~~~~~~~Gt~~y~APE~i~~~--~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~--~~~~~~~p~~~ 514 (575)
... .......|++.|+|||.+.+. .++.++|||||||+||+|++|+.||...+..+....+.. ....+.+|..+
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence 433 234456799999999999764 478899999999999999999999977543333222222 12345678899
Q ss_pred cHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 008171 515 QPKLAELLERCWQQDPALRPD-----FSEIIE 541 (575)
Q Consensus 515 ~~~l~~Li~~cL~~dP~~RPs-----~~ell~ 541 (575)
++++.+||.+||++||.+||| ++|+++
T Consensus 260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 999999999999999999994 788764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=384.78 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=211.7
Q ss_pred CCCCceeeCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeec
Q 008171 282 DGTDVWEIDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACT 359 (575)
Q Consensus 282 ~~~~~~~i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~ 359 (575)
.+.+.|++. ++|+++++||+|+||+||+|.+ +++.||||+++....+....+.+.+|+.+|++++|||||++++++.
T Consensus 9 ~~~~~~~~~-~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 9 LNKTIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp CSSSEEEEE-TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCccccCC-CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 345678884 7899999999999999999987 4788999999877666666778999999999999999999999885
Q ss_pred CC-----CCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeec
Q 008171 360 KP-----PSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADF 434 (575)
Q Consensus 360 ~~-----~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DF 434 (575)
.. ...+++|+|+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++||
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~df 165 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDF 165 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred eccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccccccccc
Confidence 33 334667778889999999954 57999999999999999999999999999999999999999999999999
Q ss_pred ccceecccCCccccCCCCCCccCcccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-----
Q 008171 435 GVARVKAQSGVMTAETGTYRWMAPEVIEHK-PYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRP----- 508 (575)
Q Consensus 435 G~a~~~~~~~~~~~~~Gt~~y~APE~i~~~-~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~~----- 508 (575)
|++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+......+
T Consensus 166 g~a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 166 GLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp ----CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred chhcccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 99975543 34456789999999987665 46889999999999999999999999887766555443321111
Q ss_pred ----------------C--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 509 ----------------T--------IPKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 509 ----------------~--------~p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
. ....+++++.+||.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 12357899999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=384.09 Aligned_cols=246 Identities=25% Similarity=0.348 Sum_probs=196.0
Q ss_pred CceeeeeeeeecCceEEEEEEEC--CccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCceEEEeeecC------CCC
Q 008171 292 KHLKFGSKVASGSYGDLYRGTYC--SQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNVVQFIGACTK------PPS 363 (575)
Q Consensus 292 ~~~~i~~~LG~G~fG~Vy~~~~~--~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~------~~~ 363 (575)
++|+++++||+|+||+||+|.+. ++.||||+++....+......+.+|+.+|++++|||||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999985 7889999998877777777789999999999999999999999853 357
Q ss_pred ceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeecccceecccC
Q 008171 364 LCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQS 443 (575)
Q Consensus 364 l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 443 (575)
+|+||||+.|+.+ +.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++.....
T Consensus 97 ~~iv~Ey~~~~l~-~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEECCSEEHH-HHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEeccchHHH-Hhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 8999999966544 443 356899999999999999999999999999999999999999999999999999877776
Q ss_pred CccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC----------------
Q 008171 444 GVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR---------------- 507 (575)
Q Consensus 444 ~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~~~~~v~~~~~~---------------- 507 (575)
...+...||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......++.....
T Consensus 173 ~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 252 (355)
T d2b1pa1 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252 (355)
T ss_dssp --------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHH
T ss_pred cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHH
Confidence 6677778999999999999999999999999999999999999999887765554433211100
Q ss_pred ----CC--------------C------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 008171 508 ----PT--------------I------PKNSQPKLAELLERCWQQDPALRPDFSEIIE 541 (575)
Q Consensus 508 ----~~--------------~------p~~~~~~l~~Li~~cL~~dP~~RPs~~ell~ 541 (575)
+. . +...++++.+||++||..||.+|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 0 0123577999999999999999999999973
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-39 Score=335.90 Aligned_cols=248 Identities=20% Similarity=0.338 Sum_probs=189.4
Q ss_pred eCCCceeeeeeeeecCceEEEEEEE--CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-----------CCCceEEE
Q 008171 289 IDPKHLKFGSKVASGSYGDLYRGTY--CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-----------HKNVVQFI 355 (575)
Q Consensus 289 i~~~~~~i~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-----------HpnIv~l~ 355 (575)
+...+|+++++||+|+||+||+|++ +++.||||+++.. ......+.+|+.+++.++ |+||++++
T Consensus 10 ~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 10 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred ccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 4456799999999999999999987 4788999999854 233456788999998886 47899998
Q ss_pred eeecC--CCCceeEEEeccCCchhhh--hhhccCcCChHHHHHHHHHHHHHHHHHHH-CCceecccCCCCEEecCCC---
Q 008171 356 GACTK--PPSLCIVTEFMSGGSVYDY--LHKLKGVFKLPSLLKVAIDVSKGMNYLHQ-NNIIHRDLKAANLLMDENE--- 427 (575)
Q Consensus 356 ~~~~~--~~~l~lV~E~~~ggsL~d~--l~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~gIiHrDLKp~NILl~~~~--- 427 (575)
+++.. ....+++++++..+..... .......+++..+..++.||+.||.|||+ .||+||||||+||||+.++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 88754 3445666766655443322 23335678999999999999999999998 8999999999999998655
Q ss_pred ---cEEEeecccceecccCCccccCCCCCCccCcccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH------HH
Q 008171 428 ---VVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQ------AA 498 (575)
Q Consensus 428 ---~vkL~DFG~a~~~~~~~~~~~~~Gt~~y~APE~i~~~~~s~ksDVwSlGviL~eLltG~~Pf~~~~~~~------~~ 498 (575)
.++++|||.+...... .....||+.|+|||++....|+.++||||+||++++|++|+.||....... ..
T Consensus 167 ~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp TEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ccceeeEeecccccccccc--cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 4999999999765543 355679999999999999999999999999999999999999997543210 00
Q ss_pred H---HHHh--------c---------------C--------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 008171 499 V---GVVQ--------K---------------G--------------LRPTIPKNSQPKLAELLERCWQQDPALRPDFSE 538 (575)
Q Consensus 499 ~---~v~~--------~---------------~--------------~~~~~p~~~~~~l~~Li~~cL~~dP~~RPs~~e 538 (575)
. ..+. . . .....+...++++.+||.+||..||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 0 0000 0 0 011122345688999999999999999999999
Q ss_pred HHH
Q 008171 539 IIE 541 (575)
Q Consensus 539 ll~ 541 (575)
+++
T Consensus 325 ~L~ 327 (362)
T d1q8ya_ 325 LVN 327 (362)
T ss_dssp HHT
T ss_pred Hhc
Confidence 875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=1.8e-24 Score=205.12 Aligned_cols=166 Identities=14% Similarity=0.137 Sum_probs=122.7
Q ss_pred eeeeeeeeecCceEEEEEEE-CCccEEEEEecCCCCC----------------hHHHHHHHHHHHHHHhcCCCCceEEEe
Q 008171 294 LKFGSKVASGSYGDLYRGTY-CSQDVAIKVLKPERIN----------------SDMQKEFAQEVFIMRKVRHKNVVQFIG 356 (575)
Q Consensus 294 ~~i~~~LG~G~fG~Vy~~~~-~~~~VAvKvl~~~~~~----------------~~~~~~~~~Ev~iL~~L~HpnIv~l~~ 356 (575)
+.++++||+|+||+||+|++ +++.||||+++..... ......+..|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 35789999999999999986 5788999998643211 111234567899999999999999887
Q ss_pred eecCCCCceeEEEeccCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHHCCceecccCCCCEEecCCCcEEEeeccc
Q 008171 357 ACTKPPSLCIVTEFMSGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGV 436 (575)
Q Consensus 357 ~~~~~~~l~lV~E~~~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~~gIiHrDLKp~NILl~~~~~vkL~DFG~ 436 (575)
+.. .+++|||+++..+.+ ++...+..++.||+.+|.|||++||+||||||+|||++++ .++|+|||.
T Consensus 82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 643 489999998765433 4555677899999999999999999999999999999965 489999999
Q ss_pred ceecccCCccccCCCCCCccCc--cc---ccCCCCCchHHHHHHHHHH
Q 008171 437 ARVKAQSGVMTAETGTYRWMAP--EV---IEHKPYDHKADVFSFGIVL 479 (575)
Q Consensus 437 a~~~~~~~~~~~~~Gt~~y~AP--E~---i~~~~~s~ksDVwSlGviL 479 (575)
|.....+... .|... +. +..+.|+.++|+||+.--+
T Consensus 149 a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 149 SVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred cccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 9765433211 11111 00 1235688899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.47 E-value=2.5e-07 Score=88.94 Aligned_cols=139 Identities=12% Similarity=0.094 Sum_probs=92.3
Q ss_pred ceeeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCceEEEeeecCCCCceeEEEec
Q 008171 293 HLKFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVR-HKNVVQFIGACTKPPSLCIVTEFM 371 (575)
Q Consensus 293 ~~~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~l~lV~E~~ 371 (575)
.|++.+..+-|+.+.||+....++.+.+|......... ...+.+|..+++.+. +--+.+++.++..++..++||+++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l 92 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence 45555554445567899998888889999876543221 234677888888775 333677888888788889999999
Q ss_pred cCCchhhhhhhccCcCChHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 008171 372 SGGSVYDYLHKLKGVFKLPSLLKVAIDVSKGMNYLHQ------------------------------------------- 408 (575)
Q Consensus 372 ~ggsL~d~l~~~~~~l~~~~~~~i~~qI~~aL~yLH~------------------------------------------- 408 (575)
+|.++.+.... ......++.++...+..||+
T Consensus 93 ~G~~~~~~~~~------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T d1j7la_ 93 DGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SSEEHHHHTTT------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred ccccccccccc------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence 99877554321 01111222333333333331
Q ss_pred ----------C------CceecccCCCCEEecCCCcEEEeeccccee
Q 008171 409 ----------N------NIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 409 ----------~------gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
. .++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1 279999999999999877777999998853
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.93 E-value=2.6e-05 Score=74.02 Aligned_cols=136 Identities=13% Similarity=0.148 Sum_probs=83.8
Q ss_pred eeeecCc-eEEEEEEECC-ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCC--CceEEEeeecCCCCceeEEEeccCC
Q 008171 299 KVASGSY-GDLYRGTYCS-QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHK--NVVQFIGACTKPPSLCIVTEFMSGG 374 (575)
Q Consensus 299 ~LG~G~f-G~Vy~~~~~~-~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~Hp--nIv~l~~~~~~~~~l~lV~E~~~gg 374 (575)
.+..|.. +.||+.+..+ ..+++|....... ..+..|+..|+.+... .+.+++.++.+++..++||++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 4455553 6799988755 4578898765432 2356788888777543 3567888888888899999999987
Q ss_pred chhhhh--------------hhcc------CcCC--hHHHHHHH--------------------HHHHHHHHHHHHC---
Q 008171 375 SVYDYL--------------HKLK------GVFK--LPSLLKVA--------------------IDVSKGMNYLHQN--- 409 (575)
Q Consensus 375 sL~d~l--------------~~~~------~~l~--~~~~~~i~--------------------~qI~~aL~yLH~~--- 409 (575)
++.+.. .+.. ..+. ......-. ......+..+...
T Consensus 92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (255)
T d1nd4a_ 92 DLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD 171 (255)
T ss_dssp ETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred ccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence 664421 0000 0000 00000000 0112223333332
Q ss_pred ----CceecccCCCCEEecCCCcEEEeeccccee
Q 008171 410 ----NIIHRDLKAANLLMDENEVVKVADFGVARV 439 (575)
Q Consensus 410 ----gIiHrDLKp~NILl~~~~~vkL~DFG~a~~ 439 (575)
.++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp SCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 379999999999999877778999998853
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.52 E-value=0.00011 Score=74.92 Aligned_cols=78 Identities=14% Similarity=0.056 Sum_probs=48.9
Q ss_pred eeeeeecCceEEEEEEE--CCccEEEEEecCC-CC----ChHHHHHHHHHHHHHHhcC-C--CCceEEEeeecCCCCcee
Q 008171 297 GSKVASGSYGDLYRGTY--CSQDVAIKVLKPE-RI----NSDMQKEFAQEVFIMRKVR-H--KNVVQFIGACTKPPSLCI 366 (575)
Q Consensus 297 ~~~LG~G~fG~Vy~~~~--~~~~VAvKvl~~~-~~----~~~~~~~~~~Ev~iL~~L~-H--pnIv~l~~~~~~~~~l~l 366 (575)
.+.||.|..-.||+.+. .++.++||.-.+. +. ......+...|...|+.+. + ..+++++.+.. ...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--EMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--TTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--CCCEE
Confidence 34689999999999975 3567999975431 11 0111223456777777664 2 34666776644 45689
Q ss_pred EEEeccCCch
Q 008171 367 VTEFMSGGSV 376 (575)
Q Consensus 367 V~E~~~ggsL 376 (575)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.73 E-value=0.0019 Score=63.64 Aligned_cols=68 Identities=13% Similarity=0.158 Sum_probs=43.4
Q ss_pred eEEEEEEE-CCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCc--eEEEe-----eecCCCCceeEEEeccCCch
Q 008171 306 GDLYRGTY-CSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV--VQFIG-----ACTKPPSLCIVTEFMSGGSV 376 (575)
Q Consensus 306 G~Vy~~~~-~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnI--v~l~~-----~~~~~~~l~lV~E~~~ggsL 376 (575)
=.||+++. .|+.|++|+..+...+. .++..|...+..|...+| +..+. .+...+..+.+++++.|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 36999876 56789999998765543 456678888888763322 11111 11234456788999977543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.34 E-value=0.0065 Score=61.26 Aligned_cols=72 Identities=13% Similarity=0.261 Sum_probs=48.6
Q ss_pred eeeeecCceEEEEEEECC---------ccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCc-eEEEeeecCCCCceeE
Q 008171 298 SKVASGSYGDLYRGTYCS---------QDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV-VQFIGACTKPPSLCIV 367 (575)
Q Consensus 298 ~~LG~G~fG~Vy~~~~~~---------~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnI-v~l~~~~~~~~~l~lV 367 (575)
+.|+-|-.=.+|+.+..+ +.|.+++.-. . .. .....+|..+++.+.-.++ +++++++.+ ++|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-ch--hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 577878888899988643 3467777542 1 11 2345578899888864344 578887754 789
Q ss_pred EEeccCCchh
Q 008171 368 TEFMSGGSVY 377 (575)
Q Consensus 368 ~E~~~ggsL~ 377 (575)
+||++|.+|.
T Consensus 120 ~efi~g~~l~ 129 (395)
T d1nw1a_ 120 EEYIPSRPLS 129 (395)
T ss_dssp ECCCCEEECC
T ss_pred EEEeccccCC
Confidence 9999886554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.27 E-value=0.0076 Score=58.38 Aligned_cols=140 Identities=12% Similarity=0.037 Sum_probs=73.2
Q ss_pred eeeeeeeecCceEEEEEEECCccEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCc--eEEEeee------cCCCCcee
Q 008171 295 KFGSKVASGSYGDLYRGTYCSQDVAIKVLKPERINSDMQKEFAQEVFIMRKVRHKNV--VQFIGAC------TKPPSLCI 366 (575)
Q Consensus 295 ~i~~~LG~G~fG~Vy~~~~~~~~VAvKvl~~~~~~~~~~~~~~~Ev~iL~~L~HpnI--v~l~~~~------~~~~~l~l 366 (575)
.-.+.|..|--=+.|+.+..+..+++|+...... . .++..|+.+|..|...++ +..+... ......+.
T Consensus 21 ~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~-~---~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~ 96 (316)
T d2ppqa1 21 TSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE-K---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 96 (316)
T ss_dssp EEEEEECC---EEEEEEEESSCCEEEEEECC----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred eEeecCCCCcccCeEEEEECCCcEEEEEcCCCCC-H---HHHHHHHHHHHhhhhccccccccceecCCCcceeeecccce
Confidence 3344566777778899988888899999865321 1 234456677777753222 1111110 11122344
Q ss_pred EEEeccCCchhhhh--------------hhc----c----C------------------cCChHHHHHHHHHHHHHHHHH
Q 008171 367 VTEFMSGGSVYDYL--------------HKL----K----G------------------VFKLPSLLKVAIDVSKGMNYL 406 (575)
Q Consensus 367 V~E~~~ggsL~d~l--------------~~~----~----~------------------~l~~~~~~~i~~qI~~aL~yL 406 (575)
++.++.|....... +.. . . ..........+..+...+.-.
T Consensus 97 ~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 176 (316)
T d2ppqa1 97 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 176 (316)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred eeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhcc
Confidence 55555554332110 000 0 0 000111122222333333333
Q ss_pred HH----CCceecccCCCCEEecCCCcEEEeecccce
Q 008171 407 HQ----NNIIHRDLKAANLLMDENEVVKVADFGVAR 438 (575)
Q Consensus 407 H~----~gIiHrDLKp~NILl~~~~~vkL~DFG~a~ 438 (575)
.. .|+||+|+.+.||+++.+...-|+||+.+.
T Consensus 177 ~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 177 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccccccccccCCcchhhhhcccccceeEecccccc
Confidence 32 479999999999999988878999999884
|
| >d1u8sa1 d.58.18.5 (A:2-87) putative transcriptional repressor VC2159 {Vibrio cholerae [TaxId: 666]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Glycine cleavage system transcriptional repressor domain: putative transcriptional repressor VC2159 species: Vibrio cholerae [TaxId: 666]
Probab=96.16 E-value=0.0028 Score=50.02 Aligned_cols=64 Identities=14% Similarity=0.126 Sum_probs=48.4
Q ss_pred eeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCceeEEEEEcCCChhhHHHHHHHHHHHHHH
Q 008171 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLK 247 (575)
Q Consensus 182 i~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ldv~vv~g~~~e~~~~l~~al~~~~~~ 247 (575)
||+...|+|+++++++.+|++.|.||.+...+..- |...-++.|. ++....++|+.+|++.-.+
T Consensus 8 itv~G~DrpGiva~vt~~l~~~g~NI~d~~~~~~~-~~~~~~~~v~-~~~~~~~~l~~~L~~l~~~ 71 (86)
T d1u8sa1 8 ITAVGTDRPGICNEVVRLVTQAGCNIIDSRIAMFG-KEFTLLMLIS-GSPSNITRVETTLPLLGQQ 71 (86)
T ss_dssp EEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEET-TEEEEEEEEE-ECHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCChHHHHHHHHHHHCCCeEEEeEeEEEC-CeeEEEEEEE-cCcccHHHHHHHHHHHHHH
Confidence 88999999999999999999999999998766544 4444444454 4556677787777765443
|
| >d1zpva1 d.58.18.7 (A:1-83) UPF0237 protein SP0238 {Streptococcus pneumoniae [TaxId: 1313]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: SP0238-like domain: UPF0237 protein SP0238 species: Streptococcus pneumoniae [TaxId: 1313]
Probab=96.10 E-value=0.0039 Score=48.79 Aligned_cols=65 Identities=22% Similarity=0.285 Sum_probs=48.4
Q ss_pred eeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCceeEEEEEcCCChhhHHHHHHHHHHHHHH
Q 008171 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEKEVLK 247 (575)
Q Consensus 182 i~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ldv~vv~g~~~e~~~~l~~al~~~~~~ 247 (575)
||+++.|+|++++.+|.+|++.|.||.+...+...+-|.. .+.|+.-...+.++|+++|+..-.+
T Consensus 5 itv~g~DrpGiVa~vt~~l~~~g~NI~d~~q~~~~~~f~~-~~~v~~~~~~~~~~l~~~l~~la~~ 69 (83)
T d1zpva1 5 ITVVGKDKSGIVAGVSGKIAELGLNIDDISQTVLDEYFTM-MAVVSSDEKQDFTYLRNEFEAFGQT 69 (83)
T ss_dssp EEEEESCCTTHHHHHHHHHHHTTCEEEEEEEEEETTEEEE-EEEEEESSCCCHHHHHHHHHHHHHH
T ss_pred EEEEcCCCCCHHHHHHHHHHHCCCeEEEEEeEEeCCEEEE-EEEEEEecCCCHHHHHHHHHHHHHH
Confidence 7999999999999999999999999999988765443444 3444432233567788888764433
|
| >d1u8sa2 d.58.18.5 (A:88-180) putative transcriptional repressor VC2159 {Vibrio cholerae [TaxId: 666]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Glycine cleavage system transcriptional repressor domain: putative transcriptional repressor VC2159 species: Vibrio cholerae [TaxId: 666]
Probab=93.19 E-value=0.081 Score=41.80 Aligned_cols=68 Identities=16% Similarity=0.143 Sum_probs=45.6
Q ss_pred cceeeecCChhhHHHHHHHHHHhcccchhhcccccCC---CC-----ceeEEEEEcCCChhhHHHHHHHHHHHHHHh
Q 008171 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTV---DG-----YSLDVFVVDGWPYEETEQLRAALEKEVLKL 248 (575)
Q Consensus 180 ~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~---~g-----~~ldv~vv~g~~~e~~~~l~~al~~~~~~~ 248 (575)
-+|++.+.|+|++++++|.+|++.|.||.+....... .+ |...+ ++..-..-+.++|+++|+.-...+
T Consensus 7 v~v~v~g~DrpGIV~~it~~la~~~~nI~~l~t~~~~a~~~~~~~~~f~~~~-~~~~p~~~~~~~l~~~l~~l~~~l 82 (93)
T d1u8sa2 7 VEVYVESDDKLGLTEKFTQFFAQRQIGMASLSAQTISKDKLHSEQNQFHIAI-SARVDSGCNLMQLQEEFDALCTAL 82 (93)
T ss_dssp EEEEEEESCCTTHHHHHHHHHHHTTCCEEEEEEEEEC--------CEEEEEE-EEEECTTSCHHHHHHHHHHHHHHH
T ss_pred EEEEEEECCCCCHHHHHHHHHHHcCCCchhhhcccccccCCcccCccEEEEE-EEEcCccccHHHHHHHHHHHHHHc
Confidence 3899999999999999999999999999887544311 11 22222 222222335677888777655544
|
| >d1ygya3 d.58.18.1 (A:452-529) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=91.71 E-value=0.2 Score=38.08 Aligned_cols=53 Identities=21% Similarity=0.211 Sum_probs=43.6
Q ss_pred cceeeecCChhhHHHHHHHHHHhcccchhhccccc-CCCCceeEEEEEcCCChh
Q 008171 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFS-TVDGYSLDVFVVDGWPYE 232 (575)
Q Consensus 180 ~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~-t~~g~~ldv~vv~g~~~e 232 (575)
|=+.+.-.|+|+.+.+++++|++-|.||...++.. ...|...-++.||+-..+
T Consensus 4 ~~L~i~~~D~PGvi~~I~~~l~~~~iNI~~m~~~~~~~g~~a~~vi~vD~~~~~ 57 (78)
T d1ygya3 4 INLIIHYVDRPGALGKIGTLLGTAGVNIQAAQLSEDAEGPGATILLRLDQDVPD 57 (78)
T ss_dssp EEEEEEESCCTTHHHHHHHHHHHTTCCEEEEEEEECSSSSCEEEEEEESSCCCH
T ss_pred eEEEEEeCCcCCHHHHHHHHHHhcCcChhhheeeecCCCCeEEEEEEcCCCccH
Confidence 45677788999999999999999999999988865 455677778888876554
|
| >d1sc6a3 d.58.18.1 (A:327-410) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain species: Escherichia coli [TaxId: 562]
Probab=91.07 E-value=0.082 Score=41.01 Aligned_cols=43 Identities=21% Similarity=0.465 Sum_probs=36.5
Q ss_pred ccceeeecCChhhHHHHHHHHHHhcccchhhcccccCCC-Ccee
Q 008171 179 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVD-GYSL 221 (575)
Q Consensus 179 ~~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~-g~~l 221 (575)
-|-+++.-.|+|+.|.+++++|++-|+||..-+.-+..+ ||.+
T Consensus 11 ~~rl~i~~~d~PGvla~I~~~l~~~~iNI~~~~~~~~~~~~~a~ 54 (84)
T d1sc6a3 11 GRRLMHIHENRPGVLTALNKIFAEQGVNIAAQYLQTSAQMGYVV 54 (84)
T ss_dssp SEEEEEEEESCTTHHHHHHHHHHHTTCEEEEEEEEECSSEEEEE
T ss_pred CeEEEEEeCCcCCHHHHHHHHHHHcCCCHHHhccccCCCCcEEE
Confidence 478999999999999999999999999999987766655 3443
|
| >d2f06a1 d.58.18.11 (A:71-141) Hypothetical protein BT0572 {Bacteroides thetaiotaomicron [TaxId: 818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: BT0572-like domain: Hypothetical protein BT0572 species: Bacteroides thetaiotaomicron [TaxId: 818]
Probab=90.31 E-value=0.19 Score=37.64 Aligned_cols=56 Identities=16% Similarity=0.223 Sum_probs=44.7
Q ss_pred eeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCceeEEEEEcCCChhhHHHHHHHHHH
Q 008171 182 ITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRAALEK 243 (575)
Q Consensus 182 i~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ldv~vv~g~~~e~~~~l~~al~~ 243 (575)
|.+.-.|+|+-|..++++|++-|+||.-..+|.+. ++..=+|.|| +.+..++.|++
T Consensus 2 iaV~v~d~pG~L~~v~~~L~~~~InI~~~y~~~~~-~~~~~vl~vd-----d~~~a~~~L~~ 57 (71)
T d2f06a1 2 VGISCPNVPGALAKVLGFLSAEGVFIEYMYSFANN-NVANVVIRPS-----NMDKCIEVLKE 57 (71)
T ss_dssp EEEEEESSTTHHHHHHHHHHHTTCCEEEEEEEEET-TEEEEEEEES-----CHHHHHHHHHH
T ss_pred EEEEecCCccHHHHHHHHHHHCCCCEEEEEEEcCC-CcEEEEEEEC-----CHHHHHHHHHH
Confidence 34556799999999999999999999999999986 6888888886 34445555543
|
| >d1y7pa2 d.58.18.12 (A:2-78) Hypothetical protein AF1403, N-terminal domain {Archaeon Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: AF1403 N-terminal domain-like domain: Hypothetical protein AF1403, N-terminal domain species: Archaeon Archaeoglobus fulgidus [TaxId: 2234]
Probab=89.11 E-value=0.054 Score=41.43 Aligned_cols=62 Identities=19% Similarity=0.172 Sum_probs=40.7
Q ss_pred ceeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCceeEEEEEcCCC-hhhHHHHHHHHH
Q 008171 181 EITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDGWP-YEETEQLRAALE 242 (575)
Q Consensus 181 ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ldv~vv~g~~-~e~~~~l~~al~ 242 (575)
.|.+-..|+|++|+.++.++++-|.||...+.+...+|..--.|.++=-. ..+-+.+.++|+
T Consensus 3 ~i~i~~~Dr~GlL~di~~~ia~~~~NI~~i~~~~~~~g~~~~~~~i~v~~~~~~l~~ll~kL~ 65 (77)
T d1y7pa2 3 GLRIIAENKIGVLRDLTTIIAEEGGNITFAQTFLIKHGEHEGKALIYFEIEGGDFEKILERVK 65 (77)
T ss_dssp EEEEEEECCTTHHHHHHHHCC----CEEEEEEEECCSSTTTTEEEEEEEECSSCHHHHHHHHH
T ss_pred eEEEEEecCCChHHHHHHHHHHcCCCeEEEEeeccCCCeEEEEEEEEEEcCcccHHHHHHHHH
Confidence 47788899999999999999999999999998887777554444443211 113455555443
|
| >d2f06a2 d.58.18.11 (A:1-70) Hypothetical protein BT0572 {Bacteroides thetaiotaomicron [TaxId: 818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: BT0572-like domain: Hypothetical protein BT0572 species: Bacteroides thetaiotaomicron [TaxId: 818]
Probab=88.82 E-value=0.38 Score=35.82 Aligned_cols=49 Identities=16% Similarity=0.271 Sum_probs=42.1
Q ss_pred ccceeeecCChhhHHHHHHHHHHhcccchhhcccccCCCCceeEEEEEcC
Q 008171 179 MHEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFSTVDGYSLDVFVVDG 228 (575)
Q Consensus 179 ~~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~t~~g~~ldv~vv~g 228 (575)
++.|.+-..|||+.|.+++.+|++-|.||.--.++.|.+ +.+--++||.
T Consensus 3 ~~QisV~~eNkpG~L~~v~~~~~~~~inI~sl~v~~t~~-~~i~Riiv~~ 51 (70)
T d2f06a2 3 AKQLSIFLENKSGRLTEVTEVLAKENINLSALCIAENAD-FGILRGIVSD 51 (70)
T ss_dssp EEEEEEEECSSSSHHHHHHHHHHHTTCCEEEEEEEECSS-CEEEEEEESC
T ss_pred eEEEEEEEeCCCcHHHHHHHHHHHCCCCEEEEEEeecCC-CCEEEEEECC
Confidence 567888889999999999999999999999988888876 5666677773
|
| >d2pc6a2 d.58.18.6 (A:1-77) Acetolactate synthase small subunit, IlvH {Nitrosomonas europaea [TaxId: 915]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: IlvH-like domain: Acetolactate synthase small subunit, IlvH species: Nitrosomonas europaea [TaxId: 915]
Probab=80.76 E-value=1.7 Score=32.71 Aligned_cols=63 Identities=25% Similarity=0.299 Sum_probs=48.7
Q ss_pred cceeeecCChhhHHHHHHHHHHhcccchhhccccc-CCCCceeEEEEEcCCChhhHHHHHHHHHH
Q 008171 180 HEITFSTDDKPKLLSQLTALLADIGLNIQEAHAFS-TVDGYSLDVFVVDGWPYEETEQLRAALEK 243 (575)
Q Consensus 180 ~ei~~~~~d~~~ll~~~~~~~~~~~~~i~~a~~f~-t~~g~~ldv~vv~g~~~e~~~~l~~al~~ 243 (575)
|-|.+-..|+|+.|.+++.+.+.-|.||.--.+-- -.+|.|==.+||.|- .+..+++...|++
T Consensus 3 ~tisv~veN~pGvL~Ris~lF~rRg~NI~Sltv~~te~~~iSRmtivv~~~-~~~i~qi~kQL~K 66 (77)
T d2pc6a2 3 HIISLLMENEAGALSRVAGLFSARGYNIESLSVAPTEDPTLSRMTLVTNGP-DEIVEQITKQLNK 66 (77)
T ss_dssp EEEEEEEECSTTHHHHHHHHHHHHTCCCCEEEEEECSSTTEEEEEEEEEEC-HHHHHHHHHHHHH
T ss_pred EEEEEEEECCccHHHHHHHHHhccCcceEEEEEeccCCCCeEEEEEEEECC-HHHHHHHHHHHhC
Confidence 45667778999999999999999999998766553 456777777788774 4566777666665
|